Identification NN O
of IN O
APC2 NNP O
, , O
a DT O
homologue NN O
of IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli VB I-Disease
tumour NN I-Disease
suppressor NN O
. . O

The DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( I-Disease
APC NNP I-Disease
) ) I-Disease
tumour VBP I-Disease
- : O
suppressor NN O
protein NN O
controls VBZ O
the DT O
Wnt NNP O
signalling VBG O
pathway RB O
by IN O
forming VBG O
a DT O
complex JJ O
with IN O
glycogen NN O
synthase NN O
kinase NN O
3beta CD O
( ( O
GSK NNP O
- : O
3beta CD O
) ) O
, , O
axin JJ O
/ NNP O
conductin NN O
and CC O
betacatenin NN O
. . O

Complex JJ O
formation NN O
induces VBZ O
the DT O
rapid JJ O
degradation NN O
of IN O
betacatenin NN O
. . O

In IN O
colon NN B-Disease
carcinoma NN I-Disease
cells NNS O
, , O
loss NN O
of IN O
APC NNP O
leads VBZ O
to TO O
the DT O
accumulation NN O
of IN O
betacatenin NN O
in IN O
the DT O
nucleus NN O
, , O
where WRB O
it PRP O
binds VBZ O
to TO O
and CC O
activates VBZ O
the DT O
Tcf NNP O
- : O
4 CD O
transcription NN O
factor NN O
( ( O
reviewed VBN O
in IN O
[ JJ O
1 CD O
] JJ O
[ $ O
2 CD O
] NN O
) ) O
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
identification NN O
and CC O
genomic JJ O
structure NN O
of IN O
APC NNP O
homologues NNS O
. . O

Mammalian JJ O
APC2 NNP O
, , O
which WDT O
closely RB O
resembles VBZ O
APC NNP O
in IN O
overall JJ O
domain NN O
structure NN O
, , O
was VBD O
functionally RB O
analyzed VBN O
and CC O
shown VBN O
to TO O
contain VB O
two CD O
SAMP NNP O
domains NNS O
, , O
both DT O
of IN O
which WDT O
are VBP O
required VBN O
for IN O
binding VBG O
to TO O
conductin VB O
. . O

Like IN O
APC NNP O
, , O
APC2 NNP O
regulates VBZ O
the DT O
formation NN O
of IN O
active JJ O
betacatenin NN O
- : O
Tcf NN O
complexes NNS O
, , O
as IN O
demonstrated VBN O
using VBG O
transient JJ O
transcriptional JJ O
activation NN O
assays NNS O
in IN O
APC NNP O
- : O
/ SYM O
- : O
colon NN B-Disease
carcinoma NN I-Disease
cells NNS O
. . O

Human NNP O
APC2 NNP O
maps NNS O
to TO O
chromosome VB O
19p13 CD O
. . O

3 CD O
. . O

APC NNP O
and CC O
APC2 NNP O
may MD O
therefore RB O
have VB O
comparable JJ O
functions NNS O
in IN O
development NN O
and CC O
cancer NN B-Disease
. . O

A DT O
common JJ O
MSH2 NNP O
mutation NN O
in IN O
English NNP O
and CC O
North JJ O
American JJ O
HNPCC NNP B-Disease
families NNS O
: : O
origin NN O
, , O
phenotypic NN O
expression NN O
, , O
and CC O
sex NN O
specific JJ O
differences NNS O
in IN O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

The DT O
frequency NN O
, , O
origin NN O
, , O
and CC O
phenotypic JJ O
expression NN O
of IN O
a DT O
germline NN O
MSH2 NNP O
gene NN O
mutation NN O
previously RB O
identified VBN O
in IN O
seven CD O
kindreds NNS O
with IN O
hereditary JJ B-Disease
non SYM I-Disease
- : I-Disease
polyposis NN I-Disease
cancer NN I-Disease
syndrome NN I-Disease
( ( O
HNPCC NNP B-Disease
) ) O
was VBD O
investigated VBN O
. . O

The DT O
mutation NN O
( ( O
A DT O
- : O
- : O
> NN O
T NNP O
at IN O
nt943 JJ O
+ NNP O
3 CD O
) ) O
disrupts VBZ O
the DT O
3 CD O
splice NN O
site NN O
of IN O
exon $ O
5 CD O
leading VBG O
to TO O
the DT O
deletion NN O
of IN O
this DT O
exon NN O
from IN O
MSH2 NNP O
mRNA NN O
and CC O
represents VBZ O
the DT O
only JJ O
frequent JJ O
MSH2 NNP O
mutation NN O
so RB O
far RB O
reported VBN O
. . O

Although IN O
this DT O
mutation NN O
was VBD O
initially RB O
detected VBN O
in IN O
four CD O
of IN O
33 CD O
colorectal JJ B-Disease
cancer NN I-Disease
families NNS O
analysed VBN O
from IN O
eastern JJ O
England NNP O
, , O
more RBR O
extensive JJ O
analysis NN O
has VBZ O
reduced VBN O
the DT O
frequency NN O
to TO O
four CD O
of IN O
52 CD O
( ( O
8 CD O
% NN O
) ) O
English NNP O
HNPCC NNP B-Disease
kindreds NNS O
analysed VBD O
. . O

In IN O
contrast NN O
, , O
the DT O
MSH2 NNP O
mutation NN O
was VBD O
identified VBN O
in IN O
10 CD O
of IN O
20 CD O
( ( O
50 CD O
% NN O
) ) O
separately RB O
identified VBN O
colorectal JJ B-Disease
families NNS O
from IN O
Newfoundland NNP O
. . O

To TO O
investigate VB O
the DT O
origin NN O
of IN O
this DT O
mutation NN O
in IN O
colorectal JJ B-Disease
cancer NN I-Disease
families NNS O
from IN O
England NNP O
( ( O
n JJ O
= NNP O
4 CD O
) ) O
, , O
Newfoundland NNP O
( ( O
n JJ O
= NNP O
10 CD O
) ) O
, , O
and CC O
the DT O
United NNP O
States NNPS O
( ( O
n JJ O
= NNP O
3 CD O
) ) O
, , O
haplotype JJ O
analysis NN O
using VBG O
microsatellite JJ O
markers NNS O
linked VBN O
to TO O
MSH2 NNP O
was VBD O
performed VBN O
. . O

Within IN O
the DT O
English NNP O
and CC O
US NNP O
families NNS O
there EX O
was VBD O
little JJ O
evidence NN O
for IN O
a DT O
recent JJ O
common JJ O
origin NN O
of IN O
the DT O
MSH2 NNP O
splice NN O
site NN O
mutation NN O
in IN O
most JJS O
families NNS O
. . O

In IN O
contrast NN O
, , O
a DT O
common JJ O
haplotype NN O
was VBD O
identified VBN O
at IN O
the DT O
two CD O
flanking NN O
markers NNS O
( ( O
CA5 NNP O
and CC O
D2S288 NNP O
) ) O
in IN O
eight CD O
of IN O
the DT O
Newfoundland NNP O
families NNS O
. . O

These DT O
findings NNS O
suggested VBD O
a DT O
founder NN O
effect NN O
within IN O
Newfoundland NNP O
similar JJ O
to TO O
that DT O
reported VBN O
by IN O
others NNS O
for IN O
two CD O
MLH1 NNP O
mutations NNS O
in IN O
Finnish JJ O
HNPCC NNP B-Disease
families NNS O
. . O

We PRP O
calculated VBD O
age NN O
related JJ O
risks NNS O
of IN O
all DT O
, , O
colorectal NN B-Disease
, , I-Disease
endometrial JJ I-Disease
, , I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
in IN O
nt943 JJ O
+ $ O
3 CD O
A NNP O
- : O
- : O
> NN O
T NNP O
MSH2 NNP O
mutation NN O
carriers NNS O
( ( O
n JJ O
= NNP O
76 CD O
) ) O
for IN O
all DT O
patients NNS O
and CC O
for IN O
men NNS O
and CC O
women NNS O
separately RB O
. . O

For IN O
both DT O
sexes NNS O
combined VBN O
, , O
the DT O
penetrances NNS O
at IN O
age NN O
60 CD O
years NNS O
for IN O
all DT O
cancers NNS B-Disease
and CC O
for IN O
colorectal JJ B-Disease
cancer NN I-Disease
were VBD O
0 CD O
. . O

86 CD O
and CC O
0 CD O
. . O

57 CD O
, , O
respectively RB O
. . O

The DT O
risk NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
was VBD O
significantly RB O
higher JJR O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
) ) O
in IN O
males NNS O
than IN O
females NNS O
( ( O
0 CD O
. . O
63 CD O
v JJ O
0 CD O
. . O
30 CD O
and CC O
0 CD O
. . O
84 CD O
v JJ O
0 CD O
. . O
44 CD O
at IN O
ages NNS O
50 CD O
and CC O
60 CD O
years NNS O
, , O
respectively RB O
) ) O
. . O

For IN O
females NNS O
there EX O
was VBD O
a DT O
high JJ O
risk NN O
of IN O
endometrial JJ B-Disease
cancer NN I-Disease
( ( O
0 CD O
. . O
5 CD O
at IN O
age NN O
60 CD O
years NNS O
) ) O
and CC O
premenopausal JJ B-Disease
ovarian JJ I-Disease
cancer NN I-Disease
( ( O
0 CD O
. . O
2 CD O
at IN O
50 CD O
years NNS O
) ) O
. . O

These DT O
intersex NN O
differences NNS O
in IN O
colorectal JJ B-Disease
cancer NN I-Disease
risks NNS O
have VBP O
implications NNS O
for IN O
screening VBG O
programmes NNS O
and CC O
for IN O
attempts NNS O
to TO O
identify VB O
colorectal JJ B-Disease
cancer NN I-Disease
susceptibility NN O
modifiers NNS O
. . O

Age NNP O
of IN O
onset NN O
in IN O
Huntington NNP B-Disease
disease NN I-Disease
: : O
sex NN O
specific JJ O
influence NN O
of IN O
apolipoprotein NN O
E NNP O
genotype NN O
and CC O
normal JJ O
CAG NNP O
repeat NN O
length NN O
. . O

Age NNP O
of IN O
onset NN O
( ( O
AO NNP O
) ) O
of IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
is VBZ O
known VBN O
to TO O
be VB O
correlated VBN O
with IN O
the DT O
length NN O
of IN O
an DT O
expanded VBN O
CAG NNP O
repeat NN O
in IN O
the DT O
HD NNP B-Disease
gene NN O
. . O

Apolipoprotein NNP O
E NNP O
( ( O
APOE NNP O
) ) O
genotype NN O
, , O
in IN O
turn NN O
, , O
is VBZ O
known VBN O
to TO O
influence VB O
AO NNP O
in IN O
Alzheimer NNP B-Disease
disease NN I-Disease
, , O
rendering VBG O
the DT O
APOE NNP O
gene NN O
a DT O
likely JJ O
candidate NN O
to TO O
affect VB O
AO NNP O
in IN O
other JJ O
neurological JJ B-Disease
diseases NNS I-Disease
too RB O
. . O

We PRP O
therefore VBP O
determined JJ O
APOE NNP O
genotype NN O
and CC O
normal JJ O
CAG NNP O
repeat NN O
length NN O
in IN O
the DT O
HD NNP B-Disease
gene NN O
for IN O
138 CD O
HD NNP B-Disease
patients NNS O
who WP O
were VBD O
previously RB O
analysed VBN O
with IN O
respect NN O
to TO O
CAG NNP O
repeat NN O
length NN O
. . O

Genotyping VBG O
for IN O
APOE NNP O
was VBD O
performed VBN O
blind IN O
to TO O
clinical JJ O
information NN O
. . O

In IN O
addition NN O
to TO O
highlighting VBG O
the DT O
effect NN O
of IN O
the DT O
normal JJ O
repeat NN O
length NN O
upon IN O
AO NNP O
in IN O
maternally RB O
inherited VBN O
HD NNP B-Disease
and CC O
in IN O
male JJ O
patients NNS O
, , O
we PRP O
show VBP O
that IN O
the DT O
APOE NNP O
epsilon2epsilon3 NN O
genotype NN O
is VBZ O
associated VBN O
with IN O
significantly RB O
earlier JJR O
AO NNP O
in IN O
males NNS O
than IN O
in IN O
females NNS O
. . O

Such JJ O
a DT O
sex NN O
difference NN O
in IN O
AO NNP O
was VBD O
not RB O
apparent JJ O
for IN O
any DT O
of IN O
the DT O
other JJ O
APOE NNP O
genotypes NNS O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
subtle JJ O
differences NNS O
in IN O
the DT O
course NN O
of IN O
the DT O
neurodegeneration NN B-Disease
in IN O
HD NNP B-Disease
may MD O
allow VB O
interacting VBG O
genes NNS O
to TO O
exert VB O
gender NN O
specific JJ O
effects NNS O
upon IN O
AO NNP O
. . O

Familial JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
associated VBN O
with IN O
recurrent JJ O
bacteremic JJ B-Disease
infections NNS I-Disease
due JJ I-Disease
to TO I-Disease
Neisseria NNP I-Disease
. . O

The DT O
serum NN O
of IN O
a DT O
29 CD O
- : O
year NN O
old JJ O
woman NN O
with IN O
a DT O
recent JJ O
episode NN O
of IN O
disseminated JJ B-Disease
gonococcal JJ I-Disease
infection NN I-Disease
and CC O
a DT O
history NN O
of IN O
meningococcal JJ B-Disease
meningitis NN I-Disease
and CC O
arthritis NN B-Disease
as IN O
a DT O
child NN O
was VBD O
found VBN O
to TO O
lack VB O
serum JJ O
hemolytic JJ O
complement NN O
activity NN O
. . O

The DT O
seventh JJ O
component NN O
of IN O
complement NN O
( ( O
C7 NNP O
) ) O
was VBD O
not RB O
detected VBN O
by IN O
functional JJ O
or CC O
immunochemical JJ O
assays NNS O
, , O
whereas IN O
other JJ O
components NNS O
were VBD O
normal JJ O
by IN O
hemolytic JJ O
and CC O
immunochemical JJ O
assessment NN O
. . O

Her PRP$ O
fresh JJ O
serum NN O
lacked VBD O
complement JJ O
- : O
mediated VBN O
bactericidal JJ O
activity NN O
against IN O
Neisseria NNP O
gonorrhoeae NN O
, , O
but CC O
the DT O
addition NN O
of IN O
fresh JJ O
normal JJ O
serum NN O
or CC O
purified VBN O
C7 NNP O
restored VBD O
bactericidal JJ O
activity NN O
as RB O
well RB O
as IN O
hemolytic JJ O
activity NN O
. . O

The DT O
absence NN B-Disease
of IN I-Disease
functional JJ I-Disease
C7 NNP I-Disease
activity NN O
could MD O
not RB O
be VB O
accounted VBN O
for IN O
on IN O
the DT O
basis NN O
of IN O
an DT O
inhibitor NN O
. . O

Opsonization NN O
and CC O
generation NN O
of IN O
chemotactic JJ O
activity NN O
functioned VBD O
normally RB O
. . O

Complete JJ B-Disease
absence NN I-Disease
of IN I-Disease
C7 NNP I-Disease
was VBD O
also RB O
found VBN O
in IN O
one CD O
sibling NN O
who WP O
had VBD O
the DT O
clinical JJ O
syndrome NN O
of IN O
meningococcal JJ B-Disease
meningitis NN I-Disease
and CC O
arthritis NN B-Disease
as IN O
a DT O
child NN O
and CC O
in IN O
this DT O
siblings NNS O
clinically RB O
well RB O
eight CD O
- : O
year NN O
- : O
old JJ O
son NN O
. . O

HLA NNP O
histocompatibility NN O
typing NN O
of IN O
the DT O
family NN O
members NNS O
did VBD O
not RB O
demonstrate VB O
evidence NN O
for IN O
genetic JJ O
linkage NN O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
with IN O
the DT O
major JJ O
histocompatibility NN O
loci NN O
. . O

This DT O
report NN O
represents VBZ O
the DT O
first JJ O
cases NNS O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
associated VBN O
with IN O
infectious JJ O
complications NNS O
and CC O
suggests VBZ O
that DT O
bactericidal JJ O
activity NN O
may MD O
be VB O
important JJ O
in IN O
host NN O
defense NN O
against IN O
bacteremic JJ B-Disease
neisseria JJ I-Disease
infections NNS I-Disease
. . O

Increased VBN O
incidence NN O
of IN O
cancer NN B-Disease
in IN O
patients NNS O
with IN O
cartilage NN B-Disease
- : I-Disease
hair NN I-Disease
hypoplasia NN I-Disease
. . O

OBJECTIVE NNP O
Previous NNP O
reports NNS O
have VBP O
suggested VBN O
an DT O
increased VBN O
risk NN O
of IN O
cancer NN B-Disease
among IN O
patients NNS O
with IN O
cartilage NN B-Disease
- : I-Disease
hair NN I-Disease
hypoplasia NN I-Disease
( ( O
CHH NNP B-Disease
) ) O
. . O

This DT O
study NN O
was VBD O
carried VBN O
out IN O
to TO O
further JJ O
evaluate VB O
this DT O
risk NN O
among IN O
patients NNS O
with IN O
CHH NNP B-Disease
and CC O
their PRP$ O
first JJ O
- : O
degree NN O
relatives NNS O
. . O

STUDY NNP O
DESIGN NNP O
One CD O
hundred VBD O
twenty SYM O
- : O
two CD O
patients NNS O
with IN O
CHH NNP B-Disease
were VBD O
identified VBN O
through IN O
2 CD O
countrywide JJ O
epidemiologic JJ O
surveys NNS O
in IN O
1974 CD O
and CC O
in IN O
1986 CD O
. . O

Their PRP$ O
parents NNS O
and CC O
nonaffected JJ O
siblings NNS O
were VBD O
identified VBN O
through IN O
the DT O
Population NNP O
Register NNP O
Center NNP O
. . O

This DT O
cohort NN O
underwent NN O
follow SYM O
- : O
up RB O
for IN O
cancer NN B-Disease
incidence NN O
through IN O
the DT O
Finnish JJ O
Cancer NNP O
Registry NNP O
to TO O
the DT O
end NN O
of IN O
1995 CD O
. . O

RESULTS VB O
A NNP O
statistically RB O
significant JJ O
excess JJ O
risk NN O
of IN O
cancer NN B-Disease
was VBD O
seen VBN O
among IN O
the DT O
patients NNS O
with IN O
CHH NNP B-Disease
( ( O
standardized VBN O
incidence NN O
ratio NN O
6 CD O
. . O
9 CD O
, , O
95 CD O
% NN O
confidence NN O
interval JJ O
2 CD O
. . O
3 CD O
to TO O
16 CD O
) ) O
, , O
which WDT O
was VBD O
mainly RB O
attributable JJ O
to TO O
non VB B-Disease
- : I-Disease
Hodgkins VBZ I-Disease
lymphoma NN I-Disease
( ( O
standardized JJ O
incidence NN O
ratio NN O
90 CD O
, , O
95 CD O
% NN O
confidence NN O
interval NN O
18 CD O
to TO O
264 CD O
) ) O
. . O

In IN O
addition NN O
, , O
a DT O
significant JJ O
excess JJ O
risk NN O
of IN O
basal NN B-Disease
cell NN I-Disease
carcinoma NN I-Disease
was VBD O
seen VBN O
( ( O
standardized JJ O
incidence NN O
ratio NN O
35 CD O
, , O
95 CD O
% NN O
confidence NN O
interval JJ O
7 CD O
. . O
2 CD O
to TO O
102 CD O
) ) O
. . O

The DT O
cancer NN B-Disease
incidence NN O
among IN O
the DT O
siblings NNS O
or CC O
the DT O
parents NNS O
did VBD O
not RB O
differ VB O
from IN O
the DT O
average JJ O
cancer NN B-Disease
incidence NN O
in IN O
the DT O
Finnish JJ O
population NN O
. . O

CONCLUSIONS NNP O
This DT O
study NN O
confirms VBZ O
an DT O
increased VBN O
risk NN O
of IN O
cancer NN B-Disease
, , O
especially RB O
non JJ B-Disease
- : I-Disease
Hodgkins VBZ I-Disease
lymphoma NN I-Disease
, , O
probably RB O
attributable JJ O
to TO O
defective JJ O
immunity NN O
, , O
among IN O
patients NNS O
with IN O
CHH NNP B-Disease
. . O

Genotype NNP O
and CC O
phenotype NN O
in IN O
patients NNS O
with IN O
dihydropyrimidine JJ B-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
. . O

Dihydropyrimidine NNP B-Disease
dehydrogenase NN I-Disease
( ( I-Disease
DPD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disease NN I-Disease
characterised VBN O
by IN O
thymine JJ O
- : O
uraciluria NN O
in IN O
homozygous JJ O
deficient NN O
patients NNS O
and CC O
has VBZ O
been VBN O
associated VBN O
with IN O
a DT O
variable JJ O
clinical JJ O
phenotype NN O
. . O

In IN O
order NN O
to TO O
understand VB O
the DT O
genetic JJ O
and CC O
phenotypic JJ O
basis NN O
for IN O
DPD NNP B-Disease
deficiency NN I-Disease
, , O
we PRP O
have VBP O
reviewed VBN O
17 CD O
families NNS O
presenting VBG O
22 CD O
patients NNS O
with IN O
complete JJ O
deficiency NN B-Disease
of IN I-Disease
DPD NNP I-Disease
. . O

In IN O
this DT O
group NN O
of IN O
patients NNS O
, , O
7 CD O
different JJ O
mutations NNS O
have VBP O
been VBN O
identified VBN O
, , O
including VBG O
2 CD O
deletions NNS O
[ VBP O
295 CD O
- : O
298delTCAT CD O
, , O
1897delC CD O
] NN O
, , O
1 CD O
splice NN O
- : O
site NN O
mutation NN O
[ NNP O
IVS14 NNP O
+ VBD O
1G CD O
> IN O
A NNP O
) ) O
] NN O
and CC O
4 CD O
missense NN O
mutations NNS O
( ( O
85T CD O
> NNP O
C NNP O
, , O
703C CD O
> NN O
T NNP O
, , O
2658G CD O
> NN O
A NNP O
, , O
2983G CD O
> NNP O
T NNP O
) ) O
. . O

Analysis NN O
of IN O
the DT O
prevalence NN O
of IN O
the DT O
various JJ O
mutations NNS O
among IN O
DPD NNP B-Disease
patients NNS O
has VBZ O
shown VBN O
that IN O
the DT O
G NNP O
- : O
- : O
> VB O
A DT O
point NN O
mutation NN O
in IN O
the DT O
invariant JJ O
splice NN O
donor NN O
site NN O
is VBZ O
by IN O
far RB O
the DT O
most RBS O
common JJ O
( ( O
52 CD O
% NN O
) ) O
, , O
whereas VBP O
the DT O
other JJ O
six CD O
mutations NNS O
are VBP O
less RBR O
frequently RB O
observed VBN O
. . O

A DT O
large JJ O
phenotypic NN O
variability NN O
has VBZ O
been VBN O
observed VBN O
, , O
with IN O
convulsive JJ B-Disease
disorders NNS I-Disease
, , O
motor NN B-Disease
retardation NN I-Disease
and CC O
mental JJ B-Disease
retardation NN I-Disease
being VBG O
the DT O
most RBS O
abundant JJ O
manifestations NNS O
. . O

A DT O
clear JJ O
correlation NN O
between IN O
the DT O
genotype NN O
and CC O
phenotype NN O
has VBZ O
not RB O
been VBN O
established VBN O
. . O

An DT O
altered JJ O
beta NN O
- : O
alanine NN O
, , O
uracil NN O
and CC O
thymine JJ O
homeostasis NN O
might MD O
underlie VB O
the DT O
various JJ O
clinical JJ B-Disease
abnormalities NNS I-Disease
encountered VBN O
in IN O
patients NNS O
with IN O
DPD NNP B-Disease
deficiency NN I-Disease
. . O

Fibroblast NNP O
growth NN O
factor NN O
homologous JJ O
factor NN O
2 CD O
( ( O
FHF2 NNP O
) ) O
: : O
gene NN O
structure NN O
, , O
expression NN O
and CC O
mapping NN O
to TO O
the DT O
Borjeson NNP B-Disease
- : I-Disease
Forssman NNP I-Disease
- : I-Disease
Lehmann NNP I-Disease
syndrome JJ I-Disease
region NN O
in IN O
Xq26 NNP O
delineated VBN O
by IN O
a DT O
duplication NN O
breakpoint NN O
in IN O
a DT O
BFLS NNP B-Disease
- : O
like IN O
patient NN O
. . O

Borjeson NNP B-Disease
- : I-Disease
Forssman NNP I-Disease
- : I-Disease
Lehmann NNP I-Disease
syndrome NN I-Disease
( ( O
BFLS NNP B-Disease
) ) O
is VBZ O
a DT O
syndromal JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
mental JJ I-Disease
retardation NN I-Disease
, , O
which WDT O
maps VBZ O
by IN O
linkage NN O
to TO O
the DT O
q26 JJ O
region NN O
of IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
male JJ O
patient NN O
with IN O
BFLS NNP B-Disease
- : O
like IN O
features NNS O
and CC O
a DT O
duplication NN O
, , O
46 CD O
, , O
Y NNP O
, , O
dup NN O
( ( O
X NNP O
) ) O
( ( O
q26q28 NN O
) ) O
, , O
inherited VBN O
from IN O
his PRP$ O
phenotypically RB O
normal JJ O
mother NN O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridisation NN O
using VBG O
yeast JJ O
artificial JJ O
chromosome NN O
clones NNS O
from IN O
Xq26 NNP O
localised VBD O
the DT O
duplication NN O
breakpoint NN O
to TO O
an DT O
approximately RB O
400 CD O
- : O
kb NN O
interval NN O
in IN O
the DT O
Xq26 NN O
. . O

3 CD O
region NN O
between IN O
DXS155 NNP O
and CC O
DXS294 NNP O
/ NNP O
DXS730 NNP O
. . O

Database NNP O
searches NNS O
and CC O
analysis NN O
of IN O
available JJ O
genomic JJ O
DNA NNP O
sequence NN O
from IN O
the DT O
region NN O
revealed VBD O
the DT O
presence NN O
of IN O
the DT O
fibroblast JJ O
growth NN O
factor NN O
homologous JJ O
factor NN O
gene NN O
, , O
FHF2 NNP O
, , O
within IN O
the DT O
duplication NN O
breakpoint NN O
interval NN O
. . O

The DT O
gene NN O
structure NN O
of IN O
FHF2 NNP O
was VBD O
determined VBN O
and CC O
two CD O
new JJ O
exons NNS O
were VBD O
identified VBN O
, , O
including VBG O
a DT O
new JJ O
5 CD O
end NN O
exon NN O
, , O
1B CD O
. . O

FHF2 NNP O
is VBZ O
a DT O
large JJ O
gene NN O
extending VBG O
over IN O
approximately RB O
200 CD O
kb NNS O
in IN O
Xq26 NNP O
. . O

3 CD O
and CC O
is VBZ O
composed VBN O
of IN O
at IN O
least JJS O
seven CD O
exons NNS O
. . O

It PRP O
shows VBZ O
tissue NN O
- : O
specific JJ O
alternative JJ O
splicing NN O
and CC O
alternative JJ O
transcription NN O
starts NNS O
. . O

Northern NNP O
blot NN O
hybridisation NN O
showed VBD O
highest JJS O
expression NN O
in IN O
brain NN O
and CC O
skeletal JJ O
muscle NN O
. . O

The DT O
FHF2 NNP O
gene NN O
localisation NN O
and CC O
tissue NN O
- : O
specific JJ O
expression NN O
pattern NN O
suggest VBP O
it PRP O
to TO O
be VB O
a DT O
candidate JJ O
gene NN O
for IN O
familial JJ O
cases NNS O
of IN O
the DT O
BFLS NNP B-Disease
syndrome NN I-Disease
and CC O
other JJ O
syndromal JJ O
and CC O
non JJ O
- : O
specific JJ O
forms NNS O
of IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
mental JJ I-Disease
retardation NN I-Disease
mapping NN O
to TO O
the DT O
region NN O
. . O

Germline NNP O
E NNP O
- : O
cadherin NN O
gene NN O
( ( O
CDH1 NNP O
) ) O
mutations NNS O
predispose VBP O
to TO O
familial JJ B-Disease
gastric JJ I-Disease
cancer NN I-Disease
and CC O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

Inherited VBN O
mutations NNS O
in IN O
the DT O
E NNP O
- : O
cadherin NN O
gene NN O
( ( O
CDH1 NNP O
) ) O
were VBD O
described VBN O
recently RB O
in IN O
three CD O
Maori NNP O
kindreds NNS O
with IN O
familial JJ B-Disease
gastric JJ I-Disease
cancer NN I-Disease
. . O

Familial JJ B-Disease
gastric JJ I-Disease
cancer NN I-Disease
is VBZ O
genetically RB O
heterogeneous JJ O
and CC O
it PRP O
is VBZ O
not RB O
clear JJ O
what WP O
proportion NN O
of IN O
gastric JJ B-Disease
cancer NN I-Disease
susceptibility NN O
in IN O
non JJ O
- : O
Maori JJ O
populations NNS O
is VBZ O
due JJ O
to TO O
germline VB O
CDH1 NNP O
mutations NNS O
. . O

Therefore RB O
, , O
we PRP O
screened VBD O
eight CD O
familial JJ B-Disease
gastric NN I-Disease
cancer NN I-Disease
kindreds NNS O
of IN O
British JJ O
and CC O
Irish JJ O
origin NN O
for IN O
germline NN O
CDH1 NNP O
mutations NNS O
, , O
by IN O
SSCP NNP O
analysis NN O
of IN O
all DT O
16 CD O
exons NNS O
and CC O
flanking VBG O
sequences NNS O
. . O

Each DT O
family NN O
contained VBN O
( ( O
i JJ O
) ) O
two CD O
cases NNS O
of IN O
gastric JJ B-Disease
cancer NN I-Disease
in IN O
first JJ O
degree NN O
relatives NNS O
with IN O
one CD O
affected VBD O
before IN O
age NN O
50 CD O
years NNS O
; : O
or CC O
( ( O
ii NN O
) ) O
three CD O
or CC O
more JJR O
cases NNS O
of IN O
gastric JJ B-Disease
cancer NN I-Disease
. . O

Novel NNP O
germline NN O
CDH1 NNP O
mutations NNS O
( ( O
a DT O
nonsense NN O
and CC O
a DT O
splice JJ O
site NN O
) ) O
were VBD O
detected VBN O
in IN O
two CD O
families NNS O
( ( O
25 CD O
% NN O
) ) O
. . O

Both DT O
mutations NNS O
were VBD O
predicted VBN O
to TO O
truncate VB O
the DT O
E NNP O
- : O
cadherin NN O
protein NN O
in IN O
the DT O
signal JJ O
peptide NN O
domain NN O
. . O

In IN O
one CD O
family NN O
there EX O
was VBD O
evidence NN O
of IN O
non JJ O
- : O
penetrance NN O
and CC O
susceptibility NN O
to TO O
both DT O
gastric JJ B-Disease
and CC I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
; : O
thus RB O
, , O
in IN O
addition NN O
to TO O
six CD O
cases NNS O
of IN O
gastric JJ B-Disease
cancer NN I-Disease
, , O
a DT O
CDH1 NNP O
mutation NN O
carrier NN O
developed VBD O
colorectal JJ B-Disease
cancer NN I-Disease
at IN O
age NN O
30 CD O
years NNS O
. . O

We PRP O
have VBP O
confirmed VBN O
that IN O
germline NN O
mutations NNS O
in IN O
the DT O
CDH1 NNP O
gene NN O
cause NN O
familial JJ B-Disease
gastric JJ I-Disease
cancer NN I-Disease
in IN O
non JJ O
- : O
Maori JJ O
populations NNS O
. . O

However RB O
, , O
only RB O
a DT O
minority NN O
of IN O
familial JJ O
gastric JJ B-Disease
cancers NNS I-Disease
can MD O
be VB O
accounted VBN O
for IN O
by IN O
CDH1 NNP O
mutations NNS O
. . O

Loss NNP O
of IN O
E NNP O
- : O
cadherin NN O
function NN O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
sporadic JJ O
colorectal NN B-Disease
and CC I-Disease
other JJ I-Disease
cancers NNS I-Disease
, , O
and CC O
our PRP$ O
findings NNS O
provide VBP O
evidence NN O
that IN O
germline NN O
CDH1 NNP O
mutations NNS O
predispose VBP O
to TO O
early JJ O
onset NN O
colorectal NN B-Disease
cancer NN I-Disease
. . O

Thus RB O
, , O
CDH1 NNP O
should MD O
be VB O
investigated VBN O
as IN O
a DT O
cause NN O
of IN O
inherited JJ O
susceptibility NN O
to TO O
both DT O
gastric JJ B-Disease
and CC I-Disease
colorectal JJ I-Disease
cancers NNS I-Disease
. . O

A DT O
zinc NN O
finger NN O
truncation NN O
of IN O
murine NN O
WT1 NNP O
results NNS O
in IN O
the DT O
characteristic JJ O
urogenital JJ B-Disease
abnormalities NNS I-Disease
of IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
Wilms NNP B-Disease
tumor NN I-Disease
- : O
suppressor NN O
gene NN O
, , O
WT1 NNP O
, , O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
urogenital JJ O
development NN O
, , O
and CC O
WT1 NNP B-Disease
dysfunction NN I-Disease
is VBZ O
implicated VBN O
in IN O
both DT O
neoplastic JJ B-Disease
( ( O
Wilms NNP B-Disease
tumor NN I-Disease
, , O
mesothelioma NN B-Disease
, , O
leukemias NN B-Disease
, , O
and CC O
breast NN B-Disease
cancer NN I-Disease
) ) O
and CC O
nonneoplastic JJ B-Disease
( ( O
glomerulosclerosis NN B-Disease
) ) O
disease NN O
. . O

The DT O
analysis NN O
of IN O
diseases NNS O
linked VBN O
specifically RB O
with IN O
WT1 NNP O
mutations NNS O
, , O
such JJ O
as IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
( ( O
DDS NNP B-Disease
) ) O
, , O
can MD O
provide VB O
valuable JJ O
insight NN O
concerning VBG O
the DT O
role NN O
of IN O
WT1 NNP O
in IN O
development NN O
and CC O
disease NN O
. . O

DDS NNP B-Disease
is VBZ O
a DT O
rare JJ O
childhood NN O
disease NN O
characterized VBN O
by IN O
a DT O
nephropathy JJ B-Disease
involving VBG O
mesangial JJ B-Disease
sclerosis NN I-Disease
, , O
XY NNP O
pseudohermaphroditism NN B-Disease
, , O
and CC O
/ NNP O
or CC O
Wilms NNP B-Disease
tumor NN I-Disease
( ( O
WT NNP B-Disease
) ) O
. . O

DDS NN B-Disease
patients NNS O
are VBP O
constitutionally RB O
heterozygous JJ O
for IN O
exonic JJ O
point NN O
mutations NNS O
in IN O
WT1 NNP O
, , O
which WDT O
include VBP O
mutations NNS O
predicted VBD O
to TO O
truncate VB O
the DT O
protein NN O
within IN O
the DT O
C NNP O
- : O
terminal JJ O
zinc NN O
finger NN O
( ( O
ZF NNP O
) ) O
region NN O
. . O

We PRP O
report VBP O
that DT O
heterozygosity NN O
for IN O
a DT O
targeted JJ O
murine NN O
Wt1 NNP O
allele NN O
, , O
Wt1 NNP O
( ( O
tmT396 NN O
) ) O
, , O
which WDT O
truncates VBZ O
ZF3 NNP O
at IN O
codon NN O
396 CD O
, , O
induces NNS O
mesangial JJ B-Disease
sclerosis NN I-Disease
characteristic NN O
of IN O
DDS NNP B-Disease
in IN O
adult NN O
heterozygous JJ O
and CC O
chimeric JJ O
mice NN O
. . O

Male JJ B-Disease
genital NN I-Disease
defects NNS I-Disease
also RB O
were VBD O
evident JJ O
and CC O
there EX O
was VBD O
a DT O
single JJ O
case NN O
of IN O
Wilms NNP B-Disease
tumor NN I-Disease
in IN O
which WDT O
the DT O
transcript NN O
of IN O
the DT O
nontargeted JJ O
allele NN O
showed VBD O
an DT O
exon JJ O
9 CD O
skipping VBG O
event NN O
, , O
implying VBG O
a DT O
causal NN O
link NN O
between IN O
Wt1 NNP B-Disease
dysfunction NN I-Disease
and CC O
Wilms NNP B-Disease
tumorigenesis NN I-Disease
in IN O
mice NN O
. . O

However RB O
, , O
the DT O
mutant JJ O
WT1 NNP O
( ( O
tmT396 NN O
) ) O
protein NN O
accounted VBD O
for IN O
only RB O
5 CD O
% NN O
of IN O
WT1 NNP O
in IN O
both DT O
heterozygous JJ O
embryonic JJ O
stem NN O
cells NNS O
and CC O
the DT O
WT NNP B-Disease
. . O

This DT O
has VBZ O
implications NNS O
regarding VBG O
the DT O
mechanism NN O
by IN O
which WDT O
the DT O
mutant NN O
allele VBZ O
exerts VBZ O
its PRP$ O
effect NN O
. . O

Mechanism NN O
of IN O
increased VBN O
iron NN O
absorption NN O
in IN O
murine JJ O
model NN O
of IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
: : O
increased VBN O
duodenal JJ O
expression NN O
of IN O
the DT O
iron NN O
transporter NN O
DMT1 NNP O
. . O

Hereditary JJ B-Disease
hemochromatosis NN I-Disease
( ( O
HH NNP B-Disease
) ) O
is VBZ O
a DT O
common JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
tissue NN O
iron NN O
deposition NN O
secondary JJ O
to TO O
excessive JJ O
dietary JJ O
iron NN O
absorption NN O
. . O

We PRP O
recently RB O
reported VBD O
that IN O
HFE NNP O
, , O
the DT O
protein NN O
defective JJ O
in IN O
HH NNP B-Disease
, , O
was VBD O
physically RB O
associated VBN O
with IN O
the DT O
transferrin NN O
receptor NN O
( ( O
TfR NNP O
) ) O
in IN O
duodenal JJ O
crypt NN O
cells NNS O
and CC O
proposed VBD O
that IN O
mutations NNS O
in IN O
HFE NNP O
attenuate VBP O
the DT O
uptake NN O
of IN O
transferrin JJ O
- : O
bound NN O
iron NN O
from IN O
plasma NN O
by IN O
duodenal JJ O
crypt NN O
cells NNS O
, , O
leading VBG O
to TO O
up RP O
- : O
regulation NN O
of IN O
transporters NNS O
for IN O
dietary JJ O
iron NN O
. . O

Here RB O
, , O
we PRP O
tested VBD O
the DT O
hypothesis NN O
that WDT O
HFE NNP O
- : O
/ SYM O
- : O
mice NN O
have VBP O
increased VBN O
duodenal JJ O
expression NN O
of IN O
the DT O
divalent NN O
metal NN O
transporter NN O
( ( O
DMT1 NNP O
) ) O
. . O

By IN O
4 CD O
weeks NNS O
of IN O
age NN O
, , O
the DT O
HFE NNP O
- : O
/ SYM O
- : O
mice NN O
demonstrated VBD O
iron NN O
loading NN O
when WRB O
compared VBN O
with IN O
HFE NNP O
+ NNP O
/ NNP O
+ NNP O
littermates VBZ O
, , O
with IN O
elevated JJ O
transferrin NN O
saturations NNS O
( ( O
68 CD O
. . O
4 CD O
% NN O
vs NN O
. . O
49 CD O
. . O
8 CD O
% NN O
) ) O
and CC O
elevated VBN O
liver NN O
iron NN O
concentrations NNS O
( ( O
985 CD O
micrograms NNS O
vs VBP O
. . O
381 CD O
micrograms NNS O
) ) O
. . O

By IN O
using VBG O
Northern NNP O
blot NN O
analyses NNS O
, , O
we PRP O
quantitated VBD O
duodenal JJ O
expression NN O
of IN O
both DT O
classes NNS O
of IN O
DMT1 NNP O
transcripts VBP O
one CD O
containing VBG O
an DT O
iron NN O
responsive JJ O
element NN O
( ( O
IRE NNP O
) ) O
, , O
called VBN O
DMT1 NNP O
( ( O
IRE NNP O
) ) O
, , O
and CC O
one CD O
containing VBG O
no DT O
IRE NNP O
, , O
called VBD O
DMT1 NNP O
( ( O
non SYM O
- : O
IRE NN O
) ) O
. . O

The DT O
positive JJ O
control NN O
for IN O
DMT1 NNP O
up RP O
- : O
regulation NN O
was VBD O
a DT O
murine JJ O
model NN O
of IN O
dietary JJ B-Disease
iron NN I-Disease
deficiency NN I-Disease
that WDT O
demonstrated VBD O
greatly RB O
increased JJ O
levels NNS O
of IN O
duodenal JJ O
DMT1 NNP O
( ( O
IRE NNP O
) ) O
mRNA NN O
. . O

HFE NNP O
- : O
/ SYM O
- : O
mice NN O
also RB O
demonstrated VBD O
an DT O
increase NN O
in IN O
duodenal JJ O
DMT1 NNP O
( ( O
IRE NNP O
) ) O
mRNA NN O
( ( O
average JJ O
7 CD O
. . O
7 CD O
- : O
fold NN O
) ) O
, , O
despite IN O
their PRP$ O
elevated JJ O
transferrin NN O
saturation NN O
and CC O
hepatic JJ O
iron NN O
content NN O
. . O

Duodenal JJ O
expression NN O
of IN O
DMT1 NNP O
( ( O
non SYM O
- : O
IRE NN O
) ) O
was VBD O
not RB O
increased VBN O
, , O
nor CC O
was VBD O
hepatic JJ O
expression NN O
of IN O
DMT1 NNP O
increased VBD O
. . O

These DT O
data NNS O
support NN O
the DT O
model NN O
for IN O
HH NNP O
in IN O
which WDT O
HFE NNP O
mutations NNS O
lead VBP O
to TO O
inappropriately RB O
low JJ O
crypt NN O
cell NN O
iron NN O
, , O
with IN O
resultant JJ O
stabilization NN O
of IN O
DMT1 NNP O
( ( O
IRE NNP O
) ) O
mRNA NN O
, , O
up RB O
- : O
regulation NN O
of IN O
DMT1 NNP O
, , O
and CC O
increased VBD O
absorption NN O
of IN O
dietary JJ O
iron NN O
. . O

Neurophysiologic NNP O
follow SYM O
- : O
up IN O
of IN O
long JJ O
- : O
term NN O
dietary JJ O
treatment NN O
in IN O
adult NN O
- : O
onset NN O
adrenoleukodystrophy NN B-Disease
. . O

OBJECTIVE NN O
To TO O
monitor VB O
the DT O
effects NNS O
of IN O
dietary JJ O
treatment NN O
in IN O
adult NN O
- : O
onset NN O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
by IN O
means NNS O
of IN O
somatosensory NN O
evoked VBN O
potentials NNS O
( ( O
SEPs NNP O
) ) O
and CC O
motor NN O
evoked JJ O
potentials NNS O
( ( O
MEPs NNP O
) ) O
. . O

BACKGROUND NNP O
SEPs NNP O
and CC O
MEPs NNP O
have VBP O
proved VBN O
useful JJ O
in IN O
revealing VBG O
signs NNS O
of IN O
progressively RB O
severe JJ O
, , O
central JJ O
dying VBG B-Disease
- : I-Disease
back RB I-Disease
axonopathy NN I-Disease
in IN O
early JJ O
stages NNS O
of IN O
adult NN O
- : O
onset NN O
ALD NNP B-Disease
. . O

METHODS NNP O
Eight NNP O
patients NNS O
with IN O
adult JJ O
- : O
onset NN O
ALD NNP B-Disease
underwent JJ O
clinical JJ O
examination NN O
, , O
brain NN O
and CC O
spine NN O
MRI NNP O
, , O
and CC O
SEP NNP O
and CC O
MEP NNP O
studies NNS O
before IN O
and CC O
after IN O
3 CD O
years NNS O
of IN O
Lorenzos NNP O
oil NN O
dietary JJ O
therapy NN O
. . O

RESULTS NNP O
Before NNP O
treatment NN O
, , O
brain NN O
MRI NNP O
was VBD O
normal JJ O
in IN O
five CD O
patients NNS O
. . O

Three CD O
of IN O
these DT O
patients NNS O
had VBD O
pure JJ O
spinal JJ B-Disease
SEP NNP I-Disease
abnormalities NNS I-Disease
and CC O
in IN O
the DT O
remaining VBG O
two CD O
patients NNS O
SEPs VBP O
showed JJ O
signs NNS O
of IN O
involvement NN O
of IN O
both CC O
the DT O
spinal NN O
and CC O
cerebral JJ O
somatosensory NN O
tracts NNS O
. . O

After IN O
treatment NN O
, , O
the DT O
three CD O
patients NNS O
with IN O
pure JJ O
spinal JJ B-Disease
abnormalities NNS I-Disease
showed VBD O
clinical JJ O
and CC O
neurophysiologic JJ O
worsening NN O
, , O
whereas IN O
the DT O
two CD O
patients NNS O
with IN O
a DT O
more RBR O
advanced JJ O
stage NN O
of IN O
disease NN O
( ( O
exhibited VBN O
by IN O
SEPs NNP O
) ) O
showed VBD O
substantially RB O
unchanged JJ O
clinical JJ O
and CC O
neurophysiologic JJ O
features NNS O
. . O

The DT O
patients NNS O
with IN O
abnormal JJ O
brain NN O
MRI NNP O
at IN O
the DT O
onset NN O
of IN O
treatment NN O
showed VBD O
clinical JJ O
and CC O
neurophysiologic JJ O
worsening NN O
. . O

CONCLUSIONS NNP O
Lorenzos NNP O
oil NN O
therapy NN O
had VBD O
no DT O
effect NN O
on IN O
patients NNS O
with IN O
evidence NN O
of IN O
inflammatory JJ B-Disease
brain NN I-Disease
lesions NNS I-Disease
. . O

Moreover RB O
, , O
in IN O
patients NNS O
without IN O
clear JJ O
signs NNS O
of IN O
inflammatory JJ O
damage NN O
, , O
this DT O
treatment NN O
does VBZ O
not RB O
modify VB O
significantly RB O
the DT O
natural JJ O
course NN O
of IN O
the DT O
disease NN O
. . O

However RB O
, , O
because IN O
effective JJ O
treatments NNS O
should MD O
begin VB O
before IN O
the DT O
onset NN O
of IN O
severe JJ O
neurologic NN O
symptoms NNS O
, , O
SEPs NNP O
and CC O
MEPs NNP O
should MD O
be VB O
considered VBN O
to TO O
evaluate VB O
the DT O
effectiveness NN O
of IN O
other JJ O
experimental JJ O
treatments NNS O
in IN O
the DT O
patient NN O
with IN O
a DT O
negative JJ O
brain NN O
MRI NNP O
. . O

GCH1 NNP O
mutation NN O
in IN O
a DT O
patient NN O
with IN O
adult JJ O
- : O
onset NN O
oromandibular JJ B-Disease
dystonia NN I-Disease
. . O

The DT O
authors NNS O
report VBP O
a DT O
mutation NN O
in IN O
exon JJ O
5 CD O
of IN O
GCH1 NNP O
in IN O
a DT O
patient NN O
with IN O
adult JJ O
- : O
onset NN O
oromandibular JJ B-Disease
dystonia NN I-Disease
and CC O
no DT O
obvious JJ O
family NN O
history NN O
of IN O
dystonia NN B-Disease
. . O

The DT O
patient NN O
responded VBD O
positively RB O
to TO O
treatment NN O
with IN O
L NNP O
- : O
dopa NN O
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
GCH1 NNP O
mutations NNS O
must MD O
be VB O
considered VBN O
even RB O
in IN O
patients NNS O
with IN O
dystonic JJ B-Disease
symptoms NNS O
not RB O
typical JJ O
of IN O
dopa JJ B-Disease
- : I-Disease
responsive JJ I-Disease
dystonia NN I-Disease
. . O

Germline NNP O
mutations NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
Korean NNP O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
patients NNS O
. . O

We PRP O
extensively RB O
analyzed VBD O
genomic JJ O
DNA NNP O
and CC O
messenger JJR O
RNA NNP O
( ( O
mRNA NN O
) ) O
from IN O
62 CD O
unrelated JJ O
Korean JJ O
patients NNS O
with IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
for IN O
identification NN O
of IN O
germline NN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
mutations NNS O
. . O

We PRP O
adopted VBD O
both DT O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
analysis NN O
and CC O
a DT O
method NN O
of IN O
analysis NN O
involving VBG O
the DT O
reverse NN O
transcription NN O
- : O
polymerase NN O
chain NN O
reaction NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
followed VBN O
by IN O
a DT O
protein NN O
truncation NN O
test NN O
( ( O
PTT NNP O
) ) O
. . O

DNA NN O
sequencing VBG O
confirmed VBD O
all DT O
alterations NNS O
represented VBN O
by IN O
aberrant JJ O
bands NNS O
. . O

Germline JJ O
mutations NNS O
were VBD O
identified VBN O
in IN O
38 CD O
patients NNS O
( ( O
61 CD O
% NN O
) ) O
. . O

Nineteen NN O
of IN O
the DT O
detected JJ O
mutations NNS O
were VBD O
presumed VBN O
to TO O
be VB O
novel JJ O
, , O
thus RB O
emphasizing VBG O
the DT O
heterogeneity NN O
of IN O
the DT O
mutational JJ O
spectrum NN O
in IN O
Korean JJ O
FAP NNP B-Disease
patients NNS O
. . O

In IN O
the DT O
initial JJ O
48 CD O
patients NNS O
, , O
SSCP NNP O
analysis NN O
was VBD O
followed VBN O
by IN O
PTT NNP O
for IN O
those DT O
patients NNS O
for IN O
whom WP O
no DT O
detectable JJ O
mutations NNS O
were VBD O
found VBN O
by IN O
SSCP NNP O
. . O

Using VBG O
this DT O
combined JJ O
approach NN O
, , O
we PRP O
identified VBD O
germline JJ O
APC NNP B-Disease
gene NN O
mutations NNS O
in IN O
29 CD O
of IN O
the DT O
48 CD O
FAP NNP B-Disease
patients NNS O
( ( O
60 CD O
% NN O
) ) O
, , O
including VBG O
6 CD O
patients NNS O
in IN O
whom WP O
SSCP NNP O
analysis NN O
failed VBD O
to TO O
distinguish VB O
the DT O
mutant JJ O
allele NN O
. . O

In IN O
the DT O
14 CD O
later JJ O
patients NNS O
, , O
we PRP O
identified VBD O
truncating VBG O
mutations NNS O
in IN O
9 CD O
patients NNS O
( ( O
64 CD O
% NN O
) ) O
using VBG O
PTT NNP O
only RB O
. . O

Our PRP$ O
results NNS O
confirm VBP O
that IN O
the DT O
mutation NN O
detection NN O
rate NN O
with IN O
PTT NNP O
was VBD O
superior JJ O
to TO O
that DT O
with IN O
SSCP NNP O
, , O
and CC O
suggest VBP O
that IN O
PTT NNP O
would MD O
be VB O
a DT O
more RBR O
practical JJ O
screening NN O
method NN O
to TO O
detect VB O
germline JJ O
mutations NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
FAP NNP B-Disease
patients NNS O
. . O

Molecular JJ O
epidemiology NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
heterozygotes VBZ O
with IN O
an DT O
Arg95Stop NNP O
mutation NN O
of IN O
the DT O
C9 NNP O
gene NN O
in IN O
Japan NNP O
. . O

Deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
ninth JJ I-Disease
component NN I-Disease
of IN I-Disease
human JJ I-Disease
complement NN I-Disease
( ( O
C9 NNP O
) ) O
is VBZ O
the DT O
most RBS O
common JJ O
complement NN B-Disease
deficiency NN I-Disease
in IN O
Japan NNP O
, , O
with IN O
an DT O
incidence NN O
of IN O
approximately RB O
one CD O
homozygote NN O
in IN O
1000 CD O
, , O
but CC O
is VBZ O
very RB O
rare JJ O
in IN O
other JJ O
countries NNS O
. . O

Genetic JJ O
analyses NNS O
of IN O
Japanese JJ O
C9 NNP B-Disease
deficiency NN I-Disease
have VBP O
shown VBN O
that IN O
a DT O
C NNP O
- : O
to TO O
- : O
T NNP O
transition NN O
leading VBG O
to TO O
TGA NNP O
stop VB O
codon NN O
for IN O
Arg95 NNP O
in IN O
exon JJ O
4 CD O
of IN O
the DT O
C9 NNP O
gene NN O
( ( O
Arg95Stop NNP O
) ) O
is VBZ O
common JJ O
in IN O
Japanese JJ O
C9 NNP B-Disease
deficiency NN I-Disease
. . O

To TO O
determine VB O
the DT O
prevalence NN O
of IN O
heterozygous JJ O
carriers NNS O
of IN O
the DT O
Arg95Stop NNP O
mutation NN O
in IN O
a DT O
Japanese JJ O
population NN O
, , O
we PRP O
collected VBD O
DNA NNP O
samples NNS O
from IN O
300 CD O
individuals NNS O
in IN O
two CD O
of IN O
the DT O
four CD O
main JJ O
islands NNS O
of IN O
Japan NNP O
. . O

Heterozygote NNP O
detection NN O
was VBD O
performed VBN O
with IN O
an DT O
allele JJ O
- : O
specific JJ O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
system NN O
designed VBN O
to TO O
detect VB O
exclusively RB O
only RB O
one CD O
of IN O
the DT O
normal JJ O
and CC O
mutant JJ O
alleles NNS O
, , O
followed VBN O
by IN O
confirmation NN O
with IN O
PCR NNP O
/ NNP O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
analysis NN O
and CC O
direct JJ O
sequencing NN O
. . O

Twenty CD O
individuals NNS O
were VBD O
heterozygous JJ O
for IN O
the DT O
Arg95Stop NNP O
mutation NN O
. . O

None NN O
was VBD O
homozygous JJ O
. . O

The DT O
prevalence NN O
of IN O
carriers NNS O
of IN O
the DT O
Arg95Stop NNP O
mutation NN O
was VBD O
6 CD O
. . O

7 CD O
% NN O
( ( O
20 CD O
/ RB O
300 CD O
) ) O
. . O

An DT O
estimated JJ O
frequency NN O
( ( O
0 CD O
. . O
12 CD O
% NN O
) ) O
of IN O
complete JJ O
C9 NNP B-Disease
deficiency NN I-Disease
due JJ O
to TO O
homozygous JJ O
Arg95Stop NNP O
mutation NN O
was VBD O
consistent JJ O
with IN O
frequencies NNS O
determined VBN O
by IN O
serological JJ O
studies NNS O

The DT O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
protein NN O
, , O
HFE NNP O
, , O
specifically RB O
regulates VBZ O
transferrin JJ O
- : O
mediated VBN O
iron NN O
uptake NN O
in IN O
HeLa NNP O
cells NNS O
. . O

HFE NNP O
is VBZ O
the DT O
protein JJ O
product NN O
of IN O
the DT O
gene NN O
mutated VBN O
in IN O
the DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disease NN I-Disease
hereditary JJ B-Disease
hemochromatosis NN I-Disease
( ( O
Feder NNP O
, , O
J NNP O
. . O

N NNP O
. . O
, , O
Gnirke NNP O
, , O
A NNP O
. . O
, , O
Thomas NNP O
, , O
W NNP O
. . O
, , O
Tsuchihashi NNP O
, , O
Z NNP O
. . O
, , O
Ruddy NNP O
, , O
D NNP O
. . O

A DT O
. . O
, , O
Basava NNP O
, , O
A NNP O
. . O
, , O
Dormishian JJ O
, , O
F NNP O
. . O
, , O
Domingo NNP O
, , O
R NNP O
. . O

J NNP O
. . O
, , O
Ellis NNP O
, , O
M NNP O
. . O

C NNP O
. . O
, , O
Fullan NNP O
, , O
A NNP O
. . O
, , O
Hinton NNP O
, , O
L NNP O
. . O

M NNP O
. . O
, , O
Jones NNP O
, , O
N NNP O
. . O

L NNP O
. . O
, , O
Kimmel NNP O
, , O
B NNP O
. . O

E NN O
. . O
, , O
Kronmal NNP O
, , O
G NNP O
. . O

S NNP O
. . O
, , O
Lauer NNP O
, , O
P NNP O
. . O
, , O
Lee NNP O
, , O
V NNP O
. . O

K NNP O
. . O
, , O
Loeb NNP O
, , O
D NNP O
. . O

B NNP O
. . O
, , O
Mapa NNP O
, , O
F NNP O
. . O

A DT O
. . O
, , O
McClelland NNP O
, , O
E NNP O
. . O
, , O
Meyer NNP O
, , O
N NNP O
. . O

C NNP O
. . O
, , O
Mintier NNP O
, , O
G NNP O
. . O

A DT O
. . O
, , O
Moeller NNP O
, , O
N NNP O
. . O
, , O
Moore NNP O
, , O
T NNP O
. . O
, , O
Morikang NNP O
, , O
E NNP O
. . O
, , O
Prasss NNP O
, , O
C NNP O
. . O

E NN O
. . O
, , O
Quintana NNP O
, , O
L NNP O
. . O
, , O
Starnes NNPS O
, , O
S NNP O
. . O

M NNP O
. . O
, , O
Schatzman NNP O
, , O
R NNP O
. . O

C NNP O
. . O
, , O
Brunke NNP O
, , O
K NNP O
. . O

J NNP O
. . O
, , O
Drayna NNP O
, , O
D NNP O
. . O

T NNP O
. . O
, , O
Risch NNP O
, , O
N NNP O
. . O

J NNP O
. . O
, , O
Bacon NNP O
, , O
B NNP O
. . O

R NNP O
. . O
, , O
and CC O
Wolff NNP O
, , O
R NNP O
. . O

R NN O
. . O

( ( O
1996 CD O
) ) O
Nat NNP O
. . O

Genet NNP O
. . O

13 CD O
, , O
399 CD O
- : O
408 CD O
) ) O
. . O

At IN O
the DT O
cell NN O
surface NN O
, , O
HFE NNP O
complexes NNS O
with IN O
transferrin JJ O
receptor NN O
( ( O
TfR NNP O
) ) O
, , O
increasing VBG O
the DT O
dissociation NN O
constant NN O
of IN O
transferrin NN O
( ( O
Tf NNP O
) ) O
for IN O
its PRP$ O
receptor NN O
10 CD O
- : O
fold NN O
( ( O
Gross NNP O
, , O
C NNP O
. . O

N NNP O
. . O
, , O
Irrinki NNP O
, , O
A NNP O
. . O
, , O
Feder NNP O
, , O
J NNP O
. . O
N NNP O
. . O
, , O
and CC O
Enns NNP O
, , O
C NNP O
. . O
A NNP O
. . O
( ( O
1998 CD O
) ) O
J NNP O
. . O
Biol NNP O
. . O
Chem NNP O
. . O
273 CD O
, , O
22068 CD O
- : O
22074 CD O
; : O
Feder NNP O
, , O
J NNP O
. . O
N NNP O
. . O
, , O
Penny NNP O
, , O
D NNP O
. . O
M NNP O
. . O
, , O
Irrinki NNP O
, , O
A NNP O
. . O
, , O
Lee NNP O
, , O
V NNP O
. . O
K NNP O
. . O
, , O
Lebron NNP O
, , O
J NNP O
. . O
A NNP O
. . O
, , O
Watson NNP O
, , O
N NNP O
. . O
, , O
Tsuchihashi NNP O
, , O
Z NNP O
. . O
, , O
Sigal NNP O
, , O
E NNP O
. . O
, , O
Bjorkman NNP O
, , O
P NNP O
. . O
J NNP O
. . O
, , O
and CC O
Schatzman NNP O
, , O
R NNP O
. . O
C NNP O
. . O
( ( O
1998 CD O
) ) O
Proc NNP O
. . O
Natl NNP O
. . O

Acad NNP O
. . O

Sci NNP O
. . O

U NNP O
S NNP O
A NNP O
95 CD O
, , O
1472 CD O
- : O
1477 CD O
) ) O
. . O

HFE NNP O
does VBZ O
not RB O
remain VB O
at IN O
the DT O
cell NN O
surface NN O
, , O
but CC O
traffics NNS O
with IN O
TfR NNP O
to TO O
Tf NNP O
- : O
positive JJ O
internal JJ O
compartments NNS O
( ( O
Gross NNP O
et VBZ O
al NN O
. . O
, , O
1998 CD O
) ) O
. . O

Using VBG O
a DT O
HeLa NNP O
cell NN O
line NN O
in IN O
which WDT O
the DT O
expression NN O
of IN O
HFE NNP O
is VBZ O
controlled VBN O
by IN O
tetracycline NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
expression NN O
of IN O
HFE NNP O
reduces VBZ O
55Fe CD O
uptake NN O
from IN O
Tf NNP O
by IN O
33 CD O
% NN O
but CC O
does VBZ O
not RB O
affect VB O
the DT O
endocytic JJ O
or CC O
exocytic JJ O
rates NNS O
of IN O
TfR NNP O
cycling NN O
. . O

Therefore RB O
, , O
HFE NNP O
appears VBZ O
to TO O
reduce VB O
cellular JJ O
acquisition NN O
of IN O
iron NN O
from IN O
Tf NNP O
within IN O
endocytic JJ O
compartments NNS O
. . O

HFE NNP O
specifically RB O
reduces VBZ O
iron NN O
uptake NN O
from IN O
Tf NNP O
, , O
as IN O
non JJ O
- : O
Tf NNP O
- : O
mediated VBD O
iron JJ O
uptake NN O
from IN O
Fe NNP O
- : O
nitrilotriacetic JJ O
acid NN O
is VBZ O
not RB O
altered VBN O
. . O

These DT O
results NNS O
explain VBP O
the DT O
decreased JJ O
ferritin NN O
levels NNS O
seen VBN O
in IN O
our PRP$ O
HeLa NNP O
cell NN O
system NN O
and CC O
demonstrate VB O
the DT O
specific JJ O
control NN O
of IN O
HFE NNP O
over IN O
the DT O
Tf NNP O
- : O
mediated VBD O
pathway NN O
of IN O
iron NN O
uptake NN O
. . O

These DT O
results NNS O
also RB O
have VBP O
implications NNS O
for IN O
the DT O
understanding NN O
of IN O
cellular JJ O
iron NN O
homeostasis NN O
in IN O
organs NNS O
such JJ O
as IN O
the DT O
liver NN O
, , O
pancreas NNS O
, , O
heart NN O
, , O
and CC O
spleen NN O
that WDT O
are VBP O
iron RB O
loaded VBN O
in IN O
hereditary JJ B-Disease
hemochromatotic JJ I-Disease
individuals NNS O
lacking VBG O
functional JJ O
HFE NNP O
. . O

Mutation NN O
and CC O
haplotype JJ O
studies NNS O
of IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
reveal VBP O
new JJ O
ancestral JJ O
relationships NNS O
and CC O
evidence NN O
for IN O
a DT O
high JJ O
carrier NN O
frequency NN O
with IN O
reduced JJ O
penetrance NN O
in IN O
the DT O
Ashkenazi NNP O
Jewish NNP O
population NN O
. . O

Familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
is VBZ O
a DT O
recessive JJ B-Disease
disorder NN I-Disease
characterized VBN O
by IN O
episodes NNS O
of IN O
fever NN O
with IN O
serositis NN B-Disease
or CC O
synovitis NN B-Disease
. . O

The DT O
FMF NNP B-Disease
gene NN O
( ( O
MEFV NNP O
) ) O
was VBD O
cloned VBN O
recently RB O
, , O
and CC O
four CD O
missense NN O
mutations NNS O
were VBD O
identified VBN O
. . O

Here RB O
we PRP O
present VBP O
data NNS O
from IN O
non JJ O
- : O
Ashkenazi JJ O
Jewish JJ O
and CC O
Arab JJ O
patients NNS O
in IN O
whom WP O
we PRP O
had VBD O
not RB O
originally RB O
found VBN O
mutations NNS O
and CC O
from IN O
a DT O
new JJ O
, , O
more RBR O
ethnically RB O
diverse JJ O
panel NN O
. . O

Among IN O
90 CD O
symptomatic JJ O
mutation NN O
- : O
positive JJ O
individuals NNS O
, , O
11 CD O
mutations NNS O
accounted VBD O
for IN O
79 CD O
% NN O
of IN O
carrier NN O
chromosomes NNS O
. . O

Of IN O
the DT O
two CD O
mutations NNS O
that WDT O
are VBP O
novel JJ O
, , O
one CD O
alters VBZ O
the DT O
same JJ O
residue NN O
( ( O
680 CD O
) ) O
as IN O
a DT O
previously RB O
known VBN O
mutation NN O
, , O
and CC O
the DT O
other JJ O
( ( O
P369S NNP O
) ) O
is VBZ O
located VBN O
in IN O
exon JJ O
3 CD O
. . O

Consistent JJ O
with IN O
another DT O
recent JJ O
report NN O
, , O
the DT O
E148Q NNP O
mutation NN O
was VBD O
observed VBN O
in IN O
patients NNS O
of IN O
several JJ O
ethnicities NNS O
and CC O
on IN O
multiple JJ O
microsatellite JJ O
haplotypes NNS O
, , O
but CC O
haplotype JJ O
data NNS O
indicate VBP O
an DT O
ancestral JJ O
relationships NNS O
between IN O
non NN O
- : O
Jewish JJ O
Italian JJ O
and CC O
Ashkenazi JJ O
Jewish JJ O
patients NNS O
with IN O
FMF NNP B-Disease
and CC O
other JJ O
affected JJ O
populations NNS O
. . O

Among IN O
approximately RB O
200 CD O
anonymous JJ O
Ashkenazi NNP O
Jewish NNP O
DNA NNP O
samples NNS O
, , O
the DT O
MEFV NNP O
carrier NN O
frequency NN O
was VBD O
21 CD O
% NN O
, , O
with IN O
E148Q NNP O
the DT O
most RBS O
common JJ O
mutation NN O
. . O

Several JJ O
lines NNS O
of IN O
evidence NN O
indicate NN O
reduced VBN O
penetrance NN O
among IN O
Ashkenazi NNP O
Jews NNP O
, , O
especially RB O
for IN O
E148Q NNP O
, , O
P369S NNP O
, , O
and CC O
K695R NNP O
. . O

Nevertheless RB O
, , O
E148Q NNP O
helps VBZ O
account VB O
for IN O
recessive JJ O
inheritance NN O
in IN O
an DT O
Ashkenazi NNP O
family NN O
previously RB O
reported VBD O
as IN O
an DT O
unusual JJ O
case NN O
of IN O
dominantly RB O
inherited VBN O
FMF NNP B-Disease
. . O

The DT O
presence NN O
of IN O
three CD O
frequent JJ O
MEFV NNP O
mutations NNS O
in IN O
multiple JJ O
Mediterranean NNP O
populations NNS O
strongly RB O
suggests VBZ O
a DT O
heterozygote NN O
advantage NN O
in IN O
this DT O
geographic JJ O
region NN O
. . O

Autoimmune NNP B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
with IN O
defective JJ O
Fas NNS O
: : O
genotype NN O
influences NNS O
penetrance NN O
. . O

Autoimmune NNP B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
( ( O
ALPS NNP B-Disease
) ) O
is VBZ O
a DT O
disorder NN B-Disease
of IN I-Disease
lymphocyte JJ I-Disease
homeostasis NN I-Disease
and CC I-Disease
immunological JJ I-Disease
tolerance NN I-Disease
. . O

Most JJS O
patients NNS O
have VBP O
a DT O
heterozygous JJ O
mutation NN O
in IN O
the DT O
APT1 NNP O
gene NN O
, , O
which WDT O
encodes VBZ O
Fas NNP O
( ( O
CD95 NNP O
, , O
APO NNP O
- : O
1 CD O
) ) O
, , O
mediator NN O
of IN O
an DT O
apoptotic JJ O
pathway NN O
crucial JJ O
to TO O
lymphocyte VB O
homeostasis NN O
. . O

Of IN O
17 CD O
unique JJ O
APT1 NNP O
mutations NNS O
in IN O
unrelated JJ O
ALPS NNP B-Disease
probands NNS O
, , O
12 CD O
( ( O
71 CD O
% NN O
) ) O
occurred VBD O
in IN O
exons NNS O
7 CD O
- : O
9 CD O
, , O
which WDT O
encode VBP O
the DT O
intracellular JJ O
portion NN O
of IN O
Fas NNP O
. . O

In IN O
vitro NN O
, , O
activated VBN O
lymphocytes NNS O
from IN O
all DT O
17 CD O
patients NNS O
showed VBD O
apoptotic JJ O
defects NNS O
when WRB O
exposed VBN O
to TO O
an DT O
anti JJ O
- : O
Fas NNP O
agonist VBP O
monoclonal JJ O
antibody NN O
. . O

Similar JJ O
defects NNS O
were VBD O
found VBN O
in IN O
a DT O
Fas NNP O
- : O
negative JJ O
cell NN O
line NN O
transfected VBN O
with IN O
cDNAs JJ O
bearing VBG O
each DT O
of IN O
the DT O
mutations NNS O
. . O

In IN O
cotransfection NN O
experiments NNS O
, , O
Fas NNP O
constructs VBZ O
with IN O
either DT O
intra JJ O
- : O
or CC O
extracellular JJ O
mutations NNS O
caused VBD O
dominant JJ O
inhibition NN O
of IN O
apoptosis NN O
mediated VBN O
by IN O
wild JJ O
- : O
type NN O
Fas NNP O
. . O

Two CD O
missense NN O
Fas NNP O
variants NNS O
, , O
not RB O
restricted VBN O
to TO O
patients NNS O
with IN O
ALPS NNP B-Disease
, , O
were VBD O
identified VBN O
. . O

Variant VB O
A NNP O
( ( O
- : O
1 CD O
) ) O
T NN O
at IN O
the DT O
Fas NNP O
signal JJ O
- : O
sequence NN O
cleavage NN O
site NN O
, , O
which WDT O
mediates VBZ O
apoptosis NN O
less JJR O
well RB O
than IN O
wild JJ O
- : O
type NN O
Fas NNP O
and CC O
is VBZ O
partially RB O
inhibitory JJ O
, , O
was VBD O
present JJ O
in IN O
13 CD O
% NN O
of IN O
African JJ O
American JJ O
alleles NNS O
. . O

Among IN O
the DT O
ALPS NNP B-Disease
- : O
associated VBN O
Fas NNP O
mutants NNS O
, , O
dominant JJ O
inhibition NN O
of IN O
apoptosis NN O
was VBD O
much RB O
more JJR O
pronounced JJ O
in IN O
mutants NNS O
affecting VBG O
the DT O
intracellular NN O
, , O
versus NN O
extracellular NN O
, , O
portion NN O
of IN O
the DT O
Fas NNP O
receptor NN O
. . O

Mutations NNS O
causing VBG O
disruption NN O
of IN O
the DT O
intracellular JJ O
Fas NNP O
death NN O
domain NN O
also RB O
showed VBD O
a DT O
higher JJR O
penetrance NN O
of IN O
ALPS NNP B-Disease
phenotype NN O
features NNS O
in IN O
mutation NN O
- : O
bearing NN O
relatives NNS O
. . O

Significant NNP O
ALPS NNP B-Disease
- : O
related JJ O
morbidity NN O
occurred VBD O
in IN O
44 CD O
% NN O
of IN O
relatives NNS O
with IN O
intracellular JJ O
mutations NNS O
, , O
versus VBP O
0 CD O
% NN O
of IN O
relatives NNS O
with IN O
extracellular JJ O
mutations NNS O
. . O

Thus RB O
, , O
the DT O
location NN O
of IN O
mutations NNS O
within IN O
APT1 NNP O
strongly RB O
influences VBZ O
the DT O
development NN O
and CC O
the DT O
severity NN O
of IN O
ALPS NNP B-Disease
. . O

Multicentric NNP O
origin NN O
of IN O
hemochromatosis NN B-Disease
gene NN O
( ( O
HFE NNP O
) ) O
mutations NNS O
. . O

Genetic JJ B-Disease
hemochromatosis NN I-Disease
( ( O
GH NNP B-Disease
) ) O
is VBZ O
believed VBN O
to TO O
be VB O
a DT O
disease NN O
restricted VBN O
to TO O
those DT O
of IN O
European JJ O
ancestry NN O
. . O

In IN O
northwestern JJ O
Europe NNP O
, , O
> VBD O
80 CD O
% NN O
of IN O
GH NNP B-Disease
patients NNS O
are VBP O
homozygous JJ O
for IN O
one CD O
mutation NN O
, , O
the DT O
substitution NN O
of IN O
tyrosine NN O
for IN O
cysteine NN O
at IN O
position NN O
282 CD O
( ( O
C282Y NNP O
) ) O
in IN O
the DT O
unprocessed JJ O
protein NN O
. . O

In IN O
a DT O
proportion NN O
of IN O
GH NNP B-Disease
patients NNS O
, , O
two CD O
mutations NNS O
are VBP O
present JJ O
, , O
C282Y NNP O
and CC O
H63D NNP O
. . O

The DT O
clinical JJ O
significance NN O
of IN O
this DT O
second JJ O
mutation NN O
is VBZ O
such JJ O
that IN O
it PRP O
appears VBZ O
to TO O
predispose VB O
1 CD O
% NN O
- : O
2 CD O
% NN O
of IN O
compound NN O
heterozygotes NNS O
to TO O
expression NN O
of IN O
the DT O
disease NN O
. . O

The DT O
distribution NN O
of IN O
the DT O
two CD O
mutations NNS O
differ VBP O
, , O
C282Y NNP O
being VBG O
limited VBN O
to TO O
those DT O
of IN O
northwestern JJ O
European JJ O
ancestry NN O
and CC O
H63D NNP O
being VBG O
found VBN O
at IN O
allele JJ O
frequencies NNS O
> VBP O
5 CD O
% NN O
, , O
in IN O
Europe NNP O
, , O
in IN O
countries NNS O
bordering VBG O
the DT O
Mediterranean NNP O
, , O
in IN O
the DT O
Middle NNP O
East NNP O
, , O
and CC O
in IN O
the DT O
Indian JJ O
subcontinent NN O
. . O

The DT O
C282Y NNP O
mutation NN O
occurs VBZ O
on IN O
a DT O
haplotype NN O
that WDT O
extends VBZ O
< JJ O
/ NNP O
= NNP O
6 CD O
Mb NNP O
, , O
suggesting VBG O
that IN O
this DT O
mutation NN O
has VBZ O
arisen VBN O
during IN O
the DT O
past JJ O
2 CD O
, , O
0 CD O
years NNS O
. . O

The DT O
H63D NNP O
mutation NN O
is VBZ O
older JJR O
and CC O
does VBZ O
not RB O
occur VB O
on IN O
such PDT O
a DT O
large JJ O
extended JJ O
haplotype NN O
, , O
the DT O
haplotype NN O
in IN O
this DT O
case NN O
extending VBG O
< NNP O
/ NNP O
= VBD O
700 CD O
kb NN O
. . O

Here RB O
we PRP O
report VBP O
the DT O
finding NN O
of IN O
the DT O
H63D NNP O
and CC O
C282Y NNP O
mutations NNS O
on IN O
new JJ O
haplotypes NNS O
. . O

In IN O
Sri NNP O
Lanka NNP O
we PRP O
have VBP O
found VBN O
H63D NNP O
on IN O
three CD O
new JJ O
haplotypes NNS O
and CC O
have VBP O
found VBN O
C282Y NNP O
on IN O
one CD O
new JJ O
haplotype NN O
, , O
demonstrating VBG O
that IN O
these DT O
mutations NNS O
have VBP O
arisen VBN O
independently RB O
on IN O
this DT O
island NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
HFE NNP O
gene NN O
has VBZ O
been VBN O
the DT O
subject NN O
of IN O
selection NN O
pressure NN O
. . O

These DT O
selection NN O
pressures NNS O
could MD O
be VB O
due JJ O
to TO O
infectious JJ B-Disease
diseases NNS I-Disease
, , O
environmental JJ O
conditions NNS O
, , O
or CC O
other JJ O
genetic JJ B-Disease
disorders NNS I-Disease
such JJ O
as IN O
anemia NN B-Disease
. . O

A DT O
retrospective JJ O
anonymous JJ O
pilot NN O
study NN O
in IN O
screening VBG O
newborns NNS O
for IN O
HFE NNP O
mutations NNS O
in IN O
Scandinavian JJ O
populations NNS O
. . O

We PRP O
have VBP O
retrospectively RB O
analyzed VBN O
837 CD O
random JJ O
anonymized VBN O
dried JJ O
blood NN O
spot NN O
( ( O
DBS NNP O
) ) O
samples VBZ O
from IN O
neonatal JJ O
screening VBG O
programs NNS O
in IN O
Scandinavia NNP O
for IN O
mutations NNS O
in IN O
HFE NNP O
, , O
the DT O
candidate NN O
gene NN O
for IN O
hemochromatosis NN B-Disease
. . O

We PRP O
have VBP O
found VBN O
C282Y NNP O
allele JJ O
frequencies NNS O
of IN O
2 CD O
. . O

3 CD O
% NN O
( ( O
+ JJ O
2 CD O
. . O
0 CD O
% NN O
) ) O
( ( O
- : O
1 CD O
. . O
3 CD O
% NN O
) ) O
in IN O
Greenland NNP O
, , O
4 CD O
. . O

5 CD O
% NN O
+ NNP O
/ NNP O
- : O
1 CD O
. . O

9 CD O
% NN O
in IN O
Iceland NNP O
, , O
5 CD O
. . O

1 CD O
% NN O
+ NNP O
/ NNP O
- : O
2 CD O
. . O

3 CD O
% NN O
in IN O
the DT O
Faeroe NNP O
Islands NNP O
, , O
and CC O
8 CD O
. . O

2 CD O
% NN O
+ NNP O
/ NNP O
- : O
2 CD O
. . O

7 CD O
% NN O
in IN O
Denmark NNP O
. . O

The DT O
high JJ O
prevalence NN O
of IN O
HFE NNP O
mutations NNS O
in IN O
Denmark NNP O
suggests VBZ O
that IN O
population NN O
screening VBG O
for IN O
the DT O
C282Y NNP O
mutation NN O
could MD O
be VB O
highly RB O
advantageous JJ O
in IN O
terms NNS O
of IN O
preventive JJ O
health NN O
care NN O
. . O

Long NNP O
- : O
term NN O
follow SYM O
- : O
up IN O
evaluation NN O
of IN O
C282Y NNP O
homozygotes NNS O
and CC O
H63D NNP O
/ NNP O
C282Y NNP O
compound NN O
heterozygotes NNS O
will MD O
give VB O
an DT O
indication NN O
of IN O
the DT O
penetrance NN O
of IN O
the DT O
mutations NNS O
. . O

Identification NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
alkaptonuria NN B-Disease
mouse NN O
model NN O
. . O

Alkaptonuria NNP B-Disease
( ( O
aku NN B-Disease
) ) O
, , O
an DT O
inborn JJ B-Disease
error NN I-Disease
of IN I-Disease
metabolism NN I-Disease
caused VBN O
by IN O
the DT O
loss NN O
of IN O
homogentisate NN O
1 CD O
, , O
2 CD O
- : O
dioxygenase NN O
( ( O
HGD NNP O
) ) O
, , O
has VBZ O
been VBN O
described VBN O
in IN O
a DT O
mouse NN O
model NN O
created VBN O
by IN O
ethylnitrosourea JJ O
mutagenesis NN O
but CC O
the DT O
mutation NN O
in IN O
these DT O
mice NN O
has VBZ O
not RB O
previously RB O
been VBN O
identified VBN O
. . O

We PRP O
used VBD O
RT NNP O
- : O
PCR NN O
to TO O
amplify VB O
the DT O
Hgd NNP O
cDNA NN O
from IN O
Hgd NNP O
( ( O
aku NN O
) ) O
/ NN O
Hgd NNP O
( ( O
aku NN O
) ) O
mice NN O
. . O

Two CD O
products NNS O
shorter JJR O
than IN O
the DT O
wild JJ O
- : O
type NN O
product NN O
were VBD O
amplified VBN O
. . O

Restriction NN O
mapping NN O
and CC O
DNA NNP O
sequencing VBG O
were VBD O
then RB O
used VBN O
to TO O
identify VB O
the DT O
Hgd NNP O
( ( O
aku NN O
) ) O
mouse NN O
mutation NN O
, , O
found VBN O
to TO O
be VB O
a DT O
single JJ O
base NN O
change NN O
in IN O
a DT O
splice NN O
donor NN O
consensus NN O
sequence NN O
, , O
causing VBG O
exon NN O
skipping NN O
and CC O
frame NN O
- : O
shifted VBN O
products NNS O
. . O

This DT O
base NN O
change NN O
allowed VBD O
us PRP O
to TO O
create VB O
a DT O
non JJ O
- : O
radioactive JJ O
genotyping NN O
assay NN O
for IN O
this DT O
allele NN O
. . O

Non NNP B-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
associated VBN O
with IN O
enlarged JJ B-Disease
vestibular JJ I-Disease
aqueduct NN I-Disease
is VBZ O
caused VBN O
by IN O
PDS NNP B-Disease
mutations NNS O
. . O

Enlarged NNP B-Disease
vestibular JJ I-Disease
aqueduct NN I-Disease
( ( O
EVA NNP B-Disease
) ) O
, , O
known VBN O
as IN O
the DT O
most RBS O
common JJ O
form NN O
of IN O
inner JJ B-Disease
ear JJ I-Disease
abnormality NN I-Disease
, , O
has VBZ O
recently RB O
been VBN O
of IN O
particular JJ O
genetic JJ O
interest NN O
because IN O
this DT O
anomaly NN O
is VBZ O
inherited VBN O
in IN O
a DT O
recessive JJ O
manner NN O
. . O

The DT O
locus NN O
for IN O
non JJ B-Disease
- : I-Disease
syndromic JJ I-Disease
sensorineural JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
with IN O
EVA NNP B-Disease
has VBZ O
been VBN O
mapped VBN O
to TO O
the DT O
same JJ O
chromosomal JJ O
region NN O
, , O
7q31 CD O
, , O
as IN O
the DT O
Pendred NNP B-Disease
syndrome NN I-Disease
locus NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
seven CD O
mutations NNS O
in IN O
the DT O
PDS NNP B-Disease
gene NN O
( ( O
PDS NNP O
) ) O
, , O
the DT O
gene NN O
responsible JJ O
for IN O
Pendred NNP B-Disease
syndrome NN I-Disease
, , O
have VBP O
been VBN O
found VBN O
in IN O
families NNS O
of IN O
non JJ B-Disease
- : I-Disease
syndromic JJ I-Disease
sensorineural JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
with IN O
EVA NNP B-Disease
. . O

One CD O
family NN O
is VBZ O
homozygous JJ O
, , O
three CD O
families NNS O
are VBP O
compound JJ O
heterozygotes NNS O
, , O
and CC O
two CD O
families NNS O
are VBP O
heterozygous JJ O
but CC O
with IN O
no DT O
other JJ O
mutation NN O
detected VBN O
. . O

The DT O
present JJ O
results NNS O
provide VBP O
evidence NN O
that IN O
mutations NNS O
in IN O
PDS NNP O
cause NN O
both DT O
syndromic JJ B-Disease
and CC I-Disease
non JJ I-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
. . O
. . O

Mutational JJ O
analysis NN O
and CC O
genotype NN O
- : O
phenotype JJ O
correlation NN O
of IN O
29 CD O
unrelated JJ O
Japanese JJ O
patients NNS O
with IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
adrenoleukodystrophy NN I-Disease
. . O

BACKGROUND NNP O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
ALD NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ B-Disease
disease NN I-Disease
characterized VBN O
by IN O
progressive JJ O
neurologic JJ B-Disease
dysfunction NN I-Disease
, , O
occasionally RB O
associated VBN O
with IN O
adrenal JJ B-Disease
insufficiency NN I-Disease
. . O

The DT O
classic JJ O
form NN O
of IN O
ALD NNP B-Disease
usually RB O
has VBZ O
onset VBN O
in IN O
childhood NN O
( ( O
childhood JJ B-Disease
cerebral JJ I-Disease
ALD NNP I-Disease
) ) O
, , O
with IN O
rapid JJ O
neurologic JJ B-Disease
deterioration NN I-Disease
leading VBG O
to TO O
a DT O
vegetative JJ O
state NN O
. . O

Adult NNP O
- : O
onset JJ O
cerebral JJ B-Disease
ALD NNP I-Disease
also RB O
presents VBZ O
with IN O
rapidly RB O
progressive JJ O
neurologic JJ B-Disease
dysfunction NN I-Disease
. . O

Milder NNP O
phenotypes NNS O
such JJ O
as IN O
adrenomyeloneuropathy JJ B-Disease
and CC O
Addison NNP B-Disease
disease NN I-Disease
only RB O
also RB O
have VBP O
been VBN O
recognized VBN O
. . O

Despite IN O
discovery NN O
of IN O
the DT O
causative JJ O
gene NN O
, , O
a DT O
molecular JJ O
basis NN O
for IN O
the DT O
diverse JJ O
clinical JJ O
presentations NNS O
remains VBZ O
to TO O
be VB O
elucidated VBN O
. . O

OBJECTIVES NNP O
To TO O
conduct VB O
mutational JJ O
analyses NNS O
in IN O
29 CD O
Japanese JJ O
patients NNS O
with IN O
ALD NNP B-Disease
from IN O
29 CD O
unrelated JJ O
families NNS O
, , O
to TO O
obtain VB O
knowledge NN O
of IN O
the DT O
spectrum NN O
of IN O
mutations NNS O
in IN O
this DT O
gene NN O
, , O
and CC O
to TO O
study VB O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
in IN O
Japanese JJ O
patients NNS O
. . O

METHODS NNP O
The DT O
29 CD O
patients NNS O
comprised VBD O
13 CD O
patients NNS O
with IN O
childhood JJ B-Disease
cerebral JJ I-Disease
ALD NNP I-Disease
, , O
11 CD O
patients NNS O
with IN O
adult JJ O
- : O
onset JJ O
cerebral JJ B-Disease
ALD NNP I-Disease
, , O
and CC O
5 CD O
patients NNS O
with IN O
adrenomyeloneuropathy JJ B-Disease
. . O

We PRP O
conducted VBD O
detailed JJ O
mutational JJ O
analyses NNS O
of IN O
29 CD O
unrelated JJ O
Japanese JJ O
patients NNS O
with IN O
ALD NNP B-Disease
by IN O
genomic JJ O
Southern NNP O
blot NN O
analysis NN O
and CC O
direct JJ O
nucleotide JJ O
sequence NN O
analysis NN O
of IN O
reverse NN O
transcriptase NN O
- : O
polymerase NN O
chain NN O
reaction NN O
products NNS O
derived VBN O
from IN O
total JJ O
RNA NNP O
that WDT O
was VBD O
extracted VBN O
from IN O
cultured VBN O
skin NN O
fibroblasts NNS O
, , O
lymphoblastoid JJ O
cells NNS O
, , O
or CC O
peripheral JJ O
blood NN O
leukocytes NNS O
. . O

RESULTS NNP O
Three CD O
patients NNS O
with IN O
adult JJ O
- : O
onset JJ O
cerebral JJ B-Disease
ALD NNP I-Disease
were VBD O
identified VBN O
as IN O
having VBG O
large JJ O
genomic JJ O
rearrangements NNS O
. . O

The DT O
remaining VBG O
26 CD O
patients NNS O
were VBD O
identified VBN O
as IN O
having VBG O
21 CD O
independent JJ O
mutations NNS O
, , O
including VBG O
12 CD O
novel JJ O
mutations NNS O
resulting VBG O
in IN O
small JJ O
nucleotide JJ O
alterations NNS O
in IN O
the DT O
ALD NNP B-Disease
gene NN O
. . O

Eighteen NNP O
( ( O
69 CD O
% NN O
) ) O
of IN O
26 CD O
mutations NNS O
were VBD O
missense JJ O
mutations NNS O
. . O

Most JJS O
missense JJ O
mutations NNS O
involved VBN O
amino JJ O
acids NNS O
conserved VBN O
in IN O
homologous JJ O
gene NN O
products NNS O
, , O
including VBG O
PMP70 NNP O
, , O
mALDRP NN O
, , O
and CC O
Pxa1p NNP O
. . O

The DT O
AG NNP O
dinucleotide NN O
deletion NN O
at IN O
position NN O
1081 CD O
- : O
1082 CD O
, , O
which WDT O
has VBZ O
been VBN O
reported VBN O
previously RB O
to TO O
be VB O
the DT O
most RBS O
common JJ O
mutation NN O
in IN O
white JJ O
patients NNS O
( ( O
12 CD O
% NN O
- : O
17 CD O
% NN O
) ) O
, , O
was VBD O
also RB O
identified VBN O
as IN O
the DT O
most RBS O
common JJ O
mutation NN O
in IN O
Japanese JJ O
patients NNS O
( ( O
12 CD O
% NN O
) ) O
. . O

All DT O
phenotypes NNS O
were VBD O
associated VBN O
with IN O
mutations NNS O
resulting VBG O
in IN O
protein NN O
truncation NN O
or CC O
subtle JJ O
amino NN O
acid NN O
changes NNS O
. . O

There EX O
were VBD O
no DT O
differences NNS O
in IN O
phenotypic JJ O
expressions NNS O
between IN O
missense JJ O
mutations NNS O
involving VBG O
conserved VBD O
amino JJ O
acids NNS O
and CC O
those DT O
involving VBG O
nonconserved JJ O
amino JJ O
acids NNS O
. . O

CONCLUSIONS NNP O
There EX O
are VBP O
no DT O
obvious JJ O
correlations NNS O
between IN O
the DT O
phenotypes NNS O
of IN O
patients NNS O
with IN O
ALD NNP B-Disease
and CC O
their PRP$ O
genotypes NNS O
, , O
suggesting VBG O
that IN O
other JJ O
genetic JJ O
or CC O
environmental JJ O
factors NNS O
modify VBP O
the DT O
phenotypic NN O
expressions NNS O
of IN O
ALD NNP B-Disease
. . O
. . O

A DT O
common JJ O
human JJ O
skin FW B-Disease
tumour NN I-Disease
is VBZ O
caused VBN O
by IN O
activating VBG O
mutations NNS O
in IN O
beta NN O
- : O
catenin NN O
. . O

WNT NNP O
signalling VBG O
orchestrates VBZ O
a DT O
number NN O
of IN O
developmental JJ O
programs NNS O
. . O

In IN O
response NN O
to TO O
this DT O
stimulus NN O
, , O
cytoplasmic JJ O
beta NN O
- : O
catenin NN O
( ( O
encoded VBN O
by IN O
CTNNB1 NNP O
) ) O
is VBZ O
stabilized VBN O
, , O
enabling VBG O
downstream JJ O
transcriptional JJ O
activation NN O
by IN O
members NNS O
of IN O
the DT O
LEF NNP O
/ NNP O
TCF NNP O
family NN O
. . O

One CD O
of IN O
the DT O
target NN O
genes NNS O
for IN O
beta NN O
- : O
catenin NN O
/ NN O
TCF NNP O
encodes VBZ O
c SYM O
- : O
MYC NNP O
, , O
explaining VBG O
why WRB O
constitutive JJ O
activation NN O
of IN O
the DT O
WNT NNP O
pathway NN O
can MD O
lead VB O
to TO O
cancer NN B-Disease
, , O
particularly RB O
in IN O
the DT O
colon NN O
. . O

Most JJS O
colon NN B-Disease
cancers NNS I-Disease
arise VBP O
from IN O
mutations NNS O
in IN O
the DT O
gene NN O
encoding VBG O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
, , O
a DT O
protein NN O
required VBN O
for IN O
ubiquitin JJ O
- : O
mediated VBN O
degradation NN O
of IN O
beta NN O
- : O
catenin NN O
, , O
but CC O
a DT O
small JJ O
percentage NN O
of IN O
colon NN B-Disease
and CC I-Disease
some DT I-Disease
other JJ I-Disease
cancers NNS I-Disease
harbour VBP O
beta SYM O
- : O
catenin NN O
- : O
stabilizing NN O
mutations NNS O
. . O

Recently RB O
, , O
we PRP O
discovered VBD O
that IN O
transgenic JJ O
mice NN O
expressing VBG O
an DT O
activated VBN O
beta NN O
- : O
catenin NN O
are VBP O
predisposed VBN O
to TO O
developing VBG O
skin JJ B-Disease
tumours NNS I-Disease
resembling VBG O
pilomatricomas NN B-Disease
. . O

Given VBN O
that IN O
the DT O
skin NN O
of IN O
these DT O
adult NN O
mice NN O
also RB O
exhibits VBZ O
signs NNS O
of IN O
de FW O
novo FW O
hair NN O
- : O
follicle NN O
morphogenesis NN O
, , O
we PRP O
wondered VBD O
whether IN O
human JJ O
pilomatricomas NN B-Disease
might MD O
originate VB O
from IN O
hair NN O
matrix NN O
cells NNS O
and CC O
whether IN O
they PRP O
might MD O
possess VB O
beta SYM O
- : O
catenin NN O
- : O
stabilizing NN O
mutations NNS O
. . O

Here RB O
, , O
we PRP O
explore VBP O
the DT O
cell NN O
origin NN O
and CC O
aetiology NN O
of IN O
this DT O
common JJ O
human JJ O
skin FW B-Disease
tumour NN I-Disease
. . O

We PRP O
found VBD O
nuclear JJ O
LEF NNP O
- : O
1 CD O
in IN O
the DT O
dividing VBG O
tumour NN B-Disease
cells NNS O
, , O
providing VBG O
biochemical JJ O
evidence NN O
that IN O
pilomatricomas NN B-Disease
are VBP O
derived VBN O
from IN O
hair NN O
matrix NN O
cells NNS O
. . O

At IN O
least JJS O
75 CD O
% NN O
of IN O
these DT O
tumours NNS B-Disease
possess VBP O
mutations NNS O
affecting VBG O
the DT O
amino NN O
- : O
terminal NN O
segment NN O
, , O
normally RB O
involved VBN O
in IN O
phosphorylation NN O
- : O
dependent NN O
, , O
ubiquitin JJ O
- : O
mediated VBN O
degradation NN O
of IN O
the DT O
protein NN O
. . O

This DT O
percentage NN O
of IN O
CTNNB1 NNP O
mutations NNS O
is VBZ O
greater JJR O
than IN O
in IN O
all DT O
other JJ O
human JJ O
tumours NNS B-Disease
examined VBD O
thus RB O
far RB O
, , O
and CC O
directly RB O
implicates VBZ O
beta SYM O
- : O
catenin NN O
/ NN O
LEF NNP O
misregulation NN O
as IN O
the DT O
major JJ O
cause NN O
of IN O
hair NN O
matrix NN O
cell NN O
tumorigenesis NN O
in IN O
humans NNS O
. . O
. . O

The DT O
Pendred NNP B-Disease
syndrome JJ I-Disease
gene NN O
encodes VBZ O
a DT O
chloride JJ O
- : O
iodide NN O
transport NN O
protein NN O
. . O

Pendred NNP B-Disease
syndrome NN I-Disease
is VBZ O
the DT O
most RBS O
common JJ O
form NN O
of IN O
syndromic JJ B-Disease
deafness NN I-Disease
and CC O
characterized VBN O
by IN O
congenital JJ O
sensorineural JJ B-Disease
hearing NN I-Disease
loss NN I-Disease
and CC O
goitre NN B-Disease
. . O

This DT O
disorder NN O
was VBD O
mapped VBN O
to TO O
chromosome VB O
7 CD O
and CC O
the DT O
gene NN O
causing VBG O
Pendred NNP B-Disease
syndrome NN I-Disease
( ( O
PDS NNP B-Disease
) ) O
was VBD O
subsequently RB O
identified VBN O
by IN O
positional JJ O
cloning NN O
. . O

PDS NNP O
encodes VBZ O
a DT O
putative JJ O
transmembrane NN O
protein NN O
designated VBD O
pendrin NN O
. . O

Pendrin NNP O
is VBZ O
closely RB O
related VBN O
to TO O
a DT O
family NN O
of IN O
sulfate NN O
transport NN O
proteins VBZ O
that WDT O
includes VBZ O
the DT O
rat NN O
sulfate NN O
- : O
anion NN O
transporter NN O
( ( O
encoded VBN O
by IN O
Sat NNP O
- : O
1 CD O
; : O
29 CD O
% NN O
amino NN O
acid JJ O
sequence NN O
identity NN O
) ) O
, , O
the DT O
human JJ O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulfate NN O
transporter NN O
( ( O
encoded VBN O
by IN O
DTD NNP O
; : O
32 CD O
% NN O
) ) O
and CC O
the DT O
human JJ O
sulfate NN O
transporter NN O
downregulated VBN O
in IN O
adenoma NN B-Disease
( ( O
encoded VBN O
by IN O
DRA NNP O
; : O
45 CD O
% NN O
) ) O
. . O

On IN O
the DT O
basis NN O
of IN O
this DT O
homology NN O
and CC O
the DT O
presence NN O
of IN O
a DT O
slightly RB O
modified VBN O
sulfate NN O
- : O
transporter NN O
signature NN O
sequence NN O
comprising VBG O
its PRP$ O
putative JJ O
second JJ O
transmembrane NN O
domain NN O
, , O
pendrin NN O
has VBZ O
been VBN O
proposed VBN O
to TO O
function VB O
as IN O
a DT O
sulfate NN O
transporter NN O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
detect VB O
evidence NN O
of IN O
sulfate JJ O
transport NN O
following VBG O
the DT O
expression NN O
of IN O
pendrin NN O
in IN O
Xenopus NNP O
laevis NN O
oocytes NNS O
by IN O
microinjection NN O
of IN O
PDS NNP O
cRNA NN O
or CC O
in IN O
Sf9 NNP O
cells NNS O
following VBG O
infection NN O
with IN O
PDS NNP O
- : O
recombinant NN O
baculovirus NN O
. . O

The DT O
rates NNS O
of IN O
transport NN O
for IN O
iodide NN O
and CC O
chloride NN O
were VBD O
significantly RB O
increased VBN O
following VBG O
the DT O
expression NN O
of IN O
pendrin NN O
in IN O
both DT O
cell NN O
systems NNS O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
pendrin JJ O
functions NNS O
as IN O
a DT O
transporter NN O
of IN O
chloride NN O
and CC O
iodide NN O
, , O
but CC O
not RB O
sulfate VB O
, , O
and CC O
may MD O
provide VB O
insight NN O
into IN O
thyroid JJ O
physiology NN O
and CC O
the DT O
pathophysiology NN O
of IN O
Pendred NNP B-Disease
syndrome NN I-Disease
. . O
. . O

HFE NNP O
mutations NNS O
analysis NN O
in IN O
711 CD O
hemochromatosis NN B-Disease
probands NNS O
: : O
evidence NN O
for IN O
S65C NNP O
implication NN O
in IN O
mild JJ O
form NN O
of IN O
hemochromatosis NN B-Disease
. . O

Hereditary JJ B-Disease
hemochromatosis NN I-Disease
( ( O
HH NNP B-Disease
) ) O
is VBZ O
a DT O
common JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
of IN O
iron NN O
metabolism NN O
. . O

The DT O
HFE NNP O
candidate NN O
gene NN O
encoding VBG O
an DT O
HLA NNP O
class NN O
I PRP O
- : O
like IN O
protein NNS O
involved VBN O
in IN O
HH NNP B-Disease
was VBD O
identified VBN O
in IN O
1996 CD O
. . O

Two CD O
missense NN O
mutations NNS O
have VBP O
been VBN O
described VBN O
C282Y NNP O
, , O
accounting VBG O
for IN O
80 CD O
% NN O
to TO O
90 CD O
% NN O
of IN O
HH NNP B-Disease
chromosomes NNS O
, , O
and CC O
H63D NNP O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
a DT O
milder NN O
form NN O
of IN O
the DT O
disease NN O
representing VBG O
40 CD O
% NN O
to TO O
70 CD O
% NN O
of IN O
non JJ O
- : O
C282Y NNP O
HH NNP B-Disease
chromosomes NNS O
. . O

We PRP O
report VBP O
here RB O
on IN O
the DT O
analysis NN O
of IN O
C282Y NNP O
, , O
H63D NNP O
, , O
and CC O
the DT O
193A CD O
- : O
- : O
> NN O
T NNP O
substitution NN O
leading VBG O
to TO O
the DT O
S65C NNP O
missense NN O
substitution NN O
in IN O
a DT O
large JJ O
series NN O
of IN O
probands NNS O
and CC O
controls NNS O
. . O

The DT O
results NNS O
confirm VBP O
that IN O
the DT O
C282Y NNP O
substitution NN O
was VBD O
the DT O
main JJ O
mutation NN O
involved VBN O
in IN O
hemochromatosis NN B-Disease
, , O
accounting VBG O
for IN O
85 CD O
% NN O
of IN O
carrier NN O
chromosomes NNS O
, , O
whereas IN O
the DT O
H63D NNP O
substitution NN O
represented VBD O
39 CD O
% NN O
of IN O
the DT O
HH NNP B-Disease
chromosomes NNS O
that WDT O
did VBD O
not RB O
carry VB O
the DT O
C282Y NNP O
mutation NN O
. . O

In IN O
addition NN O
, , O
our PRP$ O
screening NN O
showed VBD O
that IN O
the DT O
S65C NNP O
substitution NN O
was VBD O
significantly RB O
enriched VBN O
in IN O
probands NNS O
with IN O
at IN O
least JJS O
one CD O
chromosome NN O
without IN O
an DT O
assigned JJ O
mutation NN O
. . O

This DT O
substitution NN O
accounted VBD O
for IN O
7 CD O
. . O

8 CD O
% NN O
of IN O
HH NNP B-Disease
chromosomes NNS O
that WDT O
were VBD O
neither DT O
C282Y NNP O
nor CC O
H63D NNP O
. . O

This DT O
enrichment NN O
of IN O
S65C NNP O
among IN O
HH NNP B-Disease
chromosomes NNS O
suggests VBZ O
that IN O
the DT O
S65C NNP O
substitution NN O
is VBZ O
associated VBN O
with IN O
the DT O
mild JJ O
form NN O
of IN O
hemochromatosis NN B-Disease
. . O

Germline NNP O
BRCA1 NNP O
alterations NNS O
in IN O
a DT O
population NN O
- : O
based VBN O
series NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
cases NNS O
. . O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
provide VB O
more JJR O
accurate JJ O
frequency NN O
estimates NNS O
of IN O
breast NN B-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
1 CD O
( ( O
BRCA1 NNP O
) ) O
germline NN O
alterations NNS O
in IN O
the DT O
ovarian JJ B-Disease
cancer NN I-Disease
population NN O
. . O

To TO O
achieve VB O
this DT O
, , O
we PRP O
determined VBD O
the DT O
prevalence NN O
of IN O
BRCA1 NNP O
alterations NNS O
in IN O
a DT O
population NN O
- : O
based VBN O
series NN O
of IN O
consecutive JJ O
ovarian JJ B-Disease
cancer NN I-Disease
cases NNS O
. . O

This DT O
is VBZ O
the DT O
first JJ O
population NN O
- : O
based VBN O
ovarian JJ B-Disease
cancer NN I-Disease
study NN O
reporting VBG O
BRCA1 NNP O
alterations NNS O
derived VBD O
from IN O
a DT O
comprehensive JJ O
screen NN O
of IN O
the DT O
entire JJ O
coding NN O
region NN O
. . O

One CD O
hundred CD O
and CC O
seven CD O
ovarian JJ B-Disease
cancer NN I-Disease
cases NNS O
were VBD O
analyzed VBN O
for IN O
BRCA1 NNP O
alterations NNS O
using VBG O
the DT O
RNase NNP O
mismatch NN O
cleavage NN O
assay VBP O
followed VBN O
by IN O
direct JJ O
sequencing NN O
. . O

Two CD O
truncating VBG O
mutations NNS O
, , O
962del4 CD O
and CC O
3600del11 CD O
, , O
were VBD O
identified VBN O
. . O

Both DT O
patients NNS O
had VBD O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Several JJ O
novel NN O
as RB O
well RB O
as IN O
previously RB O
reported VBN O
uncharacterized JJ O
variants NNS O
were VBD O
also RB O
identified VBN O
, , O
some DT O
of IN O
which WDT O
were VBD O
associated VBN O
with IN O
a DT O
family NN O
history NN O
of IN O
cancer NN B-Disease
. . O

The DT O
frequency NN O
distribution NN O
of IN O
common JJ O
polymorphisms NN O
was VBD O
determined VBN O
in IN O
the DT O
91 CD O
Caucasian JJ O
cancer NN B-Disease
cases NNS O
in IN O
this DT O
series NN O
and CC O
24 CD O
sister NN O
controls NNS O
using VBG O
allele JJ O
- : O
specific JJ O
amplification NN O
. . O

The DT O
rare JJ O
form NN O
of IN O
the DT O
Q356R NNP O
polymorphism NN O
was VBD O
significantly RB O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
associated VBN O
with IN O
a DT O
family NN O
history NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
, , O
suggesting VBG O
that IN O
this DT O
polymorphism NN O
may MD O
influence VB O
ovarian JJ B-Disease
cancer NN I-Disease
risk NN O
. . O

In IN O
summary JJ O
, , O
our PRP$ O
data NNS O
suggest VBP O
a DT O
role NN O
for IN O
some DT O
uncharacterized JJ O
variants NNS O
and CC O
rare JJ O
forms NNS O
of IN O
polymorphisms NNS O
in IN O
determining VBG O
ovarian JJ B-Disease
cancer NN I-Disease
risk NN O
, , O
and CC O
highlight VBD O
the DT O
necessity NN O
to TO O
screen VB O
for IN O
missense JJ O
alterations NNS O
as RB O
well RB O
as IN O
truncating VBG O
mutations NNS O
in IN O
this DT O
population NN O
. . O

Adrenoleukodystrophy NNP O
- : O
related JJ O
protein NN O
can MD O
compensate VB O
functionally RB O
for IN O
adrenoleukodystrophy NN B-Disease
protein NN I-Disease
deficiency NN I-Disease
( ( O
X NNP B-Disease
- : I-Disease
ALD NN I-Disease
) ) O
: : O
implications NNS O
for IN O
therapy NN O
. . O

Inherited VBN B-Disease
defects NNS I-Disease
in IN O
the DT O
peroxisomal JJ O
ATP NNP O
- : O
binding NN O
cassette NN O
( ( O
ABC NNP O
) ) O
transporter NN O
adrenoleukodystrophy NN B-Disease
protein NN O
( ( O
ALDP NNP O
) ) O
lead NN O
to TO O
the DT O
lethal JJ O
peroxisomal JJ B-Disease
disorder NN I-Disease
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
) ) O
, , O
for IN O
which WDT O
no DT O
efficient NN O
treatment NN O
has VBZ O
been VBN O
established VBN O
so RB O
far RB O
. . O

Three CD O
other JJ O
peroxisomal JJ O
ABC NNP O
transporters NNS O
currently RB O
are VBP O
known VBN O
adrenoleukodystrophy IN O
- : O
related JJ O
protein NN O
( ( O
ALDRP NNP O
) ) O
, , O
70 CD O
kDa NN O
peroxisomal JJ O
membrane NN O
protein NN O
( ( O
PMP70 NNP O
) ) O
and CC O
PMP70 NNP O
- : O
related JJ O
protein NN O
. . O

By IN O
using VBG O
transient NN O
and CC O
stable JJ O
overexpression NN O
of IN O
human JJ O
cDNAs NN O
encoding VBG O
ALDP NNP O
and CC O
its PRP$ O
closest JJS O
relative JJ O
ALDRP NNP O
, , O
we PRP O
could MD O
restore VB O
the DT O
impaired JJ O
peroxisomal NN O
beta SYM O
- : O
oxidation NN O
in IN O
fibroblasts NNS O
of IN O
X NNP B-Disease
- : I-Disease
ALD JJ I-Disease
patients NNS O
. . O

The DT O
pathognomonic JJ O
accumulation NN O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
could MD O
also RB O
be VB O
prevented VBN O
by IN O
overexpression NN O
of IN O
ALDRP NNP O
in IN O
immortalized JJ O
X NNP O
- : O
ALD NNP O
cells NNS O
. . O

Immunofluorescence NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
functional JJ O
replacement NN O
of IN O
ALDP NNP O
by IN O
ALDRP NNP O
was VBD O
not RB O
due JJ O
to TO O
stabilization NN O
of IN O
the DT O
mutated VBN O
ALDP NNP O
itself PRP O
. . O

Moreover RB O
, , O
we PRP O
were VBD O
able JJ O
to TO O
restore VB O
the DT O
peroxisomal JJ O
beta NN O
- : O
oxidation NN O
defect NN O
in IN O
the DT O
liver NN O
of IN O
ALDP NNP O
- : O
deficient NN O
mice NN O
by IN O
stimulation NN O
of IN O
ALDRP NNP O
and CC O
PMP70 NNP O
gene NN O
expression NN O
through IN O
a DT O
dietary JJ O
treatment NN O
with IN O
the DT O
peroxisome NN O
proliferator NN O
fenofibrate NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
a DT O
correction NN O
of IN O
the DT O
biochemical JJ O
defect NN O
in IN O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
could MD O
be VB O
possible JJ O
by IN O
drug NN O
- : O
induced JJ O
overexpression NN O
or CC O
ectopic JJ O
expression NN O
of IN O
ALDRP NNP O
. . O
. . O

Centrosome NNP O
amplification NN O
and CC O
a DT O
defective JJ O
G2 NNP O
- : O
M NNP O
cell NN O
cycle NN O
checkpoint NN O
induce VB O
genetic JJ O
instability NN O
in IN O
BRCA1 NNP O
exon VBP O
11 CD O
isoform NN O
- : O
deficient NN O
cells NNS O
. . O

Germline NNP O
mutations NNS O
of IN O
the DT O
Brca1 NNP O
tumor NN B-Disease
suppressor NN O
gene NN O
predispose JJ O
women NNS O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

To TO O
study VB O
mechanisms NNS O
underlying VBG O
BRCA1 NNP O
- : O
related JJ O
tumorigenesis NN O
, , O
we PRP O
derived VBD O
mouse RB O
embryonic JJ O
fibroblast NN O
cells NNS O
carrying VBG O
a DT O
targeted JJ O
deletion NN O
of IN O
exon JJ O
11 CD O
of IN O
the DT O
Brca1 NNP O
gene NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
mutant JJ O
cells NNS O
maintain VBP O
an DT O
intact JJ O
G1 NNP O
- : O
S NNP O
cell NN O
cycle NN O
checkpoint NN O
and CC O
proliferate VB O
poorly RB O
. . O

However RB O
, , O
a DT O
defective JJ O
G2 NNP O
- : O
M NNP O
checkpoint NN O
in IN O
these DT O
cells NNS O
is VBZ O
accompanied VBN O
by IN O
extensive JJ O
chromosomal JJ B-Disease
abnormalities NNS I-Disease
. . O

Mutant JJ O
fibroblasts NNS O
contain VBP O
multiple JJ O
, , O
functional JJ O
centrosomes NNS O
, , O
which WDT O
lead VBP O
to TO O
unequal JJ O
chromosome NN O
segregation NN O
, , O
abnormal JJ O
nuclear JJ O
division NN O
, , O
and CC O
aneuploidy NN B-Disease
. . O

These DT O
data NNS O
uncover RB O
an DT O
essential JJ O
role NN O
of IN O
BRCA1 NNP O
in IN O
maintaining VBG O
genetic JJ O
stability NN O
through IN O
the DT O
regulation NN O
of IN O
centrosome JJ O
duplication NN O
and CC O
the DT O
G2 NNP O
- : O
M NNP O
checkpoint NN O
and CC O
provide VB O
a DT O
molecular JJ O
basis NN O
for IN O
the DT O
role NN O
of IN O
BRCA1 NNP O
in IN O
tumorigenesis NN O
. . O
. . O

Defective JJ O
CD95 NNP O
/ NNP O
APO NNP O
- : O
1 CD O
/ JJ O
Fas NNP O
signal NN O
complex NN O
formation NN O
in IN O
the DT O
human JJ O
autoimmune NN B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
, , I-Disease
type NN I-Disease
Ia NNP I-Disease
. . O

Heterozygous JJ O
mutations NNS O
in IN O
the DT O
CD95 NNP O
( ( O
APO NNP O
- : O
1 CD O
/ NNP O
Fas NNP O
) ) O
receptor NN O
occur VBP O
in IN O
most JJS O
individuals NNS O
with IN O
autoimmune JJ B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
( ( O
ALPS NNP B-Disease
) ) O
and CC O
dominantly RB O
interfere RB O
with IN O
apoptosis NN O
by IN O
an DT O
unknown JJ O
mechanism NN O
. . O

We PRP O
show VBP O
that DT O
local JJ O
or CC O
global JJ O
alterations NNS O
in IN O
the DT O
structure NN O
of IN O
the DT O
cytoplasmic JJ O
death NN O
domain NN O
from IN O
nine CD O
independent JJ O
ALPS NNP B-Disease
CD95 NNP O
death NN O
- : O
domain NN O
mutations NNS O
result VBP O
in IN O
a DT O
failure NN O
to TO O
bind VB O
the DT O
FADD NNP O
/ NNP O
MORT1 NNP O
signaling VBG O
protein NN O
. . O

Despite IN O
heterozygosity NN O
for IN O
the DT O
abnormal JJ O
allele NN O
, , O
lymphocytes VBZ O
from IN O
ALPS NNP B-Disease
patients NNS O
showed VBD O
markedly RB O
decreased VBN O
FADD NNP O
association NN O
and CC O
a DT O
loss NN O
of IN O
caspase NN O
recruitment NN O
and CC O
activation NN O
after IN O
CD95 NNP O
crosslinking NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
intracytoplasmic JJ O
CD95 NNP O
mutations NNS O
in IN O
ALPS NNP B-Disease
impair NN O
apoptosis NN O
chiefly NN O
by IN O
disrupting VBG O
death NN O
- : O
domain NN O
interactions NNS O
with IN O
the DT O
signaling VBG O
protein NN O
FADD NNP O
/ NNP O
MORT1 NNP O
. . O
. . O

Analysis NN O
of IN O
alkaptonuria NN B-Disease
( ( O
AKU NNP B-Disease
) ) O
mutations NNS O
and CC O
polymorphisms NN O
reveals NNS O
that IN O
the DT O
CCC NNP O
sequence NN O
motif NN O
is VBZ O
a DT O
mutational JJ O
hot JJ O
spot NN O
in IN O
the DT O
homogentisate NN O
1 CD O
, , O
2 CD O
dioxygenase NN O
gene NN O
( ( O
HGO NNP O
) ) O
. . O

We PRP O
recently RB O
showed VBD O
that IN O
alkaptonuria NN B-Disease
( ( O
AKU NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
loss NN O
- : O
of IN O
- : O
function NN O
mutations NNS O
in IN O
the DT O
homogentisate NN O
1 CD O
, , O
2 CD O
dioxygenase NN O
gene NN O
( ( O
HGO NNP O
) ) O
. . O

Herein NNP O
we PRP O
describe VBP O
haplotype JJ O
and CC O
mutational JJ O
analyses NNS O
of IN O
HGO NNP O
in IN O
seven CD O
new JJ O
AKU NNP B-Disease
pedigrees NNS O
. . O

These DT O
analyses NNS O
identified VBD O
two CD O
novel JJ O
single JJ O
- : O
nucleotide JJ O
polymorphisms NN O
( ( O
INV4 NNP O
+ VBZ O
31A CD O
- : O
- : O
> NN O
G NNP O
and CC O
INV11 NNP O
+ NNP O
18A CD O
- : O
- : O
> NN O
G NNP O
) ) O
and CC O
six CD O
novel JJ O
AKU NNP B-Disease
mutations NNS O
( ( O
INV1 NNP O
- : O
1G CD O
- : O
- : O
> NN O
A NNP O
, , O
W60G NNP O
, , O
Y62C NNP O
, , O
A122D NNP O
, , O
P230T NNP O
, , O
and CC O
D291E NNP O
) ) O
, , O
which WDT O
further RB O
illustrates VBZ O
the DT O
remarkable JJ O
allelic JJ O
heterogeneity NN O
found VBN O
in IN O
AKU NNP B-Disease
. . O

Reexamination NN O
of IN O
all DT O
29 CD O
mutations NNS O
and CC O
polymorphisms NNS O
thus RB O
far RB O
described VBN O
in IN O
HGO NNP O
shows NNS O
that IN O
these DT O
nucleotide IN O
changes NNS O
are VBP O
not RB O
randomly RB O
distributed VBN O
; : O
the DT O
CCC NNP O
sequence NN O
motif NN O
and CC O
its PRP$ O
inverted JJ O
complement NN O
, , O
GGG NNP O
, , O
are VBP O
preferentially RB O
mutated VBN O
. . O

These DT O
analyses NNS O
also RB O
demonstrated VBD O
that IN O
the DT O
nucleotide JJ O
substitutions NNS O
in IN O
HGO NNP O
do VBP O
not RB O
involve VB O
CpG NNP O
dinucleotides NNS O
, , O
which WDT O
illustrates VBZ O
important JJ O
differences NNS O
between IN O
HGO NNP O
and CC O
other JJ O
genes NNS O
for IN O
the DT O
occurrence NN O
of IN O
mutation NN O
at IN O
specific JJ O
short JJ O
- : O
sequence NN O
motifs NNS O
. . O

Because IN O
the DT O
CCC NNP O
sequence NN O
motifs NNS O
comprise VBP O
a DT O
significant JJ O
proportion NN O
( ( O
34 CD O
. . O
5 CD O
% NN O
) ) O
of IN O
all DT O
mutated VBN O
bases NNS O
that WDT O
have VBP O
been VBN O
observed VBN O
in IN O
HGO NNP O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
CCC NNP O
triplet NN O
is VBZ O
a DT O
mutational JJ O
hot JJ O
spot NN O
in IN O
HGO NNP O
. . O

Fabry JJ B-Disease
disease NN I-Disease
: : O
identification NN O
of IN O
novel JJ O
alpha SYM O
- : O
galactosidase NN O
A DT O
mutations NNS O
and CC O
molecular JJ O
carrier NN O
detection NN O
by IN O
use NN O
of IN O
fluorescent JJ O
chemical JJ O
cleavage NN O
of IN O
mismatches NNS O
. . O

Fabry NNP B-Disease
disease NN I-Disease
( ( O
FD NNP B-Disease
) ) O
( ( O
angiokeratoma JJ B-Disease
corporis NN I-Disease
diffusum NN I-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
inborn JJ I-Disease
error NN I-Disease
of IN I-Disease
glycosphingolipid JJ I-Disease
metabolism NN I-Disease
caused VBN O
by IN O
defects NNS O
in IN O
the DT O
lysosomal JJ O
alpha NN O
- : O
galactosidase NN O
A DT O
gene NN O
( ( O
GLA NNP O
) ) O
. . O

The DT O
enzymatic JJ O
defect NN O
leads VBZ O
to TO O
the DT O
systemic JJ O
accumulation NN O
of IN O
neutral JJ O
glycosphingolipids NNS O
with IN O
terminal JJ O
alpha NN O
- : O
galactosyl NN O
moieties NNS O
. . O

Clinically RB O
, , O
affected VBD O
hemizygous JJ O
males NNS O
have VBP O
angiokeratoma VBN B-Disease
, , O
severe JJ B-Disease
acroparesthesia NN I-Disease
, , O
renal JJ B-Disease
failure NN I-Disease
, , O
and CC O
vasculopathy NN B-Disease
of IN I-Disease
the DT I-Disease
heart NN I-Disease
and CC I-Disease
brain NN I-Disease
. . O

While IN O
demonstration NN O
of IN O
alpha JJ B-Disease
- : I-Disease
galactosidase NN I-Disease
deficiency NN I-Disease
in IN O
leukocytes NNS O
is VBZ O
diagnostic JJ O
in IN O
affected JJ O
males NNS O
, , O
enzymatic JJ O
detection NN O
of IN O
female JJ O
carriers NNS O
is VBZ O
often RB O
inconclusive JJ O
, , O
due JJ O
to TO O
random VB O
X NNP O
- : O
chromosomal JJ O
inactivation NN O
, , O
underlining VBG O
the DT O
need NN O
of IN O
molecular JJ O
investigations NNS O
for IN O
accurate JJ O
genetic JJ O
counseling NN O
. . O

By IN O
use NN O
of IN O
chemical JJ O
cleavage NN O
of IN O
mismatches NNS O
adapted VBN O
to TO O
fluorescence VB O
- : O
based VBN O
detection NN O
systems NNS O
, , O
we PRP O
have VBP O
characterized VBN O
the DT O
mutations NNS O
underlying VBG O
alpha JJ B-Disease
- : I-Disease
Gal VB I-Disease
A DT I-Disease
deficiency NN I-Disease
in IN O
16 CD O
individuals NNS O
from IN O
six CD O
unrelated JJ O
families NNS O
with IN O
FD NNP B-Disease
. . O

The DT O
mutational JJ O
spectrum NN O
included VBD O
five CD O
missense NN O
mutations NNS O
( ( O
C202W NNP O
, , O
C223G NNP O
, , O
N224D NNP O
, , O
R301Q NNP O
, , O
and CC O
Q327K NNP O
) ) O
and CC O
one CD O
splice NN O
- : O
site NN O
mutation NN O
[ NNP O
IVS3 NNP O
G NNP O
( ( O
- : O
1 CD O
) ) O
- : O
- : O
> NN O
C NNP O
] NNP O
. . O

Studies NNS O
at IN O
the DT O
mRNA NN O
level NN O
showed VBD O
that IN O
the DT O
latter NN O
led VBD O
to TO O
altered VB O
pre JJ O
- : O
mRNA NN O
splicing VBG O
with IN O
consequent JJ O
alteration NN O
of IN O
the DT O
mRNA JJ O
translational JJ O
reading NN O
frame NN O
and CC O
generation NN O
of IN O
a DT O
premature JJ O
termination NN O
codon NN O
of IN O
translation NN O
. . O

By IN O
use NN O
of IN O
this DT O
strategy NN O
, , O
carrier NN O
status NN O
was VBD O
accurately RB O
assessed VBN O
in IN O
all DT O
seven CD O
at IN O
- : O
risk NN O
females NNS O
tested VBN O
, , O
whereas JJ O
enzymatic JJ O
dosages NNS O
failed VBD O
to TO O
diagnose VB O
or CC O
exclude VB O
heterozygosity NN O
. . O
. . O

Prenatal JJ O
diagnosis NN O
by IN O
FISH NNP O
in IN O
a DT O
family NN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
caused VBN O
by IN O
duplication NN O
of IN O
PLP NNP O
gene NN O
. . O

A DT O
diagnosis NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( O
MIM NNP O
312080 CD O
) ) O
was VBD O
made VBN O
in IN O
a DT O
young JJ O
boy NN O
. . O

No DT O
mutation NN O
in IN O
the DT O
coding JJ O
region NN O
of IN O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
had VBD O
been VBN O
found VBN O
. . O

The DT O
boys JJ O
maternal JJ O
aunt NN O
came VBD O
for IN O
prenatal JJ O
diagnosis NN O
when WRB O
16 CD O
+ JJ O
weeks NNS O
pregnant JJ O
and CC O
carrying VBG O
a DT O
male NN O
fetus NN O
. . O

Samples NNS O
were VBD O
tested VBN O
for IN O
duplication NN O
of IN O
the DT O
PLP NNP O
gene NN O
, , O
by IN O
interphase JJ O
FISH NNP O
, , O
in IN O
lymphocyte JJ O
preparations NNS O
from IN O
the DT O
proband NN O
, , O
his PRP$ O
aunt NN O
and CC O
an DT O
amniotic JJ O
fluid NN O
cell NN O
preparation NN O
from IN O
the DT O
fetus NN O
. . O

The DT O
proband NN O
was VBD O
found VBN O
to TO O
carry VB O
the DT O
duplication NN O
, , O
thus RB O
confirming VBG O
the DT O
diagnosis NN O
of IN O
Pelizaeus NNP B-Disease
Merzbacher NNP I-Disease
disease NN I-Disease
, , O
but CC O
neither CC O
the DT O
aunt NN O
nor CC O
the DT O
fetus NN O
carried VBD O
a DT O
duplication NN O
. . O
. . O

Dominant JJ O
negative JJ O
effect NN O
of IN O
the DT O
APC1309 NNP O
mutation NN O
: : O
a DT O
possible JJ O
explanation NN O
for IN O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
. . O

Inactivation NN O
of IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
product NN O
initiates VBZ O
colorectal JJ O
tumorigenesis NN O
. . O

Patients NNS O
with IN O
familial JJ B-Disease
APC NNP I-Disease
( ( O
FAP NNP B-Disease
) ) O
carry VBP O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
and CC O
develop VB O
multiple JJ O
colorectal JJ B-Disease
adenomas NN I-Disease
and CC O
subsequent JJ O
carcinomas NN B-Disease
early RB O
in IN O
life NN O
. . O

The DT O
severity NN O
of IN O
the DT O
disease NN O
correlates VBZ O
with IN O
the DT O
position NN O
of IN O
the DT O
inherited JJ O
APC NNP B-Disease
mutation NN O
( ( O
genotype JJ O
- : O
phenotype NN O
correlation NN O
) ) O
. . O

Together RB O
with IN O
the DT O
fact NN O
that IN O
both DT O
germ FW O
- : O
line NN O
and CC O
sporadic JJ O
APC NNP B-Disease
mutations NNS O
cluster NN O
in IN O
the DT O
central JJ O
region NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
, , O
this DT O
points NNS O
to TO O
a DT O
dominant JJ O
negative JJ O
effect NN O
of IN O
certain JJ O
APC NNP B-Disease
mutants NNS O
. . O

Loss NNP O
of IN O
APC NNP B-Disease
function NN O
was VBD O
recently RB O
shown VBN O
to TO O
result VB O
in IN O
enhanced JJ O
beta NN O
- : O
catenin NN O
- : O
/ NN O
Tcf NNP O
- : O
mediated VBN O
transcription NN O
in IN O
colon NN O
epithelial JJ O
cells NNS O
. . O

Here RB O
, , O
we PRP O
provide VBP O
experimental JJ O
evidence NN O
for IN O
a DT O
dominant JJ O
negative JJ O
effect NN O
of IN O
APC NNP B-Disease
gene NN O
products NNS O
associated VBN O
with IN O
severe JJ O
polyposis NN B-Disease
. . O

Wild NNP O
- : O
type NN O
APC NNP B-Disease
activity NN O
in IN O
beta NN O
- : O
catenin NN O
- : O
/ NN O
Tcf NNP O
- : O
mediated VBD O
transcription NN O
was VBD O
strongly RB O
inhibited VBN O
by IN O
a DT O
mutant JJ O
APC NNP B-Disease
that WDT O
is VBZ O
truncated VBN O
at IN O
codon NN O
1309 CD O
. . O

In IN O
contrast NN O
, , O
mutant JJ O
APC NNP B-Disease
gene NN O
products NNS O
that WDT O
are VBP O
associated VBN O
with IN O
attenuated JJ B-Disease
polyposis NN I-Disease
( ( O
codon JJ O
386 CD O
or CC O
1465 CD O
) ) O
interfered VBD O
only RB O
weakly JJ O
with IN O
wild JJ O
- : O
type NN O
APC NNP B-Disease
activity NN O
. . O

These DT O
results NNS O
suggest VBP O
a DT O
molecular JJ O
explanation NN O
for IN O
the DT O
genotype NN O
- : O
phenotype NN O
correlation NN O
in IN O
FAP NNP B-Disease
patients NNS O
and CC O
support VB O
the DT O
idea NN O
that IN O
colorectal JJ B-Disease
tumor NN I-Disease
growth NN O
might MD O
be VB O
, , O
in IN O
part NN O
, , O
driven VBN O
by IN O
selection NN O
for IN O
a DT O
mutation NN O
in IN O
the DT O
mutation NN O
cluster NN O
region NN O
. . O
. . O

BRCA1 NNP O
interacts VBZ O
with IN O
components NNS O
of IN O
the DT O
histone NN O
deacetylase NN O
complex NN O
. . O

Germ NNP O
- : O
line NN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
tumor NN O
- : O
suppressor NN O
gene NN O
are VBP O
associated VBN O
with IN O
an DT O
increased VBN O
susceptibility NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

BRCA1 NNP O
contains VBZ O
a DT O
carboxyl NN O
- : O
terminal NN O
domain NN O
( ( O
BRCT NNP O
) ) O
that WDT O
is VBZ O
shared VBN O
with IN O
several JJ O
other JJ O
proteins NNS O
involved VBN O
in IN O
maintaining VBG O
genome JJ O
integrity NN O
. . O

In IN O
an DT O
effort NN O
to TO O
understand VB O
the DT O
function NN O
of IN O
BRCA1 NNP O
, , O
we PRP O
sought VBD O
to TO O
isolate VB O
proteins NNS O
that WDT O
interact VBP O
with IN O
the DT O
BRCT NNP O
domain NN O
. . O

Purified NNP O
BRCT NNP O
polypeptide NN O
was VBD O
used VBN O
as IN O
a DT O
probe NN O
to TO O
screen VB O
a DT O
human JJ O
placenta NN O
cDNA NN O
expression NN O
library NN O
by IN O
Far NNP O
Western JJ O
analysis NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
BRCA1 NNP O
interacts NNS O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
with IN O
the DT O
Rb NNP O
- : O
binding NN O
proteins NNS O
, , O
RbAp46 NNP O
and CC O
RbAp48 NNP O
, , O
as RB O
well RB O
as IN O
with IN O
Rb NNP O
. . O

Moreover RB O
, , O
the DT O
BRCT NNP O
domain NN O
associates NNS O
with IN O
the DT O
histone NN O
deacetylases VBZ O
HDAC1 NNP O
and CC O
HDAC2 NNP O
. . O

These DT O
results NNS O
demonstrate VBP O
that IN O
BRCA1 NNP O
interacts VBZ O
with IN O
components NNS O
of IN O
the DT O
histone NN O
deacetylase NN O
complex NN O
, , O
and CC O
therefore RB O
may MD O
explain VB O
the DT O
involvement NN O
of IN O
BRCA1 NNP O
in IN O
multiple JJ O
processes NNS O
such JJ O
as IN O
transcription NN O
, , O
DNA NNP O
repair NN O
, , O
and CC O
recombination NN O
. . O
. . O

Combined VBN B-Disease
genetic JJ I-Disease
deficiency NN I-Disease
of IN I-Disease
C6 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
in IN O
man NN O
. . O

By IN O
routine JJ O
screening NN O
of IN O
sera NN O
, , O
a DT O
subject NN O
was VBD O
discovered VBN O
who WP O
showed VBD O
a DT O
sub NN B-Disease
- : I-Disease
total JJ I-Disease
deficiency NN I-Disease
of IN I-Disease
C6 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
. . O

No DT O
clinical JJ O
disease NN O
was VBD O
associated VBN O
with IN O
this DT O
deficiency NN O
which WDT O
was VBD O
transmitted VBN O
through IN O
the DT O
subjects NNS O
family NN O
as IN O
a DT O
single JJ O
genetic JJ O
characteristic NN O
, , O
the DT O
C6 NNP B-Disease
deficiency NN I-Disease
being VBG O
associated VBN O
with IN O
a DT O
silent JJ O
allele NN O
at IN O
the DT O
structural JJ O
locus NN O
. . O

The DT O
propositus NN O
was VBD O
found VBN O
to TO O
have VB O
low JJ O
quantities NNS O
of IN O
an DT O
abnormal JJ O
C6 NNP O
which WDT O
was VBD O
both DT O
antigenically RB O
deficient NN O
and CC O
smaller JJR O
in IN O
size NN O
than IN O
normal JJ O
C6 NNP O
( ( O
110 CD O
, , O
0 CD O
daltons NNS O
compared VBN O
with IN O
140 CD O
, , O
0 CD O
daltons NNS O
) ) O
and CC O
small JJ O
quantities NNS O
of IN O
apparently RB O
normal JJ O
C7 NNP O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
most RBS O
likely JJ O
explanation NN O
for IN O
this DT O
defect NN O
is VBZ O
that IN O
the DT O
subject NN O
has VBZ O
a DT O
structural JJ O
mutation NN O
in IN O
his PRP$ O
C6 NNP O
gene NN O
which WDT O
produces VBZ O
hyopsynthesis NN O
not RB O
only RB O
of IN O
C6 NNP O
but CC O
also RB O
of IN O
the DT O
closely RB O
linked VBN O
gene NN O
for IN O
C7 NNP O
. . O

These DT O
findings NNS O
suggest VBP O
the DT O
possibility NN O
that IN O
C6 NNP O
and CC O
C7 NNP O
may MD O
function VB O
as IN O
a DT O
single JJ O
genetic JJ O
unit NN O
and CC O
that IN O
the DT O
primary JJ O
transcript NN O
copied VBN O
from IN O
the DT O
genome NN O
includes VBZ O
information NN O
for IN O
both DT O
proteins NNS O
. . O
. . O

Changes NNS O
at IN O
P183 NNP O
of IN O
emerin RB O
weaken VB O
its PRP$ O
protein NN O
- : O
protein NN O
interactions NNS O
resulting VBG O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EDMD NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
characterized VBN O
by IN O
early JJ O
contractures NNS B-Disease
of IN I-Disease
the DT I-Disease
elbows NNS I-Disease
, , I-Disease
Achilles NNP I-Disease
tendons NNS I-Disease
and CC I-Disease
spine NN I-Disease
, , O
slowly RB O
progressive JJ O
muscle NN B-Disease
wasting NN I-Disease
and CC O
weakness NN B-Disease
, , O
and CC O
cardiomyopathy NN B-Disease
associated VBN O
with IN O
cardiac JJ B-Disease
conduction NN I-Disease
defects NNS I-Disease
. . O

The DT O
emerin NN O
gene NN O
has VBZ O
been VBN O
mapped VBN O
to TO O
Xq28 VB O
and CC O
encodes VB O
a DT O
34 CD O
- : O
kDa NN O
serine NN O
- : O
rich JJ O
protein NN O
, , O
emerin NN O
, , O
which WDT O
has VBZ O
been VBN O
localized VBN O
to TO O
the DT O
nuclear JJ O
envelope NN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
tissues NNS O
, , O
including VBG O
skeletal JJ O
and CC O
cardiac JJ O
muscle NN O
. . O

Mutations NNS O
spanning VBG O
the DT O
emerin NN O
gene NN O
have VBP O
been VBN O
identified VBN O
in IN O
patients NNS O
with IN O
EDMD NNP B-Disease
. . O

We PRP O
present VBP O
here RB O
the DT O
effect NN O
, , O
on IN O
emerin JJ O
protein NN O
expression NN O
, , O
of IN O
two CD O
missense JJ O
mutations NNS O
identified VBN O
in IN O
unrelated JJ O
EDMD NNP B-Disease
patients NNS O
. . O

These DT O
alterations NNS O
predict VBP O
the DT O
replacement NN O
of IN O
a DT O
proline NN O
residue NN O
at IN O
position NN O
183 CD O
with IN O
either DT O
a DT O
histidine NN O
or CC O
a DT O
threonine NN O
. . O

Biochemical JJ O
analysis NN O
has VBZ O
demonstrated VBN O
that IN O
the DT O
mobility NN O
and CC O
expression NN O
levels NNS O
of IN O
the DT O
mutant JJ O
forms NNS O
of IN O
emerin NN O
are VBP O
indistinguishable JJ O
from IN O
that DT O
of IN O
wild JJ O
- : O
type NN O
emerin NN O
, , O
but CC O
that IN O
they PRP O
have VBP O
weakened VBN O
interactions NNS O
with IN O
nuclear JJ O
lamina JJ O
components NNS O
. . O

In IN O
comparison NN O
with IN O
the DT O
usual JJ O
EDMD NNP B-Disease
phenotype NN O
, , O
patients NNS O
with IN O
P183 NNP O
missense NN O
mutations NNS O
have VBP O
a DT O
later JJ O
age NN O
at IN O
onset NN O
of IN O
first JJ O
symptoms NNS O
, , O
elbow NN B-Disease
contractures NNS I-Disease
, , O
ankle NN B-Disease
contractures NNS I-Disease
, , O
upper JJ B-Disease
limb NN I-Disease
weakness NN I-Disease
and CC O
lower JJR B-Disease
limb NN I-Disease
weakness NN I-Disease
, , O
but CC O
there EX O
is VBZ O
no DT O
difference NN O
for IN O
the DT O
age NN O
at IN O
onset NN O
of IN O
cardiac JJ B-Disease
involvement NN I-Disease
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
protein JJ O
studies NNS O
on IN O
patients NNS O
with IN O
missense JJ O
mutations NNS O
resulting VBG O
in IN O
the DT O
clinical JJ O
features NNS O
of IN O
EDMD NNP B-Disease
. . O

These DT O
studies NNS O
demonstrate VBP O
the DT O
importance NN O
of IN O
proline NN O
183 CD O
for IN O
the DT O
proper JJ O
structure NN O
/ NNP O
function NN O
of IN O
emerin NN O
. . O
. . O

Microdeletions NNS O
at IN O
chromosome NN O
bands NNS O
1q32 CD O
- : O
q41 NN O
as IN O
a DT O
cause NN O
of IN O
Van NNP B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
. . O

Van NNP B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
( ( O
VWS NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
comprising VBG O
cleft NN B-Disease
lip NN I-Disease
and CC O
/ NN O
or CC O
cleft NN B-Disease
palate NN I-Disease
and CC O
lip NN B-Disease
pits NNS I-Disease
. . O

We PRP O
reported VBD O
previously RB O
a DT O
family NN O
whose WP$ O
underlying JJ O
mutation NN O
is VBZ O
a DT O
500 CD O
- : O
800 CD O
kb JJ O
deletion NN O
localized VBN O
to TO O
chromosome VB O
bands NNS O
1q32 CD O
- : O
q41 NN O
[ JJ O
Sander NNP O
et NN O
al NN O
. . O
, , O
1994 CD O
Hum NNP O
Mol NNP O
Genet NNP O
3 CD O
576 CD O
- : O
578 CD O
] NN O
. . O

Along IN O
with IN O
cleft NN B-Disease
lip NN I-Disease
/ NNP I-Disease
palate NN I-Disease
and CC O
lip NN B-Disease
pits NNS I-Disease
, , O
affected VBD O
relatives NNS O
exhibit VBP O
developmental JJ B-Disease
delays NNS I-Disease
, , O
suggesting VBG O
that IN O
the DT O
function NN O
of IN O
a DT O
gene NN O
nearby JJ O
may MD O
also RB O
be VB O
disrupted VBN O
. . O

To TO O
further RBR O
localize VB O
the DT O
VWS NNP B-Disease
gene NN O
we PRP O
searched VBD O
for IN O
other JJ O
deletions NNS O
that WDT O
cause VBP O
VWS NNP B-Disease
. . O

An DT O
allele JJ O
loss NN O
assay NN O
was VBD O
performed VBN O
using VBG O
a DT O
novel JJ O
highly RB O
polymorphic JJ O
marker NN O
, , O
D1S3753 NNP O
. . O

From IN O
a DT O
panel NN O
of IN O
37 CD O
unrelated JJ O
individuals NNS O
, , O
we PRP O
detected VBD O
an DT O
allele JJ O
loss NN O
in IN O
one CD O
family NN O
, , O
indicating VBG O
the DT O
presence NN O
of IN O
a DT O
deletion NN O
. . O

In IN O
this DT O
family NN O
, , O
the DT O
phenotype NN O
in IN O
three CD O
generations NNS O
of IN O
affected JJ O
individuals NNS O
was VBD O
confined VBN O
to TO O
the DT O
cardinal JJ O
signs NNS O
of IN O
VWS NNP B-Disease
. . O

Surprisingly RB O
, , O
mapping NN O
of IN O
the DT O
new JJ O
deletion NN O
showed VBD O
that IN O
it PRP O
extended VBD O
0 CD O
. . O

2 CD O
- : O
1 CD O
Mb NNP O
beyond IN O
the DT O
proximal JJ O
breakpoint NN O
for IN O
the DT O
deletion NN O
described VBD O
previously RB O
. . O

No DT O
deletions NNS O
were VBD O
detected VBN O
in IN O
seven CD O
cases NNS O
of IN O
popliteal JJ B-Disease
pterygia JJ I-Disease
syndrome NN I-Disease
, , O
76 CD O
cases NNS O
of IN O
mixed JJ O
syndromic JJ B-Disease
forms NNS I-Disease
of IN I-Disease
cleft NN I-Disease
lip NN I-Disease
and CC I-Disease
palate NN I-Disease
, , O
and CC O
178 CD O
cases NNS O
of IN O
nonsyndromic JJ B-Disease
cleft NN I-Disease
lip NN I-Disease
and CC I-Disease
palate NN I-Disease
. . O

Splicing VBG O
defects NNS O
in IN O
the DT O
ataxia NN B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
, , O
ATM NNP O
: : O
underlying JJ O
mutations NNS O
and CC O
consequences NNS O
. . O

Mutations NNS O
resulting VBG O
in IN O
defective JJ O
splicing VBG O
constitute NN O
a DT O
significant JJ O
proportion NN O
( ( O
30 CD O
/ RB O
62 CD O
[ JJ O
48 CD O
% NN O
] NN O
) ) O
of IN O
a DT O
new JJ O
series NN O
of IN O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
in IN O
patients NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
AT NNP B-Disease
) ) O
that WDT O
were VBD O
detected VBN O
by IN O
the DT O
protein NN O
- : O
truncation NN O
assay VBP O
followed VBN O
by IN O
sequence NN O
analysis NN O
of IN O
genomic JJ O
DNA NNP O
. . O

Fewer JJR O
than IN O
half NN O
of IN O
the DT O
splicing JJ O
mutations NNS O
involved VBD O
the DT O
canonical JJ O
AG NNP O
splice NN O
- : O
acceptor NN O
site NN O
or CC O
GT NNP O
splice SYM O
- : O
donor NN O
site NN O
. . O

A DT O
higher JJR O
percentage NN O
of IN O
mutations NNS O
occurred VBD O
at IN O
less RBR O
stringently RB O
conserved VBN O
sites NNS O
, , O
including VBG O
silent JJ O
mutations NNS O
of IN O
the DT O
last JJ O
nucleotide NN O
of IN O
exons NNS O
, , O
mutations NNS O
in IN O
nucleotides NNS O
other JJ O
than IN O
the DT O
conserved JJ O
AG NNP O
and CC O
GT NNP O
in IN O
the DT O
consensus NN O
splice NN O
sites NNS O
, , O
and CC O
creation NN O
of IN O
splice NN O
- : O
acceptor NN O
or CC O
splice NN O
- : O
donor NN O
sites VBZ O
in IN O
either CC O
introns NNS O
or CC O
exons NNS O
. . O

These DT O
splicing VBG O
mutations NNS O
led VBD O
to TO O
a DT O
variety NN O
of IN O
consequences NNS O
, , O
including VBG O
exon JJ O
skipping NN O
and CC O
, , O
to TO O
a DT O
lesser JJR O
degree NN O
, , O
intron NN O
retention NN O
, , O
activation NN O
of IN O
cryptic JJ O
splice NN O
sites NNS O
, , O
or CC O
creation NN O
of IN O
new JJ O
splice NN O
sites NNS O
. . O

In IN O
addition NN O
, , O
5 CD O
of IN O
12 CD O
nonsense JJ O
mutations NNS O
and CC O
1 CD O
missense NN O
mutation NN O
were VBD O
associated VBN O
with IN O
deletion NN O
in IN O
the DT O
cDNA NN O
of IN O
the DT O
exons NNS O
in IN O
which WDT O
the DT O
mutations NNS O
occurred VBD O
. . O

No DT O
ATM NNP O
protein NN O
was VBD O
detected VBN O
by IN O
western JJ O
blotting NN O
in IN O
any DT O
AT NNP B-Disease
cell NN O
line NN O
in IN O
which WDT O
splicing VBG O
mutations NNS O
were VBD O
identified VBN O
. . O

Several JJ O
cases NNS O
of IN O
exon NN O
skipping NN O
in IN O
both DT O
normal JJ O
controls NNS O
and CC O
patients NNS O
for IN O
whom WP O
no DT O
underlying VBG O
defect NN O
could MD O
be VB O
found VBN O
in IN O
genomic JJ O
DNA NN O
were VBD O
also RB O
observed VBN O
, , O
suggesting VBG O
caution NN O
in IN O
the DT O
interpretation NN O
of IN O
exon JJ O
deletions NNS O
observed VBN O
in IN O
ATM NNP O
cDNA NN O
when WRB O
there EX O
is VBZ O
no DT O
accompanying VBG O
identification NN O
of IN O
genomic JJ O
mutations NNS O
. . O
. . O

Alpha NNP O
- : O
cardiac NN O
actin NN O
is VBZ O
a DT O
novel JJ O
disease NN O
gene NN O
in IN O
familial JJ B-Disease
hypertrophic JJ I-Disease
cardiomyopathy NN I-Disease
. . O

We PRP O
identified VBD O
the DT O
alpha JJ O
- : O
cardiac NN O
actin NN O
gene NN O
( ( O
ACTC NNP O
) ) O
as IN O
a DT O
novel JJ O
disease NN O
gene NN O
in IN O
a DT O
pedigree JJ O
suffering NN O
from IN O
familial JJ B-Disease
hypertrophic JJ I-Disease
cardiomyopathy NN I-Disease
( ( O
FHC NNP B-Disease
) ) O
. . O

Linkage NN O
analyses NNS O
excluded VBD O
all PDT O
the DT O
previously RB O
reported VBN O
FHC NNP B-Disease
loci NN O
as IN O
possible JJ O
disease NN O
loci NN O
in IN O
the DT O
family NN O
studied VBD O
, , O
with IN O
lod JJ O
scores NNS O
varying VBG O
between IN O
- : O
2 CD O
. . O

5 CD O
and CC O
- : O
6 CD O
. . O

0 CD O
0 CD O
. . O

Further JJ O
linkage NN O
analyses NNS O
of IN O
plausible JJ O
candidate NN O
genes NNS O
highly RB O
expressed VBN O
in IN O
the DT O
adult NN O
human JJ O
heart NN O
identified VBD O
ACTC NNP O
as IN O
the DT O
most RBS O
likely JJ O
disease NN O
gene NN O
, , O
showing VBG O
a DT O
maximal JJ O
lod NN O
score NN O
of IN O
3 CD O
. . O

6 CD O
6 CD O
. . O

Mutation NNP O
analysis NN O
of IN O
ACTC NNP O
revealed VBD O
an DT O
Ala295Ser NNP O
mutation NN O
in IN O
exon $ O
5 CD O
close NN O
to TO O
2 CD O
missense NN O
mutations NNS O
recently RB O
described VBD O
to TO O
cause VB O
the DT O
inherited JJ O
form NN O
of IN O
idiopathic JJ B-Disease
dilated VBN I-Disease
cardiomyopathy NN I-Disease
( ( O
IDC NNP B-Disease
) ) O
. . O

Overgrowth NN B-Disease
of IN I-Disease
oral JJ I-Disease
mucosa NN I-Disease
and CC I-Disease
facial JJ I-Disease
skin NN I-Disease
, , O
a DT O
novel JJ O
feature NN O
of IN O
aspartylglucosaminuria NN B-Disease
. . O

Aspartylglucosaminuria NNP B-Disease
( ( O
AGU NNP B-Disease
) ) O
is VBZ O
a DT O
lysosomal JJ B-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
deficiency NN B-Disease
of IN I-Disease
aspartylglucosaminidase NN I-Disease
( ( O
AGA NNP O
) ) O
. . O

The DT O
main JJ O
symptom NN O
is VBZ O
progressive JJ O
mental JJ B-Disease
retardation NN I-Disease
. . O

A DT O
spectrum NN O
of IN O
different JJ O
mutations NNS O
has VBZ O
been VBN O
reported VBN O
in IN O
this DT O
disease NN O
, , O
one CD O
missense NN O
mutation NN O
( ( O
Cys163Ser NNP O
) ) O
being VBG O
responsible JJ O
for IN O
the DT O
majority NN O
of IN O
Finnish JJ O
cases NNS O
. . O

We PRP O
were VBD O
able JJ O
to TO O
examine VB O
66 CD O
Finnish JJ O
AGU NNP B-Disease
patients NNS O
for IN O
changes NNS O
in IN O
the DT O
oral JJ O
mucosa NN O
and CC O
44 CD O
of IN O
these DT O
for IN O
changes NNS O
in IN O
facial JJ O
skin NN O
. . O

Biopsy NNP O
specimens NNS O
of IN O
16 CD O
oral JJ O
lesions NNS O
, , O
12 CD O
of IN O
them PRP O
associated VBN O
with IN O
the DT O
teeth NNS O
, , O
plus CC O
two CD O
facial JJ B-Disease
lesions NNS I-Disease
were VBD O
studied VBN O
histologically RB O
. . O

Immunohistochemical JJ O
staining NN O
for IN O
AGA NNP O
was VBD O
performed VBN O
on IN O
15 CD O
oral JJ O
specimens NNS O
. . O

Skin NNP O
was VBD O
seborrhoeic VBN O
in IN O
adolescent NN O
and CC O
adult NN O
patients NNS O
, , O
with IN O
erythema NN B-Disease
of IN I-Disease
the DT I-Disease
facial JJ I-Disease
skin NN I-Disease
already RB O
common JJ O
in IN O
childhood NN O
. . O

Of IN O
44 CD O
patients NNS O
, , O
nine CD O
( ( O
20 CD O
% NN O
) ) O
had VBD O
facial JJ B-Disease
angiofibromas NN I-Disease
, , O
tumours VBZ B-Disease
primarily RB O
occurring VBG O
in IN O
association NN O
with IN O
tuberous JJ B-Disease
sclerosis NN I-Disease
. . O

Oedemic NNP B-Disease
buccal JJ I-Disease
mucosa NN I-Disease
( ( O
leucoedema NN B-Disease
) ) O
and CC O
gingival JJ B-Disease
overgrowths NNS I-Disease
were VBD O
more RBR O
frequent JJ O
in IN O
AGU NNP B-Disease
patients NNS O
than IN O
in IN O
controls NNS O
( ( O
p VB O
< RB O
0 CD O
. . O
1 CD O
) ) O
. . O

Of IN O
16 CD O
oral JJ B-Disease
mucosal NN I-Disease
lesions NNS I-Disease
studied VBN O
histologically RB O
, , O
15 CD O
represented VBN O
fibroepithelial JJ B-Disease
or CC I-Disease
epithelial JJ I-Disease
hyperplasias NN I-Disease
and CC O
were VBD O
reactive JJ O
in IN O
nature NN O
. . O

Cytoplasmic NNP O
vacuolisation NN O
was VBD O
evident JJ O
in IN O
four CD O
. . O

Immunohistochemically RB O
, , O
expression NN O
of IN O
AGA NNP O
in IN O
AGU NNP B-Disease
patients NNS O
mucosal JJ B-Disease
lesions NNS I-Disease
did VBD O
not RB O
differ VB O
from IN O
that DT O
seen VBN O
in IN O
corresponding VBG O
lesions NNS O
of IN O
normal JJ O
subjects NNS O
. . O

Thus RB O
, , O
the DT O
high JJ O
frequency NN O
of IN O
mucosal NN B-Disease
overgrowth NN I-Disease
in IN O
AGU NNP B-Disease
patients NNS O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
directly RB O
associated VBN O
with IN O
lysosomal JJ O
storage NN O
or CC O
with IN O
alterations NNS O
in IN O
the DT O
level NN O
of IN O
AGA NNP O
expression NN O
. . O

Characterization NN O
of IN O
a DT O
germline JJ O
mosaicism NN O
in IN O
families NNS O
with IN O
Lowe NNP B-Disease
syndrome NN I-Disease
, , O
and CC O
identification NN O
of IN O
seven CD O
novel JJ O
mutations NNS O
in IN O
the DT O
OCRL1 NNP O
gene NN O
. . O

The DT O
oculocerebrorenal JJ B-Disease
syndrome NN I-Disease
of IN I-Disease
Lowe NNP I-Disease
( ( O
OCRL NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
major JJ O
abnormalities NNS B-Disease
of IN I-Disease
eyes NNS I-Disease
, , I-Disease
nervous JJ I-Disease
system NN I-Disease
, , I-Disease
and CC I-Disease
kidneys NNS I-Disease
. . O

Mutations NNS O
in IN O
the DT O
OCRL1 NNP O
gene NN O
have VBP O
been VBN O
associated VBN O
with IN O
the DT O
disease NN O
. . O

OCRL1 NNP O
encodes VBZ O
a DT O
phosphatidylinositol NN O
4 CD O
, , O
5 CD O
- : O
biphosphate NN O
( ( O
PtdIns NNP O
[ NNP O
4 CD O
, , O
5 CD O
] NNP O
P2 NNP O
) ) O
5 CD O
- : O
phosphatase NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
OCRL1 NNP O
gene NN O
in IN O
eight CD O
unrelated JJ O
patients NNS O
with IN O
OCRL NNP B-Disease
and CC O
have VBP O
found VBN O
seven CD O
new JJ O
mutations NNS O
and CC O
one CD O
recurrent NN O
in IN O
- : O
frame NN O
deletion NN O
. . O

Among IN O
the DT O
new JJ O
mutations NNS O
, , O
two CD O
nonsense JJ O
mutations NNS O
( ( O
R317X NNP O
and CC O
E558X NNP O
) ) O
and CC O
three CD O
other JJ O
frameshift NN O
mutations NNS O
caused VBD O
premature JJ O
termination NN O
of IN O
the DT O
protein NN O
. . O

A DT O
missense NN O
mutation NN O
, , O
R483G NNP O
, , O
was VBD O
located VBN O
in IN O
the DT O
highly RB O
conserved JJ O
PtdIns NNP O
( ( O
4 CD O
, , O
5 CD O
) ) O
P2 VBD O
5 CD O
- : O
phosphatase NN O
domain NN O
. . O

Finally RB O
, , O
one CD O
frameshift NN O
mutation NN O
, , O
2799delC CD O
, , O
modifies VBZ O
the DT O
C NNP O
- : O
terminal JJ O
part NN O
of IN O
OCRL1 NNP O
, , O
with IN O
an DT O
extension NN O
of IN O
six CD O
amino JJ O
acids NNS O
. . O

Altogether RB O
, , O
70 CD O
% NN O
of IN O
missense NN O
mutations NNS O
are VBP O
located VBN O
in IN O
exon JJ O
15 CD O
, , O
and CC O
52 CD O
% NN O
of IN O
all DT O
mutations NNS O
cluster VBP O
in IN O
exons NNS O
11 CD O
- : O
15 CD O
. . O

We PRP O
also RB O
identified VBD O
two CD O
new JJ O
microsatellite JJ O
markers NNS O
for IN O
the DT O
OCRL1 NNP O
locus NN O
, , O
and CC O
we PRP O
detected VBD O
a DT O
germline JJ O
mosaicism NN O
in IN O
one CD O
family NN O
. . O

This DT O
observation NN O
has VBZ O
direct JJ O
implications NNS O
for IN O
genetic JJ O
counseling NN O
of IN O
Lowe NNP B-Disease
syndrome JJ I-Disease
families NNS O
. . O
. . O

MEFV NNP O
- : O
Gene NNP O
analysis NN O
in IN O
armenian JJ O
patients NNS O
with IN O
Familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
: : O
diagnostic JJ O
value NN O
and CC O
unfavorable JJ O
renal JJ O
prognosis NN O
of IN O
the DT O
M694V NNP O
homozygous JJ O
genotype NN O
- : O
genetic JJ O
and CC O
therapeutic JJ O
implications NNS O
. . O

Familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
is VBZ O
a DT O
recessively RB B-Disease
inherited JJ I-Disease
disorder NN I-Disease
that WDT O
is VBZ O
common JJ O
in IN O
patients NNS O
of IN O
Armenian JJ O
ancestry NN O
. . O

To TO O
date NN O
, , O
its PRP$ O
diagnosis NN O
, , O
which WDT O
can MD O
be VB O
made VBN O
only RB O
retrospectively RB O
, , O
is VBZ O
one CD O
of IN O
exclusion NN O
, , O
based VBN O
entirely RB O
on IN O
nonspecific JJ O
clinical JJ O
signs NNS O
that WDT O
result VBP O
from IN O
serosal NN B-Disease
inflammation NN I-Disease
and CC O
that DT O
may MD O
lead VB O
to TO O
unnecessary JJ O
surgery NN O
. . O

Renal JJ B-Disease
amyloidosis NN I-Disease
, , O
prevented VBN O
by IN O
colchicine NN O
, , O
is VBZ O
the DT O
most RBS O
severe JJ O
complication NN O
of IN O
FMF NNP B-Disease
, , O
a DT O
disorder NN O
associated VBN O
with IN O
mutations NNS O
in IN O
the DT O
MEFV NNP O
gene NN O
. . O

To TO O
evaluate VB O
the DT O
diagnostic JJ O
and CC O
prognostic JJ O
value NN O
of IN O
MEFV NNP O
- : O
gene NN O
analysis NN O
, , O
we PRP O
investigated VBD O
90 CD O
Armenian JJ O
FMF NNP B-Disease
patients NNS O
from IN O
77 CD O
unrelated JJ O
families NNS O
that WDT O
were VBD O
not RB O
selected VBN O
through IN O
genetic JJ O
- : O
linkage NN O
analysis NN O
. . O

Eight CD O
mutations NNS O
, , O
one CD O
of IN O
which WDT O
( ( O
R408Q NNP O
) ) O
is VBZ O
new JJ O
, , O
were VBD O
found VBN O
to TO O
account VB O
for IN O
93 CD O
% NN O
of IN O
the DT O
163 CD O
independent JJ O
FMF NNP B-Disease
alleles NNS O
, , O
with IN O
both DT O
FMF NNP B-Disease
alleles NNS O
identified VBN O
in IN O
89 CD O
% NN O
of IN O
the DT O
patients NNS O
. . O

In IN O
several JJ O
instances NNS O
, , O
family NN O
studies NNS O
provided VBD O
molecular JJ O
evidence NN O
for IN O
pseudodominant JJ O
transmission NN O
and CC O
incomplete JJ O
penetrance NN O
of IN O
the DT O
disease NN O
phenotype NN O
. . O

The DT O
M694V NNP O
homozygous JJ O
genotype NN O
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
higher JJR O
prevalence NN O
of IN O
renal JJ B-Disease
amyloidosis NN I-Disease
and CC O
arthritis NN B-Disease
, , O
compared VBN O
with IN O
other JJ O
genotypes NNS O
( ( O
P NNP O
= NNP O
. . O
2 CD O
and CC O
P NNP O
= NNP O
. . O
6 CD O
, , O
respectively RB O
) ) O
. . O

The DT O
demonstration NN O
of IN O
both CC O
the DT O
diagnostic JJ O
and CC O
prognostic JJ O
value NN O
of IN O
MEFV NNP O
analysis NN O
and CC O
particular JJ O
modes NNS O
of IN O
inheritance NN O
should MD O
lead VB O
to TO O
new JJ O
ways NNS O
for IN O
management NN O
of IN O
FMF NNP O
- : O
including VBG O
genetic JJ O
counseling NN O
and CC O
therapeutic JJ O
decisions NNS O
in IN O
affected JJ O
families NNS O
. . O

Noninvasive JJ O
test NN O
for IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
using VBG O
hair NN O
root NN O
analysis NN O
. . O

Identification NN O
of IN O
the DT O
FMR1 NNP O
gene NN O
and CC O
the DT O
repeat NN O
- : O
amplification NN O
mechanism NN O
causing VBG O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
led VBD O
to TO O
development NN O
of IN O
reliable JJ O
DNA NNP O
- : O
based VBN O
diagnostic JJ O
methods NNS O
, , O
including VBG O
Southern JJ O
blot NN O
hybridization NN O
and CC O
PCR NNP O
. . O

Both DT O
methods NNS O
are VBP O
performed VBN O
on IN O
DNA NNP O
isolated VBD O
from IN O
peripheral JJ O
blood NN O
cells NNS O
and CC O
measure NN O
the DT O
repeat NN O
size NN O
in IN O
FMR1 NNP O
. . O

Using VBG O
an DT O
immunocytochemical JJ O
technique NN O
on IN O
blood NN O
smears NNS O
, , O
we PRP O
recently RB O
developed VBD O
a DT O
novel JJ O
test NN O
for IN O
identification NN O
of IN O
patients NNS O
with IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
. . O

This DT O
method NN O
, , O
also RB O
called VBD O
"""" NNP O
antibody NN O
test NN O
, , O
"""" JJ O
uses VBZ O
monoclonal JJ O
antibodies NNS O
against IN O
the DT O
FMR1 NNP O
gene NN O
product NN O
( ( O
FMRP NNP O
) ) O
and CC O
is VBZ O
based VBN O
on IN O
absence NN O
of IN O
FMRP NNP O
in IN O
patients NNS O
cells NNS O
. . O

Here RB O
we PRP O
describe VBP O
a DT O
new JJ O
diagnostic JJ O
test NN O
to TO O
identify VB O
male NN O
patients NNS O
with IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
on IN O
the DT O
basis NN O
of IN O
lack NN O
of IN O
FMRP NNP O
in IN O
their PRP$ O
hair NN O
roots NNS O
. . O

Expression NN O
of IN O
FMRP NNP O
in IN O
hair NN O
roots NNS O
was VBD O
studied VBN O
by IN O
use NN O
of IN O
an DT O
FMRP NNP O
- : O
specific JJ O
antibody NN O
test NN O
, , O
and CC O
the DT O
percentage NN O
of IN O
FMRP NNP O
- : O
expressing VBG O
hair NN O
roots NNS O
in IN O
controls NNS O
and CC O
in IN O
male NN O
fragile JJ B-Disease
X NN I-Disease
patients NNS O
was VBD O
determined VBN O
. . O

Control NN O
individuals NNS O
showed VBD O
clear JJ O
expression NN O
of IN O
FMRP NNP O
in IN O
nearly RB O
every DT O
hair NN O
root NN O
, , O
whereas WP O
male NN O
fragile JJ B-Disease
X NN I-Disease
patients NNS O
lacked JJ O
expression NN O
of IN O
FMRP NNP O
in IN O
almost RB O
all DT O
their PRP$ O
hair NN O
roots NNS O
. . O

Mentally RB B-Disease
retarded JJ I-Disease
female NN O
patients NNS O
with IN O
a DT O
full JJ O
mutation NN O
showed VBD O
FMRP NNP O
expression NN O
in IN O
only RB O
some DT O
of IN O
their PRP$ O
hair NN O
roots NNS O
( ( O
< VB O
55 CD O
% NN O
) ) O
, , O
and CC O
no DT O
overlap NN O
with IN O
normal JJ O
female NN O
controls NNS O
was VBD O
observed VBN O
. . O

The DT O
advantages NNS O
of IN O
this DT O
test NN O
are VBP O
( ( O
1 CD O
) ) O
plucking NN O
of IN O
hair NN O
follicles NNS O
does VBZ O
no DT O
appreciable JJ O
harm NN O
to TO O
the DT O
mentally RB B-Disease
retarded JJ I-Disease
patient NN O
, , O
( ( O
2 CD O
) ) O
hairs NNS O
can MD O
be VB O
sent VBN O
in IN O
a DT O
simple JJ O
envelope NN O
to TO O
a DT O
diagnostic JJ O
center NN O
, , O
and CC O
( ( O
3 CD O
) ) O
the DT O
result NN O
of IN O
the DT O
test NN O
is VBZ O
available JJ O
within IN O
5 CD O
h NN O
of IN O
plucking NN O
. . O

In IN O
addition NN O
, , O
this DT O
test NN O
enabled VBD O
us PRP O
to TO O
identify VB O
two CD O
fragile JJ B-Disease
X NN I-Disease
patients NNS O
who WP O
did VBD O
not RB O
show VB O
the DT O
full JJ O
mutation NN O
by IN O
analysis NN O
of IN O
DNA NNP O
isolated VBD O
from IN O
blood NN O
cells NNS O
. . O
. . O

In IN O
Swedish JJ O
families NNS O
with IN O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
, , O
linkage NN O
to TO O
the DT O
HPC1 NNP O
locus NN O
on IN O
chromosome NN O
1q24 CD O
- : O
25 CD O
is VBZ O
restricted VBN O
to TO O
families NNS O
with IN O
early JJ O
- : O
onset NN O
prostate NN B-Disease
cancer NN I-Disease
. . O

Prostate NNP B-Disease
cancer NN I-Disease
clusters NNS O
in IN O
some DT O
families NNS O
, , O
and CC O
an DT O
estimated VBN O
5 CD O
% NN O
- : O
10 CD O
% NN O
of IN O
all DT O
cases NNS O
are VBP O
estimated VBN O
to TO O
result VB O
from IN O
inheritance NN O
of IN O
prostate NN O
cancer NN O
- : O
susceptibility NN O
genes NNS O
. . O

We PRP O
previously RB O
reported VBD O
evidence NN O
of IN O
linkage NN O
to TO O
the DT O
1q24 CD O
- : O
25 CD O
region NN O
( ( O
HPC1 NNP O
) ) O
in IN O
91 CD O
North JJ O
American JJ O
and CC O
Swedish JJ O
families NNS O
each DT O
with IN O
multiple JJ O
cases NNS O
of IN O
prostate NN B-Disease
cancer NN I-Disease
( ( O
Smith NNP O
et RB O
al RB O
. . O
1996 CD O
) ) O
. . O

In IN O
the DT O
present JJ O
report NN O
we PRP O
analyze VBP O
40 CD O
( ( O
12 CD O
original JJ O
and CC O
28 CD O
newly RB O
identified VBN O
) ) O
Swedish JJ O
families NNS O
with IN O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
( ( O
HPC NNP B-Disease
) ) O
that IN O
, , O
on IN O
the DT O
basis NN O
of IN O
40 CD O
markers NNS O
spanning VBG O
a DT O
25 CD O
- : O
cM NN O
interval NN O
within IN O
1q24 CD O
- : O
25 CD O
, , O
have VBP O
evidence NN O
of IN O
linkage NN O
. . O

In IN O
the DT O
complete JJ O
set NN O
of IN O
families NNS O
, , O
a DT O
maximum JJ O
two CD O
- : O
point NN O
LOD NNP O
score NN O
of IN O
1 CD O
. . O

10 CD O
was VBD O
observed VBN O
at IN O
D1S413 NNP O
( ( O
at IN O
a DT O
recombination NN O
fraction NN O
[ NNP O
theta NN O
] NN O
of IN O
. . O
1 CD O
) ) O
, , O
with IN O
a DT O
maximum JJ O
NPL NNP O
( ( O
nonparametric JJ O
linkage NN O
) ) O
Z NNP O
score NN O
of IN O
1 CD O
. . O

64 CD O
at IN O
D1S202 NNP O
( ( O
P NNP O
= NNP O
. . O
5 CD O
) ) O
. . O

The DT O
evidence NN O
of IN O
linkage NN O
to TO O
this DT O
region NN O
originated VBD O
almost RB O
exclusively RB O
from IN O
the DT O
subset NN O
of IN O
12 CD O
early JJ O
- : O
onset NN O
( ( O
age NN O
< VBZ O
65 CD O
years NNS O
) ) O
families NNS O
, , O
which WDT O
yielded VBD O
a DT O
maximum JJ O
LOD NNP O
score NN O
of IN O
2 CD O
. . O

38 CD O
at IN O
D1S413 NNP O
( ( O
straight JJ O
theta NN O
= NNP O
0 CD O
) ) O
and CC O
an DT O
NPL NNP O
Z NNP O
score NN O
of IN O
1 CD O
. . O

95 CD O
at IN O
D1S422 NNP O
( ( O
P NNP O
= NNP O
. . O
3 CD O
) ) O
. . O

Estimates NNS O
from IN O
heterogeneity NN O
tests NNS O
suggest VBP O
that IN O
, , O
within IN O
Sweden NNP O
, , O
as RB O
many JJ O
as IN O
50 CD O
% NN O
of IN O
early JJ O
- : O
onset NN O
families NNS O
had VBD O
evidence NN O
of IN O
linkage NN O
to TO O
the DT O
HPC1 NNP O
region NN O
. . O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
hypothesis NN O
of IN O
linkage NN O
to TO O
HPC1 NNP O
in IN O
a DT O
subset NN O
of IN O
families NNS O
with IN O
prostate NN B-Disease
cancer NN I-Disease
, , O
particularly RB O
those DT O
with IN O
an DT O
early JJ O
age NN O
at IN O
diagnosis NN O
. . O

Molecular JJ O
basis NN O
of IN O
feline NN O
beta NN B-Disease
- : I-Disease
glucuronidase NN I-Disease
deficiency NN I-Disease
: : O
an DT O
animal JJ O
model NN O
of IN O
mucopolysaccharidosis NN B-Disease
VII NNP I-Disease
. . O

A DT O
family NN O
of IN O
domestic JJ O
cats NNS O
was VBD O
found VBN O
that IN O
exhibited JJ O
clinical JJ O
and CC O
biochemical JJ O
abnormalities NNS O
consistent VBP O
with IN O
mucopolysaccharidosis NN B-Disease
VII NNP I-Disease
, , O
an DT O
autosomal JJ B-Disease
recessive NN I-Disease
lysosomal JJ I-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
beta NN B-Disease
- : I-Disease
glucuronidase NN I-Disease
deficiency NN I-Disease
. . O

beta SYM O
- : O
Glucuronidase NN O
activity NN O
was VBD O
undetectable JJ O
in IN O
affected JJ O
cat NN O
fibroblasts NNS O
and CC O
restored VBN O
by IN O
retroviral JJ O
gene NN O
transfer NN O
of IN O
rat NN O
beta SYM O
- : O
glucuronidase NN O
cDNA NN O
. . O

beta SYM O
- : O
Glucuronidase NNP O
mRNA NN O
was VBD O
normal JJ O
in IN O
affected JJ O
cat NN O
testis NN O
by IN O
Northern NNP O
blot NN O
analysis NN O
. . O

Normal JJ O
feline NN O
beta SYM O
- : O
glucuronidase NN O
cDNA NN O
was VBD O
cloned VBN O
and CC O
characterized VBN O
, , O
and CC O
amplified VBD O
from IN O
affected JJ O
cat NN O
fibroblasts NNS O
by IN O
reverse JJ O
transcription NN O
coupled VBD O
polymerase NN O
chain NN O
reaction NN O
. . O

There EX O
was VBD O
a DT O
G NNP O
- : O
to TO O
- : O
A DT O
transition NN O
in IN O
the DT O
affected JJ O
cat NN O
cDNA NN O
that WDT O
predicted VBD O
an DT O
E351K NNP O
substitution NN O
, , O
destroyed VBD O
a DT O
BssSI NNP O
site NN O
, , O
and CC O
eliminated VBD O
GUSB NNP O
enzymatic JJ O
activity NN O
in IN O
expression NN O
studies NNS O
. . O

Multiple JJ O
species NNS O
comparison NN O
and CC O
the DT O
crystal JJ O
structure NN O
of IN O
human JJ O
beta NN O
- : O
glucuronidase NN O
indicated VBD O
that IN O
E351 NNP O
is VBZ O
a DT O
highly RB O
conserved VBN O
residue NN O
most RBS O
likely JJ O
essential JJ O
in IN O
maintenance NN O
of IN O
the DT O
enzymes NNS O
conformation NN O
. . O

BssSI NNP O
digestion NN O
of IN O
polymerase NN O
chain NN O
reaction NN O
products NNS O
amplified VBN O
from IN O
genomic JJ O
DNA NNP O
indicated VBD O
that IN O
affected JJ O
cats NNS O
were VBD O
homozygous JJ O
and CC O
cats NNS O
with IN O
half JJ O
- : O
normal JJ O
beta SYM O
- : O
glucuronidase NN O
activity NN O
were VBD O
heterozygous JJ O
for IN O
the DT O
missense NN O
mutation NN O
. . O

Carriers NNS O
identified VBN O
in IN O
this DT O
manner NN O
produced VBD O
affected JJ O
kittens NNS O
in IN O
prospective JJ O
breedings NNS O
, , O
and CC O
a DT O
feline JJ O
MPS NNP B-Disease
VII NNP I-Disease
breeding VBG O
colony NN O
has VBZ O
been VBN O
established VBN O
. . O
. . O

A DT O
common JJ O
molecular JJ O
basis NN O
for IN O
rearrangement NN B-Disease
disorders NNS I-Disease
on IN O
chromosome NN O
22q11 CD O
. . O

The DT O
chromosome NN O
22q11 CD O
region NN O
is VBZ O
susceptible JJ O
to TO O
rearrangements NNS O
that WDT O
are VBP O
associated VBN O
with IN O
congenital JJ B-Disease
anomaly NN I-Disease
disorders NNS I-Disease
and CC O
malignant JJ B-Disease
tumors NNS I-Disease
. . O

Three CD O
congenital JJ B-Disease
anomaly NN I-Disease
disorders NNS I-Disease
, , O
cat SYM B-Disease
- : I-Disease
eye NN I-Disease
syndrome NN I-Disease
, , O
der NN B-Disease
( ( I-Disease
) ) I-Disease
syndrome NN I-Disease
and CC O
velo NN B-Disease
- : I-Disease
cardio NN I-Disease
- : I-Disease
facial JJ I-Disease
syndrome NN I-Disease
/ NNP O
DiGeorge NNP B-Disease
syndrome NN I-Disease
( ( O
VCFS NNP B-Disease
/ NNP O
DGS NNP B-Disease
) ) O
are VBP O
associated VBN O
with IN O
tetrasomy NN O
, , O
trisomy NN O
or CC O
monosomy NN O
, , O
respectively RB O
, , O
for IN O
part NN O
of IN O
chromosome NN O
22q11 CD O
. . O

VCFS NNP B-Disease
/ NNP O
DGS NNP B-Disease
is VBZ O
the DT O
most RBS O
common JJ O
syndrome NN O
associated VBN O
with IN O
22q11 CD O
rearrangements NNS O
. . O

In IN O
order NN O
to TO O
determine VB O
whether IN O
there EX O
are VBP O
particular JJ O
regions NNS O
on IN O
22q11 CD O
that WDT O
are VBP O
prone JJ O
to TO O
rearrangements NNS O
, , O
the DT O
deletion NN O
end NN O
- : O
points NNS O
in IN O
a DT O
large JJ O
number NN O
of IN O
VCFS NNP B-Disease
/ NNP O
DGS NNP B-Disease
patients NNS O
were VBD O
defined VBN O
by IN O
haplotype JJ O
analysis NN O
. . O

Most JJS O
VCFS NNP B-Disease
/ NNP O
DGS NNP B-Disease
patients NNS O
have VBP O
a DT O
similar JJ O
3 CD O
Mb NNP O
deletion NN O
, , O
some DT O
have VBP O
a DT O
nested JJ O
distal JJ O
deletion NN O
breakpoint NN O
resulting VBG O
in IN O
a DT O
1 CD O
. . O

5 CD O
Mb NNP O
deletion NN O
and CC O
a DT O
few JJ O
rare JJ O
patients NNS O
have VBP O
unique JJ O
deletions NNS O
or CC O
translocations NNS O
. . O

The DT O
high JJ O
prevalence NN O
of IN O
the DT O
disorder NN O
in IN O
the DT O
population NN O
and CC O
the DT O
fact NN O
that IN O
most JJS O
cases NNS O
occur VBP O
sporadically RB O
suggest VBP O
that IN O
sequences NNS O
at IN O
or CC O
near IN O
the DT O
breakpoints NNS O
confer VBP O
susceptibility NN O
to TO O
chromosome VB O
rearrangements NNS O
. . O

To TO O
investigate VB O
this DT O
hypothesis NN O
, , O
we PRP O
developed VBD O
hamster JJR O
- : O
human JJ O
somatic JJ O
hybrid NN O
cell NN O
lines NNS O
from IN O
VCFS NNP B-Disease
/ NNP O
DGS NNP B-Disease
patients NNS O
with IN O
all DT O
three CD O
classes NNS O
of IN O
deletions NNS O
and CC O
we PRP O
now RB O
show VBP O
that IN O
the DT O
breakpoints NNS O
occur VBP O
within IN O
similar JJ O
low JJ O
copy NN O
repeats NNS O
, , O
termed VBD O
LCR22s NNP O
. . O

To TO O
support VB O
this DT O
idea NN O
further RB O
, , O
we PRP O
identified VBD O
a DT O
family NN O
that WDT O
carries VBZ O
an DT O
interstitial JJ O
duplication NN O
of IN O
the DT O
same JJ O
3 CD O
Mb NNP O
region NN O
that WDT O
is VBZ O
deleted VBN O
in IN O
VCFS NNP B-Disease
/ NNP O
DGS NNP B-Disease
patients NNS O
. . O

We PRP O
present JJ O
models NNS O
to TO O
explain VB O
how WRB O
the DT O
LCR22s NNP O
can MD O
mediate VB O
different JJ O
homologous JJ O
recombination NN O
events NNS O
, , O
thereby RB O
generating VBG O
a DT O
number NN O
of IN O
rearrangements NNS O
that WDT O
are VBP O
associated VBN O
with IN O
congenital JJ B-Disease
anomaly NN I-Disease
disorders NNS I-Disease
. . O

We PRP O
identified VBD O
five CD O
additional JJ O
copies NNS O
of IN O
the DT O
LCR22 NNP O
on IN O
22q11 CD O
that WDT O
may MD O
mediate VB O
other JJ O
rearrangements NNS O
leading VBG O
to TO O
disease VB O
. . O

Functional JJ O
consequences NNS O
of IN O
mutations NNS O
in IN O
the DT O
early JJ O
growth NN O
response NN O
2 CD O
gene NN O
( ( O
EGR2 NNP O
) ) O
correlate NN O
with IN O
severity NN O
of IN O
human JJ O
myelinopathies NNS B-Disease
. . O

The DT O
early JJ O
growth NN O
response NN O
2 CD O
gene NN O
( ( O
EGR2 NNP O
) ) O
is VBZ O
a DT O
Cys2His2zinc NNP O
finger NN O
transcription NN O
factor NN O
which WDT O
is VBZ O
thought VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
peripheral JJ O
nervous JJ O
system NN O
myelination NN O
. . O

This DT O
idea NN O
is VBZ O
based VBN O
partly RB O
on IN O
the DT O
phenotype NN O
of IN O
homozygous JJ O
Krox20 NNP O
( ( O
Egr2 NNP O
) ) O
knockout NN O
mice NN O
, , O
which WDT O
display VBP O
hypomyelination NN B-Disease
of IN I-Disease
the DT I-Disease
PNS NNP I-Disease
and CC O
a DT O
block NN O
of IN O
Schwann NNP O
cells NNS O
at IN O
an DT O
early JJ O
stage NN O
of IN O
differentiation NN O
. . O

Mutations NNS O
in IN O
the DT O
human JJ O
EGR2 NNP O
gene NN O
have VBP O
recently RB O
been VBN O
associated VBN O
with IN O
the DT O
inherited JJ B-Disease
peripheral JJ I-Disease
neuropathies NNS I-Disease
Charcot NNP B-Disease
- : I-Disease
Marie NNP I-Disease
- : I-Disease
Tooth NNP I-Disease
type VBZ I-Disease
1 CD I-Disease
, , O
Dejerine NNP B-Disease
- : I-Disease
Sottas NNP I-Disease
syndrome NN I-Disease
and CC O
congenital JJ B-Disease
hypomyelinating NN I-Disease
neuropathy NN I-Disease
. . O

Three CD O
of IN O
the DT O
four CD O
EGR2 NNP O
mutations NNS O
are VBP O
dominant JJ O
and CC O
occur VB O
within IN O
the DT O
zinc NN O
finger NN O
DNA NNP O
- : O
binding NN O
domain NN O
. . O

The DT O
fourth JJ O
mutation NN O
is VBZ O
recessive JJ O
and CC O
affects VBZ O
the DT O
inhibitory NN O
domain NN O
( ( O
R1 NNP O
) ) O
that WDT O
binds VBZ O
the DT O
NAB NNP O
transcriptional JJ O
co NN O
- : O
repressors NNS O
. . O

A DT O
combination NN O
of IN O
DNA NNP O
- : O
binding NN O
assays NNS O
and CC O
transcriptional JJ O
analysis NN O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
functional JJ O
consequences NNS O
of IN O
these DT O
mutations NNS O
. . O

The DT O
zinc NN O
finger NN O
mutations NNS O
affect VBP O
DNA NNP O
binding NN O
and CC O
the DT O
amount NN O
of IN O
residual JJ O
binding VBG O
directly RB O
correlates VBZ O
with IN O
disease NN O
severity NN O
. . O

The DT O
R1 NNP O
domain NN O
mutation NN O
prevents VBZ O
interaction NN O
of IN O
EGR2 NNP O
with IN O
the DT O
NAB NNP O
co SYM O
- : O
repressors NNS O
and CC O
thereby NN O
increases NNS O
transcriptional JJ O
activity NN O
. . O

These DT O
data NNS O
provide VBP O
insight NN O
into IN O
the DT O
possible JJ O
disease NN O
mechanisms NNS O
underlying VBG O
EGR2 NNP O
mutations NNS O
and CC O
the DT O
reason NN O
for IN O
varying VBG O
severity NN O
and CC O
differences NNS O
in IN O
inheritance NN O
patterns NNS O
. . O
. . O

Autosomal NNP B-Disease
recessive JJ I-Disease
familial JJ I-Disease
neurohypophyseal NN I-Disease
diabetes VBZ I-Disease
insipidus NN I-Disease
with IN O
continued JJ O
secretion NN O
of IN O
mutant JJ O
weakly JJ O
active JJ O
vasopressin NN O
. . O

Familial JJ B-Disease
neurohypophyseal NN I-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
post NN O
- : O
natal JJ O
development NN O
of IN O
arginine NN B-Disease
vasopressin NN I-Disease
( ( I-Disease
AVP NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
due JJ O
to TO O
mutations NNS O
in IN O
the DT O
AVP NNP O
gene NN O
. . O

All DT O
published VBN O
mutations NNS O
affect VBP O
the DT O
signal JJ O
peptide NN O
or CC O
the DT O
neurophysin JJ O
- : O
II NNP O
carrier NN O
protein NN O
and CC O
are VBP O
presumed VBN O
to TO O
interfere VB O
with IN O
processing NN O
of IN O
the DT O
preprohormone NN O
, , O
leading VBG O
to TO O
neuronal JJ B-Disease
damage NN I-Disease
. . O

We PRP O
studied VBD O
an DT O
unusual JJ O
Palestinian JJ O
family NN O
consisting VBG O
of IN O
asymptomatic JJ O
first JJ O
cousin NN O
parents NNS O
and CC O
three CD O
children NNS O
affected VBD O
with IN O
neurohypophyseal JJ B-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
, , O
suggesting VBG O
autosomal JJ O
recessive JJ O
inheritance NN O
. . O

All DT O
three CD O
affected VBD O
children NNS O
were VBD O
homozygous JJ O
and CC O
the DT O
parents NNS O
heterozygous JJ O
for IN O
a DT O
single JJ O
novel NN O
mutation NN O
( ( O
C301 NNP O
- : O
> NN O
T NNP O
) ) O
in IN O
exon $ O
1 CD O
, , O
replacing VBG O
Pro7 NNP O
of IN O
mature NN O
AVP NNP O
with IN O
Leu NNP O
( ( O
Leu NNP O
- : O
AVP NN O
) ) O
. . O

Leu NNP O
- : O
AVP NNP O
was VBD O
a DT O
weak JJ O
agonist NN O
with IN O
approximately RB O
30 CD O
- : O
fold NN O
reduced VBD O
binding VBG O
to TO O
the DT O
human JJ O
V2 NNP O
receptor NN O
. . O

Measured VBN O
by IN O
radioimmunoassay NN O
with IN O
a DT O
synthetic JJ O
Leu NNP O
- : O
AVP NNP O
standard NN O
, , O
serum NN O
Leu NNP O
- : O
AVP NN O
levels NNS O
were VBD O
elevated VBN O
in IN O
all DT O
three CD O
children NNS O
and CC O
further RBR O
increased VBD O
during IN O
water NN O
deprivation NN O
to TO O
as RB O
high JJ O
as IN O
30 CD O
times NNS O
normal JJ O
. . O

The DT O
youngest JJS O
child NN O
( ( O
2 CD O
years NNS O
old JJ O
) ) O
was VBD O
only RB O
mildly RB O
affected VBN O
but CC O
had VBD O
Leu NNP O
- : O
AVP NN O
levels NNS O
similar JJ O
to TO O
her PRP$ O
severely RB O
affected JJ O
8 CD O
- : O
year NN O
- : O
old JJ O
brother NN O
, , O
suggesting VBG O
that IN O
unknown JJ O
mechanisms NNS O
may MD O
partially RB O
compensate VB O
for IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
active JJ I-Disease
AVP NNP I-Disease
in IN O
very RB O
young JJ O
children NNS O
. . O
. . O

X JJ O
inactivation NN O
and CC O
somatic JJ O
cell NN O
selection NN O
rescue NN O
female JJ O
mice NN O
carrying VBG O
a DT O
Piga NNP O
- : O
null JJ O
mutation NN O
. . O

A DT O
somatic JJ O
mutation NN O
in IN O
the DT O
X NNP O
linked VBD O
PIGA NNP O
gene NN O
is VBZ O
responsible JJ O
for IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
glycosyl NN I-Disease
phosphatidylinositol NN I-Disease
( ( I-Disease
GPI NNP I-Disease
) ) I-Disease
- : I-Disease
anchored JJ I-Disease
proteins NNS I-Disease
on IN O
blood NN O
cells NNS O
from IN O
patients NNS O
with IN O
paroxysmal JJ B-Disease
nocturnal JJ I-Disease
hemoglobinuria NN I-Disease
. . O

No DT O
inherited JJ O
form NN O
of IN O
GPI NNP B-Disease
- : I-Disease
anchor NN I-Disease
deficiency NN I-Disease
has VBZ O
been VBN O
described VBN O
. . O

Because IN O
conventional JJ O
Piga NNP O
gene NN O
knockout NN O
is VBZ O
associated VBN O
with IN O
high JJ O
embryonic JJ B-Disease
lethality NN I-Disease
in IN O
chimeric JJ O
mice NN O
, , O
we PRP O
used VBD O
the DT O
Cre NNP O
/ NNP O
loxP NN O
system NN O
. . O

We PRP O
generated VBD O
mice NN O
in IN O
which WDT O
two CD O
loxP NN O
sites NNS O
flank VBP O
part NN O
of IN O
Piga NNP O
exon $ O
2 CD O
. . O

After IN O
crossbreeding VBG O
with IN O
female JJ O
mice NN O
of IN O
the DT O
EIIa NNP O
- : O
cre NN O
strain NN O
, , O
the DT O
floxed JJ O
allele NN O
undergoes NNS O
Cre NNP O
- : O
mediated VBD O
recombination NN O
with IN O
high JJ O
efficiency NN O
during IN O
early JJ O
embryonic JJ O
development NN O
. . O

Because IN O
of IN O
X NNP O
chromosome NN O
inactivation NN O
, , O
female JJ O
offspring NN O
are VBP O
mosaic VBN O
for IN O
cells NNS O
that WDT O
express VBP O
or CC O
lack VBP O
GPI NNP O
- : O
linked VBD O
proteins NNS O
. . O

Analysis NN O
of IN O
mosaic NN O
mice NN O
showed VBD O
that IN O
in IN O
heart NN O
, , O
lung NN O
, , O
kidney NN O
, , O
brain NN O
, , O
and CC O
liver RB O
, , O
mainly RB O
wild JJ O
- : O
type NN O
Piga NNP O
is VBZ O
active JJ O
, , O
suggesting VBG O
that IN O
these DT O
tissues NNS O
require VBP O
GPI NNP O
- : O
linked VBD O
proteins NNS O
. . O

The DT O
salient JJ O
exceptions NNS O
were VBD O
spleen JJ O
, , O
thymus NN O
, , O
and CC O
red JJ O
blood NN O
cells NNS O
, , O
which WDT O
had VBD O
almost RB O
equal JJ O
numbers NNS O
of IN O
cells NNS O
expressing VBG O
the DT O
wild JJ O
- : O
type NN O
or CC O
the DT O
recombined JJ O
allele NN O
, , O
implying VBG O
that IN O
GPI NNP O
- : O
linked VBN O
proteins NNS O
are VBP O
not RB O
essential JJ O
for IN O
the DT O
derivation NN O
of IN O
these DT O
tissues NNS O
. . O

PIGA NNP O
( ( O
- : O
) ) O
cells NNS O
had VBD O
no DT O
growth NN O
advantage NN O
, , O
suggesting VBG O
that IN O
other JJ O
factors NNS O
are VBP O
needed VBN O
for IN O
their PRP$ O
clonal JJ O
dominance NN O
in IN O
patients NNS O
with IN O
paroxysmal JJ B-Disease
nocturnal JJ I-Disease
hemoglobinuria NN I-Disease
. . O
. . O

The DT O
C282Y NNP O
mutation NN O
causing VBG O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
does VBZ O
not RB O
produce VB O
a DT O
null JJ O
allele NN O
. . O

Targeted VBN O
mutagenesis NN O
was VBD O
used VBN O
to TO O
produce VB O
two CD O
mutations NNS O
in IN O
the DT O
murine NN O
hemochromatosis NN B-Disease
gene NN O
( ( O
Hfe NNP O
) ) O
locus NN O
. . O

The DT O
first JJ O
mutation NN O
deletes VBZ O
a DT O
large JJ O
portion NN O
of IN O
the DT O
coding NN O
sequence NN O
, , O
generating VBG O
a DT O
null JJ O
allele NN O
. . O

The DT O
second JJ O
mutation NN O
introduces VBZ O
a DT O
missense JJ O
mutation NN O
( ( O
C282Y NNP O
) ) O
into IN O
the DT O
Hfe NNP O
locus NN O
, , O
but CC O
otherwise RB O
leaves VBZ O
the DT O
gene NN O
intact JJ O
. . O

This DT O
mutation NN O
is VBZ O
identical JJ O
to TO O
the DT O
disease NN O
- : O
causing VBG O
mutation NN O
in IN O
patients NNS O
with IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
. . O

Mice NNP O
carrying VBG O
each DT O
of IN O
the DT O
two CD O
mutations NNS O
were VBD O
bred VBN O
and CC O
analyzed VBN O
. . O

Homozygosity NN O
for IN O
either DT O
mutation NN O
results NNS O
in IN O
postnatal JJ O
iron NN O
loading NN O
. . O

The DT O
effects NNS O
of IN O
the DT O
null JJ O
mutation NN O
are VBP O
more RBR O
severe JJ O
than IN O
the DT O
effects NNS O
of IN O
the DT O
C282Y NNP O
mutation NN O
. . O

Mice NNP O
heterozygous JJ O
for IN O
either DT O
mutation NN O
accumulate RB O
more RBR O
iron JJ O
than IN O
normal JJ O
controls NNS O
. . O

Interestingly RB O
, , O
although IN O
liver NN O
iron NN O
stores NNS O
are VBP O
greatly RB O
increased VBN O
, , O
splenic JJ O
iron NN O
is VBZ O
decreased VBN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
C282Y NNP O
mutation NN O
does VBZ O
not RB O
result VB O
in IN O
a DT O
null JJ O
allele NN O
. . O
. . O

Genotype NNP O
- : O
phenotype NN O
analysis NN O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
and CC O
identification NN O
of IN O
a DT O
missense JJ O
mutation NN O
associated VBN O
with IN O
a DT O
milder NN O
phenotype NN O
. . O

Direct JJ O
sequencing NN O
of IN O
the DT O
emerin JJ O
gene NN O
in IN O
22 CD O
families NNS O
with IN O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EMD NNP B-Disease
) ) O
revealed VBD O
mutations NNS O
in IN O
21 CD O
( ( O
95 CD O
% NN O
) ) O
, , O
confirming VBG O
that IN O
emerin JJ O
mutations NNS O
can MD O
be VB O
identified VBN O
in IN O
the DT O
majority NN O
of IN O
families NNS O
with IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
EMD NNP I-Disease
. . O

Most JJS O
emerin JJ O
mutations NNS O
result VBP O
in IN O
absence NN O
of IN O
the DT O
protein NN O
. . O

In IN O
this DT O
study NN O
three CD O
mutations NNS O
( ( O
a DT O
missense NN O
mutation NN O
Pro183Thr NNP O
and CC O
two CD O
in IN O
- : O
frame NN O
deletions NNS O
removing VBG O
residues NNS O
95 CD O
- : O
99 CD O
and CC O
236 CD O
- : O
241 CD O
, , O
respectively RB O
) ) O
were VBD O
unusual JJ O
in IN O
being VBG O
associated VBN O
with IN O
expression NN O
of IN O
mutant JJ O
protein NN O
. . O

The DT O
phenotype NN O
in IN O
these DT O
families NNS O
was VBD O
compared VBN O
in IN O
detail NN O
with IN O
the DT O
clinical JJ O
features NNS O
in IN O
cases NNS O
with IN O
typical JJ O
null JJ O
mutations NNS O
. . O

For IN O
the DT O
in IN O
- : O
frame NN O
deletions NNS O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
. . O

In IN O
the DT O
family NN O
with IN O
the DT O
missense NN O
mutation NN O
the DT O
phenotype NN O
was VBD O
milder NN O
. . O

Age NNP O
at IN O
onset NN O
was VBD O
later RB O
for IN O
first JJ O
symptoms NNS O
and CC O
for IN O
development NN O
of IN O
ankle NN B-Disease
contractures NNS I-Disease
and CC O
muscle NN B-Disease
weakness NN I-Disease
. . O

These DT O
findings NNS O
have VBP O
diagnostic JJ O
implications NNS O
as RB O
well RB O
as IN O
pointing VBG O
to TO O
functionally RB O
important JJ O
regions NNS O
of IN O
the DT O
emerin NN O
protein NN O
. . O
. . O

Severe NNP O
clinical JJ O
expression NN O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EDMD NNP B-Disease
) ) O
is VBZ O
a DT O
relatively RB O
rare JJ O
benign NN B-Disease
neuromuscular JJ I-Disease
disorder NN I-Disease
which WDT O
can MD O
vary VB O
remarkably RB O
in IN O
onset NN O
, , O
course NN O
and CC O
severity NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
a DT O
TCTAC NNP O
deletion NN O
spanning VBG O
the DT O
nucleotides NNS O
631 CD O
- : O
635 CD O
of IN O
the DT O
emerin JJ O
gene NN O
caused VBD O
an DT O
unusually RB O
severe JJ O
disease NN O
phenotype NN O
including VBG O
loss NN B-Disease
of IN I-Disease
ambulation NN I-Disease
and CC O
severe JJ O
muscle NN B-Disease
wasting VBG I-Disease
in IN O
two CD O
affected JJ O
brothers NNS O
. . O

The DT O
same JJ O
mutation NN O
has VBZ O
been VBN O
reported VBN O
previously RB O
in IN O
an DT O
unrelated JJ O
family NN O
showing VBG O
a DT O
significantly RB O
milder JJR O
phenotype NN O
. . O

The DT O
interfamilial JJ O
heterogeneity NN O
in IN O
distribution NN O
and CC O
in IN O
severity NN O
of IN O
the DT O
features NNS O
in IN O
the DT O
two CD O
families NNS O
point VBP O
to TO O
environmental JJ O
or CC O
genetic JJ O
modification NN O
as IN O
the DT O
cause NN O
of IN O
clinical JJ O
variability NN O
in IN O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O
. . O

Common JJ O
mutations NNS O
in IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
do VBP O
not RB O
contribute VB O
to TO O
early JJ O
prostate NN B-Disease
cancer NN I-Disease
in IN O
Jewish JJ O
men NNS O
. . O

BACKGROUND NNP O
Families NNP O
with IN O
a DT O
high JJ O
incidence NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
and CC O
subsequently RB O
shown VBN O
to TO O
have VB O
terminating VBG O
mutations NNS O
in IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
, , O
appear VBP O
to TO O
have VB O
a DT O
higher JJR O
incidence NN O
of IN O
prostate JJ B-Disease
cancer NN I-Disease
among IN O
male JJ O
relatives NNS O
. . O

We PRP O
aimed VBD O
to TO O
determine VB O
whether IN O
the DT O
common JJ O
germline NN O
mutations NNS O
of IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
in IN O
Ashkenazi NNP O
Jewish NNP O
men NNS O
predisposed VBD O
them PRP O
to TO O
prostate VB B-Disease
cancer NN I-Disease
. . O

METHODS NNP O
We PRP O
examined VBD O
genomic JJ O
DNA NN O
from IN O
83 CD O
( ( O
for IN O
BRCA1 NNP O
185delAG CD O
) ) O
or CC O
82 CD O
( ( O
for IN O
BRCA2 NNP O
6174delT CD O
) ) O
Ashkenazi NNP O
Jewish JJ O
prostate NN B-Disease
cancer NN I-Disease
patients NNS O
, , O
most JJS O
of IN O
whom WP O
were VBD O
treated VBN O
at IN O
a DT O
relatively RB O
young JJ O
age NN O
, , O
for IN O
the DT O
most RBS O
common JJ O
germline NN O
mutation NN O
in IN O
each DT O
gene NN O
seen VBN O
in IN O
the DT O
Ashkenazi NNP O
population NN O
. . O

RESULTS NNP O
Our PRP$ O
study NN O
should MD O
have VB O
been VBN O
able JJ O
to TO O
detect VB O
a DT O
4 CD O
- : O
5 CD O
- : O
fold JJ O
increase NN O
in IN O
the DT O
risk NN O
of IN O
prostate NN B-Disease
cancer NN I-Disease
due JJ O
to TO O
mutation NN O
of IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
. . O

However RB O
, , O
only RB O
one CD O
( ( O
1 CD O
. . O
15 CD O
% NN O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
0 CD O
- : O
3 CD O
. . O
6 CD O
% NN O
) ) O
of IN O
the DT O
patients NNS O
was VBD O
heterozygous JJ O
for IN O
the DT O
BRCA1 NNP O
mutant NN O
allele NN O
, , O
and CC O
only RB O
two CD O
were VBD O
heterozygous JJ O
for IN O
the DT O
BRCA2 NNP O
mutation NN O
( ( O
2 CD O
. . O
4 CD O
% NN O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
0 CD O
- : O
6 CD O
. . O
2 CD O
% NN O
) ) O
. . O

CONCLUSIONS NNP O
The DT O
incidence NN O
of IN O
each DT O
of IN O
the DT O
germline NN O
mutations NNS O
in IN O
these DT O
prostate JJ B-Disease
cancer NN I-Disease
patients NNS O
closely RB O
matched VBD O
their PRP$ O
incidence NN O
( ( O
about IN O
1 CD O
% NN O
) ) O
in IN O
the DT O
general JJ O
Ashkenazi NNP O
Jewish NNP O
population NN O
. . O

This DT O
suggests VBZ O
that IN O
unlike IN O
cases NNS O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
, , O
mutations NNS O
in IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
do VBP O
not RB O
significantly RB O
predispose VB O
men NNS O
to TO O
prostate VB B-Disease
cancer NN I-Disease

Beta NNP O
- : O
catenin NN O
accumulation NN O
and CC O
mutation NN O
of IN O
the DT O
CTNNB1 NNP O
gene NN O
in IN O
hepatoblastoma NN B-Disease
. . O

Hepatoblastoma NNP B-Disease
is VBZ O
a DT O
rare JJ O
malignant JJ B-Disease
tumor NN I-Disease
of IN I-Disease
the DT I-Disease
liver NN I-Disease
that WDT O
occurs VBZ O
in IN O
children NNS O
at IN O
an DT O
average JJ O
age NN O
of IN O
2 CD O
to TO O
3 CD O
years NNS O
. . O

Epidemiologic NNP O
studies NNS O
have VBP O
shown VBN O
an DT O
increased JJ O
frequency NN O
of IN O
this DT O
tumor NN B-Disease
type NN O
in IN O
families NNS O
affected VBN O
by IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
. . O

In IN O
addition NN O
to TO O
the DT O
epidemiologic NN O
data NNS O
, , O
molecular JJ O
genetic JJ O
studies NNS O
suggest VBP O
that IN O
inactivation NN O
of IN O
the DT O
APC NNP B-Disease
tumor NN I-Disease
suppressor NN O
may MD O
be VB O
involved VBN O
in IN O
hepatoblastoma JJ B-Disease
tumorigenesis NN O
. . O

A DT O
major JJ O
function NN O
of IN O
APC NNP O
is VBZ O
the DT O
downregulation NN O
of IN O
beta NN O
- : O
catenin NN O
, , O
a DT O
transcription NN O
- : O
activating VBG O
protein NN O
with IN O
oncogenic JJ O
potential NN O
. . O

In IN O
an DT O
ongoing JJ O
immunohistochemical JJ O
study NN O
of IN O
beta NN O
- : O
catenin NN O
expression NN O
in IN O
sporadic JJ O
cases NNS O
of IN O
tumor NN B-Disease
types NNS O
that WDT O
are VBP O
associated VBN O
with IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
, , O
we PRP O
observed VBD O
increased VBN O
beta NN O
- : O
catenin NN O
levels NNS O
in IN O
the DT O
cytoplasm NN O
and CC O
in IN O
the DT O
nuclei NN O
of IN O
three CD O
investigated JJ O
hepatoblastomas NN B-Disease
. . O

Sequencing VBG O
of IN O
exon JJ O
3 CD O
of IN O
the DT O
beta NN O
- : O
catenin NN O
gene NN O
( ( O
CTNNB1 NNP O
) ) O
revealed VBD O
an DT O
activating VBG O
mutation NN O
in IN O
one CD O
of IN O
the DT O
tumor NN B-Disease
samples NNS O
. . O

Our PRP$ O
data NNS O
indicate NN O
for IN O
the DT O
first JJ O
time NN O
that WDT O
beta VBZ O
- : O
catenin NN O
accumulation NN O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
development NN O
of IN O
hepatoblastoma NN B-Disease
and CC O
that IN O
activating VBG O
mutations NNS O
of IN O
the DT O
beta NN O
- : O
catenin NN O
gene NN O
may MD O
substitute VB O
biallelic JJ O
APC NNP O
inactivation NN O
in IN O
this DT O
tumor NN B-Disease
type NN O
. . O

Genes NNS O
Chromosomes NNP O
Cancer NNP O
25 CD O
399 CD O
- : O
402 CD O
, , O
1999 CD O
. . O
. . O

Decrease NNP O
in IN O
GTP NNP O
cyclohydrolase NN O
I PRP O
gene NN O
expression NN O
caused VBN O
by IN O
inactivation NN O
of IN O
one CD O
allele NN O
in IN O
hereditary JJ B-Disease
progressive JJ I-Disease
dystonia NN I-Disease
with IN O
marked JJ O
diurnal JJ O
fluctuation NN O
. . O

Hereditary NNP B-Disease
progressive JJ I-Disease
dystonia NN I-Disease
with IN O
marked JJ O
diurnal JJ O
fluctuation NN O
( ( O
HPD NNP B-Disease
; : O
dopa SYM B-Disease
- : I-Disease
responsive JJ I-Disease
dystonia NN I-Disease
, , O
DRD NNP B-Disease
) ) O
have VBP O
been VBN O
recently RB O
found VBN O
to TO O
be VB O
caused VBN O
by IN O
a DT O
genetic JJ B-Disease
defect NN I-Disease
in IN O
the DT O
GTP NNP O
cyclohydrolase NN O
I PRP O
( ( O
GCH1 NNP O
) ) O
gene NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
quantified VBD O
the DT O
mRNA JJ O
level NN O
of IN O
GCH1 NNP O
in IN O
phytohemagglutinin NN O
( ( O
PHA NNP O
) ) O
- : O
stimulated VBN O
mononuclear JJ O
blood NN O
cells NNS O
from IN O
one CD O
Japanese JJ O
family NN O
that WDT O
do VBP O
not RB O
have VB O
a DT O
mutation NN O
in IN O
the DT O
coding JJ O
region NN O
or CC O
splice NN O
junctions NNS O
of IN O
the DT O
gene NN O
. . O

The DT O
results NNS O
showed VBD O
that IN O
the DT O
amounts NNS O
of IN O
the DT O
GCH1 NNP O
mRNA NN O
were VBD O
decreased VBN O
to TO O
about IN O
40 CD O
% NN O
of IN O
the DT O
normal JJ O
level NN O
in IN O
both DT O
patients NNS O
and CC O
carriers NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
GCH1 NNP O
mRNA NN O
was VBD O
transcribed VBN O
from IN O
only RB O
one CD O
allele NN O
, , O
indicating VBG O
that IN O
the DT O
other JJ O
allele NN O
was VBD O
in IN O
an DT O
inactive JJ O
state NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
some DT O
novel JJ O
mutations NNS O
should MD O
exist VB O
on IN O
one CD O
of IN O
the DT O
alleles NNS O
in IN O
some DT O
unknown JJ O
region NN O
of IN O
the DT O
GCH1 NNP O
gene NN O
, , O
and CC O
may MD O
decrease VB O
the DT O
GCH1 NNP O
mRNA NN O
causing VBG O
the DT O
HPD NNP B-Disease
/ NNP O
DRD NNP B-Disease
symptoms NNS O
. . O
. . O

Sulfate NNP O
transport NN O
is VBZ O
not RB O
impaired VBN O
in IN O
pendred JJ B-Disease
syndrome NN I-Disease
thyrocytes NNS O
. . O

Pendred NNP B-Disease
syndrome NN I-Disease
is VBZ O
the DT O
most RBS O
common JJ O
form NN O
of IN O
syndromic JJ B-Disease
deafness NN I-Disease
, , O
characterized VBN O
by IN O
dyshormonogenic JJ B-Disease
goiter NN I-Disease
associated VBN O
with IN O
sensory JJ B-Disease
- : I-Disease
neural JJ I-Disease
deafness NN I-Disease
. . O

The DT O
gene NN O
responsible JJ O
for IN O
the DT O
disease NN O
( ( O
PDS NNP B-Disease
) ) O
has VBZ O
been VBN O
cloned VBN O
, , O
but CC O
its PRP$ O
function NN O
is VBZ O
as IN O
yet RB O
unknown JJ O
and CC O
the DT O
connection NN O
between IN O
thyroid JJ B-Disease
goiter NN I-Disease
and CC O
sensory JJ B-Disease
- : I-Disease
neural JJ I-Disease
deafness NN I-Disease
remains VBZ O
an DT O
enigma NN O
. . O

PDS NNP O
codes NNS O
for IN O
a DT O
novel JJ O
protein NN O
, , O
pendrin NN O
, , O
which WDT O
is VBZ O
closely RB O
related VBN O
to TO O
a DT O
number NN O
of IN O
sufate JJ O
transporters NNS O
. . O

Mechanisms NNS O
by IN O
which WDT O
abnormal JJ O
sulfate NN O
transport NN O
could MD O
deleteriously RB O
affect VB O
iodide JJ O
organification NN O
have VBP O
been VBN O
proposed VBN O
. . O

We PRP O
tested VBD O
sulfate JJ O
transport NN O
in IN O
thyrocytes NNS O
obtained VBN O
from IN O
Pendred NNP B-Disease
syndrome NN I-Disease
patients NNS O
and CC O
found VBD O
that IN O
it PRP O
was VBD O
not RB O
defective JJ O
. . O

This DT O
suggests VBZ O
that IN O
pendrin NN O
in IN O
fact NN O
may MD O
not RB O
be VB O
a DT O
sulfate NN O
transporter NN O
, , O
and CC O
emphasizes VBZ O
the DT O
importance NN O
of IN O
functional JJ O
studies NNS O
on IN O
this DT O
novel JJ O
protein NN O
. . O
. . O

Small JJ O
deletions NNS O
in IN O
the DT O
type NN O
II NNP O
collagen NN O
triple NN O
helix NN O
produce VBP O
kniest JJS B-Disease
dysplasia NN I-Disease
. . O

Kniest NNP B-Disease
dysplasia NN I-Disease
is VBZ O
a DT O
moderately RB O
severe JJ O
type NN B-Disease
II NNP I-Disease
collagenopathy NN I-Disease
, , O
characterized VBN O
by IN O
short JJ O
trunk NN O
and CC O
limbs NNS O
, , O
kyphoscoliosis NN B-Disease
, , O
midface NN B-Disease
hypoplasia NN I-Disease
, , O
severe JJ O
myopia NN B-Disease
, , O
and CC O
hearing JJ B-Disease
loss NN I-Disease
. . O

Mutations NNS O
in IN O
the DT O
gene NN O
that WDT O
encodes VBZ O
type JJ O
II NNP O
collagen NN O
( ( O
COL2A1 NNP O
) ) O
, , O
the DT O
predominant JJ O
protein NN O
of IN O
cartilage NN O
, , O
have VBP O
been VBN O
identified VBN O
in IN O
a DT O
number NN O
of IN O
individuals NNS O
with IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
. . O

All DT O
but CC O
two CD O
of IN O
these DT O
previously RB O
described VBN O
mutations NNS O
cause VBP O
in IN O
- : O
frame NN O
deletions NNS O
in IN O
type NN O
II NNP O
collagen NN O
, , O
either CC O
by IN O
small JJ O
deletions NNS O
in IN O
the DT O
gene NN O
or CC O
splice NN O
site NN O
alterations NNS O
. . O

Furthermore RB O
, , O
all DT O
but CC O
one CD O
of IN O
these DT O
mutations NNS O
is VBZ O
located VBN O
between IN O
exons NNS O
12 CD O
and CC O
24 CD O
in IN O
the DT O
COL2A1 NNP O
gene NN O
. . O

We PRP O
used VBD O
heteroduplex JJ O
analysis NN O
to TO O
identify VB O
sequence NN O
anomalies NNS O
in IN O
five CD O
individuals NNS O
with IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
. . O

Sequencing VBG O
of IN O
the DT O
index NN O
patients NNS O
genomic JJ O
DNA NNP O
identified VBD O
four CD O
new JJ O
dominant JJ O
mutations NNS O
in IN O
COL2A1 NNP O
that WDT O
result NN O
in IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
a DT O
21 CD O
- : O
bp NN O
deletion NN O
in IN O
exon JJ O
16 CD O
, , O
an DT O
18 CD O
- : O
bp NN O
deletion NN O
in IN O
exon JJ O
19 CD O
, , O
and CC O
4 CD O
- : O
bp NN O
deletions NNS O
in IN O
the DT O
splice NN O
donor NN O
sites NNS O
of IN O
introns NNS O
14 CD O
and CC O
20 CD O
. . O

A DT O
previously RB O
described VBN O
28 CD O
- : O
bp NN O
deletion NN O
at IN O
the DT O
COL2A1 NNP O
exon VBD O
12 CD O
- : O
intron NN O
12 CD O
junction NN O
, , O
deleting VBG O
the DT O
splice NN O
donor NN O
site NN O
, , O
was VBD O
identified VBN O
in IN O
the DT O
fifth JJ O
case NN O
. . O

The DT O
latter JJ O
three CD O
mutations NNS O
are VBP O
predicted VBN O
to TO O
result VB O
in IN O
exon NN O
skipping NN O
in IN O
the DT O
mRNA NN O
encoded VBD O
from IN O
the DT O
mutant JJ O
allele NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
results NNS O
from IN O
shorter JJR O
type NN O
II NNP O
collagen NN O
monomers NNS O
, , O
and CC O
support VB O
the DT O
hypothesis NN O
that IN O
alteration NN O
of IN O
a DT O
specific JJ O
COL2A1 NNP O
domain NN O
, , O
which WDT O
may MD O
span VB O
from IN O
exons NNS O
12 CD O
to TO O
24 CD O
, , O
leads VBZ O
to TO O
the DT O
Kniest NNP B-Disease
dysplasia NN I-Disease
phenotype NN O
. . O
. . O

Classical JJ B-Disease
galactosemia NN I-Disease
and CC O
mutations NNS O
at IN O
the DT O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyl JJ O
transferase NN O
( ( O
GALT NNP O
) ) O
gene NN O
. . O

Classical JJ B-Disease
galactosemia NN I-Disease
is VBZ O
caused VBN O
by IN O
a DT O
deficiency NN O
in IN O
activity NN O
of IN O
the DT O
enzyme NN O
galactose VBD O
- : O
1 CD O
- : O
phosphate NN O
uridyl JJ O
transferase NN O
( ( O
GALT NNP O
) ) O
, , O
which WDT O
, , O
in IN O
turn NN O
, , O
is VBZ O
caused VBN O
by IN O
mutations NNS O
at IN O
the DT O
GALT NNP O
gene NN O
. . O

The DT O
disorder NN O
exhibits VBZ O
considerable JJ O
allelic JJ O
heterogeneity NN O
and CC O
, , O
at IN O
the DT O
end NN O
of IN O
1998 CD O
, , O
more JJR O
than IN O
150 CD O
different JJ O
base NN O
changes NNS O
were VBD O
recorded VBN O
in IN O
24 CD O
different JJ O
populations NNS O
and CC O
ethnic JJ O
groups NNS O
in IN O
15 CD O
countries NNS O
worldwide RB O
. . O

The DT O
mutations NNS O
most RBS O
frequently RB O
cited VBN O
are VBP O
Q188R NNP O
, , O
K285N NNP O
, , O
S135L NNP O
, , O
and CC O
N314D NNP O
. . O

Q188R NNP O
is VBZ O
the DT O
most RBS O
common JJ O
mutation NN O
in IN O
European JJ O
populations NNS O
or CC O
in IN O
those DT O
predominantly RB O
of IN O
European JJ O
descent NN O
. . O

Overall JJ O
, , O
it PRP O
accounts VBZ O
for IN O
60 CD O
- : O
70 CD O
% NN O
of IN O
mutant JJ O
chromosomes NNS O
, , O
but CC O
there EX O
are VBP O
significant JJ O
differences NNS O
in IN O
its PRP$ O
relative JJ O
frequency NN O
in IN O
individual JJ O
populations NNS O
. . O

Individuals NNS O
homoallelic VBP O
for IN O
Q188R NNP O
tend VBP O
to TO O
have VB O
a DT O
severe JJ O
phenotype NN O
and CC O
this DT O
is VBZ O
in IN O
keeping VBG O
with IN O
the DT O
virtually RB O
complete JJ O
loss NN O
of IN O
enzyme JJ O
activity NN O
observed VBN O
in IN O
in IN O
vitro JJ O
expression NN O
systems NNS O
. . O

Globally RB O
, , O
K285N NNP O
is VBZ O
rarer JJ O
, , O
but CC O
in IN O
many JJ O
European JJ O
populations NNS O
it PRP O
can MD O
be VB O
found VBN O
on IN O
25 CD O
- : O
40 CD O
% NN O
of IN O
mutant JJ O
chromosomes NNS O
. . O

It PRP O
is VBZ O
invariably RB O
associated VBN O
with IN O
a DT O
severe JJ O
phenotype NN O
. . O

S135L NNP O
is VBZ O
found VBN O
almost RB O
exclusively RB O
in IN O
African JJ O
Americans NNPS O
. . O

In IN O
vitro JJ O
expression NN O
results NNS O
are VBP O
discrepant JJ O
, , O
but CC O
some DT O
individuals NNS O
carrying VBG O
S135L NNP O
appear VBP O
to TO O
exhibit VB O
GALT NNP O
activity NN O
in IN O
some DT O
tissues NNS O
. . O

Duarte NNP O
1 CD O
( ( O
or CC O
Los NNP O
Angeles NNP O
) ) O
and CC O
Duarte $ O
2 CD O
( ( O
or CC O
Duarte NNP O
) ) O
variants NNS O
carry VBP O
the DT O
same JJ O
amino NN O
acid NN O
substitution NN O
, , O
N314D NNP O
, , O
even RB O
though IN O
D1 NNP O
is VBZ O
associated VBN O
with IN O
increased JJ O
erythrocyte NN O
GALT NNP O
activity NN O
and CC O
D2 NNP O
with IN O
reduced JJ O
activity NN O
. . O

N314D NNP O
is VBZ O
in IN O
linkage NN O
disequilibrium NN O
with IN O
other JJ O
base NN O
changes NNS O
that WDT O
differ VBP O
on IN O
the DT O
D1 NNP O
and CC O
D2 NNP O
alleles NNS O
. . O

N314D NN O
does VBZ O
not RB O
impair VB O
GALT NNP O
activity NN O
in IN O
in IN O
vitro JJ O
expression NN O
systems NNS O
. . O

However RB O
, , O
there EX O
are VBP O
differences NNS O
in IN O
the DT O
abundance NN O
of IN O
GALT NNP O
protein NN O
in IN O
lymphoblastoid JJ O
cells NNS O
lines NNS O
from IN O
D2 NNP O
and CC O
D1 NNP O
individuals NNS O
. . O

It PRP O
is VBZ O
unclear JJ O
whether IN O
the DT O
specific JJ O
molecular JJ O
changes NNS O
that WDT O
distinguish VBP O
the DT O
D1 NNP O
and CC O
D2 NNP O
alleles VBZ O
account NN O
for IN O
the DT O
different JJ O
activities NNS O
. . O

The DT O
considerable JJ O
genetic JJ O
heterogeneity NN O
documented VBN O
to TO O
date NN O
undoubtedly RB O
contributes VBZ O
to TO O
the DT O
phenotypic NN O
heterogeneity NN O
that WDT O
is VBZ O
observed VBN O
in IN O
galactosemia NN B-Disease
. . O

The DT O
additional JJ O
effects NNS O
of IN O
nonallelic JJ O
variation NN O
and CC O
other JJ O
constitutional JJ O
factors NNS O
on IN O
phenotypic NN O
variability NN O
remain VBP O
to TO O
be VB O
elucidated VBN O
. . O
. . O

Mutations NNS O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
in IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
: : O
definition NN O
of IN O
a DT O
risk NN O
factor NN O
for IN O
VHL NNP B-Disease
patients NNS O
to TO O
develop VB O
an DT O
RCC NNP B-Disease
. . O

To TO O
investigate VB O
the DT O
nature NN O
of IN O
somatic JJ O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( O
VHL NNP B-Disease
) ) O
mutations NNS O
, , O
we PRP O
analyzed VBD O
173 CD O
primary JJ O
sporadic JJ O
human JJ O
renal NN B-Disease
cell NN I-Disease
carcinomas NN I-Disease
for IN O
mutations NNS O
of IN O
the DT O
VHL NNP B-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
, , O
using VBG O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
and CC O
single JJ O
- : O
strand NN O
conformational JJ O
polymorphism NN O
analysis NN O
( ( O
SSCP NNP O
) ) O
of IN O
DNA NN O
. . O

We PRP O
detected VBD O
abnormal JJ O
SSCP NNP O
pattern NN O
in IN O
73 CD O
samples NNS O
. . O

After IN O
sequencing VBG O
, , O
we PRP O
identified VBD O
microdeletions NNS O
in IN O
58 CD O
% NN O
of IN O
cases NNS O
, , O
microinsertions NNS O
in IN O
17 CD O
% NN O
, , O
nonsense JJ O
mutations NNS O
in IN O
8 CD O
% NN O
, , O
and CC O
missense JJ O
mutations NNS O
in IN O
17 CD O
% NN O
. . O

Among IN O
these DT O
mutations NNS O
, , O
50 CD O
% NN O
correspond NN O
to TO O
new JJ O
mutations NNS O
. . O

VHL NNP B-Disease
mutations NNS O
were VBD O
found VBN O
only RB O
in IN O
the DT O
nonpapillary JJ B-Disease
renal NN I-Disease
cell NN I-Disease
carcinoma NN I-Disease
( ( O
RCC NNP B-Disease
) ) O
subtype NN O
, , O
as IN O
previously RB O
reported VBN O
. . O

To TO O
compare VB O
somatic JJ O
and CC O
germline JJ O
mutations NNS O
, , O
we PRP O
used VBD O
the DT O
VHL NNP B-Disease
database NN O
, , O
which WDT O
includes VBZ O
507 CD O
mutations NNS O
. . O

The DT O
study NN O
of IN O
mutational JJ O
events NNS O
revealed VBD O
a DT O
significant JJ O
difference NN O
between IN O
somatic JJ O
and CC O
germline JJ O
mutations NNS O
with IN O
mutations NNS O
leading VBG O
to TO O
truncated JJ O
proteins NNS O
observed VBN O
in IN O
78 CD O
% NN O
of IN O
somatic JJ O
mutations NNS O
vs VBP O
only RB O
37 CD O
% NN O
in IN O
germline JJ O
mutations NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

We PRP O
postulated VBD O
that IN O
a DT O
specific JJ O
pattern NN O
of IN O
VHL NNP B-Disease
mutations NNS O
is VBZ O
associated VBN O
with IN O
sporadic JJ B-Disease
RCC NNP I-Disease
. . O

This DT O
pattern NN O
corresponds VBZ O
to TO O
mutations NNS O
leading VBG O
mainly RB O
to TO O
truncated JJ O
proteins NNS O
with IN O
few JJ O
specific JJ O
missense NN O
mutations NNS O
. . O

We PRP O
then RB O
analyzed VBD O
the DT O
occurrence NN O
of IN O
RCC NNP B-Disease
in IN O
VHL NNP B-Disease
families NNS O
, , O
based VBN O
on IN O
the DT O
nature NN O
of IN O
mutations NNS O
. . O

We PRP O
observed VBD O
RCC NNP B-Disease
in IN O
at IN O
least JJS O
one CD O
member NN O
of IN O
the DT O
VHL NNP B-Disease
families NNS O
in IN O
77 CD O
% NN O
of IN O
cases NNS O
with IN O
mutations NNS O
leading VBG O
to TO O
truncated JJ O
proteins NNS O
versus VBP O
55 CD O
% NN O
in IN O
cases NNS O
with IN O
missense JJ O
mutations NNS O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
5 CD O
) ) O
. . O

Thus RB O
, , O
mutations NNS O
resulting VBG O
in IN O
truncated JJ O
proteins NNS O
may MD O
lead VB O
to TO O
a DT O
higher JJR O
risk NN O
of IN O
RCC NNP B-Disease
in IN O
VHL NNP B-Disease
patients NNS O

Defective JJ O
CTLA NNP O
- : O
4 CD O
cycling VBG O
pathway NN O
in IN O
Chediak NNP B-Disease
- : I-Disease
Higashi NNP I-Disease
syndrome NN I-Disease
: : O
a DT O
possible JJ O
mechanism NN O
for IN O
deregulation NN O
of IN O
T NNP O
lymphocyte JJ O
activation NN O
. . O

Cytotoxic NNP O
T NNP O
lymphocyte SYM O
- : O
associated VBN O
antigen NN O
4 CD O
( ( O
CTLA NNP O
- : O
4 CD O
, , O
also RB O
known VBN O
as IN O
CD152 NNP O
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
major JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
T NNP O
cell NN O
activation NN O
. . O

Its PRP$ O
membrane NN O
expression NN O
is VBZ O
highly RB O
regulated VBN O
by IN O
endocytosis NN O
and CC O
trafficking VBG O
through IN O
the DT O
secretory JJ O
lysosome JJ O
pathway NN O
. . O

Chediak NNP B-Disease
- : I-Disease
Higashi NNP I-Disease
syndrome NN I-Disease
( ( O
CHS NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ B-Disease
disorder NN I-Disease
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
lysosomal JJ O
trafficking NN O
regulator NN O
gene NN O
, , O
LYST NNP O
. . O

It PRP O
results NNS O
in IN O
defective JJ O
membrane NN O
targeting NN O
of IN O
the DT O
proteins NNS O
present JJ O
in IN O
secretory JJ O
lysosomes NNS O
, , O
and CC O
it PRP O
is VBZ O
associated VBN O
with IN O
a DT O
variety NN O
of IN O
features NNS O
, , O
including VBG O
a DT O
lymphoproliferative JJ B-Disease
syndrome NN I-Disease
with IN O
hemophagocytosis NN B-Disease
. . O

The DT O
murine JJ O
equivalent NN O
of IN O
CHS NNP B-Disease
, , O
beige JJ O
mice NN O
, , O
present JJ O
similar JJ O
characteristics NNS O
but CC O
do VBP O
not RB O
develop VB O
the DT O
lymphoproliferative JJ B-Disease
syndrome NN I-Disease
. . O

We PRP O
show VBP O
herein JJ O
that IN O
CTLA NNP O
- : O
4 CD O
is VBZ O
present JJ O
in IN O
enlarged JJ O
, , O
abnormal JJ O
vesicles NNS O
in IN O
CHS NNP B-Disease
T NNP O
cells NNS O
and CC O
is VBZ O
not RB O
properly RB O
expressed VBN O
at IN O
the DT O
cell NN O
surface NN O
after IN O
T NNP O
cell NN O
activation NN O
, , O
whereas IN O
its PRP$ O
surface NN O
expression NN O
is VBZ O
not RB O
impaired JJ O
. . O

It PRP O
is VBZ O
therefore RB O
proposed VBN O
that IN O
the DT O
defective JJ O
surface NN O
expression NN O
of IN O
CTLA NNP O
- : O
4 CD O
by IN O
CHS NNP B-Disease
T NNP O
cells NNS O
is VBZ O
involved VBN O
in IN O
the DT O
generation NN O
of IN O
lymphoproliferative JJ B-Disease
disease NN I-Disease
. . O

This DT O
observation NN O
may MD O
provide VB O
insight NN O
into IN O
the DT O
role NN O
of IN O
CTLA NNP O
- : O
4 CD O
in IN O
humans NNS O
. . O
. . O

Proteolipoprotein NNP O
gene NN O
analysis NN O
in IN O
82 CD O
patients NNS O
with IN O
sporadic JJ O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
Disease NN I-Disease
: : O
duplications NNS O
, , O
the DT O
major JJ O
cause NN O
of IN O
the DT O
disease NN O
, , O
originate VB O
more RBR O
frequently RB O
in IN O
male JJ O
germ NN O
cells NNS O
, , O
but CC O
point NN O
mutations NNS O
do VBP O
not RB O
. . O

The DT O
Clinical JJ O
European JJ O
Network NNP O
on IN O
Brain NNP B-Disease
Dysmyelinating NNP I-Disease
Disease NNP I-Disease
. . O

Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
Disease NNP I-Disease
( ( O
PMD NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
developmental JJ I-Disease
defect NN I-Disease
of IN I-Disease
myelination NN I-Disease
affecting VBG O
the DT O
central JJ O
nervous JJ O
system NN O
and CC O
segregating VBG O
with IN O
the DT O
proteolipoprotein NN O
( ( O
PLP NNP O
) ) O
locus NN O
. . O

Investigating VBG O
82 CD O
strictly RB O
selected VBN O
sporadic JJ O
cases NNS O
of IN O
PMD NNP B-Disease
, , O
we PRP O
found VBD O
PLP NNP O
mutations NNS O
in IN O
77 CD O
% NN O
; : O
complete JJ O
PLP NNP O
- : O
gene NN O
duplications NNS O
were VBD O
the DT O
most RBS O
frequent JJ O
abnormality NN O
( ( O
62 CD O
% NN O
) ) O
, , O
whereas JJ O
point NN O
mutations NNS O
in IN O
coding VBG O
or CC O
splice JJ O
- : O
site NN O
regions NNS O
of IN O
the DT O
gene NN O
were VBD O
involved VBN O
less RBR O
frequently RB O
( ( O
38 CD O
% NN O
) ) O
. . O

We PRP O
analyzed VBD O
the DT O
maternal JJ O
status NN O
of IN O
56 CD O
cases NNS O
to TO O
determine VB O
the DT O
origin NN O
of IN O
both DT O
types NNS O
of IN O
PLP NNP O
mutation NN O
, , O
since IN O
this DT O
is VBZ O
relevant JJ O
to TO O
genetic JJ O
counseling NN O
. . O

In IN O
the DT O
22 CD O
point NN O
mutations NNS O
, , O
68 CD O
% NN O
of IN O
mothers NNS O
were VBD O
heterozygous JJ O
for IN O
the DT O
mutation NN O
, , O
a DT O
value NN O
identical JJ O
to TO O
the DT O
two CD O
- : O
thirds NNS O
of IN O
carrier NN O
mothers NNS O
that WDT O
would MD O
be VB O
expected VBN O
if IN O
there EX O
were VBD O
an DT O
equal JJ O
mutation NN O
rate NN O
in IN O
male NN O
and CC O
female JJ O
germ NN O
cells NNS O
. . O

In IN O
sharp JJ O
contrast NN O
, , O
among IN O
the DT O
34 CD O
duplicated JJ O
cases NNS O
, , O
91 CD O
% NN O
of IN O
mothers NNS O
were VBD O
carriers NNS O
, , O
a DT O
value NN O
significantly RB O
( ( O
chi2 JJ O
= NN O
9 CD O
. . O
20 CD O
, , O
P NNP O
< NNP O
. . O
1 CD O
) ) O
in IN O
favor NN O
of IN O
a DT O
male NN O
bias NN O
, , O
with IN O
an DT O
estimation NN O
of IN O
the DT O
male NN O
/ NNP O
female JJ O
mutation NN O
frequency NN O
( ( O
k NN O
) ) O
of IN O
9 CD O
. . O

3 CD O
3 CD O
. . O

Moreover RB O
, , O
we PRP O
observed VBD O
the DT O
occurrence NN O
of IN O
de FW O
novo FW O
mutations NNS O
between IN O
parental JJ O
and CC O
grandparental JJ O
generations NNS O
in IN O
17 CD O
three CD O
- : O
generation NN O
families NNS O
, , O
which WDT O
allowed VBD O
a DT O
direct JJ O
estimation NN O
of IN O
the DT O
k NN O
value NN O
( ( O
k VB O
= NNP O
11 CD O
) ) O
. . O

Again NNP O
, , O
a DT O
significant JJ O
male JJ O
mutation NN O
imbalance NN O
was VBD O
observed VBN O
only RB O
for IN O
the DT O
duplications NNS O
. . O

Chromosome NNP O
breakage NN O
in IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
and CC I-Disease
Angelman NNP I-Disease
syndromes VBZ I-Disease
involves VBZ O
recombination NN O
between IN O
large JJ O
, , O
transcribed JJ O
repeats NNS O
at IN O
proximal JJ O
and CC O
distal JJ O
breakpoints NNS O
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
and CC O
Angelman NNP B-Disease
syndrome VBP I-Disease
( ( O
AS IN B-Disease
) ) O
are VBP O
distinct JJ O
neurobehavioral JJ B-Disease
disorders NNS I-Disease
that IN O
most JJS O
often RB O
arise VBP O
from IN O
a DT O
4 CD O
- : O
Mb NNP O
deletion NN O
of IN O
chromosome NN O
15q11 CD O
- : O
q13 NN O
during IN O
paternal JJ O
or CC O
maternal JJ O
gametogenesis NN O
, , O
respectively RB O
. . O

At IN O
a DT O
de FW O
novo FW O
frequency NN O
of IN O
approximately RB O
. . O

67 CD O
- : O
1 CD O
/ NN O
10 CD O
, , O
0 CD O
births NNS O
, , O
these DT O
deletions NNS O
represent VBP O
a DT O
common JJ O
structural JJ O
chromosome NN O
change NN O
in IN O
the DT O
human JJ O
genome NN O
. . O

To TO O
elucidate VB O
the DT O
mechanism NN O
underlying VBG O
these DT O
events NNS O
, , O
we PRP O
characterized VBD O
the DT O
regions NNS O
that WDT O
contain VBP O
two CD O
proximal JJ O
breakpoint NN O
clusters NNS O
and CC O
a DT O
distal JJ O
cluster NN O
. . O

Novel NNP O
DNA NNP O
sequences VBZ O
potentially RB O
associated VBN O
with IN O
the DT O
breakpoints NNS O
were VBD O
positionally RB O
cloned VBN O
from IN O
YACs NNP O
within IN O
or CC O
near IN O
these DT O
regions NNS O
. . O

Analyses NNS O
of IN O
rodent JJ O
- : O
human JJ O
somatic JJ O
- : O
cell NN O
hybrids NNS O
, , O
YAC NNP O
contigs NN O
, , O
and CC O
FISH NNP O
of IN O
normal JJ O
or CC O
rearranged VBN O
chromosomes NNS O
15 CD O
identified VBN O
duplicated VBN O
sequences NNS O
( ( O
the DT O
END NNP O
repeats NN O
) ) O
at IN O
or CC O
near IN O
the DT O
breakpoints NNS O
. . O

The DT O
END NNP O
- : O
repeat NN O
units NNS O
are VBP O
derived VBN O
from IN O
large JJ O
genomic JJ O
duplications NNS O
of IN O
a DT O
novel JJ O
gene NN O
( ( O
HERC2 NNP O
) ) O
, , O
many JJ O
copies NNS O
of IN O
which WDT O
are VBP O
transcriptionally RB O
active JJ O
in IN O
germline NN O
tissues NNS O
. . O

One CD O
of IN O
five CD O
PWS NNP B-Disease
/ NN O
AS IN B-Disease
patients NNS O
analyzed VBN O
to TO O
date NN O
has VBZ O
an DT O
identifiable JJ O
, , O
rearranged VBD O
HERC2 NNP O
transcript NN O
derived VBN O
from IN O
the DT O
deletion NN O
event NN O
. . O

We PRP O
postulate VBP O
that IN O
the DT O
END NNP O
repeats VBZ O
flanking VBG O
15q11 CD O
- : O
q13 NN O
mediate VBP O
homologous JJ O
recombination NN O
resulting VBG O
in IN O
deletion NN O
. . O

Furthermore RB O
, , O
we PRP O
propose VBP O
that IN O
active JJ O
transcription NN O
of IN O
these DT O
repeats NNS O
in IN O
male NN O
and CC O
female JJ O
germ NN O
cells NNS O
may MD O
facilitate VB O
the DT O
homologous JJ O
recombination NN O
process NN O
. . O

Linkage NN O
analysis NN O
in IN O
a DT O
large JJ O
Brazilian JJ O
family NN O
with IN O
van JJ B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
suggests VBZ O
the DT O
existence NN O
of IN O
a DT O
susceptibility NN O
locus NN O
for IN O
cleft NN B-Disease
palate NN I-Disease
at IN O
17p11 CD O
. . O
2 CD O
- : O
11 CD O
. . O
1 CD O
. . O

van NN B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
( ( O
VWS NNP B-Disease
) ) O
, , O
which WDT O
has VBZ O
been VBN O
mapped VBN O
to TO O
1q32 CD O
- : O
41 CD O
, , O
is VBZ O
characterized VBN O
by IN O
pits NNS B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
sinuses NNS I-Disease
of IN I-Disease
the DT I-Disease
lower JJR I-Disease
lip NN I-Disease
, , O
cleft VBD B-Disease
lip JJ I-Disease
/ JJ I-Disease
palate NN I-Disease
( ( O
CL NNP B-Disease
/ NNP I-Disease
P NNP I-Disease
) ) O
, , O
cleft JJ B-Disease
palate NN I-Disease
( ( O
CP NNP B-Disease
) ) O
, , O
bifid JJ B-Disease
uvula NN I-Disease
, , O
and CC O
hypodontia NN B-Disease
( ( O
H NNP B-Disease
) ) O
. . O

The DT O
expression NN O
of IN O
VWS NNP B-Disease
, , O
which WDT O
has VBZ O
incomplete JJ O
penetrance NN O
, , O
is VBZ O
highly RB O
variable JJ O
. . O

Both DT O
the DT O
occurrence NN O
of IN O
CL NNP B-Disease
/ NNP I-Disease
P NNP I-Disease
and CC O
CP NNP B-Disease
within IN O
the DT O
same JJ O
genealogy NN O
and CC O
a DT O
recurrence NN O
risk NN O
< VBP O
40 CD O
% NN O
for IN O
CP NNP B-Disease
among IN O
descendants NNS O
with IN O
VWS NNP B-Disease
have VBP O
suggested VBN O
that IN O
the DT O
development NN O
of IN O
clefts NNS B-Disease
in IN O
this DT O
syndrome NN O
is VBZ O
influenced VBN O
by IN O
modifying VBG O
genes NNS O
at IN O
other JJ O
loci NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
have VBP O
conducted VBN O
linkage NN O
analysis NN O
in IN O
a DT O
large JJ O
Brazilian JJ O
kindred VBN O
with IN O
VWS NNP B-Disease
, , O
considering VBG O
as IN O
affected VBN O
the DT O
individuals NNS O
with IN O
CP NNP B-Disease
, , O
regardless RB O
of IN O
whether IN O
it PRP O
is VBZ O
associated VBN O
with IN O
other JJ O
clinical JJ O
signs NNS O
of IN O
VWS NNP B-Disease
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
a DT O
gene NN O
at IN O
17p11 CD O
. . O

2 CD O
- : O
11 CD O
2 CD O
- : O
11 CD O
. . O

1 CD O
, , O
together RB O
with IN O
the DT O
VWS NNP B-Disease
gene NN O
at IN O
1p32 CD O
- : O
41 CD O
, , O
enhances VBZ O
the DT O
probability NN O
of IN O
CP NNP B-Disease
in IN O
an DT O
individual JJ O
carrying VBG O
the DT O
two CD O
at IN O
- : O
risk NN O
genes NNS O
. . O

If IN O
this DT O
hypothesis NN O
is VBZ O
confirmed VBN O
in IN O
other JJ O
VWS NNP B-Disease
pedigrees NNS O
, , O
it PRP O
will MD O
represent VB O
one CD O
of IN O
the DT O
first JJ O
examples NNS O
of IN O
a DT O
gene NN O
, , O
mapped VBD O
through IN O
linkage NN O
analysis NN O
, , O
which WDT O
modifies VBZ O
the DT O
expression NN O
of IN O
a DT O
major JJ O
gene NN O
. . O

New NNP O
mutations NNS O
, , O
polymorphisms NNS O
, , O
and CC O
rare JJ O
variants NNS O
in IN O
the DT O
ATM NNP O
gene NN O
detected VBN O
by IN O
a DT O
novel JJ O
SSCP NNP O
strategy NN O
. . O

The DT O
gene NN O
for IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
, , O
ATM NNP O
, , O
spans VBZ O
about IN O
150 CD O
kb NNS O
of IN O
genomic JJ O
DNA NNP O
. . O

ATM NNP O
mutations NNS O
are VBP O
found VBN O
along IN O
the DT O
entire JJ O
gene NN O
, , O
with IN O
no DT O
evidence NN O
of IN O
a DT O
mutational JJ O
hot JJ O
spot NN O
. . O

Using VBG O
DNA NNP O
as IN O
the DT O
starting VBG O
material NN O
, , O
we PRP O
screened VBD O
the DT O
ATM NNP O
gene NN O
in IN O
92 CD O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
, , O
using VBG O
an DT O
optimized VBN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
technique NN O
that WDT O
detected VBD O
all DT O
previously RB O
known VBN O
mutations NNS O
in IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
segments NNS O
being VBG O
analyzed VBN O
. . O

To TO O
expedite VB O
screening NN O
, , O
we PRP O
sequentially RB O
loaded VBD O
the DT O
SSCP NNP O
gels NNS O
with IN O
three CD O
different JJ O
sets NNS O
of IN O
PCR NNP O
products NNS O
that WDT O
were VBD O
pretested VBN O
to TO O
avoid VB O
overlapping VBG O
patterns NNS O
. . O

Many JJ O
of IN O
the DT O
DNA NN O
changes VBZ O
we PRP O
detected VBD O
were VBD O
intragenic JJ O
polymorphisms NNS O
. . O

Of IN O
an DT O
expected JJ O
177 CD O
unknown JJ O
mutations NNS O
, , O
we PRP O
detected VBD O
approximately RB O
70 CD O
% NN O
, , O
mostly RB O
protein VBZ O
truncating VBG O
mutations NNS O
( ( O
that WDT O
would MD O
have VB O
been VBN O
detectable JJ O
by IN O
protein JJ O
truncation NN O
testing VBG O
if IN O
RNA NNP O
starting VBG O
material NN O
had VBD O
been VBN O
available JJ O
) ) O
. . O

Mutations NNS O
have VBP O
now RB O
been VBN O
defined VBN O
for IN O
every DT O
exon NN O
of IN O
the DT O
ATM NNP O
gene NN O
. . O

Herein NNP O
, , O
we PRP O
present VBP O
35 CD O
new JJ O
mutations NNS O
and CC O
34 CD O
new JJ O
intragenic JJ O
polymorphisms NNS O
or CC O
rare JJ O
variants NNS O
within IN O
the DT O
ATM NNP O
gene NN O
. . O

This DT O
is VBZ O
the DT O
most RBS O
comprehensive JJ O
compilation NN O
of IN O
ATM NNP O
polymorphisms NNS O
assembled VBD O
to TO O
date NN O
. . O

Defining VBG O
polymorphic JJ O
sites NNS O
as RB O
well RB O
as IN O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
will MD O
be VB O
of IN O
great JJ O
importance NN O
in IN O
designing VBG O
automated VBN O
methods NNS O
for IN O
detecting VBG O
mutations NNS O
. . O
. . O

A DT O
novel JJ O
frameshift NN O
mutation NN O
in IN O
the DT O
McLeod NNP B-Disease
syndrome JJ I-Disease
gene NN O
in IN O
a DT O
Japanese JJ O
family NN O
. . O

We PRP O
report VBP O
a DT O
novel JJ O
mutation NN O
in IN O
the DT O
XK NNP O
gene NN O
( ( O
XK NNP O
) ) O
in IN O
a DT O
Japanese JJ O
patient NN O
with IN O
McLeod NNP B-Disease
syndrome NN I-Disease
. . O

A DT O
50 CD O
- : O
year NN O
- : O
old JJ O
man NN O
showed VBD O
progressive JJ O
muscular JJ B-Disease
atrophy NN I-Disease
, , O
choreic JJ B-Disease
movement NN I-Disease
, , O
elevated VBD O
level NN O
of IN O
serum JJ O
creatinine NN O
kinase NN O
, , O
and CC O
acanthocytosis NN B-Disease
. . O

The DT O
expression NN O
level NN O
of IN O
all PDT O
the DT O
Kell NNP O
antigens NNS O
in IN O
erythrocyte NN O
was VBD O
decreased VBN O
and CC O
molecular JJ O
analysis NN O
revealed VBD O
a DT O
single JJ O
- : O
base NN O
( ( O
T NNP O
) ) O
deletion NN O
at IN O
the DT O
nucleotide JJ O
position NN O
1095 CD O
in IN O
XK NNP O
. . O

This DT O
deletion NN O
caused VBD O
a DT O
frameshift NN O
in IN O
translation NN O
, , O
leading VBG O
to TO O
a DT O
premature NN O
stop NN O
codon NN O
at IN O
the DT O
amino NN O
acid JJ O
position NN O
408 CD O
. . O

We PRP O
conclude VBP O
this DT O
single JJ O
- : O
base NN O
deletion NN O
causes VBZ O
defective JJ O
Kx NNP O
protein NN O
, , O
which WDT O
is VBZ O
responsible JJ O
for IN O
the DT O
McLeod NNP B-Disease
phenotype NN O
in IN O
this DT O
patient NN O
. . O
. . O

Association NNP O
of IN O
BRCA1 NNP O
with IN O
the DT O
hRad50 NN O
- : O
hMre11 NN O
- : O
p95 NN O
complex NN O
and CC O
the DT O
DNA NNP O
damage NN O
response NN O
. . O

BRCA1 NNP O
encodes VBZ O
a DT O
tumor NN B-Disease
suppressor NN O
that WDT O
is VBZ O
mutated VBN O
in IN O
familial JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

Here RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
BRCA1 NNP O
interacts NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
with IN O
hRad50 NN O
, , O
which WDT O
forms VBZ O
a DT O
complex JJ O
with IN O
hMre11 NN O
and CC O
p95 NN O
/ NNP O
nibrin NN O
. . O

Upon IN O
irradiation NN O
, , O
BRCA1 NNP O
was VBD O
detected VBN O
in IN O
discrete JJ O
foci NN O
in IN O
the DT O
nucleus NN O
, , O
which WDT O
colocalize VBP O
with IN O
hRad50 NN O
. . O

Formation NN O
of IN O
irradiation NN O
- : O
induced JJ O
foci NN O
positive JJ O
for IN O
BRCA1 NNP O
, , O
hRad50 NN O
, , O
hMre11 NN O
, , O
or CC O
p95 NN O
was VBD O
dramatically RB O
reduced VBN O
in IN O
HCC NNP O
/ NN O
1937 CD O
breast NN B-Disease
cancer NN I-Disease
cells NNS O
carrying VBG O
a DT O
homozygous JJ O
mutation NN O
in IN O
BRCA1 NNP O
but CC O
was VBD O
restored VBN O
by IN O
transfection NN O
of IN O
wild JJ O
- : O
type NN O
BRCA1 NNP O
. . O

Ectopic NNP O
expression NN O
of IN O
wild JJ O
- : O
type NN O
, , O
but CC O
not RB O
mutated VBN O
, , O
BRCA1 NNP O
in IN O
these DT O
cells NNS O
rendered VBD O
them PRP O
less RBR O
sensitive JJ O
to TO O
the DT O
DNA NNP O
damage NN O
agent NN O
, , O
methyl JJ O
methanesulfonate NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
BRCA1 NNP O
is VBZ O
important JJ O
for IN O
the DT O
cellular JJ O
responses NNS O
to TO O
DNA NNP O
damage NN O
that WDT O
are VBP O
mediated VBN O
by IN O
the DT O
hRad50 NN O
- : O
hMre11 NN O
- : O
p95 NN O
complex NN O
. . O
. . O

Relationship NNP O
among IN O
genotype NN O
, , O
biochemical JJ O
phenotype NN O
, , O
and CC O
cognitive JJ O
performance NN O
in IN O
females NNS O
with IN O
phenylalanine JJ B-Disease
hydroxylase NN I-Disease
deficiency NN I-Disease
: : O
report NN O
from IN O
the DT O
Maternal NNP B-Disease
Phenylketonuria NNP I-Disease
Collaborative NNP O
Study NNP O
. . O

OBJECTIVE NN O
To TO O
examine VB O
the DT O
relationship NN O
of IN O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
genotypes VBZ O
to TO O
biochemical JJ O
phenotype NN O
and CC O
cognitive JJ O
development NN O
in IN O
maternal JJ B-Disease
phenylketonuria NN I-Disease
( ( O
PKU NNP B-Disease
) ) O
. . O

METHODOLOGY NNP O
PAH NNP O
gene NN O
mutations NNS O
were VBD O
examined VBN O
in IN O
222 CD O
hyperphenylalaninemic JJ B-Disease
females NNS O
enrolled VBN O
in IN O
the DT O
Maternal NNP B-Disease
PKU NNP I-Disease
Collaborative NNP O
Study NNP O
( ( O
MPKUCS NNP O
) ) O
. . O

A DT O
total NN O
of IN O
84 CD O
different JJ O
mutations NNS O
were VBD O
detected VBN O
, , O
and CC O
complete JJ O
genotype NN O
was VBD O
obtained VBN O
in IN O
199 CD O
individuals NNS O
. . O

Based VBN O
on IN O
previous JJ O
knowledge NN O
about IN O
mutation NN O
- : O
phenotype NN O
associations NNS O
, , O
78 CD O
of IN O
the DT O
mutations NNS O
could MD O
be VB O
assigned VBN O
to TO O
one CD O
of IN O
four CD O
classes NNS O
of IN O
severity NN O
( ( O
severe JJ O
PKU NNP B-Disease
, , O
moderate JJ O
PKU NNP B-Disease
, , O
mild JJ O
PKU NNP B-Disease
, , O
and CC O
mild JJ B-Disease
hyperphenylalaninemia NN I-Disease
[ NNP O
MHP NNP B-Disease
] NNP O
) ) O
. . O

Then RB O
, , O
189 CD O
MPKUCS NNP O
subjects NNS O
were VBD O
grouped VBN O
according VBG O
to TO O
the DT O
various JJ O
combinations NNS O
of IN O
mutation NN O
classifications NNS O
. . O

The DT O
sample NN O
sizes NNS O
were VBD O
large JJ O
enough RB O
for IN O
statistical JJ O
testing NN O
in IN O
four CD O
groups NNS O
with IN O
at IN O
least JJS O
one CD O
mutation NN O
that WDT O
completely RB O
abolishes VBZ O
enzyme JJ O
activity NN O
. . O

These DT O
patients NNS O
are VBP O
considered VBN O
functionally RB O
hemizygous JJ O
. . O

RESULTS VB O
The DT O
biochemical JJ O
phenotype NN O
predicted VBD O
from IN O
the DT O
genotype NN O
in IN O
functionally RB O
hemizygous JJ O
patients NNS O
was VBD O
related VBN O
significantly RB O
to TO O
the DT O
assigned JJ O
phenylalanine NN O
level NN O
. . O

Cognitive JJ O
performance NN O
( ( O
IQ NNP O
) ) O
was VBD O
also RB O
significantly RB O
related VBN O
to TO O
genotype NN O
. . O

The DT O
IQ NNP O
of IN O
PAH NNP B-Disease
- : I-Disease
deficient NN I-Disease
mothers NNS O
with IN O
a DT O
severe JJ O
PKU NNP B-Disease
mutation NN O
in IN O
combination NN O
with IN O
a DT O
MHP NNP B-Disease
mutation NN O
or CC O
a DT O
mild JJ O
PKU NNP B-Disease
mutation NN O
was VBD O
99 CD O
and CC O
96 CD O
, , O
respectively RB O
, , O
whereas IN O
the DT O
IQ NNP O
of IN O
PKU NNP B-Disease
mothers NNS O
with IN O
two CD O
severe JJ O
PKU NNP B-Disease
mutations NNS O
or CC O
with IN O
one CD O
severe NN O
and CC O
one CD O
moderate NN O
PKU NNP B-Disease
mutation NN O
was VBD O
83 CD O
and CC O
84 CD O
, , O
respectively RB O
. . O

Of IN O
the DT O
patients NNS O
with IN O
PKU NNP B-Disease
, , O
92 CD O
% NN O
had VBD O
been VBN O
treated VBN O
during IN O
childhood NN O
. . O

Those DT O
who WP O
were VBD O
untreated JJ O
or CC O
treated VBN O
late JJ O
had VBD O
lower JJR O
than IN O
average JJ O
IQ JJ O
scores NNS O
for IN O
their PRP$ O
group NN O
of IN O
mutation NN O
combinations NNS O
. . O

Females NNS O
with IN O
moderate JJ O
or CC O
mild JJ O
PKU NNS B-Disease
who WP O
were VBD O
treated VBN O
early RB O
and CC O
treated VBN O
for IN O
> JJ O
6 CD O
years NNS O
showed VBD O
IQ NNP O
scores NNS O
10 CD O
points NNS O
above JJ O
average NN O
for IN O
their PRP$ O
group NN O
. . O

CONCLUSIONS NNP O
The DT O
reproductive JJ O
outcome NN O
in IN O
maternal JJ B-Disease
phenylketonuria NN I-Disease
is VBZ O
dependent JJ O
on IN O
prenatal JJ O
metabolic JJ O
control NN O
and CC O
postnatal JJ O
environmental JJ O
circumstances NNS O
. . O

Both DT O
factors NNS O
depend VBP O
on IN O
the DT O
intellectual JJ O
resources NNS O
of IN O
the DT O
mother NN O
with IN O
PKU NNP B-Disease
. . O

The DT O
significant JJ O
relationship NN O
among IN O
genotype NN O
, , O
biochemical JJ O
phenotype NN O
, , O
and CC O
cognitive JJ O
performance NN O
observed VBN O
in IN O
the DT O
present JJ O
study NN O
is VBZ O
of IN O
importance NN O
for IN O
the DT O
development NN O
of IN O
an DT O
optimal JJ O
strategy NN O
for IN O
future JJ O
treatment NN O
of IN O
females NNS O
with IN O
PKU NNP B-Disease
who WP O
plan VBP O
pregnancy NN O
. . O
. . O

Spinal JJ B-Disease
xanthomatosis NN I-Disease
: : O
a DT O
variant NN O
of IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
. . O

We PRP O
describe VBP O
seven CD O
Dutch JJ O
patients NNS O
from IN O
six CD O
families NNS O
with IN O
a DT O
slowly RB O
progressive JJ O
, , O
mainly RB O
spinal JJ B-Disease
cord NN I-Disease
syndrome NN I-Disease
that WDT O
remained VBD O
for IN O
many JJ O
years NNS O
the DT O
sole JJ O
expression NN O
of IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
. . O

MRI NNP O
demonstrated VBD O
white JJ B-Disease
matter NN I-Disease
abnormalities NNS I-Disease
in IN O
the DT O
lateral JJ O
and CC O
dorsal JJ O
columns NN O
of IN O
the DT O
spinal JJ O
cord NN O
. . O

Post NNP O
- : O
mortem NN O
examination NN O
of IN O
one CD O
of IN O
the DT O
patients NNS O
showed VBD O
extensive JJ O
myelin NN O
loss NN O
in IN O
these DT O
columns NNS O
. . O

An DT O
array NN O
of IN O
genotypes NNS O
was VBD O
found VBN O
in IN O
these DT O
patients NNS O
. . O

We PRP O
conclude VBP O
that IN O
spinal JJ B-Disease
xanthomatosis NN I-Disease
is VBZ O
a DT O
clinical JJ O
and CC O
radiological JJ O
separate JJ O
entity NN O
of IN O
CTX NNP B-Disease
that WDT O
should MD O
be VB O
included VBN O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
chronic JJ B-Disease
myelopathy NN I-Disease
. . O
. . O

A DT O
transgene JJ O
insertion NN O
creating VBG O
a DT O
heritable JJ O
chromosome NN O
deletion NN O
mouse IN O
model NN O
of IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
and CC I-Disease
angelman JJ I-Disease
syndromes NNS I-Disease
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
and CC O
Angelman NNP B-Disease
syndrome VBP I-Disease
( ( O
AS IN B-Disease
) ) O
result NN O
from IN O
the DT O
loss NN O
of IN O
function NN O
of IN O
imprinted JJ O
genes NNS O
in IN O
human JJ O
chromosome NN O
15q11 CD O
- : O
q13 NN O
. . O

The DT O
central JJ O
part NN O
of IN O
mouse NN O
chromosome NN O
7 CD O
is VBZ O
homologous JJ O
to TO O
human JJ O
15q11 CD O
- : O
q13 NN O
, , O
with IN O
conservation NN O
of IN O
both DT O
gene NN O
order NN O
and CC O
imprinted JJ O
features NNS O
. . O

We PRP O
report VBP O
here RB O
the DT O
characterization NN O
of IN O
a DT O
transgene JJ O
insertion NN O
( ( O
Epstein NNP O
- : O
Barr NNP O
virus NN O
Latent NNP O
Membrane NNP O
Protein NNP O
2A CD O
, , O
LMP2A NNP O
) ) O
into IN O
mouse NN O
chromosome NN O
7C CD O
, , O
which WDT O
has VBZ O
resulted VBN O
in IN O
mouse NN O
models NNS O
for IN O
PWS NNP B-Disease
and CC O
AS NNP B-Disease
dependent NN O
on IN O
the DT O
sex NN O
of IN O
the DT O
transmitting JJ O
parent NN O
. . O

Epigenotype NNP O
( ( O
allelic JJ O
expression NN O
and CC O
DNA NNP O
methylation NN O
) ) O
and CC O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
analyses NNS O
indicate VBP O
that IN O
the DT O
transgene NN O
- : O
induced JJ O
mutation NN O
has VBZ O
generated VBN O
a DT O
complete JJ O
deletion NN O
of IN O
the DT O
PWS NNP B-Disease
/ NNP O
AS NNP B-Disease
- : O
homologous JJ O
region NN O
but CC O
has VBZ O
not RB O
deleted VBN O
flanking VBG O
loci NN O
. . O

Because IN O
the DT O
intact JJ O
chromosome NN O
7 CD O
, , O
opposite PDT O
the DT O
deleted JJ O
homolog NN O
, , O
maintains VBZ O
the DT O
correct JJ O
imprint NN O
in IN O
somatic JJ O
cells NNS O
of IN O
PWS NNP B-Disease
and CC O
AS NNP B-Disease
mice NN O
and CC O
establishes VBZ O
the DT O
correct JJ O
imprint NN O
in IN O
male NN O
and CC O
female JJ O
germ NN O
cells NNS O
of IN O
AS NNP B-Disease
mice NN O
, , O
homologous JJ O
association NN O
and CC O
replication NN O
asynchrony NN O
are VBP O
not RB O
part NN O
of IN O
the DT O
imprinting NN O
mechanism NN O
. . O

This DT O
heritable JJ O
- : O
deletion NN O
mouse NN O
model NN O
will MD O
be VB O
particularly RB O
useful JJ O
for IN O
the DT O
identification NN O
of IN O
the DT O
etiological JJ O
genes NNS O
and CC O
mechanisms NNS O
, , O
phenotypic JJ O
basis NN O
, , O
and CC O
investigation NN O
of IN O
therapeutic JJ O
approaches NNS O
for IN O
PWS NNP B-Disease
. . O
. . O

Linkage JJ O
analysis NN O
of IN O
5 CD O
novel JJ O
van NN B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
kindreds NNS O
to TO O
1q32 CD O
- : O
q41 NN O
markers NNS O
further RBR O
supports NNS O
locus VBP O
homogeneity NN O
of IN O
the DT O
disease NN O
trait NN O
. . O

van NN B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
( ( O
vWS NN B-Disease
, , O
MIM NNP O
119300 CD O
) ) O
is VBZ O
a DT O
rare JJ O
autosomal JJ B-Disease
dominant JJ I-Disease
clefting VBG I-Disease
condition NN I-Disease
with IN O
cardinal JJ O
features NNS O
of IN O
mucous JJ B-Disease
cysts NNS I-Disease
( ( O
lower JJR B-Disease
- : I-Disease
lip NN I-Disease
pits NNS I-Disease
) ) O
and CC O
clefts NNS B-Disease
to TO I-Disease
the DT I-Disease
lip NN I-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
palate NN I-Disease
. . O

The DT O
vWS NN B-Disease
gene NN O
has VBZ O
been VBN O
assigned VBN O
to TO O
a DT O
locus NN O
in IN O
1q32 CD O
- : O
q41 NN O
by IN O
linkage NN O
analysis NN O
and CC O
physical JJ O
mapping NN O
. . O

We PRP O
have VBP O
investigated VBN O
5 CD O
novel JJ O
vWS NN B-Disease
families NNS O
through IN O
probands NNS O
attended VBN O
for IN O
cleft NN B-Disease
lip NN I-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
palate VB I-Disease
repair NN O
at IN O
the DT O
Department NNP O
of IN O
Maxillofacial NNP O
Surgery NNP O
of IN O
Hopital NNP O
Trousseau NNP O
, , O
Paris NNP O
, , O
in IN O
order NN O
to TO O
tentatively RB O
refine VB O
the DT O
genetic JJ O
map NN O
of IN O
the DT O
vWS JJ B-Disease
region NN O
in IN O
1q32 CD O
- : O
q41 NN O
and CC O
possibly RB O
identify VB O
unlinked JJ O
pedigrees NNS O
. . O

Linkage NN O
analysis NN O
was VBD O
carried VBN O
out IN O
to TO O
6 CD O
microsatellite NN O
markers NNS O
( ( O
D1S249 NNP O
, , O
D1S425 NNP O
, , O
D1S491 NNP O
, , O
D1S205 NNP O
, , O
D1S414 NNP O
, , O
D1S425 NNP O
) ) O
, , O
yielding VBG O
a DT O
maximum JJ O
cumulative JJ O
LOD NNP O
score NN O
of IN O
Z NNP O
= NNP O
3 CD O
. . O

27 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

0 CD O
for IN O
D1S245 NNP O
. . O

The DT O
innermost NN O
four CD O
markers NNS O
were VBD O
found VBN O
to TO O
be VB O
tightly RB O
linked VBN O
to TO O
one CD O
another DT O
, , O
with IN O
no DT O
evidence NN O
for IN O
recombination NN O
. . O

Our PRP$ O
results NNS O
support JJ O
linkage NN O
of IN O
vWS NN B-Disease
within IN O
a DT O
region NN O
of IN O
tightly RB O
linked VBN O
markers NNS O
and CC O
do VBP O
not RB O
favour VB O
locus JJ O
heterogeneity NN O
of IN O
the DT O
disease NN O
trait NN O
. . O

Null NNP O
mutation NN O
of IN O
the DT O
murine NN O
ATP7B NNP O
( ( O
Wilson NNP B-Disease
disease NN I-Disease
) ) O
gene NN O
results NNS O
in IN O
intracellular JJ B-Disease
copper NN I-Disease
accumulation NN I-Disease
and CC O
late JJ B-Disease
- : I-Disease
onset VBN I-Disease
hepatic JJ I-Disease
nodular JJ I-Disease
transformation NN I-Disease
. . O

The DT O
Atp7b NNP O
protein NN O
is VBZ O
a DT O
copper NN O
- : O
transporting VBG O
ATPase NNP O
expressed VBD O
predominantly RB O
in IN O
the DT O
liver NN O
and CC O
to TO O
a DT O
lesser JJR O
extent NN O
in IN O
most JJS O
other JJ O
tissues NNS O
. . O

Mutations NNS O
in IN O
the DT O
ATP7B NNP O
gene NN O
lead NN O
to TO O
Wilson NNP B-Disease
disease NN I-Disease
, , O
a DT O
copper NN B-Disease
toxicity NN I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
dramatic JJ O
build NN O
- : O
up IN O
of IN O
intracellular JJ O
hepatic JJ O
copper NN O
with IN O
subsequent JJ O
hepatic NN B-Disease
and CC I-Disease
neuro JJ I-Disease
- : I-Disease
logical JJ I-Disease
abnormalities NNS I-Disease
. . O

Using VBG O
homologous JJ O
recombination NN O
to TO O
disrupt VB O
the DT O
normal JJ O
translation NN O
of IN O
ATP7B NNP O
, , O
we PRP O
have VBP O
generated VBN O
a DT O
strain NN O
of IN O
mice NN O
that WDT O
are VBP O
homozygous JJ O
mutants NNS O
( ( O
null NN O
) ) O
for IN O
the DT O
Wilson NNP B-Disease
disease NN I-Disease
gene NN O
. . O

The DT O
ATP7B NNP O
null JJ O
mice NN O
display VBD O
a DT O
gradual JJ O
accumulation NN O
of IN O
hepatic JJ O
copper NN O
that WDT O
increases VBZ O
to TO O
a DT O
level NN O
60 CD O
- : O
fold NN O
greater JJR O
than IN O
normal JJ O
by IN O
5 CD O
months NNS O
of IN O
age NN O
. . O

An DT O
increase NN O
in IN O
copper NN O
concentration NN O
was VBD O
also RB O
observed VBN O
in IN O
the DT O
kidney NN O
, , O
brain NN O
, , O
placenta NN O
and CC O
lactating VBG O
mammary JJ O
glands NNS O
of IN O
homo NN O
- : O
zygous JJ O
mutants NNS O
, , O
although IN O
milk NN O
from IN O
the DT O
mutant JJ O
glands NNS O
was VBD O
copper JJ B-Disease
deficient NN I-Disease
. . O

Morphological JJ B-Disease
abnormalities NNS I-Disease
resembling VBG O
cirrhosis NN B-Disease
developed VBD O
in IN O
the DT O
majority NN O
of IN O
the DT O
livers NNS O
from IN O
homozygous JJ O
mutants NNS O
older JJR O
than IN O
7 CD O
months NNS O
of IN O
age NN O
. . O

Progeny NNP O
of IN O
the DT O
homozygous JJ O
mutant NN O
females NNS O
demonstrated VBD O
neurological JJ B-Disease
abnormalities NNS I-Disease
and CC O
growth NN B-Disease
retardation NN I-Disease
characteristic NN O
of IN O
copper NN B-Disease
deficiency NN I-Disease
. . O

Copper NN O
concentration NN O
in IN O
the DT O
livers NNS O
of IN O
the DT O
newborn JJ O
homozygous JJ O
null NN O
mutants NNS O
was VBD O
decreased VBN O
dramatically RB O
. . O

In IN O
summary JJ O
, , O
inactivation NN O
of IN O
the DT O
murine NN O
ATP7B NNP O
gene NN O
produces VBZ O
a DT O
form NN O
of IN O
cirrhotic JJ B-Disease
liver NN I-Disease
disease NN I-Disease
that WDT O
resembles VBZ O
Wilson NNP B-Disease
disease NN I-Disease
in IN O
humans NNS O
and CC O
the DT O
toxic JJ O
milk NN O
phenotype NN O
in IN O
the DT O
mouse NN O
. . O
. . O

French JJ O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
patients NNS O
do VBP O
not RB O
exhibit VB O
gametic JJ O
segregation NN O
distortion NN O
: : O
a DT O
sperm JJ O
typing NN O
analysis NN O
. . O

Segregation NN O
distortion NN O
has VBZ O
been VBN O
reported VBN O
to TO O
occur VB O
in IN O
a DT O
number NN O
of IN O
the DT O
trinucleotide JJ B-Disease
repeat NN I-Disease
disorders NNS I-Disease
. . O

On IN O
the DT O
basis NN O
of IN O
a DT O
sperm NN O
typing VBG O
study NN O
performed VBD O
in IN O
patients NNS O
of IN O
Japanese JJ O
descent NN O
with IN O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
MJD NNP B-Disease
) ) O
, , O
it PRP O
was VBD O
reported VBN O
that IN O
disease NN O
alleles NNS O
are VBP O
preferentially RB O
transmitted VBN O
during IN O
meiosis NN O
. . O

We PRP O
performed VBD O
a DT O
sperm NN O
typing VBG O
study NN O
of IN O
five CD O
MJD NNP B-Disease
patients NNS O
of IN O
French JJ O
descent NN O
and CC O
analysis NN O
of IN O
the DT O
pooled VBN O
data NN O
shows VBZ O
a DT O
ratio NN O
of IN O
mutant JJ O
to TO O
normal JJ O
alleles NNS O
of IN O
379 CD O
436 CD O
( ( O
46 CD O
. . O
5 CD O
53 CD O
. . O
5 CD O
% NN O
) ) O
, , O
which WDT O
does VBZ O
not RB O
support VB O
meiotic JJ O
segregation NN O
distortion NN O
. . O

To TO O
confirm VB O
these DT O
results NNS O
, , O
sperm JJ O
typing VBG O
analysis NN O
was VBD O
also RB O
performed VBN O
using VBG O
a DT O
polymorphic JJ O
marker NN O
, , O
D14S1050 NNP O
, , O
closely RB O
linked VBN O
to TO O
the DT O
MJD1 NNP O
gene NN O
. . O

Among IN O
910 CD O
sperm NNS O
analyzed VBN O
, , O
the DT O
allele NN O
linked VBD O
to TO O
the DT O
disease NN O
chromosome NN O
was VBD O
detected VBN O
in IN O
50 CD O
. . O

3 CD O
% NN O
of IN O
the DT O
samples NNS O
and CC O
the DT O
allele NN O
linked VBD O
to TO O
the DT O
normal JJ O
chromosome NN O
was VBD O
found VBN O
in IN O
49 CD O
. . O

6 CD O
% NN O
of IN O
the DT O
sperm NN O
. . O

The DT O
difference NN O
in IN O
frequency NN O
of IN O
these DT O
two CD O
alleles NNS O
is VBZ O
not RB O
significant JJ O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
8423 CD O
) ) O
. . O

Likelihood NNP O
- : O
based VBN O
analysis NN O
of IN O
segregation NN O
distortion NN O
in IN O
the DT O
single JJ O
sperm NN O
data NNS O
using VBG O
the DT O
SPERMSEG NNP O
program NN O
also RB O
showed VBD O
no DT O
support NN O
for IN O
segregation NN O
distortion NN O
at IN O
the DT O
gamete JJ O
level NN O
in IN O
this DT O
patient JJ O
population NN O
. . O

The DT O
previous JJ O
report NN O
on IN O
the DT O
Japanese JJ O
patients NNS O
also RB O
suggested VBD O
that IN O
disease NN O
allele JJ O
stability NN O
may MD O
be VB O
influenced VBN O
by IN O
a DT O
trans JJ O
effect NN O
of IN O
an DT O
intragenic JJ O
polymorphism NN O
( ( O
987 CD O
G NNP O
/ NNP O
C NNP O
) ) O
in IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
. . O

All DT O
of IN O
the DT O
French JJ O
patients NNS O
were VBD O
heterozygous JJ O
for IN O
this DT O
polymorphism NN O
. . O

However RB O
, , O
analysis NN O
of IN O
the DT O
variance NN O
in IN O
repeat NN O
number NN O
in IN O
sperm NN O
from IN O
the DT O
French JJ O
MJD NNP B-Disease
patients NNS O
overlapped VBD O
significantly RB O
with IN O
the DT O
variance NN O
in IN O
repeat NN O
number NN O
observed VBN O
in IN O
the DT O
C NNP O
/ NNP O
C NNP O
homozygous JJ O
Japanese JJ O
patients NNS O
. . O

Missense NNP O
mutation NN O
in IN O
the DT O
alternative JJ O
splice JJ O
region NN O
of IN O
the DT O
PAX6 NNP O
gene NN O
in IN O
eye NN B-Disease
anomalies NNS I-Disease
. . O

The DT O
PAX6 NNP O
gene NN O
is VBZ O
involved VBN O
in IN O
ocular JJ O
morphogenesis NN O
, , O
and CC O
PAX6 NNP O
mutations NNS O
have VBP O
been VBN O
detected VBN O
in IN O
various JJ O
types NNS O
of IN O
ocular JJ B-Disease
anomalies NNS I-Disease
, , O
including VBG O
aniridia NN B-Disease
, , O
Peters NNP B-Disease
anomaly VBP I-Disease
, , O
corneal JJ B-Disease
dystrophy NN I-Disease
, , O
congenital JJ B-Disease
cataract NN I-Disease
, , O
and CC O
foveal JJ B-Disease
hypoplasia NN I-Disease
. . O

The DT O
gene NN O
encodes VBZ O
a DT O
transcriptional JJ O
regulator NN O
that WDT O
recognizes VBZ O
target NN O
genes NNS O
through IN O
its PRP$ O
paired VBN O
- : O
type NN O
DNA NNP O
- : O
binding NN O
domain NN O
. . O

The DT O
paired JJ O
domain NN O
is VBZ O
composed VBN O
of IN O
two CD O
distinct JJ O
DNA NNP O
- : O
binding NN O
subdomains NNS O
, , O
the DT O
N NNP O
- : O
terminal NN O
subdomain NN O
( ( O
NTS NNP O
) ) O
and CC O
the DT O
C NNP O
- : O
terminal NN O
subdomain NN O
( ( O
CTS NNP O
) ) O
, , O
which WDT O
bind VBP O
respective JJ O
consensus NN O
DNA NNP O
sequences NNS O
. . O

The DT O
human JJ O
PAX6 NNP O
gene NN O
produces VBZ O
two CD O
alternative JJ O
splice NN O
isoforms NNS O
that WDT O
have VBP O
the DT O
distinct JJ O
structure NN O
of IN O
the DT O
paired JJ O
domain NN O
. . O

The DT O
insertion NN O
, , O
into IN O
the DT O
NTS NNP O
, , O
of IN O
14 CD O
additional JJ O
amino NN O
acids NNS O
encoded VBN O
by IN O
exon JJ O
5a CD O
abolishes VBZ O
the DT O
DNA NNP O
- : O
binding NN O
activity NN O
of IN O
the DT O
NTS NNP O
and CC O
unmasks VBZ O
the DT O
DNA NNP O
- : O
binding VBG O
ability NN O
of IN O
the DT O
CTS NNP O
. . O

Thus RB O
, , O
exon VBZ O
5a CD O
appears VBZ O
to TO O
function VB O
as IN O
a DT O
molecular JJ O
switch NN O
that IN O
specifies VBZ O
target NN O
genes NNS O
. . O

We PRP O
ascertained VBD O
a DT O
novel JJ O
missense NN O
mutation NN O
in IN O
four CD O
pedigrees NNS O
with IN O
Peters NNP B-Disease
anomaly VBP I-Disease
, , O
congenital JJ B-Disease
cataract NN I-Disease
, , O
Axenfeldt NNP B-Disease
anomaly NN I-Disease
, , O
and CC O
/ NNP O
or CC O
foveal JJ B-Disease
hypoplasia NN I-Disease
, , O
which WDT O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
is VBZ O
the DT O
first JJ O
mutation NN O
identified VBN O
in IN O
the DT O
splice NN O
- : O
variant JJ O
region NN O
. . O

A DT O
T NNP O
- : O
- : O
> VB O
A DT O
transition NN O
at IN O
the DT O
20th JJ O
nucleotide JJ O
position NN O
of IN O
exon JJ O
5a CD O
results NNS O
in IN O
a DT O
Val NNP O
- : O
- : O
> NN O
Asp NNP O
( ( O
GTC NNP O
- : O
- : O
> NN O
GAC NNP O
) ) O
substitution NN O
at IN O
the DT O
7th CD O
codon NN O
of IN O
the DT O
alternative JJ O
splice NN O
region NN O
. . O

Functional JJ O
analyses NNS O
demonstrated VBD O
that IN O
the DT O
V54D NNP O
mutation NN O
slightly RB O
increased VBD O
NTS NNP O
binding NN O
and CC O
decreased JJ O
CTS NNP O
transactivation NN O
activity NN O
to TO O
almost RB O
half NN O
. . O
. . O

Penetrances NNS O
of IN O
BRCA1 NNP O
1675delA CD O
and CC O
1135insA CD O
with IN O
respect NN O
to TO O
breast VB B-Disease
cancer NN I-Disease
and CC O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

For IN O
genetic JJ O
counseling NN O
and CC O
predictive JJ O
testing NN O
in IN O
families NNS O
with IN O
inherited JJ B-Disease
breast NN I-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
penetrances NNS O
and CC O
expressions NNS O
of IN O
the DT O
underlying JJ O
mutations NNS O
should MD O
be VB O
known VBN O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
two CD O
BRCA1 NNP O
founder NN O
mutations NNS O
in IN O
the DT O
Norwegian JJ O
population NN O
. . O

Index NN O
cases NNS O
for IN O
the DT O
present JJ O
study NN O
were VBD O
found VBN O
two CD O
different JJ O
ways NNS O
through IN O
a DT O
series NN O
of IN O
consecutive JJ O
ovarian JJ B-Disease
cancers NNS I-Disease
( ( O
n JJ O
= NNP O
16 CD O
) ) O
and CC O
through IN O
our PRP$ O
family NN O
cancer NN B-Disease
clinic NN O
( ( O
n JJ O
= NNP O
14 CD O
) ) O
. . O

Altogether RB O
, , O
20 CD O
of IN O
the DT O
patients NNS O
had VBD O
BRCA1 NNP O
1675delA CD O
, , O
and CC O
10 CD O
had VBD O
1135insA CD O
. . O

Their PRP$ O
relatives NNS O
were VBD O
described VBN O
with IN O
respect NN O
to TO O
absence VB O
/ JJ O
presence NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Of IN O
133 CD O
living VBG O
female JJ O
relatives NNS O
, , O
83 CD O
( ( O
62 CD O
% NN O
) ) O
were VBD O
tested VBN O
for IN O
the DT O
presence NN O
of IN O
a DT O
mutation NN O
. . O

No DT O
difference NN O
, , O
in IN O
penetrance NN O
and CC O
expression NN O
, , O
between IN O
the DT O
two CD O
mutations NNS O
were VBD O
found VBN O
, , O
whereas JJ O
differences NNS O
according VBG O
to TO O
method NN O
of IN O
ascertainment NN O
were VBD O
seen VBN O
. . O

The DT O
overall JJ O
findings NNS O
were VBD O
that IN O
disease NN O
started VBD O
to TO O
occur VB O
at IN O
age NN O
30 CD O
years NNS O
and CC O
that IN O
by IN O
age NN O
50 CD O
years NNS O
48 CD O
% NN O
of IN O
the DT O
mutation NN O
- : O
carrying VBG O
women NNS O
had VBD O
experienced VBN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

More RBR O
ovarian JJ B-Disease
cancers NNS I-Disease
than IN O
breast NN B-Disease
cancers NNS I-Disease
were VBD O
recorded VBN O
. . O

Both DT O
penetrance NN O
and CC O
expression NN O
( ( O
breast JJ B-Disease
cancer NN I-Disease
vs NN O
. . O
ovarian JJ B-Disease
cancer NN I-Disease
) ) O
were VBD O
different JJ O
from IN O
those DT O
in IN O
reports NNS O
of IN O
the DT O
Ashkenazi NNP O
founder NN O
mutations NNS O
. . O

Whether IN O
the DT O
reported JJ O
differences NNS O
reflect VBP O
true JJ O
differences NNS O
and CC O
/ NN O
or CC O
methodological JJ O
problems NNS O
is VBZ O
discussed VBN O
. . O

An DT O
observed JJ O
excess NN O
of IN O
mutation NN O
carriers NNS O
could MD O
not RB O
be VB O
accounted VBN O
for IN O
by IN O
methodological JJ O
problems NNS O
; : O
possible JJ O
explanations NNS O
were VBD O
a DT O
"""" JJ O
true JJ O
"""" NN O
low JJ O
penetrance NN O
or CC O
preferential JJ O
segregation NN O
. . O
. . O

The DT O
dermatofibrosarcoma NN B-Disease
protuberans VBZ I-Disease
- : O
associated VBN O
collagen NN O
type NN O
Ialpha1 NNP O
/ NNP O
platelet NN O
- : O
derived JJ O
growth NN O
factor NN O
( ( O
PDGF NNP O
) ) O
B NNP O
- : O
chain NN O
fusion NN O
gene NN O
generates VBZ O
a DT O
transforming NN O
protein NN O
that WDT O
is VBZ O
processed VBN O
to TO O
functional VB O
PDGF NNP O
- : O
BB NNP O
. . O

Dermatofibrosarcoma NNP B-Disease
protuberans NNS I-Disease
( ( O
DFSP NNP B-Disease
) ) O
displays VBZ O
chromosomal JJ O
rearrangements NNS O
involving VBG O
chromosome NN O
17 CD O
and CC O
22 CD O
, , O
which WDT O
fuse VBP O
the DT O
collagen NN O
type NN O
Ialpha1 NNP O
( ( O
COLIA1 NNP O
) ) O
gene NN O
to TO O
the DT O
platelet NN O
- : O
derived JJ O
growth NN O
factor NN O
( ( O
PDGF NNP O
) ) O
B NNP O
- : O
chain NN O
( ( O
PDGFB NNP O
) ) O
gene NN O
. . O

To TO O
characterize VB O
the DT O
functional JJ O
and CC O
structural JJ O
properties NNS O
of IN O
the DT O
COLIA1 NNP O
/ NNP O
PDGFB NNP O
fusion NN O
protein NN O
, , O
we PRP O
generated VBD O
a DT O
stable JJ O
NIH3T3 NNP O
cell NN O
line NN O
that WDT O
contained VBD O
a DT O
tumor NN O
- : O
derived VBN O
chimeric JJ O
gene NN O
resulting VBG O
from IN O
a DT O
COIA1 NNP O
intron NN O
7 CD O
- : O
PDGFB NNP O
intron VBZ O
1 CD O
fusion NN O
. . O

Expression NN O
of IN O
the DT O
fusion NN O
protein NN O
led VBD O
to TO O
morphological JJ O
transformation NN O
and CC O
increased JJ O
growth NN O
rate NN O
of IN O
these DT O
cells NNS O
. . O

The DT O
PDGF NNP O
receptor NN O
kinase NN O
inhibitor NN O
CGP57148B NNP O
reversed VBD O
the DT O
transformed JJ O
phenotype NN O
and CC O
reduced VBD O
the DT O
growth NN O
rate NN O
of IN O
COLIA1 NNP O
/ NNP O
PDGFB NNP O
- : O
expressing VBG O
cells NNS O
but CC O
had VBD O
no DT O
effects NNS O
on IN O
control NN O
cells NNS O
. . O

The DT O
presence NN O
of IN O
dimeric JJ O
COLIA1 NNP O
/ NNP O
PDGFB NNP O
precursors NNS O
was VBD O
demonstrated VBN O
through IN O
PDGFB NNP O
immunoprecipitations NNS O
of IN O
metabolically RB O
labeled VBN O
cells NNS O
and CC O
also RB O
by IN O
PDGFB NNP O
immunoprecipitations NNS O
followed VBN O
by IN O
immunoblotting VBG O
with IN O
COLIA1 NNP O
antibodies NNS O
. . O

Pulse NNP O
- : O
chase NN O
studies NNS O
demonstrated VBD O
that IN O
the DT O
COLIA1 NNP O
/ NNP O
PDGFB NNP O
precursor NN O
was VBD O
processed VBN O
to TO O
an DT O
end NN O
product NN O
that WDT O
was VBD O
indistinguishable JJ O
from IN O
wild JJ O
- : O
type NN O
PDGF NNP O
- : O
BB NNP O
. . O

Finally RB O
, , O
COLIA1 NNP O
/ NNP O
PDGFB NNP O
- : O
expressing VBG O
cells NNS O
generated VBD O
tumors NNS B-Disease
after IN O
s NN O
. . O

c JJ O
c NN O
. . O
injection NN O
into IN O
nude JJ O
mice NN O
, , O
and CC O
tumor NN B-Disease
growth NN O
was VBD O
reduced VBN O
by IN O
treatment NN O
with IN O
CGP57148B NNP O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
COLIA1 NNP O
/ NNP O
PDGFB NNP O
fusion NN O
associated VBN O
with IN O
DFSP NNP B-Disease
contributes NNS O
to TO O
tumor VB B-Disease
development NN O
through IN O
ectopic JJ O
production NN O
of IN O
PDGF NNP O
- : O
BB NNP O
and CC O
the DT O
formation NN O
of IN O
an DT O
autocrine JJ O
loop NN O
. . O

Our PRP$ O
findings NNS O
, , O
thus RB O
, , O
suggest VBP O
that IN O
PDGF NNP O
receptors NNS O
could MD O
be VB O
a DT O
target NN O
for IN O
pharmacological JJ O
treatment NN O
of IN O
DFSP NNP B-Disease
and CC O
giant JJ B-Disease
cell NN I-Disease
fibroblastoma NN I-Disease
, , O
e NN O
. . O
g NN O
. . O
, , O
through IN O
the DT O
use NN O
of IN O
PDGF NNP O
receptor NN O
kinase NN O
inhibitors NNS O
such JJ O
as IN O
CGP57148B NNP O
. . O

Identification NN O
of IN O
a DT O
common JJ O
PEX1 NNP O
mutation NN O
in IN O
Zellweger NNP B-Disease
syndrome NN I-Disease
. . O

The DT O
Zellweger NNP B-Disease
spectrum NN I-Disease
of IN I-Disease
disease NN I-Disease
, , O
encompassing VBG O
Zellweger NNP B-Disease
syndrome NN I-Disease
and CC O
the DT O
progressively RB O
milder JJ O
phenotypes NNS O
of IN O
neonatal JJ B-Disease
adrenoleukodystrophy NN I-Disease
and CC O
infantile JJ B-Disease
Refsum NNP I-Disease
disease NN I-Disease
, , O
is VBZ O
due JJ O
to TO O
a DT O
failure NN O
to TO O
form VB O
functional JJ O
peroxisomes NNS O
. . O

Cell NNP O
fusion NN O
complementation NN O
studies NNS O
demonstrated VBD O
that IN O
these DT O
diseases NNS O
are VBP O
genetically RB O
heterogeneous JJ O
, , O
with IN O
two CD O
- : O
thirds NNS O
of IN O
all DT O
patients NNS O
lying VBG O
within IN O
a DT O
single JJ O
complementation NN O
group NN O
, , O
CG1 NNP O
. . O

Molecular JJ O
genetic JJ O
and CC O
cell NN O
biology NN O
studies NNS O
have VBP O
shown VBN O
that IN O
PEX1 NNP O
is VBZ O
deficient JJ O
in IN O
many JJ O
CG1 NNP O
patients NNS O
. . O

However RB O
, , O
previous JJ O
studies NNS O
have VBP O
focused VBN O
on IN O
mildly RB O
affected JJ O
patients NNS O
and CC O
there EX O
is VBZ O
still RB O
no DT O
report NN O
of IN O
two CD O
mutant JJ O
PEX1 NNP O
alleles NNS O
in IN O
any DT O
Zellweger NNP B-Disease
syndrome JJ I-Disease
patient NN O
. . O

Furthermore RB O
, , O
mutations NNS O
in IN O
the DT O
PMP70 NNP O
gene NN O
have VBP O
also RB O
been VBN O
identified VBN O
in IN O
two CD O
Zellweger NNP B-Disease
syndrome JJ I-Disease
patients NNS O
from IN O
CG1 NNP O
, , O
raising VBG O
the DT O
possibility NN O
that WDT O
CG1 NNP O
patients NNS O
may MD O
represent VB O
a DT O
mixture NN O
of IN O
PEX1 NNP O
- : O
deficient NN O
and CC O
PMP70 NNP O
- : O
deficient NN O
individuals NNS O
. . O

To TO O
address VB O
the DT O
molecular JJ O
basis NN O
of IN O
disease NN O
in IN O
Zellweger NNP B-Disease
syndrome JJ I-Disease
patients NNS O
from IN O
CG1 NNP O
, , O
we PRP O
examined VBD O
all DT O
24 CD O
PEX1 NNP O
exons NNS O
in IN O
four CD O
patients NNS O
, , O
including VBG O
both DT O
patients NNS O
that WDT O
have VBP O
mutations NNS O
in IN O
PMP70 NNP O
. . O

PEX1 NNP O
mutations NNS O
were VBD O
detected VBN O
in IN O
all DT O
four CD O
patients NNS O
, , O
including VBG O
a DT O
1 CD O
- : O
bp NN O
insertion NN O
( ( O
c NN O
. . O
2097insT CD O
) ) O
in IN O
exon $ O
13 CD O
that WDT O
was VBD O
present JJ O
in IN O
three CD O
of IN O
the DT O
four CD O
patients NNS O
. . O

Subsequent JJ O
studies NNS O
demonstrated VBD O
that IN O
this DT O
mutation NN O
is VBZ O
present JJ O
in IN O
one CD O
- : O
half NN O
of IN O
all DT O
CG1 NNP O
patients NNS O
and CC O
correlates NNS O
with IN O
the DT O
Zellweger NNP B-Disease
syndrome NN I-Disease
phenotype NN O
. . O

As IN O
this DT O
mutation NN O
leads VBZ O
to TO O
a DT O
loss NN O
of IN O
protein JJ O
function NN O
its PRP$ O
frequency NN O
makes VBZ O
it PRP O
the DT O
most RBS O
common JJ O
cause NN O
of IN O
Zellweger NNP B-Disease
syndrome NN I-Disease
, , O
helping VBG O
to TO O
explain VB O
the DT O
high JJ O
percentage NN O
of IN O
patients NNS O
that WDT O
belong VBP O
to TO O
CG1 NNP O
. . O

Novel JJ O
mutations NNS O
in IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBP I-Disease
protein JJ O
gene NN O
and CC O
their PRP$ O
effects NNS O
on IN O
transcriptional JJ O
, , O
translational JJ O
, , O
and CC O
clinical JJ O
phenotypes NNS O
. . O

Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
immunodeficiency NN I-Disease
characterized VBN O
by IN O
thrombocytopenia NN B-Disease
, , O
eczema NN B-Disease
, , O
and CC O
recurrent JJ O
infections NNS O
, , O
and CC O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
WAS NNP B-Disease
protein NN O
( ( O
WASP NNP O
) ) O
gene NN O
. . O

WASP NNP O
contains VBZ O
several JJ O
functional JJ O
domains NNS O
through IN O
which WDT O
it PRP O
interacts VBZ O
with IN O
proteins NNS O
involved VBN O
in IN O
intracellular JJ O
signaling NN O
and CC O
regulation NN O
of IN O
the DT O
actin JJ O
cytoskeleton NN O
. . O

In IN O
this DT O
report NN O
, , O
17 CD O
WASP NNP O
gene NN O
mutations NNS O
were VBD O
identified VBN O
, , O
12 CD O
of IN O
which WDT O
are VBP O
novel JJ O
. . O

DNA NN O
of IN O
affected JJ O
males NNS O
and CC O
obligate JJ O
carriers NNS O
was VBD O
PCR NNP O
amplified VBD O
and CC O
analyzed VBN O
by IN O
SSCA NNP O
, , O
heteroduplex JJ O
analysis NN O
, , O
and CC O
direct JJ O
sequencing NN O
. . O

The DT O
effects NNS O
of IN O
the DT O
mutations NNS O
at IN O
the DT O
mRNA NN O
and CC O
protein JJ O
level NN O
were VBD O
ascertained VBN O
by IN O
RT NNP O
- : O
PCR NN O
and CC O
Western JJ O
blot NN O
analyses NNS O
. . O

All DT O
missense JJ O
mutations NNS O
were VBD O
located VBN O
in IN O
exons NNS O
1 CD O
- : O
4 CD O
. . O

Most JJS O
of IN O
the DT O
nonsense NN O
, , O
frameshift NN O
and CC O
splice NN O
site NN O
mutations NNS O
were VBD O
found VBN O
in IN O
exons NNS O
6 CD O
- : O
11 CD O
. . O

Mutations NNS O
that WDT O
alter VBP O
splice NN O
sites NNS O
led VBD O
to TO O
the DT O
synthesis NN O
of IN O
several JJ O
types NNS O
of IN O
mRNAs NN O
, , O
a DT O
fraction NN O
of IN O
which WDT O
represented VBD O
the DT O
normally RB O
spliced JJ O
product NN O
. . O

The DT O
presence NN O
of IN O
normally RB O
spliced VBN O
transcripts NNS O
was VBD O
correlated VBN O
with IN O
a DT O
milder NN O
phenotype NN O
. . O

When WRB O
one CD O
such JJ O
case NN O
was VBD O
studied VBN O
by IN O
Western JJ O
blotting NN O
, , O
reduced VBD O
amounts NNS O
of IN O
normal JJ O
- : O
size NN O
WASP NNP O
were VBD O
present JJ O
. . O

In IN O
other JJ O
cases NNS O
as IN O
well RB O
, , O
a DT O
correlation NN O
was VBD O
found VBN O
between IN O
the DT O
amount NN O
of IN O
normal JJ O
or CC O
mutant JJ O
WASP NNP O
present NN O
and CC O
the DT O
phenotypes NNS O
of IN O
the DT O
affected JJ O
individuals NNS O
. . O

No DT O
protein NN O
was VBD O
detected VBN O
in IN O
two CD O
individuals NNS O
with IN O
severe NN O
WAS NNP B-Disease
. . O

Reduced VBN O
levels NNS O
of IN O
a DT O
normal JJ O
- : O
size NN O
WASP NNP O
with IN O
a DT O
missense JJ O
mutation NN O
were VBD O
seen VBN O
in IN O
two CD O
individuals NNS O
with IN O
XLT NNP B-Disease
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
mutation NN O
analysis NN O
at IN O
the DT O
DNA NNP O
level NN O
is VBZ O
not RB O
sufficient JJ O
for IN O
predicting VBG O
clinical JJ O
course NN O
. . O

Studies NNS O
at IN O
the DT O
transcript NN O
and CC O
protein NN O
level NN O
are VBP O
needed VBN O
for IN O
a DT O
better JJR O
assessment NN O
. . O
. . O

Aminoglycoside IN O
antibiotics NNS O
restore VBP O
dystrophin JJ O
function NN O
to TO O
skeletal JJ O
muscles NNS O
of IN O
mdx NN O
mice NN O
. . O

Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
dystrophin JJ O
gene NN O
, , O
leading VBG O
to TO O
the DT O
absence NN O
of IN O
the DT O
dystrophin JJ O
protein NN O
in IN O
striated JJ O
muscle NN O
. . O

A DT O
significant JJ O
number NN O
of IN O
these DT O
mutations NNS O
are VBP O
premature JJ O
stop JJ O
codons NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
observation NN O
that IN O
aminoglycoside JJ O
treatment NN O
can MD O
suppress VB O
stop JJ O
codons NNS O
in IN O
cultured JJ O
cells NNS O
, , O
we PRP O
tested VBD O
the DT O
effect NN O
of IN O
gentamicin NN O
on IN O
cultured JJ O
muscle NN O
cells NNS O
from IN O
the DT O
mdx NN O
mouse SYM O
- : O
an DT O
animal JJ O
model NN O
for IN O
DMD NNP B-Disease
that WDT O
possesses VBZ O
a DT O
premature NN O
stop NN O
codon NN O
in IN O
the DT O
dystrophin JJ O
gene NN O
. . O

Exposure NN O
of IN O
mdx NN O
myotubes NNS O
to TO O
gentamicin VB O
led VBN O
to TO O
the DT O
expression NN O
and CC O
localization NN O
of IN O
dystrophin NN O
to TO O
the DT O
cell NN O
membrane NN O
. . O

We PRP O
then RB O
evaluated VBD O
the DT O
effects NNS O
of IN O
differing VBG O
dosages NNS O
of IN O
gentamicin NN O
on IN O
expression NN O
and CC O
functional JJ O
protection NN O
of IN O
the DT O
muscles NNS O
of IN O
mdx NN O
mice NN O
. . O

We PRP O
identified VBD O
a DT O
treatment NN O
regimen NN O
that WDT O
resulted VBD O
in IN O
the DT O
presence NN O
of IN O
dystrophin NN O
in IN O
the DT O
cell NN O
membrane NN O
in IN O
all DT O
striated JJ O
muscles NNS O
examined VBN O
and CC O
that IN O
provided VBD O
functional JJ O
protection NN O
against IN O
muscular JJ B-Disease
injury NN I-Disease
. . O

To TO O
our PRP$ O
knowledge NN O
, , O
our PRP$ O
results NNS O
are VBP O
the DT O
first JJ O
to TO O
demonstrate VB O
that DT O
aminoglycosides NNS O
can MD O
suppress VB O
stop VB O
codons NNS O
not RB O
only RB O
in IN O
vitro NN O
but CC O
also RB O
in IN O
vivo NN O
. . O

Furthermore RB O
, , O
these DT O
results NNS O
raise VBP O
the DT O
possibility NN O
of IN O
a DT O
novel JJ O
treatment NN O
regimen NNS O
for IN O
muscular JJ B-Disease
dystrophy NN I-Disease
and CC O
other JJ O
diseases NNS O
caused VBN O
by IN O
premature JJ O
stop JJ O
codon NN O
mutations NNS O
. . O

This DT O
treatment NN O
could MD O
prove VB O
effective JJ O
in IN O
up RB O
to TO O
15 CD O
% NN O
of IN O
patients NNS O
with IN O
DMD NNP B-Disease
. . O
. . O

Loss NNP O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
product NN O
causes VBZ O
oxidative JJ O
damage NN O
in IN O
target NN O
organs NNS O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
is VBZ O
characterized VBN O
by IN O
a DT O
markedly RB O
increased JJ O
sensitivity NN O
to TO O
ionizing VBG O
radiation NN O
, , O
increased VBD O
incidence NN O
of IN O
cancer NN B-Disease
, , O
and CC O
neurodegeneration NN B-Disease
, , O
especially RB O
of IN O
the DT O
cerebellar JJ O
Purkinje NNP O
cells NNS O
. . O

Ionizing VBG O
radiation NN O
oxidizes VBZ O
macromolecules NNS O
and CC O
causes VBZ O
tissue NN O
damage NN O
through IN O
the DT O
generation NN O
of IN O
reactive JJ O
oxygen NN O
species NNS O
( ( O
ROS NNP O
) ) O
. . O

We PRP O
therefore VBP O
hypothesized VBD O
that IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
is VBZ O
due JJ O
to TO O
oxidative JJ O
damage NN O
resulting VBG O
from IN O
loss NN O
of IN O
function NN O
of IN O
the DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
gene NN O
product NN O
. . O

To TO O
assess VB O
this DT O
hypothesis NN O
, , O
we PRP O
employed VBD O
an DT O
animal JJ O
model NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
, , O
the DT O
mouse NN O
with IN O
a DT O
disrupted VBN O
Atm NNP O
gene NN O
. . O

We PRP O
show VBP O
that IN O
organs NNS O
which WDT O
develop VBP O
pathologic JJ O
changes NNS O
in IN O
the DT O
Atm NNP O
- : O
deficient NN O
mice NN O
are VBP O
targets NNS O
of IN O
oxidative JJ O
damage NN O
, , O
and CC O
that IN O
cerebellar JJ O
Purkinje NNP O
cells NNS O
are VBP O
particularly RB O
affected VBN O
. . O

These DT O
observations NNS O
provide VBP O
a DT O
mechanistic JJ O
basis NN O
for IN O
the DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
phenotype NN O
and CC O
lay VBD O
a DT O
rational JJ O
foundation NN O
for IN O
therapeutic JJ O
intervention NN O
. . O
. . O

Recessively RB O
inherited JJ O
multiple JJ B-Disease
epiphyseal NN I-Disease
dysplasia NN I-Disease
with IN O
normal JJ O
stature NN O
, , O
club JJ B-Disease
foot NN I-Disease
, , O
and CC O
double RB B-Disease
layered JJ I-Disease
patella NN I-Disease
caused VBN O
by IN O
a DT O
DTDST NNP O
mutation NN O
. . O

We PRP O
have VBP O
observed VBN O
over IN O
25 CD O
different JJ O
mutations NNS O
in IN O
the DT O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulphate NN O
transporter NN O
gene NN O
( ( O
DTDST NNP O
) ) O
in IN O
association NN O
with IN O
the DT O
recessive JJ B-Disease
disorders NNS I-Disease
achondrogenesis VBP B-Disease
1B CD I-Disease
, , O
atelosteogenesis NN B-Disease
2 CD I-Disease
, , O
and CC O
diastrophic JJ B-Disease
dysplasia NN I-Disease
. . O

The DT O
c862t NN O
( ( O
R279W NNP O
) ) O
transition NN O
is VBZ O
the DT O
most RBS O
common JJ O
mutation NN O
in IN O
non JJ O
- : O
Finnish JJ O
patients NNS O
, , O
but CC O
in IN O
these DT O
disorders NNS O
it PRP O
is VBZ O
usually RB O
combined VBN O
with IN O
other JJ O
DTDST NNP O
mutations NNS O
. . O

We PRP O
had VBD O
not RB O
seen VBN O
a DT O
case NN O
of IN O
homozygosity NN O
for IN O
c862t NN O
( ( O
R279W NNP O
) ) O
until IN O
we PRP O
analysed VBD O
DNA NNP O
from IN O
a DT O
36 CD O
year NN O
old JJ O
male NN O
with IN O
tall JJ O
- : O
normal JJ O
stature NN O
( ( O
180 CD O
cm NN O
) ) O
who WP O
asked VBD O
for IN O
genetic JJ O
counselling NN O
for IN O
suspected JJ O
multiple JJ B-Disease
epiphyseal NN I-Disease
dysplasia NN I-Disease
. . O

He PRP O
was VBD O
treated VBN O
for IN O
club JJ B-Disease
foot NN I-Disease
and CC O
hip NN B-Disease
dysplasia NN I-Disease
at IN O
birth NN O
. . O

Skeletal JJ O
changes NNS O
consistent JJ O
with IN O
multiple JJ B-Disease
epiphyseal NN I-Disease
dysplasia NN I-Disease
, , O
with IN O
the DT O
peculiar JJ O
finding NN O
of IN O
a DT O
double JJ B-Disease
layered JJ I-Disease
patella NN I-Disease
, , O
were VBD O
recognised VBN O
during IN O
childhood NN O
. . O

Cleft NNP B-Disease
palate NN I-Disease
, , O
swelling VBG B-Disease
of IN I-Disease
the DT I-Disease
ear JJ I-Disease
pinna NN I-Disease
, , O
and CC O
hitch NN B-Disease
hiker NN I-Disease
thumb NN I-Disease
were VBD O
absent JJ O
. . O

He PRP O
was VBD O
found VBN O
to TO O
be VB O
homozygous JJ O
, , O
and CC O
both DT O
healthy JJ O
parents NNS O
heterozygous JJ O
, , O
for IN O
the DT O
R279W NNP O
mutation NN O
in IN O
DTDST NNP O
, , O
and CC O
his PRP$ O
fibroblasts NNS O
showed VBD O
a DT O
sulphate JJ O
incorporation NN O
defect JJ O
typical JJ O
of IN O
DTDST NNP B-Disease
disorders NNS I-Disease
. . O

Counselling NN O
was VBD O
given VBN O
for IN O
a DT O
recessive JJ B-Disease
disorder NN I-Disease
, , O
thereby RB O
considerably RB O
reducing VBG O
the DT O
probability NN O
of IN O
affected JJ O
offspring NN O
. . O

Multiple JJ B-Disease
epiphyseal NN I-Disease
dysplasia NN I-Disease
is VBZ O
more RBR O
frequently RB O
caused VBN O
by IN O
dominant JJ O
mutations NNS O
in IN O
the DT O
COMP NNP O
( ( O
EDM1 NNP B-Disease
, , O
McKusick NNP O
132400 CD O
) ) O
and CC O
COL9A2 NNP O
genes NNS O
( ( O
EDM2 NNP B-Disease
, , O
McKusick NNP O
600204 CD O
) ) O
. . O

A DT O
few JJ O
other JJ O
patients NNS O
and CC O
families NNS O
with IN O
features NNS O
similar JJ O
to TO O
our PRP$ O
proband NN O
have VBP O
been VBN O
described VBN O
previously RB O
and CC O
considered VBN O
to TO O
have VB O
autosomal JJ O
recessive NN O
MED NNP B-Disease
( ( O
EDM4 NNP B-Disease
, , O
McKusick NNP O
226900 CD O
) ) O
. . O

This DT O
observation NN O
confirms VBZ O
the DT O
existence NN O
of IN O
this DT O
entity NN O
and CC O
assigns VBZ O
it PRP O
to TO O
the DT O
phenotypic NN O
spectrum NN O
associated VBN O
with IN O
mutations NNS O
at IN O
the DT O
DTDST NNP O
locus NN O
. . O
. . O

Homozygosity NNP O
for IN O
a DT O
novel JJ O
DTDST NNP O
mutation NN O
in IN O
a DT O
child NN O
with IN O
a DT O
' POS O
broad JJ O
bone NN O
- : O
platyspondylic NN O
' '' O
variant NN O
of IN O
diastrophic JJ B-Disease
dysplasia NN I-Disease
. . O

Atypical JJ O
or CC O
variant JJ O
forms NNS O
of IN O
well RB O
- : O
known VBN O
chondrodysplasias NN B-Disease
may MD O
pose VB O
diagnostic JJ O
problems NNS O
. . O

We PRP O
report VBP O
on IN O
a DT O
girl NN O
with IN O
clinical JJ O
features NNS O
suggesting VBG O
diastrophic JJ B-Disease
dysplasia NNS I-Disease
but CC O
with IN O
unusual JJ O
radiographic JJ O
features NNS O
including VBG O
severe JJ O
platyspondyly NN B-Disease
, , O
wide JJ O
metaphyses NNS O
, , O
and CC O
fibular JJ O
overgrowth NN O
, , O
which WDT O
are VBP O
partially RB O
reminiscent JJ O
of IN O
metatropic NN B-Disease
dysplasia NN I-Disease
. . O

The DT O
diagnosis NN O
was VBD O
clarified VBN O
by IN O
molecular JJ O
analysis NN O
of IN O
the DT O
DTDST NNP O
gene NN O
, , O
which WDT O
revealed VBD O
homozygosity NN O
for IN O
a DT O
previously RB O
undescribed JJ O
mutation NN O
leading VBG O
to TO O
a DT O
Q454P NNP O
substitution NN O
in IN O
the DT O
10th JJ O
transmembrane NN O
domain NN O
of IN O
the DT O
DTDST NNP O
sulfate NN O
transporter NN O
. . O

Molecular JJ O
analysis NN O
may MD O
be VB O
of IN O
particular JJ O
value NN O
in IN O
such JJ O
atypical JJ O
cases NNS O
. . O
. . O

The DT O
type NN O
of IN O
somatic JJ O
mutation NN O
at IN O
APC NNP O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
is VBZ O
determined VBN O
by IN O
the DT O
site NN O
of IN O
the DT O
germline JJ O
mutation NN O
: : O
a DT O
new JJ O
facet NN O
to TO O
Knudson NNP O
' POS O
s NN O
' '' O
two CD O
- : O
hit NN O
' '' O
hypothesis NN O
. . O

APC NNP O
is VBZ O
often RB O
cited VBN O
as IN O
a DT O
prime JJ O
example NN O
of IN O
a DT O
tumor NN B-Disease
suppressor NN O
gene NN O
. . O

Truncating VBG O
germline NN O
and CC O
somatic JJ O
mutations NNS O
( ( O
or CC O
, , O
infrequently RB O
, , O
allelic JJ O
loss NN O
) ) O
occur VBP O
in IN O
tumors NNS B-Disease
in IN O
FAP NNP B-Disease
( ( O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
) ) O
. . O

Most JJS O
sporadic JJ B-Disease
colorectal NN I-Disease
cancers NNS I-Disease
also RB O
have VBP O
two CD O
APC NNP B-Disease
mutations NNS O
. . O

Clues NNS O
from IN O
attenuated VBN B-Disease
polyposis NN I-Disease
, , O
missense JJ O
germline NN O
variants NNS O
with IN O
mild JJ O
disease NN O
and CC O
the DT O
somatic JJ O
mutation NN O
cluster NN O
region NN O
( ( O
codons NNS O
1 CD O
, , O
250 CD O
- : O
1 CD O
, , O
450 CD O
) ) O
indicate NN O
, , O
however RB O
, , O
that IN O
APC NNP B-Disease
mutations NNS O
might MD O
not RB O
result VB O
in IN O
simple JJ O
loss NN O
of IN O
protein JJ O
function NN O
. . O

We PRP O
have VBP O
found VBN O
that IN O
FAP NNP B-Disease
patients NNS O
with IN O
germline JJ O
APC NNP B-Disease
mutations NNS O
within IN O
a DT O
small JJ O
region NN O
( ( O
codons NNS O
1 CD O
, , O
194 CD O
- : O
1 CD O
, , O
392 CD O
at IN O
most JJS O
) ) O
mainly RB O
show VBP O
allelic JJ O
loss NN O
in IN O
their PRP$ O
colorectal JJ B-Disease
adenomas NN I-Disease
, , O
in IN O
contrast NN O
to TO O
other JJ O
FAP NNP B-Disease
patients NNS O
, , O
whose WP$ O
second JJ O
hits NNS O
tend VBP O
to TO O
occur VB O
by IN O
truncating VBG O
mutations NNS O
in IN O
the DT O
mutation NN O
cluster NN O
region NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
different JJ O
APC NNP B-Disease
mutations NNS O
provide VBP O
cells NNS O
with IN O
different JJ O
selective JJ O
advantages NNS O
, , O
with IN O
mutations NNS O
close RB O
to TO O
codon VB O
1 CD O
, , O
300 CD O
providing VBG O
the DT O
greatest JJS O
advantage NN O
. . O

Allelic JJ O
loss NN O
is VBZ O
selected VBN O
strongly RB O
in IN O
cells NNS O
with IN O
one CD O
mutation NN O
near IN O
codon NN O
1 CD O
, , O
300 CD O
. . O

A DT O
different JJ O
germline NN O
- : O
somatic JJ O
APC NNP B-Disease
mutation NN O
association NN O
exists VBZ O
in IN O
FAP NNP B-Disease
desmoids NNS I-Disease
. . O

APC NNP O
is VBZ O
not RB O
, , O
therefore RB O
, , O
a DT O
classical JJ O
tumor NN B-Disease
suppressor NN O
. . O

Our PRP$ O
findings NNS O
also RB O
indicate VBP O
a DT O
new JJ O
mechanism NN O
for IN O
disease NN O
severity NN O
if IN O
a DT O
broader JJR O
spectrum NN O
of IN O
mutations NNS O
is VBZ O
selected VBN O
in IN O
tumors NNS B-Disease
, , O
the DT O
somatic JJ O
mutation NN O
rate NN O
is VBZ O
effectively RB O
higher JJR O
and CC O
more RBR O
tumors NNS B-Disease
grow VBP O
. . O
. . O

Mxi1 NNP O
mutations NNS O
in IN O
human JJ O
neurofibrosarcomas NN B-Disease
. . O

Mxi1 NNP O
is VBZ O
thought VBN O
to TO O
negatively RB O
regulate VB O
Myc NNP O
function NN O
and CC O
may MD O
therefore RB O
be VB O
a DT O
potential JJ O
tumor NN B-Disease
suppressor NN O
gene NN O
. . O

Little JJ O
effort NN O
has VBZ O
yet RB O
been VBN O
made VBN O
to TO O
find VB O
alterations NNS O
involving VBG O
this DT O
gene NN O
in IN O
human JJ O
solid JJ B-Disease
tumors NNS I-Disease
. . O

We PRP O
screened VBD O
31 CD O
human JJ O
gastric NN B-Disease
cancers NNS I-Disease
, , O
7 CD O
esophageal NN B-Disease
cancers NNS I-Disease
, , O
85 CD O
bone NN B-Disease
and CC I-Disease
soft JJ I-Disease
tissue NN I-Disease
tumors NNS I-Disease
of IN O
various JJ O
types NNS O
, , O
including VBG O
4 CD O
neurofibrosarcomas NN B-Disease
. . O

We PRP O
also RB O
examined VBD O
29 CD O
human JJ O
tumor NN B-Disease
cell NN O
lines NNS O
consisting VBG O
of IN O
12 CD O
esophageal NN B-Disease
cancers NNS I-Disease
, , O
7 CD O
glioma NN B-Disease
/ NNP O
glioblastomas NN B-Disease
and CC O
10 CD O
others NNS O
for IN O
Mxi1 NNP O
mutations NNS O
in IN O
exons NNS O
1 CD O
, , O
2 CD O
, , O
4 CD O
( ( O
HLH NNP O
domain NN O
) ) O
, , O
5 CD O
and CC O
6 CD O
. . O

Polymerase NNP O
chain NN O
reaction NN O
- : O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
PCR NNP O
- : O
SSCP NN O
) ) O
and CC O
subsequent JJ O
sequencing NN O
revealed VBD O
three CD O
distinct JJ O
polymorphisms NNS O
in IN O
the DT O
intron NN O
- : O
exon NN O
boundary JJ O
upstream NN O
from IN O
exon JJ O
6 CD O
. . O

We PRP O
discovered VBD O
a DT O
missense JJ O
mutation NN O
, , O
GCA NNP O
to TO O
GTA NNP O
( ( O
Ala NNP O
54 CD O
Val NNP O
) ) O
, , O
in IN O
exon JJ O
2 CD O
in IN O
a DT O
neurofibrosarcoma JJ B-Disease
patient NN O
( ( O
case NN O
1 CD O
) ) O
, , O
two CD O
missense NN O
mutations NNS O
, , O
AAA NNP O
to TO O
CAA NNP O
( ( O
Lys NNP O
118 CD O
Gln NNP O
) ) O
and CC O
GAA NNP O
to TO O
GGA NNP O
( ( O
Glu NNP O
154 CD O
Gly NNP O
) ) O
in IN O
exon $ O
5 CD O
of IN O
another DT O
neurofibrosarcoma JJ B-Disease
patient NN O
( ( O
case NN O
2 CD O
) ) O
, , O
and CC O
3 CD O
amino NN O
acid NN O
substitutions NNS O
, , O
GTG NNP O
to TO O
GCG NNP O
( ( O
Val NNP O
179 CD O
Ala NNP O
) ) O
, , O
GTT NNP O
to TO O
GCT NNP O
( ( O
Val NNP O
181 CD O
Ala NNP O
) ) O
and CC O
TTC NNP O
to TO O
CTC NNP O
( ( O
Phe NNP O
186 CD O
Leu NNP O
) ) O
, , O
in IN O
a DT O
third JJ O
neurofibrosarcoma JJ B-Disease
patient NN O
( ( O
case NN O
3 CD O
) ) O
. . O

In IN O
case NN O
3 CD O
, , O
loss NN O
of IN O
heterozygosity NN O
was VBD O
also RB O
demonstrated VBN O
by IN O
informative JJ O
( ( O
TTC NNP O
) ) O
3 CD O
/ NN O
( ( O
TTC NNP O
) ) O
2 CD O
polymorphism NN O
. . O

Our PRP$ O
data NNS O
demonstrate NN O
that IN O
mutations NNS O
occur VBP O
in IN O
the DT O
Mxi1 NNP O
gene NN O
in IN O
neurofibrosarcoma NN B-Disease
. . O

Missense JJ O
mutations NNS O
in IN O
the DT O
functional JJ O
domain NN O
of IN O
Mxi1 NNP O
in IN O
these DT O
cases NNS O
may MD O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
neurofibrosarcoma NN B-Disease
. . O
. . O

A DT O
population NN O
- : O
based VBN O
study NN O
of IN O
the DT O
clinical JJ O
expression NN O
of IN O
the DT O
hemochromatosis NN B-Disease
gene NN O
. . O

BACKGROUND NNP O
AND NNP O
METHODS NNP O
Hereditary NNP B-Disease
hemochromatosis NN I-Disease
is VBZ O
associated VBN O
with IN O
homozygosity NN O
for IN O
the DT O
C282Y NNP O
mutation NN O
in IN O
the DT O
hemochromatosis NN B-Disease
( ( O
HFE NNP O
) ) O
gene NN O
on IN O
chromosome NN O
6 CD O
, , O
elevated VBD O
serum JJ O
transferrin NN O
saturation NN O
, , O
and CC O
excess JJ B-Disease
iron NN I-Disease
deposits NNS I-Disease
throughout IN O
the DT O
body NN O
. . O

To TO O
assess VB O
the DT O
prevalence NN O
and CC O
clinical JJ O
expression NN O
of IN O
the DT O
HFE NNP O
gene NN O
, , O
we PRP O
conducted VBD O
a DT O
population NN O
- : O
based VBN O
study NN O
in IN O
Busselton NNP O
, , O
Australia NNP O
. . O

In IN O
1994 CD O
, , O
we PRP O
obtained VBD O
blood NN O
samples NNS O
for IN O
the DT O
determination NN O
of IN O
serum NN O
transferrin NN O
saturation NN O
and CC O
ferritin NN O
levels NNS O
and CC O
the DT O
presence NN O
or CC O
absence NN O
of IN O
the DT O
C282Y NNP O
mutation NN O
and CC O
the DT O
H63D NNP O
mutation NN O
( ( O
which WDT O
may MD O
contribute VB O
to TO O
increased VBN O
hepatic JJ O
iron NN O
levels NNS O
) ) O
in IN O
3011 CD O
unrelated JJ O
white JJ O
adults NNS O
. . O

We PRP O
evaluated VBD O
all DT O
subjects NNS O
who WP O
had VBD O
persistently RB O
elevated VBN O
transferrin SYM O
- : O
saturation NN O
values NNS O
( ( O
45 CD O
percent NN O
or CC O
higher JJR O
) ) O
or CC O
were VBD O
homozygous JJ O
for IN O
the DT O
C282Y NNP O
mutation NN O
. . O

We PRP O
recommended VBD O
liver RB O
biopsy NN O
for IN O
subjects NNS O
with IN O
serum JJ O
ferritin NN O
levels NNS O
of IN O
300 CD O
ng NNS O
per IN O
milliliter NN O
or CC O
higher JJR O
. . O

The DT O
subjects NNS O
were VBD O
followed VBN O
for IN O
up IN O
to TO O
four CD O
years NNS O
. . O

RESULTS NNP O
Sixteen NNP O
of IN O
the DT O
subjects NNS O
( ( O
0 CD O
. . O
5 CD O
percent NN O
) ) O
were VBD O
homozygous JJ O
for IN O
the DT O
C282Y NNP O
mutation NN O
, , O
and CC O
424 CD O
( ( O
14 CD O
. . O
1 CD O
percent NN O
) ) O
were VBD O
heterozygous JJ O
. . O

The DT O
serum NN O
transferrin NN O
saturation NN O
was VBD O
45 CD O
percent NN O
or CC O
higher JJR O
in IN O
15 CD O
of IN O
the DT O
16 CD O
who WP O
were VBD O
homozygous JJ O
; : O
in IN O
1 CD O
subject JJ O
it PRP O
was VBD O
43 CD O
percent NN O
. . O

Four CD O
of IN O
the DT O
homozygous JJ O
subjects NNS O
had VBD O
previously RB O
been VBN O
given VBN O
a DT O
diagnosis NN O
of IN O
hemochromatosis NN B-Disease
, , O
and CC O
12 CD O
had VBD O
not RB O
. . O

Seven CD O
of IN O
these DT O
12 CD O
patients NNS O
had VBD O
elevated VBN O
serum JJ O
ferritin NN O
levels NNS O
in IN O
1994 CD O
; : O
6 CD O
of IN O
the DT O
7 CD O
had VBD O
further JJ O
increases NNS O
in IN O
1998 CD O
, , O
and CC O
1 CD O
had VBD O
a DT O
decrease NN O
, , O
although IN O
the DT O
value NN O
remained VBD O
elevated JJ O
. . O

The DT O
serum NN O
ferritin NN O
levels NNS O
in IN O
the DT O
four CD O
other JJ O
homozygous JJ O
patients NNS O
remained VBN O
in IN O
the DT O
normal JJ O
range NN O
. . O

Eleven NNP O
of IN O
the DT O
16 CD O
homozygous JJ O
subjects NNS O
underwent JJ O
liver RB O
biopsy VBP O
; : O
3 CD O
had VBD O
hepatic JJ B-Disease
fibrosis NN I-Disease
, , O
and CC O
1 CD O
, , O
who WP O
had VBD O
a DT O
history NN O
of IN O
excessive JJ B-Disease
alcohol NN I-Disease
consumption NN I-Disease
, , O
had VBD O
cirrhosis NN B-Disease
and CC O
mild VB O
microvesicular JJ B-Disease
steatosis NN I-Disease
. . O

Eight CD O
of IN O
the DT O
16 CD O
homozygous JJ O
subjects NNS O
had VBD O
clinical JJ O
findings NNS O
that WDT O
were VBD O
consistent JJ O
with IN O
the DT O
presence NN O
of IN O
hereditary JJ B-Disease
hemochromatosis NN I-Disease
, , O
such JJ O
as IN O
hepatomegaly NN B-Disease
, , O
skin JJ B-Disease
pigmentation NN I-Disease
, , O
and CC O
arthritis NN B-Disease
. . O

CONCLUSIONS NNP O
In IN O
a DT O
population NN O
of IN O
white JJ O
adults NNS O
of IN O
northern JJ O
European JJ O
ancestry NN O
, , O
0 CD O
. . O

5 CD O
percent NN O
were VBD O
homozygous JJ O
for IN O
the DT O
C282Y NNP O
mutation NN O
in IN O
the DT O
HFE NNP O
gene NN O
. . O

However RB O
, , O
only RB O
half NN O
of IN O
those DT O
who WP O
were VBD O
homozygous JJ O
had VBD O
clinical JJ O
features NNS O
of IN O
hemochromatosis NN B-Disease
, , O
and CC O
one CD O
quarter NN O
had VBD O
serum VBN O
ferritin NN O
levels NNS O
that WDT O
remained VBD O
normal JJ O
over IN O
a DT O
four CD O
- : O
year NN O
period NN O
. . O

Large JJ O
heterozygous JJ O
deletion NN O
masquerading VBG O
as IN O
homozygous JJ O
missense NN O
mutation NN O
: : O
a DT O
pitfall NN O
in IN O
diagnostic JJ O
mutation NN O
analysis NN O
. . O

The DT O
clinical JJ O
use NN O
of IN O
molecular JJ O
analyses NNS O
in IN O
recessive JJ B-Disease
disorders NNS I-Disease
relies NNS O
on IN O
the DT O
exact JJ O
characterization NN O
of IN O
both DT O
mutant JJ O
alleles NNS O
in IN O
the DT O
affected JJ O
patient NN O
. . O

This DT O
can MD O
be VB O
problematic JJ O
when WRB O
only RB O
part NN O
of IN O
the DT O
gene NN O
is VBZ O
examined VBN O
or CC O
when WRB O
relevant JJ O
DNA NN O
alterations NNS O
are VBP O
not RB O
recognized VBN O
by IN O
standard JJ O
methods NNS O
. . O

We PRP O
present VBP O
a DT O
child NN O
in IN O
whom WP O
phenylketonuria NN B-Disease
was VBD O
apparently RB O
caused VBN O
by IN O
homozygosity NN O
for IN O
the DT O
mutation NN O
E390G NNP O
in IN O
exon JJ O
11 CD O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
gene NN O
. . O

However RB O
, , O
the DT O
clinical JJ O
severity NN O
of IN O
the DT O
disease NN O
was VBD O
not RB O
quite RB O
as RB O
mild JJ O
as IN O
expected VBN O
, , O
the DT O
mutation NN O
was VBD O
not RB O
identified VBN O
in IN O
the DT O
father NN O
despite IN O
confirmed JJ O
paternity NN O
, , O
and CC O
the DT O
paternal JJ O
allele NN O
showed VBD O
a DT O
highly RB O
unusual JJ O
pattern NN O
of IN O
polymorphic JJ O
markers NNS O
in IN O
the DT O
PAH NNP O
gene NN O
. . O

Presence NN O
of IN O
a DT O
large JJ O
deletion NN O
involving VBG O
exons NNS O
9 CD O
, , O
10 CD O
and CC O
11 CD O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
gene NN O
was VBD O
confirmed VBN O
by IN O
long JJ O
- : O
range NN O
PCR NNP O
. . O

Diagnostic JJ O
DNA NNP O
analyses NNS O
should MD O
include VB O
a DT O
comprehensive JJ O
examination NN O
of IN O
the DT O
whole JJ O
relevant JJ O
gene NN O
in IN O
the DT O
patient NN O
and CC O
confirmation NN O
of IN O
carrier NN O
status NN O
in IN O
both DT O
parents NNS O
. . O
. . O

Early JJ O
onset NN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
in IN O
a DT O
boy NN O
with IN O
emerin JJ O
gene NN O
deletion NN O
. . O

A DT O
boy NN O
developed VBD O
contractures NNS B-Disease
of IN I-Disease
the DT I-Disease
Achilles NNP I-Disease
tendons NNS I-Disease
at IN O
3 CD O
years NNS O
and CC O
of IN O
the DT O
postcervical JJ O
muscles NNS O
at IN O
7 CD O
years NNS O
, , O
although IN O
neither DT O
contractures NNS B-Disease
of IN I-Disease
the DT I-Disease
elbows NNS I-Disease
nor CC O
cardiac JJ B-Disease
abnormality NN I-Disease
were VBD O
recognized VBN O
by IN O
the DT O
age NN O
of IN O
9 CD O
years NNS O
. . O

Muscle NNP O
computed VBD O
tomography NN O
scanning VBG O
revealed VBD O
changes NNS O
characteristic JJ O
of IN O
muscle NN O
involvement NN O
. . O

Emerin NNP O
was VBD O
not RB O
detected VBN O
in IN O
the DT O
biopsied JJ O
muscle NN O
, , O
and CC O
RT NNP O
- : O
PCR NN O
and CC O
PCR NNP O
- : O
based VBN O
genomic JJ O
DNA NNP O
analyses NNS O
of IN O
the DT O
emerin JJ O
gene NN O
demonstrated VBD O
no DT O
amplification NN O
product NN O
in IN O
the DT O
patient NN O
. . O

These DT O
results NNS O
confirmed VBD O
the DT O
diagnosis NN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EDMD NNP B-Disease
) ) O
, , O
and CC O
reinforce VB O
the DT O
necessity NN O
of IN O
molecular JJ O
genetic JJ O
diagnosis NN O
of IN O
the DT O
membrane NN O
protein NN O
emerin NN O
in IN O
younger JJR O
patients NNS O
with IN O
possible JJ O
EDMD NNP B-Disease
before IN O
appearance NN O
of IN O
the DT O
typical JJ O
symptoms NNS O
, , O
to TO O
avoid VB O
sudden JJ B-Disease
cardiac JJ I-Disease
death NN I-Disease
. . O
. . O

Duchenne NNP B-Disease
/ NNP I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
: : O
correlation NN O
of IN O
phenotype NN O
by IN O
electroretinography NN O
with IN O
sites NNS O
of IN O
dystrophin JJ O
mutations NNS O
. . O

The DT O
dark JJ O
- : O
adapted VBN O
electroretinogram NN O
( ( O
ERG NNP O
) ) O
of IN O
patients NNS O
with IN O
Duchenne NNP B-Disease
and CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
/ NNP O
BMD NNP B-Disease
) ) O
shows VBZ O
a DT O
marked JJ O
reduction NN O
in IN O
b NN O
- : O
wave NN O
amplitude NN O
. . O

Genotype NNP O
- : O
phenotype NN O
studies NNS O
of IN O
mouse NN O
models NNS O
for IN O
DMD NNP B-Disease
show VBP O
position NN O
- : O
specific JJ O
effects NNS O
of IN O
the DT O
mutations NNS O
upon IN O
the DT O
phenotype NN O
mice NN O
with IN O
5 CD O
defects NNS O
of IN O
dystrophin NNS O
have VBP O
normal JJ O
ERGs NNP O
, , O
those DT O
with IN O
defects NNS O
in IN O
the DT O
central JJ O
region NN O
have VBP O
a DT O
normal JJ O
b SYM O
- : O
wave NN O
amplitude NN O
associated VBN O
with IN O
prolonged JJ O
implicit NN O
times NNS O
for IN O
both DT O
the DT O
b SYM O
- : O
wave NN O
and CC O
oscillatory NN O
potentials NNS O
, , O
and CC O
mice NN O
with IN O
3 CD O
defects NNS O
have VBP O
a DT O
phenotype NN O
similar JJ O
to TO O
that DT O
seen VBN O
in IN O
DMD NNP B-Disease
/ NNP O
BMD NNP B-Disease
patients NNS O
. . O

The DT O
mouse NN O
studies NNS O
suggest VBP O
a DT O
key JJ O
role NN O
for IN O
the DT O
carboxyl JJ O
terminal NN O
dystrophin NN O
isoform NN O
, , O
Dp260 NNP O
, , O
in IN O
retinal JJ O
electrophysiology NN O
. . O

We PRP O
have VBP O
undertaken VBN O
a DT O
systematic JJ O
evaluation NN O
of IN O
DMD NNP B-Disease
/ NNP O
BMD NNP B-Disease
patients NNS O
through IN O
clinical JJ O
examination NN O
and CC O
review NN O
of IN O
the DT O
literature NN O
in IN O
order NN O
to TO O
determine VB O
whether IN O
the DT O
position NN O
- : O
specific JJ O
effects NNS O
of IN O
mutations NNS O
noted VBN O
in IN O
the DT O
mouse NN O
are VBP O
present JJ O
in IN O
man NN O
. . O

We PRP O
have VBP O
found VBN O
that IN O
, , O
in IN O
man NN O
, , O
a DT O
wider JJR O
variation NN O
of IN O
DMD NNP B-Disease
defects NNS I-Disease
correlate VBP O
with IN O
reductions NNS O
in IN O
the DT O
b NN O
- : O
wave NN O
amplitude NN O
. . O

Individuals NNS O
with IN O
normal JJ O
ERGs NNP O
have VBP O
mutations NNS O
predominantly RB O
located VBD O
5 CD O
of IN O
the DT O
transcript NN O
initiation NN O
site NN O
of IN O
Dp260 NNP O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
most RBS O
important JJ O
determinant NN O
in IN O
the DT O
ERG NNP O
b SYM O
- : O
wave NN O
phenotype NN O
is VBZ O
the DT O
mutation NN O
position NN O
, , O
rather RB O
than IN O
muscle VB B-Disease
disease JJ I-Disease
severity NN O
. . O

Forty NNP O
- : O
six CD O
per IN O
cent NN O
of IN O
patients NNS O
with IN O
mutations NNS O
5 CD O
of IN O
the DT O
Dp260 NNP O
transcript JJ O
start NN O
site NN O
have VBP O
abnormal JJ O
ERGs NNP O
, , O
as IN O
opposed VBN O
to TO O
94 CD O
% NN O
with IN O
more JJR O
distal JJ O
mutations NNS O
. . O

The DT O
human JJ O
genotype NN O
- : O
phenotype NN O
correlations NNS O
are VBP O
consistent JJ O
with IN O
a DT O
role NN O
for IN O
Dp260 NNP O
in IN O
normal JJ O
retinal JJ O
electrophysiology NN O
and CC O
may MD O
also RB O
reflect VB O
the DT O
expression NN O
of IN O
other JJ O
C NNP O
- : O
terminal NN O
dystrophin NN O
isoforms NNS O
and CC O
their PRP$ O
contributions NNS O
to TO O
retinal JJ O
signal JJ O
transmission NN O
. . O
. . O

Cis NNP O
and CC O
trans VBZ O
effects NNS O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
mutation NN O
in IN O
a DT O
cell NN O
culture NN O
model NN O
. . O

The DT O
mutation NN O
causing VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
CTG NNP O
expansion NN O
in IN O
the DT O
3 CD O
- : O
untranslated JJ O
region NN O
( ( O
3 CD O
- : O
UTR NN O
) ) O
of IN O
the DT O
DM NNP B-Disease
protein NN O
kinase NN O
gene NN O
( ( O
DMPK NNP O
) ) O
, , O
but CC O
the DT O
mechanism NN O
( ( O
s JJ O
) ) O
of IN O
pathogenesis NN O
remain VBP O
unknown JJ O
. . O

Studies NNS O
using VBG O
DM NNP B-Disease
patient NN O
materials NNS O
have VBP O
often RB O
produced VBN O
confusing JJ O
results NNS O
. . O

Therefore RB O
, , O
to TO O
study VB O
the DT O
effects NNS O
of IN O
the DT O
DM NNP B-Disease
mutation NN O
in IN O
a DT O
controlled JJ O
environment NN O
, , O
we PRP O
have VBP O
established VBN O
a DT O
cell NN O
culture NN O
model NN O
system NN O
using VBG O
C2C12 NNP O
mouse NN O
myoblasts NNS O
. . O

By IN O
expressing VBG O
chimeric JJ O
reporter NN O
constructs NNS O
containing VBG O
a DT O
reporter NN O
gene NN O
fused VBD O
to TO O
a DT O
human JJ O
DMPK NNP O
3 CD O
- : O
UTR NN O
, , O
we PRP O
identified VBD O
both DT O
cis NNS O
and CC O
trans NNS O
effects NNS O
that WDT O
are VBP O
mediated VBN O
by IN O
the DT O
DM NNP B-Disease
mutation NN O
. . O

Our PRP$ O
data NNS O
show VBP O
that IN O
a DT O
mutant JJ O
DMPK NNP O
3 CD O
- : O
UTR NN O
, , O
with IN O
as RB O
few JJ O
as IN O
57 CD O
CTGs NNP O
, , O
had VBD O
a DT O
negative JJ O
cis NN O
effect NN O
on IN O
protein NN O
expression NN O
and CC O
resulted VBD O
in IN O
the DT O
aggregation NN O
of IN O
reporter NN O
transcripts NNS O
into IN O
discrete JJ O
nuclear JJ O
foci NN O
. . O

We PRP O
determined VBN O
by IN O
deletion NN O
analysis NN O
that IN O
an DT O
expanded VBN O
( ( O
CTG NNP O
) ) O
( ( O
n JJ O
) ) O
tract NN O
alone RB O
was VBD O
sufficient JJ O
to TO O
mediate VB O
these DT O
cis JJ O
effects NNS O
. . O

Furthermore RB O
, , O
in IN O
contrast NN O
to TO O
the DT O
normal JJ O
DMPK NNP O
3 CD O
- : O
UTR NN O
mRNA NN O
, , O
a DT O
mutant JJ O
DMPK NNP O
3 CD O
- : O
UTR NN O
mRNA NN O
with IN O
( ( O
CUG NNP O
) ) O
( ( O
200 CD O
) ) O
selectively RB O
inhibited VBN O
myogenic JJ O
differentiation NN O
of IN O
C2C12 NNP O
myoblasts NNS O
. . O

Genetic JJ O
analysis NN O
and CC O
the DT O
Cre NNP O
- : O
loxP NN O
system NN O
were VBD O
used VBN O
to TO O
clearly RB O
demonstrate VB O
that IN O
the DT O
myoblast NN O
fusion NN O
defect NN O
could MD O
be VB O
rescued VBN O
by IN O
eliminating VBG O
the DT O
expression NN O
of IN O
the DT O
mutant JJ O
DMPK NNP O
3 CD O
- : O
UTR NN O
transcript NN O
. . O

Characterization NN O
of IN O
spontaneous JJ O
deletion NN O
events NNS O
mapped VBD O
the DT O
inhibitory JJ O
effect NN O
to TO O
the DT O
( ( O
CTG NNP O
) ) O
( ( O
n JJ O
) ) O
expansion NN O
and CC O
/ NN O
or CC O
the DT O
3 CD O
end NN O
of IN O
the DT O
DMPK NNP O
3 CD O
- : O
UTR NN O
. . O

These DT O
results NNS O
provide VBP O
evidence NN O
that IN O
the DT O
DM NNP B-Disease
mutation NN O
acts NNS O
in IN O
cis NN O
to TO O
reduce VB O
protein NN O
production NN O
( ( O
consistent JJ O
with IN O
DMPK NNP B-Disease
haploinsufficiency NN I-Disease
) ) O
and CC O
in IN O
trans NNS O
as IN O
a DT O
riboregulator NN O
to TO O
inhibit VB O
myogenesis NN O
. . O
. . O

Coats NNP B-Disease
' POS I-Disease
disease NN I-Disease
of IN O
the DT O
retina NN O
( ( O
unilateral JJ B-Disease
retinal JJ I-Disease
telangiectasis NN I-Disease
) ) O
caused VBN O
by IN O
somatic JJ O
mutation NN O
in IN O
the DT O
NDP NNP O
gene NN O
: : O
a DT O
role NN O
for IN O
norrin NN O
in IN O
retinal JJ O
angiogenesis NN O
. . O

Coats NNS B-Disease
disease NN I-Disease
is VBZ O
characterized VBN O
by IN O
abnormal JJ B-Disease
retinal JJ I-Disease
vascular NN I-Disease
development NN I-Disease
( ( O
so IN O
- : O
called VBN O
retinal JJ B-Disease
telangiectasis NN I-Disease
) ) O
which WDT O
results NNS O
in IN O
massive JJ O
intraretinal NN B-Disease
and CC I-Disease
subretinal JJ I-Disease
lipid JJ I-Disease
accumulation NN I-Disease
( ( O
exudative JJ B-Disease
retinal JJ I-Disease
detachment NN I-Disease
) ) O
. . O

The DT O
classical JJ O
form NN O
of IN O
Coats NNP B-Disease
disease NN I-Disease
is VBZ O
almost RB O
invariably RB O
isolated JJ O
, , O
unilateral JJ O
and CC O
seen VBN O
in IN O
males NNS O
. . O

A DT O
female NN O
with IN O
a DT O
unilateral JJ O
variant NN O
of IN O
Coats NNP B-Disease
disease NN I-Disease
gave VBD O
birth NN O
to TO O
a DT O
son NN O
affected VBN O
by IN O
Norrie NNP B-Disease
disease NN I-Disease
. . O

Both DT O
carried VBD O
a DT O
missense NN O
mutation NN O
within IN O
the DT O
NDP NNP O
gene NN O
on IN O
chromosome NN O
Xp11 NN O
. . O

2 CD O
2 CD O
. . O

Subsequently RB O
analysis NN O
of IN O
the DT O
retinas NN O
of IN O
nine CD O
enucleated JJ O
eyes NNS O
from IN O
males NNS O
with IN O
Coats NNP B-Disease
disease NN I-Disease
demonstrated VBD O
in IN O
one CD O
a DT O
somatic JJ O
mutation NN O
in IN O
the DT O
NDP NNP O
gene NN O
which WDT O
was VBD O
not RB O
present JJ O
within IN O
non JJ O
- : O
retinal JJ O
tissue NN O
. . O

We PRP O
suggest VBP O
that IN O
Coats NNP B-Disease
telangiectasis NN I-Disease
is VBZ O
secondary JJ O
to TO O
somatic JJ O
mutation NN O
in IN O
the DT O
NDP NNP O
gene NN O
which WDT O
results NNS O
in IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
norrin NN I-Disease
( ( O
the DT O
protein NN O
product NN O
of IN O
the DT O
NDP NNP O
gene NN O
) ) O
within IN O
the DT O
developing VBG O
retina NN O
. . O

This DT O
supports VBZ O
recent JJ O
observations NNS O
that IN O
the DT O
protein NN O
is VBZ O
critical JJ O
for IN O
normal JJ O
retinal JJ O
vasculogenesis NN O
. . O

Hereditary NNP O
TP53 NNP O
codon VBD O
292 CD O
and CC O
somatic JJ O
P16INK4A NNP O
codon NN O
94 CD O
mutations NNS O
in IN O
a DT O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome VBD I-Disease
family NN O
. . O

Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
that WDT O
is VBZ O
characterized VBN O
by IN O
various JJ O
types NNS O
of IN O
cancer NN B-Disease
in IN O
childhood NN O
and CC O
adult NN O
cases NNS O
. . O

Although IN O
hereditary JJ O
TP53 NNP O
mutation NN O
is VBZ O
very RB O
rare JJ O
in IN O
different JJ O
human JJ O
cancers NNS B-Disease
, , O
it PRP O
has VBZ O
been VBN O
frequently RB O
reported VBN O
in IN O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
hereditary JJ O
mutations NNS O
of IN O
TP57KIP2 NNP O
, , O
P15INK4B NNP O
, , O
and CC O
P16INK4A NNP O
, , O
which WDT O
affect VBP O
the DT O
cell NN O
cycle NN O
similar JJ O
to TO O
TP53 NNP O
, , O
were VBD O
observed VBN O
in IN O
some DT O
types NNS O
of IN O
cancer NN B-Disease
. . O

In IN O
a DT O
Turkish JJ O
family NN O
with IN O
the DT O
diagnosis NN O
of IN O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
, , O
we PRP O
analyzed VBD O
the DT O
mutation NN O
pattern NN O
of IN O
TP53 NNP O
, , O
P57KIP2 NNP O
, , O
P15INK4B NNP O
, , O
and CC O
P16INK4A NNP O
in IN O
the DT O
peripheral JJ O
blood NN O
, , O
and CC O
loss NN O
of IN O
heterozygosity NN O
( ( O
homo JJ O
/ NNP O
hemizygous JJ O
deletion NN O
) ) O
pattern NN O
of IN O
TP53 NNP O
and CC O
P15INK4B NNP O
/ NNP O
P16INK4A NNP O
in IN O
two CD O
tumor NN B-Disease
tissues NNS O
. . O

The DT O
propositus NN O
had VBD O
a DT O
seminoma NN B-Disease
, , O
his PRP$ O
daughter NN O
a DT O
medulloblastoma NN B-Disease
, , O
and CC O
one CD O
of IN O
his PRP$ O
healthy JJ O
cousins NNS O
, , O
a DT O
TP53 NNP O
codon NN O
292 CD O
missense NN O
point NN O
mutation NN O
( ( O
AAA NNP O
- : O
- : O
> NN O
ATA NNP O
; : O
Lys NNP O
- : O
- : O
> NN O
Ile NNP O
) ) O
in IN O
the DT O
peripheral JJ O
blood NN O
cells NNS O
. . O

Tumor NNP O
tissue NN O
obtained VBN O
from IN O
the DT O
propositus NN O
with IN O
the DT O
seminoma NN B-Disease
revealed VBD O
loss NN O
of IN O
heterozygosity NN O
in IN O
the DT O
TP53 NNP O
gene NN O
. . O

In IN O
the DT O
analyses NNS O
of IN O
tumor NN B-Disease
tissues NNS O
from IN O
the DT O
propositus NN O
and CC O
his PRP$ O
daughter NN O
, , O
a DT O
P16INK4A NNP O
codon NN O
94 CD O
missense NN O
point NN O
mutation NN O
( ( O
GCG NNP O
- : O
- : O
> NN O
GAG NNP O
; : O
Ala NNP O
- : O
- : O
> NN O
Glu NNP O
) ) O
was VBD O
observed VBN O
with IN O
the DT O
hereditary JJ O
TP53 NNP O
mutation NN O
. . O

P16INK4A NNP O
codon VBD O
94 CD O
mutation NN O
observed VBN O
in IN O
our PRP$ O
family NN O
is VBZ O
a DT O
novel JJ O
mutation NN O
in IN O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
. . O

No DT O
other JJ O
gene NN O
alteration NN O
in IN O
TP53 NNP O
, , O
P57KIP2 NNP O
, , O
P15INK4B NNP O
, , O
and CC O
P16INK4A NNP O
was VBD O
observed VBN O
. . O

Existence NN O
of IN O
the DT O
P16INK4A NNP O
mutation NN O
and CC O
the DT O
hereditary JJ O
TP53 NNP O
mutation NN O
with IN O
or CC O
without IN O
loss NN O
of IN O
heterozygosity NN O
in IN O
the DT O
TP53 NNP O
gene NN O
( ( O
seminoma JJ B-Disease
/ NNP O
medulloblastoma NN B-Disease
) ) O
may MD O
be VB O
evidence NN O
for IN O
a DT O
common JJ O
mechanism NN O
involved VBN O
in IN O
tumorogenesis NN B-Disease
. . O

The DT O
gene NN O
alterations NNS O
in IN O
TP53 NNP O
and CC O
P16INK4A NNP O
genes NNS O
may MD O
be VB O
used VBN O
as IN O
tumor NN B-Disease
markers NNS O
in IN O
our PRP$ O
family NN O
. . O
. . O

A DT O
novel JJ O
mutation NN O
in IN O
the DT O
sodium NN O
/ NNP O
iodide RB O
symporter RB O
gene NN O
in IN O
the DT O
largest JJS O
family NN O
with IN O
iodide JJ B-Disease
transport NN I-Disease
defect NN I-Disease
. . O

We PRP O
previously RB O
reported VBD O
nine CD O
children NNS O
with IN O
an DT O
autosomally RB O
recessive JJ O
form NN O
of IN O
congenital JJ B-Disease
hypothyroidism NN I-Disease
due JJ O
to TO O
an DT O
iodide JJ B-Disease
transport NN I-Disease
defect NN I-Disease
in IN O
a DT O
large JJ O
Hutterite NNP O
family NN O
with IN O
extensive JJ O
consanguinity NN O
living NN O
in IN O
central JJ O
Canada NNP O
. . O

Since IN O
the DT O
original JJ O
report NN O
, , O
we PRP O
have VBP O
diagnosed VBN O
congenital JJ B-Disease
hypothyroidism NN I-Disease
by IN O
newborn JJ O
TSH NNP O
screening NN O
in IN O
9 CD O
additional JJ O
children NNS O
from IN O
the DT O
family NN O
. . O

We PRP O
performed VBD O
direct JJ O
sequencing NN O
of IN O
the DT O
PCR NNP O
products NNS O
of IN O
each DT O
NIS NNP O
( ( O
sodium NN O
/ NNP O
iodide RB O
symporter RB O
) ) O
gene NN O
exon NN O
with IN O
flanking JJ O
introns NNS O
amplified VBN O
from IN O
genomic JJ O
DNA NN O
extracted VBN O
from IN O
peripheral JJ O
blood NN O
cells NNS O
of IN O
the DT O
patients NNS O
. . O

We PRP O
identified VBD O
a DT O
novel JJ O
NIS NNP O
gene NN O
mutation NN O
, , O
G395R NNP O
( ( O
Gly395 NNP O
- : O
- : O
> NN O
Arg NNP O
; : O
GGA NNP O
- : O
- : O
> NN O
AGA NNP O
) ) O
, , O
in IN O
10 CD O
patients NNS O
examined VBN O
in IN O
the DT O
present JJ O
study NN O
. . O

All DT O
of IN O
the DT O
parents NNS O
tested VBN O
were VBD O
heterozygous JJ O
for IN O
the DT O
mutation NN O
, , O
suggesting VBG O
that IN O
the DT O
patients NNS O
were VBD O
homozygous JJ O
. . O

The DT O
mutation NN O
was VBD O
located VBN O
in IN O
the DT O
10th JJ O
transmembrane NN O
helix NN O
. . O

Expression NN O
experiments NNS O
by IN O
transfection NN O
of IN O
the DT O
mutant JJ O
NIS NNP O
complimentary JJ O
DNA NNP O
into IN O
COS NNP O
- : O
7 CD O
cells NNS O
showed VBD O
no DT O
perchlorate NN O
- : O
sensitive JJ O
iodide JJ O
uptake NN O
, , O
confirming VBG O
that IN O
the DT O
mutation NN O
is VBZ O
the DT O
direct JJ O
cause NN O
of IN O
the DT O
iodide JJ B-Disease
transport NN I-Disease
defect NN I-Disease
in IN O
these DT O
patients NNS O
. . O

A DT O
patient NN O
who WP O
showed VBD O
an DT O
intermediate JJ O
saliva NN O
/ NNP O
serum NN O
technetium NN O
ratio NN O
( ( O
14 CD O
. . O
0 CD O
; : O
normal JJ O
, , O
> JJ O
or CC O
= JJ O
20 CD O
) ) O
and CC O
was VBD O
considered VBN O
to TO O
have VB O
a DT O
partial JJ O
or CC O
less RBR O
severe JJ O
defect NN O
in IN O
the DT O
previous JJ O
report NN O
( ( O
IX NNP O
- : O
24 CD O
) ) O
did VBD O
not RB O
have VB O
a DT O
NIS NNP O
gene NN O
mutation NN O
. . O

It PRP O
is VBZ O
now RB O
possible JJ O
to TO O
use VB O
gene NN O
diagnostics NNS O
of IN O
this DT O
unique JJ O
NIS NNP O
mutation NN O
to TO O
identify VB O
patients NNS O
with IN O
congenital JJ B-Disease
hypothyroidism NN I-Disease
due JJ O
to TO O
an DT O
iodide JJ B-Disease
transport NN I-Disease
defect NN I-Disease
in IN O
this DT O
family NN O
and CC O
to TO O
determine VB O
the DT O
carrier NN O
state NN O
of IN O
potential JJ O
parents NNS O
for IN O
genetic JJ O
counseling NN O
and CC O
arranging VBG O
rapid JJ O
and CC O
early JJ O
diagnosis NN O
of IN O
their PRP$ O
infants NNS O
. . O

Molecular JJ O
analysis NN O
in IN O
familial JJ B-Disease
neurohypophyseal NN I-Disease
diabetes VBZ I-Disease
insipidus NN I-Disease
: : O
early JJ O
diagnosis NN O
of IN O
an DT O
asymptomatic JJ O
carrier NN O
. . O

Familial JJ B-Disease
neurohypophyseal NN I-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
( ( O
FNDI NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
hormone NN I-Disease
arginine NN I-Disease
vasopressin NN I-Disease
( ( O
AVP NNP O
) ) O
and CC O
is VBZ O
transmitted VBN O
as IN O
an DT O
autosomal JJ O
dominant JJ O
trait NN O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
have VBP O
analyzed VBN O
the DT O
AVP NNP O
- : O
neurophysin NN O
II NNP O
( ( O
AVP NNP O
- : O
NPII NN O
) ) O
gene NN O
in IN O
a DT O
Spanish JJ O
kindred VBN O
. . O

Studies NNS O
were VBD O
performed VBN O
on IN O
seven CD O
members NNS O
( ( O
four CD O
clinically RB O
affected VBN O
) ) O
of IN O
the DT O
family NN O
. . O

Patients NNS O
were VBD O
diagnosed VBN O
at IN O
the DT O
Hospital NNP O
Universitario NNP O
Gregorio NNP O
Maranon NNP O
( ( O
Madrid NNP O
, , O
Spain NNP O
) ) O
. . O

The DT O
entire JJ O
coding NN O
region NN O
of IN O
the DT O
AVP NNP O
- : O
NPII NNP O
gene NN O
of IN O
all DT O
family NN O
members NNS O
was VBD O
amplified VBN O
by IN O
PCR NNP O
and CC O
sequenced VBD O
. . O

All DT O
affected JJ O
individuals NNS O
presented VBD O
a DT O
missense JJ O
mutation NN O
( ( O
G1757 NNP O
- : O
- : O
> VB O
A DT O
) ) O
that WDT O
replaces VBZ O
glycine NN O
at IN O
position NN O
23 CD O
with IN O
arginine NN O
within IN O
the DT O
NPII NNP O
domain NN O
. . O

The DT O
substitution NN O
was VBD O
confirmed VBN O
by IN O
restriction NN O
endonuclease NN O
analysis NN O
and CC O
was VBD O
present JJ O
in IN O
heterozygosis NN O
. . O

Additionally RB O
, , O
one CD O
of IN O
the DT O
asymptomatic JJ O
relatives NNS O
( ( O
a DT O
girl NN O
8 CD O
months NNS O
old JJ O
at IN O
the DT O
time NN O
of IN O
study NN O
) ) O
was VBD O
identified VBN O
as IN O
carrier NN O
of IN O
the DT O
same JJ O
mutation NN O
and CC O
developed VBD O
the DT O
disease NN O
3 CD O
months NNS O
later RB O
. . O

The DT O
alteration NN O
found VBD O
in IN O
the DT O
second JJ O
exon NN O
of IN O
the DT O
gene NN O
in IN O
this DT O
family NN O
seems VBZ O
to TO O
be VB O
responsible JJ O
for IN O
the DT O
disease NN O
, , O
as IN O
all DT O
individuals NNS O
harboring VBG O
the DT O
mutation NN O
had VBD O
been VBN O
previously RB O
diagnosed VBN O
or CC O
have VBP O
eventually RB O
developed VBN O
FNDI NNP B-Disease
. . O

Identification NN O
of IN O
the DT O
molecular JJ O
defect NN O
underlying VBG O
FNDI NNP B-Disease
in IN O
affected JJ O
families NNS O
is VBZ O
a DT O
powerful JJ O
tool NN O
for IN O
early JJ O
asymptomatic JJ O
diagnosis NN O
in IN O
infants NNS O
. . O
. . O

Deficit NNP O
of IN O
in IN O
vivo JJ O
mitochondrial JJ O
ATP NNP O
production NN O
in IN O
patients NNS O
with IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
, , O
the DT O
most RBS O
common JJ O
of IN O
the DT O
inherited JJ B-Disease
ataxias NN I-Disease
, , O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
degenerative JJ I-Disease
disorder NN I-Disease
, , O
characterized VBN O
clinically RB O
by IN O
onset NN O
before IN O
the DT O
age NN O
of IN O
25 CD O
of IN O
progressive JJ B-Disease
gait NN I-Disease
and CC I-Disease
limb NN I-Disease
ataxia NN I-Disease
, , O
absence NN B-Disease
of IN I-Disease
deep JJ I-Disease
tendon NN I-Disease
reflexes NNS I-Disease
, , O
extensor NN B-Disease
plantar NN I-Disease
responses NNS I-Disease
, , O
and CC O
loss NN B-Disease
of IN I-Disease
position NN I-Disease
and CC I-Disease
vibration NN I-Disease
sense NN I-Disease
in IN O
the DT O
lower JJR O
limbs NN O
. . O

FRDA NNP B-Disease
is VBZ O
caused VBN O
by IN O
a DT O
GAA NNP O
triplet NN O
expansion NN O
in IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
FRDA NNP B-Disease
gene NN O
on IN O
chromosome NN O
9q13 CD O
in IN O
97 CD O
% NN O
of IN O
patients NNS O
. . O

The DT O
FRDA NNP B-Disease
gene NN O
encodes VBZ O
a DT O
widely RB O
expressed VBN O
210 CD O
- : O
aa NN O
protein NN O
, , O
frataxin NN O
, , O
which WDT O
is VBZ O
located VBN O
in IN O
mitochondria NN O
and CC O
is VBZ O
severely RB O
reduced VBN O
in IN O
FRDA NNP B-Disease
patients NNS O
. . O

Frataxin NNP O
function NN O
is VBZ O
still RB O
unknown JJ O
but CC O
the DT O
knockout NN O
of IN O
the DT O
yeast NN O
frataxin NN O
homologue NN O
gene NN O
( ( O
YFH1 NNP O
) ) O
showed VBD O
a DT O
severe JJ O
defect NN O
of IN O
mitochondrial JJ O
respiration NN O
and CC O
loss NN O
of IN O
mtDNA NN O
associated VBN O
with IN O
elevated JJ O
intramitochondrial JJ O
iron NN O
. . O

Here RB O
we PRP O
report VBP O
in IN O
vivo JJ O
evidence NN O
of IN O
impaired JJ O
mitochondrial JJ O
respiration NN O
in IN O
skeletal JJ O
muscle NN O
of IN O
FRDA NNP B-Disease
patients NNS O
. . O

Using VBG O
phosphorus JJ O
magnetic JJ O
resonance NN O
spectroscopy NN O
we PRP O
demonstrated VBD O
a DT O
maximum JJ O
rate NN O
of IN O
muscle NN O
mitochondrial JJ O
ATP NNP O
production NN O
( ( O
V NNP O
( ( O
max NN O
) ) O
) ) O
below IN O
the DT O
normal JJ O
range NN O
in IN O
all DT O
12 CD O
FRDA NNP B-Disease
patients NNS O
and CC O
a DT O
strong JJ O
negative JJ O
correlation NN O
between IN O
mitochondrial JJ O
V NNP O
( ( O
max NN O
) ) O
and CC O
the DT O
number NN O
of IN O
GAA NNP O
repeats NNS O
in IN O
the DT O
smaller JJR O
allele NN O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
FRDA NNP B-Disease
is VBZ O
a DT O
nuclear JJ O
- : O
encoded VBN O
mitochondrial JJ B-Disease
disorder NN I-Disease
affecting VBG O
oxidative JJ O
phosphorylation NN O
and CC O
give VB O
a DT O
rationale NN O
for IN O
treatments NNS O
aimed VBN O
to TO O
improve VB O
mitochondrial JJ O
function NN O
in IN O
this DT O
condition NN O
. . O
. . O

Identification NN O
of IN O
a DT O
novel JJ O
R21X NNP O
mutation NN O
in IN O
the DT O
liver NN O
- : O
type NN O
arginase NN O
gene NN O
( ( O
ARG1 NNP O
) ) O
in IN O
four CD O
Portuguese JJ O
patients NNS O
with IN O
argininemia NN B-Disease
. . O

Argininemia NNP B-Disease
is VBZ O
a DT O
rare JJ O
autossomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
deficiency NN B-Disease
in IN I-Disease
the DT I-Disease
cytosolic NN I-Disease
liver SYM I-Disease
- : I-Disease
type NN I-Disease
arginase NN I-Disease
enzyme NN I-Disease
( ( O
L NNP O
- : O
arginine NN O
urea JJ O
- : O
hydrolase NN O
; : O
E NNP O
. . O
C NNP O
. . O
3 CD O
. . O
5 CD O
. . O
3 CD O
. . O
1 CD O
) ) O
. . O

In IN O
order NN O
to TO O
investigate VB O
the DT O
molecular JJ O
basis NN O
for IN O
argininemia NN B-Disease
in IN O
four CD O
unrelated JJ O
Portuguese JJ O
patients NNS O
( ( O
two CD O
from IN O
northern JJ O
Portugal NNP O
and CC O
two CD O
from IN O
Madeira NNP O
Island NNP O
) ) O
we PRP O
performed VBD O
a DT O
DNA NN O
sequence NN O
analysis NN O
of IN O
all PDT O
the DT O
exons NNS O
and CC O
exon VB O
/ NNP O
intron NN O
boundaries NNS O
of IN O
the DT O
liver NN O
- : O
type NN O
arginase NN O
gene NN O
( ( O
ARG1 NNP O
) ) O
. . O

All DT O
patients NNS O
were VBD O
found VBN O
to TO O
be VB O
homozygous JJ O
for IN O
a DT O
newly RB O
identified VBN O
C NNP O
- : O
> NN O
T NNP O
transition NN O
in IN O
codon NN O
21 CD O
( ( O
exon VB O
2 CD O
) ) O
substituting VBG O
arginine NN O
for IN O
a DT O
premature NN O
stop NN O
codon NN O
( ( O
R21X NNP O
CGA NNP O
to TO O
TGA NNP O
) ) O
and CC O
generating VBG O
a DT O
NlaIII NNP O
restriction NN O
site NN O
. . O

Restriction NNP O
digestion NN O
following VBG O
PCR NNP O
amplification NN O
of IN O
ARG1 NNP O
exon FW O
2 CD O
confirmed VBD O
the DT O
presence NN O
of IN O
the DT O
mutation NN O
. . O

Mutation NN O
of IN O
the DT O
sterol NN O
27 CD O
- : O
hydroxylase NN O
gene NN O
( ( O
CYP27 NNP O
) ) O
results NNS O
in IN O
truncation NN O
of IN O
mRNA NN O
expressed VBN O
in IN O
leucocytes NNS O
in IN O
a DT O
Japanese JJ O
family NN O
with IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
. . O

OBJECTIVES IN O
A NNP O
Japanese JJ O
family NN O
with IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
was VBD O
investigated VBN O
for IN O
a DT O
sequence NN O
alteration NN O
in IN O
the DT O
sterol NN O
27 CD O
- : O
hydroxylase NN O
gene NN O
( ( O
CYP27 NNP O
) ) O
. . O

The DT O
expression NN O
of IN O
CYP27 NNP O
has VBZ O
been VBN O
mostly RB O
explored VBN O
using VBG O
cultured JJ O
fibroblasts NNS O
, , O
prompting VBG O
the DT O
examination NN O
of IN O
the DT O
transcripts NNS O
from IN O
blood NN O
leucocytes NNS O
as IN O
a DT O
simple JJ O
and CC O
rapid JJ O
technique NN O
. . O

METHODS NNP O
An DT O
alteration NN O
in IN O
CYP27 NNP O
of IN O
the DT O
proband NN O
was VBD O
searched VBN O
for IN O
by IN O
polymerase NN O
chain NN O
reaction NN O
- : O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
( ( O
PCR NNP O
- : O
SSCP NN O
) ) O
analysis NN O
and CC O
subsequent JJ O
sequencing NN O
. . O

Samples NNS O
of IN O
RNA NNP O
were VBD O
subjected VBN O
to TO O
reverse VB O
transcription NN O
PCR NNP O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
and CC O
the DT O
product NN O
of IN O
the DT O
proband NN O
was VBD O
amplified VBN O
with IN O
nested JJ O
primers NNS O
and CC O
sequenced VBD O
. . O

RESULTS VB O
A DT O
homozygous JJ O
G NNP O
to TO O
A DT O
transition NN O
at IN O
the DT O
5 CD O
end NN O
of IN O
intron NN O
7 CD O
was VBD O
detected VBN O
in IN O
the DT O
patient NN O
. . O

In IN O
RT NNP O
- : O
PCR NN O
analysis NN O
, , O
only RB O
a DT O
truncated JJ O
transcript NN O
was VBD O
detected VBN O
in IN O
the DT O
patient NN O
, , O
whereas IN O
both DT O
normal JJ O
and CC O
truncated JJ O
transcripts NNS O
were VBD O
detected VBN O
in IN O
the DT O
siblings NNS O
. . O

The DT O
sequencing NN O
of IN O
the DT O
patients NNS O
cDNA VBP O
fragment JJ O
disclosed VBD O
a DT O
direct JJ O
conjuction NN O
of IN O
exon $ O
6 CD O
and CC O
exon $ O
8 CD O
. . O

CONCLUSION NNP O
The DT O
mutation NN O
at IN O
splice NN O
donor NN O
site NN O
and CC O
the DT O
truncation NN O
of IN O
mRNA NN O
were VBD O
identical JJ O
with IN O
those DT O
of IN O
a DT O
recently RB O
reported VBN O
Italian JJ O
patient NN O
, , O
although IN O
different JJ O
in IN O
symptomatology NN O
. . O

The DT O
application NN O
of IN O
blood NN O
leucocytes NNS O
can MD O
be VB O
a DT O
simple JJ O
technique NN O
on IN O
analysing VBG O
a DT O
constructive JJ O
abnormality NN B-Disease
of IN I-Disease
CYP27 NNP I-Disease
mRNA NN O
. . O
. . O

Clinical JJ O
and CC O
molecular JJ O
genetic JJ O
analysis NN O
of IN O
19 CD O
Wolfram NNP B-Disease
syndrome NN I-Disease
kindreds NNS O
demonstrating VBG O
a DT O
wide JJ O
spectrum NN O
of IN O
mutations NNS O
in IN O
WFS1 NNP O
. . O

Wolfram NNP B-Disease
syndrome NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
neurodegenerative JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
juvenile NN B-Disease
- : I-Disease
onset NN I-Disease
diabetes VBZ I-Disease
mellitus NNS I-Disease
and CC O
progressive JJ O
optic JJ B-Disease
atrophy NN I-Disease
. . O

mtDNA NN O
deletions NNS O
have VBP O
been VBN O
described VBN O
, , O
and CC O
a DT O
gene NN O
( ( O
WFS1 NNP O
) ) O
recently RB O
has VBZ O
been VBN O
identified VBN O
, , O
on IN O
chromosome NN O
4p16 CD O
, , O
encoding VBG O
a DT O
predicted JJ O
890 CD O
amino NN O
acid NN O
transmembrane NN O
protein NN O
. . O

Direct JJ O
DNA NNP O
sequencing NN O
was VBD O
done VBN O
to TO O
screen VB O
the DT O
entire JJ O
coding NN O
region NN O
of IN O
the DT O
WFS1 NNP O
gene NN O
in IN O
30 CD O
patients NNS O
from IN O
19 CD O
British JJ O
kindreds NNS O
with IN O
Wolfram NNP B-Disease
syndrome NN I-Disease
. . O

DNA NN O
was VBD O
also RB O
screened VBN O
for IN O
structural JJ O
rearrangements NNS O
( ( O
deletions NNS O
and CC O
duplications NNS O
) ) O
and CC O
point NN O
mutations NNS O
in IN O
mtDNA NN O
. . O

No DT O
pathogenic JJ O
mtDNA NN O
mutations NNS O
were VBD O
found VBN O
in IN O
our PRP$ O
cohort NN O
. . O

We PRP O
identified VBD O
24 CD O
mutations NNS O
in IN O
the DT O
WFS1 NNP O
gene NN O
8 CD O
nonsense JJ O
mutations NNS O
, , O
8 CD O
missense NN O
mutations NNS O
, , O
3 CD O
in IN O
- : O
frame NN O
deletions NNS O
, , O
1 CD O
in IN O
- : O
frame NN O
insertion NN O
, , O
and CC O
4 CD O
frameshift NN O
mutations NNS O
. . O

Of IN O
these DT O
, , O
23 CD O
were VBD O
novel JJ O
mutations NNS O
, , O
and CC O
most JJS O
occurred VBN O
in IN O
exon NN O
8 CD O
. . O

The DT O
majority NN O
of IN O
patients NNS O
were VBD O
compound JJ O
heterozygotes NNS O
for IN O
two CD O
mutations NNS O
, , O
and CC O
there EX O
was VBD O
no DT O
common JJ O
founder NN O
mutation NN O
. . O

The DT O
data NNS O
were VBD O
also RB O
analyzed VBN O
for IN O
genotype NN O
- : O
phenotype JJ O
relationships NNS O
. . O

Although IN O
some DT O
interesting JJ O
cases NNS O
were VBD O
noted VBN O
, , O
consideration NN O
of IN O
the DT O
small JJ O
sample NN O
size NN O
and CC O
frequency NN O
of IN O
each DT O
mutation NN O
indicated VBD O
no DT O
clear JJ O
- : O
cut NN O
correlations NNS O
between IN O
any DT O
of IN O
the DT O
observed JJ O
mutations NNS O
and CC O
disease NN O
severity NN O
. . O

There EX O
were VBD O
no DT O
obvious JJ O
mutation NN O
hot JJ O
spots NNS O
or CC O
clusters NNS O
. . O

Hence NNP O
, , O
molecular JJ O
screening NN O
for IN O
Wolfram NNP B-Disease
syndrome NN I-Disease
in IN O
affected JJ O
families NNS O
and CC O
for IN O
Wolfram NNP B-Disease
syndrome JJ I-Disease
- : O
carrier NN O
status NN O
in IN O
subjects NNS O
with IN O
psychiatric JJ B-Disease
disorders NNS I-Disease
or CC O
diabetes VBZ B-Disease
mellitus NNS I-Disease
will MD O
require VB O
complete JJ O
analysis NN O
of IN O
exon $ O
8 CD O
and CC O
upstream JJ O
exons NNS O
. . O
. . O

Late JJ O
- : O
onset VBN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
: : O
a DT O
subset NN O
with IN O
distinct JJ O
clinical JJ O
, , O
demographic JJ O
, , O
and CC O
molecular JJ O
genetic JJ O
characteristics NNS O
. . O

To TO O
determine VB O
the DT O
prevalence NN O
and CC O
characterize VB O
demographic JJ O
, , O
clinical JJ O
, , O
and CC O
genetic JJ O
features NNS O
of IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
of IN O
late JJ O
onset NN O
, , O
all DT O
patients NNS O
experiencing VBG O
their PRP$ O
first JJ O
FMF NNP B-Disease
attack NN O
at IN O
age NN O
40 CD O
years NNS O
or CC O
more JJR O
were VBD O
identified VBN O
using VBG O
the DT O
computerized JJ O
registry NN O
of IN O
our PRP$ O
FMF NNP B-Disease
clinic NN O
, , O
and CC O
then RB O
thoroughly RB O
interviewed VBN O
and CC O
examined VBN O
. . O

The DT O
control NN O
group NN O
consisted VBD O
of IN O
40 CD O
consecutive JJ O
FMF NNP B-Disease
patients NNS O
, , O
who WP O
arrived VBD O
at IN O
the DT O
FMF NNP B-Disease
clinic NN O
for IN O
their PRP$ O
regular JJ O
follow NN O
- : O
up IN O
visit NN O
and CC O
were VBD O
40 CD O
years NNS O
of IN O
age NN O
or CC O
older JJR O
at IN O
the DT O
time NN O
of IN O
the DT O
examination NN O
. . O

The DT O
severity NN O
of IN O
the DT O
disease NN O
in IN O
patients NNS O
and CC O
controls NNS O
was VBD O
determined VBN O
using VBG O
a DT O
modified VBN O
score NN O
, , O
developed VBD O
previously RB O
. . O

Mutational JJ O
analysis NN O
in IN O
the DT O
FMF NNP B-Disease
gene NN O
was VBD O
performed VBN O
using VBG O
a DT O
commercial JJ O
kit NN O
. . O

Only RB O
20 CD O
of IN O
4000 CD O
( ( O
0 CD O
. . O
5 CD O
% NN O
) ) O
patients NNS O
had VBD O
late JJ O
- : O
onset NN O
FMF NNP B-Disease
. . O

These DT O
patients NNS O
were VBD O
mostly RB O
men NNS O
, , O
of IN O
non JJ O
- : O
North JJ O
African JJ O
origin NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O

5 CD O
compared VBN O
to TO O
controls NNS O
. . O

All DT O
had VBD O
abdominal JJ O
attacks NNS O
and CC O
in IN O
most JJS O
these DT O
were VBD O
the DT O
only JJ O
manifestation NN O
of IN O
their PRP$ O
disease NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O

1 CD O
1 CD O
. . O

None NN O
had VBD O
chronic JJ O
or CC O
prolonged JJ O
manifestations NNS O
of IN O
FMF NNP B-Disease
, , O
for IN O
example NN O
, , O
amyloidosis NN B-Disease
, , O
chronic JJ B-Disease
arthritis NN I-Disease
, , O
or CC O
protracted VBN O
myalgia NN B-Disease
, , O
P NNP O
< VBZ O
0 CD O
. . O

1 CD O
. . O

The DT O
response NN O
to TO O
treatment NN O
was VBD O
good JJ O
despite IN O
using VBG O
low JJ O
colchicine NN O
dose NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O

5 CD O
. . O

The DT O
overall JJ O
severity NN O
score NN O
indicated VBD O
a DT O
mild JJ O
disease NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O

1 CD O
. . O

Mutational JJ O
analysis NN O
revealed VBD O
absence NN O
of IN O
M694V NNP O
homozygosity NN O
, , O
P NNP O
< VBZ O
0 CD O
. . O

1 CD O
, , O
compared VBN O
to TO O
our PRP$ O
regular JJ O
FMF NNP B-Disease
population NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
onset NN O
of IN O
FMF NNP B-Disease
in IN O
a DT O
late JJ O
age NN O
defines VBZ O
a DT O
milder NN O
form NN O
of IN O
disease NN O
with IN O
typical JJ O
clinical JJ O
, , O
demographic JJ O
, , O
and CC O
molecular JJ O
genetic JJ O
characteristics NNS O

A DT O
highly RB O
accurate JJ O
, , O
low JJ O
cost NN O
test NN O
for IN O
BRCA1 NNP O
mutations NNS O
. . O

The DT O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
syndrome NN I-Disease
is VBZ O
associated VBN O
with IN O
a DT O
high JJ O
frequency NN O
of IN O
BRCA1 NNP O
mutations NNS O
. . O

However RB O
, , O
the DT O
widespread JJ O
use NN O
of IN O
BRCA1 NNP O
testing NN O
has VBZ O
been VBN O
limited VBN O
to TO O
date NN O
by IN O
three CD O
principal JJ O
concerns NNS O
the DT O
fear NN O
of IN O
loss NN O
of IN O
health NN O
and CC O
life NN O
insurance NN O
, , O
the DT O
uncertain JJ O
clinical JJ O
value NN O
of IN O
a DT O
positive JJ O
test NN O
result NN O
, , O
and CC O
the DT O
current JJ O
lack NN O
of IN O
an DT O
inexpensive JJ O
and CC O
sensitive JJ O
screening NN O
test NN O
for IN O
BRCA1 NNP O
mutations NNS O
. . O

We PRP O
have VBP O
developed VBN O
an DT O
inexpensive JJ O
system NN O
for IN O
gene NN O
mutational JJ O
scanning NN O
, , O
based VBN O
on IN O
a DT O
combination NN O
of IN O
extensive JJ O
multiplex NN O
PCR NNP O
amplification NN O
and CC O
two CD O
dimensional JJ O
electrophoresis NN O
. . O

The DT O
efficiency NN O
of IN O
this DT O
system NN O
, , O
as IN O
a DT O
screening JJ O
test NN O
for IN O
BRCA1 NNP O
mutations NNS O
, , O
was VBD O
evaluated VBN O
in IN O
a DT O
panel NN O
of IN O
60 CD O
samples NNS O
from IN O
high JJ O
risk NN O
women NNS O
, , O
14 CD O
of IN O
which WDT O
contained VBD O
a DT O
previously RB O
identified VBN O
mutation NN O
in IN O
BRCA1 NNP O
. . O

All DT O
14 CD O
mutations NNS O
were VBD O
identified VBN O
, , O
as RB O
well RB O
as IN O
an DT O
additional JJ O
five CD O
that WDT O
had VBD O
previously RB O
escaped VBN O
detection NN O
. . O

In IN O
addition NN O
to TO O
the DT O
19 CD O
mutations NNS O
, , O
a DT O
total NN O
of IN O
15 CD O
different JJ O
polymorphic JJ O
variants NNS O
were VBD O
scored VBN O
, , O
most JJS O
of IN O
which WDT O
were VBD O
recurring VBG O
. . O

All DT O
were VBD O
confirmed VBN O
by IN O
nucleotide JJ O
sequencing NN O
. . O

The DT O
cost NN O
of IN O
screening VBG O
per IN O
sample NN O
was VBD O
calculated VBN O
to TO O
be VB O
approximately RB O
US NNP O
$ $ O
70 CD O
for IN O
the DT O
manual JJ O
technique NN O
used VBN O
in IN O
this DT O
study NN O
, , O
and CC O
may MD O
be VB O
reduced VBN O
to TO O
approximately RB O
US VB O
$ $ O
10 CD O
with IN O
the DT O
introduction NN O
of IN O
commercially RB O
available JJ O
PCR NNP O
robotics NNS O
and CC O
fluorescent JJ O
imaging NN O
. . O

Implementation NN O
of IN O
this DT O
method NN O
of IN O
mutation NN O
screening NN O
in IN O
the DT O
research NN O
and CC O
clinical JJ O
setting NN O
should MD O
permit VB O
rapid JJ O
accrual NNS O
of IN O
quantitative JJ O
data NNS O
on IN O
genotype NN O
- : O
phenotype NN O
associations NNS O
for IN O
the DT O
evaluation NN O
of IN O
diagnostic JJ O
testing NN O
. . O
. . O

Maternal NNP B-Disease
uniparental JJ I-Disease
disomy NN I-Disease
for IN I-Disease
chromosome NN I-Disease
14 CD I-Disease
in IN O
a DT O
boy NN O
with IN O
a DT O
normal JJ O
karyotype NN O
. . O

We PRP O
report VBP O
on IN O
a DT O
boy NN O
with IN O
a DT O
maternal JJ B-Disease
uniparental JJ I-Disease
disomy NN I-Disease
for IN I-Disease
chromosome NN I-Disease
14 CD I-Disease
( ( O
UPD NNP B-Disease
( ( O
14 CD O
) ) O
) ) O
. . O

At IN O
7 CD O
years NNS O
of IN O
age NN O
he PRP O
was VBD O
referred VBN O
to TO O
us PRP O
by IN O
the DT O
paediatrician JJ O
because IN O
of IN O
symptoms NNS O
of IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

He PRP O
showed VBD O
short JJ B-Disease
stature NN I-Disease
, , O
obesity NN B-Disease
, , O
mild JJ O
developmental JJ B-Disease
delay NN I-Disease
, , O
cryptorchidism NN B-Disease
, , O
and CC O
some DT O
mild JJ O
dysmorphic JJ B-Disease
features NNS I-Disease
. . O

The DT O
history NN O
further RB O
indicated VBD O
intrauterine JJ B-Disease
growth NN I-Disease
retardation NN I-Disease
at IN O
the DT O
end NN O
of IN O
the DT O
pregnancy NN O
. . O

His PRP$ O
mother NN O
was VBD O
44 CD O
years NNS O
of IN O
age NN O
at IN O
the DT O
time NN O
of IN O
his PRP$ O
birth NN O
. . O

After IN O
birth NN O
he PRP O
showed VBD O
hypotonia NN B-Disease
with IN O
poor JJ O
sucking NN O
, , O
for IN O
which WDT O
gavage NN O
feeding NN O
was VBD O
needed VBN O
. . O

Motor NNP O
development NN O
was VBD O
delayed VBN O
. . O

After IN O
1 CD O
year NN O
he PRP O
became VBD O
obese JJ B-Disease
despite IN O
a DT O
normal JJ O
appetite NN O
. . O

Recurrent NNP O
middle JJ B-Disease
ear JJ I-Disease
infections NNS I-Disease
, , O
a DT O
high JJ O
pain NN O
threshold NN O
, , O
and CC O
a DT O
great JJ O
skill NN O
with IN O
jigsaw NN O
puzzles NNS O
were VBD O
reported VBN O
. . O

There EX O
were VBD O
no DT O
behavioural JJ O
problems NNS O
or CC O
sleep JJ O
disturbance NN O
. . O

Chromosomal JJ O
analysis NN O
was VBD O
normal JJ O
( ( O
46 CD O
, , O
XY NNP O
) ) O
. . O

DNA NN O
analysis NN O
for IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
showed VBD O
no DT O
abnormalities NNS O
. . O

Two CD O
years NNS O
later RB O
he PRP O
was VBD O
re JJ O
- : O
examined VBN O
because IN O
we PRP O
thought VBD O
his PRP$ O
features NNS O
fitted VBD O
the DT O
PWS NNP B-Disease
- : O
like IN O
phenotype NN O
associated VBN O
with IN O
maternal JJ O
UPD NNP B-Disease
( ( O
14 CD O
) ) O
. . O

At IN O
that DT O
time NN O
precocious JJ O
puberty NN O
was VBD O
evident JJ O
. . O

DNA NN O
analysis NN O
showed VBD O
maternal JJ B-Disease
heterodisomy NN I-Disease
for IN O
chromosome NN O
14 CD O
. . O

In IN O
all PDT O
the DT O
previously RB O
described VBN O
11 CD O
cases NNS O
with IN O
maternal JJ O
UPD NNP B-Disease
( ( O
14 CD O
) ) O
, , O
a DT O
Robertsonian JJ O
translocation NN O
involving VBG O
chromosome NN O
14 CD O
was VBD O
detected VBN O
cytogenetically RB O
before IN O
DNA NNP O
analysis NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
diagnosis NN O
of IN O
maternal JJ O
UPD NNP B-Disease
( ( O
14 CD O
) ) O
based VBN O
on IN O
clinical JJ O
features NNS O
. . O

This DT O
finding NN O
underlines VBZ O
the DT O
importance NN O
of IN O
DNA NNP O
analysis NN O
for IN O
maternal JJ O
UPD NNP O
( ( O
14 CD O
) ) O
in IN O
patients NNS O
with IN O
a DT O
similar JJ O
PWS NNP B-Disease
- : O
like IN O
phenotype NN O
even RB O
without IN O
previous JJ O
identification NN O
of IN O
a DT O
Robertsonian JJ O
translocation NN O
involving VBG O
chromosome NN O
14 CD O
. . O
. . O

Clinical JJ O
and CC O
genetic JJ O
study NN O
of IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
in IN O
an DT O
Australian JJ O
population NN O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
FRDA NNP B-Disease
gene NN O
that WDT O
encodes VBZ O
a DT O
210 CD O
- : O
amino NN O
acid NN O
protein NN O
called VBD O
frataxin NN O
. . O

An DT O
expansion NN O
of IN O
a DT O
GAA NNP O
trinucleotide NN O
repeat NN O
in IN O
intron NN O
1 CD O
of IN O
the DT O
gene NN O
is VBZ O
present JJ O
in IN O
more JJR O
than IN O
95 CD O
% NN O
of IN O
mutant JJ O
alleles NNS O
. . O

Of IN O
the DT O
83 CD O
people NNS O
we PRP O
studied VBD O
who WP O
have VBP O
mutations NNS O
in IN O
FRDA NNP O
, , O
78 CD O
are VBP O
homozygous JJ O
for IN O
an DT O
expanded VBN O
GAA NNP O
repeat NN O
; : O
the DT O
other JJ O
five CD O
patients NNS O
have VBP O
an DT O
expansion NN O
in IN O
one CD O
allele NN O
and CC O
a DT O
point NN O
mutation NN O
in IN O
the DT O
other JJ O
. . O

Here RB O
we PRP O
present VBP O
a DT O
detailed JJ O
clinical JJ O
and CC O
genetic JJ O
study NN O
of IN O
a DT O
subset NN O
of IN O
51 CD O
patients NNS O
homozygous JJ O
for IN O
an DT O
expansion NN O
of IN O
the DT O
GAA NNP O
repeat NN O
. . O

We PRP O
found VBD O
a DT O
correlation NN O
between IN O
the DT O
size NN O
of IN O
the DT O
smaller JJR O
of IN O
the DT O
two CD O
expanded VBD O
alleles NNS O
and CC O
age NN O
at IN O
onset NN O
, , O
age NN O
into IN O
wheelchair NN O
, , O
scoliosis NN B-Disease
, , O
impaired JJ O
vibration NN O
sense NN O
, , O
and CC O
the DT O
presence NN O
of IN O
foot NN B-Disease
deformity NN I-Disease
. . O

There EX O
was VBD O
no DT O
significant JJ O
correlation NN O
between IN O
the DT O
size NN O
of IN O
the DT O
smaller JJR O
allele NN O
and CC O
cardiomyopathy NN B-Disease
, , O
diabetes VBZ B-Disease
mellitus NNS I-Disease
, , O
loss NN B-Disease
of IN I-Disease
proprioception NN I-Disease
, , O
or CC O
bladder NN B-Disease
symptoms NNS I-Disease
. . O

The DT O
larger JJR O
allele JJ O
size NN O
correlated VBN O
with IN O
bladder NN B-Disease
symptoms NNS I-Disease
and CC O
the DT O
presence NN O
of IN O
foot NN B-Disease
deformity NN I-Disease
. . O

The DT O
duration NN O
of IN O
disease NN O
is VBZ O
correlated VBN O
with IN O
wheelchair NN O
use NN O
and CC O
the DT O
presence NN O
of IN O
diabetes NNS B-Disease
, , O
scoliosis NN B-Disease
, , O
bladder NN B-Disease
symptoms NNS I-Disease
and CC O
impaired JJ B-Disease
proprioception NN I-Disease
, , O
and CC O
vibration NN O
sense NN O
but CC O
no DT O
other JJ O
complications NNS O
studied VBN O
. . O
. . O

Novel JJ O
mutations NNS O
in IN O
XLRS1 NNP O
causing VBG O
retinoschisis NN B-Disease
, , O
including VBG O
first JJ O
evidence NN O
of IN O
putative JJ O
leader NN O
sequence NN O
change NN O
. . O

Juvenile JJ B-Disease
retinoschisis NN I-Disease
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
disease NN I-Disease
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
XLRS1 NNP O
gene NN O
. . O

We PRP O
screened VBD O
31 CD O
new JJ O
unrelated JJ O
patients NNS O
and CC O
families NNS O
for IN O
XLRS1 NNP O
mutations NNS O
in IN O
addition NN O
to TO O
previously RB O
reported VBN O
mutations NNS O
for IN O
60 CD O
of IN O
our PRP$ O
families NNS O
( ( O
Retinoschisis NNP B-Disease
Consortium NNP O
, , O
Hum NNP O
Mol NNP O
Genet NNP O
1998 CD O
; : O
7 CD O
1185 CD O
- : O
1192 CD O
) ) O
. . O

Twenty NNP O
- : O
three CD O
different JJ O
mutations NNS O
including VBG O
12 CD O
novel JJ O
ones NNS O
were VBD O
identified VBN O
in IN O
28 CD O
patients NNS O
. . O

Mutations NNS O
identified VBN O
in IN O
this DT O
study NN O
include VBP O
19 CD O
missense JJ O
mutations NNS O
, , O
two CD O
nonsense JJ O
mutations NNS O
, , O
one CD O
intragenic JJ O
deletion NN O
, , O
four CD O
microdeletions NNS O
, , O
one CD O
insertion NN O
, , O
and CC O
one CD O
intronic JJ O
sequence NN O
substitution NN O
that WDT O
is VBZ O
likely JJ O
to TO O
result VB O
in IN O
a DT O
splice NN O
site NN O
defect NN O
. . O

Two CD O
novel JJ O
mutations NNS O
, , O
c NN O
. . O

38T LS O
- : O
- : O
> NN O
C NNP O
( ( O
L13P NNP O
) ) O
and CC O
c $ O
. . O

667T CD O
- : O
- : O
> NN O
C NNP O
( ( O
C223R NNP O
) ) O
, , O
respectively RB O
, , O
present VBD O
the DT O
first JJ O
genetic JJ O
evidence NN O
for IN O
the DT O
functional JJ O
significance NN O
of IN O
the DT O
putative JJ O
leader NN O
peptide NN O
sequence NN O
and CC O
for IN O
the DT O
functional JJ O
significance NN O
at IN O
the DT O
carboxyl JJ O
terminal NN O
of IN O
the DT O
XLRS1 NNP O
protein NN O
beyond IN O
the DT O
discoidin NN O
domain NN O
. . O

Mutations NNS O
in IN O
25 CD O
of IN O
the DT O
families NNS O
were VBD O
localized VBN O
to TO O
exons NNS O
4 CD O
- : O
6 CD O
, , O
emphasizing VBG O
the DT O
critical JJ O
functional JJ O
significance NN O
of IN O
the DT O
discoidin NN O
domain NN O
of IN O
the DT O
XLRS1 NNP O
protein NN O

Growth NNP O
hormone NN O
treatment NN O
increases NNS O
CO NNP O
( ( O
2 CD O
) ) O
response NN O
, , O
ventilation NN O
and CC O
central JJ O
inspiratory NN O
drive NN O
in IN O
children NNS O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

We PRP O
studied VBD O
whether IN O
the DT O
beneficial JJ O
effects NNS O
of IN O
growth NN O
hormone NN O
( ( O
GH NNP O
) ) O
treatment NN O
on IN O
growth NN O
and CC O
body NN O
composition NN O
in IN O
PWS NNP B-Disease
are VBP O
accompanied VBN O
by IN O
an DT O
improvement NN O
in IN O
respiratory NN O
function NN O
. . O

We PRP O
measured VBD O
resting VBG O
ventilation NN O
, , O
airway JJ O
occlusion NN O
pressure NN O
( ( O
P NNP O
( ( O
0 CD O
. . O
1 CD O
) ) O
) ) O
and CC O
ventilatory JJ O
response NN O
to TO O
CO NNP O
( ( O
2 CD O
) ) O
in IN O
nine CD O
children NNS O
, , O
aged VBD O
7 CD O
- : O
14 CD O
years NNS O
, , O
before IN O
and CC O
6 CD O
- : O
9 CD O
months NNS O
after IN O
the DT O
start NN O
of IN O
GH NNP O
treatment NN O
. . O

During IN O
GH NNP O
treatment NN O
, , O
resting VBG O
ventilation NN O
increased VBN O
by IN O
26 CD O
% NN O
, , O
P NNP O
( ( O
0 CD O
. . O
1 CD O
) ) O
by IN O
72 CD O
% NN O
and CC O
the DT O
response NN O
to TO O
CO NNP O
( ( O
2 CD O
) ) O
by IN O
65 CD O
% NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
2 CD O
, , O
< VBD O
0 CD O
. . O
4 CD O
and CC O
< $ O
0 CD O
. . O
2 CD O
, , O
respectively RB O
) ) O
. . O

This DT O
observed JJ O
increase NN O
in IN O
ventilatory JJ O
output NN O
was VBD O
not RB O
correlated VBN O
to TO O
changes NNS O
in IN O
body NN O
mass NN O
index NN O
. . O

CONCLUSION NNP O
Treatment NNP O
of IN O
children NNS O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
seems VBZ O
to TO O
have VB O
a DT O
stimulatory JJ O
effect NN O
on IN O
central JJ O
respiratory NN O
structures NNS O
. . O

The DT O
observed JJ O
increase NN O
in IN O
ventilation NN O
and CC O
inspiratory JJ O
drive NN O
may MD O
contribute VB O
to TO O
the DT O
improved JJ O
activity NN O
level NN O
reported VBN O
by IN O
parents NNS O
of IN O
PWS NNP B-Disease
children NNS O
during IN O
growth NN O
hormone CD O
therapy NN O

G130V NNP O
, , O
a DT O
common JJ O
FRDA NNP B-Disease
point NN O
mutation NN O
, , O
appears VBZ O
to TO O
have VB O
arisen VBN O
from IN O
a DT O
common JJ O
founder NN O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
is VBZ O
the DT O
most RBS O
common JJ O
inherited JJ B-Disease
ataxia NN I-Disease
. . O

About RB O
98 CD O
% NN O
of IN O
mutant JJ O
alleles NNS O
have VBP O
an DT O
expansion NN O
of IN O
a DT O
GAA NNP O
trinucleotide NN O
repeat NN O
in IN O
intron NN O
1 CD O
of IN O
the DT O
affected JJ O
gene NN O
, , O
FRDA NNP O
. . O

The DT O
other JJ O
2 CD O
% NN O
are VBP O
point JJ O
mutations NNS O
. . O

Of IN O
the DT O
17 CD O
point NN O
mutations NNS O
so RB O
far RB O
described VBN O
, , O
three CD O
appear VBP O
to TO O
be VB O
more JJR O
common JJ O
. . O

One CD O
of IN O
these DT O
is VBZ O
the DT O
G130V NNP O
mutation NN O
in IN O
exon JJ O
4 CD O
of IN O
FRDA NNP O
. . O

G130V NNP O
, , O
when WRB O
present NN O
with IN O
an DT O
expanded VBN O
GAA NNP O
repeat NN O
on IN O
the DT O
other JJ O
allele NN O
, , O
is VBZ O
associated VBN O
with IN O
an DT O
atypical JJ O
FRDA NNP B-Disease
phenotype NN O
. . O

Haplotype NNP O
analysis NN O
was VBD O
undertaken VBN O
on IN O
the DT O
four CD O
families NNS O
who WP O
have VBP O
been VBN O
described VBN O
with IN O
this DT O
mutation NN O
. . O

The DT O
results NNS O
suggest VBP O
a DT O
common JJ O
founder NN O
for IN O
this DT O
mutation NN O
. . O

Although IN O
marked JJ O
differences NNS O
in IN O
extragenic JJ O
marker NN O
haplotypes NNS O
were VBD O
seen VBN O
in IN O
one CD O
family NN O
, , O
similar JJ O
intragenic JJ O
haplotyping NN O
suggests VBZ O
the DT O
same JJ O
mutation NN O
founder NN O
for IN O
this DT O
family NN O
with IN O
the DT O
differences NNS O
explicable JJ O
by IN O
two CD O
recombination NN O
events NNS O
. . O
. . O

Synergistic JJ O
effect NN O
of IN O
histone NN O
hyperacetylation NN O
and CC O
DNA NNP O
demethylation NN O
in IN O
the DT O
reactivation NN O
of IN O
the DT O
FMR1 NNP O
gene NN O
. . O

Most JJS O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
patients NNS O
have VBP O
expansion NN O
of IN O
a DT O
( ( O
CGG NNP O
) ) O
( ( O
n JJ O
) ) O
sequence NN O
with IN O
> JJ O
200 CD O
repeats NNS O
( ( O
full JJ O
mutation NN O
) ) O
in IN O
the DT O
FMR1 NNP O
gene NN O
responsible JJ O
for IN O
this DT O
condition NN O
. . O

Hypermethylation NN O
of IN O
the DT O
expanded VBN O
repeat NN O
and CC O
of IN O
the DT O
FMR1 NNP O
promoter NN O
is VBZ O
almost RB O
always RB O
present JJ O
and CC O
apparently RB O
suppresses VBZ O
transcription NN O
, , O
resulting VBG O
in IN O
absence NN O
of IN O
the DT O
FMR1 NNP O
protein NN O
. . O

We PRP O
recently RB O
showed VBD O
that IN O
transcriptional JJ O
reactivation NN O
of IN O
FMR1 NNP O
full JJ O
mutations NNS O
can MD O
be VB O
achieved VBN O
by IN O
inducing VBG O
DNA NNP O
demethylation NN O
with IN O
5 CD O
- : O
azadeoxycytidine NN O
( ( O
5 CD O
- : O
azadC NN O
) ) O
. . O

The DT O
level NN O
of IN O
histone NN O
acetylation NN O
is VBZ O
another DT O
important JJ O
factor NN O
in IN O
regulating VBG O
gene NN O
expression NN O
; : O
therefore RB O
, , O
we PRP O
treated VBD O
lymphoblastoid JJ O
cell NN O
lines NNS O
of IN O
non JJ O
- : O
mosaic NN O
full JJ O
mutation NN O
patients NNS O
with IN O
three CD O
drugs NNS O
capable JJ O
of IN O
inducing VBG O
histone NN O
hyperacetylation NN O
. . O

We PRP O
observed VBD O
a DT O
consistent NN O
, , O
although IN O
modest JJ O
, , O
reactivation NN O
of IN O
the DT O
FMR1 NNP O
gene NN O
with IN O
4 CD O
- : O
phenylbutyrate NN O
, , O
sodium NN O
butyrate NN O
and CC O
trichostatin VB O
A NNP O
, , O
as IN O
shown VBN O
by IN O
RT NNP O
- : O
PCR NN O
. . O

However RB O
, , O
we PRP O
report VBP O
that IN O
combining VBG O
these DT O
drugs NNS O
with IN O
5 CD O
- : O
azadC NN O
results NNS O
in IN O
a DT O
2 CD O
- : O
to TO O
5 CD O
- : O
fold JJ O
increase NN O
in IN O
FMR1 NNP O
mRNA NN O
levels NNS O
obtained VBN O
with IN O
5 CD O
- : O
azadC NN O
alone RB O
, , O
thus RB O
showing VBG O
a DT O
marked JJ O
synergistic JJ O
effect NN O
of IN O
histone NN O
hyperacetylation NN O
and CC O
DNA NNP O
demethylation NN O
in IN O
the DT O
reactivation NN O
of IN O
FMR1 NNP O
full JJ O
mutations NNS O
. . O
. . O

Constitutional NNP O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( O
VHL NNP B-Disease
) ) O
gene NN O
deletions NNS O
detected VBN O
in IN O
VHL NNP B-Disease
families NNS O
by IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
. . O

von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
disease NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
dominantly RB I-Disease
inherited VBN I-Disease
cancer NN I-Disease
syndrome NN I-Disease
predisposing VBG O
to TO O
a DT O
variety NN O
of IN O
tumor NN B-Disease
types NNS O
that WDT O
include VBP O
retinal JJ O
hemangioblastomas NN B-Disease
, , O
hemangioblastomas NN B-Disease
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
renal JJ B-Disease
cell NN I-Disease
carcinomas NN I-Disease
, , O
pancreatic JJ B-Disease
cysts NNS I-Disease
and CC I-Disease
tumors NNS I-Disease
, , O
pheochromocytomas NN B-Disease
, , O
endolymphatic JJ B-Disease
sac NN I-Disease
tumors NNS I-Disease
, , O
and CC O
epididymal JJ B-Disease
cystadenomas NN I-Disease
[ NNP O
W NNP O
. . O

M NNP O
. . O

Linehan NNP O
et CC O
al NN O
. . O
, , O
J NNP O
. . O

Am NNP O
. . O
Med NNP O
. . O
Assoc NNP O
. . O
, , O
273 CD O
564 CD O
- : O
570 CD O
, , O
1995 CD O
; : O
E NNP O
. . O
A NNP O
. . O
Maher NNP O
and CC O
W NNP O
. . O
G NNP O
. . O
Kaelin NNP O
, , O
Jr NNP O
. . O
, , O
Medicine NNP O
( ( O
Baltimore NNP O
) ) O
, , O
76 CD O
381 CD O
- : O
391 CD O
, , O
1997 CD O
; : O
W NNP O
. . O
M NNP O
. . O
Linehan NNP O
and CC O
R NNP O
. . O
D NNP O
. . O
Klausner NNP O
, , O
In IN O
B NNP O
. . O
Vogelstein NNP O
and CC O
K NNP O
. . O
Kinzler NNP O
( ( O
eds NNS O
. . O
) ) O
, , O
The DT O
Genetic JJ O
Basis NNP O
of IN O
Human NNP O
Cancer NNP O
, , O
pp NN O
. . O

455 CD O
- : O
473 CD O
, , O
McGraw NNP O
- : O
Hill NNP O
, , O
1998 CD O
] NN O
. . O

The DT O
VHL NNP B-Disease
gene NN O
was VBD O
localized VBN O
to TO O
chromosome VB O
3p25 CD O
- : O
26 CD O
and CC O
cloned VBD O
[ NNP O
F NNP O
. . O
Latif NNP O
et CC O
al NN O
. . O
, , O
Science NNP O
( ( O
Washington NNP O
DC NNP O
) ) O
, , O
260 CD O
1317 CD O
- : O
1320 CD O
, , O
1993 CD O
] NN O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
VHL NNP B-Disease
gene NN O
have VBP O
been VBN O
detected VBN O
in IN O
the DT O
majority NN O
of IN O
VHL NNP B-Disease
kindreds NNS O
. . O

The DT O
reported JJ O
frequency NN O
of IN O
detection NN O
of IN O
VHL NNP B-Disease
germline NN O
mutations NNS O
has VBZ O
varied VBN O
from IN O
39 CD O
to TO O
80 CD O
% NN O
( ( O
J NNP O
. . O
M NNP O
. . O
Whaley NNP O
et CC O
al NN O
. . O
, , O
Am NNP O
. . O
J NNP O
. . O
Hum NNP O
. . O
Genet NNP O
. . O
, , O
55 CD O
1092 CD O
- : O
1102 CD O
, , O
1994 CD O
; : O
Clinical NNP O
Research NNP O
Group NNP O
for IN O
Japan NNP O
, , O
Hum NNP O
. . O
Mol NNP O
. . O
Genet NNP O
. . O
, , O
4 CD O
2233 CD O
- : O
2237 CD O
, , O
1995 CD O
; : O
F NNP O
. . O
Chen NNP O
et CC O
al NN O
. . O
, , O
Hum NNP O
. . O
Mutat NNP O
. . O
, , O
5 CD O
66 CD O
- : O
75 CD O
, , O
1995 CD O
; : O
E NNP O
. . O
R NNP O
. . O
Maher NNP O
et CC O
al NN O
. . O
, , O
J NNP O
. . O
Med NNP O
. . O
Genet NNP O
. . O
, , O
33 CD O
328 CD O
- : O
332 CD O
, , O
1996 CD O
; : O
B NNP O
. . O
Zbar NNP O
, , O
Cancer NNP O
Surv NNP O
. . O
, , O
25 CD O
219 CD O
- : O
232 CD O
, , O
1995 CD O
) ) O
. . O

Recently RB O
a DT O
quantitative JJ O
Southern NNP O
blotting NN O
procedure NN O
was VBD O
found VBN O
to TO O
improve VB O
this DT O
frequency NN O
( ( O
C NNP O
. . O
Stolle NNP O
et CC O
al NN O
. . O
, , O
Hum NNP O
. . O
Mutat NNP O
. . O
, , O
12 CD O
417 CD O
- : O
423 CD O
, , O
1998 CD O
) ) O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
report VBP O
the DT O
use NN O
of IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
as IN O
a DT O
method NN O
to TO O
detect VB O
and CC O
characterize VB O
VHL NNP B-Disease
germline JJ O
deletions NNS O
. . O

We PRP O
reexamined VBD O
a DT O
group NN O
of IN O
VHL NNP B-Disease
patients NNS O
shown VBN O
previously RB O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
and CC O
sequencing VBG O
analysis NN O
not RB O
to TO O
harbor VB O
point NN O
mutations NNS O
in IN O
the DT O
VHL NNP B-Disease
locus NN O
. . O

We PRP O
found VBD O
constitutional JJ O
deletions NNS O
in IN O
29 CD O
of IN O
30 CD O
VHL NNP B-Disease
patients NNS O
in IN O
this DT O
group NN O
using VBG O
cosmid NN O
and CC O
P1 NNP O
probes VBP O
that IN O
cover VBP O
the DT O
VHL NNP B-Disease
locus NN O
. . O

We PRP O
then RB O
tested VBD O
six CD O
phenotypically RB O
normal JJ O
offspring VBG O
from IN O
four CD O
of IN O
these DT O
VHL NNP B-Disease
families NNS O
two CD O
were VBD O
found VBN O
to TO O
carry VB O
the DT O
deletion NN O
and CC O
the DT O
other JJ O
four CD O
were VBD O
deletion NN O
- : O
free JJ O
. . O

In IN O
addition NN O
, , O
germline JJ O
mosaicism NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
was VBD O
identified VBN O
in IN O
one CD O
family NN O
. . O

In IN O
sum NN O
, , O
FISH NNP O
was VBD O
found VBN O
to TO O
be VB O
a DT O
simple JJ O
and CC O
reliable JJ O
method NN O
to TO O
detect VB O
VHL NNP B-Disease
germline NN O
deletions NNS O
and CC O
practically RB O
useful JJ O
in IN O
cases NNS O
where WRB O
other JJ O
methods NNS O
of IN O
screening VBG O
have VB O
failed VBN O
to TO O
detect VB O
a DT O
VHL NNP B-Disease
gene NN I-Disease
abnormality NN I-Disease

Spectrum NNP O
of IN O
hSNF5 NN O
/ NNP O
INI1 NNP O
somatic JJ O
mutations NNS O
in IN O
human JJ O
cancer NN B-Disease
and CC O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
. . O

The DT O
hSNF5 NN O
/ NNP O
INI1 NNP O
gene NN O
which WDT O
encodes VBZ O
a DT O
member NN O
of IN O
the DT O
SWI NNP O
/ NNP O
SNF NNP O
chromatin NN O
ATP NNP O
- : O
dependent JJ O
remodeling VBG O
complex JJ O
, , O
is VBZ O
a DT O
new JJ O
tumor NN B-Disease
suppressor NN O
gene NN O
localized VBN O
on IN O
chromosome NN O
22q11 CD O
. . O

2 CD O
and CC O
recently RB O
shown VBN O
to TO O
be VB O
mutated VBN O
in IN O
malignant JJ B-Disease
rhabdoid NN I-Disease
tumors NNS I-Disease
. . O

We PRP O
have VBP O
searched VBN O
for IN O
hSNF5 NN O
/ NNP O
INI1 NNP O
mutations NNS O
in IN O
229 CD O
tumors NNS B-Disease
of IN O
various JJ O
origins NNS O
using VBG O
a DT O
screening NN O
method NN O
based VBN O
on IN O
denaturing VBG O
high JJ O
- : O
performance NN O
liquid NN O
chromatography NN O
. . O

A DT O
total NN O
of IN O
31 CD O
homozygous JJ O
deletions NNS O
and CC O
36 CD O
point NN O
alterations NNS O
were VBD O
identified VBN O
. . O

Point NN O
mutations NNS O
were VBD O
scattered VBN O
along IN O
the DT O
coding NN O
sequence NN O
and CC O
included VBD O
15 CD O
nonsense NN O
, , O
15 CD O
frameshift NN O
, , O
three CD O
splice NN O
site NN O
, , O
two CD O
missense NN O
and CC O
one CD O
editing NN O
mutations NNS O
. . O

Mutations NNS O
were VBD O
retrieved VBN O
in IN O
most JJS O
rhabdoid JJ B-Disease
tumors NNS I-Disease
, , O
whatever WDT O
their PRP$ O
sites NNS O
of IN O
occurrence NN O
, , O
indicating VBG O
the DT O
common JJ O
pathogenetic JJ O
origin NN O
of IN O
these DT O
tumors NNS B-Disease
. . O

Recurrent NNP O
hSNF5 NN O
/ NNP O
INI1 NNP O
alterations NNS O
were VBD O
also RB O
observed VBN O
in IN O
choroid JJ B-Disease
plexus NN I-Disease
carcinomas NN I-Disease
and CC O
in IN O
a DT O
subset NN O
of IN O
central JJ O
primitive JJ O
neuroectodermal JJ B-Disease
tumors NNS I-Disease
( ( O
cPNETs NN O
) ) O
and CC O
medulloblastomas $ B-Disease
. . O

In IN O
contrast NN O
, , O
hSNF5 VBP O
/ JJ O
INI1 NNP O
point NN O
mutations NNS O
were VBD O
not RB O
detected VBN O
in IN O
breast NN B-Disease
cancers NNS I-Disease
, , O
Wilms NNP B-Disease
tumors NNS I-Disease
, , O
gliomas NN B-Disease
, , O
ependymomas NN B-Disease
, , O
sarcomas NN B-Disease
and CC O
other JJ O
tumor NN B-Disease
types NNS O
, , O
even RB O
though IN O
most JJS O
analyzed JJ O
cases NNS O
harbored VBD O
loss NN O
of IN O
heterozygosity NN O
at IN O
22q11 CD O
. . O

2 CD O
loci NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
rhabdoid NN B-Disease
tumors NNS I-Disease
, , O
choroid JJ B-Disease
plexus NN I-Disease
carcinomas NN I-Disease
and CC O
a DT O
subset NN O
of IN O
medulloblastomas NN B-Disease
and CC O
cPNETs NN O
share NN O
common JJ O
pathways NNS O
of IN O
oncogenesis NN O
related VBN O
to TO O
hSNF5 VB O
/ NNP O
INI1 NNP O
alteration NN O
and CC O
that IN O
hSNF5 JJ O
/ NNP O
INI1 NNP O
mutations NNS O
define VBP O
a DT O
genetically RB O
homogeneous JJ O
family NN O
of IN O
highly RB O
aggressive JJ O
cancers NNS B-Disease
mainly RB O
occurring VBG O
in IN O
young JJ O
children NNS O
and CC O
frequently RB O
, , O
but CC O
not RB O
always RB O
, , O
exhibiting VBG O
a DT O
rhabdoid NN B-Disease
phenotype NN O

Ataxin NNP O
- : O
3 CD O
with IN O
an DT O
altered JJ O
conformation NN O
that WDT O
exposes VBZ O
the DT O
polyglutamine NN O
domain NN O
is VBZ O
associated VBN O
with IN O
the DT O
nuclear JJ O
matrix NN O
. . O

Spinocerebellar JJ B-Disease
ataxia NN I-Disease
type NN I-Disease
- : I-Disease
3 CD I-Disease
or CC O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
SCA3 NNP B-Disease
/ NNP O
MJD NNP B-Disease
) ) O
is VBZ O
a DT O
member NN O
of IN O
the DT O
CAG NNP B-Disease
/ NNP I-Disease
polyglutamine NN I-Disease
repeat NN I-Disease
disease NN I-Disease
family NN O
. . O

In IN O
this DT O
family NN O
of IN O
disorders NNS O
, , O
a DT O
normally RB O
polymorphic JJ O
CAG NNP O
repeat NN O
becomes NNS O
expanded VBD O
, , O
resulting VBG O
in IN O
expression NN O
of IN O
an DT O
expanded JJ O
polyglutamine NN O
domain NN O
in IN O
the DT O
disease NN O
gene NN O
product NN O
. . O

Experimental JJ O
models NNS O
of IN O
polyglutamine JJ B-Disease
disease NN I-Disease
implicate VB O
the DT O
nucleus NN O
in IN O
pathogenesis NN O
; : O
however RB O
, , O
the DT O
link NN O
between IN O
intranuclear JJ O
expression NN O
of IN O
expanded JJ O
polyglutamine NN O
and CC O
neuronal JJ B-Disease
dysfunction NN I-Disease
remains VBZ O
unclear JJ O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
ataxin NN O
- : O
3 CD O
, , O
the DT O
disease NN O
protein NN O
in IN O
SCA3 NNP B-Disease
/ NNP O
MJD NNP B-Disease
, , O
adopts VBZ O
a DT O
unique JJ O
conformation NN O
when WRB O
expressed VBN O
within IN O
the DT O
nucleus NN O
of IN O
transfected JJ O
cells NNS O
. . O

The DT O
monoclonal JJ O
antibody NN O
1C2 CD O
is VBZ O
known VBN O
preferentially RB O
to TO O
bind VB O
expanded JJ O
polyglutamine NN O
, , O
but CC O
we PRP O
find VBP O
that IN O
it PRP O
also RB O
binds VBZ O
a DT O
fragment NN O
of IN O
ataxin NN O
- : O
3 CD O
containing VBG O
a DT O
normal JJ O
glutamine NN O
repeat NN O
. . O

In IN O
addition NN O
, , O
expression NN O
of IN O
ataxin NN O
- : O
3 CD O
within IN O
the DT O
nucleus JJ O
exposes VBZ O
the DT O
glutamine NN O
domain NN O
of IN O
the DT O
full JJ O
- : O
length NN O
non SYM O
- : O
pathological JJ O
protein NN O
, , O
allowing VBG O
it PRP O
to TO O
bind VB O
the DT O
monoclonal JJ O
antibody NN O
1C2 CD O
. . O

Fractionation NN O
and CC O
immunochemical JJ O
experiments NNS O
indicate VBP O
that IN O
this DT O
novel JJ O
conformation NN O
of IN O
intranuclear JJ O
ataxin NN O
- : O
3 CD O
is VBZ O
not RB O
due JJ O
to TO O
proteolysis VB O
, , O
suggesting VBG O
instead RB O
that IN O
association NN O
with IN O
nuclear JJ O
protein NN O
( ( O
s PRP O
) ) O
alters VBZ O
the DT O
structure NN O
of IN O
full JJ O
- : O
length NN O
ataxin NN O
- : O
3 CD O
which WDT O
exposes VBZ O
the DT O
polyglutamine NN O
domain NN O
. . O

This DT O
conformationally RB O
altered VBN O
ataxin NN O
- : O
3 CD O
is VBZ O
bound VBN O
to TO O
the DT O
nuclear JJ O
matrix NN O
. . O

The DT O
pathological JJ O
form NN O
of IN O
ataxin NN O
- : O
3 CD O
with IN O
an DT O
expanded VBN O
polyglutamine NN O
domain NN O
also RB O
associates VBZ O
with IN O
the DT O
nuclear JJ O
matrix NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
an DT O
early JJ O
event NN O
in IN O
the DT O
pathogenesis NN O
of IN O
SCA3 NNP B-Disease
/ NNP O
MJD NNP B-Disease
may MD O
be VB O
an DT O
altered JJ O
conformation NN O
of IN O
ataxin NN O
- : O
3 CD O
within IN O
the DT O
nucleus NN O
that WDT O
exposes VBZ O
the DT O
polyglutamine NN O
domain NN O
. . O
. . O

The DT O
human JJ O
MAGEL2 NNP O
gene NN O
and CC O
its PRP$ O
mouse NN O
homologue NN O
are VBP O
paternally RB O
expressed VBN O
and CC O
mapped VBN O
to TO O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi JJ I-Disease
region NN O
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
is VBZ O
a DT O
complex JJ O
neurogenetic JJ B-Disease
disorder NN I-Disease
. . O

The DT O
phenotype NN O
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
contiguous JJ B-Disease
gene NN I-Disease
syndrome NN I-Disease
involving VBG O
genes NNS O
which WDT O
are VBP O
paternally RB O
expressed VBN O
only RB O
, , O
located VBN O
in IN O
the DT O
human JJ O
15q11 CD O
- : O
q13 JJ O
region NN O
. . O

Four CD O
mouse NN O
models NNS O
of IN O
PWS NNP B-Disease
have VBP O
been VBN O
reported VBN O
but CC O
these DT O
do VBP O
not RB O
definitively RB O
allow VB O
the DT O
delineation NN O
of IN O
the DT O
critical JJ O
region NN O
and CC O
the DT O
associated VBN O
genes NNS O
involved VBN O
in IN O
the DT O
aetiology NN O
of IN O
PWS NNP B-Disease
. . O

Moreover RB O
, , O
targeted VBD O
mutagenesis NN O
of IN O
mouse NN O
homologues NNS O
of IN O
the DT O
human JJ O
candidate NN O
PWS NNP B-Disease
genes NNS O
does VBZ O
not RB O
appear VB O
to TO O
result VB O
in IN O
any DT O
of IN O
the DT O
features NNS O
of IN O
PWS NNP B-Disease
. . O

Therefore RB O
, , O
the DT O
isolation NN O
of IN O
new JJ O
genes NNS O
in IN O
this DT O
region NN O
remains VBZ O
crucial JJ O
for IN O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
molecular JJ O
basis NN O
of IN O
PWS NNP B-Disease
. . O

In IN O
this DT O
manuscript NN O
, , O
we PRP O
report VBP O
the DT O
characterization NN O
of IN O
MAGEL2 NNP O
and CC O
its PRP$ O
mouse NN O
homologue NN O
Magel2 NNP O
. . O

These DT O
are VBP O
located VBN O
in IN O
the DT O
human JJ O
15q11 CD O
- : O
q13 NN O
and CC O
mouse NN O
7C CD O
regions NNS O
, , O
in IN O
close JJ O
proximity NN O
to TO O
NDN NNP O
/ NNP O
Ndn NNP O
. . O

By IN O
northern JJ O
blot NN O
analysis NN O
we PRP O
did VBD O
not RB O
detect VB O
any DT O
expression NN O
of IN O
MAGEL2 NNP O
/ NNP O
Magel2 NNP O
but CC O
by IN O
RT NNP O
- : O
PCR NN O
analysis NN O
, , O
specific JJ O
expression NN O
was VBD O
detected VBN O
in IN O
fetal JJ O
and CC O
adult NN O
brain NN O
and CC O
in IN O
placenta NN O
. . O

Both DT O
genes NNS O
are VBP O
intronless JJ O
with IN O
tandem JJ O
direct JJ O
repeat NN O
sequences NNS O
contained VBD O
within IN O
a DT O
CpG NNP O
island NN O
in IN O
the DT O
5 CD O
- : O
untranscribed JJ O
region NN O
. . O

The DT O
transcripts NNS O
encode VBP O
putative JJ O
proteins NNS O
that WDT O
are VBP O
homologous JJ O
to TO O
the DT O
MAGE NNP O
proteins NNS O
and CC O
NDN NNP O
. . O

Moreover RB O
, , O
MAGEL2 NNP O
/ NNP O
Magel2 NNP O
are VBP O
expressed VBN O
only RB O
from IN O
the DT O
paternal JJ O
allele NN O
in IN O
brain NN O
, , O
suggesting VBG O
a DT O
potential JJ O
role NN O
in IN O
the DT O
aetiology NN O
of IN O
PWS NNP B-Disease
and CC O
its PRP$ O
mouse NN O
model NN O
, , O
respectively RB O
. . O
. . O

cDNA NN O
microarrays NNS O
detect VBP O
activation NN O
of IN O
a DT O
myogenic JJ O
transcription NN O
program NN O
by IN O
the DT O
PAX3 NNP O
- : O
FKHR NNP O
fusion NN O
oncogene NN O
. . O

Alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
is VBZ O
an DT O
aggressive JJ O
pediatric JJ B-Disease
cancer NN I-Disease
of IN I-Disease
striated JJ I-Disease
muscle NN I-Disease
characterized VBN O
in IN O
60 CD O
% NN O
of IN O
cases NNS O
by IN O
a DT O
t NN O
( ( O
2 CD O
; : O
13 CD O
) ) O
( ( O
q35 NN O
; : O
q14 NN O
) ) O
. . O

This DT O
results NNS O
in IN O
the DT O
fusion NN O
of IN O
PAX3 NNP O
, , O
a DT O
developmental JJ O
transcription NN O
factor NN O
required VBN O
for IN O
limb JJ O
myogenesis NN O
, , O
with IN O
FKHR NNP O
, , O
a DT O
member NN O
of IN O
the DT O
forkhead JJ O
family NN O
of IN O
transcription NN O
factors NNS O
. . O

The DT O
resultant NN O
PAX3 NNP O
- : O
FKHR NNP O
gene NN O
possesses NNS O
transforming VBG O
properties NNS O
; : O
however RB O
, , O
the DT O
effects NNS O
of IN O
this DT O
chimeric JJ O
oncogene NN O
on IN O
gene NN O
expression NN O
are VBP O
largely RB O
unknown JJ O
. . O

To TO O
investigate VB O
the DT O
actions NNS O
of IN O
these DT O
transcription NN O
factors NNS O
, , O
both DT O
Pax3 NNP O
and CC O
PAX3 NNP O
- : O
FKHR NN O
were VBD O
introduced VBN O
into IN O
NIH NNP O
3T3 CD O
cells NNS O
, , O
and CC O
the DT O
resultant JJ O
gene NN O
expression NN O
changes NNS O
were VBD O
analyzed VBN O
with IN O
a DT O
murine NN O
cDNA NN O
microarray NN O
containing VBG O
2 CD O
, , O
225 CD O
elements NNS O
. . O

We PRP O
found VBD O
that IN O
PAX3 NNP O
- : O
FKHR NN O
but CC O
not RB O
PAX3 NNP O
activated VBD O
a DT O
myogenic JJ O
transcription NN O
program NN O
including VBG O
the DT O
induction NN O
of IN O
transcription NN O
factors NNS O
MyoD NNP O
, , O
Myogenin NNP O
, , O
Six1 NNP O
, , O
and CC O
Slug NNP O
as RB O
well RB O
as IN O
a DT O
battery NN O
of IN O
genes NNS O
involved VBN O
in IN O
several JJ O
aspects NNS O
of IN O
muscle NN O
function NN O
. . O

Notable JJ O
among IN O
this DT O
group NN O
were VBD O
the DT O
growth NN O
factor NN O
gene NN O
Igf2 NNP O
and CC O
its PRP$ O
binding NN O
protein NN O
Igfbp5 NNP O
. . O

Relevance NN O
of IN O
this DT O
model NN O
was VBD O
suggested VBN O
by IN O
verification NN O
that IN O
three CD O
of IN O
these DT O
genes NNS O
( ( O
IGFBP5 NNP O
, , O
HSIX1 NNP O
, , O
and CC O
Slug NNP O
) ) O
were VBD O
also RB O
expressed VBN O
in IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
cell NN O
lines NNS O
. . O

This DT O
study NN O
utilizes VBZ O
cDNA NN O
microarrays NNS O
to TO O
elucidate VB O
the DT O
pattern NN O
of IN O
gene NN O
expression NN O
induced VBN O
by IN O
an DT O
oncogenic JJ O
transcription NN O
factor NN O
and CC O
demonstrates VBZ O
the DT O
profound NN O
myogenic JJ O
properties NNS O
of IN O
PAX3 NNP O
- : O
FKHR NN O
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O
. . O

Experimental JJ O
hemochromatosis NN B-Disease
due JJ O
to TO O
MHC NNP O
class NN O
I PRP O
HFE VBP B-Disease
deficiency NN I-Disease
: : O
immune JJ O
status NN O
and CC O
iron NN O
metabolism NN O
. . O

The DT O
puzzling VBG O
linkage NN O
between IN O
genetic JJ O
hemochromatosis NN B-Disease
and CC O
histocompatibility NN O
loci NN O
became VBD O
even RB O
more RBR O
so RB O
when WRB O
the DT O
gene NN O
involved VBN O
, , O
HFE NNP O
, , O
was VBD O
identified VBN O
. . O

Indeed RB O
, , O
within IN O
the DT O
well NN O
defined VBN O
, , O
mainly RB O
peptide IN O
- : O
binding NN O
, , O
MHC NNP O
class NN O
I PRP O
family NN O
of IN O
molecules NNS O
, , O
HFE NNP O
seems VBZ O
to TO O
perform VB O
an DT O
unusual JJ O
yet RB O
essential JJ O
function NN O
. . O

As IN O
yet RB O
, , O
our PRP$ O
understanding NN O
of IN O
HFE NNP O
function NN O
in IN O
iron NN O
homeostasis NN O
is VBZ O
only RB O
partial JJ O
; : O
an DT O
even RB O
more RBR O
open JJ O
question NN O
is VBZ O
its PRP$ O
possible JJ O
role NN O
in IN O
the DT O
immune NN O
system NN O
. . O

To TO O
advance VB O
on IN O
both DT O
of IN O
these DT O
avenues NNS O
, , O
we PRP O
report VBP O
the DT O
deletion NN O
of IN O
HFE NNP O
alpha1 NN O
and CC O
alpha2 JJ O
putative JJ O
ligand NN O
binding VBG O
domains NNS O
in IN O
vivo NN O
. . O

HFE NNP B-Disease
- : I-Disease
deficient NN I-Disease
animals NNS O
were VBD O
analyzed VBN O
for IN O
a DT O
comprehensive JJ O
set NN O
of IN O
metabolic JJ O
and CC O
immune JJ O
parameters NNS O
. . O

Faithfully RB O
mimicking VBG O
human JJ O
hemochromatosis NN B-Disease
, , O
mice RB O
homozygous JJ O
for IN O
this DT O
deletion NN O
develop VB O
iron NN O
overload NN O
, , O
characterized VBN O
by IN O
a DT O
higher JJR O
plasma NN O
iron NN O
content NN O
and CC O
a DT O
raised VBN O
transferrin NN O
saturation NN O
as RB O
well RB O
as IN O
an DT O
elevated JJ O
hepatic JJ O
iron NN O
load NN O
. . O

The DT O
primary JJ O
defect NN O
could MD O
, , O
indeed RB O
, , O
be VB O
traced VBN O
to TO O
an DT O
augmented VBN O
duodenal JJ O
iron NN O
absorption NN O
. . O

In IN O
parallel NN O
, , O
measurement NN O
of IN O
the DT O
gut NN O
mucosal NN O
iron NN O
content NN O
as RB O
well RB O
as IN O
iron NN O
regulatory JJ O
proteins NNS O
allows VBZ O
a DT O
more RBR O
informed JJ O
evaluation NN O
of IN O
various JJ O
hypotheses NNS O
regarding VBG O
the DT O
precise JJ O
role NN O
of IN O
HFE NNP O
in IN O
iron NN O
homeostasis NN O
. . O

Finally RB O
, , O
an DT O
extensive JJ O
phenotyping NN O
of IN O
primary JJ O
and CC O
secondary JJ O
lymphoid NNS O
organs NNS O
including VBG O
the DT O
gut NN O
provides VBZ O
no DT O
compelling JJ O
evidence NN O
for IN O
an DT O
obvious JJ O
immune NN O
- : O
linked VBN O
function NN O
for IN O
HFE NNP O
. . O
. . O

Somatic JJ O
rearrangement NN O
of IN O
chromosome NN O
14 CD O
in IN O
human JJ O
lymphocytes NNS O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
is VBZ O
a DT O
rare JJ O
genetic JJ B-Disease
disorder NN I-Disease
associated VBN O
with IN O
immune JJ B-Disease
deficiency NN I-Disease
, , O
chromosome NN B-Disease
instability NN I-Disease
, , O
and CC O
a DT O
predisposition NN O
to TO O
lymphoid VB B-Disease
malignancy NN I-Disease
. . O

We PRP O
have VBP O
detected VBN O
chromosomally RB O
anomalous JJ O
clones NNS O
of IN O
lymphocytes NNS O
in IN O
eight CD O
patients NNS O
with IN O
this DT O
disorder NN O
. . O

Chromosome NNP O
banding NN O
disclosed VBD O
that IN O
the DT O
clones NNS O
are VBP O
consistently RB O
marked VBN O
by IN O
structural JJ O
rearrangement NN O
of IN O
the DT O
long JJ O
arm NN O
( ( O
q NN O
) ) O
of IN O
chromosome NN O
14 CD O
. . O

A DT O
translocation NN O
involving VBG O
14q CD O
was VBD O
found VBN O
in IN O
clones NNS O
obtained VBN O
from IN O
seven CD O
of IN O
the DT O
eight CD O
patients NNS O
whereas IN O
a DT O
ring NN O
14 CD O
chromosome NN O
was VBD O
found VBN O
in IN O
a DT O
clone NN O
obtained VBN O
from IN O
the DT O
other JJ O
. . O

These DT O
findings NNS O
as RB O
well RB O
as IN O
data NNS O
obtained VBN O
by IN O
others NNS O
for IN O
patients NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
suggest VBP O
that IN O
structural JJ O
rearrangement NN O
of IN O
14q CD O
is VBZ O
the DT O
initial JJ O
chromosomal JJ O
change NN O
in IN O
lymphocyte JJ O
clones NNS O
of IN O
patients NNS O
with IN O
this DT O
disorder NN O
. . O

Chromosomes NNS O
of IN O
lymphocytes NNS O
from IN O
one CD O
of IN O
the DT O
patients NNS O
were VBD O
studied VBN O
before IN O
and CC O
after IN O
the DT O
onset NN O
of IN O
chronic JJ B-Disease
lymphocytic JJ I-Disease
leukemia NN I-Disease
. . O

Before IN O
leukemia NN B-Disease
was VBD O
diagnosed VBN O
, , O
the DT O
patient NN O
had VBD O
a DT O
lymphocyte JJ O
clone NN O
with IN O
a DT O
14q CD O
translocation NN O
. . O

This DT O
clone NN O
appears VBZ O
to TO O
have VB O
given VBN O
rise NN O
to TO O
the DT O
leukemic JJ B-Disease
cells NNS O
. . O

We PRP O
hypothesize VBP O
that IN O
structural JJ O
rearrangement NN O
of IN O
14q CD O
is VBZ O
directly RB O
related VBN O
to TO O
abnormal JJ O
growth NN O
of IN O
lymphocytes NNS O
and CC O
that IN O
it PRP O
may MD O
be VB O
a DT O
step NN O
toward IN O
the DT O
development NN O
of IN O
lymphoid JJ B-Disease
malignancies NNS I-Disease
. . O

Increasing VBG O
evidence NN O
, , O
provided VBN O
by IN O
others NNS O
, , O
for IN O
the DT O
nonrandom JJ O
involvement NN O
of IN O
14q CD O
in IN O
African JJ O
- : O
type NN O
Burkitts NNP B-Disease
lymphoma NN I-Disease
and CC O
other JJ O
lymphoid JJ B-Disease
neoplasms NNS I-Disease
further RB O
strengthens VBZ O
this DT O
hypothesis NN O
. . O
. . O

Exon NNP O
9 CD O
mutations NNS O
in IN O
the DT O
WT1 NNP O
gene NN O
, , O
without IN O
influencing VBG O
KTS NNP O
splice NN O
isoforms NNS O
, , O
are VBP O
also RB O
responsible JJ O
for IN O
Frasier NNP B-Disease
syndrome NN I-Disease
. . O

We PRP O
report VBP O
new JJ O
mutations NNS O
in IN O
exon JJ O
9 CD O
of IN O
the DT O
WT1 NNP O
gene NN O
that WDT O
did VBD O
not RB O
alter VB O
the DT O
ratio NN O
of IN O
+ NNP O
/ NNP O
- : O
KTS NNP O
splice NN O
isoforms NNS O
in IN O
two CD O
unrelated JJ O
patients NNS O
with IN O
Frasier NNP B-Disease
syndrome NN I-Disease
( ( O
FS NNP B-Disease
) ) O
. . O

The DT O
mutation NN O
of IN O
intron NN O
9 CD O
inducing VBG O
defective JJ O
alternative JJ O
splicing NN O
was VBD O
reported VBN O
to TO O
be VB O
responsible JJ O
for IN O
this DT O
syndrome NN O
. . O

The DT O
mutations NNS O
found VBN O
in IN O
our PRP$ O
cases NNS O
occurred VBD O
in IN O
the DT O
same JJ O
exon NN O
of IN O
the DT O
WT1 NNP O
gene NN O
as IN O
detected VBN O
in IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
( ( O
DDS NNP B-Disease
) ) O
and CC O
could MD O
not RB O
be VB O
explained VBN O
by IN O
the DT O
previously RB O
proposed VBN O
mechanism NN O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
two CD O
syndromes NNS O
originate VBP O
from IN O
the DT O
same JJ O
WT1 NNP B-Disease
gene NN I-Disease
abnormality NN I-Disease
. . O

From IN O
a DT O
molecular JJ O
biological JJ O
point NN O
of IN O
view NN O
, , O
we PRP O
concluded VBD O
that IN O
the DT O
two CD O
diseases NNS O
were VBD O
not RB O
separable JJ O
, , O
and CC O
that IN O
FS NNP B-Disease
should MD O
be VB O
included VBN O
as IN O
an DT O
atypical JJ O
form NN O
of IN O
DDS NNP B-Disease
. . O
. . O

Splice NNP O
- : O
site NN O
mutation NN O
in IN O
the DT O
PDS NNP B-Disease
gene NN O
may MD O
result VB O
in IN O
intrafamilial JJ O
variability NN O
for IN O
deafness NN B-Disease
in IN O
Pendred NNP B-Disease
syndrome NN I-Disease
. . O

Pendred NNP B-Disease
syndrome NN I-Disease
is VBZ O
a DT O
recessive JJ B-Disease
inherited JJ I-Disease
disorder NN I-Disease
that IN O
consists VBZ O
of IN O
developmental JJ B-Disease
abnormalities NNS I-Disease
of IN I-Disease
the DT I-Disease
cochlea NN I-Disease
, , O
sensorineural JJ B-Disease
hearing NN I-Disease
loss NN I-Disease
, , O
and CC O
diffuse VB B-Disease
thyroid JJ I-Disease
enlargement NN I-Disease
( ( O
goiter NN B-Disease
) ) O
. . O

This DT O
disorder NN O
may MD O
account VB O
for IN O
up RB O
to TO O
10 CD O
% NN O
of IN O
cases NNS O
of IN O
hereditary JJ B-Disease
deafness NN I-Disease
. . O

The DT O
disease NN O
gene NN O
( ( O
PDS NNP B-Disease
) ) O
has VBZ O
been VBN O
mapped VBN O
to TO O
chromosome VB O
7q22 CD O
- : O
q31 NN O
, , O
and CC O
encodes VBZ O
a DT O
chloride JJ O
- : O
iodide NN O
transport NN O
protein NN O
. . O

We PRP O
performed VBD O
mutation NN O
analysis NN O
of IN O
individual JJ O
exons NNS O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
in IN O
one CD O
Spanish JJ O
family NN O
that WDT O
shows VBZ O
intrafamilial JJ O
variability NN O
of IN O
the DT O
deafness NN B-Disease
phenotype NN O
( ( O
two CD O
patients NNS O
with IN O
profound NN O
and CC O
one CD O
with IN O
moderate JJ O
- : O
severe JJ O
deafness NN B-Disease
) ) O
. . O

We PRP O
identified VBD O
a DT O
new JJ O
splice NN O
- : O
site NN O
mutation NN O
affecting VBG O
intron JJ O
4 CD O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
, , O
at IN O
nucleotide JJ O
position NN O
639 CD O
+ JJ O
7 CD O
. . O

RNA JJ O
analysis NN O
from IN O
lymphocytes NNS O
of IN O
the DT O
affected JJ O
patients NNS O
showed VBD O
that IN O
mutation NN O
639 CD O
+ NN O
7A CD O
- : O
- : O
> NN O
G NNP O
generates VBZ O
a DT O
new JJ O
donor NN O
splice NN O
site NN O
, , O
leading VBG O
to TO O
an DT O
mRNA NN O
with IN O
an DT O
insertion NN O
of IN O
six CD O
nucleotides NNS O
from IN O
intron NN O
4 CD O
of IN O
PDS NNP O
. . O

Since IN O
the DT O
newly RB O
created VBN O
donor NN O
splice NN O
site NN O
is VBZ O
likely JJ O
to TO O
compete VB O
with IN O
the DT O
normal JJ O
one CD O
, , O
variations NNS O
of IN O
the DT O
levels NNS O
of IN O
normal JJ O
and CC O
aberrant JJ O
transcripts NNS O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
in IN O
the DT O
cochlea NN O
may MD O
explain VB O
the DT O
variability NN O
in IN O
the DT O
deafness NN B-Disease
presentation NN O
. . O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
Sjogren NNP B-Disease
- : I-Disease
Larsson NNP I-Disease
syndrome NN I-Disease
: : O
mutation NN O
analysis NN O
of IN O
the DT O
fatty JJ O
aldehyde JJ O
dehydrogenase NN O
gene NN O
. . O

Sjogren NNP B-Disease
- : I-Disease
Larsson NNP I-Disease
syndrome NN I-Disease
( ( O
SLS NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
ichthyosis NN B-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
spasticity NN B-Disease
, , O
and CC O
deficient JJ B-Disease
activity NN I-Disease
of IN I-Disease
fatty JJ I-Disease
aldehyde JJ I-Disease
dehydrogenase NN I-Disease
( ( O
FALDH NNP O
) ) O
. . O

To TO O
define VB O
the DT O
molecular JJ O
defects NNS O
causing VBG O
SLS NNP B-Disease
, , O
we PRP O
performed VBD O
mutation NN O
analysis NN O
of IN O
the DT O
FALDH NNP O
gene NN O
in IN O
probands NNS O
from IN O
63 CD O
kindreds NNS O
with IN O
SLS NNP B-Disease
. . O

Among IN O
these DT O
patients NNS O
, , O
49 CD O
different JJ O
mutations NNS O
- : O
including VBG O
10 CD O
deletions NNS O
, , O
2 CD O
insertions NNS O
, , O
22 CD O
amino NN O
acid NN O
substitutions NNS O
, , O
3 CD O
nonsense NN O
mutations NNS O
, , O
9 CD O
splice NN O
- : O
site NN O
defects NNS O
, , O
and CC O
3 CD O
complex JJ O
mutations NNS O
- : O
were VBD O
found VBN O
. . O

All DT O
of IN O
the DT O
patients NNS O
with IN O
SLS NNP B-Disease
were VBD O
found VBN O
to TO O
carry VB O
mutations NNS O
. . O

Nineteen NN O
of IN O
the DT O
missense NN O
mutations NNS O
resulted VBD O
in IN O
a DT O
severe JJ O
reduction NN O
of IN O
FALDH NNP O
enzyme FW O
catalytic JJ O
activity NN O
when WRB O
expressed VBN O
in IN O
mammalian JJ O
cells NNS O
, , O
but CC O
one CD O
mutation NN O
( ( O
798G CD O
- : O
- : O
> NN O
C NNP O
[ NNP O
K266N NNP O
] NNP O
) ) O
seemed VBD O
to TO O
have VB O
a DT O
greater JJR O
effect NN O
on IN O
mRNA NN O
stability NN O
. . O

The DT O
splice NN O
- : O
site NN O
mutations NNS O
led VBD O
to TO O
exon VB O
skipping VBG O
or CC O
utilization NN O
of IN O
cryptic JJ O
acceptor NN O
- : O
splice NN O
sites NNS O
. . O

Thirty NNP O
- : O
seven CD O
mutations NNS O
were VBD O
private JJ O
, , O
and CC O
12 CD O
mutations NNS O
were VBD O
seen VBN O
in IN O
two CD O
or CC O
more JJR O
probands NNS O
of IN O
European JJ O
or CC O
Middle JJ O
Eastern JJ O
descent NN O
. . O

Four CD O
single JJ O
- : O
nucleotide JJ O
polymorphisms NN O
( ( O
SNPs NNP O
) ) O
were VBD O
found VBN O
in IN O
the DT O
FALDH NNP O
gene NN O
. . O

At IN O
least JJS O
four CD O
of IN O
the DT O
common JJ O
mutations NNS O
( ( O
551C CD O
- : O
- : O
> NN O
T NNP O
, , O
682C CD O
- : O
- : O
> NN O
T NNP O
, , O
733G CD O
- : O
- : O
> NN O
A NNP O
, , O
and CC O
798 CD O
+ NNS O
1delG CD O
) ) O
were VBD O
associated VBN O
with IN O
multiple JJ O
SNP NNP O
haplotypes NNS O
, , O
suggesting VBG O
that IN O
these DT O
mutations NNS O
originated VBD O
independently RB O
on IN O
more JJR O
than IN O
one CD O
occasion NN O
or CC O
were VBD O
ancient JJ O
SLS NNP B-Disease
genes NNS O
that WDT O
had VBD O
undergone JJ O
intragenic JJ O
recombination NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
SLS NNP B-Disease
is VBZ O
caused VBN O
by IN O
a DT O
strikingly RB O
heterogeneous JJ O
group NN O
of IN O
mutations NNS O
in IN O
the DT O
FALDH NNP O
gene NN O
and CC O
provide VB O
a DT O
framework NN O
for IN O
understanding VBG O
the DT O
genetic JJ O
basis NN O
of IN O
SLS NNP B-Disease
and CC O
the DT O
development NN O
of IN O
DNA NNP O
- : O
based VBN O
diagnostic JJ O
tests NNS O
. . O
. . O

Loss NNP O
- : O
of IN O
- : O
function NN O
mutations NNS O
in IN O
the DT O
cathepsin NN O
C NNP O
gene NN O
result NN O
in IN O
periodontal JJ B-Disease
disease NN I-Disease
and CC O
palmoplantar NN B-Disease
keratosis NN I-Disease
. . O

Papillon NNP B-Disease
- : I-Disease
Lefevre NNP I-Disease
syndrome NN I-Disease
, , O
or CC O
keratosis VB B-Disease
palmoplantaris NN I-Disease
with IN O
periodontopathia NN B-Disease
( ( O
PLS NNP B-Disease
, , O
MIM NNP O
245000 CD O
) ) O
, , O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
that WDT O
is VBZ O
mainly RB O
ascertained VBN O
by IN O
dentists NNS O
because IN O
of IN O
the DT O
severe JJ O
periodontitis NN B-Disease
that WDT O
afflicts VBZ O
patients NNS O
. . O

Both DT O
the DT O
deciduous JJ O
and CC O
permanent JJ O
dentitions NNS O
are VBP O
affected VBN O
, , O
resulting VBG O
in IN O
premature NN O
tooth JJ B-Disease
loss NN I-Disease
. . O

Palmoplantar NNP B-Disease
keratosis NN I-Disease
, , O
varying VBG O
from IN O
mild JJ O
psoriasiform NN O
scaly NN O
skin NN O
to TO O
overt VB O
hyperkeratosis NN B-Disease
, , O
typically RB O
develops VBZ O
within IN O
the DT O
first JJ O
three CD O
years NNS O
of IN O
life NN O
. . O

Keratosis NNP B-Disease
also RB O
affects VBZ O
other JJ O
sites NNS O
such JJ O
as IN O
elbows NNS O
and CC O
knees NNS O
. . O

Most JJS O
PLS JJ B-Disease
patients NNS O
display VBP O
both DT O
periodontitis NN B-Disease
and CC O
hyperkeratosis NN B-Disease
. . O

Some DT O
patients NNS O
have VBP O
only RB O
palmoplantar JJ B-Disease
keratosis NN I-Disease
or CC O
periodontitis NN B-Disease
, , O
and CC O
in IN O
rare JJ O
individuals NNS O
the DT O
periodontitis NN B-Disease
is VBZ O
mild JJ O
and CC O
of IN O
late JJ O
onset NN O
. . O

The DT O
PLS NNP O
locus NN O
has VBZ O
been VBN O
mapped VBN O
to TO O
chromosome VB O
11q14 CD O
- : O
q21 NN O
( ( O
refs JJ O
7 CD O
, , O
8 CD O
, , O
9 CD O
) ) O
. . O

Using VBG O
homozygosity NN O
mapping NN O
in IN O
eight CD O
small JJ O
consanguineous JJ O
families NNS O
, , O
we PRP O
have VBP O
narrowed VBN O
the DT O
candidate NN O
region NN O
to TO O
a DT O
1 CD O
. . O

2 CD O
- : O
cM NN O
interval NN O
between IN O
D11S4082 NNP O
and CC O
D11S931 NNP O
. . O

The DT O
gene NN O
( ( O
CTSC NNP O
) ) O
encoding VBG O
the DT O
lysosomal JJ O
protease NN O
cathepsin NN O
C NNP O
( ( O
or CC O
dipeptidyl VB O
aminopeptidase NN O
I PRP O
) ) O
lies VBZ O
within IN O
this DT O
interval NN O
. . O

We PRP O
defined VBD O
the DT O
genomic JJ O
structure NN O
of IN O
CTSC NNP O
and CC O
found VBD O
mutations NNS O
in IN O
all DT O
eight CD O
families NNS O
. . O

In IN O
two CD O
of IN O
these DT O
families NNS O
we PRP O
used VBD O
a DT O
functional JJ O
assay NN O
to TO O
demonstrate VB O
an DT O
almost RB O
total JJ O
loss NN O
of IN O
cathepsin JJ O
C NNP O
activity NN O
in IN O
PLS NNP B-Disease
patients NNS O
and CC O
reduced JJ O
activity NN O
in IN O
obligate NN O
carriers NNS O
. . O

Confirmation NN O
of IN O
linkage NN O
of IN O
Van NNP B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
to TO O
chromosome VB O
1q32 CD O
: : O
evidence NN O
of IN O
association NN O
with IN O
STR NNP O
alleles NNS O
suggests VBZ O
possible JJ O
unique JJ O
origin NN O
of IN O
the DT O
disease NN O
mutation NN O
. . O

Van NNP B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
( ( O
VWS NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
craniofacial JJ I-Disease
disorder NN I-Disease
with IN O
high JJ O
penetrance NN O
and CC O
variable JJ O
expression NN O
. . O

Its PRP$ O
clinical JJ O
features NNS O
are VBP O
variably RB O
expressed VBN O
, , O
but CC O
include VBP O
cleft JJ B-Disease
lip NN I-Disease
and CC O
/ NN O
or CC O
cleft NN B-Disease
palate NN I-Disease
, , O
lip NN B-Disease
pits NNS I-Disease
and CC O
hypodontia NN B-Disease
. . O

All DT O
VWS NNP B-Disease
families NNS O
studied VBD O
to TO O
date NN O
map VB O
the DT O
disease NN O
gene NN O
to TO O
a DT O
< JJ O
2 CD O
cM JJ O
region NN O
of IN O
chromosome NN O
1q32 CD O
, , O
with IN O
no DT O
evidence NN O
of IN O
locus JJ O
heterogeneity NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
is VBZ O
to TO O
refine VB O
the DT O
localization NN O
of IN O
the DT O
VWS NNP B-Disease
gene NN O
and CC O
to TO O
further RB O
assess VB O
possible JJ O
heterogeneity NN O
. . O

We PRP O
analyzed VBD O
four CD O
multiplex NN O
VWS NNP B-Disease
families NNS O
. . O

All DT O
available JJ O
members NNS O
were VBD O
clinically RB O
assessed VBN O
and CC O
genotyped VBN O
for IN O
19 CD O
short JJ O
tandem NN O
repeat NN O
markers NNS O
on IN O
chromosome NN O
1 CD O
in IN O
the DT O
VWS NNP B-Disease
candidate NN O
gene NN O
region NN O
. . O

We PRP O
performed VBD O
two CD O
- : O
point NN O
and CC O
multipoint NN O
limit NN O
of IN O
detection NN O
( ( O
LOD NNP O
) ) O
score NN O
analyses NNS O
using VBG O
a DT O
high JJ O
penetrance NN O
autosomal JJ O
dominant JJ O
model NN O
. . O

All DT O
families NNS O
showed VBD O
positive JJ O
LOD NNP O
scores NNS O
without IN O
any DT O
recombination NN O
in IN O
the DT O
candidate NN O
region NN O
. . O

The DT O
largest JJS O
two CD O
- : O
point NN O
LOD NNP O
score NN O
was VBD O
5 CD O
. . O

87 CD O
87 CD O
. . O

Our PRP$ O
assay NN O
method NN O
for IN O
short JJ O
tandem NN O
repeat NN O
( ( O
STR NNP O
) ) O
markers NNS O
provided VBD O
highly RB O
accurate JJ O
size NN O
estimation NN O
of IN O
marker NN O
allele FW O
fragment NN O
sizes NNS O
, , O
and CC O
therefore RB O
enabled VBD O
us PRP O
to TO O
determine VB O
the DT O
specific JJ O
alleles NNS O
segregating VBG O
with IN O
the DT O
VWS NNP B-Disease
gene NN O
in IN O
each DT O
of IN O
our PRP$ O
four CD O
families NNS O
. . O

We PRP O
observed VBD O
a DT O
striking JJ O
pattern NN O
of IN O
STR NNP O
allele FW O
sharing VBG O
at IN O
several JJ O
closely RB O
linked VBN O
loci NN O
among IN O
our PRP$ O
four CD O
Caucasian JJ O
VWS NNP B-Disease
families NNS O
recruited VBD O
at IN O
three CD O
different JJ O
locations NNS O
in IN O
the DT O
US NNP O
. . O

These DT O
results NNS O
suggest VBP O
the DT O
possibility NN O
of IN O
a DT O
unique JJ O
origin NN O
for IN O
a DT O
mutation NN O
responsible JJ O
for IN O
many JJ O
or CC O
most JJS O
cases NNS O
of IN O
VWS NNP B-Disease
. . O

A DT O
point NN O
mutation NN O
Thr NNP O
( ( O
799 CD O
) ) O
Met NNP O
on IN O
the DT O
alpha NN O
( ( O
2 CD O
) ) O
integrin NN O
leads VBZ O
to TO O
the DT O
formation NN O
of IN O
new JJ O
human JJ O
platelet NN O
alloantigen NN O
Sit NNP O
( ( O
a DT O
) ) O
and CC O
affects VBZ O
collagen NN O
- : O
induced JJ O
aggregation NN O
. . O

A DT O
new JJ O
platelet NN O
- : O
specific JJ O
alloantigen NN O
, , O
termed VBN O
Sit NNP O
( ( O
a DT O
) ) O
, , O
was VBD O
identified VBN O
in IN O
a DT O
severe JJ O
case NN O
of IN O
neonatal JJ B-Disease
alloimmune NN I-Disease
thrombocytopenia NN I-Disease
. . O

The DT O
Sit NNP O
( ( O
a DT O
) ) O
alloantigen NN O
is VBZ O
of IN O
low JJ O
frequency NN O
( ( O
1 CD O
/ RB O
400 CD O
) ) O
in IN O
the DT O
German JJ O
population NN O
. . O

Immunochemical JJ O
studies NNS O
demonstrated VBD O
that IN O
the DT O
Sit NNP O
( ( O
a DT O
) ) O
epitopes VBZ O
reside NN O
on IN O
platelet NN O
glycoprotein NN O
( ( O
GP NNP O
) ) O
Ia NNP O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
GPIa NNP O
cDNA NN O
derived VBD O
from IN O
Sit NNP O
( ( O
a DT O
) ) O
- : O
positive JJ O
platelets NNS O
showed VBD O
C NNP O
( ( O
2531 CD O
) ) O
- : O
- : O
> NN O
T NNP O
( ( O
2531 CD O
) ) O
point NN O
mutation NN O
, , O
resulting VBG O
in IN O
Thr NNP O
( ( O
799 CD O
) ) O
Met NNP O
dimorphism NN O
. . O

Analysis NN O
of IN O
genomic JJ O
DNA NN O
from IN O
22 CD O
Sit NNP O
( ( O
a DT O
) ) O
- : O
negative JJ O
normal JJ O
individuals NNS O
showed VBD O
that IN O
the DT O
Thr NNP O
( ( O
799 CD O
) ) O
is VBZ O
encoded VBN O
by IN O
ACG NNP O
( ( O
2532 CD O
) ) O
( ( O
90 CD O
. . O
9 CD O
% NN O
) ) O
or CC O
ACA NNP O
( ( O
2532 CD O
) ) O
( ( O
9 CD O
. . O
1 CD O
% NN O
) ) O
. . O

To TO O
establish VB O
a DT O
DNA NN O
typing NN O
technique NN O
, , O
we PRP O
elucidated VBD O
the DT O
organization NN O
of IN O
the DT O
GPIa NNP O
gene NN O
adjacent NN O
to TO O
the DT O
polymorphic JJ O
bases NNS O
. . O

The DT O
introns NNS O
( ( O
421 CD O
bp NN O
and CC O
1 CD O
. . O
2 CD O
kb NN O
) ) O
encompass VBZ O
a DT O
142 CD O
- : O
bp NN O
exon NN O
with IN O
the DT O
2 CD O
polymorphic JJ O
bases NNS O
2531 CD O
and CC O
2532 CD O
. . O

Polymerase NNP O
chain NN O
reaction NN O
- : O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
analysis NN O
on IN O
DNA NNP O
derived VBD O
from IN O
100 CD O
donors NNS O
using VBG O
the DT O
restriction NN O
enzyme VBZ O
Mae NNP O
III NNP O
showed VBD O
that IN O
the DT O
Met NNP O
( ( O
799 CD O
) ) O
form NN O
of IN O
GPIa NNP O
is VBZ O
restricted VBN O
to TO O
Sit NNP O
( ( O
a DT O
) ) O
( ( O
+ $ O
) ) O
phenotype NN O
. . O

Analysis NN O
of IN O
stable JJ O
Chinese JJ O
hamster NN O
ovary JJ O
transfectants NNS O
expressing VBG O
allele JJ O
- : O
specific JJ O
recombinant JJ O
forms NNS O
of IN O
GPIa NNP O
showed VBD O
that IN O
anti SYM O
- : O
Sit NNP O
( ( O
a DT O
) ) O
exclusively RB O
reacted VBN O
with IN O
the DT O
Glu NNP O
( ( O
505 CD O
) ) O
Met NNP O
( ( O
799 CD O
) ) O
, , O
but CC O
not RB O
with IN O
the DT O
Glu NNP O
( ( O
505 CD O
) ) O
Thr NNP O
( ( O
799 CD O
) ) O
and CC O
the DT O
Lys NNP O
( ( O
505 CD O
) ) O
Thr NNP O
( ( O
799 CD O
) ) O
isoforms NNS O
. . O

In IN O
contrast NN O
, , O
anti SYM O
- : O
Br NNP O
( ( O
a DT O
) ) O
( ( O
HPA NNP O
- : O
5b CD O
) ) O
only RB O
recognized VBD O
the DT O
Lys NNP O
( ( O
505 CD O
) ) O
Thr NNP O
( ( O
799 CD O
) ) O
form NN O
, , O
whereas WP O
anti SYM O
- : O
Br NNP O
( ( O
b NN O
) ) O
( ( O
HPA NNP O
- : O
5a CD O
) ) O
reacted VBN O
with IN O
both DT O
Glu NNP O
( ( O
505 CD O
) ) O
Thr NNP O
( ( O
799 CD O
) ) O
and CC O
Glu NNP O
( ( O
505 CD O
) ) O
Met NNP O
( ( O
799 CD O
) ) O
isoforms NNS O
. . O

These DT O
results NNS O
demonstrated VBD O
that IN O
the DT O
Met NNP O
( ( O
799 CD O
) ) O
is VBZ O
responsible JJ O
for IN O
formation NN O
of IN O
the DT O
Sit NNP O
( ( O
a DT O
) ) O
alloantigenic JJ O
determinants NNS O
, , O
whereas NNS O
amino VBP O
acid JJ O
505 CD O
( ( O
Lys NNP O
or CC O
Glu NNP O
) ) O
specifically RB O
controls VBZ O
the DT O
expression NN O
of IN O
Br NNP O
( ( O
a DT O
) ) O
and CC O
Br NNP O
( ( O
b NN O
) ) O
epitopes VBZ O
, , O
respectively RB O
. . O

Platelet NNP O
aggregation NN O
responses NNS O
of IN O
Sit NNP O
( ( O
a DT O
) ) O
( ( O
+ $ O
) ) O
individuals NNS O
were VBD O
diminished VBN O
in IN O
response NN O
to TO O
collagen NN O
, , O
indicating VBG O
that IN O
the DT O
Thr NNP O
( ( O
799 CD O
) ) O
Met NNP O
mutation NN O
affects VBZ O
the DT O
function NN O
of IN O
the DT O
GPIa NNP O
/ NNP O
IIa NNP O
complex NN O

Mutations NNS O
of IN O
the DT O
cathepsin NN O
C NNP O
gene NN O
are VBP O
responsible JJ O
for IN O
Papillon NNP B-Disease
- : I-Disease
Lefevre NNP I-Disease
syndrome NN I-Disease
. . O

Papillon NNP B-Disease
- : I-Disease
Lefevre NNP I-Disease
syndrome NN I-Disease
( ( O
PLS NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterised VBN O
by IN O
palmoplantar NN B-Disease
hyperkeratosis NN I-Disease
and CC O
severe JJ O
early JJ O
onset NN O
periodontitis NN B-Disease
that WDT O
results NNS O
in IN O
the DT O
premature JJ O
loss NN O
of IN O
the DT O
primary JJ O
and CC O
secondary JJ O
dentitions NNS O
. . O

A DT O
major JJ O
gene NN O
locus NN O
for IN O
PLS NNP B-Disease
has VBZ O
been VBN O
mapped VBN O
to TO O
a DT O
2 CD O
. . O

8 CD O
cM NN O
interval NN O
on IN O
chromosome NN O
11q14 CD O
. . O

Correlation NN O
of IN O
physical JJ O
and CC O
genetic JJ O
maps NNS O
of IN O
this DT O
interval JJ O
indicate VBP O
it PRP O
includes VBZ O
at IN O
least JJS O
40 CD O
ESTs NNP O
and CC O
six CD O
known VBN O
genes NNS O
including VBG O
the DT O
lysosomal JJ O
protease NN O
cathepsin NN O
C NNP O
gene NN O
( ( O
CTSC NNP O
) ) O
. . O

The DT O
CTSC NNP O
message NN O
is VBZ O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
a DT O
variety NN O
of IN O
immune JJ O
cells NNS O
including VBG O
polymorphonuclear JJ O
leucocytes NNS O
, , O
macrophages NNS O
, , O
and CC O
their PRP$ O
precursors NNS O
. . O

By IN O
RT NNP O
- : O
PCR NN O
, , O
we PRP O
found VBD O
CTSC NNP O
is VBZ O
also RB O
expressed VBN O
in IN O
epithelial JJ O
regions NNS O
commonly RB O
affected VBN O
by IN O
PLS NNP B-Disease
, , O
including VBG O
the DT O
palms NN O
, , O
soles NNS O
, , O
knees NNS O
, , O
and CC O
oral JJ O
keratinised VBN O
gingiva NN O
. . O

The DT O
4 CD O
. . O

7 CD O
kb NN O
CTSC NNP O
gene NN O
consists VBZ O
of IN O
two CD O
exons NNS O
. . O

Sequence NNP O
analysis NN O
of IN O
CTSC NNP O
from IN O
subjects NNS O
affected VBN O
with IN O
PLS NNP B-Disease
from IN O
five CD O
consanguineous JJ O
Turkish JJ O
families NNS O
identified VBN O
four CD O
different JJ O
mutations NNS O
. . O

An DT O
exon JJ O
1 CD O
nonsense JJ O
mutation NN O
( ( O
856C CD O
- : O
- : O
> NN O
T NNP O
) ) O
introduces VBZ O
a DT O
premature NN O
stop NN O
codon NN O
at IN O
amino NN O
acid NN O
286 CD O
. . O

Three CD O
exon $ O
2 CD O
mutations NNS O
were VBD O
identified VBN O
, , O
including VBG O
a DT O
single JJ O
nucleotide JJ O
deletion NN O
( ( O
2692delA CD O
) ) O
of IN O
codon NN O
349 CD O
introducing VBG O
a DT O
frameshift NN O
and CC O
premature NN O
termination NN O
codon NN O
, , O
a DT O
2 CD O
bp NN O
deletion NN O
( ( O
2673 CD O
- : O
2674delCT CD O
) ) O
that WDT O
results NNS O
in IN O
introduction NN O
of IN O
a DT O
stop JJ O
codon NN O
at IN O
amino NN O
acid NN O
343 CD O
, , O
and CC O
a DT O
G NNP O
- : O
- : O
> VB O
A DT O
substitution NN O
in IN O
codon NN O
429 CD O
( ( O
2931G CD O
- : O
- : O
> VB O
A DT O
) ) O
introducing VBG O
a DT O
premature NN O
termination NN O
codon NN O
. . O

All DT O
PLS NNP B-Disease
patients NNS O
were VBD O
homozygous JJ O
for IN O
cathepsin NN O
C NNP O
mutations NNS O
inherited VBN O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

Parents NNS O
and CC O
sibs VBP O
heterozygous JJ O
for IN O
cathepsin NN O
C NNP O
mutations NNS O
do VBP O
not RB O
show VB O
either RB O
the DT O
palmoplantar NN B-Disease
hyperkeratosis NN I-Disease
or CC O
severe JJ O
early JJ O
onset NN O
periodontitis NN B-Disease
characteristic NN O
of IN O
PLS NNP B-Disease
. . O

A DT O
more RBR O
complete JJ O
understanding NN O
of IN O
the DT O
functional JJ O
physiology NN O
of IN O
cathepsin NN O
C NNP O
carries VBZ O
significant JJ O
implications NNS O
for IN O
understanding VBG O
normal JJ O
and CC O
abnormal JJ O
skin NN O
development NN O
and CC O
periodontal JJ B-Disease
disease NN I-Disease
susceptibility NN O

Mutational JJ O
analysis NN O
of IN O
the DT O
HGO NNP O
gene NN O
in IN O
Finnish JJ O
alkaptonuria NN B-Disease
patients NNS O
. . O

Alkaptonuria NNP B-Disease
( ( O
AKU NNP B-Disease
) ) O
, , O
the DT O
prototypic NN O
inborn JJ B-Disease
error NN I-Disease
of IN I-Disease
metabolism NN I-Disease
, , O
has VBZ O
recently RB O
been VBN O
shown VBN O
to TO O
be VB O
caused VBN O
by IN O
loss NN O
of IN O
function NN O
mutations NNS O
in IN O
the DT O
homogentisate NN O
- : O
1 CD O
, , O
2 CD O
- : O
dioxygenase NN O
gene NN O
( ( O
HGO NNP O
) ) O
. . O

So RB O
far RB O
17 CD O
mutations NNS O
have VBP O
been VBN O
characterised VBN O
in IN O
AKU NNP B-Disease
patients NNS O
of IN O
different JJ O
ethnic JJ O
origin NN O
. . O

We PRP O
describe VBP O
three CD O
novel JJ O
mutations NNS O
( ( O
R58fs NNP O
, , O
R330S NNP O
, , O
and CC O
H371R NNP O
) ) O
and CC O
one CD O
common JJ O
AKU NNP B-Disease
mutation NN O
( ( O
M368V NNP O
) ) O
, , O
detected VBN O
by IN O
mutational JJ O
and CC O
polymorphism NN O
analysis NN O
of IN O
the DT O
HGO NNP O
gene NN O
in IN O
five CD O
Finnish JJ O
AKU NNP B-Disease
pedigrees NNS O
. . O

The DT O
three CD O
novel NN O
AKU NNP B-Disease
mutations NNS O
are VBP O
most RBS O
likely JJ O
specific NN O
for IN O
the DT O
Finnish JJ O
population NN O
and CC O
have VBP O
originated VBN O
recently RB O
. . O
. . O

The DT O
identical JJ O
5 CD O
' POS O
splice NN O
- : O
site NN O
acceptor NN O
mutation NN O
in IN O
five CD O
attenuated JJ B-Disease
APC NNP I-Disease
families NNS O
from IN O
Newfoundland NNP O
demonstrates VBZ O
a DT O
founder NN O
effect NN O
. . O

Inherited VBN O
mutations NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
predispose JJ O
carriers NNS O
to TO O
multiple VB O
adenomatous JJ B-Disease
polyps NNS I-Disease
of IN I-Disease
the DT I-Disease
colon NN I-Disease
and CC I-Disease
rectum NN I-Disease
and CC O
to TO O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

Mutations NNS O
located VBN O
at IN O
the DT O
extreme JJ O
5 CD O
end NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
, , O
however RB O
, , O
are VBP O
associated VBN O
with IN O
a DT O
less RBR O
severe JJ O
disease NN O
known VBN O
as IN O
attenuated JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
AAPC NNP B-Disease
) ) O
. . O

Many JJ O
individuals NNS O
with IN O
AAPC NNP B-Disease
develop VBP O
relatively RB O
few JJ O
colorectal JJ B-Disease
polyps NNS I-Disease
but CC O
are VBP O
still RB O
at IN O
high JJ O
risk NN O
for IN O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
a DT O
5 CD O
APC NNP B-Disease
germline NN O
mutation NN O
in IN O
five CD O
separately RB O
ascertained VBN O
AAPC NNP B-Disease
families NNS O
from IN O
Newfoundland NNP O
, , O
Canada NNP O
. . O

This DT O
disease NN O
- : O
causing NN O
mutation NN O
is VBZ O
a DT O
single JJ O
basepair NN O
change NN O
( ( O
G NNP O
to TO O
A NNP O
) ) O
in IN O
the DT O
splice NN O
- : O
acceptor NN O
region NN O
of IN O
APC NNP B-Disease
intron NN O
3 CD O
that WDT O
creates VBZ O
a DT O
mutant JJ O
RNA NNP O
without IN O
exon RB O
4 CD O
of IN O
APC NNP O
. . O

The DT O
observation NN O
of IN O
the DT O
same JJ O
APC NNP B-Disease
mutation NN O
in IN O
five CD O
families NNS O
from IN O
the DT O
same JJ O
geographic JJ O
area NN O
demonstrates VBZ O
a DT O
founder NN O
effect NN O
. . O

Furthermore RB O
, , O
the DT O
identification NN O
of IN O
this DT O
germline JJ O
mutation NN O
strengthens VBZ O
the DT O
correlation NN O
between IN O
the DT O
5 CD O
location NN O
of IN O
an DT O
APC NNP B-Disease
disease NN O
- : O
causing NN O
mutation NN O
and CC O
the DT O
attenuated JJ B-Disease
polyposis NN I-Disease
phenotype NN O
. . O
. . O

Alstrom IN B-Disease
syndrome NN I-Disease
: : O
further JJ O
evidence NN O
for IN O
linkage NN O
to TO O
human JJ O
chromosome NN O
2p13 CD O
. . O

Alstrom NNP B-Disease
syndrome NN I-Disease
is VBZ O
a DT O
rare JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
retinal JJ B-Disease
degeneration NN I-Disease
, , O
sensorineural JJ B-Disease
hearing NN I-Disease
loss NN I-Disease
, , O
early JJ O
- : O
onset NN O
obesity NN B-Disease
, , O
and CC O
non SYM B-Disease
- : I-Disease
insulin NN I-Disease
- : I-Disease
dependent NN I-Disease
diabetes VBZ I-Disease
mellitus NNS I-Disease
. . O

The DT O
gene NN O
for IN O
Alstrom NNP B-Disease
syndrome NN I-Disease
( ( O
ALMS1 NNP O
) ) O
has VBZ O
been VBN O
previously RB O
localized VBN O
to TO O
human JJ O
chromosome NN O
2p13 CD O
by IN O
homozygosity NN O
mapping NN O
in IN O
two CD O
distinct JJ O
isolated VBD O
populations NNS O
- : O
French JJ O
Acadian NNP O
and CC O
North JJ O
African NNP O
. . O

Pair NNP O
- : O
wise NN O
analyses NNS O
resulted VBD O
in IN O
maximum JJ O
lod NN O
( ( O
logarithm NN O
of IN O
the DT O
odds NNS O
ratio NN O
) ) O
scores NNS O
of IN O
3 CD O
. . O

84 CD O
and CC O
2 CD O
. . O

9 CD O
, , O
respectively RB O
. . O

To TO O
confirm VB O
these DT O
findings NNS O
, , O
a DT O
large JJ O
linkage NN O
study NN O
was VBD O
performed VBN O
in IN O
twelve JJ O
additional JJ O
families NNS O
segregating VBG O
for IN O
Alstrom NNP B-Disease
syndrome NN I-Disease
. . O

A DT O
maximum JJ O
two CD O
- : O
point NN O
lod VBZ O
score NN O
of IN O
7 CD O
. . O

13 CD O
( ( O
theta NN O
= RB O
0 CD O
. . O
0 CD O
) ) O
for IN O
marker NN O
D2S2110 NNP O
and CC O
a DT O
maximum JJ O
cumulative JJ O
multipoint NN O
lod VBD O
score NN O
of IN O
9 CD O
. . O

16 CD O
for IN O
marker NN O
D2S2110 NNP O
were VBD O
observed VBN O
, , O
further RBR O
supporting VBG O
linkage NN O
to TO O
chromosome VB O
2p13 CD O
. . O

No DT O
evidence NN O
of IN O
genetic JJ O
heterogeneity NN O
was VBD O
observed VBN O
in IN O
these DT O
families NNS O
. . O

Meiotic JJ O
recombination NN O
events NNS O
have VBP O
localized VBN O
the DT O
critical JJ O
region NN O
containing VBG O
ALMS1 NNP O
to TO O
a DT O
6 CD O
. . O

1 CD O
- : O
cM NN O
interval NN O
flanked VBN O
by IN O
markers NNS O
D2S327 NNP O
and CC O
D2S286 NNP O
. . O

A DT O
fine JJ O
resolution NN O
radiation NN O
hybrid JJ O
map NN O
of IN O
31 CD O
genes NNS O
and CC O
markers NNS O
has VBZ O
been VBN O
constructed VBN O
. . O

Pendred VBN B-Disease
syndrome NN I-Disease
: : O
phenotypic NN O
variability NN O
in IN O
two CD O
families NNS O
carrying VBG O
the DT O
same JJ O
PDS NNP B-Disease
missense NN O
mutation NN O
. . O

Pendred NNP B-Disease
syndrome NN I-Disease
comprises NNS O
congenital JJ B-Disease
sensorineural JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
, , O
thyroid JJ B-Disease
goiter NN I-Disease
, , O
and CC O
positive JJ O
perchlorate NN O
discharge NN O
test NN O
. . O

Recently RB O
, , O
this DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
was VBD O
shown VBN O
to TO O
be VB O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
PDS NNP B-Disease
gene NN O
, , O
which WDT O
encodes VBZ O
an DT O
anion NN O
transporter NN O
called VBN O
pendrin NN O
. . O

Molecular JJ O
analysis NN O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
was VBD O
performed VBN O
in IN O
two CD O
consanguineous JJ O
large JJ O
families NNS O
from IN O
Southern NNP O
Tunisia NNP O
comprising VBG O
a DT O
total NN O
of IN O
23 CD O
individuals NNS O
affected VBN O
with IN O
profound JJ O
congenital JJ B-Disease
deafness NN I-Disease
; : O
the DT O
same JJ O
missense NN O
mutation NN O
, , O
L445W NNP O
, , O
was VBD O
identified VBN O
in IN O
all DT O
affected JJ O
individuals NNS O
. . O

A DT O
widened JJ B-Disease
vestibular JJ I-Disease
aqueduct NN I-Disease
was VBD O
found VBN O
in IN O
all DT O
patients NNS O
who WP O
underwent VBP O
computed VBN O
tomography NN O
( ( O
CT NNP O
) ) O
scan JJ O
exploration NN O
of IN O
the DT O
inner JJ O
ear NN O
. . O

In IN O
contrast NN O
, , O
goiter NN B-Disease
was VBD O
present JJ O
in IN O
only RB O
11 CD O
affected JJ O
individuals NNS O
, , O
who WP O
interestingly RB O
had VBD O
a DT O
normal JJ O
result NN O
of IN O
the DT O
perchlorate NN O
discharge NN O
test NN O
whenever NN O
performed VBD O
. . O

The DT O
present JJ O
results NNS O
question VBP O
the DT O
sensitivity NN O
of IN O
the DT O
perchlorate NN O
test NN O
for IN O
the DT O
diagnosis NN O
of IN O
Pendred NNP B-Disease
syndrome NN I-Disease
and CC O
support VB O
the DT O
use NN O
of IN O
a DT O
molecular JJ O
analysis NN O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
in IN O
the DT O
assessment NN O
of IN O
individuals NNS O
with IN O
severe JJ O
to TO O
profound VB O
congenital JJ B-Disease
hearing NN I-Disease
loss NN I-Disease
associated VBN O
with IN O
inner JJ B-Disease
ear JJ I-Disease
morphological JJ I-Disease
anomaly NN I-Disease
even RB O
in IN O
the DT O
absence NN O
of IN O
a DT O
thyroid JJ B-Disease
goiter NN I-Disease
. . O
. . O

Knobloch NNP B-Disease
syndrome NN I-Disease
involving VBG O
midline NN B-Disease
scalp NN I-Disease
defect NN I-Disease
of IN I-Disease
the DT I-Disease
frontal JJ I-Disease
region NN I-Disease
. . O

We PRP O
report VBP O
on IN O
a DT O
4 CD O
- : O
year NN O
- : O
old JJ O
boy NN O
with IN O
Knobloch NNP B-Disease
syndrome NN I-Disease
. . O

He PRP O
has VBZ O
vitreoretinal JJ B-Disease
degeneration NN I-Disease
, , O
high JJ B-Disease
myopia NN I-Disease
, , O
cataract NN B-Disease
, , O
telecanthus RB B-Disease
, , O
hypertelorism NN B-Disease
, , O
and CC O
a DT O
high JJ B-Disease
- : I-Disease
arched JJ I-Disease
palate NN I-Disease
. . O

He PRP O
also RB O
has VBZ O
a DT O
defect NN B-Disease
of IN I-Disease
the DT I-Disease
anterior JJ I-Disease
midline NN I-Disease
scalp NN I-Disease
with IN O
involvement NN O
of IN O
the DT O
frontal JJ O
bone NN O
as IN O
documented VBN O
by IN O
a DT O
computed JJ O
tomography NN O
( ( O
CT NNP O
) ) O
scan NN O
. . O

The DT O
brain NN O
was VBD O
normal JJ O
on IN O
CT NNP O
scan JJ O
and CC O
magnetic JJ O
resonance NN O
imaging NN O
. . O

We PRP O
present VBP O
a DT O
review NN O
of IN O
the DT O
23 CD O
published VBN O
cases NNS O
with IN O
this DT O
syndrome NN O
. . O

Our PRP$ O
patient NN O
illustrates VBZ O
the DT O
importance NN O
of IN O
investigating VBG O
for IN O
underlying VBG O
ocular JJ O
and CC O
central JJ O
nervous JJ O
system NN O
pathology NN O
whenever WRB O
midline NN B-Disease
scalp NN I-Disease
defects NNS I-Disease
are VBP O
present JJ O
. . O
. . O

The DT O
DNA NNP O
double JJ O
- : O
strand NN O
break NN O
repair NN O
gene NN O
hMRE11 NN O
is VBZ O
mutated VBN O
in IN O
individuals NNS O
with IN O
an DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
- : I-Disease
like IN I-Disease
disorder NN I-Disease
. . O

We PRP O
show VBP O
that IN O
hypomorphic JJ O
mutations NNS O
in IN O
hMRE11 NN O
, , O
but CC O
not RB O
in IN O
ATM NNP O
, , O
are VBP O
present JJ O
in IN O
certain JJ O
individuals NNS O
with IN O
an DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
- : I-Disease
like IN I-Disease
disorder NN I-Disease
( ( O
ATLD NNP B-Disease
) ) O
. . O

The DT O
cellular JJ O
features NNS O
resulting VBG O
from IN O
these DT O
hMRE11 JJ O
mutations NNS O
are VBP O
similar JJ O
to TO O
those DT O
seen VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
as RB O
well RB O
as IN O
NBS NNP B-Disease
and CC O
include VBP O
hypersensitivity NN B-Disease
to TO I-Disease
ionizing VBG I-Disease
radiation NN I-Disease
, , O
radioresistant JJ O
DNA NNP O
synthesis NN O
, , O
and CC O
abrogation NN O
of IN O
ATM NNP O
- : O
dependent JJ O
events NNS O
, , O
such JJ O
as IN O
the DT O
activation NN O
of IN O
Jun NNP O
kinase NN O
following VBG O
exposure NN O
to TO O
gamma VB O
irradiation NN O
. . O

Although IN O
the DT O
mutant JJ O
hMre11 NN O
proteins NNS O
retain VBP O
some DT O
ability NN O
to TO O
interact VB O
with IN O
hRad50 NN O
and CC O
Nbs1 NNP O
, , O
formation NN O
of IN O
ionizing VBG O
radiation NN O
- : O
induced JJ O
hMre11 NN O
and CC O
Nbs1 NNP O
foci NN O
was VBD O
absent JJ O
in IN O
hMRE11 NN O
mutant NN O
cells NNS O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
ATM NNP O
and CC O
the DT O
hMre11 NN O
/ NNP O
hRad50 NN O
/ NNP O
Nbs1 NNP O
protein NN O
complex JJ O
act NN O
in IN O
the DT O
same JJ O
DNA NNP O
damage NN O
response NN O
pathway NN O
and CC O
link NN O
hMre11 NN O
to TO O
the DT O
complex JJ O
pathology NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
. . O
. . O

Mutations NNS O
in IN O
TNFRSF11A NNP O
, , O
affecting VBG O
the DT O
signal JJ O
peptide NN O
of IN O
RANK NNP O
, , O
cause NN O
familial JJ B-Disease
expansile JJ I-Disease
osteolysis NN I-Disease
. . O

Familial NNP B-Disease
expansile JJ I-Disease
osteolysis NN I-Disease
( ( O
FEO NNP B-Disease
, , O
MIM NNP O
174810 CD O
) ) O
is VBZ O
a DT O
rare JJ O
, , O
autosomal JJ B-Disease
dominant JJ I-Disease
bone NN I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
focal JJ O
areas NNS O
of IN O
increased JJ B-Disease
bone NN I-Disease
remodelling NN I-Disease
. . O

The DT O
osteolytic JJ B-Disease
lesions NNS I-Disease
, , O
which WDT O
develop VBP O
usually RB O
in IN O
the DT O
long JJ O
bones NNS O
during IN O
early JJ O
adulthood NN O
, , O
show VBP O
increased VBN O
osteoblast NN O
and CC O
osteoclast JJ O
activity NN O
. . O

Our PRP$ O
previous JJ O
linkage NN O
studies NNS O
mapped VBD O
the DT O
gene NN O
responsible JJ O
for IN O
FEO NNP B-Disease
to TO O
an DT O
interval NN O
of IN O
less JJR O
than IN O
5 CD O
cM NN O
between IN O
D18S64 NNP O
and CC O
D18S51 NNP O
on IN O
chromosome NN O
18q21 CD O
. . O

2 CD O
- : O
21 CD O
2 CD O
- : O
21 CD O
. . O

3 CD O
in IN O
a DT O
large JJ O
Northern NNP O
Irish NNP O
family NN O
. . O

The DT O
gene NN O
encoding VBG O
receptor NN O
activator NN O
of IN O
nuclear JJ O
factor NN O
- : O
kappa NN O
B NNP O
( ( O
RANK NNP O
; : O
ref NN O
. . O
5 CD O
) ) O
, , O
TNFRSF11A NNP O
, , O
maps VBZ O
to TO O
this DT O
region NN O
. . O

RANK NNP O
is VBZ O
essential JJ O
in IN O
osteoclast JJ O
formation NN O
. . O

We PRP O
identified VBD O
two CD O
heterozygous JJ O
insertion NN O
mutations NNS O
in IN O
exon JJ O
1 CD O
of IN O
TNFRSF11A NNP O
in IN O
affected JJ O
members NNS O
of IN O
four CD O
families NNS O
with IN O
FEO NNP B-Disease
or CC O
familial JJ B-Disease
Paget NNP I-Disease
disease NN I-Disease
of IN I-Disease
bone NN I-Disease
( ( O
PDB NNP B-Disease
) ) O
. . O

One CD O
was VBD O
a DT O
duplication NN O
of IN O
18 CD O
bases NNS O
and CC O
the DT O
other JJ O
a DT O
duplication NN O
of IN O
27 CD O
bases NNS O
, , O
both DT O
of IN O
which WDT O
affected VBD O
the DT O
signal JJ O
peptide JJ O
region NN O
of IN O
the DT O
RANK NNP O
molecule NN O
. . O

Expression NN O
of IN O
recombinant JJ O
forms NNS O
of IN O
the DT O
mutant JJ O
RANK NNP O
proteins NNS O
revealed VBD O
perturbations NNS O
in IN O
expression NN O
levels NNS O
and CC O
lack NN O
of IN O
normal JJ O
cleavage NN O
of IN O
the DT O
signal JJ O
peptide NN O
. . O

Both DT O
mutations NNS O
caused VBD O
an DT O
increase NN O
in IN O
RANK NNP O
- : O
mediated VBD O
nuclear JJ O
factor NN O
- : O
kappaB NN O
( ( O
NF NNP O
- : O
kappaB NN O
) ) O
signalling NN O
in IN O
vitro NN O
, , O
consistent JJ O
with IN O
the DT O
presence NN O
of IN O
an DT O
activating JJ O
mutation NN O
. . O

Cardiac NNP O
Na NNP O
( ( O
+ NNP O
) ) O
channel NN O
dysfunction NN O
in IN O
Brugada NNP B-Disease
syndrome NN I-Disease
is VBZ O
aggravated VBN O
by IN O
beta NN O
( ( O
1 CD O
) ) O
- : O
subunit NN O
. . O

BACKGROUND NNP O
Mutations NNP O
in IN O
the DT O
gene NN O
encoding VBG O
the DT O
human JJ O
cardiac NN O
Na NNP O
( ( O
+ NNP O
) ) O
channel NN O
alpha SYM O
- : O
subunit NN O
( ( O
hH1 NN O
) ) O
are VBP O
responsible JJ O
for IN O
chromosome NN O
3 CD O
- : O
linked VBN O
congenital JJ B-Disease
long JJ I-Disease
- : I-Disease
QT NN I-Disease
syndrome NN I-Disease
( ( O
LQT3 NNP B-Disease
) ) O
and CC O
idiopathic JJ B-Disease
ventricular JJ I-Disease
fibrillation NN I-Disease
( ( O
IVF NNP B-Disease
) ) O
. . O

An DT O
auxiliary JJ O
beta NN O
( ( O
1 CD O
) ) O
- : O
subunit NN O
, , O
widely RB O
expressed VBN O
in IN O
excitable JJ O
tissues NNS O
, , O
shifts VBP O
the DT O
voltage NN O
dependence NN O
of IN O
steady JJ O
- : O
state NN O
inactivation NN O
toward IN O
more RBR O
negative JJ O
potentials NNS O
and CC O
restores NNS O
normal JJ O
gating VBG O
kinetics NNS O
of IN O
brain NN O
and CC O
skeletal JJ O
muscle NN O
Na NNP O
( ( O
+ NNP O
) ) O
channels NNS O
expressed VBN O
in IN O
Xenopus NNP O
oocytes NNS O
but CC O
has VBZ O
little RB O
if IN O
any DT O
functional JJ O
effect NN O
on IN O
the DT O
cardiac JJ O
isoform NN O
. . O

Here RB O
, , O
we PRP O
characterize VBP O
the DT O
altered JJ O
effects NNS O
of IN O
a DT O
human JJ O
beta NN O
( ( O
1 CD O
) ) O
- : O
subunit NN O
( ( O
hbeta NN O
( ( O
1 CD O
) ) O
) ) O
on IN O
the DT O
heterologously RB O
expressed VBN O
hH1 NN O
mutation NN O
( ( O
T1620M NNP O
) ) O
previously RB O
associated VBN O
with IN O
IVF NNP B-Disease
. . O

METHODS NNP O
AND CC O
RESULTS NNP O
When WRB O
expressed VBD O
alone RB O
in IN O
Xenopus NNP O
oocytes NNS O
, , O
T1620M NNP O
exhibited VBD O
no DT O
persistent JJ O
currents NNS O
, , O
in IN O
contrast NN O
to TO O
the DT O
LQT3 NNP B-Disease
mutant NN O
channels NNS O
, , O
but CC O
the DT O
midpoint NN O
of IN O
steady JJ O
- : O
state NN O
inactivation NN O
( ( O
V NNP O
( ( O
1 CD O
/ RB O
2 CD O
) ) O
) ) O
was VBD O
significantly RB O
shifted VBN O
toward IN O
more RBR O
positive JJ O
potentials NNS O
than IN O
for IN O
wild JJ O
- : O
type NN O
hH1 NN O
. . O

Coexpression NN O
of IN O
hbeta NN O
( ( O
1 CD O
) ) O
did VBD O
not RB O
significantly RB O
alter RBR O
current JJ O
decay NN O
or CC O
recovery NN O
from IN O
inactivation NN O
of IN O
wild JJ O
- : O
type NN O
hH1 NN O
; : O
however RB O
, , O
it PRP O
further RB O
shifted VBD O
the DT O
V NNP O
( ( O
1 CD O
/ RB O
2 CD O
) ) O
and CC O
accelerated VBD O
the DT O
recovery NN O
from IN O
inactivation NN O
of IN O
T1620M NNP O
. . O

Oocyte NNP O
macropatch NN O
analysis NN O
revealed VBD O
that IN O
the DT O
activation NN O
kinetics NNS O
of IN O
T1620M NNP O
were VBD O
normal JJ O
. . O

CONCLUSIONS NN O
It PRP O
is VBZ O
suggested VBN O
that IN O
coexpression NN O
of IN O
hbeta NN O
( ( O
1 CD O
) ) O
exposes VBZ O
a DT O
more RBR O
severe JJ O
functional JJ O
defect NN O
that WDT O
results NNS O
in IN O
a DT O
greater JJR O
overlap NN O
in IN O
the DT O
relationship NN O
between IN O
channel NN O
inactivation NN O
and CC O
activation NN O
( ( O
window JJ O
current JJ O
) ) O
in IN O
T1620M NNP O
, , O
which WDT O
is VBZ O
proposed VBN O
to TO O
be VB O
a DT O
potential JJ O
pathophysiological JJ O
mechanism NN O
of IN O
IVF NNP B-Disease
in IN O
vivo NN O
. . O

One CD O
possible JJ O
explanation NN O
for IN O
our PRP$ O
finding NN O
is VBZ O
an DT O
altered JJ O
alpha NN O
- : O
/ NN O
beta NN O
( ( O
1 CD O
) ) O
- : O
subunit NN O
association NN O
in IN O
the DT O
mutant NN O
. . O
. . O

Meiotic JJ O
segregation NN O
analysis NN O
of IN O
RB1 NNP O
alleles NNS O
in IN O
retinoblastoma NN B-Disease
pedigrees NNS O
by IN O
use NN O
of IN O
single JJ O
- : O
sperm NN O
typing NN O
. . O

In IN O
hereditary JJ B-Disease
retinoblastoma NN I-Disease
, , O
different JJ O
epidemiological JJ O
studies NNS O
have VBP O
indicated VBN O
a DT O
preferential JJ O
paternal JJ O
transmission NN O
of IN O
mutant JJ O
retinoblastoma NN B-Disease
alleles NNS O
to TO O
offspring VBG O
, , O
suggesting VBG O
the DT O
occurrence NN O
of IN O
a DT O
meiotic JJ O
drive NN O
. . O

To TO O
investigate VB O
this DT O
mechanism NN O
, , O
we PRP O
analyzed VBD O
sperm JJ O
samples NNS O
from IN O
six CD O
individuals NNS O
from IN O
five CD O
unrelated JJ O
families NNS O
affected VBN O
with IN O
hereditary JJ B-Disease
retinoblastoma NN I-Disease
. . O

Single NNP O
- : O
sperm NN O
typing VBG O
techniques NNS O
were VBD O
performed VBN O
for IN O
each DT O
sample NN O
by IN O
study NN O
of IN O
two CD O
informative JJ O
short JJ O
tandem NN O
repeats NNS O
located VBD O
either RB O
in IN O
or CC O
close VB O
to TO O
the DT O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
. . O

The DT O
segregation NN O
probability NN O
of IN O
mutant JJ O
RB1 NNP O
alleles NNS O
in IN O
sperm JJ O
samples NNS O
was VBD O
assessed VBN O
by IN O
use NN O
of IN O
the DT O
SPERMSEG NNP O
program NN O
, , O
which WDT O
includes VBZ O
experimental JJ O
parameters NNS O
, , O
recombination NN O
fractions NNS O
between IN O
the DT O
markers NNS O
, , O
and CC O
segregation NN O
parameters NNS O
. . O

A DT O
total NN O
of IN O
2 CD O
, , O
952 CD O
single JJ O
sperm NN O
from IN O
the DT O
six CD O
donors NNS O
were VBD O
analyzed VBN O
. . O

We PRP O
detected VBD O
a DT O
significant JJ O
segregation NN O
distortion NN O
in IN O
the DT O
data NN O
as IN O
a DT O
whole NN O
( ( O
P NNP O
= NNP O
. . O
99 CD O
) ) O
and CC O
a DT O
significant JJ O
heterogeneity NN O
in IN O
the DT O
segregation NN O
rate NN O
across IN O
donors NNS O
( ( O
. . O
92 CD O
) ) O
. . O

Further JJ O
analysis NN O
shows VBZ O
that IN O
this DT O
result NN O
can MD O
be VB O
explained VBN O
by IN O
segregation NN O
distortion NN O
in IN O
favor NN O
of IN O
the DT O
normal JJ O
allele NN O
in IN O
one CD O
donor NN O
only RB O
and CC O
that IN O
it PRP O
does VBZ O
not RB O
provide VB O
evidence NN O
of IN O
a DT O
significant JJ O
segregation NN O
distortion NN O
in IN O
the DT O
other JJ O
donors NNS O
. . O

The DT O
segregation NN O
distortion NN O
favoring VBG O
the DT O
mutant JJ O
RB1 NNP O
allele NN O
does VBZ O
not RB O
seem VB O
to TO O
occur VB O
during IN O
spermatogenesis NN O
, , O
and CC O
, , O
thus RB O
, , O
meiotic JJ O
drive NN O
may MD O
result VB O
either CC O
from IN O
various JJ O
mechanisms NNS O
, , O
including VBG O
a DT O
fertilization NN O
advantage NN O
or CC O
a DT O
better JJR O
mobility NN O
in IN O
sperm JJ O
bearing VBG O
a DT O
mutant JJ O
RB1 NNP O
gene NN O
, , O
or CC O
from IN O
the DT O
existence NN O
of IN O
a DT O
defectively RB O
imprinted JJ O
gene NN O
located VBN O
on IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
: : O
an DT O
overview NN O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
, , O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
neurodegenerative JJ I-Disease
disease NN I-Disease
, , O
is VBZ O
the DT O
most RBS O
common JJ O
of IN O
the DT O
inherited JJ B-Disease
ataxias NN I-Disease
. . O

The DT O
recent JJ O
discovery NN O
of IN O
the DT O
gene NN O
that WDT O
is VBZ O
mutated VBN O
in IN O
this DT O
condition NN O
, , O
FRDA NNP O
, , O
has VBZ O
led VBN O
to TO O
rapid JJ O
advances NNS O
in IN O
the DT O
understanding NN O
of IN O
the DT O
pathogenesis NN O
of IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
. . O

About RB O
98 CD O
% NN O
of IN O
mutant JJ O
alleles NNS O
have VBP O
an DT O
expansion NN O
of IN O
a DT O
GAA NNP O
trinucleotide NN O
repeat NN O
in IN O
intron NN O
1 CD O
of IN O
the DT O
gene NN O
. . O

This DT O
leads VBZ O
to TO O
reduced JJ O
levels NNS O
of IN O
the DT O
protein NN O
, , O
frataxin NN O
. . O

There EX O
is VBZ O
mounting VBG O
evidence NN O
to TO O
suggest VB O
that IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
is VBZ O
the DT O
result NN O
of IN O
accumulation NN O
of IN O
iron NN O
in IN O
mitochondria NN O
leading VBG O
to TO O
excess JJ O
production NN O
of IN O
free JJ O
radicals NNS O
, , O
which WDT O
then RB O
results NNS O
in IN O
cellular JJ O
damage NN O
and CC O
death NN O
. . O

Currently RB O
there EX O
is VBZ O
no DT O
known JJ O
treatment NN O
that WDT O
alters VBZ O
the DT O
natural JJ O
course NN O
of IN O
the DT O
disease NN O
. . O

The DT O
discovery NN O
of IN O
the DT O
FRDA NNP B-Disease
gene NN O
and CC O
its PRP$ O
possible JJ O
function NN O
has VBZ O
raised VBN O
hope NN O
that IN O
rational JJ O
therapeutic JJ O
strategies NNS O
will MD O
be VB O
developed VBN O
. . O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
retinoschisis NN I-Disease
with IN O
point NN O
mutations NNS O
in IN O
the DT O
XLRS1 NNP O
gene NN O
. . O

BACKGROUND NNP O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
retinoschisis NN I-Disease
( ( O
XLRS NNP B-Disease
) ) O
is VBZ O
a DT O
relatively RB O
rare JJ O
vitreoretinal JJ B-Disease
dystrophy NN I-Disease
that WDT O
causes VBZ O
visual JJ B-Disease
loss NN I-Disease
in IN O
young JJ O
men NNS O
. . O

Recently RB O
, , O
a DT O
gene NN O
responsible JJ O
for IN O
this DT O
disease NN O
, , O
designated VBN O
XLRS1 NN O
, , O
was VBD O
identified VBN O
, , O
and CC O
several JJ O
deleterious JJ O
gene NN O
mutations NNS O
were VBD O
reported VBN O
. . O

OBJECTIVE NN O
To TO O
analyze VB O
Japanese JJ O
patients NNS O
clinically RB O
diagnosed VBN O
as IN O
having VBG O
XLRS NNP B-Disease
formutational JJ O
changes NNS O
in IN O
the DT O
XLRS1 NNP O
gene NN O
. . O

METHODS NNP O
Ten CD O
patients NNS O
with IN O
XLRS NNP B-Disease
underwent JJ O
full JJ O
ophthalmologic NN O
examination NN O
, , O
including VBG O
slitlamp JJ O
biomicroscopy NN O
and CC O
dilated VBD O
funduscopy NN O
. . O

Genomic NNP O
DNA NNP O
was VBD O
isolated VBN O
from IN O
leukocytes NNS O
, , O
and CC O
all DT O
exons NNS O
of IN O
the DT O
XLRS1 NNP O
gene NN O
were VBD O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
and CC O
analyzed VBD O
using VBG O
a DT O
direct JJ O
sequencing NN O
method NN O
. . O

RESULTS NNP O
Point NNP O
mutations NNS O
in IN O
the DT O
XLRS1 NNP O
gene NN O
were VBD O
identified VBN O
in IN O
all DT O
10 CD O
patients NNS O
. . O

The DT O
mutations NNS O
were VBD O
identical JJ O
in IN O
each DT O
of IN O
2 CD O
pairs NNS O
of IN O
brothers NNS O
. . O

Six CD O
of IN O
the DT O
point NN O
mutations NNS O
represented VBD O
missense JJ O
mutations NNS O
, , O
1 CD O
was VBD O
a DT O
nonsense JJ O
mutation NN O
, , O
and CC O
1 CD O
was VBD O
a DT O
frameshift JJ O
mutation NN O
. . O

Five CD O
of IN O
the DT O
mutations NNS O
are VBP O
newly RB O
reported VBN O
herein NN O
. . O

CONCLUSIONS NNP O
The DT O
discovery NN O
of IN O
new JJ O
point NN O
mutations NNS O
in IN O
this DT O
study NN O
increases VBZ O
the DT O
available JJ O
information NN O
regarding VBG O
the DT O
spectrum NN O
of IN O
genetic JJ B-Disease
abnormalities NNS I-Disease
and CC O
clinical JJ O
manifestations NNS O
of IN O
XLRS NNP B-Disease
. . O

However RB O
, , O
the DT O
limited JJ O
data NNS O
failed VBD O
to TO O
reveal VB O
a DT O
correlation NN O
between IN O
mutation NN O
and CC O
disease NN O
phenotype NN O
. . O

CLINICAL JJ O
RELEVANCE NNP O
Identification NNP O
of IN O
mutations NNS O
in IN O
the DT O
XLRS1 NNP O
gene NN O
and CC O
expanded VBN O
information NN O
on IN O
clinical JJ O
manifestations NNS O
will MD O
facilitate VB O
early JJ O
diagnosis NN O
, , O
appropriate JJ O
early JJ O
therapy NN O
, , O
and CC O
genetic JJ O
counseling NN O
regarding VBG O
the DT O
prognosis NN O
of IN O
XLRS NNP B-Disease
. . O
. . O

Atm NNP O
and CC O
Bax NNP O
cooperate NN O
in IN O
ionizing VBG O
radiation NN O
- : O
induced JJ O
apoptosis NN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
is VBZ O
a DT O
hereditary JJ B-Disease
multisystemic JJ I-Disease
disease NN I-Disease
resulting VBG O
from IN O
mutations NNS O
of IN O
ataxia NN B-Disease
telangiectasia NN I-Disease
, , O
mutated VBN O
( ( O
ATM NNP O
) ) O
and CC O
is VBZ O
characterized VBN O
by IN O
neurodegeneration NN B-Disease
, , O
cancer NN B-Disease
, , O
immune JJ B-Disease
defects NNS I-Disease
, , O
and CC O
hypersensitivity NN B-Disease
to TO I-Disease
ionizing VBG I-Disease
radiation NN I-Disease
. . O

The DT O
molecular JJ O
details NNS O
of IN O
ATM NNP O
function NN O
in IN O
the DT O
nervous JJ O
system NN O
are VBP O
unclear JJ O
, , O
although IN O
the DT O
neurological JJ B-Disease
lesion NN I-Disease
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
becomes VBZ O
apparent JJ O
early JJ O
in IN O
life NN O
, , O
suggesting VBG O
a DT O
developmental JJ O
origin NN O
. . O

The DT O
central JJ O
nervous JJ O
system NN O
( ( O
CNS NNP O
) ) O
of IN O
Atm NNP O
- : O
null NN O
mice NN O
shows VBZ O
a DT O
pronounced JJ O
defect NN O
in IN O
apoptosis NN O
induced VBN O
by IN O
genotoxic NN O
stress NN O
, , O
suggesting VBG O
ATM NNP O
functions NNS O
to TO O
eliminate VB O
neurons NNS O
with IN O
excessive JJ O
genomic JJ O
damage NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
the DT O
death NN O
effector NN O
Bax NNP O
is VBZ O
required VBN O
for IN O
a DT O
large JJ O
proportion NN O
of IN O
Atm NNP O
- : O
dependent JJ O
apoptosis NN O
in IN O
the DT O
developing NN O
CNS NNP O
after IN O
ionizing VBG O
radiation NN O
( ( O
IR NNP O
) ) O
. . O

Although IN O
many JJ O
of IN O
the DT O
same JJ O
regions NNS O
of IN O
the DT O
CNS NNP O
in IN O
both DT O
Bax NNP O
- : O
/ SYM O
- : O
and CC O
Atm NNP O
- : O
/ SYM O
- : O
mice NN O
were VBD O
radioresistant JJ O
, , O
mice RB O
nullizygous JJ O
for IN O
both DT O
Bax NNP O
and CC O
Atm NNP O
showed VBD O
additional JJ O
reduction NN O
in IN O
IR NNP O
- : O
induced JJ O
apoptosis NN O
in IN O
the DT O
CNS NNP O
. . O

Therefore RB O
, , O
although IN O
the DT O
major JJ O
IR NNP O
- : O
induced VBD O
apoptotic JJ O
pathway NN O
in IN O
the DT O
CNS NNP O
requires VBZ O
Atm NNP O
and CC O
Bax NNP O
, , O
a DT O
p53 NN O
- : O
dependent JJ O
collateral JJ O
pathway NN O
exists VBZ O
that WDT O
has VBZ O
both DT O
Atm NNP O
- : O
and CC O
Bax NNP O
- : O
independent JJ O
branches NNS O
. . O

Further RB O
, , O
Atm NNP O
- : O
and CC O
Bax NNP O
- : O
dependent JJ O
apoptosis NN O
in IN O
the DT O
CNS NNP O
also RB O
required VBD O
caspase NN O
- : O
3 CD O
activation NN O
. . O

These DT O
data NNS O
implicate NN O
Bax NNP O
and CC O
caspase VB O
- : O
3 CD O
as IN O
death NN O
effectors NNS O
in IN O
neurodegenerative JJ O
pathways NNS O
. . O
. . O

Haim NNP B-Disease
- : I-Disease
Munk NNP I-Disease
syndrome NN I-Disease
and CC O
Papillon NNP B-Disease
- : I-Disease
Lefevre NNP I-Disease
syndrome NN I-Disease
are VBP O
allelic JJ O
mutations NNS O
in IN O
cathepsin NN O
C NNP O
. . O

Of IN O
the DT O
many JJ O
palmoplantar NN B-Disease
keratoderma NNS I-Disease
( ( I-Disease
PPK NNP I-Disease
) ) I-Disease
conditions NNS I-Disease
, , O
only RB O
Papillon NNP B-Disease
- : I-Disease
Lefevre NNP I-Disease
syndrome NN I-Disease
( ( O
PLS NNP B-Disease
) ) O
and CC O
Haim NNP B-Disease
- : I-Disease
Munk NNP I-Disease
syndrome NN I-Disease
( ( O
HMS NNP B-Disease
) ) O
are VBP O
associated VBN O
with IN O
premature JJ O
periodontal JJ O
destruction NN O
. . O

Although IN O
both DT O
PLS NNP B-Disease
and CC O
HMS NNP B-Disease
share NN O
the DT O
cardinal JJ O
features NNS O
of IN O
PPK NNP B-Disease
and CC O
severe JJ O
periodontitis NN B-Disease
, , O
a DT O
number NN O
of IN O
additional JJ O
findings NNS O
are VBP O
reported VBN O
in IN O
HMS NNP B-Disease
including VBG O
arachnodactyly NN B-Disease
, , O
acro SYM B-Disease
- : I-Disease
osteolysis NN I-Disease
, , O
atrophic JJ B-Disease
changes NNS I-Disease
of IN I-Disease
the DT I-Disease
nails NNS I-Disease
, , O
and CC O
a DT O
radiographic JJ B-Disease
deformity NN I-Disease
of IN I-Disease
the DT I-Disease
fingers NNS I-Disease
. . O

While IN O
PLS NNP B-Disease
cases NNS O
have VBP O
been VBN O
identified VBN O
throughout IN O
the DT O
world NN O
, , O
HMS NNP B-Disease
has VBZ O
only RB O
been VBN O
described VBN O
among IN O
descendants NNS O
of IN O
a DT O
religious JJ O
isolate NN O
originally RB O
from IN O
Cochin NNP O
, , O
India NNP O
. . O

Parental JJ O
consanguinity NN O
is VBZ O
a DT O
characteristic JJ O
of IN O
many JJ O
cases NNS O
of IN O
both DT O
conditions NNS O
. . O

Although IN O
autosomal JJ O
recessive JJ O
transmission NN O
of IN O
PLS NNP B-Disease
is VBZ O
evident JJ O
, , O
a DT O
more RBR O
"""" JJ O
complex JJ O
"""" NN O
autosomal JJ O
recessive JJ O
pattern NN O
of IN O
inheritance NN O
with IN O
phenotypic JJ O
influences NNS O
from IN O
a DT O
closely RB O
linked VBN O
modifying NN O
locus NN O
has VBZ O
been VBN O
hypothesised VBN O
for IN O
HMS NNP B-Disease
. . O

Recently RB O
, , O
mutations NNS O
of IN O
the DT O
cathepsin NN O
C NNP O
gene NN O
have VBP O
been VBN O
identified VBN O
as IN O
the DT O
underlying JJ O
genetic JJ B-Disease
defect NN I-Disease
in IN O
PLS NNP B-Disease
. . O

To TO O
determine VB O
if IN O
a DT O
cathepsin NN O
C NNP O
mutation NN O
is VBZ O
also RB O
responsible JJ O
for IN O
HMS NNP B-Disease
, , O
we PRP O
sequenced VBD O
the DT O
gene NN O
in IN O
affected JJ O
and CC O
unaffected JJ O
subjects NNS O
from IN O
the DT O
Cochin NNP O
isolate NN O
in IN O
which WDT O
both CC O
the DT O
PLS NNP B-Disease
and CC O
HMS NNP B-Disease
phenotypes NNS O
appear VBP O
. . O

Here RB O
we PRP O
report VBP O
identification NN O
of IN O
a DT O
mutation NN O
of IN O
cathepsin NN O
C NNP O
( ( O
exon JJ O
6 CD O
, , O
2127A CD O
- : O
- : O
> NN O
G NNP O
) ) O
that WDT O
changes VBZ O
a DT O
highly RB O
conserved VBN O
amino NN O
acid NN O
in IN O
the DT O
cathepsin NN O
C NNP O
peptide NN O
. . O

This DT O
mutation NN O
segregates VBZ O
with IN O
HMS NNP B-Disease
in IN O
four CD O
nuclear JJ O
families NNS O
. . O

Additionally RB O
, , O
the DT O
existence NN O
of IN O
a DT O
shared JJ O
common JJ O
haplotype NN O
for IN O
genetic JJ O
loci NN O
flanking VBG O
the DT O
cathepsin NN O
C NNP O
gene NN O
suggests VBZ O
that IN O
affected JJ O
subjects NNS O
descended VBN O
from IN O
the DT O
Cochin NNP O
isolate NN O
are VBP O
homozygous JJ O
for IN O
a DT O
mutation NN O
inherited VBN O
"""" NNP O
identical JJ O
by IN O
descent JJ O
"""" NN O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

This DT O
finding NN O
supports VBZ O
simple JJ O
autosomal JJ O
recessive JJ O
inheritance NN O
for IN O
HMS NNP B-Disease
in IN O
these DT O
families NNS O
. . O

We PRP O
also RB O
report VBP O
a DT O
mutation NN O
of IN O
the DT O
same JJ O
exon NN O
6 CD O
CTSC NNP O
codon NN O
( ( O
2126C CD O
- : O
- : O
> NN O
T NNP O
) ) O
in IN O
a DT O
Turkish JJ O
family NN O
with IN O
classical JJ O
PLS NNP B-Disease
. . O

These DT O
findings NNS O
provide VBP O
evidence NN O
that IN O
PLS NNP B-Disease
and CC O
HMS NNP B-Disease
are VBP O
allelic JJ O
variants NNS O
of IN O
cathepsin NN O
C NNP O
gene NN O
mutations NNS O
. . O
. . O

ATM NNP O
- : O
heterozygous JJ O
germline NN O
mutations NNS O
contribute VBP O
to TO O
breast VB B-Disease
cancer NN I-Disease
- : O
susceptibility NN O
. . O

Approximately RB O
0 CD O
. . O

5 CD O
% NN O
- : O
1 CD O
% NN O
of IN O
the DT O
general JJ O
population NN O
has VBZ O
been VBN O
estimated VBN O
to TO O
be VB O
heterozygous JJ O
for IN O
a DT O
germline JJ O
mutation NN O
in IN O
the DT O
ATM NNP O
gene NN O
. . O

Mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
are VBP O
responsible JJ O
for IN O
the DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
( ( O
MIM NNP O
208900 CD O
) ) O
. . O

The DT O
finding NN O
that WDT O
ATM NNP O
- : O
heterozygotes NNS O
have VBP O
an DT O
increased VBN O
relative NN O
risk NN O
for IN O
breast NN B-Disease
cancer NN I-Disease
was VBD O
supported VBN O
by IN O
some DT O
studies NNS O
but CC O
not RB O
confirmed VBN O
by IN O
others NNS O
. . O

In IN O
view NN O
of IN O
this DT O
discrepancy NN O
, , O
we PRP O
examined VBD O
the DT O
frequency NN O
of IN O
ATM NNP O
germline NN O
mutations NNS O
in IN O
a DT O
selected VBN O
group NN O
of IN O
Dutch JJ O
patients NNS O
with IN O
breast JJ B-Disease
cancer NN I-Disease
. . O

We PRP O
have VBP O
analyzed VBN O
ATM NNP O
germline JJ O
mutations NNS O
in IN O
normal JJ O
blood NN O
lymphocytes NNS O
, , O
using VBG O
the DT O
protein NN O
- : O
truncation NN O
test NN O
followed VBN O
by IN O
genomic JJ O
- : O
sequence NN O
analysis NN O
. . O

A DT O
high JJ O
percentage NN O
of IN O
ATM NNP O
germline NN O
mutations NNS O
was VBD O
demonstrated VBN O
among IN O
patients NNS O
with IN O
sporadic JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O

The DT O
82 CD O
patients NNS O
included VBN O
in IN O
this DT O
study NN O
had VBD O
developed VBN O
breast NN B-Disease
cancer NN I-Disease
at IN O
age NN O
< $ O
45 CD O
and CC O
had VBD O
survived VBN O
> JJ O
/ NNP O
= NNP O
5 CD O
years NNS O
( ( O
mean JJ O
15 CD O
years NNS O
) ) O
, , O
and CC O
in IN O
33 CD O
( ( O
40 CD O
% NN O
) ) O
of IN O
the DT O
patients NNS O
a DT O
contralateral JJ O
breast NN O
tumor NN O
had VBD O
been VBN O
diagnosed VBN O
. . O

Among IN O
these DT O
patients NNS O
we PRP O
identified VBD O
seven CD O
( ( O
8 CD O
. . O
5 CD O
% NN O
) ) O
ATM NNP O
germline NN O
mutations NNS O
, , O
of IN O
which WDT O
five CD O
are VBP O
distinct JJ O
. . O

One CD O
splice NN O
- : O
site NN O
mutation NN O
( ( O
IVS10 NNP O
- : O
6T CD O
- : O
- : O
> NN O
G NNP O
) ) O
was VBD O
detected VBN O
three CD O
times NNS O
in IN O
our PRP$ O
series NN O
. . O

Four CD O
heterozygous JJ O
carriers NNS O
were VBD O
patients NNS O
with IN O
bilateral JJ O
breast NN O
cancer NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
mutations NNS O
identified VBN O
in IN O
this DT O
study NN O
are VBP O
"""" VBZ O
A NNP O
- : O
T NN O
disease NN O
- : O
causing NN O
"""" JJ O
mutations NNS O
that WDT O
might MD O
be VB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
breast NN O
cancer NN O
in IN O
heterozygotes NNS O
. . O

We PRP O
conclude VBP O
that IN O
ATM NNP O
heterozygotes NNS O
have VBP O
an DT O
approximately RB O
ninefold JJ O
- : O
increased VBN O
risk NN O
of IN O
developing VBG O
a DT O
type NN O
of IN O
breast NN O
cancer NN O
characterized VBN O
by IN O
frequent JJ O
bilateral JJ O
occurrence NN O
, , O
early JJ O
age NN O
at IN O
onset NN O
, , O
and CC O
long RB O
- : O
term NN O
survival NN O
. . O

The DT O
specific JJ O
characteristics NNS O
of IN O
our PRP$ O
population NN O
of IN O
patients NNS O
may MD O
explain VB O
why WRB O
such PDT O
a DT O
high JJ O
frequency NN O
was VBD O
not RB O
found VBN O
in IN O
other JJ O
series NN O
. . O

Human JJ O
mutations NNS O
in IN O
glucose JJ O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
reflect VBP O
evolutionary JJ O
history NN O
. . O

Glucose NNP O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
is VBZ O
a DT O
cytosolic JJ O
enzyme NN O
encoded VBN O
by IN O
a DT O
housekeeping NN O
X SYM O
- : O
linked VBN O
gene NN O
whose WP$ O
main JJ O
function NN O
is VBZ O
to TO O
produce VB O
NADPH NNP O
, , O
a DT O
key JJ O
electron NN O
donor NN O
in IN O
the DT O
defense NN O
against IN O
oxidizing VBG O
agents NNS O
and CC O
in IN O
reductive JJ O
biosynthetic JJ O
reactions NNS O
. . O

Inherited VBN O
G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
associated VBN O
with IN O
either DT O
episodic JJ B-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
( ( O
triggered VBN O
by IN O
fava JJ O
beans NNS O
or CC O
other JJ O
agents NNS O
) ) O
or CC O
life NN B-Disease
- : I-Disease
long JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
. . O

We PRP O
show VBP O
here RB O
that IN O
an DT O
evolutionary JJ O
analysis NN O
is VBZ O
a DT O
key JJ O
to TO O
understanding VBG O
the DT O
biology NN O
of IN O
a DT O
housekeeping JJ O
gene NN O
. . O

From IN O
the DT O
alignment NN O
of IN O
the DT O
amino NN O
acid NN O
( ( O
aa NN O
) ) O
sequence NN O
of IN O
52 CD O
glucose JJ O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
species VBZ O
from IN O
42 CD O
different JJ O
organisms NNS O
, , O
we PRP O
found VBD O
a DT O
striking JJ O
correlation NN O
between IN O
the DT O
aa NN O
replacements NNS O
that WDT O
cause VBP O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
humans NNS O
and CC O
the DT O
sequence NN O
conservation NN O
of IN O
G6PD NNP O
two CD O
- : O
thirds NNS O
of IN O
such JJ O
replacements NNS O
are VBP O
in IN O
highly RB O
and CC O
moderately RB O
conserved VBD O
( ( O
50 CD O
- : O
99 CD O
% NN O
) ) O
aa NN O
; : O
relatively RB O
few JJ O
are VBP O
in IN O
fully RB O
conserved VBN O
aa NN O
( ( O
where WRB O
they PRP O
might MD O
be VB O
lethal JJ O
) ) O
or CC O
in IN O
poorly RB O
conserved VBN O
aa NN O
, , O
where WRB O
presumably RB O
they PRP O
simply RB O
would MD O
not RB O
cause VB O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
the DT O
notion NN O
that IN O
all DT O
human JJ O
mutants NNS O
have VBP O
residual JJ O
enzyme NN O
activity NN O
and CC O
that IN O
null JJ O
mutations NNS O
are VBP O
lethal VBN O
at IN O
some DT O
stage NN O
of IN O
development NN O
. . O

Comparing VBG O
the DT O
distribution NN O
of IN O
mutations NNS O
in IN O
a DT O
human JJ O
housekeeping NN O
gene NN O
with IN O
evolutionary JJ O
conservation NN O
is VBZ O
a DT O
useful JJ O
tool NN O
for IN O
pinpointing VBG O
amino NN O
acid NN O
residues NNS O
important JJ O
for IN O
the DT O
stability NN O
or CC O
the DT O
function NN O
of IN O
the DT O
corresponding JJ O
protein NN O
. . O

In IN O
view NN O
of IN O
the DT O
current JJ O
explosive JJ O
increase NN O
in IN O
full JJ O
genome NN O
sequencing VBG O
projects NNS O
, , O
this DT O
tool NN O
will MD O
become VB O
rapidly RB O
available JJ O
for IN O
numerous JJ O
other JJ O
genes NNS O
. . O
. . O

Constitutive JJ O
and CC O
regulated JJ O
modes NNS O
of IN O
splicing VBG O
produce NN O
six CD O
major JJ O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
( ( O
DMPK NNP O
) ) O
isoforms VBZ O
with IN O
distinct JJ O
properties NNS O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
the DT O
most RBS O
prevalent JJ O
inherited JJ B-Disease
neuromuscular JJ I-Disease
disease NN I-Disease
in IN O
adults NNS O
. . O

The DT O
genetic JJ B-Disease
defect NN I-Disease
is VBZ O
a DT O
CTG NNP O
triplet NN O
repeat NN O
expansion NN O
in IN O
the DT O
3 CD O
- : O
untranslated JJ O
region NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
( ( O
DMPK NNP O
) ) O
gene NN O
, , O
consisting VBG O
of IN O
15 CD O
exons NNS O
. . O

Using VBG O
a DT O
transgenic JJ O
DMPK NNP O
- : O
overexpressor NN O
mouse NN O
model NN O
, , O
we PRP O
demonstrate VBP O
here RB O
that IN O
the DT O
endogenous JJ O
mouse NN O
DMPK NNP O
gene NN O
and CC O
the DT O
human JJ O
DMPK NNP O
transgene NN O
produce VBP O
six CD O
major JJ O
alternatively RB O
spliced VBN O
mRNAs NN O
which WDT O
have VBP O
almost RB O
identical JJ O
cell NN O
type SYM O
- : O
dependent JJ O
distribution NN O
frequencies NNS O
and CC O
expression NN O
patterns NNS O
. . O

Use NNP O
of IN O
a DT O
cryptic JJ O
5 CD O
splice NN O
site NN O
in IN O
exon JJ O
8 CD O
, , O
which WDT O
results NNS O
in IN O
absence NN O
or CC O
presence NN O
of IN O
15 CD O
nucleotides NNS O
specifying VBG O
a DT O
VSGGG NNP O
peptide NN O
motif NN O
, , O
and CC O
/ NNP O
or CC O
use NN O
of IN O
a DT O
cryptic JJ O
3 CD O
splice NN O
site NN O
in IN O
exon JJ O
14 CD O
, , O
which WDT O
leads VBZ O
to TO O
a DT O
frameshift NN O
in IN O
the DT O
mRNA NN O
reading NN O
frame NN O
, , O
occur VBP O
as IN O
independent JJ O
stochastic JJ O
events NNS O
in IN O
all DT O
tissues NNS O
examined VBN O
. . O

In IN O
contrast NN O
, , O
the DT O
excision NN O
of IN O
exons NNS O
13 CD O
/ $ O
14 CD O
that WDT O
causes VBZ O
a DT O
frameshift NN O
and CC O
creates VBZ O
a DT O
C NNP O
- : O
terminally RB O
truncated VBN O
protein NN O
is VBZ O
clearly RB O
cell JJ O
type NN O
dependent NN O
and CC O
occurs VBZ O
predominantly RB O
in IN O
smooth JJ O
muscle NN O
. . O

We PRP O
generated VBD O
all DT O
six CD O
full JJ O
- : O
length NN O
mouse NN O
cDNAs NN O
that WDT O
result NN O
from IN O
combinations NNS O
of IN O
these DT O
three CD O
major JJ O
splicing VBG O
events NNS O
and CC O
show VBP O
that IN O
their PRP$ O
transfection NN O
into IN O
cells NNS O
in IN O
culture NN O
leads VBZ O
to TO O
production NN O
of IN O
four CD O
different JJ O
approximately RB O
74 CD O
kDa NNS O
full JJ O
- : O
length NN O
( ( O
heart NN O
- : O
, , O
skeletal JJ O
muscle NN O
- : O
or CC O
brain NN O
- : O
specific NN O
) ) O
and CC O
two CD O
C NNP O
- : O
terminally RB O
truncated VBD O
approximately RB O
68 CD O
kDa NNS O
( ( O
smooth JJ O
muscle NN O
- : O
specific NN O
) ) O
isoforms NNS O
. . O

Information NN O
on IN O
DMPK NNP O
mRNA NN O
and CC O
protein NN O
isoform NN O
expression NN O
patterns NNS O
will MD O
be VB O
useful JJ O
for IN O
recognizing VBG O
differential JJ O
effects NNS O
of IN O
( ( O
CTG NNP O
) ) O
( ( O
n JJ O
) ) O
expansion NN O
in IN O
DM NNP B-Disease
manifestation NN O
. . O
. . O

Genetic JJ O
analysis NN O
, , O
phenotypic NN O
diagnosis NN O
, , O
and CC O
risk NN O
of IN O
venous JJ B-Disease
thrombosis NN I-Disease
in IN O
families NNS O
with IN O
inherited JJ O
deficiencies NNS B-Disease
of IN I-Disease
protein NN I-Disease
S NNP I-Disease
. . O

Protein NNP B-Disease
S NNP I-Disease
deficiency NN I-Disease
is VBZ O
a DT O
recognized VBN O
risk NN O
factor NN O
for IN O
venous JJ B-Disease
thrombosis NN I-Disease
. . O

Of IN O
all PDT O
the DT O
inherited VBN O
thrombophilic JJ B-Disease
conditions NNS I-Disease
, , O
it PRP O
remains VBZ O
the DT O
most RBS O
difficult JJ O
to TO O
diagnose VB O
because IN O
of IN O
phenotypic NN O
variability NN O
, , O
which WDT O
can MD O
lead VB O
to TO O
inconclusive JJ O
results NNS O
. . O

We PRP O
have VBP O
overcome VBN O
this DT O
problem NN O
by IN O
studying VBG O
a DT O
cohort NN O
of IN O
patients NNS O
from IN O
a DT O
single JJ O
center NN O
where WRB O
the DT O
diagnosis NN O
was VBD O
confirmed VBN O
at IN O
the DT O
genetic JJ O
level NN O
. . O

Twenty NNP O
- : O
eight CD O
index NN O
patients NNS O
with IN O
protein JJ B-Disease
S NNP I-Disease
deficiency NN I-Disease
and CC O
a DT O
PROS1 NNP B-Disease
gene NN I-Disease
defect NN I-Disease
were VBD O
studied VBN O
, , O
together RB O
with IN O
109 CD O
first JJ O
- : O
degree NN O
relatives NNS O
. . O

To TO O
avoid VB O
selection NN O
bias NN O
, , O
we PRP O
confined VBD O
analysis NN O
of IN O
total JJ O
and CC O
free JJ O
protein NN O
S NNP O
levels NNS O
and CC O
thrombotic JJ O
risk NN O
to TO O
the DT O
patients NNS O
relatives NNS O
. . O

In IN O
this DT O
group NN O
of IN O
relatives NNS O
, , O
a DT O
low JJ O
free JJ O
protein NN O
S NNP O
level NN O
was VBD O
the DT O
most RBS O
reliable JJ O
predictor NN O
of IN O
a DT O
PROS1 NNP B-Disease
gene NN I-Disease
defect NN I-Disease
( ( O
sensitivity NN O
97 CD O
. . O
7 CD O
% NN O
, , O
specificity NN O
100 CD O
% NN O
) ) O
. . O

First LS O
- : O
degree NN O
relatives VBZ O
with IN O
a DT O
PROS1 NNP B-Disease
gene NN I-Disease
defect NN I-Disease
had VBD O
a DT O
5 CD O
. . O

0 CD O
- : O
fold NN O
higher JJR O
risk NN O
of IN O
thrombosis NN B-Disease
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
1 CD O
. . O
5 CD O
- : O
16 CD O
. . O
8 CD O
) ) O
than IN O
those DT O
with IN O
a DT O
normal JJ O
PROS1 NNP O
gene NN O
and CC O
no DT O
other JJ O
recognized VBN O
thrombophilic JJ B-Disease
defect NN I-Disease
. . O

Although IN O
pregnancy NN O
/ NNP O
puerperium NN O
and CC O
immobility NN O
/ VBP O
trauma NN B-Disease
were VBD O
important JJ O
precipitating NN O
factors NNS O
for IN O
thrombosis NN B-Disease
, , O
almost RB O
half NN O
of IN O
the DT O
events NNS O
were VBD O
spontaneous JJ O
. . O

Relatives NNS O
with IN O
splice NN O
- : O
site NN O
or CC O
major JJ O
structural JJ O
defects NNS B-Disease
in IN I-Disease
the DT I-Disease
PROS1 NNP I-Disease
gene NN I-Disease
were VBD O
more RBR O
likely JJ O
to TO O
have VB O
had VBN O
a DT O
thrombotic JJ O
event NN O
and CC O
had VBD O
significantly RB O
lower JJR O
total NN O
and CC O
free JJ O
protein NN O
S NNP O
levels NNS O
than IN O
those DT O
relatives NNS O
having VBG O
missense JJ O
mutations NNS O
. . O

We PRP O
conclude VBP O
that IN O
persons NNS O
with IN O
PROS1 NNP B-Disease
gene NN I-Disease
defects NNS I-Disease
and CC O
protein NN B-Disease
S NNP I-Disease
deficiency NN I-Disease
are VBP O
at IN O
increased JJ O
risk NN O
of IN O
thrombosis NN B-Disease
and CC O
that IN O
free JJ O
protein NN O
S NNP O
estimation NN O
offers VBZ O
the DT O
most RBS O
reliable JJ O
way NN O
of IN O
diagnosing VBG O
the DT O
deficiency NN O
. . O

( ( O
Blood NNP O
. . O
2000 CD O
; : O
95 CD O
1935 CD O
- : O
1941 CD O
) ) O
. . O

Autoimmune NNP B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
( ( O
ALPS NNP B-Disease
) ) O
in IN O
a DT O
child NN O
from IN O
consanguineous JJ O
parents NNS O
: : O
a DT O
dominant JJ O
or CC O
recessive JJ O
disease NN O
? . O

Autoimmune NNP B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
( ( O
ALPS NNP B-Disease
) ) O
is VBZ O
characterized VBN O
by IN O
autoimmune NN O
features NNS O
and CC O
lymphoproliferations NNS O
and CC O
is VBZ O
generally RB O
caused VBN O
by IN O
defective JJ O
Fas NNP O
- : O
mediated VBD O
apoptosis NN O
. . O

This DT O
report NN O
describes VBZ O
a DT O
child NN O
with IN O
clinical JJ O
features NNS O
of IN O
ALPS NNP B-Disease
without IN O
detectable JJ O
Fas NNP O
expression NN O
on IN O
freshly RB O
isolated VBN O
blood NN O
leukocytes NNS O
. . O

Detection NN O
of IN O
FAS NNP O
transcripts NNS O
via IN O
real JJ O
- : O
time NN O
quantitative JJ O
PCR NNP O
made VBD O
a DT O
severe JJ O
transcriptional JJ O
defect NN O
unlikely JJ O
. . O

Sequencing VBG O
of IN O
the DT O
FAS NNP O
gene NN O
revealed VBD O
a DT O
20 CD O
- : O
nucleotide JJ O
duplication NN O
in IN O
the DT O
last JJ O
exon NN O
affecting VBG O
the DT O
cytoplasmic JJ O
signaling NN O
domain NN O
. . O

The DT O
patient NN O
was VBD O
homozygous JJ O
for IN O
this DT O
mutation NN O
, , O
whereas IN O
the DT O
consanguineous JJ O
parents NNS O
and CC O
the DT O
siblings NNS O
were VBD O
heterozygous JJ O
. . O

The DT O
patient NN O
reported VBD O
here RB O
is VBZ O
a DT O
human JJ O
homologue NN O
of IN O
the DT O
Fas NNP O
- : O
null NN O
mouse NN O
, , O
inasmuch JJ O
as IN O
she PRP O
carries VBZ O
an DT O
autosomal JJ O
homozygous JJ O
mutation NN O
in IN O
the DT O
FAS NNP O
gene NN O
and CC O
she PRP O
shows VBZ O
the DT O
severe JJ O
and CC O
accelerated JJ O
ALPS NNP B-Disease
phenotype NN O
. . O

The DT O
heterozygous JJ O
family NN O
members NNS O
did VBD O
not RB O
have VB O
the DT O
ALPS NNP B-Disease
phenotype NN O
, , O
indicating VBG O
that IN O
the DT O
disease NN O
- : O
causing NN O
FAS NNP O
mutation NN O
in IN O
this DT O
family NN O
is VBZ O
autosomal JJ O
recessive JJ O
. . O
. . O

Identification NN O
of IN O
novel NN O
imprinted VBN O
transcripts NNS O
in IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
and CC O
Angelman NNP B-Disease
syndrome VBP I-Disease
deletion NN O
region NN O
: : O
further JJ O
evidence NN O
for IN O
regional JJ O
imprinting NN O
control NN O
. . O

Deletions NNS O
and CC O
other JJ O
abnormalities NNS O
of IN O
human JJ O
chromosome NN O
15q11 CD O
- : O
q13 NN O
are VBP O
associated VBN O
with IN O
two CD O
developmental JJ O
disorders NNS O
, , O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
and CC O
Angelman NNP B-Disease
syndrome VBP I-Disease
( ( O
AS IN B-Disease
) ) O
. . O

Loss NNP O
of IN O
expression NN O
of IN O
imprinted JJ O
, , O
paternally RB O
expressed VBN O
genes NNS O
has VBZ O
been VBN O
implicated VBN O
in IN O
PWS NNP B-Disease
. . O

However RB O
, , O
the DT O
number NN O
of IN O
imprinted JJ O
genes NNS O
that WDT O
contribute VBP O
to TO O
PWS NNP B-Disease
, , O
and CC O
the DT O
range NN O
over IN O
which WDT O
the DT O
imprinting VBG O
signal JJ O
acts NNS O
to TO O
silence VB O
one CD O
copy NN O
of IN O
the DT O
gene NN O
in IN O
a DT O
parent NN O
- : O
of IN O
- : O
origin NN O
- : O
specific JJ O
manner NN O
, , O
are VBP O
unknown JJ O
. . O

To TO O
identify VB O
additional JJ O
imprinted VBN O
genes NNS O
that WDT O
could MD O
contribute VB O
to TO O
the DT O
PWS NNP B-Disease
phenotype NN O
and CC O
to TO O
understand VB O
the DT O
regional JJ O
control NN O
of IN O
imprinting VBG O
in IN O
15q11 CD O
- : O
q13 NN O
, , O
we PRP O
have VBP O
constructed VBN O
an DT O
imprinted JJ O
transcript NN O
map NN O
of IN O
the DT O
PWS NNP O
- : O
AS IN O
deletion NN O
interval NN O
. . O

The DT O
imprinting NN O
status NN O
of IN O
22 CD O
expressed JJ O
sequence NN O
tags NNS O
derived VBN O
from IN O
the DT O
radiation NN O
- : O
hybrid JJ O
human JJ O
transcript NN O
maps NNS O
or CC O
physical JJ O
maps NNS O
was VBD O
determined VBN O
in IN O
a DT O
reverse NN O
transcriptase NN O
- : O
PCR NNP O
assay NN O
and CC O
correlated VBN O
with IN O
the DT O
position NN O
of IN O
the DT O
transcripts NNS O
on IN O
the DT O
physical JJ O
map NN O
. . O

Seven RB O
new JJ O
paternally RB O
expressed VBN O
transcripts NNS O
localize VB O
to TO O
an DT O
approximately RB O
1 CD O
. . O

5 CD O
- : O
Mb NN O
domain NN O
surrounding VBG O
the DT O
SNRPN NNP O
- : O
associated VBD O
imprinting JJ O
center NN O
, , O
which WDT O
already RB O
includes VBZ O
four CD O
imprinted VBN O
, , O
paternally RB O
expressed VBN O
genes NNS O
. . O

All DT O
other JJ O
tested VBD O
new JJ O
transcripts NNS O
in IN O
the DT O
deletion NN O
region NN O
were VBD O
expressed VBN O
from IN O
both DT O
alleles NNS O
. . O

A DT O
domain NN O
of IN O
exclusive JJ O
paternal JJ O
expression NN O
surrounding VBG O
the DT O
imprinting NN O
center NN O
suggests VBZ O
strong JJ O
regional JJ O
control NN O
of IN O
the DT O
imprinting NN O
process NN O
. . O

This DT O
study NN O
provides VBZ O
the DT O
means NNS O
for IN O
further JJ O
investigation NN O
of IN O
additional JJ O
genes NNS O
that WDT O
cause VBP O
or CC O
modify VBP O
the DT O
phenotypes NNS O
associated VBN O
with IN O
rearrangements NNS O
of IN O
15q11 CD O
- : O
q13 NN O
. . O

Combined VBN O
analysis NN O
of IN O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
linkage NN O
to TO O
1q24 CD O
- : O
25 CD O
: : O
results NNS O
from IN O
772 CD O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
families NNS O
from IN O
the DT O
International NNP O
Consortium NNP O
for IN O
Prostate NNP B-Disease
Cancer NNP I-Disease
Genetics NNP O
. . O

A DT O
previous JJ O
linkage NN O
study NN O
provided VBD O
evidence NN O
for IN O
a DT O
prostate NN B-Disease
cancer NN I-Disease
- : O
susceptibility NN O
locus NN O
at IN O
1q24 CD O
- : O
25 CD O
. . O

Subsequent JJ O
reports NNS O
in IN O
additional JJ O
collections NNS O
of IN O
families NNS O
have VBP O
yielded VBN O
conflicting NN O
results NNS O
. . O

In IN O
addition NN O
, , O
evidence NN O
for IN O
locus NN O
heterogeneity NN O
has VBZ O
been VBN O
provided VBN O
by IN O
the DT O
identification NN O
of IN O
other JJ O
putative JJ O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
loci NN O
on IN O
Xq27 NNP O
- : O
28 CD O
, , O
1q42 CD O
- : O
43 CD O
, , O
and CC O
1p36 CD O
. . O

The DT O
present JJ O
study NN O
describes VBZ O
a DT O
combined JJ O
analysis NN O
for IN O
six CD O
markers NNS O
in IN O
the DT O
1q24 CD O
- : O
25 CD O
region NN O
in IN O
772 CD O
families NNS O
affected VBN O
by IN O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
and CC O
ascertained VBN O
by IN O
the DT O
members NNS O
of IN O
the DT O
International NNP O
Consortium NNP O
for IN O
Prostate NNP B-Disease
Cancer NNP I-Disease
Genetics NNP O
( ( O
ICPCG NNP O
) ) O
from IN O
North NNP O
America NNP O
, , O
Australia NNP O
, , O
Finland NNP O
, , O
Norway NNP O
, , O
Sweden NNP O
, , O
and CC O
the DT O
United NNP O
Kingdom NNP O
. . O

Overall JJ O
, , O
there EX O
was VBD O
some DT O
evidence NN O
for IN O
linkage NN O
, , O
with IN O
a DT O
peak JJ O
parametric JJ O
multipoint NN O
LOD NNP O
score NN O
assuming VBG O
heterogeneity NN O
( ( O
HLOD NNP O
) ) O
of IN O
1 CD O
. . O

40 CD O
( ( O
P NNP O
= NNP O
. . O
1 CD O
) ) O
at IN O
D1S212 NNP O
. . O

The DT O
estimated JJ O
proportion NN O
of IN O
families NNS O
( ( O
alpha NN O
) ) O
linked VBD O
to TO O
the DT O
locus NN O
was VBD O
. . O

6 CD O
( ( O
1 CD O
- : O
LOD JJ O
support NN O
interval NN O
. . O
1 CD O
- : O
. . O
12 CD O
) ) O
. . O

This DT O
evidence NN O
was VBD O
not RB O
observed VBN O
by IN O
a DT O
nonparametric JJ O
approach NN O
, , O
presumably RB O
because IN O
of IN O
the DT O
extensive JJ O
heterogeneity NN O
. . O

Further RB O
parametric JJ O
analysis NN O
revealed VBD O
a DT O
significant JJ O
effect NN O
of IN O
the DT O
presence NN O
of IN O
male JJ O
- : O
to TO O
- : O
male NN O
disease NN O
transmission NN O
within IN O
the DT O
families NNS O
. . O

In IN O
the DT O
subset NN O
of IN O
491 CD O
such JJ O
families NNS O
, , O
the DT O
peak NN O
HLOD NNP O
was VBD O
2 CD O
. . O

In IN O
the DT O
subset NN O
of IN O
491 CD O
such JJ O
families NNS O
, , O
the DT O
peak NN O
HLOD NNP O
was VBD O
2 CD O
. . O

56 CD O
( ( O
P NNP O
= NNP O
. . O
6 CD O
) ) O
and CC O
alpha JJ O
= NN O
. . O

11 CD O
( ( O
1 CD O
- : O
LOD JJ O
support NN O
interval NN O
. . O
4 CD O
- : O
. . O
19 CD O
) ) O
, , O
compared VBN O
with IN O
HLODs NNP O
of IN O
0 CD O
in IN O
the DT O
remaining VBG O
281 CD O
families NNS O
. . O

Within IN O
the DT O
families NNS O
with IN O
male JJ O
- : O
to TO O
- : O
male NN O
disease NN O
transmission NN O
, , O
alpha NN O
increased VBD O
with IN O
the DT O
early JJ O
mean NN O
age NN O
at IN O
diagnosis NN O
( ( O
< JJ O
65 CD O
years NNS O
, , O
alpha RB O
= NNP O
. . O
19 CD O
, , O
with IN O
1 CD O
- : O
LOD JJ O
support NN O
interval NN O
. . O
6 CD O
- : O
. . O
34 CD O
) ) O
and CC O
the DT O
number NN O
of IN O
affected JJ O
family NN O
members NNS O
( ( O
five CD O
or CC O
more JJR O
family NN O
members NNS O
, , O
alpha JJ O
= NNP O
. . O
15 CD O
, , O
with IN O
1 CD O
- : O
LOD JJ O
support NN O
interval NN O
. . O
4 CD O
- : O
. . O
28 CD O
) ) O
. . O

The DT O
highest JJS O
value NN O
of IN O
alpha NN O
was VBD O
observed VBN O
for IN O
the DT O
48 CD O
families NNS O
that WDT O
met VBD O
all DT O
three CD O
criteria NNS O
( ( O
peak JJ O
HLOD NNP O
= NNP O
2 CD O
. . O
25 CD O
, , O
P NNP O
= NNP O
. . O
1 CD O
, , O
alpha RB O
= NNP O
. . O
29 CD O
, , O
with IN O
1 CD O
- : O
LOD JJ O
support NN O
interval NN O
. . O
8 CD O
- : O
. . O
53 CD O
) ) O
. . O

These DT O
results NNS O
support VBD O
the DT O
finding NN O
of IN O
a DT O
prostate NN B-Disease
cancer NN I-Disease
- : O
susceptibility NN O
gene NN O
linked VBD O
to TO O
1q24 CD O
- : O
25 CD O
, , O
albeit NN O
in IN O
a DT O
defined JJ O
subset NN O
of IN O
prostate NN B-Disease
cancer NN I-Disease
families NNS O
. . O

Although IN O
HPC1 NNP O
accounts NNS O
for IN O
only RB O
a DT O
small JJ O
proportion NN O
of IN O
all DT O
families NNS O
affected VBN O
by IN O
hereditary JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
, , O
it PRP O
appears VBZ O
to TO O
play VB O
a DT O
more RBR O
prominent JJ O
role NN O
in IN O
the DT O
subset NN O
of IN O
families NNS O
with IN O
several JJ O
members NNS O
affected VBD O
at IN O
an DT O
early JJ O
age NN O
and CC O
with IN O
male JJ O
- : O
to TO O
- : O
male NN O
disease NN O
transmission NN O
. . O

A DT O
recurrent JJ O
expansion NN O
of IN O
a DT O
maternal JJ O
allele NN O
with IN O
36 CD O
CAG NNP O
repeats NNS O
causes VBZ O
Huntington NNP B-Disease
disease NN I-Disease
in IN O
two CD O
sisters NNS O
. . O

Large JJ O
intergenerational JJ O
repeat NN O
expansions NNS O
of IN O
the DT O
CAG NNP O
trinucleotide NN O
repeat NN O
in IN O
the DT O
HD NNP B-Disease
gene NN O
have VBP O
been VBN O
well RB O
documented VBN O
for IN O
the DT O
male JJ O
germline NN O
. . O

We PRP O
describe VBP O
a DT O
recurrent NN O
large JJ O
expansion NN O
of IN O
a DT O
maternal JJ O
allele NN O
with IN O
36 CD O
CAG NNP O
repeats NNS O
( ( O
to TO O
66 CD O
and CC O
57 CD O
repeats NNS O
, , O
respectively RB O
, , O
in IN O
two CD O
daughters NNS O
) ) O
associated VBN O
with IN O
onset NN O
of IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
in IN O
the DT O
second JJ O
and CC O
third JJ O
decade NN O
in IN O
a DT O
family NN O
without IN O
history NN O
of IN O
HD NNP B-Disease
. . O

Our PRP$ O
findings NNS O
give VBP O
evidence NN O
of IN O
a DT O
gonadal JJ O
mosaicism NN O
in IN O
the DT O
unaffected JJ O
mother NN O
. . O

We PRP O
hypothesize VBP O
that IN O
large JJ O
expansions NNS O
also RB O
occur VBP O
in IN O
the DT O
female JJ O
germline NN O
and CC O
that IN O
a DT O
negative JJ O
selection NN O
of IN O
oocytes NNS O
with IN O
long JJ O
repeats NNS O
might MD O
explain VB O
the DT O
different JJ O
instability NN O
behavior NN O
of IN O
the DT O
male NN O
and CC O
the DT O
female JJ O
germlines NNS O
. . O
. . O

Abnormal NNP O
development NN O
of IN O
Purkinje NNP O
cells NNS O
and CC O
lymphocytes NNS O
in IN O
Atm NNP O
mutant JJ O
mice NN O
. . O

Motor NNP B-Disease
incoordination NN I-Disease
, , O
immune JJ B-Disease
deficiencies NNS I-Disease
, , O
and CC O
an DT O
increased VBN O
risk NN O
of IN O
cancer NN B-Disease
are VBP O
the DT O
characteristic JJ O
features NNS O
of IN O
the DT O
hereditary JJ B-Disease
disease NN I-Disease
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
, , O
which WDT O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
. . O

Through IN O
gene NN O
targeting NN O
, , O
we PRP O
have VBP O
generated VBN O
a DT O
line NN O
of IN O
Atm NNP O
mutant JJ O
mice NN O
, , O
Atm NNP O
( ( O
y JJ O
/ NNP O
y NN O
) ) O
mice NN O
. . O

In IN O
contrast NN O
to TO O
other JJ O
Atm NNP O
mutant NN O
mice NN O
, , O
Atm NNP O
( ( O
y JJ O
/ NNP O
y NN O
) ) O
mice NN O
show VBP O
a DT O
lower JJR O
incidence NN O
of IN O
thymic JJ B-Disease
lymphoma NN I-Disease
and CC O
survive JJ O
beyond IN O
a DT O
few JJ O
months NNS O
of IN O
age NN O
. . O

Atm NNP O
( ( O
y JJ O
/ NNP O
y NN O
) ) O
mice NN O
exhibit NN O
deficits NNS O
in IN O
motor NN O
learning VBG O
indicative JJ O
of IN O
cerebellar JJ B-Disease
dysfunction NN I-Disease
. . O

Even RB O
though IN O
we PRP O
found VBD O
no DT O
gross JJ O
cerebellar JJ B-Disease
degeneration NN I-Disease
in IN O
older JJR O
Atm NNP O
( ( O
y JJ O
/ NNP O
y NN O
) ) O
animals NNS O
, , O
ectopic NN O
and CC O
abnormally RB O
differentiated VBN O
Purkinje NNP O
cells NNS O
were VBD O
apparent JJ O
in IN O
mutant JJ O
mice NN O
of IN O
all DT O
ages NNS O
. . O

These DT O
findings NNS O
establish VB O
that IN O
some DT O
neuropathological JJ B-Disease
abnormalities NNS I-Disease
seen VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
also RB O
are VBP O
present JJ O
in IN O
Atm NNP O
mutant JJ O
mice NN O
. . O

In IN O
addition NN O
, , O
we PRP O
report VBP O
a DT O
previously RB O
unrecognized JJ O
effect NN O
of IN O
Atm NNP B-Disease
deficiency NN I-Disease
on IN O
development NN O
or CC O
maintenance NN O
of IN O
CD4 NNP O
( ( O
+ NNP O
) ) O
8 CD O
( ( O
+ NN O
) ) O
thymocytes VBZ O
. . O

We PRP O
discuss VBP O
these DT O
findings NNS O
in IN O
the DT O
context NN O
of IN O
the DT O
hypothesis NN O
that WDT O
abnormal JJ O
development NN O
of IN O
Purkinje NNP O
cells NNS O
and CC O
lymphocytes VBZ O
contributes NNS O
to TO O
the DT O
pathogenesis NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
. . O
. . O

Novel NNP O
mutations NNS O
of IN O
the DT O
ATP7B NNP O
gene NN O
in IN O
Japanese JJ O
patients NNS O
with IN O
Wilson NNP B-Disease
disease NN I-Disease
. . O

Wilson NNP B-Disease
disease NN I-Disease
( ( O
WD NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
copper NN O
accumulation NN O
in IN O
the DT O
liver NN O
, , O
brain NN O
, , O
kidneys NNS O
, , O
and CC O
corneas NNS O
, , O
and CC O
culminating VBG O
in IN O
copper NN O
toxication NN O
in IN O
these DT O
organs NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
analyzed VBD O
mutations NNS O
of IN O
the DT O
responsible JJ O
gene NN O
, , O
ATP7B NNP O
, , O
in IN O
four CD O
Japanese JJ O
patients NNS O
with IN O
WD NNP B-Disease
. . O

By IN O
direct JJ O
sequencing NN O
, , O
we PRP O
identified VBD O
five CD O
mutations NNS O
, , O
of IN O
which WDT O
two CD O
were VBD O
novel JJ O
, , O
and CC O
16 CD O
polymorphisms NNS O
, , O
of IN O
which WDT O
6 CD O
were VBD O
novel NN O
. . O

The DT O
mutations NNS O
2871delC CD O
and CC O
2513delA CD O
shift NN O
the DT O
reading NN O
frame NN O
so IN O
that DT O
truncated VBD O
abnormal JJ O
protein NN O
is VBZ O
expected VBN O
. . O

In IN O
contrast NN O
to TO O
these DT O
mutations NNS O
found VBD O
in IN O
patients NNS O
with IN O
hepatic JJ O
- : O
type NN O
of IN O
early JJ O
onset NN O
, , O
the DT O
mutations NNS O
A874V NNP O
, , O
R778L NNP O
, , O
and CC O
3892delGTC CD O
were VBD O
either RB O
missense JJ O
mutations NNS O
or CC O
in IN O
frame JJ O
1 CD O
- : O
amino NN O
acid JJ O
deletion NN O
, , O
and CC O
occurred VBD O
in IN O
the DT O
patients NNS O
with IN O
hepato JJ O
- : O
neurologic JJ O
type NN O
of IN O
late JJ O
onset NN O
. . O

The DT O
mutations NNS O
2871delC CD O
and CC O
R778L NNP O
have VBP O
been VBN O
previously RB O
reported VBN O
in IN O
a DT O
relatively RB O
large JJ O
number NN O
of IN O
Japanese JJ O
patients NNS O
. . O

In IN O
particular JJ O
, , O
R778L NNP O
is VBZ O
known VBN O
to TO O
be VB O
more RBR O
prevalent JJ O
in IN O
Asian JJ O
countries NNS O
than IN O
in IN O
other JJ O
countries NNS O
of IN O
the DT O
world NN O
. . O

Our PRP$ O
data NNS O
are VBP O
compatible JJ O
with IN O
the DT O
hypothesis NN O
that IN O
the DT O
mutations NNS O
tend VBP O
to TO O
occur VB O
in IN O
a DT O
population NN O
- : O
specific JJ O
manner NN O
. . O

Therefore RB O
, , O
the DT O
accumulation NN O
of IN O
the DT O
types NNS O
of IN O
mutations NNS O
in IN O
Japanese JJ O
patients NNS O
with IN O
WD NNP B-Disease
will MD O
facilitate VB O
the DT O
fast NN O
and CC O
effective JJ O
genetic JJ O
diagnosis NN O
of IN O
WD NNP B-Disease
in IN O
Japanese JJ O
patients NNS O
. . O
. . O

Autoinhibition NN O
and CC O
activation NN O
mechanisms NNS O
of IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBD I-Disease
protein NN O
. . O

The DT O
Rho NNP O
- : O
family NN O
GTPase NNP O
, , O
Cdc42 NNP O
, , O
can MD O
regulate VB O
the DT O
actin NN O
cytoskeleton NN O
through IN O
activation NN O
of IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBP I-Disease
protein NN O
( ( O
WASP NNP O
) ) O
family NN O
members NNS O
. . O

Activation NNP O
relieves VBZ O
an DT O
autoinhibitory JJ O
contact NN O
between IN O
the DT O
GTPase NNP O
- : O
binding NN O
domain NN O
and CC O
the DT O
carboxy JJ O
- : O
terminal JJ O
region NN O
of IN O
WASP NNP O
proteins NNS O
. . O

Here RB O
we PRP O
report VBP O
the DT O
autoinhibited JJ O
structure NN O
of IN O
the DT O
GTPase NNP O
- : O
binding VBG O
domain NN O
of IN O
WASP NNP O
, , O
which WDT O
can MD O
be VB O
induced VBN O
by IN O
the DT O
C NNP O
- : O
terminal JJ O
region NN O
or CC O
by IN O
organic JJ O
co NN O
- : O
solvents NNS O
. . O

In IN O
the DT O
autoinhibited JJ O
complex NN O
, , O
intramolecular JJ O
interactions NNS O
with IN O
the DT O
GTPase NNP O
- : O
binding NN O
domain NN O
occlude VBP O
residues NNS O
of IN O
the DT O
C NNP O
terminus NN O
that WDT O
regulate VBP O
the DT O
Arp2 NNP O
/ NNP O
3 CD O
actin SYM O
- : O
nucleating NN O
complex NN O
. . O

Binding NNP O
of IN O
Cdc42 NNP O
to TO O
the DT O
GTPase NNP O
- : O
binding NN O
domain NN O
causes VBZ O
a DT O
dramatic JJ O
conformational JJ O
change NN O
, , O
resulting VBG O
in IN O
disruption NN O
of IN O
the DT O
hydrophobic NN O
core NN O
and CC O
release NN O
of IN O
the DT O
C NNP O
terminus NN O
, , O
enabling VBG O
its PRP$ O
interaction NN O
with IN O
the DT O
actin JJ O
regulatory JJ O
machinery NN O
. . O

These DT O
data NNS O
show VBP O
that IN O
intrinsically RB O
unstructured JJ O
peptides NNS O
such JJ O
as IN O
the DT O
GTPase NNP O
- : O
binding VBG O
domain NN O
of IN O
WASP NNP O
can MD O
be VB O
induced VBN O
into IN O
distinct JJ O
structural JJ O
and CC O
functional JJ O
states NNS O
depending VBG O
on IN O
context NN O
. . O
. . O

hCds1 SYM O
- : O
mediated VBN O
phosphorylation NN O
of IN O
BRCA1 NNP O
regulates VBZ O
the DT O
DNA NNP O
damage NN O
response NN O
. . O

Mutations NNS O
in IN O
the DT O
BRCA1 NNP O
( ( O
ref NN O
. . O
1 CD O
) ) O
tumour NN B-Disease
suppressor NN O
gene NN O
are VBP O
found VBN O
in IN O
almost RB O
all DT O
of IN O
the DT O
families NNS O
with IN O
inherited JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
and CC O
about IN O
half NN O
of IN O
the DT O
families NNS O
with IN O
only JJ O
breast NN B-Disease
cancer NN I-Disease
. . O

Although IN O
the DT O
biochemical JJ O
function NN O
of IN O
BRCA1 NNP O
is VBZ O
not RB O
well RB O
understood RB O
, , O
it PRP O
is VBZ O
important JJ O
for IN O
DNA NNP O
damage NN O
repair NN O
and CC O
cell NN O
- : O
cycle NN O
checkpoint NN O
. . O

BRCA1 NNP O
exists VBZ O
in IN O
nuclear JJ O
foci NN O
but CC O
is VBZ O
hyperphosphorylated VBN O
and CC O
disperses NNS O
after IN O
DNA NNP O
damage NN O
. . O

It PRP O
is VBZ O
not RB O
known VBN O
whether IN O
BRCA1 NNP O
phosphorylation NN O
and CC O
dispersion NN O
and CC O
its PRP$ O
function NN O
in IN O
DNA NNP O
damage NN O
response NN O
are VBP O
related VBN O
. . O

In IN O
yeast PDT O
the DT O
DNA NNP O
damage NN O
response NN O
and CC O
the DT O
replication NN O
- : O
block NN O
checkpoint NN O
are VBP O
mediated VBN O
partly RB O
through IN O
the DT O
Cds1 NNP O
kinase NNP O
family NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
the DT O
human JJ O
Cds1 NNP O
kinase NN O
( ( O
hCds1 JJ O
/ NNP O
Chk2 NNP O
) ) O
regulates VBZ O
BRCA1 NNP O
function NN O
after IN O
DNA NNP O
damage NN O
by IN O
phosphorylating VBG O
serine JJ O
988 CD O
of IN O
BRCA1 NNP O
. . O

We PRP O
show VBP O
that IN O
hCds1 NN O
and CC O
BRCA1 NNP O
interact NN O
and CC O
co NN O
- : O
localize NN O
within IN O
discrete JJ O
nuclear JJ O
foci NN O
but CC O
separate JJ O
after IN O
gamma JJ O
irradiation NN O
. . O

Phosphorylation NN O
of IN O
BRCA1 NNP O
at IN O
serine JJ O
988 CD O
is VBZ O
required VBN O
for IN O
the DT O
release NN O
of IN O
BRCA1 NNP O
from IN O
hCds1 NN O
. . O

This DT O
phosphorylation NN O
is VBZ O
also RB O
important JJ O
for IN O
the DT O
ability NN O
of IN O
BRCA1 NNP O
to TO O
restore VB O
survival NN O
after IN O
DNA NNP O
damage NN O
in IN O
the DT O
BRCA1 NNP O
- : O
mutated VBN O
cell NN O
line NN O
HCC1937 NNP O
. . O
. . O

Characterization NN O
of IN O
the DT O
rat NN O
spinocerebellar JJ O
ataxia NN O
type NN O
3 CD O
gene NN O
. . O

Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
MJD NNP B-Disease
) ) O
belongs VBZ O
to TO O
a DT O
group NN O
of IN O
clinically RB O
and CC O
genetically RB O
heterogeneous JJ O
neurodegenerative JJ B-Disease
disorders NNS I-Disease
characterized VBN O
by IN O
progressive JJ B-Disease
cerebellar JJ I-Disease
ataxia NN I-Disease
. . O

The DT O
disease NN O
- : O
causing NN O
mutation NN O
has VBZ O
recently RB O
been VBN O
identified VBN O
as IN O
an DT O
unstable JJ O
and CC O
expanded VBN O
( ( O
CAG NNP O
) ) O
n FW O
trinucleotide JJ O
repeat NN O
in IN O
a DT O
novel JJ O
gene NN O
of IN O
unknown JJ O
function NN O
. . O

In IN O
Caucasians NNP O
, , O
repeat NN O
expansions NNS O
in IN O
the DT O
MJD1 NNP O
gene NN O
have VBP O
also RB O
been VBN O
found VBN O
in IN O
patients NNS O
with IN O
the DT O
clinically RB O
distinct JJ O
autosomal JJ O
dominant JJ O
spinocerebellar JJ B-Disease
ataxia NN I-Disease
type NN I-Disease
3 CD I-Disease
( ( O
SCA3 NNP B-Disease
) ) O
. . O

In IN O
order NN O
to TO O
gain VB O
insight NN O
into IN O
the DT O
biology NN O
of IN O
the DT O
MJD1 NNP O
/ NNP O
SCA3 NNP O
gene NN O
we PRP O
cloned VBD O
the DT O
rat NN O
homologue NN O
and CC O
studied VBD O
its PRP$ O
expression NN O
. . O

The DT O
rat NN O
and CC O
human JJ O
ataxin NN O
- : O
3 CD O
genes NNS O
are VBP O
highly RB O
homologous JJ O
with IN O
an DT O
overall JJ O
sequence NN O
identity NN O
of IN O
approximately RB O
88 CD O
% NN O
. . O

However RB O
, , O
the DT O
C NNP O
- : O
terminal JJ O
end NN O
of IN O
the DT O
putative JJ O
protein NN O
differs NNS O
strongly RB O
from IN O
the DT O
published VBN O
human JJ O
sequence NN O
. . O

The DT O
( ( O
CAG NNP O
) ) O
n NN O
block NN O
in IN O
the DT O
rat NN O
cDNA NN O
consists VBZ O
of IN O
just RB O
three CD O
interrupted VBD O
units NNS O
suggesting VBG O
that IN O
a DT O
long JJ O
polyglutamine NN O
stretch NN O
is VBZ O
not RB O
essential JJ O
for IN O
the DT O
normal JJ O
function NN O
of IN O
the DT O
ataxin NN O
- : O
3 CD O
protein NN O
in IN O
rodents NNS O
. . O

The DT O
expression NN O
pattern NN O
of IN O
the DT O
SCA3 NNP O
gene NN O
in IN O
various JJ O
rat NN O
and CC O
human JJ O
tissues NNS O
was VBD O
investigated VBN O
by IN O
Northern NNP O
blot NN O
analyses NNS O
. . O

The DT O
mature NN O
transcript NN O
is VBZ O
approximately RB O
6 CD O
kb NNS O
in IN O
length NN O
. . O

In IN O
rat NN O
testis NN O
, , O
a DT O
smaller JJR O
transcript NN O
of IN O
1 CD O
. . O

3 CD O
kb NN O
was VBD O
identified VBN O
. . O

Transcription NN O
of IN O
rsca3 NN O
was VBD O
detected VBN O
in IN O
most JJS O
rat NNS O
tissues NNS O
including VBG O
brain NN O
. . O

Analyzing VBG O
the DT O
expression NN O
level NN O
of IN O
the DT O
SCA3 NNP O
gene NN O
in IN O
several JJ O
human JJ O
brain NN O
sections NNS O
revealed VBD O
no DT O
significant JJ O
higher JJR O
mRNA NN O
level NN O
in IN O
regions NNS O
predominantly RB O
affected VBN O
in IN O
MJD NNP B-Disease
. . O

Thus RB O
additional JJ O
molecules NNS O
and CC O
/ NN O
or CC O
regulatory JJ O
events NNS O
are VBP O
necessary JJ O
to TO O
explain VB O
the DT O
exclusive JJ O
degeneration NN B-Disease
of IN I-Disease
certain JJ I-Disease
brain NN I-Disease
areas NNS I-Disease
. . O

Emerin NNP B-Disease
, , I-Disease
deficiency NN I-Disease
of IN O
which WDT O
causes VBZ O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
, , O
is VBZ O
localized VBN O
at IN O
the DT O
inner JJ O
nuclear JJ O
membrane NN O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EDMD NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ B-Disease
muscle NN I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
the DT O
clinical JJ O
triad NN O
of IN O
progressive JJ O
wasting NN B-Disease
of IN I-Disease
humero NN I-Disease
- : I-Disease
peroneal NN I-Disease
muscles NNS I-Disease
, , O
early JJ O
contractures NNS B-Disease
of IN I-Disease
the DT I-Disease
elbows NNS I-Disease
, , I-Disease
Achilles NNP I-Disease
tendons NNS I-Disease
and CC I-Disease
postcervical JJ I-Disease
muscles NNS I-Disease
, , O
and CC O
cardiac JJ B-Disease
conduction NN I-Disease
block NN I-Disease
with IN O
a DT O
high JJ O
risk NN O
of IN O
sudden JJ B-Disease
death NN I-Disease
. . O

The DT O
gene NN O
for IN O
EDMD NNP B-Disease
on IN O
Xq28 NNP O
encodes VBZ O
a DT O
novel JJ O
protein NN O
named VBN O
emerin NN O
that WDT O
localizes VBZ O
at IN O
the DT O
nuclear JJ O
membrane NN O
of IN O
skeletal JJ O
, , O
cardiac JJ O
and CC O
smooth JJ O
muscles NNS O
and CC O
some DT O
other JJ O
non JJ O
- : O
muscle NN O
tissues NNS O
. . O

To TO O
investigate VB O
a DT O
possible JJ O
physiological JJ O
role NN O
for IN O
emerin NN O
, , O
we PRP O
examined VBD O
the DT O
ultrastructural JJ O
localization NN O
of IN O
the DT O
protein NN O
in IN O
human JJ O
skeletal JJ O
muscle NN O
and CC O
HeLa NNP O
cells NNS O
, , O
using VBG O
ultrathin JJ O
cryosections NNS O
. . O

We PRP O
found VBD O
that IN O
the DT O
immune JJ O
- : O
labeled VBN O
colloidal JJ O
gold NN O
particles NNS O
were VBD O
localized VBN O
on IN O
the DT O
nucleoplasmic JJ O
surface NN O
of IN O
the DT O
inner JJ O
nuclear JJ O
membrane NN O
, , O
but CC O
not RB O
on IN O
the DT O
nuclear JJ O
pore NN O
. . O

Emerin NNP O
stayed VBD O
on IN O
the DT O
cytoplasmic JJ O
surface NN O
of IN O
the DT O
nuclear JJ O
lamina NN O
, , O
even RB O
after IN O
detergent NN O
treatment NN O
that WDT O
solubilizes VBZ O
membrane NN O
lipids NNS O
and CC O
washes NNS O
out RP O
membrane NN O
proteins NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
emerin JJ O
anchors NNS O
at IN O
the DT O
inner JJ O
nuclear JJ O
membrane NN O
through IN O
the DT O
hydrophobic JJ O
stretch NN O
, , O
and CC O
protrudes NNS O
from IN O
the DT O
hydrophilic JJ O
region NN O
to TO O
the DT O
nucleoplasm NN O
where WRB O
it PRP O
interacts VBZ O
with IN O
the DT O
nuclear JJ O
lamina NN O
. . O

We PRP O
speculate VBP O
that IN O
emerin NN O
contributes NNS O
to TO O
maintain VB O
the DT O
nuclear JJ O
structure NN O
and CC O
stability NN O
, , O
as RB O
well RB O
as IN O
nuclear JJ O
functions NNS O
, , O
particularly RB O
in IN O
muscle NN O
tissues NNS O
that WDT O
have VBP O
severe JJ O
stress NN O
with IN O
rigorous JJ O
contraction NN O
- : O
relaxation NN O
movements NNS O
and CC O
calcium NN O
flux NN O
. . O
. . O

Locus NNP O
heterogeneity NN O
in IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
is VBZ O
the DT O
most RBS O
common JJ O
form NN O
of IN O
autosomal JJ B-Disease
recessive JJ I-Disease
ataxia NN I-Disease
. . O

The DT O
disease NN O
locus NN O
was VBD O
assigned VBN O
to TO O
chromosome VB O
9 CD O
and CC O
the DT O
disease NN O
gene NN O
, , O
STM7 NNP O
/ NNP O
X25 NNP O
, , O
has VBZ O
been VBN O
isolated VBN O
. . O

To TO O
date NN O
most RBS O
data NNS O
suggest VBP O
locus NN O
homogeneity NN O
in IN O
FRDA NNP B-Disease
. . O

We PRP O
now RB O
provide VBP O
strong JJ O
evidence NN O
of IN O
a DT O
second JJ O
FRDA NNP B-Disease
locus NN O
. . O

Studying VBG O
two CD O
siblings NNS O
with IN O
FRDA NNP B-Disease
from IN O
two CD O
families NNS O
we PRP O
did VBD O
not RB O
detect VB O
a DT O
mutation NN O
in IN O
STM7 NNP O
/ NNP O
X25 NNP O
. . O

Haplotype NNP O
analysis NN O
of IN O
the DT O
STM7 NNP O
/ NNP O
X25 NNP O
region NN O
of IN O
chromosome NN O
9 CD O
demonstrated VBD O
that IN O
the DT O
relevant JJ O
portion NN O
of IN O
chromosome NN O
9 CD O
differs NNS O
in IN O
the DT O
patients NNS O
. . O

Although IN O
the DT O
patients NNS O
studied VBN O
had VBD O
typical JJ O
FRDA NNP B-Disease
, , O
one CD O
sibpair NN O
had VBD O
the DT O
uncommon JJ O
symptom NN O
of IN O
retained JJ O
tendon NN O
reflexes NNS O
. . O

In IN O
order NN O
to TO O
investigate VB O
whether IN O
retained JJ O
tendon NN O
reflexes NNS O
are VBP O
characteristic JJ O
of IN O
FRDA NNP B-Disease
caused VBN O
by IN O
the DT O
second JJ O
locus NN O
, , O
FRDA2 NNP O
, , O
we PRP O
studied VBD O
an DT O
unrelated JJ O
FRDA NNP B-Disease
patient NN O
with IN O
retained JJ O
tendon NN O
reflexes NNS O
. . O

The DT O
observation NN O
of IN O
typical JJ O
mutations NNS O
in IN O
STM7 NNP O
/ NNP O
X25 NNP O
( ( O
GAA NNP O
expansions NNS O
) ) O
in IN O
this DT O
patient NN O
demonstrates VBZ O
that IN O
the DT O
two CD O
genetically RB O
different JJ O
forms NNS O
of IN O
FRDA NNP B-Disease
cannot NN O
be VB O
distinguished VBN O
clinically RB O
. . O
. . O

Glycerol NNP O
as IN O
a DT O
correlate NN O
of IN O
impaired JJ B-Disease
glucose JJ I-Disease
tolerance NN I-Disease
: : O
dissection NN O
of IN O
a DT O
complex JJ O
system NN O
by IN O
use NN O
of IN O
a DT O
simple JJ O
genetic JJ O
trait NN O
. . O

Glycerol NNP O
kinase NN O
( ( O
GK NNP O
) ) O
represents VBZ O
the DT O
primary JJ O
entry NN O
of IN O
glycerol NN O
into IN O
glucose JJ O
and CC O
triglyceride JJ O
metabolism NN O
. . O

Impaired NNP B-Disease
glucose JJ I-Disease
tolerance NN I-Disease
( ( O
IGT NNP B-Disease
) ) O
and CC O
hypertriglyceridemia NN B-Disease
are VBP O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
diabetes NNS B-Disease
mellitus NNS I-Disease
and CC O
cardiovascular JJ B-Disease
disease NN I-Disease
. . O

The DT O
relationship NN O
between IN O
glycerol NN O
and CC O
the DT O
risk NN O
of IN O
IGT NNP B-Disease
, , O
however RB O
, , O
is VBZ O
poorly RB O
understood JJ O
. . O

We PRP O
therefore VBP O
undertook IN O
the DT O
study NN O
of IN O
fasting VBG O
plasma JJ O
glycerol NN O
levels NNS O
in IN O
a DT O
cohort NN O
of IN O
1 CD O
, , O
56 CD O
unrelated JJ O
men NNS O
and CC O
women NNS O
of IN O
French JJ O
- : O
Canadian JJ O
descent NN O
. . O

Family RB O
screening VBG O
in IN O
the DT O
initial JJ O
cohort NN O
identified VBD O
18 CD O
men NNS O
from IN O
five CD O
families NNS O
with IN O
severe JJ O
hyperglycerolemia NN B-Disease
( ( O
values NNS O
above IN O
2 CD O
. . O
0 CD O
mmol JJ O
/ NNP O
liter NN O
) ) O
and CC O
demonstrated VBD O
an DT O
X NNP O
- : O
linked VBD O
pattern NN O
of IN O
inheritance NN O
. . O

Linkage JJ O
analysis NN O
of IN O
the DT O
data NNS O
from IN O
12 CD O
microsatellite JJ O
markers NNS O
surrounding VBG O
the DT O
Xp21 NN O
. . O

3 CD O
GK NNP O
gene NN O
resulted VBD O
in IN O
a DT O
peak JJ O
LOD NNP O
score NN O
of IN O
3 CD O
. . O

46 CD O
, , O
centered VBN O
around IN O
marker NN O
DXS8039 NNP O
. . O

In IN O
addition NN O
, , O
since IN O
all DT O
of IN O
the DT O
families NNS O
originated VBN O
in IN O
a DT O
population NN O
with IN O
a DT O
proven JJ O
founder NN O
effect NN O
- : O
the DT O
Saguenay NNP O
Lac NNP O
- : O
St NN O
. . O

- : O
Jean JJ O
region NN O
of IN O
Quebec NNP O
- : O
a DT O
common JJ O
disease NN O
haplotype NN O
was VBD O
sought VBN O
. . O

Indeed RB O
, , O
a DT O
six CD O
- : O
marker NN O
haplotype NN O
extending VBG O
over IN O
a DT O
region NN O
of IN O
5 CD O
. . O

5 CD O
cM NN O
was VBD O
observed VBN O
in IN O
all DT O
families NNS O
. . O

Resequencing VBG O
of IN O
the DT O
GK NNP O
gene NN O
in IN O
family NN O
members NNS O
led VBD O
to TO O
the DT O
discovery NN O
of IN O
a DT O
N288D NNP O
missense NN O
mutation NN O
in IN O
exon JJ O
10 CD O
, , O
which WDT O
resulted VBD O
in IN O
the DT O
substitution NN O
of IN O
a DT O
highly RB O
conserved VBN O
asparagine NN O
residue NN O
by IN O
a DT O
negatively RB O
charged VBN O
aspartic JJ O
acid NN O
. . O

Clinical JJ O
and CC O
molecular JJ O
genetics NNS O
of IN O
primary JJ B-Disease
dystonias NNS I-Disease
. . O

Primary JJ B-Disease
dystonias NNS I-Disease
are VBP O
movement NN B-Disease
disorders NNS I-Disease
with IN O
dystonia NN B-Disease
as IN O
a DT O
major JJ O
symptom NN O
. . O

They PRP O
are VBP O
frequently RB O
inherited VBN O
as IN O
Mendelian JJ O
traits NNS O
. . O

There EX O
are VBP O
at IN O
least JJS O
eight CD O
clinically RB O
distinct JJ O
autosomal JJ O
dominant JJ O
and CC O
two CD O
X NNP O
- : O
linked VBD O
recessive JJ O
forms NNS O
. . O

In IN O
addition NN O
, , O
pedigree JJ O
analyses NNS O
suggest VBP O
the DT O
occurrence NN O
of IN O
an DT O
autosomal JJ O
recessive NN O
variant NN O
. . O

The DT O
clinical JJ O
classification NN O
is VBZ O
increasingly RB O
being VBG O
replaced VBN O
by IN O
a DT O
genetic JJ O
one NN O
. . O

To TO O
date NN O
gene NN O
loci NNS O
have VBP O
been VBN O
identified VBN O
in IN O
at IN O
least JJS O
six CD O
autosomal JJ O
dominant JJ O
forms NNS O
, , O
i NN O
. . O
e NN O
. . O
, , O
in IN O
idiopathic JJ B-Disease
torsion NN I-Disease
dystonia NN I-Disease
( ( O
9q34 CD O
) ) O
, , O
focal JJ B-Disease
dystonia NN I-Disease
( ( O
18p CD O
) ) O
, , O
adult SYM O
- : O
onset NN O
idiopathic JJ B-Disease
torsion NN I-Disease
dystonia NN I-Disease
of IN O
mixed JJ O
type NN O
( ( O
8p21 CD O
- : O
q22 NN O
) ) O
, , O
dopa JJ B-Disease
- : I-Disease
responsive JJ I-Disease
dystonia NN I-Disease
( ( O
14q22 CD O
. . O
1 CD O
- : O
q22 NN O
. . O
2 CD O
) ) O
, , O
and CC O
paroxysmal JJ B-Disease
dystonic JJ I-Disease
choreoathetosis NN I-Disease
( ( O
2q25 CD O
- : O
q33 NN O
; : O
1p21 CD O
- : O
p13 NN O
. . O
3 CD O
) ) O
. . O

Gene NNP O
loci NN O
in IN O
the DT O
X NNP O
- : O
linked VBD O
recessive JJ O
forms NNS O
have VBP O
been VBN O
assigned VBN O
to TO O
Xq13 NNP O
. . O

1 CD O
in IN O
the DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
dystonia JJ I-Disease
parkinsonism NN I-Disease
syndrome NN I-Disease
and CC O
to TO O
Xq22 VB O
in IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
sensorineural JJ I-Disease
deafness NN I-Disease
, , O
dystonia NN B-Disease
, , O
and CC O
mental JJ B-Disease
retardation NN I-Disease
. . O

The DT O
disease NN O
genes NNS O
have VBP O
been VBN O
identified VBN O
in IN O
two CD O
autosomal JJ O
dominant JJ O
forms NNS O
and CC O
in IN O
one CD O
X NNP O
- : O
linked VBD O
recessive JJ O
form NN O
. . O

Mutations NNS O
in IN O
a DT O
gene NN O
coding VBG O
for IN O
an DT O
ATP NNP O
- : O
binding NN O
protein NN O
were VBD O
detected VBN O
in IN O
idiopathic JJ B-Disease
torsion NN I-Disease
dystonia NN I-Disease
( ( O
DYT1 NNP O
) ) O
, , O
and CC O
the DT O
GTP NNP O
cyclohydrolase NN O
1 CD O
gene NN O
is VBZ O
mutated VBN O
in IN O
dopa JJ B-Disease
- : I-Disease
responsive JJ I-Disease
dystonia NN I-Disease
( ( O
DYT5 NNP O
) ) O
. . O

In IN O
sensorineural JJ B-Disease
deafness NN I-Disease
, , O
dystonia NN B-Disease
, , O
and CC O
mental JJ B-Disease
retardation NN I-Disease
, , O
mutations NNS O
were VBD O
found VBN O
in IN O
the DT O
gene NN O
DDP NNP O
coding VBG O
for IN O
a DT O
polypeptide NN O
of IN O
unknown JJ O
function NN O
. . O

This DT O
article NN O
reviews VBZ O
the DT O
clinical JJ O
and CC O
molecular JJ O
genetics NNS O
of IN O
primary JJ B-Disease
dystonias NNS I-Disease
, , O
critically RB O
discusses VBZ O
present JJ O
findings NNS O
, , O
and CC O
proposes VBZ O
referring VBG O
to TO O
the DT O
known VBN O
forms NNS O
, , O
most JJS O
of IN O
which WDT O
can MD O
be VB O
distinguished VBN O
by IN O
genetic JJ O
criteria NNS O
, , O
as IN O
dystonias JJ B-Disease
1 CD I-Disease
- : I-Disease
12 CD I-Disease
. . O

Determination NN O
of IN O
30 CD O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
adrenoleukodystrophy JJ I-Disease
mutations NNS O
, , O
including VBG O
15 CD O
not RB O
previously RB O
described VBN O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
Adrenoleukodystrophy NNP I-Disease
( ( O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
) ) O
is VBZ O
the DT O
most RBS O
frequent JJ O
peroxisomal JJ B-Disease
disease NN I-Disease
. . O

It PRP O
mainly RB O
involves VBZ O
the DT O
nervous JJ O
system NN O
white JJ O
matter NN O
, , O
adrenal JJ O
cortex NN O
and CC O
testes NNS O
. . O

Several JJ O
distinct JJ O
clinical JJ O
phenotypes NNS O
are VBP O
known VBN O
. . O

The DT O
principal JJ O
biochemical JJ O
abnormality NN O
is VBZ O
the DT O
accumulation NN O
of IN O
saturated JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
fatty JJ O
acids NNS O
( ( O
VLCFAs NNP O
> NNP O
C22 NNP O
0 CD O
, , O
mainly RB O
C26 NNP O
0 CD O
) ) O
, , O
which WDT O
is VBZ O
due JJ O
to TO O
impaired JJ O
capacity NN O
for IN O
beta NN O
- : O
oxidation NN O
in IN O
peroxisomes NNS O
. . O

Diagnosis NN O
is VBZ O
usually RB O
based VBN O
on IN O
the DT O
VLCFA NNP O
levels NNS O
in IN O
plasma NN O
or CC O
cultured VBN O
skin JJ O
fibroblasts NNS O
in IN O
both DT O
patients NNS O
and CC O
carriers NNS O
. . O

In IN O
0 CD O
. . O

1 CD O
% NN O
of IN O
affected JJ O
males NNS O
, , O
however RB O
, , O
the DT O
plasma NN O
C26 NNP O
0 CD O
level NN O
is VBZ O
borderline JJ O
normal JJ O
, , O
and CC O
15 CD O
% NN O
of IN O
obligate JJ O
female NN O
carriers NNS O
have VBP O
normal JJ O
results NNS O
. . O

Effective JJ O
mutation NN O
detection NN O
in IN O
these DT O
families NNS O
is VBZ O
therefore RB O
fundamental JJ O
to TO O
unambiguously RB O
determine VB O
the DT O
genetic JJ O
status NN O
of IN O
each DT O
individual NN O
at IN O
risk NN O
. . O

Of IN O
particular JJ O
concern NN O
are VBP O
female JJ O
members NNS O
of IN O
kindreds NNS O
segregating VBG O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
mutations NNS O
, , O
because IN O
normal JJ O
VLCFA NNP O
levels NNS O
do VBP O
not RB O
guarantee VB O
lack NN O
of IN O
carrier NN O
status NN O
. . O

We PRP O
describe VBP O
a DT O
fast JJ O
method NN O
for IN O
detection NN O
of IN O
X NNP B-Disease
- : I-Disease
ALD JJ I-Disease
mutations NNS O
. . O

The DT O
method NN O
is VBZ O
based VBN O
on IN O
SSCP NNP O
analysis NN O
of IN O
nested JJ O
PCR NNP O
fragments NNS O
followed VBN O
by IN O
sequence NN O
- : O
determination NN O
reactions NNS O
. . O

Using VBG O
this DT O
methodology NN O
we PRP O
have VBP O
found VBN O
X NNP B-Disease
- : I-Disease
ALD JJ I-Disease
mutations NNS O
in IN O
30 CD O
kindreds NNS O
, , O
including VBG O
15 CD O
not RB O
previously RB O
reported VBN O
. . O

beta SYM O
- : O
galactosidase NN O
gene NN O
mutations NNS O
affecting VBG O
the DT O
lysosomal JJ O
enzyme NN O
and CC O
the DT O
elastin NN O
- : O
binding NN O
protein NN O
in IN O
GM1 NNP B-Disease
- : I-Disease
gangliosidosis NN I-Disease
patients NNS O
with IN O
cardiac JJ B-Disease
involvement NN I-Disease
. . O

GM1 NNP B-Disease
- : I-Disease
gangliosidosis NN I-Disease
is VBZ O
a DT O
lysosomal JJ B-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
deficiency NN B-Disease
of IN I-Disease
acid NN I-Disease
beta SYM I-Disease
- : I-Disease
galactosidase NN I-Disease
( ( O
GLB1 NNP O
) ) O
. . O

We PRP O
report VBP O
five CD O
new JJ O
beta NN O
- : O
galactosidase NN O
gene NN O
mutations NNS O
in IN O
nine CD O
Italian JJ O
patients NNS O
and CC O
one CD O
fetus NN O
, , O
segregating VBG O
in IN O
seven CD O
unrelated JJ O
families NNS O
. . O

Six CD O
of IN O
the DT O
eight CD O
patients NNS O
with IN O
the DT O
infantile NN O
, , O
severe JJ O
form NN O
of IN O
the DT O
disease NN O
presented VBD O
cardiac JJ B-Disease
involvement NN I-Disease
, , O
a DT O
feature NN O
rarely RB O
associated VBN O
with IN O
GM1 NNP B-Disease
- : I-Disease
gangliosidosis NN I-Disease
. . O

Molecular JJ O
analysis NN O
of IN O
the DT O
patients NNS O
RNA NNP O
and CC O
DNA NNP O
identified VBD O
two CD O
new JJ O
RNA NNP O
splicing NN O
defects NNS O
, , O
three CD O
new JJ O
and CC O
three CD O
previously RB O
described VBN O
amino JJ O
acid JJ O
substitutions NNS O
. . O

Interestingly RB O
, , O
all DT O
patients NNS O
with IN O
cardiac JJ B-Disease
involvement NN I-Disease
were VBD O
homozygous JJ O
for IN O
one CD O
of IN O
these DT O
mutations NNS O
R59H NNP O
, , O
Y591C NNP O
, , O
Y591N NNP O
, , O
or CC O
IVS14 NNP O
- : O
2A CD O
> JJ O
G NNP O
. . O

In IN O
contrast NN O
, , O
all DT O
other JJ O
patients NNS O
were VBD O
compound RB O
heterozygous JJ O
for IN O
one CD O
of IN O
the DT O
following JJ O
mutations NNS O
R201H NNP O
, , O
R482H NNP O
, , O
G579D NNP O
, , O
IVS8 NNP O
+ VBZ O
2T CD O
> JJ O
C NNP O
. . O

Although IN O
we PRP O
could MD O
not RB O
directly RB O
correlate VB O
the DT O
presence NN O
of IN O
cardiac JJ B-Disease
abnormalities NNS I-Disease
with IN O
specific JJ O
genetic JJ B-Disease
lesions NNS I-Disease
, , O
the DT O
mutations NNS O
identified VBN O
in IN O
patients NNS O
with IN O
cardiomyopathy NN B-Disease
fell VBD O
in IN O
the DT O
GLB1 NNP O
cDNA NN O
region NN O
common JJ O
to TO O
the DT O
lysosomal JJ O
enzyme NN O
and CC O
the DT O
Hbeta NNP O
- : O
Gal NNP O
- : O
related JJ O
protein NN O
, , O
also RB O
known VBN O
as IN O
the DT O
elastin NN O
binding VBG O
protein NN O
( ( O
EBP NNP O
) ) O
. . O

Consequently RB O
, , O
both DT O
molecules NNS O
are VBP O
affected VBN O
by IN O
the DT O
mutations NNS O
, , O
and CC O
they PRP O
may MD O
contribute VB O
differently RB O
to TO O
the DT O
occurrence NN O
of IN O
specific JJ O
clinical JJ O
manifestations NNS O
. . O
. . O

In IN O
vivo JJ O
modulation NN O
of IN O
Hmgic NNP O
reduces NNS O
obesity NN B-Disease
. . O

The DT O
HMGI NNP O
family NN O
of IN O
proteins NNS O
consists NNS O
of IN O
three CD O
members NNS O
, , O
HMGIC NNP O
, , O
HMGI NNP O
and CC O
HMGI NNP O
( ( O
Y NNP O
) ) O
, , O
that DT O
function NN O
as IN O
architectural JJ O
factors NNS O
and CC O
are VBP O
essential JJ O
components NNS O
of IN O
the DT O
enhancesome NN O
. . O

HMGIC NNP O
is VBZ O
predominantly RB O
expressed VBN O
in IN O
proliferating NN O
, , O
undifferentiated JJ O
mesenchymal JJ O
cells NNS O
and CC O
is VBZ O
not RB O
detected VBN O
in IN O
adult NN O
tissues NNS O
. . O

It PRP O
is VBZ O
disrupted VBN O
and CC O
misexpressed VBN O
in IN O
a DT O
number NN O
of IN O
mesenchymal JJ B-Disease
tumour NN I-Disease
cell NN O
types NNS O
, , O
including VBG O
fat JJ B-Disease
- : I-Disease
cell NN I-Disease
tumours NNS I-Disease
( ( O
lipomas NN B-Disease
) ) O
. . O

In IN O
addition NN O
Hmgic NNP O
- : O
/ SYM O
- : O
mice NN O
have VBP O
a DT O
deficiency NN O
in IN O
fat JJ O
tissue NN O
. . O

To TO O
study VB O
its PRP$ O
role NN O
in IN O
adipogenesis NN O
and CC O
obesity NN B-Disease
, , O
we PRP O
examined VBD O
Hmgic NNP O
expression NN O
in IN O
the DT O
adipose JJ O
tissue NN O
of IN O
adult NN O
, , O
obese JJ B-Disease
mice NN O
. . O

Mice NNP O
with IN O
a DT O
partial JJ B-Disease
or CC I-Disease
complete JJ I-Disease
deficiency NN I-Disease
of IN I-Disease
Hmgic NNP I-Disease
resisted VBD O
diet JJ O
- : O
induced JJ O
obesity NN B-Disease
. . O

Disruption NN O
of IN O
Hmgic NNP O
caused VBD O
a DT O
reduction NN O
in IN O
the DT O
obesity NN B-Disease
induced VBN O
by IN O
leptin JJ B-Disease
deficiency NN I-Disease
( ( O
Lepob NNP O
/ NNP O
Lepob NNP O
) ) O
in IN O
a DT O
gene NN O
- : O
dose JJ O
- : O
dependent JJ O
manner NN O
. . O

Our PRP$ O
studies NNS O
implicate VBP O
a DT O
role NN O
for IN O
HMGIC NNP O
in IN O
fat JJ O
- : O
cell NN O
proliferation NN O
, , O
indicating VBG O
that IN O
it PRP O
may MD O
be VB O
an DT O
adipose JJ O
- : O
specific JJ O
target NN O
for IN O
the DT O
treatment NN O
of IN O
obesity NN B-Disease
. . O
. . O

Molecular JJ O
analysis NN O
of IN O
the DT O
genotype NN O
- : O
phenotype NN O
relationship NN O
in IN O
factor NN B-Disease
X NNP I-Disease
deficiency NN I-Disease
. . O

Factor NNP B-Disease
X NNP I-Disease
deficiency NN I-Disease
is VBZ O
a DT O
rare JJ O
haemorrhagic JJ B-Disease
condition NN I-Disease
, , O
normally RB O
inherited VBN O
as IN O
an DT O
autosomal JJ O
recessive JJ O
trait NN O
, , O
in IN O
which WDT O
a DT O
variable JJ O
clinical JJ O
presentation NN O
correlates VBZ O
poorly RB O
with IN O
laboratory JJ O
phenotype NN O
. . O

The DT O
factor NN O
X NNP O
( ( O
F10 NNP O
) ) O
genes NNS O
of IN O
14 CD O
unrelated JJ O
individuals NNS O
with IN O
factor NN B-Disease
X NNP I-Disease
deficiency NN I-Disease
( ( O
12 CD O
familial NN O
and CC O
two CD O
sporadic JJ O
cases NNS O
) ) O
were VBD O
sequenced VBN O
yielding VBG O
a DT O
total NN O
of IN O
13 CD O
novel JJ O
mutations NNS O
. . O

Family RB O
studies NNS O
were VBD O
performed VBN O
in IN O
order NN O
to TO O
distinguish VB O
the DT O
contributions NNS O
of IN O
individual JJ O
mutant NN O
F10 NNP O
alleles VBZ O
to TO O
the DT O
clinical JJ O
and CC O
laboratory JJ O
phenotypes NNS O
. . O

Missense JJ O
mutations NNS O
were VBD O
studied VBN O
by IN O
means NNS O
of IN O
molecular JJ O
modelling NN O
, , O
whereas WP O
single JJ O
basepair NN O
substitutions NNS O
in IN O
splice NN O
sites NNS O
and CC O
the DT O
5 CD O
flanking JJ O
region NN O
were VBD O
examined VBN O
by IN O
in IN O
vitro NN O
splicing VBG O
assay NN O
and CC O
luciferase NN O
reporter NN O
gene NN O
assay VBP O
respectively RB O
. . O

The DT O
deletion NN O
allele NN O
of IN O
a DT O
novel JJ O
hexanucleotide NN O
insertion NN O
/ NNP O
deletion NN O
polymorphism NN O
in IN O
the DT O
F10 NNP O
gene NN O
promoter NN O
region NN O
was VBD O
shown VBN O
by IN O
reporter NN O
gene NN O
assay VBP O
, , O
to TO O
reduce VB O
promoter NN O
activity NN O
by IN O
approximately RB O
20 CD O
% NN O
. . O

One CD O
family NN O
manifesting VBG O
an DT O
autosomal JJ O
dominant JJ O
pattern NN O
of IN O
inheritance NN O
possessed VBD O
three CD O
clinically RB O
affected JJ O
members NNS O
who WP O
were VBD O
heterozygous JJ O
for IN O
a DT O
splice NN O
- : O
site NN O
mutation NN O
that WDT O
was VBD O
predicted VBN O
to TO O
lead VB O
to TO O
the DT O
production NN O
of IN O
a DT O
truncated JJ O
protein NN O
product NN O
. . O

A DT O
model NN O
which WDT O
accounts VBZ O
for IN O
the DT O
dominant JJ O
negative JJ O
effect NN O
of IN O
this DT O
lesion NN O
is VBZ O
presented VBN O
. . O

Variation NN O
in IN O
the DT O
antigen NN O
level NN O
of IN O
heterozygous JJ O
relatives NNS O
of IN O
probands NNS O
was VBD O
found VBN O
to TO O
be VB O
significantly RB O
higher JJR O
between IN O
families NNS O
than IN O
within IN O
families NNS O
, , O
consistent NN O
with IN O
the DT O
view NN O
that IN O
the DT O
nature NN O
of IN O
the DT O
F10 NNP O
lesion NN O
( ( O
s PRP O
) ) O
segregating VBG O
in IN O
a DT O
given VBN O
family NN O
is VBZ O
a DT O
prime JJ O
determinant NN O
of IN O
the DT O
laboratory NN O
phenotype NN O
. . O

By IN O
contrast NN O
, , O
no DT O
such JJ O
relationship NN O
could MD O
be VB O
discerned VBN O
between IN O
laboratory NN O
phenotype NN O
and CC O
polymorphism NN O
genotype NN O
. . O
. . O

Transgenic NNP O
mice NN O
expressing VBG O
a DT O
truncated JJ O
form NN O
of IN O
the DT O
high JJ O
mobility NN O
group NN O
I PRP O
- : O
C NNP O
protein NN O
develop VB O
adiposity NN O
and CC O
an DT O
abnormally RB O
high JJ O
prevalence NN O
of IN O
lipomas NN B-Disease
. . O

Chromosomal JJ O
translocations NNS O
in IN O
human JJ O
lipomas NN B-Disease
frequently RB O
create JJ O
fusion NN O
transcripts NNS O
encoding VBG O
high JJ O
mobility NN O
group NN O
( ( O
HMG NNP O
) ) O
I PRP O
- : O
C NNP O
DNA NNP O
- : O
binding NN O
domains NNS O
and CC O
C NNP O
- : O
terminal JJ O
sequences NNS O
from IN O
different JJ O
presumed VBN O
transcription NN O
factors NNS O
, , O
suggesting VBG O
a DT O
potential JJ O
role NN O
for IN O
HMG NNP O
I PRP O
- : O
C NN O
in IN O
the DT O
development NN O
of IN O
lipomas NN B-Disease
. . O

To TO O
evaluate VB O
the DT O
role NN O
of IN O
the DT O
HMG NNP O
I PRP O
- : O
C NNP O
component NN O
, , O
the DT O
three CD O
DNA NNP O
- : O
binding NN O
domains NNS O
of IN O
HMG NNP O
I PRP O
- : O
C NNS O
have VBP O
now RB O
been VBN O
expressed VBN O
in IN O
transgenic JJ O
mice NN O
. . O

Despite IN O
the DT O
ubiquitous JJ O
expression NN O
of IN O
the DT O
truncated JJ O
HMG NNP O
I PRP O
- : O
C NNP O
protein NN O
, , O
the DT O
transgenic JJ O
mice NN O
develop VB O
a DT O
selective JJ O
abundance NN O
of IN O
fat JJ O
tissue NN O
early RB O
in IN O
life NN O
, , O
show VBP O
marked VBN O
adipose JJ B-Disease
tissue NN I-Disease
inflammation NN I-Disease
, , O
and CC O
have VBP O
an DT O
abnormally RB O
high JJ O
incidence NN O
of IN O
lipomas NN B-Disease
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
the DT O
DNA NNP O
- : O
binding NN O
domains NNS O
of IN O
HMG NNP O
I PRP O
- : O
C NN O
, , O
in IN O
the DT O
absence NN O
of IN O
a DT O
C NNP O
- : O
terminal JJ O
fusion NN O
partner NN O
, , O
are VBP O
sufficient JJ O
to TO O
perturb VB O
adipogenesis NN O
and CC O
predispose VB O
to TO O
lipomas VB B-Disease
. . O

We PRP O
provide VBP O
data NNS O
supporting VBG O
the DT O
central JJ O
utility NN O
of IN O
this DT O
animal JJ O
model NN O
as IN O
a DT O
tool NN O
to TO O
understand VB O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
development NN O
of IN O
one CD O
of IN O
the DT O
most RBS O
common JJ O
kind NN O
of IN O
human JJ O
benign NN B-Disease
tumors NNS I-Disease
. . O
. . O

ATM NNP O
phosphorylates VBZ O
p95 JJ O
/ NNP O
nbs1 NN O
in IN O
an DT O
S NNP O
- : O
phase NN O
checkpoint NN O
pathway NN O
. . O

The DT O
rare JJ B-Disease
diseases NNS I-Disease
ataxia VBP B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
AT NNP B-Disease
) ) O
, , O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
ATM NNP O
gene NN O
, , O
and CC O
Nijmegen NNP B-Disease
breakage NN I-Disease
syndrome NN I-Disease
( ( O
NBS NNP B-Disease
) ) O
, , O
with IN O
mutations NNS O
in IN O
the DT O
p95 NN O
/ NNP O
nbs1 NN O
gene NN O
, , O
share NN O
a DT O
variety NN O
of IN O
phenotypic JJ B-Disease
abnormalities NNS I-Disease
such JJ O
as IN O
chromosomal JJ B-Disease
instability NN I-Disease
, , O
radiation NN O
sensitivity NN O
and CC O
defects NNS O
in IN O
cell NN O
- : O
cycle NN O
checkpoints NNS O
in IN O
response NN O
to TO O
ionizing VBG O
radiation NN O
. . O

The DT O
ATM NNP O
gene NN O
encodes VBZ O
a DT O
protein NN O
kinase NN O
that WDT O
is VBZ O
activated VBN O
by IN O
ionizing VBG O
radiation NN O
or CC O
radiomimetic JJ O
drugs NNS O
, , O
whereas NNS O
p95 VBP O
/ JJ O
nbs1 NN O
is VBZ O
part NN O
of IN O
a DT O
protein NN O
complex NN O
that WDT O
is VBZ O
involved VBN O
in IN O
responses NNS O
to TO O
DNA NNP O
double JJ O
- : O
strand NN O
breaks NNS O
. . O

Here RB O
, , O
because IN O
of IN O
the DT O
similarities NNS O
between IN O
AT NNP B-Disease
and CC O
NBS NNP B-Disease
, , O
we PRP O
evaluated VBD O
the DT O
functional JJ O
interactions NNS O
between IN O
ATM NNP O
and CC O
p95 VB O
/ NNP O
nbs1 NN O
. . O

Activation NN O
of IN O
the DT O
ATM NNP O
kinase NN O
by IN O
ionizing VBG O
radiation NN O
and CC O
induction NN O
of IN O
ATM NNP O
- : O
dependent NN O
responses NNS O
in IN O
NBS NNP B-Disease
cells NNS O
indicated VBD O
that IN O
p95 NN O
/ NNP O
nbs1 NN O
may MD O
not RB O
be VB O
required VBN O
for IN O
signalling VBG O
to TO O
ATM NNP O
after IN O
ionizing VBG O
radiation NN O
. . O

However RB O
, , O
p95 JJ O
/ NNP O
nbs1 NN O
was VBD O
phosphorylated VBN O
on IN O
serine NN O
343 CD O
in IN O
an DT O
ATM NNP O
- : O
dependent JJ O
manner NN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
after IN O
ionizing VBG O
radiation NN O
. . O

A DT O
p95 NN O
/ NNP O
nbs1 CC O
construct NN O
mutated VBN O
at IN O
the DT O
ATM NNP O
phosphorylation NN O
site NN O
abrogated VBD O
an DT O
S NNP O
- : O
phase NN O
checkpoint NN O
induced VBN O
by IN O
ionizing VBG O
radiation NN O
in IN O
normal JJ O
cells NNS O
and CC O
failed VBD O
to TO O
compensate VB O
for IN O
this DT O
functional JJ O
deficiency NN O
in IN O
NBS NNP B-Disease
cells NNS O
. . O

These DT O
observations NNS O
link VBP O
ATM NNP O
and CC O
p95 VB O
/ NNP O
nbs1 NN O
in IN O
a DT O
common JJ O
signalling NN O
pathway NN O
and CC O
provide VB O
an DT O
explanation NN O
for IN O
phenotypic NN O
similarities NNS O
in IN O
these DT O
two CD O
diseases NNS O
. . O
. . O

Understanding VBG O
the DT O
molecular JJ O
basis NN O
of IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
. . O

Fragile NNP B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
a DT O
common JJ O
form NN O
of IN O
inherited JJ B-Disease
mental JJ I-Disease
retardation NN I-Disease
, , O
is VBZ O
mainly RB O
caused VBN O
by IN O
massive JJ O
expansion NN O
of IN O
CGG NNP O
triplet NN O
repeats NNS O
located VBN O
in IN O
the DT O
5 CD O
- : O
untranslated JJ O
region NN O
of IN O
the DT O
fragile JJ B-Disease
X NNP I-Disease
mental NN I-Disease
retardation NN I-Disease
- : O
1 CD O
( ( O
FMR1 NNP O
) ) O
gene NN O
. . O

In IN O
patients NNS O
with IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
the DT O
expanded VBN O
CGG NNP O
triplet NN O
repeats NNS O
are VBP O
hypermethylated VBN O
and CC O
the DT O
expression NN O
of IN O
the DT O
FMR1 NNP O
gene NN O
is VBZ O
repressed VBN O
, , O
which WDT O
leads VBZ O
to TO O
the DT O
absence NN O
of IN O
FMR1 NNP O
protein NN O
( ( O
FMRP NNP O
) ) O
and CC O
subsequent JJ O
mental JJ B-Disease
retardation NN I-Disease
. . O

FMRP NNP O
is VBZ O
an DT O
RNA NNP O
- : O
binding NN O
protein NN O
that WDT O
shuttles VBZ O
between IN O
the DT O
nucleus NN O
and CC O
cytoplasm NN O
. . O

This DT O
protein NN O
has VBZ O
been VBN O
implicated VBN O
in IN O
protein JJ O
translation NN O
as IN O
it PRP O
is VBZ O
found VBN O
associated VBN O
with IN O
polyribosomes NNS O
and CC O
the DT O
rough JJ O
endoplasmic JJ O
reticulum NN O
. . O

We PRP O
discuss VBP O
here RB O
the DT O
recent JJ O
progress NN O
made VBD O
towards NNS O
understanding VBG O
the DT O
molecular JJ O
mechanism NN O
of IN O
CGG NNP O
repeat NN O
expansion NN O
and CC O
physiological JJ O
function NN O
( ( O
s JJ O
) ) O
of IN O
FMRP NNP O
. . O

These DT O
studies NNS O
will MD O
not RB O
only RB O
help VB O
to TO O
illuminate VB O
the DT O
molecular JJ O
basis NN O
of IN O
the DT O
general JJ O
class NN O
of IN O
human JJ O
diseases NNS O
with IN O
trinucleotide JJ O
repeat NN O
expansion NN O
but CC O
also RB O
provide VBP O
an DT O
avenue NN O
to TO O
understand VB O
aspects NNS O
of IN O
human JJ O
cognition NN O
and CC O
intelligence NN O
. . O
. . O

Haploinsufficiency NN B-Disease
of IN I-Disease
the DT I-Disease
transcription NN I-Disease
factors NNS I-Disease
FOXC1 NNP I-Disease
and CC I-Disease
FOXC2 NNP I-Disease
results NNS O
in IN O
aberrant JJ O
ocular JJ O
development NN O
. . O

Anterior NNP B-Disease
segment NN I-Disease
developmental NN I-Disease
disorders NNS I-Disease
, , O
including VBG O
Axenfeld NNP B-Disease
- : I-Disease
Rieger NN I-Disease
anomaly NN I-Disease
( ( O
ARA NNP B-Disease
) ) O
, , O
variably RB O
associate JJ O
with IN O
harmfully RB O
elevated VBN O
intraocular JJ O
pressure NN O
( ( O
IOP NNP O
) ) O
, , O
which WDT O
causes VBZ O
glaucoma NN B-Disease
. . O

Clinically RB O
observed VBN O
dysgenesis NN O
does VBZ O
not RB O
correlate VB O
with IN O
IOP NNP O
, , O
however RB O
, , O
and CC O
the DT O
etiology NN O
of IN O
glaucoma NN B-Disease
development NN O
is VBZ O
not RB O
understood JJ O
. . O

The DT O
forkhead JJ O
transcription NN O
factor NN O
genes NNS O
Foxc1 NNP O
( ( O
formerly RB O
Mf1 NNP O
) ) O
and CC O
Foxc2 NNP O
( ( O
formerly RB O
Mfh1 NNP O
) ) O
are VBP O
expressed VBN O
in IN O
the DT O
mesenchyme NN O
from IN O
which WDT O
the DT O
ocular JJ O
drainage NN O
structures NNS O
derive VBP O
. . O

Mutations NNS O
in IN O
the DT O
human JJ O
homolog NN O
of IN O
Foxc1 NNP O
, , O
FKHL7 NNP O
, , O
cause NN O
dominant JJ O
anterior JJ B-Disease
segment NN I-Disease
defects NNS I-Disease
and CC O
glaucoma NN B-Disease
in IN O
various JJ O
families NNS O
. . O

We PRP O
show VBP O
that IN O
Foxc1 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
mice NN O
have VBP O
anterior VBN B-Disease
segment NN I-Disease
abnormalities NNS I-Disease
similar JJ O
to TO O
those DT O
reported VBN O
in IN O
human JJ O
patients NNS O
. . O

These DT O
abnormalities NNS O
include VBP O
small JJ O
or CC O
absent JJ O
Schlemms NNP O
canal NN O
, , O
aberrantly RB O
developed VBD O
trabecular JJ O
meshwork NN O
, , O
iris JJ B-Disease
hypoplasia NN I-Disease
, , O
severely RB O
eccentric JJ O
pupils NNS O
and CC O
displaced VBD O
Schwalbes NNP O
line NN O
. . O

The DT O
penetrance NN O
of IN O
clinically RB O
obvious JJ O
abnormalities NNS O
varies NNS O
with IN O
genetic JJ O
background NN O
. . O

In IN O
some DT O
affected JJ O
eyes NNS O
, , O
collagen NN O
bundles NNS O
were VBD O
half JJ O
normal JJ O
diameter NN O
, , O
or CC O
collagen NN O
and CC O
elastic JJ O
tissue NN O
were VBD O
very RB O
sparse JJ O
. . O

Thus RB O
, , O
abnormalities NNS O
in IN O
extracellular JJ O
matrix NN O
synthesis NN O
or CC O
organization NN O
may MD O
contribute VB O
to TO O
development NN O
of IN O
the DT O
ocular JJ O
phenotypes NNS O
. . O

Despite IN O
the DT O
abnormalities NNS O
in IN O
ocular JJ O
drainage NN O
structures NNS O
in IN O
Foxc1 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
mice NN O
, , O
IOP NNP O
was VBD O
normal JJ O
in IN O
almost RB O
all DT O
mice NNS O
analyzed VBN O
, , O
on IN O
all DT O
genetic JJ O
backgrounds NNS O
and CC O
at IN O
all DT O
ages NNS O
. . O

Similar JJ O
abnormalities NNS O
were VBD O
found VBN O
in IN O
Foxc2 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
mice NN O
, , O
but CC O
no DT O
disease NN O
- : O
associated VBN O
mutations NNS O
were VBD O
identified VBN O
in IN O
the DT O
human JJ O
homolog NN O
FKHL14 NNP O
in IN O
32 CD O
ARA NNP B-Disease
patients NNS O
. . O

Foxc1 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
and CC O
Foxc2 NNP O
( ( O
+ NNP O
/ NNP O
- : O
) ) O
mice NN O
are VBP O
useful JJ O
models NNS O
for IN O
studying VBG O
anterior JJ O
segment NN O
development NN O
and CC O
its PRP$ O
anomalies NNS O
, , O
and CC O
may MD O
allow VB O
identification NN O
of IN O
genes NNS O
that WDT O
interact VBP O
with IN O
Foxc1 NNP O
and CC O
Foxc2 NNP O
( ( O
or CC O
FKHL7 NNP O
and CC O
FKHL14 NNP O
) ) O
to TO O
produce VB O
a DT O
phenotype NN O
with IN O
elevated JJ O
IOP NNP O
and CC O
glaucoma NN B-Disease
. . O
. . O

( ( O
Over IN O
) ) O
correction NN O
of IN O
FMR1 NNP B-Disease
deficiency NN I-Disease
with IN O
YAC NNP O
transgenics NNS O
: : O
behavioral JJ O
and CC O
physical JJ O
features NNS O
. . O

Fragile NNP B-Disease
X NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
common JJ O
cause NN O
of IN O
mental JJ B-Disease
retardation NN I-Disease
involving VBG O
loss NN O
of IN O
expression NN O
of IN O
the DT O
FMR1 NNP O
gene NN O
. . O

The DT O
role NN O
of IN O
FMR1 NNP O
remains NNS O
undetermined JJ O
but CC O
the DT O
protein NN O
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
RNA NNP O
metabolism NN O
. . O

Fmr1 NNP O
knockout NN O
mice NN O
exhibit NN O
a DT O
phenotype NN O
with IN O
some DT O
similarities NNS O
to TO O
humans NNS O
, , O
such JJ O
as IN O
macroorchidism NN B-Disease
and CC O
behavioral JJ O
abnormalities NNS O
. . O

As IN O
a DT O
step NN O
toward IN O
understanding VBG O
the DT O
function NN O
of IN O
FMR1 NNP O
and CC O
the DT O
determination NN O
of IN O
the DT O
potential NN O
for IN O
therapeutic JJ O
approaches NNS O
to TO O
fragile VB B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
yeast RB O
artificial JJ O
chromosome NN O
( ( O
YAC NNP O
) ) O
transgenic JJ O
mice NN O
were VBD O
generated VBN O
in IN O
order NN O
to TO O
determine VB O
whether IN O
the DT O
Fmr1 NNP O
knockout NN O
mouse NN O
phenotype NN O
could MD O
be VB O
rescued VBN O
. . O

Several JJ O
transgenic JJ O
lines NNS O
were VBD O
generated VBN O
that IN O
carried VBD O
the DT O
entire JJ O
FMR1 NNP O
locus NN O
with IN O
extensive JJ O
amounts NNS O
of IN O
flanking VBG O
sequence NN O
. . O

We PRP O
observed VBD O
that IN O
the DT O
YAC NNP O
transgene NN O
supported VBD O
production NN O
of IN O
the DT O
human JJ O
protein NN O
( ( O
FMRP NNP O
) ) O
which WDT O
was VBD O
present JJ O
at IN O
levels NNS O
10 CD O
to TO O
15 CD O
times NNS O
that IN O
of IN O
endogenous JJ O
protein NN O
and CC O
was VBD O
expressed VBN O
in IN O
a DT O
cell NN O
- : O
and CC O
tissue VB O
- : O
specific JJ O
manner NN O
. . O

Macro NNP O
- : O
orchidism NN O
was VBD O
absent JJ O
in IN O
knockout NN O
mice NN O
carrying VBG O
the DT O
YAC NNP O
transgene NN O
indicating VBG O
functional JJ O
rescue NN O
by IN O
the DT O
human JJ O
protein NN O
. . O

Given VBN O
the DT O
complex JJ O
behavioral JJ O
phenotype NN O
in IN O
fragile JJ B-Disease
X NN I-Disease
patients NNS O
and CC O
the DT O
mild JJ O
phenotype NN O
previously RB O
reported VBD O
for IN O
the DT O
Fmr1 NNP O
knockout NN O
mouse NN O
, , O
we PRP O
performed VBD O
a DT O
more RBR O
thorough JJ O
evaluation NN O
of IN O
the DT O
Fmr1 NNP O
knockout NN O
phenotype NN O
using VBG O
additional JJ O
behavioral JJ O
assays NNS O
that WDT O
had VBD O
not RB O
previously RB O
been VBN O
reported VBN O
for IN O
this DT O
animal JJ O
model NN O
. . O

The DT O
mouse NN O
displayed VBD O
reduced VBN O
anxiety NN B-Disease
- : O
related JJ O
responses NNS O
with IN O
increased JJ O
exploratory NN O
behavior NN O
. . O

FMR1 NNP O
YAC NNP O
transgenic JJ O
mice NN O
overexpressing VBG O
the DT O
human JJ O
protein NN O
did VBD O
produce VB O
opposing VBG O
behavioral JJ O
responses NNS O
and CC O
additional JJ O
abnormal JJ O
behaviors NNS O
were VBD O
also RB O
observed VBN O
. . O

These DT O
findings NNS O
have VBP O
significant JJ O
implications NNS O
for IN O
gene NN O
therapy NN O
for IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
since IN O
overexpression NN O
of IN O
the DT O
gene NN O
may MD O
harbor VB O
its PRP$ O
own JJ O
phenotype NN O
. . O
. . O

Transgenic NNP O
mice NN O
carrying VBG O
large JJ O
human JJ O
genomic JJ O
sequences NNS O
with IN O
expanded JJ O
CTG NNP O
repeat NN O
mimic RBR O
closely RB O
the DT O
DM NNP B-Disease
CTG NNP O
repeat NN O
intergenerational JJ O
and CC O
somatic JJ O
instability NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
a DT O
CTG NNP O
repeat NN O
expansion NN O
in IN O
the DT O
3UTR CD O
of IN O
the DT O
DM NNP B-Disease
protein NN O
kinase NN O
( ( O
DMPK NNP O
) ) O
gene NN O
. . O

A DT O
very RB O
high JJ O
level NN O
of IN O
instability NN O
is VBZ O
observed VBN O
through IN O
successive JJ O
generations NNS O
and CC O
the DT O
size NN O
of IN O
the DT O
repeat NN O
is VBZ O
generally RB O
correlated VBN O
with IN O
the DT O
severity NN O
of IN O
the DT O
disease NN O
and CC O
with IN O
age NN O
at IN O
onset NN O
. . O

Furthermore RB O
, , O
tissues NNS O
from IN O
DM NNP B-Disease
patients NNS O
exhibit VBP O
somatic JJ O
mosaicism NN O
that WDT O
increases VBZ O
with IN O
age NN O
. . O

We PRP O
generated VBD O
transgenic JJ O
mice NN O
carrying VBG O
large JJ O
human JJ O
genomic JJ O
sequences NNS O
with IN O
20 CD O
, , O
55 CD O
or CC O
> VB O
300 CD O
CTG NNP O
, , O
cloned VBD O
from IN O
patients NNS O
from IN O
the DT O
same JJ O
affected JJ O
DM NNP B-Disease
family NN O
. . O

Using VBG O
large JJ O
human JJ O
flanking NN O
sequences NNS O
and CC O
a DT O
large JJ O
amplification NN O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
intergenerational JJ O
CTG NNP O
repeat NN O
instability NN O
is VBZ O
reproduced VBN O
in IN O
mice NN O
, , O
with IN O
a DT O
strong JJ O
bias NN O
towards NNS O
expansions NNS O
and CC O
with IN O
the DT O
same JJ O
sex NN O
- : O
and CC O
size NN O
- : O
dependent JJ O
characteristics NNS O
as IN O
in IN O
humans NNS O
. . O

Moreover RB O
, , O
a DT O
high JJ O
level NN O
of IN O
instability NN O
, , O
increasing VBG O
with IN O
age NN O
, , O
can MD O
be VB O
observed VBN O
in IN O
tissues NNS O
and CC O
in IN O
sperm NN O
. . O

Although IN O
we PRP O
did VBD O
not RB O
observe VB O
dramatic JJ O
expansions NNS O
( ( O
or CC O
big JJ O
jumps NNS O
over IN O
several JJ O
hundred CD O
CTG NNP O
repeats NNS O
) ) O
as IN O
in IN O
congenital JJ O
forms NNS O
of IN O
DM NNP B-Disease
, , O
our PRP$ O
model NN O
carrying VBG O
> JJ O
300 CD O
CTG NNP O
is VBZ O
the DT O
first JJ O
to TO O
show VB O
instability NN O
so RB O
close RB O
to TO O
the DT O
human JJ O
DM NNP B-Disease
situation NN O
. . O

Our PRP$ O
three CD O
models NNS O
carrying VBG O
different JJ O
sizes NNS O
of IN O
CTG NNP O
repeat NN O
provide VBP O
insight NN O
on IN O
the DT O
different JJ O
factors NNS O
modulating VBG O
the DT O
CTG NNP O
repeat NN O
instability NN O
. . O
. . O

Inactivation NN O
of IN O
the DT O
Friedreich NNP B-Disease
ataxia NN I-Disease
mouse NN O
gene NN O
leads VBZ O
to TO O
early JJ O
embryonic JJ B-Disease
lethality NN I-Disease
without IN O
iron NN O
accumulation NN O
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
, , O
the DT O
most RBS O
common JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
ataxia NN I-Disease
, , O
is VBZ O
caused VBN O
in IN O
almost RB O
all DT O
cases NNS O
by IN O
homozygous JJ O
intronic JJ O
expansions NNS O
resulting VBG O
in IN O
the DT O
loss NN O
of IN O
frataxin NN O
, , O
a DT O
mitochondrial JJ O
protein NN O
conserved VBD O
through IN O
evolution NN O
, , O
and CC O
involved VBN O
in IN O
mitochondrial JJ O
iron NN O
homeostasis NN O
. . O

Yeast NN O
knockout NN O
models NNS O
, , O
and CC O
histological JJ O
and CC O
biochemical JJ O
data NNS O
from IN O
patient JJ O
heart NN O
biopsies NNS O
or CC O
autopsies NNS O
indicate VBP O
that IN O
the DT O
frataxin NN O
defect NN O
causes VBZ O
a DT O
specific JJ O
iron NN B-Disease
- : I-Disease
sulfur NN I-Disease
protein NN I-Disease
deficiency NN I-Disease
and CC O
mitochondrial JJ O
iron NN O
accumulation NN O
leading VBG O
to TO O
the DT O
pathological JJ O
changes NNS O
. . O

Affected JJ O
human JJ O
tissues NNS O
are VBP O
rarely RB O
available JJ O
to TO O
further JJ O
examine NN O
this DT O
hypothesis NN O
. . O

To TO O
study VB O
the DT O
mechanism NN O
of IN O
the DT O
disease NN O
, , O
we PRP O
generated VBD O
a DT O
mouse NN O
model NN O
by IN O
deletion NN O
of IN O
exon $ O
4 CD O
leading VBG O
to TO O
inactivation NN O
of IN O
the DT O
Frda NNP B-Disease
gene NN O
product NN O
. . O

We PRP O
show VBP O
that IN O
homozygous JJ O
deletions NNS O
cause VBP O
embryonic JJ B-Disease
lethality NN I-Disease
a DT O
few JJ O
days NNS O
after IN O
implantation NN O
, , O
demonstrating VBG O
an DT O
important JJ O
role NN O
for IN O
frataxin NN O
during IN O
early JJ O
development NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
milder NN O
phenotype NN O
in IN O
humans NNS O
is VBZ O
due JJ O
to TO O
residual JJ O
frataxin NN O
expression NN O
associated VBN O
with IN O
the DT O
expansion NN O
mutations NNS O
. . O

Surprisingly RB O
, , O
in IN O
the DT O
frataxin NN O
knockout NN O
mouse NN O
, , O
no DT O
iron NN O
accumulation NN O
was VBD O
observed VBN O
during IN O
embryonic JJ O
resorption NN O
, , O
suggesting VBG O
that IN O
cell NN O
death NN O
could MD O
be VB O
due JJ O
to TO O
a DT O
mechanism NN O
independent JJ O
of IN O
iron NN O
accumulation NN O
. . O
. . O

Gaucher PRP$ B-Disease
disease NN I-Disease
: : O
the DT O
origins NNS O
of IN O
the DT O
Ashkenazi NNP O
Jewish NNP O
N370S NNP O
and CC O
84GG CD O
acid NN O
beta NN O
- : O
glucosidase NN O
mutations NNS O
. . O

Type $ O
1 CD O
Gaucher NNP B-Disease
disease NN I-Disease
( ( O
GD NNP B-Disease
) ) O
, , O
a DT O
non JJ O
- : O
neuronopathic JJ O
lysosomal JJ B-Disease
storage NN I-Disease
disorder NN I-Disease
, , O
results NNS O
from IN O
the DT O
deficient NN O
activity NN O
of IN O
acid NN O
beta SYM O
- : O
glucosidase NN O
( ( O
GBA NNP O
) ) O
. . O

Type $ O
1 CD O
disease NN O
is VBZ O
panethnic JJ O
but CC O
is VBZ O
more RBR O
prevalent JJ O
in IN O
individuals NNS O
of IN O
Ashkenazi NNP O
Jewish NNP O
( ( O
AJ NNP O
) ) O
descent NN O
. . O

Of IN O
the DT O
causative JJ O
GBA NNP O
mutations NNS O
, , O
N370S NNP O
is VBZ O
particularly RB O
frequent JJ O
in IN O
the DT O
AJ NNP O
population NN O
, , O
( ( O
q JJ O
approximately RB O
. . O
3 CD O
) ) O
, , O
whereas VBD O
the DT O
84GG CD O
insertion NN O
( ( O
q JJ O
approximately RB O
. . O
3 CD O
) ) O
occurs VBZ O
exclusively RB O
in IN O
the DT O
Ashkenazim NNP O
. . O

To TO O
investigate VB O
the DT O
genetic JJ O
history NN O
of IN O
these DT O
mutations NNS O
in IN O
the DT O
AJ NNP O
population NN O
, , O
short JJ O
tandem NN O
repeat NN O
( ( O
STR NNP O
) ) O
markers NNS O
were VBD O
used VBN O
to TO O
map VB O
a DT O
9 CD O
. . O

3 LS O
- : O
cM NN O
region NN O
containing VBG O
the DT O
GBA NNP O
locus NN O
and CC O
to TO O
genotype VB O
261 CD O
AJ NNP O
N370S NNP O
chromosomes NNS O
, , O
60 CD O
European JJ O
non NN O
- : O
Jewish JJ O
N370S NNP O
chromosomes NNS O
, , O
and CC O
62 CD O
AJ NNP O
84GG CD O
chromosomes NNS O
. . O

A DT O
highly RB O
conserved VBN O
haplotype NN O
at IN O
four CD O
markers NNS O
flanking VBG O
GBA NNP O
( ( O
PKLR NNP O
, , O
D1S1595 NNP O
, , O
D1S2721 NNP O
, , O
and CC O
D1S2777 NNP O
) ) O
was VBD O
observed VBN O
on IN O
both DT O
the DT O
AJ NNP O
chromosomes NNS O
and CC O
the DT O
non NN O
- : O
Jewish JJ O
N370S NNP O
chromosomes NNS O
, , O
suggesting VBG O
the DT O
occurrence NN O
of IN O
a DT O
founder NN O
common JJ O
to TO O
both DT O
populations NNS O
. . O

Of IN O
note NN O
, , O
the DT O
presence NN O
of IN O
different JJ O
divergent NN O
haplotypes NNS O
suggested VBD O
the DT O
occurrence NN O
of IN O
de FW O
novo FW O
, , O
recurrent NN O
N370S NNP O
mutations NNS O
. . O

In IN O
contrast NN O
, , O
a DT O
different JJ O
conserved VBN O
haplotype NN O
at IN O
these DT O
markers NNS O
was VBD O
identified VBN O
on IN O
the DT O
84GG CD O
chromosomes NNS O
, , O
which WDT O
was VBD O
unique JJ O
to TO O
the DT O
AJ NNP O
population NN O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
linkage NN O
disequilibrium NN O
( ( O
LD NNP O
) ) O
delta NN O
values NNS O
, , O
the DT O
non NN O
- : O
Jewish JJ O
European JJ O
N370S NNP O
chromosomes NNS O
had VBD O
greater JJR O
haplotype JJ O
diversity NN O
and CC O
less JJR O
LD NNP O
at IN O
the DT O
markers NNS O
flanking VBG O
the DT O
conserved VBN O
haplotype NN O
than IN O
did VBD O
the DT O
AJ NNP O
N370S NNP O
chromosomes NNS O
. . O

This DT O
finding NN O
is VBZ O
consistent JJ O
with IN O
the DT O
presence NN O
of IN O
the DT O
N370S NNP O
mutation NN O
in IN O
the DT O
non NN O
- : O
Jewish JJ O
European JJ O
population NN O
prior RB O
to TO O
the DT O
founding NN O
of IN O
the DT O
AJ NNP O
population NN O
. . O

Coalescence NN O
analyses NNS O
for IN O
the DT O
N370S NNP O
and CC O
84GG CD O
mutations NNS O
estimated VBD O
similar JJ O
coalescence NN O
times NNS O
, , O
of IN O
48 CD O
and CC O
55 CD O
. . O
5 CD O
generations NNS O
ago RB O
, , O
respectively RB O
. . O

The DT O
results NNS O
of IN O
these DT O
studies NNS O
are VBP O
consistent JJ O
with IN O
a DT O
significant JJ O
bottleneck NN O
occurring VBG O
in IN O
the DT O
AJ NNP O
population NN O
during IN O
the DT O
first JJ O
millennium NN O
, , O
when WRB O
the DT O
population NN O
became VBD O
established VBN O
in IN O
Europe NNP O
. . O

HLA NNP O
B27 NNP O
and CC O
the DT O
genetics NNS O
of IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
. . O

One CD O
hundred CD O
and CC O
twenty VB O
- : O
eight CD O
of IN O
145 CD O
patients NNS O
with IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
( ( O
AS IN B-Disease
) ) O
were VBD O
found VBN O
to TO O
be VB O
HLA NNP O
B27 NNP O
positive JJ O
. . O

Five CD O
patients NNS O
had VBD O
evidence NN O
of IN O
a DT O
sero JJ O
- : O
negative JJ O
peripheral JJ B-Disease
arthritis NN I-Disease
resembling VBG O
peripheral JJ B-Disease
psoriatic JJ I-Disease
arthritis NN I-Disease
and CC O
3 CD O
of IN O
these DT O
were VBD O
B27 NNP O
negative JJ O
. . O

One CD O
further JJ O
B27 NNP O
negative JJ O
patients NNS O
had VBD O
a DT O
sister NN O
with IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
and CC O
ulcerative JJ B-Disease
colitis NN I-Disease
and CC O
a DT O
mother NN O
with IN O
ulcerative JJ B-Disease
colitis NN I-Disease
. . O

There EX O
was VBD O
evidence NN O
of IN O
a DT O
somewhat RB O
later JJ O
age NN O
of IN O
onset NN O
of IN O
symptoms NNS O
in IN O
B27 NNP O
negative JJ O
patients NNS O
. . O

These DT O
findings NNS O
are VBP O
interpreted VBN O
as IN O
suggesting VBG O
some DT O
degree NN O
of IN O
clinical JJ O
and CC O
genetic JJ O
heterogeneity NN O
in IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
with IN O
genes NNS O
for IN O
psoriasis NN B-Disease
and CC O
inflammatory JJ B-Disease
bowel NN I-Disease
disease NN I-Disease
being VBG O
important JJ O
in IN O
some DT O
individuals NNS O
, , O
particularly RB O
those DT O
who WP O
are VBP O
B27 NNP O
negative JJ O
. . O

Twenty CD O
- : O
five CD O
first JJ O
- : O
degree NN O
relatives NNS O
with IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
were VBD O
all DT O
B27 NNP O
positive JJ O
. . O

The DT O
only JJ O
instance NN O
of IN O
disassociation NN O
of IN O
B27 NNP O
and CC O
spondylitis NN B-Disease
in IN O
a DT O
family NN O
was VBD O
where WRB O
the DT O
proband NN O
had VBD O
ulcerative JJ B-Disease
colitis NN I-Disease
as RB O
well RB O
as IN O
spondylitis NN B-Disease
. . O

Of IN O
13 CD O
B27 NNP O
positive JJ O
fathers NNS O
3 CD O
could MD O
be VB O
diagnosed VBN O
as IN O
having VBG O
definite JJ O
ankylosing VBG B-Disease
spondylitis NN I-Disease
( ( O
23 CD O
% NN O
) ) O
. . O

These DT O
findings NNS O
are VBP O
thought VBN O
to TO O
provide VB O
evidence NN O
against IN O
the DT O
concept NN O
that IN O
the DT O
gene NN O
for IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
is VBZ O
not RB O
B27 NNP O
but CC O
a DT O
closely RB O
linked VBN O
gene NN O
and CC O
favour VB O
the DT O
occurrence NN O
of IN O
an DT O
environmental JJ O
event NN O
affecting VBG O
approximately RB O
one CD O
- : O
fifth NN O
of IN O
B27 NNP O
positive JJ O
males NNS O
to TO O
result VB O
in IN O
disease NN O
. . O
. . O

Founder NNP O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
in IN O
Polish JJ O
families NNS O
with IN O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

We PRP O
have VBP O
undertaken VBN O
a DT O
hospital NN O
- : O
based VBN O
study NN O
, , O
to TO O
identify VB O
possible JJ O
BRCA1 NNP O
and CC O
BRCA2 NNP O
founder NN O
mutations NNS O
in IN O
the DT O
Polish JJ O
population NN O
. . O

The DT O
study NN O
group NN O
consisted VBD O
of IN O
66 CD O
Polish JJ O
families NNS O
with IN O
cancer NN B-Disease
who WP O
have VBP O
at IN O
least JJS O
three CD O
related JJ O
females NNS O
affected VBN O
with IN O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
who WP O
had VBD O
cancer NN B-Disease
diagnosed VBN O
, , O
in IN O
at IN O
least JJS O
one CD O
of IN O
the DT O
three CD O
affected VBD O
females NNS O
, , O
at IN O
age NN O
< $ O
50 CD O
years NNS O
. . O

A DT O
total NN O
of IN O
26 CD O
families NNS O
had VBD O
both DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
, , O
4 CD O
families NNS O
had VBD O
ovarian JJ B-Disease
cancers NNS I-Disease
only RB O
, , O
and CC O
36 CD O
families NNS O
had VBD O
breast NN B-Disease
cancers NNS I-Disease
only RB O
. . O

Genomic NNP O
DNA NNP O
was VBD O
prepared VBN O
from IN O
the DT O
peripheral JJ O
blood NN O
leukocytes NNS O
of IN O
at IN O
least JJS O
one CD O
affected JJ O
woman NN O
from IN O
each DT O
family NN O
. . O

The DT O
entire JJ O
coding NN O
region NN O
of IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
was VBD O
screened VBN O
for IN O
the DT O
presence NN O
of IN O
germline JJ O
mutations NNS O
, , O
by IN O
use NN O
of IN O
SSCP NNP O
followed VBN O
by IN O
direct JJ O
sequencing NN O
of IN O
observed JJ O
variants NNS O
. . O

Mutations NNS O
were VBD O
found VBN O
in IN O
35 CD O
( ( O
53 CD O
% NN O
) ) O
of IN O
the DT O
66 CD O
families NNS O
studied VBN O
. . O

All DT O
but CC O
one CD O
of IN O
the DT O
mutations NNS O
were VBD O
detected VBN O
within IN O
the DT O
BRCA1 NNP O
gene NN O
. . O

BRCA1 NNP B-Disease
abnormalities NNS I-Disease
were VBD O
identified VBN O
in IN O
all DT O
four CD O
families NNS O
with IN O
ovarian JJ B-Disease
cancer NN I-Disease
only RB O
, , O
in IN O
67 CD O
% NN O
of IN O
27 CD O
families NNS O
with IN O
both DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
and CC O
in IN O
34 CD O
% NN O
of IN O
35 CD O
families NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
only RB O
. . O

The DT O
single JJ O
family NN O
with IN O
a DT O
BRCA2 NNP O
mutation NN O
had VBD O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
syndrome NN I-Disease
. . O

Seven NNP O
distinct JJ O
mutations NNS O
were VBD O
identified VBN O
; : O
five CD O
of IN O
these DT O
occurred VBN O
in IN O
two CD O
or CC O
more JJR O
families NNS O
. . O

In IN O
total JJ O
, , O
recurrent JJ O
mutations NNS O
were VBD O
found VBN O
in IN O
33 CD O
( ( O
94 CD O
% NN O
) ) O
of IN O
the DT O
35 CD O
families NNS O
with IN O
detected JJ O
mutations NNS O
. . O

Three CD O
BRCA1 NNP B-Disease
abnormalities NNS I-Disease
- : O
5382insC CD O
, , O
C61G NNP O
, , O
and CC O
4153delA CD O
- : O
accounted VBN O
for IN O
51 CD O
% NN O
, , O
20 CD O
% NN O
, , O
and CC O
11 CD O
% NN O
of IN O
the DT O
identified JJ O
mutations NNS O
, , O
respectively RB O
. . O
. . O

Molecular JJ O
basis NN O
of IN O
very RB B-Disease
long RB I-Disease
chain NN I-Disease
acyl JJ I-Disease
- : I-Disease
CoA NNP I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
three CD O
Israeli JJ O
patients NNS O
: : O
identification NN O
of IN O
a DT O
complex JJ O
mutant NN O
allele NN O
with IN O
P65L NNP O
and CC O
K247Q NNP O
mutations NNS O
, , O
the DT O
former JJ O
being VBG O
an DT O
exonic JJ O
mutation NN O
causing VBG O
exon $ O
3 CD O
skipping NN O
. . O

Very RB B-Disease
long RB I-Disease
chain NN I-Disease
acyl JJ I-Disease
- : I-Disease
CoA NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
VLCAD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
is VBZ O
a DT O
life NN O
- : O
threatening VBG O
disorder NN O
of IN O
mitochondrial JJ O
fatty JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
. . O

We PRP O
identified VBD O
four CD O
novel JJ O
mutations NNS O
in IN O
three CD O
unrelated JJ O
patients NNS O
. . O

All DT O
patients NNS O
had VBD O
the DT O
severe JJ O
childhood NN O
form NN O
of IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
with IN O
early JJ O
onset NN O
and CC O
high JJ O
mortality NN O
. . O

Immunoblot NNP O
analysis NN O
revealed VBD O
that IN O
VLCAD NNP O
protein NN O
was VBD O
undetectable JJ O
in IN O
patients NNS O
2 CD O
and CC O
3 CD O
, , O
whereas NNS O
normal JJ O
- : O
size NN O
VLCAD NNP O
protein NN O
and CC O
an DT O
aberrant JJ O
form NN O
of IN O
VLCAD NNP O
( ( O
4kDa CD O
smaller JJR O
) ) O
were VBD O
detected VBN O
in IN O
patient JJ O
1 CD O
. . O

As IN O
expected VBN O
, , O
null JJ O
mutations NNS O
were VBD O
found VBN O
in IN O
patients NNS O
2 CD O
and CC O
3 CD O
patient NN O
2 CD O
is VBZ O
homozygous JJ O
for IN O
a DT O
frameshift NN O
mutation NN O
, , O
del FW O
4 CD O
bp NN O
at IN O
798 CD O
- : O
801 CD O
, , O
and CC O
patient JJ O
3 CD O
is VBZ O
homozygous JJ O
for IN O
a DT O
nonsense JJ O
mutation NN O
65C CD O
> NN O
A NNP O
( ( O
S22X NNP O
) ) O
. . O

Patient JJ O
1 CD O
was VBD O
homozygous JJ O
for IN O
a DT O
complex JJ O
mutant NN O
allele IN O
containing VBG O
two CD O
alterations NNS O
, , O
including VBG O
a DT O
194C CD O
> NN O
T NNP O
transition NN O
( ( O
P65L NNP O
) ) O
and CC O
739A CD O
> NNS O
C NNP O
transversion NN O
( ( O
K247Q NNP O
) ) O
; : O
in IN O
the DT O
case NN O
of IN O
P65L NNP O
, , O
the DT O
amino NN O
acid JJ O
change NN O
does VBZ O
not RB O
reduce VB O
enzyme NN O
activity NN O
. . O

However RB O
, , O
the DT O
nucleotide JJ O
change NN O
resulted VBD O
in IN O
exon JJ O
3 CD O
skipping NN O
, , O
whereas IN O
the DT O
latter JJ O
K247Q NNP O
mutation NN O
had VBD O
a DT O
drastic JJ O
effect NN O
on IN O
enzyme NN O
activity NN O
. . O

We PRP O
verified VBD O
these DT O
events NNS O
by IN O
in IN O
vivo NN O
splicing NN O
experiments NNS O
and CC O
transient JJ O
expression NN O
analysis NN O
of IN O
mutant JJ O
cDNAs NN O
. . O

The DT O
P65L NNP O
mutation NN O
locates VBZ O
11 CD O
bases NNS O
upstream RB O
of IN O
a DT O
splice NN O
donor NN O
site NN O
of IN O
intron NN O
3 CD O
. . O

This DT O
is VBZ O
an DT O
example NN O
of IN O
an DT O
exonic JJ O
mutation NN O
which WDT O
affects VBZ O
exon SYM O
- : O
splicing NN O
. . O
. . O

Submicroscopic NNP O
deletion NN O
in IN O
cousins NNS O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome VBP I-Disease
causes VBZ O
a DT O
grandmatrilineal JJ O
inheritance NN O
pattern NN O
: : O
effects NNS O
of IN O
imprinting NN O
. . O

The DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
critical JJ O
region NN O
on IN O
15q11 CD O
- : O
q13 NN O
is VBZ O
subject JJ O
to TO O
imprinting VBG O
. . O

PWS NNP B-Disease
becomes VBZ O
apparent JJ O
when WRB O
genes NNS O
on IN O
the DT O
paternally RB O
inherited JJ O
chromosome NN O
are VBP O
not RB O
expressed VBN O
. . O

Familial JJ B-Disease
PWS NNP I-Disease
is VBZ O
rare JJ O
. . O

We PRP O
report VBP O
on IN O
a DT O
family NN O
in IN O
which WDT O
a DT O
male NN O
and CC O
a DT O
female JJ O
paternal NN O
first RB O
cousin VBZ O
both DT O
have VBP O
PWS VBN B-Disease
with IN O
cytogenetically RB O
normal JJ O
karyotypes NNS O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
analysis NN O
shows VBZ O
a DT O
submicroscopic JJ O
deletion NN O
of IN O
SNRPN NNP O
, , O
but CC O
not RB O
the DT O
closely RB O
associated VBN O
loci NN O
D15S10 NNP O
, , O
D15S11 NNP O
, , O
D15S63 NNP O
, , O
and CC O
GABRB3 NNP O
. . O

The DT O
cousins NNS O
fathers NNS O
and CC O
two CD O
paternal JJ O
aunts NNS O
have VBP O
the DT O
same JJ O
deletion NN O
and CC O
are VBP O
clinically RB O
normal JJ O
. . O

The DT O
grandmother NN O
of IN O
the DT O
cousins NNS O
is VBZ O
deceased VBN O
and CC O
not RB O
available JJ O
for IN O
study NN O
, , O
and CC O
their PRP$ O
grandfather NN O
is VBZ O
not RB O
deleted VBN O
for IN O
SNRPN NNP O
. . O

DNA NN O
methylation NN O
analysis NN O
of IN O
D15S63 NNP O
is VBZ O
consistent JJ O
with IN O
an DT O
abnormality NN O
of IN O
the DT O
imprinting NN O
center NN O
associated VBN O
with IN O
PWS NNP B-Disease
. . O

"""" JJ O
Grandmatrilineal NNP O
"""" NNP O
inheritance NN O
occurs VBZ O
when WRB O
a DT O
woman NN O
with IN O
deletion NN O
of IN O
an DT O
imprinted JJ O
, , O
paternally RB O
expressed VBN O
gene NN O
is VBZ O
at IN O
risk NN O
of IN O
having VBG O
affected VBN O
grandchildren NNS O
through IN O
her PRP$ O
sons NNS O
. . O

In IN O
this DT O
case NN O
, , O
PWS NNP B-Disease
does VBZ O
not RB O
become VB O
evident JJ O
as RB O
long RB O
as IN O
the DT O
deletion NN O
is VBZ O
passed VBN O
through IN O
the DT O
matrilineal JJ O
line NN O
. . O

This DT O
represents VBZ O
a DT O
unique JJ O
inheritance NN O
pattern NN O
due JJ O
to TO O
imprinting VBG O
. . O
. . O

Human NNP O
glycine NN O
decarboxylase NN O
gene NN O
( ( O
GLDC NNP O
) ) O
and CC O
its PRP$ O
highly RB O
conserved VBN O
processed VBN O
pseudogene NN O
( ( O
psiGLDC NN O
) ) O
: : O
their PRP$ O
structure NN O
and CC O
expression NN O
, , O
and CC O
the DT O
identification NN O
of IN O
a DT O
large JJ O
deletion NN O
in IN O
a DT O
family NN O
with IN O
nonketotic JJ B-Disease
hyperglycinemia NN I-Disease
. . O

Mutations NNS O
in IN O
the DT O
glycine NN O
decarboxylase NN O
gene NN O
( ( O
GLDC NNP O
) ) O
cause NN O
nonketotic JJ B-Disease
hyperglycinemia NN I-Disease
( ( O
NKH NNP B-Disease
) ) O
, , O
an DT O
in IN B-Disease
- : I-Disease
born JJ I-Disease
error NN I-Disease
of IN I-Disease
metabolism NN I-Disease
characterized VBN O
by IN O
severe JJ O
neurological JJ B-Disease
disturbance NN I-Disease
. . O

We PRP O
have VBP O
determined VBN O
the DT O
structure NN O
of IN O
GLDC NNP O
and CC O
of IN O
its PRP$ O
pseudogene NN O
( ( O
psiGLDC NN O
) ) O
and CC O
studied VBN O
their PRP$ O
expression NN O
for IN O
a DT O
molecular JJ O
analysis NN O
of IN O
NKH NNP B-Disease
. . O

The DT O
GLDC NNP O
gene NN O
spans NNS O
at IN O
least JJS O
135 CD O
kb NN O
and CC O
consists VBZ O
of IN O
25 CD O
exons NNS O
. . O

All DT O
donor NN O
and CC O
acceptor NN O
sites NNS O
adhere RB O
to TO O
the DT O
canonical JJ O
GT NNP O
- : O
AG NNP O
rule NN O
, , O
except IN O
for IN O
the DT O
donor JJ O
site NN O
of IN O
intron NN O
21 CD O
, , O
where WRB O
a DT O
variant JJ O
form NN O
GC NNP O
is VBZ O
used VBN O
instead RB O
of IN O
GT NNP O
. . O

The DT O
transcription NN O
initiation NN O
site NN O
has VBZ O
been VBN O
assigned VBN O
to TO O
a DT O
residue JJ O
163 CD O
bp NN O
upstream NN O
from IN O
the DT O
translation NN O
initiation NN O
triplet NN O
by IN O
primer JJ O
extension NN O
analysis NN O
. . O

The DT O
psiGLDC NN O
gene NN O
has VBZ O
no DT O
intron NN O
and CC O
shares NNS O
97 CD O
. . O

5 CD O
% NN O
homology NN O
with IN O
the DT O
coding VBG O
region NN O
of IN O
functional JJ O
GLDC NNP O
, , O
suggesting VBG O
that IN O
psiGLDC NN O
is VBZ O
a DT O
processed JJ O
pseudogene NN O
that WDT O
arose VBP O
from IN O
the DT O
GLDC NNP O
transcript NN O
about IN O
4 CD O
- : O
8 CD O
million CD O
years NNS O
ago RB O
. . O

RNA NNP O
blotting VBG O
analysis NN O
has VBZ O
revealed VBN O
that IN O
GLDC NNP O
is VBZ O
expressed VBN O
in IN O
human JJ O
liver NN O
, , O
kidney NN O
, , O
brain NN O
, , O
and CC O
placenta NN O
. . O

We PRP O
have VBP O
also RB O
examined VBN O
a DT O
patient NN O
with IN O
NKH NNP B-Disease
with IN O
no DT O
detectable JJ O
GLDC NNP O
mRNA NN O
in IN O
his PRP$ O
lymphoblasts NNS O
. . O

Exons NNS O
1 CD O
- : O
3 CD O
of IN O
the DT O
functional JJ O
GLDC NNP O
gene NN O
from IN O
this DT O
patient NN O
are VBP O
not RB O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
, , O
whereas VBP O
those DT O
from IN O
control NN O
subjects NNS O
are VBP O
. . O

These DT O
results NNS O
suggest VBP O
a DT O
large JJ O
homozygous JJ O
deletion NN O
( ( O
at IN O
least JJS O
30 CD O
kb NN O
) ) O
in IN O
the DT O
patient NN O
. . O

Furthermore RB O
, , O
we PRP O
have VBP O
devised VBN O
a DT O
semi JJ O
- : O
quantitative JJ O
PCR NNP O
to TO O
estimate VB O
the DT O
number NN O
of IN O
GLDC NNP O
alleles NNS O
by IN O
using VBG O
psiGLDC NN O
as IN O
an DT O
internal JJ O
control NN O
and CC O
have VBP O
confirmed VBN O
the DT O
homozygosity NN O
and CC O
heterozygosity NN O
of IN O
the DT O
deletion NN O
in IN O
the DT O
patient NN O
and CC O
his PRP$ O
parents NNS O
, , O
respectively RB O
. . O

Structural JJ O
information NN O
of IN O
GLDC NNP O
and CC O
psiGLDC NN O
should MD O
facilitate VB O
the DT O
molecular JJ O
analysis NN O
of IN O
NKH NNP B-Disease
. . O

De NNP O
novo FW O
deletions NNS O
of IN O
SNRPN NNP O
exon VBP O
1 CD O
in IN O
early JJ O
human NN O
and CC O
mouse NN O
embryos NN O
result NN O
in IN O
a DT O
paternal JJ O
to TO O
maternal JJ O
imprint NN O
switch NN O
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
is VBZ O
a DT O
neurogenetic JJ B-Disease
disease NN I-Disease
characterized VBN O
by IN O
infantile JJ B-Disease
hypotonia NN I-Disease
, , O
gonadal JJ B-Disease
hypoplasia NN I-Disease
, , O
obsessive JJ O
behaviour NN O
and CC O
neonatal JJ O
feeding NN O
difficulties NNS O
followed VBN O
by IN O
hyperphagia NN B-Disease
, , O
leading VBG O
to TO O
profound VB O
obesity NN B-Disease
. . O

PWS NNP B-Disease
is VBZ O
due JJ O
to TO O
a DT O
lack NN O
of IN O
paternal JJ O
genetic JJ O
information NN O
at IN O
15q11 CD O
- : O
q13 NN O
( ( O
ref NN O
. . O
2 CD O
) ) O
. . O

Five CD O
imprinted VBN O
, , O
paternally RB O
expressed VBN O
genes NNS O
map RBR O
to TO O
the DT O
PWS NNP B-Disease
region NN O
, , O
MKRN3 NNP O
( ( O
ref NN O
. . O
3 CD O
) ) O
, , O
NDN NNP O
( ( O
ref NN O
. . O
4 CD O
) ) O
, , O
NDNL1 NNP O
( ( O
ref NN O
. . O
5 CD O
) ) O
, , O
SNRPN NNP O
( ( O
refs VB O
6 CD O
- : O
8 CD O
) ) O
and CC O
IPW NNP O
( ( O
ref NN O
. . O
9 CD O
) ) O
, , O
as RB O
well RB O
as IN O
two CD O
poorly RB O
characterized VBN O
framents NNS O
designated VBN O
PAR NNP O
- : O
1 CD O
and CC O
PAR NNP O
- : O
5 CD O
( ( O
ref NN O
. . O
10 CD O
) ) O
. . O

Imprinting NN O
of IN O
this DT O
region NN O
involves VBZ O
a DT O
bipartite NN O
imprinting VBG O
centre NN O
( ( O
IC NNP O
) ) O
, , O
which WDT O
overlaps VBZ O
SNRPN NNP O
( ( O
refs JJ O
10 CD O
, , O
11 CD O
) ) O
. . O

Deletion NN O
of IN O
the DT O
SNRPN NNP O
promoter NN O
/ NNP O
exon VBZ O
1 CD O
region NN O
( ( O
the DT O
PWS NNP B-Disease
IC NNP O
element NN O
) ) O
appears VBZ O
to TO O
impair VB O
the DT O
establishment NN O
of IN O
the DT O
paternal JJ O
imprint NN O
in IN O
the DT O
male JJ O
germ JJ O
line NN O
and CC O
leads VBZ O
to TO O
PWS NNP B-Disease
. . O

Here RB O
we PRP O
report VBP O
a DT O
PWS NNP B-Disease
family NN O
in IN O
which WDT O
the DT O
father NN O
is VBZ O
mosaic VBN O
for IN O
an DT O
IC NNP O
deletion NN O
on IN O
his PRP$ O
paternal JJ O
chromosome NN O
. . O

The DT O
deletion NN O
chromosome NN O
has VBZ O
acquired VBN O
a DT O
maternal JJ O
methylation NN O
imprint NN O
in IN O
his PRP$ O
somatic JJ O
cells NNS O
. . O

We PRP O
have VBP O
made VBN O
identical JJ O
findings NNS O
in IN O
chimaeric JJ O
mice NN O
generated VBN O
from IN O
two CD O
independent JJ O
embryonic JJ O
stem NN O
( ( O
ES NNP O
) ) O
cell NN O
lines NNS O
harbouring VBG O
a DT O
similar JJ O
deletion NN O
. . O

Our PRP$ O
studies NNS O
demonstrate VBP O
that IN O
the DT O
PWS NNP B-Disease
IC NNP O
element NN O
is VBZ O
not RB O
only RB O
required VBN O
for IN O
the DT O
establishment NN O
of IN O
the DT O
paternal JJ O
imprint NN O
, , O
but CC O
also RB O
for IN O
its PRP$ O
postzygotic JJ O
maintenance NN O
. . O
. . O

Mice NNP O
deficient NN B-Disease
in IN I-Disease
Six5 NNP I-Disease
develop NN O
cataracts NNS B-Disease
: : O
implications NNS O
for IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

Expansion NN O
of IN O
a DT O
CTG NNP O
trinucleotide NN O
repeat NN O
in IN O
the DT O
3 CD O
UTR NNP O
of IN O
the DT O
gene NN O
DMPK NNP O
at IN O
the DT O
DM1 NNP O
locus NN O
on IN O
chromosome NN O
19 CD O
causes VBZ O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
a DT O
dominantly RB B-Disease
inherited VBN I-Disease
disease NN I-Disease
characterized VBN O
by IN O
skeletal JJ O
muscle NN B-Disease
dystrophy NN I-Disease
and CC O
myotonia NN B-Disease
, , O
cataracts NNS B-Disease
and CC O
cardiac JJ B-Disease
conduction NN I-Disease
defects NNS I-Disease
. . O

Targeted VBN O
deletion NN O
of IN O
Dm15 NNP O
, , O
the DT O
mouse NN O
orthologue NN O
of IN O
human JJ O
DMPK NNP O
, , O
produced VBD O
mice NN O
with IN O
a DT O
mild JJ O
myopathy NN B-Disease
and CC O
cardiac JJ B-Disease
conduction NN I-Disease
abnormalities NNS I-Disease
, , O
but CC O
without IN O
other JJ O
features NNS O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
such JJ O
as IN O
myotonia NN B-Disease
and CC O
cataracts NNS B-Disease
. . O

We PRP O
, , O
and CC O
others NNS O
, , O
have VBP O
demonstrated VBN O
that IN O
repeat NN O
expansion NN O
decreases VBZ O
expression NN O
of IN O
the DT O
adjacent JJ O
gene NN O
SIX5 NNP O
( ( O
refs JJ O
7 CD O
, , O
8 CD O
) ) O
, , O
which WDT O
encodes VBZ O
a DT O
homeodomain NN O
transcription NN O
factor NN O
. . O

To TO O
determine VB O
whether IN O
SIX5 NNP B-Disease
deficiency NN I-Disease
contributes VBZ O
to TO O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
phenotype NN O
, , O
we PRP O
disrupted VBD O
mouse RB O
Six5 NNP O
by IN O
replacing VBG O
the DT O
first JJ O
exon NN O
with IN O
a DT O
beta NN O
- : O
galactosidase NN O
reporter NN O
. . O

Six5 NNP O
- : O
mutant NN O
mice NN O
showed VBD O
reporter JJ O
expression NN O
in IN O
multiple JJ O
tissues NNS O
, , O
including VBG O
the DT O
developing NN O
lens VBZ O
. . O

Homozygous JJ O
mutant JJ O
mice NN O
had VBD O
no DT O
apparent JJ O
abnormalities NNS B-Disease
of IN I-Disease
skeletal JJ I-Disease
muscle NN I-Disease
function NN I-Disease
, , O
but CC O
developed VBD O
lenticular JJ B-Disease
opacities NNS I-Disease
at IN O
a DT O
higher JJR O
rate NN O
than IN O
controls NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
SIX5 NNP B-Disease
deficiency NN I-Disease
contributes VBZ O
to TO O
the DT O
cataract NN B-Disease
phenotype NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
and CC O
that IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
represents VBZ O
a DT O
multigenic JJ B-Disease
disorder NN I-Disease
. . O
. . O

Heterozygous JJ O
loss NN O
of IN O
Six5 NNP O
in IN O
mice NN O
is VBZ O
sufficient JJ O
to TO O
cause VB O
ocular JJ O
cataracts NNS B-Disease
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
skeletal JJ O
muscle NN B-Disease
wasting NN I-Disease
, , O
myotonia NN B-Disease
, , O
cardiac JJ B-Disease
arrhythmia NN I-Disease
, , O
hyperinsulinaemia NN B-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
and CC O
ocular JJ O
cataracts NNS B-Disease
. . O

The DT O
genetic JJ B-Disease
defect NN I-Disease
in IN O
DM NNP B-Disease
is VBZ O
a DT O
CTG NNP O
repeat NN O
expansion NN O
located VBN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
DMPK NNP O
and CC O
5 CD O
of IN O
a DT O
homeodomain NN O
- : O
encoding VBG O
gene NN O
, , O
SIX5 NNP O
( ( O
formerly RB O
DMAHP NNP O
; : O
refs VBZ O
2 CD O
- : O
5 CD O
) ) O
. . O

There EX O
are VBP O
three CD O
mechanisms NNS O
by IN O
which WDT O
CTG NNP O
expansion NN O
can MD O
result VB O
in IN O
DM NNP B-Disease
. . O

First RB O
, , O
repeat JJ O
expansion NN O
may MD O
alter VB O
the DT O
processing NN O
or CC O
transport NN O
of IN O
the DT O
mutant JJ O
DMPK NNP O
mRNA NN O
and CC O
consequently RB O
reduce VB O
DMPK NNP O
levels NNS O
. . O

Second JJ O
, , O
CTG NNP O
expansion NN O
may MD O
establish VB O
a DT O
region NN O
of IN O
heterochromatin NN O
3 CD O
of IN O
the DT O
repeat NN O
sequence NN O
and CC O
decrease NN O
SIX5 NNP O
transcription NN O
. . O

Third NNP O
, , O
toxic JJ O
effects NNS O
of IN O
the DT O
repeat NN O
expansion NN O
may MD O
be VB O
intrinsic JJ O
to TO O
the DT O
repeated JJ O
elements NNS O
at IN O
the DT O
level NN O
of IN O
DNA NNP O
or CC O
RNA NNP O
( ( O
refs JJ O
10 CD O
, , O
11 CD O
) ) O
. . O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
a DT O
dose JJ O
- : O
dependent JJ O
loss NN O
of IN O
Dm15 NNP O
( ( O
the DT O
mouse NN O
DMPK NNP O
homologue NN O
) ) O
in IN O
mice NN O
produces VBZ O
a DT O
partial JJ O
DM NNP B-Disease
phenotype NN O
characterized VBN O
by IN O
decreased JJ O
development NN O
of IN O
skeletal JJ O
muscle NN O
force NN O
and CC O
cardiac JJ B-Disease
conduction NN I-Disease
disorders NNS I-Disease
. . O

To TO O
test VB O
the DT O
role NN O
of IN O
Six5 NNP O
loss NN O
in IN O
DM NNP B-Disease
, , O
we PRP O
have VBP O
analysed VBN O
a DT O
strain NN O
of IN O
mice NN O
in IN O
which WDT O
Six5 NNP O
was VBD O
deleted VBN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
the DT O
rate NN O
and CC O
severity NN O
of IN O
cataract JJ B-Disease
formation NN O
is VBZ O
inversely RB O
related VBN O
to TO O
Six5 NNP O
dosage NN O
and CC O
is VBZ O
temporally RB O
progressive JJ O
. . O

Six5 NNP O
+ NNP O
/ NNP O
- : O
and CC O
Six5 NNP O
- : O
/ SYM O
- : O
mice NN O
show NN O
increased VBD O
steady JJ O
- : O
state NN O
levels NNS O
of IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
K NNP O
+ NNP O
- : O
ATPase NNP O
alpha VBZ O
- : O
1 CD O
subunit NN O
and CC O
decreased VBD O
Dm15 NNP O
mRNA NN O
levels NNS O
. . O

Thus RB O
, , O
altered VBD O
ion NN O
homeostasis NN O
within IN O
the DT O
lens NNS O
may MD O
contribute VB O
to TO O
cataract VB B-Disease
formation NN O
. . O

As IN O
ocular JJ O
cataracts NNS B-Disease
are VBP O
a DT O
characteristic JJ O
feature NN O
of IN O
DM NNP B-Disease
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
decreased VBD O
SIX5 NNP O
transcription NN O
is VBZ O
important JJ O
in IN O
the DT O
aetiology NN O
of IN O
DM NNP B-Disease
. . O

Our PRP$ O
data NNS O
support NN O
the DT O
hypothesis NN O
that IN O
DM NNP B-Disease
is VBZ O
a DT O
contiguous JJ O
gene NN O
syndrome NN O
associated VBN O
with IN O
the DT O
partial JJ O
loss NN O
of IN O
both DT O
DMPK NNP O
and CC O
SIX5 NNP O
. . O
. . O

ATM NNP O
- : O
dependent JJ O
phosphorylation NN O
of IN O
nibrin NN O
in IN O
response NN O
to TO O
radiation NN O
exposure NN O
. . O

Mutations NNS O
in IN O
the DT O
gene NN O
ATM NNP O
are VBP O
responsible JJ O
for IN O
the DT O
genetic JJ B-Disease
disorder NN I-Disease
ataxia NN B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
, , O
which WDT O
is VBZ O
characterized VBN O
by IN O
cerebellar JJ B-Disease
dysfunction NN I-Disease
, , O
radiosensitivity NN O
, , O
chromosomal JJ O
instability NN O
and CC O
cancer NN B-Disease
predisposition NN O
. . O

Both DT O
the DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
phenotype NN O
and CC O
the DT O
similarity NN O
of IN O
the DT O
ATM NNP O
protein NN O
to TO O
other JJ O
DNA NNP O
- : O
damage NN O
sensors NNS O
suggests VBZ O
a DT O
role NN O
for IN O
ATM NNP O
in IN O
biochemical JJ O
pathways NNS O
involved VBN O
in IN O
the DT O
recognition NN O
, , O
signalling VBG O
and CC O
repair NN O
of IN O
DNA NNP O
double JJ O
- : O
strand NN O
breaks NNS O
( ( O
DSBs NNP O
) ) O
. . O

There EX O
are VBP O
strong JJ O
parallels NNS O
between IN O
the DT O
pattern NN O
of IN O
radiosensitivity NN O
, , O
chromosomal JJ O
instability NN O
and CC O
cancer NN B-Disease
predisposition NN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
and CC O
that DT O
in IN O
patients NNS O
with IN O
Nijmegen NNP B-Disease
breakage NN I-Disease
syndrome NN I-Disease
( ( O
NBS NNP B-Disease
) ) O
. . O

The DT O
protein NN O
defective JJ O
in IN O
NBS NNP B-Disease
, , O
nibrin NN O
( ( O
encoded VBN O
by IN O
NBS1 NNP O
) ) O
, , O
forms VBZ O
a DT O
complex JJ O
with IN O
MRE11 NNP O
and CC O
RAD50 NNP O
( ( O
refs JJ O
1 CD O
, , O
2 CD O
) ) O
. . O

This DT O
complex JJ O
localizes VBZ O
to TO O
DSBs NNP O
within IN O
30 CD O
minutes NNS O
after IN O
cellular JJ O
exposure NN O
to TO O
ionizing VBG O
radiation NN O
( ( O
IR NNP O
) ) O
and CC O
is VBZ O
observed VBN O
in IN O
brightly RB O
staining VBG O
nuclear JJ O
foci NN O
after IN O
a DT O
longer RBR O
period NN O
of IN O
time NN O
. . O

The DT O
overlap NN O
between IN O
clinical JJ O
and CC O
cellular JJ O
phenotypes NNS O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
and CC O
NBS NNP B-Disease
suggests VBZ O
that IN O
ATM NNP O
and CC O
nibrin NN O
may MD O
function VB O
in IN O
the DT O
same JJ O
biochemical JJ O
pathway NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that DT O
nibrin NN O
is VBZ O
phosphorylated VBN O
within IN O
one CD O
hour NN O
of IN O
treatment NN O
of IN O
cells NNS O
with IN O
IR NNP O
. . O

This DT O
response NN O
is VBZ O
abrogated VBN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
cells NNS O
that IN O
either DT O
do VBP O
not RB O
express VB O
ATM NNP O
protein NN O
or CC O
express NN O
near IN O
full JJ O
- : O
length NN O
mutant JJ O
protein NN O
. . O

We PRP O
also RB O
show VBP O
that IN O
ATM NNP O
physically RB O
interacts VBZ O
with IN O
and CC O
phosphorylates NNS O
nibrin VBP O
on IN O
serine NN O
343 CD O
both DT O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
. . O

Phosphorylation NN O
of IN O
this DT O
site NN O
appears VBZ O
to TO O
be VB O
functionally RB O
important JJ O
because IN O
mutated VBN O
nibrin NN O
( ( O
S343A NNP O
) ) O
does VBZ O
not RB O
completely RB O
complement JJ O
radiosensitivity NN O
in IN O
NBS NNP B-Disease
cells NNS O
. . O

ATM NNP O
phosphorylation NN O
of IN O
nibrin NN O
does VBZ O
not RB O
affect VB O
nibrin SYM O
- : O
MRE11 NNP O
- : O
RAD50 NNP O
association NN O
as IN O
revealed VBN O
by IN O
radiation NN O
- : O
induced JJ O
foci JJ O
formation NN O
. . O

Our PRP$ O
data NNS O
provide VB O
a DT O
biochemical JJ O
explanation NN O
for IN O
the DT O
similarity NN O
in IN O
phenotype NN O
between IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
and CC O
NBS NNP B-Disease
. . O
. . O

Clinicopathologic NNP O
features NNS O
of IN O
BRCA NNP B-Disease
- : I-Disease
linked VBN I-Disease
and CC I-Disease
sporadic JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

CONTEXT NNP O
Most NNP O
hereditary JJ B-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
are VBP O
associated VBN O
with IN O
germline JJ O
mutations NNS O
in IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
. . O

Attempts NNS O
to TO O
define VB O
the DT O
clinical JJ O
significance NN O
of IN O
BRCA NNP O
mutation NN O
status NN O
in IN O
ovarian JJ B-Disease
cancer NN I-Disease
have VBP O
produced VBN O
conflicting JJ O
results NNS O
, , O
especially RB O
regarding VBG O
survival NN O
. . O

OBJECTIVE NN O
To TO O
determine VB O
whether IN O
hereditary JJ B-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
have VBP O
distinct JJ O
clinical JJ O
and CC O
pathological JJ O
features NNS O
compared VBN O
with IN O
sporadic JJ B-Disease
( ( I-Disease
nonhereditary JJ I-Disease
) ) I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

DESIGN NNP O
AND CC O
SETTING NNP O
Retrospective NNP O
cohort NN O
study NN O
of IN O
a DT O
consecutive JJ O
series NN O
of IN O
933 CD O
ovarian JJ B-Disease
cancers NNS I-Disease
diagnosed VBD O
and CC O
treated VBD O
at IN O
our PRP$ O
institution NN O
, , O
which WDT O
is VBZ O
a DT O
comprehensive JJ O
cancer NN B-Disease
center NN O
as IN O
designated VBN O
by IN O
the DT O
National NNP O
Cancer NNP B-Disease
Institute NNP O
, , O
over IN O
a DT O
12 CD O
- : O
year NN O
period NN O
( ( O
December NNP O
1986 CD O
to TO O
August NNP O
1998 CD O
) ) O
. . O

PATIENTS VB O
The DT O
study NN O
was VBD O
restricted VBN O
to TO O
patients NNS O
of IN O
Jewish JJ O
origin NN O
because IN O
of IN O
the DT O
ease NN O
of IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
genotyping NN O
in IN O
this DT O
ethnic JJ O
group NN O
. . O

From IN O
the DT O
189 CD O
patients NNS O
who WP O
identified VBD O
themselves PRP O
as IN O
Jewish NNP O
, , O
88 CD O
hereditary JJ O
cases NNS O
were VBD O
identified VBN O
with IN O
the DT O
presence NN O
of IN O
a DT O
germline NN O
founder NN O
mutation NN O
in IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
. . O

The DT O
remaining VBG O
101 CD O
cases NNS O
from IN O
the DT O
same JJ O
series NN O
not RB O
associated VBN O
with IN O
a DT O
BRCA NNP O
mutation NN O
and CC O
2 CD O
additional JJ O
groups NNS O
( ( O
Gynecologic NNP O
Oncology NNP O
Group NNP O
protocols VBZ O
52 CD O
and CC O
111 CD O
) ) O
with IN O
ovarian JJ B-Disease
cancer NN I-Disease
from IN O
clinical JJ O
trials NNS O
( ( O
for IN O
the DT O
survival JJ O
analysis NN O
) ) O
were VBD O
included VBN O
for IN O
comparison NN O
. . O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
Age NNP O
at IN O
diagnosis NN O
, , O
surgical JJ O
stage NN O
, , O
histologic NN O
cell NN O
type NN O
and CC O
grade NN O
, , O
and CC O
surgical JJ O
outcome NN O
; : O
and CC O
response NN O
to TO O
chemotherapy NN O
and CC O
survival NN O
for IN O
advanced JJ O
- : O
stage NN O
( ( O
II NNP O
and CC O
IV NNP O
) ) O
cases NNS O
. . O

RESULTS NNP O
Hereditary NNP B-Disease
cancers NNS I-Disease
were VBD O
rarely RB O
diagnosed VBN O
before RB O
age NN O
40 CD O
years NNS O
and CC O
were VBD O
common JJ O
after IN O
age NN O
60 CD O
years NNS O
, , O
with IN O
mean JJ O
age NN O
at IN O
diagnosis NN O
being VBG O
significantly RB O
younger JJR O
for IN O
BRCA1 NNP O
- : O
vs NN O
BRCA2 NNP O
- : O
linked VBN O
patients NNS O
( ( O
54 CD O
vs RB O
62 CD O
years NNS O
; : O
P NNP O
= NNP O
. . O
4 CD O
) ) O
. . O

Histology NNP O
, , O
grade NN O
, , O
stage NN O
, , O
and CC O
success NN O
of IN O
cytoreductive JJ O
surgery NN O
were VBD O
similar JJ O
for IN O
hereditary JJ O
and CC O
sporadic JJ O
cases NNS O
. . O

The DT O
hereditary JJ O
group NN O
had VBD O
a DT O
longer RBR O
disease JJ O
- : O
free JJ O
interval NN O
following VBG O
primary JJ O
chemotherapy NN O
in IN O
comparison NN O
with IN O
the DT O
nonhereditary JJ O
group NN O
, , O
with IN O
a DT O
median JJ O
time NN O
to TO O
recurrence VB O
of IN O
14 CD O
months NNS O
and CC O
7 CD O
months NNS O
, , O
respectively RB O
( ( O
P NNP O
< NNP O
. . O
1 CD O
) ) O
. . O

Those DT O
with IN O
hereditary JJ B-Disease
cancers NNS I-Disease
had VBD O
improved VBN O
survival JJ O
compared VBN O
with IN O
the DT O
nonhereditary JJ O
group NN O
( ( O
P NNP O
= NNP O
. . O
4 CD O
) ) O
. . O

For IN O
stage NN B-Disease
III NNP I-Disease
cancers NNS I-Disease
, , O
BRCA NNP O
mutation NN O
status NN O
was VBD O
an DT O
independent JJ O
prognostic JJ O
variable NN O
( ( O
P NNP O
= NNP O
. . O
3 CD O
) ) O
. . O

CONCLUSIONS NNP O
Although IN O
BRCA NNP B-Disease
- : I-Disease
associated VBN I-Disease
hereditary JJ I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
in IN O
this DT O
population NN O
have VBP O
surgical JJ O
and CC O
pathological JJ O
characteristics NNS O
similar JJ O
to TO O
those DT O
of IN O
sporadic JJ B-Disease
cancers NNS I-Disease
, , O
advanced VBD B-Disease
- : I-Disease
stage NN I-Disease
hereditary JJ I-Disease
cancer NN I-Disease
patients NNS O
survive VBP O
longer JJR O
than IN O
nonhereditary JJ B-Disease
cancer NN I-Disease
patients NNS O
. . O

Age NNP O
penetrance NN O
is VBZ O
greater JJR O
for IN O
BRCA1 NNP B-Disease
- : I-Disease
linked VBD I-Disease
than IN I-Disease
for IN I-Disease
BRCA2 NNP I-Disease
- : I-Disease
linked VBD I-Disease
cancers NNS I-Disease
in IN O
this DT O
population NN O
. . O

The DT O
gene NN O
for IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
, , O
MEFV NNP O
, , O
is VBZ O
expressed VBN O
in IN O
early JJ O
leukocyte NN O
development NN O
and CC O
is VBZ O
regulated VBN O
in IN O
response NN O
to TO O
inflammatory JJ O
mediators NNS O
. . O

Familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
is VBZ O
a DT O
recessive JJ B-Disease
disorder NN I-Disease
characterized VBN O
by IN O
episodes NNS O
of IN O
fever NN B-Disease
and CC O
neutrophil JJ B-Disease
- : I-Disease
mediated VBN I-Disease
serosal JJ I-Disease
inflammation NN I-Disease
. . O

We PRP O
recently RB O
identified VBD O
the DT O
gene NN O
causing VBG O
FMF NNP B-Disease
, , O
designated VBD O
MEFV NNP O
, , O
and CC O
found VBD O
it PRP O
to TO O
be VB O
expressed VBN O
in IN O
mature NN O
neutrophils NNS O
, , O
suggesting VBG O
that IN O
it PRP O
functions VBZ O
as IN O
an DT O
inflammatory JJ O
regulator NN O
. . O

To TO O
facilitate VB O
our PRP$ O
understanding NN O
of IN O
the DT O
normal JJ O
function NN O
of IN O
MEFV NNP O
, , O
we PRP O
extended VBD O
our PRP$ O
previous JJ O
studies NNS O
. . O

MEFV NNP O
messenger NN O
RNA NNP O
was VBD O
detected VBN O
by IN O
reverse NN O
transcriptase NN O
- : O
polymerase NN O
chain NN O
reaction NN O
in IN O
bone NN O
marrow NN O
leukocytes VBZ O
, , O
with IN O
differential JJ O
expression NN O
observed VBD O
among IN O
cells NNS O
by IN O
in IN O
situ JJ O
hybridization NN O
. . O

CD34 NNP O
hematopoietic JJ O
stem NN O
- : O
cell NN O
cultures NNS O
induced VBD O
toward IN O
the DT O
granulocytic JJ O
lineage NN O
expressed VBD O
MEFV NNP O
at IN O
the DT O
myelocyte NN O
stage NN O
, , O
concurrently RB O
with IN O
lineage JJ O
commitment NN O
. . O

The DT O
prepromyelocytic JJ O
cell NN O
line NN O
HL60 NNP O
expressed VBD O
MEFV NNP O
only RB O
at IN O
granulocytic JJ O
and CC O
monocytic JJ O
differentiation NN O
. . O

MEFV NNP O
was VBD O
also RB O
expressed VBN O
in IN O
the DT O
monocytic JJ O
cell NN O
lines NNS O
U937 NNP O
and CC O
THP NNP O
- : O
1 CD O
. . O

Among IN O
peripheral JJ O
blood NN O
leukocytes NNS O
, , O
MEFV NNP O
expression NN O
was VBD O
detected VBN O
in IN O
neutrophils NNS O
, , O
eosinophils NNS O
, , O
and CC O
to TO O
varying VBG O
degrees NNS O
, , O
monocytes NNS O
. . O

Consistent JJ O
with IN O
the DT O
tissue NN O
specificity NN O
of IN O
expression NN O
, , O
complete JJ O
sequencing NN O
and CC O
analysis NN O
of IN O
upstream JJ O
regulatory JJ O
regions NNS O
of IN O
MEFV NNP O
revealed VBD O
homology NN O
to TO O
myeloid VB O
- : O
specific JJ O
promoters NNS O
and CC O
to TO O
more RBR O
broadly RB O
expressed VBD O
inflammatory JJ O
promoter NN O
elements NNS O
. . O

In IN O
vitro JJ O
stimulation NN O
of IN O
monocytes NNS O
with IN O
the DT O
proinflammatory NN O
agents NNS O
interferon VBP O
( ( O
IFN NNP O
) ) O
gamma NN O
, , O
tumor NN B-Disease
necrosis NN O
factor NN O
, , O
and CC O
lipopolysaccharide RB O
induced VBD O
MEFV NNP O
expression NN O
, , O
whereas IN O
the DT O
antiinflammatory NN O
cytokines NNS O
interleukin FW O
( ( O
IL NNP O
) ) O
4 CD O
, , O
IL NNP O
- : O
10 CD O
, , O
and CC O
transforming VBG O
growth NN O
factor NN O
beta NN O
inhibited VBD O
such JJ O
expression NN O
. . O

Induction NN O
by IN O
IFN NNP O
- : O
gamma NN O
occurred VBD O
rapidly RB O
and CC O
was VBD O
resistant JJ O
to TO O
cycloheximide VB O
. . O

IFN NNP O
- : O
alpha NN O
also RB O
induced VBD O
MEFV NNP O
expression NN O
. . O

In IN O
granulocytes NNS O
, , O
MEFV NNP O
was VBD O
up RP O
- : O
regulated VBN O
by IN O
IFN NNP O
- : O
gamma NN O
and CC O
the DT O
combination NN O
of IN O
IFN NNP O
- : O
alpha NN O
and CC O
colchicine NN O
. . O

These DT O
results NNS O
refine VBP O
understanding NN O
of IN O
MEFV NNP O
by IN O
placing VBG O
the DT O
gene NN O
in IN O
the DT O
myelomonocytic JJ O
- : O
specific JJ O
proinflammatory JJ O
pathway NN O
and CC O
identifying VBG O
it PRP O
as IN O
an DT O
IFN NNP O
- : O
gamma NN O
immediate VBP O
early JJ O
gene NN O
. . O
. . O

Biochemical NNP O
and CC O
structural JJ O
analysis NN O
of IN O
missense JJ O
mutations NNS O
in IN O
N NNP O
- : O
acetylgalactosamine NN O
- : O
6 CD O
- : O
sulfate NN O
sulfatase NN O
causing VBG O
mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
phenotypes NNS O
. . O

Mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
( ( O
MPS NNP B-Disease
IVA NNP I-Disease
; : O
OMIM NNP O
# # O
253000 CD O
) ) O
, , O
a DT O
lysosomal JJ B-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
N NNP I-Disease
- : I-Disease
acetylgalactosamine NN I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
sulfate NN I-Disease
sulfatase NN I-Disease
( ( O
GALNS NNP O
) ) O
, , O
has VBZ O
variable JJ O
clinical JJ O
phenotypes NNS O
. . O

To TO O
date NN O
we PRP O
have VBP O
identified VBN O
65 CD O
missense JJ O
mutations NNS O
in IN O
the DT O
GALNS NNP O
gene NN O
from IN O
MPS NNP B-Disease
IVA NNP I-Disease
patients NNS O
, , O
but CC O
the DT O
correlation NN O
between IN O
genotype NN O
and CC O
phenotype NN O
has VBZ O
remained VBN O
unclear JJ O
. . O

We PRP O
studied VBD O
17 CD O
missense NN O
mutations NNS O
using VBG O
biochemical JJ O
approaches NNS O
and CC O
32 CD O
missense NN O
mutations NNS O
, , O
using VBG O
structural JJ O
analyses NNS O
. . O

Fifteen NNP O
missense NN O
mutations NNS O
and CC O
two CD O
newly RB O
engineered VBN O
active JJ O
site NN O
mutations NNS O
( ( O
C79S NNP O
, , O
C79T NNP O
) ) O
were VBD O
characterized VBN O
by IN O
transient JJ O
expression NN O
analysis NN O
. . O

Mutant JJ O
proteins NNS O
, , O
except IN O
for IN O
C79S NNP O
and CC O
C79T NNP O
, , O
were VBD O
destabilized VBN O
and CC O
detected VBN O
as IN O
insoluble JJ O
precursor NN O
forms NNS O
while IN O
the DT O
C79S NNP O
and CC O
C79T NNP O
mutants NNS O
were VBD O
of IN O
a DT O
soluble JJ O
mature NN O
size NN O
. . O

Mutants NNS O
found VBN O
in IN O
the DT O
severe JJ O
phenotype NN O
had VBD O
no DT O
activity NN O
. . O

Mutants NNS O
found VBN O
in IN O
the DT O
mild JJ O
phenotype NN O
had VBD O
a DT O
considerable JJ O
residual JJ O
activity NN O
( ( O
1 CD O
. . O
3 CD O
- : O
13 CD O
. . O
3 CD O
% NN O
of IN O
wild JJ O
- : O
type NN O
GALNS NNP O
activity NN O
) ) O
. . O

Sulfatases NNS O
, , O
including VBG O
GALNS NNP O
, , O
are VBP O
members NNS O
of IN O
a DT O
highly RB O
conserved VBN O
gene NN O
family NN O
sharing VBG O
an DT O
extensive JJ O
sequence NN O
homology NN O
. . O

Thus RB O
, , O
a DT O
tertiary JJ O
structural JJ O
model NN O
of IN O
human JJ O
GALNS NNP O
was VBD O
constructed VBN O
from IN O
the DT O
X NNP O
- : O
ray JJ O
crystal JJ O
structure NN O
of IN O
N NNP O
- : O
acetylgalacto NN O
- : O
samine NN O
- : O
4 CD O
- : O
sulfatase NN O
and CC O
arylsulfatase VB O
A NNP O
, , O
using VBG O
homology NN O
modeling NN O
, , O
and CC O
32 CD O
missense NN O
mutations NNS O
were VBD O
investigated VBN O
. . O

Consequently RB O
, , O
we PRP O
propose VBP O
that IN O
there EX O
are VBP O
at IN O
least JJS O
three CD O
different JJ O
reasons NNS O
for IN O
the DT O
severe JJ O
phenotype NN O
( ( O
i NN O
) ) O
destruction NN O
of IN O
the DT O
hydrophobic JJ O
core NN O
or CC O
modification NN O
of IN O
the DT O
packing NN O
; : O
( ( O
ii NN O
) ) O
removal NN O
of IN O
a DT O
salt NN O
bridge NN O
to TO O
destabilize VB O
the DT O
entire JJ O
conformation NN O
; : O
( ( O
iii NN O
) ) O
modification NN O
of IN O
the DT O
active JJ O
site NN O
. . O

In IN O
contrast NN O
, , O
mild JJ O
mutations NNS O
were VBD O
mostly RB O
located VBN O
on IN O
the DT O
surface NN O
of IN O
the DT O
GALNS NNP O
protein NN O
. . O

These DT O
studies NNS O
shed VBD O
further RB O
light NN O
on IN O
the DT O
genotype NN O
- : O
phenotype JJ O
correlation NN O
of IN O
MPS NNP B-Disease
IVA NNP I-Disease
and CC O
structure NN O
- : O
function NN O
relationship NN O
in IN O
the DT O
sulfatase NN O
family NN O
. . O

Mutations NNS O
at IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
locus NN O
and CC O
clinical JJ O
phenotypes NNS O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
. . O

Mutations NNS O
at IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
locus NN O
on IN O
chromosome NN O
band NN O
11q22 CD O
cause NN O
a DT O
distinctive JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
syndrome NN I-Disease
in IN O
homozygotes NNS O
and CC O
predispose VB O
heterozygotes NNS O
to TO O
cancer NN B-Disease
, , O
ischemic JJ B-Disease
heart NN I-Disease
disease NN I-Disease
, , O
and CC O
early JJ O
mortality NN O
. . O

PCR NNP O
amplification NN O
from IN O
genomic JJ O
DNA NNP O
and CC O
automated VBD O
sequencing NN O
of IN O
the DT O
entire JJ O
coding NN O
region NN O
( ( O
66 CD O
exons NNS O
) ) O
and CC O
splice JJ O
junctions NNS O
detected VBD O
77 CD O
mutations NNS O
( ( O
85 CD O
% NN O
) ) O
in IN O
90 CD O
A NNP B-Disease
- : I-Disease
T NN I-Disease
chromosomes NNS O
. . O

Heteroduplex NNP O
analysis NN O
detected VBD O
another DT O
42 CD O
mutations NNS O
at IN O
the DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
locus NN O
. . O

Out IN O
of IN O
a DT O
total NN O
of IN O
71 CD O
unique JJ O
mutations NNS O
, , O
50 CD O
were VBD O
found VBN O
only RB O
in IN O
a DT O
single JJ O
family NN O
, , O
and CC O
51 CD O
had VBD O
not RB O
been VBN O
reported VBN O
previously RB O
. . O

Most JJS O
( ( O
58 CD O
/ RB O
71 CD O
, , O
82 CD O
% NN O
) ) O
mutations NNS O
were VBD O
frameshift JJ O
and CC O
nonsense JJ O
mutations NNS O
that WDT O
are VBP O
predicted VBN O
to TO O
cause VB O
truncation NN O
of IN O
the DT O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
protein NN O
; : O
the DT O
less JJR O
common JJ O
mutation NN O
types NNS O
were VBD O
missense NN O
( ( O
9 CD O
/ RB O
71 CD O
, , O
13 CD O
% NN O
) ) O
, , O
splicing VBG O
( ( O
3 CD O
/ RB O
71 CD O
, , O
4 CD O
% NN O
) ) O
and CC O
one CD O
in IN O
- : O
frame NN O
deletion NN O
, , O
2546 CD O
3 CD O
( ( O
1 CD O
/ RB O
71 CD O
, , O
1 CD O
% NN O
) ) O
. . O

The DT O
mean JJ O
survival NN O
and CC O
height JJ O
distribution NN O
of IN O
134 CD O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
correlated VBD O
significantly RB O
with IN O
the DT O
specific JJ O
mutations NNS O
present JJ O
in IN O
the DT O
patients NNS O
. . O

Patients NNS O
homozygous JJ O
for IN O
a DT O
single JJ O
truncating NN O
mutation NN O
, , O
typically RB O
near IN O
the DT O
N NNP O
- : O
terminal JJ O
end NN O
of IN O
the DT O
gene NN O
, , O
or CC O
heterozygous JJ O
for IN O
the DT O
in IN O
- : O
frame NN O
deletion NN O
2546 CD O
3 CD O
, , O
were VBD O
shorter JJR O
and CC O
had VBD O
significantly RB O
shorter JJR O
survival NN O
than IN O
those DT O
heterozygous JJ O
for IN O
a DT O
splice NN O
site NN O
or CC O
missense JJ O
mutation NN O
, , O
or CC O
heterozygous JJ O
for IN O
two CD O
truncating VBG O
mutations NNS O
. . O

Alterations NNS O
of IN O
the DT O
length NN O
or CC O
amino NN O
acid JJ O
composition NN O
of IN O
the DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
gene NN O
product NN O
affect VB O
the DT O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
clinical JJ O
phenotype NN O
in IN O
different JJ O
ways NNS O
. . O

Mutation NN O
analysis NN O
at IN O
the DT O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
locus NN O
may MD O
help VB O
estimate VB O
the DT O
prognosis NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
. . O
. . O

Isolation NN O
, , O
genomic JJ O
organization NN O
, , O
and CC O
expression NN O
analysis NN O
of IN O
the DT O
mouse NN O
and CC O
rat VB O
homologs NNS O
of IN O
MEFV NNP O
, , O
the DT O
gene NN O
for IN O
familial JJ B-Disease
mediterranean NN I-Disease
fever NN I-Disease
. . O

Familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
is VBZ O
a DT O
recessive JJ B-Disease
disorder NN I-Disease
characterized VBN O
by IN O
episodes NNS O
of IN O
fever NN B-Disease
with IN O
serositis NN B-Disease
or CC O
synovitis NN B-Disease
. . O

Recently RB O
the DT O
FMF NNP B-Disease
gene NN O
( ( O
MEFV NNP O
) ) O
was VBD O
cloned VBN O
; : O
the DT O
protein NN O
product NN O
, , O
pyrin JJ O
/ NNP O
marenostrin NN O
, , O
is VBZ O
thought VBN O
to TO O
regulate VB O
inflammation NN O
in IN O
myeloid JJ O
cells NNS O
. . O

In IN O
this DT O
manuscript NN O
we PRP O
report VBP O
the DT O
mouse NN O
and CC O
rat VB O
homologs NNS O
of IN O
MEFV NNP O
. . O

The DT O
murine NN O
gene NN O
contains NNS O
ten JJ O
exons NNS O
with IN O
a DT O
coding VBG O
sequence NN O
of IN O
2304 CD O
bp NN O
, , O
while IN O
the DT O
rat NN O
homolog NN O
has VBZ O
nine CD O
exons NNS O
with IN O
a DT O
coding VBG O
sequence NN O
of IN O
2253 CD O
bp NN O
. . O

A DT O
considerable JJ O
amino NN O
acid NN O
sequence NN O
homology NN O
was VBD O
observed VBN O
between IN O
the DT O
mouse NN O
and CC O
human NN O
( ( O
47 CD O
. . O
6 CD O
% NN O
identity NN O
and CC O
65 CD O
. . O
5 CD O
% NN O
similarity NN O
) ) O
and CC O
between IN O
the DT O
mouse NN O
and CC O
rat NN O
genes NNS O
( ( O
73 CD O
. . O
5 CD O
% NN O
identity NN O
and CC O
82 CD O
. . O
1 CD O
% NN O
similarity NN O
) ) O
. . O

The DT O
predicted JJ O
rodent NN O
proteins NNS O
have VBP O
several JJ O
important JJ O
domains NNS O
and CC O
signals NNS O
found VBN O
in IN O
human JJ O
pyrin NN O
, , O
including VBG O
a DT O
B NNP O
- : O
box NN O
zinc NN O
finger NN O
domain NN O
, , O
Robbins NNP O
- : O
Dingwall NN O
nuclear JJ O
localization NN O
signal NN O
, , O
and CC O
coiled VBD O
- : O
coil NN O
domain NN O
. . O

However RB O
, , O
perhaps RB O
because IN O
of IN O
an DT O
ancient NN O
frame NN O
- : O
shift NN O
mutation NN O
, , O
neither CC O
the DT O
mouse NN O
nor CC O
the DT O
rat NN O
protein NN O
has VBZ O
an DT O
intact JJ O
C NNP O
- : O
terminal JJ O
B30 NNP O
. . O

2 CD O
domain NN O
, , O
in IN O
which WDT O
most JJS O
FMF NNP B-Disease
- : O
associated VBN O
mutations NNS O
have VBP O
been VBN O
found VBN O
in IN O
human JJ O
MEFV NNP O
. . O

Nevertheless RB O
, , O
like IN O
the DT O
human JJ O
gene NN O
, , O
mouse NN O
Mefv NNP O
is VBZ O
expressed VBN O
in IN O
peripheral JJ O
blood NN O
granulocytes NNS O
but CC O
not RB O
lymphocytes NNS O
. . O

Consistent JJ O
with IN O
its PRP$ O
expression NN O
in IN O
granulocytes NNS O
, , O
Mefv NNP O
was VBD O
detected VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
primary JJ O
follicles NNS O
and CC O
marginal JJ O
zones NNS O
of IN O
the DT O
splenic JJ O
white JJ O
pulp NN O
. . O

Mefv NNP O
is VBZ O
localized VBN O
on IN O
mouse NN O
Chromosome NNP O
( ( O
Chr NNP O
) ) O
16 CD O
, , O
region NN O
A3 NNP O
- : O
B1 NNP O
, , O
extending VBG O
a DT O
region NN O
of IN O
synteny NN O
with IN O
human JJ O
Chr NNP O
16p13 CD O
. . O

3 CD O
. . O

Development NNP O
of IN O
knockout NN O
and CC O
knockin VB O
mouse NN O
models NNS O
may MD O
provide VB O
further JJR O
insights NNS O
into IN O
the DT O
functional JJ O
evolution NN O
of IN O
this DT O
gene NN O
. . O

Additional JJ O
copies NNS O
of IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
causing VBG O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
arise NN O
by IN O
separate JJ O
integration NN O
into IN O
the DT O
X NNP O
chromosome NN O
. . O

The DT O
proteolipid JJ O
protein NN O
gene NN O
( ( O
PLP NNP O
) ) O
is VBZ O
normally RB O
present JJ O
at IN O
chromosome NN O
Xq22 NN O
. . O

Mutations NNS O
and CC O
duplications NNS O
of IN O
this DT O
gene NN O
are VBP O
associated VBN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( O
PMD NNP B-Disease
) ) O
. . O

Here RB O
we PRP O
describe VBP O
two CD O
new JJ O
families NNS O
in IN O
which WDT O
males NNS O
affected VBD O
with IN O
PMD NNP B-Disease
were VBD O
found VBN O
to TO O
have VB O
a DT O
copy NN O
of IN O
PLP NNP O
on IN O
the DT O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
, , O
in IN O
addition NN O
to TO O
a DT O
normal JJ O
copy NN O
on IN O
Xq22 NN O
. . O

In IN O
the DT O
first JJ O
family NN O
, , O
the DT O
extra JJ O
copy NN O
was VBD O
first RB O
detected VBN O
by IN O
the DT O
presence NN O
of IN O
heterozygosity NN O
of IN O
the DT O
AhaII NNP O
dimorphism NN O
within IN O
the DT O
PLP NNP O
gene NN O
. . O

The DT O
results NNS O
of IN O
FISH NNP O
analysis NN O
showed VBD O
an DT O
additional JJ O
copy NN O
of IN O
PLP NNP O
in IN O
Xp22 NNP O
. . O

1 CD O
, , O
although IN O
no DT O
chromosomal JJ O
rearrangements NNS O
could MD O
be VB O
detected VBN O
by IN O
standard JJ O
karyotype NN O
analysis NN O
. . O

Another DT O
three CD O
affected VBD O
males NNS O
from IN O
the DT O
family NN O
had VBD O
similar JJ O
findings NNS O
. . O

In IN O
a DT O
second JJ O
unrelated JJ O
family NN O
with IN O
signs NNS O
of IN O
PMD NNP B-Disease
, , O
cytogenetic JJ O
analysis NN O
showed VBD O
a DT O
pericentric JJ O
inversion NN O
of IN O
the DT O
X NNP O
chromosome NN O
. . O

In IN O
the DT O
inv NN O
( ( O
X NNP O
) ) O
carried VBN O
by IN O
several JJ O
affected JJ O
family NN O
members NNS O
, , O
FISH NNP O
showed VBD O
PLP NNP O
signals NNS O
at IN O
Xp11 NNP O
. . O

4 CD O
and CC O
Xq22 NNP O
. . O

A DT O
third JJ O
family NN O
has VBZ O
previously RB O
been VBN O
reported VBN O
, , O
in IN O
which WDT O
affected VBD O
members NNS O
had VBD O
an DT O
extra JJ O
copy NN O
of IN O
the DT O
PLP NNP O
gene NN O
detected VBD O
at IN O
Xq26 NNP O
in IN O
a DT O
chromosome NN O
with IN O
an DT O
otherwise NN O
normal JJ O
banding NN O
pattern NN O
. . O

The DT O
identification NN O
of IN O
three CD O
separate JJ O
families NNS O
in IN O
which WDT O
PLP NNP O
is VBZ O
duplicated VBN O
at IN O
a DT O
noncontiguous JJ O
site NN O
suggests VBZ O
that IN O
such JJ O
duplications NNS O
could MD O
be VB O
a DT O
relatively RB O
common JJ O
but CC O
previously RB O
undetected JJ O
cause NN O
of IN O
genetic JJ B-Disease
disorders NNS I-Disease
. . O

The DT O
exon NN O
13 CD O
duplication NN O
in IN O
the DT O
BRCA1 NNP O
gene NN O
is VBZ O
a DT O
founder NN O
mutation NN O
present NN O
in IN O
geographically RB O
diverse JJ O
populations NNS O
. . O

The DT O
BRCA1 NNP O
Exon NNP O
13 CD O
Duplication NNP O
Screening NNP O
Group NNP O
. . O

Recently RB O
, , O
a DT O
6 CD O
- : O
kb NN O
duplication NN O
of IN O
exon $ O
13 CD O
, , O
which WDT O
creates VBZ O
a DT O
frameshift NN O
in IN O
the DT O
coding VBG O
sequence NN O
of IN O
the DT O
BRCA1 NNP O
gene NN O
, , O
has VBZ O
been VBN O
described VBN O
in IN O
three CD O
unrelated JJ O
U NNP O
. . O

S NNP O
S NNP O
. . O
families NNS O
of IN O
European JJ O
ancestry NN O
and CC O
in IN O
one CD O
Portuguese JJ O
family NN O
. . O

Here RB O
, , O
our PRP$ O
goal NN O
was VBD O
to TO O
estimate VB O
the DT O
frequency NN O
and CC O
geographic JJ O
diversity NN O
of IN O
carriers NNS O
of IN O
this DT O
duplication NN O
. . O

To TO O
do VB O
this DT O
, , O
a DT O
collaborative JJ O
screening NN O
study NN O
was VBD O
set VBN O
up RP O
that DT O
involved VBD O
39 CD O
institutions NNS O
from IN O
19 CD O
countries NNS O
and CC O
included VBD O
3 CD O
, , O
580 CD O
unrelated JJ O
individuals NNS O
with IN O
a DT O
family NN O
history NN O
of IN O
the DT O
disease NN O
and CC O
934 CD O
early JJ O
- : O
onset NN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
. . O

A DT O
total NN O
of IN O
11 CD O
additional JJ O
families NNS O
carrying VBG O
this DT O
mutation NN O
were VBD O
identified VBN O
in IN O
Australia NNP O
( ( O
1 CD O
) ) O
, , O
Belgium NNP O
( ( O
1 CD O
) ) O
, , O
Canada NNP O
( ( O
1 CD O
) ) O
, , O
Great NNP O
Britain NNP O
( ( O
6 CD O
) ) O
, , O
and CC O
the DT O
United NNP O
States NNPS O
( ( O
2 CD O
) ) O
. . O

Haplotyping VBG O
showed VBD O
that IN O
they PRP O
are VBP O
likely JJ O
to TO O
derive VB O
from IN O
a DT O
common JJ O
ancestor NN O
, , O
possibly RB O
of IN O
northern JJ O
British JJ O
origin NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
it PRP O
is VBZ O
strongly RB O
advisable JJ O
, , O
for IN O
laboratories NNS O
carrying VBG O
out RP O
screening VBG O
either RB O
in IN O
English NNP O
- : O
speaking NN O
countries NNS O
or CC O
in IN O
countries NNS O
with IN O
historical JJ O
links NNS O
with IN O
Britain NNP O
, , O
to TO O
include VB O
within IN O
their PRP$ O
BRCA1 NNP O
screening NN O
protocols VBZ O
the DT O
polymerase NN O
chain NN O
reaction NN O
- : O
based VBN O
assay NN O
described VBN O
in IN O
this DT O
report NN O
. . O

Genotype NNP O
- : O
phenotype NN O
correlations NNS O
in IN O
families NNS O
with IN O
deletions NNS O
in IN O
the DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( O
VHL NNP B-Disease
) ) O
gene NN O
. . O

Von NNP B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
disease NN I-Disease
is VBZ O
a DT O
hereditary JJ B-Disease
tumor NN I-Disease
syndrome NN I-Disease
characterized VBN O
by IN O
predisposition NN O
for IN O
bilateral JJ B-Disease
and CC I-Disease
multi JJ I-Disease
- : I-Disease
centric JJ I-Disease
hemangioblastoma NN I-Disease
in IN O
the DT O
retina NN O
and CC O
central JJ O
nervous JJ O
system NN O
, , O
pheochromocytoma NN B-Disease
, , O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
, , O
and CC O
cysts NNS B-Disease
in IN I-Disease
the DT I-Disease
kidney NN I-Disease
, , I-Disease
pancreas NNS I-Disease
, , I-Disease
and CC I-Disease
epididymis NN I-Disease
. . O

We PRP O
describe VBP O
five CD O
families NNS O
for IN O
which WDT O
direct JJ O
sequencing NN O
of IN O
the DT O
coding VBG O
region NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
had VBD O
failed VBN O
to TO O
identify VB O
the DT O
family NN O
- : O
specific JJ O
mutation NN O
. . O

Further RB O
molecular JJ O
analysis NN O
revealed VBD O
deletions NNS O
involving VBG O
the DT O
VHL NNP B-Disease
gene NN O
in IN O
each DT O
of IN O
these DT O
families NNS O
. . O

In IN O
four CD O
families NNS O
, , O
partial JJ O
deletions NNS O
of IN O
one CD O
or CC O
more JJR O
exons NNS O
were VBD O
detected VBN O
by IN O
Southern NNP O
blot NN O
analysis NN O
. . O

In IN O
the DT O
fifth JJ O
family NN O
, , O
FISH NNP O
analysis NN O
demonstrated VBD O
the DT O
deletion NN O
of IN O
the DT O
entire JJ O
VHL NNP B-Disease
gene NN O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
( ( O
quantitative JJ O
) ) O
Southern NNP O
blot NN O
analysis NN O
is VBZ O
a DT O
sensitive JJ O
method NN O
for IN O
detecting VBG O
germline JJ O
deletions NNS O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
and CC O
should MD O
be VB O
implemented VBN O
in IN O
routine JJ O
DNA NNP O
diagnosis NN O
for IN O
VHL NNP B-Disease
disease NN I-Disease
. . O

Our PRP$ O
data NNS O
support NN O
the DT O
previously RB O
established VBN O
observation NN O
that IN O
families NNS O
with IN O
a DT O
germline NN O
deletion NN O
have VBP O
a DT O
low JJ O
risk NN O
for IN O
pheochromocytoma NN B-Disease
. . O

Further RB O
unraveling NN O
of IN O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
in IN O
VHL NNP B-Disease
disease NN I-Disease
has VBZ O
revealed VBN O
that IN O
families NNS O
with IN O
a DT O
full JJ O
or CC O
partial JJ O
deletion NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
exhibit NN O
a DT O
phenotype NN O
with IN O
a DT O
preponderance NN O
of IN O
central JJ B-Disease
nervous JJ I-Disease
system NN I-Disease
hemangioblastoma NN I-Disease
. . O
. . O

Age NNP O
of IN O
the DT O
intronic JJ O
GAA NNP O
triplet NN O
repeat NN O
expansion NN O
mutation NN O
in IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
. . O

Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
, , O
the DT O
most RBS O
frequently RB O
inherited VBN B-Disease
ataxia NN I-Disease
, , O
is VBZ O
due JJ O
in IN O
the DT O
vast JJ O
majority NN O
of IN O
cases NNS O
to TO O
a DT O
large JJ O
expansion NN O
of IN O
an DT O
intronic JJ O
GAA NNP O
repeat NN O
. . O

Using VBG O
linkage NN O
disequilibrium NN O
analysis NN O
based VBN O
on IN O
haplotype NN O
data NNS O
of IN O
seven CD O
polymorphic JJ O
markers NNS O
close RB O
to TO O
the DT O
frataxin NN O
gene NN O
, , O
the DT O
age NN O
of IN O
FRDA NNP B-Disease
founding VBG O
mutational JJ O
event NN O
( ( O
s NN O
) ) O
is VBZ O
estimated VBN O
to TO O
be VB O
at IN O
least JJS O
682 CD O
+ JJ O
/ NNP O
- : O
203 CD O
generations NNS O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
564 CD O
- : O
801 CD O
g NN O
) ) O
, , O
a DT O
dating NN O
which WDT O
is VBZ O
consistent JJ O
with IN O
little JJ O
or CC O
no DT O
negative JJ O
selection NN O
and CC O
provides VBZ O
further JJ O
evidence NN O
for IN O
an DT O
ancient JJ O
spread NN O
of IN O
a DT O
pre JJ O
- : O
mutation NN O
( ( O
at IN O
- : O
risk NN O
alleles NNS O
) ) O
in IN O
western JJ O
Europe NNP O
. . O
. . O

Functional JJ O
link NN O
between IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
and CC O
Nijmegen NNP B-Disease
breakage NN I-Disease
syndrome VBD I-Disease
gene NN O
products NNS O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
and CC O
Nijmegen NNP B-Disease
breakage NN I-Disease
syndrome NN I-Disease
( ( O
NBS NNP B-Disease
) ) O
are VBP O
recessive JJ B-Disease
genetic JJ I-Disease
disorders NNS I-Disease
with IN O
susceptibility NN O
to TO O
cancer NN B-Disease
and CC O
similar JJ O
cellular JJ O
phenotypes NNS O
. . O

The DT O
protein JJ O
product NN O
of IN O
the DT O
gene NN O
responsible JJ O
for IN O
A DT B-Disease
- : I-Disease
T NN I-Disease
, , O
designated VBN O
ATM NNP O
, , O
is VBZ O
a DT O
member NN O
of IN O
a DT O
family NN O
of IN O
kinases NNS O
characterized VBN O
by IN O
a DT O
carboxy JJ O
- : O
terminal JJ O
phosphatidylinositol NN O
3 CD O
- : O
kinase NN O
- : O
like IN O
domain NN O
. . O

The DT O
NBS1 NNP O
protein NN O
is VBZ O
specifically RB O
mutated VBN O
in IN O
patients NNS O
with IN O
Nijmegen NNP B-Disease
breakage NN I-Disease
syndrome NN I-Disease
and CC O
forms VBZ O
a DT O
complex JJ O
with IN O
the DT O
DNA NNP O
repair NN O
proteins NNS O
Rad50 NNP O
and CC O
Mrel1 NNP O
. . O

Here RB O
we PRP O
show VBP O
that DT O
phosphorylation NN O
of IN O
NBS1 NNP O
, , O
induced VBN O
by IN O
ionizing VBG O
radiation NN O
, , O
requires VBZ O
catalytically RB O
active JJ O
ATM NNP O
. . O

Complexes NNP O
containing VBG O
ATM NNP O
and CC O
NBS1 NNP O
exist VBP O
in IN O
vivo NN O
in IN O
both DT O
untreated JJ O
cells NNS O
and CC O
cells NNS O
treated VBN O
with IN O
ionizing VBG O
radiation NN O
. . O

We PRP O
have VBP O
identified VBN O
two CD O
residues NNS O
of IN O
NBS1 NNP O
, , O
Ser NNP O
278 CD O
and CC O
Ser NNP O
343 CD O
that WDT O
are VBP O
phosphorylated VBN O
in IN O
vitro NN O
by IN O
ATM NNP O
and CC O
whose WP$ O
modification NN O
in IN O
vivo NN O
is VBZ O
essential JJ O
for IN O
the DT O
cellular JJ O
response NN O
to TO O
DNA NNP O
damage NN O
. . O

This DT O
response NN O
includes VBZ O
S NNP O
- : O
phase NN O
checkpoint NN O
activation NN O
, , O
formation NN O
of IN O
the DT O
NBS1 NNP O
/ NNP O
Mrel1 NNP O
/ NNP O
Rad50 NNP O
nuclear JJ O
foci NN O
and CC O
rescue NN O
of IN O
hypersensitivity NN B-Disease
to TO I-Disease
ionizing VBG I-Disease
radiation NN I-Disease
. . O

Together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
a DT O
biochemical JJ O
link NN O
between IN O
cell NN O
- : O
cycle NN O
checkpoints NNS O
activated VBN O
by IN O
DNA NNP O
damage NN O
and CC O
DNA NNP O
repair NN O
in IN O
two CD O
genetic JJ B-Disease
diseases NNS I-Disease
with IN O
overlapping VBG O
phenotypes NNS O
. . O
. . O

Homozygosity NNP O
mapping NN O
in IN O
a DT O
family NN O
with IN O
microcephaly NN B-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
short JJ B-Disease
stature NN I-Disease
to TO O
a DT O
Cohen NNP B-Disease
syndrome JJ I-Disease
region NN O
on IN O
8q21 CD O
. . O
3 CD O
- : O
8q22 CD O
. . O
1 CD O
: : O
redefining VBG O
a DT O
clinical JJ O
entity NN O
. . O

A DT O
syndrome NN O
of IN O
microcephaly NN B-Disease
, , O
progressive JJ O
postnatal JJ B-Disease
growth NN I-Disease
deficiency NN I-Disease
, , O
and CC O
mental JJ B-Disease
retardation NN I-Disease
was VBD O
observed VBN O
in IN O
two CD O
brothers NNS O
and CC O
their PRP$ O
cousin NN O
from IN O
a DT O
multiply NN O
consanguineous JJ O
kindred VBN O
of IN O
Lebanese JJ O
descent NN O
. . O

Hypotonia NNP B-Disease
, , O
chorioretinal JJ B-Disease
dystrophy NN I-Disease
, , O
and CC O
myopia NN B-Disease
were VBD O
also RB O
identified VBN O
. . O

The DT O
severity NN O
of IN O
the DT O
condition NN O
varied VBD O
among IN O
the DT O
closely RB O
related JJ O
patients NNS O
. . O

Because IN O
of IN O
absence NN O
of IN O
a DT O
distinctive JJ O
facial JJ O
appearance NN O
, , O
the DT O
degree NN O
of IN O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
short JJ B-Disease
stature NN I-Disease
, , O
the DT O
initially RB O
considered VBN O
clinical JJ O
diagnosis NN O
of IN O
Cohen NNP B-Disease
syndrome NN I-Disease
was VBD O
withdrawn VBN O
and CC O
a DT O
novel JJ O
genetic JJ O
entity NN O
was VBD O
assumed VBN O
. . O

Homozygosity NNP O
mapping NN O
in IN O
this DT O
family NN O
assigned VBD O
the DT O
gene NN O
to TO O
a DT O
26 CD O
. . O

8 CD O
- : O
cM NN O
region NN O
on IN O
the DT O
chromosome NN O
band NN O
8q21 CD O
. . O

3 LS O
- : O
22 CD O
. . O

1 CD O
, , O
between IN O
the DT O
microsatellites NNS O
at IN O
D8S270 NNP O
and CC O
D8S514 NNP O
. . O

The DT O
maximum JJ O
two CD O
- : O
point NN O
LOD NNP O
score NN O
was VBD O
found VBN O
for IN O
marker NN O
at IN O
D8S267 NNP O
( ( O
Zmax NNP O
= VBZ O
3 CD O
. . O
. . O
237 CD O
at IN O
Omax NNP O
= NNP O
0 CD O
. . O
0 CD O
) ) O
. . O

Intriguingly RB O
enough RB O
, , O
the DT O
identified VBN O
gene NN O
region NN O
overlaps VBZ O
the DT O
refined JJ O
gene NN O
region NN O
for IN O
Cohen NNP B-Disease
syndrome NN I-Disease
( ( O
COH1 NNP O
) ) O
[ VBP O
Kolehmainen NNP O
et CC O
al NN O
. . O
, , O
1997 CD O
Euro NNP O
J NNP O
Hum NNP O
Genet NNP O
5 CD O
206 CD O
- : O
213 CD O
] NN O
. . O

This DT O
fact NN O
encourages VBZ O
the DT O
hypothesis NN O
that IN O
the DT O
described NN O
kindred VBD O
segregates NNS O
for IN O
a DT O
variant NN O
of IN O
Cohen NNP B-Disease
syndrome NN I-Disease
and CC O
suggests VBZ O
a DT O
redefinition NN O
of IN O
its PRP$ O
phenotype NN O

Polymorphisms NNP O
of IN O
the DT O
CYP2D6 NNP O
gene NN O
increase NN O
susceptibility NN O
to TO O
ankylosing VBG B-Disease
spondylitis NN I-Disease
. . O

Ankylosing VBG B-Disease
spondylitis NN I-Disease
( ( O
AS IN B-Disease
) ) O
is VBZ O
a DT O
common JJ O
and CC O
highly RB O
familial JJ O
rheumatic JJ B-Disease
disorder NN I-Disease
. . O

The DT O
sibling VBG O
recurrence NN O
risk NN O
ratio NN O
for IN O
the DT O
disease NN O
is VBZ O
63 CD O
and CC O
heritability NN O
assessed VBN O
in IN O
twins NNS O
> VBP O
90 CD O
% NN O
. . O

Although IN O
MHC NNP O
genes NNS O
, , O
including VBG O
HLA NNP O
- : O
B27 NNP O
, , O
contribute VBZ O
only RB O
20 CD O
- : O
50 CD O
% NN O
of IN O
the DT O
genetic JJ O
risk NN O
for IN O
the DT O
disease NN O
, , O
no DT O
non JJ O
- : O
MHC NNP O
gene NN O
has VBZ O
yet RB O
been VBN O
convincingly RB O
demonstrated VBN O
to TO O
influence VB O
either DT O
susceptibility NN O
to TO O
the DT O
disease NN O
or CC O
its PRP$ O
phenotypic JJ O
expression NN O
. . O

Previous JJ O
linkage NN O
and CC O
association NN O
studies NNS O
have VBP O
suggested VBN O
the DT O
presence NN O
of IN O
a DT O
susceptibility NN O
gene NN O
for IN O
AS NNP B-Disease
close NN O
to TO O
, , O
or CC O
within IN O
, , O
the DT O
cytochrome NN O
P450 NNP O
2D6 CD O
gene NN O
( ( O
CYP2D6 NNP O
, , O
debrisoquine JJ O
hydroxylase NN O
) ) O
located VBN O
at IN O
chromosome NN O
22q13 CD O
. . O
1 CD O
. . O

We PRP O
performed VBD O
a DT O
linkage NN O
study NN O
of IN O
chromosome NN O
22 CD O
in IN O
200 CD O
families NNS O
with IN O
AS NNP B-Disease
affected VBD O
sibling VBG O
- : O
pairs NN O
. . O

Association NNP O
of IN O
alleles NNS O
of IN O
the DT O
CYP2D6 NNP O
gene NN O
was VBD O
examined VBN O
by IN O
both DT O
case NN O
- : O
control NN O
and CC O
within IN O
- : O
family NN O
means VBZ O
. . O

For IN O
case NN O
- : O
control NN O
studies NNS O
, , O
617 CD O
unrelated JJ O
individuals NNS O
with IN O
AS NNP B-Disease
( ( O
361 CD O
probands NNS O
from IN O
sibling VBG O
- : O
pair NN O
and CC O
parent NN O
- : O
case NN O
trio NN O
families NNS O
and CC O
256 CD O
unrelated JJ O
non SYM O
- : O
familial JJ O
sporadic JJ O
cases NNS O
) ) O
and CC O
402 CD O
healthy JJ O
ethnically RB O
matched VBN O
controls NNS O
were VBD O
employed VBN O
. . O

For IN O
within IN O
- : O
family NN O
association NN O
studies NNS O
, , O
361 CD O
families NNS O
including VBG O
161 CD O
parent NN O
- : O
case NN O
trios NNS O
and CC O
200 CD O
affected VBD O
sibling VBG O
- : O
pair NN O
families NNS O
were VBD O
employed VBN O
. . O

Homozygosity NN O
for IN O
poor JJ O
metabolizer NN O
alleles NNS O
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
AS NNP B-Disease
. . O

Heterozygosity NN O
for IN O
the DT O
most RBS O
frequent JJ O
poor JJ O
metabolizer NN O
allele NN O
( ( O
CYP2D6 NNP O
* NNP O
4 CD O
) ) O
was VBD O
not RB O
associated VBN O
with IN O
increased JJ O
susceptibility NN O
to TO O
AS NNP B-Disease
. . O

Significant NNP O
within IN O
- : O
family NN O
association NN O
of IN O
CYP2D6 NNP O
* NNP O
4 CD O
alleles NNS O
and CC O
AS NNP B-Disease
was VBD O
demonstrated VBN O
. . O

Weak NNP O
linkage NN O
was VBD O
also RB O
demonstrated VBN O
between IN O
CYP2D6 NNP O
and CC O
AS NNP B-Disease
. . O

We PRP O
postulate VBP O
that IN O
altered VBD O
metabolism NN O
of IN O
a DT O
natural JJ O
toxin NN O
or CC O
antigen NN O
by IN O
the DT O
CYP2D6 NNP O
gene NN O
may MD O
increase VB O
susceptibility NN O
to TO O
AS NNP B-Disease
. . O

Functional JJ O
differences NNS O
of IN O
the DT O
PDS NNP B-Disease
gene NN O
product NN O
are VBP O
associated VBN O
with IN O
phenotypic NN O
variation NN O
in IN O
patients NNS O
with IN O
Pendred NNP B-Disease
syndrome NN I-Disease
and CC O
non JJ B-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
( ( O
DFNB4 NNP B-Disease
) ) O
. . O

The DT O
PDS NNP B-Disease
gene NN O
encodes VBZ O
a DT O
transmembrane NN O
protein NN O
, , O
known VBN O
as IN O
pendrin NN O
, , O
which WDT O
functions VBZ O
as IN O
a DT O
transporter NN O
of IN O
iodide NN O
and CC O
chloride NN O
. . O

Mutations NNS O
in IN O
this DT O
gene NN O
are VBP O
responsible JJ O
for IN O
Pendred NNP B-Disease
syndrome NN I-Disease
and CC O
autosomal JJ B-Disease
recessive NN I-Disease
non SYM I-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
at IN O
the DT O
DFNB4 NNP B-Disease
locus NN O
on IN O
chromosome NN O
7q31 CD O
. . O

A DT O
screen NN O
of IN O
20 CD O
individuals NNS O
from IN O
the DT O
midwestern JJ O
USA NNP O
with IN O
non JJ B-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
and CC O
dilated VBD O
vestibular JJ O
aqueducts NNS O
identified VBN O
three CD O
people NNS O
( ( O
15 CD O
% NN O
) ) O
with IN O
PDS NNP B-Disease
mutations NNS O
. . O

To TO O
determine VB O
whether IN O
PDS NNP B-Disease
mutations NNS O
in IN O
individuals NNS O
with IN O
Pendred NNP B-Disease
syndrome NN I-Disease
differ VBP O
functionally RB O
from IN O
PDS NNP B-Disease
mutations NNS O
in IN O
individuals NNS O
with IN O
non JJ B-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
, , O
we PRP O
compared VBN O
three CD O
common JJ O
Pendred NNP B-Disease
syndrome NN I-Disease
allele NN O
variants NNS O
( ( O
L236P NNP O
, , O
T416P NNP O
and CC O
E384G NNP O
) ) O
, , O
with IN O
three CD O
PDS NNP B-Disease
mutations NNS O
reported VBD O
only RB O
in IN O
individuals NNS O
with IN O
non JJ B-Disease
- : I-Disease
syndromic JJ I-Disease
hearing NN I-Disease
loss NN I-Disease
( ( O
V480D NNP O
, , O
V653A NNP O
and CC O
I490L NNP O
/ NNP O
G497S NNP O
) ) O
. . O

The DT O
mutations NNS O
associated VBN O
with IN O
Pendred NNP B-Disease
syndrome NN I-Disease
have VBP O
complete JJ O
loss NN O
of IN O
pendrin JJ O
- : O
induced JJ O
chloride NN O
and CC O
iodide JJ O
transport NN O
, , O
while IN O
alleles NNS O
unique JJ O
to TO O
people NNS O
with IN O
DFNB4 NNP B-Disease
are VBP O
able JJ O
to TO O
transport VB O
both DT O
iodide JJ O
and CC O
chloride NN O
, , O
albeit NN O
at IN O
a DT O
much RB O
lower JJR O
level NN O
than IN O
wild JJ O
- : O
type NN O
pendrin NN O
. . O

We PRP O
hypothesize VBP O
that IN O
this DT O
residual JJ O
level NN O
of IN O
anion NN O
transport NN O
is VBZ O
sufficient JJ O
to TO O
eliminate VB O
or CC O
postpone VB O
the DT O
onset NN O
of IN O
goiter NN B-Disease
in IN O
individuals NNS O
with IN O
DFNB4 NNP B-Disease
. . O

We PRP O
propose VBP O
a DT O
model NN O
for IN O
pendrin JJ O
function NN O
in IN O
the DT O
thyroid NN O
in IN O
which WDT O
pendrin NN O
transports NNS O
iodide RB O
across IN O
the DT O
apical JJ O
membrane NN O
of IN O
the DT O
thyrocyte NN O
into IN O
the DT O
colloid JJ O
space NN O
. . O
. . O

The DT O
human JJ O
factor NN O
IX NNP O
gene NN O
as IN O
germline JJ O
mutagen NN O
test NN O
: : O
samples NNS O
from IN O
Mainland NNP O
China NNP O
have VBP O
the DT O
putatively RB O
endogenous JJ O
pattern NN O
of IN O
mutation NN O
. . O

Germline NNP O
mutations NNS O
are VBP O
the DT O
major JJ O
source NN O
of IN O
genetic JJ O
variation NN O
that WDT O
allows VBZ O
a DT O
species NNS O
to TO O
evolve VB O
over IN O
time NN O
but CC O
at IN O
the DT O
cost NN O
of IN O
Mendelian JJ B-Disease
disease NN I-Disease
and CC O
genetic JJ O
predisposition NN O
to TO O
multifactorial JJ B-Disease
diseases NNS I-Disease
. . O

Previous JJ O
analyses NNS O
have VBP O
revealed VBN O
that IN O
the DT O
pattern NN O
of IN O
germline JJ O
mutations NNS O
in IN O
the DT O
factor NN O
IX NNP O
gene NN O
( ( O
F9 NNP O
) ) O
is VBZ O
similar JJ O
among IN O
a DT O
variety NN O
of IN O
ethnically RB O
and CC O
geographically RB O
diverse JJ O
populations NNS O
and CC O
compatible JJ O
with IN O
the DT O
ancient NN O
pattern NN O
that WDT O
has VBZ O
shaped VBN O
the DT O
mammalian JJ O
genome NN O
. . O

Here RB O
, , O
we PRP O
compare VBP O
the DT O
pattern NN O
of IN O
germline JJ O
mutation NN O
in IN O
a DT O
population NN O
of IN O
hemophilia NN B-Disease
B NNP I-Disease
patients NNS O
from IN O
Mainland NNP O
China NNP O
( ( O
n JJ O
= NNP O
66 CD O
) ) O
to TO O
that DT O
in IN O
U NNP O
. . O

S NNP O
. . O

Caucasians NNS O
, , O
Blacks NNP O
, , O
and CC O
Mexican NNP O
Hispanics NNP O
and CC O
stratify VBN O
by IN O
disease NN O
severity NN O
and CC O
ethnicity NN O
. . O

The DT O
similar JJ O
pattern NN O
of IN O
germline JJ O
mutation NN O
in IN O
all DT O
ethnic JJ O
groups NNS O
studied VBD O
to TO O
date NN O
provides VBZ O
additional JJ O
data NNS O
compatible NN O
with IN O
the DT O
inference NN O
that WDT O
endogenous JJ O
processes NNS O
predominate VBP O
in IN O
germline JJ O
mutations NNS O
. . O

Fas NNP O
preassociation NN O
required VBN O
for IN O
apoptosis NN O
signaling NN O
and CC O
dominant JJ O
inhibition NN O
by IN O
pathogenic JJ O
mutations NNS O
. . O

Heterozygous JJ O
mutations NNS O
encoding VBG O
abnormal JJ O
forms NNS O
of IN O
the DT O
death NN O
receptor NN O
Fas NNP O
dominantly RB O
interfere RB O
with IN O
Fas NNP O
- : O
induced VBD O
lymphocyte JJ O
apoptosis NN O
in IN O
human JJ O
autoimmune JJ B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
. . O

This DT O
effect NN O
, , O
rather RB O
than IN O
depending VBG O
on IN O
ligand NN O
- : O
induced JJ O
receptor NN O
oligomerization NN O
, , O
was VBD O
found VBN O
to TO O
stem VB O
from IN O
ligand NN O
- : O
independent JJ O
interaction NN O
of IN O
wild JJ O
- : O
type NN O
and CC O
mutant JJ O
Fas NNP O
receptors NNS O
through IN O
a DT O
specific JJ O
region NN O
in IN O
the DT O
extracellular JJ O
domain NN O
. . O

Preassociated VBN O
Fas NNP O
complexes NNS O
were VBD O
found VBN O
in IN O
living VBG O
cells NNS O
by IN O
means NNS O
of IN O
fluorescence NN O
resonance NN O
energy NN O
transfer NN O
between IN O
variants NNS O
of IN O
green JJ O
fluorescent NN O
protein NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
formation NN O
of IN O
preassociated JJ O
receptor NN O
complexes NNS O
is VBZ O
necessary JJ O
for IN O
Fas NNP O
signaling VBG O
and CC O
dominant JJ O
interference NN O
in IN O
human JJ O
disease NN O
. . O
. . O

Determination NN O
of IN O
carrier NN O
status NN O
for IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
by IN O
flow JJ O
cytometric JJ O
analysis NN O
of IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBP I-Disease
protein JJ O
expression NN O
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
defects NNS O
in IN O
the DT O
WAS NNP B-Disease
protein NN O
( ( O
WASP NNP O
) ) O
gene NN O
on IN O
the DT O
X NNP O
chromosome NN O
. . O

Previous JJ O
study NN O
disclosed VBD O
that IN O
flow JJ O
cytometric JJ O
analysis NN O
of IN O
intracellular JJ O
WASP NNP O
expression NN O
( ( O
FCM NNP O
- : O
WASP NNP O
analysis NN O
) ) O
in IN O
lymphocytes NN O
was VBD O
useful JJ O
for IN O
the DT O
diagnosis NN O
of IN O
WAS NNP B-Disease
patients NNS O
. . O

Lymphocytes NNS O
from IN O
all DT O
WAS NNP B-Disease
patients NNS O
showed VBD O
WASPdim NNP O
instead RB O
of IN O
WASPbright NNP O
. . O

Here RB O
we PRP O
report VBP O
that IN O
FCM NNP O
- : O
WASP JJ O
analysis NN O
in IN O
monocytes NNS O
could MD O
be VB O
a DT O
useful JJ O
tool NN O
for IN O
the DT O
WAS NNP B-Disease
carrier NN O
diagnosis NN O
. . O

Monocytes NNS O
from IN O
all DT O
nine CD O
WAS NNP B-Disease
carriers NNS O
showed VBD O
varied JJ O
population NN O
of IN O
WASPdim NNP O
together RB O
with IN O
WASPbright NNP O
. . O

None NN O
of IN O
control NN O
individuals NNS O
possessed VBD O
the DT O
WASPdim NNP O
population NN O
. . O

In IN O
contrast NN O
, , O
lymphocytes VBZ O
from IN O
all PDT O
the DT O
carriers NNS O
except IN O
two CD O
lacked VBD O
the DT O
WASPdim NNP O
population NN O
. . O

The DT O
difference NN O
of IN O
the DT O
WASPdim NNP O
population NN O
in IN O
monocytes NNS O
and CC O
lymphocytes VBZ O
observed VBN O
in IN O
WAS NNP B-Disease
carriers NNS O
suggests VBZ O
that IN O
WASP NNP O
plays VBZ O
a DT O
more RBR O
critical JJ O
role NN O
in IN O
the DT O
development NN O
of IN O
lymphocytes NNS O
than IN O
in IN O
that DT O
of IN O
monocytes NNS O
. . O

The DT O
present JJ O
studies NNS O
suggest VBP O
that IN O
a DT O
skewed JJ O
X NNP O
- : O
chromosomal JJ O
inactivation NN O
pattern NN O
observed VBN O
in IN O
WAS NNP B-Disease
carrier NN O
peripheral JJ O
blood NN O
cells NNS O
is VBZ O
not RB O
fixed VBN O
at IN O
the DT O
hemopoietic JJ O
stem NN O
cell NN O
level NN O
but CC O
progresses VBZ O
after IN O
the DT O
lineage NN O
commitment NN O
. . O
. . O

Restoration NN O
of IN O
photoreceptor NN O
ultrastructure NN O
and CC O
function NN O
in IN O
retinal JJ B-Disease
degeneration NN I-Disease
slow JJ O
mice NN O
by IN O
gene NN O
therapy NN O
. . O

The DT O
gene NN O
Prph2 NNP O
encodes VBZ O
a DT O
photoreceptor NN O
- : O
specific JJ O
membrane NN O
glycoprotein NN O
, , O
peripherin SYM O
- : O
2 CD O
( ( O
also RB O
known VBN O
as IN O
peripherin NN O
/ NNP O
rds NNS O
) ) O
, , O
which WDT O
is VBZ O
inserted VBN O
into IN O
the DT O
rims NNS O
of IN O
photoreceptor NN O
outer NN O
segment NN O
discs NN O
in IN O
a DT O
complex JJ O
with IN O
rom NN O
- : O
1 CD O
( ( O
ref NN O
. . O
2 CD O
) ) O
. . O

The DT O
complex NN O
is VBZ O
necessary JJ O
for IN O
the DT O
stabilization NN O
of IN O
the DT O
discs NN O
, , O
which WDT O
are VBP O
renewed VBN O
constantly RB O
throughout IN O
life NN O
, , O
and CC O
which WDT O
contain VBP O
the DT O
visual JJ O
pigments NNS O
necessary JJ O
for IN O
photon NN O
capture NN O
. . O

Mutations NNS O
in IN O
Prph2 NNP O
have VBP O
been VBN O
shown VBN O
to TO O
result VB O
in IN O
a DT O
variety NN O
of IN O
photoreceptor NN B-Disease
dystrophies NNS I-Disease
, , O
including VBG O
autosomal JJ B-Disease
dominant JJ I-Disease
retinitis NN I-Disease
pigmentosa NN I-Disease
and CC O
macular JJ B-Disease
dystrophy NN I-Disease
. . O

A DT O
common JJ O
feature NN O
of IN O
these DT O
diseases NNS O
is VBZ O
the DT O
loss NN O
of IN O
photoreceptor NN O
function NN O
, , O
also RB O
seen VBN O
in IN O
the DT O
retinal JJ B-Disease
degeneration NN I-Disease
slow NN O
( ( O
rds NNS O
or CC O
Prph2 NNP O
Rd2 NNP O
/ NNP O
Rd2 NNP O
) ) O
mouse NN O
, , O
which WDT O
is VBZ O
homozygous JJ O
for IN O
a DT O
null JJ O
mutation NN O
in IN O
Prph2 NNP O
. . O

It PRP O
is VBZ O
characterized VBN O
by IN O
a DT O
complete JJ O
failure NN O
to TO O
develop VB O
photoreceptor NN O
discs NN O
and CC O
outer NN O
segments NNS O
, , O
downregulation NN O
of IN O
rhodopsin NN O
and CC O
apoptotic JJ O
loss NN O
of IN O
photoreceptor NN O
cells NNS O
. . O

The DT O
electroretinograms NN O
( ( O
ERGs NNP O
) ) O
of IN O
Prph2Rd2 NNP O
/ NNP O
Rd2 NNP O
mice NN O
have VBP O
greatly RB O
diminished VBN O
a DT O
- : O
wave NN O
and CC O
b SYM O
- : O
wave NN O
amplitudes NNS O
, , O
which WDT O
decline VBP O
to TO O
virtually RB O
undetectable JJ O
concentrations NNS O
by IN O
two CD O
months NNS O
. . O

Subretinal JJ O
injection NN O
of IN O
recombinant JJ O
adeno JJ O
- : O
associated VBN O
virus NN O
( ( O
AAV NNP O
) ) O
encoding VBG O
a DT O
Prph2 NNP O
transgene NN O
results NNS O
in IN O
stable JJ O
generation NN O
of IN O
outer NN O
segment NN O
structures NNS O
and CC O
formation NN O
of IN O
new JJ O
stacks NNS O
of IN O
discs NN O
containing VBG O
both DT O
perpherin JJ O
- : O
2 CD O
and CC O
rhodopsin NN O
, , O
which WDT O
in IN O
many JJ O
cases NNS O
are VBP O
morphologically RB O
similar JJ O
to TO O
normal JJ O
outer JJ O
segments NNS O
. . O

Moreover RB O
, , O
the DT O
re NN O
- : O
establishment NN O
of IN O
the DT O
structural JJ O
integrity NN O
of IN O
the DT O
photoreceptor NN O
layer NN O
also RB O
results NNS O
in IN O
electrophysiological JJ O
correction NN O
. . O

These DT O
studies NNS O
demonstrate VBP O
for IN O
the DT O
first JJ O
time NN O
that IN O
a DT O
complex JJ O
ultrastructural JJ O
cell NN O
defect NN O
can MD O
be VB O
corrected VBN O
both DT O
morphologically RB O
and CC O
functionally RB O
by IN O
in IN O
vivo JJ O
gene NN O
transfer NN O
. . O
. . O

Mutations NNS O
in IN O
the DT O
fibrinogen NN O
aalpha JJ O
gene NN O
account NN O
for IN O
the DT O
majority NN O
of IN O
cases NNS O
of IN O
congenital JJ B-Disease
afibrinogenemia NN I-Disease
. . O

Congenital JJ B-Disease
afibrinogenemia NN I-Disease
is VBZ O
a DT O
rare JJ O
, , O
autosomal JJ B-Disease
, , I-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
the DT O
complete JJ O
absence NN O
of IN O
detectable JJ O
fibrinogen NN O
. . O

We PRP O
previously RB O
identified VBD O
the DT O
first JJ O
causative JJ O
mutations NNS O
in IN O
a DT O
nonconsanguineous JJ O
Swiss JJ O
family NN O
; : O
the DT O
4 CD O
affected JJ O
persons NNS O
have VBP O
homozygous JJ O
deletions NNS O
of IN O
approximately RB O
11 CD O
kb NNS O
of IN O
the DT O
fibrinogen NN O
alpha NN O
( ( O
FGA NNP O
) ) O
gene NN O
. . O

Haplotype NNP O
data NNS O
implied VBD O
that IN O
these DT O
deletions NNS O
occurred VBD O
on IN O
distinct JJ O
ancestral JJ O
chromosomes NNS O
, , O
suggesting VBG O
that IN O
this DT O
region NN O
may MD O
be VB O
susceptible JJ O
to TO O
deletion NN O
by IN O
a DT O
common JJ O
mechanism NN O
. . O

We PRP O
subsequently RB O
showed VBD O
that IN O
all PDT O
the DT O
deletions NNS O
were VBD O
identical JJ O
to TO O
the DT O
base NN O
pair NN O
and CC O
probably RB O
resulted VBD O
from IN O
a DT O
nonhomologous JJ O
recombination NN O
mediated VBN O
by IN O
7 CD O
- : O
bp NN O
direct JJ O
repeats NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
collected VBN O
data NNS O
on IN O
13 CD O
additional JJ O
unrelated JJ O
patients NNS O
to TO O
identify VB O
the DT O
causative JJ O
mutations NNS O
and CC O
to TO O
determine VB O
the DT O
prevalence NN O
of IN O
the DT O
11 CD O
- : O
kb NN O
deletion NN O
. . O

A DT O
common JJ O
recurrent NN O
mutation NN O
, , O
at IN O
the DT O
donor NN O
splice NN O
site NN O
of IN O
FGA NNP O
intron NN O
4 CD O
( ( O
IVS4 NNP O
+ VBZ O
1 CD O
G NNP O
> NNP O
T NNP O
) ) O
, , O
accounted VBD O
for IN O
14 CD O
of IN O
the DT O
26 CD O
( ( O
54 CD O
% NN O
) ) O
alleles VBZ O
. . O

One CD O
patient NN O
was VBD O
heterozygous JJ O
for IN O
the DT O
previously RB O
identified VBN O
deletion NN O
. . O

Three CD O
more JJR O
frameshift NN O
mutations NNS O
, , O
2 CD O
nonsense NN O
mutations NNS O
, , O
and CC O
a DT O
second JJ O
splice NN O
site NN O
mutation NN O
were VBD O
also RB O
identified VBN O
. . O

Consequently RB O
, , O
86 CD O
% NN O
of IN O
afibrinogenemia NN B-Disease
alleles NNS O
analyzed VBN O
to TO O
date NN O
have VB O
truncating VBG O
mutations NNS O
of IN O
FGA NNP O
, , O
though IN O
mutations NNS O
in IN O
all DT O
3 CD O
fibrinogen NN O
genes NNS O
, , O
FGG NNP O
, , O
FGA NNP O
, , O
and CC O
FGB NNP O
, , O
might MD O
be VB O
predicted VBN O
to TO O
cause VB O
congenital JJ B-Disease
afibrinogenemia NN I-Disease
. . O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
: : O
the DT O
role NN O
of IN O
the DT O
CUG NNP O
triplet NN O
repeats NNS O
in IN O
splicing NN O
of IN O
a DT O
novel JJ O
DMPK NNP O
exon NN O
and CC O
altered VBD O
cytoplasmic JJ O
DMPK NNP O
mRNA NN O
isoform NN O
ratios NNS O
. . O

The DT O
mechanism NN O
by IN O
which WDT O
( ( O
CTG NNP O
) ) O
n JJ O
expansion NN O
in IN O
the DT O
3 CD O
UTR NNP O
of IN O
the DT O
DMPK NNP O
gene NN O
causes VBZ O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
unknown JJ O
. . O

We PRP O
identified VBD O
four CD O
RNA NNP O
splicing VBG O
factors NNS O
- : O
- : O
hnRNP NN O
C NNP O
, , O
U2AF NNP O
( ( O
U2 NNP O
auxiliary JJ O
factor NN O
) ) O
, , O
PTB NNP O
( ( O
polypyrimidine JJ O
tract NN O
binding VBG O
protein NN O
) ) O
, , O
and CC O
PSF NNP O
( ( O
PTB NNP O
associated VBD O
splicing VBG O
factor NN O
) ) O
- : O
- : O
that WDT O
bind VBP O
to TO O
two CD O
short JJ O
regions NNS O
3 CD O
of IN O
the DT O
( ( O
CUG NNP O
) ) O
n NN O
, , O
and CC O
found VBD O
a DT O
novel JJ O
3 CD O
DMPK NNP O
exon NN O
resulting VBG O
in IN O
an DT O
mRNA NN O
lacking VBG O
the DT O
repeats NNS O
. . O

We PRP O
propose VBP O
that IN O
the DT O
( ( O
CUG NNP O
) ) O
n NN O
is VBZ O
an DT O
essential JJ O
cis NN O
acting VBG O
element NN O
for IN O
this DT O
splicing JJ O
event NN O
. . O

In IN O
contrast NN O
to TO O
( ( O
CUG NNP O
) ) O
n VBP O
containing VBG O
mRNAs NN O
, , O
the DT O
novel JJ O
isoform NN O
is VBZ O
not RB O
retained VBN O
in IN O
the DT O
nucleus NN O
in IN O
DM NNP B-Disease
cells NNS O
, , O
resulting VBG O
in IN O
imbalances NNS O
in IN O
relative JJ O
levels NNS O
of IN O
cytoplasmic JJ O
DMPK NNP O
mRNA NN O
isoforms NNS O
and CC O
a DT O
new JJ O
dominant JJ O
effect NN O
of IN O
the DT O
mutation NN O
on IN O
DMPK NNP O
. . O
. . O

Expression NN O
and CC O
imprinting NN O
of IN O
MAGEL2 NNP O
suggest VBP O
a DT O
role NN O
in IN O
Prader NNP B-Disease
- : I-Disease
willi NN I-Disease
syndrome NN I-Disease
and CC O
the DT O
homologous JJ O
murine NN O
imprinting VBG O
phenotype NN O
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
the DT O
loss NN O
of IN O
expression NN O
of IN O
imprinted JJ O
genes NNS O
in IN O
chromosome NN O
15q11 CD O
- : O
q13 NN O
. . O

Affected JJ O
individuals NNS O
exhibit VBP O
neonatal JJ B-Disease
hypotonia NN I-Disease
, , O
developmental JJ B-Disease
delay NN I-Disease
and CC O
childhood NN B-Disease
- : I-Disease
onset NN I-Disease
obesity NN I-Disease
. . O

Necdin NNP O
, , O
a DT O
protein NN O
implicated VBN O
in IN O
the DT O
terminal JJ O
differentiation NN O
of IN O
neurons NNS O
, , O
is VBZ O
the DT O
only JJ O
PWS NNP B-Disease
candidate NN O
gene NN O
to TO O
reduce VB O
viability NN O
when WRB O
disrupted VBN O
in IN O
a DT O
mouse NN O
model NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
characterized VBN O
MAGEL2 NNP O
( ( O
also RB O
known VBN O
as IN O
NDNL1 NNP O
) ) O
, , O
a DT O
gene NN O
with IN O
51 CD O
% NN O
amino NN O
acid JJ O
sequence NN O
similarity NN O
to TO O
necdin VB O
and CC O
located VBN O
41 CD O
kb JJ O
distal NN O
to TO O
NDN NNP O
in IN O
the DT O
PWS NNP B-Disease
deletion NN O
region NN O
. . O

MAGEL2 NNP O
is VBZ O
expressed VBN O
predominantly RB O
in IN O
brain NN O
, , O
the DT O
primary JJ O
tissue NN O
affected VBD O
in IN O
PWS NNP B-Disease
and CC O
in IN O
several JJ O
fetal JJ O
tissues NNS O
as IN O
shown VBN O
by IN O
northern JJ O
blot NN O
analysis NN O
. . O

MAGEL2 NNP O
is VBZ O
imprinted VBN O
with IN O
monoallelic JJ O
expression NN O
in IN O
control NN O
brain NN O
, , O
and CC O
paternal JJ O
- : O
only RB O
expression NN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
as IN O
demonstrated VBN O
by IN O
its PRP$ O
lack NN O
of IN O
expression NN O
in IN O
brain NN O
from IN O
a DT O
PWS NNP B-Disease
- : O
affected VBD O
individual JJ O
. . O

The DT O
orthologous JJ O
mouse NN O
gene NN O
( ( O
Magel2 NNP O
) ) O
is VBZ O
located VBN O
within IN O
150 CD O
kb NNS O
of IN O
NDN NNP O
, , O
is VBZ O
imprinted VBN O
with IN O
paternal JJ O
- : O
only JJ O
expression NN O
and CC O
is VBZ O
expressed VBN O
predominantly RB O
in IN O
late JJ O
developmental JJ O
stages NNS O
and CC O
adult NN O
brain NN O
as IN O
shown VBN O
by IN O
northern JJ O
blotting NN O
, , O
RT NNP O
- : O
PCR NN O
and CC O
whole JJ O
- : O
mount NN O
RNA NNP O
in IN O
situ JJ O
hybridization NN O
. . O

Magel2 NNP O
distribution NN O
partially RB O
overlaps VBZ O
that IN O
of IN O
NDN NNP O
, , O
with IN O
strong JJ O
expression NN O
being VBG O
detected VBN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
in IN O
mid JJ O
- : O
gestation NN O
mouse IN O
embryos NN O
by IN O
in IN O
situ JJ O
hybridization NN O
. . O

We PRP O
hypothesize VBP O
that IN O
, , O
although IN O
loss NN O
of IN O
necdin JJ O
expression NN O
may MD O
be VB O
important JJ O
in IN O
the DT O
neonatal JJ O
presentation NN O
of IN O
PWS NNP B-Disease
, , O
loss NN O
of IN O
MAGEL2 NNP O
may MD O
be VB O
critical JJ O
to TO O
abnormalities NNS B-Disease
in IN I-Disease
brain NN I-Disease
development NN I-Disease
and CC O
dysmorphic JJ B-Disease
features NNS I-Disease
in IN O
individuals NNS O
with IN O
PWS NNP B-Disease
. . O
. . O

Retinoschisin NNP O
, , O
the DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
retinoschisis NN I-Disease
protein NN O
, , O
is VBZ O
a DT O
secreted JJ O
photoreceptor NN O
protein NN O
, , O
and CC O
is VBZ O
expressed VBN O
and CC O
released VBN O
by IN O
Weri NNP O
- : O
Rb1 NNP O
cells NNS O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
retinoschisis NN I-Disease
is VBZ O
characterized VBN O
by IN O
microcystic JJ O
- : O
like IN O
changes NNS O
of IN O
the DT O
macular JJ O
region NN O
and CC O
schisis NN O
within IN O
the DT O
inner JJ O
retinal JJ O
layers NNS O
, , O
leading VBG O
to TO O
visual JJ B-Disease
deterioration NN I-Disease
in IN O
males NNS O
. . O

Many JJ O
missense NN O
and CC O
protein NN O
- : O
truncating VBG O
mutations NNS O
of IN O
the DT O
causative JJ O
gene NN O
RS1 NNP O
have VBP O
now RB O
been VBN O
identified VBN O
and CC O
are VBP O
thought VBN O
to TO O
be VB O
inactivating VBG O
. . O

RS1 NNP O
encodes VBZ O
a DT O
224 CD O
amino NN O
acid NN O
protein NN O
, , O
retinoschisin NN O
, , O
which WDT O
contains VBZ O
a DT O
discoidin NN O
domain NN O
but CC O
is VBZ O
of IN O
unknown JJ O
function NN O
. . O

We PRP O
have VBP O
generated VBN O
a DT O
polyclonal JJ O
antibody NN O
against IN O
a DT O
peptide NN O
from IN O
a DT O
unique JJ O
region NN O
within IN O
retinoschisin NN O
, , O
which WDT O
detects VBZ O
a DT O
protein NN O
of IN O
approximately RB O
28 CD O
kDa NNS O
in IN O
retinal JJ O
samples NNS O
reduced VBN O
with IN O
dithiothreitol NN O
, , O
but CC O
multimers NNS O
sized VBD O
> RB O
40 CD O
kDa NNS O
under IN O
non JJ O
- : O
reducing VBG O
conditions NNS O
. . O

A DT O
screen NN O
of IN O
human JJ O
tissues NNS O
with IN O
this DT O
antibody NN O
reveals VBZ O
retinoschisin NN O
to TO O
be VB O
retina VBN O
specific JJ O
and CC O
the DT O
antibody NN O
detects VBZ O
a DT O
protein NN O
of IN O
similar JJ O
size NN O
in IN O
bovine NN O
and CC O
murine NN O
retinae NN O
. . O

We PRP O
investigated VBD O
the DT O
expression NN O
pattern NN O
in IN O
the DT O
retina NN O
of IN O
both DT O
RS1 NNP O
mRNA NN O
( ( O
using VBG O
in IN O
situ JJ O
hybridization NN O
with IN O
riboprobes NNS O
) ) O
and CC O
retinoschisin NN O
( ( O
using VBG O
immunohistochemistry NN O
) ) O
. . O

The DT O
antisense NN O
riboprobe NN O
detected VBD O
RS1 NNP O
mRNA MD O
only RB O
in IN O
the DT O
photoreceptor NN O
layer NN O
but CC O
the DT O
protein JJ O
product NN O
of IN O
the DT O
gene NN O
was VBD O
present JJ O
both DT O
in IN O
the DT O
photoreceptors NNS O
and CC O
within IN O
the DT O
inner JJ O
portions NNS O
of IN O
the DT O
retina NN O
. . O

Furthermore RB O
, , O
differentiated VBD O
retinoblastoma NN B-Disease
cells NNS O
( ( O
Weri NNP O
- : O
Rb1 NNP O
cells NNS O
) ) O
were VBD O
found VBN O
to TO O
express VB O
RS1 NNP O
mRNA NN O
and CC O
to TO O
release VB O
retinoschisin NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
retinoschisin NN O
is VBZ O
released VBN O
by IN O
photo NN O
- : O
receptors NNS O
and CC O
has VBZ O
functions NNS O
within IN O
the DT O
inner JJ O
retinal JJ O
layers NNS O
. . O

Thus RB O
, , O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
retinoschisis NN I-Disease
is VBZ O
caused VBN O
by IN O
abnormalities NNS O
in IN O
a DT O
putative JJ O
secreted JJ O
photoreceptor NN O
protein NN O
and CC O
is VBZ O
the DT O
first JJ O
example NN O
of IN O
a DT O
secreted JJ O
photo NN O
- : O
receptor NN O
protein NN O
associated VBN O
with IN O
a DT O
retinal JJ B-Disease
dystrophy NN I-Disease
. . O
. . O

Study NN O
of IN O
the DT O
voltage NN O
- : O
gated JJ O
sodium NN O
channel NN O
beta NN O
1 CD O
subunit NN O
gene NN O
( ( O
SCN1B NNP O
) ) O
in IN O
the DT O
benign JJ B-Disease
familial JJ I-Disease
infantile NN I-Disease
convulsions NNS I-Disease
syndrome VBP I-Disease
( ( O
BFIC NNP B-Disease
) ) O
. . O

Benign NNP B-Disease
familial JJ I-Disease
infantile NN I-Disease
convulsions NNS I-Disease
( ( O
BFIC NNP B-Disease
) ) O
is VBZ O
a DT O
rare JJ O
autosomal JJ B-Disease
dominant JJ I-Disease
epilepsy NN I-Disease
syndrome NN I-Disease
. . O

This DT O
syndrome NN O
has VBZ O
been VBN O
recently RB O
described VBN O
in IN O
Italian JJ O
and CC O
French JJ O
pedigrees NNS O
. . O

Patients NNS O
present JJ O
with IN O
partial JJ O
, , O
then RB O
generalized VBD O
seizures NNS O
, , O
with IN O
onset VBN O
at IN O
age NN O
three CD O
months NNS O
. . O

The DT O
seizures NNS O
usually RB O
spontaneously RB O
cease NN O
after IN O
one CD O
year NN O
without IN O
treatment NN O
, , O
leaving VBG O
no DT O
neurological JJ B-Disease
abnormalities NNS I-Disease
. . O

We PRP O
have VBP O
mapped VBN O
BFIC NNP B-Disease
to TO O
chromosome VB O
19q CD O
in IN O
five CD O
Italian JJ O
pedigrees NNS O
. . O

The DT O
sodium NN O
channel NN O
beta1 NN O
subunit NN O
gene NN O
( ( O
SCN1B NNP O
) ) O
maps VBZ O
to TO O
this DT O
candidate NN O
region NN O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
one CD O
Australian JJ O
pedigree NN O
with IN O
generalized JJ B-Disease
epilepsy NN I-Disease
and CC I-Disease
febrile NN I-Disease
seizures NNS I-Disease
"""" VBP I-Disease
plus CC I-Disease
"""" NNP I-Disease
( ( O
GEFS NNP O
+ NNP O
) ) O
. . O

In IN O
this DT O
family NN O
, , O
a DT O
missense JJ O
mutation NN O
in IN O
SCN1B NNP O
cosegregates NNS O
with IN O
the DT O
GEFS NNP O
+ NNP O
phenotype NN O
. . O

BFIC NNP B-Disease
and CC O
GEFS NNP O
+ NNP O
have VBP O
clinical JJ O
features NNS O
in IN O
common JJ O
, , O
therefore RB O
SCN1B NNP O
is VBZ O
a DT O
candidate JJ O
gene NN O
for IN O
BFIC NNP B-Disease
. . O

We PRP O
studied VBD O
SCN1B NNP O
exons NNS O
1 CD O
, , O
2 CD O
, , O
3 CD O
, , O
4 CD O
, , O
and CC O
5 CD O
, , O
using VBG O
four CD O
SSCP NNP O
methods NNS O
in IN O
10 CD O
Caucasian JJ O
BFIC NNP B-Disease
probands NNS O
of IN O
Western NNP O
Europe NNP O
. . O

We PRP O
found VBD O
no DT O
exon JJ O
variants NNS O
. . O

One CD O
variant NN O
was VBD O
identified VBN O
in IN O
intron NN O
5 CD O
( ( O
IVS5 NNP O
- : O
10C CD O
> NNP O
G NNP O
) ) O
, , O
which WDT O
did VBD O
not RB O
segregate VB O
with IN O
BFIC NNP B-Disease
and CC O
was VBD O
observed VBN O
in IN O
9 CD O
. . O

2 CD O
% NN O
controls NNS O
. . O

A DT O
second JJ O
variant NN O
in IN O
intron NN O
5 CD O
was VBD O
identified VBN O
( ( O
IVS5 NNP O
+ VBZ O
30G CD O
> IN O
A DT O
) ) O
. . O

It PRP O
was VBD O
rare JJ O
, , O
as IN O
not RB O
observed VBN O
in IN O
controls NNS O
, , O
but CC O
not RB O
segregating VBG O
with IN O
the DT O
BFIC NNP B-Disease
phenotype NN O
. . O

Inactivation NN O
of IN O
germline NN O
mutant NN O
APC NNP B-Disease
alleles NNS O
by IN O
attenuated JJ O
somatic JJ O
mutations NNS O
: : O
a DT O
molecular JJ O
genetic JJ O
mechanism NN O
for IN O
attenuated JJ B-Disease
familial JJ I-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
. . O

Germline NNP O
mutations NNS O
of IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( I-Disease
APC NNP I-Disease
) ) I-Disease
tumor NN I-Disease
- : O
suppressor NN O
gene NN O
result NN O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
. . O

Patients NNS O
with IN O
FAP NNP B-Disease
typically RB O
develop VB O
hundreds NNS O
to TO O
thousands NNS O
of IN O
benign JJ B-Disease
colorectal JJ I-Disease
tumors NNS I-Disease
and CC O
early JJ O
- : O
onset NN O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

A DT O
subset NN O
of IN O
germline NN O
APC NNP B-Disease
mutations NNS O
results NNS O
in IN O
an DT O
attenuated JJ B-Disease
FAP NNP I-Disease
( ( O
AFAP NNP B-Disease
) ) O
phenotype NN O
, , O
in IN O
which WDT O
patients NNS O
develop VB O
fewer JJR O
tumors NNS B-Disease
and CC O
develop VB O
them PRP O
at IN O
an DT O
older JJR O
age NN O
. . O

Although IN O
a DT O
genotype JJ O
- : O
phenotype NN O
correlation NN O
between IN O
the DT O
locations NNS O
of IN O
APC NNP B-Disease
germline NN O
mutations NNS O
and CC O
the DT O
development NN O
of IN O
AFAP NNP B-Disease
has VBZ O
been VBN O
well RB O
documented VBN O
, , O
the DT O
mechanism NN O
for IN O
AFAP NNP B-Disease
has VBZ O
not RB O
been VBN O
well RB O
defined VBN O
. . O

We PRP O
investigated VBD O
the DT O
mechanism NN O
for IN O
AFAP NNP B-Disease
in IN O
patients NNS O
carrying VBG O
a DT O
mutant JJ O
APC NNP B-Disease
allele NN O
( ( O
APC NNP O
( ( O
AS9 NNP O
) ) O
) ) O
that WDT O
has VBZ O
a DT O
mutation NN O
in IN O
the DT O
alternatively RB O
spliced JJ O
region NN O
of IN O
exon $ O
9 CD O
. . O

APC NNP O
( ( O
AS9 NNP O
) ) O
was VBD O
found VBN O
to TO O
down VB O
- : O
regulate NN O
beta SYM O
- : O
catenin NN O
- : O
regulated VBN O
transcription NN O
, , O
the DT O
major JJ O
tumor NN B-Disease
- : O
suppressor NN O
function NN O
of IN O
APC NNP O
, , O
as IN O
did VBD O
the DT O
wild JJ O
- : O
type NN O
APC NNP O
. . O

Mutation NN O
analysis NN O
showed VBD O
that IN O
both DT O
APC NNP O
( ( O
AS9 NNP O
) ) O
and CC O
the DT O
wild JJ O
- : O
type NN O
APC NNP B-Disease
alleles NNS O
were VBD O
somatically RB O
mutated VBN O
in IN O
most JJS O
colorectal JJ B-Disease
tumors NNS I-Disease
from IN O
these DT O
patients NNS O
. . O

Functional JJ O
analysis NN O
showed VBD O
that IN O
4666insA CD O
, , O
a DT O
common JJ O
somatic JJ O
mutation NN O
in IN O
APC NNP O
( ( O
AS9 NNP O
) ) O
in IN O
these DT O
tumors NNS B-Disease
, , O
did VBD O
not RB O
inactivate VB O
the DT O
wild JJ O
- : O
type NN O
APC NNP O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
carriers NNS O
of IN O
APC NNP O
( ( O
AS9 NNP O
) ) O
develop VB O
fewer JJR O
colorectal NN B-Disease
tumors NNS I-Disease
than IN O
do VBP O
typical JJ O
patients NNS O
with IN O
FAP NNP B-Disease
because IN O
somatic JJ O
inactivation NN O
of IN O
both DT O
APC NNP B-Disease
alleles NNS O
is VBZ O
necessary JJ O
for IN O
colorectal JJ O
tumorigenesis NN O
. . O

However RB O
, , O
these DT O
patients NNS O
develop VBP O
colorectal JJ B-Disease
tumors NNS I-Disease
more RBR O
frequently RB O
than IN O
does VBZ O
the DT O
general JJ O
population NN O
because IN O
APC NNP O
( ( O
AS9 NNP O
) ) O
is VBZ O
inactivated VBN O
by IN O
mutations NNS O
that WDT O
do VBP O
not RB O
inactivate VB O
the DT O
wild JJ O
- : O
type NN O
APC NNP O
. . O
. . O

Iron NNP O
- : O
dependent NN O
self PRP O
- : O
assembly NN O
of IN O
recombinant JJ O
yeast NN O
frataxin NN O
: : O
implications NNS O
for IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
. . O

Frataxin NNP B-Disease
deficiency NN I-Disease
is VBZ O
the DT O
primary JJ O
cause NN O
of IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
, , O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
cardiodegenerative NN I-Disease
and CC I-Disease
neurodegenerative JJ I-Disease
disease NN I-Disease
. . O

Frataxin NNP O
is VBZ O
a DT O
nuclear JJ O
- : O
encoded VBN O
mitochondrial JJ O
protein NN O
that WDT O
is VBZ O
widely RB O
conserved VBN O
among IN O
eukaryotes NNS O
. . O

Genetic JJ O
inactivation NN O
of IN O
the DT O
yeast NN O
frataxin NN O
homologue NN O
( ( O
Yfh1p NNP O
) ) O
results NNS O
in IN O
mitochondrial JJ B-Disease
iron NN I-Disease
accumulation NN I-Disease
and CC O
hypersensitivity NN B-Disease
to TO I-Disease
oxidative JJ I-Disease
stress NN I-Disease
. . O

Increased VBN O
iron NN O
deposition NN O
and CC O
evidence NN O
of IN O
oxidative JJ O
damage NN O
have VBP O
also RB O
been VBN O
observed VBN O
in IN O
cardiac JJ O
tissue NN O
and CC O
cultured JJ O
fibroblasts NNS O
from IN O
patients NNS O
with IN O
FRDA NNP B-Disease
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
frataxin NN O
is VBZ O
essential JJ O
for IN O
mitochondrial JJ O
iron NN O
homeostasis NN O
and CC O
protection NN O
from IN O
iron NN O
- : O
induced JJ O
formation NN O
of IN O
free JJ O
radicals NNS O
. . O

The DT O
functional JJ O
mechanism NN O
of IN O
frataxin NN O
, , O
however RB O
, , O
is VBZ O
still RB O
unknown JJ O
. . O

We PRP O
have VBP O
expressed VBN O
the DT O
mature NN O
form NN O
of IN O
Yfh1p NNP O
( ( O
mYfh1p NN O
) ) O
in IN O
Escherichia NNP O
coli NN O
and CC O
have VB O
analyzed VBN O
its PRP$ O
function NN O
in IN O
vitro NN O
. . O

Isolated VBN O
mYfh1p NN O
is VBZ O
a DT O
soluble JJ O
monomer NN O
( ( O
13 CD O
, , O
783 CD O
Da NNP O
) ) O
that WDT O
contains VBZ O
no DT O
iron NN O
and CC O
shows VBZ O
no DT O
significant JJ O
tendency NN O
to TO O
self VB O
- : O
associate NN O
. . O

Aerobic NNP O
addition NN O
of IN O
ferrous JJ O
iron NN O
to TO O
mYfh1p VB O
results NNS O
in IN O
assembly NN O
of IN O
regular JJ O
spherical JJ O
multimers NNS O
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
approximately RB O
1 CD O
. . O

1 CD O
MDa NNP O
( ( O
megadaltons NNS O
) ) O
and CC O
a DT O
diameter NN O
of IN O
13 CD O
+ NNS O
/ SYM O
- : O
2 CD O
nm NN O
. . O

Each DT O
multimer NN O
consists VBZ O
of IN O
approximately RB O
60 CD O
subunits NNS O
and CC O
can MD O
sequester VB O
> JJ O
3 CD O
, , O
0 CD O
atoms NNS O
of IN O
iron NN O
. . O

Titration NN O
of IN O
mYfh1p NN O
with IN O
increasing VBG O
iron NN O
concentrations NNS O
supports VBZ O
a DT O
stepwise NN O
mechanism NN O
of IN O
multimer NN O
assembly NN O
. . O

Sequential JJ O
addition NN O
of IN O
an DT O
iron NN O
chelator NN O
and CC O
a DT O
reducing VBG O
agent NN O
results NNS O
in IN O
quantitative JJ O
iron NN O
release NN O
with IN O
concomitant JJ O
disassembly NN O
of IN O
the DT O
multimer NN O
, , O
indicating VBG O
that IN O
mYfh1p NN O
sequesters NNS O
iron VBP O
in IN O
an DT O
available JJ O
form NN O
. . O

In IN O
yeast NN O
mitochondria NN O
, , O
native JJ O
mYfh1p NN O
exists VBZ O
as IN O
monomer NN O
and CC O
a DT O
higher JJR O
- : O
order NN O
species NNS O
with IN O
a DT O
molecular JJ O
weight NN O
> NN O
600 CD O
, , O
0 CD O
. . O

After IN O
addition NN O
of IN O
( ( O
55 CD O
) ) O
Fe NNP O
to TO O
the DT O
medium NN O
, , O
immunoprecipitates NNS O
of IN O
this DT O
species NNS O
contain VBP O
> JJ O
16 CD O
atoms NNS O
of IN O
( ( O
55 CD O
) ) O
Fe NNP O
per IN O
molecule NN O
of IN O
mYfh1p NN O
. . O

We PRP O
propose VBP O
that IN O
iron NN O
- : O
dependent NN O
self PRP O
- : O
assembly NN O
of IN O
recombinant JJ O
mYfh1p NN O
reflects VBZ O
a DT O
physiological JJ O
role NN O
for IN O
frataxin NN O
in IN O
mitochondrial JJ O
iron NN O
sequestration NN O
and CC O
bioavailability NN O
. . O
. . O

A DT O
mutation NN O
in IN O
the DT O
pleckstrin NN O
homology NN O
( ( O
PH NNP O
) ) O
domain NN O
of IN O
the DT O
FGD1 NNP O
gene NN O
in IN O
an DT O
Italian JJ O
family NN O
with IN O
faciogenital JJ B-Disease
dysplasia NN I-Disease
( ( O
Aarskog NNP B-Disease
- : I-Disease
Scott NNP I-Disease
syndrome NN I-Disease
) ) O
. . O

Aarskog NNP B-Disease
- : I-Disease
Scott NNP I-Disease
Syndrome NNP I-Disease
( ( O
AAS NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
disorder NN I-Disease
characterised VBN O
by IN O
short JJ B-Disease
stature NN I-Disease
and CC O
multiple JJ O
facial NN B-Disease
, , I-Disease
limb NN I-Disease
and CC I-Disease
genital JJ I-Disease
abnormalities NNS I-Disease
. . O

A DT O
gene NN O
, , O
FGD1 NNP O
, , O
altered VBD O
in IN O
a DT O
patient NN O
with IN O
AAS NNP B-Disease
phenotype NN O
, , O
has VBZ O
been VBN O
identified VBN O
and CC O
found VBN O
to TO O
encode VB O
a DT O
protein NN O
with IN O
homology NN O
to TO O
Rho NNP O
/ NNP O
Rac NNP O
guanine NNP O
nucleotide IN O
exchange NN O
factors NNS O
( ( O
Rho NNP O
/ NNP O
Rac NNP O
GEF NNP O
) ) O
. . O

However RB O
, , O
since IN O
this DT O
original JJ O
report NN O
on IN O
identification NN O
of IN O
a DT O
mutated VBN O
FGD1 NNP O
gene NN O
in IN O
an DT O
AAS NNP B-Disease
patient NN O
, , O
no DT O
additional JJ O
mutations NNS O
in IN O
the DT O
FGD1 NNP O
gene NN O
have VBP O
been VBN O
described VBN O
. . O

We PRP O
analysed VBD O
13 CD O
independent JJ O
patients NNS O
with IN O
clinical JJ O
diagnosis NN O
of IN O
AAS NNP B-Disease
. . O

One CD O
patient NN O
presented VBD O
a DT O
mutation NN O
that WDT O
results NNS O
in IN O
a DT O
nucleotide JJ O
change NN O
in IN O
exon JJ O
10 CD O
of IN O
the DT O
FGD1 NNP O
gene NN O
( ( O
G2559 NNP O
> NNP O
A NNP O
) ) O
substituting VBG O
a DT O
Gln NNP O
for IN O
Arg NNP O
in IN O
position NN O
610 CD O
. . O

The DT O
mutation NN O
was VBD O
found VBN O
to TO O
segregate VB O
with IN O
the DT O
AAS NNP B-Disease
phenotype NN O
in IN O
affected JJ O
males NNS O
and CC O
carrier NN O
females NNS O
in IN O
the DT O
family NN O
of IN O
this DT O
patient NN O
. . O

Interestingly RB O
, , O
Arg NNP O
- : O
610 CD O
is VBZ O
located VBN O
within IN O
one CD O
of IN O
the DT O
two CD O
pleckstrin NN O
homology NN O
( ( O
PH NNP O
) ) O
domains VBZ O
of IN O
the DT O
FGD1 NNP O
gene NN O
and CC O
it PRP O
corresponds VBZ O
to TO O
a DT O
highly RB O
conserved VBN O
residue NN O
which WDT O
has VBZ O
been VBN O
involved VBN O
in IN O
InsP NNP O
binding NN O
in IN O
PH NNP O
domains NNS O
of IN O
other JJ O
proteins NNS O
. . O

The DT O
same JJ O
residue NN O
is VBZ O
often RB O
mutated VBN O
in IN O
the DT O
Brutons NNP O
tyrosine NN O
kinase NN O
( ( O
Btk NNP O
) ) O
gene NN O
in IN O
patients NNS O
with IN O
an DT O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
agammaglobulinemia NN I-Disease
. . O

The DT O
Arg610Gln NNP O
mutation NN O
represents VBZ O
the DT O
first JJ O
case NN O
of IN O
a DT O
mutation NN O
in IN O
the DT O
PH NNP O
domain NN O
of IN O
the DT O
FGD1 NNP O
gene NN O
and CC O
additional JJ O
evidence NN O
that IN O
mutations NNS O
in IN O
PH NNP O
domains NNS O
can MD O
be VB O
associated VBN O
to TO O
human JJ O
diseases NNS O
. . O
. . O

Amino NNP O
- : O
terminal JJ O
fragments NNS O
of IN O
mutant JJ O
huntingtin NN O
show NN O
selective JJ O
accumulation NN O
in IN O
striatal JJ O
neurons NNS O
and CC O
synaptic JJ O
toxicity NN O
. . O

Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
expansion NN O
of IN O
a DT O
glutamine JJ O
repeat NN O
in IN O
the DT O
amino NN O
- : O
terminal JJ O
region NN O
of IN O
huntingtin NN O
. . O

Despite IN O
its PRP$ O
widespread JJ O
expression NN O
, , O
mutant JJ O
huntingtin NN O
induces NNS O
selective JJ O
neuronal JJ O
loss NN O
in IN O
striatal JJ O
neurons NNS O
. . O

Here RB O
we PRP O
report VBP O
that DT O
, , O
in IN O
mutant JJ O
mice NN O
expressing VBG O
HD NNP B-Disease
repeats NNS O
, , O
the DT O
production NN O
and CC O
aggregation NN O
of IN O
N NNP O
- : O
terminal NN O
huntingtin NN O
fragments NNS O
preferentially RB O
occur VBP O
in IN O
HD NNP B-Disease
- : O
affected JJ O
neurons NNS O
and CC O
their PRP$ O
processes NNS O
and CC O
axonal JJ O
terminals NNS O
. . O

N NNP O
- : O
terminal JJ O
fragments NNS O
of IN O
mutant JJ O
huntingtin NN O
form NN O
aggregates NNS O
and CC O
induce VB O
neuritic JJ B-Disease
degeneration NN I-Disease
in IN O
cultured JJ O
striatal JJ O
neurons NNS O
. . O

N NNP O
- : O
terminal NN O
mutant NN O
huntingtin NN O
also RB O
binds VBZ O
to TO O
synaptic JJ O
vesicles NNS O
and CC O
inhibits NNS O
their PRP$ O
glutamate JJ O
uptake NN O
in IN O
vitro NN O
. . O

The DT O
specific JJ O
processing NN O
and CC O
accumulation NN O
of IN O
toxic JJ O
fragments NNS O
of IN O
N NNP O
- : O
terminal NN O
huntingtin NN O
in IN O
HD NNP B-Disease
- : O
affected VBD O
striatal JJ O
neurons NNS O
, , O
especially RB O
in IN O
their PRP$ O
neuronal JJ O
processes NNS O
and CC O
axonal JJ O
terminals NNS O
, , O
may MD O
contribute VB O
to TO O
the DT O
selective JJ O
neuropathology NN O
of IN O
HD NNP B-Disease
. . O
. . O

BRCA1 NNP O
is VBZ O
associated VBN O
with IN O
a DT O
human JJ O
SWI NNP O
/ NNP O
SNF NNP O
- : O
related VBN O
complex JJ O
: : O
linking VBG O
chromatin NN O
remodeling VBG O
to TO O
breast VB B-Disease
cancer NN I-Disease
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
BRCA1 NNP O
, , O
predispose JJ O
individuals NNS O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

Using VBG O
a DT O
combination NN O
of IN O
affinity NN O
- : O
and CC O
conventional JJ O
chromatographic JJ O
techniques NNS O
, , O
we PRP O
have VBP O
isolated VBN O
a DT O
predominant JJ O
form NN O
of IN O
a DT O
multiprotein NN O
BRCA1 NNP O
- : O
containing VBG O
complex JJ O
from IN O
human JJ O
cells NNS O
displaying VBG O
chromatin NN O
- : O
remodeling NN O
activity NN O
. . O

Mass NNP O
spectrometric JJ O
sequencing NN O
of IN O
components NNS O
of IN O
this DT O
complex JJ O
indicated VBD O
that IN O
BRCA1 NNP O
is VBZ O
associated VBN O
with IN O
a DT O
SWI NNP O
/ NNP O
SNF NNP O
- : O
related VBN O
complex JJ O
. . O

We PRP O
show VBP O
that IN O
BRCA1 NNP O
can MD O
directly RB O
interact VB O
with IN O
the DT O
BRG1 NNP O
subunit NN O
of IN O
the DT O
SWI NNP O
/ NNP O
SNF NNP O
complex NN O
. . O

Moreover RB O
, , O
p53 SYM O
- : O
mediated JJ O
stimulation NN O
of IN O
transcription NN O
by IN O
BRCA1 NNP O
was VBD O
completely RB O
abrogated VBN O
by IN O
either CC O
a DT O
dominant JJ O
- : O
negative JJ O
mutant NN O
of IN O
BRG1 NNP O
or CC O
the DT O
cancer NN B-Disease
- : O
causing VBG O
deletion NN O
in IN O
exon JJ O
11 CD O
of IN O
BRCA1 NNP O
. . O

These DT O
findings NNS O
reveal VBP O
a DT O
direct JJ O
function NN O
for IN O
BRCA1 NNP O
in IN O
transcriptional JJ O
control NN O
through IN O
modulation NN O
of IN O
chromatin NN O
structure NN O
. . O
. . O

Asef NNP O
, , O
a DT O
link NN O
between IN O
the DT O
tumor NN B-Disease
suppressor NN O
APC NNP O
and CC O
G NNP O
- : O
protein NN O
signaling NN O
. . O

The DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NNS I-Disease
gene NN O
( ( O
APC NNP O
) ) O
is VBZ O
mutated VBN O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
and CC O
in IN O
sporadic JJ O
colorectal JJ B-Disease
tumors NNS I-Disease
. . O

Here RB O
the DT O
APC NNP B-Disease
gene NN O
product NN O
is VBZ O
shown VBN O
to TO O
bind VB O
through IN O
its PRP$ O
armadillo JJ O
repeat NN O
domain NN O
to TO O
a DT O
Rac NNP O
- : O
specific JJ O
guanine NN O
nucleotide JJ O
exchange NN O
factor NN O
( ( O
GEF NNP O
) ) O
, , O
termed VBD O
Asef NNP O
. . O

Endogenous JJ O
APC NNP O
colocalized VBD O
with IN O
Asef NNP O
in IN O
mouse NN O
colon NN O
epithelial JJ O
cells NNS O
and CC O
neuronal JJ O
cells NNS O
. . O

Furthermore RB O
, , O
APC NNP O
enhanced VBD O
the DT O
GEF NNP O
activity NN O
of IN O
Asef NNP O
and CC O
stimulated VBD O
Asef NNP O
- : O
mediated VBN O
cell NN O
flattening NN O
, , O
membrane NN O
ruffling NN O
, , O
and CC O
lamellipodia JJS O
formation NN O
in IN O
MDCK NNP O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
APC NNP O
- : O
Asef NNP O
complex NN O
may MD O
regulate VB O
the DT O
actin NN O
cytoskeletal JJ O
network NN O
, , O
cell NN O
morphology NN O
and CC O
migration NN O
, , O
and CC O
neuronal JJ O
function NN O
. . O
. . O

Function NN O
of IN O
an DT O
axonal JJ O
chemoattractant NN O
modulated VBN O
by IN O
metalloprotease NN O
activity NN O
. . O

The DT O
axonal JJ O
chemoattractant NN O
netrin SYM O
- : O
1 CD O
guides NNS O
spinal JJ O
commissural JJ O
axons NNS O
by IN O
activating VBG O
its PRP$ O
receptor NN O
DCC NNP O
( ( O
Deleted VBN O
in IN O
Colorectal NNP B-Disease
Cancer NNP I-Disease
) ) O
. . O

We PRP O
have VBP O
found VBN O
that IN O
chemical JJ O
inhibitors NNS O
of IN O
metalloproteases NNS O
potentiate VBP O
netrin JJ O
- : O
mediated VBN O
axon JJ O
outgrowth NN O
in IN O
vitro NN O
. . O

We PRP O
have VBP O
also RB O
found VBN O
that IN O
DCC NNP O
is VBZ O
a DT O
substrate NN O
for IN O
metalloprotease NN O
- : O
dependent NN O
ectodomain NN O
shedding NN O
, , O
and CC O
that IN O
the DT O
inhibitors NNS O
block VBP O
proteolytic JJ O
processing NN O
of IN O
DCC NNP O
and CC O
cause VB O
an DT O
increase NN O
in IN O
DCC NNP O
protein NN O
levels NNS O
on IN O
axons NNS O
within IN O
spinal JJ O
cord NN O
explants NNS O
. . O

Thus RB O
, , O
potentiation NN O
of IN O
netrin JJ O
activity NN O
by IN O
inhibitors NNS O
may MD O
result VB O
from IN O
stabilization NN O
of IN O
DCC NNP O
on IN O
the DT O
axons NNS O
, , O
and CC O
proteolytic JJ O
activity NN O
may MD O
regulate VB O
axon NNS O
migration NN O
by IN O
controlling VBG O
the DT O
number NN O
of IN O
functional JJ O
extracellular JJ O
axon NN O
guidance NN O
receptors NNS O
. . O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
in IN O
transgenic JJ O
mice NN O
expressing VBG O
an DT O
expanded VBN O
CUG NNP O
repeat NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
, , O
the DT O
most RBS O
common JJ O
form NN O
of IN O
muscular JJ B-Disease
dystrophy NN I-Disease
in IN O
adult NN O
humans NNS O
, , O
results NNS O
from IN O
expansion NN O
of IN O
a DT O
CTG NNP O
repeat NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
the DT O
DMPK NNP O
gene NN O
. . O

The DT O
mutant JJ O
DMPK NNP O
messenger NN O
RNA NNP O
( ( O
mRNA NN O
) ) O
contains VBZ O
an DT O
expanded JJ O
CUG NNP O
repeat NN O
and CC O
is VBZ O
retained VBN O
in IN O
the DT O
nucleus NN O
. . O

We PRP O
have VBP O
expressed VBN O
an DT O
untranslated JJ O
CUG NNP O
repeat NN O
in IN O
an DT O
unrelated JJ O
mRNA NN O
in IN O
transgenic JJ O
mice NN O
. . O

Mice NNP O
that WDT O
expressed VBD O
expanded VBD O
CUG NNP O
repeats NNS O
developed VBD O
myotonia NN B-Disease
and CC O
myopathy NN B-Disease
, , O
whereas JJ O
mice NN O
expressing VBG O
a DT O
nonexpanded JJ O
repeat NN O
did VBD O
not RB O
. . O

Thus RB O
, , O
transcripts NNS O
with IN O
expanded JJ O
CUG NNP O
repeats NNS O
are VBP O
sufficient JJ O
to TO O
generate VB O
a DT O
DM NNP B-Disease
phenotype NN O
. . O

This DT O
result NN O
supports VBZ O
a DT O
role NN O
for IN O
RNA NNP O
gain NN O
of IN O
function NN O
in IN O
disease NN O
pathogenesis NN O
. . O
. . O

Genomic JJ O
rearrangements NNS O
of IN O
the DT O
APC NNP B-Disease
tumor NN I-Disease
- : O
suppressor NN O
gene NN O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
. . O

Germline NNP O
mutations NNS O
of IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( I-Disease
APC NNP I-Disease
) ) I-Disease
tumor NN I-Disease
- : O
suppressor NN O
gene NN O
result NN O
in IN O
the DT O
hereditary JJ B-Disease
colorectal NN I-Disease
cancer NN I-Disease
syndrome VBP I-Disease
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
. . O

Almost RB O
all DT O
APC NNP B-Disease
mutations NNS O
that WDT O
have VBP O
been VBN O
identified VBN O
are VBP O
single JJ O
- : O
nucleotide JJ O
alterations NNS O
, , O
small JJ O
insertions NNS O
, , O
or CC O
small JJ O
deletions NNS O
that WDT O
would MD O
truncate VB O
the DT O
protein JJ O
product NN O
of IN O
the DT O
gene NN O
. . O

No DT O
well NN O
- : O
characterized VBN O
intragenic JJ O
rearrangement NN O
of IN O
APC NNP O
has VBZ O
been VBN O
described VBN O
, , O
and CC O
the DT O
prevalence NN O
of IN O
this DT O
type NN O
of IN O
mutation NN O
in IN O
FAP NNP B-Disease
patients NNS O
is VBZ O
not RB O
clear JJ O
. . O

We PRP O
screened VBD O
49 CD O
potential JJ O
FAP NNP B-Disease
families NNS O
and CC O
identified VBD O
26 CD O
different JJ O
germline NN O
APC NNP B-Disease
mutations NNS O
in IN O
30 CD O
families NNS O
. . O

Four CD O
of IN O
these DT O
mutations NNS O
were VBD O
genomic JJ O
rearrangements NNS O
resulting VBG O
from IN O
homologous JJ O
and CC O
nonhomologous JJ O
recombinations NNS O
mediated VBN O
by IN O
Alu NNP O
elements NNS O
. . O

Two CD O
of IN O
these DT O
four CD O
rearrangements NNS O
were VBD O
complex JJ O
, , O
involving VBG O
deletion NN O
and CC O
insertion NN O
of IN O
nucleotides NNS O
. . O

Of IN O
these DT O
four CD O
rearrangements NNS O
, , O
one CD O
resulted VBD O
in IN O
the DT O
deletion NN O
of IN O
exons NNS O
11 CD O
and CC O
12 CD O
and CC O
two CD O
others NNS O
resulted VBD O
in IN O
either CC O
complete JJ O
or CC O
partial JJ O
deletion NN O
of IN O
exon $ O
14 CD O
. . O

The DT O
fourth JJ O
rearrangement NN O
grossly RB O
altered VBD O
the DT O
sequence NN O
within IN O
intron $ O
14 CD O
. . O

Although IN O
this DT O
rearrangement NN O
did VBD O
not RB O
affect VB O
any DT O
coding VBG O
sequence NN O
of IN O
APC NNP O
at IN O
the DT O
genomic JJ O
DNA NNP O
level NN O
, , O
it PRP O
caused VBD O
inappropriate JJ O
splicing NN O
of IN O
exon $ O
14 CD O
. . O

These DT O
rearrangements NNS O
were VBD O
initially RB O
revealed VBN O
by IN O
analyzing VBG O
cDNAs NN O
and CC O
could MD O
not RB O
have VB O
been VBN O
identified VBN O
by IN O
using VBG O
mutation NN O
detection NN O
methods NNS O
that WDT O
screened VBD O
each DT O
exon NN O
individually RB O
. . O

The DT O
identification NN O
of IN O
a DT O
rearrangement NN O
that WDT O
did VBD O
not RB O
alter VB O
any DT O
coding NN O
exons NNS O
yet RB O
affected VBD O
the DT O
splicing VBG O
further JJ O
underscores NNS O
the DT O
importance NN O
of IN O
using VBG O
cDNA NN O
for IN O
mutation NN O
analysis NN O
. . O

The DT O
identification NN O
of IN O
four CD O
genomic JJ O
rearrangements NNS O
among IN O
30 CD O
mutations NNS O
suggests VBZ O
that IN O
genomic JJ O
rearrangements NNS O
are VBP O
frequent JJ O
germline NN O
APC NNP B-Disease
mutations NNS O
. . O
. . O

Detection NN O
of IN O
a DT O
novel JJ O
missense NN O
mutation NN O
and CC O
second JJ O
recurrent NN O
mutation NN O
in IN O
the DT O
CACNA1A NNP O
gene NN O
in IN O
individuals NNS O
with IN O
EA NNP B-Disease
- : I-Disease
2 CD I-Disease
and CC O
FHM NNP B-Disease
. . O

Mutations NNS O
in IN O
the DT O
brain NN O
specific JJ O
P NNP O
/ NNP O
Q NNP O
type NN O
Ca2 NNP O
+ NNP O
channel NN O
alpha1 NN O
subunit NN O
gene NN O
, , O
CACNA1A NNP O
, , O
have VBP O
been VBN O
identified VBN O
in IN O
three CD O
clinically RB O
distinct JJ O
disorders NNS O
, , O
viz NN O
. . O
episodic JJ B-Disease
ataxia JJ I-Disease
type NN I-Disease
2 CD I-Disease
( ( O
EA NNP B-Disease
- : I-Disease
2 CD I-Disease
) ) O
, , O
familial JJ B-Disease
hemiplegic NN I-Disease
migraine NN I-Disease
( ( O
FHM NNP B-Disease
) ) O
and CC O
spinocerebellar JJ B-Disease
ataxia NN I-Disease
6 CD I-Disease
( ( O
SCA6 NNP B-Disease
) ) O
. . O

For IN O
individuals NNS O
with IN O
EA NNP B-Disease
- : I-Disease
2 CD I-Disease
, , O
the DT O
mutations NNS O
described VBD O
thus RB O
far RB O
are VBP O
presumed VBN O
to TO O
result VB O
in IN O
a DT O
truncated JJ O
protein NN O
product NN O
. . O

Several JJ O
different JJ O
missense NN O
mutations NNS O
have VBP O
been VBN O
identified VBN O
in IN O
patients NNS O
with IN O
FHM NNP B-Disease
. . O

At IN O
least JJS O
two CD O
of IN O
these DT O
mutations NNS O
have VBP O
been VBN O
identified VBN O
on IN O
two CD O
different JJ O
chromosome NN O
19p13 CD O
haplotypes NNS O
and CC O
thus RB O
represent VB O
recurrent JJ O
mutations NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
screened VBN O
several JJ O
individuals NNS O
for IN O
mutations NNS O
in IN O
all DT O
47 CD O
exons NNS O
in IN O
the DT O
CACNA1A NNP O
gene NN O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
analysis NN O
. . O

We PRP O
have VBP O
characterised VBN O
a DT O
novel JJ O
missense NN O
mutation NN O
, , O
G5260A NNP O
, , O
in IN O
exon JJ O
32 CD O
in IN O
a DT O
family NN O
segregating VBG O
for IN O
EA NNP B-Disease
- : I-Disease
2 CD I-Disease
. . O

The DT O
consequence NN O
of IN O
this DT O
mutation NN O
is VBZ O
an DT O
amino JJ O
acid NN O
substitution NN O
at IN O
a DT O
highly RB O
conserved VBN O
position NN O
within IN O
the DT O
CACNA1A NNP O
gene NN O
. . O

This DT O
represents VBZ O
the DT O
first JJ O
point NN O
mutation NN O
not RB O
resulting VBG O
in IN O
a DT O
proposed VBN O
truncated VBN O
protein NN O
. . O

Furthermore RB O
, , O
this DT O
mutation NN O
has VBZ O
been VBN O
detected VBN O
in IN O
a DT O
family NN O
member NN O
with IN O
mild JJ O
clinical JJ O
signs NNS O
including VBG O
only RB O
migraine NN B-Disease
. . O

Additionally RB O
, , O
a DT O
second JJ O
previously RB O
identified VBN O
recurrent NN O
muta NN O
tion NN O
, , O
C2272T NNP O
, , O
in IN O
exon JJ O
16 CD O
has VBZ O
been VBN O
discovered VBN O
in IN O
a DT O
patient NN O
with IN O
FHM NNP B-Disease
. . O
. . O

Analbuminemia NNP B-Disease
in IN O
a DT O
neonate NN O
. . O

A DT O
small JJ O
- : O
for IN O
- : O
gestational JJ O
- : O
age NN O
infant NN O
, , O
found VBN O
to TO O
have VB O
analbuminemia VBN B-Disease
in IN O
the DT O
neonatal JJ O
period NN O
, , O
is VBZ O
reported VBN O
and CC O
the DT O
twelve NN O
cases NNS O
recorded VBN O
in IN O
the DT O
world NN O
literature NN O
are VBP O
reviewed VBN O
. . O

Patients NNS O
lacking VBG O
this DT O
serum NN O
protein NN O
are VBP O
essentially RB O
asymptomatic JJ O
, , O
apart RB O
from IN O
minimal JJ O
ankle NN B-Disease
edema NN I-Disease
and CC O
ease NN B-Disease
of IN I-Disease
fatigue NN I-Disease
. . O

Apparent JJ O
compensatory NN O
mechanisms NNS O
which WDT O
come VBP O
into IN O
play NN O
when WRB O
serum NN O
albumin NN O
is VBZ O
low JJ O
include VBP O
prolonged VBN O
half NN O
- : O
life NN O
of IN O
albumin NN O
and CC O
transferrin NN O
, , O
an DT O
increase NN O
in IN O
serum JJ O
globulins NNS O
, , O
beta NN O
lipoprotein NN O
, , O
and CC O
glycoproteins NNS O
, , O
arterial JJ B-Disease
hypotension NN I-Disease
with IN O
reduced JJ O
capillary JJ O
hydrostatic JJ O
pressure NN O
, , O
and CC O
the DT O
ability NN O
to TO O
respond VB O
with IN O
rapid JJ O
sodium NN O
and CC O
chloride JJ O
diuresis NN O
in IN O
response NN O
to TO O
small JJ O
volume NN O
changes NNS O
. . O

Examination NN O
of IN O
plasma NN O
amino NN O
acids NNS O
, , O
an DT O
investigation NN O
not RB O
previously RB O
reported VBN O
, , O
revealed VBD O
an DT O
extremely RB O
low JJ O
plasma NN O
tryptophan NN O
level NN O
, , O
a DT O
finding NN O
which WDT O
may MD O
be VB O
important JJ O
in IN O
view NN O
of IN O
the DT O
role NN O
of IN O
tryptophan NN O
in IN O
albumin JJ O
synthesis NN O
. . O
. . O

Histidinemia NNP B-Disease
. . O

Classical JJ O
and CC O
atypical JJ O
form NN O
in IN O
siblings NNS O
. . O

Two CD O
brothers NNS O
, , O
6 CD O
and CC O
13 CD O
years NNS O
old JJ O
, , O
had VBD O
histidinemia NN B-Disease
. . O

On IN O
the DT O
basis NN O
of IN O
clinical JJ O
and CC O
biochemical JJ O
observations NNS O
, , O
the DT O
younger JJR O
boy NN O
was VBD O
considered VBN O
to TO O
have VB O
a DT O
classical JJ O
type NN O
of IN O
the DT O
disease NN O
, , O
while IN O
the DT O
older JJR O
boy NN O
had VBD O
an DT O
atypical JJ O
form NN O
characterized VBN O
by IN O
partial JJ O
impairment NN O
of IN O
the DT O
skin JJ O
histidase NN O
activity NN O
and CC O
a DT O
moderately RB O
prolonged JJ O
half NN O
- : O
life NN O
of IN O
blood NN O
histidine NN O
. . O

The DT O
mother NN O
is VBZ O
a DT O
heterozygous JJ O
carrier NN O
, , O
while IN O
the DT O
father NN O
and CC O
sister NN O
seem VBP O
to TO O
be VB O
normal JJ O
. . O
. . O

Carrier NNP O
detection NN O
of IN O
pyruvate JJ B-Disease
carboxylase NN I-Disease
deficiency NN I-Disease
in IN O
fibroblasts NNS O
and CC O
lymphocytes NNS O
. . O

Pyruvate NNP O
carboxylase NN O
( ( O
E NNP O
. . O
C NNP O
. . O
6 CD O
. . O
4 CD O
. . O
1 CD O
. . O
1 CD O
) ) O
activity NN O
was VBD O
determined VBN O
in IN O
the DT O
circulating VBG O
peripheral JJ O
lymphocytes NNS O
and CC O
cultured VBD O
skin JJ O
fibroblasts NNS O
from IN O
the DT O
family NN O
of IN O
a DT O
patient NN O
with IN O
hepatic JJ O
, , O
cerebral JJ O
, , O
renal JJ O
cortical NN O
, , O
leukocyte NN O
, , O
and CC O
fibroblast JJ O
pyruvate NN B-Disease
carboxylase NN I-Disease
deficiency NN I-Disease
( ( O
PC NN B-Disease
Portland NNP I-Disease
deficiency NN I-Disease
) ) O
. . O

Lymphocyte JJ O
activities NNS O
were VBD O
mother RB O
, , O
33 CD O
- : O
- : O
39 CD O
% NN O
; : O
father CC O
, , O
11 CD O
- : O
- : O
29 CD O
% NN O
; : O
brother CC O
, , O
82 CD O
- : O
- : O
103 CD O
% NN O
; : O
and CC O
sister NN O
, , O
38 CD O
- : O
- : O
48 CD O
% NN O
of IN O
the DT O
lowest JJS O
normal JJ O
. . O

Fibroblasts NNS O
from IN O
the DT O
patients NNS O
mother NN O
and CC O
father NN O
had VBD O
42 CD O
and CC O
34 CD O
% NN O
, , O
respectively RB O
, , O
of IN O
the DT O
activity NN O
of IN O
the DT O
lowest JJS O
normal JJ O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
the DT O
disease NN O
is VBZ O
inherited VBN O
in IN O
an DT O
autosomal JJ O
recessive JJ O
manner NN O
and CC O
that IN O
lymphocytes NNS O
and CC O
fibroblasts NNS O
can MD O
be VB O
used VBN O
to TO O
detect VB O
carriers NNS O
. . O

Neither DT O
pyruvate NN O
carboxylase NN O
nor CC O
mitochondrial JJ O
PEPCK NNP O
activity NN O
in IN O
lymphocytes NNS O
was VBD O
increased VBN O
by IN O
a DT O
21 CD O
- : O
hr NN O
fast NN O
. . O

Glucose NNP O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variants NNS O
from IN O
Italian JJ O
subjects NNS O
associated VBN O
with IN O
severe JJ B-Disease
neonatal JJ I-Disease
jaundice NN I-Disease
. . O

Screening VBG O
for IN O
the DT O
G6PD NNP B-Disease
deficiency NN I-Disease
was VBD O
carried VBN O
out RP O
at IN O
the DT O
Maternity NNP O
Division NNP O
of IN O
the DT O
Galliera NNP O
Hospital NNP O
in IN O
Genoa NNP O
, , O
Italy NNP O
. . O

Two CD O
groups NNS O
of IN O
subjects NNS O
with IN O
hyperbilirubinaemia NN B-Disease
of IN O
non JJ O
- : O
immunological JJ O
origin NN O
were VBD O
examined VBN O
( ( O
a DT O
) ) O
302 CD O
newborn JJ O
babies NNS O
of IN O
Sardinian JJ O
extraction NN O
( ( O
on IN O
cord NN O
blood NN O
) ) O
and CC O
( ( O
b NN O
) ) O
201 CD O
newborn JJ O
babies NNS O
of IN O
south JJ O
Italian JJ O
ancestry NN O
( ( O
on IN O
peripheral JJ O
blood NN O
) ) O
. . O

Among IN O
503 CD O
subjects NNS O
, , O
43 CD O
showed VBD O
an DT O
enzyme JJ O
deficiency NN O
; : O
in IN O
39 CD O
the DT O
defect NN O
was VBD O
of IN O
the DT O
Mediterranean NNP O
type NN O
. . O

In IN O
one CD O
case NN O
, , O
previously RB O
described VBN O
, , O
the DT O
enzyme NN O
was VBD O
of IN O
the DT O
A NNP O
- : O
type NN O
. . O

In IN O
the DT O
remaining VBG O
cases NNS O
three CD O
different JJ O
variants NNS O
were VBD O
identified VBN O
. . O

In IN O
the DT O
present JJ O
work NN O
these DT O
three CD O
cases NNS O
, , O
each DT O
with IN O
severe JJ B-Disease
neonatal JJ I-Disease
jaundice NN I-Disease
, , O
are VBP O
reported VBN O
. . O

Their PRP$ O
parents NNS O
originated VBN O
from IN O
Calabria NNP O
, , O
from IN O
Sardinia NNP O
and CC O
from IN O
Sicily NNP O
. . O

The DT O
abnormal JJ O
enzymes NNS O
are VBP O
respectively RB O
designated VBN O
as IN O
GdDcbrousse NNP O
- : O
like IN O
, , O
GdGallura NNP O
and CC O
GdAgrigento NNP O
. . O
. . O

Cytogenetic JJ O
investigations NNS O
in IN O
families NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

Chromosomal JJ O
studies NNS O
were VBD O
performed VBN O
on IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
and CC O
cultured VBD O
skin JJ O
fibroblasts NNS O
from IN O
five CD O
Israeli NNP O
- : O
Moroccan JJ O
families NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

A DT O
total NN O
of IN O
24 CD O
individuals NNS O
, , O
including VBG O
seven CD O
propositi NN O
, , O
was VBD O
investigated VBN O
. . O

Among IN O
the DT O
probands NNS O
, , O
significantly RB O
elevated VBN O
rates NNS O
of IN O
chromosome NN O
damage NN O
were VBD O
observed VBN O
in IN O
both DT O
blood NN O
and CC O
skin NN O
. . O

Skin NNP O
fibroblasts NNS O
of IN O
affected JJ O
individuals NNS O
showed VBD O
several JJ O
orders NNS O
of IN O
magnitude NN O
more RBR O
chromosome NN O
breakage NN O
than IN O
lymphocytes NNS O
. . O

Increased VBN O
rates NNS O
of IN O
chromosome NN O
damage NN O
were VBD O
also RB O
observed VBN O
in IN O
the DT O
fibroblasts NNS O
of IN O
some DT O
phenotypically RB O
normal JJ O
family NN O
members NNS O
( ( O
obligate JJ O
heterozygotes NNS O
and CC O
sibs NN O
) ) O
when WRB O
compared VBN O
to TO O
normal JJ O
controls NNS O
. . O

An DT O
apparent JJ O
abnormal JJ O
clone NN O
of IN O
cells NNS O
, , O
possessing VBG O
a DT O
large JJ O
acrocentric JJ O
marker NN O
chromosome NN O
( ( O
14q CD O
+ NN O
) ) O
, , O
was VBD O
observed VBN O
in IN O
varying VBG O
proportions NNS O
among IN O
cells NNS O
of IN O
all PDT O
the DT O
propositi NN O
( ( O
2 CD O
- : O
5 CD O
% NN O
of IN O
lymphocytes NNS O
; : O
1 CD O
- : O
9 CD O
% NN O
of IN O
fibroblasts NNS O
) ) O
. . O
. . O

Prenatal JJ O
diagnosis NN O
of IN O
Wolman NNP B-Disease
disease NN I-Disease
. . O

Two CD O
pregnancies NNS O
at IN O
risk NN O
for IN O
Wolman NNP B-Disease
disease NN I-Disease
were VBD O
monitored VBN O
by IN O
assay NN O
and CC O
electrophoresis NN O
of IN O
acid JJ O
lipase NN O
in IN O
cultured JJ O
amniotic JJ O
- : O
fluid NN O
cells NNS O
. . O

Cells NNS O
from IN O
patient JJ O
1 CD O
had VBD O
5 CD O
% NN O
of IN O
control NN O
levels NNS O
of IN O
acid NN O
lipase NN O
, , O
using VBG O
14C CD O
- : O
triolein NN O
as IN O
substrate NN O
; : O
however RB O
, , O
when WRB O
artificial JJ O
substrates NNS O
( ( O
esters NNS O
of IN O
4 CD O
- : O
methylumbelliferone NN O
and CC O
p NN O
- : O
nitrophenol NN O
) ) O
were VBD O
used VBN O
to TO O
measure VB O
acid JJ O
lipase NN O
, , O
these DT O
cells NNS O
had VBD O
30 CD O
% NN O
of IN O
control NN O
levels NNS O
. . O

Electrophoresis NN O
of IN O
cell NN O
extracts NNS O
revealed VBD O
the DT O
absence NN O
of IN O
the DT O
A NNP O
form NN O
of IN O
acid JJ O
lipase NN O
, , O
consistent JJ O
with IN O
the DT O
diagnosis NN O
of IN O
Wolman NNP B-Disease
disease NN I-Disease
. . O

Analysis NN O
of IN O
fetal JJ O
tissues NNS O
following VBG O
prostaglandin JJ O
termination NN O
of IN O
this DT O
pregnancy NN O
confirmed VBD O
the DT O
diagnosis NN O
. . O

Assay NNP O
of IN O
fetal JJ O
- : O
skin NN O
fibroblasts NNS O
with IN O
14C CD O
- : O
triolein NN O
, , O
as RB O
well RB O
as IN O
with IN O
artificial JJ O
substrates NNS O
, , O
showed VBD O
marked JJ O
deficiency NN O
of IN O
acid JJ O
lipase NN O
activity NN O
. . O

Electrophoresis NN O
of IN O
fetal JJ O
- : O
tissue NN O
extracts NNS O
also RB O
demonstrated VBD O
the DT O
absence NN O
of IN O
the DT O
A NNP O
form NN O
of IN O
acid JJ O
lipase NN O
. . O

Amniotic JJ O
- : O
fluid NN O
cells NNS O
from IN O
patient NN O
2 CD O
showed VBD O
normal JJ O
levels NNS O
of IN O
acid JJ O
lipase NN O
with IN O
all DT O
substrates NNS O
tested VBN O
; : O
the DT O
electrophoretic JJ O
pattern NN O
of IN O
acid JJ O
lipase NN O
was VBD O
normal JJ O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
prenatal JJ O
diagnosis NN O
of IN O
Wolman NNP B-Disease
disease NN I-Disease
be VB O
made VBN O
using VBG O
the DT O
radioassay NN O
of IN O
acid JJ O
lipase NN O
and CC O
/ NN O
or CC O
electrophoresis NN O
. . O
. . O

Malignant JJ B-Disease
neoplasms NNS I-Disease
in IN O
the DT O
families NNS O
of IN O
patients NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
syndrome NN I-Disease
associated VBN O
with IN O
a DT O
greatly RB O
increased JJ O
incidence NN O
of IN O
malignant JJ B-Disease
neoplasms NNS I-Disease
in IN O
homozygous JJ O
affected JJ O
individuals NNS O
. . O

Heterozygotes NNS O
for IN O
the DT O
gene NN O
for IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
are VBP O
thought VBN O
to TO O
comprise VB O
about RB O
1 CD O
% NN O
of IN O
the DT O
general JJ O
population NN O
and CC O
, , O
therefore RB O
, , O
it PRP O
is VBZ O
important JJ O
to TO O
know VB O
whether IN O
this DT O
gene NN O
also RB O
predisposes VBZ O
the DT O
heterozygous JJ O
carrier NN O
to TO O
cancers NNS B-Disease
. . O

Heterozygous JJ O
carriers NNS O
of IN O
this DT O
gene NN O
are VBP O
common JJ O
among IN O
the DT O
close JJ O
relatives NNS O
of IN O
patients NNS O
with IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
, , O
although IN O
individual JJ O
carriers NNS O
cannot VBP O
be VB O
identified VBN O
by IN O
any DT O
clinical JJ O
criterion NN O
or CC O
laboratory JJ O
test NN O
. . O

For IN O
this DT O
reason NN O
, , O
we PRP O
compared VBN O
the DT O
incidence NN O
of IN O
death NN O
from IN O
malignant JJ B-Disease
neoplasms NNS I-Disease
in IN O
2 CD O
families NNS O
of IN O
patients NNS O
with IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
to TO O
that DT O
expected VBN O
in IN O
a DT O
random JJ O
sample NN O
of IN O
the DT O
general JJ O
population NN O
. . O

There EX O
were VBD O
59 CD O
deaths NNS O
from IN O
malignant JJ B-Disease
neoplasms NNS I-Disease
in IN O
relatives NNS O
dying VBG O
before IN O
age NN O
75 CD O
, , O
compared VBN O
to TO O
42 CD O
. . O

6 CD O
expected VBN O
( ( O
p NN O
less JJR O
than IN O
0 CD O
. . O
2 CD O
) ) O
. . O

For IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
heterozygotes VBZ O
younger JJR O
than IN O
age NN O
45 CD O
, , O
the DT O
risk NN O
of IN O
dying VBG O
from IN O
a DT O
malignant JJ B-Disease
neoplasm NN I-Disease
was VBD O
estimated VBN O
to TO O
be VB O
greater JJR O
than IN O
5 CD O
times NNS O
the DT O
risk NN O
for IN O
the DT O
general JJ O
population NN O
. . O

A DT B-Disease
- : I-Disease
T NN I-Disease
heterozygotes NNS O
may MD O
comprise VB O
more JJR O
than IN O
5 CD O
% NN O
of IN O
all DT O
persons NNS O
dying VBG O
from IN O
a DT O
cancer NN B-Disease
before IN O
age NN O
45 CD O
. . O

The DT O
incidence NN O
of IN O
ovarian JJ B-Disease
, , I-Disease
gastric JJ I-Disease
, , I-Disease
and CC I-Disease
biliary JJ I-Disease
system NN I-Disease
carcinomas NN I-Disease
and CC O
of IN O
leukemia NN B-Disease
and CC O
lymphoma NN B-Disease
was VBD O
increased VBN O
in IN O
these DT O
A NNP B-Disease
- : I-Disease
T NN I-Disease
families NNS O
. . O

Other JJ O
neoplasms NNS B-Disease
that WDT O
may MD O
be VB O
associated VBN O
with IN O
this DT O
gene NN O
in IN O
heterozygotes NNS O
include VBP O
pancreatic JJ B-Disease
, , I-Disease
basal NN I-Disease
cell NN I-Disease
, , I-Disease
colonic NN I-Disease
, , I-Disease
breast NN I-Disease
, , I-Disease
and CC I-Disease
cervical JJ I-Disease
carcinomas NN I-Disease
. . O

Striking VBG O
prevalence NN O
of IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
in IN O
"""" NNP O
healthy JJ O
"""" NNP O
w27 NN O
positive JJ O
males NNS O
and CC O
females NNS O
. . O

Ankylosing VBG B-Disease
spondylitis NN I-Disease
is VBZ O
diagnosed VBN O
once RB O
or CC O
twice RB O
in IN O
each DT O
1000 CD O
males NNS O
and CC O
one CD O
tenth NN O
as IN O
frequently RB O
in IN O
females NNS O
, , O
but CC O
the DT O
true JJ O
prevalence NN O
is VBZ O
unknown JJ O
. . O

Indentification NN O
of IN O
genetic JJ O
marker NN O
, , O
HL NNP O
- : O
A DT O
W27 NNP O
, , O
for IN O
susceptible JJ O
persons NNS O
has VBZ O
provided VBN O
a DT O
tool NN O
facilitating VBG O
epidemiologic JJ O
studies NNS O
and CC O
allowing VBG O
identification NN O
of IN O
"""" NNP O
control NN O
"""" NNP O
populations NNS O
without IN O
the DT O
marker NN O
. . O

Evaluation NN O
by IN O
postal JJ O
questionnaires NNS O
, , O
and CC O
pelvic JJ O
radiography NN O
of IN O
78 CD O
HL NNP O
- : O
A DT O
27W CD O
- : O
positive JJ O
blood NN O
donors NNS O
selected VBD O
from IN O
a DT O
group NN O
of IN O
apparently RB O
healthy JJ O
subjects NNS O
revealed VBD O
14 CD O
who WP O
satisfied VBD O
the DT O
criteria NNS O
for IN O
definite NN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
. . O

The DT O
prevalence NN O
was VBD O
similar JJ O
in IN O
both DT O
sexes NNS O
. . O

One CD O
hundred CD O
and CC O
twenty VB O
- : O
six CD O
W27 NNP O
- : O
negative JJ O
controls NNS O
matched VBN O
for IN O
race NN O
, , O
sex NN O
, , O
and CC O
age NN O
failed VBD O
to TO O
yield VB O
a DT O
single JJ O
case NN O
. . O

For IN O
a DT O
person NN O
of IN O
either DT O
sex NN O
with IN O
HL NNP O
- : O
A DT O
W27 NNP O
, , O
there EX O
appears VBZ O
to TO O
be VB O
about IN O
a DT O
20 CD O
per IN O
cent NN O
chance NN O
that IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
will MD O
develop VB O
, , O
suggesting VBG O
a DT O
prevalence NN O
of IN O
10 CD O
to TO O
15 CD O
per IN O
thousand NN O
. . O

Hitherto NNP O
accepted VBD O
figures NNS O
may MD O
underestimate VB O
the DT O
frequency NN O
by IN O
a DT O
factor NN O
of IN O
10 CD O
to TO O
20 CD O
. . O
. . O

Analbuminemia NNP B-Disease
in IN O
an DT O
American JJ O
Indian JJ O
girl NN O
. . O

Analbuminemia NNP B-Disease
was VBD O
fortuitously RB O
detected VBN O
in IN O
a DT O
nonedematous JJ O
12 CD O
- : O
year NN O
- : O
old JJ O
American JJ O
Indian NNP O
girl NN O
with IN O
atopic NN B-Disease
dermatitis NN I-Disease
, , O
mild JJ O
bronchial JJ B-Disease
asthma NN I-Disease
, , O
a DT O
mild JJ O
seizure NN B-Disease
disorder NN I-Disease
, , O
and CC O
hyperlipoproteinemia NN B-Disease
with IN O
a DT O
corneal JJ B-Disease
arcus NN I-Disease
. . O

Immunologic NNP O
methods NNS O
revealed VBD O
trace NN O
amounts NNS O
( ( O
17 CD O
mg NN O
/ VBD O
100 CD O
ml NN O
) ) O
of IN O
apparently RB O
normal JJ O
serum JJ O
albumin NN O
. . O

The DT O
patients NNS O
parents NNS O
were VBD O
remotely RB O
related VBN O
. . O

The DT O
pedigree NN O
and CC O
clinical JJ O
findings NNS O
were VBD O
compatible JJ O
with IN O
autosomal JJ O
recessive JJ O
transmission NN O
of IN O
analbuminemia NN B-Disease
. . O

Heterozygotes NNS O
had VBD O
subnormal JJ O
levels NNS O
of IN O
serum NN O
albumin NN O
. . O

The DT O
Gc NNP O
- : O
locus NN O
is VBZ O
closely RB O
linked VBN O
to TO O
the DT O
structural JJ O
albumin NN O
locus NN O
. . O

Gc NNP O
- : O
protein NN O
levels NNS O
were VBD O
normal JJ O
in IN O
the DT O
patient NN O
and CC O
together RB O
with IN O
normal JJ O
chromosomal JJ O
banding NN O
studies NNS O
make VBP O
it PRP O
unlikely JJ O
that IN O
a DT O
chromosomal JJ O
deletion NN O
caused VBD O
analbuminemia NN B-Disease
. . O

Gc NNP O
- : O
types NNS O
in IN O
the DT O
family NN O
were VBD O
compatible JJ O
with IN O
, , O
but CC O
did VBD O
not RB O
prove VB O
, , O
linkage NN O
of IN O
analbuminemia NN B-Disease
to TO O
the DT O
Gc NNP O
- : O
locus NN O
. . O

These DT O
findings NNS O
suggest VBP O
a DT O
"""" JJ O
thalassemia NN B-Disease
"""" SYM O
- : O
like IN O
mutation NN O
for IN O
this DT O
disorder NN O
. . O
. . O

Deletion NN O
of IN O
the DT O
KIT NNP O
and CC O
PDGFRA NNP O
genes NNS O
in IN O
a DT O
patient NN O
with IN O
piebaldism NN B-Disease
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
human JJ O
piebaldism NN B-Disease
results NNS O
from IN O
mutations NNS O
of IN O
the DT O
KIT NNP O
gene NN O
, , O
which WDT O
encodes VBZ O
the DT O
receptor NN O
for IN O
the DT O
mast NN O
/ JJ O
stem NN O
cell NN O
growth NN O
factor NN O
and CC O
is VBZ O
located VBN O
in IN O
chromosome NN O
segment NN O
4q12 CD O
. . O

Using VBG O
DNA NNP O
of IN O
a DT O
patient NN O
with IN O
piebaldism NN B-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
multiple JJ B-Disease
congenital JJ I-Disease
anomalies NNS I-Disease
associated VBN O
with IN O
a DT O
46 CD O
, , O
XY NNP O
, , O
del NN O
( ( O
4 CD O
) ) O
( ( O
q12q21 UH O
. . O
1 CD O
) ) O
karyotype NN O
, , O
we PRP O
carried VBD O
out RP O
quantitative JJ O
Southern NNP O
blot NN O
hybridization NN O
analyses NNS O
of IN O
the DT O
KIT NNP O
gene NN O
and CC O
the DT O
adjacent JJ O
PDGFRA NNP O
( ( O
platelet VB O
- : O
derived VBN O
growth NN O
factor NN O
receptor NN O
alpha IN O
subunit NN O
) ) O
genes NNS O
. . O

The DT O
patient NN O
was VBD O
hemizygous JJ O
for IN O
both DT O
the DT O
KIT NNP O
and CC O
PDGFRA NNP O
genes NNS O
, , O
indicating VBG O
that IN O
both DT O
of IN O
these DT O
genes NNS O
are VBP O
included VBN O
within IN O
the DT O
deleted JJ O
region NN O
. . O

Therefore RB O
, , O
deletion NN O
of IN O
the DT O
KIT NNP O
and CC O
PDGFRA NNP O
genes NNS O
may MD O
account VB O
for IN O
the DT O
piebald NN B-Disease
phenotype NN O
in IN O
this DT O
patient NN O
. . O

A DT O
germ JJ O
line NN O
mutation NN O
within IN O
the DT O
coding NN O
sequence NN O
for IN O
the DT O
putative JJ O
5 CD O
- : O
phosphoribosyl NN O
- : O
1 CD O
- : O
pyrophosphate NN O
binding VBG O
site NN O
of IN O
hypoxanthine JJ O
- : O
guanine NN O
phosphoribosyltransferase NN O
( ( O
HPRT NNP O
) ) O
in IN O
a DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan JJ I-Disease
patient NN O
: : O
missense NN O
mutations NNS O
within IN O
a DT O
functionally RB O
important JJ O
region NN O
probably RB O
cause NN O
disease NN O
. . O

Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
caused VBN O
by IN O
a DT O
complete JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
hypoxanthine JJ I-Disease
guanine NN I-Disease
phosphoribosyltransferase NN I-Disease
( ( O
HPRT NNP O
) ) O
is VBZ O
the DT O
result NN O
of IN O
a DT O
heterogeneous JJ O
group NN O
of IN O
germ JJ O
line NN O
mutations NNS O
. . O

Identification NN O
of IN O
each DT O
mutant JJ O
gene NN O
provides VBZ O
valuable JJ O
information NN O
as IN O
to TO O
the DT O
type NN O
of IN O
mutation NN O
that WDT O
occurs VBZ O
spontaneously RB O
. . O

We PRP O
report VBP O
here RB O
a DT O
newly RB O
identified VBN O
HPRT NNP O
mutation NN O
in IN O
a DT O
Japanese JJ O
patient NN O
with IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

This DT O
gene NN O
, , O
designated VBN O
HPRT NNP O
Tokyo NNP O
, , O
had VBD O
a DT O
single JJ O
nucleotide JJ O
change NN O
from IN O
G NNP O
to TO O
A NNP O
, , O
as IN O
identified VBN O
by IN O
sequencing VBG O
cDNA NN O
amplified VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
. . O

Allele NNP O
specific JJ O
oligonucleotide JJ O
hybridization NN O
analysis NN O
using VBG O
amplified JJ O
genomic JJ O
DNA NN O
showed VBD O
that IN O
the DT O
mutant JJ O
gene NN O
was VBD O
transmitted VBN O
from IN O
the DT O
maternal JJ O
germ NN O
line NN O
. . O

This DT O
mutation NN O
would MD O
lead VB O
to TO O
an DT O
amino NN O
acid JJ O
substitution NN O
of IN O
Asp NNP O
for IN O
Gly NNP O
at IN O
the DT O
amino NN O
acid JJ O
position NN O
140 CD O
located VBN O
within IN O
the DT O
putative JJ O
5 CD O
- : O
phosphoribosyl NN O
- : O
1 CD O
- : O
pyrophosphate NN O
( ( O
PRPP NNP O
) ) O
binding VBG O
region NN O
. . O

Missense JJ O
mutations NNS O
in IN O
human JJ O
HPRT NNP B-Disease
deficient NN I-Disease
patients NNS O
thus RB O
far RB O
reported JJ O
tend VBP O
to TO O
accumulate VB O
in IN O
this DT O
functionally RB O
active JJ O
region NN O
. . O

However RB O
, , O
a DT O
comparison NN O
of IN O
the DT O
data NNS O
suggested VBD O
that IN O
both DT O
missense NN O
and CC O
synonymous JJ O
mutations NNS O
can MD O
occur VB O
at IN O
any DT O
coding VBG O
sequence NN O
of IN O
the DT O
human JJ O
germ NN O
line NN O
HPRT NNP O
gene NN O
, , O
but CC O
that IN O
a DT O
limited JJ O
percentage NN O
of IN O
all PDT O
the DT O
missense JJ O
mutations NNS O
cause VBP O
disease NN O
. . O

The DT O
probability NN O
that IN O
a DT O
mutation NN O
will MD O
cause VB O
disease NN O
tends VBZ O
to TO O
be VB O
higher JJR O
when WRB O
the DT O
missense NN O
mutation NN O
is VBZ O
within IN O
a DT O
functionally RB O
important JJ O
sequence NN O
. . O
. . O

Characterisation NN O
of IN O
a DT O
new JJ O
rare JJ O
fragile JJ O
site NN O
easily RB O
confused VBN O
with IN O
the DT O
fragile JJ B-Disease
X NN I-Disease
. . O

A DT O
new JJ O
fragile JJ O
site NN O
( ( O
FRAXE NNP O
) ) O
in IN O
Xq28 NNP O
is VBZ O
described VBN O
. . O

It PRP O
appears VBZ O
to TO O
be VB O
a DT O
typical JJ O
folate NN O
sensitive JJ O
fragile JJ O
site NN O
. . O

The DT O
fragile JJ O
site NN O
is VBZ O
not RB O
associated VBN O
with IN O
mental JJ B-Disease
retardation NN I-Disease
, , O
it PRP O
does VBZ O
not RB O
give VB O
abnormal JJ O
results NNS O
when WRB O
subjected VBN O
to TO O
Southern NNP O
analysis NN O
with IN O
probe NN O
pfxa3 NN O
which WDT O
detects VBZ O
the DT O
unstable JJ O
DNA NNP O
sequence NN O
characteristic NN O
of IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
. . O

In IN O
situ JJ O
hybridization NN O
mapping NN O
locates VBZ O
the DT O
fragile JJ O
site NN O
between IN O
150 CD O
kb NNS O
and CC O
600 CD O
kb NNS O
distal JJ O
to TO O
FRAXA NNP O
. . O

The DT O
distinction NN O
between IN O
the DT O
two CD O
fragile NN O
sites NNS O
is VBZ O
important JJ O
clinically RB O
since IN O
cytogenetic JJ O
detection NN O
of IN O
FRAXE NNP O
, , O
without IN O
molecular JJ O
analysis NN O
, , O
could MD O
result VB O
in IN O
misdiagnosis NN O
of IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
. . O
. . O

The DT O
Norrie NNP B-Disease
disease NN I-Disease
gene NN O
maps NNS O
to TO O
a DT O
150 CD O
kb JJ O
region NN O
on IN O
chromosome NN O
Xp11 NNP O
. . O
3 CD O
. . O

Norrie NNP B-Disease
disease NN I-Disease
is VBZ O
a DT O
human JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
recessive JJ I-Disease
disorder NN I-Disease
of IN O
unknown JJ O
etiology NN O
characterized VBN O
by IN O
congenital JJ B-Disease
blindness NN I-Disease
, , O
sensory JJ B-Disease
neural JJ I-Disease
deafness NN I-Disease
and CC O
mental JJ B-Disease
retardation NN I-Disease
. . O

This DT O
disease NN O
gene NN O
was VBD O
previously RB O
linked VBN O
to TO O
the DT O
DXS7 NNP O
( ( O
L1 NNP O
. . O
28 CD O
) ) O
locus NN O
and CC O
the DT O
MAO NNP O
genes NNS O
in IN O
band NN O
Xp11 NNP O
. . O

3 CD O
3 CD O
. . O

We PRP O
report VBP O
here RB O
fine JJ O
physical JJ O
mapping NN O
of IN O
the DT O
obligate JJ O
region NN O
containing VBG O
the DT O
Norrie NNP B-Disease
disease NN I-Disease
gene NN O
( ( O
NDP NNP O
) ) O
defined VBN O
by IN O
a DT O
recombination NN O
and CC O
by IN O
the DT O
smallest JJS O
submicroscopic NN O
chromosomal JJ O
deletion NN O
associated VBN O
with IN O
Norrie NNP B-Disease
disease NN I-Disease
identified VBD O
to TO O
date NN O
. . O

Analysis NN O
, , O
using VBG O
in IN O
addition NN O
two CD O
overlapping VBG O
YAC NNP O
clones NNS O
from IN O
this DT O
region NN O
, , O
allowed VBN O
orientation NN O
of IN O
the DT O
MAOA NNP O
and CC O
MAOB NNP O
genes NNS O
in IN O
a DT O
5 CD O
- : O
3 CD O
- : O
3 CD O
- : O
5 CD O
configuration NN O
. . O

A DT O
recombination NN O
event NN O
between IN O
a DT O
( ( O
GT NNP O
) ) O
n VBP O
polymorphism NN O
in IN O
intron NN O
2 CD O
of IN O
the DT O
MAOB NNP O
gene NN O
and CC O
the DT O
NDP NNP O
locus NN O
, , O
in IN O
a DT O
family NN O
previously RB O
reported VBN O
to TO O
have VB O
a DT O
recombination NN O
between IN O
DXS7 NNP O
and CC O
NDP NNP O
, , O
delineates VBZ O
a DT O
flanking NN O
marker NN O
telomeric NN O
to TO O
this DT O
disease NN O
gene NN O
. . O

An DT O
anonymous JJ O
DNA NN O
probe NN O
, , O
dc12 NN O
, , O
present NN O
in IN O
one CD O
of IN O
the DT O
YACs NNP O
and CC O
in IN O
a DT O
patient NN O
with IN O
a DT O
submicroscopic NN O
deletion NN O
which WDT O
includes VBZ O
MAOA NNP O
and CC O
MAOB NNP O
but CC O
not RB O
L1 NNP O
. . O

28 CD O
, , O
serves VBZ O
as IN O
a DT O
flanking NN O
marker NN O
centromeric NN O
to TO O
the DT O
disease NN O
gene NN O
. . O

An DT O
Alu NNP O
- : O
PCR NNP O
fragment NN O
from IN O
the DT O
right JJ O
arm NN O
of IN O
the DT O
MAO NNP O
YAC NNP O
( ( O
YMAO NNP O
. . O
AluR NNP O
) ) O
is VBZ O
not RB O
deleted VBN O
in IN O
this DT O
patient NN O
and CC O
also RB O
delineates VBZ O
the DT O
centromeric JJ O
extent NN O
of IN O
the DT O
obligate JJ O
disease NN O
region NN O
. . O

The DT O
apparent JJ O
order NN O
of IN O
these DT O
loci NN O
is VBZ O
telomere RB O
. . O

DXS7 NNP O
- : O
MAOA NNP O
- : O
MAOB NNP O
- : O
NDP NNP O
- : O
dc12 NN O
- : O
YMAO NN O
DXS7 NNP O
- : O
MAOA NNP O
- : O
MAOB NNP O
- : O
NDP NNP O
- : O
dc12 NN O
- : O
YMAO NN O
. . O

AluR NNP O
. . O
centromere NN O
. . O

Together RB O
these DT O
data NNS O
define VBP O
the DT O
obligate JJ O
region NN O
containing VBG O
the DT O
NDP NNP O
gene NN O
to TO O
a DT O
chromosomal JJ O
segment NN O
less JJR O
than IN O
150 CD O
kb NN O
. . O

Molecular JJ O
basis NN O
of IN O
phenylketonuria NNS B-Disease
and CC O
related JJ O
hyperphenylalaninemias NN B-Disease
: : O
mutations NNS O
and CC O
polymorphisms NNS O
in IN O
the DT O
human JJ O
phenylalanine NN O
hydroxylase NN O
gene NN O
. . O

Mutations NNS O
in IN O
the DT O
human JJ O
phenylalanine NN O
hydroxylase NN O
gene NN O
producing VBG O
phenylketonuria NNS B-Disease
or CC O
hyperphenylalaninemia NNS B-Disease
have VBP O
now RB O
been VBN O
identified VBN O
in IN O
many JJ O
patients NNS O
from IN O
various JJ O
ethnic JJ O
groups NNS O
. . O

These DT O
mutations NNS O
all DT O
exhibit VBP O
a DT O
high JJ O
degree NN O
of IN O
association NN O
with IN O
specific JJ O
restriction NN O
fragment NN O
- : O
length NN O
polymorphism NN O
haplotypes NNS O
at IN O
the DT O
PAH NNP O
locus NN O
. . O

About IN O
50 CD O
of IN O
these DT O
mutations NNS O
are VBP O
single JJ O
- : O
base NN O
substitutions NNS O
, , O
including VBG O
six CD O
nonsense JJ O
mutations NNS O
and CC O
eight CD O
splicing VBG O
mutations NNS O
, , O
with IN O
the DT O
remainder NN O
being VBG O
missense JJ O
mutations NNS O
. . O

One CD O
splicing VBG O
mutation NN O
results NNS O
in IN O
a DT O
3 CD O
amino NN O
acid NN O
in IN O
- : O
frame NN O
insertion NN O
. . O

Two CD O
or CC O
3 CD O
large JJ O
deletions NNS O
, , O
2 CD O
single JJ O
codon NN O
deletions NNS O
, , O
and CC O
2 CD O
single JJ O
base NN O
deletions NNS O
have VBP O
been VBN O
found VBN O
. . O

Twelve NN O
of IN O
the DT O
missense NN O
mutations NNS O
apparently RB O
result VBP O
from IN O
the DT O
methylation NN O
and CC O
subsequent JJ O
deamination NN O
of IN O
highly RB O
mutagenic JJ O
CpG NNP O
dinucleotides NNS O
. . O

Recurrent JJ O
mutation NN O
has VBZ O
been VBN O
observed VBN O
at IN O
several JJ O
of IN O
these DT O
sites NNS O
, , O
producing VBG O
associations NNS O
with IN O
different JJ O
haplotypes NNS O
in IN O
different JJ O
populations NNS O
. . O

About IN O
half NN O
of IN O
all DT O
missense NN O
mutations NNS O
have VBP O
been VBN O
examined VBN O
by IN O
in IN O
vitro JJ O
expression NN O
analysis NN O
, , O
and CC O
a DT O
significant JJ O
correlation NN O
has VBZ O
been VBN O
observed VBN O
between IN O
residual JJ O
PAH NNP O
activity NN O
and CC O
disease NN O
phenotype NN O
. . O

Since IN O
continuing VBG O
advances NNS O
in IN O
molecular JJ O
methodologies NNS O
have VBP O
dramatically RB O
accelerated VBN O
the DT O
rate NN O
in IN O
which WDT O
new JJ O
mutations NNS O
are VBP O
being VBG O
identified VBN O
and CC O
characterized VBN O
, , O
this DT O
register NN O
of IN O
mutations NNS O
will MD O
be VB O
updated VBN O
periodically RB O
. . O
. . O

A DT O
glycine250 NN O
- : O
- : O
> NN O
aspartate JJ O
substitution NN O
in IN O
the DT O
alpha NN O
- : O
subunit NN O
of IN O
hexosaminidase NN O
A NNP O
causes VBZ O
juvenile JJ O
- : O
onset NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
in IN O
a DT O
Lebanese JJ O
- : O
Canadian JJ O
family NN O
. . O

The DT O
mutation NN O
causing VBG O
juvenile NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
in IN O
two CD O
sibs NN O
of IN O
Lebanese NNP O
- : O
Maronite NNP O
origin NN O
is VBZ O
described VBN O
. . O

An DT O
mRNA NN O
- : O
containing VBG O
extract NN O
of IN O
cultured JJ O
fibroblasts NNS O
obtained VBD O
from IN O
one CD O
of IN O
the DT O
probands NNS O
was VBD O
used VBN O
as IN O
a DT O
template NN O
to TO O
amplify VB O
the DT O
coding VBG O
sequence NN O
of IN O
the DT O
hexosaminidase NN O
A NNP O
( ( O
Hex NNP O
A NNP O
) ) O
alpha SYM O
- : O
subunit NN O
. . O

Sequencing VBG O
of IN O
amplified JJ O
cDNA NN O
fragments NNS O
revealed VBD O
a DT O
single JJ O
alteration NN O
, , O
guanine NN O
to TO O
adenine VB O
at IN O
nt JJ O
749 CD O
creating VBG O
a DT O
G250D NNP O
mutation NN O
. . O

The DT O
mutation NN O
introduces VBZ O
a DT O
new JJ O
recognition NN O
site NN O
for IN O
the DT O
restriction NN O
enzyme VBZ O
Eco NNP O
RV NNP O
, , O
permitting VBG O
identification NN O
of IN O
heterozygotes NNS O
for IN O
this DT O
allele NN O
following VBG O
PCR NNP O
amplification NN O
and CC O
Eco NNP O
RV NNP O
digestion NN O
of IN O
exon $ O
7 CD O
sequences NNS O
from IN O
genomic JJ O
DNA NNP O
templates NNS O
. . O

In IN O
order NN O
to TO O
test VB O
the DT O
effect NN O
of IN O
this DT O
substitution NN O
, , O
an DT O
in IN O
vitro NN O
mutagenized VBN O
cDNA NN O
construct NN O
was VBD O
introduced VBN O
into IN O
a DT O
mammalian JJ O
expression NN O
vector NN O
and CC O
transfected VBD O
into IN O
monkey JJ O
Cos NNP O
- : O
1 CD O
cells NNS O
separately RB O
or CC O
along RB O
with IN O
a DT O
beta NN O
- : O
cDNA NN O
expression NN O
vector NN O
. . O

When WRB O
the DT O
mutant NN O
alpha SYM O
- : O
cDNA NN O
was VBD O
the DT O
only JJ O
gene NN O
introduced VBD O
into IN O
COS NNP O
cells NNS O
no DT O
enzymatic JJ O
activity NN O
above IN O
endogenous JJ O
COS NNP O
cell NN O
activity NN O
was VBD O
detected VBN O
. . O

Cotransfection NN O
of IN O
normal JJ O
alpha JJ O
- : O
cDNA NN O
and CC O
beta NN O
- : O
cDNA NN O
followed VBN O
by IN O
immunoprecipitation NN O
of IN O
human JJ O
Hex NNP O
A NNP O
resulted VBD O
in IN O
20 CD O
- : O
fold JJ O
increase NN O
in IN O
the DT O
ratio NN O
between IN O
positive JJ O
and CC O
negative JJ O
( ( O
mock JJ O
transfection NN O
) ) O
control NN O
values NNS O
. . O

This DT O
allowed VBD O
the DT O
detection NN O
of IN O
some DT O
residual JJ O
activity NN O
( ( O
12 CD O
% NN O
of IN O
the DT O
positive JJ O
control NN O
) ) O
when WRB O
the DT O
mutant NN O
alpha SYM O
- : O
cDNA NN O
replaced VBD O
its PRP$ O
wild JJ O
- : O
type NN O
counterpart NN O
. . O

The DT O
predicted JJ O
protein NN O
environment NN O
in IN O
which WDT O
the DT O
mutation NN O
occurs VBZ O
is VBZ O
compared VBN O
to TO O
that DT O
of IN O
the DT O
adult NN O
- : O
onset NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
mutation NN O
caused VBN O
by IN O
a DT O
Gly269 NNP O
- : O
- : O
> NN O
Ser NNP O
substitution NN O
in IN O
exon JJ O
7 CD O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O
. . O

Novel NNP O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
mutations NNS O
from IN O
China NNP O
. . O

We PRP O
describe VBP O
three CD O
HEXA NNP O
mutations NNS O
associated VBN O
with IN O
infantile JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
in IN O
three CD O
unrelated JJ O
nonconsanguineous JJ O
Chinese JJ O
families NNS O
. . O

Novel JJ O
mutations NNS O
were VBD O
found VBN O
in IN O
two CD O
of IN O
these DT O
families NNS O
. . O

The DT O
third JJ O
is VBZ O
a DT O
previously RB O
reported VBN O
mutation NN O
( ( O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
at IN O
nt JJ O
1444 CD O
) ) O
( ( O
Nakano NNP O
et RB O
al RB O
. . O
, , O
1988 CD O
) ) O
. . O

Direct JJ O
sequencing NN O
of IN O
PCR NNP O
products NNS O
identified VBD O
a DT O
novel JJ O
insertion NN O
of IN O
an DT O
A NNP O
after IN O
nt JJ O
547 CD O
in IN O
family NN O
1 CD O
. . O

This DT O
change NN O
generates VBZ O
an DT O
early JJ O
termination NN O
codon VBZ O
6 CD O
bp NN O
downstream NN O
from IN O
the DT O
insertion NN O
site NN O
. . O

Allele NNP O
- : O
specific JJ O
oligonucleotide JJ O
hybridization NN O
confirmed VBD O
homozygosity NN O
in IN O
the DT O
proband NN O
. . O

Single NNP O
strand VBP O
conformational JJ O
polymorphism NN O
analysis NN O
and CC O
direct JJ O
sequencing NN O
of IN O
amplified JJ O
exon NN O
13 CD O
revealed VBD O
a DT O
T NNP O
- : O
- : O
> NN O
C NNP O
transition NN O
at IN O
nt JJ O
1453 CD O
with IN O
the DT O
corresponding VBG O
amino NN O
acid JJ O
substitution NN O
W485R NNP O
in IN O
the DT O
second JJ O
family NN O
. . O

This DT O
mutation NN O
creates VBZ O
an DT O
Fnu4HI NNP O
restriction NN O
site NN O
. . O

The DT O
proband NN O
is VBZ O
homozygous JJ O
for IN O
this DT O
allele NN O
. . O

When WRB O
the DT O
site NN O
- : O
specific JJ O
mutagenized VBN O
alpha JJ O
cDNA NN O
carrying VBG O
the DT O
T NNP O
- : O
- : O
> NN O
C NNP O
transition NN O
at IN O
nt JJ O
1453 CD O
was VBD O
expressed VBN O
in IN O
COS NNP O
1 CD O
cells NNS O
hexosaminidase JJ O
S NNP O
activity NN O
was VBD O
not RB O
detectable JJ O
above IN O
background NN O
. . O

A DT O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
at IN O
nt JJ O
1444 CD O
( ( O
exon VB O
13 CD O
) ) O
corresponding NN O
to TO O
the DT O
E482K NNP O
substitution NN O
was VBD O
found VBN O
in IN O
the DT O
third JJ O
family NN O
. . O

This DT O
mutation NN O
occurs VBZ O
at IN O
a DT O
CpG NNP O
dinucleotide NN O
. . O

It PRP O
has VBZ O
been VBN O
reported VBN O
in IN O
an DT O
Italian JJ O
TSD NNP B-Disease
proband NN O
and CC O
causes VBZ O
defective JJ O
intracellular JJ O
transport NN O
of IN O
the DT O
alpha JJ O
- : O
subunit NN O
from IN O
the DT O
rough JJ O
endoplasmic JJ O
reticulum NN O
to TO O
the DT O
Golgi NNP O
apparatus NN O
. . O

Two CD O
missense JJ O
mutations NNS O
causing VBG O
mild JJ O
hyperphenylalaninemia NN B-Disease
associated VBN O
with IN O
DNA NNP O
haplotype NN O
12 CD O
. . O

The DT O
genetic JJ B-Disease
defects NNS I-Disease
responsible JJ O
for IN O
most JJS O
phenylketonuria NNS B-Disease
( ( O
PKU NNP B-Disease
) ) O
and CC O
hyperphenylalaninemia NN B-Disease
( ( O
HPA NNP B-Disease
) ) O
cases NNS O
are VBP O
located VBN O
in IN O
the DT O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
gene NN O
. . O

Approximately RB O
50 CD O
- : O
60 CD O
mutations NNS O
have VBP O
been VBN O
reported VBN O
in IN O
Caucasians NNPS O
and CC O
are VBP O
reflected VBN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
clinical JJ O
severities NNS O
. . O

Most JJS O
mutations NNS O
are VBP O
linked VBN O
to TO O
specific JJ O
haplotypes NNS O
, , O
as IN O
defined VBN O
by IN O
eight CD O
polymorphic JJ O
restriction NN O
sites NNS O
in IN O
the DT O
PAH NNP O
gene NN O
. . O

We PRP O
hypothesized VBD O
that IN O
there EX O
is VBZ O
at IN O
least JJS O
one CD O
mild JJ O
mutation NN O
linked VBD O
to TO O
haplotype VB O
12 CD O
in IN O
the DT O
Swedish JJ O
PKU NNP B-Disease
/ NNP O
HPA NNP B-Disease
population NN O
, , O
since IN O
7 CD O
of IN O
8 CD O
patients NNS O
carrying VBG O
haplotype JJ O
12 CD O
had VBD O
mild VBN O
HPA NNP B-Disease
. . O

Sequence NN O
analysis NN O
revealed VBD O
a DT O
C NNP O
- : O
to TO O
- : O
G NNP O
transversion NN O
at IN O
the DT O
second JJ O
base NN O
of IN O
codon NN O
322 CD O
, , O
resulting VBG O
in IN O
a DT O
substitution NN O
of IN O
glycine NN O
for IN O
alanine NN O
, , O
in IN O
four CD O
mutant NN O
haplotype NN O
12 CD O
genes NNS O
, , O
and CC O
a DT O
G NNP O
- : O
to TO O
- : O
A DT O
transition NN O
at IN O
the DT O
second JJ O
base NN O
of IN O
codon NN O
408 CD O
, , O
resulting VBG O
in IN O
a DT O
substitution NN O
of IN O
glutamine NN O
for IN O
arginine NN O
, , O
in IN O
another DT O
three CD O
mutant NN O
haplotype VBD O
12 CD O
genes NNS O
. . O

These DT O
mutations NNS O
segregated VBD O
with IN O
mutant JJ O
haplotype NN O
12 CD O
alleles NNS O
in IN O
nuclear JJ O
families NNS O
but CC O
were VBD O
not RB O
present JJ O
on IN O
normal JJ O
or CC O
other JJ O
mutant JJ O
alleles NNS O
. . O

Both DT O
mutations NNS O
were VBD O
tested VBN O
in IN O
a DT O
eukaryotic JJ O
expression NN O
system NN O
in IN O
which WDT O
enzyme JJ O
activities NNS O
of IN O
different JJ O
mutant JJ O
PAH NNP O
enzymes NNS O
reflect VBP O
the DT O
relative JJ O
severities NNS O
of IN O
the DT O
mutations NNS O
, , O
although IN O
these DT O
in IN O
vitro NN O
activities NNS O
cannot VBP O
be VB O
translated VBN O
directly RB O
into IN O
in IN O
vivo JJ O
hepatic JJ O
activities NNS O
. . O

The DT O
A322G NNP O
mutant NN O
PAH NNP O
had VBD O
about IN O
75 CD O
% NN O
and CC O
the DT O
R408Q NNP O
mutant NN O
PAH NNP O
about IN O
55 CD O
% NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
PAH NNP O
enzyme NN O
activity NN O
. . O

These DT O
in IN O
vitro NN O
activities NNS O
are VBP O
the DT O
highest JJS O
reported VBD O
for IN O
mutant JJ O
PAH NNP O
enzymes NNS O
produced VBD O
in IN O
the DT O
same JJ O
expression NN O
system NN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O
. . O

In IN O
vitro NN O
and CC O
in IN O
vivo JJ O
correlations NNS O
for IN O
I65T NNP O
and CC O
M1V NNP O
mutations NNS O
at IN O
the DT O
phenylalanine NN O
hydroxylase NN O
locus NN O
. . O

Mutations NNS O
at IN O
the DT O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
locus NN O
are VBP O
the DT O
major JJ O
cause NN O
of IN O
hyperphenylalaninemia NN B-Disease
. . O

We PRP O
have VBP O
previously RB O
described VBN O
four CD O
mutations NNS O
( ( O
M1V NNP O
, , O
IVS12nt1 NNP O
, , O
R408W NNP O
, , O
and CC O
S349P NNP O
) ) O
at IN O
the DT O
PAH NNP O
locus NN O
in IN O
French JJ O
Canadians NNPS O
with IN O
ancestry NN O
in IN O
eastern JJ O
Quebec NNP O
. . O

Here RB O
we PRP O
report VBP O
( ( O
1 CD O
) ) O
identification NN O
of IN O
another DT O
mutation NN O
, , O
on IN O
a DT O
haplotype NN O
9 CD O
chromosome NN O
, , O
which WDT O
converts VBZ O
codon NN O
65 CD O
from IN O
isoleucine NN O
( ( O
ATT NNP O
) ) O
to TO O
threonine VB O
( ( O
ACT NNP O
) ) O
, , O
( ( O
2 CD O
) ) O
expression NN O
analysis NN O
of IN O
the DT O
I65T NNP O
mutation NN O
in IN O
COS NNP O
cells NNS O
demonstrating VBG O
75 CD O
% NN O
loss NN O
of IN O
both DT O
immunoreactive JJ O
protein NN O
and CC O
enzyme NN O
activity NN O
, , O
and CC O
( ( O
3 CD O
) ) O
expression NN O
analysis NN O
of IN O
the DT O
most RBS O
prevalent JJ O
PKU NNP B-Disease
allele NN O
( ( O
M1V NNP O
) ) O
in IN O
eastern JJ O
Quebec NNP O
, , O
showing VBG O
nondetectable JJ O
levels NNS O
of IN O
PAH NNP O
protein NN O
and CC O
activity NN O
, , O
a DT O
finding NN O
compatible JJ O
with IN O
a DT O
mutation NN O
in IN O
the DT O
translation NN O
initiation NN O
codon NN O
. . O

Homozygosity NN O
for IN O
M1V NNP O
and CC O
codominant JJ O
inheritance NN O
of IN O
I65T NNP O
/ NNP O
R408W NNP O
were VBD O
both DT O
associated VBN O
with IN O
classical JJ B-Disease
phenylketonuria NN I-Disease
. . O
. . O

Molecular JJ O
basis NN O
of IN O
hexosaminidase NN B-Disease
A NNP I-Disease
deficiency NN I-Disease
and CC O
pseudodeficiency NN O
in IN O
the DT O
Berks NNP O
County NNP O
Pennsylvania NNP O
Dutch NNP O
. . O

Following VBG O
the DT O
birth NN O
of IN O
two CD O
infants NNS O
with IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
, , O
a DT O
non JJ O
- : O
Jewish NN O
, , O
Pennsylvania NNP O
Dutch NNP O
kindred VBD O
was VBD O
screened VBN O
for IN O
TSD NNP B-Disease
carriers NNS O
using VBG O
the DT O
biochemical JJ O
assay NN O
. . O

A DT O
high JJ O
frequency NN O
of IN O
individuals NNS O
who WP O
appeared VBD O
to TO O
be VB O
TSD NNP B-Disease
heterozygotes NNS O
was VBD O
detected VBN O
( ( O
Kelly NNP O
et VBZ O
al NN O
. . O
, , O
1975 CD O
) ) O
. . O

Clinical JJ O
and CC O
biochemical JJ O
evidence NN O
suggested VBD O
that IN O
the DT O
increased VBN O
carrier NN O
frequency NN O
was VBD O
due JJ O
to TO O
at IN O
least JJS O
two CD O
altered JJ O
alleles NNS O
for IN O
the DT O
hexosaminidase NN O
A NNP O
alpha NN O
- : O
subunit NN O
. . O

We PRP O
now RB O
report VBP O
two CD O
mutant JJ O
alleles NNS O
in IN O
this DT O
Pennsylvania NNP O
Dutch NNP O
kindred VBD O
, , O
and CC O
one CD O
polymorphism NN O
. . O

One CD O
allele NN O
, , O
reported VBD O
originally RB O
in IN O
a DT O
French JJ O
TSD NNP B-Disease
patient NN O
( ( O
Akli NNP O
et RB O
al RB O
. . O
, , O
1991 CD O
) ) O
, , O
is VBZ O
a DT O
GT NNP O
- : O
- : O
> NN O
AT NNP O
transition NN O
at IN O
the DT O
donor NN O
splice NN O
- : O
site NN O
of IN O
intron NN O
9 CD O
. . O

The DT O
second JJ O
, , O
a DT O
C NNP O
- : O
- : O
> NN O
T NNP O
transition NN O
at IN O
nucleotide JJ O
739 CD O
( ( O
Arg247Trp NNP O
) ) O
, , O
has VBZ O
been VBN O
shown VBN O
by IN O
Triggs NNP O
- : O
Raine NNP O
et CC O
al NN O
. . O

( ( O
1992 CD O
) ) O
to TO O
be VB O
a DT O
clinically RB O
benign JJ O
"""" NNP O
pseudodeficient NN O
"""" NNP O
allele RB O
associated VBD O
with IN O
reduced JJ O
enzyme JJ O
activity NN O
against IN O
artificial JJ O
substrate NN O
. . O

Finally RB O
, , O
a DT O
polymorphism NN O
[ NNP O
G NNP O
- : O
- : O
> VB O
A NNP O
( ( O
759 CD O
) ) O
] NN O
, , O
which WDT O
leaves VBZ O
valine NN O
at IN O
codon $ O
253 CD O
unchanged JJ O
, , O
is VBZ O
described VBN O
. . O

A DT O
mutation NN O
common JJ O
in IN O
non JJ O
- : O
Jewish JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
: : O
frequency NN O
and CC O
RNA NNP O
studies NNS O
. . O

Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
resulting VBG O
from IN O
mutation NN O
of IN O
the DT O
HEXA NNP O
gene NN O
encoding VBG O
the DT O
alpha NN O
- : O
subunit NN O
of IN O
the DT O
lysosomal JJ O
enzyme NN O
, , O
beta SYM O
- : O
N NNP O
- : O
acetylhexosaminidase NN O
A NNP O
( ( O
Hex NNP O
A NNP O
) ) O
. . O

We PRP O
have VBP O
discovered VBN O
that IN O
a DT O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
mutation NN O
, , O
IVS NNP O
- : O
9 CD O
+ $ O
1 CD O
G NNP O
- : O
- : O
> NN O
A NNP O
, , O
first RB O
detected VBN O
by IN O
Akli NNP O
et CC O
al NN O
. . O

( ( O
Genomics NNS O
11 CD O
124 CD O
- : O
134 CD O
, , O
1991 CD O
) ) O
, , O
is VBZ O
a DT O
common JJ O
disease NN O
allele NN O
in IN O
non JJ O
- : O
Jewish JJ O
Caucasians NNPS O
( ( O
10 CD O
/ RB O
58 CD O
alleles NNS O
examined VBN O
) ) O
. . O

A DT O
PCR NNP O
- : O
based VBN O
diagnostic JJ O
test NN O
, , O
which WDT O
detects VBZ O
an DT O
NlaIII NNP O
site NN O
generated VBN O
by IN O
the DT O
mutation NN O
, , O
revealed VBD O
a DT O
frequency NN O
among IN O
enzyme JJ O
- : O
defined JJ O
carriers NNS O
of IN O
9 CD O
/ NNS O
64 CD O
( ( O
14 CD O
% NN O
) ) O
. . O

Most JJS O
of IN O
those DT O
carrying VBG O
the DT O
allele JJ O
trace VBP O
their PRP$ O
origins NNS O
to TO O
the DT O
United NNP O
Kingdom NNP O
, , O
Ireland NNP O
, , O
or CC O
Western NNP O
Europe NNP O
. . O

It PRP O
was VBD O
not RB O
identified VBN O
among IN O
12 CD O
Black NNP O
American NNP O
TSD NNP B-Disease
alleles VBZ O
or CC O
in IN O
any DT O
of IN O
18 CD O
Ashkenazi NNP O
Jewish NNP O
, , O
enzyme SYM O
- : O
defined VBN O
carriers NNS O
who WP O
did VBD O
not RB O
carry VB O
any DT O
of IN O
the DT O
mutations NNS O
common JJ O
to TO O
this DT O
population NN O
. . O

No DT O
normally RB O
spliced VBN O
RNA NNP O
was VBD O
detected VBN O
in IN O
PCR NNP O
products NNS O
generated VBD O
from IN O
reverse JJ O
transcription NN O
of IN O
RNA NNP O
carrying VBG O
the DT O
IVS NNP O
- : O
9 CD O
mutation NN O
. . O

Instead RB O
, , O
the DT O
low JJ O
levels NNS O
of IN O
mRNA NN O
from IN O
this DT O
allele NN O
were VBD O
comprised VBN O
of IN O
aberrant JJ O
species NNS O
resulting VBG O
from IN O
the DT O
use NN O
of IN O
either DT O
of IN O
two CD O
cryptic JJ O
donor NN O
sites NNS O
, , O
one CD O
truncating NN O
exon CC O
9 CD O
and CC O
the DT O
other JJ O
within IN O
IVS NNP O
- : O
9 CD O
, , O
spliced VBD O
to TO O
exon VB O
10 CD O
. . O

Numerous JJ O
additional JJ O
splice NN O
products NNS O
were VBD O
detected VBN O
, , O
most JJS O
involving VBG O
skipping NN O
of IN O
one CD O
or CC O
more JJR O
surrounding JJ O
exons NNS O
. . O

Together RB O
with IN O
a DT O
recently RB O
identified VBN O
allele NN O
responsible JJ O
for IN O
Hex NNP O
A NNP O
pseudodeficiency NN O
( ( O
Triggs NNP O
- : O
Raine NNP O
et CC O
al NN O
. . O
Am NNP O
J NNP O
Hum NNP O
Genet NNP O
, , O
1992 CD O
) ) O
, , O
these DT O
two CD O
alleles NNS O
accounted VBD O
for IN O
almost RB O
50 CD O
% NN O
( ( O
29 CD O
/ RB O
64 CD O
) ) O
of IN O
TSD NNP B-Disease
or CC O
carrier NN O
alleles NNS O
ascertained VBN O
by IN O
enzyme JJ O
screening VBG O
tests NNS O
in IN O
non JJ O
- : O
Jewish JJ O
Caucasians NNPS O
. . O
. . O

Aberrant JJ O
splicing NN O
of IN O
the DT O
CHM NNP B-Disease
gene NN O
is VBZ O
a DT O
significant JJ O
cause NN O
of IN O
choroideremia NN B-Disease
. . O

Choroideremia NNP B-Disease
( ( O
CHM NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
progressive JJ I-Disease
degeneration NN I-Disease
of IN I-Disease
the DT I-Disease
choroid NN I-Disease
and CC I-Disease
retina NN I-Disease
. . O

12 CD O
% NN O
of IN O
unrelated JJ O
male JJ O
patients NNS O
carry VBP O
deletions NNS O
of IN O
the DT O
partially RB O
cloned VBN O
CHM NNP B-Disease
gene NN O
. . O

In IN O
Finland NNP O
, , O
there EX O
are VBP O
more JJR O
than IN O
120 CD O
living VBG O
CHM NNP B-Disease
patients NNS O
belonging VBG O
to TO O
eight CD O
apparently RB O
unrelated JJ O
pedigrees NNS O
. . O

Molecular JJ O
deletions NNS O
involving VBG O
the DT O
CHM NNP B-Disease
gene NN O
have VBP O
been VBN O
detected VBN O
in IN O
three CD O
families NNS O
. . O

We PRP O
have VBP O
screened VBN O
the DT O
remaining VBG O
five CD O
families NNS O
for IN O
point NN O
mutations NNS O
. . O

In IN O
one CD O
large JJ O
family NN O
a DT O
single JJ O
nucleotide NN O
( ( O
T NNP O
) ) O
insertion NN O
into IN O
the DT O
donor JJ O
splice NN O
site NN O
of IN O
exon JJ O
C NNP O
leads VBZ O
to TO O
two CD O
aberrantly RB O
spliced VBN O
mRNAs JJ O
both DT O
producing VBG O
a DT O
premature NN O
stop NN O
codon NN O
. . O

The DT O
mutation NN O
can MD O
be VB O
assayed VBN O
easily RB O
by IN O
amplification NN O
and CC O
digestion NN O
with IN O
Msel NNP O
. . O

Our PRP$ O
findings NNS O
provide VBP O
additional JJ O
evidence NN O
for IN O
the DT O
pathogenetic JJ O
role NN O
of IN O
CHM NNP B-Disease
mutations NNS O
and CC O
provide VB O
a DT O
diagnostic JJ O
tool NN O
for IN O
one CD O
fifth NN O
of IN O
the DT O
worlds NNS O
known VBN O
CHM NNP B-Disease
patients NNS O
. . O
. . O

Germline NNP O
intronic NN O
and CC O
exonic JJ O
mutations NNS O
in IN O
the DT O
Wilms NNP B-Disease
' POS I-Disease
tumour NN I-Disease
gene NN O
( ( O
WT1 NNP O
) ) O
affecting VBG O
urogenital JJ O
development NN O
. . O

Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
rare JJ O
human JJ O
developmental JJ B-Disease
disorder NN I-Disease
affecting VBG O
the DT O
urogenital JJ O
system NN O
and CC O
leading VBG O
to TO O
renal JJ B-Disease
failure NN I-Disease
, , O
intersex NN B-Disease
disorders NNS I-Disease
and CC O
Wilms NNP B-Disease
tumour NN I-Disease
. . O

In IN O
this DT O
report NN O
, , O
four CD O
individuals NNS O
with IN O
this DT O
syndrome NN O
are VBP O
described VBN O
carrying VBG O
germline JJ O
point NN O
mutations NNS O
in IN O
the DT O
Wilms NNP B-Disease
tumour NN I-Disease
suppressor NN O
gene NN O
, , O
WT1 NNP O
. . O

Three CD O
of IN O
these DT O
mutations NNS O
were VBD O
in IN O
the DT O
zinc NN O
finger NN O
domains NNS O
of IN O
WT1 NNP O
. . O

The DT O
fourth JJ O
occurred VBD O
within IN O
intron NN O
9 CD O
, , O
preventing VBG O
splicing VBG O
at IN O
one CD O
of IN O
the DT O
alternatively RB O
chosen VBN O
splice NN O
donor NN O
sites NNS O
of IN O
exon NN O
9 CD O
when WRB O
assayed VBN O
in IN O
vitro NN O
. . O

These DT O
results NNS O
provide VBP O
genetic JJ O
evidence NN O
for IN O
distinct JJ O
functional JJ O
roles NNS O
of IN O
the DT O
WT1 NNP O
isoforms NNS O
in IN O
urogenital JJ O
development NN O
. . O
. . O

Characterization NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
region NN O
predicts VBZ O
multiple JJ O
protein NN O
isoform NN O
- : O
encoding VBG O
mRNAs NN O
. . O

The DT O
mutation NN O
underlying VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
has VBZ O
been VBN O
identified VBN O
as IN O
an DT O
expansion NN O
of IN O
a DT O
polymorphic JJ O
CTG NNP O
- : O
repeat NN O
in IN O
a DT O
gene NN O
encoding VBG O
protein JJ O
kinase NN O
activity NN O
. . O

Brain NNP O
and CC O
heart NN O
transcripts NNS O
of IN O
the DT O
DM NNP O
- : O
kinase NN O
( ( O
DMR NNP O
- : O
B15 NNP O
) ) O
gene NN O
are VBP O
subject JJ O
to TO O
alternative JJ O
RNA NNP O
splicing NN O
in IN O
both DT O
human JJ O
and CC O
mouse NN O
. . O

The DT O
unstable JJ O
[ NN O
CTG NNP O
] VBZ O
5 CD O
- : O
30 CD O
motif NN O
is VBZ O
found VBN O
uniquely RB O
in IN O
humans NNS O
, , O
although IN O
the DT O
flanking NN O
nucleotides NNS O
are VBP O
also RB O
present JJ O
in IN O
mouse NN O
. . O

Characterization NN O
of IN O
the DT O
DM NNP B-Disease
region NN O
of IN O
both DT O
species NNS O
reveals VBP O
another DT O
active JJ O
gene NN O
( ( O
DMR NNP O
- : O
N9 NN O
) ) O
in IN O
close JJ O
proximity NN O
to TO O
the DT O
kinase NN O
gene NN O
. . O

DMR NNP O
- : O
N9 NNP O
transcripts NNS O
, , O
mainly RB O
expressed VBN O
in IN O
brain NN O
and CC O
testis NN O
, , O
possess VB O
a DT O
single JJ O
, , O
large JJ O
open JJ O
reading NN O
frame NN O
, , O
but CC O
the DT O
function NN O
of IN O
its PRP$ O
protein JJ O
product NN O
is VBZ O
unknown JJ O
. . O

Clinical JJ O
manifestation NN O
of IN O
DM NNP B-Disease
may MD O
be VB O
caused VBN O
by IN O
the DT O
expanded VBN O
CTG NNP O
- : O
repeat NN O
compromising VBG O
the DT O
( ( O
alternative JJ O
) ) O
expression NN O
of IN O
DM NNP O
- : O
kinase NN O
or CC O
DMR NNP O
- : O
N9 NN O
proteins NNS O
. . O
. . O

Fragile NNP B-Disease
X NNP I-Disease
syndrome NN I-Disease
without IN O
CCG NNP O
amplification NN O
has VBZ O
an DT O
FMR1 NNP O
deletion NN O
. . O

We PRP O
describe VBP O
a DT O
patient NN O
with IN O
typical JJ O
clinical JJ O
features NNS O
of IN O
the DT O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
but CC O
without IN O
cytogenetic JJ O
expression NN O
of IN O
the DT O
fragile JJ B-Disease
X NN I-Disease
or CC O
an DT O
amplified JJ O
CCG NNP O
trinucleotide NN O
repeat NN O
fragment NN O
. . O

The DT O
patient NN O
has VBZ O
a DT O
previously RB O
uncharacterized JJ O
submicroscopic NN O
deletion NN O
encompassing VBG O
the DT O
CCG NNP O
repeat NN O
, , O
the DT O
entire JJ O
FMR1 NNP O
gene NN O
and CC O
about IN O
2 CD O
. . O

5 CD O
megabases NNS O
of IN O
flanking VBG O
sequences NNS O
. . O

This DT O
finding NN O
confirms VBZ O
that IN O
the DT O
fragile JJ B-Disease
X NNP I-Disease
phenotype NN O
can MD O
exist VB O
, , O
without IN O
amplification NN O
of IN O
the DT O
CCG NNP O
repeat NN O
or CC O
cytogenetic JJ O
expression NN O
of IN O
the DT O
fragile JJ B-Disease
X NN I-Disease
, , O
and CC O
that IN O
fragile JJ B-Disease
X NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
genetically RB O
homogeneous JJ O
disorder NN O
involving VBG O
FMR1 NNP O
. . O

We PRP O
also RB O
found VBD O
random RB O
X NNP O
- : O
inactivation NN O
in IN O
the DT O
mother NN O
of IN O
the DT O
patient NN O
who WP O
was VBD O
shown VBN O
to TO O
be VB O
a DT O
carrier NN O
of IN O
this DT O
deletion NN O
. . O

Cloning NN O
of IN O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
region NN O
in IN O
yeast JJ O
artificial JJ O
chromosomes NNS O
. . O

The DT O
gene NN O
responsible JJ O
for IN O
Huntington NNP B-Disease
disease NN I-Disease
has VBZ O
been VBN O
localized VBN O
to TO O
a DT O
2 CD O
. . O

5 CD O
million CD O
base NN O
pair NN O
( ( O
Mb NNP O
) ) O
region NN O
between IN O
the DT O
loci NN O
D4S10 NNP O
and CC O
D4S168 NNP O
on IN O
the DT O
short JJ O
arm NN O
of IN O
chromosome NN O
4 CD O
. . O

As IN O
part NN O
of IN O
a DT O
strategy NN O
to TO O
clone VB O
the DT O
HD NNP B-Disease
gene NN O
on IN O
the DT O
basis NN O
of IN O
its PRP$ O
chromosomal JJ O
location NN O
, , O
we PRP O
isolated VBD O
genomic JJ O
DNA NN O
from IN O
the DT O
HD NNP B-Disease
region NN O
as IN O
a DT O
set NN O
of IN O
overlapping VBG O
yeast JJ O
artificial JJ O
chromosome NN O
( ( O
YAC NNP O
) ) O
clones NNS O
. . O

Twenty NNP O
- : O
eight CD O
YAC NNP O
clones NNS O
were VBD O
identified VBN O
by IN O
screening VBG O
human JJ O
YAC NNP O
libraries NNS O
with IN O
twelve NN O
PCR NNP O
- : O
based VBN O
sequence NN O
- : O
tagged VBN O
sites NNS O
( ( O
STSs NNP O
) ) O
from IN O
the DT O
region NN O
. . O

We PRP O
assembled VBD O
the DT O
YAC NNP O
clones NNS O
into IN O
overlapping VBG O
sets NNS O
by IN O
hybridizing VBG O
them PRP O
to TO O
a DT O
large JJ O
number NN O
of IN O
DNA NNP O
probes NNS O
from IN O
the DT O
HD NNP B-Disease
region NN O
, , O
including VBG O
the DT O
STSs NNP O
. . O

In IN O
addition NN O
, , O
we PRP O
isolated VBD O
the DT O
ends NNS O
of IN O
the DT O
human JJ O
DNA NNP O
inserts NNS O
of IN O
most JJS O
of IN O
the DT O
YAC NNP O
clones NNS O
to TO O
assist VB O
in IN O
the DT O
construction NN O
of IN O
the DT O
contig NN O
. . O

Although IN O
almost RB O
half NN O
of IN O
the DT O
YACs NNPS O
appear VBP O
to TO O
contain VB O
chimeric JJ O
inserts NNS O
and CC O
several JJ O
contain NN O
internal JJ O
deletions NNS O
or CC O
other JJ O
rearrangements NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
obtain VB O
over IN O
2 CD O
. . O

2 CD O
Mb NNP O
of IN O
the DT O
HD NNP B-Disease
region NN O
in IN O
YACs NNP O
, , O
including VBG O
one CD O
continuous JJ O
segment NN O
of IN O
2 CD O
. . O

0 CD O
Mb NNP O
covering VBG O
the DT O
region NN O
that IN O
most JJS O
likely JJ O
contains VBZ O
the DT O
HD NNP B-Disease
gene NN O
. . O

Ten CD O
of IN O
the DT O
twenty NN O
eight CD O
YAC NNP O
clones NNS O
comprise VBP O
a DT O
minimal JJ O
set NN O
spanning VBG O
the DT O
2 CD O
. . O

2 CD O
Mb NNP O
. . O

These DT O
clones NNS O
provide VBP O
reagents NNS O
for IN O
the DT O
complete JJ O
characterization NN O
of IN O
this DT O
region NN O
of IN O
the DT O
genome NN O
and CC O
for IN O
the DT O
eventual JJ O
isolation NN O
of IN O
the DT O
HD NNP B-Disease
gene NN O
. . O

Characterization NN O
of IN O
a DT O
YAC NNP O
containing VBG O
part NN O
or CC O
all DT O
of IN O
the DT O
Norrie NNP B-Disease
disease NN I-Disease
locus NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
from IN O
pulsed VBN O
- : O
field NN O
gel JJ O
electrophoresis NN O
( ( O
PFGE NNP O
) ) O
that IN O
the DT O
monoamine NN O
oxidase NN O
genes NNS O
A NNP O
and CC O
B NNP O
( ( O
MAOA NNP O
& CC O
MAOB NNP O
) ) O
and CC O
DXS7 NNP O
loci NN O
are VBP O
physically RB O
very RB O
close RB O
. . O

We PRP O
have VBP O
therefore RB O
extended VBN O
studies NNS O
on IN O
their PRP$ O
relationship NN O
through IN O
the DT O
characterisation NN O
of IN O
a DT O
650 CD O
kb NN O
YAC NNP O
isolated VBD O
using VBG O
L1 NNP O
. . O

28 CD O
( ( O
recognising VBG O
the DT O
DXS7 NNP O
locus NN O
) ) O
as IN O
a DT O
probe NN O
. . O

Restriction NNP O
mapping NN O
of IN O
the DT O
YAC NNP O
indicates VBZ O
that IN O
it PRP O
contains VBZ O
both DT O
MAOA NNP O
and CC O
MAOB NNP O
genes NNS O
in IN O
addition NN O
to TO O
the DT O
DXS7 NNP O
locus NN O
. . O

The DT O
map NN O
derived VBN O
from IN O
the DT O
YL1 NNP O
. . O

28 CD O
- : O
YAC NN O
is VBZ O
compatible JJ O
both DT O
with IN O
the DT O
map NN O
from IN O
an DT O
independently RB O
derived VBN O
YAC NNP O
carrying VBG O
MAOA NNP O
and CC O
B NNP O
genes NNS O
and CC O
with IN O
the DT O
long JJ O
range NN O
genomic JJ O
map NN O
for IN O
the DT O
region NN O
. . O

A DT O
series NN O
of IN O
subclones NNS O
prepared VBN O
from IN O
a DT O
phage NN O
library NN O
( ( O
lambda JJ O
DASH NNP O
II NNP O
) ) O
of IN O
the DT O
YAC NNP O
have VBP O
been VBN O
characterised VBN O
and CC O
have VBP O
been VBN O
employed VBN O
to TO O
determine VB O
the DT O
end NN O
point NN O
of IN O
the DT O
deletion NN O
of IN O
a DT O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
NDP NNP B-Disease
) ) O
patient NN O
who WP O
has VBZ O
been VBN O
shown VBN O
to TO O
lack VB O
both DT O
DXS7 NNP O
and CC O
MAO NNP O
coding VBG O
sequences NNS O
. . O

The DT O
pattern NN O
of IN O
retention NN O
of IN O
subclones NNS O
in IN O
the DT O
deletion NN O
patient JJ O
place NN O
the DT O
end NN O
point NN O
of IN O
the DT O
deletion NN O
within IN O
30 CD O
- : O
130 CD O
kb NN O
of IN O
the DT O
proximal JJ O
end NN O
of IN O
the DT O
YAC NNP O
. . O

By IN O
combining VBG O
the DT O
data NN O
with IN O
established VBN O
recombination NN O
analysis NN O
, , O
we PRP O
provide VBP O
evidence NN O
that IN O
all DT O
or CC O
part NN O
of IN O
the DT O
NDP NNP O
lies VBZ O
in IN O
the DT O
interval NN O
of IN O
approximately RB O
250kb CD O
within IN O
the DT O
YAC NNP O
. . O

Both DT O
mutations NNS O
in IN O
G6PD NNP O
A NNP O
- : O
are VBP O
necessary JJ O
to TO O
produce VB O
the DT O
G6PD NNP B-Disease
deficient NN I-Disease
phenotype NN O
. . O

The DT O
high JJ O
prevalence NN O
of IN O
glucose JJ B-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
African JJ O
populations NNS O
is VBZ O
due JJ O
almost RB O
entirely RB O
to TO O
the DT O
enzyme NN O
variant NN O
A NNP O
- : O
, , O
which WDT O
differs VBZ O
from IN O
the DT O
wild JJ O
- : O
type NN O
G6PD NNP O
B NNP O
by IN O
two CD O
amino NN O
acid NN O
replacements NNS O
, , O
68 CD O
Val NNP O
- : O
- : O
> NN O
Met NNP O
and CC O
126 CD O
Asn NNP O
- : O
- : O
> NN O
Asp NNP O
. . O

The DT O
non JJ O
- : O
deficient NN O
polymorphic JJ O
variant NN O
G6PD NNP O
A NNP O
contains VBZ O
only RB O
the DT O
mutation NN O
126 CD O
Asn NNP O
- : O
- : O
> NN O
Asp NNP O
. . O

The DT O
frequencies NNS O
of IN O
the DT O
G6PD NNP O
A NNP O
and CC O
of IN O
the DT O
G6PD NNP O
A NNP O
- : O
genes NNS O
in IN O
parts NNS O
of IN O
Africa NNP O
are VBP O
both DT O
about IN O
0 CD O
. . O

2 CD O
. . O

The DT O
68 CD O
Val NNP O
- : O
- : O
> NN O
Met NNP O
mutation NN O
has VBZ O
not RB O
been VBN O
found VBN O
in IN O
a DT O
B NNP O
background NN O
. . O

This DT O
could MD O
be VB O
because IN O
the DT O
68 CD O
Val NNP O
- : O
- : O
> NN O
Met NNP O
mutation NN O
happened VBD O
to TO O
arise VB O
in IN O
an DT O
A NNP O
gene NN O
in IN O
the DT O
first JJ O
instance NN O
, , O
or CC O
because IN O
the DT O
68 CD O
Val NNP O
- : O
- : O
> NN O
Met NNP O
mutation NN O
alone RB O
is VBZ O
not RB O
sufficient JJ O
to TO O
cause VB O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O

We PRP O
have VBP O
approached VBN O
this DT O
question NN O
by IN O
producing VBG O
G6PD NNP O
B NNP O
, , O
A NNP O
, , O
A NNP O
- : O
, , O
and CC O
G6PD NNP O
68 CD O
Val NNP O
- : O
- : O
> NN O
Met NNP O
in IN O
a DT O
bacterial JJ O
expression NN O
system NN O
and CC O
analysing VBG O
their PRP$ O
biochemical JJ O
properties NNS O
. . O

With IN O
each DT O
single JJ O
mutation NN O
we PRP O
found VBD O
a DT O
slight JJ O
decrease NN O
in IN O
both CC O
the DT O
specific JJ O
activity NN O
and CC O
the DT O
yield NN O
of IN O
enzyme NN O
when WRB O
compared VBN O
to TO O
G6PD NNP O
B NNP O
. . O

When WRB O
both DT O
mutations NNS O
were VBD O
introduced VBN O
together RB O
, , O
there EX O
was VBD O
a DT O
roughly RB O
additive JJ O
effect NN O
on IN O
specific JJ O
activity NN O
, , O
but CC O
a DT O
much RB O
more RBR O
drastic JJ O
effect NN O
on IN O
enzyme JJ O
yield NN O
( ( O
4 CD O
% NN O
of IN O
normal JJ O
) ) O
. . O

This DT O
synergistic JJ O
effect NN O
was VBD O
also RB O
demonstrated VBN O
on IN O
thermal JJ O
stability NN O
, , O
especially RB O
at IN O
low JJ O
NADP NNP O
concentrations NNS O
. . O

Comparable JJ O
results NNS O
were VBD O
produced VBN O
when WRB O
the DT O
replacement NN O
119 CD O
Gln NNP O
- : O
- : O
> NN O
Glu NNP O
was VBD O
studied VBN O
instead RB O
of IN O
126 CD O
Asn NNP O
- : O
- : O
> NN O
Asp NNP O
. . O

We PRP O
infer VBP O
that IN O
the DT O
coexistence NN O
of IN O
the DT O
two CD O
mutations NNS O
is VBZ O
responsible JJ O
for IN O
enzyme JJ B-Disease
deficiency NN I-Disease
in IN I-Disease
G6PD NNP I-Disease
A NNP O
- : O
because IN O
they PRP O
act VBP O
synergistically RB O
in IN O
causing VBG O
instability NN O
of IN O
the DT O
enzyme NN O
. . O

Small JJ O
nuclear JJ O
ribonucleoprotein NN O
polypeptide IN O
N NNP O
( ( O
SNRPN NNP O
) ) O
, , O
an DT O
expressed VBN O
gene NN O
in IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome VB I-Disease
critical JJ O
region NN O
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
is VBZ O
associated VBN O
with IN O
paternally RB O
derived VBN O
chromosomal JJ O
deletions NNS O
in IN O
region NN O
15q11 CD O
- : O
13 CD O
or CC O
with IN O
maternal JJ B-Disease
disomy NN I-Disease
for IN I-Disease
chromosome NN I-Disease
15 CD I-Disease
. . O

Therefore RB O
, , O
loss NN O
of IN O
the DT O
expressed JJ O
paternal JJ O
alleles NNS O
of IN O
maternally RB O
imprinted VBN O
genes NNS O
must MD O
be VB O
responsible JJ O
for IN O
the DT O
PWS NNP B-Disease
phenotype NN O
. . O

We PRP O
have VBP O
mapped VBN O
the DT O
gene NN O
encoding VBG O
the DT O
small JJ O
nuclear JJ O
RNA NNP O
associated VBD O
polypeptide JJ O
SmN NNP O
( ( O
SNRPN NNP O
) ) O
to TO O
human JJ O
chromosome NN O
15q12 CD O
and CC O
a DT O
processed JJ O
pseudogene NN O
SNRPNP1 NNP O
to TO O
chromosome VB O
region NN O
6pter CD O
- : O
p21 NN O
. . O

Furthermore RB O
, , O
SNRPN NNP O
was VBD O
mapped VBN O
to TO O
the DT O
minimal JJ O
deletion NN O
interval NN O
that WDT O
is VBZ O
critical JJ O
for IN O
PWS NNP B-Disease
. . O

The DT O
fact NN O
that IN O
the DT O
mouse NN O
Snrpn NNP O
gene NN O
is VBZ O
maternally RB O
imprinted VBN O
in IN O
brain NN O
suggests NNS O
that IN O
loss NN O
of IN O
the DT O
paternally RB O
derived VBN O
SNRPN NNP O
allele NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
PWS NNP B-Disease
phenotype NN O
. . O
. . O

The DT O
presence NN O
of IN O
two CD O
different JJ O
infantile NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
mutations NNS O
in IN O
a DT O
Cajun NNP O
population NN O
. . O

A DT O
study NN O
was VBD O
undertaken VBN O
to TO O
characterize VB O
the DT O
mutation NN O
( ( O
s PRP O
) ) O
responsible JJ O
for IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
in IN O
a DT O
Cajun NNP O
population NN O
in IN O
southwest JJ O
Louisiana NNP O
and CC O
to TO O
identify VB O
the DT O
origins NNS O
of IN O
these DT O
mutations NNS O
. . O

Eleven NNP O
of IN O
12 CD O
infantile JJ O
TSD NNP B-Disease
alleles NNS O
examined VBD O
in IN O
six CD O
families NNS O
had VBD O
the DT O
beta NN O
- : O
hexosaminidase NN O
A NNP O
( ( O
Hex NNP O
A NNP O
) ) O
alpha SYM O
- : O
subunit NN O
exon VBZ O
11 CD O
insertion NN O
mutation NN O
that WDT O
is VBZ O
present JJ O
in IN O
approximately RB O
70 CD O
% NN O
of IN O
Ashkenazi NNP O
Jewish NNP O
TSD NNP B-Disease
heterozygotes VBZ O
. . O

The DT O
mutation NN O
in IN O
the DT O
remaining VBG O
allele NN O
was VBD O
a DT O
single JJ O
- : O
base NN O
transition NN O
in IN O
the DT O
donor NN O
splice NN O
site NN O
of IN O
the DT O
alpha JJ O
- : O
subunit NN O
intron NN O
9 CD O
. . O

To TO O
determine VB O
the DT O
origins NNS O
of IN O
these DT O
two CD O
mutations NNS O
in IN O
the DT O
Cajun NNP O
population NN O
, , O
the DT O
TSD NNP B-Disease
carrier NN O
status NN O
was VBD O
enzymatically RB O
determined VBN O
for IN O
90 CD O
members NNS O
of IN O
four CD O
of IN O
the DT O
six CD O
families NNS O
, , O
and CC O
extensive JJ O
pedigrees NNS O
were VBD O
constructed VBN O
for IN O
all DT O
carriers NNS O
. . O

A DT O
single JJ O
ancestral JJ O
couple NN O
from IN O
France NNP O
was VBD O
found VBN O
to TO O
be VB O
common JJ O
to TO O
most JJS O
of IN O
the DT O
carriers NNS O
of IN O
the DT O
exon NN O
11 CD O
insertion NN O
. . O

Pedigree NNP O
data NNS O
suggest VBP O
that IN O
this DT O
mutation NN O
has VBZ O
been VBN O
in IN O
the DT O
Cajun NNP O
population NN O
since IN O
its PRP$ O
founding NN O
over IN O
2 CD O
centuries NNS O
ago RB O
and CC O
that IN O
it PRP O
may MD O
be VB O
widely RB O
distributed VBN O
within IN O
the DT O
population NN O
. . O

In IN O
contrast NN O
, , O
the DT O
intron NN O
9 CD O
mutation NN O
apparently RB O
was VBD O
introduced VBN O
within IN O
the DT O
last JJ O
century NN O
and CC O
probably RB O
is VBZ O
limited VBN O
to TO O
a DT O
few JJ O
Louisiana NNP O
families NNS O
. . O
. . O

Mutations NNS O
in IN O
the DT O
candidate NN O
gene NN O
for IN O
Norrie NNP B-Disease
disease NN I-Disease
. . O

Recently RB O
, , O
we PRP O
and CC O
others NNS O
have VBP O
isolated VBN O
a DT O
candidate JJ O
gene NN O
for IN O
X NNP B-Disease
linked VBD I-Disease
Norrie NNP I-Disease
disease NN I-Disease
( ( O
ND NNP B-Disease
) ) O
which WDT O
was VBD O
found VBN O
to TO O
be VB O
deleted VBN O
or CC O
disrupted VBN O
in IN O
several JJ O
patients NNS O
. . O

As IN O
a DT O
prerequisite NN O
for IN O
the DT O
identification NN O
of IN O
point NN O
mutations NNS O
in IN O
the DT O
ND NNP B-Disease
gene NN O
we PRP O
have VBP O
established VBN O
the DT O
exon NN O
- : O
intron NN O
structure NN O
of IN O
this DT O
gene NN O
. . O

In IN O
17 CD O
unrelated JJ O
patients NNS O
and CC O
15 CD O
controls NNS O
, , O
PCR NNP O
products NNS O
derived VBN O
from IN O
the DT O
promoter NN O
region NN O
, , O
exons NNS O
1 CD O
and CC O
2 CD O
as RB O
well RB O
as IN O
the DT O
coding VBG O
part NN O
of IN O
exon $ O
3 CD O
were VBD O
analysed VBN O
with IN O
the DT O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
technique NN O
. . O

In IN O
12 CD O
patients NNS O
altered VBD O
PCR NNP O
fragments NNS O
were VBD O
detected VBN O
which WDT O
were VBD O
studied VBN O
in IN O
detail NN O
by IN O
direct JJ O
sequencing NN O
. . O

Eleven RB O
different JJ O
mutations NNS O
were VBD O
found VBN O
, , O
and CC O
all DT O
but CC O
one CD O
are VBP O
likely JJ O
to TO O
give VB O
rise NN O
to TO O
significant JJ O
structural JJ O
changes NNS O
in IN O
the DT O
predicted JJ O
protein NN O
. . O

These DT O
findings NNS O
, , O
and CC O
the DT O
absence NN O
of IN O
functionally RB O
relevant JJ O
base NN O
changes NNS O
in IN O
healthy JJ O
controls NNS O
, , O
emphasize VB O
the DT O
causal JJ O
role NN O
of IN O
this DT O
candidate NN O
gene NN O
in IN O
Norrie NNP B-Disease
disease NN I-Disease
and CC O
pave VB O
the DT O
way NN O
for IN O
reliable JJ O
diagnosis NN O
and CC O
carrier NN O
detection NN O
. . O
. . O

Detection NN O
of IN O
a DT O
nonsense JJ O
mutation NN O
in IN O
the DT O
dystrophin JJ O
gene NN O
by IN O
multiple JJ O
SSCP NNP O
. . O

A DT O
combination NN O
of IN O
multiplex JJ O
PCR NNP O
with IN O
the DT O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
technique NN O
was VBD O
employed VBN O
to TO O
screen VB O
for IN O
point NN O
mutations NNS O
in IN O
the DT O
human JJ O
dystrophin JJ O
gene NN O
. . O

Co NNP O
- : O
amplification NN O
of IN O
11 CD O
exons NNS O
from IN O
genomic JJ O
DNA NN O
of IN O
Duchenne NNP B-Disease
and CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
/ NNP O
BMD NNP B-Disease
) ) O
patients NNS O
with IN O
no DT O
deletion NN O
or CC O
duplication NN O
was VBD O
performed VBN O
and CC O
the DT O
samples NNS O
subjected VBN O
to TO O
multiple VB O
SSCP NNP O
analysis NN O
. . O

We PRP O
report VBP O
the DT O
case NN O
of IN O
a DT O
nonsense JJ O
mutation NN O
in IN O
a DT O
Duchenne NNP B-Disease
patient NN O
identified VBN O
by IN O
this DT O
approach NN O
. . O

The DT O
mutation NN O
introduces VBZ O
a DT O
termination NN O
codon NN O
within IN O
exon $ O
8 CD O
of IN O
the DT O
dystrophin JJ O
gene NN O
. . O

It PRP O
is VBZ O
predicted VBN O
to TO O
cause VB O
a DT O
very RB O
premature JJ O
translational JJ O
termination NN O
accounting NN O
for IN O
the DT O
severe JJ O
phenotype NN O
observed VBD O
. . O

The DT O
patient NN O
inherited VBD O
this DT O
mutation NN O
from IN O
his PRP$ O
mother NN O
. . O

In IN O
addition NN O
the DT O
analysis NN O
revealed VBD O
5 CD O
polymorphisms NNS O
useful JJ O
for IN O
internal JJ O
control NN O
. . O
. . O

Proliferation NNP O
- : O
related JJ O
expression NN O
of IN O
p19 NN O
/ NNP O
nm23 NN O
nucleoside RB O
diphosphate JJ O
kinase NN O
. . O

High JJ O
level NN O
expression NN O
of IN O
the DT O
nm23 JJ O
- : O
H1 NNP O
gene NN O
, , O
which WDT O
encodes VBZ O
for IN O
a DT O
nucleoside JJ O
diphosphate NN O
kinase NN O
, , O
has VBZ O
been VBN O
found VBN O
to TO O
correlate VB O
with IN O
diminished JJ O
metastasis NN O
in IN O
some DT O
tumors NNS B-Disease
but CC O
not RB O
in IN O
others NNS O
. . O

We PRP O
have VBP O
previously RB O
identified VBN O
the DT O
protein JJ O
product NN O
of IN O
the DT O
nm23 JJ O
- : O
H1 NNP O
gene NN O
in IN O
two CD O
- : O
dimensional JJ O
electrophoretic JJ O
gels NNS O
and CC O
have VBP O
designated VBN O
it PRP O
p19 JJ O
/ JJ O
nm23 NN O
. . O

In IN O
neuroblastoma NN B-Disease
, , O
higher JJR O
levels NNS O
of IN O
p19 NN O
/ NNP O
nm23 NN O
, , O
which WDT O
are VBP O
associated VBN O
with IN O
amplification NN O
of IN O
the DT O
N NNP O
- : O
myc NN O
oncogene NN O
, , O
large JJ O
tumor NN B-Disease
mass NN O
, , O
and CC O
metastasis NN O
, , O
were VBD O
observed VBN O
in IN O
advanced JJ O
stage NN O
tumors NNS B-Disease
compared VBN O
with IN O
limited JJ O
stage NN O
disease NN O
. . O

Because IN O
of IN O
the DT O
variable JJ O
expression NN O
of IN O
nm23 JJ O
- : O
H1 NN O
in IN O
different JJ O
tumors NNS B-Disease
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
relationship NN O
between IN O
amounts NNS O
of IN O
the DT O
protein NN O
and CC O
cell NN O
proliferation NN O
. . O

The DT O
levels NNS O
of IN O
p19 NN O
/ NNP O
nm23 NN O
were VBD O
compared VBN O
between IN O
resting VBG O
and CC O
mitotically RB O
stimulated VBN O
normal JJ O
human JJ O
PBLs NNP O
and CC O
in IN O
leukemia JJ B-Disease
cells NNS O
. . O

The DT O
amount NN O
of IN O
p19 NN O
/ NNP O
nm23 NN O
increased VBD O
in IN O
normal JJ O
lymphocytes NNS O
in IN O
response NN O
to TO O
mitotic JJ O
stimulation NN O
and CC O
paralleled VBD O
the DT O
increase NN O
in IN O
DNA NNP O
synthesis NN O
. . O

In IN O
leukemia NN B-Disease
cells NNS O
obtained VBN O
from IN O
patients NNS O
with IN O
different JJ O
subtypes NNS O
of IN O
acute JJ B-Disease
leukemia NN I-Disease
, , O
p19 NN O
/ NNP O
nm23 NN O
levels NNS O
were VBD O
also RB O
increased VBN O
relative NN O
to TO O
resting VBG O
normal JJ O
lymphocytes NNS O
. . O

Treatment NN O
of IN O
mitotically RB O
stimulated VBN O
lymphocytes NNS O
with IN O
cyclosporin NN O
, , O
which WDT O
inhibits VBZ O
proliferation NN O
, , O
blocked VBD O
the DT O
increase NN O
in IN O
p19 JJ O
/ NNP O
nm23 NN O
; : O
treatment NN O
of IN O
the DT O
leukemia NN B-Disease
cell NN O
line NN O
HL NNP O
- : O
60 CD O
with IN O
dimethylsulfoxide NN O
, , O
which WDT O
induces VBZ O
terminal JJ O
differentiation NN O
, , O
resulted VBD O
in IN O
diminished JJ O
levels NNS O
of IN O
p19 NN O
/ NNP O
nm23 NN O
. . O

Our PRP$ O
data NNS O
therefore RB O
provide VBP O
evidence NN O
that IN O
nm23 JJ O
- : O
H1 NNP O
expression NN O
is VBZ O
related VBN O
to TO O
cell VB O
proliferative JJ O
activity NN O
. . O
. . O

An DT O
intrachromosomal JJ O
insertion NN O
causing VBG O
5q22 CD O
deletion NN O
and CC O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NNS I-Disease
in IN O
two CD O
generations NNS O
. . O

We PRP O
report VBP O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
FAPC NNP B-Disease
) ) O
with IN O
epidermoid JJ B-Disease
cysts NNS I-Disease
, , O
osteomata NNS B-Disease
, , O
and CC O
areas NNS O
of IN O
congenital JJ B-Disease
hypertrophy NN I-Disease
of IN I-Disease
the DT I-Disease
retinal JJ I-Disease
pigment NN I-Disease
epithelium NN I-Disease
( ( O
CHRPEs NNP B-Disease
) ) O
in IN O
a DT O
male JJ O
patient NN O
and CC O
his PRP$ O
maternal JJ O
aunt NN O
, , O
both DT O
of IN O
whom WP O
suffered VBD O
a DT O
mild NN O
to TO O
moderate VB O
degree NN O
of IN O
mental JJ B-Disease
handicap NN I-Disease
. . O

Both DT O
had VBD O
an DT O
interstitial JJ O
deletion NN O
of IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
5 CD O
( ( O
del NN O
( ( O
5 CD O
) ) O
( ( O
q22q23 UH O
. . O
2 CD O
) ) O
) ) O
. . O

Two CD O
other JJ O
normal JJ O
family NN O
members NNS O
had VBD O
the DT O
underlying VBG O
direct JJ O
insertion NN O
of IN O
chromosome NN O
5 CD O
( ( O
dir NN O
ins NNS O
( ( O
5 CD O
) ) O
( ( O
q31 UH O
. . O
3q22q23 CD O
3q22q23 CD O
. . O
2 CD O
) ) O
) ) O
. . O

Molecular JJ O
genetic JJ O
and CC O
fluorescent JJ O
hybridisation NN O
studies NNS O
have VBP O
shown VBN O
that IN O
loci NN O
D5S37 NNP O
and CC O
D5S98 NNP O
are VBP O
outside IN O
the DT O
deletion NN O
whereas IN O
loci NN O
detected VBN O
by IN O
probes NNS O
EF5 NNP O
. . O

44 CD O
and CC O
YN5 NNP O
. . O

48 CD O
are VBP O
lost VBN O
. . O

As IN O
expected VBN O
, , O
the DT O
molecular JJ O
analyses NNS O
indicate VBP O
loss NN O
of IN O
one CD O
allele NN O
at IN O
the DT O
MCC NNP O
and CC O
APC NNP B-Disease
loci NN O
. . O

The DT O
APC NNP B-Disease
gene NN O
is VBZ O
located VBN O
within IN O
band NN O
5q22 CD O
. . O

Familial JJ O
direct JJ O
insertions NNS O
should MD O
be VB O
considered VBN O
as IN O
a DT O
cause NN O
of IN O
recurrent JJ O
microdeletion NN O
syndromes NNS O
. . O

Chromosome NNP O
mapping NN O
of IN O
the DT O
rod NN O
photoreceptor NN O
cGMP NN O
phosphodiesterase NN O
beta SYM O
- : O
subunit NN O
gene NN O
in IN O
mouse NN O
and CC O
human NN O
: : O
tight JJ O
linkage NN O
to TO O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
region NN O
( ( O
4p16 CD O
. . O
3 CD O
) ) O
. . O

The DT O
retinal JJ B-Disease
degeneration NN I-Disease
mouse NN O
( ( O
gene NN O
symbol NN O
, , O
rd NN O
) ) O
is VBZ O
an DT O
animal JJ O
model NN O
for IN O
certain JJ O
forms NNS O
of IN O
human JJ O
hereditary JJ B-Disease
retinopathies NNS I-Disease
. . O

Recent JJ O
findings NNS O
of IN O
a DT O
nonsense JJ O
mutation NN O
in IN O
the DT O
rd NN O
mouse NN O
PDE NNP O
beta SYM O
- : O
subunit NN O
gene NN O
( ( O
Pdeb NNP O
) ) O
prompted VBD O
us PRP O
to TO O
investigate VB O
the DT O
chromosome NN O
locations NNS O
of IN O
the DT O
mouse NN O
and CC O
human JJ O
genes NNS O
. . O

We PRP O
have VBP O
utilized VBN O
backcross NN O
analysis NN O
in IN O
mice NN O
to TO O
verify VB O
and CC O
define VB O
more RBR O
precisely RB O
the DT O
location NN O
of IN O
the DT O
Pdeb NNP O
locus NN O
6 CD O
. . O

1 CD O
+ JJ O
/ NNP O
- : O
2 CD O
. . O

3 CD O
cM JJ O
distal NN O
of IN O
Mgsa NNP O
on IN O
mouse NN O
chromosome NN O
5 CD O
. . O

We PRP O
have VBP O
determined VBN O
that IN O
the DT O
human JJ O
gene NN O
( ( O
PDEB NNP O
) ) O
maps VBZ O
to TO O
4p16 CD O
. . O

3 CD O
, , O
very RB O
close RB O
to TO O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
region NN O
. . O

Analysis NN O
of IN O
the DT O
comparative JJ O
map NN O
for IN O
mice NN O
and CC O
humans NNS O
shows VBZ O
that IN O
the DT O
mouse NN O
homologue NN O
of IN O
the DT O
HD NNP B-Disease
gene NN O
will MD O
reside VB O
on IN O
chromosome NN O
5 CD O
. . O

Linkage NN O
of IN O
the DT O
mouse NN O
Pdeb NNP O
locus NN O
with IN O
other JJ O
homologues NNS O
in IN O
the DT O
human JJ O
4p16 CD O
. . O

3 CD O
region NN O
is VBZ O
maintained VBN O
but CC O
gene NN O
order NN O
is VBZ O
not RB O
, , O
suggesting VBG O
at IN O
least JJS O
three CD O
possible JJ O
sites NNS O
for IN O
the DT O
corresponding JJ O
mouse NN O
HD NNP B-Disease
gene NN O
. . O

Coincident NNP O
Kaposi NNP B-Disease
sarcoma NN I-Disease
and CC O
T NNP B-Disease
- : I-Disease
cell NN I-Disease
lymphoma NN I-Disease
in IN O
a DT O
patient NN O
with IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
. . O

A DT O
24 CD O
year NN O
old JJ O
male NN O
with IN O
a DT O
history NN O
of IN O
eczema NN B-Disease
, , O
recurrent JJ O
mild NN O
infections NNS O
, , O
and CC O
thrombocytopenia VB B-Disease
consistent NN O
with IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
presented VBD O
with IN O
a DT O
mediastinal JJ O
mass NN O
, , O
generalized VBN O
lymphadenopathy NN B-Disease
, , O
splenomegaly NN B-Disease
, , O
and CC O
severe JJ O
thrombocytopenia NN B-Disease
. . O

Studies NNS O
of IN O
immune JJ O
function NN O
including VBG O
immunoglobulin NN O
levels NNS O
and CC O
T NNP O
- : O
cell NN O
subsets NNS O
were VBD O
normal JJ O
. . O

Furthermore RB O
, , O
his PRP$ O
T NNP O
lymphocytes VBZ O
proliferated VBN O
normally RB O
in IN O
response NN O
to TO O
phytohemagglutinin VB O
, , O
concanavalin VB O
A NNP O
, , O
and CC O
the DT O
combination NN O
of IN O
neuraminidase JJ O
/ NNP O
galactose NN O
oxidase NN O
. . O

However RB O
, , O
their PRP$ O
proliferative JJ O
responses NNS O
to TO O
anti VB O
- : O
CD43 NNP O
antibody NN O
and CC O
periodate NN O
were VBD O
diminished VBN O
, , O
consistent JJ O
with IN O
the DT O
clinical JJ O
diagnosis NN O
of IN O
WAS NNP B-Disease
. . O

An DT O
initial JJ O
inguinal JJ O
lymph NN O
node NN O
biopsy NN O
surprisingly RB O
revealed VBD O
Kaposi NNP B-Disease
sarcoma NN I-Disease
. . O

However RB O
, , O
following VBG O
splenectomy NN O
to TO O
increase VB O
the DT O
platelet NN O
count NN O
, , O
biopsy NN O
of IN O
the DT O
mediastinal JJ O
mass NN O
revealed VBD O
T NNP B-Disease
- : I-Disease
cell NN I-Disease
large JJ I-Disease
cell NN I-Disease
lymphoma NN I-Disease
. . O

Studies NNS O
of IN O
biopsied JJ O
tissue NN O
for IN O
the DT O
presence NN O
of IN O
Epstein NNP B-Disease
- : I-Disease
Barr NNP I-Disease
virus NN I-Disease
and CC O
cytomegalovirus NN B-Disease
were VBD O
negative JJ O
, , O
as IN O
were VBD O
studies NNS O
of IN O
blood NN O
, , O
including VBG O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
for IN O
the DT O
presence NN O
of IN O
the DT O
human JJ B-Disease
immunodeficiency NN I-Disease
virus NN I-Disease
( ( O
HIV NNP B-Disease
) ) O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
Kaposi NNP B-Disease
sarcoma NN I-Disease
arising VBG O
in IN O
a DT O
patient NN O
with IN O
a DT O
congenital JJ B-Disease
immunodeficiency NN I-Disease
syndrome NN I-Disease
. . O

Although IN O
Kaposi NNP B-Disease
sarcoma NN I-Disease
can MD O
arise VB O
in IN O
the DT O
face NN O
of IN O
the DT O
severe JJ O
immunosuppression NN O
that WDT O
follows VBZ O
allograft NN O
transplantation NN O
and CC O
in IN O
patients NNS O
infected VBN O
with IN O
HIV NNP B-Disease
, , O
we PRP O
postulate VBP O
that DT O
longevity NN O
in IN O
the DT O
face NN O
of IN O
mild JJ O
immunosuppression NN O
was VBD O
the DT O
major JJ O
factor NN O
in IN O
the DT O
development NN O
of IN O
Kaposi NNP B-Disease
sarcoma NN I-Disease
in IN O
this DT O
patient NN O
. . O
. . O

The DT O
APC NNP B-Disease
gene NN O
, , O
responsible JJ O
for IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
, , O
is VBZ O
mutated VBN O
in IN O
human JJ O
gastric JJ B-Disease
cancer NN I-Disease
. . O

Although IN O
gastric JJ B-Disease
cancer NN I-Disease
is VBZ O
the DT O
most RBS O
common JJ O
cancer NN B-Disease
in IN O
the DT O
world NN O
, , O
genetic JJ O
changes NNS O
during IN O
its PRP$ O
carcinogenesis NN O
are VBP O
not RB O
well RB O
understood RB O
. . O

Since IN O
some DT O
gastric JJ B-Disease
cancers NNS I-Disease
are VBP O
considered VBN O
to TO O
originate VB O
from IN O
the DT O
intestinal JJ O
metaplasia NN O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
, , O
the DT O
mutation NN O
of IN O
which WDT O
causes VBZ O
adenomatous JJ B-Disease
polyps NNS I-Disease
in IN I-Disease
the DT I-Disease
colon NN I-Disease
, , O
is VBZ O
associated VBN O
with IN O
carcinogenesis NN O
of IN O
gastric JJ B-Disease
cancer NN I-Disease
. . O

Based VBN O
on IN O
this DT O
idea NN O
, , O
DNAs NNP O
isolated VBD O
from IN O
gastric JJ B-Disease
cancers NNS I-Disease
were VBD O
examined VBN O
by IN O
means NNS O
of IN O
a DT O
RNase NNP O
protection NN O
analysis NN O
coupled VBN O
with IN O
polymerase NN O
chain NN O
reaction NN O
followed VBN O
by IN O
sequencing VBG O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
products NNS O
. . O

By IN O
screening VBG O
nearly RB O
one CD O
- : O
half NN O
of IN O
the DT O
coding VBG O
region NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
44 CD O
tumors NNS B-Disease
, , O
somatic JJ O
mutations NNS O
were VBD O
detected VBN O
in IN O
three CD O
tumors NNS B-Disease
a DT O
missense NN O
mutation NN O
, , O
a DT O
nonsense JJ O
mutation NN O
, , O
and CC O
a DT O
5 CD O
- : O
base NN O
pair NN O
deletion NN O
resulting VBG O
in IN O
a DT O
frame NN O
shift NN O
which WDT O
causes VBZ O
truncation NN O
of IN O
the DT O
gene NN O
product NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
mutation NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
also RB O
plays VBZ O
an DT O
important JJ O
role NN O
during IN O
the DT O
carcinogenesis NN O
of IN O
at IN O
least JJS O
some DT O
gastric JJ B-Disease
cancers NNS I-Disease
. . O
. . O

A DT O
71 CD O
- : O
kilodalton NN O
protein NN O
is VBZ O
a DT O
major JJ O
product NN O
of IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
in IN O
brain NN O
and CC O
other JJ O
nonmuscle NN O
tissues NNS O
. . O

The DT O
known VBN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
products NNS O
, , O
the DT O
muscle NN O
- : O
and CC O
brain NN O
- : O
type NN O
dystrophin NN O
isoforms NNS O
, , O
are VBP O
427 CD O
- : O
kDa NN O
proteins NNS O
translated VBN O
from IN O
14 CD O
- : O
kilobase NN O
( ( O
kb NN O
) ) O
mRNAs NN O
. . O

Recently RB O
we PRP O
described VBD O
a DT O
6 CD O
. . O

5 CD O
- : O
kb NN O
mRNA NN O
that IN O
also RB O
is VBZ O
transcribed VBN O
from IN O
the DT O
DMD NNP B-Disease
gene NN O
. . O

Cloning VBG O
and CC O
in IN O
vitro JJ O
transcription NN O
and CC O
translation NN O
of IN O
the DT O
entire JJ O
coding NN O
region NN O
show NN O
that IN O
the DT O
6 CD O
. . O

5 CD O
- : O
kb NN O
mRNA NN O
encodes VBZ O
a DT O
70 CD O
. . O

8 CD O
- : O
kDa NN O
protein NN O
that WDT O
is VBZ O
a DT O
major JJ O
product NN O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
. . O

It PRP O
contains VBZ O
the DT O
C NNP O
- : O
terminal NN O
and CC O
the DT O
cysteine NN O
- : O
rich JJ O
domains NNS O
of IN O
dystrophin NN O
, , O
seven CD O
additional JJ O
amino NN O
acids NNS O
at IN O
the DT O
N NNP O
terminus NN O
, , O
and CC O
some DT O
modifications NNS O
formed VBN O
by IN O
alternative JJ O
splicing NN O
in IN O
the DT O
C NNP O
- : O
terminal NN O
domain NN O
. . O

It PRP O
lacks VBZ O
the DT O
entire JJ O
large JJ O
domain NN O
of IN O
spectrin JJ O
- : O
like IN O
repeats NNS O
and CC O
the DT O
actin NN O
- : O
binding NN O
N NNP O
- : O
terminal JJ O
domain NN O
of IN O
dystrophin NN O
. . O

This DT O
protein NN O
is VBZ O
the DT O
major JJ O
DMD NNP B-Disease
gene NN O
product NN O
in IN O
brain NN O
and CC O
other JJ O
nonmuscle NN O
tissues NNS O
but CC O
is VBZ O
undetectable JJ O
in IN O
skeletal JJ O
muscle NN O
extracts NNS O
. . O

Correlation NN O
between IN O
the DT O
location NN O
of IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
and CC O
the DT O
number NN O
of IN O
colorectal JJ B-Disease
polyps NNS I-Disease
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
patients NNS O
. . O

Recently RB O
we PRP O
have VBP O
isolated VBN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
which WDT O
causes VBZ O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
, , O
and CC O
its PRP$ O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
a DT O
substantial JJ O
number NN O
of IN O
FAP NNP B-Disease
patients NNS O
have VBP O
been VBN O
identified VBN O
. . O

On IN O
the DT O
basis NN O
of IN O
this DT O
information NN O
, , O
we PRP O
compared VBN O
the DT O
location NN O
of IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
22 CD O
unrelated JJ O
patients NNS O
( ( O
12 CD O
of IN O
whom WP O
have VBP O
been VBN O
reported VBN O
previously RB O
) ) O
with IN O
the DT O
number NN O
of IN O
colorectal JJ B-Disease
polyps NNS I-Disease
developed VBN O
in IN O
FAP NNP B-Disease
patients NNS O
; : O
17 CD O
were VBD O
sparse JJ O
types NNS O
and CC O
five CD O
were VBD O
profuse NN O
types NNS O
. . O

All DT O
but CC O
one CD O
of IN O
the DT O
mutations NNS O
were VBD O
considered VBN O
to TO O
cause VB O
truncation NN O
of IN O
the DT O
gene NN O
product NN O
by IN O
frame JJ O
- : O
shift NN O
due JJ O
to TO O
deletion NN O
( ( O
14 CD O
cases NNS O
) ) O
or CC O
nonsense JJ O
mutation NN O
( ( O
seven CD O
cases NNS O
) ) O
. . O

The DT O
location NN O
of IN O
the DT O
germ JJ O
- : O
line NN O
mutations NNS O
seems VBZ O
to TO O
correlate VB O
with IN O
the DT O
two CD O
clinical JJ O
types NNS O
; : O
germ SYM O
- : O
line NN O
mutations NNS O
in IN O
five CD O
FAP NNP B-Disease
patients NNS O
with IN O
profuse JJ O
polyps NNS B-Disease
were VBD O
observed VBN O
between IN O
codon NN O
1250 CD O
and CC O
codon VB O
1464 CD O
, , O
whereas JJ O
mutations NNS O
in IN O
17 CD O
FAP NNP B-Disease
patients NNS O
with IN O
fewer JJR O
polyps NNS B-Disease
were VBD O
observed VBN O
in IN O
the DT O
other JJ O
regions NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
. . O

The DT O
result NN O
suggests VBZ O
that IN O
the DT O
number NN O
of IN O
colorectal JJ B-Disease
polyps NNS I-Disease
in IN O
FAP NNP B-Disease
patients NNS O
may MD O
be VB O
associated VBN O
with IN O
a DT O
difference NN O
in IN O
the DT O
stability NN O
or CC O
biological JJ O
function NN O
of IN O
the DT O
truncated JJ O
APC NNP B-Disease
protein NN O
. . O
. . O

Identification NN O
and CC O
rapid JJ O
detection NN O
of IN O
three CD O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
mutations NNS O
in IN O
the DT O
Moroccan NNP O
Jewish NNP O
population NN O
. . O

Infantile NNP O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
HEXA NNP O
gene NN O
that WDT O
result NN O
in IN O
the DT O
complete JJ O
absence NN O
of IN O
beta NN O
- : O
hexosaminidase NN O
A DT O
activity NN O
. . O

It PRP O
is VBZ O
well RB O
known VBN O
that IN O
an DT O
elevated JJ O
frequency NN O
of IN O
TSD NNP B-Disease
mutations NNS O
exists VBZ O
among IN O
Ashkenazi JJ O
Jews NNPS O
. . O

More RBR O
recently RB O
it PRP O
has VBZ O
become VBN O
apparent JJ O
that IN O
elevated VBD O
carrier NN O
frequencies NNS O
for IN O
TSD NNP B-Disease
also RB O
occur VBP O
in IN O
several JJ O
other JJ O
ethnic JJ O
groups NNS O
, , O
including VBG O
Moroccan JJ O
Jews NNP O
, , O
a DT O
subgroup NN O
of IN O
Sephardic NNP O
Jews NNP O
. . O

Elsewhere RB O
we PRP O
reported VBD O
an DT O
in IN O
- : O
frame NN O
deletion NN O
of IN O
one CD O
of IN O
the DT O
two CD O
adjacent JJ O
phenylalanine NN O
codons NNS O
at IN O
position NN O
304 CD O
or CC O
305 CD O
( ( O
delta JJ O
F304 NNP O
/ NNP O
305 CD O
) ) O
in IN O
one CD O
HEXA NNP O
allele NN O
of IN O
a DT O
Moroccan JJ O
Jewish NNP O
TSD NNP B-Disease
patient NN O
and CC O
in IN O
three CD O
obligate JJ O
carriers NNS O
from IN O
six CD O
unrelated JJ O
Moroccan NNP O
Jewish NNP O
families NNS O
. . O

We PRP O
have VBP O
now RB O
identified VBN O
two CD O
additional JJ O
mutations NNS O
within IN O
exon JJ O
5 CD O
of IN O
the DT O
HEXA NNP O
gene NN O
that WDT O
account VBP O
for IN O
the DT O
remaining VBG O
TSD NNP B-Disease
alleles NNS O
in IN O
the DT O
patient NN O
and CC O
carriers NNS O
. . O

One CD O
of IN O
the DT O
mutations NNS O
is VBZ O
a DT O
novel JJ O
C NNP O
- : O
to TO O
- : O
G NNP O
transversion NN O
, , O
resulting VBG O
in IN O
a DT O
replacement NN O
of IN O
Tyr180 NNP O
by IN O
a DT O
stop JJ O
codon NN O
. . O

The DT O
other JJ O
mutation NN O
is VBZ O
a DT O
G NNP O
- : O
to TO O
- : O
A DT O
transition NN O
resulting VBG O
in IN O
an DT O
Arg170 NNP O
- : O
to TO O
- : O
Gln NNP O
substitution NN O
. . O

This DT O
mutation NN O
is VBZ O
at IN O
a DT O
CpG NNP O
site NN O
in IN O
a DT O
Japanese JJ O
infant NN O
with IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
and CC O
was VBD O
described VBN O
elsewhere RB O
. . O

Analysis NN O
of IN O
nine CD O
obligate JJ O
carriers NNS O
from IN O
seven CD O
unrelated JJ O
families NNS O
showed VBD O
that IN O
four CD O
harbor NN O
the DT O
delta NN O
F304 NNP O
/ VBZ O
305 CD O
mutation NN O
, , O
two CD O
the DT O
Arg170 NNP O
- : O
- : O
- : O
- : O
Gln NNP O
mutation NN O
, , O
and CC O
one CD O
the DT O
Tyr180 NNP O
- : O
- : O
- : O
- : O
Stop JJ O
mutation NN O
. . O

We PRP O
also RB O
have VBP O
developed VBN O
rapid JJ O
, , O
nonradioactive JJ O
assays NNS O
for IN O
the DT O
detection NN O
of IN O
each DT O
mutation NN O
, , O
which WDT O
should MD O
be VB O
helpful JJ O
for IN O
carrier NN O
screening NN O
. . O
. . O

Molecular JJ O
characterization NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
by IN O
natural JJ O
and CC O
amplification NN O
created VBD O
restriction NN O
sites NNS O
: : O
five CD O
mutations NNS O
account VBP O
for IN O
most JJS O
G6PD NNP B-Disease
deficiency NN I-Disease
cases NNS O
in IN O
Taiwan NNP O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
rapid JJ O
and CC O
simple JJ O
method NN O
to TO O
diagnose VB O
the DT O
molecular JJ O
defects NNS O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
Chinese NNP O
in IN O
Taiwan NNP O
. . O

This DT O
method NN O
involves VBZ O
the DT O
selective JJ O
amplification NN O
of IN O
a DT O
DNA NNP O
fragment NN O
from IN O
human JJ O
G6PD NNP O
gene NN O
with IN O
specific JJ O
oligonucleotide NN O
primers NNS O
followed VBN O
by IN O
digestion NN O
with IN O
restriction NN O
enzymes NNS O
that WDT O
recognize VBP O
artificially RB O
created VBN O
or CC O
naturally RB O
occurring VBG O
restriction NN O
sites NNS O
. . O

Ninety NNP O
- : O
four CD O
Chinese JJ O
males NNS O
with IN O
G6PD NNP B-Disease
deficiency NN I-Disease
were VBD O
studied VBN O
. . O

The DT O
results NNS O
show VBP O
that IN O
50 CD O
% NN O
( ( O
47 CD O
of IN O
94 CD O
) ) O
were VBD O
G NNP O
to TO O
T VB O
mutation NN O
at IN O
nucleotide NN O
( ( O
nt NN O
) ) O
1376 CD O
, , O
21 CD O
. . O

3 CD O
% NN O
( ( O
20 CD O
of IN O
94 CD O
) ) O
were VBD O
G NNP O
to TO O
A DT O
mutation NN O
at IN O
nt JJ O
1388 CD O
, , O
7 CD O
. . O

4 CD O
% NN O
( ( O
7 CD O
of IN O
94 CD O
) ) O
were VBD O
A DT O
to TO O
G NNP O
mutation NN O
at IN O
nt JJ O
493 CD O
, , O
7 CD O
. . O

4 CD O
% NN O
( ( O
7 CD O
of IN O
94 CD O
) ) O
were VBD O
A DT O
to TO O
G NNP O
mutation NN O
at IN O
nt JJ O
95 CD O
, , O
4 CD O
. . O

2 CD O
% NN O
( ( O
4 CD O
of IN O
94 CD O
) ) O
were VBD O
C NNP O
to TO O
T VB O
mutation NN O
at IN O
nt JJ O
1024 CD O
, , O
1 CD O
. . O

1 CD O
% NN O
( ( O
1 CD O
of IN O
94 CD O
) ) O
was VBD O
G NNP O
to TO O
T VB O
mutation NN O
at IN O
nt JJ O
392 CD O
, , O
and CC O
1 CD O
. . O

1 CD O
% NN O
( ( O
1 CD O
of IN O
94 CD O
) ) O
was VBD O
G NNP O
to TO O
A DT O
mutation NN O
at IN O
nt JJ O
487 CD O
. . O

These DT O
results NNS O
show VBP O
that IN O
the DT O
former JJ O
five CD O
mutations NNS O
account VBP O
for IN O
more JJR O
than IN O
90 CD O
% NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
cases NNS O
in IN O
Taiwan NNP O
. . O

Aside RB O
from IN O
showing VBG O
that IN O
G NNP O
to TO O
T VB O
change NN O
at IN O
nt JJ O
1376 CD O
is VBZ O
the DT O
most RBS O
common JJ O
mutation NN O
, , O
our PRP$ O
research NN O
indicates VBZ O
that IN O
nt $ O
493 CD O
mutation NN O
is VBZ O
a DT O
frequent JJ O
mutation NN O
among IN O
Chinese JJ O
in IN O
Taiwan NNP O
. . O

We PRP O
compared VBN O
G6PD NNP O
activity NN O
among IN O
different JJ O
mutations NNS O
, , O
without IN O
discovering VBG O
significant JJ O
differences NNS O
between IN O
them PRP O
. . O

Eight CD O
novel JJ O
inactivating VBG O
germ JJ O
line NN O
mutations NNS O
at IN O
the DT O
APC NNP B-Disease
gene NN O
identified VBN O
by IN O
denaturing VBG O
gradient JJ O
gel JJ O
electrophoresis NN O
. . O

Familial NNP B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
is VBZ O
a DT O
dominantly RB O
inherited VBN O
condition NN O
predisposing VBG O
to TO O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

The DT O
recent JJ O
isolation NN O
of IN O
the DT O
responsible JJ O
gene NN O
( ( O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
or CC O
APC NNP B-Disease
) ) O
has VBZ O
facilitated VBN O
the DT O
search NN O
for IN O
germ JJ O
line NN O
mutations NNS O
in IN O
affected JJ O
individuals NNS O
. . O

Previous JJ O
authors NNS O
have VBP O
used VBN O
the DT O
RNase NNP O
protection NN O
assay NN O
and CC O
the DT O
single JJ O
- : O
strand NN O
conformation NN O
polymorphisms VBZ O
procedure NN O
to TO O
screen VB O
for IN O
mutations NNS O
. . O

In IN O
this DT O
study NN O
we PRP O
used VBD O
denaturing VBG O
gradient JJ O
gel NN O
electrophoresis NN O
( ( O
DGGE NNP O
) ) O
. . O

DGGE NNP O
analysis NN O
of IN O
10 CD O
APC NNP B-Disease
exons NNS O
( ( O
4 CD O
, , O
5 CD O
, , O
7 CD O
, , O
8 CD O
, , O
9 CD O
, , O
10 CD O
, , O
12 CD O
, , O
13 CD O
, , O
14 CD O
, , O
and CC O
part NN O
of IN O
15 CD O
) ) O
in IN O
33 CD O
unrelated JJ O
Dutch NNP O
FAP NNP B-Disease
patients NNS O
has VBZ O
led VBN O
to TO O
the DT O
identification NN O
of IN O
eight CD O
novel JJ O
germ FW O
line NN O
mutations NNS O
resulting VBG O
in IN O
stop JJ O
codons NNS O
or CC O
frameshifts NNS O
. . O

The DT O
results NNS O
reported VBD O
here RB O
indicate JJ O
that IN O
( ( O
1 CD O
) ) O
familial NN B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
is VBZ O
caused VBN O
by IN O
an DT O
extremely RB O
heterogeneous JJ O
spectrum NN O
of IN O
point NN O
mutations NNS O
; : O
( ( O
2 CD O
) ) O
all PDT O
the DT O
mutations NNS O
found VBN O
in IN O
this DT O
study NN O
are VBP O
chain NN O
terminating NN O
; : O
and CC O
( ( O
3 CD O
) ) O
DGGE NNP O
represents VBZ O
a DT O
rapid JJ O
and CC O
sensitive JJ O
technique NN O
for IN O
the DT O
detection NN O
of IN O
mutations NNS O
in IN O
the DT O
unusually RB O
large JJ O
APC NNP B-Disease
gene NN O
. . O

An DT O
extension NN O
of IN O
the DT O
DGGE NNP O
analysis NN O
to TO O
the DT O
entire JJ O
coding NN O
region NN O
in IN O
a DT O
sufficient JJ O
number NN O
of IN O
clinically RB O
well RB O
- : O
characterized VBN O
, , O
unrelated JJ O
patients NNS O
will MD O
facilitate VB O
the DT O
establishment NN O
of IN O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
occurrence NN O
of IN O
an DT O
extremely RB O
heterogeneous JJ O
spectrum NN O
of IN O
mutations NNS O
spread VBP O
throughout IN O
the DT O
entire JJ O
length NN O
of IN O
the DT O
large JJ O
APC NNP B-Disease
gene NN O
among IN O
the DT O
FAP NNP B-Disease
patients NNS O
indicates VBZ O
that IN O
this DT O
approach NN O
may MD O
not RB O
be VB O
useful JJ O
as IN O
a DT O
rapid JJ O
presymptomatic JJ O
diagnostic JJ O
procedure NN O
in IN O
a DT O
routine JJ O
laboratory NN O
. . O

Nevertheless RB O
, , O
the DT O
above JJ O
DGGE NNP O
approach NN O
has VBZ O
incidentally RB O
led VBN O
to TO O
the DT O
identification NN O
of IN O
a DT O
common JJ O
polymorphism NN O
in IN O
exon JJ O
13 CD O
. . O

Such JJ O
intragenic JJ O
polymorphisms NNS O
offer VBP O
a DT O
practical JJ O
approach NN O
to TO O
a DT O
more RBR O
rapid JJ O
procedure NN O
for IN O
presymptomatic JJ O
diagnosis NN O
of IN O
FAP NNP B-Disease
by IN O
linkage NN O
analysis NN O
in IN O
informative JJ O
families NNS O
. . O
. . O

Yeast NNP O
artificial JJ O
chromosomes NNS O
for IN O
the DT O
molecular JJ O
analysis NN O
of IN O
the DT O
familial JJ B-Disease
polyposis NN I-Disease
APC NNP I-Disease
gene NN O
region NN O
. . O

Two CD O
yeast JJ O
artificial JJ O
chromosomes NNS O
( ( O
YACs NNP O
) ) O
spanning VBG O
a DT O
total JJ O
distance NN O
of IN O
1 CD O
. . O

1 CD O
megabase NN O
pairs NNS O
of IN O
DNA NNP O
around IN O
the DT O
MCC NNP O
( ( O
for IN O
mutated VBN O
in IN O
colorectal JJ B-Disease
carcinoma NN I-Disease
) ) O
and CC O
APC NNP B-Disease
( ( O
for IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
) ) O
genes NNS O
at IN O
5q21 CD O
have VBP O
been VBN O
isolated VBN O
and CC O
characterized VBN O
. . O

Starting VBG O
from IN O
the DT O
MCC NNP O
gene NN O
, , O
a DT O
strategy NN O
was VBD O
undertaken VBN O
to TO O
identify VB O
constitutional JJ O
submicroscopic NN O
deletions NNS O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
patients NNS O
that WDT O
might MD O
considerably RB O
narrow VB O
down RP O
the DT O
position NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
. . O

To TO O
this DT O
end NN O
, , O
YACs NNP O
identified VBN O
by IN O
the DT O
MCC NNP O
gene NN O
were VBD O
screened VBN O
across IN O
a DT O
chromosome NN O
5 CD O
- : O
specific JJ O
cosmid JJ O
library NN O
to TO O
provide VB O
a DT O
source NN O
of IN O
DNA NNP O
probes NNS O
for IN O
genomic JJ O
scanning NN O
. . O

The DT O
cosmids NNS O
isolated VBD O
from IN O
these DT O
experiments NNS O
were VBD O
used VBN O
to TO O
screen VB O
a DT O
panel NN O
of IN O
somatic JJ O
cell NN O
hybrids NNS O
containing VBG O
chromosome NN O
5 CD O
segregated VBN O
from IN O
patients NNS O
suspected VBN O
to TO O
carry VB O
putative JJ O
interstitial JJ O
deletions NNS O
. . O

This DT O
screening NN O
approach NN O
led VBD O
to TO O
the DT O
confirmation NN O
of IN O
a DT O
small JJ O
heterozygous JJ O
deletion NN O
in IN O
a DT O
polyposis NN B-Disease
patient NN O
that WDT O
overlaps VBZ O
one CD O
of IN O
the DT O
two CD O
isolated JJ O
YACs NNPS O
. . O

This DT O
YAC NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
contain VB O
the DT O
entire JJ O
APC NNP B-Disease
gene NN O
, , O
in IN O
addition NN O
to TO O
a DT O
significant JJ O
portion NN O
of IN O
DNA NNP O
flanking VBG O
the DT O
5 CD O
end NN O
of IN O
the DT O
gene NN O
, , O
and CC O
should MD O
therefore VB O
prove VB O
a DT O
valuable JJ O
resource NN O
for IN O
functional JJ O
studies NNS O
by IN O
transfer NN O
to TO O
colorectal VB B-Disease
tumor NN I-Disease
- : O
derived VBN O
cell NN O
lines NNS O
. . O

Inherited VBN O
WT1 NNP O
mutation NN O
in IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
. . O

Patients NNS O
with IN O
the DT O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
( ( O
Wilms NNP B-Disease
tumor NN I-Disease
, , O
genital JJ B-Disease
anomalies NNS I-Disease
, , O
and CC O
nephropathy RB B-Disease
) ) O
have VBP O
been VBN O
demonstrated VBN O
to TO O
carry VB O
de FW O
novo FW O
constitutional JJ O
mutations NNS O
in IN O
WT1 NNP O
, , O
the DT O
Wilms NNP B-Disease
tumor NN I-Disease
gene NN O
at IN O
chromosome NN O
11p13 CD O
. . O

We PRP O
report VBP O
three CD O
new JJ O
cases NNS O
, , O
two CD O
carrying VBG O
a DT O
previously RB O
described VBN O
WT1 NNP O
exon VBZ O
9 CD O
mutation NN O
and CC O
one CD O
with IN O
a DT O
novel JJ O
WT1 NNP O
exon NN O
8 CD O
mutation NN O
. . O

However RB O
, , O
unlike IN O
patients NNS O
in IN O
previous JJ O
reports NNS O
, , O
one CD O
of IN O
our PRP$ O
three CD O
patients NNS O
inherited VBD O
the DT O
affected JJ O
allele NN O
from IN O
his PRP$ O
phenotypically RB O
unaffected JJ O
father NN O
. . O

This DT O
observation NN O
indicates VBZ O
that IN O
the DT O
WT1 NNP O
exon VBD O
9 CD O
mutation NN O
affecting VBG O
394Arg CD O
demonstrated VBN O
in IN O
over IN O
one CD O
- : O
half NN O
of IN O
the DT O
patients NNS O
with IN O
the DT O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
may MD O
exhibit VB O
incomplete JJ O
penetrance NN O
. . O

Consequently RB O
, , O
familial JJ O
studies NNS O
in IN O
patients NNS O
affected VBN O
by IN O
this DT O
syndrome NN O
are VBP O
recommended VBN O
. . O
. . O

Submicroscopic NNP O
deletions NNS O
at IN O
the DT O
WAGR NNP B-Disease
locus NN O
, , O
revealed VBN O
by IN O
nonradioactive JJ O
in IN O
situ JJ O
hybridization NN O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
with IN O
biotin NN O
- : O
labeled VBN O
probes NNS O
mapping VBG O
to TO O
11p13 CD O
has VBZ O
been VBN O
used VBN O
for IN O
the DT O
molecular JJ O
analysis NN O
of IN O
deletions NNS O
of IN O
the DT O
WAGR NNP B-Disease
( ( O
Wilms NNP B-Disease
tumor NN I-Disease
, , O
aniridia NN B-Disease
, , O
genitourinary JJ B-Disease
abnormalities NNS I-Disease
, , O
and CC O
mental JJ B-Disease
retardation NN I-Disease
) ) O
locus NN O
. . O

We PRP O
have VBP O
detected VBN O
a DT O
submicroscopic NN O
11p13 CD O
deletion NN O
in IN O
a DT O
child NN O
with IN O
inherited JJ O
aniridia NN B-Disease
who WP O
subsequently RB O
presented VBN O
with IN O
Wilms NNP B-Disease
tumor NN I-Disease
in IN O
a DT O
horseshoe NN O
kidney NN O
, , O
only RB O
revealed VBD O
at IN O
surgery NN O
. . O

The DT O
mother NN O
, , O
who WP O
has VBZ O
aniridia NN B-Disease
, , O
was VBD O
also RB O
found VBN O
to TO O
carry VB O
a DT O
deletion NN O
including VBG O
both CC O
the DT O
aniridia NN B-Disease
candidate NN O
gene NN O
( ( O
AN2 NNP O
) ) O
and CC O
the DT O
Wilms NNP B-Disease
tumor NN I-Disease
predisposition NN O
gene NN O
( ( O
WT1 NNP O
) ) O
. . O

This DT O
is VBZ O
therefore RB O
a DT O
rare JJ O
case NN O
of IN O
an DT O
inherited JJ O
WAGR NNP B-Disease
deletion NN O
. . O

Wilms NNP B-Disease
tumor NN I-Disease
has VBZ O
so RB O
far RB O
only RB O
been VBN O
associated VBN O
with IN O
sporadic JJ O
de FW O
novo FW O
aniridia NN B-Disease
cases NNS O
. . O

We PRP O
have VBP O
shown VBN O
that IN O
a DT O
cosmid NN O
probe NN O
for IN O
a DT O
candidate NN O
aniridia NN B-Disease
gene NN O
, , O
homologous JJ O
to TO O
the DT O
mouse NN O
Pax NNP O
- : O
6 CD O
gene NN O
, , O
is VBZ O
deleted VBN O
in IN O
cell NN O
lines NNS O
from IN O
aniridia JJ B-Disease
patients NNS O
with IN O
previously RB O
characterized VBN O
deletions NNS O
at IN O
11p13 CD O
, , O
while IN O
another DT O
cosmid NN O
marker NN O
mapping VBG O
between IN O
two CD O
aniridia SYM B-Disease
- : O
associated VBN O
translocation NN O
breakpoints NNS O
( ( O
and CC O
hence RB O
a DT O
second JJ O
candidate NN O
marker NN O
) ) O
is VBZ O
present JJ O
on IN O
both DT O
chromosomes NNS O
. . O

These DT O
results NNS O
support VBD O
the DT O
Pax NNP O
- : O
6 CD O
homologue NN O
as IN O
a DT O
strong JJ O
candidate NN O
for IN O
the DT O
AN2 NNP O
gene NN O
. . O

FISH NN O
with IN O
cosmid NN O
probes NNS O
has VBZ O
proved VBN O
to TO O
be VB O
a DT O
fast JJ O
and CC O
reliable JJ O
technique NN O
for IN O
the DT O
molecular JJ O
analysis NN O
of IN O
deletions NNS O
. . O

It PRP O
can MD O
be VB O
used VBN O
with IN O
limited JJ O
amounts NNS O
of IN O
material NN O
and CC O
has VBZ O
strong JJ O
potential NN O
for IN O
clinical JJ O
applications NNS O
. . O
. . O

Linkage NN O
of IN O
gene NN O
for IN O
C2 NNP B-Disease
deficiency NN I-Disease
and CC O
the DT O
major JJ O
histocompatibility NN O
complex JJ O
MHC NNP O
in IN O
man NN O
. . O

Family RB O
study NN O
of IN O
a DT O
further JJ O
case NN O
. . O

Close JJ O
linkage NN O
between IN O
HL NNP O
- : O
A DT O
and CC O
C2 NNP B-Disease
deficiency NN I-Disease
was VBD O
first RB O
reported VBN O
by IN O
FU NNP O
and CC O
co SYM O
- : O
workers NNS O
in IN O
1974 CD O
. . O

We PRP O
present VBP O
here RB O
a DT O
pedigree NN O
of IN O
a DT O
31 CD O
- : O
year NN O
- : O
old JJ O
C2 NNP B-Disease
- : I-Disease
deficient NN I-Disease
individual JJ O
with IN O
clinical JJ O
manifestations NNS O
of IN O
Hodgkins NNP B-Disease
disease NN I-Disease
. . O

The DT O
following JJ O
markers NNS O
were VBD O
tested VBN O
C2 NNP O
levels NNS O
, , O
factor NN O
B NNP O
polymorphism NN O
, , O
blood NN O
groups NNS O
, , O
and CC O
enzyme RB O
typing NN O
. . O

In IN O
addition NN O
to TO O
close VB O
linkage NN O
between IN O
HL NNP O
- : O
A DT O
and CC O
C2 NNP B-Disease
deficiency NN I-Disease
, , O
both DT O
parents NNS O
were VBD O
heterozygous JJ O
for IN O
Bf NNP O
( ( O
HL NNP O
- : O
A DT O
linked VBN O
, , O
electrophoretic JJ O
variation NN O
of IN O
B NNP O
) ) O
. . O

The DT O
two CD O
HL NNP O
- : O
A DT O
haplotypes NNS O
closely RB O
linked VBN O
to TO O
C2 NNP B-Disease
deficiency NN I-Disease
are VBP O
different JJ O
2 CD O
, , O
W18 NNP O
and CC O
W24 NNP O
, , O
W18 NNP O
. . O

They PRP O
share NN O
, , O
however RB O
, , O
the DT O
SD2 NNP O
antigen NN O
W18 NNP O
and CC O
the DT O
LD NNP O
type NN O
7a CD O
. . O
. . O

Screening VBG O
for IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
patients NNS O
: : O
61 CD O
new JJ O
patients NNS O
and CC O
a DT O
summary NN O
of IN O
150 CD O
unrelated JJ O
patients NNS O
. . O

We PRP O
report VBP O
here RB O
the DT O
result NN O
of IN O
a DT O
screening NN O
for IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
in IN O
61 CD O
new JJ O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
patients NNS O
as RB O
well RB O
as IN O
a DT O
summary NN O
of IN O
the DT O
results NNS O
of IN O
150 CD O
patients NNS O
. . O

Examination NN O
of IN O
the DT O
entire JJ O
coding NN O
region NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
, , O
based VBN O
on IN O
a DT O
ribonuclease NN O
protection NN O
assay VBP O
coupled VBN O
with IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
, , O
disclosed VBD O
mutations NNS O
that WDT O
were VBD O
considered VBN O
to TO O
cause VB O
significant JJ O
defects NNS O
in IN O
the DT O
APC NNP B-Disease
product NN O
in IN O
97 CD O
of IN O
150 CD O
unrelated JJ O
FAP NNP B-Disease
patients NNS O
. . O

Our PRP$ O
findings NNS O
revealed VBD O
the DT O
following JJ O
characteristics NNS O
of IN O
the DT O
germ JJ O
- : O
line NN O
mutations NNS O
of IN O
APC NNP O
1 CD O
) ) O
the DT O
great JJ O
majority NN O
of IN O
the DT O
mutations NNS O
were VBD O
found VBN O
to TO O
truncate VB O
the DT O
APC NNP B-Disease
product NN O
; : O
2 CD O
) ) O
almost RB O
all DT O
of IN O
the DT O
mutations NNS O
were VBD O
located VBN O
within IN O
the DT O
first JJ O
half NN O
of IN O
the DT O
coding JJ O
region NN O
; : O
3 CD O
) ) O
no DT O
correlation NN O
was VBD O
observed VBN O
between IN O
the DT O
locations NNS O
of IN O
germ JJ O
- : O
line NN O
mutations NNS O
and CC O
extracolonic JJ O
manifestations NNS O
in IN O
FAP NNP B-Disease
patients NNS O
; : O
4 CD O
) ) O
more JJR O
than IN O
80 CD O
% NN O
of IN O
base NN O
substitutions NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
were VBD O
from IN O
cytosine NN O
to TO O
other JJ O
nucleotides NNS O
, , O
nearly RB O
one CD O
- : O
third NN O
of IN O
which WDT O
occurred VBD O
at IN O
the DT O
GpG NNP O
site NN O
. . O

Our PRP$ O
results NNS O
provide VB O
information NN O
helpful NN O
to TO O
an DT O
understanding NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
and CC O
will MD O
also RB O
contribute VB O
to TO O
presymptomatic JJ O
diagnosis NN O
of IN O
members NNS O
in IN O
FAP NNP B-Disease
families NNS O
. . O
. . O

Somatic JJ O
mutations NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
colorectal JJ B-Disease
tumors NNS I-Disease
: : O
mutation NN O
cluster NN O
region NN O
in IN O
the DT O
APC NNP B-Disease
gene NN O
. . O

We PRP O
examined VBD O
somatic JJ O
mutations NNS O
of IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
in IN O
63 CD O
colorectal JJ B-Disease
tumors NNS I-Disease
( ( O
16 CD O
adenomas NN B-Disease
and CC O
47 CD O
carcinomas NN B-Disease
) ) O
developed VBD O
in IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
and CC O
non $ O
- : O
FAP NN O
patients NNS O
. . O

In IN O
addition NN O
to TO O
loss NN O
of IN O
heterozygosity NN O
( ( O
LOH NNP O
) ) O
at IN O
the DT O
APC NNP B-Disease
locus NN O
in IN O
30 CD O
tumors NNS B-Disease
, , O
43 CD O
other JJ O
somatic JJ O
mutations NNS O
were VBD O
detected VBN O
. . O

Twenty NNP O
- : O
one CD O
of IN O
them PRP O
were VBD O
point JJ O
mutations NNS O
; : O
16 CD O
nonsense NN O
and CC O
two CD O
missense NN O
mutations NNS O
, , O
and CC O
three CD O
occurred VBD O
in IN O
introns NNS O
at IN O
the DT O
splicing VBG O
site NN O
. . O

Twenty CD O
- : O
two CD O
tumors NNS B-Disease
had VBD O
frameshift JJ O
mutations NNS O
due JJ O
to TO O
deletion NN O
or CC O
insertion NN O
; : O
nineteen NN O
of IN O
them PRP O
were VBD O
deletions NNS O
of IN O
one CD O
to TO O
31 CD O
bp NN O
and CC O
three CD O
were VBD O
a DT O
1 CD O
- : O
bp NN O
insertion NN O
. . O

One CD O
tumor NN B-Disease
had VBD O
a DT O
1 CD O
- : O
bp NN O
deletion NN O
in IN O
an DT O
intron NN O
near IN O
the DT O
splicing VBG O
site NN O
. . O

Hence NNP O
, , O
41 CD O
( ( O
95 CD O
% NN O
) ) O
of IN O
43 CD O
mutations NNS O
resulted VBD O
in IN O
truncation NN O
of IN O
the DT O
APC NNP B-Disease
protein NN O
. . O

Over IN O
60 CD O
% NN O
of IN O
the DT O
somatic JJ O
mutations NNS O
in IN O
the DT O
APC NNP B-Disease
gene NN O
were VBD O
clustered VBN O
within IN O
a DT O
small JJ O
region NN O
of IN O
exon NN O
15 CD O
, , O
designated VBN O
as IN O
MCR NNP O
( ( O
mutation NN O
cluster NN O
region NN O
) ) O
, , O
which WDT O
accounted VBD O
for IN O
less JJR O
than IN O
10 CD O
% NN O
of IN O
the DT O
coding VBG O
region NN O
. . O

Combining VBG O
these DT O
data NNS O
and CC O
the DT O
results NNS O
of IN O
LOH NNP O
, , O
more JJR O
than IN O
80 CD O
% NN O
of IN O
tumors NNS B-Disease
( ( O
14 CD O
adenomas NN B-Disease
and CC O
39 CD O
carcinomas NN B-Disease
) ) O
had VBD O
at IN O
least JJS O
one CD O
mutation NN O
in IN O
the DT O
APC NNP B-Disease
gene NN O
, , O
of IN O
which WDT O
more JJR O
than IN O
60 CD O
% NN O
( ( O
9 CD O
adenomas NN B-Disease
and CC O
23 CD O
carcinomas NN B-Disease
) ) O
had VBD O
two CD O
mutations NNS O
. . O

These DT O
results NNS O
strongly RB O
suggest VBP O
that IN O
somatic JJ O
mutations NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
are VBP O
associated VBN O
with IN O
development NN O
of IN O
a DT O
great JJ O
majority NN O
of IN O
colorectal JJ B-Disease
tumors NNS I-Disease
. . O
. . O

Constitutional JJ O
mutations NNS O
in IN O
the DT O
WT1 NNP O
gene NN O
in IN O
patients NNS O
with IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
is VBZ O
characterised VBN O
by IN O
a DT O
typical JJ O
nephropathy NN B-Disease
, , O
genital JJ B-Disease
abnormalities NNS I-Disease
and CC O
also RB O
predisposes VBZ O
to TO O
the DT O
development NN O
of IN O
Wilms NNP B-Disease
tumor NN I-Disease
. . O

These DT O
patients NNS O
eventually RB O
go VBP O
into IN O
end NN O
stage NN O
renal JJ B-Disease
failure NN I-Disease
. . O

A DT O
candidate NN O
Wilms NNP B-Disease
tumor NN I-Disease
gene NN O
, , O
WT1 NNP O
, , O
from IN O
the DT O
11p13 CD O
chromosome NN O
region NN O
has VBZ O
recently RB O
been VBN O
cloned VBN O
. . O

We PRP O
have VBP O
analysed VBN O
the DT O
DNA NNP O
sequence NN O
in IN O
constitutional JJ O
cells NNS O
from IN O
eight CD O
patients NNS O
and CC O
have VBP O
shown VBN O
heterozygous JJ O
mutations NNS O
in IN O
six CD O
of IN O
them PRP O
. . O

Four CD O
of IN O
the DT O
mutations NNS O
were VBD O
in IN O
exon JJ O
9 CD O
, , O
all DT O
resulting VBG O
in IN O
missense NN O
mutations NNS O
. . O

Three CD O
were VBD O
at IN O
nucleotide JJ O
position NN O
1180 CD O
resulting VBG O
in IN O
an DT O
arg NN O
> NN O
trp NN O
amino NN O
acid JJ O
change NN O
. . O

The DT O
other JJ O
was VBD O
at IN O
position NN O
1186 CD O
converting VBG O
an DT O
asp JJ O
> NN O
asn NN O
in IN O
the DT O
predicted JJ O
resultant NN O
protein NN O
. . O

One CD O
patient NN O
had VBD O
a DT O
missense JJ O
mutation NN O
in IN O
exon JJ O
8 CD O
, , O
converting VBG O
an DT O
arg NN O
> VBD O
his PRP$ O
. . O

A DT O
single JJ O
base NN O
pair NN O
insertion NN O
at IN O
nucleotide JJ O
position NN O
821 CD O
in IN O
exon NN O
6 CD O
resulted VBD O
in IN O
the DT O
generation NN O
of IN O
a DT O
premature NN O
stop NN O
codon NN O
in IN O
the DT O
last JJ O
patient NN O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
find VB O
a DT O
mutation NN O
in IN O
one CD O
patient NN O
despite IN O
complete JJ O
sequencing NN O
of IN O
the DT O
genomic JJ O
sequence NN O
of IN O
the DT O
gene NN O
. . O

The DT O
last JJ O
patient NN O
carried VBD O
a DT O
constitutional JJ O
deletion NN O
of IN O
the DT O
11p13 CD O
region NN O
and CC O
no DT O
additional JJ O
mutation NN O
was VBD O
found VBN O
. . O

There EX O
was VBD O
no DT O
obvious JJ O
correlation NN O
between IN O
the DT O
type NN O
of IN O
mutation NN O
and CC O
phenotypic NN O
expression NN O
. . O

These DT O
results NNS O
further RBR O
demonstrate NN O
that IN O
the DT O
WT1 NNP O
gene NN O
is VBZ O
important JJ O
in IN O
both DT O
the DT O
development NN O
of IN O
the DT O
kidney NN O
and CC O
the DT O
genito NN O
- : O
urinary JJ O
system NN O
. . O
. . O

Linkage NNP O
disequilibrium NN O
mapping NN O
in IN O
isolated JJ O
founder NN O
populations NNS O
: : O
diastrophic JJ B-Disease
dysplasia NN I-Disease
in IN O
Finland NNP O
. . O

Linkage NNP O
disequilibrium NN O
mapping NN O
in IN O
isolated JJ O
populations NNS O
provides VBZ O
a DT O
powerful JJ O
tool NN O
for IN O
fine JJ O
structure NN O
localization NN O
of IN O
disease NN O
genes NNS O
. . O

Here RB O
, , O
Luria NNP O
and CC O
Delbrucks NNP O
classical JJ O
methods NNS O
for IN O
analysing VBG O
bacterial JJ O
cultures NNS O
are VBP O
adapted VBN O
to TO O
the DT O
study NN O
of IN O
human JJ O
isolated JJ O
founder NN O
populations NNS O
in IN O
order NN O
to TO O
estimate VB O
( ( O
i NN O
) ) O
the DT O
recombination NN O
fraction NN O
between IN O
a DT O
disease NN O
locus NN O
and CC O
a DT O
marker NN O
; : O
( ( O
ii NN O
) ) O
the DT O
expected JJ O
degree NN O
of IN O
allelic JJ O
homogeneity NN O
in IN O
a DT O
population NN O
; : O
and CC O
( ( O
iii NN O
) ) O
the DT O
mutation NN O
rate NN O
of IN O
marker NN O
loci NN O
. . O

Using VBG O
these DT O
methods NNS O
, , O
we PRP O
report VBP O
striking VBG O
linkage NN O
disequilibrium NN O
for IN O
diastrophic JJ B-Disease
dysplasia NN I-Disease
( ( O
DTD NNP B-Disease
) ) O
in IN O
Finland NNP O
indicating VBG O
that IN O
the DT O
DTD NNP B-Disease
gene NN O
should MD O
lie VB O
within IN O
0 CD O
. . O

6 CD O
centimorgans NNS O
( ( O
or CC O
about IN O
60 CD O
kilobases NNS O
) ) O
of IN O
the DT O
CSF1R NNP O
gene NN O
. . O

Predictions NNS O
about IN O
allelic JJ O
homogeneity NN O
in IN O
Finland NNP O
and CC O
mutation NN O
rates NNS O
in IN O
simple JJ O
sequence NN O
repeats NNS O
are VBP O
confirmed VBN O
by IN O
independent JJ O
observations NNS O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich JJ I-Disease
syndrome NN I-Disease
: : O
refinement NN O
of IN O
the DT O
localization NN O
on IN O
Xp NNP O
and CC O
identification NN O
of IN O
another DT O
closely RB O
linked VBN O
marker NN O
locus NN O
, , O
OATL1 NNP O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
has VBZ O
previously RB O
been VBN O
mapped VBN O
to TO O
the DT O
proximal JJ O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
between IN O
the DT O
DXS14 NNP O
and CC O
DXS7 NNP O
loci NN O
. . O

In IN O
this DT O
study NN O
, , O
further JJ O
segregation NN O
analysis NN O
has VBZ O
been VBN O
performed VBN O
using VBG O
a DT O
newly RB O
identified VBN O
WAS NNP B-Disease
family NN O
as RB O
well RB O
as IN O
an DT O
additional JJ O
marker NN O
probe NN O
, , O
HOATL1 NNP O
. . O

The DT O
results NNS O
indicate VBP O
close JJ O
linkage NN O
between IN O
the DT O
WAS NNP B-Disease
and CC O
OATL1 NNP O
loci NN O
( ( O
Z NNP O
= VBZ O
6 CD O
. . O
8 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O
0 CD O
) ) O
and CC O
localize VB O
the DT O
TIMP NNP O
, , O
OATL1 NNP O
, , O
DXS255 NNP O
, , O
and CC O
WAS NNP B-Disease
loci JJ O
distal NN O
to TO O
DXS146 NNP O
and CC O
the DT O
OATL1 NNP O
and CC O
WAS NNP B-Disease
loci RB O
proximal JJ O
to TO O
TIMP NNP O
. . O

These DT O
linkage NN O
data NNS O
narrow VBP O
the DT O
boundaries NNS O
within IN O
which WDT O
the DT O
WAS NNP B-Disease
locus NN O
maps NNS O
to TO O
the DT O
chromosomal JJ O
region NN O
bracketed VBN O
by IN O
TIMP NNP O
and CC O
DXS146 NNP O
and CC O
support VB O
the DT O
loci NN O
order NN O
Xpter NNP O
- : O
DXS7 NNP O
- : O
TIMP NNP O
- : O
( ( O
OATL1 NNP O
, , O
WAS NNP O
, , O
DXS255 NNP O
) ) O
- : O
DXS146 NN O
. . O

Detection NN O
of IN O
an DT O
unstable JJ O
fragment NN O
of IN O
DNA NNP O
specific JJ O
to TO O
individuals NNS O
with IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
the DT O
most RBS O
common JJ O
form NN O
of IN O
adult NN O
muscular JJ B-Disease
dystrophy NN I-Disease
, , O
with IN O
a DT O
prevalence NN O
of IN O
2 CD O
- : O
14 CD O
per IN O
100 CD O
, , O
0 CD O
individuals NNS O
. . O

The DT O
disease NN O
is VBZ O
characterized VBN O
by IN O
progressive JJ O
muscle NN B-Disease
weakness NN I-Disease
and CC O
sustained JJ B-Disease
muscle NN I-Disease
contraction NN I-Disease
, , O
often RB O
with IN O
a DT O
wide JJ O
range NN O
of IN O
accompanying VBG O
symptoms NNS O
. . O

The DT O
age NN O
at IN O
onset NN O
and CC O
severity NN O
of IN O
the DT O
disease NN O
show NN O
extreme JJ O
variation NN O
, , O
both DT O
within IN O
and CC O
between IN O
families NNS O
. . O

Despite IN O
its PRP$ O
clinical JJ O
variability NN O
, , O
this DT O
dominant JJ O
condition NN O
segregates NNS O
as IN O
a DT O
single JJ O
locus NN O
at IN O
chromosome NN O
19q13 CD O
. . O

3 CD O
in IN O
every DT O
population NN O
studied VBN O
. . O

It PRP O
is VBZ O
flanked VBN O
by IN O
the DT O
tightly RB O
linked VBN O
genetic JJ O
markers NNS O
ERCC1 NNP O
proximally RB O
and CC O
D19S51 NNP O
distally RB O
; : O
these DT O
define VBP O
the DT O
DM NNP B-Disease
critical JJ O
region NN O
. . O

We PRP O
report VBP O
the DT O
isolation NN O
of IN O
an DT O
expressed JJ O
sequence NN O
from IN O
this DT O
region NN O
which WDT O
detects VBZ O
a DT O
DNA NN O
fragment NN O
that WDT O
is VBZ O
larger JJR O
in IN O
affected JJ O
individuals NNS O
than IN O
in IN O
normal JJ O
siblings NNS O
or CC O
unaffected JJ O
controls NNS O
. . O

The DT O
size NN O
of IN O
this DT O
fragment JJ O
varies NNS O
between IN O
affected JJ O
siblings NNS O
, , O
and CC O
increases VBZ O
in IN O
size NN O
through IN O
generations NNS O
in IN O
parallel JJ O
with IN O
increasing VBG O
severity NN O
of IN O
the DT O
disease NN O
. . O

We PRP O
postulate VBP O
that IN O
this DT O
unstable JJ O
DNA NN O
sequence NN O
is VBZ O
the DT O
molecular JJ O
feature NN O
that WDT O
underlies VBZ O
DM NNP B-Disease
. . O

Common JJ O
sequence NN O
motifs NNS O
at IN O
the DT O
rearrangement NN O
sites NNS O
of IN O
a DT O
constitutional JJ O
X NN O
/ NNP O
autosome JJ O
translocation NN O
and CC O
associated VBN O
deletion NN O
. . O

Reciprocal JJ O
chromosome NN O
translocations NNS O
are VBP O
common JJ O
de IN O
novo JJ O
rearrangements NNS O
that WDT O
occur VBP O
randomly RB O
throughout IN O
the DT O
human JJ O
genome NN O
. . O

To TO O
learn VB O
about IN O
causative JJ O
mechanisms NNS O
, , O
we PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBD O
the DT O
breakpoints NNS O
of IN O
a DT O
cytologically RB O
balanced JJ O
constitutional JJ O
reciprocal JJ O
translocation NN O
, , O
t NN O
( ( O
X NNP O
; : O
4 CD O
) ) O
( ( O
p21 NN O
. . O
2 CD O
; : O
q31 NN O
. . O
22 CD O
) ) O
, , O
present JJ O
in IN O
a DT O
girl NN O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

Physical JJ O
mapping NN O
of IN O
the DT O
derivative JJ O
chromosomes NNS O
, , O
after IN O
their PRP$ O
separation NN O
in IN O
somatic JJ O
cell NN O
hybrids NNS O
, , O
reveals NNS O
that IN O
the DT O
translocation NN O
disrupts VBZ O
the DT O
DMD NNP B-Disease
gene NN O
in IN O
Xp21 NNP O
within IN O
the DT O
18 CD O
- : O
kb NN O
intron NN O
16 CD O
. . O

Restriction NN O
mapping NN O
and CC O
sequencing NN O
of IN O
clones NNS O
that WDT O
span VBP O
both DT O
translocation NN O
breakpoints NNS O
as RB O
well RB O
as IN O
the DT O
corresponding VBG O
normal JJ O
regions NNS O
indicate VBP O
the DT O
loss NN O
of IN O
approximately RB O
5 CD O
kb NNS O
in IN O
the DT O
formation NN O
of IN O
the DT O
derivative JJ O
X NNP O
chromosome NN O
, , O
with IN O
4 CD O
- : O
6 CD O
bp NN O
deleted VBN O
from IN O
chromosome NN O
4 CD O
. . O

RFLP NNP O
and CC O
Southern NNP O
analyses VBZ O
indicate VBP O
that IN O
the DT O
de FW O
novo FW O
translocation NN O
is VBZ O
a DT O
paternal JJ O
origin NN O
and CC O
that IN O
the DT O
fathers NNS O
X VBP O
chromosome NN O
contains VBZ O
the DT O
DNA NN O
that WDT O
is VBZ O
deleted VBN O
in IN O
the DT O
derivative JJ O
X NN O
. . O

Most JJS O
likely JJ O
, , O
deletion NN O
and CC O
translation NN O
arose VBP O
simultaneously RB O
from IN O
a DT O
complex JJ O
rearrangement NN O
event NN O
that WDT O
involves VBZ O
three CD O
chromosomal JJ O
breakpoints NNS O
. . O

Short JJ O
regions NNS O
of IN O
sequence NN O
homology NN O
were VBD O
present JJ O
at IN O
the DT O
three CD O
sites NNS O
. . O

A DT O
5 CD O
- : O
bp NN O
sequence NN O
, , O
GGAAT NNP O
, , O
found VBD O
exactly RB O
at IN O
the DT O
translocation NN O
breakpoints NNS O
on IN O
both DT O
normal JJ O
chromosomes NNS O
X NNP O
and CC O
4 CD O
, , O
has VBZ O
been VBN O
preserved VBN O
only RB O
on IN O
the DT O
der NN O
( ( O
4 CD O
) ) O
chromosome NN O
. . O

It PRP O
is VBZ O
likely JJ O
that IN O
the DT O
X NNP O
- : O
derived VBD O
sequence NN O
GGAATCA NNP O
has VBZ O
been VBN O
lost VBN O
in IN O
the DT O
formation NN O
of IN O
the DT O
der NN O
( ( O
X NNP O
) ) O
chromosome NN O
, , O
as IN O
it PRP O
matches VBZ O
an DT O
inverted JJ O
GAATCA NNP O
sequence NN O
present NN O
on IN O
the DT O
opposite JJ O
strand NN O
exactly RB O
at IN O
the DT O
other JJ O
end NN O
of IN O
the DT O
deleted JJ O
5 CD O
- : O
kb NN O
fragment NN O
. . O

A DT O
genetic JJ O
etiology NN O
for IN O
DiGeorge NNP B-Disease
syndrome NN I-Disease
: : O
consistent JJ O
deletions NNS O
and CC O
microdeletions NNS O
of IN O
22q11 CD O
. . O

DiGeorge NNP B-Disease
syndrome NN I-Disease
( ( O
DGS NNP B-Disease
) ) O
, , O
a DT O
developmental JJ O
field NN O
defect NN O
of IN O
the DT O
third JJ O
and CC O
fourth JJ O
pharyngeal NN O
pouches NNS O
, , O
is VBZ O
characterized VBN O
by IN O
aplasia NN B-Disease
or CC I-Disease
hypoplasia NN I-Disease
of IN I-Disease
the DT I-Disease
thymus NN I-Disease
and CC I-Disease
parathyroid JJ I-Disease
glands NNS I-Disease
and CC O
by IN O
conotruncal JJ B-Disease
cardiac JJ I-Disease
malformations NNS I-Disease
. . O

Cytogenetic JJ O
studies NNS O
support VBP O
the DT O
presence NN O
of IN O
a DT O
DGS NNP B-Disease
critical JJ O
region NN O
in IN O
band NN O
22q11 CD O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
report VBP O
the DT O
results NNS O
of IN O
clinical JJ O
, , O
cytogenetic JJ O
, , O
and CC O
molecular JJ O
studies NNS O
of IN O
14 CD O
patients NNS O
with IN O
DGS NNP B-Disease
. . O

Chromosome NNP O
analysis NN O
, , O
utilizing VBG O
high JJ O
- : O
resolution NN O
banding VBG O
techniques NNS O
, , O
detected VBN O
interstitial JJ O
deletions NNS O
in IN O
five CD O
probands NNS O
and CC O
was VBD O
inconclusive JJ O
for IN O
a DT O
deletion NN O
in IN O
three CD O
probands NNS O
. . O

The DT O
remaining VBG O
six CD O
patients NNS O
had VBD O
normal JJ O
karyotypes NNS O
. . O

In IN O
contrast NN O
, , O
molecular JJ O
analysis NN O
detected VBD O
DNA NNP O
deletions NNS O
in IN O
all DT O
14 CD O
probands NNS O
. . O

Two CD O
of IN O
10 CD O
loci NN O
tested VBN O
, , O
D22S75 NNP O
and CC O
D22S259 NNP O
, , O
are VBP O
deleted VBN O
in IN O
all DT O
14 CD O
patients NNS O
. . O

A DT O
third JJ O
locus NN O
, , O
D22S66 NNP O
, , O
is VBZ O
deleted VBN O
in IN O
the DT O
eight CD O
DGS NNP B-Disease
probands NNS O
tested VBD O
. . O

Physical JJ O
mapping NN O
using VBG O
somatic JJ O
cell NN O
hybrids NNS O
places VBZ O
D22S66 NNP O
between IN O
D22S75 NNP O
and CC O
D22S259 NNP O
, , O
suggesting VBG O
that IN O
it PRP O
should MD O
be VB O
deleted VBN O
in IN O
the DT O
remaining VBG O
six CD O
cases NNS O
. . O

Parent NNP O
- : O
of IN O
- : O
origin NN O
studies NNS O
were VBD O
performed VBN O
in IN O
five CD O
families NNS O
. . O

Four CD O
probands NNS O
failed VBD O
to TO O
inherit VB O
a DT O
maternal JJ O
allele NN O
, , O
and CC O
one CD O
failed VBD O
to TO O
inherit VB O
a DT O
paternal JJ O
allele NN O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
families NNS O
, , O
and CC O
of IN O
six CD O
maternally RB O
and CC O
five CD O
paternally RB O
derived VBN O
unbalanced JJ O
- : O
translocation NN O
DGS NNP B-Disease
probands VBZ O
in IN O
the DT O
literature NN O
, , O
parent NN O
of IN O
origin NN O
or CC O
imprinting NN O
does VBZ O
not RB O
appear VB O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
DGS NNP B-Disease
. . O

Deletion NN O
of IN O
the DT O
same JJ O
three CD O
loci NN O
in IN O
all DT O
14 CD O
DGS NNP B-Disease
probands NNS O
begins VBZ O
to TO O
delineate VB O
the DT O
region NN O
of IN O
chromosome NN O
22 CD O
critical JJ O
for IN O
DGS NNP B-Disease
and CC O
confirms VBZ O
the DT O
hypothesis NN O
that WDT O
submicroscopic VBD O
deletions NNS O
of IN O
22q11 CD O
are VBP O
etiologic VBN O
in IN O
the DT O
vast JJ O
majority NN O
of IN O
cases NNS O
. . O
. . O

Loss NNP O
of IN O
normal JJ O
allele NNS O
of IN O
the DT O
APC NNP B-Disease
gene NN O
in IN O
an DT O
adrenocortical JJ B-Disease
carcinoma NN I-Disease
from IN O
a DT O
patient NN O
with IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
. . O

Endocrine NNP B-Disease
neoplasms NNS I-Disease
have VBP O
been VBN O
reported VBN O
occasionally RB O
in IN O
patients NNS O
with IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
. . O

An DT O
adrenocorotical JJ B-Disease
carcinoma NN I-Disease
was VBD O
studied VBN O
in IN O
a DT O
patient NN O
with IN O
a DT O
family NN O
history NN O
of IN O
FAP NNP B-Disease
. . O

Loss NNP O
of IN O
heterozygosity NN O
( ( O
LOH NNP O
) ) O
in IN O
the DT O
region NN O
close RB O
to TO O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
was VBD O
detected VBN O
in IN O
this DT O
carcinoma NN B-Disease
, , O
and CC O
evidence NN O
was VBD O
obtained VBN O
that IN O
there EX O
was VBD O
a DT O
loss NN O
of IN O
the DT O
normal JJ O
allele NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
demonstration NN O
of IN O
LOH NNP O
at IN O
the DT O
APC NNP B-Disease
locus NN O
in IN O
adrenocortical JJ B-Disease
tumors NNS I-Disease
. . O

The DT O
present JJ O
results NNS O
and CC O
our PRP$ O
previous JJ O
data NNS O
on IN O
LOH NNP O
in IN O
a DT O
recurring VBG O
desmoid JJ B-Disease
tumor NN I-Disease
suggest VBP O
that IN O
the DT O
heterozygous JJ O
mutant NN O
/ NNP O
wild SYM O
- : O
type JJ O
condition NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
may MD O
give VB O
rise NN O
to TO O
benign VB B-Disease
tumors NNS I-Disease
, , O
and CC O
that IN O
functional JJ O
loss NN O
of IN O
this DT O
gene NN O
leads VBZ O
to TO O
development NN O
of IN O
tumors NNS B-Disease
not RB O
only RB O
in IN O
the DT O
colon NN O
but CC O
also RB O
in IN O
other JJ O
various JJ O
parts NNS O
of IN O
the DT O
body NN O
in IN O
FAP NNP B-Disease
patients NNS O
. . O
. . O

Oncogenic JJ O
point NN O
mutations NNS O
in IN O
exon JJ O
20 CD O
of IN O
the DT O
RB1 NNP O
gene NN O
in IN O
families NNS O
showing VBG O
incomplete JJ O
penetrance NN O
and CC O
mild JJ O
expression NN O
of IN O
the DT O
retinoblastoma NN B-Disease
phenotype NN O
. . O

The DT O
retinoblastoma NN B-Disease
- : O
predisposition NN O
gene NN O
, , O
RB1 NNP O
, , O
segregates VBZ O
as IN O
an DT O
autosomal JJ O
dominant JJ O
trait NN O
with IN O
high JJ O
( ( O
90 CD O
% NN O
) ) O
penetrance NN O
. . O

Certain NNP O
families NNS O
, , O
however RB O
, , O
show VBP O
an DT O
unusual JJ O
low JJ O
- : O
penetrance NN O
phenotype NN O
with IN O
many JJ O
individuals NNS O
being VBG O
unaffected JJ O
, , O
unilaterally RB O
affected VBN O
, , O
or CC O
with IN O
evidence NN O
of IN O
spontaneously RB O
regressed VBN O
tumors NNS B-Disease
. . O

We PRP O
have VBP O
used VBN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
and CC O
PCR NNP O
sequencing VBG O
to TO O
study VB O
two CD O
such JJ O
families NNS O
. . O

Mutations NNS O
were VBD O
found VBN O
in IN O
exon JJ O
20 CD O
of IN O
RB1 NNP O
in IN O
both DT O
cases NNS O
. . O

In IN O
one CD O
family NN O
a DT O
C NNP O
- : O
- : O
- : O
- : O
T DT O
transition NN O
in IN O
codon NN O
661 CD O
converts NNS O
an DT O
arginine NN O
( ( O
CGG NNP O
) ) O
to TO O
a DT O
tryptophan NN O
( ( O
TGG NNP O
) ) O
codon NN O
. . O

In IN O
this DT O
family NN O
, , O
incomplete JJ O
penetrance NN O
and CC O
mild JJ O
phenotypic NN O
expression NN O
were VBD O
observed VBN O
in IN O
virtually RB O
all DT O
patients NNS O
, , O
possibly RB O
indicating VBG O
that IN O
single JJ O
amino NN O
acid IN O
changes NNS O
may MD O
modify VB O
protein NN O
structure NN O
/ JJ O
function NN O
such JJ O
that IN O
tumorigenesis NN O
is VBZ O
not RB O
inevitable JJ O
. . O

In IN O
the DT O
second JJ O
family NN O
the DT O
mutation NN O
in IN O
codon NN O
675 CD O
is VBZ O
a DT O
G NNP O
- : O
- : O
- : O
- : O
T NN O
transversion NN O
that WDT O
converts VBZ O
a DT O
glutamine NN O
( ( O
GAA NNP O
) ) O
to TO O
a DT O
stop NN O
( ( O
TAA NNP O
) ) O
codon NN O
. . O

However RB O
, , O
this DT O
mutation NN O
also RB O
occurs VBZ O
near IN O
a DT O
potential JJ O
cryptic JJ O
splice NN O
acceptor NN O
site NN O
, , O
raising VBG O
the DT O
possibility NN O
of IN O
alternative JJ O
splicing VBG O
resulting VBG O
in IN O
a DT O
less RBR O
severely RB O
disrupted VBN O
protein NN O
. . O
. . O

Late JJ O
- : O
onset VBN O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
: : O
molecular JJ O
pathology NN O
in IN O
two CD O
siblings NNS O
. . O

We PRP O
report VBP O
on IN O
a DT O
new JJ O
allele NN O
at IN O
the DT O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
locus VBD O
causing VBG O
late JJ O
- : O
onset VBN O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
. . O

In IN O
that DT O
allele NN O
arginine84 NN O
, , O
a DT O
residue NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
in IN O
the DT O
arylsulfatase NN O
gene NN O
family NN O
, , O
is VBZ O
replaced VBN O
by IN O
glutamine NN O
. . O

In IN O
contrast NN O
to TO O
alleles NNS O
that WDT O
cause VBP O
early JJ O
- : O
onset NN O
MLD NNP B-Disease
, , O
the DT O
arginine84 NN O
to TO O
glutamine VB O
substitution NN O
is VBZ O
associated VBN O
with IN O
some DT O
residual JJ O
ARSA NNP O
activity NN O
. . O

A DT O
comparison NN O
of IN O
genotypes NNS O
, , O
ARSA NNP O
activities NNS O
, , O
and CC O
clinical JJ O
data NNS O
on IN O
4 CD O
individuals NNS O
carrying VBG O
the DT O
allele NN O
of IN O
81 CD O
patients NNS O
with IN O
MLD NNP B-Disease
examined VBD O
, , O
further JJ O
validates VBZ O
the DT O
concept NN O
that WDT O
different JJ O
degrees NNS O
of IN O
residual JJ O
ARSA NNP O
activity NN O
are VBP O
the DT O
basis NN O
of IN O
phenotypical JJ O
variation NN O
in IN O
MLD NNP B-Disease
. . O
. . O

Trisomy $ B-Disease
15 CD I-Disease
with IN O
loss NN O
of IN O
the DT O
paternal JJ O
15 CD O
as IN O
a DT O
cause NN O
of IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
due JJ O
to TO O
maternal JJ B-Disease
disomy NN I-Disease
. . O

Uniparental JJ B-Disease
disomy NN I-Disease
has VBZ O
recently RB O
been VBN O
recognized VBN O
to TO O
cause VB O
human JJ O
disorders NNS O
, , O
including VBG O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

We PRP O
describe VBP O
a DT O
particularly RB O
instructive JJ O
case NN O
which WDT O
raises VBZ O
important JJ O
issues NNS O
concerning VBG O
the DT O
mechanisms NN O
producing VBG O
uniparental JJ B-Disease
disomy NN I-Disease
and CC O
whose WP$ O
evaluation NN O
provides VBZ O
evidence NN O
that IN O
trisomy NN O
may MD O
precede VB O
uniparental JJ B-Disease
disomy NN I-Disease
in IN O
a DT O
fetus NN O
. . O

Chorionic JJ O
villus NN O
sampling NN O
performed VBD O
for IN O
advanced JJ O
maternal JJ O
age NN O
revealed VBD O
trisomy JJ B-Disease
15 CD I-Disease
in IN O
all DT O
direct JJ O
and CC O
cultured JJ O
cells NNS O
, , O
though IN O
the DT O
fetus NN O
appeared VBD O
normal JJ O
. . O

Chromosome NNP O
analysis NN O
of IN O
amniocytes NNS O
obtained VBN O
at IN O
15 CD O
wk NN O
was VBD O
normal JJ O
in IN O
over IN O
100 CD O
cells NNS O
studied VBN O
. . O

The DT O
child NN O
was VBD O
hypotonic JJ B-Disease
at IN O
birth NN O
, , O
and CC O
high JJ O
- : O
resolution NN O
banding VBG O
failed VBD O
to TO O
reveal VB O
the DT O
deletion NN O
of IN O
15q11 CD O
- : O
13 CD O
, , O
a DT O
deletion NN O
which WDT O
is VBZ O
found VBN O
in IN O
50 CD O
% NN O
- : O
70 CD O
% NN O
of IN O
patients NNS O
with IN O
PWS NNP B-Disease
. . O

Over IN O
time NN O
, , O
typical JJ O
features NNS O
of IN O
PWS NNP B-Disease
developed VBD O
. . O

Molecular JJ O
genetic JJ O
analysis NN O
using VBG O
probes NNS O
for IN O
chromosome NN O
15 CD O
revealed VBD O
maternal JJ O
disomy NN O
. . O

Maternal JJ O
nondisjunction NN O
with IN O
fertilization NN O
of IN O
a DT O
disomic JJ O
egg NN O
by IN O
a DT O
normal JJ O
sperm NN O
, , O
followed VBN O
by IN O
loss NN O
of IN O
the DT O
paternal JJ O
15 CD O
, , O
is VBZ O
a DT O
likely JJ O
cause NN O
of IN O
confined JJ O
placental JJ O
mosaicism NN O
and CC O
uniparental JJ B-Disease
disomy NN I-Disease
in IN O
this DT O
case NN O
of IN O
PWS NNP B-Disease
, , O
and CC O
advanced VBD O
maternal JJ O
age NN O
may MD O
be VB O
a DT O
predisposing JJ O
factor NN O
. . O
. . O

Genetic JJ O
heterogeneity NN O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
amelogenesis NN I-Disease
imperfecta NN I-Disease
. . O

The DT O
AMELX NNP O
gene NN O
located VBN O
at IN O
Xp22 NNP O
. . O

1 CD O
- : O
p22 NN O
. . O

3 CD O
encodes NNS O
for IN O
the DT O
enamel NN O
protein NN O
amelogenin NN O
and CC O
has VBZ O
been VBN O
implicated VBN O
as IN O
the DT O
gene NN O
responsible JJ O
for IN O
the DT O
inherited JJ B-Disease
dental JJ I-Disease
abnormality NN I-Disease
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
amelogenesis NN I-Disease
imperfecta NN I-Disease
( ( O
XAI NNP B-Disease
) ) O
. . O

Three CD O
families NNS O
with IN O
XAI NNS B-Disease
have VBP O
been VBN O
investigated VBN O
using VBG O
polymorphic JJ O
DNA NNP O
markers NNS O
flanking VBG O
the DT O
position NN O
of IN O
AMELX NNP O
. . O

Using VBG O
two CD O
- : O
point NN O
linkage NN O
analysis NN O
, , O
linkage NN O
was VBD O
established VBN O
between IN O
XAI NNP B-Disease
and CC O
several JJ O
of IN O
these DT O
markers NNS O
in IN O
two CD O
families NNS O
, , O
with IN O
a DT O
combined JJ O
lod NN O
score NN O
of IN O
6 CD O
. . O

5 CD O
for IN O
DXS16 NNP O
at IN O
theta NN O
= $ O
0 CD O
. . O

4 CD O
4 CD O
. . O

This DT O
supports VBZ O
the DT O
involvement NN O
of IN O
AMELX NNP O
, , O
located VBN O
close RB O
to TO O
DXS16 NNP O
, , O
in IN O
the DT O
XAI NNP B-Disease
disease NN I-Disease
process NN O
( ( O
AIH1 NNP O
) ) O
in IN O
those DT O
families NNS O
. . O

Using VBG O
multipoint NN O
linkage NN O
analysis NN O
, , O
the DT O
combined JJ O
maximum JJ O
lod NN O
score NN O
for IN O
these DT O
two CD O
families NNS O
was VBD O
7 CD O
. . O

30 CD O
for IN O
a DT O
location NN O
of IN O
AIH1 NNP O
at IN O
2 CD O
cM NN O
distal NN O
to TO O
DXS16 NNP O
. . O

The DT O
support NN O
interval NN O
around IN O
this DT O
location NN O
extended VBD O
about IN O
8 CD O
cM NNS O
proximal JJ O
to TO O
DXS92 NNP O
, , O
and CC O
the DT O
AIH1 NNP O
location NN O
could MD O
not RB O
be VB O
precisely RB O
defined VBN O
by IN O
multipoint NN O
mapping NN O
. . O

Study NNP O
of IN O
recombination NN O
events NNS O
indicated VBD O
that IN O
AIH1 NNP O
lies VBZ O
in IN O
the DT O
interval NN O
between IN O
DXS143 NNP O
and CC O
DXS85 NNP O
. . O

There EX O
was VBD O
significant JJ O
evidence NN O
against IN O
linkage NN O
to TO O
this DT O
region NN O
in IN O
the DT O
third JJ O
family NN O
, , O
indicating VBG O
locus NN O
heterogeneity NN O
in IN O
XAI NNP B-Disease
. . O

Further JJ O
analysis NN O
with IN O
markers NNS O
on IN O
the DT O
long JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
showed VBD O
evidence NN O
of IN O
linkage NN O
to TO O
DXS144E NNP O
and CC O
F9 NNP O
with IN O
no DT O
recombination NN O
with IN O
either DT O
of IN O
these DT O
markers NNS O
. . O

Two CD O
- : O
point NN O
analysis NN O
gave VBD O
a DT O
peak JJ O
lod NN O
score NN O
at IN O
DXS144E NNP O
with IN O
a DT O
maximum JJ O
lod JJ O
score NN O
of IN O
2 CD O
. . O

83 CD O
at IN O
theta NN O
= NN O
0 CD O
, , O
with IN O
a DT O
peak JJ O
lod NN O
score NN O
in IN O
multipoint NN O
linkage NN O
analysis NN O
of IN O
2 CD O
. . O

84 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

The DT O
support NN O
interval NN O
extended VBD O
9 CD O
cM NN O
proximal NN O
to TO O
DXS144E NNP O
and CC O
14 CD O
cM NN O
distal NN O
to TO O
F9 NNP O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O
. . O

Multiple JJ O
origins NNS O
for IN O
phenylketonuria NN B-Disease
in IN O
Europe NNP O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
, , O
a DT O
disorder NN B-Disease
of IN I-Disease
amino NN I-Disease
acid JJ I-Disease
metabolism NN I-Disease
prevalent NN O
among IN O
Caucasians NNPS O
and CC O
other JJ O
ethnic JJ O
groups NNS O
, , O
is VBZ O
caused VBN O
primarily RB O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
hepatic JJ I-Disease
enzyme NN I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

PKU NNP B-Disease
is VBZ O
a DT O
highly RB O
heterogeneous JJ O
disorder NN O
, , O
with IN O
more JJR O
than IN O
60 CD O
molecular JJ O
lesions NNS O
identified VBN O
in IN O
the DT O
PAH NNP O
gene NN O
. . O

The DT O
haplotype NN O
associations NNS O
, , O
relative JJ O
frequencies NNS O
, , O
and CC O
distributions NNS O
of IN O
five CD O
prevalent JJ O
PAH NNP O
mutations NNS O
( ( O
R158Q NNP O
, , O
R261Q NNP O
, , O
IVS10nt546 NNP O
, , O
R408W NNP O
, , O
and CC O
IVS12n1 NNP O
) ) O
were VBD O
established VBN O
in IN O
a DT O
comprehensive JJ O
European JJ O
sample NN O
population NN O
and CC O
subsequently RB O
were VBD O
examined VBN O
to TO O
determine VB O
the DT O
potential JJ O
roles NNS O
of IN O
several JJ O
genetic JJ O
mechanisms NNS O
in IN O
explaining VBG O
the DT O
present JJ O
distribution NN O
of IN O
the DT O
major JJ O
PKU NNP B-Disease
alleles NNS O
. . O

Each DT O
of IN O
these DT O
five CD O
mutations NNS O
was VBD O
strongly RB O
associated VBN O
with IN O
only RB O
one CD O
of IN O
the DT O
more JJR O
than IN O
70 CD O
chromosomal JJ O
haplotypes NNS O
defined VBN O
by IN O
eight CD O
RFLPs NNP O
in IN O
or CC O
near IN O
the DT O
PAH NNP O
gene NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
each DT O
of IN O
these DT O
mutations NNS O
arose VBP O
through IN O
a DT O
single JJ O
founding NN O
event NN O
that WDT O
occurred VBD O
within IN O
time NN O
periods NNS O
ranging VBG O
from IN O
several JJ O
hundred CD O
to TO O
several JJ O
thousand CD O
years NNS O
ago RB O
. . O

From IN O
the DT O
significant JJ O
differences NNS O
observed VBN O
in IN O
the DT O
relative JJ O
frequencies NNS O
and CC O
distributions NNS O
of IN O
these DT O
five CD O
alleles NNS O
throughout IN O
Europe NNP O
, , O
four CD O
of IN O
these DT O
putative JJ O
founding NN O
events NNS O
could MD O
be VB O
localized VBN O
to TO O
specific VB O
ethnic JJ O
subgroups NNS O
. . O

Together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
there EX O
were VBD O
multiple NNS O
, , O
geographically RB O
and CC O
ethnically RB O
distinct JJ O
origins NNS O
for IN O
PKU NNP B-Disease
within IN O
the DT O
European JJ O
population NN O
. . O
. . O

Complement NNP B-Disease
factor NN I-Disease
2 CD I-Disease
deficiency NN I-Disease
: : O
a DT O
clinical JJ O
and CC O
serological JJ O
family NN O
study NN O
. . O

Inherited VBN B-Disease
complement NN I-Disease
deficiencies NNS I-Disease
are VBP O
associated VBN O
with IN O
a DT O
variety NN O
of IN O
connective JJ O
tissue NN O
diseases NNS O
. . O

A DT O
family NN O
with IN O
inherited JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
complement JJ I-Disease
factor NN I-Disease
2 CD I-Disease
( ( O
C2 NNP O
) ) O
is VBZ O
described VBN O
in IN O
which WDT O
two CD O
family NN O
members NNS O
with IN O
homozygous JJ O
C2 NNP B-Disease
deficiency NN I-Disease
developed VBD O
cutaneous JJ B-Disease
vasculitis NN I-Disease
and CC O
sicca JJ B-Disease
syndrome NN I-Disease
. . O

The DT O
other JJ O
family NN O
members NNS O
had VBD O
heterozygous JJ O
C2 NNP B-Disease
deficiency NN I-Disease
and CC O
each DT O
member NN O
had VBD O
the DT O
HLA NNP O
- : O
A25 NNP O
, , O
B18 NNP O
, , O
DR2 NNP O
( ( O
w15 NN O
) ) O
haplotype NN O
. . O

The DT O
mother NN O
had VBD O
seropositive JJ B-Disease
rheumatoid NN I-Disease
arthritis NN I-Disease
. . O

Further JJ O
studies NNS O
showed VBD O
the DT O
presence NN O
of IN O
cryoglobulins NNS O
, , O
antibodies NNS O
against IN O
endothelial JJ O
cells NNS O
, , O
and CC O
anticardiolipin JJ O
antibodies NNS O
. . O
. . O

New NNP O
variant NN O
in IN O
exon JJ O
3 CD O
of IN O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
in IN O
a DT O
family NN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

A DT O
C NNP O
- : O
- : O
greater JJR O
than IN O
G NNP O
transversion NN O
has VBZ O
been VBN O
found VBN O
in IN O
exon JJ O
3 CD O
of IN O
the DT O
PLP NNP O
gene NN O
of IN O
affected JJ O
males NNS O
and CC O
their PRP$ O
mother NN O
in IN O
a DT O
single JJ O
sibship NN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
merzbacher NN I-Disease
disease NN I-Disease
( ( O
PMD NNP B-Disease
) ) O
. . O

The DT O
transversion NN O
should MD O
not RB O
result VB O
in IN O
an DT O
amino NN O
acid NN O
change NN O
in IN O
the DT O
protein NN O
but CC O
it PRP O
does VBZ O
result VB O
in IN O
the DT O
loss NN O
of IN O
a DT O
HaeIII NNP O
restriction NN O
endonuclease NN O
cleavage NN O
site NN O
. . O

It PRP O
is VBZ O
concordant JJ O
with IN O
the DT O
disease NN O
in IN O
this DT O
family NN O
. . O

One CD O
- : O
hundred VBD O
- : O
ten NN O
unrelated JJ O
X NNP O
chromosomes NNS O
are VBP O
negative JJ O
for IN O
this DT O
mutation NN O
. . O

No DT O
other JJ O
sequence NN O
defect NN O
was VBD O
found VBN O
in IN O
the DT O
PLP NNP O
exons NNS O
of IN O
the DT O
affected JJ O
males NNS O
. . O

The DT O
cause NN O
of IN O
disease NN O
in IN O
this DT O
family NN O
remains VBZ O
unknown JJ O
, , O
but CC O
the DT O
association NN O
between IN O
this DT O
rare JJ O
mutation NN O
and CC O
PMD NNP B-Disease
is VBZ O
intriguing VBG O
. . O

The DT O
mutation NN O
can MD O
serve VB O
as IN O
a DT O
marker NN O
for IN O
following VBG O
segregation NN O
of IN O
the DT O
PLP NNP O
gene NN O
. . O
. . O

Uncoupling NN O
of IN O
hypomyelination NN B-Disease
and CC O
glial JJ B-Disease
cell NN I-Disease
death NN I-Disease
by IN O
a DT O
mutation NN O
in IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
. . O

Proteolipid NNP O
protein NN O
( ( O
PLP NNP O
; : O
M NNP O
( ( O
r NN O
) ) O
30 CD O
, , O
0 CD O
) ) O
is VBZ O
a DT O
highly RB O
conserved JJ O
major JJ O
polytopic NN O
membrane NN O
protein NN O
in IN O
myelin NN O
but CC O
its PRP$ O
cellular JJ O
function NN O
remains VBZ O
obscure JJ O
. . O

Neurological JJ O
mutant JJ O
mice NN O
can MD O
often RB O
provide VB O
model NN O
systems NNS O
for IN O
human JJ O
genetic JJ B-Disease
disorders NNS I-Disease
. . O

Mutations NNS O
of IN O
the DT O
X NNP O
- : O
chromosome NN O
- : O
linked VBN O
PLP NNP O
gene NN O
are VBP O
lethal JJ O
, , O
identified VBN O
first RB O
in IN O
the DT O
jimpy NN O
mouse NN O
and CC O
subsequently RB O
in IN O
patients NNS O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

The DT O
unexplained JJ O
phenotype NN O
of IN O
these DT O
mutations NNS O
includes VBZ O
degeneration NN B-Disease
and CC I-Disease
premature NN I-Disease
cell VBP I-Disease
death NN I-Disease
of IN I-Disease
oligodendrocytes NNS I-Disease
with IN O
associated JJ O
hypomyelination NN B-Disease
. . O

Here RB O
we PRP O
show VBP O
that IN O
a DT O
new JJ O
mouse NN O
mutant JJ O
rumpshaker NN O
is VBZ O
defined VBN O
by IN O
the DT O
amino NN O
- : O
acid NN O
substitution NN O
Ile NNP O
- : O
to TO O
- : O
Thr NN O
at IN O
residue JJ O
186 CD O
in IN O
a DT O
membrane NN O
- : O
embedded VBD O
domain NN O
of IN O
PLP NNP O
. . O

Surprisingly RB O
, , O
rumpshaker NN O
mice NN O
, , O
although IN O
myelin SYM B-Disease
- : I-Disease
deficient NN I-Disease
, , O
have VBP O
normal JJ O
longevity NN O
and CC O
a DT O
full JJ O
complement NN O
of IN O
morphologically RB O
normal JJ O
oligodendrocytes NNS O
. . O

Hypomyelination NN B-Disease
can MD O
thus RB O
be VB O
genetically RB O
separated VBN O
from IN O
the DT O
PLP NNP O
- : O
dependent NN O
oligodendrocyte JJ B-Disease
degeneration NN I-Disease
. . O

We PRP O
suggest VBP O
that IN O
PLP NNP O
has VBZ O
a DT O
vital JJ O
function NN O
in IN O
glial JJ O
cell NN O
development NN O
, , O
distinct NN O
from IN O
its PRP$ O
later JJ O
role NN O
in IN O
myelin NN O
assembly NN O
, , O
and CC O
that IN O
this DT O
dichotomy NN O
of IN O
action NN O
may MD O
explain VB O
the DT O
clinical JJ O
spectrum NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O
. . O

A DT O
pseudodeficiency NN O
allele JJ O
common JJ O
in IN O
non JJ O
- : O
Jewish JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
carriers NNS O
: : O
implications NNS O
for IN O
carrier NN O
screening NN O
. . O

Deficiency NN B-Disease
of IN I-Disease
beta NN I-Disease
- : I-Disease
hexosaminidase NN I-Disease
A NNP I-Disease
( ( O
Hex NNP O
A NNP O
) ) O
activity NN O
typically RB O
results NNS O
in IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
. . O

However RB O
, , O
healthy JJ O
subjects NNS O
found VBN O
to TO O
be VB O
deficient JJ B-Disease
in IN I-Disease
Hex NNP I-Disease
A NNP I-Disease
activity NN O
( ( O
i NN O
. . O
e NN O
. . O
, , O
pseudodeficient NN O
) ) O
by IN O
means NNS O
of IN O
in IN O
vitro JJ O
biochemical JJ O
tests NNS O
have VBP O
been VBN O
described VBN O
. . O

We PRP O
analyzed VBD O
the DT O
HEXA NNP O
gene NN O
of IN O
one CD O
pseudodeficient NN O
subject NN O
and CC O
identified VBD O
both DT O
a DT O
C739 NNP O
- : O
to TO O
- : O
T NNP O
substitution NN O
that IN O
changes VBZ O
Arg247 NNP O
- : O
- : O
- : O
- : O
Trp NN O
on IN O
one CD O
allele NN O
and CC O
a DT O
previously RB O
identified VBN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
mutation NN O
on IN O
the DT O
second JJ O
allele NN O
. . O

Six NNP O
additional JJ O
pseudodeficient NN O
subjects NNS O
were VBD O
found VBN O
to TO O
have VB O
the DT O
C739 NNP O
- : O
to TO O
- : O
T NNP O
mutation NN O
. . O

This DT O
allele NN O
accounted VBD O
for IN O
32 CD O
% NN O
( ( O
20 CD O
/ RB O
62 CD O
) ) O
of IN O
non NN O
- : O
Jewish JJ O
enzyme SYM O
- : O
defined VBN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
carriers NNS O
but CC O
for IN O
none NN O
of IN O
36 CD O
Jewish JJ O
enzyme SYM O
- : O
defined VBN O
carriers NNS O
who WP O
did VBD O
not RB O
have VB O
one CD O
of IN O
three CD O
known JJ O
mutations NNS O
common JJ O
to TO O
this DT O
group NN O
. . O

The DT O
C739 NNP O
- : O
to TO O
- : O
T NNP O
allele NN O
, , O
together RB O
with IN O
a DT O
"""" JJ O
true JJ O
"""" NN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
allele NN O
, , O
causes VBZ O
Hex NNP O
A NNP O
pseudodeficiency NN O
. . O

Given VBN O
both DT O
the DT O
large JJ O
proportion NN O
of IN O
non JJ O
- : O
Jewish JJ O
carriers NNS O
with IN O
this DT O
allele NN O
and CC O
that DT O
standard JJ O
biochemical JJ O
screening NN O
cannot NN O
differentiate NN O
between IN O
heterozygotes NNS O
for IN O
the DT O
C739 NNP O
- : O
to TO O
- : O
T NNP O
mutations NNS O
and CC O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
carriers NNS O
, , O
DNA NNP O
testing VBG O
for IN O
this DT O
mutation NN O
in IN O
at IN O
- : O
risk NN O
couples NNS O
is VBZ O
essential JJ O
. . O

Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
: : O
detection NN O
of IN O
mutations NNS O
Thr181 NNP O
- : O
- : O
- : O
- : O
Pro NN O
and CC O
Leu223 NNP O
- : O
- : O
- : O
- : O
Pro NN O
in IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
, , O
and CC O
prenatal JJ O
diagnosis NN O
. . O

A DT O
family NN O
with IN O
an DT O
apparent JJ O
history NN O
of IN O
X NNP O
- : O
linked VBN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
presented VBN O
for IN O
genetic JJ O
counseling NN O
, , O
requesting VBG O
carrier NN O
detection NN O
and CC O
prenatal JJ O
diagnosis NN O
. . O

RFLP NNP O
analysis NN O
using VBG O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
probe NN O
was VBD O
uninformative JJ O
in IN O
this DT O
family NN O
. . O

A DT O
prenatal JJ O
diagnosis NN O
on IN O
a DT O
chorionic JJ O
villus NN O
sample NN O
( ( O
CVS NNP O
) ) O
was VBD O
carried VBN O
out RP O
using VBG O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
analysis NN O
of IN O
a DT O
variant NN O
in IN O
exon JJ O
4 CD O
of IN O
the DT O
PLP NNP O
gene NN O
. . O

The DT O
fetus NN O
was VBD O
predicted VBN O
to TO O
be VB O
unaffected VBN O
. . O

Sequencing VBG O
of IN O
the DT O
exon NN O
from IN O
the DT O
CVS NNP O
, , O
the DT O
predicted VBN O
- : O
carrier NN O
mother NN O
, , O
and CC O
the DT O
obligate JJ O
- : O
carrier NN O
grandmother NN O
revealed VBD O
an DT O
A NNP O
- : O
to TO O
- : O
C NNP O
change NN O
at IN O
nucleotide JJ O
541 CD O
in IN O
the DT O
two CD O
women NNS O
but CC O
not RB O
in IN O
the DT O
fetus NN O
. . O

As IN O
this DT O
change NN O
results NNS O
in IN O
a DT O
Thr NNP O
- : O
to TO O
- : O
Pro VB O
change NN O
at IN O
amino NN O
acid VBP O
181 CD O
in IN O
a DT O
region NN O
of IN O
the DT O
gene NN O
predicted VBD O
to TO O
be VB O
part NN O
of IN O
a DT O
transmembrane NN O
segment NN O
, , O
it PRP O
was VBD O
concluded VBN O
that IN O
this DT O
was VBD O
the DT O
mutation NN O
causing VBG O
the DT O
disease NN O
in IN O
this DT O
family NN O
. . O

In IN O
addition NN O
, , O
in IN O
a DT O
second JJ O
family NN O
, , O
an DT O
exon JJ O
5 CD O
variant JJ O
band NN O
pattern NN O
on IN O
SSCP NNP O
analysis NN O
was VBD O
shown VBN O
by IN O
sequencing VBG O
to TO O
be VB O
due JJ O
to TO O
a DT O
T NNP O
- : O
to TO O
- : O
C NNP O
change NN O
at IN O
nucleotide JJ O
668 CD O
. . O

This DT O
results NNS O
in IN O
a DT O
Leu NNP O
- : O
to TO O
- : O
Pro NNP O
change NN O
in IN O
a DT O
carrier NN O
mother NN O
and CC O
in IN O
her PRP$ O
two CD O
affected JJ O
sons NNS O
. . O

These DT O
results NNS O
provide VBP O
further JJ O
examples NNS O
of IN O
mutations NNS O
in IN O
PLP NNP O
that IN O
cause NN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
and CC O
illustrate VB O
the DT O
value NN O
of IN O
SSCP NNP O
in IN O
genetic JJ O
analysis NN O
. . O
. . O

von NN B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
type NN I-Disease
B NNP I-Disease
: : O
a DT O
missense NN O
mutation NN O
selectively RB O
abolishes VBZ O
ristocetin JJ O
- : O
induced JJ O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
binding VBG O
to TO O
platelet VB O
glycoprotein JJ O
Ib NNP O
. . O

von NN B-Disease
Willebrand NNP I-Disease
factor NN O
( ( O
vWF NN O
) ) O
is VBZ O
a DT O
multimeric JJ O
glycoprotein NN O
that WDT O
mediates VBZ O
the DT O
adhesion NN O
of IN O
platelets NNS O
to TO O
the DT O
subendothelium NN O
by IN O
binding VBG O
to TO O
platelet VB O
glycoprotein JJ O
Ib NNP O
. . O

For IN O
human JJ O
vWF NN O
, , O
this DT O
interaction NN O
can MD O
be VB O
induced VBN O
in IN O
vitro NN O
by IN O
the DT O
antibiotic JJ O
ristocetin NN O
or CC O
the DT O
snake JJ O
venom NN O
protein NN O
botrocetin NN O
. . O

A DT O
missense NN O
mutation NN O
, , O
Gly NNP O
- : O
561 CD O
- : O
- : O
> NN O
Ser NNP O
, , O
was VBD O
identified VBN O
within IN O
the DT O
proposed VBN O
glycoprotein NN O
Ib NNP O
binding VBG O
domain NN O
of IN O
vWF NN O
in IN O
the DT O
proband NN O
with IN O
von JJ B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
type NN I-Disease
B NNP I-Disease
, , O
a DT O
unique JJ O
variant NN O
characterized VBN O
by IN O
no DT O
ristocetin NN O
- : O
induced JJ O
, , O
but CC O
normal JJ O
botrocetin SYM O
- : O
induced VBN O
, , O
binding VBG O
to TO O
glycoprotein VB O
Ib NNP O
. . O

The DT O
corresponding JJ O
mutant NN O
recombinant NN O
protein NN O
, , O
rvWF NN O
( ( O
G561S NNP O
) ) O
, , O
formed VBN O
normal JJ O
multimers NNS O
and CC O
exhibited VBD O
the DT O
same JJ O
functional JJ O
defect NN O
as IN O
the DT O
patients NNS O
plasma VBP O
vWF NN O
, , O
confirming VBG O
that IN O
this DT O
mutation NN O
causes VBZ O
von JJ B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
type NN I-Disease
B NNP I-Disease
. . O

These DT O
data NNS O
show VBP O
that IN O
botrocetin NN O
and CC O
ristocetin NN O
cofactor NN O
activities NNS O
of IN O
vWF NN O
can MD O
be VB O
dissociated VBN O
by IN O
a DT O
point NN O
mutation NN O
and CC O
confirm NN O
that IN O
these DT O
mediators NNS O
promote VBP O
vWF JJ O
binding NN O
to TO O
platelets NNS O
by IN O
different JJ O
mechanisms NNS O
. . O

The DT O
normal JJ O
botrocetin NN O
- : O
induced JJ O
binding NN O
and CC O
the DT O
defective JJ O
ristocetin NN O
- : O
induced JJ O
binding NN O
of IN O
rvWF NN O
( ( O
G561S NNP O
) ) O
suggest VBP O
that IN O
the DT O
primary JJ O
defect NN O
in IN O
von JJ B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
type NN I-Disease
B NNP I-Disease
may MD O
be VB O
a DT O
failure NN O
of IN O
normal JJ O
allosteric JJ O
regulation NN O
of IN O
the DT O
glycoprotein NN O
Ib NNP O
binding VBG O
function NN O
of IN O
vWF NN O
. . O
. . O

Typical JJ O
and CC O
partial JJ O
cat NN B-Disease
eye NN I-Disease
syndrome NN I-Disease
: : O
identification NN O
of IN O
the DT O
marker NN O
chromosome NN O
by IN O
FISH NNP O
. . O

Three CD O
children NNS O
are VBP O
reported VBN O
with IN O
typical JJ O
cat NN B-Disease
eye NN I-Disease
syndrome NN I-Disease
( ( O
CES NNP B-Disease
) ) O
and CC O
three CD O
more JJR O
children NNS O
with IN O
partial JJ O
CES NNP B-Disease
because IN O
of IN O
absence NN O
of IN O
coloboma NN O
, , O
in IN O
which WDT O
the DT O
supernumerary NN O
marker NN O
chromosome NN O
was VBD O
studied VBN O
by IN O
FISH NNP O
. . O

Using VBG O
a DT O
genomic JJ O
library NN O
, , O
and CC O
also RB O
a DT O
centromeric JJ O
and CC O
particularly RB O
a DT O
cosmid JJ O
probe NN O
of IN O
22q11 CD O
, , O
partial JJ O
tetrasomy NN B-Disease
was VBD O
shown VBN O
in IN O
all DT O
cases NNS O
. . O
. . O

[ JJ O
Genetic NNP O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
: : O
mutant JJ O
alleles NNS O
of IN O
G6PD NNP O
in IN O
the DT O
Shekii NNP O
district NN O
of IN O
Azerbaijan NNP O
] NNP O

Examination NN O
on IN O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
349 CD O
patients NNS O
of IN O
Shekii NNP O
district NN O
hospital NN O
( ( O
Azerbaijan NNP O
) ) O
revealed VBD O
16 CD O
hemi NN O
- : O
, , O
4 CD O
homo NN O
- : O
and CC O
9 CD O
heterozygotic JJ O
carriers NNS O
of IN O
the DT O
defect NN O
. . O

Gd NNP O
- : O
frequency NN O
, , O
calculated VBN O
from IN O
the DT O
data NNS O
obtained VBD O
( ( O
7 CD O
. . O
7 CD O
% NN O
) ) O
, , O
may MD O
be VB O
compared VBN O
to TO O
neighbouring VBG O
regions NNS O
frequencies NNS O
( ( O
6 CD O
- : O
30 CD O
% NN O
) ) O
. . O

Carriers NNS O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
are VBP O
residents NNS O
of IN O
11 CD O
villages NNS O
located VBN O
in IN O
Alasani NNP O
- : O
Aphtalan NNP O
valley NNP O
, , O
highly RB O
endemic JJ O
with IN O
malaria NNS B-Disease
in IN O
the DT O
past NN O
; : O
nearly RB O
all DT O
marriages NNS O
are VBP O
endogamic JJ O
. . O

Physico NNP O
- : O
chemical NN O
and CC O
kinetic JJ O
study NN O
of IN O
10 CD O
mutant JJ O
forms NNS O
of IN O
G6PD NNP O
, , O
according VBG O
to TO O
WHO NNP O
program NN O
, , O
led VBD O
to TO O
identification NN O
of IN O
5 CD O
variants NNS O
of IN O
the DT O
II NNP O
class NN O
( ( O
Shekii NNP O
, , O
Bideiz NNP O
, , O
Shirin NNP O
- : O
Bulakh NNP O
, , O
Okhut NNP O
I PRP O
and CC O
Zakataly NNP O
) ) O
and CC O
2 CD O
variants NNS O
of IN O
the DT O
III NNP O
class NN O
( ( O
Okhut NNP O
II NNP O
and CC O
Martinique NNP O
- : O
like IN O
) ) O
. . O

Resemblance NN O
of IN O
the DT O
majority NN O
of IN O
variants NNS O
in IN O
electrophoretic JJ O
mobility NN O
and CC O
the DT O
level NN O
of IN O
erythrocyte JJ O
enzyme JJ O
activity NN O
permit NN O
to TO O
suggest VB O
the DT O
existence NN O
of IN O
a DT O
common JJ O
parental NN O
mutant JJ O
G6PD NNP O
allele NN O
distributed VBN O
in IN O
this DT O
area NN O
. . O

Craniofrontonasal NNP B-Disease
dysplasia NN I-Disease
. . O

We PRP O
report VBP O
on IN O
nine CD O
patients NNS O
with IN O
craniofrontonasal JJ B-Disease
dysplasia NN I-Disease
( ( O
CFND NNP B-Disease
) ) O
. . O

Seven RB O
classical JJ O
cases NNS O
had VBD O
facial JJ O
features NNS O
suggestive VBP O
of IN O
frontonasal NN B-Disease
dysplasia NN I-Disease
and CC O
coronal JJ B-Disease
craniosynostosis NN I-Disease
. . O

Extracranial JJ B-Disease
abnormalities NNS I-Disease
such JJ O
as IN O
brittle JJ B-Disease
nails NNS I-Disease
with IN I-Disease
prominent JJ I-Disease
longitudinal JJ I-Disease
grooves NNS I-Disease
or CC O
syndactyly NN B-Disease
of IN I-Disease
fingers NNS I-Disease
and CC I-Disease
toes NNS I-Disease
were VBD O
observed VBN O
in IN O
individual JJ O
patients NNS O
. . O

In IN O
two CD O
families NNS O
the DT O
father NN O
of IN O
classical JJ O
cases NNS O
showed VBD O
a DT O
milder NN O
pattern NN O
of IN O
abnormalities NNS O
, , O
consistent NN O
with IN O
the DT O
diagnosis NN O
. . O

We PRP O
present VBP O
a DT O
2 CD O
- : O
to TO O
13 CD O
- : O
year NN O
follow SYM O
- : O
up RB O
on IN O
our PRP$ O
patients NNS O
. . O

Hypotonia NNP B-Disease
and CC O
laxity NN B-Disease
of IN I-Disease
joints NNS I-Disease
are VBP O
common JJ O
and CC O
may MD O
necessitate VB O
supportive JJ O
measures NNS O
. . O

Mild NNP O
developmental JJ B-Disease
delay NN I-Disease
was VBD O
noted VBN O
in IN O
three CD O
out IN O
of IN O
six CD O
classical JJ O
cases NNS O
studied VBN O
in IN O
detail NN O
. . O

Unlike IN O
almost RB O
all DT O
other JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
disorders NNS I-Disease
, , O
clinical JJ O
expression NN O
in IN O
CFND NNP B-Disease
is VBZ O
generally RB O
much RB O
more RBR O
severe JJ O
in IN O
females NNS O
than IN O
in IN O
males NNS O
. . O

In IN O
contrast NN O
to TO O
previous JJ O
reports NNS O
of IN O
this DT O
condition NN O
, , O
one CD O
of IN O
our PRP$ O
severely RB O
affected JJ O
cases NNS O
is VBZ O
a DT O
male NN O
. . O
. . O

The DT O
intron NN O
7 CD O
donor NN O
splice NN O
site NN O
transition NN O
: : O
a DT O
second JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
mutation NN O
in IN O
French NNP O
Canada NNP O
. . O

Mutations NNS O
at IN O
the DT O
hexosaminidase NN O
A NNP O
( ( O
HEXA NNP O
) ) O
gene NN O
which WDT O
cause VBP O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
have VBP O
elevated VBN O
frequency NN O
in IN O
the DT O
Ashkenazi NNP O
Jewish NNP O
and CC O
French NNP O
- : O
Canadian JJ O
populations NNS O
. . O

We PRP O
report VBP O
a DT O
novel JJ O
TSD NNP B-Disease
allele NN O
in IN O
the DT O
French JJ O
- : O
Canadian JJ O
population NN O
associated VBN O
with IN O
the DT O
infantile JJ O
form NN O
of IN O
the DT O
disease NN O
. . O

The DT O
mutation NN O
, , O
a DT O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
at IN O
the DT O
+ NN O
1 CD O
position NN O
of IN O
intron NN O
7 CD O
, , O
abolishes VBZ O
the DT O
donor NN O
splice NN O
site NN O
. . O

Cultured NNP O
human JJ O
fibroblasts NNS O
from IN O
a DT O
compound NN O
heterozygote NN O
for IN O
this DT O
transition NN O
( ( O
and CC O
for IN O
a DT O
deletion NN O
mutation NN O
) ) O
produce VBP O
no DT O
detectable JJ O
HEXA NNP O
mRNA NN O
. . O

The DT O
intron NN O
7 CD O
+ NN O
1 CD O
mutation NN O
occurs NNS O
in IN O
the DT O
base NN O
adjacent NN O
to TO O
the DT O
site NN O
of IN O
the DT O
adult NN O
- : O
onset NN O
TSD NNP B-Disease
mutation NN O
( ( O
G805A NNP O
) ) O
. . O

In IN O
both DT O
mutations NNS O
a DT O
restriction NN O
site NN O
for IN O
the DT O
endonuclease NN O
EcoRII NNP O
is VBZ O
abolished VBN O
. . O

Unambiguous JJ O
diagnosis NN O
, , O
therefore RB O
, , O
requires VBZ O
allele SYM O
- : O
specific JJ O
oligonucleotide JJ O
hybridization NN O
to TO O
distinguish VB O
between IN O
these DT O
two CD O
mutant NN O
alleles NNS O
. . O

The DT O
intron NN O
7 CD O
+ NN O
1 CD O
mutation NN O
has VBZ O
been VBN O
detected VBN O
in IN O
three CD O
unrelated JJ O
families NNS O
. . O

Obligate NNP O
heterozygotes NNS O
for IN O
the DT O
intron NN O
7 CD O
+ NN O
1 CD O
mutation NN O
were VBD O
born VBN O
in IN O
the DT O
Saguenay NNP O
- : O
Lac NNP O
- : O
St NNP O
- : O
Jean JJ O
region NN O
of IN O
Quebec NNP O
. . O

The DT O
most RBS O
recent JJ O
ancestors NNS O
common JJ O
to TO O
obligate VB O
carriers NNS O
of IN O
this DT O
mutation NN O
were VBD O
from IN O
the DT O
Charlevoix NNP O
region NN O
of IN O
the DT O
province NN O
of IN O
Quebec NNP O
. . O

This DT O
mutation NN O
thus RB O
has VBZ O
a DT O
different JJ O
geographic JJ O
centre NN O
of IN O
diffusion NN O
and CC O
is VBZ O
probably RB O
less RBR O
common JJ O
than IN O
the DT O
exon JJ O
1 CD O
deletion NN O
TSD NNP B-Disease
mutation NN O
in IN O
French JJ O
Canadians NNPS O
. . O

Neither DT O
mutation NN O
has VBZ O
been VBN O
detected VBN O
in IN O
France NNP O
, , O
the DT O
ancestral JJ O
homeland NN O
of IN O
French NNP O
Canada NNP O
. . O
. . O

Assignment NN O
of IN O
the DT O
aspartylglucosaminidase NN O
gene NN O
( ( O
AGA NNP O
) ) O
to TO O
4q33 CD O
- : O
- : O
- : O
- : O
q35 NN O
based VBN O
on IN O
decreased JJ O
activity NN O
in IN O
a DT O
girl NN O
with IN O
a DT O
46 CD O
, , O
XX NNP O
, , O
del NN O
( ( O
4 CD O
) ) O
( ( O
q33 NN O
) ) O
karyotype NN O
. . O

Aspartylglucosaminuria NNP B-Disease
( ( O
AGU NNP B-Disease
) ) O
is VBZ O
a DT O
recessive JJ O
autosomally RB O
inherited VBN O
lysosomal JJ B-Disease
storage NN I-Disease
disorder NN I-Disease
due JJ O
to TO O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
enzyme JJ I-Disease
aspartylglucosaminidase NN I-Disease
( ( O
AGA NNP O
) ) O
. . O

The DT O
structural JJ O
gene NN O
for IN O
this DT O
human JJ O
enzyme NN O
( ( O
AGA NNP O
) ) O
has VBZ O
been VBN O
assigned VBN O
to TO O
the DT O
region NN O
4q21 CD O
- : O
- : O
- : O
- : O
qter NN O
. . O

We PRP O
determined VBD O
the DT O
AGA NNP O
activity NN O
in IN O
cultured JJ O
fibroblasts NNS O
of IN O
a DT O
girl NN O
with IN O
a DT O
46 CD O
, , O
XX NNP O
, , O
del NN O
( ( O
4 CD O
) ) O
( ( O
q33 NN O
) ) O
karyotype NN O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
girl NN O
is VBZ O
a DT O
hemizygote NN O
for IN O
AGA NNP O
, , O
permitting VBG O
the DT O
assignment NN O
of IN O
human JJ O
AGA NNP O
to TO O
the DT O
region NN O
4q33 CD O
- : O
- : O
- : O
- : O
qter NN O
. . O
. . O

Resolution NN O
of IN O
the DT O
two CD O
loci NN O
for IN O
autosomal JJ O
dominant JJ O
aniridia NN B-Disease
, , O
AN1 NNP O
and CC O
AN2 NNP O
, , O
to TO O
a DT O
single JJ O
locus NN O
on IN O
chromosome NN O
11p13 CD O
. . O

Two CD O
distinct JJ O
loci NNS O
have VBP O
been VBN O
proposed VBN O
for IN O
aniridia NN B-Disease
; : O
AN1 NNP O
for IN O
autosomal JJ O
dominant JJ O
aniridia NN B-Disease
on IN O
chromosome NN O
2p CD O
and CC O
AN2 NNP O
for IN O
the DT O
aniridia NN B-Disease
in IN O
the DT O
WAGR NNP B-Disease
contiguous JJ I-Disease
gene NN I-Disease
syndrome NN I-Disease
on IN O
chromosome NN O
11p13 CD O
. . O

In IN O
this DT O
report NN O
, , O
the DT O
kindred JJ O
segregating NN O
for IN O
autosomal JJ O
dominant JJ O
aniridia NN B-Disease
, , O
which WDT O
suggested VBD O
linkage NN O
to TO O
acid VB O
phosphatase NN O
- : O
1 CD O
( ( O
ACP1 NNP O
) ) O
and CC O
led VBN O
to TO O
the DT O
assignment NN O
of IN O
the DT O
AN1 NNP O
locus NN O
on IN O
chromosome NN O
2p CD O
, , O
has VBZ O
been VBN O
updated VBN O
and CC O
expanded VBN O
. . O

Linkage NN O
analysis NN O
between IN O
the DT O
aniridia NN B-Disease
phenotype NN O
and CC O
ACP1 NNP O
does VBZ O
not RB O
support VB O
the DT O
original JJ O
linkage NN O
results NNS O
, , O
excluding VBG O
linkage NN O
up RB O
to TO O
theta VB O
= JJ O
0 CD O
. . O

17 CD O
with IN O
Z NNP O
= NNP O
- : O
2 CD O
. . O

Tests NNS O
for IN O
linkage NN O
to TO O
other JJ O
chromosome NN O
2p CD O
markers NNS O
. . O

APOB NNP O
, , O
D2S71 NNP O
, , O
D2S5 NNP O
, , O
and CC O
D2S1 NNP O
, , O
also RB O
excluded VBD O
linkage NN O
to TO O
aniridia VB B-Disease
. . O

Markers NNS O
that WDT O
have VBP O
been VBN O
isolated VBN O
from IN O
the DT O
chromosome NN O
11p13 CD O
region NN O
were VBD O
then RB O
analyzed VBN O
in IN O
this DT O
aniridia JJ B-Disease
family NN O
. . O

Two CD O
RFLPs NNP O
at IN O
the DT O
D11S323 NNP O
locus NN O
give VBP O
significant JJ O
evidence NN O
for IN O
linkage NN O
. . O

The DT O
PvuII NNP O
polymorphism NN O
detected VBN O
by IN O
probe NN O
p5S1 NN O
. . O

6 CD O
detects VBZ O
no DT O
recombinants NNS O
, , O
with IN O
a DT O
maximum JJ O
lod JJ O
score NN O
of IN O
Z NNP O
= NNP O
6 CD O
. . O

97 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

0 CD O
0 CD O
. . O

The DT O
HaeIII NNP O
polymorphism NN O
detected VBN O
by IN O
the DT O
probe NN O
p5BE1 NN O
. . O

2 CD O
gives VBZ O
a DT O
maximum JJ O
lod JJ O
score NN O
of IN O
Z NNP O
= NNP O
2 CD O
. . O

57 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

0 CD O
0 CD O
. . O

Locus NNP O
D11S325 NNP O
gives VBZ O
a DT O
lod JJ O
score NN O
of IN O
Z NNP O
= NNP O
1 CD O
. . O

53 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

0 CD O
0 CD O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
a DT O
locus NN O
for IN O
aniridia NN B-Disease
( ( O
AN1 NNP O
) ) O
on IN O
chromosome NN O
2p CD O
has VBZ O
been VBN O
misassigned VBN O
and CC O
that IN O
this DT O
autosomal JJ O
dominant JJ O
aniridia JJ B-Disease
family NN O
is VBZ O
segregating VBG O
for IN O
an DT O
aniridia JJ B-Disease
mutation NN O
linked VBD O
to TO O
markers NNS O
in IN O
the DT O
11p13 CD O
region NN O
. . O

Fatal NNP O
pyoderma NN B-Disease
gangrenosum NN I-Disease
in IN O
association NN O
with IN O
C7 NNP B-Disease
deficiency NN I-Disease
. . O

Although IN O
pyoderma JJ B-Disease
gangrenosum NN I-Disease
( ( O
PG NNP B-Disease
) ) O
is VBZ O
often RB O
associated VBN O
with IN O
systemic JJ B-Disease
diseases NNS I-Disease
, , O
it PRP O
has VBZ O
not RB O
been VBN O
reported VBN O
in IN O
association NN O
with IN O
congenital JJ B-Disease
complement NN I-Disease
deficiencies NNS I-Disease
. . O

We PRP O
describe VBP O
an DT O
aggressive JJ O
and CC O
ultimately RB O
fatal JJ O
case NN O
of IN O
PG NNP B-Disease
in IN O
a DT O
patient NN O
with IN O
a DT O
congenital JJ O
C7 NNP B-Disease
deficiency NN I-Disease
. . O

Deficiencies NNS B-Disease
of IN I-Disease
C7 NNP I-Disease
can MD O
be VB O
associated VBN O
with IN O
decreased JJ O
neutrophil NN O
chemotaxis NN O
, , O
phagocytosis NN O
, , O
and CC O
opsonization NN O
, , O
similar JJ O
to TO O
the DT O
immunologic JJ B-Disease
abnormalities NNS I-Disease
described VBN O
in IN O
patients NNS O
with IN O
PG NNP B-Disease
. . O

Our PRP$ O
patients NNS O
decreased VBN O
complement JJ O
level NN O
, , O
if IN O
not RB O
directly RB O
related VBN O
to TO O
the DT O
development NN O
of IN O
PG NNP B-Disease
, , O
may MD O
have VB O
contributed VBN O
to TO O
the DT O
aggressive JJ O
nature NN O
of IN O
her PRP$ O
disease NN O
. . O
. . O

Diverse NNP O
point NN O
mutations NNS O
result VBP O
in IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
polymorphism NN O
in IN O
Taiwan NNP O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
PHOSPHATE NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
; : I-Disease
EC NNP I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
49 CD I-Disease
) ) I-Disease
deficiency NN I-Disease
is VBZ O
the DT O
most RBS O
common JJ O
human JJ O
enzymopathy NN B-Disease
, , O
affecting VBG O
more JJR O
than IN O
200 CD O
million CD O
people NNS O
worldwide VBP O
. . O

Although IN O
greater JJR O
than IN O
400 CD O
variants NNS O
have VBP O
been VBN O
described VBN O
based VBN O
on IN O
clinical JJ O
and CC O
biochemical JJ O
criteria NNS O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
molecular JJ O
basis NN O
of IN O
these DT O
G6PD NNP B-Disease
deficiencies NNS I-Disease
. . O

Recently RB O
, , O
the DT O
gene NN O
that WDT O
encodes VBZ O
human JJ O
G6PD NNP O
has VBZ O
been VBN O
cloned VBN O
and CC O
sequenced VBN O
, , O
which WDT O
enables VBZ O
us PRP O
to TO O
examine VB O
directly RB O
the DT O
heterogeneity NN O
of IN O
G6PD NNP O
at IN O
the DT O
DNA NNP O
level NN O
. . O

During IN O
the DT O
past JJ O
10 CD O
years NNS O
, , O
we PRP O
examined VBD O
the DT O
G6PD NNP O
activity NN O
in IN O
21 CD O
, , O
271 CD O
newborn JJ O
Chinese JJ O
infants NNS O
( ( O
11 CD O
, , O
400 CD O
males NNS O
and CC O
9 CD O
, , O
871 CD O
females NNS O
) ) O
and CC O
identified VBN O
314 CD O
( ( O
2 CD O
. . O
8 CD O
% NN O
) ) O
males NNS O
and CC O
246 CD O
( ( O
2 CD O
. . O
5 CD O
% NN O
) ) O
females VBZ O
having VBG O
low JJ O
G6PD NNP O
activity NN O
. . O

The DT O
G6PD NNP O
gene NN O
from IN O
10 CD O
randomly RB O
selected VBN O
affected JJ O
individuals NNS O
and CC O
their PRP$ O
relatives NNS O
was VBD O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
amplified VBD O
, , O
subcloned VBD O
, , O
and CC O
sequenced VBD O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that DT O
at IN O
least JJS O
four CD O
types NNS O
of IN O
mutation NN O
are VBP O
responsible JJ O
for IN O
the DT O
G6PD NNP O
polymorphism NN O
in IN O
Taiwan NNP O
. . O

The DT O
first JJ O
type NN O
of IN O
mutation NN O
( ( O
487 CD O
G NNP O
- : O
- : O
- : O
- : O
A DT O
) ) O
was VBD O
found VBN O
in IN O
an DT O
affected JJ O
Chinese JJ O
with IN O
a DT O
G NNP O
to TO O
A DT O
change NN O
at IN O
nucleotide JJ O
487 CD O
, , O
which WDT O
results NNS O
in IN O
a DT O
( ( O
163 CD O
) ) O
Gly NNP O
to TO O
Ser NNP O
substitution NN O
. . O

The DT O
second JJ O
type NN O
of IN O
mutation NN O
( ( O
493 CD O
A NNP O
- : O
- : O
- : O
- : O
G NN O
) ) O
is VBZ O
a DT O
novel JJ O
mutation NN O
that WDT O
has VBZ O
not RB O
been VBN O
reported VBN O
in IN O
any DT O
other JJ O
ethnic JJ O
group NN O
and CC O
was VBD O
identified VBN O
in IN O
two CD O
affected JJ O
Chinese NNPS O
. . O

This DT O
mutation NN O
causes VBZ O
an DT O
A NN O
to TO O
G NNP O
change NN O
at IN O
nucleotide JJ O
position NN O
493 CD O
, , O
producing VBG O
an DT O
( ( O
165 CD O
) ) O
Asn NNP O
to TO O
Asp NNP O
substitution NN O
. . O

Interestingly RB O
, , O
the DT O
487 CD O
G NNP O
- : O
- : O
- : O
- : O
A DT O
and CC O
493 CD O
A NNP O
- : O
- : O
- : O
- : O
G NNP O
mutations NNS O
create VBP O
Alu NNP O
I PRP O
and CC O
Ava NNP O
II NNP O
recognition NN O
sites NNS O
, , O
respectively RB O
, , O
which WDT O
enabled VBD O
us PRP O
to TO O
rapidly RB O
detect VB O
these DT O
two CD O
mutations NNS O
by IN O
PCR NNP O
/ NNP O
restriction NN O
enzyme NN O
( ( O
RE NNP O
) ) O
digestion NN O
method NN O
. . O

The DT O
third JJ O
mutation NN O
( ( O
1376 CD O
G NNP O
- : O
- : O
- : O
- : O
T NN O
) ) O
was VBD O
found VBN O
in IN O
four CD O
affected JJ O
Chinese NNP O
. . O

This DT O
mutation NN O
causes VBZ O
a DT O
G NNP O
to TO O
T VB O
change NN O
at IN O
nucleotide JJ O
position NN O
1376 CD O
that WDT O
results NNS O
in IN O
an DT O
( ( O
459 CD O
) ) O
Arg NNP O
to TO O
Leu NNP O
substitution NN O
. . O

The DT O
1376 CD O
G NNP O
- : O
- : O
- : O
- : O
T NN O
mutation NN O
seems VBZ O
to TO O
be VB O
the DT O
dominant JJ O
allele NN O
that WDT O
causes VBZ O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
Taiwan NNP O
. . O

Finally RB O
, , O
two CD O
affected VBD O
Chinese NNPS O
were VBD O
identified VBN O
as IN O
having VBG O
the DT O
fourth JJ O
mutation NN O
( ( O
1388 CD O
G NNP O
- : O
- : O
- : O
- : O
A DT O
) ) O
. . O

This DT O
mutation NN O
causes VBZ O
a DT O
G NNP O
to TO O
A DT O
change NN O
at IN O
nucleotide JJ O
1388 CD O
that WDT O
produces VBZ O
an DT O
( ( O
463 CD O
) ) O
Arg NN O
to TO O
His PRP$ O
substitution NN O
. . O

Our PRP$ O
studies NNS O
provide VBP O
the DT O
direct JJ O
proof NN O
of IN O
the DT O
genetic JJ O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
the DT O
Chinese JJ O
populations NNS O
of IN O
Taiwan NNP O
and CC O
the DT O
PCR NNP O
/ NNP O
RE NNP O
digestion NN O
method NN O
is VBZ O
suitable JJ O
for IN O
simultaneous JJ O
detection NN O
of IN O
the DT O
487 CD O
G NNP O
- : O
- : O
- : O
- : O
A DT O
and CC O
493 CD O
A NNP O
- : O
- : O
- : O
- : O
G NN O
mutations NNS O
. . O

An DT O
error NN O
in IN O
dystrophin JJ O
mRNA NN O
processing NN O
in IN O
golden JJ B-Disease
retriever NN I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
, , O
an DT O
animal JJ O
homologue NN O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Golden NNP B-Disease
retriever NN I-Disease
muscular NN I-Disease
dystrophy NN I-Disease
( ( O
GRMD NNP B-Disease
) ) O
is VBZ O
a DT O
spontaneous JJ O
, , O
X NNP O
- : O
linked VBN O
, , O
progressively RB O
fatal JJ O
disease NN O
of IN O
dogs NNS O
and CC O
is VBZ O
also RB O
a DT O
homologue NN O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

Two CD O
- : O
thirds NNS O
of IN O
DMD NNP B-Disease
patients NNS O
carry VBP O
detectable JJ O
deletions NNS O
in IN O
their PRP$ O
dystrophin JJ O
gene NN O
. . O

The DT O
defect NN O
underlying VBG O
the DT O
remaining VBG O
one CD O
- : O
third NN O
of IN O
DMD NNP B-Disease
patients NNS O
is VBZ O
undetermined JJ O
. . O

Analysis NN O
of IN O
the DT O
canine NN O
dystrophin JJ O
gene NN O
in IN O
normal JJ O
and CC O
GRMD NNP B-Disease
dogs NNS O
has VBZ O
failed VBN O
to TO O
demonstrate VB O
any DT O
detectable JJ O
loss NN O
of IN O
exons NNS O
. . O

Here RB O
, , O
we PRP O
have VBP O
demonstrated VBN O
a DT O
RNA NNP O
processing NN O
error NN O
in IN O
GRMD NNP B-Disease
that WDT O
results NNS O
from IN O
a DT O
single JJ O
base NN O
change NN O
in IN O
the DT O
3 CD O
consensus NN O
splice NN O
site NN O
of IN O
intron NN O
6 CD O
. . O

The DT O
seventh JJ O
exon NN O
is VBZ O
then RB O
skipped VBN O
, , O
which WDT O
predicts VBZ O
a DT O
termination NN O
of IN O
the DT O
dystrophin JJ O
reading NN O
frame NN O
within IN O
its PRP$ O
N NNP O
- : O
terminal NN O
domain NN O
in IN O
exon JJ O
8 CD O
. . O

This DT O
is VBZ O
the DT O
first JJ O
example NN O
of IN O
dystrophin JJ B-Disease
deficiency NN I-Disease
caused VBN O
by IN O
a DT O
splice NN O
- : O
site NN O
mutation NN O
. . O
. . O

Type NN B-Disease
I PRP I-Disease
human VBP I-Disease
complement JJ I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
. . O

A DT O
28 CD O
- : O
base NN O
pair NN O
gene NN O
deletion NN O
causes VBZ O
skipping VBG O
of IN O
exon JJ O
6 CD O
during IN O
RNA NNP O
splicing NN O
. . O

Two CD O
variants NNS O
of IN O
a DT O
genetic JJ O
deficiency NN B-Disease
of IN I-Disease
complement NN I-Disease
protein NN I-Disease
C2 NNP I-Disease
( ( O
C2D NNP O
) ) O
have VBP O
been VBN O
previously RB O
identified VBN O
. . O

No DT O
C2 NNP O
protein NN O
translation NN O
is VBZ O
detected VBN O
in IN O
type NN O
I PRP O
deficiency VBP O
, , O
while IN O
type JJ O
II NNP O
deficiency NN O
is VBZ O
characterized VBN O
by IN O
a DT O
selective JJ O
block NN O
in IN O
C2 NNP O
secretion NN O
. . O

Type NN B-Disease
I PRP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
was VBD O
described VBN O
in IN O
a DT O
family NN O
in IN O
which WDT O
the DT O
C2 NNP O
null NN O
allele NN O
( ( O
C2Q0 NNP O
) ) O
is VBZ O
associated VBN O
with IN O
the DT O
major JJ O
histocompatibility NN O
haplotype NN O
/ NNP O
complotype NN O
HLA NNP O
- : O
A25 NNP O
, , O
B18 NNP O
, , O
C2Q0 NNP O
, , O
BfS NNP O
, , O
C4A4 NNP O
, , O
C4B2 NNP O
, , O
Drw2 NNP O
; : O
this DT O
extended VBD O
haplotype NN O
occurs NNS O
in IN O
over IN O
90 CD O
% NN O
of IN O
C2 NNP B-Disease
- : I-Disease
deficient NN I-Disease
individuals NNS O
( ( O
common JJ O
complotype NN O
/ NNP O
haplotype NN O
) ) O
. . O

To TO O
determine VB O
the DT O
molecular JJ O
basis NN O
of IN O
type NN B-Disease
I PRP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
, , O
the DT O
C2 NNP O
gene NN O
and CC O
cDNA NN O
were VBD O
characterized VBN O
from IN O
a DT O
homozygous JJ O
type NN B-Disease
I PRP I-Disease
C2 NNP I-Disease
- : I-Disease
deficient NN I-Disease
individual NN O
with IN O
the DT O
common JJ O
associated VBN O
haplotype JJ O
/ NN O
complotype NN O
. . O

We PRP O
found VBD O
a DT O
28 CD O
- : O
base NN O
pair NN O
deletion NN O
in IN O
the DT O
type NN O
I PRP O
C2Q0 NNP O
gene NN O
, , O
beginning VBG O
9 CD O
base JJ O
pairs NNS O
upstream NN O
of IN O
the DT O
3 CD O
- : O
end NN O
of IN O
exon JJ O
6 CD O
, , O
that WDT O
generates VBZ O
a DT O
C2 NNP O
transcript NN O
with IN O
a DT O
complete JJ O
deletion NN O
of IN O
exon $ O
6 CD O
( ( O
134 CD O
base NN O
pair NN O
) ) O
and CC O
a DT O
premature JJ O
termination NN O
codon NN O
. . O

In IN O
studies NNS O
of IN O
eight CD O
kindred NNS O
, , O
the DT O
28 CD O
- : O
base NN O
pair NN O
deletion NN O
was VBD O
observed VBN O
in IN O
all DT O
C2Q0 NNP O
alleles NNS O
associated VBN O
with IN O
the DT O
common JJ O
type NN O
I PRP O
deficient VBP O
complotype JJ O
/ NNP O
haplotype NN O
; : O
this DT O
deletion NN O
was VBD O
not RB O
present JJ O
in IN O
normal JJ O
C2 NNP O
nor CC O
in IN O
type JJ B-Disease
II NNP I-Disease
C2 NNP I-Disease
- : I-Disease
deficient NN I-Disease
genes NNS O
. . O

These DT O
data NNS O
demonstrate VBP O
that IN O
1 CD O
) ) O
type NN B-Disease
I PRP I-Disease
human VBP I-Disease
complement JJ I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
is VBZ O
caused VBN O
by IN O
a DT O
28 CD O
- : O
base NN O
pair NN O
genomic JJ O
deletion NN O
that WDT O
causes VBZ O
skipping NN O
of IN O
exon $ O
6 CD O
during IN O
RNA NNP O
splicing NN O
, , O
resulting VBG O
in IN O
generation NN O
of IN O
a DT O
premature JJ O
termination NN O
codon NN O
, , O
2 CD O
) ) O
the DT O
28 CD O
- : O
base NN O
pair NN O
deletion NN O
in IN O
the DT O
type NN O
I PRP O
C2Q0 NNP O
gene NN O
is VBZ O
strongly RB O
associated VBN O
with IN O
the DT O
HLA NNP O
haplotype NN O
/ NNP O
complotype NN O
A25 NNP O
, , O
B18 NNP O
, , O
C2Q0 NNP O
, , O
BfS NNP O
, , O
C4A4 NNP O
, , O
C4B2 NNP O
, , O
Drw2 NNP O
, , O
suggesting VBG O
that IN O
all DT O
C2 NNP B-Disease
- : I-Disease
deficient NN I-Disease
individuals NNS O
with IN O
this DT O
haplotype NN O
/ NN O
complotype NN O
will MD O
harbor VB O
the DT O
28 CD O
- : O
base NN O
pair NN O
C2 NNP O
gene NN O
deletion NN O
, , O
and CC O
3 CD O
) ) O
type NN B-Disease
II NNP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
is VBZ O
caused VBN O
by IN O
a DT O
different JJ O
, , O
as IN O
yet RB O
uncharacterized VBN O
, , O
molecular JJ O
genetic JJ B-Disease
defect NN I-Disease
. . O
. . O

Molecular JJ O
characterization NN O
of IN O
two CD O
galactosemia NN B-Disease
mutations NNS O
and CC O
one CD O
polymorphism NN O
: : O
implications NNS O
for IN O
structure NN O
- : O
function NN O
analysis NN O
of IN O
human JJ O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
molecular JJ O
characterization NN O
of IN O
two CD O
galactosemia NN B-Disease
mutations NNS O
, , O
L74P NNP O
and CC O
F171S NNP O
, , O
and CC O
one CD O
polymorphism NN O
, , O
S135L NNP O
, , O
in IN O
human JJ O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
( ( O
GALT NNP O
) ) O
. . O

Both DT O
galactosemia JJ B-Disease
mutations NNS O
result VBP O
in IN O
reduced JJ O
enzymatic JJ O
activity NN O
when WRB O
reconstructed VBN O
in IN O
the DT O
cDNA NN O
and CC O
overexpressed VBN O
. . O

The DT O
polymorphism NN O
, , O
in IN O
contrast NN O
, , O
has VBZ O
near IN O
normal JJ O
activity NN O
. . O

Both DT O
mutations NNS O
affect VBP O
evolutionarily RB O
conserved VBN O
residues NNS O
, , O
suggesting VBG O
that IN O
they PRP O
are VBP O
functionally RB O
important JJ O
, , O
while IN O
the DT O
polymorphism NN O
occurs VBZ O
in IN O
a DT O
nonconserved JJ O
domain NN O
which WDT O
is VBZ O
presumably RB O
not RB O
critical JJ O
for IN O
enzymatic JJ O
function NN O
. . O

The DT O
F171S NNP O
mutation NN O
is VBZ O
close RB O
to TO O
the DT O
putative JJ O
active JJ O
- : O
site NN O
nucleophile NN O
. . O

Our PRP$ O
data NNS O
further RBR O
support VB O
the DT O
notion NN O
of IN O
molecular JJ O
heterogeneity NN O
of IN O
galactosemia NN B-Disease
and CC O
suggest VBP O
that IN O
galactosemia NN B-Disease
mutations NNS O
and CC O
GALT NNP O
polymorphisms NNS O
may MD O
be VB O
useful JJ O
tools NNS O
in IN O
highlighting VBG O
different JJ O
functional JJ O
domains NNS O
in IN O
human JJ O
GALT NNP O
. . O
. . O

Linkage NN O
relationship NN O
of IN O
C2 NNP B-Disease
deficiency NN I-Disease
, , O
HLA NNP O
and CC O
glyoxalase NN O
I PRP O
loci VBP O
. . O

Immunogenetic JJ O
analysis NN O
of IN O
a DT O
homozygous JJ O
C2 NNP B-Disease
- : I-Disease
deficient NN I-Disease
individual JJ O
and CC O
family NN O
members NNS O
demonstrated VBD O
linkage NN O
of IN O
HLA NNP O
- : O
A25 NNP O
, , O
B18 NNP O
and CC O
C2o NNP O
. . O

HLA NNP O
- : O
D NN O
typing NN O
showed VBD O
that IN O
5 CD O
members NNS O
typed VBD O
with IN O
homozygous JJ O
Dw2 NNP O
typing VBG O
cells NNS O
from IN O
an DT O
individual NN O
with IN O
C2 NNP B-Disease
deficiency NN I-Disease
but CC O
not RB O
with IN O
Dw2 NNP O
typing VBG O
cells NNS O
from IN O
2 CD O
individuals NNS O
with IN O
normal JJ O
C2 NNP O
. . O

The DT O
homozygous JJ O
C2 NNP B-Disease
- : I-Disease
deficient NN I-Disease
propositus NN O
and CC O
brother NN O
were VBD O
HLA NNP O
- : O
A DT O
and CC O
B NNP O
homozygous JJ O
but CC O
heterozygous JJ O
at IN O
the DT O
HLA NNP O
- : O
D NN O
and CC O
glyoxalase NN O
I PRP O
loci VBP O
. . O

Therefore RB O
, , O
in IN O
this DT O
family NN O
, , O
the DT O
C2o NNP O
gene NN O
is VBZ O
linked VBN O
with IN O
two CD O
distinct JJ O
haplotypes NNS O
HLA NNP O
- : O
A25 NNP O
, , O
B18 NNP O
, , O
Dw2 NNP O
, , O
GLO1 NNP O
and CC O
HLA NNP O
- : O
A25 NNP O
, , O
B18 NNP O
, , O
D NNP O
unknown RB O
, , O
GL02 NNP O
. . O

These DT O
results NNS O
could MD O
be VB O
explained VBN O
by IN O
an DT O
ancestral JJ O
recombinant JJ O
event NN O
, , O
which WDT O
occurred VBD O
between IN O
the DT O
C2o NNP O
locus NN O
and CC O
HLA NNP O
- : O
D NNP O
locus NN O
in IN O
which WDT O
C2o NNP O
segregated VBD O
with IN O
HLA NNP O
- : O
B NN O
. . O

This DT O
would MD O
suggest VB O
that IN O
the DT O
locus NN O
for IN O
the DT O
C2o NNP O
gene NN O
maps NNS O
between IN O
HLA NNP O
- : O
B NN O
and CC O
HLA NNP O
- : O
D NN O
on IN O
the DT O
sixth JJ O
chromosome NN O
. . O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
Wilms NNP B-Disease
' POS I-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
are VBP O
associated VBN O
with IN O
abnormal JJ O
urogenital JJ O
development NN O
in IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
. . O

Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
rare JJ O
human JJ O
condition NN O
in IN O
which WDT O
severe JJ O
urogenital JJ B-Disease
aberrations NNS I-Disease
result VBP O
in IN O
renal JJ B-Disease
failure NN I-Disease
, , O
pseudohermaphroditism NN B-Disease
, , O
and CC O
Wilms NNP B-Disease
tumor NN I-Disease
( ( O
nephroblastoma NN B-Disease
) ) O
. . O

To TO O
investigate VB O
its PRP$ O
possible JJ O
role NN O
, , O
we PRP O
have VBP O
analyzed VBN O
the DT O
coding VBG O
exons NNS O
of IN O
the DT O
Wilms NNP B-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
( ( O
WT1 NNP O
) ) O
for IN O
germline NN O
mutations NNS O
. . O

In IN O
ten JJ O
independent JJ O
cases NNS O
of IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
, , O
point NN O
mutations NNS O
in IN O
the DT O
zinc NN O
finger NN O
domains NNS O
of IN O
one CD O
WT1 NNP O
gene NN O
copy NN O
were VBD O
found VBN O
. . O

Nine CD O
of IN O
these DT O
mutations NNS O
are VBP O
found VBN O
within IN O
exon JJ O
9 CD O
( ( O
zinc NN O
finger NN O
III NNP O
) ) O
; : O
the DT O
remaining VBG O
mutation NN O
is VBZ O
in IN O
exon JJ O
8 CD O
( ( O
zinc NN O
finger NN O
II NNP O
) ) O
. . O

These DT O
mutations NNS O
directly RB O
affect VBP O
DNA NNP O
sequence NN O
recognition NN O
. . O

In IN O
two CD O
families NNS O
analyzed VBN O
, , O
the DT O
mutations NNS O
were VBD O
shown VBN O
to TO O
arise VB O
de FW O
novo FW O
. . O

Wilms JJ B-Disease
tumors NNS I-Disease
from IN O
three CD O
individuals NNS O
and CC O
one CD O
juvenile NN O
granulosa NN O
cell NN O
tumor NN B-Disease
demonstrate NN O
reduction NN O
to TO O
homozygosity NN O
for IN O
the DT O
mutated JJ O
WT1 NNP O
allele NN O
. . O

Our PRP$ O
results NNS O
provide VBP O
evidence NN O
of IN O
a DT O
direct JJ O
role NN O
for IN O
WT1 NNP O
in IN O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
and CC O
thus RB O
urogenital JJ O
system NN O
development NN O
. . O
. . O

Linkage NN O
analysis NN O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
and CC O
application NN O
in IN O
post NN O
- : O
and CC O
prenatal JJ O
diagnosis NN O
. . O

We PRP O
have VBP O
performed VBN O
linkage JJ O
analysis NN O
with IN O
the DT O
DNA NN O
markers NNS O
DXS52 NNP O
and CC O
the DT O
clotting NN O
factor NN O
VIII NNP O
gene NN O
( ( O
F8C NNP O
) ) O
, , O
in IN O
several JJ O
large JJ O
families NNS O
with IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
ALD NNP B-Disease
) ) O
. . O

The DT O
tight JJ O
linkage NN O
to TO O
DXS52 NNP O
could MD O
be VB O
extended VBN O
giving VBG O
a DT O
maximal JJ O
LOD NNP O
score NN O
of IN O
22 CD O
. . O

5 CD O
at IN O
1 CD O
cM NN O
. . O

F8C NNP O
was VBD O
also RB O
tightly RB O
linked VBN O
to TO O
ALD NNP B-Disease
with IN O
a DT O
maximal JJ O
LOD NNP O
score NN O
of IN O
7 CD O
. . O

8 CD O
without IN O
recombination NN O
. . O

Multipoint NNP O
linkage NN O
analysis NN O
with IN O
the DT O
markers NNS O
DXS304 NNP O
, , O
DXS52 NNP O
, , O
and CC O
F8C NNP O
indicated VBD O
that IN O
both DT O
the DT O
gene NN O
for IN O
ALD NNP B-Disease
and CC O
for IN O
F8C NNP O
are VBP O
distal JJ O
to TO O
DXS52 NNP O
. . O

In IN O
four CD O
patients NNS O
with IN O
ALD NNP B-Disease
, , O
no DT O
major JJ O
structural JJ O
rearrangement NN O
in IN O
the DT O
Xqter NNP O
region NN O
was VBD O
observed VBN O
; : O
in IN O
particular JJ O
, , O
there EX O
were VBD O
no DT O
abnormalities NNS B-Disease
in IN I-Disease
the DT I-Disease
vision NN I-Disease
blindness NN I-Disease
genes NNS I-Disease
. . O

DNA NN O
analysis NN O
appeared VBD O
to TO O
be VB O
of IN O
use NN O
in IN O
determination NN O
of IN O
the DT O
carrier NN O
status NN O
of IN O
females NNS O
at IN O
risk NN O
, , O
for IN O
the DT O
determination NN O
of IN O
the DT O
origin NN O
of IN O
the DT O
mutation NN O
in IN O
a DT O
particular JJ O
family NN O
, , O
and CC O
for IN O
prenatal JJ O
diagnosis NN O
. . O

Two CD O
distinct JJ O
mutations NNS O
at IN O
a DT O
single JJ O
BamHI NNP O
site NN O
in IN O
phenylketonuria NN B-Disease
. . O

Classical JJ B-Disease
phenylketonuria NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disease NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

The DT O
abolition NN O
of IN O
an DT O
invariant JJ O
BamHI NNP O
site NN O
located VBN O
in IN O
the DT O
coding VBG O
sequence NN O
of IN O
the DT O
PAH NNP O
gene NN O
( ( O
exon JJ O
7 CD O
) ) O
led VBN O
to TO O
the DT O
recognition NN O
of IN O
two CD O
new JJ O
point NN O
mutations NNS O
at IN O
codon NN O
272 CD O
and CC O
273 CD O
( ( O
272gly CD O
- : O
- : O
- : O
- : O
stop NN O
and CC O
273ser CD O
- : O
- : O
- : O
- : O
phe NN O
, , O
respectively RB O
) ) O
. . O

Both DT O
mutations NNS O
were VBD O
detected VBN O
in IN O
north JJ O
eastern JJ O
France NNP O
or CC O
Belgium NNP O
and CC O
occurred VBD O
on IN O
the DT O
background NN O
of IN O
RFLP NNP O
haplotype NN O
7 CD O
alleles NNS O
. . O

The DT O
present JJ O
study NN O
supports VBZ O
the DT O
view NN O
that IN O
the DT O
clinical JJ O
heterogeneity NN O
in IN O
PKU NNP B-Disease
is VBZ O
accounted VBN O
for IN O
by IN O
the DT O
large JJ O
variety NN O
of IN O
mutant JJ O
genotypes NNS O
associated VBN O
with IN O
PAH NNP B-Disease
deficiencies NNS I-Disease
. . O
. . O

A DT O
detailed JJ O
multipoint NN O
map NN O
of IN O
human JJ O
chromosome NN O
4 CD O
provides VBZ O
evidence NN O
for IN O
linkage NN O
heterogeneity NN O
and CC O
position NN O
- : O
specific JJ O
recombination NN O
rates NNS O
. . O

Utilizing VBG O
the DT O
CEPH NNP O
reference NN O
panel NN O
and CC O
genotypic NN O
data NNS O
for IN O
53 CD O
markers NNS O
, , O
we PRP O
have VBP O
constructed VBN O
a DT O
20 CD O
- : O
locus NN O
multipoint NN O
genetic JJ O
map NN O
of IN O
human JJ O
chromosome NN O
4 CD O
. . O

New NNP O
RFLPs NNP O
are VBP O
reported VBN O
for IN O
four CD O
loci NN O
. . O

The DT O
map NN O
integrates VBZ O
a DT O
high JJ O
- : O
resolution NN O
genetic JJ O
map NN O
of IN O
4p16 CD O
into IN O
a DT O
continuous JJ O
map NN O
extending VBG O
to TO O
4q31 CD O
and CC O
an DT O
unlinked JJ O
cluster NN O
of IN O
three CD O
loci NN O
at IN O
4q35 CD O
. . O

The DT O
20 CD O
linked VBD O
markers NNS O
form VBP O
a DT O
continuous JJ O
linkage NN O
group NN O
of IN O
152 CD O
cM NN O
in IN O
males NNS O
and CC O
202 CD O
cM NN O
in IN O
females NNS O
. . O

Likely JJ O
genetic JJ O
locations NNS O
are VBP O
provided VBN O
for IN O
25 CD O
polymorphic JJ O
anonymous JJ O
sequences NNS O
and CC O
28 CD O
gene NN O
- : O
specific JJ O
RFLPs NNP O
. . O

The DT O
map NN O
was VBD O
constructed VBN O
employing VBG O
the DT O
LINKAGE NNP O
and CC O
CRIMAP NNP O
computational JJ O
methodologies NNS O
to TO O
build VB O
the DT O
multipoint NN O
map NN O
via IN O
a DT O
stepwise NN O
algorithm NN O
. . O

A DT O
detailed JJ O
10 CD O
- : O
point NN O
map NN O
of IN O
the DT O
4p16 CD O
region NN O
constructed VBN O
from IN O
the DT O
CEPH NNP O
panel NN O
provides VBZ O
evidence NN O
for IN O
heterogeneity NN O
in IN O
the DT O
linkage NN O
maps NNS O
constructed VBN O
from IN O
families NNS O
segregating VBG O
for IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

It PRP O
additionally RB O
provides VBZ O
evidence NN O
for IN O
position NN O
- : O
specific JJ O
recombination NN O
frequencies NNS O
in IN O
the DT O
telomeric JJ O
region NN O
of IN O
4p CD O
. . O
. . O

Carrier NNP O
detection NN O
and CC O
prenatal JJ O
diagnosis NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
using VBG O
a DT O
combination NN O
of IN O
anonymous JJ O
DNA NNP O
polymorphisms NN O
and CC O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
cDNA NN O
. . O

We PRP O
report VBP O
carrier NN O
identification NN O
and CC O
a DT O
prenatal JJ O
diagnosis NN O
using VBG O
DNA NNP O
polymorphisms NNS O
in IN O
2 CD O
families NNS O
with IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Pelizaeus NNP I-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( O
PMD NNP B-Disease
) ) O
. . O

In IN O
both DT O
families NNS O
, , O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
in IN O
the DT O
single JJ O
affected JJ O
male NN O
could MD O
be VB O
traced VBN O
back RB O
to TO O
his PRP$ O
unaffected JJ O
maternal JJ O
grandfather NN O
. . O

Therefore RB O
, , O
each DT O
family NN O
contains VBZ O
a DT O
new JJ O
mutation NN O
. . O

In IN O
the DT O
case NN O
of IN O
the DT O
prenatal JJ O
diagnosis NN O
, , O
the DT O
fetus NN O
was VBD O
shown VBN O
by IN O
cytogenetic JJ O
analysis NN O
to TO O
be VB O
a DT O
female JJ O
, , O
who WP O
we PRP O
predict VBP O
will MD O
be VB O
a DT O
noncarrier JJR O
of IN O
PMD NNP B-Disease
based VBN O
on IN O
her PRP$ O
genotype NN O
with IN O
the DT O
PLP NNP O
intragenic JJ O
polymorphism NN O
. . O
. . O

Identification NN O
of IN O
deletion NN O
mutations NNS O
and CC O
three CD O
new JJ O
genes NNS O
at IN O
the DT O
familial JJ B-Disease
polyposis NN I-Disease
locus NN O
. . O

Small NNP O
( ( O
100 CD O
- : O
260 CD O
kb NN O
) ) O
, , O
nested JJ O
deletions NNS O
were VBD O
characterized VBN O
in IN O
DNA NN O
from IN O
two CD O
unrelated JJ O
patients NNS O
with IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
. . O

Three CD O
candidate NN O
genes NNS O
located VBN O
within IN O
the DT O
deleted JJ O
region NN O
were VBD O
ascertained VBN O
and CC O
a DT O
previous JJ O
candidate NN O
gene NN O
, , O
MCC NNP O
, , O
was VBD O
shown VBN O
to TO O
be VB O
located VBN O
outside IN O
the DT O
deleted JJ O
region NN O
. . O

One CD O
of IN O
the DT O
new JJ O
genes NNS O
contained VBN O
sequence RB O
identical JJ O
to TO O
SRP19 NNP O
, , O
the DT O
gene NN O
coding VBG O
for IN O
the DT O
19 CD O
kd JJ O
component NN O
of IN O
the DT O
ribosomal JJ O
signal JJ O
recognition NN O
particle NN O
. . O

The DT O
second JJ O
, , O
provisionally RB O
designated VBN O
DP1 NNP O
( ( O
deleted VBN O
in IN O
polyposis NN O
1 CD O
) ) O
, , O
was VBD O
found VBN O
to TO O
be VB O
transcribed VBN O
in IN O
the DT O
same JJ O
orientation NN O
as IN O
MCC NNP O
. . O

Two CD O
other JJ O
cDNAs NN O
, , O
DP2 NNP O
and CC O
DP3 NNP O
, , O
were VBD O
found VBN O
to TO O
overlap VB O
, , O
forming VBG O
a DT O
single JJ O
gene NN O
, , O
DP2 NNP O
. . O

5 CD O
, , O
that WDT O
is VBZ O
transcribed VBN O
in IN O
the DT O
same JJ O
orientation NN O
as IN O
SRP19 NNP O
. . O

Exclusion NN O
of IN O
linkage NN O
between IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
and CC O
the DT O
human JJ O
serum NN O
amyloid VBZ O
A NNP O
( ( O
SAA NNP O
) ) O
gene NN O
cluster NN O
. . O

We PRP O
studied VBD O
the DT O
relationship NN O
between IN O
the DT O
autosomal JJ O
recessive JJ O
trait NN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
and CC O
the DT O
serum NN O
amyloid VBZ O
A NNP O
( ( O
SAA NNP O
) ) O
genes NNS O
by IN O
comparing VBG O
alleles NNS O
of IN O
a DT O
highly RB O
polymorphic JJ O
dinucleotide NN O
repeat NN O
and CC O
a DT O
conventional JJ O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
( ( O
RFLP NNP O
) ) O
in IN O
the DT O
SAA NNP O
gene NN O
cluster NN O
in IN O
Israeli NNP O
FMF NNP B-Disease
kindreds NNS O
. . O

By IN O
haplotype JJ O
analysis NN O
, , O
our PRP$ O
data NNS O
indicate VBP O
a DT O
minimum JJ O
crossover NN O
frequency NN O
of IN O
22 CD O
% NN O
between IN O
the DT O
SAA NNP O
gene NN O
marker NN O
and CC O
FMF NNP B-Disease
. . O

By IN O
conventional JJ O
linkage NN O
analysis NN O
this DT O
eliminates VBZ O
a DT O
minimum NN O
of IN O
10 CD O
. . O

4 CD O
cM NN O
including VBG O
and CC O
surrounding VBG O
the DT O
SAA NNP O
gene NN O
cluster NN O
as IN O
the DT O
site NN O
of IN O
the DT O
FMF NNP B-Disease
mutation NN O
although IN O
SAA NNP O
proteins NNS O
are VBP O
prominent JJ O
physiologic JJ O
markers NNS O
of IN O
the DT O
acute NN O
attacks NNS O
. . O

PRAD1 NNP O
, , O
a DT O
candidate NN O
BCL1 NNP O
oncogene NN O
: : O
mapping NN O
and CC O
expression NN O
in IN O
centrocytic JJ B-Disease
lymphoma NN I-Disease
. . O

Rearrangement NN O
of IN O
the DT O
BCL1 NNP O
( ( O
B NNP O
- : O
cell NN O
lymphoma VBZ O
1 CD O
) ) O
region NN O
on IN O
chromosome NN O
11q13 CD O
appears VBZ O
to TO O
be VB O
highly RB O
characteristic JJ O
of IN O
centrocytic JJ B-Disease
lymphoma NN I-Disease
and CC O
also RB O
is VBZ O
found VBN O
infrequently RB O
in IN O
other JJ O
B NNP B-Disease
- : I-Disease
cell NN I-Disease
neoplasms NNS I-Disease
. . O

Rearrangement NNP O
is VBZ O
thought VBN O
to TO O
deregulate VB O
a DT O
nearby JJ O
protooncogene NN O
, , O
but CC O
transcribed VBD O
sequences NNS O
in IN O
the DT O
immediate JJ O
vicinity NN O
of IN O
BCL1 NNP O
breakpoints NNS O
had VBD O
not RB O
been VBN O
identified VBN O
. . O

PRAD1 NNP O
, , O
previously RB O
designated VBN O
D11S287E NNP O
, , O
was VBD O
identified VBN O
on IN O
11q13 CD O
as IN O
a DT O
chromosomal JJ O
breakpoint NN O
region NN O
rearranged VBN O
with IN O
the DT O
parathyroid NN O
hormone NN O
gene NN O
in IN O
a DT O
subset NN O
of IN O
parathyroid JJ B-Disease
adenomas NN I-Disease
; : O
this DT O
highly RB O
conserved JJ O
putative JJ O
oncogene NN O
, , O
which WDT O
encodes VBZ O
a DT O
novel JJ O
cyclin NN O
, , O
has VBZ O
been VBN O
linked VBN O
to TO O
BCL1 NNP O
and CC O
implicated VBN O
also RB O
in IN O
subsets NNS O
of IN O
breast NN B-Disease
and CC I-Disease
squamous JJ I-Disease
cell NN I-Disease
neoplasms NNS I-Disease
with IN O
11q13 CD O
amplification NN O
. . O

We PRP O
report VBP O
pulsed VBD O
- : O
field NN O
gel JJ O
electrophoresis NN O
data NNS O
showing VBG O
BCL1 NNP O
and CC O
PRAD1 NNP O
to TO O
be VB O
no RB O
more JJR O
than IN O
130 CD O
kilobases NNS O
apart RB O
. . O

PRAD1 NNP O
mRNA NN O
is VBZ O
abundantly RB O
expressed VBN O
in IN O
seven CD O
of IN O
seven CD O
centrocytic JJ B-Disease
lymphomas NN I-Disease
( ( O
Kiel NNP O
classification NN O
) ) O
, , O
in IN O
contrast NN O
to TO O
13 CD O
closely RB O
related JJ O
but CC O
noncentrocytic JJ B-Disease
lymphomas NN I-Disease
. . O

Three CD O
of IN O
the DT O
seven CD O
centrocytic JJ B-Disease
lymphomas NN I-Disease
had VBD O
detectable JJ O
BCL1 NNP O
DNA NNP O
rearrangement NN O
. . O

Also RB O
, , O
two CD O
unusual JJ O
cases NNS O
of IN O
CLL NNP O
with IN O
BCL1 NNP O
rearrangement NN O
overexpressed VBD O
PRAD1 NNP O
, , O
in IN O
contrast NN O
to TO O
five CD O
CLL NNP O
controls NNS O
. . O

Thus RB O
, , O
PRAD1 NNP O
is VBZ O
an DT O
excellent JJ O
candidate NN O
"""" NNP O
BCL1 NNP O
oncogene NN O
. . O

"""" VB O
Its PRP$ O
overexpression NN O
may MD O
be VB O
a DT O
key JJ O
consequence NN O
of IN O
rearrangement NN O
of IN O
the DT O
BCL1 NNP O
vicinity NN O
in IN O
B NNP B-Disease
- : I-Disease
cell NN I-Disease
neoplasms NNS I-Disease
and CC O
a DT O
unifying JJ O
pathogenetic JJ O
feature NN O
in IN O
centrocytic JJ B-Disease
lymphoma NN I-Disease
. . O

Two CD O
new JJ O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
mutations NNS O
in IN O
a DT O
juvenile NN O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
patient NN O
. . O

Fragments NNS O
of IN O
the DT O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
gene NN O
from IN O
a DT O
patient NN O
with IN O
juvenile JJ O
- : O
onset VBN O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
were VBD O
amplified VBN O
by IN O
PCR NNP O
and CC O
ligated VBN O
into IN O
MP13 NNP O
cloning VBG O
vectors NNS O
. . O

Clones NNS O
hybridizing VBG O
with IN O
cDNA NN O
for IN O
human JJ O
ARSA NNP O
were VBD O
selected VBN O
, , O
examined VBN O
for IN O
appropriate JJ O
size NN O
inserts NNS O
, , O
and CC O
used VBD O
to TO O
prepare VB O
single JJ O
- : O
stranded JJ O
phage NN O
DNA NN O
. . O

Examination NN O
of IN O
the DT O
entire JJ O
coding NN O
and CC O
most JJS O
of IN O
the DT O
intronic JJ O
sequence NN O
revealed VBD O
two CD O
putative JJ O
disease NN O
- : O
related JJ O
mutations NNS O
. . O

One CD O
, , O
a DT O
point NN O
mutation NN O
in IN O
exon JJ O
3 CD O
, , O
resulted VBD O
in IN O
the DT O
substitution NN O
of IN O
isoleucine NN O
by IN O
serine NN O
. . O

Introduction NN O
of IN O
this DT O
alteration NN O
into IN O
the DT O
normal JJ O
ARSA NNP O
cDNA NN O
sequence NN O
resulted VBD O
in IN O
a DT O
substantial JJ O
decrease NN O
in IN O
ARSA NNP O
activity NN O
on IN O
transient JJ O
expression NN O
in IN O
cultured JJ O
baby NN O
hamster NN O
kidney NN O
cells NNS O
. . O

About RB O
5 CD O
% NN O
of IN O
the DT O
control NN O
expression NN O
was VBD O
observed VBN O
, , O
suggesting VBG O
a DT O
small JJ O
residual JJ O
activity NN O
in IN O
the DT O
mutated JJ O
ARSA NNP O
. . O

The DT O
second JJ O
mutation NN O
, , O
a DT O
G NNP O
- : O
to TO O
- : O
A DT O
transition NN O
, , O
occurred VBD O
in IN O
the DT O
other JJ O
allele NN O
and CC O
resulted VBD O
in IN O
an DT O
altered JJ O
splice NN O
- : O
recognition NN O
sequence NN O
between IN O
exon $ O
7 CD O
and CC O
the DT O
following JJ O
intron NN O
. . O

The DT O
mutation NN O
also RB O
resulted VBD O
in IN O
the DT O
loss NN O
of IN O
a DT O
restriction NN O
site NN O
. . O

Apparently RB O
normal JJ O
levels NNS O
of IN O
mRNA NN O
were VBD O
generated VBN O
from IN O
this DT O
allele NN O
, , O
but CC O
no DT O
ARSA NNP O
activity NN O
or CC O
immuno NN O
- : O
cross NN O
- : O
reactive JJ O
material NN O
could MD O
be VB O
detected VBN O
. . O

A DT O
collection NN O
of IN O
DNA NNP O
samples NNS O
from IN O
known VBN O
or CC O
suspected VBN O
MLD NNP B-Disease
patients NNS O
, , O
members NNS O
of IN O
their PRP$ O
families NNS O
, , O
and CC O
normal JJ O
controls NNS O
was VBD O
screened VBN O
for IN O
these DT O
mutations NNS O
. . O

Four CD O
additional JJ O
individuals NNS O
carrying VBG O
each DT O
of IN O
the DT O
mutations NNS O
were VBD O
found VBN O
among IN O
the DT O
nearly RB O
100 CD O
MLD JJ B-Disease
patients NNS O
in IN O
the DT O
sample NN O
. . O

Gene NNP O
segregation NN O
in IN O
the DT O
original JJ O
patients NNS O
family NN O
was VBD O
consistent JJ O
with IN O
available JJ O
clinical JJ O
and CC O
biochemical JJ O
data NNS O
. . O

No DT O
individuals NNS O
homozygous JJ O
for IN O
either DT O
of IN O
these DT O
two CD O
mutations NNS O
were VBD O
identified VBN O
. . O

However RB O
, , O
combinations NNS O
with IN O
other JJ O
MLD NNP B-Disease
mutations NNS O
suggest VBP O
that IN O
the DT O
point NN O
mutation NN O
in IN O
exon JJ O
3 CD O
does VBZ O
result NN O
in IN O
some DT O
residual JJ O
enzyme NN O
activity NN O
and CC O
is VBZ O
associated VBN O
with IN O
late JJ O
- : O
onset NN O
forms NNS O
of IN O
the DT O
disease NN O
. . O

The DT O
splice NN O
- : O
site NN O
mutation NN O
following VBG O
exon $ O
7 CD O
produces NNS O
late JJ O
- : O
infantile NN O
MLD NNP B-Disease
when WRB O
combined VBN O
with IN O
other JJ O
enzyme JJ O
- : O
null JJ O
mutations NNS O
, , O
implying VBG O
that IN O
it PRP O
is VBZ O
completely RB O
silent JJ O
enzymatically RB O
. . O
. . O

Analysis NN O
of IN O
X NNP O
- : O
chromosome NN O
inactivation NN O
and CC O
presumptive JJ O
expression NN O
of IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
gene NN O
in IN O
hematopoietic JJ O
cell NN O
lineages NNS O
of IN O
a DT O
thrombocytopenic JJ O
carrier NN O
female NN O
of IN O
WAS NNP B-Disease
. . O

We PRP O
report VBP O
on IN O
a DT O
thrombocytopenic JJ B-Disease
female NN O
belonging NN O
to TO O
a DT O
pedigree NN O
with IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
. . O

Restriction NNP O
fragment NN O
length NN O
polymorphism NN O
( ( O
RFLP NNP O
) ) O
analysis NN O
with IN O
probe NN O
M27 NNP O
beta NN O
, , O
closely RB O
linked VBN O
to TO O
the DT O
WAS NNP B-Disease
gene NN O
, , O
demonstrated VBD O
that IN O
she PRP O
is VBZ O
a DT O
carrier NN O
of IN O
WAS NNP B-Disease
. . O

Both DT O
small JJ O
- : O
sized VBN O
and CC O
normal JJ O
- : O
sized VBN O
platelets NNS O
were VBD O
present JJ O
, , O
suggesting VBG O
that IN O
, , O
unlike IN O
the DT O
vast JJ O
majority NN O
of IN O
WAS NNP B-Disease
carriers NNS O
, , O
she PRP O
does VBZ O
not RB O
manifest VB O
nonrandom RB O
X NNP O
- : O
chromosome NN O
inactivation NN O
in IN O
the DT O
thrombopoietic JJ O
cell NN O
lineage NN O
. . O

Study NNP O
of IN O
X NNP O
- : O
chromosome NN O
inactivation NN O
by IN O
means NNS O
of IN O
RFLP NNP O
and CC O
methylation NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
pattern NN O
of IN O
X NNP O
- : O
chromosome NN O
inactivation NN O
was VBD O
nonrandom RB O
in IN O
T NNP O
lymphocytes NNS O
, , O
but CC O
random NN O
in IN O
granulocytes NNS O
. . O

While IN O
this DT O
is VBZ O
the DT O
first JJ O
complete JJ O
report NN O
on IN O
the DT O
occurrence NN O
of IN O
thrombocytopenia NN B-Disease
in IN O
a DT O
carrier NN O
female NN O
of IN O
WAS NNP B-Disease
as IN O
the DT O
result NN O
of IN O
atypical JJ O
lyonization NN O
, , O
it PRP O
also RB O
suggests VBZ O
that IN O
expression NN O
of IN O
the DT O
WAS NNP B-Disease
gene NN O
occurs VBZ O
at IN O
( ( O
or CC O
extends VBZ O
up RP O
to TO O
) ) O
a DT O
later RBR O
stage NN O
than IN O
the DT O
multipotent JJ O
stem NN O
cell NN O
along IN O
the DT O
hematopoietic JJ O
differentiation NN O
pathway NN O
. . O
. . O

A DT O
new JJ O
mutation NN O
in IN O
the DT O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
in IN O
a DT O
German JJ O
family NN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

A DT O
C NNP O
- : O
to TO O
- : O
T NNP O
transition NN O
in IN O
exon JJ O
4 CD O
of IN O
the DT O
PLP NNP O
gene NN O
was VBD O
found VBN O
in IN O
2 CD O
affected JJ O
males NNS O
and CC O
two CD O
obligate NN O
carriers NNS O
in IN O
a DT O
German JJ O
family NN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

The DT O
mutation NN O
, , O
which WDT O
causes VBZ O
loss NN O
of IN O
an DT O
HphI NNP O
site NN O
and CC O
changes NNS O
amino VBP O
acid JJ O
155 CD O
from IN O
threonine NN O
to TO O
isoleucine VB O
, , O
was VBD O
absent NN O
from IN O
108 CD O
normal JJ O
chromosomes NNS O
. . O

There EX O
are VBP O
5 CD O
concordances NNS O
and CC O
1 CD O
discrepancy NN O
between IN O
these DT O
results NNS O
and CC O
those DT O
obtained VBN O
by IN O
magnetic JJ O
resonance NN O
imaging NN O
in IN O
this DT O
family NN O
. . O
. . O

A DT O
3 CD O
- : O
base NN O
pair NN O
in IN O
- : O
frame NN O
deletion NN O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
gene NN O
results NNS O
in IN O
a DT O
kinetic JJ O
variant NN O
of IN O
phenylketonuria NN B-Disease
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disease NN I-Disease
due JJ O
to TO O
deficiency NN B-Disease
of IN I-Disease
a DT I-Disease
hepatic JJ I-Disease
enzyme NN I-Disease
, , I-Disease
phenylalanine JJ I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

The DT O
absence NN O
of IN O
PAH NNP O
activity NN O
results NNS O
in IN O
typical JJ O
PKU NNP B-Disease
while IN O
persistence NN O
of IN O
a DT O
residual JJ O
enzyme NN O
activity NN O
gives VBZ O
rise NN O
to TO O
variant VB O
forms NNS O
of IN O
the DT O
disease NN O
. . O

We PRP O
report VBP O
here RB O
a DT O
3 CD O
- : O
base NN O
pair NN O
in IN O
- : O
frame NN O
deletion NN O
of IN O
the DT O
PAH NNP O
gene NN O
( ( O
delta JJ O
194 CD O
) ) O
in IN O
a DT O
mild JJ O
variant NN O
, , O
with IN O
markedly RB O
reduced VBN O
affinity NN O
of IN O
the DT O
enzyme NN O
for IN O
phenylalanine NN O
( ( O
Km NNP O
= VBZ O
160 CD O
nM NN O
) ) O
, , O
and CC O
we PRP O
provide VBP O
functional JJ O
evidence NN O
for IN O
responsibility NN O
of IN O
the DT O
deletion NN O
in IN O
the DT O
mutant JJ O
phenotype NN O
. . O

Since IN O
the DT O
deletion NN O
was VBD O
located VBN O
in IN O
the DT O
third JJ O
exon NN O
of IN O
the DT O
gene NN O
, , O
which WDT O
presents VBZ O
no DT O
homology NN O
with IN O
other JJ O
hydroxylases NNS O
, , O
we PRP O
suggest VBP O
that IN O
exon $ O
3 CD O
is VBZ O
involved VBN O
in IN O
the DT O
specificity NN O
of IN O
the DT O
enzyme NN O
for IN O
phenylalanine NN O
. . O

Finally RB O
, , O
since IN O
none NN O
of IN O
the DT O
98 CD O
PKU NNP B-Disease
patients NNS O
tested VBN O
were VBD O
found VBN O
to TO O
carry VB O
this DT O
particular JJ O
deletion NN O
, , O
our PRP$ O
study NN O
suggests VBZ O
that IN O
this DT O
molecular JJ O
event NN O
probably RB O
occurred VBD O
recently RB O
on IN O
the DT O
background NN O
of IN O
a DT O
haplotype NN O
2 CD O
gene NN O
in IN O
Portugal NNP O
. . O
. . O

Mutation NN O
of IN O
the DT O
KIT NNP O
( ( O
mast JJ O
/ NNP O
stem NN O
cell NN O
growth NN O
factor NN O
receptor NN O
) ) O
protooncogene NN O
in IN O
human JJ O
piebaldism NN B-Disease
. . O

Piebaldism NN B-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
cogenital JJ O
patches NNS O
of IN O
skin NN O
and CC O
hair NN O
from IN O
which WDT O
melanocytes NNS O
are VBP O
completely RB O
absent JJ O
. . O

A DT O
similar JJ O
disorder NN O
of IN O
mouse NN O
, , O
dominant JJ O
white JJ O
spotting NN O
( ( O
W NNP O
) ) O
, , O
results NNS O
from IN O
mutations NNS O
of IN O
the DT O
c JJ O
- : O
Kit NNP O
protooncogene NN O
, , O
which WDT O
encodes VBZ O
and CC O
receptor NN O
for IN O
mast NN O
/ JJ O
stem NN O
cell NN O
growth NN O
factor NN O
. . O

We PRP O
identified VBD O
a DT O
KIT NNP O
gene NN O
mutation NN O
in IN O
a DT O
proband NN O
with IN O
classic JJ O
autosomal JJ O
dominant JJ O
piebaldism NN B-Disease
. . O

This DT O
mutation NN O
results NNS O
in IN O
a DT O
Gly NNP O
- : O
- : O
- : O
- : O
Arg DT O
substitution NN O
at IN O
codon NN O
664 CD O
, , O
within IN O
the DT O
tyrosine JJ O
kinase NN O
domain NN O
. . O

This DT O
substitution NN O
was VBD O
not RB O
seen VBN O
in IN O
any DT O
normal JJ O
individuals NNS O
and CC O
was VBD O
completely RB O
linked VBN O
to TO O
the DT O
piebald NN B-Disease
phenotype NN O
in IN O
the DT O
probands NNS O
family NN O
. . O

Piebaldism NN B-Disease
in IN O
this DT O
family NN O
thus RB O
appears VBZ O
to TO O
be VB O
the DT O
human JJ O
homologue NN O
to TO O
dominant VB O
white JJ O
spotting NN O
( ( O
W NNP O
) ) O
of IN O
the DT O
mouse NN O
. . O
. . O

Genetic JJ O
analysis NN O
of IN O
a DT O
Japanese JJ O
family NN O
with IN O
normotriglyceridemic JJ B-Disease
abetalipoproteinemia NN I-Disease
indicates VBZ O
a DT O
lack NN O
of IN O
linkage NN O
to TO O
the DT O
apolipoprotein NN O
B NNP O
gene NN O
. . O

Normotriglyceridemic NNP B-Disease
abetalipoproteinemia NN I-Disease
is VBZ O
a DT O
rare JJ O
familial JJ B-Disease
disorder NN I-Disease
characterized VBN O
by IN O
an DT O
isolated JJ O
deficiency NN B-Disease
of IN I-Disease
apoB JJ I-Disease
- : I-Disease
100 CD I-Disease
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
a DT O
patient NN O
with IN O
this DT O
disease NN O
, , O
who WP O
had VBD O
normal JJ O
apoB JJ O
- : O
48 CD O
but CC O
no DT O
apoB JJ O
- : O
100 CD O
. . O

To TO O
elucidate VB O
the DT O
genetic JJ B-Disease
abnormalities NNS I-Disease
in IN O
this DT O
family NN O
, , O
we PRP O
studied VBD O
the DT O
linkage NN O
of IN O
apoB JJ O
gene NN O
using VBG O
three CD O
genetic JJ O
markers NNS O
. . O

The DT O
proband NN O
and CC O
her PRP$ O
affected JJ O
brother NN O
showed VBD O
completely RB O
different JJ O
apoB NNS O
gene NN O
alleles NNS O
, , O
suggesting VBG O
that IN O
the DT O
apoB NN O
gene NN O
itself PRP O
is VBZ O
not RB O
related VBN O
to TO O
this DT O
disorder NN O
in IN O
this DT O
family NN O
. . O

By IN O
contrast NN O
, , O
an DT O
American JJ O
case NN O
had VBD O
a DT O
point NN O
substitution NN O
in IN O
the DT O
apoB JJ O
gene NN O
generating VBG O
an DT O
in IN O
- : O
frame NN O
stop JJ O
codon NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
this DT O
disorder NN O
can MD O
be VB O
caused VBN O
by IN O
defect NN O
( ( O
s JJ O
) ) O
of IN O
either DT O
an DT O
apoB JJ O
gene NN O
or CC O
other JJ O
genes NNS O
. . O
. . O

Localisation NN O
of IN O
the DT O
gene NN O
for IN O
Norrie NNP B-Disease
disease NN I-Disease
to TO O
between IN O
DXS7 NNP O
and CC O
DXS426 NNP O
on IN O
Xp NNP O
. . O

A DT O
highly RB O
informative JJ O
microsatellite NN O
marker NN O
, , O
DXS426 NNP O
, , O
which WDT O
maps VBZ O
proximal NN O
to TO O
DXS7 NNP O
in IN O
the DT O
interval JJ O
Xp11 NNP O
. . O

4 CD O
- : O
Xp11 NN O
4 CD O
- : O
Xp11 NN O
. . O

23 CD O
, , O
has VBZ O
been VBN O
used VBN O
to TO O
refine VB O
further RB O
the DT O
localisation NN O
of IN O
the DT O
gene NN O
for IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
NDP NNP B-Disease
) ) O
. . O

The DT O
results NNS O
from IN O
a DT O
multiply NN O
informative JJ O
crossover NN O
localize VB O
the DT O
NDP NNP B-Disease
gene NN O
proximal NN O
to TO O
DXS7 NNP O
. . O

In IN O
conjunction NN O
with IN O
information NN O
from IN O
2 CD O
NDP NNP B-Disease
patients NNS O
who WP O
have VBP O
a DT O
deletion NN O
for IN O
DXS7 NNP O
but CC O
not RB O
for IN O
DSX426 NNP O
, , O
our PRP$ O
data NNS O
indicate VBP O
that IN O
the DT O
NDP NNP B-Disease
gene NN O
lies VBZ O
between IN O
DXS7 NNP O
and CC O
DXS426 NNP O
on IN O
proximal JJ O
Xp NNP O
. . O

Aberrant JJ O
splicing NN O
of IN O
phenylalanine JJ O
hydroxylase NN O
mRNA NN O
: : O
the DT O
major JJ O
cause NN O
for IN O
phenylketonuria NN B-Disease
in IN O
parts NNS O
of IN O
southern JJ O
Europe NNP O
. . O

We PRP O
report VBP O
a DT O
mutation NN O
within IN O
the DT O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
gene NN O
that WDT O
causes VBZ O
aberrant JJ O
splicing NN O
of IN O
the DT O
mRNA NN O
and CC O
that DT O
is VBZ O
in IN O
tight JJ O
association NN O
with IN O
chromosomal JJ O
haplotypes NNS O
6 CD O
, , O
10 CD O
, , O
and CC O
36 CD O
. . O

Because IN O
of IN O
the DT O
high JJ O
frequency NN O
of IN O
these DT O
particular JJ O
haplotypes NNS O
in IN O
Bulgaria NNP O
, , O
Italy NNP O
, , O
and CC O
Turkey NNP O
, , O
it PRP O
appears VBZ O
to TO O
be VB O
one CD O
of IN O
the DT O
more RBR O
frequent JJ O
defects NNS O
in IN O
the DT O
PAH NNP O
gene NN O
causing VBG O
classical JJ O
phenylketonuria NN B-Disease
in IN O
this DT O
part NN O
of IN O
Europe NNP O
. . O

The DT O
mutation NN O
is VBZ O
a DT O
G NNP O
to TO O
A DT O
transition NN O
at IN O
position NN O
546 CD O
in IN O
intron NN O
10 CD O
of IN O
the DT O
PAH NNP O
gene NN O
, , O
11 CD O
bp NN O
upstream NN O
from IN O
the DT O
intron NN O
10 CD O
/ NNP O
exon VBD O
11 CD O
boundary NN O
. . O

It PRP O
activates VBZ O
a DT O
cryptic JJ O
splice NN O
site NN O
and CC O
results NNS O
in IN O
an DT O
in IN O
- : O
frame NN O
insertion NN O
of IN O
9 CD O
nucleotides NNS O
between IN O
exon $ O
10 CD O
and CC O
exon $ O
11 CD O
of IN O
the DT O
processed JJ O
mRNA NN O
. . O

Normal JJ O
amounts NNS O
of IN O
liver NN O
PAH NNP O
protein NN O
are VBP O
present JJ O
in IN O
homozygous JJ O
patients NNS O
, , O
but CC O
no DT O
catalytic JJ O
activity NN O
can MD O
be VB O
detected VBN O
. . O

This DT O
loss NN O
of IN O
enzyme JJ O
activity NN O
is VBZ O
probably RB O
caused VBN O
by IN O
conformational JJ O
changes NNS O
resulting VBG O
from IN O
the DT O
insertion NN O
of IN O
three CD O
additional JJ O
amino NN O
acids NNS O
( ( O
Gly NNP O
- : O
Leu NNP O
- : O
Gln NN O
) ) O
between IN O
the DT O
normal JJ O
sequences NNS O
encoded VBN O
by IN O
exon JJ O
10 CD O
and CC O
exon $ O
11 CD O
. . O
. . O

Gardner NNP B-Disease
syndrome NN I-Disease
in IN O
a DT O
boy NN O
with IN O
interstitial JJ O
deletion NN O
of IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
5 CD O
. . O

We PRP O
described VBD O
a DT O
15 CD O
- : O
year NN O
- : O
old JJ O
boy NN O
with IN O
Gardner NNP B-Disease
syndrome NN I-Disease
( ( O
GS NNP B-Disease
) ) O
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
craniofacial JJ B-Disease
abnormalities NNS I-Disease
. . O

High JJ O
- : O
resolution NN O
banding NN O
analysis NN O
showed VBD O
an DT O
interstitial JJ O
deletion NN O
of IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
5 CD O
( ( O
q22 NN O
. . O
1 CD O
- : O
- : O
- : O
- : O
q31 NN O
1 CD O
- : O
- : O
- : O
- : O
q31 NN O
. . O
1 CD O
) ) O
. . O

The DT O
breakpoints NNS O
in IN O
the DT O
present JJ O
case NN O
and CC O
in IN O
3 CD O
previously RB O
reported VBD O
5q CD O
- : O
patients NNS O
with IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
suggest VBP O
that IN O
the DT O
gene NN O
responsible JJ O
for IN O
GS NNP B-Disease
/ NNP O
or CC O
familial JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
FPC NNP B-Disease
) ) O
is VBZ O
in IN O
the DT O
5q22 CD O
region NN O
, , O
a DT O
result NN O
consistent NN O
with IN O
the DT O
findings NNS O
of IN O
linkage NN O
studies NNS O

Huntington NNP B-Disease
disease NN I-Disease
and CC O
childhood NN O
- : O
onset NN O
Tourette NNP B-Disease
syndrome NN I-Disease
. . O

A DT O
40 CD O
- : O
year NN O
- : O
old JJ O
man NN O
with IN O
childhood NN O
- : O
onset NN O
Tourette NNP B-Disease
syndrome NN I-Disease
( ( O
TS NNP B-Disease
) ) O
developed VBD O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

We PRP O
believe VBP O
this DT O
to TO O
be VB O
the DT O
first JJ O
reported VBD O
case NN O
of IN O
childhood NN O
- : O
onset NN O
TS NNP B-Disease
with IN O
adult NN O
onset VBN O
HD NNP B-Disease
. . O

Discovery NN O
of IN O
other JJ O
cases NNS O
with IN O
both DT O
disorders NNS O
may MD O
provide VB O
clues NNS O
to TO O
the DT O
pathophysiology NN O
of IN O
both DT O
conditions NNS O
. . O
. . O

Sequence NN O
of IN O
DNA NNP O
flanking VBG O
the DT O
exons NNS O
of IN O
the DT O
HEXA NNP O
gene NN O
, , O
and CC O
identification NN O
of IN O
mutations NNS O
in IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
. . O

The DT O
rapid JJ O
identification NN O
of IN O
mutations NNS O
causing VBG O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
requires VBZ O
the DT O
capacity NN O
to TO O
readily RB O
screen VB O
the DT O
regions NNS O
of IN O
the DT O
HEXA NNP O
gene NN O
most RBS O
likely JJ O
to TO O
be VB O
affected VBN O
by IN O
mutation NN O
. . O

We PRP O
have VBP O
sequenced VBN O
the DT O
portions NNS O
of IN O
the DT O
introns NNS O
flanking VBG O
each DT O
of IN O
the DT O
14 CD O
HEXA NNP O
exons NNS O
in IN O
order NN O
to TO O
specify VB O
oligonucleotide JJ O
primers NNS O
for IN O
the DT O
PCR NNP O
- : O
dependent JJ O
amplification NN O
of IN O
each DT O
exon NN O
and CC O
splice NN O
- : O
junction NN O
sequence NN O
. . O

The DT O
amplified JJ O
products NNS O
were VBD O
analyzed VBN O
, , O
by IN O
electrophoresis NN O
in IN O
nondenaturing VBG O
polyacrylamide NN O
gels NNS O
, , O
for IN O
the DT O
presence NN O
of IN O
either DT O
heteroduplexes NNS O
, , O
derived VBN O
from IN O
the DT O
annealing NN O
of IN O
normal JJ O
and CC O
mutant JJ O
DNA NNP O
strands NNS O
, , O
or CC O
single JJ O
- : O
strand NN O
conformational JJ O
polymorphisms NN O
( ( O
SSCP NNP O
) ) O
, , O
derived VBN O
from IN O
the DT O
renaturation NN O
of IN O
single JJ O
- : O
stranded VBD O
DNA NN O
. . O

Five CD O
novel JJ O
mutations NNS O
from IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
patients NNS O
were VBD O
detected VBN O
a DT O
5 CD O
- : O
bp NN O
deletion NN O
of IN O
TCTCC NNP O
in IN O
IVS NNP O
- : O
9 CD O
; : O
a DT O
2 CD O
- : O
bp NN O
deletion NN O
of IN O
TG NNP O
in IN O
exon JJ O
5 CD O
; : O
G78 NNP O
to TO O
A NNP O
, , O
giving VBG O
a DT O
stop JJ O
codon NN O
in IN O
exon JJ O
1 CD O
; : O
G533 NNP O
to TO O
T NNP O
in IN O
exon JJ O
5 CD O
, , O
producing VBG O
the DT O
third JJ O
amino NN O
acid JJ O
substitution NN O
detected VBN O
at IN O
this DT O
site NN O
; : O
and CC O
G NNP O
to TO O
C NNP O
at IN O
position NN O
1 CD O
of IN O
IVS NNP O
- : O
2 CD O
, , O
expected VBN O
to TO O
produce VB O
abnormal JJ O
splicing NN O
. . O

In IN O
addition NN O
, , O
two CD O
mutations NNS O
, , O
( ( O
G1496 NNP O
to TO O
A NNP O
in IN O
exon JJ O
13 CD O
and CC O
a DT O
4 CD O
- : O
bp NN O
insertion NN O
in IN O
exon $ O
11 CD O
) ) O
that WDT O
have VBP O
previously RB O
been VBN O
reported VBN O
were VBD O
identified VBN O
. . O
. . O

Molecular JJ O
characterization NN O
of IN O
two CD O
galactosemia JJ B-Disease
mutations NNS O
: : O
correlation NN O
of IN O
mutations NNS O
with IN O
highly RB O
conserved VBN O
domains NNS O
in IN O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyl JJ O
transferase NN O
. . O

Galactosemia NNP B-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
of IN I-Disease
human JJ I-Disease
galactose JJ I-Disease
metabolism NN I-Disease
caused VBN O
by IN O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
enzyme NN I-Disease
galactose VBD I-Disease
- : I-Disease
1 CD I-Disease
- : I-Disease
phosphate NN I-Disease
uridyl JJ I-Disease
transferase NN I-Disease
( ( O
GALT NNP O
) ) O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
this DT O
disorder NN O
is VBZ O
at IN O
present JJ O
not RB O
well RB O
understood RB O
. . O

We PRP O
report VBP O
here RB O
two CD O
missense NN O
mutations NNS O
which WDT O
result VBP O
in IN O
low JJ O
or CC O
undetectable JJ O
enzymatic JJ O
activity NN O
. . O

First RB O
, , O
we PRP O
identified VBD O
at IN O
nucleotide RB O
591 CD O
a DT O
transition NN O
which WDT O
substitutes VBZ O
glutamine VBP O
188 CD O
by IN O
arginine NN O
. . O

The DT O
mutated JJ O
glutamine NN O
is VBZ O
not RB O
only RB O
highly RB O
conserved VBN O
in IN O
evolution NN O
( ( O
conserved VBN O
also RB O
in IN O
Escherichia NNP O
coli NN O
and CC O
Saccharomyces NNP O
cerevisiae NN O
) ) O
, , O
but CC O
is VBZ O
also RB O
two CD O
amino JJ O
acid NN O
residues NNS O
downstream VBP O
from IN O
the DT O
active JJ O
site NN O
histidine NN O
- : O
proline NN O
- : O
histidine NN O
triad NN O
and CC O
results NNS O
in IN O
about RB O
10 CD O
% NN O
of IN O
normal JJ O
enzymatic JJ O
activity NN O
. . O

The DT O
arginine NN O
188 CD O
mutation NN O
is VBZ O
the DT O
most RBS O
common JJ O
galactosemia NN B-Disease
mutation NN O
characterized VBN O
to TO O
date NN O
. . O

It PRP O
accounts VBZ O
for IN O
one CD O
- : O
fourth JJ O
of IN O
the DT O
galactosemia NN B-Disease
alleles VBZ O
studied VBN O
. . O

Second JJ O
, , O
we PRP O
report VBP O
the DT O
substitution NN O
of IN O
arginine JJ O
333 CD O
by IN O
tryptophan NN O
, , O
caused VBN O
by IN O
a DT O
transition NN O
at IN O
nucleotide JJ O
1025 CD O
. . O

The DT O
area NN O
surrounding VBG O
this DT O
missense NN O
mutation NN O
is VBZ O
the DT O
most RBS O
highly RB O
conserved JJ O
domain NN O
in IN O
the DT O
homologous JJ O
enzymes NNS O
from IN O
E NNP O
. . O
coli NN O
, , O
yeast NN O
, , O
and CC O
humans NNS O
, , O
and CC O
this DT O
mutation NN O
results NNS O
in IN O
undetectable JJ O
enzymatic JJ O
activity NN O
, , O
suggesting VBG O
that IN O
this DT O
is VBZ O
a DT O
severe JJ O
mutation NN O
. . O

This DT O
second JJ O
mutation NN O
appears VBZ O
to TO O
be VB O
rare JJ O
, , O
since IN O
it PRP O
was VBD O
found VBN O
only RB O
in IN O
the DT O
patient NN O
we PRP O
sequenced VBD O
. . O

Our PRP$ O
data NNS O
provide VB O
further JJ O
evidence NN O
for IN O
the DT O
heterogeneity NN O
of IN O
galactosemia NN B-Disease
at IN O
the DT O
molecular JJ O
level NN O
, , O
heterogeneity NN O
which WDT O
might MD O
be VB O
related VBN O
to TO O
the DT O
variable JJ O
clinical JJ O
outcome NN O
observed VBN O
in IN O
this DT O
disorder NN O
. . O
. . O

Hypoxanthine NNP B-Disease
- : I-Disease
guanine NN I-Disease
phosphoribosyltransferase NN I-Disease
deficiency NN I-Disease
: : O
analysis NN O
of IN O
HPRT NNP O
mutations NNS O
by IN O
direct JJ O
sequencing NN O
and CC O
allele VB O
- : O
specific JJ O
amplification NN O
. . O

The DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
severe JJ O
X NNP B-Disease
chromosome NN I-Disease
- : I-Disease
linked VBN I-Disease
human JJ I-Disease
disease NN I-Disease
caused VBN O
by IN O
a DT O
virtual JJ O
absence NN B-Disease
of IN I-Disease
hypoxanthine NN I-Disease
- : I-Disease
guanine NN I-Disease
phosphoribosyltransferase NN I-Disease
( ( I-Disease
HPRT NNP I-Disease
) ) I-Disease
activity NN I-Disease
. . O

A DT O
partial JJ O
deficiency NN O
in IN O
the DT O
activity NN O
of IN O
this DT O
enzyme NN O
can MD O
result VB O
in IN O
gouty NN B-Disease
arthritis NN I-Disease
. . O

To TO O
determine VB O
the DT O
genetic JJ O
basis NN O
for IN O
reduction NN O
or CC O
loss NN O
of IN O
enzyme JJ O
activity NN O
, , O
we PRP O
have VBP O
amplified VBN O
and CC O
sequenced VBD O
the DT O
coding VBG O
region NN O
of IN O
HPRT NNP O
cDNA NN O
from IN O
four CD O
patients NNS O
one CD O
with IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
( ( O
HPRTPerth NNP O
) ) O
and CC O
three CD O
with IN O
partial JJ B-Disease
deficiencies NNS I-Disease
of IN I-Disease
HPRT NNP I-Disease
activity NN I-Disease
, , O
which WDT O
have VBP O
been VBN O
designated VBN O
HPRTUrangan NNP O
, , O
HPRTSwan NNP O
and CC O
HPRTToowong NNP O
. . O

In IN O
all DT O
four CD O
patients NNS O
, , O
the DT O
only JJ O
mutation NN O
identified VBN O
was VBD O
a DT O
single JJ O
base NN O
substitution NN O
in IN O
exons NNS O
2 CD O
or CC O
3 CD O
of IN O
the DT O
coding VBG O
region NN O
, , O
which WDT O
in IN O
each DT O
case NN O
predicts VBZ O
a DT O
single JJ O
amino NN O
acid JJ O
substitution NN O
in IN O
the DT O
translated JJ O
protein NN O
. . O

Each DT O
base NN O
change NN O
was VBD O
confirmed VBN O
by IN O
allele NN O
- : O
specific JJ O
amplification NN O
of IN O
the DT O
patients NNS O
genomic JJ O
DNA NNP O
. . O

It PRP O
is VBZ O
interesting VBG O
to TO O
note VB O
that IN O
the DT O
mutation NN O
found VBD O
for IN O
HPRTPerth NNP O
is VBZ O
identical JJ O
to TO O
that DT O
reported VBD O
for IN O
HPRTFlint NNP O
. . O

It PRP O
appears VBZ O
that IN O
the DT O
two CD O
mutations NNS O
are VBP O
de JJ O
novo JJ O
events NNS O
. . O
. . O

Molecular JJ O
and CC O
metabolic JJ O
basis NN O
for IN O
the DT O
metabolic JJ B-Disease
disorder NN I-Disease
normotriglyceridemic JJ B-Disease
abetalipoproteinemia NN I-Disease
. . O

We PRP O
have VBP O
previously RB O
described VBN O
a DT O
disorder NN O
, , O
normotriglyceridemic JJ B-Disease
abetalipoproteinemia NN I-Disease
, , O
that WDT O
is VBZ O
characterized VBN O
by IN O
the DT O
virtual JJ O
absence NN O
of IN O
plasma NN O
low JJ O
density NN O
lipoproteins NNS O
and CC O
complete JJ O
absence NN O
of IN O
apoB JJ O
- : O
100 CD O
, , O
but CC O
with IN O
apparently RB O
normal JJ O
secretion NN O
of IN O
triglyceride JJ O
- : O
rich JJ O
lipoproteins VBZ O
containing VBG O
apoB SYM O
- : O
48 CD O
. . O

The DT O
patients NNS O
plasma VBP O
lipoproteins NNS O
were VBD O
shown VBN O
on IN O
polyacrylamide NN O
gels NNS O
and CC O
by IN O
antibody NN O
mapping NN O
to TO O
have VB O
a DT O
new JJ O
truncated VBN O
apoB NN O
variant NN O
, , O
apoB SYM O
- : O
50 CD O
, , O
circulating VBG O
along RB O
with IN O
her PRP$ O
apoB JJ O
- : O
48 CD O
. . O

We PRP O
have VBP O
found VBN O
this DT O
individual NN O
to TO O
be VB O
homozygous JJ O
for IN O
a DT O
single JJ O
C NNP O
- : O
to TO O
- : O
T NNP O
nucleotide JJ O
substitution NN O
at IN O
apoB NN O
codon NN O
2252 CD O
, , O
which WDT O
produces VBZ O
a DT O
premature NN O
in IN O
- : O
frame NN O
stop JJ O
codon NN O
. . O

Thus RB O
, , O
this DT O
is VBZ O
a DT O
rare JJ O
example NN O
of IN O
homozygous JJ B-Disease
hypobetalipoproteinemia NN I-Disease
. . O

Electron NNP O
photomicrographs NN O
revealed VBD O
that IN O
the DT O
diameters NNS O
of IN O
particles NNS O
in IN O
the DT O
d NN O
less JJR O
than IN O
1 CD O
. . O

6 CD O
g JJ O
/ NNP O
ml NN O
lipoprotein NN O
fraction NN O
, , O
in IN O
both DT O
the DT O
postprandial NN O
and CC O
postabsorptive JJ O
state NN O
, , O
are VBP O
bimodally RB O
distributed VBN O
. . O

The DT O
molar JJ O
ratio NN O
of IN O
apoE NN O
to TO O
apoB VB O
in IN O
these DT O
particles NNS O
is VBZ O
3 CD O
. . O

5 CD O
1 CD O
, , O
similar JJ O
to TO O
normal JJ O
VLDL NNP O
. . O

The DT O
plasma NN O
LDL NNP O
interval NN O
contains VBZ O
both DT O
spherical JJ O
and CC O
cuboidal JJ O
particles NNS O
. . O

Autologous JJ O
reinfusion NN O
of IN O
labeled JJ O
d NN O
less JJR O
than IN O
1 CD O
. . O

6 CD O
g JJ O
/ NNP O
ml NN O
lipoproteins VBZ O
showed VBN O
exponential JJ O
disappearance NN O
from IN O
plasma NN O
, , O
with IN O
an DT O
apparent JJ O
half NN O
- : O
removal JJ O
time NN O
of IN O
50 CD O
min NNS O
, , O
somewhat RB O
slower JJR O
than IN O
for IN O
normal JJ O
chylomicrons NNS O
but CC O
within IN O
the DT O
normal JJ O
range NN O
for IN O
VLDL NNP O
. . O

The DT O
calculated JJ O
production NN O
rate NN O
for IN O
apoB NN O
was VBD O
within IN O
the DT O
normal JJ O
range NN O
in IN O
this DT O
subject NN O
. . O

A DT O
single JJ O
origin NN O
of IN O
phenylketonuria NN B-Disease
in IN O
Yemenite NNP O
Jews NNPS O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
a DT O
metabolic JJ B-Disease
disease NN I-Disease
caused VBN O
by IN O
recessive JJ O
mutations NNS O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
hepatic JJ O
enzyme NN O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
. . O

The DT O
incidence NN O
of IN O
PKU NNP B-Disease
varies NNS O
widely RB O
across IN O
different JJ O
geographic JJ O
areas NNS O
, , O
and CC O
is VBZ O
highest JJS O
( ( O
about IN O
1 CD O
in IN O
5 CD O
, , O
0 CD O
live JJ O
births NNS O
) ) O
in IN O
Ireland NNP O
and CC O
western JJ O
Scotland NNP O
, , O
and CC O
among IN O
Yemenite JJ O
Jews NNPS O
. . O

A DT O
limited JJ O
number NN O
of IN O
point NN O
mutations NNS O
account VBP O
for IN O
most JJS O
of IN O
the DT O
PKU NNP B-Disease
cases NNS O
in IN O
the DT O
European JJ O
population NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
a DT O
single JJ O
molecular NN O
defect NN O
- : O
- : O
a DT O
deletion NN O
spanning VBG O
the DT O
third JJ O
exon NN O
of IN O
the DT O
PAH NNP O
gene NN O
- : O
- : O
is VBZ O
responsible JJ O
for IN O
all PDT O
the DT O
PKU NNP B-Disease
cases NNS O
among IN O
the DT O
Yemenite NNP O
Jews NNPS O
. . O

Examination NN O
of IN O
a DT O
random JJ O
sample NN O
of IN O
Yemenite NNP O
Jews NNPS O
using VBG O
a DT O
molecular JJ O
probe NN O
that WDT O
detects VBZ O
the DT O
carriers NNS O
of IN O
this DT O
deletion NN O
indicated VBD O
a DT O
high JJ O
frequency NN O
of IN O
the DT O
defective JJ O
gene NN O
in IN O
this DT O
community NN O
. . O

Although IN O
the DT O
deleted JJ O
PAH NNP O
gene NN O
was VBD O
traced VBN O
to TO O
25 CD O
different JJ O
locations NNS O
throughout IN O
Yemen NNP O
, , O
family NN O
histories NNS O
and CC O
official JJ O
documents NNS O
of IN O
the DT O
Yemenite NNP O
Jewish NNP O
community NN O
showed VBD O
that IN O
the DT O
common JJ O
ancestor NN O
of IN O
all PDT O
the DT O
carriers NNS O
of IN O
this DT O
genetic JJ B-Disease
defect NN I-Disease
lived VBN O
in IN O
Sana NNP O
, , O
the DT O
capital NN O
of IN O
Yemen NNP O
, , O
before IN O
the DT O
eighteenth JJ O
century NN O
. . O
. . O

Linkage NN O
of IN O
aspartylglucosaminuria NN B-Disease
( ( O
AGU NNP B-Disease
) ) O
to TO O
marker VB O
loci NN O
on IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
4 CD O
. . O

Aspartylglucosaminuria NNP B-Disease
( ( O
AGU NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
deficient JJ O
activity NN O
of IN O
the DT O
enzyme JJ O
aspartylglucosaminidase NN O
( ( O
AGA NNP O
) ) O
. . O

The DT O
structural JJ O
gene NN O
for IN O
AGA NNP O
has VBZ O
been VBN O
assigned VBN O
to TO O
the DT O
region NN O
4q21 CD O
- : O
qter NN O
of IN O
chromosome NN O
4 CD O
. . O

We PRP O
have VBP O
studied VBN O
the DT O
map JJ O
position NN O
of IN O
the DT O
AGU NNP O
locus NN O
in IN O
relation NN O
to TO O
other JJ O
marker NN O
loci NN O
on IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
4 CD O
using VBG O
linkage NN O
analyses NNS O
. . O

Restriction NNP O
fragment NN O
length NN O
polymorphism NN O
alleles NNS O
for IN O
the DT O
ADH2 NNP O
, , O
ADH3 NNP O
, , O
EGF NNP O
, , O
FG NNP O
alpha NN O
and CC O
FG NNP O
beta NN O
loci NN O
and CC O
blood NN O
group NN O
antigens VBZ O
for IN O
the DT O
MNS NNP O
locus NN O
were VBD O
determined VBN O
in IN O
a DT O
panel NN O
of IN O
12 CD O
Finnish JJ O
AGU NNP B-Disease
families NNS O
. . O

The DT O
heterozygous JJ O
family NN O
members NNS O
were VBD O
identified VBN O
by IN O
reduced JJ O
activity NN O
of IN O
AGA NNP O
in IN O
lymphocytes NNS O
. . O

Linkage NN O
studies NNS O
were VBD O
performed VBN O
using VBG O
both DT O
pairwise NN O
and CC O
multipoint NN O
analyses NNS O
. . O

Loose JJ O
linkage NN O
of IN O
the DT O
AGU NNP B-Disease
locus NN O
to TO O
the DT O
FG NNP O
and CC O
MNS NNP O
loci NN O
was VBD O
observed VBN O
( ( O
z JJ O
= NN O
1 CD O
. . O
16 CD O
, , O
z NN O
= VBD O
1 CD O
. . O
39 CD O
, , O
respectively RB O
) ) O
. . O

Multipoint NN O
analysis NN O
to TO O
the DT O
fixed VBN O
map NN O
[ NN O
ADH NNP O
- : O
( ( O
0 CD O
. . O
3 CD O
) ) O
- : O
EGF SYM O
- : O
( ( O
0 CD O
. . O
35 CD O
) ) O
- : O
FG NNP O
- : O
( ( O
0 CD O
. . O
11 CD O
) ) O
- : O
MNS NNP O
] NNP O
suggests VBZ O
that IN O
the DT O
location NN O
of IN O
the DT O
AGU NNP O
locus NN O
is VBZ O
0 CD O
. . O

5 CD O
- : O
0 CD O
. . O

30 CD O
recombination NN O
units NNS O
distal VBP O
to TO O
MNS NNP O
( ( O
z NNP O
= VBZ O
3 CD O
. . O
3 CD O
) ) O
. . O

The DT O
order NN O
cen SYM O
- : O
ADH NNP O
- : O
EGF NNP O
- : O
FG NNP O
- : O
MNS NNP O
- : O
AGU NNP O
is VBZ O
35 CD O
times NNS O
more RBR O
likely JJ O
than IN O
the DT O
next JJ O
best JJS O
order NN O
cen NN O
- : O
ADH NNP O
- : O
EGF NNP O
- : O
AGU NNP O
- : O
FG NNP O
- : O
MNS NN O
. . O

Linkage JJ O
relationships NNS O
of IN O
the DT O
apolipoprotein NN O
C1 NNP O
gene NN O
and CC O
a DT O
cytochrome JJ O
P450 NNP O
gene NN O
( ( O
CYP2A NNP O
) ) O
to TO O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

We PRP O
have VBP O
studied VBN O
the DT O
genetic JJ O
linkage NN O
of IN O
two CD O
markers NNS O
, , O
the DT O
apolipoprotein NN O
C1 NNP O
( ( O
APOC1 NNP O
) ) O
gene NN O
and CC O
a DT O
cytochrome JJ O
P450 NNP O
( ( O
CYP2A NNP O
) ) O
gene NN O
, , O
in IN O
relation NN O
to TO O
the DT O
gene NN O
for IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

A DT O
peak JJ O
lod NN O
score NN O
of IN O
9 CD O
. . O

29 CD O
at IN O
2 CD O
cM NN O
was VBD O
observed VBN O
for IN O
APOC1 NNP O
- : O
DM NNP O
, , O
with IN O
a DT O
lod JJ O
score NN O
of IN O
8 CD O
. . O

55 CD O
at IN O
4 CD O
cM NN O
for IN O
CYP2A NNP O
- : O
DM NN O
. . O

These DT O
two CD O
markers NNS O
also RB O
show VBP O
close JJ O
linkage NN O
to TO O
each DT O
other JJ O
( ( O
theta JJ O
max NN O
= VBD O
0 CD O
. . O
5 CD O
, , O
Zmax NNP O
= VBZ O
9 CD O
. . O
9 CD O
) ) O
. . O

From IN O
examination NN O
of IN O
the DT O
genotypes NNS O
of IN O
the DT O
recombinant JJ O
individuals NNS O
, , O
CYP2A NNP O
appears VBZ O
to TO O
map VB O
proximal JJ O
to TO O
DM NNP O
because IN O
in IN O
one CD O
recombinant JJ O
individual JJ O
CYP2A NNP O
, , O
APOC2 NNP O
and CC O
CKMM NNP O
had VBD O
all DT O
recombined VBN O
with IN O
DM NNP O
. . O

Evidence NN O
from IN O
another DT O
CYP2A NNP O
- : O
DM NNP O
recombinant JJ O
individual JJ O
places NNS O
CYP2A NNP O
proximal NN O
to TO O
APOC2 NNP O
and CC O
CKMM NNP O
. . O

Localisation NN O
of IN O
CYP2A NNP O
on IN O
a DT O
panel NN O
of IN O
somatic JJ O
cell NN O
hybrids NNS O
also RB O
suggests VBZ O
that IN O
it PRP O
is VBZ O
proximal JJ O
to TO O
DM NNP O
and CC O
APOC2 NNP O
/ NNP O
C1 NNP O
/ NNP O
E NNP O
gene NN O
cluster NN O
. . O

Genetic JJ O
linkage NN O
map NN O
of IN O
six CD O
polymorphic JJ O
DNA NN O
markers NNS O
around IN O
the DT O
gene NN O
for IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
on IN O
chromosome NN O
5 CD O
. . O

A DT O
genetic JJ O
linkage NN O
map NN O
of IN O
six CD O
polymorphic JJ O
DNA NNP O
markers NNS O
close RB O
to TO O
the DT O
gene NN O
( ( O
APC NNP O
) ) O
for IN O
familial JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
on IN O
chromosome NN O
5q CD O
is VBZ O
reported VBN O
. . O

One CD O
hundred CD O
fifty SYM O
- : O
five CD O
typed VBD O
members NNS O
of IN O
nine CD O
FAP NNP B-Disease
kindred VBD O
provided VBD O
more JJR O
than IN O
90 CD O
meioses NNS O
for IN O
linkage NN O
analysis NN O
. . O

A DT O
number NN O
of IN O
crucial JJ O
recombination NN O
events NNS O
have VBP O
been VBN O
identified VBN O
which WDT O
are VBP O
informative JJ O
at IN O
three CD O
or CC O
more JJR O
loci NNS O
, , O
allowing VBG O
confident JJ O
ordering NN O
of IN O
parts NNS O
of IN O
the DT O
map NN O
. . O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
genetic JJ O
heterogeneity NN O
, , O
with IN O
all DT O
families NNS O
showing VBG O
linkage NN O
of IN O
at IN O
least JJS O
one CD O
chromosome NN O
5 CD O
marker NN O
to TO O
the DT O
gene NN O
. . O

Recombination NNP O
data NNS O
and CC O
two CD O
- : O
point NN O
linkage NN O
analysis NN O
support NN O
a DT O
locus NN O
order NN O
of IN O
centromere JJ O
- : O
pi NN O
227 CD O
- : O
C11P11 NNP O
- : O
ECB27 NNP O
- : O
L5 NN O
. . O

62 CD O
- : O
APC NNP O
- : O
EF5 NN O
62 CD O
- : O
APC NNP O
- : O
EF5 NN O
. . O

44 CD O
- : O
YN5 NN O
44 CD O
- : O
YN5 NN O
. . O

48 CD O
- : O
telomer NN O
e NN O
, , O
although IN O
EF5 NNP O
. . O

44 CD O
could MD O
lie VB O
in IN O
the DT O
interval JJ O
L5 NNP O
. . O

62 CD O
- : O
APC NN O
or CC O
ECB27 NNP O
- : O
L5 NN O
. . O

62 CD O
. . O

No DT O
recombinants NNS O
were VBD O
identified VBN O
between IN O
APC NNP O
and CC O
either DT O
EF5 NNP O
. . O

44 CD O
or CC O
YN5 NNP O
. . O

48 CD O
, , O
but CC O
published VBN O
deletion NN O
mapping NN O
in IN O
colorectal JJ B-Disease
carcinomas NN I-Disease
and CC O
linkage NN O
analysis NN O
in IN O
FAP NNP B-Disease
suggest VBP O
that IN O
YN5 NNP O
. . O

48 CD O
is VBZ O
1 CD O
- : O
3 CD O
cM NN O
from IN O
APC NNP O
. . O

The DT O
present JJ O
study NN O
suggests VBZ O
that IN O
YN5 NNP O
. . O

48 CD O
and CC O
L5 NNP O
. . O

62 CD O
delineate NN O
a DT O
small JJ O
region NN O
of IN O
chromosome NN O
5 CD O
within IN O
which WDT O
the DT O
EF5 NNP O
. . O

44 CD O
locus NN O
lies VBZ O
very RB O
close RB O
to TO O
the DT O
APC NNP B-Disease
gene NN O
. . O

These DT O
data NNS O
not RB O
only RB O
allow VB O
use NN O
of IN O
flanking VBG O
markers NNS O
for IN O
presymptomatic JJ O
diagnosis NN O
of IN O
FAP NNP B-Disease
but CC O
also RB O
provide VBP O
a DT O
high JJ O
- : O
density NN O
map NN O
of IN O
the DT O
region NN O
for IN O
isolation NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
itself PRP O
and CC O
for IN O
further JJ O
assessment NN O
of IN O
the DT O
role NN O
of IN O
chromosome NN O
5 CD O
deletions NNS O
in IN O
the DT O
biology NN O
of IN O
sporadic JJ O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

Serum NNP O
amyloid VBZ O
A NNP O
and CC O
P NNP O
protein VBP O
genes NNS O
in IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
. . O

Two CD O
recent JJ O
studies NNS O
have VBP O
suggested VBN O
the DT O
involvement NN O
of IN O
serum NN O
amyloid NN O
A NNP O
( ( O
SAA NNP O
) ) O
and CC O
P NNP O
( ( O
APCS NNP O
) ) O
genes NNS O
in IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
MEF NNP B-Disease
) ) O
. . O

To TO O
test VB O
the DT O
role NN O
of IN O
SAA NNP O
and CC O
APCS NNP O
in IN O
MEF NNP B-Disease
and CC O
MEF NNP B-Disease
- : I-Disease
amyloidosis NN I-Disease
, , O
we PRP O
studied VBD O
17 CD O
informative JJ O
families NNS O
( ( O
15 CD O
Armenians NNPS O
, , O
2 CD O
non SYM O
- : O
Ashkenazi NNP O
Jews NNPS O
) ) O
and CC O
8 CD O
MEF NNP B-Disease
patients NNS O
with IN O
amyloidosis NN B-Disease
using VBG O
a DT O
candidate NN O
gene NN O
approach NN O
. . O

No DT O
evidence NN O
for IN O
any DT O
MEF NNP B-Disease
- : O
associated VBD O
polymorphism NN O
was VBD O
found VBN O
in IN O
any DT O
of IN O
the DT O
41 CD O
Armenian JJ O
and CC O
Jewish JJ O
MEF NNP B-Disease
patients NNS O
tested VBD O
. . O

Our PRP$ O
family NN O
studies NNS O
allowed VBD O
us PRP O
to TO O
rule VB O
out RP O
tight JJ O
linkage NN O
between IN O
SAA NNP O
and CC O
MEF NNP B-Disease
( ( O
lod JJ O
score NN O
= NNP O
- : O
2 CD O
. . O
16 CD O
, , O
theta NN O
less JJR O
than IN O
or CC O
equal JJ O
to TO O
0 CD O
. . O
6 CD O
) ) O
. . O

For IN O
APCS NNP O
we PRP O
found VBD O
that IN O
the DT O
allele JJ O
frequency NN O
in IN O
the DT O
MEF NNP B-Disease
- : I-Disease
amyloidosis NN I-Disease
patients NNS O
was VBD O
similar JJ O
to TO O
that DT O
in IN O
18 CD O
unrelated JJ O
MEF NNP B-Disease
patients NNS O
without IN O
amyloidosis NN B-Disease
and CC O
their PRP$ O
33 CD O
healthy JJ O
parents NNS O
. . O

Some DT O
Mexican NNP O
glucose VBD O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variants NNS O
revisited VBD O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
appears VBZ O
to TO O
be VB O
fairly RB O
common JJ O
in IN O
Mexico NNP O
. . O

We PRP O
have VBP O
now RB O
examined VBN O
the DT O
DNA NN O
of IN O
three CD O
previously RB O
reported VBN O
electrophoretically RB O
fast JJ O
Mexican NNP O
G6PD NNP O
variants NNS O
, , O
- : O
G6PD NNP O
Distrito NNP O
Federal NNP O
, , O
G6PD NNP O
Tepic NNP O
, , O
and CC O
G6PD NNP O
Castilla NNP O
. . O

All DT O
three CD O
of IN O
these DT O
variants NNS O
, , O
believed VBN O
on IN O
the DT O
basis NN O
of IN O
biochemical JJ O
characterization NN O
and CC O
population NN O
origin NN O
to TO O
be VB O
unique JJ O
, , O
have VBP O
the DT O
G NNP O
- : O
- : O
- : O
- : O
A DT O
transition NN O
at IN O
nucleotide JJ O
202 CD O
and CC O
the DT O
A NNP O
- : O
- : O
- : O
- : O
G JJ O
transition NN O
at IN O
nucleotide JJ O
376 CD O
, , O
mutations NNS O
that IN O
we PRP O
now RB O
recognize VBP O
to TO O
be VB O
characteristic JJ O
of IN O
G6PD NNP O
A NNP O
- : O
. . O

Two CD O
other JJ O
Mexican JJ O
males NNS O
with IN O
G6PD NNP B-Disease
deficiency NN I-Disease
were VBD O
found VBN O
to TO O
have VB O
the DT O
same JJ O
mutation NN O
. . O

All DT O
five CD O
have VBP O
the DT O
( ( O
NlaIII NNP O
/ NNP O
FokI NNP O
/ NNP O
PvuII NNP O
/ NNP O
PstI NNP O
) ) O
haplotype VBD O
characteristic JJ O
of IN O
G6PD NNP O
A NNP O
- : O
in IN O
Africa NNP O
. . O

Since IN O
the DT O
PvuII NNP O
+ NNP O
genotype NN O
seems VBZ O
to TO O
be VB O
rare JJ O
in IN O
Europe NNP O
, , O
we PRP O
conclude VBP O
that IN O
all DT O
of IN O
these DT O
G6PD NNP O
A NNP O
- : O
genes NNS O
had VBD O
their PRP$ O
ancient JJ O
origin NN O
in IN O
Africa NNP O
, , O
although IN O
in IN O
many JJ O
of IN O
the DT O
Mexican JJ O
patients NNS O
with IN O
G6PD NNP O
A NNP O
- : O
202A CD O
/ $ O
376G CD O
the DT O
gene NN O
may MD O
have VB O
been VBN O
imported VBN O
more RBR O
recently RB O
from IN O
Spain NNP O
, , O
where WRB O
this DT O
variant NN O
, , O
formerly RB O
known VBN O
as IN O
G6PD NNP O
Betica NNP O
, , O
is VBZ O
also RB O
prevalent JJ O
. . O
. . O

Hereditary JJ O
deficiency NN B-Disease
of IN I-Disease
C5 NNP I-Disease
in IN O
association NN O
with IN O
discoid JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
. . O

A DT O
29 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
discoid JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
had VBD O
undetectable JJ O
classic JJ O
pathway NN O
complement NN O
activity NN O
. . O

Hypocomplementemia NNP B-Disease
was VBD O
due JJ O
to TO O
selective JJ O
deficiency NN B-Disease
of IN I-Disease
C5 NNP I-Disease
. . O

One CD O
of IN O
her PRP$ O
children NNS O
was VBD O
also RB O
deficient JJ O
. . O

To TO O
our PRP$ O
knowledge NN O
this DT O
is VBZ O
the DT O
first JJ O
documented JJ O
case NN O
of IN O
an DT O
association NN O
between IN O
discoid JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
and CC O
C5 NNP B-Disease
deficiency NN I-Disease
. . O
. . O

Founder NNP O
effect NN O
of IN O
a DT O
prevalent JJ O
phenylketonuria NN B-Disease
mutation NN O
in IN O
the DT O
Oriental JJ O
population NN O
. . O

A DT O
missense NN O
mutation NN O
has VBZ O
been VBN O
identified VBN O
in IN O
the DT O
human JJ O
phenylalanine NN O
hydroxylase NN O
[ NNP O
PAH NNP O
; : O
phenylalanine NN O
4 CD O
- : O
monooxygenase NN O
; : O
L NNP O
- : O
phenylalanine NN O
, , O
tetrahydrobiopterin JJ O
oxygen NN O
oxidoreductase NN O
( ( O
4 CD O
- : O
hydroxylating NN O
) ) O
, , O
EC NNP O
1 CD O
. . O
14 CD O
. . O
16 CD O
. . O
1 CD O
] JJ O
gene NN O
in IN O
a DT O
Chinese JJ O
patient NN O
with IN O
classic JJ O
phenylketonuria NN B-Disease
( ( O
PKU NNP B-Disease
) ) O
. . O

A DT O
G NNP O
- : O
to TO O
- : O
C NNP O
transition NN O
at IN O
the DT O
second JJ O
base NN O
of IN O
codon NN O
413 CD O
in IN O
exon JJ O
12 CD O
of IN O
the DT O
gene NN O
results NNS O
in IN O
the DT O
substitution NN O
of IN O
Pro413 NNP O
for IN O
Arg413 NNP O
in IN O
the DT O
mutant JJ O
protein NN O
. . O

This DT O
mutation NN O
( ( O
R413P NNP O
) ) O
results NNS O
in IN O
negligible JJ O
enzymatic JJ O
activity NN O
when WRB O
expressed VBN O
in IN O
heterologous JJ O
mammalian JJ O
cells NNS O
and CC O
is VBZ O
compatible JJ O
with IN O
a DT O
classic JJ O
PKU NNP B-Disease
phenotype NN O
in IN O
the DT O
patient NN O
. . O

Population NNP O
genetic JJ O
studies NNS O
reveal VBP O
that IN O
this DT O
mutation NN O
is VBZ O
tightly RB O
linked VBN O
to TO O
restriction VB O
fragment JJ O
length NN O
polymorphism NN O
haplotype NN O
4 CD O
, , O
which WDT O
is VBZ O
the DT O
predominant JJ O
haplotype NN O
of IN O
the DT O
PAH NNP O
locus NN O
in IN O
the DT O
Oriental JJ O
population NN O
. . O

It PRP O
accounts VBZ O
for IN O
13 CD O
. . O

8 CD O
% NN O
of IN O
northern JJ O
Chinese NNP O
and CC O
27 CD O
% NN O
of IN O
Japanese JJ O
PKU NNP B-Disease
alleles NNS O
, , O
but CC O
it PRP O
is VBZ O
rare JJ O
in IN O
southern JJ O
Chinese NNP O
( ( O
2 CD O
. . O
2 CD O
% NN O
) ) O
and CC O
is VBZ O
absent JJ O
in IN O
the DT O
Caucasian JJ O
population NN O
. . O

The DT O
data NN O
demonstrate NN O
unambiguously RB O
that IN O
the DT O
mutation NN O
occurred VBD O
after IN O
racial JJ O
divergence NN O
of IN O
Orientals NNS O
and CC O
Caucasians NNPS O
and CC O
suggest VB O
that IN O
the DT O
allele NN O
has VBZ O
spread VBN O
throughout IN O
the DT O
Orient NNP O
by IN O
a DT O
founder NN O
effect NN O
. . O

Previous JJ O
protein NN O
polymorphism NN O
studies NNS O
in IN O
eastern JJ O
Asia NNP O
have VBP O
led VBN O
to TO O
the DT O
hypothesis NN O
that WDT O
"""" VBZ O
northern JJ O
Mongoloids NNP O
"""" NNP O
represented VBD O
a DT O
founding JJ O
population NN O
in IN O
Asia NNP O
. . O

Our PRP$ O
results NNS O
are VBP O
compatible JJ O
with IN O
this DT O
hypothesis NN O
in IN O
that DT O
the DT O
PKU NNP B-Disease
mutation NN O
might MD O
have VB O
occurred VBN O
in IN O
northern JJ O
Mongoloids NNP O
and CC O
subsequently RB O
spread VBN O
to TO O
the DT O
Chinese NNPS O
and CC O
Japanese JJ O
populations NNS O
. . O

Glucose NNP B-Disease
/ NNP I-Disease
galactose JJ I-Disease
malabsorption NN I-Disease
caused VBN O
by IN O
a DT O
defect NN O
in IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
glucose JJ O
cotransporter NN O
. . O

Glucose NNP B-Disease
/ NNP I-Disease
galactose JJ I-Disease
malabsorption NN I-Disease
( ( O
GGM NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disease NN I-Disease
manifesting VBG O
within IN O
the DT O
first JJ O
weeks NNS O
of IN O
life NN O
and CC O
characterized VBN O
by IN O
a DT O
selective JJ O
failure NN O
to TO O
absorb VB O
dietary JJ O
glucose NN O
and CC O
galactose NN O
from IN O
the DT O
intestine NN O
. . O

The DT O
consequent NN O
severe JJ O
diarrhoea NN B-Disease
and CC O
dehydration NN B-Disease
are VBP O
usually RB O
fatal JJ O
unless IN O
these DT O
sugars NNS O
are VBP O
eliminated VBN O
from IN O
the DT O
diet NN O
. . O

Intestinal JJ O
biopsies NNS O
of IN O
GGM NNP B-Disease
patients NNS O
have VBP O
revealed VBN O
a DT O
specific JJ O
defect NN O
in IN O
Na NNP O
( ( O
+ NNP O
) ) O
- : O
dependent JJ O
absorption NN O
of IN O
glucose NN O
in IN O
the DT O
brush NN O
border NN O
. . O

Normal NNP O
glucose JJ O
absorption NN O
is VBZ O
mediated VBN O
by IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
in IN O
the DT O
brush NN O
border NN O
membrane NN O
of IN O
the DT O
intestinal JJ O
epithelium NN O
. . O

Cellular JJ O
influx NN O
is VBZ O
driven VBN O
by IN O
the DT O
transmembrane NN O
Na NNP O
+ NNP O
electrochemical JJ O
potential JJ O
gradient NN O
; : O
thereafter RB O
the DT O
sugar NN O
moves NNS O
to TO O
the DT O
blood NN O
across IN O
the DT O
basolateral JJ O
membrane NN O
via IN O
the DT O
facilitated VBN O
glucose NN O
carrier NN O
. . O

We PRP O
have VBP O
previously RB O
cloned VBN O
and CC O
sequenced VBD O
a DT O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
from IN O
normal JJ O
human JJ O
ileum NN O
and CC O
shown VBN O
that IN O
this DT O
gene NN O
, , O
SGLT1 NNP O
, , O
resides VBZ O
on IN O
the DT O
distal JJ O
q NN O
arm NN O
of IN O
chromosome NN O
22 CD O
. . O

We PRP O
have VBP O
now RB O
amplified VBN O
SGLT1 NNP O
complementary JJ O
DNA NNP O
and CC O
genomic JJ O
DNA NN O
from IN O
members NNS O
of IN O
a DT O
family NN O
affected VBN O
with IN O
GGM NNP B-Disease
by IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
amplified JJ O
products NNS O
has VBZ O
revealed VBN O
a DT O
single JJ O
missense NN O
mutation NN O
in IN O
SGLT1 NNP O
which WDT O
cosegregates VBZ O
with IN O
the DT O
GGM NNP B-Disease
phenotype NN O
and CC O
results NNS O
in IN O
a DT O
complete JJ O
loss NN O
of IN O
Na NNP O
( ( O
+ NNP O
) ) O
- : O
dependent NN O
glucose JJ O
transport NN O
in IN O
Xenopus NNP O
oocytes NNS O
injected VBD O
with IN O
this DT O
complementary JJ O
RNA NNP O
. . O
. . O

A DT O
de FW O
novo FW O
unbalanced JJ O
reciprocal JJ O
translocation NN O
identified VBN O
as IN O
paternal JJ O
in IN O
origin NN O
in IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

Interstitial NNP O
cytogenetic JJ O
deletions NNS O
involving VBG O
the DT O
paternally RB O
derived VBN O
chromosome NN O
15q11 CD O
- : O
13 CD O
have VBP O
been VBN O
described VBN O
in IN O
patients NNS O
with IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

We PRP O
report VBP O
a DT O
child NN O
with IN O
PWS NNP B-Disease
and CC O
a DT O
de FW O
novo FW O
unbalanced JJ O
karyotype NN O
- : O
45 CD O
, , O
XY NNP O
, , O
- : O
9 CD O
, , O
- : O
15 CD O
, , O
+ FW O
der NN O
( ( O
9 CD O
) ) O
t NN O
( ( O
9 CD O
; : O
15 CD O
) ) O
( ( O
q34 NN O
; : O
q13 NN O
) ) O
. . O

Molecular JJ O
studies NNS O
with IN O
the DT O
DNA NNP O
probe NN O
pML34 NN O
confirmed VBD O
that IN O
only RB O
a DT O
single JJ O
Prader NNP B-Disease
Willi NNP I-Disease
critical JJ O
region NN O
( ( O
PWCR NNP O
15q11 CD O
. . O
2 CD O
- : O
q12 NN O
) ) O
copy NN O
was VBD O
present JJ O
. . O

Hybridisation NN O
of IN O
patient NN O
and CC O
parental JJ O
DNA NN O
with IN O
the DT O
multi NN O
- : O
allelic JJ O
probe NN O
CMW1 NNP O
, , O
which WDT O
maps VBZ O
to TO O
pter VB O
- : O
15q13 CD O
, , O
showed VBD O
that IN O
the DT O
chromosome NN O
involved VBN O
in IN O
the DT O
translocation NN O
was VBD O
paternal JJ O
in IN O
origin NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
example NN O
of IN O
a DT O
paternally RB O
- : O
derived VBN O
PWCR NNP O
allele JJ O
loss NN O
caused VBN O
by IN O
an DT O
unbalanced JJ O
translocation NN O
that WDT O
has VBZ O
arisen VBN O
de IN O
novo FW O
. . O

Localisation NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
to TO O
19q13 CD O
. . O
2 CD O
- : O
19q13 CD O
. . O
3 CD O
and CC O
its PRP$ O
relationship NN O
to TO O
twelve VB O
polymorphic JJ O
loci NN O
on IN O
19q CD O
. . O

The DT O
order NN O
of IN O
fourteen JJ O
polymorphic JJ O
markers NNS O
localised VBD O
to TO O
the DT O
long JJ O
arm NN O
of IN O
human JJ O
chromosome NN O
19 CD O
has VBZ O
been VBN O
established VBN O
by IN O
multipoint NN O
mapping NN O
in IN O
a DT O
set NN O
of IN O
40 CD O
CEPH NNP O
( ( O
Centre NNP O
dEtude VBP O
de FW O
Polymorphisme NNP O
Humain NNP O
, , O
Paris NNP O
) ) O
reference NN O
families NNS O
. . O

We PRP O
report VBP O
here RB O
the DT O
linkage NN O
relationship NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
locus NN O
to TO O
twelve VB O
of IN O
these DT O
markers NNS O
as IN O
studied VBN O
in IN O
45 CD O
families NNS O
with IN O
DM NNP B-Disease
. . O

The DT O
resulting JJ O
genetic JJ O
map NN O
is VBZ O
supported VBN O
by IN O
the DT O
localisation NN O
of IN O
the DT O
DNA NN O
markers NNS O
in IN O
a DT O
panel NN O
of IN O
somatic JJ O
cell NN O
hybrids NNS O
. . O

Ten CD O
of IN O
the DT O
twelve NN O
markers NNS O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
proximal JJ O
to TO O
the DT O
DM NNP B-Disease
gene NN O
and CC O
two CD O
, , O
PRKCG NNP O
and CC O
D19S22 NNP O
, , O
distal JJ O
but CC O
at IN O
distances NNS O
of IN O
approximately RB O
25 CD O
cM NNS O
and CC O
15 CD O
cM NN O
, , O
respectively RB O
. . O

The DT O
closest JJS O
proximal JJ O
markers NNS O
are VBP O
APOC2 NNP O
( ( O
apolipoprotein JJ O
C NNP O
- : O
II NNP O
) ) O
and CC O
CKM NNP O
( ( O
creatine JJ O
kinase NN O
, , O
muscle NN O
) ) O
approximately RB O
3 CD O
cM NNS O
and CC O
2 CD O
cM NN O
from IN O
the DT O
DM NNP B-Disease
gene NN O
respectively RB O
, , O
in IN O
the DT O
order NN O
APOC2 NNP O
- : O
CKM NNP O
- : O
DM NN O
. . O

The DT O
distance NN O
between IN O
APOC2 NNP O
, , O
CKM NNP O
and CC O
DM NNP B-Disease
( ( O
of IN O
the DT O
order NN O
of IN O
2 CD O
million CD O
base NN O
pairs NN O
) ) O
and CC O
their PRP$ O
known VBN O
orientation NN O
should MD O
permit VB O
directional JJ O
chromosome NN O
walking NN O
and CC O
jumping NN O
. . O

The DT O
data NN O
presented VBD O
here RB O
should MD O
enable VB O
us PRP O
to TO O
determine VB O
whether IN O
or CC O
not RB O
new JJ O
markers NNS O
are VBP O
distal JJ O
to TO O
APOC2 NNP O
/ NNP O
CKM NNP O
and CC O
thus RB O
potentially RB O
flank VBZ O
the DT O
DM NNP B-Disease
gene NN O
. . O
. . O

Localization NN O
of IN O
histidase NN O
to TO O
human JJ O
chromosome NN O
region NN O
12q22 CD O
- : O
- : O
- : O
- : O
q24 NN O
. . O
1 CD O
and CC O
mouse VB O
chromosome JJ O
region NN O
10C2 CD O
- : O
- : O
- : O
- : O
D1 NN O
. . O

The DT O
human JJ O
gene NN O
for IN O
histidase NN O
( ( O
histidine JJ O
ammonia NN O
- : O
lyase NN O
; : O
HAL NNP O
) ) O
, , O
the DT O
enzyme JJ O
deficient NN O
in IN O
histidinemia NN B-Disease
, , O
was VBD O
assigned VBN O
to TO O
human JJ O
chromosome NN O
12 CD O
by IN O
Southern NNP O
blot NN O
analysis NN O
of IN O
human JJ O
X NNP O
mouse NN O
somatic JJ O
cell NN O
hybrid JJ O
DNA NNP O
. . O

The DT O
gene NN O
was VBD O
sublocalized VBN O
to TO O
region NN O
12q22 CD O
- : O
- : O
- : O
- : O
q24 NN O
. . O

1 CD O
by IN O
in IN O
situ JJ O
hybridization NN O
, , O
using VBG O
a DT O
human JJ O
histidase NN O
cDNA NN O
. . O

The DT O
homologous JJ O
locus NN O
in IN O
the DT O
mouse NN O
( ( O
Hal NNP O
) ) O
was VBD O
mapped VBN O
to TO O
region NN O
10C2 CD O
- : O
- : O
- : O
- : O
D1 NN O
by IN O
in IN O
situ JJ O
hybridization NN O
, , O
using VBG O
a DT O
cell NN O
line NN O
from IN O
a DT O
mouse NN O
homozygous JJ O
for IN O
a DT O
1 CD O
. . O

10 CD O
Robertsonian JJ O
translocation NN O
. . O

These DT O
assignments NNS O
extend VBP O
the DT O
conserved JJ O
syntenic JJ O
region NN O
between IN O
human JJ O
chromosome NN O
12 CD O
and CC O
mouse VB O
chromosome NN O
10 CD O
that WDT O
includes VBZ O
the DT O
genes NNS O
for IN O
phenylalanine NN O
hydroxylase NN O
, , O
gamma NN O
interferon NN O
, , O
peptidase NN O
, , O
and CC O
citrate JJ O
synthase NN O
. . O

The DT O
localization NN O
of IN O
histidase NN O
to TO O
mouse VB O
chromosome NN O
10 CD O
suggests VBZ O
that IN O
the DT O
histidase NN O
regulatory JJ O
locus NN O
( ( O
Hsd NNP O
) ) O
and CC O
the DT O
histidinemia NN O
mutation NN O
( ( O
his PRP$ O
) ) O
, , O
which WDT O
are VBP O
both DT O
known VBN O
to TO O
be VB O
on IN O
chromosome NN O
10 CD O
, , O
may MD O
be VB O
alleles NNS O
of IN O
the DT O
histidase JJ O
structural JJ O
gene NN O
locus NN O
. . O

Determination NN O
of IN O
the DT O
mutations NNS O
responsible JJ O
for IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome VBP I-Disease
in IN O
17 CD O
subjects NNS O
. . O

Hypoxanthine NNP O
- : O
- : O
guanine NN O
phosphoribosyltransferase NN O
( ( O
HPRT NNP O
) ) O
is VBZ O
a DT O
purine JJ O
salvage NN O
enzyme NN O
that WDT O
catalyzes VBZ O
the DT O
conversion NN O
of IN O
hypoxanthine NN O
to TO O
inosine VB O
monophosphate NN O
and CC O
guanine NN O
to TO O
guanosine VB O
monophosphate NN O
. . O

Previous JJ O
studies NNS O
of IN O
mutant JJ O
HPRT NNP O
proteins VBZ O
analyzed VBN O
at IN O
the DT O
molecular JJ O
level NN O
have VBP O
shown VBN O
a DT O
significant JJ O
heterogeneity NN O
. . O

This DT O
investigation NN O
further RB O
verifies VBZ O
this DT O
heterogeneity NN O
and CC O
identifies NNS O
insertions NNS O
, , O
deletions NNS O
, , O
and CC O
point NN O
mutations NNS O
. . O

The DT O
direct JJ O
sequencing NN O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
- : O
amplified JJ O
product NN O
of IN O
reverse JJ O
- : O
transcribed NN O
HPRT NNP O
mRNA NN O
enabled VBD O
the DT O
rapid JJ O
identification NN O
of IN O
the DT O
mutations NNS O
found VBD O
in IN O
17 CD O
previously RB O
uncharacterized VBN O
cell NN O
lines NNS O
derived VBN O
from IN O
patients NNS O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O
. . O

Linkage NN O
of IN O
DNA NN O
markers NNS O
at IN O
Xq28 NNP O
to TO O
adrenoleukodystrophy VB B-Disease
and CC O
adrenomyeloneuropathy VB B-Disease
present NN O
within IN O
the DT O
same JJ O
family NN O
. . O

We PRP O
present VBP O
a DT O
large JJ O
kindred VBD O
that IN O
contained VBD O
patients NNS O
with IN O
either DT O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
or CC O
adrenomyeloneuropathy JJ B-Disease
( ( O
AMN NNP B-Disease
) ) O
. . O

The DT O
pedigree JJ O
clearly RB O
supported VBD O
the DT O
X NNP O
- : O
linked VBD O
mode NN O
of IN O
inheritance NN O
of IN O
the DT O
nonneonatal JJ O
form NN O
of IN O
ALD NNP B-Disease
/ NNP O
AMN NNP B-Disease
. . O

Analysis NN O
with IN O
DNA NNP O
markers NNS O
at IN O
Xq28 NNP O
suggested VBD O
segregation NN O
of IN O
both DT O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
with IN O
an DT O
identical JJ O
haplotype NN O
. . O

This DT O
indicated VBD O
that IN O
nonneonatal JJ O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
are VBP O
caused VBN O
by IN O
a DT O
mutation NN O
in IN O
the DT O
same JJ O
gene NN O
at IN O
Xq28 NNP O
. . O

It PRP O
showed VBD O
, , O
furthermore RB O
, , O
that IN O
phenotypic NN O
differences NNS O
between IN O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
are VBP O
not RB O
necessarily RB O
the DT O
consequence NN O
of IN O
allelic JJ O
heterogeneity NN O
due JJ O
to TO O
different JJ O
mutations NNS O
within IN O
the DT O
same JJ O
gene NN O
. . O

The DT O
maximal JJ O
lod NN O
score NN O
for IN O
linkage NN O
of IN O
the DT O
ALD NNP B-Disease
/ NNP O
AMN NNP B-Disease
gene NN O
and CC O
the DT O
multiallelic JJ O
anonymous JJ O
DNA NN O
marker NN O
at IN O
DXS52 NNP O
was VBD O
3 CD O
. . O

0 CD O
at IN O
a DT O
recombination NN O
fraction NN O
of IN O
0 CD O
. . O

0 CD O
. . O

This DT O
made VBD O
a DT O
prenatal JJ O
or CC O
presymptomatic JJ O
diagnosis NN O
and CC O
heterozygote NN O
detection NN O
by IN O
DNA NNP O
analysis NN O
with IN O
this DT O
marker NN O
reliable NN O
. . O

Skewed NNP O
X NNP O
inactivation NN O
in IN O
a DT O
female JJ O
MZ NNP O
twin NN O
results NNS O
in IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

One CD O
of IN O
female JJ O
MZ NNP O
twins NNS O
presented VBN O
with IN O
muscular JJ B-Disease
dystrophy NN I-Disease
. . O

Physical JJ O
examination NN O
, , O
creatine JJ O
phosphokinase NN O
levels NNS O
, , O
and CC O
muscle NN O
biopsy NN O
were VBD O
consistent JJ O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

However RB O
, , O
because IN O
of IN O
her PRP$ O
sex NN O
she PRP O
was VBD O
diagnosed VBN O
as IN O
having VBG O
limb SYM B-Disease
- : I-Disease
girdle JJ I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

With IN O
cDNA NN O
probes NNS O
to TO O
the DT O
DMD NNP B-Disease
gene NN O
, , O
a DT O
gene NN O
deletion NN O
was VBD O
detected VBN O
in IN O
the DT O
twins NNS O
and CC O
their PRP$ O
mother NN O
. . O

The DT O
de FW O
novo FW O
mutation NN O
which WDT O
arose VBP O
in IN O
the DT O
mother NN O
was VBD O
shown VBN O
by IN O
novel JJ O
junction NN O
fragments NNS O
generated VBN O
by IN O
HindIII NNP O
, , O
PstI NNP O
, , O
or CC O
TaqI NNP O
when WRB O
probed NN O
with IN O
cDNA8 NN O
. . O

Additional JJ O
evidence NN O
of IN O
a DT O
large JJ O
gene NN O
deletion NN O
was VBD O
given VBN O
by IN O
novel JJ O
SfiI NNP O
junction NN O
fragments NNS O
detected VBN O
by IN O
probes NNS O
p20 NNS O
, , O
J NNP O
- : O
Bir NNP O
, , O
and CC O
J NNP O
- : O
66 CD O
on IN O
pulsed JJ O
- : O
field NN O
gel JJ O
electrophoresis NN O
( ( O
PFGE NNP O
) ) O
. . O

Immunoblot NNP O
analysis NN O
of IN O
muscle NN O
from IN O
the DT O
affected JJ O
twin NN O
showed VBD O
dystrophin IN O
of IN O
normal JJ O
size NN O
but CC O
of IN O
reduced JJ O
amount NN O
. . O

Immunofluorescent JJ O
visualization NN O
of IN O
dystrophin NN O
revealed VBD O
foci NN O
of IN O
dystrophin JJ O
- : O
positive JJ O
fibers NNS O
adjacent JJ O
to TO O
foci VB O
of IN O
dystrophin JJ O
- : O
negative JJ O
fibers NNS O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
affected JJ O
twin NN O
is VBZ O
a DT O
manifesting VBG O
carrier NN O
of IN O
an DT O
abnormal JJ O
DMD NNP B-Disease
gene NN O
, , O
her PRP$ O
myopathy JJ B-Disease
being VBG O
a DT O
direct JJ O
result NN O
of IN O
underexpression NN O
of IN O
dystrophin NN O
. . O

Cytogenetic JJ O
analysis NN O
revealed VBD O
normal JJ O
karyotypes NNS O
, , O
eliminating VBG O
the DT O
possibility NN O
of IN O
a DT O
translocation NN O
affecting VBG O
DMD NNP B-Disease
gene NN O
function NN O
. . O

Both DT O
linkage JJ O
analysis NN O
and CC O
DNA NNP O
fingerprint NN O
analysis NN O
revealed VBD O
that IN O
each DT O
twin NN O
has VBZ O
two CD O
different JJ O
X NNP O
chromosomes NNS O
, , O
eliminating VBG O
the DT O
possibility NN O
of IN O
uniparental JJ B-Disease
disomy NN I-Disease
as IN O
a DT O
mechanism NN O
for IN O
DMD NNP B-Disease
expression NN O
. . O

On IN O
the DT O
basis NN O
of IN O
methylation NN O
differences NNS O
of IN O
the DT O
paternal JJ O
and CC O
maternal JJ O
X NNP O
chromosomes NNS O
in IN O
these DT O
MZ NNP O
twins NNS O
, , O
we PRP O
propose VBP O
uneven JJ O
lyonization NN O
( ( O
X NNP O
chromosome VBP O
inactivation NN O
) ) O
as IN O
the DT O
underlying VBG O
mechanism NN O
for IN O
disease NN O
expression NN O
in IN O
the DT O
affected JJ O
female NN O
. . O
. . O

Adrenoleukodystrophy NNP B-Disease
and CC O
adrenomyeloneuropathy RB B-Disease
associated VBN O
with IN O
partial JJ O
adrenal JJ B-Disease
insufficiency NN I-Disease
in IN O
three CD O
generations NNS O
of IN O
a DT O
kindred VBN O
. . O

Four CD O
cases NNS O
of IN O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
and CC O
one CD O
case NN O
of IN O
adrenomyeloneuropathy NN B-Disease
( ( O
AMN NNP B-Disease
) ) O
have VBP O
developed VBN O
in IN O
a DT O
kindred VBN O
over IN O
three CD O
generations NNS O
demonstrating VBG O
that IN O
AMN NNP B-Disease
is VBZ O
a DT O
clinical JJ O
variant NN O
of IN O
ALD NNP B-Disease
. . O

Pituitary NNP O
- : O
adrenal JJ O
function NN O
studies NNS O
were VBD O
performed VBN O
in IN O
10 CD O
family NN O
members NNS O
, , O
including VBG O
two CD O
affected JJ O
males NNS O
and CC O
four CD O
females NNS O
identified VBN O
as IN O
carriers NNS O
of IN O
ALD NNP B-Disease
/ NNP O
AMN NNP B-Disease
. . O

No DT O
pituitary JJ B-Disease
- : I-Disease
adrenal JJ I-Disease
abnormality NN I-Disease
was VBD O
found VBN O
in IN O
the DT O
carriers NNS O
. . O

However RB O
, , O
basal JJ O
morning NN O
plasma NN O
adrenocorticotropic NN O
hormone NN O
( ( O
ACTH NNP O
) ) O
levels NNS O
were VBD O
markedly RB O
elevated VBN O
in IN O
the DT O
two CD O
males NNS O
with IN O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
, , O
despite IN O
the DT O
fact NN O
that IN O
they PRP O
had VBD O
no DT O
clinical JJ O
signs NNS O
of IN O
adrenal JJ B-Disease
insufficiency NN I-Disease
and CC O
that IN O
morning NN O
plasma NN O
cortisol NN O
levels NNS O
and CC O
their PRP$ O
response NN O
to TO O
maximal VB O
exogenous JJ O
ACTH NNP O
stimulation NN O
appeared VBD O
to TO O
be VB O
normal JJ O
. . O

In IN O
addition NN O
, , O
the DT O
integrated VBN O
24 CD O
- : O
hour NN O
response NN O
to TO O
the DT O
administration NN O
were VBD O
also RB O
subnormal JJ O
in IN O
these DT O
two CD O
cases NNS O
. . O

Thus RB O
, , O
people NNS O
with IN O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
may MD O
have VB O
subclinical JJ O
partial JJ O
adrenocrotical JJ B-Disease
insufficiency NN I-Disease
. . O

No DT O
other JJ O
endocrinologic JJ B-Disease
dysfunction NN I-Disease
was VBD O
identified VBN O
. . O
. . O

Regional JJ O
localisation NN O
of IN O
the DT O
Friedreich NNP B-Disease
ataxia NN I-Disease
locus NN O
to TO O
human JJ O
chromosome NN O
9q13 CD O
- : O
- : O
- : O
- : O
q21 NN O
. . O
1 CD O
. . O

We PRP O
have VBP O
previously RB O
assigned VBN O
the DT O
Friedreich NNP B-Disease
ataxia NN I-Disease
locus NN O
( ( O
FRDA NNP O
) ) O
to TO O
chromosome VB O
9 CD O
; : O
the DT O
current JJ O
maximal JJ O
lod NN O
score NN O
between IN O
FRDA NNP O
and CC O
MCT112 NNP O
( ( O
D9S15 NNP O
) ) O
is VBZ O
greater JJR O
than IN O
50 CD O
at IN O
a DT O
recombination NN O
fraction NN O
of IN O
theta NN O
= $ O
0 CD O
. . O

The DT O
physical JJ O
assignment NN O
of IN O
the DT O
locus NN O
defined VBN O
by IN O
MCT112 NNP O
, , O
and CC O
hence RB O
FRDA NNP O
, , O
has VBZ O
not RB O
been VBN O
determined VBN O
, , O
although IN O
linkage JJ O
analysis NN O
of IN O
MCT112 NNP O
with IN O
other JJ O
chromosome NN O
9 CD O
markers NNS O
inferred VBD O
a DT O
location NN O
close RB O
to TO O
the DT O
centromere NN O
. . O

We PRP O
have VBP O
used VBN O
in IN O
situ JJ O
hybridisation NN O
with IN O
MCT112 NNP O
, , O
a DT O
corresponding JJ O
cosmid NN O
MJ1 NNP O
, , O
and CC O
DR47 NNP O
( ( O
D9S5 NNP O
) ) O
, , O
coupled VBN O
with IN O
mapping VBG O
studies NNS O
on IN O
hybrid JJ O
cell NN O
panels NNS O
, , O
to TO O
define VB O
more RBR O
precisely RB O
the DT O
location NN O
of IN O
the DT O
disease NN O
locus NN O
. . O

The DT O
in IN O
situ JJ O
location NN O
of IN O
all DT O
three CD O
probes NNS O
is VBZ O
9q13 CD O
- : O
- : O
- : O
- : O
q21 NN O
. . O

1 CD O
, , O
distal NN O
to TO O
the DT O
variable JJ O
heterochromatin NN O
region NN O
. . O

Physical JJ O
assignment NN O
of IN O
FRDA NNP O
will MD O
allow VB O
us PRP O
to TO O
identify VB O
hybrid NN O
cell NN O
lines NNS O
containing VBG O
the DT O
mutated VBN O
gene NN O
. . O

Increased VBN O
high JJ O
- : O
density NN O
lipoprotein NN O
levels NNS O
caused VBN O
by IN O
a DT O
common JJ O
cholesteryl NN O
- : O
ester NN O
transfer NN O
protein NN O
gene NN O
mutation NN O
. . O

BACKGROUND NNP O
AND NNP O
METHODS NNP O
. . O

The DT O
plasma NN O
cholesteryl SYM O
- : O
ester NN O
transfer NN O
protein NN O
( ( O
CETP NNP O
) ) O
catalyzes VBZ O
the DT O
transfer NN O
of IN O
cholesteryl NN O
esters NNS O
from IN O
high JJ O
- : O
density NN O
lipoprotein NN O
( ( O
HDL NNP O
) ) O
to TO O
other JJ O
lipoproteins NNS O
. . O

We PRP O
recently RB O
described VBD O
a DT O
Japanese JJ O
family NN O
with IN O
increased JJ O
HDL NNP O
levels NNS O
and CC O
CETP NNP B-Disease
deficiency NN I-Disease
due JJ O
to TO O
a DT O
splicing VBG O
defect NN O
of IN O
the DT O
CETP NNP O
gene NN O
. . O

To TO O
assess VB O
the DT O
frequency NN O
and CC O
phenotype NN O
of IN O
this DT O
condition NN O
, , O
we PRP O
screened VBD O
11 CD O
additional JJ O
families NNS O
with IN O
high JJ O
HDL NNP O
levels NNS O
by IN O
means NNS O
of IN O
a DT O
radioimmunoassay NN O
for IN O
CETP NNP O
and CC O
DNA NNP O
analysis NN O
. . O

RESULTS NNP O
. . O

We PRP O
found VBD O
the DT O
same JJ O
CETP NNP O
gene NN O
mutation NN O
in IN O
four CD O
families NNS O
from IN O
three CD O
different JJ O
regions NNS O
of IN O
Japan NNP O
. . O

Analysis NN O
of IN O
restriction NN O
- : O
fragment NN O
- : O
length NN O
polymorphisms NN O
of IN O
the DT O
mutant JJ O
CETP NNP O
allele NN O
showed VBD O
that IN O
all DT O
probands NNS O
were VBD O
homozygous JJ O
for IN O
the DT O
identical JJ O
haplotype NN O
. . O

Family RB O
members NNS O
homozygous JJ O
for IN O
CETP NNP B-Disease
deficiency NN I-Disease
( ( O
n JJ O
= NNP O
10 CD O
) ) O
had VBD O
moderate JJ O
hypercholesterolemia NN B-Disease
( ( O
mean JJ O
total NN O
cholesterol NN O
level NN O
[ NNP O
+ NNP O
/ NNP O
- : O
SD NNP O
] NNP O
, , O
7 CD O
. . O
1 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
83 CD O
mmol NN O
per IN O
liter NN O
) ) O
, , O
markedly RB O
increased VBD O
levels NNS O
of IN O
HDL NNP O
cholesterol NN O
( ( O
4 CD O
. . O
24 CD O
+ JJ O
/ NNP O
- : O
1 CD O
. . O
1 CD O
mmol NN O
per IN O
liter NN O
) ) O
and CC O
apolipoprotein VBZ O
A DT O
- : O
I PRP O
, , O
and CC O
decreased JJ O
levels NNS O
of IN O
low JJ O
- : O
density NN O
lipoprotein NN O
cholesterol NN O
( ( O
1 CD O
. . O
99 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
80 CD O
mmol NN O
per IN O
liter NN O
) ) O
and CC O
apolipoprotein $ O
B NNP O
. . O

Members NNS O
heterozygous JJ O
for IN O
the DT O
deficiency NN O
( ( O
n JJ O
= NNP O
20 CD O
) ) O
, , O
whose WP$ O
CETP NNP O
levels NNS O
were VBD O
in IN O
the DT O
lower JJR O
part NN O
of IN O
the DT O
normal JJ O
range NN O
, , O
had VBD O
moderately RB O
increased JJ O
levels NNS O
of IN O
HDL NNP O
cholesterol NN O
and CC O
apolipoprotein VB O
A NNP O
- : O
I PRP O
and CC O
an DT O
increased VBN O
ratio NN O
of IN O
HDL NNP O
subclass NN O
2 CD O
to TO O
HDL NNP O
subclass NN O
3 CD O
, , O
as IN O
compared VBN O
with IN O
unaffected JJ O
family NN O
members NNS O
( ( O
1 CD O
. . O
5 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
8 CD O
vs NN O
. . O
0 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
4 CD O
) ) O
. . O

CETP NNP B-Disease
deficiency NN I-Disease
was VBD O
not RB O
found VBN O
in IN O
six CD O
unrelated JJ O
subjects NNS O
with IN O
elevated JJ O
HDL NNP O
cholesterol NN O
levels NNS O
who WP O
were VBD O
from IN O
different JJ O
parts NNS O
of IN O
the DT O
United NNP O
States NNPS O
. . O

CONCLUSIONS NNP O
. . O

CETP NNP B-Disease
deficiency NN I-Disease
appears VBZ O
to TO O
be VB O
a DT O
frequent JJ O
cause NN O
of IN O
increased VBN O
HDL NNP O
levels NNS O
in IN O
the DT O
population NN O
of IN O
Japan NNP O
, , O
possibly RB O
because IN O
of IN O
a DT O
founder NN O
effect NN O
. . O

The DT O
results NNS O
that IN O
we PRP O
observed VBD O
in IN O
heterozygotes NNS O
suggest VBP O
that IN O
CETP NNP O
normally RB O
plays VBZ O
a DT O
part NN O
in IN O
the DT O
regulation NN O
of IN O
levels NNS O
of IN O
HDL NNP O
subclass NN O
2 CD O
. . O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
premature JJ B-Disease
atherosclerosis NN I-Disease
in IN O
the DT O
families NNS O
with IN O
CETP NNP B-Disease
deficiency NN I-Disease
. . O

In IN O
fact NN O
, , O
the DT O
lipoprotein NN O
profile NN O
of IN O
persons NNS O
with IN O
CETP NNP B-Disease
deficiency NN I-Disease
is VBZ O
potentially RB O
antiatherogenic JJ O
and CC O
may MD O
be VB O
associated VBN O
with IN O
an DT O
increased JJ O
life NN O
span NN O
. . O

Further RB O
mapping NN O
of IN O
an DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
locus NN O
to TO O
the DT O
chromosome NN O
11q23 CD O
region NN O
. . O

We PRP O
recently RB O
mapped VBD O
the DT O
gene NN O
for IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
group NN O
A NNP O
( ( O
ATA NNP O
) ) O
to TO O
chromosome VB O
11q22 CD O
- : O
23 CD O
by IN O
linkage NN O
analysis NN O
, , O
using VBG O
the DT O
genetic JJ O
markers NNS O
THY1 NNP O
and CC O
pYNB3 NN O
. . O

12 CD O
( ( O
D11S144 NNP O
) ) O
. . O

The DT O
most RBS O
likely JJ O
order NN O
was VBD O
cent JJ O
- : O
AT NNP O
- : O
S144 NNP O
- : O
THY1 NN O
. . O

The DT O
present JJ O
paper NN O
describes VBZ O
further JJ O
mapping NN O
of IN O
the DT O
AT NNP B-Disease
locus NN O
by IN O
means NNS O
of IN O
a DT O
panel NN O
of IN O
10 CD O
markers NNS O
that IN O
span VBP O
approximately RB O
60 CD O
cM NN O
in IN O
the DT O
11q22 CD O
- : O
23 CD O
region NN O
centered VBN O
around IN O
S144 NNP O
and CC O
THY1 NNP O
. . O

Location NN O
scores NNS O
indicate VBP O
that IN O
three CD O
contiguous JJ O
subsegments NNS O
within IN O
the DT O
[ NNP O
S144 NNP O
- : O
THY1 NNP O
] NNP O
segment NN O
, , O
as RB O
well RB O
as IN O
three CD O
contiguous JJ O
segments NNS O
telomeric JJ O
to TO O
THY1 NNP O
, , O
are VBP O
each DT O
unlikely JJ O
to TO O
contain VB O
the DT O
AT NNP B-Disease
locus NN O
, , O
while IN O
the DT O
more JJR O
centromeric JJ O
[ NN O
STMY NNP O
- : O
S144 NNP O
] NNP O
segment NN O
is VBZ O
most RBS O
likely JJ O
to TO O
contain VB O
the DT O
AT NNP B-Disease
locus NN O
. . O

These DT O
data NNS O
, , O
together RB O
with IN O
recent JJ O
refinements NNS O
in IN O
the DT O
linkage NN O
and CC O
physical JJ O
maps NNS O
of IN O
11q22 CD O
- : O
23 CD O
, , O
place NN O
the DT O
AT NNP B-Disease
locus NN O
at IN O
11q23 CD O
. . O

Recurrent JJ O
meningitis NN B-Disease
in IN O
a DT O
patient NN O
with IN O
congenital JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
C9 NNP I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
. . O

First NNP O
case NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
in IN O
Europe NNP O
. . O

We PRP O
describe VBP O
the DT O
first JJ O
cases NNS O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
in IN O
Europe NNP O
that WDT O
were VBD O
detected VBN O
in IN O
a DT O
Swiss JJ O
family NN O
, , O
of IN O
which WDT O
two CD O
members NNS O
- : O
- : O
one NN O
with IN O
a DT O
complete JJ O
deficiency NN O
and CC O
the DT O
other JJ O
with IN O
approximately RB O
half JJ O
- : O
normal JJ O
C9 NNP O
levels NNS O
- : O
- : O
experienced JJ O
bacterial JJ B-Disease
meningitis NN I-Disease
. . O

The DT O
index NN O
patient NN O
, , O
a DT O
56 CD O
- : O
year NN O
- : O
old JJ O
white JJ O
man NN O
with IN O
a DT O
history NN O
of IN O
purulent NN B-Disease
meningitis NN I-Disease
at IN O
the DT O
age NN O
of IN O
23 CD O
years NNS O
, , O
presented VBN O
with IN O
an DT O
acute JJ B-Disease
meningococcal JJ I-Disease
meningitis NN I-Disease
. . O

No DT O
impairment NN B-Disease
of IN I-Disease
cellular JJ I-Disease
immunity NN I-Disease
or CC O
immunoglobulin JJ B-Disease
deficiency NN I-Disease
could MD O
be VB O
found VBN O
. . O

Complement NNP O
assays VBZ O
showed VBD O
a DT O
complete JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
C9 NNP I-Disease
component NN I-Disease
, , O
while IN O
the DT O
other JJ O
individual JJ O
component NN O
levels NNS O
were VBD O
normal JJ O
and CC O
the DT O
hemolytic JJ O
activity NN O
( ( O
measured VBN O
using VBG O
the DT O
CH50 NNP O
assay NN O
) ) O
was VBD O
only RB O
slightly RB O
reduced VBN O
. . O

A DT O
family NN O
study NN O
revealed VBD O
complete JJ B-Disease
C9 NNP I-Disease
deficiency NN I-Disease
in IN O
the DT O
patients NNS O
healthy JJ O
brother NN O
and CC O
half NN O
- : O
normal JJ O
C9 NNP O
concentrations NNS O
in IN O
his PRP$ O
sister NN O
, , O
his PRP$ O
son NN O
( ( O
who WP O
also RB O
had VBD O
experienced VBN O
an DT O
episode NN O
of IN O
bacterial JJ B-Disease
meningitis NN I-Disease
) ) O
, , O
and CC O
his PRP$ O
niece NN O
, , O
consistent NN O
with IN O
an DT O
inherited JJ O
C9 NNP B-Disease
deficiency NN I-Disease
. . O

This DT O
first JJ O
case NN O
of IN O
recurrent NN B-Disease
meningitis NN I-Disease
in IN O
a DT O
white JJ O
patient NN O
with IN O
complete JJ B-Disease
C9 NNP I-Disease
deficiency NN I-Disease
suggests VBZ O
that IN O
this DT O
complement NN B-Disease
defect NN I-Disease
may MD O
also RB O
be VB O
a DT O
risk NN O
factor NN O
for IN O
bacterial JJ B-Disease
, , I-Disease
especially RB I-Disease
neisserial JJ I-Disease
, , I-Disease
infections NNS I-Disease
. . O
. . O

Detection NN O
of IN O
98 CD O
% NN O
of IN O
DMD NNP B-Disease
/ NNP O
BMD NNP B-Disease
gene NN O
deletions NNS O
by IN O
polymerase NN O
chain NN O
reaction NN O
. . O

We PRP O
describe VBP O
oligonucleotide JJ O
primer NN O
sequences NNS O
that WDT O
can MD O
be VB O
used VBN O
to TO O
amplify VB O
eight CD O
exons NNS O
plus CC O
the DT O
muscle NN O
promoter NN O
of IN O
the DT O
dystrophin JJ O
gene NN O
in IN O
a DT O
single JJ O
multiplex JJ O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
. . O

When WRB O
used VBN O
in IN O
conjunction NN O
with IN O
an DT O
existing VBG O
primer NN O
set NN O
, , O
these DT O
two CD O
multiplex NN O
reactions NNS O
detect VBP O
about IN O
98 CD O
% NN O
of IN O
deletions NNS O
in IN O
patients NNS O
with IN O
Duchenne NNP B-Disease
or CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
, , O
BMD NNP B-Disease
) ) O
. . O

Furthermore RB O
, , O
these DT O
primers NNS O
amplify VBP O
most JJS O
of IN O
the DT O
exons NNS O
in IN O
the DT O
deletion NN O
prone NN O
"""" NNP O
hot JJ O
spot NN O
"""" JJ O
region NN O
around IN O
exons NNS O
44 CD O
to TO O
53 CD O
, , O
allowing VBG O
determination NN O
of IN O
deletion NN O
endpoints NNS O
and CC O
prediction NN O
of IN O
mutational JJ O
effects NNS O
on IN O
the DT O
translational JJ O
reading NN O
frame NN O
. . O

Thus RB O
, , O
use NN O
of IN O
these DT O
PCR NNP O
- : O
based VBN O
assays NNS O
will MD O
allow VB O
deletion NN O
detection NN O
and CC O
prenatal JJ O
diagnosis NN O
for IN O
most JJS O
DMD NNP B-Disease
/ NNP O
BMD NNP B-Disease
patients NNS O
in IN O
a DT O
fraction NN O
of IN O
the DT O
time NN O
required VBN O
for IN O
Southern NNP O
blot NN O
analysis NN O
. . O
. . O

Genetic JJ O
heterogeneity NN O
at IN O
the DT O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
locus NN O
in IN O
southern JJ O
Italy NNP O
: : O
a DT O
study NN O
on IN O
a DT O
population NN O
from IN O
the DT O
Matera NNP O
district NN O
. . O

Glucose NNP O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
has VBZ O
been VBN O
analyzed VBN O
by IN O
gel JJ O
electrophoresis NN O
and CC O
by IN O
quantitative JJ O
assay NN O
in IN O
an DT O
unselected JJ O
sample NN O
of IN O
1524 CD O
schoolboys NNS O
from IN O
the DT O
province NN O
of IN O
Matera NNP O
( ( O
Lucania NNP O
) ) O
in IN O
southern JJ O
Italy NNP O
. . O

We PRP O
have VBP O
identified VBN O
43 CD O
subjects NNS O
with IN O
a DT O
G6PD NNP O
variant NN O
. . O

Of IN O
these DT O
, , O
31 CD O
had VBD O
severe VBN O
G6PD NNP B-Disease
deficiency NN I-Disease
, , O
nine CD O
had VBD O
mild VBN O
to TO O
moderate VB O
deficiency NN O
, , O
and CC O
three CD O
had VBD O
a DT O
non JJ O
- : O
deficient NN O
electrophoretic JJ O
variant NN O
. . O

The DT O
overall JJ O
rate NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
was VBD O
2 CD O
. . O

6 CD O
% NN O
. . O

The DT O
frequency NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
, , O
ranging VBG O
from IN O
7 CD O
. . O

2 CD O
% NN O
on IN O
the DT O
Ionian JJ O
Coast NNP O
to TO O
zero VB O
on IN O
the DT O
eastern JJ O
side NN O
of IN O
the DT O
Lucanian JJ O
Apennines NNP O
, , O
appears VBZ O
to TO O
be VB O
inversely RB O
related VBN O
to TO O
the DT O
distance NN O
of IN O
each DT O
town NN O
examined VBD O
from IN O
the DT O
Ionian NNP O
Coast NNP O
, , O
suggesting VBG O
that IN O
this DT O
geographic JJ O
distribution NN O
may MD O
reflect VB O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
gene NN O
flow NN O
from IN O
Greek JJ O
settlers NNS O
. . O

Biochemical JJ O
characterization NN O
has VBZ O
shown VBN O
that IN O
most JJS O
of IN O
the DT O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
this DT O
population NN O
is VBZ O
accounted VBN O
for IN O
by IN O
G6PD NNP O
Mediterranean NNP O
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
found VBN O
several JJ O
examples NNS O
of IN O
two CD O
other JJ O
known VBN O
polymorphic JJ O
variants NNS O
( ( O
G6PD NNP O
Cagliari NNP O
and CC O
G6PD NNP O
A NNP O
- : O
) ) O
; : O
three CD O
new JJ O
polymorphic JJ O
variants NNS O
, , O
G6PD NNP O
Metaponto NNP O
( ( O
class NN O
III NNP O
) ) O
, , O
G6PD NNP O
Montalbano NNP O
( ( O
class NN O
III NNP O
) ) O
, , O
and CC O
G6PD NNP O
Pisticci NNP O
( ( O
class NN O
IV NNP O
) ) O
; : O
and CC O
two CD O
sporadic JJ O
variants NNS O
, , O
G6PD NNP O
Tursi NNP O
( ( O
class NN O
III NNP O
) ) O
and CC O
G6PD NNP O
Ferrandina NNP O
( ( O
class NN O
II NNP O
) ) O
. . O

These DT O
data NNS O
provide VBP O
further JJ O
evidence NN O
for IN O
the DT O
marked JJ O
genetic JJ O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
within IN O
a DT O
relatively RB O
narrow JJ O
geographic JJ O
area NN O
and CC O
they PRP O
prove VBP O
the DT O
presence NN O
in IN O
the DT O
Italian JJ O
peninsula NN O
of IN O
a DT O
gene NN O
( ( O
GdA NNP O
- : O
) ) O
regarded VBD O
as IN O
characteristically RB O
African NNP O
. . O

Deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
murine NN I-Disease
fifth JJ I-Disease
complement NN I-Disease
component NN I-Disease
( ( I-Disease
C5 NNP I-Disease
) ) I-Disease
. . O

A DT O
2 CD O
- : O
base NN O
pair NN O
gene NN O
deletion NN O
in IN O
a DT O
5 CD O
' POS O
- : O
exon NN O
. . O

To TO O
ascertain VB O
the DT O
molecular JJ O
mechanism NN O
that WDT O
causes VBZ O
murine JJ O
C5 NNP B-Disease
deficiency NN I-Disease
, , O
genomic JJ O
and CC O
cDNA JJ O
libraries NNS O
were VBD O
constructed VBN O
from IN O
mouse NN O
liver NN O
DNA NNP O
and CC O
mRNA NN O
employing VBG O
the DT O
congenic JJ O
strains NNS O
B10 NNP O
. . O

D2 NNP O
/ NNP O
nSnJ NN O
and CC O
B10 NNP O
. . O

D2 NNP O
/ NNP O
oSnJ IN O
that DT O
are VBP O
sufficient JJ O
and CC O
deficient NN B-Disease
for IN I-Disease
C5 NNP I-Disease
, , O
respectively RB O
. . O

Genomic JJ O
fragments NNS O
were VBD O
isolated VBN O
which WDT O
correspond NN O
to TO O
PvuII NNP O
and CC O
HindIII NNP O
restriction NN O
fragment NN O
length NN O
polymorphisms NNS O
associated VBN O
with IN O
C5 NNP B-Disease
deficiency NN I-Disease
. . O

Sequence NN O
analyses NNS O
demonstrated VBD O
that IN O
each DT O
of IN O
these DT O
polymorphisms NNS O
resulted VBD O
from IN O
single JJ O
base NN O
pair NN O
substitutions NNS O
and CC O
that IN O
neither DT O
substitution NN O
would MD O
probably RB O
cause VB O
or CC O
contribute VB O
to TO O
the DT O
C5 NNP B-Disease
deficiency NN I-Disease
. . O

Sequence NN O
analyses NNS O
of IN O
C5 NNP O
sufficient NN O
and CC O
deficient NN O
cDNAs NN O
revealed VBD O
a DT O
2 CD O
base NN O
- : O
pair NN O
deletion NN O
in IN O
the DT O
deficient NN O
cDNAs NN O
. . O

The DT O
"""" NNP O
TA NNP O
"""" NNP O
deletion NN O
was VBD O
located VBN O
near IN O
the DT O
5 CD O
end NN O
of IN O
the DT O
cDNA NN O
. . O

This DT O
deletion NN O
shifts VBZ O
the DT O
reading NN O
frame NN O
of IN O
the DT O
C5 NNP O
mRNA NN O
so RB O
that IN O
the DT O
termination NN O
codon NN O
UGA NNP O
is VBZ O
present JJ O
4 CD O
base NN O
pairs NNS O
downstream NN O
from IN O
the DT O
deletion NN O
. . O

Genomic NNP O
DNA NNP O
was VBD O
amplified VBN O
and CC O
sequenced VBN O
corresponding NN O
to TO O
the DT O
area NN O
surrounding VBG O
the DT O
2 CD O
- : O
base NN O
pair NN O
deletion NN O
. . O

Six NNP O
C5 NNP B-Disease
- : I-Disease
deficient NN I-Disease
strains NNS O
, , O
A NNP O
/ NNP O
HeJ NNP O
, , O
AKR NNP O
/ NNP O
J NNP O
, , O
DBA NNP O
/ NNP O
2J CD O
, , O
NZB NNP O
/ NNP O
B1NJ NNP O
, , O
SWR NNP O
/ NNP O
J NNP O
, , O
and CC O
B10 NNP O
. . O

D2 NNP O
/ NNP O
oSnJ NN O
, , O
and CC O
four CD O
C5 NNP O
- : O
sufficient NN O
strains NNS O
, , O
Balb NNP O
/ NNP O
CJ NNP O
, , O
C57Bl NNP O
/ NNP O
6J CD O
, , O
DBA NNP O
/ NNP O
1J CD O
, , O
and CC O
B10 NNP O
. . O

D2 NNP O
/ NNP O
nSnJ NN O
, , O
were VBD O
analyzed VBN O
. . O

The DT O
sequencing NN O
data NNS O
revealed VBD O
that IN O
the DT O
2 CD O
base NN O
pairs NNS O
were VBD O
deleted VBN O
from IN O
the DT O
C5 NNP O
gene NN O
of IN O
each DT O
deficient NN O
mouse NN O
tested VBD O
but CC O
not RB O
from IN O
the DT O
C5 NNP O
gene NN O
of IN O
any DT O
sufficient JJ O
mouse NN O
. . O

These DT O
data NNS O
demonstrate VBP O
that IN O
1 CD O
) ) O
there EX O
is VBZ O
an DT O
identical JJ O
2 CD O
- : O
base NN O
pair NN O
deletion NN O
in IN O
an DT O
exon NN O
of IN O
the DT O
C5 NNP O
gene NN O
in IN O
several JJ O
different JJ O
C5 NNP B-Disease
- : I-Disease
deficient NN I-Disease
mouse NN O
strains VBZ O
; : O
2 CD O
) ) O
the DT O
mRNA NN O
transcribed VBD O
from IN O
the DT O
C5D NNP O
gene NN O
retains VBZ O
this DT O
deletion NN O
; : O
and CC O
3 CD O
) ) O
this DT O
mutation NN O
should MD O
result VB O
in IN O
C5 NNP B-Disease
protein NN I-Disease
deficiency NN I-Disease
. . O

Molecular JJ O
genetics NNS O
of IN O
PKU NNP B-Disease
in IN O
eastern JJ O
Europe NNP O
: : O
a DT O
nonsense JJ O
mutation NN O
associated VBN O
with IN O
haplotype JJ O
4 CD O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
gene NN O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
a DT O
genetic JJ B-Disease
disorder NN I-Disease
secondary NN O
to TO O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

Several JJ O
mutations NNS O
in IN O
the DT O
PAH NNP O
gene NN O
have VBP O
recently RB O
been VBN O
reported VBN O
, , O
and CC O
linkage NN O
disequilibrium NN O
was VBD O
observed VBN O
between IN O
RFLP NNP O
haplotypes NNS O
and CC O
specific JJ O
mutations NNS O
. . O

A DT O
new JJ O
molecular JJ B-Disease
lesion NN I-Disease
has VBZ O
been VBN O
identified VBN O
in IN O
exon JJ O
7 CD O
of IN O
the DT O
PAH NNP O
gene NN O
in IN O
a DT O
Hungarian JJ O
PKU NNP B-Disease
patient NN O
by IN O
direct JJ O
sequencing NN O
of IN O
PCR NNP O
- : O
amplified VBD O
DNA NNP O
. . O

The DT O
C NNP O
- : O
to TO O
- : O
T NNP O
transition NN O
causes VBZ O
the DT O
substitution NN O
of IN O
Arg243 NNP O
to TO O
a DT O
termination NN O
codon NN O
, , O
and CC O
the DT O
mutant JJ O
allele NN O
is VBZ O
associated VBN O
with IN O
haplotype JJ O
4 CD O
of IN O
the DT O
PAH NNP O
gene NN O
. . O

The DT O
mutation NN O
is VBZ O
present JJ O
in IN O
two CD O
of IN O
nine CD O
mutant JJ O
haplotype NN O
4 CD O
alleles NNS O
among IN O
Eastern JJ O
Europeans NNPS O
and CC O
is VBZ O
not RB O
present JJ O
among IN O
Western JJ O
Europeans NNPS O
and CC O
Asians NNPS O
. . O

The DT O
rarity NN O
of IN O
this DT O
mutant JJ O
allele NN O
and CC O
its PRP$ O
restricted JJ O
geographic JJ O
distribution NN O
suggest VBP O
that IN O
the DT O
mutational JJ O
event NN O
occurred VBD O
recently RB O
on IN O
a DT O
normal JJ O
haplotype NN O
4 CD O
background NN O
in IN O
Eastern NNP O
Europe NNP O
. . O
. . O

The DT O
red JJ O
- : O
green JJ O
visual JJ O
pigment NN O
gene NN O
region NN O
in IN O
adrenoleukodystrophy NN B-Disease
. . O

Although IN O
recent JJ O
data NNS O
established VBD O
that IN O
a DT O
specific JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
fatty JJ O
acyl JJ O
- : O
CoA JJ O
synthetase NN O
is VBZ O
defective JJ O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
ALD NNP B-Disease
) ) O
, , O
the DT O
ALD NNP B-Disease
gene NN O
is VBZ O
still RB O
unidentified JJ O
. . O

The DT O
ALD NNP B-Disease
locus NN O
has VBZ O
been VBN O
mapped VBN O
to TO O
Xq28 VB O
, , O
like IN O
the DT O
red JJ O
and CC O
green JJ O
color NN O
pigment NN O
genes NNS O
. . O

Abnormal NNP B-Disease
color NN I-Disease
vision NN I-Disease
has VBZ O
been VBN O
observed VBN O
in IN O
12 CD O
of IN O
27 CD O
patients NNS O
with IN O
adrenomyeloneuropathy JJ B-Disease
( ( O
AMN NNP B-Disease
) ) O
, , O
a DT O
milder NN O
form NN O
of IN O
ALD NNP B-Disease
. . O

Furthermore RB O
, , O
rearrangements NNS O
of IN O
the DT O
color NN O
vision NN O
gene NN O
cluster NN O
were VBD O
found VBN O
in IN O
four CD O
of IN O
eight CD O
ALD NNP B-Disease
kindreds NNS O
. . O

This DT O
led VBD O
us PRP O
to TO O
propose VB O
that IN O
a DT O
single JJ O
DNA NNP O
rearrangement NN O
could MD O
underlie VB O
both DT O
ALD NNP B-Disease
and CC O
abnormal JJ B-Disease
color NN I-Disease
vision NN I-Disease
in IN O
these DT O
patients NNS O
. . O

Study NNP O
of IN O
34 CD O
French JJ O
ALD NNP B-Disease
patients NNS O
failed VBD O
to TO O
reveal VB O
a DT O
higher JJR O
than IN O
expected VBN O
frequency NN O
of IN O
green JJ O
/ NNP O
red VBD O
visual JJ O
pigment NN O
rearrangements NNS O
3 CD O
to TO O
the DT O
red JJ O
/ NN O
green JJ O
color NN O
vision NN O
gene NN O
complex NN O
. . O

The DT O
previous JJ O
report NN O
of IN O
such JJ O
rearrangements NNS O
was VBD O
based VBN O
on IN O
small JJ O
numbers NNS O
and CC O
lack NN O
of IN O
knowledge NN O
that IN O
the DT O
frequency NN O
of IN O
"""" NNP O
abnormal JJ O
"""" NNP O
color NN O
vision NN O
arrays NNS O
on IN O
molecular JJ O
analysis NN O
was VBD O
twice RB O
as RB O
high JJ O
as IN O
expected VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
frequency NN O
of IN O
phenotypic NN B-Disease
color NN I-Disease
vision NN I-Disease
defects NNS I-Disease
. . O

The DT O
red JJ O
/ NN O
green JJ O
color NN O
pigment NN O
( ( O
R NNP O
/ NNP O
GCP NNP O
) ) O
region NN O
was VBD O
studied VBN O
by IN O
pulsed JJ O
- : O
field NN O
gel JJ O
electrophoresis NN O
in IN O
14 CD O
of IN O
these DT O
patients NNS O
, , O
and CC O
we PRP O
did VBD O
not RB O
find VB O
any DT O
fragment JJ O
size NN O
difference NN O
between IN O
the DT O
patients NNS O
and CC O
normal JJ O
individuals NNS O
who WP O
have VBP O
the DT O
same JJ O
number NN O
of IN O
pigment JJ O
genes NNS O
. . O

The DT O
R NNP O
/ NNP O
GCP NNP O
region NN O
was VBD O
also RB O
analyzed VBN O
in IN O
29 CD O
French JJ O
and CC O
seven CD O
North JJ O
American JJ O
ALD NNP B-Disease
patients NNS O
by IN O
using VBG O
six CD O
genomic JJ O
DNA NNP O
probes NNS O
, , O
isolated VBN O
from IN O
a DT O
cosmid NN O
walk NN O
, , O
that WDT O
flank VBD O
the DT O
color NN O
vision NN O
genes NNS O
. . O

No DT O
deletions NNS O
were VBD O
found VBN O
with IN O
probes NNS O
that WDT O
lie VBP O
3 CD O
of IN O
the DT O
green JJ O
pigment NN O
genes NNS O
. . O

One CD O
of IN O
the DT O
eight CD O
previously RB O
reported VBN O
ALD NNP B-Disease
individuals NNS O
has VBZ O
a DT O
long JJ O
deletion NN O
5 CD O
of IN O
the DT O
red JJ O
pigment NN O
gene NN O
, , O
a DT O
deletion NN O
causing VBG O
blue JJ O
cone NN O
monochromacy NN O
. . O

This DT O
finding NN O
and CC O
the DT O
previous JJ O
findings NNS O
of IN O
a DT O
45 CD O
% NN O
frequency NN O
of IN O
phenotypic NN O
color NN O
vision NN O
defects NNS O
in IN O
patients NNS O
with IN O
AMN NNP B-Disease
may MD O
suggest VB O
that IN O
the DT O
ALD NNP B-Disease
/ NNP O
AMN NNP B-Disease
gene NN O
lies VBZ O
5 CD O
to TO O
the DT O
red JJ O
pigment NN O
gene NN O
and CC O
that IN O
the DT O
frequent JJ O
phenotypic NN O
color NN B-Disease
vision NN I-Disease
anomalies NNS I-Disease
owe VBP O
their PRP$ O
origin NN O
to TO O
deleted VB O
DNA NNP O
that WDT O
includes VBZ O
regulatory JJ O
genes NNS O
for IN O
color NN O
vision NN O
. . O

It PRP O
is VBZ O
possible JJ O
, , O
however RB O
, , O
that IN O
phenotypic NN O
color NN B-Disease
vision NN I-Disease
anomalies NNS I-Disease
in IN O
AMN NNP B-Disease
may MD O
be VB O
phenocopies NNS O
secondary JJ O
to TO O
retinal VB O
or CC O
neural JJ O
involvement NN O
by IN O
the DT O
disease NN O
. . O

The DT O
single JJ O
case NN O
of IN O
blue JJ O
cone NN O
monochromacy NN O
may MD O
therefore RB O
be VB O
a DT O
fortuitous JJ O
coincidence NN O
of IN O
two CD O
diseases NNS O
. . O
. . O

Paroxysmal NNP B-Disease
nocturnal JJ I-Disease
haemoglobinuria NN I-Disease
with IN O
coexisting VBG O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
ninth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
: : O
lack NN O
of IN O
massive JJ O
haemolytic JJ B-Disease
attack NN I-Disease
. . O

A DT O
47 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
paroxysmal JJ B-Disease
nocturnal JJ I-Disease
haemoglobinuria NN I-Disease
( ( O
PNH NNP B-Disease
) ) O
was VBD O
found VBN O
to TO O
have VB O
an DT O
inherited JJ B-Disease
deficiency NN I-Disease
in IN I-Disease
the DT I-Disease
ninth JJ I-Disease
complement NN I-Disease
component NN I-Disease
( ( O
C9 NNP O
) ) O
. . O

In IN O
complement JJ O
- : O
sensitivity NN O
lysis NN O
tests NNS O
, , O
80 CD O
% NN O
of IN O
her PRP$ O
erythrocytes NNS O
were VBD O
markedly RB O
complement JJ O
- : O
sensitive JJ O
( ( O
PNH NNP O
- : O
III NN O
) ) O
. . O

Laser NNP O
cytofluorimetry NN O
with IN O
a DT O
monoclonal JJ O
antibody NN O
against IN O
decay JJ O
- : O
accelerating VBG O
factor NN O
( ( O
DAF NNP O
) ) O
revealed VBD O
that IN O
95 CD O
% NN O
of IN O
her PRP$ O
erythrocytes NNS O
were VBD O
DAF NNP O
- : O
negative JJ O
. . O

Surprisingly RB O
, , O
she PRP O
has VBZ O
suffered VBN O
only RB O
mild JJ O
haemolysis NN B-Disease
and CC O
has VBZ O
never RB O
experienced VBN O
massive JJ O
spontaneous JJ O
haemolysis NN B-Disease
. . O

Gross NNP O
haemoglobinuria NN B-Disease
and CC O
jaundice NN B-Disease
occurred VBD O
only RB O
after IN O
receiving VBG O
postoperative JJ O
transfusion NN O
of IN O
whole JJ O
blood NN O
. . O

In IN O
her PRP$ O
serum NN O
, , O
C9 NNP O
was VBD O
not RB O
detectable JJ O
either CC O
by IN O
immunological JJ O
or CC O
by IN O
functional JJ O
assays NNS O
. . O

Both DT O
the DT O
Ham NNP O
test NN O
and CC O
the DT O
sugar NN O
water NN O
test NN O
using VBG O
normal JJ O
human JJ O
serum NN O
or CC O
plasma NN O
yielded VBN O
marked JJ O
haemolysis NN O
of IN O
the DT O
patients NNS O
erythrocytes VBZ O
. . O

When WRB O
the DT O
patients NNS O
serum VBP O
or CC O
plasma NN O
was VBD O
used VBN O
, , O
only RB O
a DT O
trace NN O
of IN O
lysis NN O
was VBD O
detected VBN O
. . O

Addition NN O
of IN O
purified JJ O
human JJ O
C9 NNP O
to TO O
her PRP$ O
plasma NN O
fully RB O
restored VBN O
haemolysis NN O
. . O

These DT O
observations NNS O
indicated VBD O
that IN O
C9 NNP O
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
haemolytic JJ B-Disease
attacks NNS I-Disease
in IN O
patients NNS O
with IN O
PNH NNP B-Disease
and CC O
that IN O
characteristic JJ O
haemolysis NN B-Disease
in IN O
PNH NNP B-Disease
may MD O
be VB O
tempered VBN O
by IN O
coexisting VBG O
C9 NNP B-Disease
deficiency NN I-Disease
. . O
. . O

Duplicational JJ O
mutation NN O
at IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
locus NN O
: : O
its PRP$ O
frequency NN O
, , O
distribution NN O
, , O
origin NN O
, , O
and CC O
phenotypegenotype JJ O
correlation NN O
. . O

Partial JJ O
gene NN O
deletion NN O
is VBZ O
the DT O
major JJ O
cause NN O
of IN O
mutation NN O
leading VBG O
to TO O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
and CC O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
BMD NNP B-Disease
) ) O
. . O

Partial JJ O
gene NN O
duplication NN O
has VBZ O
also RB O
been VBN O
recognized VBN O
in IN O
a DT O
few JJ O
cases NNS O
. . O

We PRP O
have VBP O
conducted VBN O
a DT O
survey NN O
for IN O
duplication NN O
in IN O
72 CD O
unrelated JJ O
nondeletion NN O
patients NNS O
, , O
analyzed VBN O
by IN O
Southern NNP O
blot NN O
hybridization NN O
with IN O
clones NNS O
representing VBG O
the DT O
entire JJ O
DMD NNP B-Disease
cDNA NN O
. . O

With IN O
careful JJ O
quantitative JJ O
analysis NN O
of IN O
hybridization NN O
band NN O
intensity NN O
, , O
10 CD O
cases NNS O
were VBD O
found VBN O
to TO O
carry VB O
a DT O
duplication NN O
of IN O
part NN O
of IN O
the DT O
gene NN O
, , O
a DT O
frequency NN O
of IN O
14 CD O
% NN O
for IN O
nondeletion NN O
cases NNS O
( ( O
10 CD O
/ RB O
72 CD O
) ) O
, , O
or CC O
6 CD O
% NN O
for IN O
all DT O
cases NNS O
( ( O
10 CD O
/ RB O
181 CD O
) ) O
. . O

The DT O
extent NN O
of IN O
these DT O
duplications NNS O
has VBZ O
been VBN O
characterized VBN O
according VBG O
to TO O
the DT O
published VBN O
exon SYM O
- : O
containing VBG O
HindIII NNP O
fragment NN O
map NN O
, , O
and CC O
in IN O
six CD O
of IN O
the DT O
10 CD O
duplications NNS O
a DT O
novel JJ O
restriction NN O
fragment NN O
that WDT O
spanned VBD O
the DT O
duplication NN O
junction NN O
was VBD O
detected VBN O
. . O

The DT O
resulting VBG O
translational JJ O
reading NN O
frame NN O
of IN O
mRNA NN O
has VBZ O
been VBN O
predicted VBN O
for IN O
nine CD O
duplications NNS O
. . O

A DT O
shift NN O
of IN O
the DT O
reading NN O
frame NN O
was VBD O
predicted VBN O
in IN O
four CD O
of IN O
the DT O
six CD O
DMD NNP B-Disease
cases NNS O
and CC O
in IN O
one CD O
of IN O
the DT O
two CD O
intermediate JJ O
cases NNS O
, , O
while IN O
the DT O
reading NN O
frame NN O
remained VBD O
uninterrupted JJ O
in IN O
both DT O
BMD NNP B-Disease
cases NNS O
. . O

RFLP NNP O
and CC O
quantitative JJ O
Southern NNP O
blot NN O
analyses NNS O
revealed VBD O
a DT O
grandpaternal JJ O
origin NN O
of IN O
duplication NN O
in IN O
four CD O
families NNS O
and CC O
grandmaternal JJ O
origin NN O
in IN O
one CD O
family NN O
. . O

In IN O
all DT O
five CD O
families NNS O
, , O
the DT O
duplication NN O
was VBD O
found VBN O
to TO O
originate VB O
from IN O
a DT O
single JJ O
X NNP O
chromosome NN O
. . O

Unequal JJ O
sister NN O
- : O
chromatid NN O
exchange NN O
is VBZ O
proposed VBN O
to TO O
be VB O
the DT O
mechanism NN O
for IN O
the DT O
formation NN O
of IN O
these DT O
duplications NNS O
. . O
. . O

Glucose NNP O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variants NNS O
: : O
Gd NNP O
( ( O
+ NNP O
) ) O
Alexandra NNP O
associated VBN O
with IN O
neonatal JJ B-Disease
jaundice NN I-Disease
and CC O
Gd NNP O
( ( O
- : O
) ) O
Camperdown NNP O
in IN O
a DT O
young JJ O
man NN O
with IN O
lamellar JJ B-Disease
cataracts NNS I-Disease
. . O

Two CD O
male JJ O
subjects NNS O
are VBP O
described VBN O
, , O
with IN O
unusual JJ O
clinical JJ O
presentations NNS O
and CC O
with IN O
hitherto JJ O
undescribed JJ O
G6PD NNP O
variants NNS O
. . O

The DT O
first JJ O
, , O
of IN O
Italian JJ O
extraction NN O
, , O
suffered VBD O
from IN O
severe JJ O
neonatal JJ B-Disease
jaundice NN I-Disease
following VBG O
maternal JJ O
ingestion NN O
of IN O
fresh JJ O
broad JJ O
beans NNS O
( ( O
Vicia NNP O
fava NN O
) ) O
both DT O
prenatally RB O
and CC O
postnatally RB O
the DT O
expression NN O
of IN O
the DT O
enzymatic JJ O
defect NN O
was VBD O
much RB O
more JJR O
severe JJ O
in IN O
the DT O
neonatal JJ O
period NN O
than IN O
on IN O
retesting VBG O
in IN O
adolescence NN O
, , O
when WRB O
biochemical JJ O
characterization NN O
showed VBD O
unique JJ O
features NNS O
which WDT O
justify VBP O
designation NN O
as IN O
a DT O
new JJ O
variant NN O
Gd NNP O
( ( O
+ NNP O
) ) O
Alexandra NNP O
. . O

The DT O
second JJ O
patient NN O
, , O
a DT O
boy NN O
of IN O
Maltese JJ O
extraction NN O
who WP O
was VBD O
found VBN O
to TO O
have VB O
bilateral JJ B-Disease
lamellar JJ I-Disease
cataracts NNS I-Disease
at IN O
the DT O
age NN O
of IN O
4 CD O
years NNS O
, , O
was VBD O
identified VBN O
as IN O
G6PD NNP B-Disease
deficient NN I-Disease
only RB O
as IN O
a DT O
result NN O
of IN O
a DT O
survey NN O
of IN O
children NNS O
of IN O
Mediterranean NNP O
origin NN O
with IN O
unexplained JJ O
cataract JJ B-Disease
formation NN O
; : O
he PRP O
has VBZ O
approximately RB O
15 CD O
% NN O
of IN O
normal JJ O
enzyme JJ O
activity NN O
, , O
with IN O
another DT O
unique JJ O
combination NN O
of IN O
biochemical JJ O
characteristics NNS O
which WDT O
has VBZ O
led VBN O
to TO O
its PRP$ O
designation NN O
as IN O
Gd NNP O
( ( O
- : O
) ) O
Camperdown NNP O
. . O

Although IN O
this DT O
association NN O
may MD O
be VB O
coincidental JJ O
, , O
it PRP O
prompts VBZ O
further JJ O
attention NN O
to TO O
the DT O
possibility NN O
that WDT O
under IN O
certain JJ O
circumstances NNS O
G6PD NNP B-Disease
deficiency NN I-Disease
may MD O
favor VB O
cataract JJ B-Disease
formation NN O
. . O

The DT O
two CD O
cases NNS O
illustrate VBP O
the DT O
value NN O
of IN O
characterization NN O
of IN O
the DT O
mutant JJ O
enzyme NN O
whenever WRB O
unexpected JJ O
clinical JJ O
or CC O
laboratory JJ O
results NNS O
are VBP O
obtained VBN O
. . O
. . O

Statistical JJ O
analysis NN O
of IN O
the DT O
two CD O
stage NN O
mutation NN O
model NN O
in IN O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
, , O
and CC O
in IN O
sporadic JJ B-Disease
cerebellar JJ I-Disease
haemangioblastoma NN I-Disease
and CC O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
. . O

Analysis NN O
of IN O
the DT O
age NN O
incidence NN O
curves NNS O
for IN O
unilateral JJ B-Disease
and CC I-Disease
bilateral JJ I-Disease
retinoblastoma NN I-Disease
led VBD O
Knudson NNP O
to TO O
propose VB O
that IN O
hereditary JJ B-Disease
tumours NNS I-Disease
may MD O
arise VB O
by IN O
a DT O
single JJ O
event NN O
and CC O
sporadic JJ B-Disease
tumours NNS I-Disease
by IN O
a DT O
two CD O
stage NN O
mutation NN O
process NN O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
recently RB O
that IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
may MD O
arise VB O
from IN O
a DT O
two CD O
stage NN O
mutation NN O
process NN O
. . O

We PRP O
analysed VBD O
the DT O
age NN O
incidence NN O
curves NNS O
for IN O
symptomatic JJ O
renal NN B-Disease
cell NN I-Disease
carcinoma NN I-Disease
( ( O
n JJ O
= NNP O
26 CD O
) ) O
and CC O
cerebellar JJ B-Disease
haemangioblastoma NN I-Disease
( ( O
n JJ O
= NNP O
68 CD O
) ) O
in IN O
109 CD O
patients NNS O
with IN O
von JJ B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
disease NN I-Disease
, , O
and CC O
compared VBN O
them PRP O
to TO O
104 CD O
patients NNS O
with IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
43 CD O
patients NNS O
with IN O
sporadic JJ B-Disease
cerebellar JJ I-Disease
haemangioblastoma NN I-Disease
. . O

The DT O
age NN O
incidence NN O
curves NNS O
for IN O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
cerebellar JJ B-Disease
haemangioblastoma NN I-Disease
in IN O
VHL NNP B-Disease
disease NN I-Disease
were VBD O
compatible JJ O
with IN O
a DT O
single JJ O
mutation NN O
model NN O
, , O
whereas IN O
the DT O
age NN O
incidence NN O
curves NNS O
for IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
cerebellar JJ B-Disease
haemangioblastoma NN I-Disease
suggested VBD O
a DT O
two CD O
stage NN O
mutation NN O
process NN O
. . O

These DT O
data NNS O
are VBP O
compatible JJ O
with IN O
the DT O
VHL NNP B-Disease
gene NN O
functioning VBG O
as IN O
a DT O
recessive JJ O
tumour NN B-Disease
suppressor NN O
gene NN O
. . O

Sporadic JJ B-Disease
cerebellar JJ I-Disease
haemangioblastoma NN I-Disease
and CC O
some DT O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
may MD O
arise VB O
from IN O
somatic JJ O
mutations NNS O
inactivating VBG O
both DT O
alleles NNS O
at IN O
the DT O
VHL NNP B-Disease
locus NN O
. . O
. . O

Screening VBG O
for IN O
carriers NNS O
of IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
among IN O
Ashkenazi JJ O
Jews NNPS O
. . O

A DT O
comparison NN O
of IN O
DNA NNP O
- : O
based VBN O
and CC O
enzyme SYM O
- : O
based VBN O
tests NNS O
. . O

BACKGROUND NNP O
AND NNP O
METHODS NNP O
. . O

The DT O
prevention NN O
of IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
GM2 NNP B-Disease
gangliosidosis NN I-Disease
, , I-Disease
type RB I-Disease
1 CD I-Disease
) ) O
depends VBZ O
on IN O
the DT O
identification NN O
of IN O
carriers NNS O
of IN O
the DT O
gene NN O
for IN O
this DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
. . O

We PRP O
compared VBN O
the DT O
enzyme NN O
- : O
based VBN O
test NN O
widely RB O
used VBN O
in IN O
screening VBG O
for IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
with IN O
a DT O
test NN O
based VBN O
on IN O
analysis NN O
of IN O
DNA NNP O
. . O

We PRP O
developed VBD O
methods NNS O
to TO O
detect VB O
the DT O
three CD O
mutations NNS O
in IN O
the DT O
HEXA NNP O
gene NN O
that WDT O
occur VBZ O
with IN O
high JJ O
frequency NN O
among IN O
Ashkenazi JJ O
Jews NNPS O
two CD O
mutations NNS O
cause VBP O
infantile JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
, , O
and CC O
the DT O
third JJ O
causes VBZ O
the DT O
adult NN O
- : O
onset JJ O
form NN O
of IN O
the DT O
disease NN O
. . O

DNA NN O
segments NNS O
containing VBG O
these DT O
mutation NN O
sites NNS O
were VBD O
amplified VBN O
with IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
and CC O
analyzed VBN O
for IN O
the DT O
presence NN O
of IN O
the DT O
mutations NNS O
. . O

RESULTS NNP O
. . O

Among IN O
62 CD O
Ashkenazi NNP O
obligate JJ O
carriers NNS O
of IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
, , O
the DT O
three CD O
specific JJ O
mutations NNS O
accounted VBD O
for IN O
all DT O
but CC O
one CD O
of IN O
the DT O
mutant JJ O
alleles NNS O
( ( O
98 CD O
percent NN O
) ) O
. . O

In IN O
216 CD O
Ashkenazi NNP O
carriers NNS O
identified VBN O
by IN O
the DT O
enzyme JJ O
test NN O
, , O
DNA NNP O
analysis NN O
showed VBD O
that IN O
177 CD O
( ( O
82 CD O
percent NN O
) ) O
had VBD O
one CD O
of IN O
the DT O
identified JJ O
mutations NNS O
. . O

Of IN O
the DT O
177 CD O
, , O
79 CD O
percent NN O
had VBD O
the DT O
exon JJ O
11 CD O
insertion NN O
mutation NN O
, , O
18 CD O
percent NN O
had VBD O
the DT O
intron NN O
12 CD O
splice NN O
- : O
junction NN O
mutation NN O
, , O
and CC O
3 CD O
percent NN O
had VBD O
the DT O
less RBR O
severe JJ O
exon NN O
7 CD O
mutation NN O
associated VBN O
with IN O
adult NN O
- : O
onset NN O
disease NN O
. . O

The DT O
results NNS O
of IN O
the DT O
enzyme NN O
tests NNS O
in IN O
the DT O
39 CD O
subjects NNS O
( ( O
18 CD O
percent NN O
) ) O
who WP O
were VBD O
defined VBN O
as IN O
carriers NNS O
but CC O
in IN O
whom WP O
DNA NNP O
analysis NN O
did VBD O
not RB O
identify VB O
a DT O
mutant JJ O
allele NN O
were VBD O
probably RB O
false JJ O
positive JJ O
( ( O
although IN O
there EX O
remains VBZ O
some DT O
possibility NN O
of IN O
unidentified JJ O
mutations NNS O
) ) O
. . O

In IN O
addition NN O
, , O
of IN O
152 CD O
persons NNS O
defined VBD O
as IN O
noncarriers NNS O
by IN O
the DT O
enzyme NN O
- : O
based VBN O
test NN O
, , O
1 CD O
was VBD O
identified VBN O
as IN O
a DT O
carrier NN O
by IN O
DNA NN O
analysis NN O
( ( O
i JJ O
. . O
e NN O
e NN O
. . O
, , O
a DT O
false JJ O
negative JJ O
enzyme NN O
- : O
test NN O
result NN O
) ) O
. . O

CONCLUSIONS NNP O
. . O

The DT O
increased VBN O
specificity NN O
and CC O
predictive JJ O
value NN O
of IN O
the DT O
DNA NNP O
- : O
based VBN O
test NN O
make VBP O
it PRP O
a DT O
useful JJ O
adjunct NN O
to TO O
the DT O
diagnostic JJ O
tests NNS O
currently RB O
used VBN O
to TO O
screen VB O
for IN O
carriers NNS O
of IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
. . O

Total JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
plasma NN I-Disease
cholesteryl NN I-Disease
ester NN I-Disease
transfer NN I-Disease
protein NN I-Disease
in IN O
subjects NNS O
homozygous JJ O
and CC O
heterozygous JJ O
for IN O
the DT O
intron NN O
14 CD O
splicing NN O
defect NN O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
cholesteryl NN B-Disease
ester NN I-Disease
transfer NN I-Disease
protein NN I-Disease
( ( I-Disease
CETP NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
was VBD O
investigated VBN O
in IN O
4 CD O
unrelated JJ O
CETP NNP B-Disease
- : I-Disease
deficient NN I-Disease
families NNS O
. . O

The DT O
high JJ O
density NN O
lipoprotein SYM O
- : O
cholesterol NN O
levels NNS O
of IN O
the DT O
probands NNS O
exceeded VBD O
150 CD O
mg NN O
/ NNP O
dl NN O
. . O

The DT O
plasma NN O
of IN O
the DT O
probands NNS O
was VBD O
totally RB O
deficient JJ O
in IN O
CETP NNP O
activity NN O
and CC O
mass NN O
. . O

The DT O
genomic JJ O
DNA NN O
of IN O
the DT O
patients NNS O
was VBD O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
, , O
using VBG O
two CD O
oligonucleotide JJ O
primers NNS O
located VBN O
in IN O
the DT O
intron NN O
12 CD O
and CC O
14 CD O
of IN O
the DT O
CETP NNP O
gene NN O
, , O
and CC O
the DT O
amplified JJ O
products NNS O
were VBD O
directly RB O
sequenced VBN O
. . O

Two CD O
patients NNS O
were VBD O
homozygous JJ O
for IN O
a DT O
G NNP O
- : O
to TO O
- : O
A DT O
change NN O
at IN O
the DT O
5 CD O
- : O
splice NN O
donor JJ O
site NN O
of IN O
the DT O
intron NN O
14 CD O
. . O

The DT O
G NNP O
- : O
to TO O
- : O
A DT O
change NN O
would MD O
cause VB O
impaired JJ O
splicing NN O
of IN O
pre JJ O
- : O
messenger NN O
RNA NNP O
. . O

The DT O
other JJ O
two CD O
probands NNS O
were VBD O
heterozygous JJ O
for IN O
the DT O
mutation NN O
, , O
but CC O
totally RB O
lacked JJ O
CETP NNP O
. . O

Their PRP$ O
lipoprotein NN O
patterns NNS O
were VBD O
also RB O
similar JJ O
to TO O
those DT O
of IN O
the DT O
two CD O
homozygotes NNS O
. . O

Thus RB O
, , O
other JJ O
genetic JJ B-Disease
defects NNS I-Disease
or CC O
metabolic JJ O
factors NNS O
influencing VBG O
CETP NNP O
expression NN O
are VBP O
implicated VBN O
. . O

The DT O
data NN O
suggest NN O
that IN O
the DT O
G NNP O
- : O
to TO O
- : O
A DT O
mutation NN O
may MD O
be VB O
common JJ O
in IN O
human JJ O
plasma NN O
CETP NNP B-Disease
deficiency NN I-Disease
. . O

Furthermore RB O
, , O
there EX O
could MD O
be VB O
compound VBN O
heterozygotes NNS O
who WP O
totally RB O
lack VBP O
plasma JJ O
CETP NNP O
and CC O
have VBP O
lipoprotein VBN O
profiles NNS O
similar JJ O
to TO O
those DT O
of IN O
homozygotes NNS O
. . O
. . O

Molecular JJ O
genetics NNS O
of IN O
the DT O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
Mediterranean NNP O
variant NN O
and CC O
description NN O
of IN O
a DT O
new JJ O
G6PD NNP O
mutant NN O
, , O
G6PD NNP O
Andalus1361A NNP O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
; : I-Disease
E NNP I-Disease
. . I-Disease
C NNP I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
49 CD I-Disease
) ) I-Disease
deficiency NN I-Disease
is VBZ O
the DT O
most RBS O
common JJ O
human JJ O
enzymopathy NN B-Disease
; : O
more JJR O
than IN O
300 CD O
different JJ O
biochemical JJ O
variants NNS O
of IN O
the DT O
enzyme NN O
have VBP O
been VBN O
described VBN O
. . O

In IN O
many JJ O
parts NNS O
of IN O
the DT O
world NN O
the DT O
Mediterranean NNP O
type NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
prevalent JJ O
. . O

However RB O
, , O
G6PD NNP O
Mediterranean NNP O
has VBZ O
come VBN O
to TO O
be VB O
regarded VBN O
as IN O
a DT O
generic JJ O
term NN O
applied VBN O
to TO O
similar JJ O
G6PD NNP O
mutations NNS O
thought VBD O
, , O
however RB O
, , O
to TO O
represent VB O
a DT O
somewhat RB O
heterogeneous JJ O
group NN O
. . O

A DT O
C NNP O
- : O
- : O
- : O
- : O
T NN O
mutation NN O
at IN O
nucleotide JJ O
563 CD O
of IN O
G6PD NNP O
Mediterranean NNP O
has VBZ O
been VBN O
identified VBN O
by IN O
Vulliamy NNP O
et CC O
al NN O
. . O
, , O
and CC O
the DT O
same JJ O
mutation NN O
has VBZ O
been VBN O
found VBN O
by IN O
De NNP O
Vita NNP O
et CC O
al NN O
. . O
in IN O
G6PD NNP O
Mediterranean NNP O
, , O
G6PD NNP O
Sassari NNP O
, , O
and CC O
G6PD NNP O
Cagliari NNP O
. . O

The DT O
latter JJ O
subjects NNS O
had VBD O
an DT O
additional JJ O
mutation NN O
, , O
at IN O
nucleotide JJ O
1311 CD O
, , O
that WDT O
did VBD O
not RB O
produce VB O
a DT O
coding NN O
change NN O
. . O

We PRP O
have VBP O
examined VBN O
genomic JJ O
DNA NN O
of IN O
five CD O
patients NNS O
- : O
- : O
four CD O
of IN O
Spanish JJ O
origin NN O
and CC O
one CD O
of IN O
Jewish JJ O
origin NN O
- : O
- : O
having VBG O
enzymatically RB O
documented VBN O
G6PD NNP O
Mediterranean NNP O
. . O

All DT O
had VBD O
both CC O
the DT O
mutation NN O
at IN O
nucleotide JJ O
563 CD O
and CC O
that DT O
at IN O
nucleotide RB O
1311 CD O
. . O

A DT O
sixth JJ O
sample NN O
, , O
resembling VBG O
G6PD NNP O
Mediterranean NNP O
kinetically RB O
but CC O
with IN O
a DT O
slightly RB O
rapid JJ O
electrophoretic JJ O
mobility NN O
, , O
was VBD O
designated VBN O
G6PD NNP O
Andalus NNP O
and CC O
was VBD O
found VBN O
to TO O
have VB O
a DT O
different JJ O
mutation NN O
, , O
a DT O
G NNP O
- : O
- : O
- : O
- : O
A DT O
transition NN O
at IN O
nucleotide JJ O
1361 CD O
, , O
producing VBG O
an DT O
arginine JJ O
- : O
to TO O
- : O
histidine NN O
substitution NN O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
G6PD NNP O
Mediterranean NNP O
is VBZ O
, , O
after IN O
all DT O
, , O
relatively RB O
homogeneous JJ O
. . O

A DT O
normal JJ O
male NN O
with IN O
an DT O
inherited JJ O
deletion NN O
of IN O
one CD O
exon NN O
within IN O
the DT O
DMD NNP B-Disease
gene NN O
. . O

We PRP O
describe VBP O
two CD O
brothers NNS O
with IN O
identical JJ O
inherited JJ O
deletions NNS O
of IN O
one CD O
single JJ O
exon NN O
within IN O
the DT O
middle NN O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
; : O
one CD O
brother NN O
has VBZ O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
diagnosed VBD O
at IN O
11 CD O
years NNS O
of IN O
age NN O
, , O
whereas IN O
the DT O
older JJR O
brother NN O
is VBZ O
normal JJ O
at IN O
18 CD O
. . O

These DT O
results NNS O
have VBP O
implications NNS O
for IN O
genetic JJ O
counselling NN O
and CC O
prenatal JJ O
diagnosis NN O
in IN O
families NNS O
with IN O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O
. . O

Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
expression NN O
in IN O
normal JJ O
and CC O
diseased JJ O
human JJ O
muscle NN O
. . O

A DT O
probe NN O
for IN O
the DT O
5 CD O
end NN O
of IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
was VBD O
used VBN O
to TO O
study VB O
expression NN O
of IN O
the DT O
gene NN O
in IN O
normal JJ O
human JJ O
muscle NN O
, , O
myogenic JJ O
cell NN O
cultures NNS O
, , O
and CC O
muscle NN O
from IN O
patients NNS O
with IN O
DMD NNP B-Disease
. . O

Expression NN O
was VBD O
found VBN O
in IN O
RNA NNP O
from IN O
normal JJ O
fetal JJ O
muscle NN O
, , O
adult NN O
cardiac NN O
and CC O
skeletal JJ O
muscle NN O
, , O
and CC O
cultured VBD O
muscle NN O
after IN O
myoblast JJ O
fusion NN O
. . O

In IN O
DMD NNP B-Disease
muscle NN O
, , O
expression NN O
of IN O
this DT O
portion NN O
of IN O
the DT O
gene NN O
was VBD O
also RB O
revealed VBN O
by IN O
in IN O
situ NN O
RNA NNP O
hybridization NN O
, , O
particularly RB O
in IN O
regenerating VBG O
muscle NN O
fibers NNS O
. . O
. . O

Molecular JJ O
and CC O
phenotypic JJ O
analysis NN O
of IN O
patients NNS O
with IN O
deletions NNS O
within IN O
the DT O
deletion NN O
- : O
rich JJ O
region NN O
of IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
. . O

Eighty NNP O
unrelated JJ O
individuals NNS O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
or CC O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
BMD NNP B-Disease
) ) O
were VBD O
found VBN O
to TO O
have VB O
deletions NNS O
in IN O
the DT O
major JJ O
deletion NN O
- : O
rich JJ O
region NN O
of IN O
the DT O
DMD NNP B-Disease
locus NN O
. . O

This DT O
region NN O
includes VBZ O
the DT O
last JJ O
five CD O
exons NNS O
detected VBN O
by IN O
cDNA5b NN O
- : O
7 CD O
, , O
all DT O
exons NNS O
detected VBN O
by IN O
cDNA8 NN O
, , O
and CC O
the DT O
first JJ O
two CD O
exons NNS O
detected VBN O
by IN O
cDNA9 NN O
. . O

These DT O
80 CD O
individuals NNS O
account VBP O
for IN O
approximately RB O
75 CD O
% NN O
of IN O
109 CD O
deletions NNS O
of IN O
the DT O
gene NN O
, , O
detected VBN O
among IN O
181 CD O
patients NNS O
analyzed VBN O
with IN O
the DT O
entire JJ O
dystrophin NN O
cDNA NN O
. . O

Endpoints NNS O
for IN O
many JJ O
of IN O
these DT O
deletions NNS O
were VBD O
further RB O
characterized VBN O
using VBG O
two CD O
genomic JJ O
probes NNS O
, , O
p20 NN O
( ( O
DXS269 NNP O
; : O
Wapenaar NNP O
et FW O
al NN O
. . O
) ) O
and CC O
GMGX11 NNP O
( ( O
DXS239 NNP O
; : O
present JJ O
paper NN O
) ) O
. . O

Clinical JJ O
findings NNS O
are VBP O
presented VBN O
for IN O
all DT O
80 CD O
patients NNS O
allowing VBG O
a DT O
correlation NN O
of IN O
phenotypic NN O
severity NN O
with IN O
the DT O
genotype NN O
. . O

Thirty NNP O
- : O
eight CD O
independent JJ O
patients NNS O
were VBD O
old JJ O
enough RB O
to TO O
be VB O
classified VBN O
as IN O
DMD NNP B-Disease
, , O
BMD NNP B-Disease
, , O
or CC O
intermediate JJ O
phenotype NN O
and CC O
had VBD O
deletions NNS O
of IN O
exons NNS O
with IN O
sequenced JJ O
intron NN O
/ NNP O
exon NN O
boundaries NNS O
. . O

Of IN O
these DT O
, , O
eight CD O
BMD NNP B-Disease
patients NNS O
and CC O
one CD O
intermediate NN O
patient NN O
had VBD O
gene NN O
deletions NNS O
predicted VBD O
to TO O
leave VB O
the DT O
reading NN O
frame NN O
intact JJ O
, , O
while IN O
21 CD O
DMD NNP B-Disease
patients NNS O
, , O
7 CD O
intermediate JJ O
patients NNS O
, , O
and CC O
1 CD O
BMD NNP B-Disease
patient NN O
had VBD O
gene NN O
deletions NNS O
predicted VBD O
to TO O
disrupt VB O
the DT O
reading NN O
frame NN O
. . O

Thus RB O
, , O
with IN O
two CD O
exceptions NNS O
, , O
frameshift JJ O
deletions NNS O
of IN O
the DT O
gene NN O
resulted VBD O
in IN O
more RBR O
severe JJ O
phenotype NN O
than IN O
did VBD O
in IN O
- : O
frame NN O
deletions NNS O
. . O

This DT O
is VBZ O
in IN O
agreement NN O
with IN O
recent JJ O
findings NNS O
by IN O
Baumbach NNP O
et CC O
al NN O
. . O
and CC O
Koenig NNP O
et VBP O
al NN O
. . O
but CC O
is VBZ O
in IN O
contrast NN O
to TO O
findings NNS O
, , O
by IN O
Malhotra NNP O
et CC O
al NN O
. . O
at IN O
the DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
gene NN O
. . O

Cloning NN O
of IN O
breakpoints NNS O
of IN O
a DT O
chromosome NN O
translocation NN O
identifies VBZ O
the DT O
AN2 NNP O
locus NN O
. . O

Chromosome NNP O
translocations NNS O
involving VBG O
11p13 CD O
have VBP O
been VBN O
associated VBN O
with IN O
familial JJ B-Disease
aniridia NN I-Disease
in IN O
two CD O
kindreds NNS O
highlighting VBG O
the DT O
chromosomal JJ O
localization NN O
of IN O
the DT O
AN2 NNP O
locus NN O
. . O

This DT O
locus NN O
is VBZ O
also RB O
part NN O
of IN O
the DT O
WAGR NNP B-Disease
complex NN O
( ( O
Wilms NNP B-Disease
tumor NN I-Disease
, , O
aniridia NN B-Disease
, , O
genitourinary JJ B-Disease
abnormalities NNS I-Disease
, , O
and CC O
mental JJ B-Disease
retardation NN I-Disease
) ) O
. . O

In IN O
one CD O
kindred VBD O
, , O
the DT O
translocation NN O
is VBZ O
associated VBN O
with IN O
a DT O
deletion NN O
, , O
and CC O
probes NNS O
for IN O
this DT O
region NN O
were VBD O
used VBN O
to TO O
identify VB O
and CC O
clone VB O
the DT O
breakpoints NNS O
of IN O
the DT O
translocation NN O
in IN O
the DT O
second JJ O
kindred VBN O
. . O

Comparison NNP O
of IN O
phage NN O
restriction NN O
maps NNS O
exclude VBP O
the DT O
presence NN O
of IN O
any DT O
sizable JJ O
deletion NN O
in IN O
this DT O
case NN O
. . O

Sequences NNS O
at IN O
the DT O
chromosome NN O
11 CD O
breakpoint NN O
are VBP O
conserved VBN O
in IN O
multiple JJ O
species NNS O
, , O
suggesting VBG O
that IN O
the DT O
translocation NN O
falls VBZ O
within IN O
the DT O
AN2 NNP O
gene NN O
. . O
. . O

Linkage JJ O
analysis NN O
of IN O
the DT O
apolipoprotein NN O
C2 NNP O
gene NN O
and CC O
myotonic JJ B-Disease
dystrophy NN I-Disease
on IN O
human JJ O
chromosome NN O
19 CD O
reveals NNS O
linkage JJ O
disequilibrium NN O
in IN O
a DT O
French JJ O
- : O
Canadian JJ O
population NN O
. . O

The DT O
gene NN O
for IN O
human JJ O
apolipoprotein NN O
C2 NNP O
( ( O
APOC2 NNP O
) ) O
, , O
situated VBN O
on IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
chromosome NN O
19 CD O
, , O
is VBZ O
closely RB O
linked VBN O
to TO O
the DT O
gene NN O
for IN O
the DT O
most RBS O
common JJ O
form NN O
of IN O
adult NN O
muscular JJ B-Disease
dystrophy NN I-Disease
, , O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

Six NNP O
APOC2 NNP O
RFLPs NNP O
( ( O
TaqI NNP O
, , O
BglI NNP O
, , O
BanI NNP O
, , O
BamHI NNP O
, , O
NcoI NNP O
, , O
and CC O
AvaII NNP O
) ) O
have VBP O
been VBN O
identified VBN O
to TO O
date NN O
. . O

We PRP O
have VBP O
conducted VBN O
a DT O
comprehensive JJ O
DM NNP B-Disease
linkage NN O
study NN O
utilizing VBG O
all DT O
six CD O
RFLPs NNP O
and CC O
involving VBG O
50 CD O
families NNS O
and CC O
372 CD O
individuals NNS O
. . O

The DT O
most RBS O
informative JJ O
RFLPs NNP O
are VBP O
, , O
in IN O
descending VBG O
order NN O
, , O
NcoI NNP O
( ( O
lod JJ O
= NN O
6 CD O
. . O
64 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
5 CD O
) ) O
, , O
BglI NNP O
( ( O
lod JJ O
= NN O
6 CD O
. . O
12 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
5 CD O
) ) O
, , O
AvaII NNP O
( ( O
lod JJ O
= NN O
6 CD O
. . O
2 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
3 CD O
) ) O
, , O
BanI NNP O
( ( O
lod JJ O
= NN O
5 CD O
. . O
76 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
4 CD O
) ) O
, , O
TaqI NNP O
( ( O
lod JJ O
= NN O
4 CD O
. . O
29 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
6 CD O
) ) O
, , O
and CC O
BamHI NNP O
( ( O
lod JJ O
= NN O
1 CD O
. . O
75 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
1 CD O
) ) O
. . O

A DT O
substantial JJ O
increase NN O
in IN O
the DT O
lod NN O
scores VBZ O
over IN O
those DT O
seen VBN O
with IN O
the DT O
individual NN O
RFLPs NNP O
was VBD O
obtained VBN O
when WRB O
the DT O
linkage NN O
of IN O
the DT O
entire JJ O
APOC2 NNP O
haplotype NN O
( ( O
composed VBN O
of IN O
the DT O
six CD O
RFLPs NNP O
) ) O
was VBD O
studied VBN O
( ( O
lod JJ O
= NN O
17 CD O
. . O
87 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
4 CD O
) ) O
. . O

We PRP O
have VBP O
observed VBN O
significant JJ O
inter NN O
- : O
APOC2 NNP O
RFLP NNP O
linkage NN O
disequilibrium NN O
. . O

Consequently RB O
, , O
the DT O
three CD O
most RBS O
informative JJ O
RFLPs NNP O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
BanI NNP O
, , O
TaqI NNP O
, , O
and CC O
either DT O
BglI NNP O
, , O
AvaII NNP O
, , O
or CC O
NcoI NNP O
polymorphisms NNS O
. . O

We PRP O
also RB O
demonstrate VBP O
linkage JJ O
disequilibrium NN O
between IN O
DM NNP O
and CC O
APOC2 NNP O
in IN O
our PRP$ O
French JJ O
- : O
Canadian JJ O
population NN O
( ( O
standardized JJ O
disequilibrium NN O
constant JJ O
phi NN O
= NN O
. . O
22 CD O
, , O
chi VBD O
2 CD O
= JJ O
5 CD O
. . O
12 CD O
, , O
df NN O
= VBD O
1 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
4 CD O
) ) O
. . O

This DT O
represents VBZ O
the DT O
first JJ O
evidence NN O
of IN O
linkage NN O
disequilibrium NN O
between IN O
APOC2 NNP O
and CC O
the DT O
DM NNP B-Disease
locus NN O
. . O

Phenylalanine NNP O
hydroxylase NN O
gene NN O
haplotypes NNS O
in IN O
Polynesians NNS O
: : O
evolutionary JJ O
origins NNS O
and CC O
absence NN O
of IN O
alleles NNS O
associated VBN O
with IN O
severe JJ O
phenylketonuria NNS B-Disease
. . O

A DT O
total NN O
of IN O
630 CD O
haplotypes NNS O
for IN O
the DT O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
gene NN O
locus NN O
were VBD O
established VBN O
in IN O
five CD O
groups NNS O
of IN O
Polynesians NNPS O
comprising VBG O
Samoans NNPS O
, , O
Tongans NNPS O
, , O
Cook NNP O
Islanders NNP O
, , O
Maori NNP O
, , O
and CC O
Niueans NNP O
. . O

Considerable JJ O
genetic JJ O
continuity NN O
was VBD O
demonstrated VBN O
between IN O
these DT O
widely RB O
dispersed JJ O
populations NNS O
, , O
since IN O
three CD O
common JJ O
haplotypes NNS O
( ( O
4 CD O
, , O
1 CD O
, , O
and CC O
7 CD O
) ) O
constituted VBD O
over IN O
95 CD O
% NN O
of IN O
alleles NNS O
. . O

A DT O
control NN O
group NN O
of IN O
individuals NNS O
from IN O
Southeast NNP O
Asia NNP O
shared VBD O
the DT O
same JJ O
major JJ O
haplotypes NNS O
, , O
4 CD O
, , O
1 CD O
, , O
and CC O
7 CD O
, , O
with IN O
Polynesians NNPS O
. . O

These DT O
data NNS O
provide VBP O
further JJ O
support NN O
for IN O
the DT O
theories NNS O
of IN O
genetic JJ O
homogeneity NN O
and CC O
of IN O
Asian JJ O
affinities NNS O
of IN O
the DT O
Polynesian NNP O
precursor NN O
populations NNS O
. . O

The DT O
absence NN O
of IN O
severe JJ O
phenylketonuria NN B-Disease
( ( O
PKU NNP B-Disease
) ) O
in IN O
both DT O
Polynesians NNP O
and CC O
Southeast NNP O
Asians NNPS O
is VBZ O
consistent JJ O
with IN O
the DT O
lack NN O
of IN O
PAH NNP O
haplotypes VBZ O
2 CD O
and CC O
3 CD O
, , O
on IN O
which WDT O
the DT O
severe JJ O
PKU NNP B-Disease
mutants NNS O
have VBP O
arisen VBN O
among IN O
Caucasians NNPS O
. . O
. . O

Preferential JJ O
germline NN O
mutation NN O
of IN O
the DT O
paternal JJ O
allele NN O
in IN O
retinoblastoma NN B-Disease
. . O

The DT O
event NN O
triggering VBG O
malignant JJ O
proliferation NN O
in IN O
70 CD O
% NN O
of IN O
retinoblastoma NN B-Disease
tumours NNS I-Disease
is VBZ O
loss NN O
of IN O
heterozygosity NN O
for IN O
chromosome NN O
13q14 CD O
, , O
whereby WRB O
the DT O
normal JJ O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
allele NN O
is VBZ O
lost VBN O
and CC O
an DT O
already RB O
mutated VBN O
RB1 NNP O
allele NN O
remains VBZ O
in IN O
the DT O
tumour NN B-Disease
. . O

The DT O
first JJ O
allele NN O
suffers NNS O
a DT O
mutational JJ O
event NN O
- : O
- : O
deletion NN O
, , O
duplication NN O
or CC O
point NN O
mutation NN O
( ( O
manuscript NN O
in IN O
preparation NN O
) ) O
- : O
- : O
either CC O
in IN O
the DT O
germ JJ O
line NN O
( ( O
all DT O
bilateral JJ O
patients NNS O
) ) O
or CC O
in IN O
a DT O
somatic JJ O
retinal NN O
cell NN O
( ( O
most RBS O
unilateral JJ O
patients NNS O
) ) O
. . O

Most JJS O
bilateral JJ O
patients NNS O
have VBP O
no DT O
family NN O
history NN O
of IN O
retinoblastoma NN B-Disease
and CC O
are VBP O
presumed VBN O
to TO O
have VB O
new JJ O
germline NN O
mutations NNS O
which WDT O
arose VBP O
in IN O
the DT O
egg NN O
, , O
sperm NN O
or CC O
early JJ O
embryo NN O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
parental JJ O
origin NN O
of IN O
the DT O
retained JJ O
allele NN O
in IN O
nine CD O
retinoblastoma NN B-Disease
tumours NNS I-Disease
from IN O
eight CD O
unrelated JJ O
non SYM O
- : O
familial JJ O
cases NNS O
by IN O
using VBG O
RB1 NNP O
- : O
linked VBN O
genetic JJ O
markers NNS O
. . O

Six CD O
tumours NNS B-Disease
retained VBD O
the DT O
paternal JJ O
allele NN O
and CC O
three CD O
retained VBD O
the DT O
maternal JJ O
allele NN O
. . O

Of IN O
the DT O
three CD O
unilateral JJ B-Disease
tumours NNS I-Disease
, , O
only RB O
one CD O
retained VBD O
the DT O
paternal JJ O
RB1 NNP O
allele NN O
. . O

Thus RB O
, , O
there EX O
is VBZ O
no DT O
evidence NN O
that IN O
the DT O
paternal JJ O
RB1 NNP O
allele NN O
is VBZ O
preferentially RB O
retained VBN O
in IN O
retinoblastoma NN B-Disease
, , O
as IN O
has VBZ O
been VBN O
suggested VBN O
to TO O
be VB O
the DT O
case NN O
in IN O
osteosarcoma NN B-Disease
. . O

By IN O
contrast NN O
, , O
tumours NNS B-Disease
from IN O
four CD O
of IN O
the DT O
five CD O
bilateral JJ O
patients NNS O
retained VBD O
the DT O
paternal JJ O
RB1 NNP O
allele NN O
. . O

This DT O
suggests VBZ O
either CC O
that IN O
new JJ O
germline NN O
RB1 NNP O
mutations NNS O
arise RB O
more RBR O
frequently RB O
during IN O
spermatogenesis NN O
than IN O
during IN O
oogenesis NN O
, , O
or CC O
that IN O
imprinting VBG O
in IN O
the DT O
early JJ O
embryo NN O
affects NNS O
chromosomal JJ O
susceptibility NN O
to TO O
mutation NN O
. . O
. . O

Haplotype NNP O
analysis NN O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
gene NN O
in IN O
Turkish JJ O
phenylketonuria NN B-Disease
families NNS O
. . O

We PRP O
have VBP O
estimated VBN O
the DT O
haplotype JJ O
distribution NN O
of IN O
mutant JJ O
and CC O
normal JJ O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
alleles VBZ O
for IN O
17 CD O
Turkish JJ O
phenylketonuria NN B-Disease
( ( O
PKU NNP B-Disease
) ) O
families NNS O
20 CD O
normal JJ O
and CC O
27 CD O
mutated VBD O
PAH NNP O
alleles NNS O
could MD O
be VB O
identified VBN O
. . O

Of IN O
the DT O
latter NN O
, , O
the DT O
most RBS O
prevalent JJ O
were VBD O
associated VBN O
with IN O
haplotype NN O
6 CD O
( ( O
29 CD O
. . O
6 CD O
% NN O
) ) O
, , O
1 CD O
( ( O
18 CD O
. . O
5 CD O
% NN O
) ) O
and CC O
36 CD O
( ( O
11 CD O
. . O
1 CD O
% NN O
) ) O
, , O
while IN O
the DT O
normal JJ O
alleles NNS O
were VBD O
preferentially RB O
associated VBN O
with IN O
haplotype NN O
1 CD O
( ( O
20 CD O
% NN O
) ) O
. . O

Of IN O
the DT O
19 CD O
different JJ O
haplotypes NNS O
observed VBD O
, , O
5 CD O
have VBP O
not RB O
been VBN O
described VBN O
previously RB O
. . O

The DT O
haplotype NN O
distribution NN O
differed VBD O
significantly RB O
from IN O
that DT O
of IN O
the DT O
Northern NNP O
European NNP O
population NN O
. . O

Two CD O
of IN O
the DT O
eight CD O
polymorphic NNS O
sites NNS O
were VBD O
in IN O
association NN O
with IN O
PKU NNP B-Disease
. . O

No DT O
deletions NNS O
of IN O
exon JJ O
sequences NNS O
were VBD O
found VBN O
in IN O
the DT O
families NNS O
analysed VBD O
. . O

Huntington NNP B-Disease
disease NN I-Disease
: : O
no DT O
evidence NN O
for IN O
locus JJ O
heterogeneity NN O
. . O

A DT O
total NN O
of IN O
63 CD O
families NNS O
with IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
were VBD O
examined VBN O
for IN O
linkage NN O
between IN O
HD NNP B-Disease
and CC O
G8 NNP O
( ( O
D4S10 NNP O
) ) O
. . O

The DT O
families NNS O
included VBD O
57 CD O
Caucasian NNP O
, , O
four CD O
Black NNP O
American NNP O
, , O
and CC O
two CD O
Japanese JJ O
. . O

The DT O
combined JJ O
maximum JJ O
lod NN O
score NN O
was VBD O
87 CD O
. . O

69 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O

4 CD O
( ( O
99 CD O
% NN O
confidence NN O
interval JJ O
0 CD O
. . O
18 CD O
- : O
0 CD O
. . O
71 CD O
) ) O
. . O

The DT O
maximum JJ O
frequency NN O
of IN O
recombination NN O
was VBD O
0 CD O
. . O

3 CD O
in IN O
males NNS O
and CC O
0 CD O
. . O

5 CD O
in IN O
females NNS O
. . O

Fifty NNP O
- : O
seven CD O
families NNS O
gave VBD O
positive JJ O
lod NN O
scores NNS O
; : O
five CD O
small JJ O
families NNS O
gave VBD O
mildly RB O
negative JJ O
lod NN O
scores NNS O
. . O

The DT O
maximum JJ O
likelihood JJ O
estimate NN O
of IN O
alpha NN O
, , O
the DT O
proportion NN O
of IN O
linked VBN O
loci NN O
, , O
was VBD O
1 CD O
. . O

0 CD O
with IN O
a DT O
lower JJR O
99 CD O
% NN O
confidence NN O
interval NN O
of IN O
0 CD O
. . O

88 CD O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
there EX O
is VBZ O
only RB O
one CD O
HD NNP B-Disease
locus NN O
, , O
although IN O
a DT O
second JJ O
rare JJ O
locus NN O
cannot NN O
be VB O
ruled VBN O
out RP O
. . O

Haplotype NNP O
and CC O
multipoint NN O
linkage NN O
analysis NN O
in IN O
Finnish JJ O
choroideremia NN B-Disease
families NNS O
. . O

Multipoint NNP O
linkage NN O
analysis NN O
of IN O
choroideremia NN B-Disease
( ( O
TCD NNP B-Disease
) ) O
and CC O
seven CD O
X NNP O
chromosomal JJ O
restriction NN O
fragment NN O
length NN O
polymorphisms NN O
( ( O
RFLPs NNP O
) ) O
was VBD O
carried VBN O
out RP O
in IN O
18 CD O
Finnish JJ O
TCD NNP B-Disease
families NNS O
. . O

The DT O
data NN O
place NN O
TCD NNP B-Disease
distal NN O
to TO O
PGK NNP O
and CC O
DXS72 NNP O
, , O
very RB O
close RB O
to TO O
DXYS1 NNP O
and CC O
DXYS5 NNP O
( ( O
Zmax NNP O
= VBZ O
24 CD O
at IN O
theta NN O
= NNP O
0 CD O
) ) O
and CC O
proximal JJ O
to TO O
DXYS4 NNP O
and CC O
DXYS12 NNP O
. . O

This DT O
agrees VBZ O
with IN O
the DT O
data NNS O
obtained VBN O
from IN O
other JJ O
linkage NN O
studies NNS O
and CC O
from IN O
physical JJ O
mapping NN O
. . O

All PDT O
the DT O
TCD NNP B-Disease
males NNS O
and CC O
carrier NN O
females NNS O
studied VBN O
have VBP O
the DT O
same JJ O
DXYS1 NNP O
allele NN O
in IN O
coupling VBG O
with IN O
TCD NNP B-Disease
. . O

In IN O
Northeastern NNP O
Finland NNP O
, , O
66 CD O
/ NN O
69 CD O
chromosomes NNS O
carrying VBG O
TCD NNP B-Disease
had VBD O
the DT O
same JJ O
haplotype NN O
at IN O
loci JJ O
DXS72 NNP O
, , O
DXYS1 NNP O
, , O
DXYS4 NNP O
, , O
and CC O
DXYS12 NNP O
. . O

The DT O
same JJ O
haplotype NN O
is VBZ O
seen VBN O
in IN O
only RB O
15 CD O
/ JJ O
99 CD O
chromosomes NNS O
not RB O
carrying VBG O
TCD NNP B-Disease
. . O

Moreover RB O
, , O
in IN O
71 CD O
/ JJ O
104 CD O
non JJ O
- : O
TCD NN O
chromosomes NNS O
, , O
the DT O
haplotype NN O
at IN O
six CD O
marker NN O
loci NN O
is VBZ O
different JJ O
from IN O
those DT O
seen VBN O
in IN O
any DT O
of IN O
the DT O
76 CD O
TCD NNP B-Disease
chromosomes NNS O
. . O

This DT O
supports VBZ O
the DT O
previously RB O
described VBN O
hypothesis NN O
that IN O
the DT O
large JJ O
Northern NNP O
Finnish NNP O
choroideremia NN B-Disease
pedigrees NNS O
, , O
comprising VBG O
a DT O
total NN O
of IN O
over IN O
80 CD O
living JJ O
patients NNS O
representing VBG O
more JJR O
than IN O
a DT O
fifth NN O
of IN O
all DT O
TCD NNP B-Disease
patients NNS O
described VBD O
worldwide RB O
, , O
carry VBP O
the DT O
same JJ O
mutation NN O
. . O

These DT O
linkage NN O
and CC O
haplotype NN O
data NNS O
provide VBP O
improved JJ O
opportunities NNS O
for IN O
prenatal JJ O
diagnosis NN O
based VBN O
on IN O
RFLP NNP O
studies NNS O
. . O
. . O

Autosomal NNP O
dominant JJ O
aniridia NN B-Disease
linked VBN O
to TO O
the DT O
chromosome NN O
11p13 CD O
markers NNS O
catalase NN O
and CC O
D11S151 NNP O
in IN O
a DT O
large JJ O
Dutch NNP O
family NN O
. . O

In IN O
a DT O
large JJ O
pedigree NN O
with IN O
autosomal JJ O
dominant JJ O
aniridia NN B-Disease
, , O
we PRP O
found VBD O
close JJ O
linkage NN O
between IN O
the DT O
aniridia NN B-Disease
locus NN O
AN2 NNP O
and CC O
the DT O
markers NNS O
catalase VBP O
( ( O
CAT NNP O
) ) O
( ( O
zeta JJ O
= NN O
7 CD O
. . O
27 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O
0 CD O
) ) O
and CC O
D11S151 NNP O
( ( O
zeta NNP O
= RB O
3 CD O
. . O
86 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O
10 CD O
) ) O
flanking VBG O
the DT O
AN2 NNP O
locus NN O
on IN O
11p13 CD O
. . O

Positive JJ O
lod NN O
scores NNS O
were VBD O
also RB O
obtained VBN O
for IN O
the DT O
11p13 CD O
- : O
- : O
- : O
- : O
11p14 CD O
markers NNS O
D11S16 NNP O
and CC O
FSHB NNP O
with IN O
the DT O
linkage NN O
group NN O
CAT NNP O
/ NNP O
AN2 NNP O
/ NNP O
D11S151 NNP O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
autosomal JJ O
dominant JJ O
aniridia NN B-Disease
in IN O
this DT O
family NN O
is VBZ O
due JJ O
to TO O
a DT O
mutation NN O
at IN O
the DT O
AN2 NNP O
locus NN O
on IN O
11p13 CD O
. . O

We PRP O
have VBP O
excluded VBN O
linkage NN O
( ( O
zeta NN O
less JJR O
than IN O
- : O
2 CD O
at IN O
theta NN O
less JJR O
than IN O
0 CD O
. . O
18 CD O
) ) O
between IN O
the DT O
aniridia NN B-Disease
and CC O
the DT O
chromosome NN O
2p25 CD O
marker NN O
D2S1 NNP O
( ( O
linked VBN O
to TO O
ACP1 NNP O
) ) O
. . O

Recombination NN O
events NNS O
that WDT O
locate VBP O
myotonic JJ B-Disease
dystrophy NN I-Disease
distal NN O
to TO O
APOC2 NNP O
on IN O
19q CD O
. . O

We PRP O
previously RB O
reported VBD O
a DT O
recombination NN O
in IN O
an DT O
individual NN O
with IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
which WDT O
placed VBD O
the DT O
markers NNS O
D19S19 NNP O
and CC O
APOC2 NNP O
on IN O
the DT O
same JJ O
side NN O
of IN O
the DT O
DM NNP B-Disease
locus NN O
. . O

Haplotyping VBG O
of IN O
this DT O
family NN O
with IN O
more RBR O
recently RB O
characterized VBN O
probes NNS O
which WDT O
are VBP O
either DT O
tightly RB O
linked VBN O
to TO O
DM NNP B-Disease
or CC O
distal NN O
to TO O
the DT O
linkage NN O
group NN O
at IN O
q13 NN O
. . O

2 CD O
shows NNS O
that IN O
the DT O
DM NNP B-Disease
locus NN O
is VBZ O
distal JJ O
to TO O
APOC2 NNP O
. . O

This DT O
is VBZ O
confirmed VBN O
by IN O
other JJ O
recombinants NNS O
where WRB O
DM NNP B-Disease
segregates VBZ O
with IN O
distal JJ O
probes NNS O
. . O

Additional JJ O
marker NN O
to TO O
marker VB O
recombinations NNS O
in IN O
unaffected JJ O
individuals NNS O
are VBP O
reported VBN O
and CC O
support VB O
the DT O
order NN O
and CC O
orientation NN O
of IN O
the DT O
DM NNP B-Disease
linkage NN O
group NN O
as IN O
pter NN O
- : O
( ( O
INSR NNP O
, , O
LDLR NNP O
, , O
S9 NNP O
) ) O
- : O
( ( O
S19 NNP O
, , O
BCL3 NNP O
, , O
APOC2 NNP O
) ) O
- : O
( ( O
CKMM NNP O
, , O
DM NNP O
) ) O
- : O
( ( O
S22 NNP O
, , O
+ NNP O
+ NNP O
+ NNP O
PRKCG NNP O
) ) O
- : O
qter NN O
. . O

The DT O
data NN O
presented VBD O
here RB O
cannot JJ O
determine VB O
whether IN O
DM NNP B-Disease
is VBZ O
proximal JJ O
or CC O
distal JJ O
to TO O
CKMM NNP O
. . O

The DT O
consequences NNS O
of IN O
this DT O
probe NN O
order NN O
for IN O
antenatal JJ O
diagnosis NN O
and CC O
future JJ O
research NN O
aiming VBG O
to TO O
isolate VB O
the DT O
gene NN O
which WDT O
is VBZ O
affected VBN O
in IN O
DM NNP B-Disease
are VBP O
discussed VBN O
. . O

Mutations NNS O
in IN O
the DT O
RB1 NNP O
gene NN O
and CC O
their PRP$ O
effects NNS O
on IN O
transcription NN O
. . O

Inactivation NN O
of IN O
both DT O
alleles NNS O
of IN O
the DT O
RB1 NNP O
gene NN O
during IN O
normal JJ O
retinal JJ O
development NN O
initiates VBZ O
the DT O
formation NN O
of IN O
a DT O
retinoblastoma NN B-Disease
( ( I-Disease
RB NNP I-Disease
) ) I-Disease
tumor NN I-Disease
. . O

To TO O
identify VB O
the DT O
mutations NNS O
which WDT O
inactivate VBP O
RB1 NNP O
, , O
21 CD O
RB NNP B-Disease
tumors NNS I-Disease
isolated VBD O
from IN O
19 CD O
patients NNS O
were VBD O
analyzed VBN O
with IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
or CC O
an DT O
RNase NNP O
protection NN O
assay NN O
or CC O
both DT O
. . O

Mutations NNS O
were VBD O
identified VBN O
in IN O
13 CD O
of IN O
21 CD O
RB NNP B-Disease
tumors NNS I-Disease
; : O
in IN O
8 CD O
tumors NNS B-Disease
, , O
the DT O
precise JJ O
errors NNS O
in IN O
nucleotide JJ O
sequence NN O
were VBD O
characterized VBN O
. . O

Each DT O
of IN O
four CD O
germ JJ O
line NN O
mutations NNS O
involved VBD O
a DT O
small JJ O
deletion NN O
or CC O
duplication NN O
, , O
while IN O
three CD O
somatic JJ O
mutations NNS O
were VBD O
point JJ O
mutations NNS O
leading VBG O
to TO O
splice VB O
alterations NNS O
and CC O
loss NN O
of IN O
an DT O
exon NN O
from IN O
the DT O
mature NN O
RB1 NNP O
mRNA NN O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
detect VB O
expression NN O
of IN O
the DT O
mutant JJ O
allele NN O
in IN O
lymphoblasts NNS O
of IN O
three CD O
bilaterally RB O
affected JJ O
patients NNS O
, , O
although IN O
the DT O
mutation NN O
was VBD O
present JJ O
in IN O
the DT O
genomic JJ O
DNA NN O
and CC O
transcripts NNS O
containing VBG O
the DT O
mutations NNS O
were VBD O
obvious JJ O
in IN O
the DT O
RB NNP B-Disease
tumors NNS I-Disease
in IN O
the DT O
absence NN O
of IN O
a DT O
normal JJ O
RB1 NNP O
allele NN O
. . O

The DT O
variations NNS O
in IN O
the DT O
level NN O
of IN O
expression NN O
of IN O
mutant JJ O
transcripts NNS O
suggest VBP O
deregulation NN O
of IN O
RB1 NNP O
transcription NN O
in IN O
the DT O
absence NN O
of IN O
a DT O
functional JJ O
RB1 NNP O
gene NN O
product NN O
. . O
. . O

Partial JJ O
deletion NN O
8q CD O
without IN O
Langer NNP B-Disease
- : I-Disease
Giedion NN I-Disease
syndrome NN I-Disease
: : O
a DT O
recognisable JJ O
syndrome NN O
. . O

We PRP O
report VBP O
two CD O
de IN O
novo FW O
cases NNS O
of IN O
del NN O
( ( O
8 CD O
) ) O
( ( O
pter JJ O
- : O
- : O
- : O
- : O
q24 NN O
. . O
1 CD O
) ) O
with IN O
breakpoints NNS O
involving VBG O
the DT O
distal JJ O
part NN O
of IN O
band NN O
8q24 CD O
. . O

1 CD O
1 CD O
. . O

The DT O
clinical JJ O
features NNS O
were VBD O
similar JJ O
and CC O
there EX O
were VBD O
no DT O
obvious JJ O
stigmata NN O
of IN O
Langer NNP B-Disease
- : I-Disease
Giedion NN I-Disease
syndrome NN I-Disease
( ( O
LGS NNP B-Disease
) ) O
. . O

There EX O
are VBP O
three CD O
other JJ O
cases NNS O
reported VBN O
with IN O
a DT O
deletion NN O
of IN O
chromosome NN O
8 CD O
at IN O
approximately RB O
the DT O
same JJ O
breakpoint NN O
, , O
one CD O
without IN O
LGS NNP B-Disease
and CC O
some DT O
similarities NNS O
to TO O
our PRP$ O
cases NNS O
, , O
the DT O
other JJ O
two CD O
with IN O
LGS NNP B-Disease
. . O

Our PRP$ O
findings NNS O
would MD O
support VB O
the DT O
observation NN O
that IN O
the DT O
critical JJ O
segment NN O
for IN O
the DT O
assignment NN O
of IN O
LGS NNP B-Disease
is VBZ O
proximal JJ O
to TO O
or CC O
involves VBZ O
the DT O
proximal JJ O
part NN O
of IN O
8q24 CD O
. . O

1 CD O
, , O
but CC O
a DT O
review NN O
of IN O
published VBN O
reports NNS O
suggests VBZ O
that IN O
the DT O
aetiology NN O
of IN O
LGS NNP B-Disease
may MD O
be VB O
a DT O
more RBR O
complex JJ O
issue NN O

Myotonic NNP B-Disease
dystrophy NN I-Disease
is VBZ O
closely RB O
linked VBN O
to TO O
the DT O
gene NN O
for IN O
muscle NN O
- : O
type NN O
creatine NN O
kinase NN O
( ( O
CKMM NNP O
) ) O
. . O

We PRP O
have VBP O
studied VBN O
genetic JJ O
linkage NN O
between IN O
the DT O
gene NN O
for IN O
creatine JJ O
kinase NN O
muscle NN O
type NN O
( ( O
CKMM NNP O
) ) O
and CC O
the DT O
gene NN O
for IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

In IN O
a DT O
panel NN O
of IN O
65 CD O
myotonic JJ B-Disease
dystrophy NN I-Disease
families NNS O
from IN O
Canada NNP O
and CC O
the DT O
Netherlands NNP O
, , O
a DT O
maximum JJ O
lod NN O
score NN O
( ( O
Zmax NNP O
) ) O
of IN O
22 CD O
. . O

8 CD O
at IN O
a DT O
recombination NN O
frequency NN O
( ( O
theta NN O
) ) O
of IN O
0 CD O
. . O

3 CD O
was VBD O
obtained VBN O
. . O

Tight NNP O
linkage NN O
was VBD O
also RB O
demonstrated VBN O
for IN O
CKMM NNP O
and CC O
the DT O
gene NN O
for IN O
apolipoprotein JJ O
C2 NNP O
( ( O
ApoC2 NNP O
) ) O
. . O

This DT O
establishes VBZ O
CKMM NNP O
as IN O
a DT O
useful JJ O
marker NN O
for IN O
myotonic JJ B-Disease
dystrophy NN I-Disease

Color NNP B-Disease
vision NN I-Disease
defects NNS I-Disease
in IN O
adrenomyeloneuropathy NN B-Disease
. . O

The DT O
relationship NN O
between IN O
abnormal JJ B-Disease
color NN I-Disease
vision NN I-Disease
and CC O
adrenomyeloneuropathy NN B-Disease
( ( O
AMN NNP B-Disease
) ) O
was VBD O
investigated VBN O
in IN O
27 CD O
AMN NNP B-Disease
patients NNS O
and CC O
31 CD O
age NN O
- : O
matched VBN O
controls NNS O
by IN O
using VBG O
the DT O
Farnsworth NNP O
- : O
Munsell NNP O
100 CD O
Hue NNP O
test NN O
. . O

Twelve NNP O
( ( O
44 CD O
% NN O
) ) O
of IN O
27 CD O
patients NNS O
showed VBD O
test JJ O
scores NNS O
significantly RB O
above IN O
normal JJ O
. . O

The DT O
axes NNS O
of IN O
bipolarity NN O
determined VBN O
by IN O
the DT O
testing NN O
differed VBD O
widely RB O
between IN O
the DT O
patients NNS O
with IN O
abnormal JJ O
scores NNS O
, , O
compatible JJ O
with IN O
the DT O
notion NN O
that WDT O
different JJ O
alterations NNS O
in IN O
visual JJ O
pigment NN O
genes NNS O
occur VBP O
in IN O
different JJ O
AMN NNP B-Disease
kindreds NNS O
. . O

These DT O
observations NNS O
confirm VBP O
our PRP$ O
earlier JJR O
impression NN O
that IN O
the DT O
frequency NN O
of IN O
abnormal JJ B-Disease
color NN I-Disease
vision NN I-Disease
is VBZ O
increased VBN O
in IN O
these DT O
kindreds NNS O
, , O
and CC O
it PRP O
supports VBZ O
our PRP$ O
contentions NNS O
that IN O
( ( O
1 CD O
) ) O
AMN NNP B-Disease
( ( O
and CC O
its PRP$ O
companion NN O
, , O
adrenoleukodystrophy NN B-Disease
) ) O
are VBP O
very RB O
closely RB O
linked VBN O
to TO O
the DT O
visual JJ O
pigment NN O
loci NN O
at IN O
Xq28 NNP O
and CC O
( ( O
2 CD O
) ) O
this DT O
proximity NN O
might MD O
provide VB O
the DT O
opportunity NN O
to TO O
observe VB O
contiguous JJ B-Disease
gene NN I-Disease
defects NNS I-Disease
. . O
. . O

Molecular JJ O
analysis NN O
of IN O
a DT O
female JJ O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
patient NN O
. . O

We PRP O
report VBP O
the DT O
identification NN O
of IN O
a DT O
female JJ O
patient NN O
with IN O
the DT O
X NNP O
- : O
linked VBD O
recessive JJ O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
( ( O
hypoxanthine JJ B-Disease
phosphoribosyltransferase NN I-Disease
[ NNP I-Disease
HPRT NNP I-Disease
] NNP I-Disease
deficiency NN I-Disease
) ) O
. . O

Cytogenetic JJ O
and CC O
carrier NN O
studies NNS O
revealed VBD O
structurally RB O
normal JJ O
chromosomes NNS O
for IN O
this DT O
patient NN O
and CC O
her PRP$ O
parents NNS O
and CC O
demonstrated VBD O
that IN O
this DT O
mutation NN O
arose VBD O
through IN O
a DT O
de FW O
novo FW O
gametic JJ O
event NN O
. . O

Comparison NNP O
of IN O
this DT O
patients NNS O
DNA VBZ O
with IN O
the DT O
DNA NN O
of IN O
her PRP$ O
parents NNS O
revealed VBD O
that IN O
a DT O
microdeletion NN O
, , O
which WDT O
occurred VBD O
within IN O
a DT O
maternal JJ O
gamete NN O
and CC O
involved VBD O
the DT O
entire JJ O
HPRT NNP O
gene NN O
, , O
was VBD O
partially RB O
responsible JJ O
for IN O
the DT O
disease NN O
in IN O
this DT O
patient NN O
. . O

Somatic NNP O
cell NN O
hybrids NNS O
, , O
generated VBD O
to TO O
separate VB O
maternal JJ O
and CC O
paternal JJ O
X NNP O
chromosomes NNS O
, , O
showed VBD O
that IN O
expression NN O
of IN O
two CD O
additional JJ O
X NNP O
- : O
linked VBN O
enzymes NNS O
, , O
phosphoglycerate JJ O
kinase NN O
and CC O
glucose VB O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
, , O
were VBD O
expressed VBN O
only RB O
in IN O
cells NNS O
that WDT O
contained VBD O
the DT O
maternal JJ O
X NNP O
chromosome NN O
, , O
suggesting VBG O
the DT O
presence NN O
of IN O
a DT O
functionally RB O
inactive JJ O
paternal JJ O
X NNP O
chromosome NN O
. . O

Furthermore RB O
, , O
comparison NN O
of IN O
methylation NN O
patterns NNS O
within IN O
a DT O
region NN O
of IN O
the DT O
HPRT NNP O
gene NN O
known VBN O
to TO O
be VB O
important JJ O
in IN O
gene NN O
regulation NN O
revealed VBD O
differences NNS O
between IN O
DNA NN O
from IN O
the DT O
father NN O
and CC O
the DT O
patient NN O
, , O
in IN O
keeping VBG O
with IN O
an DT O
active JJ O
HPRT NNP O
locus NN O
in IN O
the DT O
father NN O
and CC O
an DT O
inactive JJ O
HPRT NNP O
locus NN O
in IN O
the DT O
patient NN O
. . O

Together RB O
these DT O
data NNS O
indicate VBP O
that IN O
nonrandom JJ O
inactivation NN O
of IN O
the DT O
cytogenetically NN O
normal JJ O
paternal JJ O
X NNP O
chromosome NN O
and CC O
a DT O
microdeletion NN O
of IN O
the DT O
HPRT NNP O
gene NN O
on IN O
an DT O
active JJ O
maternal JJ O
X NN O
chromosome NN O
were VBD O
responsible JJ O
for IN O
the DT O
absence NN O
of IN O
HPRT NNP O
in IN O
this DT O
patient NN O
. . O
. . O

Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
: : O
an DT O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
neurologic JJ I-Disease
disorder NN I-Disease
of IN I-Disease
myelin JJ I-Disease
metabolism NN I-Disease
with IN O
a DT O
novel JJ O
mutation NN O
in IN O
the DT O
gene NN O
encoding VBG O
proteolipid JJ O
protein NN O
. . O

The DT O
nosology NN O
of IN O
the DT O
inborn JJ B-Disease
errors NNS I-Disease
of IN I-Disease
myelin NN I-Disease
metabolism NN I-Disease
has VBZ O
been VBN O
stymied VBN O
by IN O
the DT O
lack NN O
of IN O
molecular JJ O
genetic JJ O
analysis NN O
. . O

Historically RB O
, , O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
has VBZ O
encompassed VBN O
a DT O
host NN O
of IN O
neurologic JJ B-Disease
disorders NNS I-Disease
that WDT O
present VBP O
with IN O
a DT O
deficit NN B-Disease
of IN I-Disease
myelin NN I-Disease
, , O
the DT O
membrane NN O
elaborated VBN O
by IN O
glial JJ O
cells NNS O
that IN O
encircles NNS O
and CC O
successively RB O
enwraps JJ O
axons NNS O
. . O

We PRP O
describe VBP O
here RB O
a DT O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher NNP I-Disease
pedigree NN O
of IN O
the DT O
classical JJ O
type NN O
, , O
with IN O
X NNP O
- : O
linked VBD O
inheritance NN O
, , O
a DT O
typical JJ O
clinical JJ O
progression NN O
, , O
and CC O
a DT O
pathologic JJ O
loss NN O
of IN O
myelinating VBG O
cells NNS O
and CC O
myelin NN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

To TO O
discriminate VB O
variants NNS O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher NNP I-Disease
disease NN I-Disease
, , O
a DT O
set NN O
of IN O
oligonucleotide JJ O
primers NNS O
was VBD O
constructed VBN O
to TO O
polymerase VB O
- : O
chain NN O
- : O
reaction NN O
( ( O
PCR NNP O
) ) O
amplify NN O
and CC O
sequence VB O
the DT O
gene NN O
encoding VBG O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
, , O
a DT O
structural JJ O
protein NN O
that WDT O
comprises VBZ O
half NN O
of IN O
the DT O
protein NN O
of IN O
the DT O
myelin NN O
sheath NN O
. . O

The DT O
PLP NNP O
gene NN O
in IN O
one CD O
of IN O
two CD O
affected JJ O
males NNS O
and CC O
the DT O
carrier NN O
mother NN O
of IN O
this DT O
family NN O
exhibited VBD O
a DT O
single JJ O
base NN O
difference NN O
in IN O
the DT O
more JJR O
than IN O
2 CD O
kb NN O
of IN O
the DT O
PLP NNP O
gene NN O
sequenced VBD O
, , O
a DT O
C NNP O
- : O
- : O
- : O
- : O
T NN O
transition NN O
that WDT O
would MD O
create VB O
a DT O
serine JJ O
substitution NN O
for IN O
proline NN O
at IN O
the DT O
carboxy JJ O
end NN O
of IN O
the DT O
protein NN O
. . O

Our PRP$ O
results NNS O
delineate VB O
the DT O
clinical JJ O
features NNS O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher NNP I-Disease
disease NN I-Disease
, , O
define VB O
the DT O
possible JJ O
molecular JJ O
pathology NN O
of IN O
this DT O
dysmyelinating VBG B-Disease
disorder NN I-Disease
, , O
and CC O
address VB O
the DT O
molecular JJ O
classification NN O
of IN O
inborn JJ B-Disease
errors NNS I-Disease
of IN I-Disease
myelin NN I-Disease
metabolism NN I-Disease
. . O

Patients NNS O
with IN O
the DT O
classical JJ O
form NN O
( ( O
type JJ O
I PRP O
) ) O
and CC O
the DT O
more RBR O
severely RB O
affected JJ O
, , O
connatal JJ O
variant NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( I-Disease
type JJ I-Disease
II NNP I-Disease
) ) I-Disease
would MD O
be VB O
predicted VBN O
to TO O
display VB O
mutation NN O
at IN O
the DT O
PLP NNP O
locus NN O
. . O

The DT O
other JJ O
variants NNS O
( ( O
types NNS O
III NNP O
- : O
VI NNP O
) ) O
, , O
which WDT O
have VBP O
sometimes RB O
been VBN O
categorized VBN O
as IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher NNP I-Disease
disease NN I-Disease
, , O
may MD O
represent VB O
mutations NNS O
in IN O
genes NNS O
encoding VBG O
other JJ O
structural JJ O
myelin NN O
proteins NNS O
or CC O
proteins VBZ O
critical JJ O
to TO O
myelination NN O
. . O
. . O

Molecular JJ O
basis NN O
of IN O
human JJ O
von NN B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
: : O
analysis NN O
of IN O
platelet NN O
von NNP B-Disease
Willebrand NNP I-Disease
factor NN O
mRNA NN O
. . O

von NN B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
( ( O
vWD NN B-Disease
) ) O
, , O
the DT O
most RBS O
common JJ O
inherited JJ B-Disease
bleeding VBG I-Disease
disorder NN I-Disease
in IN O
humans NNS O
, , O
can MD O
result VB O
from IN O
either CC O
a DT O
quantitative JJ O
or CC O
a DT O
qualitative JJ O
defect NN O
in IN O
the DT O
adhesive JJ O
glycoprotein NN O
, , O
von FW B-Disease
Willebrand NNP I-Disease
factor NN O
( ( O
vWF NN O
) ) O
. . O

Molecular JJ O
studies NNS O
of IN O
vWD NNS B-Disease
have VBP O
been VBN O
limited VBN O
by IN O
the DT O
large JJ O
size NN O
of IN O
the DT O
vWF JJ O
gene NN O
and CC O
difficulty NN O
in IN O
obtaining VBG O
the DT O
vWF NN O
mRNA NN O
from IN O
patients NNS O
. . O

By IN O
use NN O
of IN O
an DT O
adaptation NN O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
vWF FW O
mRNA NN O
was VBD O
amplified VBN O
and CC O
sequenced VBN O
from IN O
peripheral JJ O
blood NN O
platelets NNS O
. . O

A DT O
silent JJ O
vWF NN O
allele NN O
was VBD O
identified VBN O
, , O
resulting VBG O
from IN O
a DT O
cis NN O
defect NN O
in IN O
vWF NN O
mRNA NN O
transcription NN O
or CC O
processing NN O
. . O

In IN O
two CD O
type NN B-Disease
IIA NNP I-Disease
vWD NN I-Disease
patients NNS O
, , O
two CD O
different JJ O
but CC O
adjacent JJ O
missense NN O
mutations NNS O
were VBD O
identified VBN O
, , O
the DT O
locations NNS O
of IN O
which WDT O
may MD O
identify VB O
an DT O
important JJ O
vWF NN O
functional JJ O
domain NN O
. . O

Expression NN O
in IN O
heterologous JJ O
cells NNS O
of IN O
recombinant JJ O
vWF NN O
containing VBG O
one CD O
of IN O
these DT O
latter JJ O
mutations NNS O
reproduced VBD O
the DT O
characteristic JJ O
structural JJ O
abnormality NN O
seen VBN O
in IN O
type JJ B-Disease
IIA NNP I-Disease
vWD NN I-Disease
plasma NN O
. . O
. . O

Familial JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
associated VBN O
with IN O
recurrent JJ O
meningococcal JJ B-Disease
infections NNS I-Disease
. . O

We PRP O
describe VBP O
an DT O
11 CD O
- : O
year NN O
- : O
old JJ O
girl NN O
suffering VBG O
from IN O
recurrent JJ B-Disease
meningitis NN I-Disease
with IN O
a DT O
complete JJ O
absence NN B-Disease
of IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C7 NNP O
) ) O
. . O

Diagnosis NN O
was VBD O
established VBN O
by IN O
haemolytic JJ O
titration NN O
and CC O
western JJ O
blotting NN O
. . O

The DT O
patients NNS O
serum VBP O
lacked VBD O
the DT O
85 CD O
kDa NN O
C7 NNP O
chain NN O
. . O

Haemolytic JJ O
activity NN O
of IN O
serum NN O
was VBD O
reconstituted VBN O
with IN O
either DT O
pooled VBN O
normal JJ O
human JJ O
serum NN O
or CC O
with IN O
purified JJ O
C7 NNP O
. . O

The DT O
relatives NNS O
( ( O
parents NNS O
and CC O
one CD O
sister NN O
) ) O
had VBD O
half VBN O
- : O
normal JJ O
levels NNS O
of IN O
both DT O
immunochemically RB O
and CC O
functionally RB O
determined VBD O
C7 NNP O
, , O
indicating VBG O
a DT O
heterozygous JJ O
state NN O
for IN O
C7 NNP B-Disease
deficiency NN I-Disease
. . O
. . O

Translocation NN O
t NN O
( ( O
5 CD O
; : O
11 CD O
) ) O
( ( O
q13 UH O
. . O
1 CD O
; : O
p13 NN O
) ) O
associated VBN O
with IN O
familial JJ O
isolated JJ B-Disease
aniridia NN I-Disease
. . O

A DT O
father NN O
and CC O
daughter NN O
with IN O
isolated JJ B-Disease
aniridia NNS I-Disease
were VBD O
observed VBN O
to TO O
have VB O
an DT O
apparently RB O
balanced VBN O
, , O
reciprocal JJ O
translocation NN O
involving VBG O
chromosomes NNS O
5 CD O
and CC O
11 CD O
[ NN O
t NN O
( ( O
5 CD O
; : O
11 CD O
) ) O
( ( O
q13 UH O
. . O
1 CD O
; : O
p13 NN O
) ) O
] NN O
. . O

No DT O
other JJ O
clinical JJ O
characteristics NNS O
often RB O
associated VBN O
with IN O
the DT O
deletion NN O
of IN O
11p13 CD O
were VBD O
observed VBN O
in IN O
this DT O
family NN O
. . O

This DT O
finding NN O
, , O
in IN O
association NN O
with IN O
3 CD O
other JJ O
instances NNS O
of IN O
single JJ O
breaks NNS O
at IN O
11p13 CD O
and CC O
aniridia RB B-Disease
, , O
supports VBZ O
the DT O
assignment NN O
of IN O
AN2 NNP O
to TO O
11p13 CD O
. . O

Homozygous JJ B-Disease
hypobetalipoproteinemia NN I-Disease
: : O
a DT O
disease NN O
distinct NN O
from IN O
abetalipoproproteinemia NN B-Disease
at IN O
the DT O
molecular JJ O
level NN O
. . O

apoB NN O
DNA NNP O
, , O
RNA NNP O
, , O
and CC O
protein RB O
from IN O
two CD O
patients NNS O
with IN O
homozygous JJ B-Disease
hypobetalipoproteinemia NN I-Disease
( ( O
HBL NNP B-Disease
) ) O
were VBD O
evaluated VBN O
and CC O
compared VBN O
with IN O
normal JJ O
individuals NNS O
. . O

Southern NNP O
blot NN O
analysis NN O
with IN O
10 CD O
different JJ O
cDNA NN O
probes NNS O
revealed VBD O
a DT O
normal JJ O
gene NN O
without IN O
major JJ O
insertions NNS O
, , O
deletions NNS O
, , O
or CC O
rearrangements NNS O
. . O

Northern NNP O
and CC O
slot NN O
blot NN O
analyses NNS O
of IN O
total JJ O
liver NN O
mRNA NN O
from IN O
HBL NNP B-Disease
patients NNS O
documented VBD O
a DT O
normal JJ O
size NN O
apoB NN O
mRNA NN O
that WDT O
was VBD O
present JJ O
in IN O
greatly RB O
reduced JJ O
quantities NNS O
. . O

ApoB NNP O
protein NN O
was VBD O
detected VBN O
within IN O
HBL NNP B-Disease
hepatocytes VBZ O
utilizing JJ O
immunohistochemical JJ O
techniques NNS O
; : O
however RB O
, , O
it PRP O
was VBD O
markedly RB O
reduced VBN O
in IN O
quantity NN O
when WRB O
compared VBN O
with IN O
control NN O
samples NNS O
. . O

No DT O
apoB NN O
was VBD O
detectable JJ O
in IN O
the DT O
plasma NN O
of IN O
HBL NNP B-Disease
individuals NNS O
with IN O
an DT O
ELISA NNP O
assay NN O
. . O

These DT O
data NNS O
are VBP O
most RBS O
consistent JJ O
with IN O
a DT O
mutation NN O
in IN O
the DT O
coding VBG O
portion NN O
of IN O
the DT O
apoB JJ O
gene NN O
in IN O
HBL NNP B-Disease
patients NNS O
, , O
leading VBG O
to TO O
an DT O
abnormal JJ O
apoB NN O
protein NN O
and CC O
apoB JJ O
mRNA NN O
instability NN O
. . O

These DT O
results NNS O
are VBP O
distinct JJ O
from IN O
those DT O
previously RB O
noted VBN O
in IN O
abetalipoproteinemia NN B-Disease
, , O
which WDT O
was VBD O
characterized VBN O
by IN O
an DT O
elevated JJ O
level NN O
of IN O
hepatic JJ O
apoB NN O
mRNA NN O
and CC O
accumulation NN O
of IN O
intracellular JJ O
hepatic JJ O
apoB NN O
protein NN O
. . O
. . O

Spontaneous JJ O
reversion NN O
of IN O
novel JJ O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
mutation NN O
by IN O
HPRT NNP O
gene NN O
rearrangement NN O
. . O

Molecular JJ O
analysis NN O
of IN O
an DT O
unusual JJ O
patient NN O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
has VBZ O
suggested VBN O
that IN O
the DT O
mutation NN O
is VBZ O
due JJ O
to TO O
a DT O
partial JJ O
HPRT NNP O
gene NN O
duplication NN O
. . O

We PRP O
now RB O
report VBP O
the DT O
cloning NN O
and CC O
sequencing NN O
of IN O
the DT O
mutant JJ O
HPRT NNP O
cDNA NN O
which WDT O
shows VBZ O
the DT O
precise JJ O
duplication NN O
of IN O
exons NNS O
2 CD O
and CC O
3 CD O
. . O

This DT O
mutation NN O
is VBZ O
the DT O
result NN O
of IN O
an DT O
internal JJ O
duplication NN O
of IN O
16 CD O
- : O
20 CD O
kilobases NNS O
of IN O
the DT O
gene NN O
. . O

The DT O
structure NN O
of IN O
the DT O
mutant JJ O
gene NN O
suggests VBZ O
that IN O
the DT O
duplication NN O
was VBD O
not RB O
generated VBN O
by IN O
a DT O
single JJ O
unequal JJ O
crossing VBG O
- : O
over IN O
event NN O
between IN O
two CD O
normal JJ O
HPRT NNP O
alleles NNS O
. . O

Growth NNP O
of IN O
Epstein NNP B-Disease
- : I-Disease
Barr NNP I-Disease
virus SYM O
- : O
transformed JJ O
lymphoblasts NNS O
from IN O
this DT O
patient NN O
in IN O
selective JJ O
medium NN O
has VBZ O
permitted VBN O
isolation NN O
of IN O
spontaneous JJ O
HPRT NNP O
+ NNP O
revertants NNS O
of IN O
this DT O
mutation NN O
. . O

The DT O
reversion NN O
event NN O
involves VBZ O
a DT O
second JJ O
major JJ O
HPRT NNP O
gene NN O
rearrangement NN O
where WRB O
most RBS O
or CC O
all DT O
of IN O
the DT O
duplicated JJ O
portion NN O
of IN O
the DT O
mutant JJ O
gene NN O
is VBZ O
deleted VBN O
. . O

The DT O
original JJ O
mutation NN O
therefore NN O
has VBZ O
the DT O
potential NN O
for IN O
spontaneous JJ O
somatic JJ O
reversion NN O
. . O

This DT O
may MD O
explain VB O
the DT O
relatively RB O
mild JJ O
symptoms NNS O
of IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
exhibited VBN O
by IN O
this DT O
patient NN O
. . O
. . O

Complex NNP B-Disease
glycerol NN I-Disease
kinase NN I-Disease
deficiency NN I-Disease
: : O
molecular JJ O
- : O
genetic JJ O
, , O
cytogenetic JJ O
, , O
and CC O
clinical JJ O
studies NNS O
of IN O
five CD O
Japanese JJ O
patients NNS O
. . O

Five CD O
male JJ O
Japanese JJ O
patients NNS O
with IN O
complex JJ B-Disease
glycerol NN I-Disease
kinase NN I-Disease
deficiency NN I-Disease
( ( O
CGKD NNP B-Disease
) ) O
and CC O
their PRP$ O
relatives NNS O
were VBD O
studied VBN O
clinically RB O
, , O
cytogenetically RB O
, , O
and CC O
molecular JJ O
- : O
genetically RB O
. . O

All DT O
patients NNS O
had VBD O
muscular JJ B-Disease
dystrophy NN I-Disease
or CC O
muscle NN B-Disease
weakness NN I-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
congenital JJ B-Disease
adrenal JJ I-Disease
hypoplasia NN I-Disease
, , O
and CC O
glycerol NN B-Disease
kinase NN I-Disease
deficiency NN I-Disease
. . O

High JJ O
- : O
resolution NN O
GTG NNP O
- : O
banded VBD O
chromosomes NNS O
showed VBD O
a DT O
microdeletion NN O
in IN O
the DT O
Xp21 NNP O
region NN O
in IN O
all DT O
four CD O
patients NNS O
examined VBN O
and CC O
in IN O
all DT O
five CD O
mothers NNS O
. . O

Southern JJ O
hybridizations NNS O
, , O
after IN O
digestions NNS O
by IN O
restriction NN O
endonucleases NNS O
, , O
with IN O
various JJ O
cloned VBN O
DNAs NNP O
( ( O
D2 NNP O
, , O
99 CD O
- : O
6 CD O
, , O
B24 NNP O
, , O
C7 NNP O
, , O
L1 NNP O
- : O
4 CD O
, , O
cDMD13 SYM O
- : O
14 CD O
, , O
J66 NNP O
- : O
HI NNP O
, , O
P20 NNP O
, , O
J NNP O
- : O
Bir NNP O
, , O
ERT87 NNP O
- : O
30 CD O
, , O
ERT87 NNP O
- : O
15 CD O
, , O
ERT87 NNP O
- : O
8 CD O
, , O
ERT87 NNP O
- : O
1 CD O
, , O
XJ NNP O
- : O
1 CD O
. . O
1 CD O
, , O
754 CD O
, , O
cx5 NN O
. . O
7 CD O
, , O
and CC O
OTC NNP O
- : O
1 CD O
) ) O
that WDT O
are VBP O
located VBN O
around IN O
Xp21 NNP O
also RB O
showed VBD O
a DT O
deletion NN O
in IN O
the DT O
genome NN O
of IN O
all DT O
patients NNS O
and CC O
mothers NNS O
. . O

Although IN O
the DT O
deletion NN O
differed VBD O
in IN O
size NN O
among IN O
patients NNS O
, , O
a DT O
segment NN O
commonly RB O
absent NN O
was VBD O
located VBN O
between IN O
the DT O
genomic JJ O
sequences NNS O
corresponding VBG O
to TO O
L1 NNP O
- : O
4 CD O
and CC O
cDMD13 VB O
- : O
14 CD O
. . O

This DT O
finding NN O
indicated VBD O
that IN O
the DT O
gene NN O
coding VBG O
for IN O
glycerol NN O
kinase NN O
( ( O
GK NNP O
) ) O
is VBZ O
located VBN O
within IN O
this DT O
segment NN O
. . O

A DT O
comparison NN O
of IN O
the DT O
clinical JJ O
manifestations NNS O
of IN O
the DT O
present JJ O
five CD O
patients NNS O
and CC O
reported VBD O
CGKD NNP B-Disease
or CC O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
patients NNS O
with IN O
DNA NNP O
deletion NN O
suggests VBZ O
the DT O
existence NN O
of IN O
a DT O
certain JJ O
gene NN O
responsible JJ O
for IN O
gonadotropin JJ B-Disease
deficiency NN I-Disease
( ( O
GTD NNP B-Disease
) ) O
. . O

The DT O
result NN O
of IN O
the DT O
present JJ O
study NN O
and CC O
results NNS O
of IN O
previous JJ O
studies NNS O
suggest VBP O
that IN O
genes NNS O
for IN O
ornithine JJ O
transcarbamylase NN O
( ( O
OTC NNP O
) ) O
, , O
DMD NNP B-Disease
, , O
and CC O
GK NNP O
and CC O
putative JJ O
genes NNS O
responsible JJ O
for IN O
congenital JJ B-Disease
adrenal JJ I-Disease
hypoplasia NN I-Disease
( ( O
AHC NNP B-Disease
) ) O
and CC O
GTD NNP B-Disease
are VBP O
arranged VBN O
from IN O
telomere RB O
to TO O
centromere VB O
as IN O
pter NN O
- : O
- : O
GTD NNP O
- : O
- : O
AHC SYM O
- : O
- : O
GK NNP O
- : O
- : O
DMD NNP O
- : O
- : O
OTC NNP O
- : O
- : O
cen NN O

Genetically RB O
determined VBN O
low JJ O
C4 NNP O
: : O
a DT O
predisposing VBG O
factor NN O
to TO O
autoimmune VB B-Disease
chronic JJ I-Disease
active JJ I-Disease
hepatitis NN I-Disease
. . O

Of IN O
26 CD O
patients NNS O
with IN O
autoimmune JJ B-Disease
chronic JJ I-Disease
active JJ I-Disease
hepatitis NN I-Disease
( ( O
CAH NNP B-Disease
) ) O
starting VBG O
in IN O
childhood NN O
18 CD O
( ( O
69 CD O
% NN O
) ) O
had VBD O
low JJ O
C4 NNP O
and CC O
5 CD O
( ( O
19 CD O
% NN O
) ) O
had VBD O
low JJ O
C3 NNP O
serum NN O
levels NNS O
. . O

Impaired NNP O
hepatic JJ O
synthesis NN O
and CC O
immune JJ O
- : O
consumption NN O
were VBD O
unlikely JJ O
since IN O
transferrin NN O
levels NNS O
were VBD O
normal JJ O
in IN O
all DT O
patients NNS O
, , O
albumin JJ O
levels NNS O
were VBD O
persistently RB O
low JJ O
in IN O
only RB O
3 CD O
, , O
and CC O
only RB O
3 CD O
had VBD O
raised VBN O
levels NNS O
of IN O
activation NN O
fragment NN O
C3d NNP O
. . O

C4d NNP O
was VBD O
normal JJ O
in IN O
all DT O
patients NNS O
studied VBN O
. . O

In IN O
the DT O
families NNS O
of IN O
12 CD O
probands NNS O
with IN O
low JJ O
C4 NNP O
, , O
7 CD O
parents NNS O
had VBD O
low JJ O
C4 NNP O
and CC O
2 CD O
had VBD O
levels NNS O
which WDT O
were VBD O
at IN O
the DT O
lower JJR O
limit NN O
of IN O
normal JJ O
. . O

5 CD O
of IN O
10 CD O
siblings NNS O
from IN O
5 CD O
families NNS O
had VBD O
low JJ O
C4 NNP O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
low JJ O
C4 NNP O
levels NNS O
in IN O
CAH NNP B-Disease
are VBP O
genetically RB O
determined VBN O
. . O

C4 NNP O
phenotyping NN O
in IN O
20 CD O
patients NNS O
and CC O
in IN O
26 CD O
parents NNS O
showed VBD O
that IN O
90 CD O
% NN O
and CC O
81 CD O
% NN O
, , O
respectively RB O
, , O
had VBD O
null JJ O
allotypes NNS O
at IN O
either CC O
the DT O
C4A NNP O
or CC O
C4B NNP O
locus NN O
compared VBN O
with IN O
59 CD O
% NN O
in IN O
controls NNS O
, , O
indicating VBG O
that IN O
defective JJ O
expression NN O
of IN O
structural JJ O
genes NNS O
may MD O
contribute VB O
to TO O
the DT O
observed VBN O
C4 NNP B-Disease
deficiency NN I-Disease
. . O
. . O

An DT O
amino NN O
- : O
acid JJ O
substitution NN O
involved VBN O
in IN O
phenylketonuria NN B-Disease
is VBZ O
in IN O
linkage NN O
disequilibrium NN O
with IN O
DNA NNP O
haplotype NN O
2 CD O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
human JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
, , O
phenylalanine NN O
4 CD O
- : O
monooxygenase NN O
, , O
EC NNP O
1 CD O
. . O
14 CD O
. . O
16 CD O
. . O
1 CD O
) ) O
. . O

PKU NNP B-Disease
is VBZ O
a DT O
common JJ O
inborn JJ B-Disease
error NN I-Disease
of IN I-Disease
amino NN I-Disease
- : I-Disease
acid NN I-Disease
metabolism NN I-Disease
in IN O
caucasian JJ O
populations NNS O
and CC O
approximately RB O
1 CD O
in IN O
50 CD O
individuals NNS O
are VBP O
carriers NNS O
of IN O
a DT O
PKU NNP B-Disease
allele NN O
. . O

To TO O
define VB O
the DT O
molecular JJ O
basis NN O
of IN O
PKU NNP B-Disease
, , O
we PRP O
characterized VBD O
twelve JJ O
restriction NN O
fragment NN O
- : O
length NN O
polymorphism NN O
( ( O
RFLP NNP O
) ) O
haplotypes NNS O
of IN O
the DT O
PAH NNP O
locus NN O
in IN O
the DT O
northern JJ O
European JJ O
population NN O
and CC O
observed VBD O
that IN O
90 CD O
% NN O
of IN O
the DT O
PKU NNP B-Disease
alleles NNS O
in IN O
this DT O
population NN O
are VBP O
confined VBN O
to TO O
four CD O
common JJ O
RFLP NNP O
haplotypes NNS O
. . O

We PRP O
have VBP O
recently RB O
reported VBN O
a DT O
splicing VBG O
mutation NN O
in IN O
the DT O
PAH NNP O
gene NN O
that WDT O
is VBZ O
associated VBN O
with IN O
RFLP NNP O
haplotype NN O
3 CD O
which WDT O
is VBZ O
present JJ O
at IN O
about RB O
40 CD O
% NN O
of IN O
mutant JJ O
alleles NNS O
. . O

We PRP O
now RB O
report VBP O
the DT O
molecular JJ B-Disease
lesion NN I-Disease
associated VBN O
with IN O
the DT O
RFLP NNP O
haplotype NN O
2 CD O
mutant JJ O
allele NN O
. . O

This DT O
defect NN O
is VBZ O
caused VBN O
by IN O
a DT O
C NNP O
- : O
to TO O
- : O
T NNP O
transition NN O
in IN O
exon $ O
12 CD O
resulting VBG O
in IN O
an DT O
amino NN O
- : O
acid NN O
substitution NN O
( ( O
Arg NNP O
to TO O
Trp NNP O
) ) O
at IN O
residue JJ O
408 CD O
of IN O
PAH NNP O
. . O

Direct JJ O
hybridization NN O
analysis NN O
of IN O
the DT O
point NN O
mutation NN O
using VBG O
a DT O
specific JJ O
oligonucleotide NN O
probe NN O
demonstrated VBD O
that IN O
this DT O
mutation NN O
is VBZ O
also RB O
in IN O
linkage NN O
disequilibrium NN O
with IN O
RFLP NNP O
haplotype NN O
2 CD O
alleles NNS O
that WDT O
make VBP O
up RP O
about RB O
20 CD O
% NN O
of IN O
mutant JJ O
PAH NNP O
genes NNS O

Choroideremia NN B-Disease
: : O
close JJ O
linkage NN O
to TO O
DXYS1 NNP O
and CC O
DXYS12 NNP O
demonstrated VBN O
by IN O
segregation NN O
analysis NN O
and CC O
historical JJ O
- : O
genealogical JJ O
evidence NN O
. . O

Linkage NN O
studies NNS O
using VBG O
restriction NN O
fragment NN O
length NN O
polymorphisms NNS O
were VBD O
conducted VBN O
in IN O
the DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
disorder NN I-Disease
, , O
choroideremia NN B-Disease
, , O
designated VBN O
TCD NNP B-Disease
for IN O
Progressive NNP B-Disease
Tapeto NNP I-Disease
- : I-Disease
Choroidal NNP I-Disease
Dystrophy NNP I-Disease
. . O

Previously RB O
demonstrated VBN O
close JJ O
linkage NN O
with IN O
locus NN O
DXYS1 NNP O
was VBD O
confirmed VBN O
( ( O
lod JJ O
11 CD O
. . O
44 CD O
at IN O
0 CD O
recombination NN O
distance NN O
) ) O
. . O

In IN O
addition NN O
, , O
locus NN O
DXYS12 NNP O
was VBD O
found VBN O
to TO O
be VB O
closely RB O
linked VBN O
with IN O
TCD NNP B-Disease
( ( O
lod JJ O
3 CD O
. . O
31 CD O
at IN O
0 CD O
recombination NN O
distance NN O
) ) O
. . O

The DT O
disease NN O
mainly RB O
occurs VBZ O
in IN O
three CD O
large JJ O
kindreds NNS O
in IN O
remote JJ O
Northern NNP O
Finland NNP O
. . O

While IN O
formal JJ O
genealogical JJ O
proof NN O
is VBZ O
lacking VBG O
, , O
all DT O
presently RB O
living VBG O
( ( O
more JJR O
than IN O
80 CD O
affected JJ O
males NNS O
and CC O
120 CD O
carrier NN O
females NNS O
) ) O
probably RB O
originate VBP O
from IN O
a DT O
common JJ O
founder NN O
couple NN O
born VBN O
in IN O
1644 CD O
and CC O
1646 CD O
, , O
twelve VBP O
generations NNS O
ago RB O
. . O

All DT O
36 CD O
patients NNS O
and CC O
48 CD O
carriers NNS O
tested VBN O
from IN O
the DT O
three CD O
kindreds NNS O
had VBD O
the DT O
same JJ O
haplotype NN O
( ( O
TCD NNP B-Disease
/ NNP O
DXYS1 NNP O
, , O
11kb CD O
/ NN O
DXYS12 NNP O
, , O
1 CD O
. . O
6kb CD O
) ) O
. . O

Given VBN O
that DT O
at IN O
least JJS O
105 CD O
female JJ O
meioses NNS O
transmitting VBG O
TCD NNP B-Disease
have VBP O
occurred VBN O
since IN O
1650 CD O
in IN O
these DT O
kindreds NNS O
, , O
extremely RB O
close JJ O
linkage NN O
between IN O
TCD NNP B-Disease
, , O
DXYS1 NNP O
and CC O
DXYS12 NNP O
is VBZ O
suggested VBN O
. . O

The DT O
above JJ O
haplotype NN O
is VBZ O
a DT O
very RB O
useful JJ O
diagnostic JJ O
tool NN O
in IN O
these DT O
TCD NNP B-Disease
families NNS O
. . O

We PRP O
suggest VBP O
that IN O
our PRP$ O
historical JJ O
- : O
genealogical JJ O
approach NN O
to TO O
linkage VB O
analysis NN O
may MD O
be VB O
possible JJ O
elsewhere RB O
in IN O
similar JJ O
isolated JJ O
populations NNS O

Von NNP B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
maps NNS O
to TO O
the DT O
region NN O
of IN O
chromosome NN O
3 CD O
associated VBN O
with IN O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
. . O

Von NNP B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
( ( O
VHL NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
with IN O
inherited JJ O
susceptibility NN O
to TO O
various JJ O
forms NNS O
of IN O
cancer NN B-Disease
, , O
including VBG O
hemangioblastomas NN B-Disease
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
phaeochromocytomas NN B-Disease
, , O
pancreatic JJ B-Disease
malignancies NNS I-Disease
, , O
and CC O
renal JJ B-Disease
cell NN I-Disease
carcinomas NN I-Disease
. . O

Renal NNP B-Disease
cell NN I-Disease
carcinomas NNS I-Disease
constitute VBP O
a DT O
particularly RB O
frequent JJ O
cause NN O
of IN O
death NN O
in IN O
this DT O
disorder NN O
, , O
occurring VBG O
as IN O
bilateral JJ B-Disease
and CC I-Disease
multifocal JJ I-Disease
tumours NNS I-Disease
, , O
and CC O
presenting VBG O
at IN O
an DT O
earlier JJR O
age NN O
than IN O
in IN O
sporadic JJ O
, , O
non JJ O
- : O
familial JJ O
cases NNS O
of IN O
this DT O
tumour NN B-Disease
type NN O
. . O

We PRP O
report VBP O
here RB O
that IN O
the DT O
VHL NNP B-Disease
gene NN O
is VBZ O
linked VBN O
to TO O
the DT O
locus NN O
encoding VBG O
the DT O
human JJ O
homologoue NN O
of IN O
the DT O
RAF1 NNP O
oncogene NN O
, , O
which WDT O
maps VBZ O
to TO O
chromosome VB O
3p25 CD O
( ( O
ref NN O
. . O
4 CD O
) ) O
. . O

Crossovers NNS O
with IN O
the DT O
VHL NNP B-Disease
locus NN O
suggest VBP O
that IN O
the DT O
defect NN O
responsible JJ O
for IN O
the DT O
VHL NNP B-Disease
phenotype NN O
is VBZ O
not RB O
a DT O
mutation NN O
in IN O
the DT O
RAF1 NNP O
gene NN O
itself PRP O
. . O

An DT O
alternative NN O
or CC O
prior JJ O
event NN O
to TO O
oncogene VB O
activation NN O
in IN O
tumour JJ B-Disease
formation NN O
may MD O
be VB O
the DT O
inactivation NN O
of IN O
a DT O
putative JJ O
tumour NN B-Disease
suppressor NN O
which WDT O
can MD O
be VB O
associated VBN O
with IN O
both DT O
the DT O
inherited VBN B-Disease
and CC I-Disease
sporadic JJ I-Disease
forms NNS I-Disease
of IN I-Disease
the DT I-Disease
cancer NN I-Disease
. . O

Sporadic JJ B-Disease
renal NN I-Disease
cell NN I-Disease
carcinomas NNS I-Disease
have VBP O
previously RB O
been VBN O
associated VBN O
with IN O
the DT O
loss NN O
of IN O
regions NNS O
on IN O
chromosome NN O
3p CD O
( ( O
refs VB O
5 CD O
, , O
6 CD O
) ) O
. . O

Consequently RB O
, , O
sporadic JJ O
and CC O
VHL NNP O
- : O
associated VBD O
forms NNS O
of IN O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
might MD O
both DT O
result NN O
from IN O
alterations NNS O
causing VBG O
loss NN O
of IN O
function NN O
of IN O
the DT O
same JJ O
tumour NN B-Disease
suppressor NN O
gene NN O
on IN O
this DT O
chromosome NN O
. . O
. . O

Tightly RB O
linked VBN O
flanking NN O
markers NNS O
for IN O
the DT O
Lowe NNP B-Disease
oculocerebrorenal JJ I-Disease
syndrome NN I-Disease
, , O
with IN O
application NN O
to TO O
carrier NN O
assessment NN O
. . O

The DT O
Lowe NNP B-Disease
oculocerebrorenal JJ I-Disease
syndrome NN I-Disease
( ( O
OCRL NNP B-Disease
) ) O
is VBZ O
characterized VBN O
by IN O
congenital JJ O
cataract NN B-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
defective JJ B-Disease
renal JJ I-Disease
tubular JJ I-Disease
function NN I-Disease
. . O

A DT O
map JJ O
assignment NN O
of IN O
OCRL NNP B-Disease
to TO O
Xq24 VB O
- : O
q26 NN O
has VBZ O
been VBN O
made VBN O
previously RB O
by IN O
linkage NN O
analysis NN O
with IN O
DXS42 NNP O
at IN O
Xq24 NNP O
- : O
q26 NN O
( ( O
theta JJ O
= NN O
0 CD O
, , O
z NN O
= VBD O
5 CD O
. . O
9 CD O
) ) O
and CC O
with IN O
DXS10 NNP O
at IN O
Xq26 NNP O
( ( O
theta JJ O
= NN O
0 CD O
, , O
z NN O
= VBD O
6 CD O
. . O
45 CD O
) ) O
. . O

Two CD O
additional JJ O
families NNS O
were VBD O
studied VBN O
and CC O
three CD O
additional JJ O
polymorphisms NNS O
were VBD O
identified VBN O
at IN O
DXS42 NNP O
by IN O
using VBG O
a DT O
35 CD O
- : O
kb NN O
sequence NN O
isolated VBN O
with IN O
the DT O
probe NN O
detecting VBG O
the DT O
original JJ O
polymorphism NN O
at IN O
DXS42 NNP O
. . O

With IN O
additional JJ O
OCRL NNP B-Disease
families NNS O
made VBD O
informative JJ O
for IN O
DXS42 NNP O
, , O
theta NN O
remained VBD O
0 CD O
with IN O
z NN O
= $ O
6 CD O
. . O

63 CD O
; : O
and CC O
for IN O
DXS10 NNP O
theta NN O
= VBD O
0 CD O
. . O

3 CD O
and CC O
z NNP O
= NNP O
7 CD O
. . O

7 CD O
. . O

Evidence NN O
for IN O
placing VBG O
OCRL NNP O
at IN O
Xq25 NNP O
also RB O
comes VBZ O
from IN O
a DT O
female NN O
with IN O
Lowe NNP B-Disease
syndrome NN I-Disease
and CC O
an DT O
X NN O
; : O
3 CD O
translocation NN O
. . O

We PRP O
have VBP O
used VBN O
the DT O
Xq25 NNP O
breakpoint NN O
in IN O
this DT O
patient NN O
to TO O
determine VB O
the DT O
position NN O
of IN O
OCRL NNP O
relative NN O
to TO O
the DT O
two CD O
linked VBD O
markers NNS O
. . O

Each DT O
derivative JJ O
chromosome NN O
was VBD O
isolated VBN O
away RB O
from IN O
its PRP$ O
normal JJ O
counterpart NN O
in IN O
somatic JJ O
cell NN O
hybrids NNS O
. . O

DXS42 NNP O
was VBD O
mapped VBN O
to TO O
the DT O
derivative JJ O
chromosome NN O
X NNP O
containing VBG O
Xpterq25 NNP O
, , O
and CC O
DXS10 NNP O
was VBD O
mapped VBN O
to TO O
the DT O
derivative JJ O
chromosome NN O
3 CD O
containing VBG O
Xq25 NNP O
- : O
qter NN O
. . O

The DT O
markers NNS O
DXS10 NNP O
and CC O
DXS42 NNP O
therefore RB O
show VBP O
tight JJ O
linkage NN O
with IN O
OCRL NNP B-Disease
in IN O
six CD O
families NNS O
and CC O
flank VB O
the DT O
Xq25 NNP O
breakpoint NN O
in IN O
a DT O
female JJ O
patient NN O
with IN O
an DT O
X NN O
; : O
3 CD O
translocation NN O
. . O

Linkage NN O
analysis NN O
with IN O
flanking VBG O
markers NNS O
was VBD O
used VBN O
to TO O
assess VB O
OCRL NNP B-Disease
carrier NN O
status NN O
in IN O
women NNS O
at IN O
risk NN O
. . O

Results NNS O
, , O
when WRB O
compared VBN O
with IN O
carrier NN O
determination NN O
by IN O
ophthalmologic JJ O
examination NN O
, , O
indicated VBD O
that IN O
the DT O
slit NN O
- : O
lamp NN O
exam NN O
can MD O
be VB O
a DT O
sensitive JJ O
and CC O
specific JJ O
method NN O
of IN O
carrier NN O
determination NN O
in IN O
many JJ O
cases NNS O

Identification NN O
of IN O
a DT O
single JJ O
nucleotide NN O
change NN O
in IN O
the DT O
hypoxanthine NN O
- : O
guanine NN O
phosphoribosyltransferase NN O
gene NN O
( ( O
HPRTYale NNP O
) ) O
responsible JJ O
for IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

Complete JJ O
deficiency NN B-Disease
of IN I-Disease
hypoxanthine NN I-Disease
- : I-Disease
guanine NN I-Disease
phosphoribosyltransferase NN I-Disease
( ( O
HPRT NNP O
) ) O
causes VBZ O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

Previous JJ O
characterization NN O
of IN O
a DT O
mutant JJ O
form NN O
of IN O
HPRT NNP O
, , O
HPRTYale NNP O
, , O
from IN O
a DT O
subject NN O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome VB I-Disease
revealed VBD O
normal JJ O
mRNA NN O
and CC O
protein NN O
concentrations NNS O
, , O
no DT O
residual JJ O
catalytic JJ O
activity NN O
, , O
and CC O
cathodal JJ O
migration NN O
upon IN O
PAGE NNP O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
HPRTYale NNP O
cDNA NN O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
full JJ O
- : O
length NN O
HPRTYale NNP O
cDNA NN O
revealed VBD O
a DT O
single JJ O
nucleotide NN O
substitution NN O
compared VBN O
with IN O
normal JJ O
HPRT NNP O
cDNA NN O
G NNP O
- : O
- : O
- : O
- : O
C NN O
at IN O
nucleotide JJ O
position NN O
211 CD O
. . O

This DT O
transversion NN O
predicts VBZ O
substitution NN O
of IN O
arginine NN O
for IN O
glycine NN O
at IN O
amino NN O
acid JJ O
position NN O
71 CD O
, , O
explaining VBG O
the DT O
cathodal JJ O
migration NN O
of IN O
HPRTYale NNP O
. . O

Chou NNP O
- : O
Fasman NNP O
secondary JJ O
structure NN O
analysis NN O
predicts VBZ O
a DT O
change NN O
in IN O
the DT O
probability NN O
of IN O
beta NN O
- : O
turn NN O
formation NN O
in IN O
the DT O
region NN O
containing VBG O
the DT O
mutation NN O
. . O

Inclusion NN O
of IN O
the DT O
bulky JJ O
arginine JJ O
side NN O
chain NN O
in IN O
place NN O
of IN O
glycine NN O
probably RB O
disrupts VBZ O
protein JJ O
folding NN O
as RB O
well RB O
. . O

Cloning VBG O
mutant JJ O
forms NNS O
of IN O
cDNA NN O
allows VBZ O
identification NN O
of IN O
specific JJ O
mutations NNS O
, , O
provides VBZ O
insight JJ O
into IN O
mutational JJ O
mechanisms NNS O
, , O
and CC O
facilitates VBZ O
structure NN O
- : O
function NN O
analysis NN O
of IN O
mutant JJ O
proteins NNS O
. . O
. . O

Two CD O
point NN O
mutations NNS O
are VBP O
responsible JJ O
for IN O
G6PD NNP O
polymorphism NN O
in IN O
Sardinia NNP O
. . O

The DT O
human JJ O
X NNP O
- : O
linked VBN O
gene NN O
encoding VBG O
glucose JJ O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
is VBZ O
highly RB O
polymorphic JJ O
; : O
more JJR O
than IN O
300 CD O
G6PD NNP O
variants NNS O
have VBP O
been VBN O
identified VBN O
. . O

G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
different JJ O
geographical JJ O
areas NNS O
appears VBZ O
to TO O
have VB O
arisen VBN O
through IN O
independent JJ O
mutational JJ O
events NNS O
, , O
but CC O
within IN O
the DT O
same JJ O
population NN O
it PRP O
may MD O
also RB O
be VB O
heterogeneous JJ O
. . O

One CD O
example NN O
is VBZ O
the DT O
island NN O
of IN O
Sardinia NNP O
, , O
where WRB O
careful JJ O
clinical JJ O
and CC O
biochemical JJ O
studies NNS O
have VBP O
identified VBN O
four CD O
different JJ O
G6PD NNP O
variants NNS O
. . O

We PRP O
cloned VBD O
and CC O
sequenced VBD O
the DT O
four CD O
G6PD NNP O
variants NNS O
from IN O
Sardinia NNP O
and CC O
found VBD O
that IN O
only RB O
two CD O
mutations NNS O
are VBP O
responsible JJ O
for IN O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
this DT O
area NN O
one CD O
mutation NN O
is VBZ O
the DT O
cause NN O
of IN O
the DT O
G6PD NNP B-Disease
Seattle NNP I-Disease
- : I-Disease
like IN I-Disease
phenotype NN I-Disease
, , O
a DT O
milder NN O
form NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
; : O
the DT O
other JJ O
mutation NN O
is VBZ O
responsible JJ O
for IN O
all DT O
forms NNS O
of IN O
very RB O
severe JJ O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
Sardinia NNP O
and CC O
, , O
possibly RB O
, , O
in IN O
the DT O
Mediterranean NNP O
. . O
. . O

Chronic NNP B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
( ( O
CNSHA NNP B-Disease
) ) O
and CC O
glucose $ B-Disease
6 CD I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
a DT O
patient NN O
with IN O
familial JJ B-Disease
amyloidotic JJ I-Disease
polyneuropathy NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
. . O

Molecular JJ O
study NN O
of IN O
a DT O
new JJ O
variant NN O
( ( O
G6PD NNP O
Clinic NNP O
) ) O
with IN O
markedly RB O
acidic JJ O
pH NN O
optimum NN O
. . O

A DT O
new JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
variant NN O
with IN O
severe JJ O
erythrocytic JJ B-Disease
G6PD NNP I-Disease
deficiency NN I-Disease
and CC O
a DT O
unique JJ O
pH NN O
optimum NN O
is VBZ O
described VBN O
in IN O
a DT O
young JJ O
patient NN O
with IN O
chronic JJ B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
( ( O
CNSHA NNP B-Disease
) ) O
and CC O
familial JJ B-Disease
amyloidotic JJ I-Disease
polyneuropathy NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
. . O

Chronic JJ B-Disease
hemolysis NN I-Disease
was VBD O
present JJ O
in IN O
the DT O
absence NN O
of IN O
infections NNS O
, , O
oxidant JJ O
drugs NNS O
or CC O
ingestion NN O
of IN O
faba JJ O
beans NNS O
. . O

Residual JJ O
enzyme NN O
activity NN O
was VBD O
about RB O
2 CD O
. . O

6 CD O
% NN O
and CC O
63 CD O
% NN O
of IN O
normal JJ O
activity NN O
in IN O
erythrocytes NNS O
and CC O
leucocytes NNS O
, , O
respectively RB O
. . O

A DT O
molecular JJ O
study NN O
using VBG O
standard JJ O
methods NNS O
showed VBD O
G6PD NNP O
in IN O
the DT O
patient NN O
to TO O
have VB O
normal JJ O
electrophoretic JJ O
mobility NN O
( ( O
at IN O
pH NN O
7 CD O
. . O
0 CD O
, , O
8 CD O
. . O
0 CD O
and CC O
8 CD O
. . O
8 CD O
) ) O
, , O
normal JJ O
apparent JJ O
affinity NN O
for IN O
substrates NNS O
( ( O
Km NNP O
, , O
G6P NNP O
and CC O
NADP NNP O
) ) O
and CC O
a DT O
slightly RB O
abnormal JJ O
utilization NN O
of IN O
substrate NN O
analogues NNS O
( ( O
decreased VBN O
deamino NN O
- : O
NADP NNP O
and CC O
increased VBD O
2 CD O
- : O
deoxyglucose NN O
- : O
6 CD O
- : O
phosphate NN O
utilization NN O
) ) O
. . O

Heat NNP O
stability NN O
was VBD O
found VBN O
to TO O
be VB O
markedly RB O
decreased VBN O
( ( O
8 CD O
% NN O
of IN O
residual JJ O
activity NN O
after IN O
20 CD O
min NN O
of IN O
incubation NN O
at IN O
46 CD O
degrees NNS O
C NNP O
) ) O
and CC O
a DT O
particular JJ O
characteristic NN O
of IN O
this DT O
enzyme NN O
was VBD O
a DT O
biphasic JJ O
pH NN O
curve NN O
with IN O
a DT O
greatly RB O
increased JJ O
activity NN O
at IN O
low JJ O
pH NN O
. . O

Although IN O
molecular JJ O
characteristics NNS O
of IN O
this DT O
variant NN O
closely RB O
resemble JJ O
those DT O
of IN O
G6PD NNP O
Bangkok NNP O
and CC O
G6PD NNP O
Duarte NNP O
, , O
it PRP O
can MD O
be VB O
distinguished VBN O
from IN O
these DT O
and CC O
all DT O
other JJ O
previously RB O
reported VBN O
variants NNS O
by IN O
virtue NN O
of IN O
its PRP$ O
unusual JJ O
pH NN O
curve NN O
. . O

Therefore RB O
the DT O
present JJ O
variant NN O
has VBZ O
been VBN O
designated VBN O
G6PD NNP O
Clinic NNP O
to TO O
distinguish VB O
it PRP O
from IN O
other JJ O
G6PD NNP O
variants NNS O
previously RB O
described VBD O

Molecular JJ O
detection NN O
of IN O
chromosomal JJ O
translocations NNS O
that WDT O
disrupt VBP O
the DT O
putative JJ O
retinoblastoma NN B-Disease
susceptibility NN O
locus NN O
. . O

A DT O
candidate NN O
DNA NN O
sequence NN O
with IN O
many JJ O
of IN O
the DT O
properties NNS O
predicted VBN O
for IN O
the DT O
retinoblastoma NN B-Disease
susceptibility NN O
( ( O
RB1 NNP O
) ) O
locus NN O
has VBZ O
been VBN O
cloned VBN O
( ( O
S NNP O
. . O
H NNP O
. . O
Friend NNP O
, , O
R NNP O
. . O
Bernards NNP O
, , O
S NNP O
. . O
Rogelj NNP O
, , O
R NNP O
. . O
A NNP O
. . O
Weinberg NNP O
, , O
J NNP O
. . O
M NNP O
. . O
Rapaport NNP O
, , O
D NNP O
. . O
M NNP O
. . O
Albert NNP O
, , O
and CC O
T NNP O
. . O
P NNP O
. . O
Dryja NNP O
, , O
Nature NNP O
[ NNP O
London NNP O
] VBD O
323 CD O
643 CD O
- : O
645 CD O
, , O
1986 CD O
) ) O
. . O

The DT O
large JJ O
size NN O
of IN O
this DT O
gene NN O
( ( O
ca MD O
. . O
200 CD O
kilobases NNS O
[ JJ O
kb NNP O
] NNP O
) ) O
and CC O
its PRP$ O
multiple NN O
dispersed VBN O
exons NNS O
( ( O
Wiggs NNP O
et RB O
al RB O
. . O
, , O
N NNP O
. . O
Engl NNP O
. . O
J NNP O
. . O
Med NNP O
. . O
318 CD O
151 CD O
- : O
157 CD O
, , O
1988 CD O
) ) O
complicate NN O
molecular JJ O
screening NN O
strategies NNS O
important JJ O
in IN O
prenatal JJ O
and CC O
presymptomatic JJ O
diagnosis NN O
and CC O
in IN O
carrier NN O
detection NN O
. . O

Here RB O
we PRP O
used VBD O
field NN O
inversion NN O
gel JJ O
electrophoresis NN O
( ( O
FIGE NNP O
) ) O
to TO O
construct VB O
a DT O
restriction NN O
map NN O
of IN O
approximately RB O
1 CD O
, , O
0 CD O
kb NN O
of IN O
DNA NNP O
surrounding VBG O
the DT O
RB1 NNP O
locus NN O
and CC O
to TO O
detect VB O
the DT O
translocation NN O
breakpoints NNS O
in IN O
three CD O
retinoblastoma NN B-Disease
patients NNS O
. . O

DNA NN O
probes NNS O
from IN O
either CC O
the DT O
5 CD O
or CC O
3 CD O
end NN O
of IN O
the DT O
gene NN O
were VBD O
used VBN O
to TO O
detect VB O
a DT O
250 CD O
- : O
kb NN O
EagI NNP O
restriction NN O
fragment NN O
in IN O
DNA NN O
from IN O
unaffected JJ O
individuals NNS O
. . O

Both DT O
probes NNS O
identified VBD O
an DT O
additional JJ O
hybridizing NN O
fragment NN O
in IN O
the DT O
DNA NN O
from IN O
each DT O
patient NN O
, , O
permitting VBG O
the DT O
breakpoints NNS O
in IN O
all DT O
three CD O
to TO O
be VB O
mapped VBN O
within IN O
the DT O
cloned VBN O
RB1 NNP O
gene NN O
. . O

Analysis NN O
of IN O
the DT O
breakpoint NN O
in IN O
one CD O
translocation NN O
cell NN O
line NN O
allowed VBD O
the DT O
RB1 NNP O
gene NN O
to TO O
be VB O
oriented VBN O
with IN O
its PRP$ O
5 CD O
end NN O
toward IN O
the DT O
centromere NN O
. . O

The DT O
5 CD O
end NN O
of IN O
the DT O
gene NN O
also RB O
appeared VBD O
to TO O
be VB O
associated VBN O
with IN O
a DT O
clustering NN O
of IN O
sites NNS O
for IN O
several JJ O
infrequently RB O
cleaving VBG O
restriction NN O
enzymes NNS O
, , O
indicating VBG O
the DT O
presence NN O
of IN O
an DT O
HpaII NNP O
tiny JJ O
fragment NN O
island NN O
. . O

The DT O
detection NN O
and CC O
mapping NN O
of IN O
the DT O
translocation NN O
breakpoints NNS O
of IN O
all DT O
three CD O
retinoblastoma NN B-Disease
patients NNS O
to TO O
within IN O
the DT O
putative JJ O
RB1 NNP O
gene NN O
substantiated VBD O
the DT O
authenticity NN O
of IN O
this DT O
candidate NN O
sequence NN O
and CC O
demonstrated VBD O
the DT O
utility NN O
of IN O
FIGE NNP O
in IN O
detecting VBG O
chromosomal JJ O
rearrangements NNS O
affecting VBG O
this DT O
locus NN O
. . O

Inherited VBN O
C3 NNP B-Disease
deficiency NN I-Disease
with IN O
recurrent JJ O
infections NNS O
and CC O
glomerulonephritis NN B-Disease
. . O

A DT O
10 CD O
- : O
year NN O
- : O
old JJ O
Laotian JJ O
boy NN O
had VBD O
homozygous JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
third JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
and CC O
recurrent JJ O
bacterial JJ B-Disease
infections NNS I-Disease
beginning VBG O
at IN O
age NN O
5 CD O
months NNS O
. . O

Cellular JJ O
and CC O
humoral JJ O
immunity NN O
were VBD O
normal JJ O
, , O
as IN O
were VBD O
polymorphonuclear JJ O
leukocyte JJ O
chemotaxis NN O
and CC O
bactericidal JJ O
activities NNS O
. . O

Serum NNP O
complement NN O
- : O
mediated VBN O
hemolytic JJ O
, , O
chemotactic JJ O
, , O
and CC O
opsonic JJ O
activities NNS O
were VBD O
deficient NN O
. . O

In IN O
vitro JJ O
addition NN O
of IN O
purified JJ O
C3 NNP O
to TO O
patient VB O
serum NN O
restored VBN O
hemolytic JJ O
complement NN O
to TO O
normal JJ O
levels NNS O
, , O
and CC O
plasma JJ O
infusion NN O
during IN O
each DT O
of IN O
four CD O
episodes NNS O
of IN O
pneumonia NN B-Disease
significantly RB O
enhanced VBD O
serum JJ O
opsonic JJ O
activity NN O
for IN O
as RB O
long RB O
as IN O
36 CD O
hours NNS O
. . O

A DT O
renal JJ O
biopsy NN O
specimen NNS O
revealed VBD O
mesangiopathic JJ B-Disease
glomerulonephritis NN I-Disease
, , O
although IN O
significant JJ O
levels NNS O
of IN O
circulating VBG O
IgG NNP O
immune NN O
complexes NNS O
were VBD O
not RB O
detected VBN O
. . O

These DT O
findings NNS O
further RBR O
support VB O
the DT O
association NN O
of IN O
C3 NNP B-Disease
deficiency NN I-Disease
with IN O
immune JJ B-Disease
- : I-Disease
complex JJ I-Disease
disease NN I-Disease
and CC O
suggest VBP O
that IN O
plasma JJ O
infusion NN O
may MD O
be VB O
an DT O
adjunct JJ O
to TO O
antibiotic JJ O
therapy NN O
in IN O
the DT O
management NN O
of IN O
severe JJ O
pyogenic JJ B-Disease
infections NNS I-Disease
in IN O
patients NNS O
with IN O
C3 NNP B-Disease
deficiency NN I-Disease
. . O
. . O

DNA NNP O
restriction NN O
fragments NNS O
associated VBN O
with IN O
alpha NN O
1 CD O
- : O
antitrypsin NN O
indicate VBP O
a DT O
single JJ O
origin NN O
for IN O
deficiency NN O
allele NN O
PI NNP O
Z NNP O
. . O

The DT O
alpha NN O
1 CD O
- : O
protease NN O
inhibitor NN O
, , O
or CC O
alpha SYM O
- : O
antitrypsin NN O
( ( O
AAT NNP O
) ) O
, , O
a DT O
major JJ O
plasma NN O
inhibitor NN O
of IN O
leukocyte JJ O
elastase NN O
and CC O
bacterial JJ O
proteases NNS O
, , O
is VBZ O
encoded VBN O
at IN O
the DT O
PI NNP O
locus NN O
on IN O
chromosome NN O
14 CD O
( ( O
14q24 CD O
. . O
3 CD O
- : O
q32 NN O
. . O
1 CD O
) ) O
. . O

A DT O
deficiency NN B-Disease
of IN I-Disease
AAT NNP I-Disease
in IN O
individuals NNS O
homozygous JJ O
for IN O
the DT O
PI NNP O
Z NNP O
allele NN O
occurs VBZ O
in IN O
about RB O
1 CD O
in IN O
2 CD O
, , O
0 CD O
- : O
8 CD O
, , O
0 CD O
caucasians NNS O
and CC O
is VBZ O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
early JJ O
adult NN O
onset VBN O
emphysema NN B-Disease
and CC O
liver JJ B-Disease
disease NN I-Disease
in IN O
childhood NN O
. . O

We PRP O
have VBP O
now RB O
used VBN O
DNA NNP O
polymorphisms NNS O
associated VBN O
with IN O
the DT O
AAT NNP O
gene NN O
to TO O
investigate VB O
the DT O
origin NN O
of IN O
the DT O
PI NNP O
Z NNP O
allele NN O
. . O

Using VBG O
two CD O
genomic JJ O
probes NNS O
extending VBG O
into IN O
the DT O
5 CD O
and CC O
3 CD O
flanking NN O
regions NNS O
, , O
respectively RB O
, , O
we PRP O
have VBP O
identified VBN O
eight CD O
polymorphic JJ O
restriction NN O
sites NNS O
. . O

Extensive JJ O
linkage NN O
disequilibrium NN O
occurs VBZ O
throughout IN O
the DT O
probed JJ O
region NN O
with IN O
the DT O
PI NNP O
Z NNP O
allele NN O
, , O
but CC O
not RB O
with IN O
normal JJ O
PI NNP O
M NNP O
alleles NNS O
. . O

The DT O
Z NNP O
allele NN O
occurs VBZ O
mainly RB O
with IN O
one CD O
haplotype NN O
, , O
indicating VBG O
a DT O
single JJ O
, , O
relatively RB O
recent JJ O
, , O
origin NN O
in IN O
caucasians NNS O

Segregation NNP O
analysis NN O
of IN O
a DT O
marker NN O
localised VBN O
Xp21 NNP O
. . O
2 CD O
- : O
Xp21 NN O
. . O
3 CD O
in IN O
Duchenne NNP B-Disease
and CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
families NNS O
. . O

A DT O
DNA NN O
marker NN O
C7 NNP O
, , O
localised VBD O
Xp21 NN O
. . O

1 CD O
- : O
Xp21 NN O
. . O

3 CD O
, , O
has VBZ O
been VBN O
studied VBN O
in IN O
kindreds NNS O
segregating VBG O
for IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
and CC O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
BMD NNP B-Disease
) ) O
. . O

In IN O
DMD NNP B-Disease
families NNS O
four CD O
crossovers NNS O
were VBD O
observed VBN O
in IN O
38 CD O
informative JJ O
meioses NNS O
between IN O
C7 NNP O
and CC O
the DT O
DMD NNP B-Disease
locus NN O
( ( O
theta JJ O
= NN O
0 CD O
. . O
12 CD O
, , O
z NN O
max NN O
= NNP O
+ VBZ O
2 CD O
. . O
72 CD O
) ) O
. . O

In IN O
BMD NNP B-Disease
families NNS O
no DT O
recombinants NNS O
were VBD O
observed VBN O
in IN O
the DT O
16 CD O
informative JJ O
meioses NNS O
studied VBN O
. . O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
the DT O
localisation NN O
of IN O
the DT O
mutations NNS O
in IN O
these DT O
disorders NNS O
being VBG O
in IN O
the DT O
same JJ O
region NN O
of IN O
Xp21 NNP O
. . O

Studies NNS O
in IN O
families NNS O
also RB O
segregating VBG O
for IN O
the DT O
DNA NNP O
marker NN O
754 CD O
support NN O
the DT O
previously RB O
reported VBN O
physical JJ O
order NN O
of IN O
these DT O
loci NNS O
as IN O
X NN O
centromere SYM O
- : O
754 CD O
- : O
DMD NNP O
- : O
BMD NNP O
- : O
C7 NNP O
- : O
X NN O
telomere RB O
. . O

A DT O
recombination NN O
fraction NN O
of IN O
0 CD O
. . O

11 CD O
( ( O
z NN O
max NN O
= NNP O
+ VBZ O
5 CD O
. . O
58 CD O
) ) O
was VBD O
found VBN O
between IN O
DMD NNP O
- : O
754 CD O
by IN O
combining VBG O
our PRP$ O
previously RB O
published VBN O
data NN O
with IN O
the DT O
data NNS O
presented VBN O
here RB O
. . O

C7 NNP O
and CC O
754 CD O
thus RB O
provide RB O
good JJ O
bridging NN O
markers NNS O
for IN O
the DT O
diagnosis NN O
of IN O
DMD NNP B-Disease
and CC O
BMD NNP B-Disease

Isolation NN O
of IN O
molecular JJ O
probes NNS O
associated VBN O
with IN O
the DT O
chromosome NN O
15 CD O
instability NN O
in IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

Flow NNP O
cytometry NN O
and CC O
recombinant JJ O
DNA NNP O
techniques NNS O
have VBP O
been VBN O
used VBN O
to TO O
obtain VB O
reagents NNS O
for IN O
a DT O
molecular JJ O
analysis NN O
of IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

HindIII NNP O
total JJ O
- : O
digest JJS O
libraries NNS O
were VBD O
prepared VBN O
in IN O
lambda JJ O
phage NN O
Charon NNP O
21A CD O
from IN O
flow JJ O
- : O
sorted VBN O
inverted JJ O
duplicated VBD O
no DT O
. . O
15 CD O
human JJ O
chromosomes NNS O
and CC O
propagated VBN O
on IN O
recombination NN O
- : O
proficient NN O
( ( O
LE392 NNP O
) ) O
and CC O
recBC JJ O
- : O
, , O
sbcB SYM O
- : O
( ( O
DB1257 NNP O
) ) O
bacteria NN O
. . O

Twelve NNP O
distinct VBZ O
chromosome NN O
15 CD O
- : O
specific JJ O
probes NNS O
have VBP O
been VBN O
isolated VBN O
. . O

Eight CD O
localized VBN O
to TO O
the DT O
region NN O
15q11 CD O
- : O
- : O
- : O
- : O
13 CD O
. . O

Four CD O
of IN O
these DT O
eight CD O
sublocalized NNS O
to TO O
band VB O
15q11 CD O
. . O

2 CD O
and CC O
are VBP O
shown VBN O
to TO O
be VB O
deleted VBN O
in IN O
DNA NN O
of IN O
one CD O
of IN O
two CD O
patients NNS O
examined VBN O
with IN O
the DT O
PWS NNP B-Disease
. . O

Heteroduplex NNP O
analysis NN O
of IN O
two CD O
of IN O
these DT O
clones NNS O
, , O
which WDT O
grew VBD O
on IN O
DB1257 NNP O
but CC O
not RB O
on IN O
LE392 NNP O
, , O
revealed VBD O
stem NN O
- : O
loop NN O
structures NNS O
in IN O
the DT O
inserts NNS O
, , O
indicative NN O
of IN O
inverted JJ O
, , O
repeated VBD O
DNA JJ O
elements NNS O
. . O

Such JJ O
DNA NNP O
repeats NNS O
might MD O
account VB O
for IN O
some DT O
of IN O
the DT O
cloning VBG O
instability NN O
of IN O
DNA NN O
segments NNS O
from IN O
proximal JJ O
15q CD O
. . O

Analysis NN O
of IN O
the DT O
genetic JJ O
and CC O
physical JJ O
instability NN O
associated VBN O
with IN O
the DT O
repeated JJ O
sequences NNS O
we PRP O
have VBP O
isolated VBN O
from IN O
band NN O
15q11 CD O
. . O

2 CD O
may MD O
elucidate VB O
the DT O
molecular JJ O
basis NN O
for IN O
the DT O
instability NN O
of IN O
this DT O
chromosomal JJ O
region NN O
in IN O
patients NNS O
with IN O
the DT O
PWS NNP B-Disease
or CC O
other JJ O
diseases NNS O
associated VBN O
with IN O
chromosomal JJ B-Disease
abnormalities NNS I-Disease
in IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
human JJ O
chromosome NN O
15 CD O

Analysis NN O
of IN O
deletions NNS O
in IN O
DNA NN O
from IN O
patients NNS O
with IN O
Becker NNP B-Disease
and CC I-Disease
Duchenne NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
for IN O
which WDT O
the DT O
biochemical NN O
defect NN O
is VBZ O
as IN O
yet RB O
unknown JJ O
. . O

Recently RB O
, , O
two CD O
cloned VBD O
segments NNS O
of IN O
human JJ O
X NNP O
- : O
chromosome NN O
DNA NN O
have VBP O
been VBN O
described VBN O
which WDT O
detect JJ O
structural JJ O
alterations NNS O
within IN O
or CC O
near IN O
the DT O
genetic JJ O
locus NN O
responsible JJ O
for IN O
the DT O
disorder NN O
. . O

Both DT O
of IN O
these DT O
cloned VBN O
segments NNS O
were VBD O
described VBN O
as IN O
tightly RB O
linked VBN O
to TO O
the DT O
locus NN O
and CC O
were VBD O
capable JJ O
of IN O
detecting VBG O
deletions NNS O
in IN O
the DT O
DNA NN O
of IN O
boys NNS O
affected VBN O
with IN O
DMD NNP B-Disease
. . O

In IN O
an DT O
attempt NN O
to TO O
determine VB O
more RBR O
precisely RB O
the DT O
occurrence NN O
of IN O
these DT O
deletions NNS O
within IN O
a DT O
large JJ O
population NN O
of IN O
DMD NNP B-Disease
patients NNS O
and CC O
the DT O
accuracy NN O
of IN O
one CD O
of IN O
the DT O
segments NNS O
, , O
DXS164 NNP O
( ( O
pERT87 NN O
) ) O
, , O
in IN O
determining VBG O
the DT O
inheritance NN O
of IN O
the DT O
DMD NNP B-Disease
X NNP O
chromosome NN O
, , O
the DT O
subclones NNS O
1 CD O
, , O
8 CD O
and CC O
15 CD O
were VBD O
made VBN O
available JJ O
to TO O
many JJ O
investigators NNS O
throughout IN O
the DT O
world NN O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
combined JJ O
results NNS O
of IN O
more JJR O
than IN O
20 CD O
research NN O
laboratories NNS O
with IN O
respect NN O
to TO O
the DT O
occurrence NN O
of IN O
deletions NNS O
at IN O
the DT O
DXS164 NNP O
locus NN O
in IN O
DNA NNP O
samples NNS O
isolated VBD O
from IN O
patients NNS O
with IN O
DMD NNP B-Disease
and CC O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
BMD NNP B-Disease
) ) O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
DXS164 NNP O
locus NN O
apparently RB O
recombines VBZ O
with IN O
DMD NNP B-Disease
5 CD O
% NN O
of IN O
the DT O
time NN O
, , O
but CC O
is VBZ O
probably RB O
located VBN O
between IN O
independent JJ O
sites NNS O
of IN O
mutation NN O
which WDT O
yield NN O
DMD NNP B-Disease
. . O

The DT O
breakpoints NNS O
of IN O
some DT O
deletions NNS O
are VBP O
delineated VBN O
within IN O
the DT O
DXS164 NNP O
locus NN O
, , O
and CC O
it PRP O
is VBZ O
evident JJ O
that IN O
the DT O
deletions NNS O
at IN O
the DT O
DMD NNP B-Disease
locus NN O
are VBP O
frequent JJ O
and CC O
extremely RB O
large JJ O
. . O
. . O

A DT O
potential JJ O
animal NN O
model NN O
for IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome VBP I-Disease
through IN O
introduction NN O
of IN O
HPRT NNP O
mutations NNS O
into IN O
mice NN O
. . O

The DT O
human JJ O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
rare JJ O
neurological JJ B-Disease
and CC I-Disease
behavioural JJ I-Disease
disorder NN I-Disease
, , O
affecting VBG O
only RB O
males NNS O
, , O
which WDT O
is VBZ O
caused VBN O
by IN O
an DT O
inherited JJ B-Disease
deficiency NN I-Disease
in IN O
the DT O
level NN O
of IN O
activity NN O
of IN O
the DT O
purine NN O
salvage NN O
enzyme FW O
hypoxanthine NN O
- : O
guanosine NN O
phosphoribosyl NN O
transferase NN O
( ( O
HPRT NNP O
) ) O
. . O

How WRB O
the DT O
resulting JJ O
alterations NNS O
in IN O
purine JJ O
metabolism NN O
lead NN O
to TO O
the DT O
severe JJ O
symptoms NNS O
characteristic JJ O
of IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NN I-Disease
patients NNS O
is VBZ O
still RB O
not RB O
understood JJ O
. . O

No DT O
mutations NNS O
at IN O
the DT O
Hprt NNP O
locus NN O
leading VBG O
to TO O
loss NN O
of IN O
activity NN O
have VBP O
been VBN O
described VBN O
in IN O
laboratory NN O
animals NNS O
. . O

To TO O
derive VB O
an DT O
animal JJ O
model NN O
for IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
, , O
we PRP O
have VBP O
used VBN O
cultured VBN O
mouse NN O
embryonic JJ O
stem NN O
cells NNS O
, , O
mutagenized VBN O
by IN O
retroviral JJ O
insertion NN O
and CC O
selected VBN O
for IN O
loss NN O
of IN O
HPRT NNP O
activity NN O
, , O
to TO O
construct VB O
chimaeric JJ O
mice NN O
. . O

Two CD O
clonal JJ O
lines NNS O
carrying VBG O
different JJ O
mutant JJ O
Hprt NNP O
alleles NNS O
have VBP O
given VBN O
rise NN O
to TO O
germ VB O
cells NNS O
in IN O
chimaeras NNS O
, , O
allowing VBG O
the DT O
derivation NN O
of IN O
strains NNS O
of IN O
mutant JJ O
mice NN O
having VBG O
the DT O
same JJ O
biochemical JJ O
defect NN O
as IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NN I-Disease
patients NNS O
. . O

Male JJ O
mice NN O
carrying VBG O
the DT O
mutant JJ O
alleles NNS O
are VBP O
viable JJ O
and CC O
analysis NN O
of IN O
their PRP$ O
cells NNS O
shows VBZ O
a DT O
total JJ O
lack NN O
of IN O
HPRT NNP O
activity NN O
. . O
. . O

Re NNP O
- : O
evaluation NN O
of IN O
the DT O
sublocalization NN O
of IN O
esterase NN O
D NNP O
and CC O
its PRP$ O
relation NN O
to TO O
the DT O
retinoblastoma NN B-Disease
locus NN O
by IN O
in IN O
situ JJ O
hybridization NN O
. . O

In IN O
situ JJ O
hybridization NN O
of IN O
a DT O
cDNA NN O
probe NN O
for IN O
the DT O
esterase NN O
D NNP O
gene NN O
( ( O
ESD NNP O
) ) O
was VBD O
carried VBN O
out RP O
on IN O
human JJ O
chromosomes NNS O
. . O

The DT O
probe NN O
hybridized VBD O
most RBS O
strongly RB O
to TO O
13q14 CD O
. . O

2 CD O
and CC O
13q14 CD O
. . O

3 CD O
. . O

This DT O
observation NN O
raises VBZ O
doubts NNS O
concerning VBG O
the DT O
most RBS O
recently RB O
published VBN O
assignment NN O
of IN O
ESD NNP O
to TO O
13q14 CD O
. . O

1 CD O
. . O

A DT O
deletion NN O
in IN O
an DT O
individual NN O
with IN O
retinoblastoma NN B-Disease
was VBD O
reported VBN O
to TO O
separate VB O
the DT O
closely RB O
linked VBN O
ESD NNP O
and CC O
retinoblastoma NN B-Disease
( ( O
RB1 NNP O
) ) O
loci NN O
, , O
placing VBG O
ESD NNP O
proximal NN O
to TO O
RB1 NNP O
. . O

Quantitative JJ O
in IN O
situ JJ O
hybridization NN O
studies NNS O
of IN O
this DT O
deletion NN O
do VBP O
not RB O
confirm VB O
this DT O
interpretation NN O
. . O

Rather RB O
, , O
they PRP O
suggest VBP O
that IN O
ESD NNP O
is VBZ O
missing VBG O
from IN O
the DT O
deleted JJ O
chromosome NN O
13 CD O
and CC O
duplicated VBN O
on IN O
the DT O
normal JJ O
homolog NN O
. . O

From IN O
these DT O
findings NNS O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
deletion NN O
in IN O
this DT O
individual JJ O
cannot NN O
be VB O
used VBN O
to TO O
determine VB O
the DT O
orientation NN O
nor CC O
the DT O
sublocalization NN O
of IN O
ESD NNP O
and CC O
RB1 NNP O
within IN O
the DT O
13q14 CD O
region NN O
. . O

Hereditary NNP B-Disease
C2 NNP I-Disease
deficiency NN I-Disease
associated VBN O
with IN O
common JJ O
variable JJ O
immunodeficiency NN B-Disease
. . O

Homozygous JJ O
C2 NNP B-Disease
deficiency NN I-Disease
in IN O
a DT O
19 CD O
- : O
year NN O
- : O
old JJ O
boy NN O
was VBD O
associated VBN O
with IN O
variable JJ O
immunodeficiency NN B-Disease
manifested VBN O
by IN O
marked JJ O
hypoimmunoglobulinemia NN B-Disease
and CC O
impaired JJ O
antibody NN O
responses NNS O
, , O
normal JJ O
circulating VBG O
B NNP O
lymphocytes NNS O
, , O
and CC O
subnormal JJ O
T NNP O
- : O
cell NN O
functions NNS O
. . O

Neither CC O
antilymphocytic JJ O
autoantibodies NNS O
nor CC O
chromosomal JJ B-Disease
abnormalities NNS I-Disease
were VBD O
found VBN O
. . O

Serum NNP O
immunoglobulin NN O
levels NNS O
were VBD O
within IN O
normal JJ O
limits NNS O
in IN O
his PRP$ O
parents NNS O
and CC O
brother NN O
who WP O
were VBD O
heterozygous JJ O
for IN O
C2 NNP B-Disease
deficiency NN I-Disease
. . O

The DT O
patients NNS O
lymphocytes NNS O
were VBD O
homozygous JJ O
at IN O
the DT O
HLA NNP O
- : O
D NNP O
locus NN O
but CC O
expressed VBD O
an DT O
antigen NN O
different JJ O
from IN O
DW2 NNP O
. . O
. . O

Mild NNP O
and CC O
severe JJ O
muscular JJ B-Disease
dystrophy NN I-Disease
associated VBN O
with IN O
deletions NNS O
in IN O
Xp21 NN O
of IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O

We PRP O
have VBP O
analysed VBN O
over IN O
300 CD O
patients NNS O
suffering VBG O
from IN O
Duchenne NNP B-Disease
or CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
or CC O
BMD NNP B-Disease
) ) O
. . O

Deletions NNS O
have VBP O
been VBN O
characterised VBN O
which WDT O
encompass NN O
either CC O
the DT O
pERT87 NN O
( ( O
DXS164 NNP O
) ) O
locus VBZ O
only RB O
, , O
the DT O
XJ1 NNP O
. . O

1 CD O
( ( O
DXS206 NNP O
) ) O
and CC O
HIP25 NNP O
loci VBZ O
only RB O
, , O
or CC O
all DT O
three CD O
loci NNS O
. . O

These DT O
loci NNS O
have VBP O
been VBN O
shown VBN O
to TO O
lie VB O
within IN O
the DT O
DMD NNP B-Disease
region NN O
covering VBG O
several JJ O
hundred CD O
kilobases NNS O
( ( O
kb NN O
) ) O
of IN O
DNA NN O
. . O

One CD O
mildly RB O
affected VBD O
BMD NNP B-Disease
patient NN O
possesses VBZ O
a DT O
deletion NN O
of IN O
at IN O
least JJS O
110 CD O
kb NNS O
including VBG O
exons NNS O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
. . O

Other JJ O
patients NNS O
with IN O
similar JJ O
exon NN O
deletions NNS O
, , O
or CC O
smaller JJR O
deletions NNS O
, , O
show VBP O
the DT O
more RBR O
severe JJ O
phenotype JJ O
typical NN O
of IN O
DMD NNP B-Disease
. . O

We PRP O
conclude VBP O
from IN O
these DT O
studies NNS O
that IN O
the DT O
severity NN O
of IN O
the DT O
clinical JJ O
phenotype NN O
cannot NN O
be VB O
explained VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
size NN O
of IN O
the DT O
deletion NN O
. . O

We PRP O
discuss VBP O
this DT O
in IN O
the DT O
context NN O
of IN O
candidate NN O
gene NN O
sequences NNS O
. . O

Patterns NNS O
of IN O
exon JJ O
deletions NNS O
in IN O
Duchenne NNP B-Disease
and CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

A DT O
panel NN O
of IN O
patients NNS O
with IN O
Duchenne NNP B-Disease
and CC I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
and CC O
BMD NNP B-Disease
) ) O
has VBZ O
been VBN O
screened VBN O
with IN O
the DT O
cDNA NN O
probes NNS O
Cf56a NNP O
and CC O
Cf23a NNP O
, , O
which WDT O
detect VBP O
exons NNS O
in IN O
the DT O
central JJ O
part NN O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
. . O

One CD O
or CC O
more JJR O
exons NNS O
were VBD O
deleted VBN O
in IN O
60 CD O
% NN O
of IN O
patients NNS O
. . O

The DT O
deletions NNS O
were VBD O
mapped VBN O
and CC O
prove VB O
to TO O
be VB O
heterogeneous JJ O
in IN O
size NN O
and CC O
extent NN O
, , O
particularly RB O
in IN O
DMD NNP B-Disease
. . O

Deletions NNS O
specific VBP O
to TO O
DMD NNP B-Disease
and CC O
to TO O
BMD NNP B-Disease
are VBP O
described VBN O
. . O

Half NN O
of IN O
all DT O
BMD NNP B-Disease
patients NNS O
have VBP O
a DT O
deletion NN O
of IN O
one CD O
particular JJ O
small JJ O
group NN O
of IN O
exons NNS O
; : O
smaller JJR O
deletions NNS O
within IN O
this DT O
same JJ O
group NN O
produce VBD O
the DT O
more RBR O
severe JJ O
DMD NNP B-Disease
. . O
. . O

Hereditary JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
third JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
a DT O
child NN O
with IN O
fever NN B-Disease
, , O
skin JJ B-Disease
rash NN I-Disease
, , O
and CC O
arthralgias NNS B-Disease
: : O
response NN O
to TO O
transfusion NN O
of IN O
whole JJ O
blood NN O
. . O

A DT O
previously RB O
well RB O
34 CD O
- : O
month NN O
- : O
old JJ O
male JJ O
presenting NN O
with IN O
fever NN B-Disease
, , O
skin JJ B-Disease
rash NN I-Disease
, , O
and CC O
arthralgias NN B-Disease
was VBD O
found VBN O
to TO O
lack VB O
C3 NNP O
by IN O
immunochemical JJ O
( ( O
undetectable JJ O
) ) O
and CC O
hemolytic JJ O
( ( O
1 CD O
% NN O
normal JJ O
) ) O
assays NNS O
. . O

No DT O
infectious JJ O
agent NN O
could MD O
be VB O
demonstrated VBN O
. . O

Protein NNP O
levels NNS O
of IN O
Clq NNP O
. . O

C4 NNP O
, , O
C5 NNP O
, , O
properdin NN O
, , O
and CC O
C3b NNP O
- : O
INA NN O
and CC O
hemolytic JJ O
activities NNS O
of IN O
complement NN O
components NNS O
C1 NNP O
to TO O
C9 NNP O
except IN O
C3 NNP O
were VBD O
normal JJ O
or CC O
elevated VBN O
; : O
total JJ O
hemolytic JJ O
complement NN O
activity NN O
was VBD O
13 CD O
% NN O
of IN O
normal JJ O
and CC O
was VBD O
reconstituted VBN O
by IN O
purified JJ O
C3 NNP O
. . O

Properdin NNP O
factor NN O
B NNP O
was VBD O
702 CD O
( ( O
normal JJ O
175 CD O
to TO O
275 CD O
) ) O
mug NN O
/ NNP O
ml NN O
, , O
and CC O
was VBD O
not RB O
cleaver JJ O
upon IN O
addition NN O
of IN O
zymosan NN O
or CC O
cobra NN O
venom JJ O
factor NN O
. . O

The DT O
serum NN O
had VBD O
normal JJ O
immune JJ O
adherence NN O
activity NN O
, , O
but CC O
was VBD O
deficient NN O
in IN O
ability NN O
to TO O
opsonize VB O
Candida NNP O
albicans NNS O
for IN O
uptake NN O
and CC O
Escherichia NNP O
coli VBP O
for IN O
killing VBG O
by IN O
neurophils NNS O
, , O
generate NN O
neutrophil JJ O
chemotactic JJ O
factors NNS O
and CC O
inhibit VB O
the DT O
growth NN O
of IN O
E NNP O
. . O
coli NN O
; : O
these DT O
activities NNS O
were VBD O
restored VBN O
by IN O
purified JJ O
C3 NNP O
. . O

A DT O
transfusion NN O
of IN O
320 CD O
ml NNS O
1 CD O
- : O
hour NN O
- : O
old JJ O
normal JJ O
whole JJ O
blood NN O
on IN O
the DT O
fifty JJ O
- : O
second JJ O
day NN O
resulted VBD O
in IN O
transitory JJ O
elevation NN O
of IN O
the DT O
C3 NNP O
level NN O
to TO O
25 CD O
mg NNS O
/ JJ O
dl NN O
with IN O
a DT O
fall NN O
- : O
off NN O
( ( O
approximately RB O
2 CD O
1 CD O
/ JJ O
2 CD O
% NN O
per IN O
hour NN O
) ) O
to TO O
undetectable JJ O
levels NNS O
by IN O
69 CD O
hours NNS O
; : O
it PRP O
was VBD O
followed VBN O
by IN O
disappearance NN O
of IN O
the DT O
skin NN B-Disease
rash NN I-Disease
and CC O
arthralgias NN B-Disease
and CC O
return NN O
to TO O
normal JJ O
of IN O
the DT O
previously RB O
elevated VBN O
temperature NN O
and CC O
CRP NNP O
levels NNS O
. . O

C3 NNP O
levels NNS O
in IN O
family NN O
members NNS O
( ( O
seven CD O
of IN O
24 CD O
half JJ O
- : O
normal JJ O
) ) O
, , O
lack NN O
of IN O
anti JJ O
- : O
C3 NN O
activity NN O
, , O
normal JJ O
C3b NNP O
- : O
INA NN O
levels NNS O
and CC O
a DT O
normal JJ O
rate NN O
of IN O
catabolism NN O
of IN O
transfused JJ O
C3 NNP O
indicated VBD O
that IN O
the DT O
deficiency NN O
was VBD O
inherited VBN O
with IN O
autosomal JJ O
codominance NN O
and CC O
involved VBN O
decreased JJ B-Disease
synthesis NN I-Disease
of IN I-Disease
C3 NNP I-Disease
. . O

Thus RB O
, , O
this DT O
child NN O
is VBZ O
a DT O
unique JJ O
individual NN O
with IN O
inherited JJ B-Disease
C3 NNP I-Disease
deficiency NN I-Disease
presenting VBG O
with IN O
absence NN O
of IN O
repeated JJ O
infections NNS O
, , O
whose WP$ O
symptoms NNS O
of IN O
fever NN B-Disease
, , O
skin JJ B-Disease
rash NN I-Disease
, , O
and CC O
arthralgia NNS B-Disease
were VBD O
abated VBN O
by IN O
whole JJ O
blood NN O
transfusion NN O
. . O
. . O

Glucose NNP O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variants NNS O
and CC O
their PRP$ O
frequency NN O
in IN O
Guangdong NNP O
, , O
China NNP O
. . O

Erythrocyte NNP O
glucose VBD O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
was VBD O
characterized VBN O
in IN O
blood NN O
samples NNS O
obtained VBD O
from IN O
97 CD O
randomly RB O
selected VBN O
males NNS O
with IN O
enzyme JJ B-Disease
deficiency NN I-Disease
from IN O
various JJ O
regions NNS O
of IN O
Guangdong NNP O
Province NNP O
, , O
China NNP O
. . O

Nine NNP O
new JJ O
variants NNS O
( ( O
Gd NNP O
Kaiping NNP O
, , O
Gd NNP O
Boluo NNP O
, , O
Gd NNP O
Huiyang NNP O
, , O
Gd NNP O
Gaomin NNP O
, , O
Gd NNP O
Qing NNP O
- : O
Baijiang NNP O
, , O
Gd NNP O
Gaozhou NNP O
, , O
Gd NNP O
Huazhou NNP O
, , O
Gd NNP O
Nanhai NNP O
, , O
and CC O
Gd NNP O
Guangzhou NNP O
) ) O
were VBD O
identified VBN O
. . O

Of IN O
the DT O
31 CD O
variants NNS O
found VBN O
in IN O
this DT O
province NN O
, , O
Gd NNP O
Kaiping NNP O
, , O
Gd NNP O
Taiwan NNP O
- : O
Hakka NNP O
, , O
Gd NNP O
Haad NNP O
Yai NNP O
, , O
Gd NNP O
Haad NNP O
Yai NNP O
- : O
like IN O
and CC O
Gd NNP O
Huiyang NNP O
occurred VBD O
most JJS O
frequently RB O
. . O

The DT O
frequency NN O
of IN O
each DT O
variant NN O
was VBD O
calculated VBN O
. . O

The DT O
results NNS O
demonstrated VBD O
that IN O
the DT O
genetic JJ O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
was VBD O
high JJ O
in IN O
this DT O
area NN O
. . O
. . O

Homozygous JJ O
and CC O
heterozygous JJ O
deletions NNS O
of IN O
the DT O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
gene NN O
in IN O
patients NNS O
and CC O
carriers NNS O
of IN O
severe JJ B-Disease
von NN I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
. . O

Severe NNP B-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
is VBZ O
characterized VBN O
by IN O
undetectable JJ O
or CC O
trace JJ O
quantities NNS O
of IN O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
in IN O
plasma NN O
and CC O
tissue NN O
stores NNS O
. . O

We PRP O
have VBP O
studied VBN O
the DT O
genomic JJ O
DNA NN O
of IN O
10 CD O
affected JJ O
individuals NNS O
from IN O
six CD O
families NNS O
with IN O
this DT O
disorder NN O
using VBG O
probes NNS O
from IN O
the DT O
5 CD O
and CC O
3 CD O
ends NNS O
of IN O
the DT O
vWF NN O
cDNA NN O
and CC O
with IN O
a DT O
probe NN O
extending VBG O
from IN O
the DT O
5 CD O
end NN O
into IN O
the DT O
central JJ O
region NN O
. . O

Southern JJ O
blots NNS O
of IN O
restriction NN O
endonuclease NN O
digests NNS O
and CC O
gene NN O
dosage NN O
analysis NN O
measurements NNS O
carried VBD O
out RP O
with IN O
quantitative JJ O
slot NN O
blots NNS O
of IN O
undigested JJ O
genomic JJ O
DNA NN O
separated VBN O
these DT O
patients NNS O
into IN O
three CD O
groups NNS O
. . O

The DT O
first JJ O
group NN O
consisted VBD O
of IN O
a DT O
family NN O
with IN O
complete JJ O
homozygous JJ O
deletions NNS O
of IN O
the DT O
vWF JJ O
gene NN O
in IN O
the DT O
four CD O
probands NNS O
. . O

Gene NNP O
dosage NN O
analysis NN O
was VBD O
consistent JJ O
with IN O
heterozygous JJ O
deletions NNS O
in IN O
both DT O
of IN O
the DT O
asymptomatic JJ O
parents NNS O
and CC O
four CD O
asymptomatic JJ O
siblings NNS O
of IN O
this DT O
kindred VBN O
( ( O
P NNP O
less JJR O
than IN O
0 CD O
. . O
1 CD O
) ) O
. . O

The DT O
second JJ O
group NN O
was VBD O
comprised VBN O
of IN O
a DT O
family NN O
in IN O
which WDT O
there EX O
was VBD O
a DT O
complete JJ O
heterozygous JJ O
deletion NN O
of IN O
the DT O
vWF JJ O
gene NN O
in IN O
the DT O
proband NN O
and CC O
one CD O
asymptomatic JJ O
parent NN O
, , O
suggesting VBG O
that IN O
a DT O
different JJ O
type NN O
of IN O
genetic JJ B-Disease
abnormality NN I-Disease
was VBD O
inherited VBN O
from IN O
the DT O
other JJ O
parent NN O
. . O

Thus RB O
, , O
the DT O
patient NN O
appeared VBD O
to TO O
be VB O
doubly RB O
heterozygous JJ O
for IN O
interacting VBG O
genetic JJ B-Disease
abnormalities NNS I-Disease
affecting VBG O
vWF JJ O
expression NN O
. . O

In IN O
the DT O
third JJ O
group NN O
, , O
no DT O
gene NN O
deletions NNS O
could MD O
be VB O
detected VBN O
. . O

Alloantibodies NNS O
developed VBD O
only RB O
in IN O
the DT O
kindred VBN O
with IN O
homozygous JJ O
deletions NNS O
. . O

These DT O
techniques NNS O
should MD O
prove VB O
useful JJ O
in IN O
identifying VBG O
carriers NNS O
of IN O
severe JJ B-Disease
von NN I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
and CC O
also RB O
in IN O
defining VBG O
patients NNS O
predictably RB O
at IN O
risk NN O
of IN O
developing VBG O
alloantibodies NNS O
to TO O
vWF VB O
. . O

Sjogren NNP B-Disease
- : I-Disease
Larsson NNP I-Disease
syndrome NN I-Disease
. . O

Impaired NNP O
fatty JJ O
alcohol NN O
oxidation NN O
in IN O
cultured JJ O
fibroblasts NNS O
due JJ O
to TO O
deficient VB O
fatty JJ O
alcohol NN O
: : O
nicotinamide JJ O
adenine NN O
dinucleotide JJ O
oxidoreductase NN O
activity NN O
. . O

Lipid JJ O
metabolism NN O
was VBD O
studied VBN O
in IN O
cultured JJ O
skin NN O
fibroblasts NNS O
from IN O
patients NNS O
with IN O
the DT O
inherited JJ B-Disease
disorder NN I-Disease
, , O
Sjogren NNP B-Disease
- : I-Disease
Larsson NNP I-Disease
syndrome NN I-Disease
( ( O
SLS NNP B-Disease
) ) O
. . O

Intact JJ O
SLS NNP B-Disease
fibroblasts NNS O
incubated VBD O
in IN O
the DT O
presence NN O
of IN O
[ $ O
1 CD O
- : O
14C CD O
] JJ O
palmitate NN O
accumulated VBD O
more RBR O
radioactive JJ O
hexadecanol NN O
than IN O
did VBD O
normal JJ O
cells NNS O
, , O
whereas JJ O
incorporation NN O
of IN O
radioactivity NN O
into IN O
other JJ O
cellular JJ O
lipids NNS O
was VBD O
unaltered JJ O
. . O

The DT O
hexadecanol NN O
content NN O
of IN O
SLS NNP B-Disease
fibroblasts NNS O
was VBD O
abnormally RB O
elevated VBN O
. . O

Hexadecanol NNP O
accumulation NN O
was VBD O
not RB O
due JJ O
to TO O
increased VBN O
fatty RB O
alcohol JJ O
synthesis NN O
nor CC O
its PRP$ O
deficient NN O
utilization NN O
for IN O
glycerol NN O
ether CC O
synthesis NN O
. . O

The DT O
half NN O
- : O
life NN O
of IN O
intracellular JJ O
hexadecanol NN O
loaded VBD O
into IN O
SLS NNP B-Disease
fibroblasts NNS O
was VBD O
increased VBN O
( ( O
70 CD O
min NN O
) ) O
compared VBN O
with IN O
normal JJ O
( ( O
15 CD O
min NN O
) ) O
, , O
and CC O
intact JJ O
SLS NNP B-Disease
fibroblasts NNS O
showed VBD O
impaired JJ O
oxidation NN O
of IN O
[ $ O
14C CD O
] NNP O
- : O
hexadecanol NN O
to TO O
fatty VB O
acid NN O
. . O

Fatty NNP O
alcohol NN O
NAD NNP O
+ NNP O
oxidoreductase NN O
, , O
the DT O
enzyme NN O
catalyzing VBG O
this DT O
reaction NN O
, , O
was VBD O
deficient NN O
in IN O
SLS NNP B-Disease
fibroblasts NNS O
. . O

Mean JJ O
total JJ O
activity NN O
in IN O
SLS NNP B-Disease
fibroblasts NNS O
( ( O
n JJ O
= NNP O
5 CD O
) ) O
was VBD O
13 CD O
% NN O
of IN O
that DT O
in IN O
normal JJ O
fibroblasts NNS O
, , O
and CC O
palmitoyl NN O
CoA NNP O
- : O
inhibitable JJ O
activity NN O
was VBD O
1 CD O
% NN O
of IN O
normal JJ O
. . O

Fibroblasts NNS O
from IN O
two CD O
obligate JJ O
SLS NNP B-Disease
heterozygotes NNS O
had VBD O
enzyme JJ O
activities NNS O
intermediate VBP O
between IN O
that DT O
in IN O
normal JJ O
fibroblasts NNS O
and CC O
individuals NNS O
with IN O
SLS NNP B-Disease
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
primary JJ O
defect NN O
in IN O
SLS NNP B-Disease
is VBZ O
deficiency NN B-Disease
of IN I-Disease
fatty JJ I-Disease
alcohol NN I-Disease
NAD NNP I-Disease
+ NNP I-Disease
oxidoreductase NN I-Disease
. . O

SLS NNP B-Disease
represents VBZ O
the DT O
first JJ O
inherited JJ B-Disease
disorder NN I-Disease
in IN O
man NN O
associated VBN O
with IN O
an DT O
isolated JJ O
abnormality NN B-Disease
in IN I-Disease
fatty JJ I-Disease
alcohol NN I-Disease
metabolism NN I-Disease
. . O
. . O

Germinal JJ O
mosaicism NN O
in IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

We PRP O
have VBP O
identified VBN O
a DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
pedigree VBP O
where WRB O
the DT O
disease NN O
is VBZ O
associated VBN O
with IN O
a DT O
molecular JJ O
deletion NN O
within IN O
the DT O
DMD NNP B-Disease
locus NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
meiotic JJ O
segregation NN O
products NNS O
of IN O
the DT O
common JJ O
female NN O
ancestor NN O
using VBG O
marker JJR O
restriction NN O
fragment NN O
length NN O
polymorphisms NN O
( ( O
RFLPs NNP O
) ) O
detected VBN O
by IN O
probes NNS O
that WDT O
lie VBP O
within IN O
this DT O
deletion NN O
. . O

These DT O
studies NNS O
show VBP O
that IN O
this DT O
female NN O
has VBZ O
transmitted VBN O
three CD O
distinct JJ O
types NNS O
of IN O
X NNP O
chromosome NN O
to TO O
her PRP$ O
offspring NN O
. . O

This DT O
observation NN O
may MD O
be VB O
explained VBN O
by IN O
postulating VBG O
that IN O
the DT O
mutation NN O
arose VBD O
as IN O
a DT O
postzygotic JJ O
deletion NN O
within IN O
this DT O
common JJ O
ancestor NN O
, , O
who WP O
was VBD O
consequently RB O
germinally RB O
mosaic JJ O
. . O
. . O

Nebulin NNP O
seen VBN O
in IN O
DMD NNP B-Disease
males NNS O
including VBG O
one CD O
patient NN O
with IN O
a DT O
large JJ O
DNA NNP O
deletion NN O
encompassing VBG O
the DT O
DMD NNP B-Disease
gene NN O
. . O

The DT O
presence NN O
of IN O
nebulin NN O
in IN O
a DT O
muscle NN O
specimen NNS O
from IN O
a DT O
patient NN O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
due JJ O
to TO O
a DT O
large JJ O
deletion NN O
precludes VBZ O
the DT O
possibility NN O
that IN O
this DT O
protein NN O
is VBZ O
the DT O
DMD NNP B-Disease
gene NN O
product NN O
. . O
. . O

Expression NN O
of IN O
the DT O
murine NN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
in IN O
muscle NN O
and CC O
brain NN O
. . O

Complementary JJ O
DNA NNP O
clones NNS O
were VBD O
isolated VBN O
that IN O
represent VBP O
the DT O
5 CD O
terminal JJ O
2 CD O
. . O

5 CD O
kilobases NNS O
of IN O
the DT O
murine NN O
Duchenne NNP B-Disease
muscular NN I-Disease
dystrophy NN I-Disease
( ( O
Dmd NNP O
) ) O
messenger NN O
RNA NNP O
( ( O
mRNA NN O
) ) O
. . O

Mouse NNP O
Dmd NNP O
mRNA NN O
was VBD O
detectable JJ O
in IN O
skeletal JJ O
and CC O
cardiac JJ O
muscle NN O
and CC O
at IN O
a DT O
level NN O
approximately RB O
90 CD O
percent NN O
lower JJR O
in IN O
brain NN O
. . O

Dmd NNP O
mRNA NN O
is VBZ O
also RB O
present JJ O
, , O
but CC O
at IN O
much RB O
lower JJR O
than IN O
normal JJ O
levels NNS O
, , O
in IN O
both DT O
the DT O
muscle NN O
and CC O
brain NN O
of IN O
three CD O
different JJ O
strains NNS O
of IN O
dystrophic JJ B-Disease
mdx NN O
mice NN O
. . O

The DT O
identification NN O
of IN O
Dmd NNP O
mRNA NN O
in IN O
brain NN O
raises VBZ O
the DT O
possibility NN O
of IN O
a DT O
relation NN O
between IN O
human JJ O
Duchenne NNP B-Disease
muscular NN I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
expression NN O
and CC O
the DT O
mental JJ B-Disease
retardation NN I-Disease
found VBN O
in IN O
some DT O
DMD NNP B-Disease
males NNS O
. . O

These DT O
results NNS O
also RB O
provide VBP O
evidence NN O
that IN O
the DT O
mdx NN O
mutations NNS O
are VBP O
allelic JJ O
variants NNS O
of IN O
mouse NN O
Dmd NNP O
gene NN O
mutations NNS O
. . O

Glucose NNP B-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
and CC O
incidence NN O
of IN O
hematologic JJ B-Disease
malignancy NN I-Disease
. . O

We PRP O
have VBP O
evaluated VBN O
the DT O
hypothesis NN O
of IN O
a DT O
negative JJ O
association NN O
between IN O
glucose $ B-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
and CC O
cancer NN B-Disease
in IN O
a DT O
cohort NN O
of IN O
481 CD O
Sardinian JJ O
males NNS O
with IN O
hematological JJ B-Disease
malignancies NNS I-Disease
. . O

The DT O
frequency NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
the DT O
patients NNS O
was VBD O
not RB O
different JJ O
from IN O
the DT O
incidence NN O
in IN O
a DT O
group NN O
of IN O
16 CD O
, , O
219 CD O
controls NNS O
. . O

The DT O
same JJ O
conclusion NN O
resulted VBD O
from IN O
the DT O
comparison NN O
of IN O
the DT O
frequency NN O
of IN O
expression NN O
of IN O
the DT O
GdB NNP O
gene NN O
in IN O
23 CD O
heterozygous JJ O
women NNS O
having VBG O
a DT O
clonal JJ O
hematologic NN B-Disease
disease NN I-Disease
and CC O
a DT O
control NN O
group NN O
of IN O
37 CD O
healthy JJ O
heterozygotes NNS O
. . O

Therefore RB O
at IN O
present JJ O
there EX O
is VBZ O
no DT O
evidence NN O
that IN O
G6PD NNP B-Disease
deficiency NN I-Disease
has VBZ O
a DT O
protective JJ O
effect NN O
against IN O
development NN O
of IN O
hematologic JJ B-Disease
neoplasms NNS I-Disease
. . O
. . O

Hepatoblastoma NNP B-Disease
, , O
pigmented VBD B-Disease
ocular JJ I-Disease
fundus NN I-Disease
lesions NNS I-Disease
and CC O
jaw NN B-Disease
lesions NNS I-Disease
in IN O
Gardner NNP B-Disease
syndrome NN I-Disease
. . O

Hepatoblastoma NNP B-Disease
is VBZ O
a DT O
rare JJ O
neoplasm NN B-Disease
of IN O
infants NNS O
and CC O
children NNS O
only RB O
recently RB O
documented VBN O
in IN O
association NN O
with IN O
hereditary JJ B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
of IN I-Disease
the DT I-Disease
colon NN I-Disease
[ NNP O
Kingston NNP O
et VBZ O
al NN O
. . O
, , O
1983 CD O
] NN O
. . O

We PRP O
report VBP O
four CD O
children NNS O
with IN O
hepatoblastoma NN B-Disease
from IN O
four CD O
unrelated JJ O
families NNS O
with IN O
Gardner NNP B-Disease
syndrome NN I-Disease
( ( O
GS NNP B-Disease
) ) O
. . O

One CD O
child NN O
, , O
now RB O
19 CD O
years NNS O
old JJ O
, , O
survived VBD O
after IN O
a DT O
resection NN O
of IN O
a DT O
hepatoblastoma NN B-Disease
in IN O
infancy NN O
and CC O
recently RB O
was VBD O
found VBN O
to TO O
have VB O
GS NNP B-Disease
. . O

He PRP O
has VBZ O
an DT O
associated VBN O
odontoma NN B-Disease
and CC O
pigmented VBD B-Disease
ocular JJ I-Disease
fundus NN I-Disease
lesions NNS I-Disease
, , O
both DT O
of IN O
which WDT O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
clinical JJ O
markers NNS O
of IN O
GS NNP B-Disease
. . O

Many JJ O
individuals NNS O
in IN O
these DT O
four CD O
GS NNP B-Disease
families NNS O
, , O
both DT O
affected JJ O
and CC O
at IN O
risk NN O
, , O
have VBP O
osteomatous JJ B-Disease
jaw NN I-Disease
lesions NNS I-Disease
and CC O
pigmented VBD B-Disease
ocular JJ I-Disease
fundus NN I-Disease
lesions NNS I-Disease
. . O

A DT O
search NN O
for IN O
colonic JJ B-Disease
polyps NNS I-Disease
should MD O
be VB O
made VBN O
in IN O
families NNS O
of IN O
infants NNS O
and CC O
children NNS O
with IN O
hepatoblastoma NN B-Disease
. . O

If IN O
the DT O
child NN O
survives VBZ O
, , O
he PRP O
or CC O
she PRP O
should MD O
be VB O
monitored VBN O
for IN O
the DT O
later JJ O
appearance NN O
of IN O
colonic JJ B-Disease
polyps NNS I-Disease
. . O

The DT O
finding NN O
of IN O
jaw NN B-Disease
lesions NNS I-Disease
and CC O
/ NN O
or CC O
pigmented VBN B-Disease
ocular JJ I-Disease
fundus NN I-Disease
lesions NNS I-Disease
in IN O
relatives NNS O
at IN O
risk NN O
are VBP O
indications NNS O
of IN O
the DT O
possible JJ O
presence NN O
of IN O
the DT O
GS NNP B-Disease
gene NN O
. . O

Identification NN O
of IN O
an DT O
altered JJ O
splice NN O
site NN O
in IN O
Ashkenazi NNP O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
. . O

Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
resulting VBG O
from IN O
mutation NN O
of IN O
the DT O
HEXA NNP O
gene NN O
encoding VBG O
the DT O
alpha NN O
- : O
subunit NN O
of IN O
the DT O
lysosomal JJ O
enzyme NN O
, , O
beta SYM O
- : O
N NNP O
- : O
acetylhexosaminidase NN O
A NNP O
( ( O
ref NN O
. . O
1 CD O
) ) O
. . O

A DT O
relatively RB O
high JJ O
frequency NN O
of IN O
carriers NNS O
( ( O
1 CD O
/ RB O
27 CD O
) ) O
of IN O
a DT O
lethal NN O
, , O
infantile JJ O
form NN O
of IN O
the DT O
disease NN O
is VBZ O
found VBN O
in IN O
the DT O
Ashkenazi NNP O
Jewish NNP O
population NN O
, , O
but CC O
it PRP O
is VBZ O
not RB O
yet RB O
evident JJ O
whether IN O
this DT O
has VBZ O
resulted VBN O
from IN O
a DT O
founder NN O
effect NN O
and CC O
random VB O
genetic JJ O
drift NN O
or CC O
from IN O
a DT O
selective JJ O
advantage NN O
of IN O
heterozygotes NNS O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
single JJ O
- : O
base NN O
mutation NN O
in IN O
a DT O
cloned JJ O
fragment NN O
of IN O
the DT O
HEXA NNP O
gene NN O
from IN O
an DT O
Ashkenazi NNP O
Jewish NNP O
patient NN O
. . O

This DT O
change NN O
, , O
the DT O
substitution NN O
of IN O
a DT O
C NNP O
for IN O
G NNP O
in IN O
the DT O
first JJ O
nucleotide NN O
of IN O
intron NN O
12 CD O
is VBZ O
expected VBN O
to TO O
result VB O
in IN O
defective JJ O
splicing NN O
of IN O
the DT O
messenger NN O
RNA NNP O
. . O

A DT O
test NN O
for IN O
the DT O
mutant NN O
allele NN O
based VBN O
on IN O
amplification NN O
of IN O
DNA NN O
by IN O
the DT O
polymerase NN O
chain NN O
rection NN O
and CC O
cleavage NN O
of IN O
a DT O
DdeI NNP O
restriction NN O
site NN O
generated VBN O
by IN O
the DT O
mutation NN O
revealed VBD O
that IN O
this DT O
case NN O
and CC O
two CD O
other JJ O
cases NNS O
of IN O
the DT O
Ashkenazi NNP O
, , O
infantile JJ O
form NN O
of IN O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
are VBP O
heterozygous JJ O
for IN O
two CD O
different JJ O
mutations NNS O
. . O

The DT O
occurrence NN O
of IN O
multiple JJ O
mutant JJ O
alleles NNS O
warrants NNS O
further JJ O
examination NN O
of IN O
the DT O
selective JJ O
advantage NN O
hypothesis NN O
. . O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
glucose JJ I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
Mus NNP O
musculus NN O
. . O

A DT O
mouse NN O
with IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
glucose JJ I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
has VBZ O
been VBN O
recovered VBN O
in IN O
offspring VBG O
of IN O
1 CD O
- : O
ethyl NN O
- : O
1 CD O
- : O
nitrosourea JJ O
- : O
treated VBN O
male JJ O
mice NN O
. . O

The DT O
activity NN O
alteration NN O
was VBD O
detected VBN O
in IN O
blood NN O
but CC O
can MD O
also RB O
be VB O
observed VBN O
in IN O
other JJ O
tissue NN O
extracts NNS O
. . O

Hemizygous NNP O
, , O
heterozygous JJ O
, , O
and CC O
homozygous JJ O
mutants NNS O
have VBP O
, , O
respectively RB O
, , O
about IN O
15 CD O
, , O
60 CD O
, , O
and CC O
15 CD O
% NN O
G6PD NNP O
remaining VBG O
activity NN O
in IN O
the DT O
blood NN O
as IN O
compared VBN O
to TO O
the DT O
wild JJ O
type NN O
. . O

Erythrocyte NNP O
indices NNS O
did VBD O
not RB O
show VB O
differences NNS O
between IN O
mutants NNS O
and CC O
wild JJ O
types NNS O
. . O

The DT O
mutation NN O
does VBZ O
not RB O
affect VB O
the DT O
electrophoretic JJ O
migration NN O
, , O
the DT O
isoelectric JJ O
point NN O
, , O
or CC O
the DT O
thermal JJ O
stability NN O
. . O

Kinetic NNP O
properties NNS O
, , O
such JJ O
as IN O
the DT O
Km NNP O
for IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
or CC O
for IN O
NADP NNP O
and CC O
the DT O
relative JJ O
utilization NN O
of IN O
substrate NN O
analogues NNS O
, , O
showed VBD O
no DT O
differences NNS O
between IN O
wild JJ O
types NNS O
and CC O
mutants NNS O
with IN O
the DT O
exception NN O
of IN O
the DT O
relative JJ O
utilization NN O
of IN O
deamino NN O
- : O
NADP NNP O
which WDT O
was VBD O
significantly RB O
lower JJR O
in IN O
mutants NNS O
. . O

This DT O
is VBZ O
presently RB O
the DT O
only JJ O
animal JJ O
model NN O
for IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
G6PD NNP I-Disease
deficiency NN I-Disease
in IN O
humans NNS O
. . O
. . O

Diverse NNP O
point NN O
mutations NNS O
in IN O
the DT O
human JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
gene NN O
cause NN O
enzyme JJ B-Disease
deficiency NN I-Disease
and CC O
mild NN O
or CC O
severe JJ O
hemolytic JJ B-Disease
anemia NN I-Disease
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
; : I-Disease
EC NNP I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
49 CD I-Disease
) ) I-Disease
deficiency NN I-Disease
is VBZ O
a DT O
common JJ O
genetic JJ B-Disease
abnormality NN I-Disease
affecting VBG O
an DT O
estimated VBN O
400 CD O
million CD O
people NNS O
worldwide VBP O
. . O

Clinical JJ O
and CC O
biochemical JJ O
analyses NNS O
have VBP O
identified VBN O
many JJ O
variants NNS O
exhibiting VBG O
a DT O
range NN O
of IN O
phenotypes NNS O
, , O
which WDT O
have VBP O
been VBN O
well RB O
characterized VBN O
from IN O
the DT O
hematological JJ O
point NN O
of IN O
view NN O
. . O

However RB O
, , O
until IN O
now RB O
, , O
their PRP$ O
precise JJ O
molecular JJ O
basis NN O
has VBZ O
remained VBN O
unknown JJ O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
seven CD O
mutant JJ O
G6PD NNP O
alleles NNS O
. . O

In IN O
the DT O
nondeficient JJ O
polymorphic JJ O
African NNP O
variant NN O
G6PD NNP O
A NNP O
we PRP O
have VBP O
found VBN O
a DT O
single JJ O
point NN O
mutation NN O
. . O

The DT O
other JJ O
six CD O
mutants NNS O
investigated VBN O
were VBD O
all DT O
associated VBN O
with IN O
enzyme JJ B-Disease
deficiency NN I-Disease
. . O

In IN O
one CD O
of IN O
the DT O
commonest JJS O
, , O
G6PD NNP O
Mediterranean NNP O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
favism NN B-Disease
among IN O
other JJ O
clinical JJ O
manifestations NNS O
, , O
a DT O
single JJ O
amino NN O
acid JJ O
replacement NN O
was VBD O
found VBN O
( ( O
serine JJ O
- : O
- : O
- : O
- : O
phenylalanine NN O
) ) O
it PRP O
must MD O
be VB O
responsible JJ O
for IN O
the DT O
decreased JJ O
stability NN O
and CC O
the DT O
reduced VBN O
catalytic JJ O
efficiency NN O
of IN O
this DT O
enzyme NN O
. . O

Single NNP O
point NN O
mutations NNS O
were VBD O
also RB O
found VBN O
in IN O
G6PD NNP O
Metaponto NNP O
( ( O
Southern NNP O
Italy NNP O
) ) O
and CC O
in IN O
G6PD NNP O
Ilesha NNP O
( ( O
Nigeria NNP O
) ) O
, , O
which WDT O
are VBP O
asymptomatic JJ O
, , O
and CC O
in IN O
G6PD NNP O
Chatham NNP O
, , O
which WDT O
was VBD O
observed VBN O
in IN O
an DT O
Indian JJ O
boy NN O
with IN O
neonatal JJ B-Disease
jaundice NN I-Disease
. . O

In IN O
G6PD NNP O
"""" NNP O
Matera NNP O
, , O
"""" NNP O
which WDT O
is VBZ O
now RB O
known VBN O
to TO O
be VB O
the DT O
same JJ O
as IN O
G6PD NNP O
A NNP O
- : O
, , O
two CD O
separate JJ O
point NN O
mutations NNS O
were VBD O
found VBN O
, , O
one CD O
of IN O
which WDT O
is VBZ O
the DT O
same JJ O
as IN O
in IN O
G6PD NNP O
A NNP O
. . O

In IN O
G6PD NNP O
Santiago NNP O
, , O
a DT O
de FW O
novo FW O
mutation NN O
( ( O
glycine JJ O
- : O
- : O
- : O
- : O
arginine NN O
) ) O
is VBZ O
associated VBN O
with IN O
severe JJ O
chronic JJ O
hemolytic JJ B-Disease
anemia NN I-Disease
. . O

The DT O
mutations NNS O
observed VBD O
show VBP O
a DT O
striking JJ O
predominance NN O
of IN O
C NNP O
- : O
- : O
- : O
- : O
T NN O
transitions NNS O
, , O
with IN O
CG NNP O
doublets NNS O
involved VBN O
in IN O
four CD O
of IN O
seven CD O
cases NNS O
. . O

Thus RB O
, , O
diverse JJ O
point NN O
mutations NNS O
may MD O
account VB O
largely RB O
for IN O
the DT O
phenotypic NN O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O

Tight JJ O
linkage NN O
between IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
and CC O
apolipoprotein NN O
E NNP O
genes NNS O
revealed VBD O
with IN O
allele JJ O
- : O
specific JJ O
oligonucleotides NNS O
. . O

In IN O
16 CD O
families NNS O
with IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
a DT O
novel JJ O
approach NN O
based VBN O
on IN O
use NN O
of IN O
allele JJ O
- : O
specific JJ O
oligonucleotides NNS O
has VBZ O
been VBN O
employed VBN O
to TO O
study VB O
the DT O
linkage NN O
relationship NN O
between IN O
the DT O
apolipoprotein NN O
E NNP O
( ( O
APOE NNP O
) ) O
gene NN O
and CC O
DM NNP B-Disease
. . O

Synthetic JJ O
oligonucleotides NNS O
, , O
designed VBN O
to TO O
discriminate VB O
between IN O
APOE NNP O
alleles VBZ O
epsilon RB O
3 CD O
and CC O
epsilon $ O
4 CD O
, , O
enabled VBD O
us PRP O
to TO O
distinguish VB O
heterozygous JJ O
carriers NNS O
in IN O
a DT O
hybridization NN O
assay NN O
. . O

In IN O
a DT O
subset NN O
of IN O
families NNS O
, , O
the DT O
relevant JJ O
segment NN O
of IN O
the DT O
APOE NNP O
gene NN O
was VBD O
enzymatically RB O
amplified VBN O
to TO O
increase VB O
the DT O
sensitivity NN O
of IN O
the DT O
method NN O
. . O

For IN O
DM NNP O
and CC O
APOE NNP O
, , O
a DT O
maximum JJ O
lod NN O
score NN O
( ( O
zmax NN O
of IN O
7 CD O
. . O

47 CD O
was VBD O
obtained VBN O
at IN O
a DT O
recombination NN O
frequency NN O
( ( O
theta NN O
) ) O
of IN O
0 CD O
. . O

47 CD O
( ( O
male JJ O
theta NN O
= NNP O
female JJ O
theta NN O
) ) O
. . O

No DT O
recombination NN O
( ( O
maximum JJ O
lod NN O
score NN O
of IN O
5 CD O
. . O
61 CD O
at IN O
theta NN O
= $ O
0 CD O
. . O
0 CD O
) ) O
was VBD O
found VBN O
between IN O
APOE NNP O
and CC O
the DT O
apolipoprotein NN O
CII NNP O
( ( O
APOC2 NNP O
) ) O
gene NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
, , O
in IN O
addition NN O
to TO O
APOC2 NNP O
, , O
APOE NNP O
is VBZ O
a DT O
useful JJ O
marker NN O
for IN O
presymptomatic JJ O
DM NNP B-Disease
diagnosis NN O
. . O

Regional JJ O
localization NN O
of IN O
polymorphic JJ O
DNA NNP O
loci NN O
on IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
using VBG O
deletions NNS O
associated VBN O
with IN O
choroideremia NN B-Disease
. . O

In IN O
two CD O
unrelated JJ O
families NNS O
, , O
males NNS O
have VBP O
been VBN O
identified VBN O
who WP O
suffer VBP O
from IN O
choroideremia NN B-Disease
and CC O
at IN O
the DT O
same JJ O
time NN O
have VBP O
an DT O
interstitial JJ O
deletion NN O
on IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
. . O

By IN O
high JJ O
- : O
resolution NN O
banding NN O
we PRP O
have VBP O
characterized VBN O
the DT O
deletion NN O
chromosomes VBZ O
as IN O
del NN O
( ( O
X NNP O
) ) O
( ( O
q21 UH O
. . O
1 CD O
- : O
q21 NN O
1 CD O
- : O
q21 NN O
. . O
33 CD O
) ) O
and CC O
del FW O
( ( O
X NN O
) ) O
( ( O
q21 UH O
. . O
2 CD O
- : O
q21 NN O
2 CD O
- : O
q21 NN O
. . O
31 CD O
) ) O
respectively RB O
. . O

By IN O
Southern NNP O
blot NN O
analysis NN O
we PRP O
have VBP O
mapped VBN O
ten VB O
different JJ O
polymorphic JJ O
DNA NNP O
loci NN O
relative NN O
to TO O
the DT O
position NN O
of IN O
the DT O
deletion NN O
and CC O
the DT O
choroideremia NN B-Disease
locus NN O
TCD NNP O
. . O

One CD O
probe NN O
, , O
p31 NN O
, , O
was VBD O
shown VBN O
to TO O
cover VB O
one CD O
of IN O
the DT O
breakpoints NNS O
of IN O
the DT O
smallest JJS O
deletion NN O
. . O

The DT O
following JJ O
order NN O
of IN O
the DT O
loci NN O
was VBD O
suggested VBN O
by IN O
deletion NN O
mapping NN O
cen SYM O
- : O
DXS106 NNP O
- : O
DXS72 NNP O
- : O
TCD NNP O
- : O
( ( O
DXYS1 NNP O
/ NNP O
DXYS23 NNP O
/ NNP O
DXYS5 NNP O
) ) O
- : O
DXYS2 NNP O
- : O
( ( O
DXYS12 NNP O
/ NNP O
DXS3 NNP O
) ) O
- : O
( ( O
DXS17 NNP O
/ NNP O
DXS101 NNP O
) ) O
- : O
Xqter NN O
. . O

Retroviral NNP O
- : O
mediated VBD O
gene NN O
transfer NN O
of IN O
human JJ O
phenylalanine NN O
hydroxylase NN O
into IN O
NIH NNP O
3T3 CD O
and CC O
hepatoma JJ B-Disease
cells NNS O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
hepatic JJ I-Disease
enzyme NN I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

A DT O
full JJ O
- : O
length NN O
human JJ O
PAH NNP O
cDNA NN O
sequence NN O
has VBZ O
been VBN O
inserted VBN O
into IN O
pzip NN O
- : O
neoSV NN O
( ( O
X NNP O
) ) O
, , O
which WDT O
is VBZ O
a DT O
retroviral JJ O
vector NN O
containing VBG O
the DT O
bacterial JJ O
neo JJ O
gene NN O
. . O

The DT O
recombinant NN O
has VBZ O
been VBN O
transfected VBN O
into IN O
psi JJ O
2 CD O
cells NNS O
, , O
which WDT O
provide VBP O
synthesis NN O
of IN O
the DT O
retroviral JJ O
capsid NN O
. . O

Recombinant JJ O
virus NN O
was VBD O
detected VBN O
in IN O
the DT O
culture NN O
medium NN O
of IN O
the DT O
transfected JJ O
psi NN O
2 CD O
cells NNS O
, , O
which WDT O
is VBZ O
capable JJ O
of IN O
transmitting VBG O
the DT O
human JJ O
PAH NNP O
gene NN O
into IN O
mouse NN O
NIH NNP O
3T3 CD O
cells NNS O
by IN O
infection NN O
leading VBG O
to TO O
stable JJ O
incorporation NN O
of IN O
the DT O
recombinant JJ O
provirus NN O
. . O

Infected VBN O
cells NNS O
express RBR O
PAH NNP O
mRNA NN O
, , O
immunoreactive JJ O
PAH NNP O
protein NN O
, , O
and CC O
exhibit NN O
pterin JJ O
- : O
dependent JJ O
phenylalanine JJ O
hydroxylase NN O
activity NN O
. . O

The DT O
recombinant JJ O
virus NN O
is VBZ O
also RB O
capable JJ O
of IN O
infecting VBG O
a DT O
mouse NN O
hepatoma NN B-Disease
cell NN O
line NN O
that WDT O
does VBZ O
not RB O
normally RB O
synthesize VB O
PAH NNP O
. . O

PAH NNP O
activity NN O
is VBZ O
present JJ O
in IN O
the DT O
cellular JJ O
extracts NNS O
and CC O
the DT O
entire JJ O
hydroxylation NN O
system NN O
is VBZ O
reconstituted VBN O
in IN O
the DT O
hepatoma NN B-Disease
cells NNS O
infected VBN O
with IN O
the DT O
recombinant JJ O
viruses NNS O
. . O

Thus RB O
, , O
recombinant JJ O
viruses NNS O
containing VBG O
human JJ O
PAH NNP O
cDNA NN O
provide VBP O
a DT O
means NN O
for IN O
introducing VBG O
functional JJ O
PAH NNP O
into IN O
mammalian JJ O
cells NNS O
of IN O
hepatic JJ O
origin NN O
and CC O
can MD O
potentially RB O
be VB O
introduced VBN O
into IN O
whole JJ O
animals NNS O
as IN O
a DT O
model NN O
for IN O
somatic JJ O
gene NN O
therapy NN O
for IN O
PKU NNP B-Disease
. . O
. . O

Estimation NN O
of IN O
the DT O
male NN O
to TO O
female VB O
ratio NN O
of IN O
mutation NN O
rates NNS O
from IN O
the DT O
segregation NN O
of IN O
X NNP O
- : O
chromosomal JJ O
DNA NNP O
haplotypes NNS O
in IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
families NNS O
. . O

A DT O
novel JJ O
procedure NN O
is VBZ O
presented VBN O
to TO O
estimate VB O
the DT O
ratio NN O
of IN O
male NN O
to TO O
female JJ O
mutation NN O
rates NNS O
for IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

X LS O
- : O
specific JJ O
restriction NN O
fragment NN O
length NN O
polymorphisms NNS O
are VBP O
used VBN O
to TO O
establish VB O
DNA NNP O
haplotypes NNS O
in IN O
three CD O
- : O
generation NN O
DMD NNP B-Disease
families NNS O
. . O

From IN O
the DT O
proportion NN O
of IN O
DMD NNP B-Disease
patients NNS O
who WP O
have VBP O
inherited VBN O
their PRP$ O
maternal JJ O
grandfathers NNS O
X VBP O
chromosome NN O
, , O
the DT O
ratio NN O
of IN O
mutation NN O
rates NNS O
can MD O
be VB O
calculated VBN O
. . O

In IN O
contrast NN O
to TO O
classical JJ O
methods NNS O
, , O
the DT O
proposed VBN O
procedure NN O
is VBZ O
not RB O
restricted VBN O
to TO O
sporadic VB O
or CC O
familiar JJ O
cases NNS O
nor CC O
is VBZ O
any DT O
information NN O
on IN O
the DT O
carrier NN O
status NN O
of IN O
female JJ O
relatives NNS O
required VBN O
. . O
. . O

Deletions NNS O
of IN O
a DT O
DNA NN O
sequence NN O
in IN O
retinoblastomas NN B-Disease
and CC O
mesenchymal JJ B-Disease
tumors NNS I-Disease
: : O
organization NN O
of IN O
the DT O
sequence NN O
and CC O
its PRP$ O
encoded JJ O
protein NN O
. . O

Retinoblastoma NNP B-Disease
is VBZ O
a DT O
childhood NN B-Disease
tumor NN I-Disease
that WDT O
can MD O
arise VB O
because IN O
of IN O
mutant JJ O
alleles NNS O
acquired VBD O
as IN O
somatic JJ O
or CC O
germinal JJ O
mutations NNS O
. . O

The DT O
mutant JJ O
allele NN O
can MD O
be VB O
carried VBN O
in IN O
the DT O
germ JJ O
line NN O
. . O

The DT O
mutations NNS O
creating VBG O
these DT O
alleles NNS O
act NN O
by IN O
inactivating VBG O
copies NNS O
of IN O
a DT O
recessive JJ O
oncogene NN O
located VBN O
within IN O
band NN O
q14 NN O
of IN O
chromosome NN O
13 CD O
and CC O
termed VBD O
the DT O
RB1 NNP O
locus NN O
. . O

We PRP O
have VBP O
reported VBN O
isolation NN O
of IN O
a DT O
cDNA NN O
fragment NN O
that WDT O
recognizes VBZ O
chromosomal JJ O
sequences NNS O
possessing VBG O
many JJ O
of IN O
the DT O
attributes NNS O
of IN O
the DT O
retinoblastoma NN B-Disease
gene NN O
associated VBN O
with IN O
the DT O
RB1 NNP O
locus NN O
. . O

We PRP O
now RB O
report VBP O
that IN O
this DT O
segment NN O
is VBZ O
additionally RB O
the DT O
target NN O
of IN O
somatic JJ O
mutations NNS O
in IN O
mesenchymal JJ B-Disease
tumors NNS I-Disease
among IN O
patients NNS O
having VBG O
no DT O
apparent JJ O
predisposition NN O
to TO O
retinoblastoma VB B-Disease
and CC O
no DT O
previous JJ O
evidence NN O
of IN O
retinoblastoma NN B-Disease
. . O

These DT O
tumors NNS B-Disease
provide VBP O
additional JJ O
evidence NN O
that IN O
the DT O
cloned JJ O
sequences NNS O
are VBP O
representative JJ O
of IN O
a DT O
gene NN O
that WDT O
is VBZ O
a DT O
frequent JJ O
target NN O
of IN O
inactivation NN O
during IN O
tumorigenesis NN O
. . O

Sequence NNP O
analysis NN O
of IN O
this DT O
cDNA NN O
provides VBZ O
little JJ O
insight JJ O
into IN O
its PRP$ O
normal JJ O
functional JJ O
role NN O
. . O
. . O

Treatment NN O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
with IN O
growth NN O
hormone NN O
inhibitors NNS O
. . O

A DT O
controlled VBN O
, , O
double JJ O
- : O
blind NN O
therapeutic JJ O
trial NN O
with IN O
the DT O
drug NN O
mazindol NN O
, , O
a DT O
growth NN O
hormone NN O
inhibitor NN O
, , O
was VBD O
performed VBN O
in IN O
a DT O
pair NN O
of IN O
7 CD O
1 CD O
/ NN O
2 CD O
year NN O
- : O
old JJ O
monozygotic JJ O
twins NNS O
, , O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

The DT O
rationale NN O
for IN O
this DT O
trial NN O
was VBD O
based VBN O
on IN O
a DT O
patient NN O
( ( O
reported VBN O
previously RB O
) ) O
affected VBD O
simultaneously RB O
with IN O
DMD NNP B-Disease
and CC O
growth NN B-Disease
hormone NN I-Disease
( ( I-Disease
GH NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
, , O
who WP O
is VBZ O
showing VBG O
a DT O
benign JJ O
course NN O
of IN O
the DT O
dystrophic JJ B-Disease
process NN I-Disease
and CC O
is VBZ O
still RB O
walking VBG O
at IN O
18 CD O
years NNS O
. . O

One CD O
of IN O
the DT O
twins NNS O
received VBD O
2 CD O
mg NN O
of IN O
mazindol JJ O
daily JJ O
, , O
while IN O
the DT O
other JJ O
received VBD O
a DT O
placebo NN O
. . O

The DT O
assessment NN O
, , O
repeated VBN O
every DT O
2 CD O
months NNS O
, , O
included VBD O
weight NN O
and CC O
height NN O
measurements NNS O
, , O
functional JJ O
and CC O
motor NN O
ability NN O
tests NNS O
, , O
ergometry NN O
and CC O
determinations NNS O
of IN O
serum NN O
enzymes NNS O
and CC O
GH NNP O
levels NNS O
. . O

After IN O
one CD O
year NN O
of IN O
trial NN O
the DT O
code NN O
was VBD O
broken VBN O
and CC O
it PRP O
was VBD O
seen VBN O
that IN O
the DT O
twin NN O
under IN O
placebo NN O
treatment NN O
was VBD O
strikingly RB O
worse JJR O
than IN O
his PRP$ O
brother NN O
, , O
the DT O
progression NN O
of IN O
whose WP$ O
condition NN O
was VBD O
practically RB O
arrested VBN O
. . O

These DT O
results NNS O
strongly RB O
suggest VBP O
that IN O
treatment NN O
with IN O
a DT O
GH NNP O
inhibitor NN O
is VBZ O
beneficial JJ O
for IN O
DMD NNP B-Disease
patients NNS O
. . O
. . O

Identification NN O
and CC O
localization NN O
of IN O
mutations NNS O
at IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
locus NN O
by IN O
ribonuclease NN O
A NNP O
cleavage NN O
. . O

Many JJ O
mutations NNS O
leading VBG O
to TO O
human JJ O
disease NN O
are VBP O
the DT O
result NN O
of IN O
single JJ O
DNA NNP O
base NN O
pair NN O
changes NNS O
that IN O
cannot NN O
be VB O
identified VBN O
by IN O
Southern JJ O
analysis NN O
. . O

This DT O
has VBZ O
prompted VBN O
the DT O
development NN O
of IN O
alternative JJ O
assays NNS O
for IN O
point NN O
mutation NN O
detection NN O
. . O

The DT O
recently RB O
described VBN O
ribonuclease NN O
A DT O
cleavage NN O
procedure NN O
, , O
with IN O
a DT O
polyuridylic JJ O
acid NN O
- : O
paper NN O
affinity NN O
chromatography NN O
step NN O
, , O
has VBZ O
been VBN O
used VBN O
to TO O
identify VB O
the DT O
mutational JJ O
lesions NNS O
in IN O
the DT O
hypoxanthine NN O
phosphoribosyltransferase NN O
( ( O
HPRT NNP O
) ) O
messenger NN O
RNAs NNP O
of IN O
patients NNS O
with IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

Distinctive JJ O
ribonuclease NN O
A NNP O
cleavage NN O
patterns NNS O
were VBD O
identified VBN O
in IN O
messenger NN O
RNA NNP O
from IN O
5 CD O
of IN O
14 CD O
Lesch NNP B-Disease
- : I-Disease
Nyhan NN I-Disease
patients NNS O
who WP O
were VBD O
chosen VBN O
because IN O
no DT O
HPRT NNP O
Southern NNP O
or CC O
Northern NNP O
blotting VBG O
pattern JJ O
changes NNS O
had VBD O
been VBN O
found VBN O
. . O

This DT O
approach NN O
now RB O
allows VBZ O
HPRT NNP O
mutation NN O
detection NN O
in IN O
50 CD O
percent NN O
of IN O
the DT O
cases NNS O
of IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
polyuridylic JJ O
acid SYM O
- : O
paper NN O
affinity NN O
procedure NN O
provides VBZ O
a DT O
general JJ O
method NN O
for IN O
analysis NN O
of IN O
low JJ O
abundance NN O
messenger NN O
RNAs NNP O
. . O
. . O

Two CD O
new JJ O
variants NNS O
of IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
associated VBN O
with IN O
hereditary JJ B-Disease
non SYM I-Disease
- : I-Disease
spherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
: : O
G6PD NNP O
Wayne NNP O
and CC O
G6PD NNP O
Huron NNP O
. . O

Two CD O
new JJ O
deficient JJ O
variants NNS O
of IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
causing VBG O
hereditary JJ B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
( ( O
HNSHA NNP B-Disease
) ) O
are VBP O
described VBN O
. . O

Both DT O
of IN O
these DT O
are VBP O
unique JJ O
and CC O
they PRP O
have VBP O
been VBN O
named VBN O
G6PD NNP O
Wayne NNP O
and CC O
G6PD NNP O
Huron NNP O
. . O

Patients NNS O
with IN O
G6PD NNP O
Wayne NNP O
underwent JJ O
splenectomy NN O
and CC O
no DT O
objective JJ O
improvement NN O
was VBD O
noted VBN O
. . O

The DT O
patients NNS O
with IN O
G6PD NNP O
Huron NNP O
were VBD O
under IN O
medical JJ O
observation NN O
for IN O
a DT O
considerable JJ O
period NN O
of IN O
time NN O
without IN O
the DT O
diagnosis NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
being VBG O
entertained VBN O
because IN O
the DT O
family NN O
was VBD O
of IN O
Northern NNP O
European NNP O
origin NN O
. . O

Since IN O
sporadic JJ O
variants NNS O
of IN O
G6PD NNP O
causing VBG O
HNSHA NNP B-Disease
show NN O
no DT O
special JJ O
racial JJ O
predilection NN O
, , O
the DT O
diagnosis NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
should MD O
always RB O
be VB O
considered VBN O
in IN O
patients NNS O
with IN O
this DT O
syndrome NN O
. . O
. . O

Sialophorin NNP O
, , O
a DT O
surface NN O
sialoglycoprotein NN O
defective JJ O
in IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
, , O
is VBZ O
involved VBN O
in IN O
human JJ O
T NNP O
lymphocyte NN O
proliferation NN O
. . O

The DT O
mAb NN O
L10 NNP O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
distribution NN O
and CC O
the DT O
function NN O
of IN O
sialophorin NN O
, , O
the DT O
heavily RB O
glycosylated VBN O
surface NN O
molecule NN O
that WDT O
is VBZ O
deficient JJ O
/ RB O
defective JJ O
in IN O
lymphocytes NNS O
of IN O
patients NNS O
with IN O
the DT O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
immunodeficiency NN I-Disease
Wiskott NNP I-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
. . O

Dual NNP O
- : O
parameter NN O
FACS NNP O
analysis NN O
indicated VBD O
that IN O
sialophorin NN O
is VBZ O
expressed VBN O
on IN O
CD4 NNP O
+ NNP O
and CC O
CD8 NNP O
+ NNP O
lymphocytes VBZ O
, , O
on IN O
a DT O
subpopulation NN O
of IN O
peripheral JJ O
blood NN O
B NNP O
lymphocytes VBZ O
, , O
on IN O
all DT O
thymocytes NNS O
, , O
and CC O
on IN O
a DT O
subpopulation NN O
of IN O
bone NN O
marrow NN O
cells NNS O
. . O

Functional JJ O
studies NNS O
demonstrated VBD O
that IN O
L10 NNP O
mAb NN O
stimulates VBZ O
the DT O
proliferation NN O
of IN O
peripheral JJ O
blood NN O
T NNP O
lymphocytes VBZ O
as IN O
measured VBN O
by IN O
stimulation NN O
of IN O
[ $ O
3H CD O
] NNP O
thymidine NN O
incorporation NN O
. . O

The DT O
time NN O
course NN O
and CC O
magnitude NN O
of IN O
increased VBN O
[ NN O
3H CD O
] JJ O
thymidine NN O
incorporation NN O
by IN O
T NNP O
lymphocytes NNS O
in IN O
response NN O
to TO O
L10 NNP O
mAb NN O
paralleled VBD O
that IN O
induced VBN O
by IN O
anti JJ O
- : O
CD3 NNP O
mAb NN O
. . O

Effective JJ O
stimulation NN O
was VBD O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
monocytes NNS O
and CC O
the DT O
Fc NNP O
portion NN O
of IN O
L10 NNP O
mAb NN O
. . O

Stimulation NN O
of IN O
lymphocytes NNS O
by IN O
L10 NNP O
, , O
like IN O
stimulation NN O
by IN O
anti JJ O
- : O
CD3 NNP O
mAb NN O
, , O
involves VBZ O
increased JJ O
expression NN O
of IN O
4F2 CD O
, , O
HLA NNP O
- : O
DR NNP O
, , O
and CC O
IL NNP O
- : O
2 CD O
- : O
R NN O
. . O

These DT O
observations NNS O
suggest VBP O
that IN O
sialophorin JJ O
functions NNS O
in IN O
T NNP O
cell NN O
activation NN O
. . O
. . O

Hypopigmentation NN B-Disease
in IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

Cutaneous JJ B-Disease
and CC I-Disease
ocular JJ I-Disease
pigmentation NN I-Disease
were VBD O
evaluated VBN O
in IN O
29 CD O
individuals NNS O
with IN O
the DT O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

Criteria NNS O
for IN O
hypopigmentation NN B-Disease
included VBD O
the DT O
presence NN O
of IN O
type NN O
I PRP O
or CC O
II NNP O
skin NN O
, , O
the DT O
lightest JJS O
skin NN O
type NN O
in IN O
the DT O
family NN O
by IN O
history NN O
, , O
and CC O
iris JJ O
translucency NN O
on IN O
globe NN O
transillumination NN O
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
criteria NNS O
, , O
48 CD O
% NN O
of IN O
the DT O
PWS NNP B-Disease
individuals NNS O
were VBD O
hypopigmented VBN B-Disease
. . O

The DT O
presence NN O
of IN O
hypopigmentation NN B-Disease
correlated VBN O
with IN O
a DT O
small JJ O
interstitial JJ O
deletion NN O
on IN O
the DT O
proximal NN O
long JJ O
arm NN O
of IN O
chromosome NN O
15 CD O
; : O
however RB O
, , O
this DT O
deletion NN O
was VBD O
also RB O
found VBN O
in IN O
individuals NNS O
who WP O
did VBD O
not RB O
meet VB O
the DT O
full JJ O
criteria NN O
for IN O
hypopigmentation NN B-Disease
. . O

Hairbulb NNP O
tyrosinase NN O
activity NN O
and CC O
glutathione NN O
content NN O
, , O
as RB O
well RB O
as IN O
urine JJ O
cysteinyldopa NN O
excretion NN O
, , O
were VBD O
low JJ O
in IN O
PWS NNP B-Disease
individuals NNS O
with IN O
and CC O
without IN O
hypopigmentation NN B-Disease
and CC O
did VBD O
not RB O
separate VB O
these DT O
two CD O
groups NNS O
. . O

We PRP O
conclude VBP O
that DT O
hypopigmentation NN B-Disease
is VBZ O
found VBN O
in IN O
a DT O
significant JJ O
proportion NN O
of IN O
individuals NNS O
with IN O
PWS NNP B-Disease
and CC O
that IN O
the DT O
hypopigmentation NN B-Disease
may MD O
be VB O
associated VBN O
with IN O
a DT O
deletion NN O
of IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
15 CD O
. . O

The DT O
mechanism NN O
for IN O
the DT O
hypopigmentation NN B-Disease
is VBZ O
unknown JJ O
. . O
. . O

Phenotype NNP O
heterogeneity NN O
among IN O
hemizygotes NNS O
in IN O
a DT O
family NN O
biochemically RB O
screened VBN O
for IN O
adrenoleukodystrophy NN B-Disease
. . O

We PRP O
report VBP O
on IN O
two CD O
clinically RB O
, , O
neurologically RB O
normal JJ O
relatives NNS O
of IN O
a DT O
boy NN O
affected VBN O
by IN O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
; : O
they PRP O
were VBD O
found VBN O
repeatedly RB O
to TO O
have VB O
the DT O
biochemical JJ O
defect NN O
of IN O
an DT O
ALD NNP B-Disease
hemizygote NN O
. . O

The DT O
assay NN O
consisted VBN O
in IN O
the DT O
determination NN O
of IN O
very RB O
- : O
long JJ O
- : O
chain NN O
fatty JJ O
acids NNS O
in IN O
lyophilized JJ O
and CC O
reconstituted JJ O
plasma NN O
. . O

While IN O
no DT O
evidence NN O
of IN O
neurologic JJ B-Disease
disease NN I-Disease
( ( O
leukodystrophy NN B-Disease
or CC O
myeloneuropathy NN B-Disease
) ) O
was VBD O
present JJ O
in IN O
these DT O
hemizygotes NNS O
, , O
adrenocortical JJ B-Disease
insufficiency NN I-Disease
provoking VBG O
compensatory JJ O
high JJ O
ACTH NNP O
release NN O
was VBD O
found VBN O
in IN O
both DT O
. . O

These DT O
findings NNS O
should MD O
be VB O
taken VBN O
into IN O
consideration NN O
when WRB O
counseling VBG O
families NNS O
in IN O
which WDT O
cases NNS O
with IN O
clinically RB O
expressed VBN O
ALD NNP B-Disease
are VBP O
represented VBN O
in IN O
several JJ O
generations NNS O
. . O
. . O

The DT O
mapping NN O
of IN O
a DT O
cDNA NN O
from IN O
the DT O
human JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
Duchenne NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
to TO O
the DT O
mouse NN O
X NNP O
chromosome NN O
. . O

The DT O
recent JJ O
discovery NN O
of IN O
sequences NNS O
at IN O
the DT O
site NN O
of IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
in IN O
humans NNS O
has VBZ O
opened VBN O
up RP O
the DT O
possibility NN O
of IN O
a DT O
detailed JJ O
molecular JJ O
analysis NN O
of IN O
the DT O
genes NNS O
in IN O
humans NNS O
and CC O
in IN O
related JJ O
mammalian JJ O
species NNS O
. . O

Until IN O
relatively RB O
recently RB O
, , O
there EX O
was VBD O
no DT O
obvious JJ O
mouse NN O
model NN O
of IN O
this DT O
genetic JJ B-Disease
disease NN I-Disease
for IN O
the DT O
development NN O
of IN O
therapeutic JJ O
strategies NNS O
. . O

The DT O
identification NN O
of IN O
a DT O
mouse NN O
X SYM O
- : O
linked VBN O
mutant JJ O
showing VBG O
muscular JJ B-Disease
dystrophy NN I-Disease
, , O
mdx NN O
, , O
has VBZ O
provided VBN O
a DT O
candidate NN O
mouse NN O
genetic JJ O
homologue NN O
to TO O
the DT O
DMD NNP B-Disease
locus NN O
; : O
the DT O
relatively RB O
mild JJ O
pathological JJ O
features NNS O
of IN O
mdx NN O
suggest VBP O
it PRP O
may MD O
have VB O
more JJR O
in IN O
common JJ O
with IN O
mutations NNS O
of IN O
the DT O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
type NN O
at IN O
the DT O
same JJ O
human JJ O
locus NN O
, , O
however RB O
. . O

But CC O
the DT O
close JJ O
genetic JJ O
linkage NN O
of IN O
mdx NN O
to TO O
G6PD NNP O
and CC O
Hprt NNP O
on IN O
the DT O
mouse NN O
X NNP O
chromosome NN O
, , O
coupled VBN O
with IN O
its PRP$ O
comparatively JJ O
mild JJ O
pathology NN O
, , O
have VBP O
suggested VBN O
that IN O
the DT O
mdx JJ O
mutation NN O
may MD O
instead RB O
correspond VB O
to TO O
Emery NNP B-Disease
Dreifuss NNP I-Disease
muscular NN I-Disease
dystrophy NN I-Disease
which WDT O
itself PRP O
is VBZ O
closely RB O
linked VBN O
to TO O
DNA NNP O
markers NNS O
at IN O
Xq28 NNP O
- : O
qter NN O
in IN O
the DT O
region NN O
of IN O
G6PD NNP O
on IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O

Using VBG O
an DT O
interspecific NN O
mouse NN O
domesticus NN O
/ NNP O
spretus NN O
cross NN O
, , O
segregating VBG O
for IN O
a DT O
variety NN O
of IN O
markers NNS O
on IN O
the DT O
mouse NN O
X NNP O
chromosome NN O
, , O
we PRP O
have VBP O
positioned VBN O
on IN O
the DT O
mouse NN O
X NNP O
chromosome NN O
sequences NNS O
homologous JJ O
to TO O
a DT O
DMD NNP B-Disease
cDNA NN O
clone NN O
. . O

These DT O
sequences NNS O
map VBP O
provocatively RB O
close JJ O
to TO O
the DT O
mdx NN O
mutation NN O
and CC O
unexpectedly RB O
distant JJ O
from IN O
sparse JJ O
fur NN O
, , O
spf NN O
, , O
the DT O
mouse NN O
homologue NN O
of IN O
OTC NNP O
( ( O
ornithine JJ O
transcarbamylase NN O
) ) O
which WDT O
is VBZ O
closely RB O
linked VBN O
to TO O
DMD NNP B-Disease
on IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O
. . O

Localization NN O
of IN O
the DT O
region NN O
homologous JJ O
to TO O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
locus NN O
on IN O
the DT O
mouse NN O
X NNP O
chromosome NN O
. . O

Recent JJ O
progress NN O
has VBZ O
resulted VBN O
in IN O
part NN O
of IN O
the DT O
gene NN O
mutated VBN O
in IN O
Duchenne NNP B-Disease
and CC I-Disease
the DT I-Disease
milder NN I-Disease
Becker NNP I-Disease
muscular NN I-Disease
dystrophies NNS I-Disease
being VBG O
cloned VBN O
and CC O
has VBZ O
suggested VBN O
that IN O
the DT O
gene NN O
itself PRP O
extends VBZ O
over IN O
1 CD O
, , O
0 CD O
to TO O
2 CD O
, , O
0 CD O
kilobases NNS O
( ( O
kb NN O
) ) O
. . O

To TO O
study VB O
how WRB O
mutations NNS O
in IN O
this DT O
gene NN O
affect JJ O
muscle NN O
development NN O
and CC O
integrity NN O
, , O
it PRP O
would MD O
be VB O
of IN O
interest NN O
to TO O
have VB O
available JJ O
a DT O
mouse NN O
model NN O
of IN O
the DT O
human JJ O
disease NN O
. . O

The DT O
mouse NN O
mdx NN O
mutation NN O
affects VBZ O
muscle NN O
and CC O
confers NNS O
a DT O
mild JJ O
dystrophic JJ B-Disease
syndrome NN I-Disease
, , O
but CC O
it PRP O
is VBZ O
not RB O
clear JJ O
whether IN O
this DT O
mutation NN O
is VBZ O
equivalent JJ O
to TO O
Duchenne NNP B-Disease
/ NNP I-Disease
Becker NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
in IN O
man NN O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
use NN O
of IN O
two CD O
sequences NNS O
from IN O
the DT O
human JJ O
Duchenne NNP B-Disease
muscular NN I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
that WDT O
cross VBZ O
- : O
hybridize NN O
to TO O
mouse VB O
X NNP O
- : O
linked VBD O
sequences NNS O
to TO O
localize VB O
the DT O
gene NN O
homologous JJ O
to TO O
DMD NNP B-Disease
in IN O
the DT O
mouse NN O
. . O

Both DT O
sequences NNS O
map VBP O
to TO O
the DT O
region NN O
of IN O
10 CD O
centimorgan NNS O
lying VBG O
between IN O
the DT O
Tabby NNP O
( ( O
Ta NNP O
) ) O
and CC O
St14 NNP O
- : O
1 CD O
( ( O
DxPas8 NNP O
) ) O
loci NN O
, , O
close RB O
to TO O
the DT O
phosphorylase NN O
b NN O
kinase NN O
locus NN O
( ( O
Phk NNP O
) ) O
. . O

By IN O
analogy NN O
with IN O
the DT O
human JJ O
X NNP O
- : O
chromosome NN O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
region NN O
in IN O
the DT O
mouse NN O
around IN O
the DT O
G6pd NNP O
and CC O
St14 NNP O
- : O
1 CD O
loci NN O
may MD O
contain VB O
two CD O
genes NNS O
corresponding VBG O
to TO O
distinct VB O
human JJ O
myopathies NNS B-Disease
Emery NNP B-Disease
Dreifuss NNP I-Disease
muscular NN I-Disease
dystrophy NN I-Disease
which WDT O
is VBZ O
known VBN O
to TO O
be VB O
closely RB O
linked VBN O
to TO O
St14 NNP O
- : O
1 CD O
in IN O
man NN O
and CC O
the DT O
DMD NNP B-Disease
homologue NN O
described VBD O
here RB O
. . O
. . O

GT NNP O
to TO O
AT NNP O
transition NN O
at IN O
a DT O
splice NN O
donor NN O
site NN O
causes VBZ O
skipping VBG O
of IN O
the DT O
preceding VBG O
exon NN O
in IN O
phenylketonuria NN B-Disease
. . O

Classical JJ B-Disease
Phenylketonuria NNP I-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
human JJ I-Disease
genetic JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

We PRP O
isolated VBD O
several JJ O
mutant JJ O
PAH NNP O
cDNA NN O
clones NNS O
from IN O
a DT O
PKU NNP B-Disease
carrier NN O
individual NN O
and CC O
showed VBD O
that IN O
they PRP O
contained VBD O
an DT O
internal JJ O
116 CD O
base NN O
pair NN O
deletion NN O
, , O
corresponding VBG O
precisely RB O
to TO O
exon VB O
12 CD O
of IN O
the DT O
human JJ O
chromosomal NN O
PAH NNP O
gene NN O
. . O

The DT O
deletion NN O
causes VBZ O
the DT O
synthesis NN O
of IN O
a DT O
truncated JJ O
protein NN O
lacking VBG O
the DT O
C NNP O
- : O
terminal JJ O
52 CD O
amino JJ O
acids NNS O
. . O

Gene NNP O
transfer NN O
and CC O
expression NN O
studies NNS O
using VBG O
the DT O
mutant JJ O
PAH NNP O
cDNA NN O
indicated VBD O
that IN O
the DT O
deletion NN O
abolishes VBZ O
PAH NNP O
activity NN O
in IN O
the DT O
cell NN O
as IN O
a DT O
result NN O
of IN O
protein NN O
instability NN O
. . O

To TO O
determine VB O
the DT O
molecular JJ O
basis NN O
of IN O
the DT O
deletion NN O
, , O
the DT O
mutant JJ O
chromosomal JJ O
PAH NNP O
gene NN O
was VBD O
isolated VBN O
from IN O
this DT O
individual NN O
and CC O
shown VBN O
to TO O
contain VB O
a DT O
GT NNP O
- : O
- : O
greater JJR O
than IN O
AT NNP O
substitution NN O
at IN O
the DT O
5 CD O
splice NN O
donor NN O
site NN O
of IN O
intron NN O
12 CD O
. . O

Thus RB O
, , O
the DT O
consequence NN O
of IN O
the DT O
splice NN O
donor NN O
site NN O
mutation NN O
in IN O
the DT O
human JJ O
liver NN O
is VBZ O
the DT O
skipping NN O
of IN O
the DT O
preceding VBG O
exon NN O
during IN O
RNA NNP O
splicing VBG O
. . O
. . O

Conservation NN O
of IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
in IN O
mice NNS O
and CC O
humans NNS O
. . O

A DT O
portion NN O
of IN O
the DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
gene NN O
transcript NN O
from IN O
human JJ O
fetal JJ O
skeletal JJ O
muscle NN O
and CC O
mouse NN O
adult NN O
heart NN O
was VBD O
sequenced VBN O
, , O
representing VBG O
approximately RB O
25 CD O
percent NN O
of IN O
the DT O
total NN O
, , O
14 CD O
- : O
kb NN O
DMD NNP B-Disease
transcript NN O
. . O

The DT O
nucleic JJ O
acid NN O
and CC O
predicted VBD O
amino NN O
acid NN O
sequences NNS O
from IN O
the DT O
two CD O
species NNS O
are VBP O
nearly RB O
90 CD O
percent NN O
homologous JJ O
. . O

The DT O
amino NN O
acid NN O
sequence NN O
that WDT O
is VBZ O
predicted VBN O
from IN O
this DT O
portion NN O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
indicates VBZ O
that IN O
the DT O
protein NN O
product NN O
might MD O
serve VB O
a DT O
structural JJ O
role NN O
in IN O
muscle NN O
, , O
but CC O
the DT O
abundance NN O
and CC O
tissue NN O
distribution NN O
of IN O
the DT O
messenger NN O
RNA NNP O
suggests VBZ O
that IN O
the DT O
DMD NNP B-Disease
protein NN O
is VBZ O
not RB O
nebulin JJ O
. . O
. . O

Familial JJ O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
with IN O
apparently RB O
normal JJ O
chromosomes NNS O
. . O

We PRP O
report VBP O
on IN O
4 CD O
sibs NN O
( ( O
2F CD O
, , O
2M CD O
) ) O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

Diagnosis NN O
was VBD O
made VBN O
clinically RB O
on IN O
the DT O
basis NN O
of IN O
history NN O
, , O
behavior NN O
, , O
and CC O
physical JJ O
findings NNS O
in IN O
3 CD O
of IN O
the DT O
sibs NN O
. . O

The DT O
other JJ O
child NN O
had VBD O
died VBN O
at IN O
age NN O
10 CD O
months NNS O
with IN O
a DT O
history NN O
and CC O
clinical JJ O
findings NNS O
typical JJ O
of IN O
first JJ O
phase NN O
of IN O
PWS NNP B-Disease
. . O

Results NNS O
of IN O
chromosome NN O
studies NNS O
on IN O
the DT O
parents NNS O
and CC O
surviving VBG O
sibs NNS O
were VBD O
normal JJ O
. . O

The DT O
implications NNS O
of IN O
this DT O
unusual JJ O
familial JJ O
occurrence NN O
for IN O
our PRP$ O
understanding NN O
of IN O
PWS NNP B-Disease
are VBP O
discussed VBN O
. . O
. . O

Nebulin NNP O
and CC O
titin JJ O
expression NN O
in IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
appears VBZ O
normal JJ O
. . O

Monoclonal NNP O
antibodies NNS O
which WDT O
recognize VBP O
different JJ O
epitopes NNS O
on IN O
either DT O
titin NN O
or CC O
nebulin JJ O
show NN O
normal JJ O
staining VBG O
patterns NNS O
on IN O
frozen JJ O
sections NNS O
of IN O
three CD O
muscle NN O
biopsies NNS O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

Gel NNP O
electrophoresis NN O
and CC O
immunoblotting NN O
performed VBN O
on IN O
two CD O
of IN O
these DT O
muscle NN O
biopsies NNS O
show VBP O
the DT O
normal JJ O
pattern NN O
of IN O
titin NN O
and CC O
nebulin JJ O
polypeptides NNS O
. . O

Since IN O
the DT O
donor NN O
of IN O
one CD O
of IN O
these DT O
biopsies NNS O
has VBZ O
a DT O
large JJ O
deletion NN O
of IN O
the DT O
5 CD O
- : O
region NN O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
, , O
our PRP$ O
results NNS O
argue VBP O
against IN O
the DT O
recent JJ O
proposal NN O
that IN O
nebulin NN O
is VBZ O
the DT O
gene NN O
mutated VBN O
in IN O
DMD NNP B-Disease
. . O
. . O

Heterozygous JJ B-Disease
C2 NNP I-Disease
deficiency NN I-Disease
associated VBN O
with IN O
angioedema NN B-Disease
, , O
myasthenia NN B-Disease
gravis NN I-Disease
, , O
and CC O
systemic JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
. . O

We PRP O
describe VBP O
a DT O
patient NN O
with IN O
myasthenia NN B-Disease
gravis NN I-Disease
, , O
systemic JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
, , O
and CC O
angioedema RB B-Disease
associated VBN O
with IN O
heterozygous JJ O
complement NN B-Disease
factor NN I-Disease
2 CD I-Disease
( ( I-Disease
C2 NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
. . O

The DT O
significance NN O
of IN O
this DT O
association NN O
is VBZ O
controversial JJ O
, , O
though IN O
the DT O
association NN O
of IN O
C2 NNP B-Disease
deficiency NN I-Disease
with IN O
certain JJ O
histocompatibility NN O
antigens NNS O
suggests VBZ O
possible JJ O
linkage NN O
to TO O
immune VB O
response NN O
genes NNS O
. . O

To TO O
our PRP$ O
knowledge NN O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
heterozygous JJ O
C2 NNP B-Disease
deficiency NN I-Disease
in IN O
association NN O
with IN O
this DT O
combination NN O
of IN O
autoimmune NN B-Disease
disorders NNS I-Disease
, , O
and CC O
we PRP O
discuss VBP O
the DT O
aetiological JJ O
implications NNS O
. . O
. . O

Genetic JJ O
analysis NN O
of IN O
an DT O
inherited JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
third JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
Brittany NNP O
spaniel JJ O
dogs NNS O
. . O

Genetically RB O
determined VBN O
C3 NNP B-Disease
deficiency NN I-Disease
in IN O
Brittany NNP O
spaniel JJ O
dogs NNS O
shares NNS O
a DT O
number NN O
of IN O
biochemical JJ O
and CC O
clinical JJ O
characteristics NNS O
with IN O
the DT O
human JJ O
disorder NN O
. . O

In IN O
humans NNS O
, , O
the DT O
gene NN O
for IN O
C3 NNP B-Disease
deficiency NN I-Disease
is VBZ O
a DT O
null JJ O
gene NN O
that WDT O
is VBZ O
allelic JJ O
to TO O
the DT O
structural JJ O
gene NN O
for IN O
C3 NNP O
and CC O
is VBZ O
not RB O
linked VBN O
to TO O
the DT O
major JJ O
histocompatibility NN O
locus NN O
. . O

The DT O
current JJ O
study NN O
used VBD O
allotype JJ O
analysis NN O
of IN O
canine NN O
C3 NNP O
in IN O
order NN O
to TO O
demonstrate VB O
that IN O
the DT O
gene NN O
for IN O
C3 NNP B-Disease
deficiency NN I-Disease
in IN O
these DT O
dogs NNS O
is VBZ O
also RB O
a DT O
null JJ O
gene NN O
allelic NN O
to TO O
the DT O
structural JJ O
gene NN O
for IN O
C3 NNP O
. . O

In IN O
addition NN O
, , O
preliminary JJ O
pedigree NN O
analysis NN O
suggests VBZ O
that IN O
the DT O
gene NN O
for IN O
canine NN O
C3 NNP B-Disease
deficiency NN I-Disease
is VBZ O
apparently RB O
not RB O
closely RB O
linked VBN O
to TO O
the DT O
major JJ O
histocompatibility NN O
complex NN O
of IN O
the DT O
dog NN O
. . O

Thus RB O
, , O
it PRP O
appears VBZ O
that IN O
C3 NNP B-Disease
deficiency NN I-Disease
in IN O
Brittany NNP O
spaniel JJ O
dogs NNS O
not RB O
only RB O
shares NNS O
biochemical JJ O
and CC O
clinical JJ O
features NNS O
with IN O
C3 NNP B-Disease
deficiency NN I-Disease
in IN O
humans NNS O
, , O
but CC O
also RB O
shares NNS O
some DT O
genetic JJ O
characteristics NNS O
with IN O
the DT O
human JJ O
disorder NN O
. . O
. . O

Gene NNP O
transfer NN O
and CC O
expression NN O
of IN O
human JJ O
phenylalanine NN O
hydroxylase NN O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
a DT O
genetic JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
enzyme JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

A DT O
full JJ O
- : O
length NN O
complementary JJ O
DNA NNP O
clone NN O
of IN O
human JJ O
PAH NNP O
was VBD O
inserted VBN O
into IN O
a DT O
eukaryotic JJ O
expression NN O
vector NN O
and CC O
transferred VBD O
into IN O
mouse NN O
NIH3T3 NNP O
cells NNS O
which WDT O
do VBP O
not RB O
normally RB O
express JJ O
PAH NNP O
. . O

The DT O
transformed JJ O
mouse NN O
cells NNS O
expressed VBD O
PAH NNP O
messenger NN O
RNA NNP O
, , O
immunoreactive JJ O
protein NN O
, , O
and CC O
enzymatic JJ O
activity NN O
that WDT O
are VBP O
characteristic JJ O
of IN O
the DT O
normal JJ O
human JJ O
liver NN O
products NNS O
, , O
demonstrating VBG O
that IN O
a DT O
single JJ O
gene NN O
contains VBZ O
all DT O
of IN O
the DT O
necessary JJ O
genetic JJ O
information NN O
to TO O
code VB O
for IN O
functional JJ O
PAH NNP O
. . O

These DT O
results NNS O
support VBP O
the DT O
use NN O
of IN O
the DT O
human JJ O
PAH NNP O
probe NN O
in IN O
prenatal JJ O
diagnosis NN O
and CC O
detection NN O
of IN O
carriers NNS O
, , O
to TO O
provide VB O
new JJ O
opportunities NNS O
for IN O
the DT O
biochemical JJ O
characterization NN O
of IN O
normal JJ O
and CC O
mutant JJ O
enzymes NNS O
, , O
and CC O
in IN O
the DT O
investigation NN O
of IN O
alternative JJ O
genetic JJ O
therapies NNS O
for IN O
PKU NNP B-Disease
. . O
. . O

Regional JJ O
mapping NN O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
gene NN O
and CC O
the DT O
phenylketonuria NN B-Disease
locus NN O
in IN O
the DT O
human JJ O
genome NN O
. . O

Phenylketonuria NNP B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
of IN O
amino NN O
acid NN O
metabolism NN O
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
hepatic JJ I-Disease
enzyme NN I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
; : O
phenylalanine NN O
4 CD O
- : O
monooxygenase NN O
, , O
EC NNP O
1 CD O
. . O
14 CD O
. . O
16 CD O
. . O
1 CD O
) ) O
. . O

A DT O
cDNA NN O
clone NN O
for IN O
human JJ O
PAH NNP O
has VBZ O
previously RB O
been VBN O
used VBN O
to TO O
assign VB O
the DT O
corresponding JJ O
gene NN O
to TO O
human JJ O
chromosome NN O
12 CD O
. . O

To TO O
define VB O
the DT O
regional JJ O
map JJ O
position NN O
of IN O
the DT O
disease NN O
locus NN O
and CC O
the DT O
PAH NNP O
gene NN O
on IN O
human JJ O
chromosome NN O
12 CD O
, , O
DNA NNP O
was VBD O
isolated VBN O
from IN O
human JJ O
- : O
hamster NN O
somatic JJ O
cell NN O
hybrids NNS O
with IN O
various JJ O
deletions NNS O
of IN O
human JJ O
chromosome NN O
12 CD O
and CC O
was VBD O
analyzed VBN O
by IN O
Southern NNP O
blot NN O
analysis NN O
using VBG O
the DT O
human JJ O
cDNA NN O
PAH NNP O
clone NN O
as IN O
a DT O
hybridization NN O
probe NN O
. . O

From IN O
these DT O
results NNS O
, , O
together RB O
with IN O
detailed JJ O
biochemical JJ O
and CC O
cytogenetic JJ O
characterization NN O
of IN O
the DT O
hybrid JJ O
cells NNS O
, , O
the DT O
region NN O
on IN O
chromosome NN O
12 CD O
containing VBG O
the DT O
human JJ O
PAH NNP O
gene NN O
has VBZ O
been VBN O
defined VBN O
as IN O
12q14 CD O
. . O

3 LS O
- : O
- : O
- : O
- : O
qter NN O
3 CD O
- : O
- : O
- : O
- : O
qter NN O
. . O

The DT O
PAH NNP O
map MD O
position NN O
on IN O
chromosome NN O
12 CD O
was VBD O
further RB O
localized VBN O
by IN O
in IN O
situ JJ O
hybridization NN O
of IN O
125I CD O
- : O
labeled VBN O
human JJ O
PAH NNP O
cDNA NN O
to TO O
chromosomes NNS O
prepared VBN O
from IN O
a DT O
human JJ O
lymphoblastoid NN O
cell NN O
line NN O
. . O

Results NNS O
of IN O
these DT O
experiments NNS O
demonstrated VBD O
that IN O
the DT O
region NN O
on IN O
chromosome NN O
12 CD O
containing VBG O
the DT O
PAH NNP O
gene NN O
and CC O
the DT O
PKU NNP B-Disease
locus NN O
in IN O
man NN O
is VBZ O
12q22 CD O
- : O
- : O
- : O
- : O
12q24 CD O
. . O

1 CD O
. . O

These DT O
results NNS O
not RB O
only RB O
provide VB O
a DT O
regionalized JJ O
map NN O
position NN O
for IN O
a DT O
major JJ O
human JJ O
disease NN O
locus NN O
but CC O
also RB O
can MD O
serve VB O
as IN O
a DT O
reference NN O
point NN O
for IN O
linkage NN O
analysis NN O
with IN O
other JJ O
DNA NNP O
markers NNS O
on IN O
human JJ O
chromosome NN O
12 CD O

Heterogeneity NN O
of IN O
type NN B-Disease
I PRP I-Disease
von VBP I-Disease
Willebrand JJ I-Disease
disease NN I-Disease
: : O
evidence NN O
for IN O
a DT O
subgroup NN O
with IN O
an DT O
abnormal JJ O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
. . O

Type NN B-Disease
I PRP I-Disease
von VBP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
( ( O
vWD NN B-Disease
) ) O
is VBZ O
characterized VBN O
by IN O
equally RB O
low JJ O
plasma JJ O
concentrations NNS O
of IN O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
antigen NN O
( ( O
vWF JJ O
Ag NNP O
) ) O
and CC O
ristocetin JJ O
cofactor NN O
( ( O
RiCof NNP O
) ) O
and CC O
by IN O
the DT O
presence NN O
of IN O
all DT O
vWF NN O
multimers NNS O
in IN O
sodium NN O
dodecyl NN O
sulfate NN O
( ( O
SDS NNP O
) ) O
- : O
agarose JJ O
gel JJ O
electrophoresis NN O
. . O

For IN O
17 CD O
patients NNS O
( ( O
13 CD O
kindreds NNS O
) ) O
diagnosed VBD O
with IN O
these DT O
criteria NNS O
, , O
we PRP O
have VBP O
studied VBN O
the DT O
platelet NN O
contents NNS O
of IN O
vWF NN O
Ag NNP O
and CC O
RiCof NNP O
and CC O
the DT O
changes NNS O
of IN O
these DT O
in IN O
plasma NN O
after IN O
DDAVP NNP O
infusion NN O
. . O

Platelet NNP O
vWF NN O
Ag NNP O
and CC O
RiCof NNP O
were VBD O
normal JJ O
in IN O
four CD O
kindreds NNS O
( ( O
called VBN O
"""" RB O
platelet NN O
normal JJ O
"""" NNP O
subgroup NN O
) ) O
; : O
following VBG O
1 CD O
- : O
deamino NN O
- : O
8 CD O
- : O
D NNP O
- : O
arginine NN O
vasopressin NN O
; : O
plasma CC O
vWF FW O
Ag NNP O
, , O
RiCof NNP O
and CC O
the DT O
bleeding NN O
time NN O
( ( O
BT NNP O
) ) O
became VBD O
normal JJ O
. . O

In IN O
six CD O
kindreds NNS O
, , O
platelet NN O
vWF NN O
Ag NNP O
and CC O
RiCof NNP O
were VBD O
equally RB O
low JJ O
( ( O
platelet VB O
low JJ O
) ) O
; : O
after IN O
DDAVP NNP O
, , O
plasma NN O
vWF NN O
Ag NNP O
and CC O
RiCof NNP O
remained VBD O
low JJ O
, , O
and CC O
the DT O
BT NNP O
was VBD O
prolonged VBN O
. . O

In IN O
three CD O
additional JJ O
kindreds NNS O
, , O
platelets NNS O
contained VBD O
normal JJ O
concentrations NNS O
of IN O
vWF NN O
Ag NNP O
, , O
but CC O
RiCof NNP O
was VBD O
very RB O
low JJ O
( ( O
platelet VB O
discordant NN O
) ) O
; : O
even RB O
though IN O
a DT O
complete JJ O
set NN O
of IN O
multimers NNS O
was VBD O
found VBN O
in IN O
plasma NN O
and CC O
platelets NNS O
, , O
there EX O
was VBD O
a DT O
relatively RB O
small JJ O
amount NN O
of IN O
large JJ O
multimers NNS O
. . O

After IN O
DDAVP NNP O
, , O
plasma NN O
vWF NN O
Ag NNP O
became VBD O
normal JJ O
, , O
but CC O
RiCof NNP O
remained VBD O
low JJ O
and CC O
the DT O
BT NNP O
was VBD O
very RB O
prolonged JJ O
. . O

These DT O
findings NNS O
demonstrated VBD O
that IN O
there EX O
can MD O
be VB O
an DT O
abnormal JJ O
vWF NN O
( ( O
RiCof NNP O
less JJR O
than IN O
vWF FW O
Ag NNP O
) ) O
even RB O
in IN O
type NN B-Disease
I PRP I-Disease
vWD VBP I-Disease
, , O
coexisting VBG O
with IN O
a DT O
complete JJ O
set NN O
of IN O
vWF NN O
multimers NNS O
( ( O
platelet VB O
discordant NN O
) ) O
; : O
that IN O
the DT O
abnormal JJ O
vWF NN O
can MD O
be VB O
shown VBN O
more JJR O
clearly RB O
in IN O
platelets NNS O
than IN O
in IN O
plasma NN O
or CC O
else RB O
in IN O
plasma NN O
after IN O
DDAVP NNP O
infusion NN O
; : O
and CC O
that IN O
DDAVP NNP O
normalizes VBZ O
the DT O
BT NNP O
only RB O
in IN O
those DT O
patients NNS O
with IN O
normal JJ O
platelet NN O
levels NNS O
of IN O
both DT O
vWF NNP O
Ag NNP O
and CC O
RiCof NNP O
( ( O
platelet VB O
normal JJ O
) ) O
. . O
. . O

Genetic JJ O
analysis NN O
in IN O
families NNS O
with IN O
van JJ B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
. . O

We PRP O
have VBP O
brought VBN O
together RB O
information NN O
on IN O
864 CD O
affected JJ O
individuals NNS O
in IN O
164 CD O
families NNS O
( ( O
including VBG O
three CD O
new JJ O
pedigrees NNS O
) ) O
reported VBD O
in IN O
the DT O
137 CD O
year NN O
period NN O
since IN O
1845 CD O
when WRB O
Demarquay NNP O
first RB O
described VBD O
a DT O
family NN O
with IN O
what WP O
was VBD O
later RB O
called VBN O
van NN B-Disease
der NN I-Disease
Woude NNP I-Disease
syndrome NN I-Disease
( ( O
VWS NNP B-Disease
) ) O
. . O

Both DT O
types NNS O
of IN O
oral JJ B-Disease
cleft NN I-Disease
, , O
cleft NN B-Disease
palate NN I-Disease
( ( O
CP NNP B-Disease
) ) O
and CC O
cleft $ B-Disease
lip NN I-Disease
with IN O
or CC O
without IN O
CP NNP B-Disease
( ( O
CLP NNP B-Disease
) ) O
, , O
segregate VBP O
in IN O
these DT O
families NNS O
together RB O
with IN O
lower JJR O
lip NN B-Disease
pits NNS I-Disease
or CC O
fistulae NN B-Disease
in IN O
an DT O
autosomal JJ O
dominant JJ O
mode NN O
with IN O
high JJ O
penetrance NN O
estimated VBN O
to TO O
be VB O
K NNP O
= NNP O
. . O

89 CD O
and CC O
. . O

99 CD O
by IN O
different JJ O
methods NNS O
. . O

Cleft NNP O
types NNS O
( ( O
CLP NNP B-Disease
and CC O
CP NNP B-Disease
) ) O
occur VBP O
in IN O
VWS NNP B-Disease
in IN O
the DT O
same JJ O
proportions NNS O
as IN O
in IN O
the DT O
general JJ O
non NN O
- : O
VWS NNP O
population NN O
, , O
ie NN O
, , O
about RB O
twice RB O
as RB O
many JJ O
cleft SYM O
- : O
bearing NN O
individuals NNS O
have VBP O
CLP VBN B-Disease
as IN O
have JJ O
CP NNP B-Disease
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
we PRP O
do VBP O
not RB O
find VB O
the DT O
usually RB O
observed JJ O
excess NN O
of IN O
females NNS O
with IN O
CP NNP B-Disease
and CC O
excess NN O
of IN O
males NNS O
with IN O
CLP NNP B-Disease
; : O
in IN O
VWS NNP B-Disease
the DT O
sex NN O
ratios NNS O
are VBP O
more JJR O
nearly RB O
equal JJ O
. . O

Lip NNP B-Disease
pits NNS I-Disease
also RB O
are VBP O
equally RB O
distributed VBN O
between IN O
the DT O
sexes NNS O
. . O

Affected JJ O
males NNS O
and CC O
females NNS O
are VBP O
equally RB O
likely JJ O
to TO O
transmit VB O
VWS NNP B-Disease
. . O

However RB O
, , O
there EX O
is VBZ O
an DT O
excess NN O
of IN O
less RBR O
severely RB O
affected JJ O
individuals NNS O
among IN O
transmitters NNS O
and CC O
a DT O
deficiency NN O
of IN O
more RBR O
severely RB O
affected JJ O
, , O
brought VBN O
about IN O
by IN O
a DT O
proband NN O
bias NN O
and CC O
differential JJ O
fecundity NN O
. . O

The DT O
expression NN O
of IN O
VWS NNP B-Disease
is VBZ O
significantly RB O
modified VBN O
by IN O
the DT O
genetic JJ O
background NN O
More RBR O
extreme JJ O
phenotypes NNS O
in IN O
parents NNS O
tend VBP O
to TO O
produce VB O
more JJR O
extreme JJ O
expression NN O
in IN O
their PRP$ O
children NNS O
. . O

For IN O
a DT O
VWS NNP B-Disease
gene NN O
carrier NN O
the DT O
relative JJ O
risk NN O
of IN O
transmitting VBG O
a DT O
cleft NN O
is VBZ O
26 CD O
. . O

45 CD O
% NN O
; : O
that IN O
of IN O
transmitting VBG O
lower JJR O
lip NN B-Disease
pits NNS I-Disease
is VBZ O
23 CD O
. . O

55 CD O
% NN O
. . O

Three CD O
pedigrees NNS O
of IN O
lip NN B-Disease
pits NNS I-Disease
in IN O
the DT O
literature NN O
show NN O
no DT O
clefts NN O
among IN O
a DT O
significant JJ O
number NN O
of IN O
affected JJ O
individuals NNS O
. . O

Control NN O
of IN O
gene NN O
expression NN O
in IN O
VWS NNP B-Disease
in IN O
the DT O
three CD O
target NN O
tissues NNS O
appears VBZ O
to TO O
be VB O
independent JJ O
and CC O
separately RB O
designated VBN O
. . O

Mutation NNP O
rate NN O
of IN O
the DT O
VWS NNP B-Disease
gene NN O
is VBZ O
calculated VBN O
to TO O
be VB O
1 CD O
. . O

8 CD O
X $ O
10 CD O
( ( O
- : O
5 CD O
) ) O

Hereditary NNP B-Disease
C7 NNP I-Disease
deficiency NN I-Disease
. . O

Diagnosis NN O
and CC O
HLA NNP O
studies NNS O
in IN O
a DT O
French JJ O
- : O
Canadian JJ O
family NN O
. . O

The DT O
serum NN O
of IN O
a DT O
44 CD O
- : O
yr NN O
- : O
old JJ O
woman NN O
of IN O
French NNP O
- : O
Canadian JJ O
descent NN O
having VBG O
a DT O
B NNP O
- : O
27 CD O
positive JJ O
ankylosing VBG B-Disease
spondylitis NN I-Disease
was VBD O
deficient NN B-Disease
in IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C7 NNP O
) ) O
as IN O
determined VBN O
by IN O
hemolytic JJ O
and CC O
immunochemical JJ O
methods NNS O
. . O

No DT O
inhibitor NN O
against IN O
C7 NNP O
was VBD O
detected VBN O
, , O
and CC O
the DT O
levels NNS O
of IN O
all DT O
other JJ O
complement JJ O
components NNS O
were VBD O
normal JJ O
. . O

No DT O
deficiency NN O
in IN O
the DT O
opsonic JJ O
activity NN O
of IN O
the DT O
serum NN O
was VBD O
found VBN O
, , O
and CC O
the DT O
results NNS O
of IN O
basic JJ O
coagulation NN O
studies NNS O
of IN O
the DT O
plasma NN O
were VBD O
normal JJ O
. . O

On IN O
investigation NN O
of IN O
the DT O
patients NNS O
family NN O
, , O
two CD O
sisters NNS O
were VBD O
found VBN O
to TO O
have VB O
the DT O
same JJ O
deficiency NN O
but CC O
were VBD O
otherwise RB O
in IN O
good JJ O
health NN O
. . O

The DT O
seven CD O
other JJ O
siblings NNS O
were VBD O
heterozygous JJ O
for IN O
C7 NNP B-Disease
deficiency NN I-Disease
, , O
while IN O
the DT O
paternal JJ O
aunt NN O
had VBD O
a DT O
normal JJ O
C7 NNP O
level NN O
. . O

In IN O
the DT O
third JJ O
generation NN O
, , O
six CD O
children NNS O
of IN O
the DT O
three CD O
homozygous JJ O
sisters NNS O
and CC O
five CD O
children NNS O
of IN O
heterozygotes NNS O
were VBD O
available JJ O
for IN O
testing VBG O
. . O

Studies NNS O
of IN O
the DT O
HLA NNP O
antigens NNS O
in IN O
all PDT O
the DT O
22 CD O
subjects NNS O
and CC O
in IN O
three CD O
spouses NNS O
indicated VBD O
no DT O
close JJ O
linkage NN O
between IN O
the DT O
CM NNP B-Disease
deficienty NN I-Disease
and CC O
the DT O
HLA NNP O
system NN O
. . O

In IN O
addition NN O
, , O
the DT O
simultaneous JJ O
occurrence NN O
of IN O
two CD O
hereditary JJ O
complement NN B-Disease
deficiencies NNS I-Disease
( ( I-Disease
C2 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
) ) I-Disease
was VBD O
discovered VBN O
in IN O
one CD O
family NN O
of IN O
this DT O
remarkable JJ O
kindred VBN O
. . O
. . O

Genetic JJ O
defect NN B-Disease
in IN I-Disease
secretion NN I-Disease
of IN I-Disease
complement NN I-Disease
C5 NNP I-Disease
in IN O
mice NN O
. . O

A DT O
genetic JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
fifth NN I-Disease
( ( I-Disease
C5 NNP I-Disease
) ) I-Disease
component NN I-Disease
of IN I-Disease
complement1 NN I-Disease
- : I-Disease
3 CD I-Disease
, , O
a DT O
serum JJ O
glycoprotein NN O
of IN O
molecular JJ O
weight NN O
( ( O
MW NNP O
) ) O
220 CD O
, , O
0 CD O
( ( O
ref NN O
. . O
4 CD O
) ) O
, , O
has VBZ O
been VBN O
found VBN O
in IN O
39 CD O
% NN O
of IN O
inbred JJ O
strains NNS O
of IN O
mice3 NN O
. . O

Sera NN O
of IN O
deficient JJ O
mice NNS O
lack VBP O
detectable JJ O
C5 NNP O
activity NN O
and CC O
protein2 NN O
, , O
3 CD O
. . O

In IN O
addition NN O
deficient NN O
mice NN O
produce VBP O
antibody NN O
to TO O
mouse VB O
C5 NNP O
when WRB O
injected VBN O
with IN O
sera NN O
from IN O
C5 NNP O
sufficient NN O
( ( O
normal JJ O
) ) O
strains NNS O
. . O

Levy NNP O
et CC O
al NN O
. . O

5 CD O
showed VBD O
that IN O
somatic JJ O
cell NN O
hybrids NNS O
between IN O
C5 NNP O
deficient NN O
( ( O
B10 NNP O
. . O
D2 NNP O
/ NNP O
old JJ O
line NN O
) ) O
macrophages NNS O
and CC O
either DT O
C5 NNP O
sufficient NN O
( ( O
B10 NNP O
. . O
D2 NNP O
/ NNP O
new JJ O
line NN O
) ) O
mouse NN O
kidney NN O
or CC O
chicken NN O
erythroblasts NNS O
secreted VBD O
haemolytically RB O
active JJ O
mouse NN O
C5 NNP O
in IN O
vitro NN O
. . O

Several JJ O
possible JJ O
molecular JJ O
mechanisms NNS O
to TO O
account VB O
for IN O
the DT O
findings NNS O
were VBD O
considered VBN O
, , O
but CC O
insufficient JJ O
direct JJ O
data NNS O
were VBD O
available JJ O
to TO O
choose VB O
among IN O
them PRP O
. . O

We PRP O
recently RB O
reported VBD O
that IN O
mouse NN O
( ( O
CD NNP O
. . O
1 CD O
strain NN O
) ) O
peritoneal NN O
cells NNS O
in IN O
culture NN O
synthesise NN O
and CC O
secrete VB O
a DT O
single JJ O
chain NN O
precursor NN O
, , O
pro FW O
- : O
C5 NN O
( ( O
MW NNP O
approximately RB O
210 CD O
, , O
0 CD O
) ) O
, , O
of IN O
the DT O
two CD O
- : O
chain NN O
( ( O
alpha JJ O
chain NN O
, , O
125 CD O
, , O
0 CD O
and CC O
beta NN O
chain NN O
83 CD O
, , O
0 CD O
MW NNP O
) ) O
C5 NNP O
protein6 NN O
. . O

Radiolabelled VBN O
precursor NN O
C5 NNP O
was VBD O
contained VBN O
within IN O
the DT O
cells NNS O
and CC O
was VBD O
secreted VBN O
into IN O
the DT O
tissue NN O
culture NN O
media NNS O
. . O

Using VBG O
similar JJ O
methods NNS O
, , O
we PRP O
now RB O
find VBP O
that IN O
C5 NNP B-Disease
deficiency NN I-Disease
in IN O
each DT O
of IN O
five CD O
different JJ O
mouse NN O
strains NNS O
( ( O
AKR NNP O
, , O
SWR NNP O
, , O
DBA NNP O
/ VBZ O
2J8 CD O
A NNP O
/ NNP O
HeJ NNP O
and CC O
B10 NNP O
. . O
D2 NNP O
/ NNP O
old JJ O
line NN O
) ) O
is VBZ O
due JJ O
to TO O
a DT O
failure NN O
in IN O
secretion NN O
of IN O
C5 NNP O
protein NN O
and CC O
not RB O
to TO O
a DT O
failure NN O
in IN O
biosynthesis NN O
of IN O
pro JJ O
- : O
C5 NN O

Recurrent NNP O
meningococcal JJ B-Disease
meningitis NN I-Disease
with IN O
absence NN B-Disease
of IN I-Disease
the DT I-Disease
sixth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
: : O
an DT O
evaluation NN O
of IN O
underlying VBG O
immunologic JJ O
mechanisms NNS O
. . O

A DT O
51 CD O
/ NN O
2 CD O
- : O
year NN O
- : O
old JJ O
black JJ O
girl NN O
with IN O
recurrent JJ O
meningococcal JJ B-Disease
meningitis NN I-Disease
and CC O
absence NN B-Disease
of IN I-Disease
the DT I-Disease
sixth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C6 NNP O
) ) O
is VBZ O
reported VBN O
. . O

To TO O
explore VB O
the DT O
pathogenesis NN O
of IN O
recurrent JJ O
neisserial JJ B-Disease
infections NNS I-Disease
in IN O
C6 NNP B-Disease
deficiency NN I-Disease
, , O
a DT O
detailed JJ O
analysis NN O
of IN O
her PRP$ O
immune JJ O
competence NN O
was VBD O
conducted VBN O
. . O

Her PRP$ O
serum NN O
had VBD O
normal JJ O
chemotactic JJ O
, , O
opsonic JJ O
, , O
alternative JJ O
complement NN O
pathway NN O
, , O
and CC O
specific JJ O
antibody NN O
activity NN O
, , O
but CC O
lacked VBD O
complement JJ O
- : O
mediated VBN O
bacteriolytic JJ O
activity NN O
. . O

In IN O
addition NN O
, , O
her PRP$ O
C6 NNP B-Disease
- : I-Disease
deficient NN I-Disease
serum NN O
was VBD O
indistinguishable JJ O
from IN O
normal JJ O
serum NN O
in IN O
a DT O
complement NN O
- : O
dependent JJ O
assay NN O
of IN O
phagocyte JJ O
bactericidal NN O
activity NN O
. . O

Absent JJ O
bacteriolysis NN O
remains VBZ O
the DT O
only JJ O
consistent JJ O
defect NN O
associated VBN O
with IN O
recurrent JJ O
neisserial JJ B-Disease
infections NNS I-Disease
and CC O
absence NN O
of IN O
one CD O
of IN O
the DT O
late JJ O
- : O
acting VBG O
complement NN O
components NNS O
. . O
. . O

Deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
human JJ O
subjects NNS O
. . O

Clinical NNP O
, , O
genetic JJ O
and CC O
immunologic JJ O
studies NNS O
in IN O
a DT O
large JJ O
kindred VBN O
. . O

The DT O
discovery NN O
of IN O
a DT O
large JJ O
kindred VBN O
with IN O
a DT O
heritable JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C5 NNP O
) ) O
has VBZ O
permitted VBN O
the DT O
accumulation NN O
of IN O
new JJ O
clinical JJ O
, , O
genetic JJ O
and CC O
immunologic JJ O
data NNS O
concerning VBG O
the DT O
role NN O
of IN O
C5 NNP O
in IN O
human JJ O
subjects NNS O
. . O

The DT O
proband NN O
, , O
who WP O
has VBZ O
had VBN O
nine CD O
episodes NNS O
of IN O
disseminated JJ O
gonococcal JJ B-Disease
infection NN I-Disease
, , O
has VBZ O
a DT O
hemolytic JJ O
C5 NNP O
level NN O
of IN O
approximately RB O
0 CD O
. . O

5 CD O
per IN O
cent NN O
of IN O
normal JJ O
. . O

No DT O
C5 NNP O
protein NN O
was VBD O
detectable JJ O
, , O
but CC O
low JJ O
levels NNS O
of IN O
functional JJ O
C5 NNP O
activity NN O
could MD O
be VB O
found VBN O
using VBG O
a DT O
sensitive JJ O
bactericidal NN O
assay NN O
. . O

The DT O
probands NNS O
twin VBP O
as RB O
well RB O
as IN O
another DT O
sister NN O
also RB O
had VBD O
extremely RB O
low JJ O
levels NNS O
of IN O
hemolytic JJ O
C5 NNP O
( ( O
approximately RB O
0 CD O
. . O
5 CD O
per IN O
cent NN O
normal JJ O
) ) O
, , O
but CC O
both DT O
these DT O
subjects NNS O
have VBP O
been VBN O
healthy JJ O
. . O

Hemolytic JJ O
complement NN O
and CC O
bacteriolytic JJ O
activity NN O
could MD O
be VB O
restored VBN O
by IN O
the DT O
addition NN O
of IN O
purified JJ O
C5 NNP O
. . O

No DT O
chemotactic JJ O
activity NN O
for IN O
polymorphonuclear NN O
leukocytes NNS O
could MD O
be VB O
generated VBN O
in IN O
the DT O
C5 NNP B-Disease
- : I-Disease
deficient NN I-Disease
serums NNS O
upon IN O
activation NN O
of IN O
either CC O
the DT O
classic JJ O
or CC O
alternative JJ O
pathways NNS O
, , O
again RB O
demonstrating VBG O
the DT O
importance NN O
of IN O
C5 NNP O
in IN O
human JJ O
subjects NNS O
for IN O
the DT O
production NN O
of IN O
chemotactic JJ O
factors NNS O
. . O

The DT O
chemotactic JJ O
responsiveness NN O
of IN O
the DT O
patients NNS O
polymorphonuclear VBP O
leukocytes NNS O
and CC O
monocytes NNS O
to TO O
preformed VB O
chemotactic JJ O
factors NNS O
was VBD O
not RB O
depressed VBN O
. . O

Twenty CD O
- : O
two CD O
of IN O
32 CD O
other JJ O
family NN O
members NNS O
from IN O
three CD O
generations NNS O
had VBD O
depressed VBN O
whole JJ O
hemolytic JJ O
complement NN O
levels NNS O
. . O

In IN O
19 CD O
of IN O
30 CD O
family NN O
members NNS O
, , O
levels NNS O
of IN O
hemolytic JJ O
C5 NNP O
ranged VBD O
from IN O
13 CD O
to TO O
64 CD O
per IN O
cent NN O
of IN O
normal JJ O
. . O

No DT O
linkage NN O
for IN O
C5 NNP B-Disease
deficiency NN I-Disease
and CC O
the DT O
A NNP O
or CC O
B NNP O
loci NN O
of IN O
the DT O
major JJ O
histocompatibility NN O
complex NN O
could MD O
be VB O
found VBN O
. . O

These DT O
data NNS O
suggest VBP O
an DT O
autosomal JJ O
codominant NN O
mode NN O
of IN O
inheritance NN O
of IN O
C5 NNP B-Disease
deficiency NN I-Disease
. . O

Deficiency NN B-Disease
of IN I-Disease
C5 NNP I-Disease
is VBZ O
compatible JJ O
with IN O
good JJ O
health NN O
, , O
but CC O
it PRP O
can MD O
be VB O
associated VBN O
with IN O
repeated VBN O
disseminated JJ O
gonococcal JJ B-Disease
infection NN I-Disease

Incidence NN O
and CC O
characteristics NNS O
of IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variants NNS O
in IN O
Japan NNP O
. . O

A DT O
total NN O
of IN O
3000 CD O
men NNS O
living VBG O
in IN O
Yamaguchi NNP O
were VBD O
screened VBN O
for IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
using VBG O
Beutlers NNP O
spot NN O
test NN O
and CC O
three CD O
types NNS O
of IN O
starch NN O
gel NN O
electrophoresis NN O
. . O

These DT O
electrophoresis NN O
used VBD O
a DT O
phosphate NN O
buffer NN O
system NN O
at IN O
pH JJ O
7 CD O
. . O

0 CD O
, , O
a DT O
TRIS NNP O
- : O
EDTA NNP O
- : O
borate NN O
buffer NN O
system NN O
at IN O
pH JJ O
8 CD O
. . O

6 CD O
, , O
and CC O
a DT O
TRIS NNP O
- : O
hydrochloride NN O
buffer NN O
system NN O
at IN O
pH JJ O
8 CD O
. . O
. . O

Fifteen NNP O
G6PD NNP B-Disease
- : I-Disease
deficient NN I-Disease
variants NNS O
were VBD O
found VBN O
at IN O
the DT O
rate NN O
of IN O
0 CD O
. . O

5 CD O
% NN O
and CC O
classified VBD O
into IN O
four CD O
groups NNS O
. . O

As IN O
new JJ O
variants NNS O
, , O
G6PD NNP O
Konan NNP O
, , O
Kamiube NNP O
, , O
and CC O
Kiwa NNP O
were VBD O
identified VBN O
. . O

These DT O
three CD O
variants NNS O
had VBD O
a DT O
mild JJ O
to TO O
moderate VB O
G6PD NNP B-Disease
deficiency NN I-Disease
and CC O
were VBD O
not RB O
associated VBN O
with IN O
any DT O
clinical JJ O
signs NNS O
. . O

G6PD NNP O
Konan NNP O
had VBD O
fast VBN O
electrophoretic JJ O
mobility NN O
as IN O
compared VBN O
with IN O
normal JJ O
levels NNS O
, , O
G6PD NNP O
Kiwa NNP O
had VBD O
slightly RB O
elevated VBN O
electrophoretic JJ O
mobility NN O
, , O
and CC O
G6PD NNP O
Kamiube NNP O
had VBD O
normal JJ O
electrophoretic JJ O
mobility NN O
. . O

These DT O
three CD O
variants NNS O
had VBD O
normal JJ O
levels NNS O
of IN O
Km NNP O
G6P NNP O
, , O
Km NNP O
NADP NNP O
, , O
and CC O
Ki NNP O
NADPH NNP O
, , O
normal JJ O
utilizations NNS O
of IN O
both DT O
2 CD O
- : O
deoxy NN O
- : O
G6P NNP O
and CC O
deamino NN O
- : O
NAPD NNP O
, , O
normal JJ O
heat NN O
stability NN O
, , O
and CC O
a DT O
normal JJ O
pH NN O
curve NN O
. . O

The DT O
other JJ O
variant NN O
was VBD O
G6PD NNP O
Ube NNP O
, , O
which WDT O
we PRP O
had VBD O
previously RB O
found VBN O
in IN O
Yamaguchi NNP O
( ( O
Nakashima NNP O
et RB O
al RB O
. . O
, , O
1977 CD O
) ) O
. . O

One CD O
boy NN O
with IN O
G6PD NNP O
Ube NNP O
was VBD O
Korean JJ O

Utilization NN O
of IN O
purines NNS O
by IN O
an DT O
HPRT NNP O
variant NN O
in IN O
an DT O
intelligent NN O
, , O
nonmutilative JJ O
patient NN O
with IN O
features NNS O
of IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
patient NN O
, , O
H NNP O
. . O

Chr NNP O
. . O

B NNP O
. . O
, , O
was VBD O
among IN O
the DT O
first JJ O
reported VBD O
with IN O
hyperuricemia NN B-Disease
and CC O
central JJ B-Disease
nervous JJ I-Disease
system NN I-Disease
symptoms NNS I-Disease
. . O

He PRP O
has VBZ O
been VBN O
found VBN O
to TO O
have VB O
a DT O
variant NN O
of IN O
hypoxanthine JJ O
guanine NN O
phosphoribosyl NN O
transferase NN O
( ( O
HPRT NNP O
; : O
E NNP O
. . O
C NNP O
. . O
2 CD O
. . O
4 CD O
. . O
2 CD O
. . O
8 CD O
) ) O
distinct NN O
from IN O
the DT O
enzyme JJ O
present NN O
in IN O
patients NNS O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
patient NN O
had VBD O
chroeoathetosis NN B-Disease
, , O
spasticity NN B-Disease
, , O
dysarthric JJ B-Disease
speech NN I-Disease
, , O
and CC O
hyperuricemia NN B-Disease
. . O

However RB O
, , O
his PRP$ O
intelligence NN O
was VBD O
normal JJ O
and CC O
he PRP O
had VBD O
no DT O
evidence NN O
of IN O
self NN O
- : O
mutilation NN O
. . O

There EX O
was VBD O
no DT O
activity NN O
of IN O
HPRT NNP O
in IN O
the DT O
lysates NNS O
of IN O
erythrocytes NNS O
and CC O
cultured JJ O
fibroblasts NNS O
when WRB O
analyzed VBN O
in IN O
the DT O
usual JJ O
manner NN O
. . O

Using VBG O
a DT O
newly RB O
developed VBN O
method NN O
for IN O
the DT O
study NN O
of IN O
purine JJ O
metabolism NN O
in IN O
intact JJ O
cultured JJ O
cells NNS O
, , O
this DT O
patient NN O
was VBD O
found VBN O
to TO O
metabolize VB O
some DT O
9 CD O
% NN O
of IN O
8 CD O
- : O
14C CD O
- : O
hypoxanthine NN O
, , O
and CC O
90 CD O
% NN O
of IN O
the DT O
isotope NN O
utilized VBD O
was VBD O
converted VBN O
to TO O
adenine VB O
and CC O
guanine VB O
nucleotides NNS O
. . O

In IN O
contrast NN O
, , O
cells NNS O
from IN O
patients NNS O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
were VBD O
virtually RB O
completely RB O
unable JJ O
to TO O
convert VB O
hypoxanthine NN O
to TO O
nucleotides NNS O
. . O

The DT O
patients NNS O
fibroblasts NNS O
were VBD O
even RB O
more RBR O
efficient JJ O
in IN O
the DT O
metabolism NN O
of IN O
8 CD O
- : O
14C CD O
- : O
guanine NN O
, , O
which WDT O
was VBD O
utilized VBN O
to TO O
the DT O
extent NN O
of IN O
27 CD O
% NN O
, , O
over IN O
80 CD O
% NN O
of IN O
which WDT O
was VBD O
converted VBN O
to TO O
guanine VB O
and CC O
adenine VB O
nucleotides NNS O
. . O

The DT O
growth NN O
of IN O
the DT O
cultured JJ O
fibroblasts NNS O
of IN O
this DT O
patient NN O
was VBD O
intermediate JJ O
in IN O
media NNS O
containing VBG O
hypoxanthine NN O
aminopterin NN O
thymidine NN O
( ( O
HAT NNP O
) ) O
, , O
whereas IN O
the DT O
growth NN O
of IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
cells NNS O
was VBD O
inhibited VBN O
and CC O
normal JJ O
cells NNS O
grew VBD O
normally RB O
. . O

Similarly RB O
in IN O
8 CD O
- : O
azaguanine NN O
, , O
6 CD O
- : O
thioguanine NN O
, , O
and CC O
8 CD O
- : O
azahypoxanthine NN O
, , O
the DT O
growth NN O
of IN O
the DT O
patients NNS O
cells NNS O
was VBD O
intermediate JJ O
between IN O
normal JJ O
and CC O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
cells NNS O
. . O

These DT O
observations NNS O
provide VBP O
further JJ O
evidence NN O
for IN O
genetic JJ O
heterogeneity NN O
among IN O
patients NNS O
with IN O
disorders NNS O
in IN O
purine JJ O
metabolism NN O
involving VBG O
the DT O
HPRT NNP O
gene NN O
. . O

They PRP O
document VBP O
that IN O
this DT O
famous JJ O
patient NN O
did VBD O
not RB O
have VB O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome VB I-Disease

Localisation NN O
of IN O
the DT O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
gene NN O
on IN O
the DT O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
by IN O
linkage NN O
to TO O
cloned VBN O
DNA NNP O
sequences NNS O
. . O

A DT O
linkage NN O
study NN O
in IN O
30 CD O
Becker NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
BMD NNP B-Disease
) ) O
kindreds VBZ O
using VBG O
three CD O
cloned VBN O
DNA NNP O
sequences NNS O
from IN O
the DT O
X NNP O
chromosome NN O
which WDT O
demonstrate VBP O
restriction NN O
fragment NN O
length NN O
polymorphisms NN O
( ( O
RFLPs NNP O
) ) O
, , O
suggests VBZ O
that IN O
the DT O
BMD NNP B-Disease
gene NN O
is VBZ O
located VBN O
on IN O
the DT O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
, , O
in IN O
the DT O
p21 JJ O
region NN O
. . O

The DT O
genes NNS O
for IN O
Becker NNP B-Disease
and CC I-Disease
Duchenne NNP I-Disease
dystrophies NNS I-Disease
must MD O
therefore RB O
be VB O
closely RB O
linked VBN O
, , O
if IN O
not RB O
allelic JJ O
, , O
and CC O
any DT O
future JJ O
DNA NNP O
probes NNS O
found VBD O
to TO O
be VB O
of IN O
practical JJ O
use NN O
in IN O
one CD O
disorder NN O
should MD O
be VB O
equally RB O
applicable JJ O
to TO O
the DT O
other JJ O
. . O

The DT O
linkage NN O
analysis NN O
also RB O
provides VBZ O
data NNS O
on IN O
the DT O
frequency NN O
of IN O
recombination NN O
along IN O
the DT O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
, , O
and CC O
across IN O
the DT O
centromeric JJ O
region NN O
. . O
. . O

Molecular JJ O
evidence NN O
for IN O
new JJ O
mutation NN O
at IN O
the DT O
hprt NN O
locus NN O
in IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NN I-Disease
patients NNS O
. . O

Hypoxanthine NNP O
- : O
guanine NN O
phosphoribosyltransferase NN O
( ( O
HPRT NNP O
; : O
EC2 NNP O
. . O
4 CD O
. . O
2 CD O
. . O
8 CD O
) ) O
, , O
which WDT O
functions NNS O
in IN O
the DT O
metabolic JJ O
salvage NN O
of IN O
purines NNS O
, , O
is VBZ O
encoded VBN O
by IN O
an DT O
X NNP O
- : O
linked VBN O
gene NN O
in IN O
man NN O
. . O

Partial JJ O
HPRT NNP B-Disease
deficiencies NNS I-Disease
are VBP O
associated VBN O
with IN O
gouty NN B-Disease
arthritis NN I-Disease
, , O
while IN O
absence NN O
of IN O
activity NN O
results NNS O
in IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
( ( O
L NNP B-Disease
- : I-Disease
N NNP I-Disease
) ) O
. . O

L NNP B-Disease
- : I-Disease
N NN I-Disease
patients NNS O
fail VBP O
to TO O
reproduce VB O
and CC O
the DT O
heterozygous JJ O
state NN O
appears VBZ O
to TO O
confer VB O
no DT O
selective JJ O
advantage NN O
. . O

Thus RB O
, , O
Haldanes NNP O
principle NN O
predicts VBZ O
that IN O
new JJ O
mutations NNS O
at IN O
the DT O
hprt NN O
locus NN O
must MD O
occur VB O
frequently RB O
in IN O
order NN O
for IN O
L NNP B-Disease
- : I-Disease
N NNP I-Disease
syndrome NN I-Disease
to TO O
be VB O
maintained VBN O
in IN O
the DT O
population NN O
. . O

This DT O
constant JJ O
introduction NN O
of IN O
new JJ O
mutations NNS O
would MD O
be VB O
expected VBN O
to TO O
result VB O
in IN O
a DT O
heterogeneous JJ O
collection NN O
of IN O
genetic JJ B-Disease
lesions NNS I-Disease
, , O
some DT O
of IN O
which WDT O
may MD O
be VB O
novel JJ O
. . O

As IN O
we PRP O
report VBP O
here RB O
, , O
the DT O
mutations NNS O
in IN O
the DT O
hprt JJ O
gene NN O
of IN O
seven CD O
L NNP B-Disease
- : I-Disease
N NNP I-Disease
patients NNS O
, , O
selected VBN O
from IN O
an DT O
initial JJ O
survey NN O
of IN O
28 CD O
patients NNS O
, , O
have VBP O
been VBN O
characterized VBN O
and CC O
all DT O
were VBD O
found VBN O
to TO O
be VB O
distinctly RB O
different JJ O
, , O
as IN O
predicted VBN O
. . O

The DT O
origin NN O
of IN O
one CD O
unusual JJ O
mutation NN O
has VBZ O
been VBN O
identified VBN O
by IN O
analysis NN O
of IN O
DNA NNP O
from IN O
four CD O
generations NNS O
of IN O
family NN O
members NNS O
. . O

Further RB O
molecular JJ O
analysis NN O
of IN O
the DT O
origin NN O
of IN O
new JJ O
mutations NNS O
at IN O
the DT O
hprt NN O
locus NN O
should MD O
aid VB O
in IN O
resolving VBG O
the DT O
issue NN O
of IN O
an DT O
apparent JJ O
difference NN O
in IN O
the DT O
frequency NN O
of IN O
hprt JJ O
mutations NNS O
in IN O
males NNS O
and CC O
females NNS O

Allelic JJ O
exclusion NN O
of IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
in IN O
platelets NNS O
and CC O
T NNP O
lymphocytes VBZ O
from IN O
a DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBD I-Disease
carrier NN O
. . O

An DT O
obligate NN O
carrier NN O
of IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
who WP O
was VBD O
also RB O
heterozygous JJ O
for IN O
the DT O
A NNP O
and CC O
B NNP O
types NNS O
of IN O
X NNP O
- : O
linked VBD O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
was VBD O
found VBN O
. . O

With IN O
her PRP$ O
it PRP O
became VBD O
possible JJ O
to TO O
determine VB O
whether IN O
allelic JJ O
exclusion NN O
occurs VBZ O
in IN O
particular JJ O
cell NN O
- : O
types NNS O
of IN O
the DT O
WAS NNP B-Disease
carrier NN O
. . O

If IN O
so RB O
, , O
the DT O
remaining VBG O
cells NNS O
of IN O
a DT O
particular JJ O
cell NN O
- : O
type NN O
would MD O
express VB O
only RB O
the DT O
normal JJ O
X NNP O
chromosome NN O
and CC O
only RB O
one CD O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
isoenzyme NN O
would MD O
be VB O
demonstrable JJ O
. . O

This DT O
carrier NN O
had VBD O
only RB O
the DT O
B NNP O
isoenzyme NN O
of IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
in IN O
platelets NNS O
and CC O
thymus SYM O
- : O
derived VBN O
T NNP O
lymphocytes NNS O
, , O
although IN O
both DT O
isoenzymes VBZ O
A NNP O
and CC O
B NNP O
were VBD O
present JJ O
in IN O
erythrocytes NNS O
and CC O
neutrophils NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
selection NN O
against IN O
the DT O
WAS NNP B-Disease
gene NN O
occurs VBZ O
in IN O
platelets NNS O
and CC O
thymus SYM O
- : O
derived VBN O
T NNP O
lymphocytes NNS O
and CC O
that IN O
the DT O
defects NNS O
associated VBN O
with IN O
WAS NNP B-Disease
expressed VBN O
in IN O
these DT O
cell NN O
- : O
types NNS O
may MD O
be VB O
implicated VBN O
in IN O
the DT O
genesis NN O
of IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
. . O
. . O

Complement JJ B-Disease
deficiency NN I-Disease
and CC O
nephritis NN B-Disease
. . O

A DT O
report NN O
of IN O
a DT O
family NN O
. . O

A DT O
family NN O
is VBZ O
described VBN O
in IN O
which WDT O
three CD O
children NNS O
had VBD O
homozygous JJ O
deficiency NN B-Disease
of IN I-Disease
C3 NNP I-Disease
and CC O
in IN O
which WDT O
both DT O
parents NNS O
and CC O
two CD O
other JJ O
children NNS O
were VBD O
heterozygous JJ O
for IN O
the DT O
C3 NNP O
null JJ O
gene NN O
. . O

One CD O
child NN O
with IN O
heterozygous JJ O
C3 NNP B-Disease
deficiency NN I-Disease
was VBD O
found VBN O
to TO O
have VB O
membranoproliferative JJ O
glomerulonephritis NN B-Disease
; : O
proteinuria NNS B-Disease
and CC O
/ NN O
or CC O
microscopical JJ O
haematuria NN B-Disease
was VBD O
present JJ O
in IN O
all DT O
three CD O
homozygous JJ O
C3 NNP B-Disease
- : I-Disease
deficient NN I-Disease
children NNS O
. . O

All DT O
children NNS O
with IN O
homozygous JJ O
or CC O
heterozygous JJ O
C3 NNP B-Disease
deficiency NN I-Disease
were VBD O
, , O
to TO O
a DT O
varying NN O
degree NN O
, , O
susceptible JJ O
to TO O
infection NN O
. . O

The DT O
only JJ O
child NN O
of IN O
the DT O
family NN O
with IN O
normal JJ O
complement NN O
had VBD O
no DT O
increased VBN O
risk NN O
of IN O
infection NN O
and CC O
no DT O
renal JJ B-Disease
disease NN I-Disease
. . O

This DT O
family NN O
study VB O
provides VBZ O
further JJ O
support NN O
for IN O
the DT O
proposal NN O
that IN O
C3 NNP B-Disease
deficiency NN I-Disease
predisposes NNS O
to TO O
nephritis VB B-Disease
. . O
. . O

Heterogeneity NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
Algeria NNP O
. . O

Study NN O
in IN O
Northern NNP O
Algeria NNP O
with IN O
description NN O
of IN O
five CD O
new JJ O
variants NNS O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
was VBD O
found VBN O
in IN O
3 CD O
. . O

2 CD O
% NN O
of IN O
the DT O
male JJ O
population NN O
living NN O
in IN O
the DT O
urban JJ O
area NN O
of IN O
Algiers NNP O
. . O

The DT O
deficient JJ O
subjects NNS O
originated VBN O
from IN O
multiple JJ O
geographic JJ O
regions NNS O
of IN O
Northern NNP O
Algeria NNP O
, , O
with IN O
prevalence NN O
of IN O
individuals NNS O
of IN O
Berber NNP O
- : O
Kabyle NNP O
origin NN O
. . O

Red JJ O
blood NN O
cell NN O
G6PD NNP O
was VBD O
partially RB O
purified VBN O
and CC O
characterized VBN O
in IN O
deficient JJ O
males NNS O
from IN O
17 CD O
families NNS O
, , O
and CC O
six CD O
different JJ O
variants NNS O
were VBD O
found VBN O
. . O

Among IN O
them PRP O
, , O
only RB O
one CD O
, , O
the DT O
Gd NNP O
( ( O
- : O
) ) O
Kabyle NNP O
variant NN O
, , O
had VBD O
been VBN O
previously RB O
described VBN O
. . O

It PRP O
was VBD O
detected VBN O
in IN O
nine CD O
families NNS O
. . O

The DT O
other JJ O
five CD O
variants NNS O
were VBD O
new JJ O
Gd NNP O
( ( O
- : O
) ) O
Laghouat NNP O
( ( O
four CD O
cases NNS O
) ) O
, , O
Gd NNP O
( ( O
- : O
) ) O
Blida NNP O
( ( O
one CD O
case NN O
) ) O
, , O
Gd NNP O
( ( O
- : O
) ) O
Thenia NNP O
( ( O
one CD O
case NN O
) ) O
, , O
Gd NNP O
( ( O
- : O
) ) O
Titteri NNP O
( ( O
one CD O
case NN O
) ) O
, , O
and CC O
Gd NNP O
( ( O
- : O
) ) O
Alger NNP O
( ( O
two CD O
brothers NNS O
) ) O
. . O

Strikingly RB O
, , O
the DT O
common JJ O
Mediterranean NNP O
variant NN O
was VBD O
not RB O
found VBN O
. . O

G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
heterogeneous JJ O
in IN O
northern JJ O
Algeria NNP O
where WRB O
autochtonous JJ O
variants NNS O
seem VBP O
to TO O
prevail VB O
. . O

The DT O
Kabyle NNP O
variant NN O
may MD O
be VB O
common JJ O
in IN O
this DT O
country NN O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
inhibits NNS O
in IN O
vitro JJ O
growth NN O
of IN O
Plasmodium NNP O
falciparum NN O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
; : I-Disease
EC NNP I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
1 CD I-Disease
. . I-Disease
49 CD I-Disease
) ) I-Disease
- : I-Disease
deficient NN I-Disease
red JJ O
blood NN O
cells NNS O
from IN O
male NN O
hemizygotes NNS O
and CC O
female JJ O
heterozygotes NNS O
from IN O
the DT O
island NN O
of IN O
Sardinia NNP O
were VBD O
studied VBN O
for IN O
their PRP$ O
ability NN O
to TO O
support VB O
growth NN O
in IN O
vitro NN O
of IN O
the DT O
malaria NNS B-Disease
- : O
causing VBG O
organism NN O
Plasmodium NNP O
falciparum NN O
. . O

Parasite NNP O
growth NN O
was VBD O
approximately RB O
one CD O
- : O
third NN O
of IN O
normal JJ O
in IN O
both DT O
hemi JJ O
- : O
and CC O
heterozygotes NNS O
for IN O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O

In IN O
Sardinians NNPS O
with IN O
the DT O
beta NN O
0 CD O
- : O
thalassemia NN O
trait NN O
, , O
parasite JJ O
growth NN O
was VBD O
normal JJ O
except IN O
when WRB O
G6PD NNP B-Disease
deficiency NN I-Disease
occurred VBD O
together RB O
with IN O
the DT O
thalassemia NN B-Disease
trait NN O
. . O

The DT O
data NN O
support NN O
the DT O
hypothesis NN O
that WDT O
G6PD NNP B-Disease
deficiency NN I-Disease
may MD O
confer VB O
a DT O
selective JJ O
advantage NN O
in IN O
a DT O
malarious JJ B-Disease
area NN O
; : O
the DT O
female JJ O
heterozygote NN O
may MD O
be VB O
at IN O
a DT O
particular JJ O
advantage NN O
because IN O
resistance NN O
to TO O
malaria VB B-Disease
equals NNS O
that IN O
of IN O
male NN O
hemizygotes NNS O
, , O
but CC O
the DT O
risk NN O
of IN O
fatal JJ B-Disease
hemolysis NN I-Disease
may MD O
be VB O
less JJR O
. . O

However RB O
, , O
more JJR O
female JJ O
heterozygotes NNS O
must MD O
be VB O
studied VBN O
to TO O
confirm VB O
this DT O
hypothesis NN O
. . O

No DT O
protective JJ O
effect NN O
of IN O
beta NN O
0 CD O
- : O
thalassemia NN O
trait NN O
could MD O
be VB O
demonstrated VBN O
in IN O
vitro NN O
. . O

Bone NNP O
marrow NN O
transplant NN O
in IN O
adrenoleukodystrophy NN B-Disease
. . O

An DT O
allogeneic NN O
bone NN O
marrow NN O
transplant NN O
( ( O
BMT NNP O
) ) O
from IN O
a DT O
normal JJ O
HLA NNP O
identical JJ O
sibling VBG O
donor NN O
was VBD O
performed VBN O
in IN O
a DT O
13 CD O
- : O
year NN O
- : O
old JJ O
boy NN O
with IN O
rapidly RB O
progressive JJ O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
. . O

Engraftment NN O
and CC O
complete JJ O
hematologic NN O
recovery NN O
occurred VBD O
within IN O
4 CD O
weeks NNS O
, , O
but CC O
neurologic JJ B-Disease
deterioration NN I-Disease
continued VBD O
. . O

The DT O
patient NN O
died VBD O
of IN O
an DT O
adenovirus JJ B-Disease
infection NN I-Disease
141 CD O
days NNS O
after IN O
BMT NNP O
. . O

ALD NNP B-Disease
is VBZ O
characterized VBN O
by IN O
abnormally RB O
high JJ O
plasma NN O
levels NNS O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
( ( O
VLCFA NNP O
) ) O
as IN O
a DT O
result NN O
of IN O
impaired JJ O
capacity NN O
to TO O
degrade VB O
them PRP O
. . O

Ten CD O
days NNS O
after IN O
BMT NNP O
, , O
the DT O
white JJ O
blood NN O
cell NN O
VLCFA NNP O
levels NNS O
and CC O
enzyme JJ O
activity NN O
became VBD O
normal JJ O
; : O
after IN O
3 CD O
months NNS O
, , O
there EX O
was VBD O
progressive JJ O
reduction NN O
of IN O
plasma NN O
VLCFA NNP O
to TO O
levels NNS O
only RB O
slightly RB O
above IN O
normal JJ O
. . O
. . O

[ NN O
Gd NNP O
- : O
allele JJ O
distribution NN O
patterns NNS O
in IN O
Azerbaijan NNP O
. . O
III NNP O
. . O
The DT O
identification NN O
of IN O
mutant JJ O
forms NNS O
of IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
] NN O

In IN O
28 CD O
families NNS O
with IN O
G6PD NNP B-Disease
deficiency NN I-Disease
living NN O
in IN O
3 CD O
settlements NNS O
of IN O
Shekii NNP O
district NN O
of IN O
Azerbaijan NNP O
11 CD O
G6PD NNP O
variants NNS O
of IN O
II NNP O
and CC O
III NNP O
classes NNS O
differing VBG O
by IN O
kinetic JJ O
properties NNS O
were VBD O
identified VBN O
according VBG O
WHO JJ O
program NN O
. . O

9 CD O
of IN O
them PRP O
are VBP O
characterized VBN O
with IN O
the DT O
same JJ O
electrophoretic JJ O
mobility NN O
. . O

Comparison NNP O
of IN O
G6PD NNP O
spectra NN O
in IN O
two CD O
subpopulations NNS O
and CC O
in IN O
a DT O
mixed JJ O
group NN O
permits VBZ O
to TO O
make VB O
a DT O
conclusion NN O
about IN O
existence NN O
of IN O
common JJ O
and CC O
rare JJ O
G6PD NNP O
alleles NNS O
in IN O
examined JJ O
population NN O
. . O

They PRP O
distribute VBP O
by IN O
gene NN O
drift NN O
supported VBN O
by IN O
natural JJ O
selection NN O
. . O

Among IN O
7 CD O
samples NNS O
of IN O
G6PD NNP O
with IN O
normal JJ O
and CC O
increased JJ O
activity NN O
two CD O
new JJ O
variants NNS O
of IN O
IV NNP O
class NN O
- : O
- : O
Nukha NN O
and CC O
Bash NNP O
- : O
Kungut NNP O
- : O
- : O
were VBD O
found VBN O
. . O
. . O

Adrenoleukodystrophy NN B-Disease
: : O
survey NN O
of IN O
303 CD O
cases NNS O
: : O
biochemistry NN O
, , O
diagnosis NN O
, , O
and CC O
therapy NN O
. . O

Adrenoleukodystrophy NNP B-Disease
( ( O
ALD NNP B-Disease
) ) O
is VBZ O
a DT O
genetically RB O
determined VBN O
disorder NN O
associated VBN O
with IN O
progressive JJ B-Disease
central JJ I-Disease
demyelination NN I-Disease
and CC O
adrenal JJ B-Disease
cortical JJ I-Disease
insufficiency NN I-Disease
. . O

All DT O
affected VBD O
persons NNS O
show VBP O
increased JJ O
levels NNS O
of IN O
saturated VBN O
unbranched JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
fatty JJ O
acids NNS O
, , O
particularly RB O
hexacosanoate NN O
( ( O
C26 NNP O
0 CD O
) ) O
, , O
because IN O
of IN O
impaired JJ O
capacity NN O
to TO O
degrade VB O
these DT O
acids NNS O
. . O

This DT O
degradation NN O
normally RB O
takes VBZ O
place NN O
in IN O
a DT O
subcellular JJ O
organelle NN O
called VBD O
the DT O
peroxisome NN O
, , O
and CC O
ALD NNP B-Disease
, , O
together RB O
with IN O
Zellwegers NNP B-Disease
cerebrohepatorenal JJ I-Disease
syndrome NN I-Disease
, , O
is VBZ O
now RB O
considered VBN O
to TO O
belong VB O
to TO O
the DT O
newly RB O
formed VBN O
category NN O
of IN O
peroxisomal JJ B-Disease
disorders NNS I-Disease
. . O

Biochemical NNP O
assays VBZ O
permit VBP O
prenatal JJ O
diagnosis NN O
, , O
as RB O
well RB O
as IN O
identification NN O
of IN O
most JJS O
heterozygotes NNS O
. . O

We PRP O
have VBP O
identified VBN O
303 CD O
patients NNS O
with IN O
ALD NNP B-Disease
in IN O
217 CD O
kindreds NNS O
. . O

These DT O
patients NNS O
show VBP O
a DT O
wide JJ O
phenotypic NN O
variation NN O
. . O

Sixty NNP O
percent NN O
of IN O
patients NNS O
had VBD O
childhood VBN O
ALD NNP B-Disease
and CC O
17 CD O
% NN O
adrenomyeloneuropathy NN B-Disease
, , O
both DT O
of IN O
which WDT O
are VBP O
X NNP O
- : O
linked VBN O
, , O
with IN O
the DT O
gene NN O
mapped VBD O
to TO O
Xq28 NNP O
. . O

Neonatal JJ B-Disease
ALD NNP I-Disease
, , O
a DT O
distinct JJ O
entity NN O
with IN O
autosomal JJ O
recessive JJ O
inheritance NN O
and CC O
points NNS O
of IN O
resemblance NN O
to TO O
Zellwegers NNP B-Disease
syndrome NN I-Disease
, , O
accounted VBD O
for IN O
7 CD O
% NN O
of IN O
the DT O
cases NNS O
. . O

Although IN O
excess JJ O
C26 NNP O
0 CD O
in IN O
the DT O
brain NN O
of IN O
patients NNS O
with IN O
ALD NNP B-Disease
is VBZ O
partially RB O
of IN O
dietary JJ O
origin NN O
, , O
dietary JJ O
C26 NNP O
0 CD O
restriction NN O
did VBD O
not RB O
produce VB O
clear JJ O
benefit NN O
. . O

Bone NNP O
marrow NN O
transplant NN O
lowered VBD O
the DT O
plasma NN O
C26 NNP O
0 CD O
level NN O
but CC O
failed VBD O
to TO O
arrest VB O
neurological JJ O
progression NN O
. . O
. . O

Genetic JJ O
polymorphism NN O
of IN O
G6PD NNP O
in IN O
a DT O
Bulgarian JJ O
population NN O
. . O

Considerable JJ O
genetic JJ O
heterogeneity NN O
in IN O
G6PD NNP O
was VBD O
found VBN O
in IN O
the DT O
Bulgarian JJ O
population NN O
- : O
14 CD O
G6PD NNP O
variants NNS O
isolated VBD O
from IN O
117 CD O
hemizygous JJ O
carriers NNS O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O

Of IN O
these DT O
, , O
G6PD NNP O
Mediterranean NNP O
type NN O
was VBD O
a DT O
polymorphic JJ O
variant NN O
and CC O
G6PD NNP O
Corinth NNP O
occurred VBD O
with IN O
high JJ O
frequency NN O
. . O

Two CD O
new JJ O
variants NNS O
were VBD O
identified VBN O
- : O
G6PD NNP O
Rudosem NNP O
and CC O
G6PD NNP O
Nedelino NNP O
. . O

In IN O
a DT O
selected VBN O
group NN O
of IN O
78 CD O
subjects NNS O
with IN O
clinical JJ O
manifestations NNS O
, , O
four CD O
variants NNS O
were VBD O
established VBN O
G6PD NNP O
Mediterranian NNP O
, , O
G6PD NNP O
Corinth NNP O
, , O
G6PD NNP O
Seattle NNP O
and CC O
G6PD NNP O
Ohut NNP O
II NNP O
. . O
. . O

Clinical JJ O
use NN O
of IN O
DNA NN O
markers NNS O
linked VBD O
to TO O
the DT O
gene NN O
for IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Seventy JJ O
families NNS O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
known VBN O
to TO O
the DT O
Institute NNP O
of IN O
Child NNP O
Health NNP O
fall NN O
into IN O
three CD O
categories NNS O
with IN O
respect NN O
to TO O
potential JJ O
linkage NN O
analysis NN O
with IN O
the DT O
X NNP O
chromosome NN O
DNA NNP O
markers NNS O
RC8 NNP O
and CC O
L1 NNP O
. . O

28 CD O
that WDT O
bridge VBP O
the DT O
DMD NNP B-Disease
gene NN O
. . O

Families NNS O
in IN O
which WDT O
there EX O
is VBZ O
at IN O
least JJS O
one CD O
obligatory JJ O
female JJ O
heterozygote NN O
( ( O
n JJ O
= NNP O
13 CD O
) ) O
. . O

Here RB O
prediction NN O
and CC O
exclusion NN O
of IN O
DMD NNP B-Disease
gene NN O
transmission NN O
may MD O
be VB O
possible JJ O
, , O
the DT O
accuracy NN O
being VBG O
dependent JJ O
on IN O
the DT O
closeness NN O
of IN O
the DT O
linkage NN O
of IN O
the DT O
DNA NN O
marker NN O
( ( O
s PRP O
) ) O
to TO O
the DT O
DMD NNP B-Disease
gene NN O
; : O
an DT O
illustrative JJ O
case NN O
is VBZ O
reported VBN O
. . O

Families NNS O
in IN O
which WDT O
there EX O
is VBZ O
a DT O
single JJ O
affected JJ O
boy NN O
, , O
who WP O
also RB O
has VBZ O
one CD O
or CC O
more JJR O
healthy JJ O
brothers NNS O
( ( O
n JJ O
= NNP O
26 CD O
) ) O
. . O

Given VBN O
an DT O
informative JJ O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
( ( O
RFLP NNP O
) ) O
, , O
the DT O
probability NN O
that IN O
the DT O
boy NN O
represents VBZ O
a DT O
new JJ O
mutation NN O
can MD O
be VB O
reassessed VBN O
; : O
it PRP O
is VBZ O
also RB O
possible JJ O
to TO O
exclude VB O
the DT O
DMD NNP B-Disease
gene NN O
in IN O
a DT O
sister NN O
. . O

Families NNS O
with IN O
a DT O
single JJ O
affected JJ O
boy NN O
with IN O
no DT O
brother NN O
( ( O
n JJ O
= NNP O
30 CD O
) ) O
. . O

Here RB O
exclusion NN O
of IN O
the DT O
DMD NNP B-Disease
gene NN O
in IN O
a DT O
sister NN O
may MD O
be VB O
possible JJ O
. . O

Only RB O
in IN O
one CD O
family NN O
was VBD O
there RB O
no DT O
possibility NN O
of IN O
useful JJ O
linkage NN O
analysis NN O
. . O

The DT O
linkage NN O
analysis NN O
required VBN O
is VBZ O
described VBN O
, , O
and CC O
the DT O
need NN O
to TO O
check VB O
DMD NNP B-Disease
families NNS O
for IN O
informative JJ O
RFLPs NNP O
is VBZ O
stressed VBN O
. . O

Family RB O
studies NNS O
in IN O
Bechterew NNP B-Disease
' POS I-Disease
s JJ I-Disease
syndrome NN I-Disease
( ( O
ankylosing VBG B-Disease
spondylitis NN I-Disease
) ) O
III NNP O
. . O

Genetics NNS O
. . O

The DT O
results NNS O
of IN O
segregation NN O
analyses NNS O
in IN O
75 CD O
families NNS O
where WRB O
the DT O
proband NN O
had VBD O
ankylosing VBG B-Disease
spondylitis NN I-Disease
, , O
are VBP O
presented VBN O
. . O

Of IN O
the DT O
278 CD O
adult NN O
, , O
living VBG O
first JJ O
degree JJ O
relatives NNS O
, , O
approximately RB O
85 CD O
% NN O
cooperated VBN O
in IN O
the DT O
study NN O
. . O

Clinical JJ O
and CC O
radiographical JJ O
examinations NNS O
were VBD O
performed VBN O
and CC O
HLA NNP O
typing NN O
was VBD O
conducted VBN O
. . O

The DT O
results NNS O
were VBD O
in IN O
agreement NN O
with IN O
our PRP$ O
hypothesis NN O
that IN O
ankylosing VBG B-Disease
spondylitis NN I-Disease
is VBZ O
part NN O
of IN O
a DT O
syndrome NN O
where WRB O
different JJ O
genetic JJ O
factors NNS O
interact NN O
. . O

Such JJ O
known VBN O
factors NNS O
are VBP O
HLA NNP O
B27 NNP O
associated VBD O
disease NN O
susceptibility NN O
, , O
susceptibility NN O
to TO O
psoriatic VB B-Disease
arthropathy NN I-Disease
and CC O
susceptibility NN O
to TO O
entero VB B-Disease
- : I-Disease
arthropathy NN I-Disease
. . O

Radiographical JJ O
sacro NN B-Disease
- : I-Disease
iliitis NN I-Disease
was VBD O
restricted VBN O
to TO O
HLA NNP O
B27 NNP O
positive JJ O
relatives NNS O
, , O
and CC O
was VBD O
more RBR O
frequently RB O
found VBN O
in IN O
relatives NNS O
to TO O
probands NNS O
with IN O
psoriasis NN B-Disease
than IN O
in IN O
relatives NNS O
to TO O
probands NNS O
without IN O
psoriasis NN B-Disease
. . O

Environmental JJ O
factors NNS O
( ( O
intestinal JJ O
bacteria NNS O
) ) O
are VBP O
known VBN O
to TO O
trigger VB O
the DT O
disease NN O
at IN O
least JJS O
in IN O
some DT O
persons NNS O
, , O
and CC O
we PRP O
have VBP O
postulated VBN O
that IN O
all DT O
or CC O
most JJS O
of IN O
them PRP O
have VBP O
the DT O
predisposition NN O
to TO O
develop VB O
disease NN O
. . O

Thus RB O
, , O
the DT O
syndrome NN O
has VBZ O
a DT O
multifactorial JJ O
etiology NN O
. . O

The DT O
phenotypic JJ O
expressions NNS O
of IN O
the DT O
different JJ O
genetic JJ O
predispositions NNS O
involved VBN O
, , O
include VBP O
sacro JJ B-Disease
- : I-Disease
iliitis NN I-Disease
, , O
psoriasis NN B-Disease
, , O
acute JJ B-Disease
anterior JJ I-Disease
uveitis NN I-Disease
, , O
peripheral JJ O
arthropathy NN B-Disease
and CC O
inflammatory JJ B-Disease
bowel NN I-Disease
disease NN I-Disease
. . O

We PRP O
suggest VBP O
the DT O
descriptive JJ O
name NN O
HEREDITARY NNP B-Disease
MULTIFOCAL NNP I-Disease
RELAPSING NNP I-Disease
INFLAMMATION NNP I-Disease
( ( O
HEMRI NNP B-Disease
) ) O
for IN O
this DT O
syndrome NN O
. . O

Ankylosing VBG B-Disease
spondylitis NN I-Disease
, , O
psoriatic JJ B-Disease
arthropathy NN I-Disease
and CC O
entero NN B-Disease
- : I-Disease
arthropathy NN I-Disease
may MD O
be VB O
regarded VBN O
as IN O
clinical JJ O
sub NN O
- : O
types NNS O
of IN O
the DT O
syndrome NN O
. . O
. . O

Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
and CC O
chromosome NN O
15 CD O
. . O

A DT O
clinical JJ O
discussion NN O
of IN O
20 CD O
cases NNS O
. . O

A DT O
chromosome NN B-Disease
15 CD I-Disease
anomaly NN I-Disease
was VBD O
observed VBN O
in IN O
12 CD O
of IN O
20 CD O
patients NNS O
, , O
17 CD O
of IN O
whom WP O
were VBD O
clinically RB O
suspected VBN O
of IN O
having VBG O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

The DT O
clinical JJ O
features NNS O
of IN O
eight CD O
cases NNS O
with IN O
15q11 CD O
- : O
12 CD O
deletion NN O
were VBD O
very RB O
similar JJ O
to TO O
those DT O
originally RB O
described VBN O
in IN O
PWS NNP B-Disease
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
group NN O
of IN O
normal JJ O
karyotype NN O
patients NNS O
is VBZ O
heterogeneous JJ O
, , O
and CC O
their PRP$ O
features NNS O
do VBP O
not RB O
strictly RB O
correspond NN O
to TO O
the DT O
clinical JJ O
definition NN O
of IN O
PWS NNP B-Disease
. . O

However RB O
, , O
the DT O
hypothesis NN O
that IN O
PWS NNP B-Disease
is VBZ O
associated VBN O
with IN O
deletion NN O
of IN O
15q11 CD O
- : O
12 CD O
can MD O
neither RB O
explain VB O
the DT O
apparently RB O
balanced JJ O
translocations NNS O
of IN O
chromosome NN O
15 CD O
nor CC O
account NN O
for IN O
the DT O
small JJ O
supernumerary JJ O
metacentric NN O
chromosomes NNS O
corresponding VBG O
to TO O
an DT O
isochromosome JJ O
15 CD O
for IN O
band NN O
15q11 CD O
observed VBN O
in IN O
some DT O
cases NNS O
. . O
. . O

The DT O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
gene NN O
in IN O
North JJ O
American JJ O
Jewish JJ O
populations NNS O
: : O
geographic JJ O
variations NNS O
and CC O
origin NN O
. . O

From IN O
data NNS O
collected VBN O
in IN O
a DT O
North JJ O
American JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
heterozygote VBP O
screening VBG O
program NN O
, , O
the DT O
TSD NNP B-Disease
carrier NN O
frequency NN O
among IN O
46 CD O
, , O
304 CD O
Jewish JJ O
individuals NNS O
was VBD O
found VBN O
to TO O
be VB O
. . O

324 CD O
( ( O
1 CD O
in IN O
31 CD O
individuals NNS O
) ) O
. . O

This DT O
frequency NN O
is VBZ O
consistent JJ O
with IN O
earlier JJR O
estimates NNS O
based VBN O
on IN O
TSD NNP B-Disease
incidence NN O
data NNS O
. . O

TSD NNP B-Disease
carrier NN O
frequencies NNS O
were VBD O
then RB O
examined VBN O
by IN O
single JJ O
country NN O
and CC O
single JJ O
region NN O
of IN O
origin NN O
in IN O
28 CD O
, , O
29 CD O
Jews NNPS O
within IN O
this DT O
sample NN O
for IN O
whom WP O
such JJ O
data NNS O
were VBD O
available JJ O
for IN O
analysis NN O
. . O

Jews NNS O
with IN O
Polish JJ O
and CC O
/ JJ O
or CC O
Russian JJ O
ancestry NN O
constituted VBD O
88 CD O
% NN O
of IN O
this DT O
sample NN O
and CC O
had VBD O
a DT O
TSD NNP B-Disease
carrier NN O
frequency NN O
of IN O
. . O

327 CD O
. . O

No DT O
TSD NNP B-Disease
carriers NNS O
were VBD O
observed VBN O
among IN O
the DT O
166 CD O
Jews NNS O
of IN O
Near NNP O
Eastern NNP O
origins VBZ O
. . O

Relative JJ O
to TO O
Jews NNPS O
of IN O
Polish NNPS O
and CC O
Russian JJ O
origins NNS O
, , O
there EX O
was VBD O
at IN O
least JJS O
a DT O
twofold JJ O
increase NN O
in IN O
the DT O
TSD NNP B-Disease
carrier NN O
frequency NN O
in IN O
Jews NNP O
of IN O
Austrian NNP O
, , O
Hungarian NNP O
, , O
and CC O
Czechoslovakian JJ O
origins NNS O
( ( O
P NNP O
less JJR O
than IN O
. . O
5 CD O
) ) O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
TSD NNP B-Disease
gene NN O
proliferated VBD O
among IN O
the DT O
antecedents NNS O
of IN O
modern JJ O
Ashkenazi NNP O
Jewry NNP O
after IN O
the DT O
Second JJ O
Diaspora NNP O
( ( O
70 CD O
A NNP O
. . O
D NNP O
. . O
) ) O
and CC O
before IN O
their PRP$ O
major JJ O
migrations NNS O
to TO O
regions NNS O
of IN O
Poland NNP O
and CC O
Russia NNP O
( ( O
before IN O
1100 CD O
A NNP O
. . O
D NNP O
. . O
) ) O
. . O

Human NNP O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
sixth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
a DT O
patient NN O
with IN O
meningococcal JJ B-Disease
meningitis NN I-Disease
and CC O
no DT O
haemostasis NN B-Disease
abnormality NN I-Disease
. . O

A DT O
case NN O
of IN O
human JJ O
complete JJ O
C6 NNP B-Disease
deficiency NN I-Disease
is VBZ O
reported VBN O
. . O

The DT O
patient NN O
, , O
a DT O
31 CD O
year NN O
old JJ O
white JJ O
male NN O
, , O
was VBD O
seen VBN O
on IN O
the DT O
occasion NN O
of IN O
an DT O
isolated JJ O
episode NN O
of IN O
meningococcal JJ B-Disease
meningitis NN I-Disease
. . O

Serum NNP O
complement NN O
hemolytic NN O
and CC O
bactericidal JJ O
activities NNS O
were VBD O
lacking VBG O
and CC O
could MD O
be VB O
restored VBN O
to TO O
normal JJ O
by IN O
addition NN O
of IN O
appropriate JJ O
amounts NNS O
of IN O
purified JJ O
C6 NNP O
. . O

No DT O
hemostatic JJ B-Disease
abnormalities NNS I-Disease
were VBD O
observed VBN O
. . O
. . O

Absence NN B-Disease
of IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
a DT O
patient NN O
with IN O
chronic JJ B-Disease
meningococcemia NN I-Disease
presenting NN O
as IN O
vasculitis NN B-Disease
. . O

A DT O
previously RB O
healthy JJ O
40 CD O
- : O
year NN O
- : O
old JJ O
man NN O
presenting VBG O
with IN O
fever NN B-Disease
, , O
arthritis NN B-Disease
, , O
and CC O
cutaneous JJ B-Disease
vasculitis NN I-Disease
was VBD O
found VBN O
to TO O
have VB O
chronic JJ B-Disease
meningococcemia NN I-Disease
. . O

Evaluation NN O
of IN O
his PRP$ O
complement NN O
system NN O
showed VBD O
an DT O
absence NN O
of IN O
functional JJ O
and CC O
antigenic JJ O
C7 NNP O
, , O
compatible JJ O
with IN O
a DT O
complete JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
. . O

Study NN O
of IN O
the DT O
patients NNS O
family NN O
spanning VBG O
four CD O
generations NNS O
showed VBD O
heterozygous JJ O
deficiency NN B-Disease
of IN I-Disease
C7 NNP I-Disease
in IN O
five CD O
members NNS O
. . O

Chronic NNP B-Disease
neisserial JJ I-Disease
infection NN I-Disease
can MD O
be VB O
associated VBN O
with IN O
C7 NNP B-Disease
deficiency NN I-Disease
and CC O
must MD O
be VB O
distinguished VBN O
from IN O
other JJ O
causes NNS O
of IN O
cutaneous JJ B-Disease
vasculitis NN I-Disease
. . O
. . O

Familial JJ B-Disease
discoid NN I-Disease
lupus NN I-Disease
erythematosus NN I-Disease
associated VBN O
with IN O
heterozygote NN O
C2 NNP B-Disease
deficiency NN I-Disease
. . O

Two CD O
siblings NNS O
with IN O
chronic JJ B-Disease
discoid NN I-Disease
lupus NN I-Disease
erythematosus NN I-Disease
and CC O
several JJ O
family NN O
members NNS O
were VBD O
found VBN O
with IN O
heterozygous JJ O
C2 NNP B-Disease
deficiency NN I-Disease
. . O

An DT O
association NN O
with IN O
histocompatibility NN O
markers NNS O
HLA NNP O
- : O
B18 NNP O
and CC O
HLA NNP O
- : O
Dw2 NN O
was VBD O
demonstrated VBN O
, , O
and CC O
the DT O
slow JJ O
allotype NN O
of IN O
factor NN O
B NNP O
was VBD O
present JJ O
. . O

Linkage NN O
studies NNS O
in IN O
this DT O
family NN O
suggested VBD O
a DT O
close JJ O
linkage NN O
between IN O
the DT O
C2 NNP B-Disease
deficiency NN I-Disease
gene NN O
and CC O
genes NNS O
coding VBG O
for IN O
B18 NNP O
, , O
Dw2 NNP O
, , O
and CC O
BfS NNP O
antigens NNS O
. . O

One CD O
HLA NNP O
- : O
ACB NNP O
/ NNP O
DBf NNP O
recombinant NN O
was VBD O
observed VBN O
showing VBG O
closer RBR O
linkage NN O
between IN O
HLA NNP O
- : O
D NN O
and CC O
Bf NNP O
than IN O
between IN O
HLA NNP O
- : O
B NN O
and CC O
Bf NNP O
. . O
. . O

Severe NNP B-Disease
- : I-Disease
glucose JJ I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
associated VBN O
with IN O
chronic JJ O
hemolytic JJ B-Disease
anemia NN I-Disease
, , O
granulocyte JJ B-Disease
dysfunction NN I-Disease
, , O
and CC O
increased VBD O
susceptibility NN O
to TO O
infections NNS O
: : O
description NN O
of IN O
a DT O
new JJ O
molecular JJ O
variant NN O
( ( O
G6PD NNP O
Barcelona NNP O
) ) O
. . O

Molecular NNP O
, , O
kinetic JJ O
, , O
and CC O
functional JJ O
studies NNS O
were VBD O
carried VBN O
out RP O
on IN O
erythrocytes NNS O
and CC O
leukocytes NNS O
in IN O
a DT O
Spanish JJ O
male NN O
with IN O
G6PD NNP B-Disease
deficiency NN I-Disease
, , O
congenital JJ B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
( ( O
CNSHA NNP B-Disease
) ) O
, , O
and CC O
increased VBD O
susceptibility NN O
to TO O
infections NNS O
. . O

G6PD NNP O
activity NN O
was VBD O
absent JJ O
in IN O
patients NNS O
red JJ O
cells NNS O
and CC O
was VBD O
about RB O
2 CD O
% NN O
of IN O
normal JJ O
in IN O
leukocytes NNS O
. . O

Molecular JJ O
studies NNS O
using VBG O
standard JJ O
methods NNS O
( ( O
WHO NNP O
, , O
1967 CD O
) ) O
showed VBD O
G6PD NNP O
in IN O
the DT O
patient NN O
to TO O
have VB O
a DT O
slightly RB O
fast JJ O
electrophoretic JJ O
mobility NN O
at IN O
pH JJ O
8 CD O
. . O

0 CD O
with IN O
otherwise RB O
normal JJ O
properties NNS O
( ( O
heat NN O
stability NN O
at IN O
46 CD O
degrees NNS O
C NNP O
, , O
apparent JJ O
affinity NN O
for IN O
substrates NNS O
, , O
optimum JJ O
pH NN O
, , O
and CC O
utilization NN O
of IN O
substrate NN O
analogues NNS O
) ) O
. . O

Other JJ O
tests NNS O
showed VBD O
the DT O
patients NNS O
granulocytes VBZ O
to TO O
engulf VB O
latex JJ O
particles NNS O
normally RB O
, , O
but CC O
to TO O
have VB O
impaired JJ O
reduction NN O
of IN O
nitroblue JJ O
tetrazolium NN O
and CC O
ferricytochrome JJ O
- : O
c NN O
as RB O
well RB O
as IN O
reduced VBN O
iodination NN O
. . O

Chemotaxis NNP O
and CC O
random JJ O
migration NN O
of IN O
the DT O
patients NNS O
granulocytes NNS O
were VBD O
normal JJ O
as IN O
were VBD O
myeloperoxidase NN O
, , O
leukocyte JJ O
alkaline NN O
phosphatase NN O
( ( O
LAP NNP O
) ) O
, , O
and CC O
ultrastructural JJ O
features NNS O
. . O

The DT O
molecular JJ O
characteristics NNS O
of IN O
G6PD NNP O
in IN O
the DT O
patient NN O
differed VBD O
from IN O
those DT O
of IN O
all DT O
previously RB O
reported VBN O
variants NNS O
associated VBN O
with IN O
CNSHA NNP B-Disease
, , O
so IN O
the DT O
present JJ O
variant NN O
was VBD O
provisionally RB O
called VBN O
G6PD NNP O
Barcelona NNP O
to TO O
distinguish VB O
it PRP O
from IN O
other JJ O
G6PD NNP O
variants NNS O
previously RB O
described VBN O
. . O

Possible JJ O
mechanisms NN O
for IN O
the DT O
severe JJ O
deficiency NN B-Disease
of IN I-Disease
G6PD NNP I-Disease
in IN O
erythrocytes NNS O
and CC O
granulocytes NNS O
was VBD O
investigated VBN O
by IN O
studies NNS O
on IN O
the DT O
immunologic JJ O
specific JJ O
activity NN O
of IN O
the DT O
mutant JJ O
enzyme NN O
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
Papua NNP O
New NNP O
Guinea NNP O
. . O

The DT O
description NN O
of IN O
13 CD O
new JJ O
variants NNS O
. . O

A DT O
total NN O
of IN O
362 CD O
males NNS O
from IN O
various JJ O
regions NNS O
of IN O
Papua NNP O
New NNP O
Guinea NNP O
were VBD O
screened VBN O
for IN O
red JJ O
cell NN O
glucose VB O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
activity NN O
. . O

Twenty NNP O
- : O
six CD O
G6PD NNP B-Disease
deficient NN I-Disease
individuals NNS O
were VBD O
identified VBN O
. . O

Biochemical JJ O
characterization NN O
of IN O
G6PD NNP O
purified VBD O
from IN O
these DT O
subjects NNS O
has VBZ O
revealed VBN O
13 CD O
new JJ O
variants NNS O
and CC O
several JJ O
copies NNS O
of IN O
previously RB O
described VBN O
forms NNS O
of IN O
G6PD NNP O
. . O

This DT O
study NN O
illustrates VBZ O
the DT O
extreme JJ O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
among IN O
the DT O
people NNS O
of IN O
Papua NNP O
New NNP O
Guinea NNP O
. . O
. . O

Heterogeneity NN O
of IN O
"""" JJ O
Mediterranean NNP O
type NN O
"""" NN O
glucose VBD B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
Spain NNP O
and CC O
description NN O
of IN O
two CD O
new JJ O
variants NNS O
associated VBN O
with IN O
favism NN B-Disease
. . O

Glucose NNP O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
; : O
EC NNP O
1 CD O
. . O

1 CD O
. . O

1 CD O
. . O

49 CD O
from IN O
thirty JJ O
- : O
six CD O
unrelated JJ O
Spanish JJ O
males NNS O
was VBD O
partially RB O
purified VBN O
from IN O
blood NN O
, , O
and CC O
the DT O
variants NNS O
were VBD O
characterized VBN O
biochemically RB O
and CC O
electrophoretically RB O
according VBG O
to TO O
the DT O
methods NNS O
recommended VBN O
by IN O
the DT O
world NN O
Health NNP O
Organization NNP O
. . O

Subjects NNS O
were VBD O
from IN O
multiple JJ O
geographic JJ O
regions NNS O
within IN O
Spain NNP O
, , O
and CC O
all DT O
suffered VBD O
from IN O
hemolytic JJ B-Disease
anemia NN I-Disease
, , O
either DT O
acute NN O
( ( O
34 CD O
cases NNS O
) ) O
or CC O
chronic JJ O
nonspherocytic JJ O
( ( O
2 CD O
cases NNS O
) ) O
. . O

Almost RB O
all PDT O
the DT O
variants NNS O
studied VBN O
presented VBN O
residual JJ O
erythrocyte NN O
G6PD NNP O
activity NN O
ranging VBG O
from IN O
0 CD O
to TO O
10 CD O
% NN O
of IN O
normal JJ O
, , O
and CC O
five CD O
different JJ O
mutants NNS O
were VBD O
responsible JJ O
for IN O
the DT O
deficient NN O
phenotype NN O
. . O

Three CD O
variants NNS O
were VBD O
similar JJ O
to TO O
others NNS O
previously RB O
described VBN O
G6PD NNP O
Mediterranean NNP O
( ( O
11 CD O
cases NNS O
) ) O
, , O
G6PD NNP O
Athens NNP O
- : O
like IN O
( ( O
3 CD O
cases NNS O
) ) O
, , O
and CC O
G6PD NNP O
Union NNP O
( ( O
2 CD O
cases NNS O
) ) O
. . O

The DT O
remaining VBG O
variants NNS O
were VBD O
different JJ O
from IN O
the DT O
numerous JJ O
variants NNS O
already RB O
reported VBN O
and CC O
have VBP O
been VBN O
considered VBN O
as IN O
new JJ O
mutants NNS O
. . O

Provisionally RB O
they PRP O
are VBP O
called VBN O
G6PD NNP O
Betica NNP O
( ( O
19 CD O
cases NNS O
) ) O
and CC O
G6PD NNP O
Menorca NNP O
( ( O
1 CD O
case NN O
) ) O
. . O

The DT O
present JJ O
study NN O
constitutes VBZ O
the DT O
first JJ O
attempt NN O
to TO O
characterize VB O
the DT O
deficient NN B-Disease
G6PD NNP I-Disease
variants NNS O
found VBD O
in IN O
Spain NNP O
and CC O
supplies NNS O
new JJ O
data NNS O
on IN O
the DT O
relationship NN O
between IN O
molecular JJ O
characteristics NNS O
of IN O
deficient NN O
variants NNS O
and CC O
their PRP$ O
clinical JJ O
manifestations NNS O
. . O

The DT O
most RBS O
important JJ O
findings NNS O
can MD O
be VB O
summarized VBN O
as IN O
follows VBZ O
( ( O
1 CD O
) ) O
The DT O
Spanish JJ O
population NN O
is VBZ O
characterized VBN O
by IN O
an DT O
important JJ O
heterogeneity NN O
in IN O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O

( ( O
2 CD O
) ) O
Although IN O
G6PD NNP O
Mediterranean NNP O
is VBZ O
very RB O
frequent JJ O
, , O
it PRP O
presents VBZ O
a DT O
relatively RB O
high JJ O
degree NN O
of IN O
polymorphism NN O
. . O

( ( O
3 CD O
) ) O
Favism NN B-Disease
has VBZ O
been VBN O
observed VBN O
associated VBN O
with IN O
all DT O
kinds NNS O
of IN O
variants NNS O
described VBN O
here RB O
. . O

( ( O
4 CD O
) ) O
G6PD NNP O
Betica NNP O
, , O
which WDT O
is VBZ O
the DT O
most RBS O
frequent JJ O
variant NN O
found VBD O
in IN O
subjects NNS O
of IN O
Southern NNP O
Spanish NNP O
origin NN O
, , O
has VBZ O
been VBN O
observed VBN O
associated VBN O
with IN O
favism NN B-Disease
in IN O
all DT O
cases NNS O
except IN O
one CD O
. . O

A DT O
new JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variant NN O
( ( O
G6PD NNP O
Nagano NNP O
) ) O
associated VBN O
with IN O
congenital JJ B-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
. . O

A DT O
new JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
variant NN O
associated VBN O
with IN O
chronic JJ B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
was VBD O
reported VBN O
. . O

The DT O
patient NN O
, , O
a DT O
6 CD O
- : O
year NN O
- : O
old JJ O
Japanese JJ O
male NN O
, , O
was VBD O
noticed VBN O
to TO O
have VB O
hemolytic JJ B-Disease
anemia NN I-Disease
soon RB O
after IN O
birth NN O
, , O
and CC O
a DT O
diagnosis NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
was VBD O
made VBN O
at IN O
the DT O
age NN O
of IN O
2 CD O
. . O

He PRP O
had VBD O
episodes NNS O
of IN O
hemolytic JJ B-Disease
crisis NN I-Disease
several JJ O
times NNS O
after IN O
upper JJ B-Disease
respiratory NN I-Disease
infection NN I-Disease
. . O

G6PD NNP O
activity NN O
of IN O
the DT O
patient NN O
was VBD O
5 CD O
. . O

5 CD O
% NN O
of IN O
normal JJ O
. . O

The DT O
enzymatic JJ O
characteristics NNS O
were VBD O
examined VBN O
when WRB O
he PRP O
was VBD O
5 CD O
years NNS O
old JJ O
, , O
and CC O
his PRP$ O
G6PD NN O
showed VBD O
faster RBR O
- : O
than IN O
- : O
normal JJ O
electrophoretic JJ O
mobility NN O
, , O
low JJ O
Km NNP O
G6P NNP O
, , O
high JJ O
Km NNP O
NADP NNP O
, , O
low JJ O
Ki NNP O
NADPH NNP O
, , O
normal JJ O
utilization NN O
of IN O
substrate NN O
analogues NNS O
, , O
heat NN O
instability NN O
, , O
and CC O
a DT O
normal JJ O
pH NN O
optimum JJ O
curve NN O
. . O

From IN O
these DT O
results NNS O
, , O
this DT O
was VBD O
considered VBN O
to TO O
be VB O
a DT O
new JJ O
variant NN O
and CC O
was VBD O
designated VBN O
G6PD NNP O
Nagano NNP O
. . O

Infection NNP O
- : O
induced JJ O
hemolysis NN B-Disease
and CC O
chronic JJ B-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
seem VBP O
to TO O
be VB O
due JJ O
to TO O
markedly RB O
impaired JJ O
enzyme NN O
activity NN O
and CC O
thermal JJ O
instability NN O
. . O

Heterozygous JJ O
C2 NNP B-Disease
- : I-Disease
deficiency NN I-Disease
and CC O
myasthenia NN B-Disease
gravis NN I-Disease
. . O

Complement NNP B-Disease
deficiency NN I-Disease
states NNS O
in IN O
myasthenia NN B-Disease
gravis NN I-Disease
( ( O
MG NNP B-Disease
) ) O
have VBP O
not RB O
been VBN O
reported VBN O
previously RB O
. . O

We PRP O
describe VBP O
a DT O
19 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
with IN O
typical JJ O
MG NNP B-Disease
and CC O
heterozygous JJ O
C2 NNP B-Disease
deficiency NN I-Disease
, , O
along IN O
with IN O
HLA NNP O
typing NN O
of IN O
the DT O
patient NN O
and CC O
her PRP$ O
immediate JJ O
family NN O
. . O
. . O

Adrenoleukodystrophy NN B-Disease
: : O
increased VBN O
plasma NN O
content NN O
of IN O
saturated JJ O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
. . O

With IN O
a DT O
new JJ O
method NN O
we PRP O
measured VBD O
the DT O
saturated JJ O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
in IN O
the DT O
plasma NN O
of IN O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
hemizygotes VBZ O
, , O
ALD NNP B-Disease
heterozygotes VBZ O
, , O
and CC O
controls NNS O
. . O

ALD NNP B-Disease
hemizygotes VBZ O
showed VBD O
increased JJ O
levels NNS O
of IN O
hexacosanoate NN O
( ( O
C26 NNP O
fatty RB O
acid NN O
) ) O
which WDT O
represented VBD O
0 CD O
. . O

81 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O

66 CD O
% NN O
( ( O
SEM NNP O
) ) O
of IN O
total JJ O
fatty JJ O
acids NNS O
, , O
compared VBN O
to TO O
0 CD O
. . O

15 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O

32 CD O
% NN O
in IN O
the DT O
controls NNS O
. . O

C25 NNP O
, , O
C24 NNP O
, , O
and CC O
C23 NNP O
fatty JJ O
acids NNS O
were VBD O
also RB O
increased VBN O
, , O
but CC O
the DT O
C22 NNP O
and CC O
C20 NNP O
fatty JJ O
acids NNS O
were VBD O
normal JJ O
. . O

C26 NN O
levels NNS O
were VBD O
also RB O
increased VBN O
in IN O
most JJS O
ALD NNP B-Disease
heterozygotes VBZ O
, , O
with IN O
a DT O
mean JJ O
level NN O
0 CD O
. . O

57 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O

63 CD O
% NN O
of IN O
total JJ O
fatty JJ O
acids NNS O
. . O

The DT O
technique NN O
can MD O
be VB O
used VBN O
for IN O
diagnosis NN O
and CC O
carrier NN O
identification NN O
, , O
and CC O
in IN O
the DT O
evaluation NN O
of IN O
therapy NN O
. . O

Abnormal JJ O
high JJ O
density NN O
lipoproteins NNS O
in IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
. . O

The DT O
plasma NN O
lipoprotein NN O
profiles NNS O
and CC O
high JJ O
density NN O
lipoproteins NNS O
( ( O
HDL NNP O
) ) O
were VBD O
characterized VBN O
in IN O
patients NNS O
with IN O
the DT O
genetic JJ B-Disease
disease NN I-Disease
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
. . O

Abnormalities NNS B-Disease
in IN I-Disease
the DT I-Disease
HDL NNP I-Disease
may MD O
contribute VB O
to TO O
their PRP$ O
increased VBN O
atherogenesis NN O
and CC O
excessive JJ O
deposits NNS O
of IN O
tissue NN O
sterols NNS O
in IN O
the DT O
presence NN O
of IN O
low JJ O
or CC O
low JJ O
- : O
normal JJ O
concentrations NNS O
of IN O
plasma NN O
cholesterol NN O
( ( O
165 CD O
+ NN O
/ NNP O
- : O
25 CD O
mg NN O
/ NNP O
dl NN O
) ) O
and CC O
low JJ O
density NN O
lipoproteins NNS O
( ( O
LDL NNP O
) ) O
. . O

The DT O
mean NN O
HDL NNP O
- : O
cholesterol NN O
concentration NN O
in IN O
the DT O
CTX NNP B-Disease
plasmas NN O
was VBD O
14 CD O
. . O

5 CD O
+ JJ O
/ NNP O
- : O
3 CD O
. . O

2 CD O
mg NN O
/ NNP O
dl NN O
, , O
about IN O
one CD O
- : O
third VBZ O
the DT O
normal JJ O
value NN O
. . O

The DT O
low JJ O
HDL NNP O
- : O
cholesterol NN O
reflects VBZ O
a DT O
low JJ O
concentration NN O
and CC O
an DT O
abnormal JJ O
lipid JJ O
composition NN O
of IN O
the DT O
plasma NN O
HDL NNP O
. . O

Relative JJ O
to TO O
normal JJ O
HDL NNP O
, , O
the DT O
cholesteryl NN O
esters NNS O
are VBP O
low JJ O
, , O
free JJ O
cholesterol NN O
and CC O
phospholipids NNS O
essentially RB O
normal JJ O
, , O
and CC O
triglycerides NNS O
increased VBD O
. . O

The DT O
ratio NN O
of IN O
apoprotein NN O
( ( O
apo NN O
) ) O
to TO O
total JJ O
cholesterol NN O
in IN O
the DT O
HDL NNP O
of IN O
CTX NNP B-Disease
was VBD O
two CD O
to TO O
three CD O
times NNS O
greater JJR O
than IN O
normal JJ O
. . O

In IN O
the DT O
CTX NNP B-Disease
HDL NNP O
, , O
the DT O
ratio NN O
of IN O
apoAI NN O
to TO O
apoAII VB O
was VBD O
high JJ O
, , O
the DT O
proportion NN O
of IN O
apoC NN O
low JJ O
, , O
and CC O
a DT O
normally RB O
minor JJ O
form NN O
of IN O
apoAI NN O
increased VBD O
relative JJ O
to TO O
other JJ O
forms NNS O
. . O

The DT O
HDL NNP O
in IN O
electron NNP O
micrographs NN O
appeared VBD O
normal JJ O
morphologically RB O
and CC O
in IN O
particle NN O
size NN O
. . O

The DT O
abnormalities NNS O
in IN O
lipoprotein JJ O
distribution NN O
profile NN O
and CC O
composition NN O
of IN O
the DT O
plasma NN O
HDL NNP O
result NN O
from IN O
metabolic JJ O
defects NNS O
that WDT O
are VBP O
not RB O
understood JJ O
but CC O
may MD O
be VB O
linked VBN O
to TO O
the DT O
genetic JJ B-Disease
defect NN I-Disease
in IN O
bile JJ O
acid JJ O
synthesis NN O
in IN O
CTX NNP B-Disease
. . O

As IN O
a DT O
consequence NN O
, , O
it PRP O
is VBZ O
probable JJ O
that IN O
the DT O
normal JJ O
functions NNS O
of IN O
the DT O
HDL NNP O
, , O
possibly RB O
including VBG O
modulation NN O
of IN O
LDL NNP O
- : O
cholesterol NN O
uptake NN O
and CC O
the DT O
removal NN O
of IN O
excess JJ O
cholesterol NN O
from IN O
peripheral JJ O
tissues NNS O
, , O
are VBP O
perturbed VBN O
significantly RB O
in IN O
this DT O
disease NN O
. . O

Genetics NNS O
of IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
: : O
an DT O
autosomal JJ O
recessive JJ O
trait NN O
with IN O
high JJ O
gene NN O
frequency NN O
in IN O
Sephardim NNP O
of IN O
Moroccan NNP O
origin NN O
. . O

We PRP O
described VBD O
6 CD O
patients NNS O
( ( O
from IN O
3 CD O
families NNS O
) ) O
affected VBD O
with IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
. . O

All DT O
are VBP O
Sephardic JJ O
Jews NNP O
of IN O
Moroccan NNP O
extraction NN O
. . O

In IN O
view NN O
of IN O
the DT O
small JJ O
number NN O
of IN O
CTX NNP B-Disease
patients NNS O
diagnosed VBD O
in IN O
the DT O
world NN O
( ( O
a DT O
total NN O
of IN O
50 CD O
including VBG O
our PRP$ O
6 CD O
patients NNS O
) ) O
, , O
we PRP O
are VBP O
probably RB O
dealing VBG O
with IN O
an DT O
ethnic JJ O
subgroup NN O
with IN O
a DT O
high JJ O
CTX NNP O
gene NN O
frequency NN O
, , O
which WDT O
we PRP O
have VBP O
estimated VBN O
to TO O
be VB O
1 CD O
/ JJ O
108 CD O
. . O

Since IN O
there EX O
are VBP O
differences NNS O
in IN O
expression NN O
in IN O
this DT O
disease NN O
, , O
we PRP O
recommend VBP O
cholestanol JJ O
study NN O
in IN O
cases NNS O
of IN O
undiagnosed JJ O
cataract NN B-Disease
or CC O
tendinous JJ B-Disease
xanthomas NNS I-Disease
in IN O
childhood NN O
or CC O
early JJ O
adolescence NN O
. . O

The DT O
diagnosis NN O
in IN O
CTX NNP B-Disease
is VBZ O
important JJ O
not RB O
only RB O
for IN O
genetic JJ O
counseling NN O
, , O
but CC O
also RB O
in IN O
veiw NN O
of IN O
possible JJ O
treatment NN O
. . O
. . O

New NNP O
genetic JJ O
variants NNS O
of IN O
glucose JJ O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
in IN O
Italy NNP O
. . O

Six CD O
new JJ O
variants NNS O
of IN O
human JJ O
erythrocyte NN O
G6PD NNP O
have VBP O
been VBN O
characterized VBN O
. . O

All DT O
of IN O
them PRP O
were VBD O
found VBN O
in IN O
Italian JJ O
males NNS O
and CC O
all DT O
were VBD O
associated VBN O
with IN O
enzyme JJ B-Disease
deficiency NN I-Disease
, , O
but CC O
only RB O
two CD O
with IN O
signs NNS O
of IN O
haemolysis NN B-Disease
. . O

These DT O
and CC O
other JJ O
variants NNS O
reported VBN O
in IN O
the DT O
literature NN O
, , O
which WDT O
must MD O
thus RB O
far RB O
be VB O
regarded VBN O
as IN O
sporadic NN O
, , O
are VBP O
found VBN O
to TO O
map VB O
in IN O
parts NNS O
of IN O
Italy NNP O
where WRB O
common JJ O
types NNS O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
are VBP O
also RB O
prevalent JJ O
. . O
. . O

Variants NNS O
of IN O
erythrocyte NN O
glucose VBP O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
( ( O
G6PD NNP O
) ) O
in IN O
Bulgarian JJ O
populations NNS O
. . O

Ten CD O
variants NNS O
of IN O
erythrocyte NN O
glucose VBP O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
were VBD O
identified VBN O
in IN O
22 CD O
patients NNS O
with IN O
G6PD NNP B-Disease
deficiency NN I-Disease
from IN O
three CD O
districts NNS O
of IN O
Bulgaria NNP O
. . O

Corinth NNP O
- : O
like IN O
and CC O
Fayoum NNP O
- : O
like IN O
variants NNS O
were VBD O
the DT O
most RBS O
frequent JJ O
; : O
Mediterranean NNP O
, , O
Ohut NNP O
II NNP O
, , O
Kilgore NNP O
, , O
Boston NNP O
, , O
Poznan NNP O
, , O
and CC O
Panay NNP O
variants NNS O
and CC O
two CD O
new JJ O
variants NNS O
, , O
Petrich NNP O
and CC O
Gotze NNP O
Delchev NNP O
, , O
were VBD O
each DT O
found VBN O
in IN O
one CD O
or CC O
two CD O
carriers NNS O
. . O

No DT O
correlation NN O
was VBD O
revealed VBN O
between IN O
clinical JJ O
and CC O
biochemical JJ O
polymorphism NN O
. . O
. . O

Nephropathy NNP B-Disease
in IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
. . O

Nephropathy NNP B-Disease
was VBD O
detected VBN O
in IN O
five CD O
of IN O
32 CD O
patients NNS O
with IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
who WP O
were VBD O
participating VBG O
in IN O
a DT O
study NN O
of IN O
transfer NN O
factor NN O
( ( O
TF NNP O
) ) O
therapy NN O
. . O

In IN O
two CD O
patients NNS O
, , O
nephropathy NN B-Disease
was VBD O
present JJ O
before IN O
TF NNP O
and CC O
did VBD O
not RB O
appear VB O
changed VBN O
by IN O
TF NNP O
therapy NN O
. . O

One CD O
of IN O
these DT O
patients NNS O
subsequently RB O
developed VBD O
progressive JJ O
renal JJ B-Disease
failure NN I-Disease
requiring VBG O
dialysis NN O
beginning VBG O
5 CD O
1 CD O
/ JJ O
2 CD O
years NNS O
after IN O
TF NNP O
therapy NN O
. . O

In IN O
two CD O
patients NNS O
, , O
decreased VBD O
renal JJ O
function NN O
appeared VBD O
very RB O
soon RB O
after IN O
the DT O
administration NN O
of IN O
TF NNP O
. . O

One CD O
patient NN O
showed VBD O
gradually RB O
decreasing VBG O
renal JJ O
function NN O
beginning VBG O
after IN O
two CD O
years NNS O
of IN O
TF NNP O
therapy NN O
. . O

An DT O
additional JJ O
patient NN O
was VBD O
identified VBN O
who WP O
died VBD O
with IN O
renal JJ B-Disease
failure NN I-Disease
without IN O
having VBG O
received VBN O
TF NNP O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
renal JJ B-Disease
failure NN I-Disease
occurs VBZ O
in IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBD I-Disease
more RBR O
frequently RB O
than IN O
generally RB O
recognized VBN O
and CC O
that DT O
administration NN O
of IN O
TF NNP O
may MD O
precipitate VB O
or CC O
accelerate VB O
the DT O
renal JJ B-Disease
disease NN I-Disease
in IN O
patients NNS O
with IN O
this DT O
syndrome NN O
. . O
. . O

Wiskott NNP B-Disease
- : I-Disease
Aldrich JJ I-Disease
syndrome NN I-Disease
: : O
cellular JJ O
impairments NNS O
and CC O
their PRP$ O
implication NN O
for IN O
carrier NN O
detection NN O
. . O

A DT O
family NN O
in IN O
which WDT O
two CD O
male NN O
siblings NNS O
were VBD O
affected VBN O
with IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
was VBD O
studied VBN O
using VBG O
G NNP O
- : O
6 CD O
- : O
PD NN O
isoenzymes NNS O
as IN O
an DT O
X NNP O
- : O
linked VBN O
marker NN O
in IN O
order NN O
to TO O
investigate VB O
the DT O
nature NN O
of IN O
cellular JJ O
abnormalities NNS O
. . O

Isolated JJ O
peripheral JJ O
blood NN O
cell NN O
types NNS O
from IN O
the DT O
doubly RB O
heterozygous JJ O
mother NN O
of IN O
the DT O
affected JJ O
males NNS O
seemingly RB O
failed VBD O
to TO O
express VB O
the DT O
G NNP O
- : O
6 CD O
- : O
PD NN O
allele NN O
in IN O
cis JJ O
position NN O
with IN O
the DT O
WAS NNP B-Disease
allele NN O
while IN O
her PRP$ O
cultured JJ O
skin NN O
fibroblasts NNS O
expressed VBD O
both DT O
G NNP O
- : O
6 CD O
- : O
PD NN O
alleles NNS O
. . O

Additionally RB O
, , O
a DT O
histogram JJ O
analysis NN O
of IN O
platelet NN O
size NN O
revealed VBD O
a DT O
single JJ O
population NN O
of IN O
abnormally RB O
small JJ O
platelets NNS O
in IN O
the DT O
affected JJ O
propositus NN O
, , O
whereas IN O
the DT O
heterozygous JJ O
mother NN O
had VBD O
no DT O
appreciable JJ O
small JJ O
platelet NN O
subpopulation NN O
. . O

In IN O
vitro JJ O
culture NN O
of IN O
hemopoietic JJ O
progenitor NN O
cells NNS O
of IN O
the DT O
heterozygous JJ O
mother NN O
showed VBD O
that IN O
the DT O
majority NN O
of IN O
progenitor NN O
cells NNS O
did VBD O
not RB O
express VB O
the DT O
WAS NNP B-Disease
allele NN O
. . O

However RB O
, , O
a DT O
small JJ O
number NN O
of IN O
cells NNS O
expressing VBG O
the DT O
G NNP O
- : O
6 CD O
- : O
PD NN O
type NN O
linked VBN O
with IN O
the DT O
WAS NNP B-Disease
allele NN O
were VBD O
detected VBN O
. . O

The DT O
proportion NN O
of IN O
the DT O
latter JJ O
progenitors NNS O
was VBD O
significantly RB O
higher JJR O
among IN O
more RBR O
primitive JJ O
progenitors NNS O
( ( O
those DT O
giving VBG O
rise NN O
to TO O
later RB O
appearing VBG O
colonies NNS O
) ) O
. . O

This DT O
observation NN O
suggests VBZ O
that IN O
selection NN O
against IN O
cells NNS O
expressing VBG O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
defect VBP I-Disease
takes VBZ O
place NN O
in IN O
the DT O
hemopoietic JJ O
system NN O
of IN O
the DT O
heterozygous JJ O
female NN O
and CC O
offers VBZ O
a DT O
possible JJ O
means NN O
of IN O
carrier NN O
detection NN O
in IN O
some DT O
women NNS O
. . O

Linkage NN O
studies NNS O
in IN O
this DT O
family NN O
revealed VBD O
one CD O
example NN O
of IN O
probable JJ O
recombination NN O
between IN O
the DT O
loci NN O
for IN O
WAS NNP B-Disease
and CC O
G NNP O
- : O
6 CD O
- : O
PD NN O
among IN O
three CD O
informative JJ O
subjects NNS O
, , O
suggesting VBG O
that IN O
these DT O
two CD O
loci NN O
may MD O
not RB O
be VB O
closely RB O
linked VBN O
on IN O
the DT O
X NNP O
- : O
chromosome NN O
. . O
. . O

A DT O
new JJ O
CT NNP O
pattern NN O
in IN O
adrenoleukodystrophy NN B-Disease
. . O

A DT O
new JJ O
CT NNP O
pattern NN O
was VBD O
observed VBN O
in IN O
2 CD O
patients NNS O
with IN O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
. . O

This DT O
pattern NN O
, , O
which WDT O
the DT O
authors NNS O
call VBP O
Type NNP O
II NNP O
, , O
is VBZ O
characterized VBN O
by IN O
the DT O
absence NN O
of IN O
posterior JJ O
periventricular JJ O
areas NNS O
of IN O
decreased JJ O
attenuation NN O
around IN O
the DT O
trigone NN O
on IN O
non JJ O
- : O
contrast NN O
scans NNS O
after IN O
contrast NN O
infusion NN O
, , O
however RB O
, , O
there EX O
is VBZ O
striking VBG O
enhancement NN O
of IN O
various JJ O
white JJ O
- : O
matter NN O
structures NNS O
( ( O
tracts NNS O
or CC O
fiber VB O
systems NNS O
) ) O
such JJ O
as IN O
the DT O
internal JJ O
capsules NNS O
, , O
corpus NN O
callosum NN O
, , O
corona NN O
radiata NN O
, , O
forceps JJ O
major JJ O
, , O
and CC O
cerebral JJ O
peduncles NNS O
. . O

This DT O
is VBZ O
different JJ O
from IN O
numerous JJ O
previous JJ O
descriptions NNS O
of IN O
the DT O
CT NNP O
pattern NN O
in IN O
ALD NNP B-Disease
. . O

Type NNP B-Disease
II NNP I-Disease
ALD NNP I-Disease
does VBZ O
not RB O
appear VB O
to TO O
have VB O
been VBN O
seen VBN O
in IN O
any DT O
other JJ O
leukoencephalopathy NN B-Disease
and CC O
is VBZ O
probably RB O
specific JJ O
for IN O
a DT O
phenotypic NN O
variant NN O
or CC O
an DT O
evolving JJ O
stage NN O
of IN O
ALD NNP B-Disease
. . O
. . O

Further JJ O
evidence NN O
for IN O
heterogeneity NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
Papua NNP O
New NNP O
Guinea NNP O
. . O

Four CD O
new JJ O
G6PD NNP O
variants NNS O
have VBP O
been VBN O
characterized VBN O
in IN O
individuals NNS O
from IN O
Papua NNP O
New NNP O
Guinea NNP O
. . O

This DT O
study NN O
demonstrates VBZ O
that IN O
the DT O
previously RB O
reported VBN O
Markham NNP O
variant NN O
and CC O
the DT O
newly RB O
characterized VBN O
Salata NNP O
variant NN O
may MD O
be VB O
widely RB O
distributed VBN O
in IN O
Papua NNP O
New NNP O
Guinea NNP O
. . O

Th NNP O
data NNS O
presented VBD O
here RB O
together RB O
with IN O
those DT O
of IN O
previously RB O
published VBN O
studies NNS O
demonstrate VBP O
a DT O
degree NN O
of IN O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
that WDT O
is VBZ O
much RB O
higher JJR O
than IN O
that DT O
in IN O
other JJ O
regions NNS O
of IN O
the DT O
world NN O
where WRB O
G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
common JJ O
. . O
. . O

Increased VBN O
incidence NN O
of IN O
cataracts NNS B-Disease
in IN O
male JJ O
subjects NNS O
deficient NN B-Disease
in IN I-Disease
glucose JJ I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
RBCs NNP O
was VBD O
found VBN O
significantly RB O
more RBR O
frequently RB O
in IN O
210 CD O
male JJ O
cataractous JJ B-Disease
patients NNS O
than IN O
in IN O
672 CD O
control NN O
subjects NNS O
of IN O
Sardinian JJ O
origin NN O
. . O

The DT O
frequency NN O
of IN O
the DT O
deficiency NN O
was VBD O
increasingly RB O
higher JJR O
in IN O
presenile JJ O
cataracts NNS B-Disease
. . O

In IN O
the DT O
G6PD NNP B-Disease
- : I-Disease
deficient NN I-Disease
group NN O
, , O
the DT O
incidence NN O
of IN O
cortical JJ B-Disease
and CC I-Disease
total JJ I-Disease
cataracts NNS I-Disease
was VBD O
also RB O
increased VBN O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
decrease NN O
of IN O
the DT O
G6PD NNP O
activity NN O
in IN O
the DT O
lens NNS O
, , O
which WDT O
accompanies VBZ O
its PRP$ O
deficiency NN O
in IN O
the DT O
erythrocyte NN O
, , O
might MD O
play VB O
a DT O
role NN O
in IN O
the DT O
cataracto NN O
- : O
genesis NN O
of IN O
these DT O
patients NNS O
. . O

Moreover RB O
, , O
G6PD NNP B-Disease
deficiency NN I-Disease
should MD O
be VB O
added VBN O
to TO O
other JJ O
conditions NNS O
, , O
such JJ O
as IN O
the DT O
galactosemic JJ B-Disease
states NNS O
and CC O
riboflavin JJ B-Disease
deficiency NN I-Disease
, , O
where WRB O
cataracts NNS B-Disease
represent VBP O
a DT O
sensitive JJ O
indicator NN O
of IN O
metabolic JJ B-Disease
abnormalities NNS I-Disease
of IN O
the DT O
RBC NNP O
. . O
. . O

Molecular JJ O
basis NN O
of IN O
human JJ O
mitochondrial JJ O
very RB B-Disease
- : I-Disease
long JJ I-Disease
- : I-Disease
chain NN I-Disease
acyl IN I-Disease
- : I-Disease
CoA NNP I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
causing VBG O
cardiomyopathy NN B-Disease
and CC O
sudden JJ B-Disease
death NN I-Disease
in IN O
childhood NN O
. . O

beta SYM O
- : O
Oxidation NN O
of IN O
long JJ O
- : O
chain NN O
fatty JJ O
acids NNS O
provides VBZ O
the DT O
major JJ O
source NN O
of IN O
energy NN O
in IN O
the DT O
heart NN O
. . O

Defects NNS O
in IN O
enzymes NNS O
of IN O
the DT O
beta NN O
- : O
oxidation NN O
pathway NN O
cause NN O
sudden JJ B-Disease
, , I-Disease
unexplained JJ I-Disease
death NN I-Disease
in IN O
childhood NN O
, , O
acute JJ O
hepatic JJ B-Disease
encephalopathy NN I-Disease
or CC O
liver JJ B-Disease
failure NN I-Disease
, , O
skeletal JJ B-Disease
myopathy NN I-Disease
, , O
and CC O
cardiomyopathy NN B-Disease
. . O

Very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
[ NNP O
VLCAD NNP O
; : O
very RB O
- : O
long JJ O
- : O
chain NN O
- : O
acyl NN O
- : O
CoA NNP O
( ( O
acceptor NN O
) ) O
2 CD O
, , O
3 CD O
- : O
oxidoreductase NN O
, , O
EC NNP O
1 CD O
. . O
3 CD O
3 CD O
. . O
99 CD O
99 CD O
. . O
13 CD O
] JJ O
catalyzes VBZ O
the DT O
first JJ O
step NN O
in IN O
beta NN O
- : O
oxidation NN O
. . O

We PRP O
have VBP O
isolated VBN O
the DT O
human JJ O
VLCAD NNP O
cDNA NN O
and CC O
gene NN O
and CC O
determined VBD O
the DT O
complete JJ O
nucleotide NN O
sequences NNS O
. . O

Polymerase NNP O
chain NN O
reaction NN O
amplification NN O
of IN O
VLCAD NNP O
mRNA NN O
and CC O
genomic JJ O
exons NNS O
defined VBD O
the DT O
molecular JJ O
defects NNS O
in IN O
two CD O
patients NNS O
with IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
who WP O
presented VBD O
with IN O
unexplained JJ O
cardiac JJ B-Disease
arrest NN I-Disease
and CC O
cardiomyopathy NN B-Disease
. . O

In IN O
one CD O
, , O
a DT O
homozygous JJ O
mutation NN O
in IN O
the DT O
consensus NN O
dinucleotide NN O
of IN O
the DT O
donor NN O
splice NN O
site NN O
( ( O
g JJ O
+ NN O
1 CD O
- : O
- : O
> VB O
a DT O
) ) O
was VBD O
associated VBN O
with IN O
universal JJ O
skipping NN O
of IN O
the DT O
prior JJ O
exon NN O
( ( O
exon JJ O
11 CD O
) ) O
. . O

The DT O
second JJ O
patient NN O
was VBD O
a DT O
compound NN O
heterozygote NN O
, , O
with IN O
a DT O
missense NN O
mutation NN O
, , O
C1837 NNP O
- : O
- : O
> NN O
T NNP O
, , O
changing VBG O
the DT O
arginine NN O
at IN O
residue JJ O
613 CD O
to TO O
tryptophan VB O
on IN O
one CD O
allele NN O
and CC O
a DT O
single JJ O
base NN O
deletion NN O
at IN O
the DT O
intron NN O
- : O
exon NN O
6 CD O
boundary NN O
as IN O
the DT O
second JJ O
mutation NN O
. . O

This DT O
initial JJ O
delineation NN O
of IN O
human JJ O
mutations NNS O
in IN O
VLCAD NNP O
suggests VBZ O
that IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
reduces VBZ O
myocardial JJ O
fatty JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
and CC O
energy NN O
production NN O
and CC O
is VBZ O
associated VBN O
with IN O
cardiomyopathy NN B-Disease
and CC O
sudden JJ B-Disease
death NN I-Disease
in IN O
childhood NN O
. . O

Aberrant NNP O
subcellular JJ O
localization NN O
of IN O
BRCA1 NNP O
in IN O
breast NN B-Disease
cancer NN I-Disease
. . O

The DT O
BRCA1 NNP O
gene NN O
product NN O
was VBD O
identified VBN O
as IN O
a DT O
220 CD O
- : O
kilodalton NN O
nuclear JJ O
phosphoprotein NN O
in IN O
normal JJ O
cells NNS O
, , O
including VBG O
breast NN O
ductal JJ O
epithelial JJ O
cells NNS O
, , O
and CC O
in IN O
18 CD O
of IN O
20 CD O
tumor NN B-Disease
cell NN O
lines NNS O
derived VBN O
from IN O
tissues NNS O
other JJ O
than IN O
breast NN O
and CC O
ovary JJ O
. . O

In IN O
16 CD O
of IN O
17 CD O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
lines NNS O
and CC O
17 CD O
of IN O
17 CD O
samples NNS O
of IN O
cells NNS O
obtained VBN O
from IN O
malignant JJ O
effusions NNS O
, , O
however RB O
, , O
BRCA1 NNP O
localized VBD O
mainly RB O
in IN O
cytoplasm NN O
. . O

Absence NN O
of IN O
BRCA1 NNP O
or CC O
aberrant JJ O
subcellular JJ O
location NN O
was VBD O
also RB O
observed VBN O
to TO O
a DT O
variable JJ O
extent NN O
in IN O
histological JJ O
sections NNS O
of IN O
many JJ O
breast NN B-Disease
cancer NN I-Disease
biopsies NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
BRCA1 NNP B-Disease
abnormalities NNS I-Disease
may MD O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
many JJ O
breast NN B-Disease
cancers NNS I-Disease
, , O
sporadic JJ O
as RB O
well RB O
as IN O
familial JJ O
. . O
. . O

Mapping NN O
of IN O
the DT O
mouse NN O
homologue NN O
of IN O
the DT O
Wilson NNP B-Disease
disease NN I-Disease
gene NN O
to TO O
mouse VB O
chromosome NN O
8 CD O
. . O

ATP7B NNP O
, , O
the DT O
gene NN O
altered VBD O
in IN O
Wilson NNP B-Disease
disease NN I-Disease
( ( O
WD NNP B-Disease
) ) O
patients NNS O
, , O
lies VBZ O
in IN O
a DT O
block NN O
of IN O
homology NN O
shared VBN O
between IN O
human JJ O
chromosome NN O
13q14 CD O
and CC O
the DT O
central JJ O
region NN O
of IN O
mouse NN O
chromosome NN O
14 CD O
. . O

However RB O
, , O
we PRP O
have VBP O
mapped VBN O
the DT O
murine NN O
homologue NN O
of IN O
ATP7B NNP O
( ( O
Atp7b NNP O
) ) O
to TO O
mouse VB O
chromosome NN O
8 CD O
by IN O
somatic JJ O
cell NN O
hybrid JJ O
analysis NN O
. . O

Analysis NN O
of IN O
80 CD O
interspecific JJ O
backcross NN O
offspring NN O
was VBD O
used VBN O
to TO O
position NN O
Atp7b NNP O
close NN O
to TO O
D8Mit3 NNP O
and CC O
another DT O
ATPase NNP O
locus NN O
, , O
Atp4b NNP O
, , O
on IN O
mouse NN O
chromosome NN O
8 CD O
. . O

ATP4B NNP O
lies VBZ O
in IN O
13q34 CD O
and CC O
is VBZ O
separated VBN O
from IN O
ATP7B NNP O
by IN O
several JJ O
loci NNS O
whose WP$ O
mouse NN O
homologues VBZ O
map NNS O
to TO O
mouse VB O
chromosome NN O
14 CD O
. . O

The DT O
assignment NN O
of IN O
Atp7b NNP O
to TO O
mouse VB O
chromosome NN O
8 CD O
identifies NNS O
a DT O
previously RB O
unrecognized JJ O
region NN O
of IN O
homology NN O
between IN O
this DT O
chromosome NN O
and CC O
human JJ O
chromosome NN O
13 CD O
. . O

This DT O
assignment NN O
suggests VBZ O
a DT O
possible JJ O
location NN O
for IN O
the DT O
toxic JJ O
milk NN O
mutation NN O
in IN O
the DT O
mouse NN O
, , O
which WDT O
has VBZ O
been VBN O
proposed VBN O
as IN O
a DT O
homologue NN O
of IN O
WD NNP B-Disease
. . O
. . O

Germline NNP O
mutations NNS O
of IN O
the DT O
BRCA1 NNP O
gene NN O
in IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
provide VBP O
evidence NN O
for IN O
a DT O
genotype JJ O
- : O
phenotype NN O
correlation NN O
. . O

Mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
, , O
discovered VBN O
in IN O
1994 CD O
, , O
are VBP O
associated VBN O
with IN O
an DT O
80 CD O
- : O
90 CD O
% NN O
lifetime NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
. . O

We PRP O
have VBP O
analysed VBN O
60 CD O
families NNS O
with IN O
a DT O
history NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
for IN O
germline JJ O
mutations NNS O
in IN O
BRCA1 NNP O
. . O

Twenty CD O
- : O
two CD O
different JJ O
mutations NNS O
were VBD O
detected VBN O
in IN O
32 CD O
families NNS O
( ( O
53 CD O
% NN O
) ) O
, , O
of IN O
which WDT O
14 CD O
are VBP O
previously RB O
unreported VBN O
. . O

We PRP O
observed VBD O
a DT O
significant JJ O
correlation NN O
between IN O
the DT O
location NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
gene NN O
and CC O
the DT O
ratio NN O
of IN O
breast NN B-Disease
to TO I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
incidence NN O
within IN O
each DT O
family NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
a DT O
transition NN O
in IN O
risk NN O
such JJ O
that IN O
mutations NNS O
in IN O
the DT O
3 CD O
third NN O
of IN O
the DT O
gene NN O
are VBP O
associated VBN O
with IN O
a DT O
lower JJR O
proportion NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

Haplotype NNP O
analysis NN O
supports VBZ O
previous JJ O
data NNS O
which WDT O
suggest VBP O
some DT O
BRCA1 NNP O
mutation NN O
carriers NNS O
have VBP O
common JJ O
ancestors NNS O
; : O
however RB O
, , O
we PRP O
have VBP O
found VBN O
at IN O
least JJS O
two CD O
examples NNS O
where WRB O
recurrent JJ O
mutations NNS O
appear VBP O
to TO O
have VB O
arisen VBN O
independently RB O
. . O
. . O

Hereditary JJ O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
and CC O
recurrent JJ O
meningococcal JJ B-Disease
infection NN I-Disease
: : O
investigations NNS O
of IN O
an DT O
Irish JJ O
family NN O
using VBG O
a DT O
novel JJ O
haemolytic JJ O
screening NN O
assay NN O
for IN O
complement NN O
activity NN O
and CC O
C7 NNP O
M NNP O
/ NNP O
N NNP O
allotyping NN O
. . O

Terminal NNP B-Disease
complement NN I-Disease
component NN I-Disease
deficiency NN I-Disease
predisposes VBZ O
to TO O
meningococcal JJ B-Disease
infection NN I-Disease
and CC O
is VBZ O
inherited VBN O
in IN O
an DT O
autosomal JJ O
co NN O
- : O
dominant JJ O
manner NN O
. . O

An DT O
Irish JJ O
family NN O
is VBZ O
described VBN O
, , O
in IN O
which WDT O
2 CD O
of IN O
3 CD O
brothers NNS O
had VBD O
recurrent JJ O
meningococcal JJ B-Disease
infection NN I-Disease
. . O

A DT O
novel JJ O
screening NN O
assay NN O
was VBD O
used VBN O
to TO O
investigate VB O
for IN O
terminal JJ B-Disease
complement NN I-Disease
deficiency NN I-Disease
and CC O
the DT O
2 CD O
affected VBD O
brothers NNS O
were VBD O
found VBN O
to TO O
be VB O
completely RB B-Disease
deficient JJ I-Disease
in IN I-Disease
the DT I-Disease
seventh JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C7 NNP O
) ) O
. . O

Enzyme NNP O
- : O
linked VBD O
immunosorbent JJ O
assay NN O
for IN O
C7 NNP O
revealed VBD O
lower JJR O
than IN O
normal JJ O
levels NNS O
in IN O
the DT O
remaining VBG O
brother NN O
and CC O
parents NNS O
. . O

C7 NNP O
M NNP O
/ NNP O
N NNP O
protein VBD O
polymorphism NN O
allotyping NN O
, , O
used VBD O
to TO O
investigate VB O
the DT O
segregation NN O
of IN O
the DT O
C7 NNP B-Disease
deficiency NN I-Disease
genes NNS O
, , O
showed VBD O
that IN O
the DT O
apparently RB O
complement JJ O
sufficient JJ O
brother NN O
was VBD O
heterozygous JJ O
C7 NNP B-Disease
deficient NN I-Disease
and CC O
a DT O
carrier NN O
of IN O
one CD O
of IN O
the DT O
deficiency NN O
genes NNS O
. . O

Complement JJ O
screening NN O
should MD O
be VB O
carried VBN O
out RP O
in IN O
any DT O
individual JJ O
suffering NN O
recurrent JJ O
meningococcal JJ B-Disease
infection NN I-Disease
or CC O
infection NN O
with IN O
an DT O
uncommon JJ O
meningococcal JJ B-Disease
serogroup NN O
. . O

Identification NN O
of IN O
complement JJ B-Disease
deficient NN I-Disease
patients NNS O
allows VBZ O
the DT O
implementation NN O
of IN O
strategies NNS O
to TO O
prevent VB O
recurrent JJ O
infection NN O
. . O
. . O

Molecular JJ O
basis NN O
of IN O
subtotal JJ B-Disease
complement NN I-Disease
C6 NNP I-Disease
deficiency NN I-Disease
. . O

A DT O
carboxy JJ O
- : O
terminally RB O
truncated VBN O
but CC O
functionally RB O
active JJ O
C6 NNP O
. . O

Individuals NNS O
with IN O
subtotal JJ B-Disease
complement NN I-Disease
C6 NNP I-Disease
deficiency NN I-Disease
possess NN O
a DT O
C6 NNP O
molecule NN O
that WDT O
is VBZ O
14 CD O
% NN O
shorter JJR O
than IN O
normal JJ O
C6 NNP O
and CC O
present JJ O
in IN O
low JJ O
but CC O
detectable JJ O
concentrations NNS O
( ( O
1 CD O
- : O
2 CD O
% NN O
of IN O
the DT O
normal JJ O
mean NN O
) ) O
. . O

We PRP O
now RB O
show VBP O
that IN O
this DT O
dysmorphic JJ O
C6 NNP O
is VBZ O
bactericidally RB O
active JJ O
and CC O
lacks VBZ O
an DT O
epitope NN O
that WDT O
was VBD O
mapped VBN O
to TO O
the DT O
most RBS O
carboxy JJ O
- : O
terminal JJ O
part NN O
of IN O
C6 NNP O
using VBG O
C6 NNP O
cDNA NN O
fragments NNS O
expressed VBD O
as IN O
fusion NN O
proteins NNS O
in IN O
the DT O
pUEX NN O
expression NN O
system NN O
. . O

We PRP O
thus RB O
predicted VBD O
that IN O
the DT O
abnormal JJ O
C6 NNP O
molecule NN O
might MD O
be VB O
carboxy JJ O
- : O
terminally RB O
truncated VBN O
and CC O
sought VBD O
a DT O
mutation NN O
in IN O
an DT O
area NN O
approximately RB O
14 CD O
% NN O
from IN O
the DT O
carboxy JJ O
- : O
terminal JJ O
end NN O
of IN O
the DT O
coding NN O
sequence NN O
. . O

By IN O
sequencing VBG O
PCR NNP O
- : O
amplified JJ O
products NNS O
from IN O
this DT O
region NN O
, , O
we PRP O
found VBD O
, , O
in IN O
three CD O
individuals NNS O
from IN O
two CD O
families NNS O
, , O
a DT O
mutation NN O
that WDT O
might MD O
plausibly RB O
be VB O
responsible JJ O
for IN O
the DT O
defect NN O
. . O

All DT O
three CD O
have VBP O
an DT O
abnormal JJ O
5 CD O
splice NN O
donor NN O
site NN O
of IN O
intron NN O
15 CD O
, , O
which WDT O
would MD O
probably RB O
prevent VB O
splicing NN O
. . O

An DT O
in IN O
- : O
frame NN O
stop JJ O
codon NN O
is VBZ O
found VBN O
17 CD O
codons NNS O
downstream NN O
from IN O
the DT O
intron NN O
boundary NN O
, , O
which WDT O
would MD O
lead VB O
to TO O
a DT O
truncated VBN O
polypeptide NN O
13 CD O
. . O

5 CD O
% NN O
smaller JJR O
than IN O
normal JJ O
C6 NNP O
. . O

This DT O
result NN O
was VBD O
unexpected JJ O
, , O
as IN O
earlier JJR O
studies NNS O
mapped VBD O
the DT O
C5b NNP O
binding NN O
site NN O
, , O
or CC O
a DT O
putative JJ O
enzymatic JJ O
region NN O
, , O
to TO O
this DT O
part NN O
of IN O
C6 NNP O
. . O

Interestingly RB O
, , O
all DT O
three CD O
subjects NNS O
were VBD O
probably RB O
heterozygous JJ O
for IN O
both DT O
subtotal JJ B-Disease
C6 NNP I-Disease
and CC I-Disease
complete JJ I-Disease
C6 NNP I-Disease
deficiency NN I-Disease
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
: : O
evidence NN O
for IN O
a DT O
possible JJ O
dominant JJ O
- : O
negative JJ O
RNA NNP O
mutation NN O
. . O

The DT O
trinucleotide JJ O
expansion NN O
mutation NN O
causing VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
is VBZ O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
a DT O
protein NN O
kinase NN O
gene NN O
. . O

The DT O
molecular JJ O
mechanisms NNS O
by IN O
which WDT O
the DT O
expanded VBN O
repeat NN O
causes VBZ O
the DT O
clinically RB O
variable JJ O
and CC O
multisystemic JJ B-Disease
disease NN I-Disease
, , O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
are VBP O
not RB O
understood JJ O
. . O

It PRP O
has VBZ O
been VBN O
particularly RB O
difficult JJ O
to TO O
rationalize VB O
the DT O
dominant JJ O
inheritance NN O
with IN O
the DT O
fact NN O
that IN O
the DT O
expansion NN O
mutation NN O
lies VBZ O
outside IN O
of IN O
the DT O
protein NN O
- : O
encoding VBG O
gene NN O
elements NNS O
, , O
and CC O
should MD O
not RB O
be VB O
translated VBN O
into IN O
protein NN O
. . O

Here RB O
we PRP O
use VBP O
muscle JJ O
biopsies NNS O
from IN O
classical JJ O
adult NN O
- : O
onset NN O
myotonic JJ B-Disease
dystrophy NN I-Disease
patients NNS O
to TO O
study VB O
the DT O
accumulation NN O
of IN O
transcripts NNS O
from IN O
both DT O
the DT O
normal JJ O
and CC O
expanded VBD O
DM NNP B-Disease
kinase NNP O
genes NNS O
in IN O
patient JJ O
muscle NN O
, , O
and CC O
compare VB O
the DT O
results NNS O
to TO O
normal JJ O
and CC O
myopathic JJ B-Disease
controls NNS O
. . O

We PRP O
found VBD O
relatively RB O
small JJ O
decreases NNS O
of IN O
DM NNP B-Disease
kinase NNP O
RNA NNP O
in IN O
the DT O
total JJ O
RNA NNP O
pool NN O
from IN O
muscle NN O
; : O
however RB O
, , O
these DT O
reductions NNS O
were VBD O
not RB O
disease JJ O
specific NN O
. . O

Analysis NN O
of IN O
poly NN O
( ( O
A DT O
) ) O
+ NN O
RNA NNP O
showed VBD O
dramatic JJ O
decreases NNS O
of IN O
both DT O
the DT O
mutant NN O
and CC O
normal JJ O
DM NNP B-Disease
kinase NN O
RNAs NNP O
, , O
and CC O
these DT O
changes NNS O
were VBD O
disease JJ O
- : O
specific NN O
. . O

Our PRP$ O
findings NNS O
are VBP O
consistent JJ O
with IN O
a DT O
novel JJ O
molecular JJ O
pathogenetic NN O
mechanism NN O
for IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
both DT O
the DT O
normal JJ O
and CC O
expanded VBD O
DM NNP B-Disease
kinase NN O
genes NNS O
are VBP O
transcribed VBN O
in IN O
patient JJ O
muscle NN O
, , O
but CC O
the DT O
abnormal JJ O
expansion NN O
- : O
containing NN O
RNA NNP O
has VBZ O
a DT O
dominant JJ O
effect NN O
on IN O
RNA NNP O
metabolism NN O
by IN O
preventing VBG O
the DT O
accumulation NN O
of IN O
poly NN O
( ( O
A DT O
) ) O
+ NN O
RNA NNP O
. . O

The DT O
ability NN O
of IN O
the DT O
expansion NN O
mutation NN O
to TO O
alter VB O
accumulation NN O
of IN O
poly NN O
( ( O
A DT O
) ) O
+ NN O
RNA NNP O
in IN O
trans NNS O
suggests NNS O
that WDT O
myotonic VBP B-Disease
dystrophy NN I-Disease
may MD O
be VB O
the DT O
first JJ O
example NN O
of IN O
a DT O
dominant JJ O
- : O
negative JJ O
mutation NN O
manifested VBN O
at IN O
the DT O
RNA NNP O
level NN O
. . O
. . O

A DT O
strong JJ O
candidate NN O
for IN O
the DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
BRCA1 NNP O
. . O

A DT O
strong JJ O
candidate NN O
for IN O
the DT O
17q CD O
- : O
linked VBN O
BRCA1 NNP O
gene NN O
, , O
which WDT O
influences VBZ O
susceptibility NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
has VBZ O
been VBN O
identified VBN O
by IN O
positional JJ O
cloning NN O
methods NNS O
. . O

Probable JJ O
predisposing VBG O
mutations NNS O
have VBP O
been VBN O
detected VBN O
in IN O
five CD O
of IN O
eight CD O
kindreds NNS O
presumed VBN O
to TO O
segregate VB O
BRCA1 NNP O
susceptibility NN O
alleles NNS O
. . O

The DT O
mutations NNS O
include VBP O
an DT O
11 CD O
- : O
base NN O
pair NN O
deletion NN O
, , O
a DT O
1 CD O
- : O
base NN O
pair NN O
insertion NN O
, , O
a DT O
stop NN O
codon NN O
, , O
a DT O
missense NN O
substitution NN O
, , O
and CC O
an DT O
inferred JJ O
regulatory JJ O
mutation NN O
. . O

The DT O
BRCA1 NNP O
gene NN O
is VBZ O
expressed VBN O
in IN O
numerous JJ O
tissues NNS O
, , O
including VBG O
breast NN O
and CC O
ovary JJ O
, , O
and CC O
encodes VBZ O
a DT O
predicted JJ O
protein NN O
of IN O
1863 CD O
amino NN O
acids NNS O
. . O

This DT O
protein NN O
contains VBZ O
a DT O
zinc NN O
finger NN O
domain NN O
in IN O
its PRP$ O
amino NN O
- : O
terminal JJ O
region NN O
, , O
but CC O
is VBZ O
otherwise RB O
unrelated JJ O
to TO O
previously RB O
described VBN O
proteins NNS O
. . O

Identification NN O
of IN O
BRCA1 NNP O
should MD O
facilitate VB O
early JJ O
diagnosis NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
in IN O
some DT O
individuals NNS O
as RB O
well RB O
as IN O
a DT O
better JJR O
understanding NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
biology NN O
. . O
. . O

Molecular JJ O
characterization NN O
of IN O
galactosemia NN B-Disease
( ( O
type JJ O
1 CD O
) ) O
mutations NNS O
in IN O
Japanese JJ O
. . O

We PRP O
characterized VBD O
two CD O
novel JJ O
mutations NNS O
of IN O
the DT O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
( ( O
GALT NNP O
) ) O
gene NN O
in IN O
two CD O
Japanese JJ O
patients NNS O
with IN O
GALT NNP B-Disease
deficiency NN I-Disease
and CC O
identified VBN O
N314D NNP O
and CC O
R333W NNP O
mutations NNS O
, , O
previously RB O
found VBN O
in IN O
Caucasians NNPS O
. . O

One CD O
novel NN O
missense NN O
mutation NN O
was VBD O
an DT O
G NNP O
- : O
to TO O
- : O
A DT O
transition NN O
in IN O
exon JJ O
8 CD O
, , O
resulting VBG O
in IN O
the DT O
substitution NN O
of IN O
arginine NN O
by IN O
histidine NN O
at IN O
the DT O
codon NN O
231 CD O
( ( O
R231H NNP O
) ) O
. . O

GALT NNP O
activity NN O
of IN O
the DT O
R231H NNP O
mutant JJ O
construct NN O
was VBD O
reduced VBN O
to TO O
15 CD O
% NN O
of IN O
normal JJ O
controls NNS O
in IN O
a DT O
COS NNP O
cell NN O
expression NN O
system NN O
. . O

The DT O
other JJ O
was VBD O
a DT O
splicing JJ O
mutation NN O
, , O
an DT O
A NNP O
- : O
to TO O
- : O
G NNP O
transition NN O
at IN O
the DT O
38th CD O
nucleotide NN O
in IN O
exon JJ O
3 CD O
( ( O
318A CD O
- : O
- : O
> NN O
G NNP O
) ) O
, , O
resulting VBG O
in IN O
a DT O
38 CD O
- : O
bp NN O
deletion NN O
in IN O
the DT O
GALT NNP O
cDNA NN O
by IN O
activating VBG O
a DT O
cryptic JJ O
splice NN O
acceptor NN O
site NN O
. . O

In IN O
seven CD O
Japanese JJ O
families NNS O
( ( O
14 CD O
alleles NNS O
for IN O
classic JJ O
form NN O
and CC O
one CD O
allele NN O
for IN O
Duarte NNP O
variant NN O
) ) O
with IN O
GALT NNP B-Disease
deficiency NN I-Disease
, , O
the DT O
R231H NNP O
and CC O
318A CD O
- : O
- : O
> NN O
G NNP O
mutations NNS O
were VBD O
found VBN O
only RB O
on IN O
both DT O
alleles NNS O
of IN O
the DT O
proband NN O
. . O

The DT O
N314D NNP O
and CC O
R333W NNP O
mutations NNS O
were VBD O
found VBN O
on IN O
one CD O
allele NN O
each DT O
. . O

The DT O
Q188R NNP O
was VBD O
prevalent VBN O
in IN O
the DT O
United NNP O
States NNPS O
but CC O
not RB O
in IN O
Japanese JJ O
patients NNS O
. . O

The DT O
N314D NNP O
mutation NN O
was VBD O
associated VBN O
with IN O
the DT O
Duarte NNP O
variant NN O
in IN O
Japanese JJ O
persons NNS O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
United NNP O
States NNPS O
. . O

We PRP O
speculate VBP O
that IN O
classic JJ B-Disease
galactosemia NN I-Disease
mutations NNS O
appear VBP O
to TO O
differ VB O
between IN O
Japanese JJ O
and CC O
Caucasian JJ O
patients NNS O
. . O

Our PRP$ O
limited JJ O
data NNS O
set VBN O
on IN O
galactosemia NN B-Disease
mutations NNS O
in IN O
Japanese JJ O
suggests NNS O
that IN O
the DT O
N314D NNP O
GALT NNP O
mutation NN O
encoding VBG O
the DT O
Duarte NNP O
variant NN O
arose VBD O
before IN O
Asian JJ O
and CC O
Caucasian JJ O
people NNS O
diverged VBD O
and CC O
that IN O
classic JJ B-Disease
galactosemia NN I-Disease
mutations NNS O
arose VBP O
and CC O
/ VBP O
or CC O
accumulated VBN O
after IN O
the DT O
divergence NN O
of IN O
Asian JJ O
and CC O
Caucasian JJ O
populations NNS O
. . O
. . O

Three CD O
novel JJ O
aniridia JJ B-Disease
mutations NNS O
in IN O
the DT O
human JJ O
PAX6 NNP O
gene NN O
. . O

Aniridia NNP B-Disease
( ( O
iris JJ B-Disease
hypoplasia NN I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
congenital JJ I-Disease
disorder NN I-Disease
of IN I-Disease
the DT I-Disease
eye NN I-Disease
. . O

Mutations NNS O
in IN O
the DT O
human JJ O
aniridia NN B-Disease
( ( O
PAX6 NNP O
) ) O
gene NN O
have VBP O
now RB O
been VBN O
identified VBN O
in IN O
many JJ O
patients NNS O
from IN O
various JJ O
ethnic JJ O
groups NNS O
. . O

In IN O
the DT O
study NN O
reported VBD O
here RB O
we PRP O
describe VBP O
PAX6 JJ O
mutations NNS O
in IN O
one CD O
sporadic NN O
and CC O
five CD O
familial JJ O
cases NNS O
with IN O
aniridia NN B-Disease
. . O

Of IN O
the DT O
four CD O
different JJ O
mutations NNS O
identified VBN O
, , O
one CD O
was VBD O
identical JJ O
to TO O
a DT O
previously RB O
reported VBN O
mutation NN O
( ( O
C NNP O
- : O
- : O
> NN O
T NNP O
transition NN O
at IN O
codon $ O
240 CD O
) ) O
, , O
and CC O
three CD O
were VBD O
novel JJ O
two CD O
in IN O
the DT O
glycine NN O
- : O
rich JJ O
region NN O
and CC O
one CD O
in IN O
the DT O
proline NN O
/ NNP O
serine NN O
/ NNP O
threonine NN O
- : O
rich JJ O
( ( O
PST NNP O
) ) O
region NN O
. . O

One CD O
PAX6 NNP O
mutation NN O
found VBD O
in IN O
the DT O
PST NNP O
region NN O
was VBD O
associated VBN O
with IN O
cataracts NNS B-Disease
in IN O
an DT O
aniridia JJ B-Disease
family NN O
. . O

Another DT O
splice NN O
mutation NN O
in IN O
the DT O
PST NNP O
domain NN O
occurred VBD O
in IN O
an DT O
aniridia JJ B-Disease
patient NN O
with IN O
anosmia NN B-Disease
( ( O
inability NN O
to TO O
smell VB O
) ) O
. . O

The DT O
six CD O
new JJ O
aniridia NN B-Disease
cases NNS O
reported VBN O
here RB O
have VBP O
mutations NNS O
predicted VBN O
to TO O
generate VB O
incomplete JJ O
PAX6 NNP O
proteins NNS O
. . O

These DT O
results NNS O
support VBD O
the DT O
theory NN O
that WDT O
human JJ O
aniridia NN B-Disease
is VBZ O
caused VBN O
by IN O
haploinsufficiency NN B-Disease
of IN I-Disease
PAX6 NNP I-Disease
. . O
. . O

The DT O
carrier NN O
frequency NN O
of IN O
the DT O
BRCA1 NNP O
185delAG CD O
mutation NN O
is VBZ O
approximately RB O
1 CD O
percent NN O
in IN O
Ashkenazi NNP O
Jewish JJ O
individuals NNS O
. . O

Since IN O
BRCA1 NNP O
, , O
the DT O
first JJ O
major JJ O
gene NN O
responsible JJ O
for IN O
inherited JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
was VBD O
cloned VBN O
, , O
more JJR O
than IN O
50 CD O
unique JJ O
mutations NNS O
have VBP O
been VBN O
detected VBN O
in IN O
the DT O
germline NN O
of IN O
individuals NNS O
with IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

In IN O
high JJ O
- : O
risk NN O
pedigrees NNS O
, , O
female JJ O
carriers NNS O
of IN O
BRCA1 NNP O
mutations NNS O
have VBP O
an DT O
80 CD O
- : O
90 CD O
% NN O
lifetime NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
, , O
and CC O
a DT O
40 CD O
- : O
50 CD O
% NN O
risk NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

However RB O
, , O
the DT O
mutation NN O
stats NNS O
of IN O
individuals NNS O
unselected VBN O
for IN O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
has VBZ O
not RB O
been VBN O
determined VBN O
, , O
and CC O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
mutations NNS O
in IN O
such JJ O
individuals NNS O
confer VBP O
the DT O
same JJ O
risk NN O
of IN O
cancer NN B-Disease
as IN O
in IN O
individuals NNS O
from IN O
the DT O
high JJ O
- : O
risk NN O
families NNS O
studied VBN O
so RB O
far RB O
. . O

Following VBG O
the DT O
finding NN O
of IN O
a DT O
185delAG CD O
frameshift NN O
mutation NN O
in IN O
several JJ O
Ashkenazi NNP O
Jewish NNP O
breast NN O
/ NNP O
ovarian JJ O
families NNS O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
frequency NN O
of IN O
this DT O
mutation NN O
in IN O
858 CD O
Ashkenazim NNP O
seeking VBG O
genetic JJ O
testing VBG O
for IN O
conditions NNS O
unrelated JJ O
to TO O
cancer NN B-Disease
, , O
and CC O
in IN O
815 CD O
reference NN O
individuals NNS O
not RB O
selected VBN O
for IN O
ethnic JJ O
origin NN O
. . O

We PRP O
observed VBD O
the DT O
185delAG CD O
mutation NN O
in IN O
0 CD O
. . O

9 CD O
% NN O
of IN O
Ashkenazim NNP O
( ( O
95 CD O
% NN O
confidence NN O
limit NN O
, , O
0 CD O
. . O
4 CD O
- : O
1 CD O
. . O
8 CD O
% NN O
) ) O
and CC O
in IN O
none NN O
of IN O
the DT O
reference NN O
samples NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
one CD O
in IN O
a DT O
hundred JJ O
women NNS O
of IN O
Ashkenazi NNP O
descent NN O
may MD O
be VB O
at IN O
especially RB O
high JJ O
risk NN O
of IN O
developing VBG O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Identification NN O
and CC O
localization NN O
of IN O
huntingtin NN O
in IN O
brain NN O
and CC O
human JJ O
lymphoblastoid NN O
cell NN O
lines NNS O
with IN O
anti JJ O
- : O
fusion NN O
protein NN O
antibodies NNS O
. . O

The DT O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
phenotype NN O
is VBZ O
associated VBN O
with IN O
expansion NN O
of IN O
a DT O
trinucleotide JJ O
repeat NN O
in IN O
the DT O
IT15 NNP O
gene NN O
, , O
which WDT O
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
348 CD O
- : O
kDa NN O
protein NN O
named VBN O
huntington NN O
. . O

We PRP O
used VBD O
polyclonal JJ O
and CC O
monoclonal JJ O
anti NN O
- : O
fusion NN O
protein NN O
antibodies NNS O
to TO O
identify VB O
native JJ O
huntingtin NN O
in IN O
rat NN O
, , O
monkey NN O
, , O
and CC O
human NN O
. . O

Western JJ O
blots NNS O
revealed VBD O
a DT O
protein NN O
with IN O
the DT O
expected JJ O
molecular NN O
weight NN O
which WDT O
is VBZ O
present JJ O
in IN O
the DT O
soluble JJ O
fraction NN O
of IN O
rat NN O
and CC O
monkey NN O
brain NN O
tissues NNS O
and CC O
lymphoblastoid JJ O
cells NNS O
from IN O
control NN O
cases NNS O
. . O

In IN O
lymphoblastoid NN O
cell NN O
lines NNS O
from IN O
juvenile NN O
- : O
onset NN O
heterozygote NN O
HD NNP B-Disease
cases NNS O
, , O
both DT O
normal JJ O
and CC O
mutant JJ O
huntingtin NN O
are VBP O
expressed VBN O
, , O
and CC O
increasing VBG O
repeat NN O
expansion NN O
leads VBZ O
to TO O
lower JJR O
levels NNS O
of IN O
the DT O
mutant JJ O
protein NN O
. . O

Immunocytochemistry NN O
indicates VBZ O
that IN O
huntingtin NN O
is VBZ O
located VBN O
in IN O
neurons NNS O
throughout IN O
the DT O
brain NN O
, , O
with IN O
the DT O
highest JJS O
levels NNS O
evident NN O
in IN O
larger JJR O
neurons NNS O
. . O

In IN O
the DT O
human JJ O
striatum NN O
, , O
huntingtin NN O
is VBZ O
enriched VBN O
in IN O
a DT O
patch NN O
- : O
like IN O
distribution NN O
, , O
potentially RB O
corresponding VBG O
to TO O
the DT O
first JJ O
areas NNS O
affected VBN O
in IN O
HD NNP B-Disease
. . O

Subcellular JJ O
localization NN O
of IN O
huntingtin NN O
is VBZ O
consistent JJ O
with IN O
a DT O
cytosolic JJ O
protein NN O
primarily RB O
found VBN O
in IN O
somatodendritic JJ O
regions NNS O
. . O

Huntingtin NNP O
appears VBZ O
to TO O
particularly RB O
associate VB O
with IN O
microtubules NNS O
, , O
although IN O
some DT O
is VBZ O
also RB O
associated VBN O
with IN O
synaptic JJ O
vesicles NNS O
. . O

On IN O
the DT O
basis NN O
of IN O
the DT O
localization NN O
of IN O
huntingtin NN O
in IN O
association NN O
with IN O
microtubules NNS O
, , O
we PRP O
speculate VBP O
that IN O
the DT O
mutation NN O
impairs VBZ O
the DT O
cytoskeletal JJ O
anchoring NN O
or CC O
transport NN O
of IN O
mitochondria NNS O
, , O
vesicles NNS O
, , O
or CC O
other JJ O
organelles NNS O
or CC O
molecules NNS O
. . O
. . O

Marked VBN O
phenotypic JJ O
heterogeneity NN O
associated VBN O
with IN O
expansion NN O
of IN O
a DT O
CAG NNP O
repeat NN O
sequence NN O
at IN O
the DT O
spinocerebellar JJ B-Disease
ataxia NN I-Disease
3 CD I-Disease
/ NN I-Disease
Machado NNP I-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
locus NN O
. . O

The DT O
spinocerebellar JJ B-Disease
ataxia NN I-Disease
3 CD I-Disease
locus NN O
( ( O
SCA3 NNP B-Disease
) ) O
for IN O
type NN B-Disease
I PRP I-Disease
autosomal VBP I-Disease
dominant JJ I-Disease
cerebellar JJ I-Disease
ataxia NN I-Disease
( ( O
ADCA NNP B-Disease
type NN I-Disease
I PRP I-Disease
) ) O
, , O
a DT O
clinically RB O
and CC O
genetically RB O
heterogeneous JJ O
group NN O
of IN O
neurodegenerative JJ B-Disease
disorders NNS I-Disease
, , O
has VBZ O
been VBN O
mapped VBN O
to TO O
chromosome VB O
14q32 CD O
. . O

1 CD O
1 CD O
. . O

ADCA NNP B-Disease
type NN I-Disease
I PRP I-Disease
patients NNS O
from IN O
families NNS O
segregating VBG O
SCA3 NNP B-Disease
share NN O
clinical JJ O
features NNS O
in IN O
common JJ O
with IN O
those DT O
with IN O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
MJD NNP B-Disease
) ) O
, , O
the DT O
gene NN O
of IN O
which WDT O
maps NNS O
to TO O
the DT O
same JJ O
region NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
the DT O
disease NN O
gene NN O
segregating VBG O
in IN O
each DT O
of IN O
three CD O
French JJ O
ADCA NNP B-Disease
type NN I-Disease
I PRP I-Disease
kindreds NNS O
and CC O
in IN O
a DT O
French JJ O
family NN O
with IN O
neuropathological JJ O
findings NNS O
suggesting VBG O
the DT O
ataxochoreic JJ O
form NN O
of IN O
dentatorubropallidoluysian JJ B-Disease
atrophy NN I-Disease
carries VBZ O
an DT O
expanded JJ O
CAG NNP O
repeat NN O
sequence NN O
located VBN O
at IN O
the DT O
same JJ O
locus NN O
as IN O
that DT O
for IN O
MJD NNP B-Disease
. . O

Analysis NN O
of IN O
the DT O
mutation NN O
in IN O
these DT O
families NNS O
shows VBZ O
a DT O
strong JJ O
negative JJ O
correlation NN O
between IN O
size NN O
of IN O
the DT O
expanded VBN O
CAG NNP O
repeat NN O
and CC O
age NN O
at IN O
onset NN O
of IN O
clinical JJ O
disease NN O
. . O

Instability NN O
of IN O
the DT O
expanded JJ O
triplet NN O
repeat NN O
was VBD O
not RB O
found VBN O
to TO O
be VB O
affected VBN O
by IN O
sex NN O
of IN O
the DT O
parent NN O
transmitting VBG O
the DT O
mutation NN O
. . O

Evidence NN O
was VBD O
found VBN O
for IN O
somatic JJ O
and CC O
gonadal JJ O
mosaicism NN O
for IN O
alleles NNS O
carrying VBG O
expanded VBD O
trinucleotide JJ O
repeats NNS O
. . O

Overexpression NN O
of IN O
DM20 NNP O
messenger NN O
RNA NNP O
in IN O
two CD O
brothers NNS O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
is VBZ O
a DT O
rare JJ B-Disease
, , I-Disease
sex NN I-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
, , I-Disease
dysmyelinating VBG I-Disease
disease NN I-Disease
of IN I-Disease
the DT I-Disease
central JJ I-Disease
nervous JJ I-Disease
system NN I-Disease
that WDT O
has VBZ O
been VBN O
associated VBN O
with IN O
mutations NNS O
in IN O
the DT O
myelin NN O
proteolipid JJ O
protein NN O
( ( O
PLP NNP O
) ) O
gene NN O
. . O

Only RB O
25 CD O
% NN O
of IN O
patients NNS O
studied VBN O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
have VBP O
exonic JJ O
mutations NNS O
in IN O
this DT O
gene NN O
, , O
the DT O
underlying VBG O
cause NN O
of IN O
the DT O
disease NN O
in IN O
the DT O
remaining VBG O
patients NNS O
is VBZ O
unknown JJ O
. . O

The DT O
PLP NNP O
gene NN O
encodes NNS O
two CD O
major JJ O
alternatively RB O
spliced VBN O
transcripts NNS O
called VBN O
PLP NNP O
and CC O
DM20 NNP O
. . O

PLP NNP O
messenger NN O
RNA NNP O
is VBZ O
specifically RB O
expressed VBN O
in IN O
central JJ O
nervous JJ O
system NN O
tissue NN O
, , O
whereas WP O
DM20 NNP O
messenger NN O
RNA NNP O
is VBZ O
found VBN O
in IN O
central JJ O
nervous JJ O
system NN O
, , O
cardiac NN O
, , O
and CC O
other JJ O
tissues NNS O
. . O

We PRP O
studied VBD O
cultured JJ O
skin NN O
fibroblasts NNS O
from IN O
2 CD O
brothers NNS O
with IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
who WP O
exhibited VBD O
no DT O
detectable JJ O
exonic JJ O
mutation NN O
of IN O
the DT O
PLP NNP O
gene NN O
. . O

Examination NN O
of IN O
RNA NNP O
from IN O
these DT O
cells NNS O
showed VBD O
that IN O
the DT O
level NN O
of IN O
DM20 NNP O
messenger NN O
RNA NNP O
is VBZ O
elevated VBN O
sixfold RB O
relative JJ O
to TO O
male VB O
control NN O
skin JJ O
fibroblasts NNS O
. . O

An DT O
unrelated JJ O
female NN O
carrier NN O
, , O
also RB O
with IN O
no DT O
detectable JJ O
exonic JJ O
mutation NN O
, , O
showed VBD O
a DT O
threefold JJ O
increase NN O
in IN O
DM20 NNP O
messenger NN O
RNA NNP O
in IN O
cultured JJ O
skin NN O
fibroblasts NNS O
. . O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
in IN O
some DT O
patients NNS O
, , O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
is VBZ O
caused VBN O
by IN O
overexpression NN O
of IN O
PLP NNP O
gene NN O
transcripts NNS O
, , O
and CC O
that IN O
in IN O
these DT O
families NNS O
a DT O
50 CD O
% NN O
increase NN O
of IN O
DM20 NNP O
messenger NN O
RNA NNP O
in IN O
females NNS O
, , O
relative JJ O
to TO O
the DT O
increase NN O
in IN O
affected JJ O
males NNS O
, , O
can MD O
identify VB O
a DT O
female NN O
carrier NN O
. . O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
and CC O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
congenital JJ I-Disease
thrombocytopenia NN I-Disease
are VBP O
caused VBN O
by IN O
mutations NNS O
of IN O
the DT O
same JJ O
gene NN O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
thrombocytopenia NN B-Disease
, , O
small JJ O
platelets NNS O
, , O
eczema NN B-Disease
, , O
recurrent JJ O
infections NNS O
, , O
and CC O
immunodeficiency NN B-Disease
. . O

Besides IN O
the DT O
classic NN O
WAS NNP B-Disease
phenotype NN O
, , O
there EX O
is VBZ O
a DT O
group NN O
of IN O
patients NNS O
with IN O
congenital JJ B-Disease
X NNP I-Disease
- : I-Disease
linked VBN I-Disease
thrombocytopenia NN I-Disease
( ( O
XLT NNP B-Disease
) ) O
who WP O
have VBP O
small JJ O
platelets NNS O
but CC O
only RB O
transient JJ O
eczema NN B-Disease
, , O
if IN O
any DT O
, , O
and CC O
minimal JJ O
immune JJ B-Disease
deficiency NN I-Disease
. . O

Because IN O
the DT O
gene NN O
responsible JJ O
for IN O
WAS NNP B-Disease
has VBZ O
been VBN O
sequenced VBN O
, , O
it PRP O
was VBD O
possible JJ O
to TO O
correlate VB O
the DT O
WAS NNP B-Disease
phenotypes NNS O
with IN O
WAS NNP B-Disease
gene NN O
mutations NNS O
. . O

Using VBG O
a DT O
fingerprinting VBG O
screening NN O
technique NN O
, , O
we PRP O
determined VBD O
the DT O
approximate JJ O
location NN O
of IN O
the DT O
mutation NN O
in IN O
13 CD O
unrelated JJ O
WAS NNP B-Disease
patients NNS O
with IN O
mild JJ O
to TO O
severe VB O
clinical JJ O
symptoms NNS O
. . O

Direct JJ O
sequence NN O
analysis NN O
of IN O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
obtained VBN O
from IN O
patient JJ O
- : O
derived VBN O
cell NN O
lines NNS O
showed VBD O
12 CD O
unique JJ O
mutations NNS O
distributed VBN O
throughout IN O
the DT O
WAS NNP B-Disease
gene NN O
, , O
including VBG O
insertions NNS O
, , O
deletions NNS O
, , O
and CC O
point NN O
mutations NNS O
resulting VBG O
in IN O
amino NN O
acid NN O
substitutions NNS O
, , O
termination NN O
, , O
exon FW O
skipping VBG O
, , O
or CC O
splicing VBG O
defects NNS O
. . O

Of IN O
4 CD O
unrelated JJ O
patients NNS O
with IN O
the DT O
XLT NNP B-Disease
phenotype NN O
, , O
3 CD O
had VBD O
missense NN O
mutations NNS O
affecting VBG O
exon JJ O
2 CD O
and CC O
1 CD O
had VBD O
a DT O
splice NN O
- : O
site NN O
mutation NN O
affecting VBG O
exon JJ O
9 CD O
. . O

Patients NNS O
with IN O
classic JJ O
WAS NNP B-Disease
had VBD O
more RBR O
complex JJ O
mutations NNS O
, , O
resulting VBG O
in IN O
termination NN O
codons NNS O
, , O
frameshift NN O
, , O
and CC O
early JJ O
termination NN O
. . O

These DT O
findings NNS O
provide VBP O
direct JJ O
evidence NN O
that IN O
XLT NNP B-Disease
and CC O
WAS NNP B-Disease
are VBP O
caused VBN O
by IN O
mutations NNS O
of IN O
the DT O
same JJ O
gene NN O
and CC O
suggest VBP O
that IN O
severe JJ O
clinical JJ O
phenotypes NNS O
are VBP O
associated VBN O
with IN O
complex JJ O
mutations NNS O
. . O
. . O

Myotonia NNP B-Disease
levior NN I-Disease
is VBZ O
a DT O
chloride JJ B-Disease
channel NN I-Disease
disorder NN I-Disease
. . O

The DT O
group NN O
of IN O
dominant JJ B-Disease
non JJ I-Disease
- : I-Disease
dystrophic JJ I-Disease
myotonias NN I-Disease
, , O
comprising VBG O
disorders NNS O
characterized VBN O
by IN O
clinically RB O
similar JJ O
forms NNS O
of IN O
myogenic JJ O
muscle NN O
stiffness NN O
, , O
is VBZ O
genetically RB O
inhomogeneous JJ O
. . O

Dominant NNP B-Disease
myotonia NN I-Disease
congenita NN I-Disease
( ( O
Thomsens NNP B-Disease
disease NN I-Disease
) ) O
is VBZ O
linked VBN O
to TO O
CLCN1 NNP O
, , O
the DT O
gene NN O
encoding VBG O
the DT O
major JJ O
muscle NN O
chloride NN O
channel NN O
, , O
localized VBN O
on IN O
chromosome NN O
7q35 CD O
. . O

In IN O
contrast NN O
, , O
dominant JJ B-Disease
myotonias RBS I-Disease
sensitive JJ O
to TO O
potassium NN O
are VBP O
caused VBN O
by IN O
point NN O
mutations NNS O
in IN O
SCN4A NNP O
on IN O
chromosome NN O
17q CD O
, , O
the DT O
gene NN O
for IN O
the DT O
alpha JJ O
subunit NN O
of IN O
the DT O
adult NN O
skeletal JJ O
muscle NN O
sodium NN O
channel NN O
. . O

No DT O
linkage NN O
or CC O
molecular JJ O
genetic JJ O
data NNS O
are VBP O
as IN O
yet RB O
available JJ O
on IN O
myotonia NN B-Disease
levior JJ I-Disease
characterized VBN O
by IN O
milder NN O
symptoms NNS O
and CC O
later RB O
onset NN O
of IN O
myotonia NN B-Disease
than IN O
in IN O
Thomsens NNP B-Disease
disease NN I-Disease
, , O
and CC O
absence NN O
of IN O
muscle NN B-Disease
hypertrophy NN I-Disease
. . O

We PRP O
report VBP O
a DT O
CLCN1 NNP O
Gln NNP O
- : O
552 CD O
- : O
Arg NNP O
substitution NN O
for IN O
a DT O
family NN O
with IN O
dominant JJ O
inheritance NN O
previously RB O
diagnosed VBN O
to TO O
have VB O
myotonia VBN B-Disease
levior RB I-Disease
. . O

Thus RB O
, , O
this DT O
disorder NN O
appears VBZ O
as IN O
a DT O
variant NN O
of IN O
Thomsens NNP B-Disease
disease NN I-Disease
due JJ O
to TO O
mutations NNS O
leading VBG O
to TO O
low JJ O
clinical JJ O
expressivity NN O
. . O

In IN O
addition NN O
, , O
we PRP O
report VBP O
a DT O
novel JJ O
Ile NNP O
- : O
290 CD O
- : O
Met NNP O
CLCN1 NNP O
mutation NN O
for IN O
a DT O
typical JJ O
Thomsen NNP O
pedigree NN O
. . O

In IN O
another DT O
family NN O
previously RB O
diagnosed VBN O
as IN O
having VBG O
Thomsens NNP B-Disease
disease NN I-Disease
, , O
we PRP O
unexpectedly RB O
found VBD O
a DT O
CLCN1 NNP O
14 CD O
bp NN O
deletion NN O
known VBN O
to TO O
cause VB O
recessive JJ B-Disease
myotonia NN I-Disease
, , O
and CC O
a DT O
rare JJ O
Trp NNP O
- : O
118 CD O
- : O
Gly NN O
polymorphism NN O
. . O
. . O

Southern JJ O
analysis NN O
reveals VBZ O
a DT O
large JJ O
deletion NN O
at IN O
the DT O
hypoxanthine NN O
phosphoribosyltransferase NN O
locus NN O
in IN O
a DT O
patient NN O
with IN O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

Whole JJ O
genomic JJ O
hprt NN O
clones NNS O
were VBD O
used VBN O
in IN O
Southern JJ O
analysis NN O
to TO O
screen VB O
the DT O
integrity NN O
of IN O
the DT O
hprt NN O
gene NN O
in IN O
a DT O
family NN O
that WDT O
includes VBZ O
a DT O
patient NN O
with IN O
HPRT NNP B-Disease
enzyme VBP I-Disease
deficiency NN I-Disease
causal NN O
to TO O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

A DT O
5 CD O
kb NN O
DNA NNP O
sequence NN O
deletion NN O
was VBD O
found VBN O
to TO O
have VB O
its PRP$ O
endpoints NNS O
in IN O
the DT O
first JJ O
and CC O
third JJ O
introns NNS O
. . O

The DT O
probes NNS O
identified VBD O
the DT O
carrier NN O
status NN O
of IN O
female JJ O
family NN O
members NNS O
, , O
aided VBN O
by IN O
an DT O
RFLP NNP O
carried VBN O
by IN O
the DT O
mothers NNS O
normal JJ O
X NNP O
- : O
chromosome NN O
. . O
. . O

Characterisation NN O
of IN O
molecular JJ O
defects NNS O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
amelogenesis NN I-Disease
imperfecta NN I-Disease
( ( O
AIH1 NNP O
) ) O
. . O

Amelogenins NNS O
are VBP O
an DT O
heterogenous JJ O
family NN O
of IN O
proteins NNS O
produced VBN O
by IN O
ameloblasts NNS O
of IN O
the DT O
enamel JJ O
organ NN O
during IN O
tooth DT O
development NN O
. . O

Disturbances NNS O
of IN O
enamel JJ O
formation NN O
occur NN O
in IN O
amelogenesis NN B-Disease
imperfecta NN I-Disease
, , O
a DT O
clinically RB O
heterogenous JJ O
group NN O
of IN O
inherited JJ B-Disease
disorders NNS I-Disease
characterised VBN O
by IN O
defective JJ O
enamel JJ O
biomineralisation NN O
. . O

An DT O
amelogenin JJ O
gene NN O
, , O
AMGX NNP O
, , O
has VBZ O
been VBN O
mapped VBN O
to TO O
the DT O
short JJ O
of IN O
the DT O
X NNP O
chromosome NN O
( ( O
Xp22 NNP O
. . O
1 CD O
- : O
p22 NN O
. . O
3 CD O
) ) O
and CC O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
molecular JJ O
pathology NN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
amelogenesis NN I-Disease
imperfecta NN I-Disease
( ( O
AIH1 NNP B-Disease
) ) O
. . O

We PRP O
have VBP O
identified VBN O
three CD O
families NNS O
exhibiting VBG O
AIH1 NNP B-Disease
and CC O
screened VBD O
the DT O
AMGX NNP O
gene NN O
for IN O
mutations NNS O
using VBG O
single JJ O
- : O
strand NN O
conformational JJ O
polymorphism NN O
analysis NN O
and CC O
DNA NNP O
sequencing NN O
. . O

Three CD O
novel JJ O
mutations NNS O
were VBD O
identified VBN O
a DT O
C NNP O
- : O
T NNP O
substitution NN O
in IN O
exon JJ O
5 CD O
, , O
and CC O
a DT O
G NNP O
- : O
T NNP O
substitution NN O
and CC O
single JJ O
cytosine NN O
deletion NN O
in IN O
exon JJ O
6 CD O
, , O
confirming VBG O
the DT O
existence NN O
of IN O
extensive JJ O
allelic JJ O
heterogeneity NN O
in IN O
this DT O
condition NN O
. . O

The DT O
identification NN O
of IN O
family NN O
- : O
specific JJ O
mutations NNS O
will MD O
enable VB O
early JJ O
identification NN O
of IN O
affected JJ O
individuals NNS O
and CC O
correlation NN O
of IN O
clinical JJ O
phenotype NN O
with IN O
genotype NN O
will MD O
facilitate VB O
an DT O
objective JJ O
system NN O
of IN O
disease NN O
classification NN O
. . O

Frequency NN O
of IN O
exon $ O
15 CD O
missense NN O
mutation NN O
( ( O
442D CD O
: : O
G NN O
) ) O
in IN O
cholesteryl NN O
ester NN O
transfer NN O
protein NN O
gene NN O
in IN O
hyperalphalipoproteinemic JJ B-Disease
Japanese JJ O
subjects NNS O
. . O

Cholesteryl NNP O
ester NN O
transfer NN O
protein NN O
( ( O
CETP NNP O
) ) O
transfers NNS O
cholesteryl VBP O
ester NN O
from IN O
high JJ O
density NN O
lipoprotein NN O
( ( O
HDL NNP O
) ) O
to TO O
apo VB O
B NNP O
- : O
containing NN O
lipoproteins NNS O
. . O

The DT O
hyperalphalipoproteinemia NN B-Disease
caused VBN O
by IN O
CETP NNP B-Disease
deficiency NN I-Disease
is VBZ O
fairly RB O
common JJ O
in IN O
Japan NNP O
and CC O
one CD O
of IN O
the DT O
most RBS O
common JJ O
mutations NNS O
in IN O
the DT O
CETP NNP O
gene NN O
is VBZ O
the DT O
splicing VBG O
defect NN O
of IN O
the DT O
intron NN O
14 CD O
, , O
the DT O
allelic JJ O
frequency NN O
of IN O
which WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
0 CD O
. . O

49 CD O
in IN O
the DT O
Japanese JJ O
general JJ O
population NN O
. . O

Recently RB O
, , O
we PRP O
have VBP O
reported VBN O
a DT O
missense NN O
mutation NN O
in IN O
exon JJ O
15 CD O
of IN O
the DT O
CETP NNP O
gene NN O
( ( O
442D CD O
G NNP O
) ) O
, , O
showing VBG O
a DT O
dominant JJ O
effect NN O
on IN O
the DT O
CETP NNP O
activity NN O
and CC O
HDL NNP O
- : O
cholesterol NN O
level NN O
. . O

In IN O
the DT O
current JJ O
study NN O
, , O
we PRP O
determined VBD O
the DT O
frequency NN O
of IN O
this DT O
new JJ O
mutation NN O
in IN O
Japanese JJ O
hyperalphalipoproteinemic JJ B-Disease
( ( O
HDL NNP O
- : O
cholesterol NN O
> NN O
or CC O
= $ O
100 CD O
mg NN O
/ NNP O
dl NN O
) ) O
subjects NNS O
. . O

A DT O
rapid JJ O
and CC O
easy JJ O
screening NN O
method NN O
for IN O
this DT O
new JJ O
mutation NN O
was VBD O
developed VBN O
using VBG O
a DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
- : O
mediated VBN O
site NN O
- : O
directed JJ O
mutagenesis NN O
. . O

Among IN O
117 CD O
Japanese JJ O
hyperalphalipoproteinemic JJ B-Disease
subjects NNS O
( ( O
HDL NNP O
- : O
cholesterol NN O
; : O
116 CD O
. . O
7 CD O
+ JJ O
/ NNP O
- : O
16 CD O
. . O
5 CD O
mg JJ O
/ NNP O
dl NN O
, , O
mean JJ O
+ NNP O
/ NNP O
- : O
S NNP O
. . O
D NNP O
. . O
) ) O
without IN O
the DT O
intron NN O
14 CD O
splice NN O
defect NN O
, , O
three CD O
homozygotes NNS O
( ( O
2 CD O
. . O
5 CD O
% NN O
) ) O
and CC O
34 CD O
heterozygotes NNS O
( ( O
29 CD O
. . O
1 CD O
% NN O
) ) O
were VBD O
found VBN O
to TO O
have VB O
the DT O
442D CD O
G NNP O
mutation NN O
. . O

The DT O
relative JJ O
allelic JJ O
frequency NN O
of IN O
this DT O
mutation NN O
was VBD O
calculated VBN O
to TO O
be VB O
0 CD O
. . O

17 CD O
. . O

One CD O
of IN O
the DT O
homozygotes NNS O
for IN O
the DT O
442D CD O
G NNP O
mutation NN O
was VBD O
the DT O
patient NN O
previously RB O
described VBN O
by IN O
us PRP O
as IN O
having VBG O
hyperalphalipoproteinemia NN B-Disease
with IN O
corneal JJ B-Disease
opacity NN I-Disease
and CC O
coronary JJ B-Disease
heart NN I-Disease
disease NN I-Disease
. . O

This DT O
was VBD O
the DT O
first JJ O
reported VBD O
subject JJ O
homozygous JJ O
for IN O
the DT O
CETP NNP B-Disease
deficiency NN I-Disease
who WP O
also RB O
demonstrated VBD O
atherosclerotic JJ B-Disease
symptoms NNS I-Disease
. . O

In IN O
homozygous JJ O
subjects NNS O
, , O
CETP NNP O
activity NN O
ranged VBD O
from IN O
37 CD O
% NN O
to TO O
62 CD O
% NN O
of IN O
the DT O
normal JJ O
value NN O
, , O
which WDT O
was VBD O
consistent JJ O
with IN O
the DT O
results NNS O
obtained VBD O
from IN O
the DT O
transient JJ O
expression NN O
experiment NN O
previously RB O
reported VBD O
; : O
however RB O
, , O
the DT O
specific JJ O
activity NN O
of IN O
CETP NNP O
was VBD O
not RB O
as RB O
low JJ O
as IN O
expected VBN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Mucopolysaccharidosis NNP B-Disease
type NN I-Disease
IVA NN I-Disease
: : O
common JJ O
double JJ O
deletion NN O
in IN O
the DT O
N NNP O
- : O
acetylgalactosamine NN O
- : O
6 CD O
- : O
sulfatase NN O
gene NN O
( ( O
GALNS NNP O
) ) O
. . O

Mucopolysaccharidosis NN B-Disease
IVA NNP I-Disease
( ( O
MPS NNP B-Disease
IVA NNP I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
in IN I-Disease
N NNP I-Disease
- : I-Disease
acetylgalactosamine NN I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
sulfatase NN I-Disease
( ( O
GALNS NNP O
) ) O
. . O

We PRP O
found VBD O
two CD O
separate JJ O
deletions NNS O
of IN O
nearly RB O
8 CD O
. . O

0 CD O
and CC O
6 CD O
. . O

0 CD O
kb NN O
in IN O
the DT O
GALNS NNP O
gene NN O
, , O
including VBG O
some DT O
exons NNS O
. . O

There EX O
are VBP O
Alu NNP O
repetitive JJ O
elements NNS O
near IN O
the DT O
breakpoints NNS O
of IN O
the DT O
8 CD O
. . O

0 CD O
- : O
kb NN O
deletion NN O
, , O
and CC O
this DT O
deletion NN O
resulted VBD O
from IN O
an DT O
Alu NNP O
- : O
Alu NNP O
recombination NN O
. . O

The DT O
other JJ O
6 CD O
. . O

0 CD O
- : O
kb NN O
deletion NN O
involved VBN O
illegitimate JJ O
recombinational JJ O
events NNS O
between IN O
incomplete JJ O
short JJ O
direct JJ O
repeats NNS O
of IN O
8 CD O
bp NN O
at IN O
deletion NN O
breakpoints NNS O
. . O

The DT O
same JJ O
rearrangement NN O
has VBZ O
been VBN O
observed VBN O
in IN O
a DT O
heteroallelic JJ O
state NN O
in IN O
four CD O
unrelated JJ O
patients NNS O
. . O

This DT O
is VBZ O
the DT O
first JJ O
documentation NN O
of IN O
a DT O
common JJ O
double JJ O
deletion NN O
a DT O
gene NN O
that WDT O
is VBZ O
not RB O
a DT O
member NN O
of IN O
a DT O
gene NN O
cluster NN O
. . O

Detection NN O
of IN O
eight CD O
BRCA1 NNP O
mutations NNS O
in IN O
10 CD O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
, , O
including VBG O
1 CD O
family NN O
with IN O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O

Genetic JJ O
epidemiological JJ O
evidence NN O
suggests VBZ O
that IN O
mutations NNS O
in IN O
BRCA1 NNP O
may MD O
be VB O
responsible JJ O
for IN O
approximately RB O
one CD O
half NN O
of IN O
early JJ O
onset VBN O
familial JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
and CC O
the DT O
majority NN O
of IN O
familial JJ B-Disease
breast NN I-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

The DT O
recent JJ O
cloning NN O
of IN O
BRCA1 NNP O
allows VBZ O
for IN O
the DT O
direct JJ O
detection NN O
of IN O
mutations NNS O
, , O
but CC O
the DT O
feasibility NN O
of IN O
presymptomatic JJ O
screening NN O
for IN O
cancer NN B-Disease
susceptibility NN O
is VBZ O
unknown JJ O
. . O

We PRP O
analyzed VBD O
genomic JJ O
DNA NN O
from IN O
one CD O
affected VBD O
individual JJ O
from IN O
each DT O
of IN O
24 CD O
families NNS O
with IN O
at IN O
least JJS O
three CD O
cases NNS O
of IN O
ovarian JJ B-Disease
or CC I-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
using VBG O
SSCP NNP O
assays NNS O
. . O

Variant NNP O
SSCP NNP O
bands NNS O
were VBD O
subcloned VBN O
and CC O
sequenced VBN O
. . O

Allele NNP O
- : O
specific JJ O
oligonucleotide JJ O
hybridization NN O
was VBD O
used VBN O
to TO O
verify VB O
sequence NN O
changes NNS O
and CC O
to TO O
screen VB O
DNA NNP O
from IN O
control NN O
individuals NNS O
. . O

Six NNP O
frameshift NN O
and CC O
two CD O
missense NN O
mutations NNS O
were VBD O
detected VBN O
in IN O
10 CD O
different JJ O
families NNS O
. . O

A DT O
frameshift NN O
mutation NN O
was VBD O
detected VBN O
in IN O
a DT O
male JJ O
proband NN O
affected VBN O
with IN O
both DT O
breast NN B-Disease
and CC I-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O

A DT O
40 CD O
- : O
bp NN O
deletion NN O
was VBD O
detected VBN O
in IN O
a DT O
patient NN O
who WP O
developed VBD O
intra JJ B-Disease
- : I-Disease
abdominal JJ I-Disease
carcinomatosis NN I-Disease
1 CD O
year NN O
after IN O
prophylactic JJ O
oophorectomy NN O
. . O

Mutations NNS O
were VBD O
detected VBN O
throughout IN O
the DT O
gene NN O
, , O
and CC O
only RB O
one CD O
was VBD O
detected VBN O
in IN O
more JJR O
than IN O
a DT O
single JJ O
family NN O
. . O

These DT O
results NNS O
provide VBP O
further JJ O
evidence NN O
that WDT O
inherited VBD B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
can MD O
occur VB O
as IN O
a DT O
consequence NN O
of IN O
a DT O
wide JJ O
array NN O
of IN O
BRCA1 NNP O
mutations NNS O
. . O

These DT O
results NNS O
suggests VBZ O
that IN O
development NN O
of IN O
a DT O
screening JJ O
test NN O
for IN O
BRCA1 NNP O
mutations NNS O
will MD O
be VB O
technically RB O
challenging VBG O
. . O

The DT O
finding NN O
of IN O
a DT O
mutation NN O
in IN O
a DT O
family NN O
with IN O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
not RB O
previously RB O
thought VBN O
to TO O
be VB O
related VBN O
to TO O
BRCA1 NNP O
, , O
also RB O
illustrates VBZ O
the DT O
potential JJ O
difficulties NNS O
of IN O
genetic JJ O
counseling NN O
for IN O
individuals NNS O
known VBN O
to TO O
carry VB O
mutations NNS O
. . O
. . O

Natural JJ O
selection NN O
of IN O
hemi NN O
- : O
and CC O
heterozygotes NNS O
for IN O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
Africa NNP O
by IN O
resistance NN O
to TO O
severe VB O
malaria NNS B-Disease
. . O

Glucose NNP B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
, , O
the DT O
most RBS O
common JJ O
enzymopathy NN B-Disease
of IN O
humans NNS O
, , O
affects VBZ O
over IN O
400 CD O
million CD O
people NNS O
. . O

The DT O
geographical JJ O
correlation NN O
of IN O
its PRP$ O
distribution NN O
with IN O
the DT O
historical JJ O
endemicity NN O
of IN O
malaria NN B-Disease
suggests VBZ O
that IN O
this DT O
disorder NN O
has VBZ O
risen VBN O
in IN O
frequency NN O
through IN O
natural JJ O
selection NN O
by IN O
malaria NNS B-Disease
. . O

However RB O
, , O
attempts NNS O
to TO O
confirm VB O
that DT O
G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
protective JJ O
in IN O
case NN O
- : O
control NN O
studies NNS O
of IN O
malaria NNS B-Disease
have VBP O
yielded VBN O
conflicting NN O
results NNS O
. . O

Hence NNP O
, , O
for IN O
this DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
disorder NN I-Disease
, , O
it PRP O
is VBZ O
unclear JJ O
whether IN O
both DT O
male JJ O
hemizygotes NNS O
and CC O
female JJ O
heterozygotes NNS O
are VBP O
protected VBN O
or CC O
, , O
as IN O
frequently RB O
suggested VBN O
, , O
only RB O
females VBZ O
. . O

Furthermore RB O
, , O
how WRB O
much JJ O
protection NN O
may MD O
be VB O
afforded VBN O
is VBZ O
unknown JJ O
. . O

Here RB O
we PRP O
report VBP O
that DT O
, , O
in IN O
two CD O
large JJ O
case NN O
- : O
control NN O
studies NNS O
of IN O
over IN O
2 CD O
, , O
0 CD O
African JJ O
children NNS O
, , O
the DT O
common JJ O
African JJ O
form NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
( ( O
G6PD NNP B-Disease
A NNP I-Disease
- : I-Disease
) ) O
is VBZ O
associated VBN O
with IN O
a DT O
46 CD O
- : O
58 CD O
% NN O
reduction NN O
in IN O
risk NN O
of IN O
severe JJ O
malaria NN B-Disease
for IN O
both DT O
female JJ O
heterozygotes NNS O
and CC O
male NN O
hemizygotes NNS O
. . O

A DT O
mathematical JJ O
model NN O
incorporating VBG O
the DT O
measured VBN O
selective JJ O
advantage NN O
against IN O
malaria NN B-Disease
suggests VBZ O
that IN O
a DT O
counterbalancing VBG O
selective JJ O
disadvantage NN O
, , O
associated VBN O
with IN O
this DT O
enzyme JJ B-Disease
deficiency NN I-Disease
, , O
has VBZ O
retarded VBN O
its PRP$ O
rise NN O
in IN O
frequency NN O
in IN O
malaria NN B-Disease
- : O
endemic JJ O
regions NNS O
. . O

Although IN O
G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
now RB O
regarded VBN O
as IN O
a DT O
generally RB O
benign JJ O
disorder NN O
, , O
in IN O
earlier JJR O
environmental JJ O
conditions NNS O
it PRP O
could MD O
have VB O
been VBN O
significantly RB O
disadvantageous JJ O
. . O
. . O

The DT O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
PAX3 NNP O
/ NNP O
FKHR NNP O
fusion NN O
protein NN O
is VBZ O
a DT O
transcriptional JJ O
activator NN O
. . O

Chimeric JJ O
transcription NN O
factors NNS O
, , O
created VBN O
by IN O
gene NN O
fusions NNS O
as IN O
the DT O
result NN O
of IN O
chromosomal JJ O
translocations NNS O
, , O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
several JJ O
pathologically RB O
disparate VBP O
solid JJ B-Disease
tumors NNS I-Disease
. . O

The DT O
PAX3 NNP O
/ NNP O
FKHR NNP O
fusion NN O
gene NN O
, , O
formed VBN O
by IN O
a DT O
t NN O
( ( O
2 CD O
; : O
13 CD O
) ) O
( ( O
q35 NN O
; : O
q14 NN O
) ) O
in IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
, , O
encodes VBZ O
a DT O
hybrid JJ O
protein NN O
that WDT O
contains VBZ O
both DT O
PAX3 NNP O
DNA NNP O
binding NN O
domains NNS O
, , O
the DT O
paired VBN O
box NN O
and CC O
homeodomain NN O
, , O
linked VBN O
to TO O
the DT O
bisected VBN O
DNA NNP O
binding VBG O
domain NN O
of IN O
FKHR NNP O
, , O
a DT O
member NN O
of IN O
the DT O
forkhead JJ O
family NN O
of IN O
transcription NN O
factors NNS O
. . O

Here RB O
we PRP O
report VBP O
that DT O
PAX3 NNP O
and CC O
PAX3 NNP O
/ NNP O
FKHR NNP O
display NN O
similar JJ O
, , O
but CC O
not RB O
identical JJ O
transactivation NN O
activities NNS O
when WRB O
tested VBN O
with IN O
model NN O
Pax NNP O
recognition NN O
sequences NNS O
. . O

No DT O
functional JJ O
role NN O
could MD O
be VB O
ascribed VBN O
solely RB O
to TO O
the DT O
residual JJ O
FKHR NNP O
binding NN O
domain NN O
present NN O
in IN O
the DT O
fusion NN O
protein NN O
, , O
but CC O
FKHR NNP O
was VBD O
found VBN O
to TO O
contribute VB O
a DT O
strong JJ O
carboxyl NN O
terminal JJ O
activation NN O
domain NN O
replacing VBG O
the DT O
one CD O
located VBN O
in IN O
the DT O
unrearranged JJ O
PAX3 NNP O
gene NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
native JJ O
PAX3 NNP O
/ NNP O
FKHR NNP O
protein NN O
present NN O
in IN O
tumor NN B-Disease
cells NNS O
with IN O
this DT O
translocation NN O
has VBZ O
transcriptional JJ O
characteristics NNS O
similar JJ O
to TO O
the DT O
in IN O
vitro NN O
expressed VBN O
protein NN O
. . O

The DT O
ability NN O
of IN O
the DT O
PAX3 NNP O
/ NNP O
FKHR NNP O
hybrid JJ O
protein NN O
to TO O
bind VB O
DNA NNP O
in IN O
a DT O
sequence NN O
specific JJ O
manner NN O
and CC O
to TO O
transactivate VB O
the DT O
expression NN O
of IN O
artificial JJ O
reporter NN O
genes NNS O
suggests VBZ O
that IN O
its PRP$ O
aberrant JJ O
expression NN O
could MD O
subvert VB O
the DT O
transcriptional JJ O
programs NNS O
that WDT O
normally RB O
control VBP O
the DT O
growth NN O
, , O
differentiation NN O
, , O
and CC O
survival NN O
of IN O
primitive JJ O
myogenic JJ O
precursors NNS O
in IN O
vivo NN O
. . O
. . O

A DT O
p16INK4a JJ O
- : O
insensitive JJ O
CDK4 NNP O
mutant NN O
targeted VBN O
by IN O
cytolytic JJ O
T NNP O
lymphocytes VBZ O
in IN O
a DT O
human JJ O
melanoma NN B-Disease
. . O

A DT O
mutated JJ O
cyclin NN O
- : O
dependent JJ O
kinase NN O
4 CD O
( ( O
CDK4 NNP O
) ) O
was VBD O
identified VBN O
as IN O
a DT O
tumor NN B-Disease
- : O
specific JJ O
antigen NN O
recognized VBN O
by IN O
HLA NNP O
- : O
A2 NN O
. . O

1 CD O
- : O
restricted VBN O
autologous JJ O
cytolytic JJ O
T NNP O
lymphocytes NNS O
( ( O
CTLs NNP O
) ) O
in IN O
a DT O
human JJ O
melanoma NN B-Disease
. . O

The DT O
mutated JJ O
CDK4 NNP O
allele NN O
was VBD O
present JJ O
in IN O
autologous JJ O
cultured JJ O
melanoma NN B-Disease
cells NNS O
and CC O
metastasis NN O
tissue NN O
, , O
but CC O
not RB O
in IN O
the DT O
patients NNS O
lymphocytes VBZ O
. . O

The DT O
mutation NN O
, , O
an DT O
arginine JJ O
- : O
to TO O
- : O
cysteine NN O
exchange NN O
at IN O
residue JJ O
24 CD O
, , O
was VBD O
part NN O
of IN O
the DT O
CDK4 NNP O
peptide NN O
recognized VBN O
by IN O
CTLs NNP O
and CC O
prevented VBD O
binding NN O
of IN O
the DT O
CDK4 NNP O
inhibitor NN O
p16INK4a NN O
, , O
but CC O
not RB O
of IN O
p21 NN O
or CC O
of IN O
p27KIP1 NN O
. . O

The DT O
same JJ O
mutation NN O
was VBD O
found VBN O
in IN O
one CD O
additional JJ O
melanoma NN B-Disease
among IN O
28 CD O
melanomas NNS B-Disease
analyzed VBN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
mutation NN O
of IN O
CDK4 NNP O
can MD O
create VB O
a DT O
tumor NN B-Disease
- : O
specific JJ O
antigen NN O
and CC O
can MD O
disrupt VB O
the DT O
cell NN O
- : O
cycle NN O
regulation NN O
exerted VBN O
by IN O
the DT O
tumor NN B-Disease
suppressor NN O
p16INK4a NN O
. . O
. . O

Rapid JJ O
detection NN O
of IN O
BRCA1 NNP O
mutations NNS O
by IN O
the DT O
protein NN O
truncation NN O
test NN O
. . O

More JJR O
than IN O
75 CD O
% NN O
of IN O
the DT O
reported JJ O
mutations NNS O
in IN O
the DT O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
gene NN O
, , O
BRCA1 NNP O
, , O
result NN O
in IN O
truncated JJ O
proteins NNS O
. . O

We PRP O
have VBP O
used VBN O
the DT O
protein NN O
truncation NN O
test NN O
( ( O
PTT NNP O
) ) O
to TO O
screen VB O
for IN O
mutations NNS O
in IN O
exon JJ O
11 CD O
, , O
which WDT O
encodes VBZ O
61 CD O
% NN O
of IN O
BRCA1 NNP O
. . O

In IN O
45 CD O
patients NNS O
from IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
we PRP O
found VBD O
six CD O
novel JJ O
mutations NNS O
two CD O
single JJ O
nucleotide JJ O
insertions NNS O
, , O
three CD O
small JJ O
deletions NNS O
( ( O
1 CD O
- : O
5 CD O
bp NN O
) ) O
and CC O
a DT O
nonsense JJ O
mutation NN O
identified VBD O
two CD O
unrelated JJ O
families NNS O
. . O

Furthermore RB O
, , O
we PRP O
were VBD O
able JJ O
to TO O
amplify VB O
the DT O
remaining VBG O
coding VBG O
region NN O
by IN O
RT NNP O
- : O
PCR NN O
using VBG O
lymphocyte JJ O
RNA NNP O
. . O

Combined VBN O
with IN O
PTT NNP O
, , O
we PRP O
detected VBD O
aberrantly RB O
spliced VBN O
products NNS O
affecting VBG O
exons NNS O
5 CD O
and CC O
6 CD O
in IN O
one CD O
of IN O
two CD O
BRCA1 NNP O
- : O
linked VBN O
families NNS O
examined VBD O
. . O

The DT O
protein NN O
truncation NN O
test NN O
promises VBZ O
to TO O
become VB O
a DT O
valuable JJ O
technique NN O
in IN O
detecting VBG O
BRCA1 NNP O
mutations NNS O
. . O
. . O

Cloning NN O
of IN O
human JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
coenzyme NN O
A DT O
dehydrogenase NN O
and CC O
molecular JJ O
characterization NN O
of IN O
its PRP$ O
deficiency NN O
in IN O
two CD O
patients NNS O
. . O

Two CD O
overlapping VBG O
cDNA NN O
clones NNS O
( ( O
1 CD O
, , O
991 CD O
bp NN O
and CC O
736 CD O
bp NN O
, , O
respectively RB O
) ) O
encoding VBG O
the DT O
precursor NN O
of IN O
human JJ O
mitochondrial JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
coenzyme NN O
A DT O
dehydrogenase NN O
( ( O
VLCAD NNP O
) ) O
were VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

The DT O
cDNA NN O
inserts NNS O
of IN O
these DT O
clones NNS O
together RB O
encompass VBP O
a DT O
region NN O
of IN O
2 CD O
, , O
177 CD O
bases NNS O
, , O
encoding VBG O
the DT O
entire JJ O
protein NN O
of IN O
655 CD O
amino NN O
acids NNS O
, , O
including VBG O
a DT O
40 CD O
- : O
amino NN O
acid JJ O
leader NN O
peptide NN O
and CC O
a DT O
615 CD O
- : O
amino NN O
acid JJ O
mature NN O
polypeptide NN O
. . O

PCR NNP O
- : O
amplified VBD O
VLCAD NNP O
cDNAs NN O
were VBD O
sequenced VBN O
in IN O
cultured JJ O
fibroblasts NNS O
from IN O
two CD O
VLCAD NNP B-Disease
- : I-Disease
deficient NN I-Disease
patients NNS O
. . O

In IN O
both DT O
patients NNS O
, , O
a DT O
105 CD O
- : O
bp NN O
deletion NN O
encompassing VBG O
bases NNS O
1078 CD O
- : O
1182 CD O
in IN O
VLCAD NNP O
cDNA NN O
was VBD O
identified VBN O
. . O

The DT O
deletion NN O
seems VBZ O
to TO O
occur VB O
due JJ O
to TO O
exon VB O
skipping VBG O
during IN O
processing NN O
of IN O
VLCAD NNP O
pre FW O
- : O
mRNA NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
demonstration NN O
of IN O
a DT O
mutation NN O
causing VBG O
VLCAD NNP B-Disease
deficiency NN I-Disease
. . O

Quantitative JJ O
cDNA NN O
expression NN O
of IN O
normal JJ O
human JJ O
VLCAD NNP O
was VBD O
performed VBN O
in IN O
the DT O
patients NNS O
fibroblasts NNS O
, , O
using VBG O
vaccinia JJ O
viral JJ O
system NN O
, , O
which WDT O
demonstrated VBD O
that IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
the DT I-Disease
normal JJ I-Disease
VLCAD NNP I-Disease
protein NN I-Disease
causes NNS O
impaired VBD O
long JJ O
- : O
chain NN O
fatty JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
activity NN O
in IN O
the DT O
patients NNS O
fibroblasts NNS O
. . O

In IN O
patient JJ O
fibroblasts NNS O
, , O
raising VBG O
VLCAD NNP O
activity NN O
to TO O
approximately RB O
20 CD O
% NN O
of IN O
normal JJ O
control NN O
fibroblast NN O
activity NN O
raised VBN O
palmitic JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
flux NN O
to TO O
the DT O
level NN O
found VBD O
in IN O
control NN O
fibroblasts NNS O
, , O
which WDT O
may MD O
offer VB O
important JJ O
information NN O
for IN O
the DT O
rational JJ O
design NN O
of IN O
future JJ O
somatic JJ O
gene NN O
therapy NN O
for IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
. . O
. . O

Brain NNP B-Disease
disease NN I-Disease
and CC O
molecular JJ O
analysis NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

Abnormal JJ O
amplification NN O
of IN O
a DT O
CTG NNP O
repeat NN O
on IN O
chromosome NN O
19 CD O
is VBZ O
the DT O
molecular JJ O
basis NN O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
. . O

Expansion NN O
of IN O
the DT O
repeat NN O
has VBZ O
been VBN O
correlated VBN O
with IN O
severity NN O
of IN O
several JJ O
clinical JJ O
features NNS O
of IN O
the DT O
disease NN O
. . O

We PRP O
performed VBD O
extensive JJ O
cognitive JJ O
testing NN O
, , O
cerebral JJ O
magnetic JJ O
resonance NN O
imaging NN O
( ( O
MRI NNP O
) ) O
and CC O
a DT O
molecular JJ O
analysis NN O
in IN O
28 CD O
cases NNS O
of IN O
DM NNP B-Disease
to TO O
determine VB O
the DT O
relationship NN O
between IN O
the DT O
molecular JJ O
defect NN O
and CC O
brain NN B-Disease
disease NN I-Disease
. . O

Performance NN O
in IN O
two CD O
or CC O
more JJR O
cognitive JJ O
tests NNS O
was VBD O
pathological JJ O
in IN O
10 CD O
cases NNS O
. . O

Fourteen JJ O
patients NNS O
had VBD O
subcortical JJ O
white JJ B-Disease
matter NN I-Disease
lesions NNS I-Disease
on IN O
MRI NNP O
, , O
14 CD O
had VBD O
cerebral JJ B-Disease
atrophy NN I-Disease
. . O

Amplification NN O
of IN O
the DT O
CTG NNP O
repeat NN O
showed VBD O
a DT O
strong JJ O
correlation NN O
with IN O
cognitive JJ O
test NN O
deficits NNS O
when WRB O
exceeding VBG O
a DT O
length NN O
of IN O
over IN O
1000 CD O
trinucleotides NNS O
. . O

MRI NNP O
lesions NNS O
were VBD O
associated VBN O
with IN O
impaired JJ O
psychometric JJ O
performance NN O
, , O
but CC O
MRI NNP O
and CC O
molecular JJ O
findings NNS O
were VBD O
only RB O
weakly RB O
related VBN O
. . O

Disease NNP O
duration NN O
influenced VBD O
the DT O
appearance NN O
and CC O
amount NN O
of IN O
white JJ B-Disease
matter NN I-Disease
lesions NNS I-Disease
on IN O
MRI NNP O
. . O

Quantification NN O
of IN O
CTG NNP O
repeat NN O
size NN O
may MD O
allow VB O
an DT O
early JJ O
estimate NN O
on IN O
the DT O
probability NN O
of IN O
brain NN O
involvement NN O
in IN O
DM NNP B-Disease
; : O
cognitive JJ B-Disease
dysfunction NN I-Disease
is VBZ O
associated VBN O
with IN O
white JJ B-Disease
matter NN I-Disease
lesions NNS I-Disease
and CC O
cerebral JJ B-Disease
atrophy NN I-Disease
later RB O
on IN O
in IN O
the DT O
course NN O
. . O
. . O

Mutations NNS O
in IN O
the DT O
gene NN O
for IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
adrenoleukodystrophy NN I-Disease
in IN O
patients NNS O
with IN O
different JJ O
clinical JJ O
phenotypes NNS O
. . O

Recently RB O
, , O
the DT O
gene NN O
for IN O
the DT O
most RBS O
common JJ O
peroxisomal JJ B-Disease
disorder NN I-Disease
, , O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
) ) O
, , O
has VBZ O
been VBN O
described VBN O
encoding VBG O
a DT O
peroxisomal JJ O
membrane NN O
transporter NN O
protein NN O
. . O

We PRP O
analyzed VBD O
the DT O
entire JJ O
protein NN O
- : O
coding VBG O
sequence NN O
of IN O
this DT O
gene NN O
by IN O
reverse JJ O
- : O
transcription NN O
PCR NNP O
, , O
SSCP NNP O
, , O
and CC O
DNA NNP O
sequencing VBG O
in IN O
five CD O
patients NNS O
with IN O
different JJ O
clinical JJ O
expression NN O
of IN O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
and CC O
in IN O
their PRP$ O
female JJ O
relatives NNS O
; : O
these DT O
clinical JJ O
expressions NNS O
were VBD O
cerebral JJ O
childhood NN O
ALD NNP B-Disease
, , O
adrenomyeloneuropathy NN B-Disease
( ( O
AMN NNP B-Disease
) ) O
, , O
and CC O
"""" NNP O
Addison NNP B-Disease
disease NN I-Disease
only RB I-Disease
"""" NNP O
( ( O
ADO NNP B-Disease
) ) O
phenotype NN O
. . O

In IN O
the DT O
three CD O
patients NNS O
exhibiting VBG O
the DT O
classical JJ O
picture NN O
of IN O
severe JJ O
childhood NN O
ALD NNP B-Disease
we PRP O
identified VBD O
in IN O
the DT O
5 CD O
portion NN O
of IN O
the DT O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
gene NN O
a DT O
38 CD O
- : O
bp NN O
deletion NN O
that WDT O
causes VBZ O
a DT O
frameshift JJ O
mutation NN O
, , O
a DT O
3 CD O
- : O
bp NN O
deletion NN O
leading VBG O
to TO O
a DT O
deletion NN O
of IN O
an DT O
amino NN O
acid NN O
in IN O
the DT O
ATP NNP O
- : O
binding VBG O
domain NN O
of IN O
the DT O
ALD NNP B-Disease
protein NN O
, , O
and CC O
a DT O
missense JJ O
mutation NN O
. . O

In IN O
the DT O
patient NN O
with IN O
the DT O
clinical JJ O
phenotype NN O
of IN O
AMN NNP B-Disease
, , O
a DT O
nonsense JJ O
mutation NN O
in IN O
codon NN O
212 CD O
, , O
along IN O
with IN O
a DT O
second JJ O
site NN O
mutation NN O
at IN O
codon NN O
178 CD O
, , O
was VBD O
observed VBN O
. . O

Analysis NN O
of IN O
the DT O
patient NN O
with IN O
the DT O
ADO NNP B-Disease
phenotype NN O
revealed VBD O
a DT O
further JJ O
missense NN O
mutation NN O
at IN O
a DT O
highly RB O
conserved VBN O
position NN O
in IN O
the DT O
ALDP NNP O
/ NNP O
PMP70 NNP O
comparison NN O
. . O

The DT O
disruptive JJ O
nature NN O
of IN O
two CD O
mutations NNS O
( ( O
i NN O
. . O
e NN O
. . O
, , O
the DT O
frameshift NN O
and CC O
the DT O
nonsense JJ O
mutation NN O
) ) O
in IN O
patients NNS O
with IN O
biochemically RB O
proved VBN O
childhood NN O
ALD NNP B-Disease
and CC O
AMN NNP B-Disease
further RB O
strongly RB O
supports VBZ O
the DT O
hypothesis NN O
that WDT O
alterations VBZ O
in IN O
this DT O
gene NN O
play VB O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
. . O

Since IN O
the DT O
current JJ O
biochemical JJ O
techniques NNS O
for IN O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
carrier NN O
detection NN O
in IN O
affected JJ O
families NNS O
lack VBP O
sufficient JJ O
reliability NN O
, , O
our PRP$ O
procedure NN O
described VBN O
for IN O
systematic JJ O
mutation NN O
scanning NN O
is VBZ O
also RB O
capable JJ O
of IN O
improving VBG O
genetic JJ O
counseling NN O
and CC O
prenatal JJ O
diagnosis NN O

Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
and CC O
myotonic JJ B-Disease
dystrophy NN I-Disease
in IN O
the DT O
same JJ O
patient NN O
. . O

We PRP O
report VBP O
on IN O
the DT O
first JJ O
patient NN O
identified VBN O
with IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
and CC O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

The DT O
family NN O
of IN O
the DT O
propositus NN O
had VBD O
a DT O
strong JJ O
history NN O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
and CC O
there EX O
was VBD O
an DT O
intrafamilial JJ O
pathological JJ O
expansion NN O
of IN O
the DT O
responsible JJ O
CTG NNP O
repeat NN O
between IN O
the DT O
mildly RB O
affected JJ O
mother NN O
( ( O
160 CD O
repeats NNS O
; : O
normal JJ O
27 CD O
repeats NNS O
) ) O
and CC O
her PRP$ O
more RBR O
severely RB O
affected JJ O
son NN O
( ( O
650 CD O
repeats NNS O
) ) O
, , O
and CC O
his PRP$ O
sister NN O
( ( O
650 CD O
repeats NNS O
) ) O
. . O

The DT O
propositus NN O
was VBD O
an DT O
isolated JJ O
case NN O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
with IN O
marked VBN O
dystrophin JJ B-Disease
deficiency NN I-Disease
in IN O
muscle NN O
biopsy NN O
. . O

The DT O
patient NN O
was VBD O
still RB O
ambulatory JJ O
post NN O
age NN O
16 CD O
. . O

Myotonic NNP B-Disease
dystrophy NN I-Disease
could MD O
interfere VB O
to TO O
some DT O
extent NN O
with IN O
the DT O
progression NN O
of IN O
Duchenne NNP B-Disease
dystrophy NN I-Disease
. . O

However RB O
, , O
other JJ O
interpretations NNS O
are VBP O
possible JJ O
. . O

Twelve NNP O
percent NN O
of IN O
dystrophin JJ O
revertant JJ O
fibers NNS O
as IN O
observed VBN O
by IN O
immunohistochemistry NN O
could MD O
be VB O
sufficient JJ O
to TO O
ameliorate VB O
typical JJ O
DMD NNP B-Disease
clinical JJ O
severity NN O
, , O
or CC O
the DT O
patient NN O
may MD O
present VB O
a DT O
somatic JJ O
mosaic NN O
. . O

The DT O
pathophysiological JJ O
interactions NNS O
of IN O
these DT O
two CD O
unlinked VBD O
disorders NNS O
are VBP O
discussed VBN O
at IN O
the DT O
clinical JJ O
and CC O
histopathological JJ O
levels NNS O
. . O
. . O

Age NNP O
at IN O
diagnosis NN O
as IN O
an DT O
indicator NN O
of IN O
eligibility NN O
for IN O
BRCA1 NNP O
DNA NNP O
testing VBG O
in IN O
familial JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O

We PRP O
searched VBD O
for IN O
criteria NNS O
that WDT O
could MD O
indicate VB O
breast NN B-Disease
cancer NN I-Disease
families NNS O
with IN O
a DT O
high JJ O
prior JJ O
probability NN O
of IN O
being VBG O
caused VBN O
by IN O
the DT O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
locus VBP O
BRCA1 NNP O
on IN O
chromosome NN O
17 CD O
. . O

To TO O
this DT O
end NN O
, , O
we PRP O
performed VBD O
a DT O
linkage NN O
study NN O
with IN O
59 CD O
consecutively RB O
collected VBN O
Dutch NNP O
breast NN B-Disease
cancer NN I-Disease
families NNS O
, , O
including VBG O
16 CD O
with IN O
at IN O
least JJS O
one CD O
case NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

We PRP O
used VBD O
an DT O
intake NN O
cut NN O
- : O
off IN O
of IN O
at IN O
least JJS O
three CD O
first JJ O
- : O
degree NN O
relatives NNS O
with IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
at IN O
any DT O
age NN O
. . O

Significant JJ O
evidence NN O
for IN O
linkage NN O
was VBD O
found VBN O
only RB O
among IN O
the DT O
13 CD O
breast NN B-Disease
cancer NN I-Disease
families NNS O
with IN O
a DT O
mean JJ O
age NN O
at IN O
diagnosis NN O
of IN O
less JJR O
than IN O
45 CD O
years NNS O
. . O

An DT O
unexpectedly RB O
low JJ O
proportion NN O
of IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
were VBD O
estimated VBN O
to TO O
be VB O
linked VBN O
to TO O
BRCA1 NNP O
, , O
which WDT O
could MD O
be VB O
due JJ O
to TO O
a DT O
founder NN O
effect NN O
in IN O
the DT O
Dutch JJ O
population NN O
. . O

Given VBN O
the DT O
expected JJ O
logistical JJ O
problems NNS O
in IN O
clinical JJ O
management NN O
now RB O
that IN O
BRCA1 NNP O
has VBZ O
been VBN O
identified VBN O
, , O
we PRP O
propose VBP O
an DT O
interim JJ O
period NN O
in IN O
which WDT O
only JJ O
families NNS O
with IN O
a DT O
strong JJ O
positive JJ O
family NN O
history NN O
for IN O
early JJ O
onset NN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
will MD O
be VB O
offered VBN O
BRCA1 NNP O
mutation NN O
testing VBG O
. . O
. . O

Linkage JJ O
analysis NN O
of IN O
26 CD O
Canadian JJ O
breast NN B-Disease
and CC I-Disease
breast NN I-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

We PRP O
have VBP O
examined VBN O
26 CD O
Canadian JJ O
families NNS O
with IN O
hereditary JJ B-Disease
breast NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
for IN O
linkage NN O
to TO O
markers NNS O
flanking VBG O
the DT O
BRCA1 NNP O
gene NN O
on IN O
chromosome NN O
17q12 CD O
- : O
q21 NN O
. . O

Of IN O
the DT O
15 CD O
families NNS O
that WDT O
contain VBP O
cases NNS O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
, , O
94 CD O
% NN O
were VBD O
estimated VBN O
to TO O
be VB O
linked VBN O
to TO O
BRCA1 NNP O
. . O

In IN O
contrast NN O
, , O
there EX O
was VBD O
no DT O
overall JJ O
evidence NN O
of IN O
linkage NN O
in IN O
the DT O
group NN O
of IN O
10 CD O
families NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
without IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

A DT O
genetic JJ O
recombinant NN O
in IN O
a DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
family NN O
indicates VBZ O
a DT O
placement NN O
of IN O
BRCA1 NNP O
telomeric NN O
to TO O
D17S776 NNP O
, , O
and CC O
helps VBZ O
to TO O
define VB O
the DT O
region NN O
of IN O
assignment NN O
of IN O
the DT O
cancer NN B-Disease
susceptibility NN O
gene NN O
. . O

Other JJ O
cancers NNS B-Disease
of IN O
interest NN O
that WDT O
appeared VBD O
in IN O
the DT O
BRCA1 NNP O
- : O
linked VBN O
families NNS O
included VBD O
primary JJ B-Disease
peritoneal NN I-Disease
cancer NN I-Disease
, , O
cancer NN B-Disease
of IN I-Disease
the DT I-Disease
fallopian JJ I-Disease
tube NN I-Disease
, , O
and CC O
malignant JJ B-Disease
melanoma NN I-Disease
. . O
. . O

Structural JJ O
analysis NN O
of IN O
the DT O
5 CD O
' POS O
region NN O
of IN O
mouse NN O
and CC O
human JJ O
Huntington NNP B-Disease
disease NN I-Disease
genes NNS O
reveals VBZ O
conservation NN O
of IN O
putative JJ O
promoter NN O
region NN O
and CC O
di VB O
- : O
and CC O
trinucleotide JJ O
polymorphisms NN O
. . O

We PRP O
have VBP O
previously RB O
cloned VBN O
and CC O
characterized VBN O
the DT O
murine NN O
homologue NN O
of IN O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
gene NN O
and CC O
shown VBN O
that IN O
it PRP O
maps VBZ O
to TO O
mouse VB O
chromosome NN O
5 CD O
within IN O
a DT O
region NN O
of IN O
conserved VBN O
synteny NN O
with IN O
human JJ O
chromosome NN O
4p16 CD O
. . O

3 CD O
3 CD O
. . O

Here RB O
we PRP O
present VBP O
a DT O
detailed JJ O
comparison NN O
of IN O
the DT O
sequence NN O
of IN O
the DT O
putative JJ O
promoter NN O
and CC O
the DT O
organization NN O
of IN O
the DT O
5 CD O
genomic JJ O
region NN O
of IN O
the DT O
murine NN O
( ( O
Hdh NNP O
) ) O
and CC O
human JJ O
HD NNP B-Disease
genes NNS O
encompassing VBG O
the DT O
first JJ O
five CD O
exons NNS O
. . O

We PRP O
show VBP O
that IN O
in IN O
this DT O
region NN O
these DT O
two CD O
genes NNS O
share NN O
identical JJ O
exon NN O
boundaries NNS O
, , O
but CC O
have VBP O
different JJ O
- : O
size NN O
introns NNS O
. . O

Two CD O
dinucleotide NN O
( ( O
CT NNP O
) ) O
and CC O
one CD O
trinucleotide NN O
intronic JJ O
polymorphism NN O
in IN O
Hdh NNP O
and CC O
an DT O
intronic JJ O
CA NNP O
polymorphism NN O
in IN O
the DT O
HD NNP B-Disease
gene NN O
were VBD O
identified VBN O
. . O

Comparison NNP O
of IN O
940 CD O
- : O
bp NN O
sequence NN O
5 CD O
to TO O
the DT O
putative JJ O
translation NN O
start NN O
site NN O
reveals VBZ O
a DT O
highly RB O
conserved VBN O
region NN O
( ( O
78 CD O
. . O
8 CD O
% NN O
nucleotide JJ O
identity NN O
) ) O
between IN O
Hdh NNP O
and CC O
the DT O
HD NNP B-Disease
gene NN O
from IN O
nucleotide JJ O
- : O
56 CD O
to TO O
- : O
206 CD O
( ( O
of IN O
Hdh NNP O
) ) O
. . O

Neither DT O
Hdh NNP O
nor CC O
the DT O
HD NNP B-Disease
gene NN O
have VBP O
typical JJ O
TATA NNP O
or CC O
CCAAT NNP O
elements NNS O
, , O
but CC O
both DT O
show VBP O
one CD O
putative JJ O
AP2 NNP O
binding NN O
site NN O
and CC O
numerous JJ O
potential JJ O
Sp1 NNP O
binding NN O
sites NNS O
. . O

The DT O
high JJ O
sequence NN O
identity NN O
between IN O
Hdh NNP O
and CC O
the DT O
HD NNP B-Disease
gene NN O
for IN O
approximately RB O
200 CD O
bp NNS O
5 CD O
to TO O
the DT O
putative JJ O
translation NN O
start NN O
site NN O
indicates VBZ O
that IN O
these DT O
sequences NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
regulating VBG O
expression NN O
of IN O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
gene NN O

The DT O
protein NN O
deficient NN O
in IN O
Lowe NNP B-Disease
syndrome NN I-Disease
is VBZ O
a DT O
phosphatidylinositol JJ O
- : O
4 CD O
, , O
5 CD O
- : O
bisphosphate NN O
5 CD O
- : O
phosphatase NN O
. . O

Lowe NNP B-Disease
syndrome NN I-Disease
, , O
also RB O
known VBN O
as IN O
oculocerebrorenal JJ B-Disease
syndrome NN I-Disease
, , O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
X NNP O
chromosome NN O
- : O
encoded VBN O
OCRL NNP O
gene NN O
. . O

The DT O
OCRL NNP O
protein NN O
is VBZ O
51 CD O
% NN O
identical JJ O
to TO O
inositol VB O
polyphosphate NN O
5 CD O
- : O
phosphatase NN O
II NNP O
( ( O
5 CD O
- : O
phosphatase NN O
II NNP O
) ) O
from IN O
human JJ O
platelets NNS O
over IN O
a DT O
span NN O
of IN O
744 CD O
aa NNS O
, , O
suggesting VBG O
that IN O
OCRL NNP O
may MD O
be VB O
a DT O
similar JJ O
enzyme NN O
. . O

We PRP O
engineered VBD O
a DT O
construct NN O
of IN O
the DT O
OCRL NNP O
cDNA NN O
that WDT O
encodes VBZ O
amino JJ O
acids NNS O
homologous JJ O
to TO O
the DT O
platelet NN O
5 CD O
- : O
phosphatase NN O
for IN O
expression NN O
in IN O
baculovirus NN O
- : O
infected JJ O
Sf9 NNP O
insect NN O
cells NNS O
. . O

This DT O
cDNA NN O
encodes VBZ O
aa RB O
264 CD O
- : O
968 CD O
of IN O
the DT O
OCRL NNP O
protein NN O
. . O

The DT O
recombinant JJ O
protein NN O
was VBD O
found VBN O
to TO O
catalyze VB O
the DT O
reactions NNS O
also RB O
carried VBD O
out RP O
by IN O
platelet NN O
5 CD O
- : O
phosphatase NN O
II NNP O
. . O

Thus RB O
OCRL NNP O
converts NNS O
inositol RB O
1 CD O
, , O
4 CD O
, , O
5 CD O
- : O
trisphosphate NN O
to TO O
inositol VB O
1 CD O
, , O
4 CD O
- : O
bisphosphate NN O
, , O
and CC O
it PRP O
converts VBZ O
inositol JJ O
1 CD O
, , O
3 CD O
, , O
4 CD O
, , O
5 CD O
- : O
tetrakisphosphate NN O
to TO O
inositol VB O
1 CD O
, , O
3 CD O
, , O
4 CD O
- : O
trisphosphate NN O
. . O

Most RBS O
important JJ O
, , O
the DT O
enzyme NN O
converts VBZ O
phosphatidylinositol RB O
4 CD O
, , O
5 CD O
- : O
bisphosphate NN O
to TO O
phosphatidylinositol VB O
4 CD O
- : O
phosphate NN O
. . O

The DT O
relative JJ O
ability NN O
of IN O
OCRL NNP O
to TO O
catalyze VB O
the DT O
three CD O
reactions NNS O
is VBZ O
different JJ O
from IN O
that DT O
of IN O
5 CD O
- : O
phosphatase NN O
II NNP O
and CC O
from IN O
that DT O
of IN O
another DT O
5 CD O
- : O
phosphatase NN O
isoenzyme NN O
from IN O
platelets NNS O
, , O
5 CD O
- : O
phosphatase NN O
I PRP O
. . O

The DT O
recombinant JJ O
OCRL NNP O
protein NN O
hydrolyzes VBZ O
the DT O
phospholipid JJ O
substrate NN O
10 CD O
- : O
to TO O
30 CD O
- : O
fold NN O
better JJR O
than IN O
5 CD O
- : O
phosphatase NN O
II NNP O
, , O
and CC O
5 CD O
- : O
phosphatase NN O
I PRP O
does VBZ O
not RB O
cleave VB O
the DT O
lipid NN O
at IN O
all DT O
. . O

We PRP O
also RB O
show VBP O
that IN O
OCRL NNP O
functions NNS O
as IN O
a DT O
phosphatidylinositol NN O
4 CD O
, , O
5 CD O
- : O
bisphosphate NN O
5 CD O
- : O
phosphatase NN O
in IN O
OCRL NNP O
- : O
expressing VBG O
Sf9 NNP O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
OCRL NNP O
is VBZ O
mainly RB O
a DT O
lipid JJ O
phosphatase NN O
that WDT O
may MD O
control VB O
cellular JJ O
levels NNS O
of IN O
a DT O
critical JJ O
metabolite NN O
, , O
phosphatidylinositol NN O
4 CD O
, , O
5 CD O
- : O
bisphosphate NN O
. . O

Deficiency NN O
of IN O
this DT O
enzyme NN O
apparently RB O
causes VBZ O
the DT O
protean JJ O
manifestations NNS O
of IN O
Lowe NNP B-Disease
syndrome NN I-Disease
. . O
. . O

New NNP O
founder NN O
haplotypes NNS O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
in IN O
southern JJ O
Africa NNP O
. . O

The DT O
association NN O
between IN O
normal JJ O
alleles NNS O
at IN O
the DT O
CTG NNP O
repeat NN O
and CC O
two CD O
nearby JJ O
polymorphisms NNS O
in IN O
the DT O
myotonin NN O
protein NN O
kinase NN O
gene NN O
, , O
the DT O
Alu NNP O
insertion NN O
/ NNP O
deletion NN O
polymorphism NN O
and CC O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
kinase NN O
( ( O
DMK NNP O
) ) O
( ( O
G NNP O
/ NNP O
T NNP O
) ) O
intron VBP O
9 CD O
/ JJ O
HinfI NNP O
polymorphism NN O
, , O
has VBZ O
been VBN O
analyzed VBN O
in IN O
South JJ O
African JJ O
Negroids NNP O
, , O
a DT O
population NN O
in IN O
which WDT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
has VBZ O
not RB O
been VBN O
described VBN O
. . O

South JJ O
African JJ O
Negroids NNS O
have VBP O
a DT O
CTG NNP O
allelic JJ O
distribution NN O
that WDT O
is VBZ O
significantly RB O
different JJ O
from IN O
that DT O
in IN O
Caucasoids NNP O
and CC O
Japanese JJ O
the DT O
CTG NNP O
repeat NN O
lengths NNS O
of IN O
> NN O
or CC O
= VB O
19 CD O
are VBP O
very RB O
rare JJ O
. . O

The DT O
striking JJ O
linkage NN O
disequilibrium NN O
between IN O
specific JJ O
alleles NNS O
at IN O
the DT O
Alu NNP O
polymorphism NN O
( ( O
Alu NNP O
( ( O
ins NNS O
) ) O
and CC O
Alu NNP O
( ( O
del FW O
) ) O
) ) O
, , O
the DT O
HinfI NNP O
polymorphism NN O
( ( O
HinfI NNP O
- : O
1 CD O
and CC O
HinfI NNP O
- : O
2 CD O
) ) O
, , O
and CC O
the DT O
CTG NNP O
repeat NN O
polymorphism NN O
seen VBN O
in IN O
Caucasoid NNP O
( ( O
Europeans NNPS O
and CC O
Canadians NNPS O
) ) O
populations NNS O
was VBD O
also RB O
found VBN O
in IN O
the DT O
South JJ O
African JJ O
Negroid NNP O
population NN O
. . O

Numerous JJ O
haplotypes NNS O
, , O
not RB O
previously RB O
described VBN O
in IN O
Europeans NNS O
, , O
were VBD O
, , O
however RB O
, , O
found VBN O
. . O

It PRP O
thus RB O
seems VBZ O
likely JJ O
that IN O
only RB O
a DT O
small JJ O
number NN O
of IN O
these DT O
"""" JJ O
African NNP O
"""" NNP O
chromosomes NNS O
were VBD O
present JJ O
in IN O
the DT O
progenitors NNS O
of IN O
all DT O
non FW O
- : O
African JJ O
peoples NNS O
. . O

These DT O
data NNS O
provide VBP O
support NN O
for IN O
the DT O
"""" NNP O
out IN O
of IN O
Africa NNP O
"""" NNP O
model NN O
for IN O
the DT O
origin NN O
of IN O
modern JJ O
humans NNS O
and CC O
suggest VBP O
that IN O
the DT O
rare JJ O
ancestral JJ O
DM NNP B-Disease
mutation NN O
event NN O
may MD O
have VB O
occurred VBN O
after IN O
the DT O
migration NN O
from IN O
Africa NNP O
, , O
hence RB O
the DT O
absence NN O
of IN O
DM NNP B-Disease
in IN O
sub JJ O
- : O
Saharan NN O
Negroid NNP O
peoples NNS O
. . O
. . O

Discordant NNP O
clinical JJ O
outcome NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
relatives NNS O
showing VBG O
( ( O
CTG NNP O
) ) O
n VBP O
> $ O
700 CD O
repeats NNS O
. . O

A DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
family NN O
is VBZ O
described VBN O
in IN O
which WDT O
discordant JJ O
DM NNP B-Disease
phenotypes NNS O
were VBD O
found VBN O
in IN O
the DT O
children NNS O
of IN O
two CD O
affected JJ O
sisters NNS O
with IN O
similar JJ O
CTG NNP O
expansion NN O
and CC O
clinical JJ O
manifestations NNS O
. . O

In IN O
this DT O
family NN O
, , O
congenital NN O
as RB O
well RB O
as IN O
early RB O
severe JJ O
childhood NN O
and CC O
later RB O
childhood NN O
onset NN O
DM NNP B-Disease
coexist NN O
. . O

This DT O
observation NN O
strengthens VBZ O
the DT O
limited JJ O
ability NN O
of IN O
lymphocytes NNS O
CTG NNP O
repeat NN O
number NN O
analysis NN O
in IN O
predicting VBG O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
in IN O
DM NNP B-Disease
patients NNS O
. . O
. . O

Purification NN O
of IN O
human JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
coenzyme NN O
A DT O
dehydrogenase NN O
and CC O
characterization NN O
of IN O
its PRP$ O
deficiency NN O
in IN O
seven CD O
patients NNS O
. . O

Mitochondrial JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
coenzyme NN O
A DT O
dehydrogenase NN O
( ( O
VLCAD NNP O
) ) O
was VBD O
purified VBN O
from IN O
human JJ O
liver NN O
. . O

The DT O
molecular JJ O
masses NNS O
of IN O
the DT O
native JJ O
enzyme NN O
and CC O
the DT O
subunit NN O
were VBD O
estimated VBN O
to TO O
be VB O
154 CD O
and CC O
70 CD O
kD NN O
, , O
respectively RB O
. . O

The DT O
enzyme NN O
was VBD O
found VBN O
to TO O
catalyze VB O
the DT O
major JJ O
part NN O
of IN O
mitochondrial JJ O
palmitoylcoenzyme NN O
A DT O
dehydrogenation NN O
in IN O
liver NN O
, , O
heart NN O
, , O
skeletal JJ O
muscle NN O
, , O
and CC O
skin JJ O
fibroblasts NNS O
( ( O
89 CD O
- : O
97 CD O
, , O
86 CD O
- : O
99 CD O
, , O
96 CD O
- : O
99 CD O
, , O
and CC O
78 CD O
- : O
87 CD O
% NN O
, , O
respectively RB O
) ) O
. . O

Skin NNP O
fibroblasts NNS O
from IN O
26 CD O
patients NNS O
suspected VBN O
of IN O
having VBG O
a DT O
disorder NN O
of IN O
mitochondrial JJ O
beta NN O
- : O
oxidation NN O
were VBD O
analyzed VBN O
for IN O
VLCAD NNP O
protein NN O
using VBG O
immunoblotting NN O
, , O
and CC O
7 CD O
of IN O
them PRP O
contained VBD O
undetectable JJ O
or CC O
trace NN O
levels NNS O
of IN O
the DT O
enzyme NN O
. . O

The DT O
seven CD O
deficient NN O
fibroblast NN O
lines NNS O
were VBD O
characterized VBN O
by IN O
measuring VBG O
acyl JJ O
- : O
coenzyme NN O
A DT O
dehydrogenation NN O
activities NNS O
, , O
overall JJ O
palmitic JJ O
acid NN O
oxidation NN O
, , O
and CC O
VLCAD NNP O
protein VBP O
synthesis NN O
using VBG O
pulse JJ O
- : O
chase NN O
, , O
further RB O
confirming VBG O
the DT O
diagnosis NN O
of IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
. . O

These DT O
results NNS O
suggested VBD O
the DT O
heterogenous JJ O
nature NN O
of IN O
the DT O
mutations NNS O
causing VBG O
the DT O
deficiency NN O
in IN O
the DT O
seven CD O
patients NNS O
. . O

Clinically RB O
, , O
all DT O
patients NNS O
with IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
exhibited VBD O
cardiac JJ B-Disease
disease NN I-Disease
. . O

At IN O
least JJS O
four CD O
of IN O
them PRP O
presented VBN O
with IN O
hypertrophic JJ B-Disease
cardiomyopathy NN I-Disease
. . O

This DT O
frequency NN O
( ( O
> JJ O
57 CD O
% NN O
) ) O
was VBD O
much RB O
higher JJR O
than IN O
that DT O
observed VBD O
in IN O
patients NNS O
with IN O
other JJ O
disorders NNS O
of IN O
mitochondrial JJ O
long JJ O
- : O
chain NN O
fatty JJ O
acid JJ O
oxidation NN O
that WDT O
may MD O
be VB O
accompanied VBN O
by IN O
cardiac JJ B-Disease
disease NN I-Disease
in IN O
infants NNS O
. . O
. . O

Hereditary JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
in IN O
man NN O
. . O

II NNP O
. . O

Biological JJ O
properties NNS O
of IN O
C5 NNP B-Disease
- : I-Disease
deficient NN I-Disease
human JJ O
serum NN O
. . O

The DT O
first JJ O
known VBN O
human JJ O
kindred VBN O
with IN O
hereditary JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
the DT I-Disease
fifth JJ I-Disease
component NN I-Disease
of IN I-Disease
complement NN I-Disease
( ( O
C5 NNP O
) ) O
was VBD O
documented VBN O
in IN O
the DT O
accompanying VBG O
report NN O
. . O

This DT O
study NN O
examines VBZ O
several JJ O
biological JJ O
properties NNS O
of IN O
C5 NNP B-Disease
- : I-Disease
deficient NN I-Disease
( ( O
C5D NNP B-Disease
) ) O
human NN O
serum NN O
, , O
particularly RB O
sera NN O
obtained VBN O
from IN O
two CD O
C5D NNP B-Disease
homozygotes NNS O
. . O

The DT O
proband NN O
, , O
who WP O
has VBZ O
inactive JJ O
systemic JJ B-Disease
lupus NN I-Disease
erythematosus NN I-Disease
is VBZ O
completely RB O
lacking JJ O
C5 NNP O
, , O
while IN O
her PRP$ O
healthy JJ O
half NN O
- : O
sister NN O
has VBZ O
1 CD O
- : O
2 CD O
% NN O
of IN O
normal JJ O
levels NNS O
. . O

Both DT O
sera NN O
were VBD O
severely RB O
impaired VBN O
in IN O
their PRP$ O
ability NN O
to TO O
generate VB O
chemotactic JJ O
activity NN O
for IN O
normal JJ O
human JJ O
neutrophils NNS O
upon IN O
incubation NN O
with IN O
aggregated JJ O
human JJ O
gamma NN O
- : O
globulin NN O
or CC O
Escherichia NNP O
coli VBP O
endotoxin NN O
. . O

This DT O
function NN O
was VBD O
fully RB O
restored VBN O
in IN O
the DT O
siblings NNS O
serum NN O
, , O
and CC O
substantially RB O
improved VBN O
in IN O
the DT O
probands NNS O
serum NN O
, , O
by IN O
addition NN O
of IN O
highly RB O
purified VBN O
human JJ O
C5 NNP O
to TO O
normal JJ O
serum JJ O
concentrations NNS O
. . O

Sera NN O
from IN O
eight CD O
family NN O
members NNS O
who WP O
were VBD O
apparently RB O
heterozygous JJ O
for IN O
C5 NNP B-Disease
deficiency NN I-Disease
gave VBD O
normal JJ O
chemotactic JJ O
scores NNS O
. . O

The DT O
ability NN O
of IN O
C5D NNP B-Disease
serum NN O
to TO O
opsonize VB O
Saccharomyces NNS O
cerevisiae NN O
( ( O
bakers NNS O
yeast RB O
) ) O
or CC O
Candida NNP O
albicans NNS O
for IN O
ingestion NN O
by IN O
normal JJ O
neutrophils NNS O
was VBD O
completely RB O
normal JJ O
. . O

In IN O
addition NN O
, , O
C5D NNP B-Disease
serum NN O
was VBD O
capable JJ O
of IN O
promoting VBG O
normal JJ O
phagocytosis NN O
and CC O
intracellular JJ O
killing NN O
of IN O
Staphylococcus NNP O
aureus NN O
. . O

The DT O
probands NNS O
serum NN O
was VBD O
incapable JJ O
of IN O
mediating VBG O
lysis NN O
of IN O
erythrocytes NNS O
from IN O
a DT O
patient NN O
with IN O
paroxysmal JJ B-Disease
nocturnal JJ I-Disease
hemoglobinuria NN I-Disease
in IN O
both CC O
the DT O
sucrose JJ O
hemolysia NN O
and CC O
acid JJ O
hemolysis NN O
tests NNS O
, , O
and CC O
also RB O
lacked VBD O
bactericidal JJ O
activity NN O
against IN O
sensitized VBN O
or CC O
unsensitized VBN O
Salmonella NNP O
typhi NN O
. . O

The DT O
siblings NNS O
serum NN O
, , O
containing VBG O
only RB O
1 CD O
- : O
2 CD O
% NN O
of IN O
normal JJ O
C5 NNP O
, , O
effectively RB O
lysed VBN O
S NNP O
. . O
typhi NN O
, , O
but CC O
only RB O
at IN O
eightfold JJ O
lower JJR O
serum NN O
dilutions NNS O
as IN O
compared VBN O
to TO O
normals NNS O
. . O

These DT O
findings NNS O
underscore VBP O
the DT O
critical JJ O
role NN O
of IN O
C5 NNP O
in IN O
the DT O
generation NN O
of IN O
chemotactic JJ O
activity NN O
and CC O
in IN O
cytolytic JJ O
reactions NNS O
, , O
as IN O
opposed VBN O
to TO O
a DT O
nonobligatory NN O
or CC O
minimal JJ O
role NN O
in IN O
opsonization NN O
, , O
at IN O
least JJS O
for IN O
the DT O
organisms NNS O
under IN O
study NN O
. . O
. . O

Human NNP O
peroxisomal JJ O
targeting VBG O
signal JJ O
- : O
1 CD O
receptor NN O
restores NNS O
peroxisomal JJ O
protein NN O
import NN O
in IN O
cells NNS O
from IN O
patients NNS O
with IN O
fatal JJ O
peroxisomal JJ B-Disease
disorders NNS I-Disease
. . O

Two CD O
peroxisomal JJ O
targeting VBG O
signals NNS O
, , O
PTS1 NNP O
and CC O
PTS2 NNP O
, , O
are VBP O
involved VBN O
in IN O
the DT O
import NN O
of IN O
proteins NNS O
into IN O
the DT O
peroxisome JJ O
matrix NN O
. . O

Human JJ O
patients NNS O
with IN O
fatal JJ O
generalized VBN O
peroxisomal JJ B-Disease
deficiency NN I-Disease
disorders NNS I-Disease
fall VBP O
into IN O
at IN O
least JJS O
nine CD O
genetic JJ O
complementation NN O
groups NNS O
. . O

Cells NNS O
from IN O
many JJ O
of IN O
these DT O
patients NNS O
are VBP O
deficient JJ O
in IN O
the DT O
import NN O
of IN O
PTS1 NNP O
- : O
containing NN O
proteins NNS O
, , O
but CC O
the DT O
causes NNS O
of IN O
the DT O
protein NN O
- : O
import NN O
defect NN O
in IN O
these DT O
patients NNS O
are VBP O
unknown JJ O
. . O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBD O
the DT O
human JJ O
cDNA NN O
homologue NN O
( ( O
PTS1R NNP O
) ) O
of IN O
the DT O
Pichia NNP O
pastoris NN O
PAS8 NNP O
gene NN O
, , O
the DT O
PTS1 NNP O
receptor NN O
( ( O
McCollum NNP O
, , O
D NNP O
. . O
, , O
E NNP O
. . O
Monosov NNP O
, , O
and CC O
S NNP O
. . O
Subramani NNP O
. . O
1993 CD O
. . O
J NNP O
. . O
Cell NNP O
Biol NNP O
. . O
121 CD O
761 CD O
- : O
774 CD O
) ) O
. . O

The DT O
PTS1R NNP O
mRNA NN O
is VBZ O
expressed VBN O
in IN O
all DT O
human JJ O
tissues NNS O
examined VBN O
. . O

Antibodies NNS O
to TO O
the DT O
human JJ O
PTS1R NNP O
recognize NN O
this DT O
protein NN O
in IN O
human JJ O
, , O
monkey NN O
, , O
rat NN O
, , O
and CC O
hamster NN O
cells NNS O
. . O

The DT O
protein NN O
is VBZ O
localized VBN O
mainly RB O
in IN O
the DT O
cytosol NN O
but CC O
is VBZ O
also RB O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
peroxisomes NNS O
. . O

Part NN O
of IN O
the DT O
peroxisomal JJ O
PTS1R NNP O
protein NN O
is VBZ O
tightly RB O
bound VBN O
to TO O
the DT O
peroxisomal JJ O
membrane NN O
. . O

Antibodies NNS O
to TO O
PTS1R NNP O
inhibit NN O
peroxisomal JJ O
protein NN O
- : O
import NN O
of IN O
PTS1 NNP O
- : O
containing VBG O
proteins NNS O
in IN O
a DT O
permeabilized JJ O
CHO NNP O
cell NN O
system NN O
. . O

In IN O
vitro JJ O
- : O
translated VBN O
PTS1R NNP O
protein NN O
specifically RB O
binds VBZ O
a DT O
serine JJ O
- : O
lysine NN O
- : O
leucine NN O
- : O
peptide NN O
. . O

A DT O
PAS8 NNP O
- : O
PTS1R NNP O
fusion NN O
protein NN O
complements VBZ O
the DT O
P NNP O
. . O
pastoris NN O
pas8 NN O
mutant NN O
. . O

The DT O
PTS1R NNP O
cDNA NN O
also RB O
complements VBZ O
the DT O
PTS1 NNP B-Disease
protein SYM I-Disease
- : I-Disease
import NN I-Disease
defect NN I-Disease
in IN O
skin JJ O
fibroblasts NNS O
from IN O
patients NNS O
- : O
- : O
belonging NN O
to TO O
complementation VB O
group NN O
two CD O
- : O
- : O
diagnosed VBN O
as IN O
having VBG O
neonatal JJ B-Disease
adrenoleukodystrophy NN I-Disease
or CC O
Zellweger NNP B-Disease
syndrome VBP I-Disease
. . O

The DT O
PTS1R NNP O
gene NN O
has VBZ O
been VBN O
localized VBN O
to TO O
a DT O
chromosomal JJ O
location NN O
where WRB O
no DT O
other JJ O
peroxisomal JJ B-Disease
disorder NN I-Disease
genes NNS O
are VBP O
known VBN O
to TO O
map VB O
. . O

Our PRP$ O
findings NNS O
represent VBP O
the DT O
only JJ O
case NN O
in IN O
which WDT O
the DT O
molecular JJ O
basis NN O
of IN O
the DT O
protein NN B-Disease
- : I-Disease
import NN I-Disease
deficiency NN I-Disease
in IN O
human JJ O
peroxisomal NN B-Disease
disorders NNS I-Disease
is VBZ O
understood JJ O
. . O

Spectrum NNP O
of IN O
germline JJ O
mutations NNS O
in IN O
the DT O
RB1 NNP O
gene NN O
: : O
a DT O
study NN O
of IN O
232 CD O
patients NNS O
with IN O
hereditary JJ B-Disease
and CC I-Disease
non JJ I-Disease
hereditary JJ I-Disease
retinoblastoma NN I-Disease
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
RB1 NNP O
gene NN O
confer VBP O
hereditary JJ O
predisposition NN O
to TO O
retinoblastoma VB B-Disease
. . O

We PRP O
have VBP O
performed VBN O
a DT O
mutation NN O
survey NN O
of IN O
the DT O
RB1 NNP O
gene NN O
in IN O
232 CD O
patients NNS O
with IN O
hereditary JJ B-Disease
or CC I-Disease
non JJ I-Disease
hereditary JJ I-Disease
retinoblastoma NN I-Disease
. . O

We PRP O
systematically RB O
explored VBD O
all DT O
27 CD O
exons NNS O
and CC O
flanking VBG O
sequences NNS O
as RB O
well RB O
as IN O
the DT O
promotor NN O
. . O

All DT O
types NNS O
of IN O
point NN O
mutations NNS O
are VBP O
represented VBN O
and CC O
are VBP O
found VBN O
unequally RB O
distributed VBN O
along IN O
the DT O
RB1 NNP O
gene NN O
sequence NN O
. . O

In IN O
the DT O
population NN O
we PRP O
studied VBD O
, , O
exons NNS O
3 CD O
, , O
8 CD O
, , O
18 CD O
and CC O
19 CD O
are VBP O
preferentially RB O
altered VBN O
. . O

The DT O
range NN O
of IN O
frequency NN O
of IN O
detection NN O
of IN O
germline JJ O
mutations NNS O
is VBZ O
about IN O
20 CD O
% NN O
, , O
indicating VBG O
that IN O
other JJ O
mechanisms NNS O
of IN O
inactivation NN O
of IN O
RB1 NNP O
should MD O
be VB O
involved VBN O
. . O

The DT O
spectrum NN O
of IN O
mutations NNS O
presented VBN O
here RB O
should MD O
help VB O
to TO O
improve VB O
the DT O
clinical JJ O
management NN O
of IN O
retinoblastoma NN B-Disease
and CC O
to TO O
understand VB O
the DT O
molecular JJ O
mechanisms NNS O
leading VBG O
to TO O
tumorigenesis NN O
. . O
. . O

Aniridia NNP B-Disease
- : O
associated VBN O
cytogenetic JJ O
rearrangements NNS O
suggest VBP O
that IN O
a DT O
position NN O
effect NN O
may MD O
cause VB O
the DT O
mutant JJ O
phenotype NN O
. . O

Current JJ O
evidence NN O
suggests VBZ O
that IN O
aniridia NN B-Disease
( ( O
absence NN B-Disease
of IN I-Disease
iris NN I-Disease
) ) O
is VBZ O
caused VBN O
by IN O
loss NN O
of IN O
function NN O
of IN O
one CD O
copy NN O
of IN O
the DT O
PAX6 NNP O
gene NN O
, , O
which WDT O
maps VBZ O
to TO O
11p13 CD O
. . O

We PRP O
present VBP O
the DT O
further JJ O
characterisation NN O
of IN O
two CD O
aniridia NN B-Disease
pedigrees NNS O
in IN O
which WDT O
the DT O
disease NN O
segregates VBZ O
with IN O
chromosomal JJ O
rearrangements NNS O
which WDT O
involve VBP O
11p13 CD O
but CC O
do VBP O
not RB O
disrupt VB O
the DT O
PAX6 NNP O
gene NN O
. . O

We PRP O
have VBP O
isolated VBN O
three CD O
human JJ O
YAC NNP O
clones NNS O
which WDT O
encompass VBP O
the DT O
PAX6 NNP O
locus NN O
and CC O
we PRP O
have VBP O
used VBN O
these DT O
to TO O
show VB O
that IN O
in IN O
both DT O
cases NNS O
the DT O
chromosomal JJ O
breakpoint NN O
is VBZ O
at IN O
least JJS O
85 CD O
kb JJ O
distal NN O
of IN O
the DT O
3 CD O
end NN O
of IN O
PAX6 NNP O
. . O

In IN O
addition NN O
, , O
the DT O
open JJ O
reading NN O
frame NN O
of IN O
PAX6 NNP O
is VBZ O
apparently RB O
free JJ O
of IN O
mutations NNS O
. . O

We PRP O
propose VBP O
that IN O
the DT O
PAX6 NNP O
gene NN O
on IN O
the DT O
rearranged VBN O
chromosome NN O
11 CD O
is VBZ O
in IN O
an DT O
inappropriate JJ O
chromatin NN O
environment NN O
for IN O
normal JJ O
expression NN O
and CC O
therefore NN O
that IN O
a DT O
position NN O
effect NN O
is VBZ O
the DT O
underlying VBG O
mechanism NN O
of IN O
disease NN O
in IN O
these DT O
families NNS O
. . O
. . O

Somatic JJ O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
in IN O
sporadic JJ B-Disease
ovarian JJ I-Disease
tumours NN I-Disease
. . O

The DT O
BRCA1 NNP O
gene NN O
on IN O
chromosome NN O
17q21 CD O
is VBZ O
responsible JJ O
for IN O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
syndrome NN I-Disease
of IN O
increased JJ O
susceptibility NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
but CC O
no DT O
somatic JJ O
mutations NNS O
in IN O
tumours NNS B-Disease
have VBP O
yet RB O
been VBN O
described VBN O
. . O

To TO O
study VB O
the DT O
potential JJ O
role NN O
of IN O
BRCA1 NNP O
in IN O
sporadic JJ O
carcinogenesis NN O
, , O
we PRP O
analysed VBD O
the DT O
genomic JJ O
DNA NN O
of IN O
tumour NN B-Disease
and CC O
normal JJ O
fractions NNS O
of IN O
47 CD O
ovarian JJ B-Disease
cancers NNS I-Disease
for IN O
mutations NNS O
in IN O
BRCA1 NNP O
using VBG O
the DT O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
technique NN O
. . O

We PRP O
now RB O
describe VBZ O
somatic JJ O
mutations NNS O
in IN O
the DT O
DNA NN O
of IN O
four CD O
tumours NNS B-Disease
which WDT O
also RB O
had VBD O
loss NN O
of IN O
heterozygosity NN O
( ( O
LOH NNP O
) ) O
at IN O
a DT O
BRCA1 NNP O
intragenic JJ O
marker NN O
. . O

Our PRP$ O
data NNS O
support NN O
a DT O
tumour NN B-Disease
suppressor NN O
mechanism NN O
for IN O
BRCA1 NNP O
; : O
somatic JJ O
mutations NNS O
and CC O
LOH NNP O
may MD O
result VB O
in IN O
inactivation NN O
of IN O
BRCA1 NNP O
in IN O
at IN O
least JJS O
a DT O
small JJ O
number NN O
of IN O
ovarian JJ B-Disease
cancers NNS I-Disease
. . O
. . O

Decreased VBN O
expression NN O
of IN O
BRCA1 NNP O
accelerates VBZ O
growth NN O
and CC O
is VBZ O
often RB O
present JJ O
during IN O
sporadic JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
progression NN O
. . O

We PRP O
have VBP O
characterized VBN O
expression NN O
of IN O
the DT O
familial JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
gene NN O
, , O
BRCA1 NNP O
, , O
in IN O
cases NNS O
of IN O
non JJ B-Disease
- : I-Disease
hereditary NN I-Disease
( ( I-Disease
sporadic JJ I-Disease
) ) I-Disease
breast NN I-Disease
cancer NN I-Disease
and CC O
analyzed VBD O
the DT O
effect NN O
of IN O
antisense JJ O
inhibition NN O
of IN O
BRCA1 NNP O
on IN O
the DT O
proliferative JJ O
rate NN O
of IN O
mammary JJ O
epithelial JJ O
cells NNS O
. . O

BRCA1 NNP O
mRNA NN O
levels NNS O
are VBP O
markedly RB O
decreased VBN O
during IN O
the DT O
transition NN O
from IN O
carcinoma NN B-Disease
in IN I-Disease
situ NN I-Disease
to TO O
invasive JJ B-Disease
cancer NN I-Disease
. . O

Experimental JJ O
inhibition NN O
of IN O
BRCA1 NNP O
expression NN O
with IN O
antisense JJ O
oligonucleotides NNS O
produced VBD O
accelerated JJ O
growth NN O
of IN O
normal JJ O
and CC O
malignant JJ O
mammary JJ O
cells NNS O
, , O
but CC O
had VBD O
no DT O
effect NN O
on IN O
non JJ O
- : O
mammary JJ O
epithelial JJ O
cells NNS O
. . O

These DT O
studies NNS O
suggest VBP O
that IN O
BRCA1 NNP O
may MD O
normally RB O
serve VB O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
mammary JJ O
epithelial JJ O
cell NN O
growth NN O
whose WP$ O
function NN O
is VBZ O
compromised VBN O
in IN O
breast NN B-Disease
cancer NN I-Disease
either CC O
by IN O
direct JJ O
mutation NN O
or CC O
alterations NNS O
in IN O
gene NN O
expression NN O
. . O
. . O

Additional JJ O
case NN O
of IN O
female JJ O
monozygotic JJ O
twins NNS O
discordant VBP O
for IN O
the DT O
clinical JJ O
manifestations NNS O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
due JJ O
to TO O
opposite VB O
X NNP O
- : O
chromosome NN O
inactivation NN O
. . O

A DT O
pair NN O
of IN O
female JJ O
monozygotic JJ O
( ( O
MZ NNP O
) ) O
twins VBZ O
, , O
heterozygous JJ O
carriers NNS O
for IN O
a DT O
deletion NN O
in IN O
the DT O
DMD NNP B-Disease
gene NN O
and CC O
discordant NN O
for IN O
the DT O
clinical JJ O
manifestations NNS O
of IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
, , O
were VBD O
analyzed VBN O
by IN O
molecular JJ O
studies NNS O
, , O
in IN O
situ JJ O
hybridization NN O
, , O
and CC O
methylation NN O
pattern NN O
of IN O
X NNP O
chromosomes NNS O
to TO O
search VB O
for IN O
opposite JJ O
X NNP O
inactivation NN O
as IN O
an DT O
explanation NN O
of IN O
their PRP$ O
clinical JJ O
discordance NN O
. . O

Results NNS O
in IN O
lymphocytes NNS O
and CC O
skin VB O
fibroblast NN O
cell NN O
lines NNS O
suggest VBP O
a DT O
partial JJ O
mirror NN O
inactivation NN O
with IN O
the DT O
normal JJ O
X NNP O
chromosome NN O
preferentially RB O
active JJ O
in IN O
the DT O
unaffected JJ O
twin NN O
, , O
and CC O
the DT O
maternal JJ O
deleted JJ O
X NNP O
chromosome NN O
preferentially RB O
active JJ O
in IN O
the DT O
affected JJ O
twin NN O
. . O

A DT O
review NN O
shows VBZ O
that IN O
MZ NNP O
female NN O
twins NNS O
discordant VBP O
for IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
diseases NNS I-Disease
are VBP O
not RB O
uncommon JJ O
. . O

Twinning VBG O
and CC O
X NNP O
inactivation NN O
may MD O
be VB O
interrelated VBN O
and CC O
could MD O
explain VB O
the DT O
female NN O
twins VBZ O
discordant JJ O
for IN O
X NNP O
- : O
linked VBD O
traits NNS O
. . O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
ALD NNP B-Disease
) ) O
: : O
a DT O
novel JJ O
mutation NN O
of IN O
the DT O
ALD NNP B-Disease
gene NN O
in IN O
6 CD O
members NNS O
of IN O
a DT O
family NN O
presenting VBG O
with IN O
5 CD O
different JJ O
phenotypes NNS O
. . O

Fragments NNS O
of IN O
the DT O
adrenoleukodystrophy NN B-Disease
( ( O
ALD NNP B-Disease
) ) O
cDNA NN O
from IN O
a DT O
patient NN O
with IN O
adolescent JJ B-Disease
ALD NNP I-Disease
were VBD O
amplified VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
and CC O
subcloned VBD O
. . O

Bidirectional NNP O
sequencing NN O
of IN O
the DT O
entire JJ O
coding NN O
ALD NNP B-Disease
gene NN O
disclosed VBD O
a DT O
cytosine NN O
to TO O
guanine VB O
transversion NN O
at IN O
nucleotide JJ O
1451 CD O
in IN O
exon JJ O
five CD O
, , O
resulting VBG O
in IN O
substitution NN O
of IN O
proline NN O
484 CD O
by IN O
arginine NN O
. . O

Five CD O
of IN O
nine CD O
siblings NNS O
of IN O
the DT O
patient NN O
, , O
comprising VBG O
two CD O
cerebral JJ B-Disease
ALD NNP I-Disease
, , O
one CD O
adrenomyeloneuropathy NN B-Disease
, , O
one CD O
Addison NNP B-Disease
only RB I-Disease
as RB O
well RB O
as IN O
the DT O
symptomatic JJ O
mother NN O
( ( O
all DT O
accumulating VBG O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
) ) O
carried VBD O
this DT O
mutation NN O
, , O
which WDT O
was VBD O
not RB O
found VBN O
in IN O
the DT O
unaffected JJ O
persons NNS O
, , O
in IN O
five CD O
unrelated JJ O
ALD NNP B-Disease
patients NNS O
, , O
and CC O
in IN O
twenty NN O
controls NNS O
. . O

We PRP O
propose VBP O
that IN O
this DT O
missense JJ O
mutation NN O
generated VBD O
the DT O
disease NN O
per FW O
se NN O
as RB O
well RB O
as IN O
the DT O
metabolic JJ O
defect NN O
; : O
the DT O
different JJ O
phenotypes NNS O
, , O
however RB O
, , O
must MD O
have VB O
originated VBN O
by IN O
means NNS O
of IN O
additional JJ O
pathogenetic JJ O
factors NNS O
. . O
. . O

Novel JJ O
mutation NN O
at IN O
the DT O
initiation NN O
codon NN O
in IN O
the DT O
Norrie NNP B-Disease
disease NN I-Disease
gene NN O
in IN O
two CD O
Japanese JJ O
families NNS O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
new JJ O
mutation NN O
of IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
ND NNP B-Disease
) ) O
gene NN O
in IN O
two CD O
Japanese JJ O
males NNS O
from IN O
unrelated JJ O
families NNS O
; : O
they PRP O
showed VBD O
typical JJ O
ocular JJ O
features NNS O
of IN O
ND NNP B-Disease
but CC O
no DT O
mental JJ B-Disease
retardation NN I-Disease
or CC O
hearing NN B-Disease
impairment NN I-Disease
. . O

A DT O
mutation NN O
was VBD O
found VBN O
in IN O
both DT O
patients NNS O
at IN O
the DT O
initiation NN O
codon NN O
of IN O
exon JJ O
2 CD O
of IN O
the DT O
ND NNP B-Disease
gene NN O
( ( O
ATG NNP O
to TO O
GTG NNP O
) ) O
, , O
with IN O
otherwise RB O
normal JJ O
nucleotide JJ O
sequences NNS O
. . O

Their PRP$ O
mothers NNS O
had VBD O
the DT O
normal JJ O
and CC O
mutant JJ O
types NNS O
of IN O
the DT O
gene NN O
, , O
which WDT O
was VBD O
expected VBN O
for IN O
heterozygotes NNS O
of IN O
the DT O
disease NN O
. . O

The DT O
mutation NN O
of IN O
the DT O
initiation NN O
codon NN O
would MD O
cause VB O
the DT O
failure NN O
of IN O
ND NNP B-Disease
gene NN O
expression NN O
or CC O
a DT O
defect NN O
in IN O
translation NN O
thereby RB O
truncating VBG O
the DT O
amino NN O
terminus NN O
of IN O
ND NNP B-Disease
protein NN O
. . O

In IN O
view NN O
of IN O
the DT O
rarity NN O
and CC O
marked JJ O
heterogeneity NN O
of IN O
mutations NNS O
in IN O
the DT O
ND NNP B-Disease
gene NN O
, , O
the DT O
present JJ O
apparently RB O
unrelated JJ O
Japanese JJ O
families NNS O
who WP O
have VBP O
lived VBN O
in IN O
the DT O
same JJ O
area NN O
for IN O
over IN O
two CD O
centuries NNS O
presumably RB O
share NN O
the DT O
origin NN O
of IN O
the DT O
mutation NN O
. . O
. . O

Anticipation NN O
resulting VBG O
in IN O
elimination NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
gene NN O
: : O
a DT O
follow VBP O
up RP O
study NN O
of IN O
one CD O
extended VBD O
family NN O
. . O

We PRP O
have VBP O
re VBN O
- : O
examined VBD O
an DT O
extended JJ O
myotonic NN B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
family NN O
, , O
previously RB O
described VBN O
in IN O
1955 CD O
, , O
in IN O
order NN O
to TO O
study VB O
the DT O
long JJ O
term NN O
effects NNS O
of IN O
anticipation NN O
in IN O
DM NNP B-Disease
and CC O
in IN O
particular JJ O
the DT O
implications NNS O
for IN O
families NNS O
affected VBN O
by IN O
this DT O
disease NN O
. . O

This DT O
follow VBP O
up RP O
study NN O
provides VBZ O
data NNS O
on IN O
35 CD O
gene NN O
carriers NNS O
and CC O
46 CD O
asymptomatic JJ O
at IN O
risk NN O
family NN O
members NNS O
in IN O
five CD O
generations NNS O
. . O

Clinical JJ O
anticipation NN O
, , O
defined VBD O
as IN O
the DT O
cascade NN O
of IN O
mild NN O
, , O
adult NN O
, , O
childhood NN O
, , O
or CC O
congenital JJ B-Disease
disease NN I-Disease
in IN O
subsequent JJ O
generations NNS O
, , O
appeared VBD O
to TO O
be VB O
a DT O
relentless JJ O
process NN O
, , O
occurring VBG O
in IN O
all DT O
affected JJ O
branches NNS O
of IN O
the DT O
family NN O
. . O

The DT O
cascade NN O
was VBD O
found VBN O
to TO O
proceed VB O
asynchronously RB O
in IN O
the DT O
different JJ O
branches NNS O
, , O
mainly RB O
because IN O
of IN O
an DT O
unequal JJ O
number NN O
of IN O
generations NNS O
with IN O
mild JJ O
disease NN O
. . O

The DT O
transition NN O
from IN O
the DT O
mild NN O
to TO O
the DT O
adult NN O
type NN O
was VBD O
associated VBN O
with IN O
transmission NN O
through IN O
a DT O
male JJ O
parent NN O
. . O

Stable JJ O
transmission NN O
of IN O
the DT O
asymptomatic JJ O
/ NNP O
mild NN O
phenotype NN O
showed VBD O
a DT O
female JJ O
transmission NN O
bias NN O
. . O

We PRP O
further RB O
examined VBD O
the DT O
extent NN O
and CC O
causes NNS O
of IN O
gene NN O
loss NN O
in IN O
this DT O
pedigree NN O
. . O

Gene NNP O
loss NN O
in IN O
the DT O
patient NN O
group NN O
was VBD O
complete JJ O
, , O
owing VBG O
to TO O
infertility NN B-Disease
of IN O
the DT O
male NN O
patients NNS O
with IN O
adult JJ O
onset JJ O
disease NN O
and CC O
the DT O
fact NN O
that IN O
mentally RB B-Disease
retarded JJ I-Disease
patients NNS O
did VBD O
not RB O
procreate VB O
. . O

Out IN O
of IN O
the DT O
46 CD O
at IN O
risk NN O
subjects NNS O
in IN O
the DT O
two CD O
youngest JJS O
generations NNS O
, , O
only RB O
one CD O
was VBD O
found VBN O
to TO O
have VB O
a DT O
full JJ O
mutation NN O
. . O

This DT O
is VBZ O
the DT O
only JJ O
subject NN O
who WP O
may MD O
transmit VB O
the DT O
gene NN O
to TO O
the DT O
sixth JJ O
generation NN O
. . O

No DT O
protomutation NN O
carriers NNS O
were VBD O
found VBN O
in IN O
the DT O
fourth JJ O
and CC O
fifth JJ O
generations NNS O
. . O

Therefore IN O
it PRP O
is VBZ O
highly RB O
probable JJ O
that IN O
the DT O
DM NNP B-Disease
gene NN O
will MD O
be VB O
eliminated VBN O
from IN O
this DT O
pedigree NN O
within IN O
one CD O
generation NN O
. . O

The DT O
high JJ O
population NN O
frequency NN O
of IN O
DM NNP B-Disease
can MD O
at IN O
present JJ O
not RB O
be VB O
explained VBN O
by IN O
the DT O
contribution NN O
of IN O
asymptomatic JJ O
cases NNS O
in IN O
the DT O
younger JJR O
generations NNS O
of IN O
known JJ O
families NNS O
, , O
but CC O
is VBZ O
probably RB O
caused VBN O
by IN O
the DT O
events NNS O
in IN O
the DT O
ancestral JJ O
generations NNS O
. . O
. . O

The DT O
gene NN O
for IN O
spinal JJ B-Disease
cerebellar JJ I-Disease
ataxia NN I-Disease
3 CD O
( ( O
SCA3 NNP O
) ) O
is VBZ O
located VBN O
in IN O
a DT O
region NN O
of IN O
approximately RB O
3 CD O
cM NNS O
on IN O
chromosome NN O
14q24 CD O
. . O
3 CD O
- : O
q32 NN O
. . O
2 CD O
. . O

SCA3 NNP O
, , O
the DT O
gene NN O
for IN O
spinal JJ B-Disease
cerebellar JJ I-Disease
ataxia NN I-Disease
3 CD O
, , O
was VBD O
recently RB O
mapped VBN O
to TO O
a DT O
15 CD O
- : O
cM NN O
interval NN O
between IN O
D14S67 NNP O
and CC O
D14S81 NNP O
on IN O
chromosome NN O
14q CD O
, , O
by IN O
linkage NN O
analysis NN O
in IN O
two CD O
families NNS O
of IN O
French JJ O
ancestry NN O
. . O

The DT O
SCA3 NNP O
candidate NN O
region NN O
has VBZ O
now RB O
been VBN O
refined VBN O
by IN O
linkage NN O
analysis NN O
with IN O
four CD O
new JJ O
microsatellite NN O
markers NNS O
( ( O
D14S256 NNP O
, , O
D14S291 NNP O
, , O
D14S280 NNP O
, , O
and CC O
AFM343vf1 NNP O
) ) O
in IN O
the DT O
same JJ O
two CD O
families NNS O
, , O
in IN O
which WDT O
19 CD O
additional JJ O
individuals NNS O
were VBD O
genotyped VBN O
, , O
and CC O
in IN O
a DT O
third JJ O
French JJ O
family NN O
. . O

Combined VBN O
two CD O
- : O
point NN O
linkage NN O
analyses VBZ O
show VBP O
that IN O
the DT O
new JJ O
markers NNS O
, , O
D14S280 NNP O
and CC O
AFM343vf1 NNP O
, , O
are VBP O
tightly RB O
linked VBN O
to TO O
the DT O
SCA3 NNP O
locus NN O
, , O
with IN O
maximal JJ O
lod NN O
scores NNS O
, , O
at IN O
recombination NN O
fraction NN O
, , O
( ( O
theta NN O
) ) O
= NN O
. . O

0 CD O
, , O
of IN O
7 CD O
. . O

5 CD O
and CC O
13 CD O
. . O

70 CD O
, , O
respectively RB O
. . O

Combined VBN O
multipoint NN O
and CC O
recombinant JJ O
haplotype NN O
analyses NNS O
localize VBP O
the DT O
SCA3 NNP O
locus NN O
to TO O
a DT O
3 CD O
- : O
cM NN O
interval NN O
flanked VBN O
by IN O
D14S291 NNP O
and CC O
D14S81 NNP O
. . O

The DT O
same JJ O
allele NN O
for IN O
D14S280 NNP O
segregates VBZ O
with IN O
the DT O
disease NN O
locus NN O
in IN O
the DT O
three CD O
kindreds NNS O
. . O

This DT O
allele NN O
is VBZ O
frequent JJ O
in IN O
the DT O
French JJ O
population NN O
, , O
however RB O
, , O
and CC O
linkage NN O
disequilibrium NN O
is VBZ O
not RB O
clearly RB O
established VBN O
. . O

The DT O
SCA3 NNP O
locus NN O
remains VBZ O
within IN O
the DT O
29 CD O
- : O
cM NN O
region NN O
on IN O
14q24 CD O
. . O

3 LS O
- : O
q32 NN O
. . O

2 CD O
containing VBG O
the DT O
gene NN O
for IN O
the DT O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
, , O
which WDT O
is VBZ O
clinically RB O
related VBN O
to TO O
the DT O
phenotype NN O
determined VBN O
by IN O
SCA3 NNP O
, , O
but CC O
it PRP O
cannot VBZ O
yet RB O
be VB O
concluded VBN O
that IN O
both DT O
diseases NNS O
result VBP O
from IN O
alterations NNS O
of IN O
the DT O
same JJ O
gene NN O

An DT O
evaluation NN O
of IN O
genetic JJ O
heterogeneity NN O
in IN O
145 CD O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

Breast NNP B-Disease
Cancer NNP I-Disease
Linkage NNP O
Consortium NNP O
. . O

The DT O
breast NN B-Disease
- : I-Disease
ovary JJ I-Disease
cancer NN I-Disease
- : I-Disease
family NN I-Disease
syndrome NN I-Disease
is VBZ O
a DT O
dominant JJ O
predisposition NN O
to TO O
cancer NN B-Disease
of IN I-Disease
the DT I-Disease
breast NN I-Disease
and CC I-Disease
ovaries NNS I-Disease
which WDT O
has VBZ O
been VBN O
mapped VBN O
to TO O
chromosome VB O
region NN O
17q12 CD O
- : O
q21 NN O
. . O

The DT O
majority NN O
, , O
but CC O
not RB O
all DT O
, , O
of IN O
breast SYM B-Disease
- : I-Disease
ovary JJ I-Disease
cancer NN I-Disease
families NNS O
show VBP O
linkage NN O
to TO O
this DT O
susceptibility NN O
locus NN O
, , O
designated VBN O
BRCA1 NNP O
. . O

We PRP O
report VBP O
here RB O
the DT O
results NNS O
of IN O
a DT O
linkage NN O
analysis NN O
of IN O
145 CD O
families NNS O
with IN O
both DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

These DT O
families NNS O
contain VBP O
either RB O
a DT O
total NN O
of IN O
three CD O
or CC O
more JJR O
cases NNS O
of IN O
early JJ O
- : O
onset NN O
( ( O
before IN O
age NN O
60 CD O
years NNS O
) ) O
breast NN B-Disease
cancer NN I-Disease
or CC O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

All DT O
families NNS O
contained VBN O
at IN O
least JJS O
one CD O
case NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

Overall JJ O
, , O
an DT O
estimated VBN O
76 CD O
% NN O
of IN O
the DT O
145 CD O
families NNS O
are VBP O
linked VBN O
to TO O
the DT O
BRCA1 NNP O
locus NN O
. . O

None NN O
of IN O
the DT O
13 CD O
families NNS O
with IN O
cases NNS O
of IN O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
appear VBP O
to TO O
be VB O
linked VBN O
, , O
but CC O
it PRP O
is VBZ O
estimated VBN O
that IN O
92 CD O
% NN O
( ( O
95 CD O
% NN O
confidence NN O
interval JJ O
76 CD O
% NN O
- : O
100 CD O
% NN O
) ) O
of IN O
families NNS O
with IN O
no DT O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
and CC O
with IN O
two CD O
or CC O
more JJR O
ovarian JJ B-Disease
cancers NNS I-Disease
are VBP O
linked VBN O
to TO O
BRCA1 NNP O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
- : I-Disease
family NN I-Disease
syndrome NN I-Disease
is VBZ O
genetically RB O
heterogeneous JJ O
. . O

However RB O
, , O
the DT O
large JJ O
majority NN O
of IN O
families NNS O
with IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
and CC O
with IN O
two CD O
or CC O
more JJR O
cases NNS O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
are VBP O
likely JJ O
to TO O
be VB O
due JJ O
to TO O
BRCA1 NNP O
mutations NNS O
. . O
. . O

Molecular JJ O
basis NN O
of IN O
essential JJ B-Disease
fructosuria NNS I-Disease
: : O
molecular JJ O
cloning NN O
and CC O
mutational JJ O
analysis NN O
of IN O
human JJ O
ketohexokinase NN O
( ( O
fructokinase NN O
) ) O
. . O

Essential JJ B-Disease
fructosuria NN I-Disease
is VBZ O
one CD O
of IN O
the DT O
oldest JJS O
known VBN O
inborn JJ B-Disease
errors NNS I-Disease
of IN I-Disease
metabolism NN I-Disease
. . O

It PRP O
is VBZ O
a DT O
benign JJ O
condition NN O
which WDT O
is VBZ O
believed VBN O
to TO O
result VB O
from IN O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
fructokinase NN I-Disease
( ( O
ketohexokinase NN O
, , O
KHK NNP O
, , O
E NNP O
. . O
C NNP O
. . O
2 CD O
. . O
7 CD O
. . O
1 CD O
. . O
3 CD O
) ) O
. . O

This DT O
enzyme NN O
catalyses VBZ O
the DT O
first JJ O
step NN O
of IN O
metabolism NN O
of IN O
dietary JJ O
fructose NN O
, , O
conversion NN O
of IN O
fructose NN O
to TO O
fructose VB O
- : O
1 CD O
- : O
phosphate NN O
. . O

Despite IN O
the DT O
early JJ O
recognition NN O
of IN O
this DT O
disorder NN O
, , O
the DT O
primary JJ O
structure NN O
of IN O
human JJ O
KHK NNP O
and CC O
the DT O
molecular JJ O
basis NN O
of IN O
essential JJ B-Disease
fructosuria NNS I-Disease
have VBP O
not RB O
been VBN O
previously RB O
defined VBN O
. . O

In IN O
this DT O
report NN O
, , O
the DT O
isolation NN O
and CC O
sequencing NN O
of IN O
full JJ O
- : O
length NN O
cDNA NN O
clones NNS O
encoding VBG O
human JJ O
ketohexokinase NN O
are VBP O
described VBN O
. . O

Alternative JJ O
mRNA NN O
species NNS O
and CC O
alternative JJ O
KHK NNP O
isozymes NNS O
are VBP O
produced VBN O
by IN O
alternative JJ O
polyadenylation NN O
and CC O
splicing NN O
of IN O
the DT O
KHK NNP O
gene NN O
. . O

The DT O
KHK NNP O
proteins VBZ O
show VB O
a DT O
high JJ O
level NN O
of IN O
sequence NN O
conservation NN O
relative NN O
to TO O
rat VB O
KHK NNP O
. . O

Direct JJ O
evidence NN O
that IN O
mutation NN O
of IN O
the DT O
KHK NNP O
structural JJ O
gene NN O
is VBZ O
the DT O
cause NN O
of IN O
essential JJ B-Disease
fructosuria NN I-Disease
was VBD O
also RB O
obtained VBN O
. . O

In IN O
a DT O
well NN O
- : O
characterized VBN O
family NN O
, , O
in IN O
which WDT O
three CD O
of IN O
eight CD O
siblings NNS O
have VBP O
fructosuria VBN B-Disease
, , O
all DT O
affected JJ O
individuals NNS O
are VBP O
compound VBN O
heterozygotes NNS O
for IN O
two CD O
mutations NNS O
Gly40Arg NNP O
and CC O
Ala43Thr NNP O
. . O

Both DT O
mutations NNS O
result VBP O
from IN O
G NNP O
- : O
- : O
> VB O
A DT O
transitions NNS O
, , O
and CC O
each DT O
alters NNS O
the DT O
same JJ O
conserved JJ O
region NN O
of IN O
the DT O
KHK NNP O
protein NN O
. . O

Neither DT O
mutation NN O
was VBD O
seen VBN O
in IN O
a DT O
sample NN O
of IN O
52 CD O
unrelated JJ O
control NN O
individuals NNS O
. . O

An DT O
additional JJ O
conservative JJ O
amino NN O
acid NN O
change NN O
( ( O
Val49IIe NNP O
) ) O
was VBD O
present JJ O
on IN O
the DT O
KHK NNP O
allele NN O
bearing NN O
Ala43Thr NNP O

Homozygous JJ O
presence NN O
of IN O
the DT O
crossover NN O
( ( O
fusion JJ O
gene NN O
) ) O
mutation NN O
identified VBN O
in IN O
a DT O
type NN B-Disease
II NNP I-Disease
Gaucher NNP I-Disease
disease NN I-Disease
fetus NN O
: : O
is VBZ O
this DT O
analogous JJ O
to TO O
the DT O
Gaucher NNP O
knock NNP O
- : O
out RP O
mouse IN O
model NN O
? . O

Gaucher NNP B-Disease
disease NN I-Disease
( ( O
GD NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ O
deficiency NN B-Disease
of IN I-Disease
beta NN I-Disease
- : I-Disease
glucocerebrosidase NN I-Disease
( ( O
EC NNP O
3 CD O
. . O
1 CD O
. . O
2 CD O
. . O
45 CD O
, , O
gene NN O
symbol NN O
GBA NNP O
) ) O
. . O

In IN O
type NN B-Disease
I PRP I-Disease
GD NNP I-Disease
, , O
the DT O
CNS NNP O
is VBZ O
not RB O
involved VBN O
( ( O
nonneuronopathic JJ O
) ) O
, , O
whereas RB O
in IN O
type NN B-Disease
II NNP I-Disease
GD NNP I-Disease
( ( O
acute JJ O
neuronopathic NN O
) ) O
CNS NNP O
involvement NN O
is VBZ O
early JJ O
and CC O
rapidly RB O
progressive JJ O
, , O
while IN O
in IN O
type NN B-Disease
III NNP I-Disease
GD NNP I-Disease
( ( O
subacute JJ O
neuronopathic NN O
) ) O
CNS NNP O
involvement NN O
occurs VBZ O
later RB O
and CC O
is VBZ O
slowly RB O
progressive JJ O
. . O

The DT O
T6433C NNP O
( ( O
L444P NNP O
) ) O
substitution NN O
is VBZ O
prevalent JJ O
in IN O
type NN B-Disease
GD NNP I-Disease
II NNP I-Disease
. . O

It PRP O
may MD O
occur VB O
alone RB O
as IN O
a DT O
single JJ O
base NN O
- : O
pair NN O
mutation NN O
but CC O
often RB O
is VBZ O
found VBN O
as IN O
part NN O
of IN O
a DT O
complex JJ O
allele NN O
containing VBG O
additional JJ O
GBA NNP O
nucleotide NN O
substitutions NNS O
, , O
G6468C NNP O
( ( O
A456P NNP O
) ) O
and CC O
G6482C NNP O
( ( O
V460V NNP O
) ) O
, , O
without IN O
( ( O
recNciI NN O
) ) O
or CC O
with IN O
( ( O
recTL NN O
) ) O
G5957C NNP O
( ( O
D409H NNP O
) ) O
. . O

This DT O
complex JJ O
allele NN O
is VBZ O
presumed VBN O
to TO O
have VB O
formed VBN O
by IN O
recombination NN O
( ( O
crossover NN O
, , O
fusion NN O
) ) O
of IN O
the DT O
structural JJ O
gene NN O
with IN O
the DT O
pseudogene NN O
, , O
which WDT O
contains VBZ O
the DT O
mutated JJ O
sequences NNS O
. . O

Two CD O
complex JJ O
alleles NNS O
have VBP O
never RB O
been VBN O
demonstrated VBN O
to TO O
coexist VB O
in IN O
any DT O
individual NN O
. . O

We PRP O
devised VBD O
a DT O
selective JJ O
PCR NNP O
method NN O
for IN O
the DT O
specific JJ O
amplification NN O
of IN O
the DT O
normal JJ O
and CC O
/ JJ O
or CC O
fusion JJ O
gene NN O
. . O

Using VBG O
this DT O
procedure NN O
we PRP O
demonstrated VBD O
the DT O
fusion NN O
gene NN O
in IN O
homozygous JJ O
form NN O
for IN O
the DT O
first JJ O
time NN O
, , O
in IN O
a DT O
Macedonian JJ O
/ NN O
Ashkenazi NNP O
Jewish NNP O
GD NNP B-Disease
type NN I-Disease
II NNP I-Disease
fetus NN O
. . O

Both DT O
parents NNS O
were VBD O
carriers NNS O
of IN O
the DT O
recombination NN O
. . O

This DT O
was VBD O
confirmed VBN O
by IN O
direct JJ O
sequence NN O
analysis NN O
. . O

A DT O
previous JJ O
conceptus NN O
in IN O
this DT O
family NN O
was VBD O
stillborn VBN B-Disease
at IN O
36 CD O
weeks NNS O
, , O
with IN O
features NNS O
of IN O
severe JJ O
type NN B-Disease
II NNP I-Disease
GD NNP I-Disease
. . O

Neonates NNS O
showing VBG O
a DT O
severe JJ O
clinical JJ O
phenotype NN O
, , O
analogous JJ O
to TO O
the DT O
early JJ O
neonatal JJ O
lethal JJ O
disease NN O
occurring VBG O
in IN O
mice NNS O
homozygous JJ O
for IN O
a DT O
null JJ O
allele NN O
produced VBN O
by IN O
targeted JJ O
disruption NN O
of IN O
GBA NNP O
, , O
have VBP O
been VBN O
described VBN O
elsewhere RB O
, , O
but CC O
the DT O
specific JJ O
mutations NNS O
in IN O
these DT O
cases NNS O
have VBP O
not RB O
yet RB O
been VBN O
characterized VBN O
. . O

( ( O
ABSTRACT NNP O
TRUNCATED NNP O
AT NNP O
250 CD O
WORDS NNP O
) ) O

Late RB O
infantile JJ O
metachromatic JJ B-Disease
leukodystrophy NN I-Disease
in IN O
Israel NNP O
. . O

Metachromatic JJ B-Disease
Leukodystrophy NNP I-Disease
( ( O
MLD NNP B-Disease
) ) O
is VBZ O
a DT O
neurodegenerative JJ B-Disease
disease NN I-Disease
in IN O
which WDT O
the DT O
lysosomal NN O
enzyme NN O
, , O
Aryl NNP O
sulfatase VBD O
A NNP O
( ( O
ARSA NNP O
) ) O
is VBZ O
deficient JJ O
. . O

The DT O
disease NN O
is VBZ O
inherited VBN O
as IN O
an DT O
autosomal JJ O
recessive JJ O
trait NN O
and CC O
its PRP$ O
frequency NN O
is VBZ O
estimated VBN O
to TO O
be VB O
1 CD O
/ JJ O
40 CD O
, , O
0 CD O
live JJ O
births NNS O
. . O

The DT O
gene NN O
of IN O
ARSA NNP O
has VBZ O
been VBN O
cloned VBN O
and CC O
up RB O
to TO O
now RB O
eight CD O
mutations NNS O
causing VBG O
MLD NNP B-Disease
have VBP O
been VBN O
reported VBN O
. . O

Another DT O
mutation NN O
, , O
PD NNP O
, , O
leads VBZ O
to TO O
the DT O
deficiency NN O
of IN O
the DT O
enzyme NN O
in IN O
vitro NN O
( ( O
pseudodeficiency NN O
) ) O
without IN O
any DT O
known JJ O
clinical JJ O
effect NN O
. . O

The DT O
PD NNP O
mutation NN O
is VBZ O
frequent JJ O
in IN O
all DT O
populations NNS O
. . O

In IN O
Israel NNP O
, , O
late RB O
infantile JJ O
MLD NNP B-Disease
was VBD O
found VBN O
to TO O
be VB O
very RB O
frequent JJ O
in IN O
a DT O
small JJ O
Jewish JJ O
isolate NN O
, , O
the DT O
Habbanite NNP O
Jews NNP O
( ( O
1 CD O
/ RB O
75 CD O
live JJ O
births NNS O
) ) O
. . O

The DT O
molecular JJ O
analysis NN O
demonstrated VBD O
that IN O
in IN O
the DT O
Habbanite NNP O
population NN O
, , O
the DT O
mutation NN O
occurred VBD O
on IN O
an DT O
allele NN O
with IN O
the DT O
PD NNP O
mutation NN O
. . O

The DT O
loss NN O
of IN O
ARSA NNP O
activity NN O
is VBZ O
due JJ O
to TO O
a DT O
point NN O
mutation NN O
C NNP O
> NNP O
T NNP O
leading VBG O
to TO O
a DT O
change NN O
of IN O
proline NN O
to TO O
leucine VB O
. . O

MLD NNP B-Disease
is VBZ O
also RB O
frequent JJ O
among IN O
Moslem NNP O
Arabs NNP O
in IN O
Jerusalem NNP O
. . O

The DT O
mutation NN O
is VBZ O
a DT O
transition NN O
G NNP O
> VBZ O
A NNP O
destroying VBG O
the DT O
splice NN O
donor NN O
site NN O
of IN O
exon JJ O
2 CD O
. . O

This DT O
mutation NN O
has VBZ O
been VBN O
reported VBN O
in IN O
patients NNS O
with IN O
the DT O
late JJ O
infantile NN O
MLD NNP B-Disease
from IN O
different JJ O
ethnic JJ O
groups NNS O
. . O

The DT O
Christian JJ O
Arabs NNPS O
in IN O
Israel NNP O
also RB O
have VBP O
a DT O
high JJ O
incidence NN O
of IN O
the DT O
disease NN O
( ( O
1 CD O
/ RB O
10 CD O
, , O
0 CD O
live JJ O
births NNS O
) ) O
; : O
the DT O
mutation NN O
in IN O
this DT O
population NN O
is VBZ O
still RB O
unknown JJ O
. . O

Knowledge NNP O
of IN O
the DT O
different JJ O
mutations NNS O
causing VBG O
MLD NNP B-Disease
in IN O
these DT O
defined VBN O
populations NNS O
will MD O
allow VB O
a DT O
carrier NN O
screening VBG O
program NN O
to TO O
be VB O
carried VBN O
out IN O
and CC O
prevent VB O
the DT O
birth NN O
of IN O
additional JJ O
affected JJ O
children NNS O
. . O
. . O

A DT O
single JJ O
amino NN O
acid JJ O
substitution NN O
( ( O
G103D NNP O
) ) O
in IN O
the DT O
type NN O
II NNP O
collagen NN O
triple NN O
helix NN O
produces VBZ O
Kniest NNP B-Disease
dysplasia NN I-Disease
. . O

Kniest NNP B-Disease
dysplasia NN I-Disease
is VBZ O
a DT O
moderately RB O
severe JJ O
chondrodysplasia NN B-Disease
phenotype NN O
that WDT O
results NNS O
from IN O
mutations NNS O
in IN O
the DT O
gene NN O
for IN O
type JJ O
II NNP O
collagen NN O
, , O
COL2A1 NNP O
. . O

Characteristics NNS O
of IN O
the DT O
disorder NN O
include VBP O
a DT O
short JJ B-Disease
trunk NN I-Disease
and CC I-Disease
extremities NNS I-Disease
, , O
mid SYM B-Disease
- : I-Disease
face NN I-Disease
hypoplasia NN I-Disease
, , O
cleft NN B-Disease
palate NN I-Disease
, , O
myopia NN B-Disease
, , O
retinal JJ B-Disease
detachment NN I-Disease
, , O
and CC O
hearing JJ B-Disease
loss NN I-Disease
. . O

Recently RB O
, , O
deletions NNS O
of IN O
all DT O
or CC O
part NN O
of IN O
exon $ O
12 CD O
have VBP O
been VBN O
identified VBN O
in IN O
individuals NNS O
with IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
, , O
suggesting VBG O
that IN O
mutations NNS O
within IN O
this DT O
region NN O
of IN O
the DT O
protein NN O
may MD O
primarily RB O
result VB O
in IN O
the DT O
Kniest NNP B-Disease
dysplasia NN I-Disease
phenotype NN O
. . O

We PRP O
used VBD O
SSCP NNP O
to TO O
analyze VB O
an DT O
amplified JJ O
genomic JJ O
DNA NNP O
fragment NN O
containing VBG O
exon $ O
12 CD O
from IN O
seven CD O
individuals NNS O
with IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
. . O

An DT O
abnormality NN O
was VBD O
identified VBN O
in IN O
one CD O
patient NN O
. . O

DNA NN O
sequence NN O
analysis NN O
demonstrated VBD O
that IN O
the DT O
patient NN O
was VBD O
heterozygous JJ O
for IN O
a DT O
G NNP O
to TO O
A DT O
transition NN O
that WDT O
implied VBD O
substitution NN O
of IN O
glycine103 NN O
of IN O
the DT O
triple JJ O
helical JJ O
domain NN O
by IN O
aspartate NN O
. . O

The DT O
mutation NN O
was VBD O
not RB O
observed VBN O
in IN O
DNA NN O
from IN O
either DT O
of IN O
the DT O
clinically RB O
unaffected JJ O
parents NNS O
of IN O
the DT O
proband NN O
. . O

Protein NNP O
microsequencing VBG O
demonstrated JJ O
expression NN O
of IN O
the DT O
abnormal JJ O
allele NN O
in IN O
cartilage NN O
. . O

These DT O
data NNS O
demonstrate NN O
that IN O
point NN O
mutations NNS O
which WDT O
result VBP O
in IN O
single JJ O
amino NN O
acid IN O
substitutions NNS O
can MD O
produce VB O
Kniest NNP B-Disease
dysplasia NN I-Disease
and CC O
further JJ O
support NN O
the DT O
hypothesis NN O
that IN O
alteration NN O
of IN O
a DT O
domain NN O
, , O
which WDT O
includes VBZ O
the DT O
region NN O
encoded VBN O
by IN O
exon NN O
12 CD O
, , O
in IN O
the DT O
type NN O
II NNP O
collagen NN O
protein NN O
leads VBZ O
to TO O
this DT O
disorder NN O
. . O
. . O

CAG NNP O
expansions NNS O
in IN O
a DT O
novel JJ O
gene NN O
for IN O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
at IN O
chromosome NN O
14q32 CD O
. . O
1 CD O
. . O

We PRP O
have VBP O
identified VBN O
a DT O
novel JJ O
gene NN O
containing VBG O
CAG NNP O
repeats NNS O
and CC O
mapped VBD O
it PRP O
to TO O
chromosome VB O
14q32 CD O
. . O

1 CD O
, , O
the DT O
genetic JJ O
locus NN O
for IN O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
MJD NNP B-Disease
) ) O
. . O

In IN O
normal JJ O
individuals NNS O
the DT O
gene NN O
contains VBZ O
between IN O
13 CD O
and CC O
36 CD O
CAG NNP O
repeats NNS O
, , O
whereas IN O
most JJS O
of IN O
the DT O
clinically NN O
diagnosed VBD O
patients NNS O
and CC O
all DT O
of IN O
the DT O
affected JJ O
members NNS O
of IN O
a DT O
family NN O
with IN O
the DT O
clinical JJ O
and CC O
pathological JJ O
diagnosis NN O
of IN O
MJD NNP B-Disease
show VBP O
expansion NN O
of IN O
the DT O
repeat NN O
- : O
number NN O
( ( O
from IN O
68 CD O
- : O
79 CD O
) ) O
. . O

Southern NNP O
blot NN O
analyses NNS O
and CC O
genomic JJ O
cloning NN O
demonstrates VBZ O
the DT O
existence NN O
of IN O
related JJ O
genes NNS O
. . O

These DT O
results NNS O
raise VBP O
the DT O
possibility NN O
that IN O
similar JJ O
abnormalities NNS O
in IN O
related JJ O
genes NNS O
may MD O
give VB O
rise NN O
to TO O
diseases NNS O
similar JJ O
to TO O
MJD NNP B-Disease
. . O

Mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
in IN O
families NNS O
with IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

We PRP O
analysed VBD O
50 CD O
probands NNS O
with IN O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
for IN O
germline JJ O
mutations NNS O
in IN O
the DT O
coding JJ O
region NN O
of IN O
the DT O
BRCA1 NNP O
candidate NN O
gene NN O
, , O
using VBG O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
analysis NN O
on IN O
PCR NNP O
- : O
amplified JJ O
genomic JJ O
DNA NN O
. . O

A DT O
total NN O
of IN O
eight CD O
putative JJ O
disease NN O
- : O
causing NN O
alterations NNS O
were VBD O
identified VBN O
four CD O
of IN O
these DT O
are VBP O
frameshifts NNS O
and CC O
two CD O
are VBP O
nonsense JJ O
mutations NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
two CD O
missense NN O
mutations NNS O
, , O
one CD O
of IN O
which WDT O
changes VBZ O
the DT O
final JJ O
cysteine NN O
of IN O
the DT O
BRCA1 NNP O
zinc NNP O
finger NN O
motif NN O
to TO O
glycine VB O
. . O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
a DT O
tumour NN B-Disease
suppressor NN O
model NN O
, , O
and CC O
support VB O
the DT O
notion NN O
that IN O
this DT O
candidate NN O
gene NN O
is VBZ O
in IN O
fact NN O
BRCA1 NNP O
. . O

The DT O
heterogeneity NN O
of IN O
mutations NNS O
, , O
coupled VBN O
with IN O
the DT O
large JJ O
size NN O
of IN O
the DT O
gene NN O
, , O
indicates VBZ O
that IN O
clinical JJ O
application NN O
of IN O
BRCA1 NNP O
mutation NN O
testing NN O
will MD O
be VB O
technically RB O
challenging VBG O
. . O
. . O

Confirmation NN O
of IN O
BRCA1 NNP O
by IN O
analysis NN O
of IN O
germline JJ O
mutations NNS O
linked VBN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
ten JJ O
families NNS O
. . O

We PRP O
provide VBP O
genetic JJ O
evidence NN O
supporting VBG O
the DT O
identity NN O
of IN O
the DT O
candidate NN O
gene NN O
for IN O
BRCA1 NNP O
through IN O
the DT O
characterization NN O
of IN O
germline JJ O
mutations NNS O
in IN O
63 CD O
breast NN B-Disease
cancer NN I-Disease
patients NNS O
and CC O
10 CD O
ovarian JJ B-Disease
cancer NN I-Disease
patients NNS O
in IN O
ten JJ O
families NNS O
with IN O
cancer NN B-Disease
linked VBN O
to TO O
chromosome VB O
17q21 CD O
. . O

Nine NNP O
different JJ O
mutations NNS O
were VBD O
detected VBN O
by IN O
screening VBG O
BRCA1 NNP O
DNA NNP O
and CC O
RNA NNP O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
and CC O
direct JJ O
sequencing NN O
. . O

Seven NNP O
mutations NNS O
lead VBP O
to TO O
protein VB O
truncations NNS O
at IN O
sites NNS O
throughout IN O
the DT O
gene NN O
. . O

One CD O
missense NN O
mutation NN O
( ( O
which WDT O
occurred VBD O
independently RB O
in IN O
two CD O
families NNS O
) ) O
leads VBZ O
to TO O
loss NN O
of IN O
a DT O
cysteine NN O
in IN O
the DT O
zinc NN O
binding NN O
domain NN O
. . O

An DT O
intronic JJ O
single JJ O
basepair NN O
substitution NN O
destroys VBZ O
an DT O
acceptor NN O
site NN O
and CC O
activates VBZ O
a DT O
cryptic JJ O
splice NN O
site NN O
, , O
leading VBG O
to TO O
a DT O
59 CD O
basepair NN O
insertion NN O
and CC O
chain NN O
termination NN O
. . O

The DT O
four CD O
families NNS O
with IN O
both DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
had VBD O
chain NN O
termination NN O
mutations NNS O
in IN O
the DT O
N NNP O
- : O
terminal JJ O
half NN O
of IN O
the DT O
protein NN O
. . O
. . O

High JJ O
resolution NN O
genetic JJ O
analysis NN O
suggests VBZ O
one CD O
ancestral JJ O
predisposing VBG O
haplotype NN O
for IN O
the DT O
origin NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
mutation NN O
. . O

The DT O
mutation NN O
causing VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
has VBZ O
been VBN O
identified VBN O
as IN O
an DT O
amplification NN O
of IN O
an DT O
unstable JJ O
trinucleotide NN O
( ( O
CTG NNP O
) ) O
n VBP O
repeat NN O
in IN O
over IN O
99 CD O
% NN O
of IN O
the DT O
global JJ O
DM NNP B-Disease
population NN O
. . O

It PRP O
is VBZ O
in IN O
complete JJ O
linkage NN O
disequilibrium NN O
with IN O
an DT O
Alu NNP O
element NN O
polymorphism NN O
within IN O
the DT O
DM NNP B-Disease
kinase NNP O
gene NN O
, , O
suggesting VBG O
that IN O
DM NNP B-Disease
is VBZ O
a DT O
consequence NN O
of IN O
one CD O
or CC O
few JJ O
ancestral JJ O
mutations NNS O
. . O

A DT O
recent JJ O
analysis NN O
utilizing VBG O
this DT O
polymorphism NN O
as RB O
well RB O
as IN O
a DT O
flanking NN O
dinucleotide NN O
marker NN O
, , O
suggested VBD O
that IN O
similar JJ O
to TO O
Fragile NNP B-Disease
X NNP I-Disease
syndrome NN I-Disease
, , O
DM NNP B-Disease
exhibited VBD O
a DT O
founder NN O
effect NN O
( ( O
Imbert NNP O
et RB O
al RB O
. . O
, , O
1993 CD O
Nature NN O
Genet NNP O
. . O
4 CD O
, , O
72 CD O
- : O
76 CD O
) ) O
. . O

In IN O
contrast NN O
, , O
the DT O
low JJ O
reproductive JJ O
fitness NN O
of IN O
individuals NNS O
with IN O
congenital JJ O
DM NNP B-Disease
( ( O
the DT O
endpoint NN O
of IN O
genetic JJ O
anticipation NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
) ) O
suggests VBZ O
a DT O
higher JJR O
rate NN O
of IN O
new JJ O
mutations NNS O
. . O

We PRP O
present VBP O
a DT O
high JJ O
resolution NN O
genetic JJ O
analysis NN O
of IN O
the DT O
DM NNP B-Disease
locus NN O
using VBG O
PCR NNP O
based VBN O
assays NNS O
of IN O
nine CD O
polymorphisms NNS O
, , O
spanning VBG O
a DT O
physical JJ O
distance NN O
of IN O
30 CD O
kb NN O
, , O
within IN O
and CC O
immediately RB O
flanking VBG O
the DT O
DM NNP B-Disease
kinase NN O
gene NN O
. . O

The DT O
persistent JJ O
complete JJ O
allelic JJ O
association NN O
of IN O
the DT O
DM NNP B-Disease
mutation NN O
with IN O
all PDT O
these DT O
polymorphisms NNS O
provides VBZ O
further JJ O
support NN O
to TO O
previous JJ O
observations NNS O
and CC O
suggests VBZ O
more RBR O
strongly RB O
that IN O
the DT O
DM NNP B-Disease
mutation NN O
occurred VBD O
on IN O
the DT O
background NN O
of IN O
a DT O
particular JJ O
haplotype NN O
in IN O
which WDT O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
became VBD O
inherently RB O
unstable JJ O
and CC O
therefore RB O
predisposed VBD O
to TO O
amplification NN O
. . O

Genetic JJ O
instability NN O
in IN O
human JJ O
ovarian JJ B-Disease
cancer NN I-Disease
cell NN O
lines NNS O
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
stability NN O
of IN O
microsatellites NNS O
in IN O
cell NN O
lines NNS O
derived VBN O
from IN O
human JJ O
ovarian JJ B-Disease
cancers NNS I-Disease
and CC O
found VBD O
that IN O
5 CD O
out IN O
of IN O
10 CD O
of IN O
the DT O
ovarian JJ B-Disease
tumor NN I-Disease
cell NN O
lines NNS O
are VBP O
genetically RB O
unstable JJ O
at IN O
the DT O
majority NN O
of IN O
the DT O
loci NN O
analyzed VBD O
. . O

In IN O
clones NNS O
and CC O
subclones NNS O
derived VBN O
serially RB O
from IN O
one CD O
of IN O
these DT O
cell NN O
lines NNS O
( ( O
2774 CD O
; : O
serous JJ B-Disease
cystadenocarcinoma NN I-Disease
) ) O
, , O
a DT O
very RB O
high JJ O
proportion NN O
of IN O
microsatellites NNS O
distributed VBN O
in IN O
many JJ O
different JJ O
regions NNS O
of IN O
the DT O
genome NN O
change VBP O
their PRP$ O
size NN O
in IN O
a DT O
mercurial JJ O
fashion NN O
. . O

We PRP O
conclude VBP O
that IN O
genomic JJ O
instability NN O
in IN O
ovarian JJ B-Disease
tumors NNS I-Disease
is VBZ O
a DT O
dynamic JJ O
and CC O
ongoing JJ O
process NN O
whose WP$ O
high JJ O
frequency NN O
may MD O
have VB O
been VBN O
previously RB O
underestimated VBN O
by IN O
PCR NNP O
- : O
based VBN O
allelotyping NN O
of IN O
bulk JJ O
tumor NN B-Disease
tissue NN O
. . O

We PRP O
have VBP O
identified VBN O
the DT O
source NN O
of IN O
the DT O
genetic JJ O
instability NN O
in IN O
one CD O
ovarian JJ B-Disease
tumor NN I-Disease
as IN O
a DT O
point NN O
mutation NN O
( ( O
R524P NNP O
) ) O
in IN O
the DT O
human JJ O
mismatch NN O
- : O
repair NN O
gene NN O
MSH2 NNP O
( ( O
Salmonella NNP O
MutS NNP O
homologue NN O
) ) O
, , O
which WDT O
has VBZ O
recently RB O
been VBN O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
hereditary JJ B-Disease
nonpolyposis NN I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
. . O

Patient JJ O
2774 CD O
was VBD O
a DT O
38 CD O
- : O
year NN O
- : O
old JJ O
heterozygote NN O
, , O
and CC O
her PRP$ O
normal JJ O
tissue NN O
carried VBD O
both DT O
mutant JJ O
and CC O
wild JJ O
- : O
type NN O
alleles NNS O
of IN O
the DT O
human JJ O
MSH2 NNP O
gene NN O
. . O

However RB O
the DT O
wild JJ O
- : O
type NN O
allele NN O
was VBD O
lost VBN O
at IN O
some DT O
point NN O
early RB O
during IN O
tumorigenesis NN O
so RB O
that IN O
DNA NNP O
isolated VBD O
either CC O
from IN O
the DT O
patients NNS O
ovarian JJ B-Disease
tumor NN I-Disease
or CC O
from IN O
the DT O
2774 CD O
cell NN O
line NN O
carries VBZ O
only RB O
the DT O
mutant JJ O
allele NN O
of IN O
the DT O
human JJ O
MSH2 NNP O
gene NN O
. . O

The DT O
genetic JJ O
instability NN O
observed VBN O
in IN O
the DT O
tumor NN B-Disease
and CC O
cell NN O
line NN O
DNA NNP O
, , O
together RB O
with IN O
the DT O
germ JJ O
- : O
line NN O
mutation NN O
in IN O
a DT O
mismatch NN O
- : O
repair NN O
gene NN O
, , O
suggest VBP O
that IN O
the DT O
MSH2 NNP O
gene NN O
is VBZ O
involved VBN O
in IN O
the DT O
onset NN O
and CC O
/ NN O
or CC O
progression NN O
in IN O
a DT O
subset NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O
. . O

BRCA1 NNP O
mutations NNS O
in IN O
primary JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
carcinomas NN I-Disease
. . O

Loss NNP O
of IN O
heterozygosity NN O
data NNS O
from IN O
familial JJ B-Disease
tumors NNS I-Disease
suggest VBP O
that IN O
BRCA1 NNP O
, , O
a DT O
gene NN O
that WDT O
confers VBZ O
susceptibility NN O
to TO O
ovarian JJ B-Disease
and CC I-Disease
early JJ I-Disease
- : I-Disease
onset NN I-Disease
breast NN B-Disease
cancer NN I-Disease
, , O
encodes VBZ O
a DT O
tumor NN B-Disease
suppressor NN O
. . O

The DT O
BRCA1 NNP O
region NN O
is VBZ O
also RB O
subject JJ O
to TO O
allelic JJ O
loss NN O
in IN O
sporadic JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
, , O
an DT O
indication NN O
that IN O
BRCA1 NNP O
mutations NNS O
may MD O
occur VB O
somatically RB O
in IN O
these DT O
tumors NNS B-Disease
. . O

The DT O
BRCA1 NNP O
coding VBG O
region NN O
was VBD O
examined VBN O
for IN O
mutations NNS O
in IN O
primary JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
tumors NNS I-Disease
that WDT O
show VBP O
allele JJ O
loss NN O
at IN O
the DT O
BRCA1 NNP O
locus NN O
. . O

Mutations NNS O
were VBD O
detected VBN O
in IN O
3 CD O
of IN O
32 CD O
breast NN O
and CC O
1 CD O
of IN O
12 CD O
ovarian JJ B-Disease
carcinomas NN I-Disease
; : O
all DT O
four CD O
mutations NNS O
were VBD O
germline JJ O
alterations NNS O
and CC O
occurred VBD O
in IN O
early JJ O
- : O
onset NN O
cancers NNS B-Disease
. . O

These DT O
results NNS O
suggest VBP O
that IN O
mutation NN O
of IN O
BRCA1 NNP O
may MD O
not RB O
be VB O
critical JJ O
in IN O
the DT O
development NN O
of IN O
the DT O
majority NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
that WDT O
arise VBP O
in IN O
the DT O
absence NN O
of IN O
a DT O
mutant JJ O
germline NN O
allele NN O
. . O
. . O

PAX6 NNP O
gene NN O
dosage NN O
effect NN O
in IN O
a DT O
family NN O
with IN O
congenital JJ B-Disease
cataracts NNS I-Disease
, , O
aniridia NN B-Disease
, , O
anophthalmia NN B-Disease
and CC O
central JJ B-Disease
nervous JJ I-Disease
system NN I-Disease
defects NNS I-Disease
. . O

The DT O
human JJ O
eye NN O
malformation NN O
aniridia JJ B-Disease
results NNS O
from IN O
haploinsufficiency NN B-Disease
of IN I-Disease
PAX6 NNP I-Disease
, , O
a DT O
paired JJ O
box NN O
DNA NNP O
- : O
binding NN O
protein NN O
. . O

To TO O
study VB O
this DT O
dosage NN O
effect NN O
, , O
we PRP O
characterized VBD O
two CD O
PAX6 NNP O
mutations NNS O
in IN O
a DT O
family NN O
segregating VBG O
aniridia NN B-Disease
and CC O
a DT O
milder NN O
syndrome NN O
consisting NN O
of IN O
congenital JJ B-Disease
cataracts NNS I-Disease
and CC O
late JJ O
onset NN O
corneal NN B-Disease
dystrophy NN I-Disease
. . O

The DT O
nonsense JJ O
mutations NNS O
, , O
at IN O
codons NNS O
103 CD O
and CC O
353 CD O
, , O
truncate NN O
PAX6 NNP O
within IN O
the DT O
N NNP O
- : O
terminal NN O
paired VBN O
and CC O
C NNP O
- : O
terminal JJ O
PST NNP O
domains NNS O
, , O
respectively RB O
. . O

The DT O
wild JJ O
- : O
type NN O
PST NNP O
domain NN O
activates NNS O
transcription VBP O
autonomously RB O
and CC O
the DT O
mutant JJ O
form NN O
has VBZ O
partial JJ O
activity NN O
. . O

A DT O
compound NN O
heterozygote NN O
had VBD O
severe JJ O
craniofacial JJ B-Disease
and CC I-Disease
central JJ I-Disease
nervous JJ I-Disease
system NN I-Disease
defects NNS I-Disease
and CC O
no DT B-Disease
eyes NNS I-Disease
. . O

The DT O
pattern NN O
of IN O
malformations NNS O
is VBZ O
similar JJ O
to TO O
that DT O
in IN O
homozygous JJ O
Sey NNP O
mice NN O
and CC O
suggests VBZ O
a DT O
critical JJ O
role NN O
for IN O
PAX6 NNP O
in IN O
controlling VBG O
the DT O
migration NN O
and CC O
differentiation NN O
of IN O
specific JJ O
neuronal JJ O
progenitor NN O
cells NNS O
in IN O
the DT O
brain NN O
. . O
. . O

A DT O
physical JJ O
map NN O
and CC O
candidate NN O
genes NNS O
in IN O
the DT O
BRCA1 NNP O
region NN O
on IN O
chromosome NN O
17q12 CD O
- : O
21 CD O
. . O

We PRP O
have VBP O
constructed VBN O
a DT O
physical JJ O
map NN O
of IN O
a DT O
4 CD O
cM JJ O
region NN O
on IN O
chromosome NN O
17q12 CD O
- : O
21 CD O
that WDT O
contains VBZ O
the DT O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
gene NN O
BRCA1 NNP O
. . O

The DT O
map NN O
comprises VBZ O
a DT O
contig NN O
of IN O
137 CD O
overlapping VBG O
yeast RB O
artificial JJ O
chromosomes NNS O
and CC O
P1 NNP O
clones NNS O
, , O
onto IN O
which WDT O
we PRP O
have VBP O
placed VBN O
112 CD O
PCR NNP O
markers NNS O
. . O

We PRP O
have VBP O
localized VBN O
more JJR O
than IN O
20 CD O
genes NNS O
on IN O
this DT O
map NN O
, , O
ten NN O
of IN O
which WDT O
had VBD O
not RB O
been VBN O
mapped VBN O
to TO O
the DT O
region NN O
previously RB O
, , O
and CC O
have VBP O
isolated VBN O
30 CD O
cDNA JJ O
clones NNS O
representing VBG O
partial JJ O
sequences NNS O
of IN O
as IN O
yet RB O
unidentified JJ O
genes NNS O
. . O

Two CD O
genes NNS O
that WDT O
lie VBP O
within IN O
a DT O
narrow JJ O
region NN O
defined VBN O
by IN O
meiotic JJ O
breakpoints NNS O
in IN O
BRCA1 NNP O
patients NNS O
have VBP O
been VBN O
sequenced VBN O
in IN O
breast NN B-Disease
cancer NN I-Disease
patients NNS O
without IN O
revealing VBG O
any DT O
deleterious JJ O
mutations NNS O
. . O

These DT O
new JJ O
reagents NNS O
should MD O
facilitate VB O
the DT O
identification NN O
of IN O
BRCA1 NNP O
. . O
. . O

The DT O
LEC NNP O
rat NN O
has VBZ O
a DT O
deletion NN O
in IN O
the DT O
copper NN O
transporting VBG O
ATPase NNP O
gene NN O
homologous JJ O
to TO O
the DT O
Wilson NNP B-Disease
disease NN I-Disease
gene NN O
. . O

The DT O
Long NNP O
- : O
Evans NNS O
Cinnamon NNP O
( ( O
LEC NNP O
) ) O
rat NN O
shows VBZ O
similarity NN O
to TO O
Wilson NNP B-Disease
disease NN I-Disease
in IN O
many JJ O
clinical JJ O
and CC O
biochemical JJ O
features NNS O
. . O

We PRP O
have VBP O
cloned VBN O
cDNAs NN O
for IN O
the DT O
rat NN O
gene NN O
( ( O
Atp7b NNP O
) ) O
homologous VBZ O
to TO O
the DT O
human JJ O
Wilson NNP B-Disease
disease NN I-Disease
gene NN O
( ( O
ATP7B NNP O
) ) O
and CC O
have VBP O
used VBN O
them PRP O
to TO O
identify VB O
a DT O
partial JJ O
deletion NN O
in IN O
the DT O
Atp7b NNP O
gene NN O
in IN O
the DT O
LEC NNP O
rat NN O
. . O

The DT O
deletion NN O
removes VBZ O
at IN O
least JJS O
900 CD O
bp NN O
of IN O
the DT O
coding VBG O
region NN O
at IN O
the DT O
3 CD O
end NN O
, , O
includes VBZ O
the DT O
crucial JJ O
ATP NNP O
binding NN O
domain NN O
and CC O
extends VBZ O
downstream NN O
of IN O
the DT O
gene NN O
. . O

Our PRP$ O
results NNS O
provide VBP O
convincing VBG O
evidence NN O
for IN O
defining VBG O
the DT O
LEC NNP O
rat NN O
as IN O
an DT O
animal JJ O
model NN O
for IN O
Wilson NNP B-Disease
disease NN I-Disease
. . O

This DT O
model NN O
will MD O
be VB O
important JJ O
for IN O
studying VBG O
liver NN O
pathophysiology NN O
, , O
for IN O
developing VBG O
therapy NN O
for IN O
Wilson NNP B-Disease
disease NN I-Disease
and CC O
for IN O
studying VBG O
the DT O
pathway NN O
of IN O
copper NN O
transport NN O
and CC O
its PRP$ O
possible JJ O
interaction NN O
with IN O
other JJ O
heavy JJ O
metals NNS O
. . O
. . O

Genomic NNP O
organization NN O
of IN O
the DT O
adrenoleukodystrophy NN B-Disease
gene NN O
. . O

Adrenoleukodystrophy NNP B-Disease
( ( O
ALD NNP B-Disease
) ) O
, , O
the DT O
most RBS O
frequent JJ O
peroxisomal JJ B-Disease
disorder NN I-Disease
, , O
is VBZ O
a DT O
severe JJ O
neurodegenerative JJ B-Disease
disease NN I-Disease
associated VBN O
with IN O
an DT O
impairment NN B-Disease
of IN I-Disease
very RB I-Disease
long RB I-Disease
chain NN I-Disease
fatty JJ I-Disease
acids NNS I-Disease
beta SYM I-Disease
- : I-Disease
oxidation NN I-Disease
. . O

We PRP O
have VBP O
recently RB O
identified VBN O
by IN O
positional JJ O
cloning VBG O
the DT O
gene NN O
responsible JJ O
for IN O
ALD NNP B-Disease
, , O
located VBN O
in IN O
Xq28 NNP O
. . O

It PRP O
encodes VBZ O
a DT O
new JJ O
member NN O
of IN O
the DT O
"""" NNP O
ABC NNP O
"""" NNP O
superfamily RB O
of IN O
membrane NN O
- : O
associated VBN O
transporters NNS O
that WDT O
shows VBZ O
, , O
in IN O
particular JJ O
, , O
significant JJ O
homology NN O
to TO O
the DT O
70 CD O
- : O
kDa NN O
peroxisomal JJ O
membrane NN O
protein NN O
( ( O
PMP70 NNP O
) ) O
. . O

We PRP O
report VBP O
here RB O
a DT O
detailed JJ O
characterization NN O
of IN O
the DT O
ALD NNP B-Disease
gene NN O
structure NN O
. . O

It PRP O
extends VBZ O
over IN O
21 CD O
kb NNS O
and CC O
consists NNS O
of IN O
10 CD O
exons NNS O
. . O

To TO O
facilitate VB O
the DT O
detection NN O
of IN O
mutations NNS O
in IN O
ALD NNP B-Disease
patients NNS O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
intronic JJ O
sequences NNS O
flanking VBG O
the DT O
exons NNS O
as RB O
well RB O
as IN O
the DT O
sequence NN O
of IN O
the DT O
3 CD O
untranslated JJ O
region NN O
and CC O
of IN O
the DT O
immediate JJ O
5 CD O
promoter NN O
region NN O
. . O

Sequences NNS O
present JJ O
in IN O
distal JJ O
exons NNS O
cross VBP O
- : O
hybridize NN O
strongly RB O
to TO O
additional JJ O
sequences NNS O
in IN O
the DT O
human JJ O
genome NN O
. . O

The DT O
ALD NNP B-Disease
gene NN O
has VBZ O
been VBN O
positioned VBN O
on IN O
a DT O
pulsed JJ O
- : O
field NN O
map NN O
between IN O
DXS15 NNP O
and CC O
the DT O
L1CAM NNP O
gene NN O
, , O
about RB O
650 CD O
kb NNS O
upstream RB O
from IN O
the DT O
color NN O
pigment NN O
genes NNS O
. . O

The DT O
frequent JJ O
occurrence NN O
of IN O
color NN O
vision NN O
anomalies NNS O
observed VBN O
in IN O
patients NNS O
with IN O
adrenomyeloneuropathy JJ B-Disease
( ( O
the DT O
adult NN O
onset JJ O
form NN O
of IN O
ALD NNP B-Disease
) ) O
thus RB O
does VBZ O
not RB O
represent VB O
a DT O
contiguous JJ B-Disease
gene NN I-Disease
syndrome NN I-Disease
but CC O
a DT O
secondary JJ O
manifestation NN O
of IN O
ALD NNP B-Disease
. . O
. . O

The DT O
murine NN O
homologues NNS O
of IN O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
gene NN O
( ( O
Hdh NNP O
) ) O
and CC O
the DT O
alpha JJ O
- : O
adducin NN O
gene NN O
( ( O
Add1 NNP O
) ) O
map NN O
to TO O
mouse VB O
chromosome NN O
5 CD O
within IN O
a DT O
region NN O
of IN O
conserved VBN O
synteny NN O
with IN O
human JJ O
chromosome NN O
4p16 CD O
. . O
3 CD O
. . O

Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
is VBZ O
a DT O
severe JJ O
autosomal JJ B-Disease
dominant JJ I-Disease
neurodegenerative JJ I-Disease
disorder NN I-Disease
associated VBN O
with IN O
a DT O
novel JJ O
gene NN O
( ( O
IT15 NNP O
) ) O
. . O

Recently RB O
, , O
we PRP O
reported VBD O
the DT O
cloning NN O
of IN O
Hdh NNP O
, , O
the DT O
murine NN O
homologue NN O
of IN O
IT15 NNP O
. . O

Here RB O
, , O
using VBG O
an DT O
interspecific JJ O
backcross NN O
, , O
we PRP O
have VBP O
mapped VBN O
both DT O
Hdh NNP O
and CC O
the DT O
mouse NN O
homologue NN O
of IN O
human JJ O
alpha SYM O
- : O
adducin NN O
( ( O
Add1 NNP O
) ) O
, , O
a DT O
membrane NN O
- : O
associated VBN O
cytoskeletal JJ O
protein NN O
gene NN O
. . O

Both DT O
of IN O
these DT O
genes NNS O
map VBP O
in IN O
the DT O
same JJ O
position NN O
on IN O
mouse NN O
chromosome NN O
5 CD O
in IN O
a DT O
region NN O
associated VBN O
with IN O
ancestral JJ O
chromosomal JJ O
rearrangements NNS O
and CC O
show VB O
no DT O
recombination NN O
with IN O
D5H4S43 NNP O
, , O
D5H4S115 NNP O
, , O
and CC O
D5H4S62 NNP O
, , O
the DT O
murine NN O
homologues NNS O
of IN O
D4S43 NNP O
, , O
D4S115 NNP O
, , O
and CC O
D4S62 NNP O
, , O
respectively RB O
. . O

Further RB O
mapping VBG O
studies NNS O
of IN O
humans NNS O
, , O
mice NN O
, , O
and CC O
other JJ O
mammalian JJ O
species NNS O
should MD O
reveal VB O
the DT O
nature NN O
of IN O
the DT O
rearrangements NNS O
affecting VBG O
this DT O
chromosomal JJ O
segment NN O
during IN O
mammalian JJ O
evolution NN O
. . O
. . O

Genetic JJ O
cholesteryl NN B-Disease
ester NN I-Disease
transfer NN I-Disease
protein NN I-Disease
deficiency NN I-Disease
caused VBN O
by IN O
two CD O
prevalent JJ O
mutations NNS O
as IN O
a DT O
major JJ O
determinant NN O
of IN O
increased JJ O
levels NNS O
of IN O
high JJ O
density NN O
lipoprotein VBP O
cholesterol NN O
. . O

Genetic JJ O
determinants NNS O
of IN O
HDL NNP O
cholesterol NN O
( ( O
HDL NNP O
- : O
C NNP O
) ) O
levels NNS O
in IN O
the DT O
general JJ O
population NN O
are VBP O
poorly RB O
understood JJ O
. . O

We PRP O
previously RB O
described VBD O
plasma JJ O
cholesteryl NN B-Disease
ester NN I-Disease
transfer NN I-Disease
protein NN I-Disease
( ( I-Disease
CETP NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
due JJ O
to TO O
an DT O
intron NN O
14 CD O
G NNP O
( ( O
+ NNP O
1 CD O
) ) O
- : O
to TO O
- : O
A DT O
mutation NN O
( ( O
Int14 NNP O
A NNP O
) ) O
in IN O
several JJ O
families NNS O
with IN O
very RB O
high JJ O
HDL NNP O
- : O
C NN O
levels NNS O
in IN O
Japan NNP O
. . O

Subjects NNS O
with IN O
HDL NNP O
- : O
C NNP O
> NNP O
or CC O
= $ O
100 CD O
mg NN O
/ NN O
dl NN O
( ( O
n JJ O
= NNP O
130 CD O
) ) O
were VBD O
screened VBN O
by IN O
PCR NNP O
single JJ O
strand NN O
conformational JJ O
polymorphism NN O
analysis NN O
of IN O
the DT O
CETP NNP O
gene NN O
. . O

Two CD O
other JJ O
mutations NNS O
were VBD O
identified VBN O
by IN O
DNA NNP O
sequencing VBG O
or CC O
primer JJ O
- : O
mediated VBN O
restriction NN O
map NN O
modification NN O
of IN O
PCR NNP O
products NNS O
a DT O
novel JJ O
intron NN O
14 CD O
splice NN O
donor NN O
site NN O
mutation NN O
caused VBN O
by IN O
a DT O
T NNP O
insertion NN O
at IN O
position NN O
+ FW O
3 CD O
from IN O
the DT O
exon14 NN O
/ NNP O
intron14 NN O
boundary NN O
( ( O
Int14 NNP O
T NNP O
) ) O
and CC O
a DT O
missense JJ O
mutation NN O
( ( O
Asp442 NNP O
to TO O
Gly NNP O
) ) O
within IN O
exon $ O
15 CD O
( ( O
D442G NNP O
) ) O
. . O

The DT O
Int14 NNP O
T NNP O
mutation NN O
was VBD O
only RB O
found VBN O
in IN O
one CD O
family NN O
. . O

However RB O
, , O
the DT O
D442G NNP O
and CC O
Int14 NNP O
A NNP O
mutations NNS O
were VBD O
highly RB O
prevalent JJ O
in IN O
subjects NNS O
with IN O
HDL NNP O
- : O
C NNP O
> NNP O
or CC O
= $ O
60 CD O
mg NN O
/ NNP O
dl NN O
, , O
with IN O
combined VBN O
allele JJ O
frequencies NNS O
of IN O
9 CD O
% NN O
, , O
12 CD O
% NN O
, , O
21 CD O
% NN O
and CC O
43 CD O
% NN O
for IN O
HDL NNP O
- : O
C $ O
60 CD O
- : O
79 CD O
, , O
80 CD O
- : O
99 CD O
, , O
100 CD O
- : O
119 CD O
, , O
and CC O
> NNP O
or CC O
= $ O
120 CD O
mg NN O
/ NNP O
dl NN O
, , O
respectively RB O
. . O

Furthermore RB O
, , O
prevalences NNS O
of IN O
the DT O
D442G NNP O
and CC O
Int14 NNP O
A NNP O
mutations NNS O
were VBD O
extremely RB O
high JJ O
in IN O
a DT O
general JJ O
sample NN O
of IN O
Japanese JJ O
men NNS O
( ( O
n JJ O
= NNP O
236 CD O
) ) O
, , O
with IN O
heterozygote JJ O
frequencies NNS O
of IN O
7 CD O
% NN O
and CC O
2 CD O
% NN O
, , O
respectively RB O
. . O

These DT O
two CD O
mutations NNS O
accounted VBD O
for IN O
about IN O
10 CD O
% NN O
of IN O
the DT O
total JJ O
variance NN O
of IN O
HDL NNP O
- : O
C NN O
in IN O
this DT O
population NN O
. . O

The DT O
phenotype NN O
in IN O
a DT O
genetic JJ O
compound NN O
heterozygote NN O
( ( O
Int14 NNP O
T NNP O
and CC O
Int14 NNP O
A NNP O
) ) O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
Int14 NNP O
A NNP O
homozygotes NNS O
( ( O
no DT O
detectable JJ O
CETP NNP O
and CC O
markedly RB O
increased VBD O
HDL NNP O
- : O
C NNP O
) ) O
, , O
indicating VBG O
that IN O
the DT O
Int14 NNP O
T NNP O
produces VBZ O
a DT O
null JJ O
allele NN O
. . O

In IN O
four CD O
D442G NNP O
homozygotes NNS O
, , O
mean VBP O
HDL NNP O
- : O
C NN O
levels NNS O
( ( O
86 CD O
+ NN O
/ NNP O
- : O
26 CD O
mg NN O
/ NNP O
dl NN O
) ) O
were VBD O
lower JJR O
than IN O
in IN O
Int14 NNP O
A NNP O
homozygotes VBZ O
( ( O
158 CD O
+ NN O
/ NNP O
- : O
35 CD O
mg NN O
/ NNP O
dl NN O
) ) O
, , O
reflecting VBG O
residual JJ O
CETP NNP O
activity NN O
in IN O
plasma NN O
. . O

In IN O
47 CD O
D442G NNP O
heterozygotes NNS O
, , O
mean VBP O
HDL NNP O
- : O
C NN O
levels NNS O
were VBD O
91 CD O
+ NNP O
/ NNP O
- : O
23 CD O
mg NN O
/ NNP O
dl NN O
, , O
similar JJ O
to TO O
the DT O
level NN O
in IN O
D442G NNP O
homozygotes NNS O
, , O
and CC O
significantly RB O
greater JJR O
than IN O
mean VB O
HDL NNP O
- : O
C NN O
levels NNS O
in IN O
Int14 NNP O
A NNP O
heterozygotes VBZ O
( ( O
69 CD O
+ NN O
/ NNP O
- : O
15 CD O
mg NN O
/ NNP O
dl NN O
) ) O
. . O

Thus RB O
, , O
the DT O
D442G NNP O
mutation NN O
acts VBZ O
differently RB O
to TO O
the DT O
null JJ O
mutations NNS O
with IN O
weaker JJR O
effects NNS O
on IN O
HDL NNP O
in IN O
the DT O
homozygous JJ O
state NN O
and CC O
stronger JJR O
effects NNS O
in IN O
the DT O
heterozygotes NNS O
, , O
suggesting VBG O
dominant JJ O
expression NN O
of IN O
a DT O
partially RB O
defective JJ O
allele NNS O
. . O

CETP NNP B-Disease
deficiency NN I-Disease
, , O
reflecting VBG O
two CD O
prevalent JJ O
mutations NNS O
( ( O
D442G NNP O
and CC O
Int14 NNP O
A NNP O
) ) O
, , O
is VBZ O
the DT O
first JJ O
example NN O
of IN O
a DT O
genetic JJ B-Disease
deficiency NN I-Disease
state NN O
which WDT O
is VBZ O
sufficiently RB O
common JJ O
to TO O
explain VB O
a DT O
significant JJ O
fraction NN O
of IN O
the DT O
variation NN O
in IN O
HDL NNP O
- : O
C NN O
in IN O
the DT O
general JJ O
population NN O
. . O
. . O

Treatment NN O
of IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
: : O
effects NNS O
of IN O
chenodeoxycholic JJ O
acid NN O
, , O
pravastatin NN O
, , O
and CC O
combined VBN O
use NN O
. . O

Treatments NNS O
by IN O
oral JJ O
administration NN O
of IN O
chenodeoxycholic JJ O
acid NN O
( ( O
CDCA NNP O
) ) O
alone RB O
, , O
3 CD O
- : O
hydroxy NN O
- : O
3 CD O
- : O
methylglutaryl NN O
( ( O
HMG NNP O
) ) O
CoA NNP O
reductase NN O
inhibitor NN O
( ( O
pravastatin NN O
) ) O
alone RB O
, , O
and CC O
combination NN O
of IN O
the DT O
two CD O
drugs NNS O
were VBD O
attempted VBN O
for IN O
7 CD O
patients NNS O
with IN O
cerebrotendinous JJ B-Disease
xanthomatosis NN I-Disease
( ( O
CTX NNP B-Disease
) ) O
. . O

CDCA NNP O
treatment NN O
at IN O
a DT O
dose NN O
of IN O
300 CD O
mg NNS O
/ JJ O
day NN O
reduced VBD O
serum JJ O
cholestanol NN O
( ( O
67 CD O
. . O
3 CD O
% NN O
reduction NN O
) ) O
, , O
lathosterol NN O
( ( O
50 CD O
. . O
8 CD O
% NN O
) ) O
, , O
campesterol NN O
( ( O
61 CD O
. . O
7 CD O
% NN O
) ) O
and CC O
sitosterol NN O
( ( O
12 CD O
. . O
7 CD O
% NN O
) ) O
. . O

However RB O
, , O
the DT O
sera NN O
of IN O
the DT O
patients NNS O
changed VBD O
to TO O
be VB O
"""" JJ O
atherogenic JJ O
"""" NN O
; : O
total JJ O
cholesterol NN O
, , O
triglyceride RB O
and CC O
low JJ O
- : O
density NN O
lipoprotein NN O
( ( O
LDL NNP O
) ) O
- : O
cholesterol NN O
were VBD O
increased VBN O
, , O
while IN O
high JJ O
- : O
density NN O
lipoprotein NN O
( ( O
HDL NNP O
) ) O
- : O
cholesterol NN O
was VBD O
decreased VBN O
. . O

Contrarily RB O
, , O
pravastatin NN O
at IN O
a DT O
dose NN O
of IN O
10 CD O
mg NNS O
/ JJ O
day NN O
improved VBD O
the DT O
sera NN O
of IN O
the DT O
patients NNS O
to TO O
be VB O
markedly RB O
"""" JJ O
anti SYM O
- : O
atherogenic JJ O
"""" NN O
, , O
but CC O
the DT O
reductions NNS O
of IN O
cholestanol NN O
( ( O
30 CD O
. . O
4 CD O
% NN O
) ) O
, , O
lathosterol NN O
( ( O
44 CD O
. . O
0 CD O
% NN O
) ) O
, , O
campesterol NN O
( ( O
22 CD O
. . O
9 CD O
% NN O
) ) O
and CC O
sitosterol NN O
( ( O
9 CD O
. . O
6 CD O
% NN O
) ) O
were VBD O
inadequate JJ O
. . O

Combined VBN O
treatment NN O
with IN O
CDCA NNP O
and CC O
pravastatin NN O
showed VBD O
good JJ O
overlapping NN O
of IN O
the DT O
effects NNS O
of IN O
each DT O
drug NN O
alone RB O
. . O

The DT O
sera NN O
of IN O
the DT O
patients NNS O
were VBD O
apparently RB O
more RBR O
"""" JJ O
anti JJ O
- : O
atherogenic NN O
"""" NN O
than IN O
those DT O
after IN O
CDCA NNP O
treatment NN O
. . O

Serum NNP O
cholestanol NN O
concentration NN O
was VBD O
still RB O
2 CD O
. . O

7 CD O
times NNS O
higher JJR O
than IN O
in IN O
controls NNS O
, , O
but CC O
the DT O
serum NN O
lathosterol NN O
level NN O
was VBD O
within IN O
the DT O
normal JJ O
range NN O
, , O
indicating VBG O
that IN O
the DT O
enhancement NN O
of IN O
overall JJ O
cholesterol NN O
synthesis NN O
in IN O
the DT O
patients NNS O
was VBD O
sufficiently RB O
suppressed VBN O
. . O

Plant NNP O
sterol NN O
levels NNS O
were VBD O
also RB O
within IN O
the DT O
normal JJ O
range NN O
. . O

The DT O
combination NN O
of IN O
CDCA NNP O
and CC O
pravastatin NN O
was VBD O
a DT O
good JJ O
treatment NN O
for IN O
CTX NNP B-Disease
, , O
based VBN O
on IN O
the DT O
improvement NN O
of IN O
serum NN O
lipoprotein NN O
metabolism NN O
, , O
the DT O
suppression NN O
of IN O
cholesterol NN O
synthesis NN O
, , O
and CC O
reductions NNS O
of IN O
cholestanol NN O
and CC O
plant NN O
sterol NN O
levels NNS O
. . O

In IN O
all DT O
of IN O
7 CD O
patients NNS O
, , O
the DT O
progression NN O
of IN O
disease NN O
was VBD O
arrested VBN O
, , O
but CC O
dramatic JJ O
effects NNS O
on IN O
clinical JJ O
manifestations NNS O
, , O
xanthoma NNP B-Disease
, , O
and CC O
electrophysiological JJ O
findings NNS O
could MD O
not RB O
be VB O
found VBN O
after IN O
the DT O
treatment NN O
of IN O
these DT O
drugs NNS O

Mutation NNP O
spectrum NN O
in IN O
the DT O
CHM NNP B-Disease
gene NN O
of IN O
Danish NNP O
and CC O
Swedish NNP O
choroideremia NN B-Disease
patients NNS O
. . O

The DT O
recent JJ O
isolation NN O
of IN O
the DT O
complete JJ O
open JJ O
reading NN O
frame NN O
of IN O
the DT O
choroideremia NN B-Disease
( ( O
CHM NNP B-Disease
) ) O
gene NN O
and CC O
the DT O
characterization NN O
of IN O
the DT O
exon JJ O
- : O
intron NN O
boundaries NNS O
has VBZ O
paved VBN O
the DT O
way NN O
to TO O
mutation VB O
detection NN O
in IN O
patients NNS O
with IN O
classical JJ O
choroideremia NN B-Disease
. . O

We PRP O
have VBP O
performed VBN O
mutation NN O
screening VBG O
in IN O
patients NNS O
from IN O
15 CD O
Danish JJ O
and CC O
Swedish JJ O
families NNS O
by IN O
using VBG O
Southern NNP O
blot NN O
hybridization NN O
and CC O
the DT O
polymerase NN O
chain NN O
reaction NN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
PCR NNP O
- : O
SSCP NN O
) ) O
technique NN O
. . O

Causative JJ O
mutations NNS O
in IN O
the DT O
CHM NNP B-Disease
gene NN O
were VBD O
detected VBN O
in IN O
at IN O
least JJS O
12 CD O
families NNS O
, , O
indicating VBG O
that IN O
a DT O
substantial JJ O
part NN O
of IN O
the DT O
mutations NNS O
can MD O
be VB O
identified VBN O
by IN O
this DT O
approach NN O
. . O

In IN O
four CD O
of IN O
these DT O
families NNS O
deletions NNS O
of IN O
different JJ O
sizes NNS O
were VBD O
found VBN O
. . O

Thus RB O
, , O
in IN O
one CD O
patient NN O
, , O
the DT O
deletion NN O
resulted VBD O
in IN O
the DT O
absence NN O
of IN O
only RB O
one CD O
exon NN O
, , O
while IN O
in IN O
another DT O
the DT O
deletion NN O
comprised VBD O
the DT O
entire JJ O
CHM NNP B-Disease
gene NN O
. . O

Mapping NN O
of IN O
the DT O
deletion NN O
endpoints NNS O
in IN O
these DT O
four CD O
patients NNS O
and CC O
in IN O
another DT O
11 CD O
male NN O
patients NNS O
with IN O
sizeable JJ O
deletions NNS O
enabled VBD O
us PRP O
to TO O
construct VB O
a DT O
very RB O
detailed JJ O
map NN O
of IN O
intervals NNS O
2 CD O
and CC O
3 CD O
of IN O
Xq21 NN O
. . O

In IN O
the DT O
remaining VBG O
11 CD O
Danish JJ O
and CC O
Swedish JJ O
families NNS O
at IN O
least JJS O
8 CD O
causative JJ O
mutations NNS O
were VBD O
found VBN O
by IN O
PCR NNP O
- : O
SSCP NN O
analysis NN O
and CC O
direct JJ O
sequencing NN O
. . O

Interestingly RB O
, , O
all DT O
CHM NNP B-Disease
gene NN O
mutations NNS O
detected VBD O
thus RB O
far RB O
in IN O
choroideremia JJ B-Disease
patients NNS O
give VBP O
rise NN O
to TO O
the DT O
introduction NN O
of IN O
a DT O
premature NN O
stop NN O
codon NN O
. . O
. . O

Predominance NN O
of IN O
the DT O
adrenomyeloneuropathy JJ B-Disease
phenotype NN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
adrenoleukodystrophy NN I-Disease
in IN O
The DT O
Netherlands NNPS O
: : O
a DT O
survey NN O
of IN O
30 CD O
kindreds NNS O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
) ) O
is VBZ O
an DT O
inherited JJ B-Disease
disorder NN I-Disease
of IN O
peroxisomal JJ O
beta NN O
- : O
oxidation NN O
associated VBN O
with IN O
accumulation NN O
of IN O
saturated JJ O
very RB O
long RB O
- : O
chain NN O
fatty JJ O
acids NNS O
, , O
which WDT O
results NNS O
in IN O
central JJ O
and CC O
peripheral JJ O
demyelination NN B-Disease
and CC O
in IN O
impaired JJ B-Disease
function NN I-Disease
of IN I-Disease
adrenal JJ I-Disease
cortex NN I-Disease
and CC I-Disease
testes NNS I-Disease
. . O

The DT O
phenotypic NN O
expression NN O
is VBZ O
highly RB O
variable JJ O
, , O
childhood JJ B-Disease
cerebral JJ I-Disease
ALD NNP I-Disease
( ( O
CCALD NNP B-Disease
) ) O
and CC O
adrenomyeloneuropathy JJ B-Disease
( ( O
AMN NNP B-Disease
) ) O
being VBG O
the DT O
main JJ O
variants NNS O
. . O

We PRP O
explored VBD O
the DT O
30 CD O
Dutch NNP O
kindreds NNS O
well RB O
known VBN O
to TO O
the DT O
Dutch NNP O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
/ NNP O
AMN NNP B-Disease
Study NNP O
Group NNP O
and CC O
phenotyped VBD O
77 CD O
male NN O
patients NNS O
35 CD O
( ( O
46 CD O
% NN O
) ) O
had VBD O
AMN NNP B-Disease
and CC O
24 CD O
( ( O
31 CD O
% NN O
) ) O
CCALD NNP B-Disease
or CC O
adolescent JJ B-Disease
cerebral JJ I-Disease
ALD NNP I-Disease
( ( O
AdolCALD NNP B-Disease
) ) O
. . O

These DT O
percentages NNS O
differ VBP O
significantly RB O
from IN O
previous JJ O
reports NNS O
, , O
in IN O
which WDT O
25 CD O
to TO O
28 CD O
% NN O
of IN O
the DT O
patients NNS O
developed VBD O
AMN NNP B-Disease
and CC O
53 CD O
to TO O
57 CD O
% NN O
CCALD NNP B-Disease
or CC O
AdolCALD NNP B-Disease
. . O

Our PRP$ O
findings NNS O
indicate VBP O
that IN O
- : O
- : O
at IN O
least JJS O
in IN O
the DT O
Netherlands NNP O
- : O
- : O
AMN NN B-Disease
may MD O
be VB O
the DT O
most RBS O
frequent JJ O
phenotype NN O
of IN O
X NNP B-Disease
- : I-Disease
ALD NNP I-Disease
. . O
. . O

Adrenoleukodystrophy NNP B-Disease
gene NN O
encodes VBZ O
an DT O
80 CD O
kDa NN O
membrane NN O
protein NN O
. . O

An DT O
antibody NN O
against IN O
the DT O
synthetic JJ O
C NNP O
- : O
terminal JJ O
peptides NNS O
deduced VBN O
from IN O
the DT O
cDNA NN O
of IN O
the DT O
gene NN O
responsible JJ O
for IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
ALD NNP B-Disease
) ) O
was VBD O
produced VBN O
to TO O
characterize VB O
the DT O
product NN O
of IN O
the DT O
ALD NNP B-Disease
gene NN O
. . O

The DT O
antibody NN O
reacted VBD O
with IN O
the DT O
80 CD O
kDa NNS O
band VBP O
protein RB O
in IN O
control NN O
fibroblasts NNS O
, , O
while IN O
no DT O
bands NNS O
were VBD O
detected VBN O
in IN O
the DT O
fibroblasts NNS O
from IN O
a DT O
patient NN O
with IN O
ALD NNP B-Disease
( ( O
# # O
163 CD O
) ) O
, , O
in IN O
which WDT O
mRNA NN O
of IN O
the DT O
ALD NNP B-Disease
gene NN O
was VBD O
undetectable JJ O
based VBN O
on IN O
Northern NNP O
blot NN O
analysis NN O
. . O

The DT O
293T CD O
cells NNS O
transfected VBN O
with IN O
the DT O
full JJ O
- : O
coding VBG O
cDNA NN O
inserted VBN O
in IN O
the DT O
expression NN O
vector NN O
produced VBD O
a DT O
new JJ O
80 CD O
kDa NN O
protein NN O
, , O
as IN O
detected VBN O
by IN O
Western JJ O
blot NN O
. . O

In IN O
an DT O
immunocytological JJ O
study NN O
, , O
the DT O
staining NN O
was VBD O
in IN O
a DT O
punctate NN O
pattern NN O
, , O
in IN O
the DT O
normal JJ O
fibroblasts NNS O
. . O

However RB O
, , O
there EX O
was VBD O
no DT O
punctate NN O
staining NN O
in IN O
the DT O
# # O
163 CD O
cells NNS O
. . O

These DT O
data NNS O
thus RB O
indicate VBP O
that IN O
the DT O
ALD NNP B-Disease
gene NN O
encodes VBZ O
an DT O
80 CD O
kDa NN O
membrane NN O
protein NN O
. . O
. . O

Isolation NN O
of IN O
the DT O
gene NN O
for IN O
McLeod NNP B-Disease
syndrome NN I-Disease
that WDT O
encodes VBZ O
a DT O
novel JJ O
membrane NN O
transport NN O
protein NN O
. . O

McLeod NNP B-Disease
syndrome NN I-Disease
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
multisystem NN I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
abnormalities NNS O
in IN O
the DT O
neuromuscular JJ O
and CC O
hematopoietic JJ O
systems NNS O
. . O

We PRP O
have VBP O
assembled VBN O
a DT O
cosmid JJ O
contig NN O
of IN O
360 CD O
kb NNS O
that WDT O
encompasses VBZ O
the DT O
McLeod NNP B-Disease
gene NN O
locus NN O
. . O

A DT O
50 CD O
kb NN O
deletion NN O
was VBD O
detected VBN O
by IN O
screening VBG O
DNA NN O
from IN O
patients NNS O
with IN O
radiolabeled JJ O
whole JJ O
cosmids NNS O
, , O
and CC O
two CD O
transcription NN O
units NNS O
were VBD O
identified VBN O
within IN O
this DT O
deletion NN O
. . O

The DT O
mRNA JJ O
expression NN O
pattern NN O
of IN O
one CD O
of IN O
them PRP O
, , O
designated VBN O
as IN O
XK NNP O
, , O
correlates VBZ O
closely RB O
to TO O
the DT O
McLeod NNP B-Disease
phenotype NN O
. . O

XK NNP O
encodes VBZ O
a DT O
novel JJ O
protein NN O
with IN O
structural JJ O
characteristics NNS O
of IN O
prokaryotic JJ O
and CC O
eukaryotic JJ O
membrane NN O
transport NN O
proteins NNS O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
XK NN O
from IN O
two CD O
unrelated JJ O
McLeod NNP B-Disease
patients NNS O
has VBZ O
identified VBN O
point NN O
mutations NNS O
at IN O
conserved JJ O
splice NN O
donor NN O
and CC O
acceptor NN O
sites NNS O
. . O

These DT O
findings NNS O
provide VBP O
direct JJ O
evidence NN O
that IN O
XK NNP O
is VBZ O
responsible JJ O
for IN O
McLeod NNP B-Disease
syndrome NN I-Disease
. . O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
spastic JJ I-Disease
paraplegia NN I-Disease
and CC O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
are VBP O
allelic JJ B-Disease
disorders NNS I-Disease
at IN O
the DT O
proteolipid JJ O
protein NN O
locus NN O
. . O

Three CD O
forms NNS O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
spastic JJ I-Disease
paraplegia NN I-Disease
( ( O
SPG NNP B-Disease
) ) O
have VBP O
been VBN O
defined VBN O
. . O

One CD O
locus NN O
( ( O
SPG NNP O
1 CD O
) ) O
maps NNS O
to TO O
Xq28 VB O
while IN O
two CD O
clinically RB O
distinct JJ O
forms NNS O
map VBP O
to TO O
Xq22 NNP O
( ( O
SPG2 NNP O
) ) O
. . O

A DT O
rare JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
dysmyelinating VBG I-Disease
disorder NN I-Disease
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( O
PMD NNP B-Disease
) ) O
, , O
has VBZ O
also RB O
been VBN O
mapped VBN O
to TO O
Xq21 VB O
- : O
q22 NN O
, , O
and CC O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
( ( O
PLP NNP O
) ) O
which WDT O
encodes VBZ O
two CD O
myelin NN O
proteins NNS O
, , O
PLP NNP O
and CC O
DM20 NNP O
. . O

While IN O
narrowing VBG O
the DT O
genetic JJ O
interval NN O
containing VBG O
SPG2 NNP O
in IN O
a DT O
large JJ O
pedigree NN O
, , O
we PRP O
found VBD O
that IN O
PLP NNP O
was VBD O
the DT O
closest JJS O
marker NN O
to TO O
the DT O
disease NN O
locus NN O
, , O
implicating VBG O
PLP NNP O
as IN O
a DT O
possible JJ O
candidate NN O
gene NN O
. . O

We PRP O
have VBP O
found VBN O
that IN O
a DT O
point NN O
mutation NN O
( ( O
His139Tyr NNP O
) ) O
in IN O
exon $ O
3B CD O
of IN O
an DT O
affected JJ O
male NN O
produces VBZ O
a DT O
mutant JJ O
PLP NNP O
but CC O
a DT O
normal JJ O
DM20 NNP O
, , O
and CC O
segregates VBZ O
with IN O
the DT O
disease NN O
( ( O
Zmax NNP O
= VBZ O
6 CD O
. . O
63 CD O
, , O
theta NN O
= VBD O
0 CD O
. . O
0 CD O
) ) O
. . O

It PRP O
appears VBZ O
, , O
therefore RB O
, , O
that IN O
SPG2 NNP O
and CC O
PMD NNP B-Disease
are VBP O
allelic JJ B-Disease
disorders NNS I-Disease

Canavan NNP B-Disease
disease NN I-Disease
: : O
mutations NNS O
among IN O
Jewish JJ O
and CC O
non JJ O
- : O
Jewish JJ O
patients NNS O
. . O

Canavan NNP B-Disease
disease NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
recessive NN I-Disease
leukodystrophy NN I-Disease
caused VBN O
by IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
aspartoacylase NN I-Disease
( ( O
ASPA NNP O
) ) O
. . O

Sixty NNP O
- : O
four CD O
probands NNS O
were VBD O
analyzed VBN O
for IN O
mutations NNS O
in IN O
the DT O
ASPA NNP O
gene NN O
. . O

Three CD O
point NN O
mutations NNS O
- : O
- : O
693C CD O
- : O
- : O
> NN O
A NNP O
, , O
854A CD O
- : O
- : O
> NN O
C NNP O
, , O
and CC O
914C CD O
- : O
- : O
> NN O
A DT O
- : O
- : O
were VBD O
identified VBN O
in IN O
the DT O
coding NN O
sequence NN O
. . O

The DT O
693C CD O
- : O
- : O
> VB O
A DT O
and CC O
914C CD O
- : O
- : O
> VB O
A DT O
base NN O
changes NNS O
, , O
resulting VBG O
in IN O
nonsense NN O
tyr231 NN O
- : O
- : O
> NN O
ter NN O
and CC O
missense NN O
ala305 NN O
- : O
- : O
> NN O
glu NN O
mutations NNS O
, , O
respectively RB O
, , O
lead JJ O
to TO O
complete JJ O
loss NN O
of IN O
ASPA NNP O
activity NN O
in IN O
in IN O
vitro JJ O
expression NN O
studies NNS O
. . O

The DT O
854A CD O
- : O
- : O
> NN O
C NNP O
transversion NN O
converted VBD O
glu NN O
to TO O
ala VB O
in IN O
codon JJ O
285 CD O
. . O

The DT O
glu285 NN O
- : O
- : O
> NN O
ala NN O
mutant NN O
ASPA NNP O
has VBZ O
2 CD O
. . O

5 CD O
% NN O
of IN O
the DT O
activity NN O
expressed VBN O
by IN O
the DT O
wild JJ O
- : O
type NN O
enzyme NN O
. . O

A DT O
fourth JJ O
mutation NN O
, , O
433 CD O
- : O
- : O
2 CD O
( ( O
A DT O
- : O
- : O
> NN O
G NNP O
) ) O
transition NN O
, , O
was VBD O
identified VBN O
at IN O
the DT O
splice NN O
- : O
acceptor NN O
site NN O
in IN O
intron NN O
2 CD O
. . O

The DT O
splice NN O
- : O
site NN O
mutation NN O
would MD O
lead VB O
to TO O
skipping VBG O
of IN O
exon JJ O
3 CD O
, , O
accompanied VBN O
by IN O
a DT O
frameshift NN O
, , O
and CC O
thus RB O
would MD O
produce VB O
aberrant JJ O
ASPA NNP O
. . O

Of IN O
the DT O
128 CD O
unrelated JJ O
Canavan NNP B-Disease
chromosomes NNS O
analyzed VBD O
, , O
88 CD O
were VBD O
from IN O
probands NNS O
of IN O
Ashkenazi NNP O
Jewish NNP O
descent NN O
. . O

The DT O
glu285 NN O
- : O
- : O
> NN O
ala JJ O
mutation NN O
was VBD O
predominant JJ O
( ( O
82 CD O
. . O
9 CD O
% NN O
) ) O
in IN O
this DT O
population NN O
, , O
followed VBN O
by IN O
the DT O
tyr231 NN O
- : O
- : O
> NN O
ter NN O
( ( O
14 CD O
. . O
8 CD O
% NN O
) ) O
and CC O
433 CD O
- : O
- : O
2 CD O
( ( O
A DT O
- : O
- : O
> NN O
G NNP O
) ) O
( ( O
1 CD O
. . O
1 CD O
% NN O
) ) O
mutations NNS O
. . O

The DT O
three CD O
mutations NNS O
account VBP O
for IN O
98 CD O
. . O

8 CD O
% NN O
of IN O
the DT O
Canavan NNP B-Disease
chromosomes NNS O
of IN O
Ashkenazi NNP O
Jewish NNP O
origin NN O
. . O

The DT O
ala305 NN O
- : O
- : O
> NN O
glu NN O
mutation NN O
was VBD O
found VBN O
exclusively RB O
in IN O
non JJ O
- : O
Jewish JJ O
probands NNS O
of IN O
European JJ O
descent NN O
and CC O
constituted VBD O
60 CD O
% NN O
of IN O
the DT O
40 CD O
mutant JJ O
chromosomes NNS O
. . O

Predominant JJ O
occurrence NN O
of IN O
certain JJ O
mutations NNS O
among IN O
Ashkenazi NNP O
Jewish NNP O
and CC O
non SYM O
- : O
Jewish JJ O
patients NNS O
with IN O
Canavan NNP B-Disease
disease NN I-Disease
would MD O
suggest VB O
a DT O
founding JJ O
- : O
father NN O
effect NN O
in IN O
propagation NN O
of IN O
these DT O
mutant JJ O
chromosomes NNS O

Intelligence NNP O
quotient NN O
profile NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
, , O
intergenerational JJ O
deficit NN O
, , O
and CC O
correlation NN O
with IN O
CTG NNP O
amplification NN O
. . O

An DT O
abbreviated JJ O
Wechsler NNP O
Adult NNP O
Intelligence NNP O
Scale NNP O
Revised VBD O
( ( O
WAIS NNP O
- : O
R NN O
) ) O
was VBD O
used VBN O
to TO O
assess VB O
verbal JJ O
and CC O
arithmetical JJ O
cognitive JJ O
performance NN O
in IN O
55 CD O
subjects NNS O
with IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
, , O
covering VBG O
all DT O
grades NNS O
of IN O
disease NN O
severity NN O
, , O
and CC O
31 CD O
controls NNS O
at IN O
50 CD O
% NN O
risk NN O
of IN O
inheriting VBG O
DM NNP B-Disease
. . O

Scaled JJ O
scores NNS O
from IN O
the DT O
assessment NN O
were VBD O
converted VBN O
into IN O
an DT O
intelligence NN O
quotient NN O
( ( O
IQ NNP O
) ) O
estimation NN O
on IN O
each DT O
person NN O
. . O

Significant JJ O
IQ NNP O
differences NNS O
were VBD O
found VBN O
between IN O
( ( O
1 CD O
) ) O
all DT O
55 CD O
DM NNP B-Disease
subjects NNS O
( ( O
mean JJ O
90 CD O
. . O
2 CD O
, , O
SD NNP O
16 CD O
. . O
1 CD O
) ) O
and CC O
31 CD O
controls NNS O
( ( O
102 CD O
. . O
6 CD O
, , O
SD NNP O
9 CD O
. . O
4 CD O
) ) O
, , O
with IN O
no DT O
sex NN O
differences NNS O
in IN O
either DT O
group NN O
; : O
( ( O
2 CD O
) ) O
15 CD O
affected JJ O
parents NNS O
( ( O
99 CD O
. . O
3 CD O
, , O
SD NNP O
12 CD O
. . O
2 CD O
) ) O
and CC O
their PRP$ O
affected JJ O
children NNS O
( ( O
88 CD O
. . O
1 CD O
, , O
SD NNP O
17 CD O
. . O
2 CD O
) ) O
, , O
where WRB O
significance NN O
was VBD O
dependent JJ O
on IN O
parental JJ O
sex NN O
being VBG O
female JJ O
; : O
and CC O
( ( O
3 CD O
) ) O
15 CD O
pairs NNS O
of IN O
affected JJ O
sibs NN O
( ( O
89 CD O
. . O
6 CD O
, , O
SD NNP O
13 CD O
. . O
2 CD O
) ) O
and CC O
their PRP$ O
normal JJ O
sibs NN O
( ( O
100 CD O
. . O
2 CD O
, , O
SD NNP O
7 CD O
. . O
6 CD O
) ) O
. . O

IQ NNP O
steadily RB O
declined VBD O
as IN O
( ( O
1 CD O
) ) O
the DT O
age NN O
of IN O
onset NN O
of IN O
signs NNS O
and CC O
symptoms NNS O
decreased VBN O
, , O
and CC O
( ( O
2 CD O
) ) O
the DT O
CTG NNP O
expansion NN O
size NN O
increased VBD O
. . O

The DT O
correlation NN O
appeared VBD O
to TO O
be VB O
more JJR O
linear JJ O
with IN O
age NN O
of IN O
onset NN O
. . O

The DT O
correlation NN O
of IN O
IQ NNP O
difference NN O
and CC O
CTG NNP O
expansion NN O
difference NN O
in IN O
both CC O
the DT O
DM NNP B-Disease
parent NN O
- : O
child NN O
pairs NNS O
and CC O
normal JJ O
sib NN O
- : O
affected JJ O
sib NN O
pairs NN O
was VBD O
poor JJ O
, , O
indicating VBG O
that IN O
CTG NNP O
expansion NN O
is VBZ O
not RB O
a DT O
reliable JJ O
predictor NN O
of IN O
IQ NNP O
either CC O
in IN O
individual JJ O
persons NNS O
or CC O
families NNS O
. . O

Further JJ O
analysis NN O
of IN O
cognitive JJ O
function NN O
in IN O
DM NNP B-Disease
is VBZ O
required VBN O
to TO O
clarify VB O
specific JJ O
deficits NNS O
characteristic JJ O
of IN O
this DT O
patient NN O
group NN O

Adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
and CC O
a DT O
cytogenetic JJ O
deletion NN O
of IN O
chromosome NN O
5 CD O
resulting VBG O
from IN O
a DT O
maternal JJ O
intrachromosomal JJ O
insertion NN O
. . O

We PRP O
present VBP O
the DT O
clinical JJ O
and CC O
laboratory JJ O
findings NNS O
in IN O
an DT O
institutionalised JJ O
adult NN O
patient NN O
originally RB O
referred VBN O
for IN O
autism NN B-Disease
. . O

A DT O
high JJ O
risk NN O
of IN O
colorectal JJ B-Disease
cancer NN I-Disease
was VBD O
predicted VBN O
when WRB O
an DT O
interstitial JJ O
deletion NN O
of IN O
the DT O
long JJ O
arm NN O
of IN O
chromosome NN O
5 CD O
, , O
del NN O
( ( O
5 CD O
) ) O
( ( O
q15q22 UH O
. . O
3 CD O
) ) O
, , O
was VBD O
detected VBN O
in IN O
her PRP$ O
lymphocytes NNS O
and CC O
deletion NN O
of IN O
the DT O
MCC NNP O
and CC O
APC NNP B-Disease
genes NNS O
confirmed VBN O
by IN O
molecular JJ O
analysis NN O
. . O

Adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
and CC O
carcinoma NN B-Disease
of IN I-Disease
the DT I-Disease
rectum NN I-Disease
were VBD O
subsequently RB O
diagnosed VBN O
in IN O
the DT O
patient NN O
. . O

She PRP O
was VBD O
profoundly RB O
mentally RB B-Disease
retarded JJ I-Disease
, , O
autistic JJ B-Disease
, , O
and CC O
had VBD O
minor JJ O
dysmorphic JJ B-Disease
features NNS I-Disease
consistent JJ O
with IN O
those DT O
of IN O
previous JJ O
patients NNS O
with IN O
similar JJ O
deletions NNS O
. . O

The DT O
deletion NN O
arose VBD O
as IN O
a DT O
result NN O
of IN O
recombination NN O
within IN O
the DT O
small JJ O
insertion NN O
loop NN O
formed VBN O
at IN O
meiosis NN O
by IN O
the DT O
direct JJ O
insertion NN O
( ( O
dir JJ O
ins NNS O
( ( O
5 CD O
) ) O
( ( O
q22 UH O
. . O
3q14 CD O
. . O
2q15 CD O
) ) O
) ) O
found VBN O
in IN O
the DT O
patients NNS O
mother NN O
. . O

This DT O
family NN O
further RB O
confirms VBZ O
the DT O
cytogenetic JJ O
mapping NN O
of IN O
both DT O
MCC NNP O
and CC O
APC NNP B-Disease
genes NNS O
to TO O
5q22 CD O
and CC O
comparison NN O
with IN O
other JJ O
recent JJ O
cases NNS O
suggests VBZ O
that IN O
both DT O
genes NNS O
and CC O
their PRP$ O
closely RB O
linked VBN O
markers NNS O
lie RBR O
within IN O
the DT O
5q22 CD O
. . O

1 CD O
subband NN O

Familial NNP B-Disease
male NN I-Disease
breast NN I-Disease
cancer NN I-Disease
is VBZ O
not RB O
linked VBN O
to TO O
the DT O
BRCA1 NNP O
locus NN O
on IN O
chromosome NN O
17q CD O
. . O

Breast NNP B-Disease
cancer NN I-Disease
in IN O
men NNS O
is VBZ O
about IN O
a DT O
hundredfold NN O
less JJR O
common JJ O
than IN O
in IN O
women NNS O
and CC O
this DT O
has VBZ O
hindered VBN O
research NN O
into IN O
its PRP$ O
genetic JJ O
basis NN O
. . O

We PRP O
have VBP O
examined VBN O
22 CD O
families NNS O
with IN O
at IN O
least JJS O
one CD O
case NN O
of IN O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
for IN O
linkage NN O
to TO O
the DT O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
locus NN O
, , O
BRCA1 NNP O
, , O
on IN O
chromosome NN O
17q CD O
. . O

We PRP O
found VBD O
strong JJ O
evidence NN O
against IN O
linkage NN O
to TO O
BRCA1 NNP O
( ( O
lod JJ O
score NN O
- : O
16 CD O
. . O
63 CD O
) ) O
and CC O
the DT O
best JJS O
estimate NN O
of IN O
the DT O
proportion NN O
of IN O
linked JJ O
families NNS O
was VBD O
0 CD O
% NN O
( ( O
95 CD O
% NN O
CI NNP O
0 CD O
- : O
18 CD O
% NN O
) ) O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
there EX O
is VBZ O
a DT O
gene NN O
( ( O
s PRP O
) ) O
other JJ O
than IN O
BRCA1 NNP O
which WDT O
predisposes VBZ O
to TO O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
in IN O
women NNS O
and CC O
which WDT O
confers VBZ O
a DT O
higher JJR O
risk NN O
of IN O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O

Identification NN O
of IN O
additional JJ O
pedigrees NNS O
that IN O
include VBP O
cases NNS O
of IN O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
may MD O
therefore VB O
facilitate VB O
the DT O
mapping NN O
and CC O
isolation NN O
of IN O
this DT O
gene NN O
. . O

The DT O
EWS NNP O
gene NN O
, , O
involved VBN O
in IN O
Ewing NNP B-Disease
family NN I-Disease
of IN I-Disease
tumors NNS I-Disease
, , O
malignant JJ B-Disease
melanoma NN I-Disease
of IN I-Disease
soft JJ I-Disease
parts NNS I-Disease
and CC O
desmoplastic JJ B-Disease
small JJ I-Disease
round NN I-Disease
cell NN I-Disease
tumors NNS I-Disease
, , O
codes NNS O
for IN O
an DT O
RNA NNP O
binding NN O
protein NN O
with IN O
novel JJ O
regulatory JJ O
domains NNS O
. . O

The DT O
EWS NNP O
gene NN O
, , O
which WDT O
maps VBZ O
to TO O
band VB O
q12 NN O
of IN O
human JJ O
chromosome NN O
22 CD O
, , O
is VBZ O
involved VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
human JJ O
solid JJ B-Disease
tumors NNS I-Disease
including VBG O
Ewing NNP B-Disease
sarcoma NN I-Disease
, , O
related JJ O
primitive JJ O
neuroectodermal JJ B-Disease
tumors NNS I-Disease
, , O
malignant JJ B-Disease
melanoma NN I-Disease
of IN I-Disease
soft JJ I-Disease
parts NNS I-Disease
and CC O
desmoplastic JJ B-Disease
small JJ I-Disease
round NN I-Disease
cell NN I-Disease
tumors NNS I-Disease
. . O

In IN O
these DT O
tumors NNS B-Disease
, , O
the DT O
EWS NNP O
is VBZ O
fused VBN O
to TO O
genes NNS O
encoding VBG O
transcriptional JJ O
activators NNS O
/ VBP O
repressors NNS O
, , O
like IN O
Fli NNP O
- : O
1 CD O
or CC O
erg VB O
or CC O
ATF VB O
1 CD O
or CC O
wt1 NN O
. . O

To TO O
better RBR O
understand VB O
the DT O
function NN O
of IN O
the DT O
EWS NNP O
protein NN O
, , O
we PRP O
cloned VBD O
the DT O
EWS NNP O
cDNA NN O
. . O

Sequence NNP O
analysis NN O
of IN O
this DT O
cDNA NN O
revealed VBD O
differential JJ O
splicing VBG O
involving VBG O
two CD O
exons NNS O
encoding VBG O
72 CD O
amino JJ O
acids NNS O
. . O

Both DT O
alternatively RB O
spliced VBN O
transcripts NNS O
, , O
EWS NNP O
and CC O
EWS NNP O
- : O
b NN O
, , O
are VBP O
expressed VBN O
in IN O
a DT O
variety NN O
of IN O
cells NNS O
. . O

Because IN O
EWS NNP O
proteins VBZ O
contain VBP O
putative JJ O
conserved VBN O
RNA NNP O
binding VBG O
motifs NNS O
, , O
we PRP O
studied VBD O
the DT O
RNA NNP O
binding NN O
properties NNS O
of IN O
the DT O
EWS NNP O
protein NN O
. . O

The DT O
EWS NNP O
- : O
b NN O
protein NN O
binds VBZ O
to TO O
RNA VB O
in IN O
vitro NN O
and CC O
, , O
specifically RB O
, , O
to TO O
poly VB O
G NNP O
and CC O
poly JJ O
U NNP O
. . O

The DT O
RNA NNP O
binding NN O
activity NN O
was VBD O
localized VBN O
to TO O
the DT O
carboxy JJ O
terminal NN O
86 CD O
amino NN O
acids NNS O
, , O
which WDT O
constitute VBP O
RGG NNP O
box NN O
. . O

Thus RB O
the DT O
amino JJ O
terminal JJ O
domain NN O
of IN O
EWS NNP O
( ( O
NTD NNP O
- : O
EWS NN O
) ) O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
chromosome NN O
translocation NN O
may MD O
regulate VB O
the DT O
specificity NN O
of IN O
RNA NNP O
binding VBG O
activity NN O
of IN O
EWS NNP O
. . O

An DT O
EWS NNP O
- : O
erg NN O
chimeric JJ O
protein NN O
, , O
which WDT O
is VBZ O
found VBN O
in IN O
Ewings NNP B-Disease
sarcoma NN I-Disease
cells NNS O
, , O
functions NNS O
as IN O
a DT O
transcriptional JJ O
activator NN O
. . O

Mutational JJ O
analysis NN O
of IN O
EWS NNP O
- : O
erg NN O
chimeric JJ O
protein NN O
revealed VBD O
that IN O
NTD NNP O
- : O
EWS JJ O
functions NNS O
as IN O
a DT O
regulatory JJ O
domain NN O
for IN O
the DT O
transcriptional JJ O
activation NN O
properties NNS O
of IN O
EWS NNP O
- : O
erg NN O
chimeric JJ O
protein NN O
. . O
. . O

Canavan NNP B-Disease
disease NN I-Disease
: : O
genomic JJ O
organization NN O
and CC O
localization NN O
of IN O
human JJ O
ASPA NNP O
to TO O
17p13 CD O
- : O
ter NN O
and CC O
conservation NN O
of IN O
the DT O
ASPA NNP O
gene NN O
during IN O
evolution NN O
. . O

Canavan NNP B-Disease
disease NN I-Disease
, , O
or CC O
spongy JJ B-Disease
degeneration NN I-Disease
of IN I-Disease
the DT I-Disease
brain NN I-Disease
, , O
is VBZ O
a DT O
severe JJ O
leukodystrophy NN B-Disease
caused VBN O
by IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
aspartoacylase NN I-Disease
( ( O
ASPA NNP O
) ) O
. . O

Recently RB O
, , O
a DT O
missense NN O
mutation NN O
was VBD O
identified VBN O
in IN O
human JJ O
ASPA NNP O
coding VBG O
sequence NN O
from IN O
patients NNS O
with IN O
Canavan NNP B-Disease
disease NN I-Disease
. . O

The DT O
human JJ O
ASPA NNP O
gene NN O
has VBZ O
been VBN O
cloned VBN O
and CC O
found VBN O
to TO O
span VB O
29 CD O
kb NN O
of IN O
the DT O
genome NN O
. . O

Human JJ O
aspartoacylase NN O
is VBZ O
coded VBN O
by IN O
six CD O
exons NNS O
intervened VBN O
by IN O
five CD O
introns NNS O
. . O

The DT O
exons NNS O
vary VBP O
from IN O
94 CD O
( ( O
exon VB O
III NNP O
) ) O
to TO O
514 CD O
( ( O
exon VB O
VI NNP O
) ) O
bases NNS O
. . O

The DT O
exon NN O
/ NNP O
intron NN O
splice NN O
junction NN O
sites VBZ O
follow VBP O
the DT O
gt NN O
/ NNP O
ag VBZ O
consensus NN O
sequence NN O
rule NN O
. . O

Southern NNP O
blot NN O
analysis NN O
of IN O
genomic JJ O
DNA NN O
from IN O
human JJ O
/ NN O
mouse NN O
somatic JJ O
cell NN O
hybrid NN O
cell NN O
lines NNS O
localized VBD O
ASPA NNP O
to TO O
human JJ O
chromosome NN O
17 CD O
. . O

The DT O
human JJ O
ASPA NNP O
locus NN O
was VBD O
further RBR O
mapped VBN O
in IN O
the DT O
17p13 CD O
- : O
ter NN O
region NN O
by IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
. . O

The DT O
bovine NN O
aspa NN O
gene NN O
has VBZ O
also RB O
been VBN O
cloned VBN O
, , O
and CC O
its PRP$ O
exon NN O
/ NNP O
intron NN O
organization NN O
is VBZ O
identical JJ O
to TO O
that DT O
of IN O
the DT O
human JJ O
gene NN O
. . O

The DT O
500 CD O
- : O
base NN O
sequence NN O
upstream NN O
of IN O
the DT O
initiator NN O
ATG NNP O
codon NN O
in IN O
the DT O
human JJ O
gene NN O
and CC O
that IN O
in IN O
the DT O
bovine NN O
gene NN O
are VBP O
77 CD O
% NN O
identical JJ O
. . O

Human NNP O
ASPA NNP O
coding VBG O
sequences NNS O
cross SYM O
- : O
hybridize NN O
with IN O
genomic JJ O
DNA NN O
from IN O
yeast NN O
, , O
chicken NN O
, , O
rabbit NN O
, , O
cow NN O
, , O
dog NN O
, , O
mouse NN O
, , O
rat NN O
, , O
and CC O
monkey NN O
. . O

The DT O
specificity NN O
of IN O
cross NN O
- : O
species NNS O
hybridization NN O
of IN O
coding VBG O
sequences NNS O
suggests VBZ O
that IN O
aspartoacylase NN O
has VBZ O
been VBN O
conserved VBN O
during IN O
evolution NN O
. . O

It PRP O
should MD O
now RB O
be VB O
possible JJ O
to TO O
identify VB O
mutations NNS O
in IN O
the DT O
noncoding JJ O
genomic JJ O
sequences NNS O
that WDT O
lead VBP O
to TO O
Canavan NNP B-Disease
disease NN I-Disease
and CC O
to TO O
study VB O
the DT O
regulation NN O
of IN O
ASPA NNP O
. . O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
: : O
size NN O
- : O
and CC O
sex NN O
- : O
dependent JJ O
dynamics NNS O
of IN O
CTG NNP O
meiotic JJ O
instability NN O
, , O
and CC O
somatic JJ O
mosaicism NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
a DT O
progressive JJ O
neuromuscular NN B-Disease
disorder NN I-Disease
which WDT O
results NNS O
from IN O
elongations NNS O
of IN O
an DT O
unstable JJ O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
, , O
located VBN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
the DT O
DM NNP B-Disease
gene NN O
. . O

A DT O
correlation NN O
has VBZ O
been VBN O
demonstrated VBN O
between IN O
the DT O
increase NN O
in IN O
the DT O
repeat NN O
number NN O
of IN O
this DT O
sequence NN O
and CC O
the DT O
severity NN O
of IN O
the DT O
disease NN O
. . O

However RB O
, , O
the DT O
clinical JJ O
status NN O
of IN O
patients NNS O
cannot JJ O
be VB O
unambiguously RB O
ascertained VBN O
solely RB O
on IN O
the DT O
basis NN O
of IN O
the DT O
number NN O
of IN O
CTG NNP O
repeats NNS O
. . O

Moreover RB O
, , O
the DT O
exclusive JJ O
maternal JJ O
inheritance NN O
of IN O
the DT O
congenital JJ O
form NN O
remains VBZ O
unexplained JJ O
. . O

Our PRP$ O
observation NN O
of IN O
differently RB O
sized VBN O
repeats NNS O
in IN O
various JJ O
DM NNP B-Disease
tissues NNS O
from IN O
the DT O
same JJ O
individual NN O
may MD O
explain VB O
why WRB O
the DT O
size NN O
of IN O
the DT O
mutation NN O
observed VBD O
in IN O
lymphocytes NNS O
does VBZ O
not RB O
necessarily RB O
correlate VB O
with IN O
the DT O
severity NN O
and CC O
nature NN O
of IN O
symptoms NNS O
. . O

Through IN O
a DT O
molecular JJ O
and CC O
genetic JJ O
study NN O
of IN O
142 CD O
families NNS O
including VBG O
418 CD O
DM NNP B-Disease
patients NNS O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
dynamics NNS O
of IN O
the DT O
CTG NNP O
repeat NN O
meiotic JJ O
instability NN O
. . O

A DT O
positive JJ O
correlation NN O
between IN O
the DT O
size NN O
of IN O
the DT O
repeat NN O
and CC O
the DT O
intergenerational JJ O
enlargement NN O
was VBD O
observed VBN O
similarly RB O
through IN O
male NN O
and CC O
female JJ O
meioses NNS O
for IN O
< NN O
or CC O
= $ O
0 CD O
. . O

5 CD O
- : O
kb NN O
CTG NNP O
sequences NNS O
. . O

Beyond IN O
0 CD O
. . O

5 CD O
kb NN O
, , O
the DT O
intergenerational JJ O
variation NN O
was VBD O
more RBR O
important JJ O
through IN O
female JJ O
meioses NNS O
, , O
whereas IN O
a DT O
tendency NN O
to TO O
compression NN O
was VBD O
observed VBN O
almost RB O
exclusively RB O
in IN O
male NN O
meioses NNS O
, , O
for IN O
> NN O
or CC O
= $ O
1 CD O
. . O

5 CD O
- : O
kb NN O
fragments NNS O
. . O

This DT O
implies VBZ O
a DT O
size NN O
- : O
and CC O
sex NN O
- : O
dependent JJ O
meiotic JJ O
instability NN O
. . O

Moreover RB O
, , O
segregation NN O
analysis NN O
supports VBZ O
the DT O
hypothesis NN O
of IN O
a DT O
maternal JJ O
as RB O
well RB O
as IN O
a DT O
familial JJ O
predisposition NN O
for IN O
the DT O
occurrence NN O
of IN O
the DT O
congenital JJ O
form NN O
. . O

Finally RB O
, , O
this DT O
analysis NN O
reveals VBZ O
a DT O
significant JJ O
excess NN O
of IN O
transmitting VBG O
grandfathers NNS O
partially RB O
accounted VBN O
for IN O
by IN O
increased JJ O
fertility NN O
in IN O
affected JJ O
males NNS O

Illegitimate NNP O
transcription NN O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
gene NN O
in IN O
lymphocytes NNS O
for IN O
identification NN O
of IN O
mutations NNS O
in IN O
phenylketonuria NN B-Disease
. . O

Taking VBG O
advantage NN O
of IN O
the DT O
illegitimate JJ O
transcription NN O
of IN O
the DT O
phenylalanine NN O
hydroxylase NN O
( ( O
PAH NNP O
) ) O
gene NN O
, , O
we PRP O
have VBP O
been VBN O
able JJ O
to TO O
analyse VB O
the DT O
PAH NNP O
cDNA NN O
sequence NN O
of IN O
hyperphenylalaninemic JJ B-Disease
children NNS O
in IN O
circulating VBG O
lymphocytes NNS O
. . O

Using VBG O
this DT O
approach NN O
, , O
we PRP O
have VBP O
also RB O
identified VBN O
3 CD O
novel JJ O
mutations NNS O
in IN O
cDNA NN O
from IN O
liver NN O
and CC O
lymphocytes NNS O
of IN O
two CD O
patients NNS O
. . O

One CD O
mutation NN O
, , O
detected VBN O
by IN O
the DT O
abnormal JJ O
pattern NN O
of IN O
migration NN O
of IN O
an DT O
amplified JJ O
fragment NN O
, , O
is VBZ O
a DT O
C NNP O
to TO O
T NNP O
transition NN O
in IN O
the DT O
splice NN O
acceptor NN O
site NN O
of IN O
intron NN O
10 CD O
, , O
which WDT O
resulted VBD O
in IN O
the DT O
skipping NN O
of IN O
exon $ O
11 CD O
with IN O
the DT O
premature JJ O
termination NN O
of IN O
RNA NNP O
translation NN O
downstream NN O
from IN O
exon JJ O
12 CD O
( ( O
- : O
3 CD O
IVS10 NNP O
) ) O
. . O

The DT O
other JJ O
two CD O
mutations NNS O
are VBP O
missense JJ O
mutations NNS O
in IN O
exons NNS O
10 CD O
and CC O
11 CD O
( ( O
respectively RB O
, , O
L333F NNP O
and CC O
E390G NNP O
) ) O
. . O

The DT O
present JJ O
study NN O
supports VBZ O
the DT O
view NN O
that IN O
circulating VBG O
lymphocytes NNS O
give VBP O
easy JJ O
access NN O
to TO O
PAH NNP O
gene NN O
transcripts NNS O
whose WP$ O
nucleotide JJ O
sequence NN O
is VBZ O
identical JJ O
to TO O
that DT O
reported VBN O
in IN O
liver NN O
and CC O
therefore RB O
represent VB O
a DT O
useful JJ O
tool NN O
for IN O
molecular JJ O
genetic JJ O
studies NNS O
in IN O
phenylketonuria NN B-Disease
. . O
. . O

High JJ O
residual JJ O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
activity NN O
in IN O
a DT O
patient NN O
with IN O
late JJ B-Disease
- : I-Disease
infantile JJ I-Disease
metachromatic JJ I-Disease
leukodystrophy NN I-Disease
. . O

We PRP O
identified VBD O
a DT O
patient JJ O
suffering NN O
from IN O
late JJ B-Disease
- : I-Disease
infantile JJ I-Disease
metachromatic JJ I-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
who WP O
has VBZ O
a DT O
residual JJ O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
activity NN O
of IN O
about RB O
10 CD O
% NN O
. . O

Fibroblasts NNS O
of IN O
the DT O
patient NN O
show NN O
significant JJ O
sulfatide JJ O
degradation NN O
activity NN O
exceeding VBG O
that IN O
of IN O
adult NN B-Disease
MLD NNP I-Disease
patients NNS O
. . O

Analysis NN O
of IN O
the DT O
ARSA NNP O
gene NN O
in IN O
this DT O
patient NN O
revealed VBD O
heterozygosity NN O
for IN O
two CD O
new JJ O
mutant JJ O
alleles NNS O
in IN O
one CD O
allele NN O
, , O
deletion NN O
of IN O
C NNP O
447 CD O
in IN O
exon NN O
2 CD O
leads VBZ O
to TO O
a DT O
frameshift NN O
and CC O
to TO O
a DT O
premature NN O
stop NN O
codon NN O
at IN O
amino NN O
acid JJ O
position NN O
105 CD O
; : O
in IN O
the DT O
second JJ O
allele NN O
, , O
a DT O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
in IN O
exon $ O
5 CD O
causes VBZ O
a DT O
Gly309 NNP O
- : O
- : O
> NN O
Ser NNP O
substitution NN O
. . O

Transient JJ O
expression NN O
of IN O
the DT O
mutant JJ O
Ser309 NNP O
- : O
ARSA NNP O
resulted VBD O
in IN O
only RB O
13 CD O
% NN O
enzyme JJ O
activity NN O
of IN O
that DT O
observed VBD O
in IN O
cells NNS O
expressing VBG O
normal JJ O
ARSA NNP O
. . O

The DT O
mutant JJ O
ARSA NNP O
is VBZ O
correctly RB O
targeted VBN O
to TO O
the DT O
lysosomes NNS O
but CC O
is VBZ O
unstable JJ O
. . O

These DT O
findings NNS O
are VBP O
in IN O
contrast NN O
to TO O
previous JJ O
results NNS O
showing VBG O
that IN O
the DT O
late JJ B-Disease
- : I-Disease
infantile JJ I-Disease
type NN I-Disease
of IN I-Disease
MLD NNP I-Disease
is VBZ O
always RB O
associated VBN O
with IN O
the DT O
complete JJ O
absence NN O
of IN O
ARSA NNP O
activity NN O
. . O

The DT O
expression NN O
of IN O
the DT O
mutant JJ O
ARSA NNP O
protein NN O
may MD O
be VB O
influenced VBN O
by IN O
particular JJ O
features NNS O
of IN O
oligodendrocytes NNS O
, , O
such JJ O
that IN O
the DT O
level NN O
of IN O
mutant JJ O
enzyme NN O
is VBZ O
lower JJR O
in IN O
these DT O
cells NNS O
than IN O
in IN O
others NNS O
. . O
. . O

An DT O
arylsulfatase NN O
A NNP O
( ( O
ARSA NNP O
) ) O
missense NN O
mutation NN O
( ( O
T274M NNP O
) ) O
causing VBG O
late JJ B-Disease
- : I-Disease
infantile JJ I-Disease
metachromatic JJ I-Disease
leukodystrophy NN I-Disease
. . O

Metachromatic JJ B-Disease
leukodystrophy NN I-Disease
( ( O
MLD NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive NN I-Disease
lysosomal JJ I-Disease
storage NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
arylsulfatase NN I-Disease
A NNP I-Disease
( ( O
ARSA NNP O
; : O
EC NNP O
3 CD O
. . O
1 CD O
. . O
6 CD O
. . O
8 CD O
) ) O
. . O

The DT O
8 CD O
ARSA NNP O
exons NNS O
and CC O
adjacent JJ O
intron NN O
boundaries NNS O
from IN O
a DT O
patient NN O
with IN O
late JJ B-Disease
- : I-Disease
infantile JJ I-Disease
metachromatic JJ I-Disease
leukodystrophy NN I-Disease
were VBD O
polymerase JJ O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
amplified VBD O
in IN O
seven CD O
discrete JJ O
reactions NNS O
. . O

Amplified NNP O
ARSA NNP O
exons NNS O
were VBD O
analysed VBN O
for IN O
the DT O
presence NN O
of IN O
sequence NN O
alterations NNS O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
, , O
followed VBN O
by IN O
direct JJ O
sequencing NN O
of IN O
PCR NNP O
products NNS O
. . O

The DT O
patient NN O
was VBD O
found VBN O
to TO O
be VB O
homozygous JJ O
for IN O
a DT O
C NNP O
- : O
- : O
> NN O
T NNP O
transition NN O
in IN O
exon JJ O
IV NNP O
that WDT O
results NNS O
in IN O
the DT O
substitution NN O
of IN O
a DT O
highly RB O
conserved VBN O
threonine NN O
residue NN O
at IN O
amino NN O
acid VBP O
274 CD O
with IN O
a DT O
methionine NN O
( ( O
T274M NNP O
) ) O
. . O

Analysis NN O
of IN O
a DT O
further JJ O
29 CD O
MLD NNP B-Disease
patients NNS O
revealed VBD O
the DT O
presence NN O
of IN O
five CD O
additional JJ O
homozygotes NNS O
for IN O
T274M NNP O
. . O

All DT O
6 CD O
T274M NNP O
homozygotes NNS O
( ( O
representing VBG O
four CD O
families NNS O
) ) O
were VBD O
of IN O
Lebanese JJ O
descent NN O
, , O
and CC O
all DT O
were VBD O
known VBN O
to TO O
be VB O
the DT O
result NN O
of IN O
consanguineous JJ O
marriages NNS O
. . O

The DT O
altered JJ O
amino NN O
acid NN O
is VBZ O
rigidly RB O
conserved VBN O
among IN O
10 CD O
sulfatases NNS O
from IN O
Escherichia NNP O
coli NNS O
to TO O
humans NNS O
; : O
therefore RB O
, , O
it PRP O
is VBZ O
most RBS O
likely JJ O
that IN O
the DT O
resultant NN O
mutant NN O
protein NN O
will MD O
have VB O
little JJ O
or CC O
no DT O
enzyme JJ O
activity NN O
. . O

This DT O
is VBZ O
consistent JJ O
with IN O
the DT O
very RB O
low JJ O
ARSA NNP O
activity NN O
measured VBN O
in IN O
these DT O
patients NNS O
and CC O
their PRP$ O
uniformly NN O
severe RB O
clinical JJ O
presentation NN O

Mutations NNS O
in IN O
the DT O
PAX6 NNP O
gene NN O
in IN O
patients NNS O
with IN O
hereditary JJ O
aniridia NN B-Disease
. . O

The DT O
14 CD O
exons NNS O
of IN O
the DT O
PAX6 NNP O
gene NN O
have VBP O
been VBN O
analysed VBN O
exon SYM O
- : O
by IN O
- : O
exon NN O
using VBG O
SSCP NNP O
in IN O
6 CD O
aniridia JJ B-Disease
families NNS O
. . O

In IN O
each DT O
family NN O
band NN O
shifts NNS O
were VBD O
observed VBN O
on IN O
the DT O
SSCP NNP O
gels NNS O
for IN O
only RB O
one CD O
exon NN O
and CC O
direct JJ O
PCR NNP O
- : O
sequencing NN O
revealed VBD O
mutations NNS O
in IN O
each DT O
case NN O
. . O

Two CD O
mutations NNS O
involved VBN O
C NNP O
- : O
- : O
> NN O
T NNP O
transitions NNS O
in IN O
CGAarg NNP O
codons NNS O
in IN O
exons NNS O
9 CD O
and CC O
11 CD O
. . O

Another DT O
C NNP O
- : O
- : O
> NN O
T NNP O
transition NN O
converted VBD O
a DT O
CAG NNP O
- : O
glutamine NN O
to TO O
a DT O
TAG NNP O
- : O
stop NN O
in IN O
exon JJ O
7 CD O
. . O

Small JJ O
insertions NNS O
created VBN O
frameshifts NNS O
which WDT O
produced VBD O
downstream NN O
stop NN O
codons NNS O
in IN O
another DT O
two CD O
patients NNS O
and CC O
an DT O
A NNP O
- : O
- : O
> NN O
T NNP O
mutation NN O
disrupted VBD O
the DT O
splice NN O
donor NN O
site NN O
of IN O
exon JJ O
5 CD O
in IN O
the DT O
remaining VBG O
family NN O
. . O

Thus RB O
, , O
complete JJ O
inactivation NN O
of IN O
the DT O
PAX6 NNP O
gene NN O
is VBZ O
predicted VBN O
in IN O
all DT O
cases NNS O
. . O

Analysis NN O
of IN O
other JJ O
affected JJ O
members NNS O
of IN O
the DT O
families NNS O
showed VBD O
that IN O
, , O
in IN O
each DT O
case NN O
, , O
all DT O
affected JJ O
individuals NNS O
carried VBD O
the DT O
same JJ O
family NN O
- : O
specific JJ O
mutation NN O
. . O

One CD O
polymorphism NN O
was VBD O
found VBN O
in IN O
exon JJ O
7 CD O
. . O

This DT O
data NN O
strongly RB O
supports VBZ O
the DT O
candidature NN O
of IN O
PAX6 NNP O
as IN O
the DT O
gene NN O
responsible JJ O
for IN O
hereditary JJ O
aniridia NN B-Disease
. . O
. . O

Three CD O
novel JJ O
mutations NNS O
in IN O
five CD O
unrelated JJ O
subjects NNS O
with IN O
hereditary JJ O
protein NN B-Disease
S NNP I-Disease
deficiency NN I-Disease
type NN I-Disease
I PRP I-Disease
. . O

A DT O
panel NN O
of IN O
eight CD O
unrelated JJ O
subjects NNS O
with IN O
inherited JJ O
type NN B-Disease
I PRP I-Disease
protein VBP I-Disease
S JJ I-Disease
deficiency NN I-Disease
was VBD O
screened VBN O
for IN O
mutations NNS O
in IN O
the DT O
PROS1 NNP O
gene NN O
. . O

In IN O
five CD O
subjects NNS O
an DT O
abnormality NN O
was VBD O
found VBN O
but CC O
mutations NNS O
were VBD O
not RB O
detected VBN O
in IN O
the DT O
remaining VBG O
three CD O
subjects NNS O
. . O

Two CD O
subjects NNS O
shared VBD O
a DT O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
at IN O
position NN O
+ FW O
5 CD O
of IN O
the DT O
donor NN O
splice NN O
site NN O
consensus NN O
sequence NN O
of IN O
intron NN O
10 CD O
. . O

Also RB O
in IN O
two CD O
subjects NNS O
an DT O
A NNP O
- : O
- : O
> NN O
T NNP O
transversion NN O
was VBD O
detected VBN O
in IN O
the DT O
stopcodon NN O
of IN O
the DT O
PROS1 NNP O
gene NN O
; : O
this DT O
transversion NN O
predicts VBZ O
a DT O
protein NN O
S NNP O
molecule NN O
that WDT O
is VBZ O
extended VBN O
by IN O
14 CD O
amino JJ O
acids NNS O
. . O

The DT O
fifth NN O
subject NN O
was VBD O
found VBN O
to TO O
possess VB O
two CD O
sequence NN O
abnormalities NNS O
. . O

One CD O
allele NN O
carried VBD O
a DT O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
near IN O
the DT O
donor NN O
splice NN O
junction NN O
of IN O
intron NN O
2 CD O
, , O
but CC O
this DT O
abnormality NN O
is VBZ O
probably RB O
neutral JJ O
, , O
since IN O
it PRP O
was VBD O
inherited VBN O
from IN O
the DT O
parent NN O
with IN O
normal JJ O
protein NNS O
S NNP O
antigen NN O
levels NNS O
. . O

In IN O
the DT O
other JJ O
allele NN O
a DT O
single JJ O
T NNP O
insertion NN O
in IN O
codon JJ O
- : O
25 CD O
was VBD O
found VBN O
. . O

Analysis NN O
of IN O
platelet NN O
RNA NNP O
showed VBD O
that IN O
only RB O
the DT O
mRNA NN O
with IN O
the DT O
A NNP O
- : O
- : O
> NN O
T NNP O
mutation NN O
in IN O
the DT O
stopcodon NN O
is VBZ O
present JJ O
in IN O
amounts NNS O
comparable JJ O
to TO O
wildtype VB O
RNA NNP O
. . O

mRNA NN O
from IN O
the DT O
alleles NNS O
with IN O
the DT O
other JJ O
two CD O
mutations NNS O
was VBD O
either CC O
undetectable JJ O
or CC O
present JJ O
in IN O
greatly RB O
reduced JJ O
amounts NNS O
. . O

The DT O
latter JJ O
indicates VBZ O
that IN O
a DT O
mRNA NN O
based VBN O
approach NN O
is VBZ O
not RB O
feasible JJ O
for IN O
the DT O
genetic JJ O
analysis NN O
of IN O
protein NN B-Disease
S NNP I-Disease
deficiency NN I-Disease
type NN I-Disease
I PRP I-Disease
. . O
. . O

Characteristics NNS O
of IN O
intergenerational JJ O
contractions NNS O
of IN O
the DT O
CTG NNP O
repeat NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
. . O

In IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
, , O
the DT O
size NN O
of IN O
a DT O
CTG NNP O
repeat NN O
in IN O
the DT O
DM NNP B-Disease
kinase NN O
gene NN O
generally RB O
increases VBZ O
in IN O
successive JJ O
generations NNS O
with IN O
clinical JJ O
evidence NN O
of IN O
anticipation NN O
. . O

However RB O
, , O
there EX O
have VBP O
also RB O
been VBN O
cases NNS O
with IN O
an DT O
intergenerational JJ O
contraction NN O
of IN O
the DT O
repeat NN O
. . O

We PRP O
examined VBD O
1 CD O
, , O
489 CD O
DM NNP B-Disease
parent NN O
- : O
offspring VBG O
pairs NNS O
, , O
of IN O
which WDT O
95 CD O
( ( O
6 CD O
. . O
4 CD O
% NN O
) ) O
showed VBD O
such JJ O
contractions NNS O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
( ( O
PBL NNP O
) ) O
. . O

In IN O
56 CD O
of IN O
the DT O
95 CD O
pairs NNS O
, , O
clinical JJ O
data NN O
allowed VBD O
an DT O
analysis NN O
of IN O
their PRP$ O
anticipation NN O
status NN O
. . O

It PRP O
is VBZ O
surprising JJ O
that IN O
anticipation NN O
occurred VBD O
in IN O
27 CD O
( ( O
48 CD O
% NN O
) ) O
of IN O
these DT O
56 CD O
pairs NNS O
, , O
while IN O
none NN O
clearly RB O
showed VBD O
a DT O
later JJ O
onset NN O
of IN O
DM NNP B-Disease
in IN O
the DT O
symptomatic JJ O
offspring NN O
. . O

The DT O
contraction NN O
occurred VBD O
in IN O
76 CD O
( ( O
10 CD O
% NN O
) ) O
of IN O
753 CD O
paternal JJ O
transmissions NNS O
and CC O
in IN O
19 CD O
( ( O
3 CD O
% NN O
) ) O
of IN O
736 CD O
maternal JJ O
transmissions NNS O
. . O

Anticipation NN O
was VBD O
observed VBN O
more RBR O
frequently RB O
in IN O
maternal JJ O
( ( O
85 CD O
% NN O
) ) O
than IN O
in IN O
paternal JJ O
( ( O
37 CD O
% NN O
) ) O
transmissions NNS O
( ( O
P NNP O
< NNP O
. . O
1 CD O
) ) O
. . O

The DT O
parental JJ O
repeat NN O
size NN O
correlated VBN O
with IN O
the DT O
size NN O
of IN O
intergenerational JJ O
contraction NN O
( ( O
r2 JJ O
= NNP O
. . O
50 CD O
, , O
P NNP O
< NNP O
< NNP O
. . O
1 CD O
) ) O
, , O
and CC O
the DT O
slope NN O
of IN O
linear JJ O
regression NN O
was VBD O
steeper VBN O
in IN O
paternal NN O
( ( O
- : O
. . O
62 CD O
) ) O
than IN O
in IN O
maternal JJ O
( ( O
- : O
. . O
30 CD O
) ) O
transmissions NNS O
( ( O
P NNP O
< NNP O
< NNP O
. . O
1 CD O
) ) O
. . O

Sixteen NNP O
DM NNP B-Disease
parents NNS O
had VBD O
multiple JJ O
DM NNP B-Disease
offspring VBG O
with IN O
the DT O
CTG NNP O
repeat NN O
contractions NNS O
. . O

This DT O
frequency NN O
was VBD O
higher JJR O
than IN O
the DT O
frequency NN O
expected VBN O
from IN O
the DT O
probability NN O
of IN O
the DT O
repeat NN O
contractions NNS O
( ( O
6 CD O
. . O
4 CD O
% NN O
) ) O
and CC O
the DT O
size NN O
of IN O
DM NNP B-Disease
sib JJ O
population NN O
( ( O
1 CD O
. . O
54 CD O
DM NNP B-Disease
offspring VBG O
per IN O
DM NNP B-Disease
parent NN O
, , O
in IN O
968 CD O
DM NNP B-Disease
parents NNS O
) ) O
. . O

We PRP O
conclude VBP O
that IN O
( ( O
1 CD O
) ) O
intergenerational JJ O
contractions NNS O
of IN O
the DT O
CTG NNP O
repeat NN O
in IN O
leukocyte NN O
DNA NNP O
frequently RB O
accompanies VBZ O
apparent JJ O
anticipation NN O
, , O
especially RB O
when WRB O
DM NNP B-Disease
is VBZ O
maternally RB O
transmitted VBN O
, , O
and CC O
( ( O
2 CD O
) ) O
the DT O
paternal JJ O
origin NN O
of IN O
the DT O
repeat NN O
and CC O
the DT O
presence NN O
of IN O
the DT O
repeat NN O
contraction NN O
in IN O
a DT O
sibling JJ O
increase NN O
the DT O
probability NN O
of IN O
the DT O
CTG NNP O
repeat NN O
contraction NN O

Gonosomal JJ O
mosaicism NN O
in IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
patients NNS O
: : O
involvement NN O
of IN O
mitotic JJ O
events NNS O
in IN O
( ( O
CTG NNP O
) ) O
n RB O
repeat JJ O
variation NN O
and CC O
selection NN O
against IN O
extreme JJ O
expansion NN O
in IN O
sperm NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
caused VBN O
by IN O
abnormal JJ O
expansion NN O
of IN O
a DT O
polymorphic JJ O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
, , O
located VBN O
in IN O
the DT O
DM NNP B-Disease
protein NN O
kinase NN O
gene NN O
. . O

We PRP O
determined VBD O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat JJ O
lengths NNS O
in IN O
a DT O
broad JJ O
range NN O
of IN O
tissue NN O
DNAs NNP O
from IN O
patients NNS O
with IN O
mild JJ O
, , O
classical JJ O
, , O
or CC O
congenital JJ O
manifestation NN O
of IN O
DM NNP B-Disease
. . O

Differences NNS O
in IN O
the DT O
repeat NN O
length NN O
were VBD O
seen VBN O
in IN O
somatic JJ O
tissues NNS O
from IN O
single JJ O
DM NNP B-Disease
individuals NNS O
and CC O
twins NNS O
. . O

Repeats NNS O
appeared VBD O
to TO O
expand VB O
to TO O
a DT O
similar JJ O
extent NN O
in IN O
tissues NNS O
originating VBG O
from IN O
the DT O
same JJ O
embryonal JJ O
origin NN O
. . O

In IN O
most JJS O
male JJ O
patients NNS O
carrying VBG O
intermediate JJ O
- : O
or CC O
small JJ O
- : O
sized JJ O
expansions NNS O
in IN O
blood NN O
, , O
the DT O
repeat NN O
lengths NNS O
covered VBD O
a DT O
markedly RB O
wider NN O
range NN O
in IN O
sperm NN O
. . O

In IN O
contrast NN O
, , O
male JJ O
patients NNS O
with IN O
large JJ O
allele JJ O
expansions NNS O
in IN O
blood NN O
( ( O
> JJ O
700 CD O
CTGs NNP O
) ) O
had VBD O
similar JJ O
or CC O
smaller JJR O
repeats NNS O
in IN O
sperm NN O
, , O
when WRB O
detectable NN O
. . O

Sperm NNP O
alleles VBZ O
with IN O
> JJ O
1 CD O
, , O
0 CD O
CTGs NNP O
were VBD O
not RB O
seen VBN O
. . O

We PRP O
conclude VBP O
that IN O
DM NNP B-Disease
patients NNS O
can MD O
be VB O
considered VBN O
gonosomal JJ O
mosaics NNS O
, , O
i NN O
. . O

e NN O
e NN O
. . O
, , O
combined VBN O
somatic JJ O
and CC O
germ JJ O
- : O
line NN O
tissue NN O
mosaics NNS O
. . O

Most JJS O
remarkably RB O
, , O
we PRP O
observed VBD O
multiple JJ O
cases NNS O
where WRB O
the DT O
length NN O
distributions NNS O
of IN O
intermediate JJ O
- : O
or CC O
small JJ O
- : O
sized JJ O
alleles NNS O
in IN O
fathers NNS O
sperm VBP O
were VBD O
significantly RB O
different JJ O
from IN O
that DT O
in IN O
their PRP$ O
offsprings NNS O
blood NN O
. . O

Our PRP$ O
combined JJ O
findings NNS O
indicate VBP O
that IN O
intergenerational JJ O
length NN O
changes NNS O
in IN O
the DT O
unstable JJ O
CTG NNP O
repeat NN O
are VBP O
most RBS O
likely JJ O
to TO O
occur VB O
during IN O
early JJ O
embryonic JJ O
mitotic JJ O
divisions NNS O
in IN O
both DT O
somatic JJ O
and CC O
germ JJ O
- : O
line NN O
tissue NN O
formation NN O
. . O

Both DT O
the DT O
initial JJ O
CTG NNP O
length NN O
, , O
the DT O
overall JJ O
number NN O
of IN O
cell NN O
divisions NNS O
involved VBN O
in IN O
tissue NN O
formation NN O
, , O
and CC O
perhaps RB O
a DT O
specific JJ O
selection NN O
process NN O
in IN O
spermatogenesis NN O
may MD O
influence VB O
the DT O
dynamics NNS O
of IN O
this DT O
process NN O
. . O

A DT O
model NN O
explaining VBG O
mitotic JJ O
instability NN O
and CC O
sex NN O
- : O
dependent JJ O
segregation NN O
phenomena NN O
in IN O
DM NNP B-Disease
manifestation NN O
is VBZ O
discussed VBN O

Regionally RB O
clustered VBN O
APC NNP B-Disease
mutations NNS O
are VBP O
associated VBN O
with IN O
a DT O
severe JJ O
phenotype NN O
and CC O
occur NN O
at IN O
a DT O
high JJ O
frequency NN O
in IN O
new JJ O
mutation NN O
cases NNS O
of IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
. . O

Germline NNP O
mutation NN O
in IN O
APC NNP O
at IN O
5q21 CD O
- : O
22 CD O
results NNS O
in IN O
the DT O
dominantly RB O
inherited VBN O
syndrome RB O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
. . O

Somatic JJ O
mutation NN O
in IN O
this DT O
gene NN O
is VBZ O
an DT O
early JJ O
event NN O
in IN O
colorectal JJ O
tumourigenesis NN O
. . O

Both DT O
types NNS O
of IN O
mutation NN O
are VBP O
concentrated VBN O
in IN O
the DT O
5 CD O
half NN O
of IN O
exon JJ O
15 CD O
. . O

We PRP O
have VBP O
used VBN O
single JJ O
strand NN O
conformational JJ O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
and CC O
heteroduplex JJ O
analysis NN O
to TO O
screen VB O
for IN O
variants NNS O
in IN O
this DT O
region NN O
of IN O
the DT O
gene NN O
in IN O
a DT O
total NN O
of IN O
45 CD O
affected JJ O
but CC O
unrelated JJ O
individuals NNS O
. . O

Eighteen JJ O
patients NNS O
had VBD O
no DT O
family NN O
history NN O
of IN O
the DT O
disease NN O
; : O
of IN O
these DT O
11 CD O
were VBD O
classified VBN O
as IN O
having VBG O
a DT O
severe JJ O
phenotype NN O
, , O
based VBN O
on IN O
an DT O
early JJ O
age NN O
at IN O
presentation NN O
or CC O
cancer NN B-Disease
development NN O
. . O

This DT O
compared VBN O
with IN O
6 CD O
of IN O
27 CD O
familial JJ O
cases NNS O
. . O

A DT O
5 CD O
bp NN O
deletion NN O
at IN O
codon NN O
1309 CD O
reported VBD O
to TO O
occur VB O
in IN O
10 CD O
- : O
15 CD O
% NN O
of IN O
unselected JJ O
APC NNP B-Disease
patients NNS O
worldwide RB O
, , O
was VBD O
found VBN O
in IN O
5 CD O
of IN O
the DT O
18 CD O
new JJ O
mutation NN O
cases NNS O
and CC O
4 CD O
of IN O
the DT O
27 CD O
familial JJ O
cases NNS O
all DT O
nine CD O
were VBD O
classed VBN O
as IN O
severe JJ O
. . O

A DT O
further JJ O
3 CD O
new JJ O
mutations NNS O
and CC O
1 CD O
familial JJ O
mutation NN O
were VBD O
located VBN O
downstream NN O
from IN O
codon NN O
1309 CD O
, , O
these DT O
individuals NNS O
similarly RB O
being VBG O
classed VBN O
as IN O
phenotypically RB O
severe JJ O
. . O

In IN O
contrast NN O
all DT O
of IN O
the DT O
APC NNP B-Disease
mutations NNS O
detected VBD O
in IN O
affected JJ O
individuals NNS O
with IN O
an DT O
average JJ O
phenotype NN O
were VBD O
located VBN O
prior RB O
to TO O
codon VB O
1309 CD O
. . O

The DT O
frequent JJ O
association NN O
of IN O
a DT O
severe JJ O
phenotype NN O
with IN O
fresh JJ O
mutation NN O
may MD O
explain VB O
the DT O
apparent JJ O
conflict NN O
of IN O
a DT O
high JJ O
mutation NN O
rate NN O
( ( O
20 CD O
- : O
30 CD O
% NN O
) ) O
in IN O
a DT O
condition NN O
, , O
which WDT O
on IN O
average NN O
, , O
is VBZ O
lethal VBN O
at IN O
a DT O
post NN O
- : O
reproductive JJ O
age NN O
. . O
. . O

Mutations NNS O
at IN O
the DT O
PAX6 NNP O
locus NN O
are VBP O
found VBN O
in IN O
heterogeneous JJ O
anterior JJ B-Disease
segment NN I-Disease
malformations NNS I-Disease
including VBG O
Peters NNP B-Disease
' POS I-Disease
anomaly NN I-Disease
. . O

Mutation NN O
or CC O
deletion NN O
of IN O
the DT O
PAX6 NNP O
gene NN O
underlies NNS O
many JJ O
cases NNS O
of IN O
aniridia NN B-Disease
. . O

Three CD O
lines NNS O
of IN O
evidence NN O
now RB O
converge VBZ O
to TO O
implicate VB O
PAX6 NNP O
more RBR O
widely RB O
in IN O
anterior JJ B-Disease
segment NN I-Disease
malformations NNS I-Disease
including VBG O
Peters NNP B-Disease
anomaly NN I-Disease
. . O

First RB O
, , O
a DT O
child NN O
with IN O
Peters NNP B-Disease
anomaly VBP I-Disease
is VBZ O
deleted VBN O
for IN O
one CD O
copy NN O
of IN O
PAX6 NNP O
. . O

Second JJ O
, , O
affected JJ O
members NNS O
of IN O
a DT O
family NN O
with IN O
dominantly RB O
inherited VBN O
anterior JJ B-Disease
segment NN I-Disease
malformations NNS I-Disease
, , O
including VBG O
Peters NNP B-Disease
anomaly NN I-Disease
are VBP O
heterozygous JJ O
for IN O
an DT O
R26G NNP O
mutation NN O
in IN O
the DT O
PAX6 NNP O
paired VBD O
box NN O
. . O

Third NNP O
, , O
a DT O
proportion NN O
of IN O
Sey NNP O
/ NNP O
+ NNP O
Smalleye NNP O
mice NN O
, , O
heterozygous JJ O
for IN O
a DT O
nonsense JJ O
mutation NN O
in IN O
murine NN O
Pax NNP O
- : O
6 CD O
, , O
have VBP O
an DT O
ocular JJ O
phenotype NN O
resembling VBG O
Peters NNP B-Disease
anomaly NN I-Disease
. . O

We PRP O
therefore VBP O
propose JJ O
that IN O
a DT O
variety NN O
of IN O
anterior JJ B-Disease
segment NN I-Disease
anomalies NNS I-Disease
may MD O
be VB O
associated VBN O
with IN O
PAX6 NNP O
mutations NNS O
. . O
. . O

Huntington NNP B-Disease
disease NN I-Disease
without IN O
CAG NNP O
expansion NN O
: : O
phenocopies NNS O
or CC O
errors NNS O
in IN O
assignment NN O
? . O

Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
an DT O
expanded VBN O
CAG NNP O
repeat NN O
within IN O
a DT O
novel JJ O
gene NN O
on IN O
4p16 CD O
. . O

3 CD O
( ( O
IT15 NNP O
) ) O
. . O

A DT O
total NN O
of IN O
30 CD O
of IN O
1 CD O
, , O
22 CD O
affected JJ O
persons NNS O
( ( O
2 CD O
. . O
9 CD O
% NN O
of IN O
our PRP$ O
cohort NN O
) ) O
did VBD O
not RB O
have VB O
an DT O
expanded VBN O
CAG NN O
in IN O
the DT O
disease NN O
range NN O
. . O

The DT O
reasons NNS O
for IN O
not RB O
observing VBG O
expansion NN O
in IN O
affected JJ O
individuals NNS O
are VBP O
important JJ O
for IN O
determining VBG O
the DT O
sensitivity NN O
of IN O
using VBG O
repeat NN O
length NN O
both DT O
for IN O
diagnosis NN O
of IN O
affected JJ O
patients NNS O
and CC O
for IN O
predictive JJ O
testing NN O
programs NNS O
and CC O
may MD O
have VB O
biological JJ O
relevance NN O
for IN O
the DT O
understanding NN O
of IN O
the DT O
molecular JJ O
mechanism NN O
underlying VBG O
HD NNP B-Disease
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
majority NN O
( ( O
18 CD O
) ) O
of IN O
the DT O
individuals NNS O
with IN O
normal JJ O
sized JJ O
alleles NNS O
represent VBP O
misdiagnosis NN O
, , O
sample JJ O
mix SYM O
- : O
up RB O
, , O
or CC O
clerical JJ O
error NN O
. . O

The DT O
remaining VBG O
12 CD O
patients NNS O
represent JJ O
possible JJ O
phenocopies NNS O
for IN O
HD NNP B-Disease
. . O

In IN O
at IN O
least JJS O
four CD O
cases NNS O
, , O
family NN O
studies NNS O
of IN O
these DT O
phenocopies NNS O
excluded VBD O
4p16 CD O
. . O

3 CD O
as IN O
the DT O
region NN O
responsible JJ O
for IN O
the DT O
phenotype NN O
. . O

Mutations NNS O
in IN O
the DT O
HD NNP B-Disease
gene NN O
that WDT O
are VBP O
other JJ O
than IN O
CAG NNP O
expansion NN O
have VBP O
not RB O
been VBN O
excluded VBN O
for IN O
the DT O
remaining VBG O
eight CD O
cases NNS O
; : O
however RB O
, , O
in IN O
as RB O
many JJ O
as IN O
seven CD O
of IN O
these DT O
persons NNS O
, , O
retrospective JJ O
review NN O
of IN O
these DT O
patients NNS O
clinical JJ O
features NNS O
identified VBN O
characteristics NNS O
not RB O
typical JJ O
for IN O
HD NNP B-Disease
. . O

This DT O
study NN O
shows VBZ O
that IN O
on IN O
rare JJ O
occasions NNS O
mutations NNS O
in IN O
other JJ O
, , O
as IN O
- : O
yet RB O
- : O
undefined JJ O
genes NNS O
can MD O
present VB O
with IN O
a DT O
clinical JJ O
phenotype NN O
very RB O
similar JJ O
to TO O
that DT O
of IN O
HD NNP B-Disease

Frequent JJ O
detection NN O
of IN O
codon NN O
877 CD O
mutation NN O
in IN O
the DT O
androgen NN O
receptor NN O
gene NN O
in IN O
advanced JJ B-Disease
prostate NN I-Disease
cancers NNS I-Disease
. . O

Prostatic JJ O
tissue NN O
specimens NNS O
derived VBN O
from IN O
transurethral JJ O
resections NNS O
of IN O
patients NNS O
with IN O
metastatic JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
were VBD O
analyzed VBN O
for IN O
genetic JJ O
alterations NNS O
in IN O
the DT O
hormone NN O
- : O
binding NN O
domain NN O
of IN O
the DT O
androgen NN O
receptor NN O
( ( O
AR NNP O
) ) O
gene NN O
. . O

Direct JJ O
sequencing NN O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
- : O
derived VBN O
DNAs NNP O
of IN O
6 CD O
of IN O
24 CD O
specimens NNS O
revealed VBD O
a DT O
codon NN O
877 CD O
mutation NN O
( ( O
ACT NNP O
- : O
- : O
> NN O
GCT NNP O
, , O
Thr NNP O
- : O
- : O
> NN O
Ala NNP O
) ) O
in IN O
the DT O
hormone NN O
- : O
binding NN O
domain NN O
of IN O
the DT O
AR NNP O
gene NN O
. . O

This DT O
same JJ O
AR NNP O
mutation NN O
has VBZ O
been VBN O
reported VBN O
previously RB O
in IN O
a DT O
metastatic JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
cell NN O
line NN O
, , O
LNCaP NNP O
, , O
where WRB O
this DT O
mutation NN O
confers VBZ O
upon IN O
the DT O
AR NNP O
an DT O
altered JJ O
ligand NN O
- : O
binding NN O
specificity NN O
which WDT O
is VBZ O
stimulated VBN O
by IN O
estrogens NNS O
, , O
progestagens NNS O
, , O
and CC O
antiandrogens NNS O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
analogous JJ O
to TO O
an DT O
activated VBN O
/ NN O
altered VBD O
growth NN O
factor NN O
receptor NN O
oncogene NN O
, , O
codon VBP O
877 CD O
mutant JJ O
AR NNP O
with IN O
altered JJ O
ligand NN O
binding NN O
may MD O
provide VB O
a DT O
selective JJ O
growth NN O
advantage NN O
in IN O
the DT O
genesis NN O
of IN O
a DT O
subset NN O
of IN O
advanced JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O

Although IN O
estrogens NNS O
are VBP O
used VBN O
infrequently RB O
, , O
antiandrogens NNS O
are VBP O
used VBN O
increasingly RB O
in IN O
hormonal JJ O
therapy NN O
for IN O
patients NNS O
with IN O
advanced JJ B-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O

The DT O
stimulatory JJ O
effect NN O
of IN O
these DT O
therapeutic JJ O
agents NNS O
on IN O
the DT O
codon NN O
877 CD O
mutant NN O
AR NNP O
further RB O
suggests VBZ O
that IN O
this DT O
frequently RB O
observed VBN O
AR NNP O
mutation NN O
may MD O
contribute VB O
to TO O
the DT O
treatment NN O
refractory NN O
disease NN O
. . O
. . O

The DT O
human JJ O
gene NN O
for IN O
alkaptonuria NNS B-Disease
( ( O
AKU NNP B-Disease
) ) O
maps VBZ O
to TO O
chromosome VB O
3q CD O
. . O

Alkaptonuria NNP B-Disease
( ( O
AKU NNP B-Disease
; : O
McKusick NNP O
no DT O
. . O
203500 CD O
) ) O
is VBZ O
a DT O
rare JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
the DT O
lack NN O
of IN O
homogentisic JJ O
acid JJ O
oxidase NN O
activity NN O
. . O

Patients NNS O
excrete VBP O
large JJ O
amounts NNS O
of IN O
homogentisic JJ O
acid NN O
in IN O
their PRP$ O
urine NN O
and CC O
a DT O
black JJ O
ochronotic JJ O
pigment NN O
is VBZ O
deposited VBN O
in IN O
their PRP$ O
cartilage NN O
and CC O
collagenous JJ O
tissues NNS O
. . O

Ochronosis NN B-Disease
is VBZ O
the DT O
predominant JJ O
clinical JJ O
complication NN O
of IN O
the DT O
disease NN O
leading VBG O
to TO O
ochronotic JJ B-Disease
arthropathy NN I-Disease
, , O
dark JJ O
urine NN O
, , O
pigment JJ O
changes NNS O
of IN O
the DT O
skin NN O
, , O
and CC O
other JJ O
clinical JJ O
features NNS O
. . O

A DT O
mutation NN O
causing VBG O
alkaptonuria NNS B-Disease
in IN O
the DT O
mouse NN O
has VBZ O
mapped VBN O
to TO O
chromosome VB O
16 CD O
. . O

Considering VBG O
conserved VBN O
synteny NN O
, , O
we PRP O
were VBD O
able JJ O
to TO O
map VB O
the DT O
human JJ O
gene NN O
to TO O
chromosome VB O
3q CD O
in IN O
six CD O
alkaptonuria NNS B-Disease
pedigrees NNS O
of IN O
Slovak NNP O
origin NN O
. . O
. . O

Structure NN O
of IN O
the DT O
human JJ O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
gene NN O
SGLT1 NNP O
. . O

Intestinal JJ O
uptake NN O
of IN O
dietary JJ O
glucose NN O
and CC O
galactose NN O
is VBZ O
mediated VBN O
by IN O
the DT O
SGLT1 NNP O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
of IN O
the DT O
brush NN O
border NN O
. . O

An DT O
SGLT1 NNP O
missense NN O
mutation NN O
underlies NNS O
hereditary VBP B-Disease
glucose JJ I-Disease
/ NNP I-Disease
galactose NN I-Disease
malabsorption NN I-Disease
, , O
characterized VBN O
by IN O
potentially RB O
fatal JJ O
diarrhea NN B-Disease
; : O
conversely RB O
, , O
oral JJ O
rehydration NN O
therapy NN O
exploits VBZ O
normal JJ O
transport NN O
to TO O
alleviate VB O
life NN O
- : O
threatening VBG O
diarrhea NN B-Disease
of IN O
infectious JJ O
origin NN O
. . O

We PRP O
have VBP O
mapped VBN O
the DT O
entire JJ O
human JJ O
SGLT1 NNP O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter JJ O
gene NN O
from IN O
cosmid NN O
and CC O
lambda JJ O
phage NN O
clones NNS O
representing VBG O
a DT O
genomic JJ O
region NN O
of IN O
112 CD O
kilobases NNS O
. . O

Transcription NN O
initiation NN O
occurred VBD O
from IN O
a DT O
site NN O
27 CD O
base NN O
pairs VBD O
3 CD O
of IN O
a DT O
TATAA NNP O
sequence NN O
. . O

All DT O
exon SYM O
- : O
flanking NN O
regions NNS O
were VBD O
sequenced VBN O
, , O
and CC O
the DT O
entire JJ O
112 CD O
- : O
kilobase NN O
region NN O
mapped VBD O
with IN O
four CD O
restriction NN O
enzymes NNS O
. . O

SGLT1 NNP O
is VBZ O
comprised VBN O
of IN O
15 CD O
exons NNS O
( ( O
spanning VBG O
72 CD O
kilobases NNS O
) ) O
; : O
a DT O
possible JJ O
evolutionary JJ O
origin NN O
from IN O
a DT O
six CD O
- : O
membrane NN O
- : O
span JJ O
ancestral JJ O
precursor NN O
via IN O
a DT O
gene NN O
duplication NN O
event NN O
is VBZ O
suggested VBN O
from IN O
comparison NN O
of IN O
exons NNS O
against IN O
protein JJ O
secondary JJ O
structure NN O
and CC O
from IN O
sequence NN O
considerations NNS O
. . O

A DT O
new JJ O
missense NN O
mutation NN O
in IN O
exon $ O
1 CD O
causing VBG O
glucose JJ B-Disease
/ NNS I-Disease
galactose JJ I-Disease
malabsorption NN I-Disease
is VBZ O
also RB O
described VBN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
Na NNP O
( ( O
+ NNP O
) ) O
- : O
dependent JJ O
cotransporter NN O
gene NN O
structure NN O
reported VBN O
. . O

These DT O
data NNS O
facilitate VBP O
the DT O
search NN O
for IN O
new JJ O
glucose JJ B-Disease
/ NNS I-Disease
galactose JJ I-Disease
malabsorption NN I-Disease
- : O
related JJ O
mutations NNS O
in IN O
this DT O
important JJ O
gene NN O
and CC O
provide VB O
a DT O
basis NN O
for IN O
future JJ O
evolutionary JJ O
comparisons NNS O
with IN O
other JJ O
Na NNP O
( ( O
+ NNP O
) ) O
- : O
dependent JJ O
cotransporters NNS O
. . O
. . O

Four CD O
novel JJ O
PEPD NNP O
alleles NNS O
causing VBG O
prolidase NN B-Disease
deficiency NN I-Disease
. . O

Mutations NNS O
at IN O
the DT O
PEPD NNP O
locus NN O
cause NN O
prolidase NN B-Disease
deficiency NN I-Disease
( ( O
McKusick NNP O
170100 CD O
) ) O
, , O
a DT O
rare JJ O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
characterized VBN O
by IN O
iminodipeptiduria NN B-Disease
, , O
skin JJ B-Disease
ulcers NNS I-Disease
, , O
mental JJ B-Disease
retardation NN I-Disease
, , O
and CC O
recurrent JJ O
infections NNS O
. . O

Four CD O
PEPD NNP O
mutations NNS O
from IN O
five CD O
severely RB O
affected JJ O
individuals NNS O
were VBD O
characterized VBN O
by IN O
analysis NN O
of IN O
reverse NN O
- : O
transcribed NN O
, , O
PCR NNP O
- : O
amplified VBD O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
cDNA NN O
. . O

We PRP O
used VBD O
SSCP NNP O
analysis NN O
on IN O
four CD O
overlapping VBG O
cDNA NN O
fragments NNS O
covering VBG O
the DT O
entire JJ O
coding NN O
region NN O
of IN O
the DT O
PEPD NNP O
gene NN O
and CC O
detected VBN O
abnormal JJ O
SSCP NNP O
bands NNS O
for IN O
the DT O
fragment NN O
spanning VBG O
all DT O
or CC O
part NN O
of IN O
exons NNS O
13 CD O
- : O
15 CD O
in IN O
three CD O
of IN O
the DT O
probands NNS O
. . O

Direct JJ O
sequencing NN O
of IN O
the DT O
mutant JJ O
cDNAs NN O
showed VBD O
a DT O
G NNP O
- : O
- : O
> NN O
A NNP O
, , O
1342 CD O
substitution NN O
( ( O
G448R NNP O
) ) O
in IN O
two CD O
patients NNS O
and CC O
a DT O
3 CD O
- : O
bp NN O
deletion NN O
( ( O
delta JJ O
E452 NNP O
or CC O
delta JJ O
E453 NNP O
) ) O
in IN O
another DT O
. . O

In IN O
the DT O
other JJ O
two CD O
probands VBZ O
the DT O
amplified JJ O
products NNS O
were VBD O
of IN O
reduced JJ O
size NN O
. . O

Direct JJ O
sequencing NN O
of IN O
these DT O
mutant JJ O
cDNAs NN O
revealed VBD O
a DT O
deletion NN O
of IN O
exon $ O
5 CD O
in IN O
one CD O
patient NN O
and CC O
of IN O
exon JJ O
7 CD O
in IN O
the DT O
other JJ O
. . O

Intronic JJ O
sequences NNS O
flanking VBG O
exons NNS O
5 CD O
and CC O
7 CD O
were VBD O
identified VBN O
using VBG O
inverse JJ O
PCR NNP O
followed VBN O
by IN O
direct JJ O
sequencing NN O
. . O

Conventional JJ O
PCR NNP O
and CC O
direct JJ O
sequencing NN O
then RB O
established VBD O
the DT O
intron NN O
- : O
exon JJ O
borders NNS O
of IN O
the DT O
mutant JJ O
genomic JJ O
DNA NN O
revealing VBG O
two CD O
splice JJ O
acceptor NN O
mutations NNS O
a DT O
G NNP O
- : O
- : O
> NN O
C NNP O
substitution NN O
at IN O
position NN O
- : O
1 CD O
of IN O
intron NN O
4 CD O
and CC O
an DT O
A NNP O
- : O
- : O
> NN O
G NNP O
substitution NN O
at IN O
position NN O
- : O
2 CD O
of IN O
intron NN O
6 CD O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
severe JJ O
form NN O
of IN O
prolidase NN B-Disease
deficiency NN I-Disease
is VBZ O
caused VBN O
by IN O
multiple JJ O
PEPD NNP O
alleles NNS O
. . O

In IN O
this DT O
report NN O
we PRP O
attempt VBP O
to TO O
begin VB O
the DT O
process NN O
of IN O
describing VBG O
these DT O
alleles NNS O
and CC O
cataloging VBG O
their PRP$ O
phenotypic NN O
expression NN O
. . O
. . O

Recombinations NNS O
in IN O
individuals NNS O
homozygous JJ O
by IN O
descent NN O
localize VB O
the DT O
Friedreich NNP B-Disease
ataxia NN I-Disease
locus NN O
in IN O
a DT O
cloned JJ O
450 CD O
- : O
kb NN O
interval NN O
. . O

The DT O
locus NN O
for IN O
Friedreich NNP B-Disease
ataxia NN I-Disease
( ( O
FRDA NNP B-Disease
) ) O
, , O
a DT O
severe JJ O
neurodegenerative JJ B-Disease
disease NN I-Disease
, , O
is VBZ O
tightly RB O
linked VBN O
to TO O
markers NNS O
D9S5 NNP O
and CC O
D9S15 NNP O
, , O
and CC O
analysis NN O
of IN O
rare JJ O
recombination NN O
events NNS O
has VBZ O
suggested VBN O
the DT O
order NN O
cen SYM O
- : O
FRDA NNP O
- : O
D9S5 NNP O
- : O
D9S15 NNP O
- : O
qter NN O
. . O

We PRP O
report VBP O
here RB O
the DT O
construction NN O
of IN O
a DT O
YAC NNP O
contig NN O
extending VBG O
800 CD O
kb JJ O
centromeric NN O
to TO O
D9S5 NNP O
and CC O
the DT O
isolation NN O
of IN O
five CD O
new JJ O
microsatellite NN O
markers NNS O
from IN O
this DT O
region NN O
. . O

In IN O
order NN O
to TO O
map VB O
these DT O
markers NNS O
with IN O
respect NN O
to TO O
the DT O
FRDA NNP B-Disease
locus NN O
, , O
all DT O
within IN O
a DT O
1 CD O
- : O
cM NN O
confidence NN O
interval NN O
, , O
we PRP O
sought VBD O
to TO O
increase VB O
the DT O
genetic JJ O
information NN O
of IN O
available JJ O
FRDA NNP B-Disease
families NNS O
by IN O
considering VBG O
homozygosity NN O
by IN O
descent NN O
and CC O
association NN O
with IN O
founder NN O
haplotypes NNS O
in IN O
isolated JJ O
populations NNS O
. . O

This DT O
approach NN O
allowed VBD O
us PRP O
to TO O
identify VB O
one CD O
phase NN O
- : O
known VBN O
recombination NN O
and CC O
one CD O
probable JJ O
historic JJ O
recombination NN O
on IN O
haplotypes NNS O
from IN O
Reunion NNP O
Island NNP O
patients NNS O
, , O
both DT O
of IN O
which WDT O
place VBP O
three CD O
of IN O
the DT O
five CD O
markers NNS O
proximal VBP O
to TO O
FRDA NNP B-Disease
. . O

This DT O
represents VBZ O
the DT O
first JJ O
identification NN O
of IN O
close JJ O
FRDA NNP B-Disease
flanking NN O
markers NNS O
on IN O
the DT O
centromeric JJ O
side NN O
. . O

The DT O
two CD O
other JJ O
markers NNS O
allowed VBD O
us PRP O
to TO O
narrow VB O
the DT O
breakpoint NN O
of IN O
a DT O
previously RB O
identified VBN O
distal JJ O
recombination NN O
that WDT O
is VBZ O
> JJ O
180 CD O
kb NN O
from IN O
D9S5 NNP O
( ( O
26P CD O
) ) O
. . O

Taken VBN O
together RB O
, , O
the DT O
results NNS O
place VBP O
the DT O
FRDA NNP B-Disease
locus NN O
in IN O
a DT O
450 CD O
- : O
kb NN O
interval NN O
, , O
which WDT O
is VBZ O
small JJ O
enough RB O
for IN O
direct JJ O
search NN O
of IN O
candidate NN O
genes NNS O
. . O

A DT O
detailed JJ O
rare JJ O
cutter NN O
restriction NN O
map NN O
and CC O
a DT O
cosmid NN O
contig NN O
covering VBG O
this DT O
interval NN O
were VBD O
constructed VBN O
and CC O
should MD O
facilitate VB O
the DT O
search NN O
of IN O
genes NNS O
in IN O
this DT O
region NN O
. . O
. . O

Investigation NN O
of IN O
thermoregulatory NN O
characteristics NNS O
in IN O
patients NNS O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

A DT O
survey NN O
instrument NN O
is VBZ O
used VBN O
to TO O
assess VB O
temperature NN O
regulation NN O
characteristics NNS O
in IN O
children NNS O
with IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
compared VBN O
to TO O
3 CD O
control NN O
groups NNS O
sibs NN O
of IN O
PWS NNP B-Disease
patients NNS O
( ( O
SIB NNP O
) ) O
, , O
neurodevelopmentally RB B-Disease
handicapped VBD I-Disease
children NNS O
( ( O
ND NNP O
) ) O
, , O
and CC O
age NN O
and CC O
gender NN O
matched VBN O
well RB O
children NNS O
( ( O
WC NNP O
) ) O
. . O

Significant JJ O
differences NNS O
were VBD O
found VBN O
between IN O
PWS NNP B-Disease
patients NNS O
, , O
SIB NNP O
controls VBZ O
, , O
and CC O
WC NNP O
controls NNS O
in IN O
the DT O
prevalence NN O
of IN O
febrile JJ O
convulsions NNS O
, , O
fever SYM O
- : O
associated VBN O
symptoms NNS O
, , O
and CC O
temperature NN O
less JJR O
than IN O
94 CD O
degrees NNS O
F NNP O
. . O

No DT O
differences NNS O
were VBD O
noted VBN O
in IN O
any DT O
variable JJ O
between IN O
the DT O
PWS NNP B-Disease
patients NNS O
and CC O
the DT O
ND NNP O
controls NNS O
, , O
suggesting VBG O
that IN O
these DT O
abnormalities NNS O
are VBP O
not RB O
unique JJ O
to TO O
PWS NNP B-Disease
, , O
but CC O
can MD O
occur VB O
in IN O
any DT O
neurodevelopmentally RB B-Disease
handicapped VBN I-Disease
individual NN O
, , O
further JJ O
suggesting VBG O
these DT O
do VBP O
not RB O
necessarily RB O
reflect VB O
syndrome JJ O
- : O
specific JJ O
hypothalamic JJ B-Disease
abnormalities NNS I-Disease
. . O
. . O

Phenotypic NNP O
variation NN O
including VBG O
retinitis NN B-Disease
pigmentosa NN I-Disease
, , O
pattern JJ B-Disease
dystrophy NN I-Disease
, , O
and CC O
fundus NN B-Disease
flavimaculatus NN I-Disease
in IN O
a DT O
single JJ O
family NN O
with IN O
a DT O
deletion NN O
of IN O
codon NN O
153 CD O
or CC O
154 CD O
of IN O
the DT O
peripherin NN O
/ NN O
RDS NNP O
gene NN O
. . O

BACKGROUND NNP O
AND NNP O
OBJECTIVES NNP O
Mutations NNP O
of IN O
the DT O
peripherin NN O
/ NN O
RDS NNP O
gene NN O
have VBP O
been VBN O
reported VBN O
in IN O
autosomal JJ B-Disease
dominant JJ I-Disease
retinitis NN I-Disease
pigmentosa NN I-Disease
, , O
pattern JJ O
macular JJ B-Disease
dystrophy NN I-Disease
, , O
and CC O
retinitis NN B-Disease
punctata NN I-Disease
albescens NNS I-Disease
. . O

We PRP O
report VBP O
herein VBD O
the DT O
occurrence NN O
of IN O
three CD O
separate JJ O
phenotypes NNS O
within IN O
a DT O
single JJ O
family NN O
with IN O
a DT O
novel JJ O
3 CD O
- : O
base NN O
pair NN O
deletion NN O
of IN O
codon NN O
153 CD O
or CC O
154 CD O
of IN O
the DT O
peripherin NN O
/ NN O
RDS NNP O
gene NN O
. . O

DESIGN NNP O
Case NNP O
reports VBZ O
with IN O
clinical JJ O
features NNS O
, , O
fluorescein NN O
angiography NN O
, , O
kinetic JJ O
perimetry NN O
, , O
electrophysiological JJ O
studies NNS O
, , O
and CC O
molecular JJ O
genetics NNS O
. . O

SETTING NN O
University NNP O
medical JJ O
centers NNS O
. . O

PATIENTS VB O
A DT O
75 CD O
- : O
year NN O
- : O
old JJ O
woman NN O
, , O
her PRP O
two CD O
daughters NNS O
( ( O
aged VBN O
44 CD O
and CC O
50 CD O
years NNS O
) ) O
, , O
and CC O
her PRP$ O
49 CD O
- : O
year NN O
- : O
old JJ O
son NN O
were VBD O
screened VBN O
for IN O
peripherin NN O
/ NN O
RDS NNP O
mutations NNS O
because IN O
of IN O
the DT O
presence NN O
of IN O
multiple JJ O
phenotypes NNS O
within IN O
the DT O
same JJ O
family NN O
. . O

RESULTS VB O
The DT O
mother NN O
presented VBD O
at IN O
age NN O
63 CD O
years NNS O
with IN O
a DT O
profoundly RB O
abnormal JJ O
electroretinogram NN O
( ( O
ERG NNP O
) ) O
and CC O
adult $ O
- : O
onset NN O
retinitis NN B-Disease
pigmentosa NN I-Disease
that WDT O
progressed VBD O
dramatically RB O
over IN O
12 CD O
years NNS O
, , O
with IN O
marked JJ O
loss NN O
of IN O
peripheral JJ O
visual JJ O
field NN O
. . O

One CD O
daughter NN O
developed VBD O
pattern JJ B-Disease
macular JJ I-Disease
dystrophy NN I-Disease
at IN O
age NN O
31 CD O
years NNS O
. . O

At IN O
age NN O
44 CD O
years NNS O
, , O
her PRP$ O
ERG NNP O
was VBD O
moderately RB O
abnormal JJ O
but CC O
her PRP$ O
clinical JJ O
disease NN O
was VBD O
limited VBN O
to TO O
the DT O
macula NN O
. . O

Another DT O
daughter NN O
presented VBN O
at IN O
age NN O
42 CD O
years NNS O
with IN O
macular JJ B-Disease
degeneration NN I-Disease
and CC O
over IN O
10 CD O
years NNS O
developed VBD O
the DT O
clinical JJ O
picture NN O
of IN O
fundus NN B-Disease
flavimaculatus NN I-Disease
. . O

Her PRP$ O
peripheral JJ O
visual JJ O
field NN O
was VBD O
preserved VBN O
but CC O
her PRP$ O
ERG NNP O
was VBD O
moderately RB O
abnormal JJ O
. . O

The DT O
son NN O
had VBD O
onset VBN O
of IN O
macular JJ B-Disease
degeneration NN I-Disease
at IN O
age NN O
44 CD O
years NNS O
. . O

Pericentral JJ B-Disease
scotomas NNS I-Disease
were VBD O
present JJ O
and CC O
the DT O
ERG NNP O
was VBD O
markedly RB O
abnormal JJ O
. . O

Fluorescein NNP O
angiography NN O
revealed VBD O
punctate JJ O
pigment NN O
epithelial JJ O
transmission NN O
defects NNS O
. . O

CONCLUSIONS VB O
A DT O
3 CD O
- : O
base NN O
pair NN O
deletion NN O
of IN O
codon NN O
153 CD O
or CC O
154 CD O
of IN O
the DT O
peripherin NN O
/ NN O
RDS NNP O
gene NN O
can MD O
produce VB O
clinically RB O
disparate JJ O
phenotypes NNS O
even RB O
within IN O
the DT O
same JJ O
family NN O
. . O
. . O

Assignment NN O
of IN O
the DT O
human JJ O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
gene NN O
SGLT1 NNP O
to TO O
chromosome VB O
22q13 CD O
. . O
1 CD O
. . O

The DT O
Na NNP O
+ NNP O
/ NNP O
glucose VBP O
cotransporter NN O
gene NN O
SGLT1 NNP O
encodes VBZ O
the DT O
primary JJ O
carrier NN O
protein NN O
responsible JJ O
for IN O
the DT O
uptake NN O
of IN O
the DT O
dietary JJ O
sugars NNS O
glucose JJ O
and CC O
galactose JJ O
from IN O
the DT O
intestinal JJ O
lumen NNS O
. . O

SGLT1 NNP O
transport NN O
activity NN O
is VBZ O
currently RB O
exploited VBN O
in IN O
oral JJ O
rehydration NN O
therapy NN O
. . O

The DT O
75 CD O
- : O
kDa NN O
glycoprotein NN O
is VBZ O
localized VBN O
in IN O
the DT O
brush NN O
border NN O
of IN O
the DT O
intestinal JJ O
epithelium NN O
and CC O
is VBZ O
predicted VBN O
to TO O
comprise VB O
12 CD O
membrane NN O
spans NNS O
. . O

In IN O
two CD O
patients NNS O
with IN O
the DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disease NN I-Disease
glucose JJ I-Disease
/ NNP I-Disease
galactose NN I-Disease
malabsorption NN I-Disease
, , O
the DT O
underlying VBG O
cause NN O
was VBD O
found VBN O
to TO O
be VB O
a DT O
missense JJ O
mutation NN O
in IN O
SGLT1 NNP O
, , O
and CC O
the DT O
Asp28 NNP O
- : O
- : O
> NN O
Asn NNP O
change NN O
was VBD O
demonstrated VBN O
in IN O
vitro NN O
to TO O
eliminate VB O
SGLT1 NNP O
transport NN O
activity NN O
. . O

The DT O
SGLT1 NNP O
gene NN O
was VBD O
previously RB O
shown VBN O
to TO O
reside VB O
on IN O
the DT O
distal JJ O
q NN O
arm NN O
of IN O
chromosome NN O
22 CD O
( ( O
11 CD O
. . O
2 CD O
- : O
- : O
> NN O
qter NN O
) ) O
. . O

We PRP O
have VBP O
used VBN O
a DT O
cosmid JJ O
probe NN O
for IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
, , O
which WDT O
refines VBZ O
the DT O
localization NN O
to TO O
22q13 CD O
. . O

1 CD O
, , O
and CC O
provide VB O
an DT O
example NN O
of IN O
the DT O
utility NN O
of IN O
the DT O
SGLT1 NNP O
probe NN O
as IN O
a DT O
diagnostic JJ O
for IN O
genetic JJ B-Disease
diseases NNS I-Disease
associated VBN O
with IN O
translocations NNS O
of IN O
chromosome NN O
22 CD O
. . O

Restriction NN O
of IN O
ocular JJ O
fundus NN O
lesions NNS O
to TO O
a DT O
specific JJ O
subgroup NN O
of IN O
APC NNP B-Disease
mutations NNS O
in IN O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
patients NNS O
. . O

In IN O
humans NNS O
, , O
alteration NN O
of IN O
the DT O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
APC NNP B-Disease
, , O
causes VBZ O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
, , O
a DT O
condition NN O
causing VBG O
predisposition NN O
to TO O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

The DT O
syndrome NN O
inconsistently RB O
associates VBZ O
characteristic JJ O
patches NNS O
of IN O
congenital JJ B-Disease
hypertrophy NN I-Disease
of IN I-Disease
the DT I-Disease
retinal JJ I-Disease
pigment NN I-Disease
epithelium NN I-Disease
( ( O
CHRPE NNP B-Disease
) ) O
. . O

Ocular JJ O
examination NN O
revealed VBD O
that IN O
patients NNS O
expressing VBG O
CHRPE NNP B-Disease
tend NN O
to TO O
cluster VB O
within IN O
specific JJ O
families NNS O
. . O

The DT O
exact JJ O
APC NNP B-Disease
mutation NN O
was VBD O
identified VBN O
in IN O
42 CD O
unrelated JJ O
patients NNS O
. . O

In IN O
all DT O
cases NNS O
these DT O
mutations NNS O
were VBD O
predicted VBN O
to TO O
lead VB O
to TO O
the DT O
synthesis NN O
of IN O
a DT O
truncated JJ O
protein NN O
. . O

The DT O
extent NN O
of IN O
CHRPE NNP B-Disease
was VBD O
found VBN O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
position NN O
of IN O
the DT O
mutation NN O
along IN O
the DT O
coding NN O
sequence NN O
. . O

CHRPE NNP B-Disease
lesions NNS O
are VBP O
almost RB O
always RB O
absent JJ O
if IN O
the DT O
mutation NN O
occurs VBZ O
before IN O
exon JJ O
9 CD O
, , O
but CC O
are VBP O
systematically RB O
present JJ O
if IN O
it PRP O
occurs VBZ O
after IN O
this DT O
exon NN O
. . O

Thus RB O
, , O
the DT O
range NN O
of IN O
phenotypic NN O
expression NN O
observed VBD O
among IN O
affected JJ O
patients NNS O
may MD O
result VB O
in IN O
part NN O
from IN O
different JJ O
allelic JJ O
manifestations NNS O
of IN O
APC NNP B-Disease
mutations NNS O
. . O
. . O

The DT O
effects NNS O
of IN O
dystrophin JJ O
gene NN O
mutations NNS O
on IN O
the DT O
ERG NNP O
in IN O
mice NN O
and CC O
humans NNS O
. . O

PURPOSE NNP O
. . O

The DT O
authors NNS O
earlier RBR O
findings NNS O
of IN O
a DT O
negative JJ O
electroretinogram NN O
( ( O
ERG NNP O
) ) O
in IN O
a DT O
boy NN O
with IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
led VBD O
them PRP O
to TO O
investigate VB O
dystrophin JJ O
gene NN O
deletions NNS O
and CC O
ERGs NNP O
in IN O
five CD O
boys NNS O
with IN O
DMD NNP B-Disease
. . O

The DT O
authors NNS O
wanted VBD O
to TO O
determined VB O
whether IN O
there EX O
were VBD O
similar JJ O
ERG NNP O
findings NNS O
in IN O
an DT O
animal JJ O
model NN O
for IN O
DMD NNP B-Disease
, , O
the DT O
mdx NN O
mouse NN O
. . O

METHODS NNP O
. . O

Ganzfeld NNP O
ERGs NNP O
were VBD O
recorded VBN O
in IN O
five CD O
boys NNS O
with IN O
DMD NNP B-Disease
after IN O
a DT O
complete JJ O
ophthalmic JJ O
examination NN O
. . O

The DT O
dystrophin JJ O
gene NN O
was VBD O
analyzed VBN O
by IN O
Southern NNP O
blot NN O
hybridization NN O
. . O

ERGs NNS O
were VBD O
recorded VBN O
in IN O
anesthetized JJ O
mdx NN O
and CC O
control NN O
mice NN O
with IN O
a DT O
modified JJ O
Grass NNP O
photostimulator NN O
( ( O
Grass NNP O
Instrument NNP O
Company NNP O
, , O
Quincy NNP O
, , O
MA NNP O
) ) O
. . O

RESULTS NNP O
. . O

Ophthalmic JJ O
examinations NNS O
in IN O
all DT O
five CD O
boys NNS O
had VBD O
normal JJ O
findings NNS O
, , O
yet RB O
an DT O
abnormal JJ O
negative JJ O
ERG NNP O
was VBD O
recorded VBN O
for IN O
each DT O
subject NN O
. . O

The DT O
subjects NNS O
gene NN O
deletions NNS O
were VBD O
variable JJ O
, , O
ranging VBG O
from IN O
large JJ O
deletions NNS O
to TO O
no DT O
detectable JJ O
deletions NNS O
. . O

The DT O
ERGs NNP O
of IN O
the DT O
mdx NN O
mice NN O
were VBD O
normal JJ O
and CC O
did VBD O
not RB O
differ VB O
significantly RB O
from IN O
those DT O
of IN O
the DT O
control NN O
mice NN O
. . O

CONCLUSIONS NNP O
. . O

The DT O
authors NNS O
believe VBP O
the DT O
unique JJ O
ERG NNP O
recorded VBD O
for IN O
the DT O
human JJ O
subjects NNS O
is VBZ O
a DT O
manifestation NN O
of IN O
DMD NNP B-Disease
associated VBN O
with IN O
defects NNS O
at IN O
the DT O
dystrophin JJ O
gene NN O
locus NN O
and CC O
represents VBZ O
a DT O
new JJ O
clinical JJ O
entity NN O
. . O

The DT O
ERG NNP O
of IN O
the DT O
mdx NN O
mouse NN O
may MD O
be VB O
spared VBN O
for IN O
several JJ O
reasons NNS O
, , O
including VBG O
milder JJR O
effects NNS O
of IN O
the DT O
mouse NN O
gene NN O
defect NN O
, , O
differences NNS O
in IN O
muscle NN O
and CC O
retinal JJ O
gene NN O
product NN O
, , O
or CC O
species NNS O
differences NNS O
in IN O
the DT O
biochemical JJ O
role NN O
of IN O
dystrophin NN O
. . O

The DT O
ERG NNP O
shows VBZ O
promise NN O
of IN O
becoming VBG O
a DT O
noninvasive JJ O
diagnostic JJ O
tool NN O
for IN O
DMD NNP B-Disease
and CC O
its PRP$ O
milder NN O
allelic NN O
forms NNS O
. . O
. . O

Association NNP O
of IN O
the DT O
APC NNP B-Disease
tumor NN I-Disease
suppressor NN O
protein NN O
with IN O
catenins NNS O
. . O

Mutations NNS O
of IN O
APC NNP O
appear VBP O
to TO O
initiate VB O
sporadic JJ O
and CC O
inherited JJ O
forms NNS O
of IN O
human JJ O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

Although IN O
these DT O
mutations NNS O
have VBP O
been VBN O
well RB O
characterized VBN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
function NN O
of IN O
the DT O
APC NNP B-Disease
gene NN O
product NN O
. . O

Two CD O
cellular JJ O
proteins NNS O
that WDT O
associate VBP O
with IN O
APC NNP B-Disease
were VBD O
identified VBN O
by IN O
nucleotide JJ O
sequence NN O
analysis NN O
and CC O
peptide RB O
mapping NN O
as IN O
the DT O
E NNP O
- : O
cadherin NN O
- : O
associated JJ O
proteins NNS O
alpha VBP O
- : O
and CC O
beta VB O
- : O
catenin NN O
. . O

A DT O
27 CD O
- : O
residue JJ O
fragment NN O
of IN O
APC NNP O
containing VBG O
a DT O
15 CD O
- : O
amino NN O
acid JJ O
repeat NN O
was VBD O
sufficient JJ O
for IN O
the DT O
interaction NN O
with IN O
the DT O
catenins NNS O
. . O

These DT O
results NNS O
suggest VBP O
an DT O
important JJ O
link NN O
between IN O
tumor NN B-Disease
initiation NN O
and CC O
cell NN O
adhesion NN O
. . O
. . O

Difference NN O
in IN O
methylation NN O
patterns NNS O
within IN O
the DT O
D15S9 NNP O
region NN O
of IN O
chromosome NN O
15q11 CD O
- : O
13 CD O
in IN O
first JJ O
cousins NNS O
with IN O
Angelman NNP B-Disease
syndrome NN I-Disease
and CC O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
. . O

Abnormalities NNS O
of IN O
chromosome NN O
region NN O
15q11 CD O
- : O
13 CD O
are VBP O
associated VBN O
with IN O
Angelman NNP B-Disease
syndrome NN I-Disease
( ( O
AS IN B-Disease
) ) O
and CC O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

Differences NNS O
between IN O
the DT O
methylation NN O
patterns NNS O
of IN O
the DT O
region NN O
of IN O
chromosome NN O
15q11 CD O
- : O
13 CD O
which WDT O
hybridizes VBZ O
to TO O
the DT O
highly RB O
conserved JJ O
DNA NNP O
, , O
DN34 NNP O
, , O
in IN O
normal JJ O
individuals NNS O
and CC O
in IN O
patients NNS O
with IN O
AS NNP B-Disease
and CC O
PWS NNP B-Disease
have VBP O
been VBN O
described VBN O
. . O

We PRP O
report VBP O
on IN O
a DT O
family NN O
in IN O
which WDT O
first JJ O
cousins NNS O
are VBP O
affected VBN O
by IN O
AS NNP B-Disease
and CC O
PWS NNP B-Disease
as IN O
a DT O
result NN O
of IN O
a DT O
familial JJ O
paracentric JJ O
inversion NN O
of IN O
15q11 CD O
- : O
q13 NN O
. . O

The DT O
results NNS O
of IN O
the DT O
studies NNS O
on IN O
this DT O
family NN O
demonstrate VB O
the DT O
differences NNS O
in IN O
the DT O
methylation NN O
patterns NNS O
in IN O
the DT O
2 CD O
conditions NNS O
and CC O
the DT O
phenomenon NN O
of IN O
genomic JJ O
imprinting NN O
, , O
whereby WRB O
genetic JJ O
information NN O
is VBZ O
expressed VBN O
differently RB O
dependent JJ O
on IN O
the DT O
parent NN O
of IN O
origin NN O
. . O
. . O

Haplotype NNP O
studies NNS O
in IN O
Wilson NNP B-Disease
disease NN I-Disease
. . O

In IN O
51 CD O
families NNS O
with IN O
Wilson NNP B-Disease
disease NN I-Disease
, , O
we PRP O
have VBP O
studied VBN O
DNA NNP O
haplotypes NNS O
of IN O
dinucleotide JJ O
repeat NN O
polymorphisms NN O
( ( O
CA NNP O
repeats NNS O
) ) O
in IN O
the DT O
13q14 CD O
. . O

3 CD O
region NN O
, , O
to TO O
examine VB O
these DT O
markers NNS O
for IN O
association NN O
with IN O
the DT O
Wilson NNP B-Disease
disease NN I-Disease
gene NN O
( ( O
WND NNP B-Disease
) ) O
. . O

In IN O
addition NN O
to TO O
a DT O
marker NN O
( ( O
D13S133 NNP O
) ) O
described VBD O
elsewhere RB O
, , O
we PRP O
have VBP O
developed VBN O
three CD O
new JJ O
highly RB O
polymorphic JJ O
markers NNS O
( ( O
D13S314 NNP O
, , O
D13S315 NNP O
, , O
and CC O
D13S316 NNP O
) ) O
close RB O
to TO O
the DT O
WND NNP B-Disease
locus NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
distribution NN O
of IN O
marker NN O
alleles NNS O
at IN O
the DT O
loci NN O
studied VBN O
and CC O
have VBP O
found VBN O
that IN O
D13S314 NNP O
, , O
D13S133 NNP O
, , O
and CC O
D13S316 NNP O
each DT O
show NN O
nonrandom JJ O
distribution NN O
on IN O
chromosomes NNS O
carrying VBG O
the DT O
WND NNP B-Disease
mutation NN O
. . O

We PRP O
have VBP O
studied VBN O
haplotypes NNS O
of IN O
these DT O
three CD O
markers NNS O
and CC O
have VBP O
found VBN O
that IN O
there EX O
are VBP O
highly RB O
significant JJ O
differences NNS O
between IN O
WND NNP B-Disease
and CC O
normal JJ O
haplotypes NNS O
in IN O
northern JJ O
European JJ O
families NNS O
. . O

These DT O
findings NNS O
have VBP O
important JJ O
implications NNS O
for IN O
mutation NN O
detection NN O
and CC O
molecular JJ O
diagnosis NN O
in IN O
families NNS O
with IN O
Wilson NNP B-Disease
disease NN I-Disease
. . O

Genetic JJ O
analysis NN O
of IN O
the DT O
BRCA1 NNP O
region NN O
in IN O
a DT O
large JJ O
breast NN O
/ NN O
ovarian JJ O
family NN O
: : O
refinement NN O
of IN O
the DT O
minimal JJ O
region NN O
containing VBG O
BRCA1 NNP O
. . O

We PRP O
have VBP O
analyzed VBN O
a DT O
single JJ O
multi NN O
- : O
affected VBD O
breast JJ B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
pedigree NN O
( ( O
BOV3 NNP O
) ) O
and CC O
have VBP O
shown VBN O
consistent JJ O
inheritance NN O
of IN O
markers NNS O
on IN O
chromosome NN O
17q CD O
with IN O
the DT O
disease NN O
confirming VBG O
that IN O
this DT O
family NN O
is VBZ O
due JJ O
to TO O
the DT O
BRCA1 NNP O
gene NN O
. . O

Analysis NN O
of IN O
17q CD O
haplotypes NNS O
shows VBZ O
a DT O
recombination NN O
event NN O
in IN O
a DT O
bilateral JJ O
breast NN B-Disease
cancer NN I-Disease
case NN O
which WDT O
suggests VBZ O
that IN O
the DT O
BRCA1 NNP O
gene NN O
lies VBZ O
distal JJ O
to TO O
D17S857 NNP O
; : O
D17S857 NNP O
is VBZ O
thus RB O
the DT O
new JJ O
proximal JJ O
boundary NN O
for IN O
the DT O
region NN O
containing VBG O
BRCA1 NNP O
. . O

Combining VBG O
this DT O
information NN O
with IN O
previously RB O
published VBN O
mapping NN O
information NN O
suggests VBZ O
that IN O
BRCA1 NNP O
is VBZ O
contained VBN O
in IN O
a DT O
region NN O
estimated VBN O
at IN O
1 CD O
- : O
1 CD O
. . O

5 CD O
Mb NNP O
in IN O
length NN O
. . O

All DT O
seven CD O
breast VBD B-Disease
tumour JJ I-Disease
/ NNP O
blood NN O
pairs NNS O
examined VBD O
from IN O
this DT O
family NN O
show VB O
loss NN O
of IN O
heterozygosity NN O
in IN O
the DT O
tumours NN B-Disease
. . O

The DT O
allel NN O
retained VBN O
in IN O
each DT O
tumour NN B-Disease
was VBD O
from IN O
the DT O
disease NN O
- : O
bearing NN O
chromosome NN O
implicating VBG O
BRCA1 NNP O
as IN O
a DT O
tumour NN B-Disease
suppressor NN O
gene NN O
. . O

We PRP O
have VBP O
sequenced VBN O
the DT O
17 CD O
beta NN O
- : O
oestradiol JJ O
dehydrogenase NN O
genes NNS O
( ( O
EDH17B1 NNP O
and CC O
EDH17B2 NNP O
) ) O
which WDT O
have VBP O
been VBN O
suggested VBN O
as IN O
candidate NN O
genes NNS O
for IN O
BRCA1 NNP O
in IN O
four CD O
members NNS O
of IN O
this DT O
family NN O
. . O

No DT O
germline NN O
mutations NNS O
were VBD O
detected VBN O
. . O

Myotonic NNP B-Disease
dystrophy NN I-Disease
kinase NN O
is VBZ O
a DT O
component NN O
of IN O
neuromuscular JJ O
junctions NNS O
. . O

The DT O
clinical JJ O
manifestation NN O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
correlated VBN O
to TO O
the DT O
extent NN O
of IN O
expansion NN O
of IN O
an DT O
unstable JJ O
[ NN O
CTG NNP O
] NNP O
n MD O
DNA NNP O
motif NN O
. . O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
this DT O
trinucleotide NN O
motif NN O
forms NNS O
part NN O
of IN O
the DT O
last JJ O
, , O
3 CD O
untranslated JJ O
exon NN O
of IN O
a DT O
gene NN O
which WDT O
potentially RB O
encodes VBZ O
multiple JJ O
protein NN O
isoforms NNS O
of IN O
a DT O
serine NN O
/ NNP O
threonine NN O
protein NN O
kinase NN O
( ( O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
, , O
DM NNP O
- : O
PK NN O
) ) O
. . O

We PRP O
report VBP O
here RB O
on IN O
the DT O
development NN O
of IN O
antisera NN O
against IN O
synthetic JJ O
DM NNP O
- : O
PK NNP O
peptide NN O
antigens NNS O
and CC O
their PRP$ O
use NN O
in IN O
biochemical JJ O
and CC O
histochemical JJ O
studies NNS O
. . O

Immunoreactive JJ O
DM NNP O
- : O
kinase NN O
protein NN O
of IN O
53 CD O
kD NN O
is VBZ O
present JJ O
at IN O
low JJ O
levels NNS O
in IN O
skeletal NN O
and CC O
cardiac JJ O
muscle NN O
extracts NNS O
of IN O
DM NNP B-Disease
patients NNS O
and CC O
normal JJ O
controls NNS O
. . O

Immunohistochemical JJ O
staining NN O
revealed VBD O
that IN O
DM NNP O
- : O
PK NN O
is VBZ O
localised VBN O
prominently RB O
at IN O
sites NNS O
of IN O
neuromuscular JJ O
and CC O
myotendinous JJ O
junctions NNS O
( ( O
NMJs NNP O
and CC O
MTJs NNP O
) ) O
of IN O
human NN O
and CC O
rodent NN O
skeletal JJ O
muscles NNS O
. . O

Furthermore RB O
, , O
very RB O
low JJ O
levels NNS O
of IN O
immunoreactive JJ O
DM NNP O
- : O
PK NNP O
protein NN O
are VBP O
present JJ O
in IN O
the DT O
sarcoplasm NN O
of IN O
predominantly RB O
type JJ O
I PRP O
fibres VBP O
in IN O
various JJ O
muscles NNS O
. . O

Strikingly RB O
, , O
presence NN O
of IN O
the DT O
protein NN O
can MD O
also RB O
be VB O
demonstrated VBN O
for IN O
NMJs NNP O
of IN O
muscular JJ O
tissues NNS O
of IN O
adult NN O
and CC O
congenital JJ O
cases NNS O
of IN O
DM NNP B-Disease
, , O
with IN O
no DT O
gross JJ O
changes NNS O
in IN O
structural JJ O
organisation NN O
. . O

Our PRP$ O
findings NNS O
provide VBP O
a DT O
basis NN O
for IN O
further JJ O
characterisation NN O
of IN O
the DT O
role NN O
of IN O
the DT O
kinase NN O
in IN O
protein NN O
assembly NN O
processes VBZ O
or CC O
signal JJ O
mediation NN O
at IN O
synaptic JJ O
sites NNS O
and CC O
ultimately RB O
for IN O
the DT O
understanding NN O
of IN O
the DT O
complex JJ O
pathophysiology NN O
of IN O
DM NNP B-Disease
. . O
. . O

Markedly RB O
accelerated VBD O
catabolism NN O
of IN O
apolipoprotein NN O
A NNP O
- : O
II NNP O
( ( O
ApoA NNP O
- : O
II NNP O
) ) O
and CC O
high JJ O
density NN O
lipoproteins VBZ O
containing VBG O
ApoA NNP O
- : O
II NN O
in IN O
classic JJ O
lecithin NN O
: : O
cholesterol NN B-Disease
acyltransferase NN I-Disease
deficiency NN I-Disease
and CC O
fish JJ B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
. . O

Classic JJ B-Disease
( ( I-Disease
complete JJ I-Disease
) ) I-Disease
lecithin FW I-Disease
cholesterol NN I-Disease
acyltransferase NN I-Disease
( ( I-Disease
LCAT NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
and CC O
Fish NNP B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
( ( O
partial JJ B-Disease
LCAT NNP I-Disease
deficiency NN I-Disease
) ) O
are VBP O
genetic JJ O
syndromes NNS O
associated VBN O
with IN O
markedly RB O
decreased VBN O
plasma NN O
levels NNS O
of IN O
high JJ O
density NN O
lipoprotein NN O
( ( O
HDL NNP O
) ) O
cholesterol NN O
but CC O
not RB O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
atherosclerotic JJ B-Disease
cardiovascular JJ I-Disease
disease NN I-Disease
. . O

We PRP O
investigated VBD O
the DT O
metabolism NN O
of IN O
the DT O
HDL NNP O
apolipoproteins NNS O
( ( O
apo NN O
) ) O
apoA IN O
- : O
I PRP O
and CC O
apoA VB O
- : O
II NNP O
in IN O
a DT O
total NN O
of IN O
five CD O
patients NNS O
with IN O
LCAT NNP B-Disease
deficiency NN I-Disease
, , O
one CD O
with IN O
classic JJ B-Disease
LCAT NNP I-Disease
deficiency NN I-Disease
and CC O
four CD O
with IN O
Fish NNP B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
. . O

Plasma NNP O
levels NNS O
of IN O
apoA NN O
- : O
II NNP O
were VBD O
decreased VBN O
to TO O
a DT O
proportionately RB O
greater JJR O
extent NN O
( ( O
23 CD O
% NN O
of IN O
normal JJ O
) ) O
than IN O
apoA SYM O
- : O
I PRP O
( ( O
30 CD O
% NN O
of IN O
normal JJ O
) ) O
. . O

In IN O
addition NN O
, , O
plasma JJ O
concentrations NNS O
of IN O
HDL NNP O
particles NNS O
containing VBG O
both DT O
apoA IN O
- : O
I PRP O
and CC O
apoA VB O
- : O
II NNP O
( ( O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NN O
) ) O
were VBD O
much JJ O
lower JJR O
( ( O
18 CD O
% NN O
of IN O
normal JJ O
) ) O
than IN O
those DT O
of IN O
particles NNS O
containing VBG O
only RB O
apoA JJ O
- : O
I PRP O
( ( O
LpA NNP O
- : O
I PRP O
) ) O
( ( O
51 CD O
% NN O
of IN O
normal JJ O
) ) O
. . O

The DT O
metabolic JJ O
basis NN O
for IN O
the DT O
low JJ O
levels NNS O
of IN O
apoA NN O
- : O
II NNP O
and CC O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NN O
was VBD O
investigated VBN O
in IN O
all DT O
five CD O
patients NNS O
using VBG O
both DT O
exogenous JJ O
radiotracer NN O
and CC O
endogenous JJ O
stable JJ O
isotope NN O
labeling VBG O
techniques NNS O
. . O

The DT O
mean JJ O
plasma NN O
residence NN O
time NN O
of IN O
apoA JJ O
- : O
I PRP O
was VBD O
decreased VBN O
at IN O
2 CD O
. . O

8 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O

27 CD O
d NN O
( ( O
controls VBZ O
4 CD O
. . O
74 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
65 CD O
days NNS O
) ) O
; : O
however RB O
, , O
the DT O
residence NN O
time NN O
of IN O
apoA JJ O
- : O
II NN O
was VBD O
even RB O
shorter JJR O
at IN O
1 CD O
. . O

66 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O

24 CD O
d NN O
( ( O
controls VBZ O
5 CD O
. . O
25 CD O
+ JJ O
/ NNP O
- : O
0 CD O
. . O
61 CD O
d NN O
) ) O
. . O

In IN O
addition NN O
, , O
the DT O
catabolism NN O
of IN O
apoA JJ O
- : O
I PRP O
in IN O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NN O
was VBD O
substantially RB O
faster JJR O
than IN O
that DT O
of IN O
apoA JJ O
- : O
I PRP O
in IN O
LpA NNP O
- : O
I PRP O
. . O

In IN O
summary JJ O
, , O
genetic JJ O
syndromes NNS O
of IN O
either DT O
complete JJ B-Disease
or CC I-Disease
partial JJ I-Disease
LCAT NNP I-Disease
deficiency NN I-Disease
result NN O
in IN O
low JJ O
levels NNS O
of IN O
HDL NNP O
through IN O
preferential JJ O
hypercatabolism NN O
of IN O
apoA JJ O
- : O
II NN O
and CC O
HDL NNP O
particles NNS O
containing VBG O
apoA SYM O
- : O
II NN O
. . O

Because IN O
LpA NNP O
- : O
I PRP O
has VBZ O
been VBN O
proposed VBN O
to TO O
be VB O
more RBR O
protective JJ O
than IN O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NNP O
against IN O
atherosclerosis NN B-Disease
, , O
this DT O
selective JJ O
effect NN O
on IN O
the DT O
metabolism NN O
of IN O
LpA NNP O
- : O
I PRP O
A VBP O
- : O
II NN O
may MD O
provide VB O
a DT O
potential JJ O
explanation NN O
why WRB O
patients NNS O
with IN O
classic JJ B-Disease
LCAT NNP I-Disease
deficiency NN I-Disease
and CC O
Fish NNP B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
are VBP O
not RB O
at IN O
increased VBN O
risk NN O
for IN O
premature JJ O
atherosclerosis NN B-Disease
despite IN O
markedly RB O
decreased JJ O
levels NNS O
of IN O
HDL NNP O
cholesterol NN O
and CC O
apoA JJ O
- : O
I PRP O

X NN B-Disease
linked VBD I-Disease
recessive JJ I-Disease
thrombocytopenia NN I-Disease
. . O

A DT O
Saudi NNP O
Arab NNP O
boy NN O
presented VBN O
in IN O
early JJ O
childhood NN O
with IN O
thrombocytopenia NN B-Disease
, , O
morphologically RB O
large JJ O
and CC O
normal JJ O
sized JJ O
platelets NNS O
, , O
increased VBD O
mean JJ O
platelet NN O
volume NN O
, , O
and CC O
a DT O
hypermegakaryocytic JJ O
bone NN O
marrow NN O
. . O

There EX O
was VBD O
no DT O
clinical JJ O
and CC O
laboratory JJ O
evidence NN O
of IN O
any DT O
significant JJ O
immunological JJ B-Disease
abnormalities NNS I-Disease
. . O

Similar JJ O
findings NNS O
in IN O
two CD O
other JJ O
brothers NNS O
suggested VBD O
strongly RB O
that IN O
they PRP O
were VBD O
all DT O
suffering VBG O
from IN O
an DT O
X NN B-Disease
linked VBD I-Disease
recessive JJ I-Disease
thrombocytopenic JJ I-Disease
disorder NN I-Disease
. . O

Results NNS O
of IN O
DNA NNP O
analysis NN O
with IN O
the DT O
probe NN O
M27 NNP O
beta NN O
are VBP O
consistent JJ O
with IN O
X NNP O
linkage NN O
and CC O
indicate NN O
also RB O
that IN O
the DT O
locus NN O
of IN O
the DT O
relevant JJ O
gene NN O
lies VBZ O
close RB O
to TO O
or CC O
is VBZ O
identical JJ O
to TO O
the DT O
locus NN O
of IN O
the DT O
gene NN O
for IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
. . O

Because IN O
of IN O
various JJ O
features NNS O
which WDT O
include VBP O
the DT O
presence NN O
of IN O
large JJ O
and CC O
normal JJ O
sized VBN O
platelets NNS O
( ( O
rather RB O
than IN O
small JJ O
platelets NNS O
) ) O
and CC O
freedom NN O
from IN O
significant JJ O
immune JJ B-Disease
deficiencies NNS I-Disease
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
X NNP B-Disease
linked VBD I-Disease
recessive JJ I-Disease
thrombocytopenia NN I-Disease
in IN O
this DT O
family NN O
is VBZ O
an DT O
isolated JJ O
entity NN O
quite RB O
distinct JJ O
from IN O
the DT O
classical JJ O
WAS NNP B-Disease
phenotype NN O
. . O

However RB O
, , O
a DT O
modified JJ O
expression NN O
of IN O
the DT O
WAS NNP B-Disease
gene NN O
producing VBG O
a DT O
mild JJ O
phenotypic NN O
variant NN O
cannot NN O
be VB O
excluded VBN O
entirely RB O
. . O
. . O

Macular JJ B-Disease
dystrophy NN I-Disease
associated VBN O
with IN O
mutations NNS O
at IN O
codon NN O
172 CD O
in IN O
the DT O
human JJ O
retinal JJ B-Disease
degeneration NN I-Disease
slow JJ O
gene NN O
. . O

BACKGROUND NNP O
Recently NNP O
, , O
mutations NNS O
in IN O
the DT O
retinal JJ B-Disease
degeneration NN I-Disease
slow NN O
( ( O
rds NNS O
) ) O
gene NN O
which WDT O
codes VBZ O
for IN O
peripherin NN O
- : O
rds NNS O
have VBP O
been VBN O
implicated VBN O
as IN O
a DT O
cause NN O
of IN O
autosomal JJ B-Disease
dominant JJ I-Disease
retinitis NN I-Disease
pigmentosa NN I-Disease
. . O

Because IN O
this DT O
gene NN O
is VBZ O
expressed VBN O
in IN O
both DT O
rods NNS O
and CC O
cones NNS O
, , O
mutations NNS O
in IN O
the DT O
rds NNS O
gene NN O
might MD O
be VB O
expected VBN O
to TO O
cause VB O
degeneration NN O
affecting VBG O
either CC O
the DT O
scotopic NN O
or CC O
photopic NN O
systems NNS O
. . O

Mutations NNS O
at IN O
codon JJ O
172 CD O
of IN O
the DT O
rds NNS O
gene NN O
have VBP O
been VBN O
identified VBN O
in IN O
three CD O
families NNS O
with IN O
autosomal JJ O
dominantly RB O
inherited VBN O
, , O
progressive JJ O
macular NN B-Disease
dystrophy NN I-Disease
. . O

METHODS NNP O
Affected NNP O
individuals NNS O
underwent JJ O
ophthalmic JJ O
examination NN O
, , O
scotopic JJ O
perimetry NN O
, , O
dark JJ O
adaptometry NN O
, , O
measurement NN O
of IN O
color NN O
- : O
contrast NN O
sensitivity NN O
, , O
and CC O
electroretinography NN O
to TO O
characterize VB O
the DT O
photoreceptor NN O
dysfunction NN O
. . O

RESULTS NNP O
In IN O
all DT O
but CC O
one CD O
affected JJ O
member NN O
, , O
symptoms NNS O
of IN O
progressive JJ O
central JJ O
visual JJ B-Disease
loss NN I-Disease
developed VBN O
in IN O
the DT O
third JJ O
or CC O
fourth JJ O
decade NN O
of IN O
life NN O
accompanied VBN O
by IN O
central JJ B-Disease
scotoma NN I-Disease
and CC O
well RB O
- : O
demarcated VBN O
atrophy NN B-Disease
of IN I-Disease
the DT I-Disease
retinal JJ I-Disease
pigment NN I-Disease
epithelium NN I-Disease
and CC O
choriocapillaris NN B-Disease
of IN I-Disease
the DT I-Disease
macula NN I-Disease
. . O

In IN O
general JJ O
, , O
cone NN O
and CC O
rod NN O
thresholds NNS O
were VBD O
elevated VBN O
, , O
and CC O
color NN O
- : O
contrast NN O
sensitivity NN O
was VBD O
absent JJ O
in IN O
the DT O
central JJ O
visual JJ O
field NN O
. . O

Peripherally RB O
, , O
the DT O
scotopic NN O
sensitivities NNS O
were VBD O
normal JJ O
, , O
as IN O
was VBD O
the DT O
recovery NN O
from IN O
bleach NN O
. . O

Cone NN O
electroretinograms NNS O
were VBD O
diminished VBN O
in IN O
amplitude NN O
, , O
and CC O
delayed VBN O
in IN O
all DT O
affected JJ O
adults NNS O
except IN O
one CD O
. . O

Rod NNP O
electroretinograms NNS O
were VBD O
normal JJ O
or CC O
near JJ O
normal JJ O
in IN O
amplitude NN O
, , O
and CC O
had VBD O
normal JJ O
implicit JJ O
times NNS O
. . O

Affected NNP O
asymptomatic JJ O
children NNS O
had VBD O
macular JJ O
changes NNS O
, , O
abnormal JJ O
color NN O
- : O
contrast NN O
sensitivity NN O
, , O
and CC O
reduced JJ O
pattern NN O
and CC O
cone NN O
electroretinograms NNS O
. . O

CONCLUSION NNP O
These DT O
results NNS O
indicate VBP O
that IN O
mutations NNS O
in IN O
the DT O
rds NNS O
gene NN O
can MD O
be VB O
expressed VBN O
as IN O
a DT O
macular JJ B-Disease
dystrophy NN I-Disease
, , O
with IN O
evidence NN O
of IN O
primary JJ O
cone NN B-Disease
dysfunction NN I-Disease
and CC O
preservation NN O
of IN O
peripheral JJ O
rod NN O
function NN O
. . O
. . O

Anonymous JJ O
marker NN O
loci NN O
within IN O
400 CD O
kb NNS O
of IN O
HLA NNP O
- : O
A DT O
generate NN O
haplotypes NNS O
in IN O
linkage NN O
disequilibrium NN O
with IN O
the DT O
hemochromatosis NN B-Disease
gene NN O
( ( O
HFE NNP O
) ) O

The DT O
hemochromatosis NN B-Disease
gene NN O
( ( O
HFE NNP O
) ) O
maps VBZ O
to TO O
6p21 CD O
. . O

3 CD O
and CC O
is VBZ O
less JJR O
than IN O
1 CD O
cM NN O
from IN O
the DT O
HLA NNP O
class NN O
I PRP O
genes NNS O
; : O
however RB O
, , O
the DT O
precise JJ O
physical JJ O
location NN O
of IN O
the DT O
gene NN O
has VBZ O
remained VBN O
elusive JJ O
and CC O
controversial JJ O
. . O

The DT O
unambiguous JJ O
identification NN O
of IN O
a DT O
crossover NN O
event NN O
within IN O
hemochromatosis NN B-Disease
families NNS O
is VBZ O
very RB O
difficult JJ O
; : O
it PRP O
is VBZ O
particularly RB O
hampered VBN O
by IN O
the DT O
variability NN O
of IN O
the DT O
phenotypic NN O
expression NN O
as RB O
well RB O
as IN O
by IN O
the DT O
sex NN O
- : O
and CC O
age NN O
- : O
related JJ O
penetrance NN O
of IN O
the DT O
disease NN O
. . O

For IN O
these DT O
practical JJ O
considerations NNS O
, , O
traditional JJ O
linkage NN O
analysis NN O
could MD O
prove VB O
of IN O
limited JJ O
value NN O
in IN O
further JJ O
refining VBG O
the DT O
extrapolated JJ O
physical JJ O
position NN O
of IN O
HFE NNP O
. . O

We PRP O
therefore VBP O
embarked JJ O
upon IN O
a DT O
linkage NN O
- : O
disequilibrium NN O
analysis NN O
of IN O
HFE NNP O
and CC O
normal JJ O
chromosomes NNS O
from IN O
the DT O
Brittany NNP O
population NN O
. . O

In IN O
the DT O
present JJ O
report NN O
, , O
66 CD O
hemochromatosis NN B-Disease
families NNS O
yielding VBG O
151 CD O
hemochromatosis NN B-Disease
chromosomes NNS O
and CC O
182 CD O
normal JJ O
chromosomes NNS O
were VBD O
RFLP NNP O
- : O
typed VBD O
with IN O
a DT O
battery NN O
of IN O
probes NNS O
, , O
including VBG O
two CD O
newly RB O
derived VBN O
polymorphic JJ O
markers NNS O
from IN O
the DT O
6 CD O
. . O

7 CD O
and CC O
HLA NNP O
- : O
F NNP O
loci NN O
located VBD O
150 CD O
and CC O
250 CD O
kb NNS O
telomeric JJ O
to TO O
HLA NNP O
- : O
A NN O
, , O
respectively RB O
. . O

The DT O
results NNS O
suggest VBP O
a DT O
strong JJ O
peak NN O
of IN O
existing VBG O
linkage NN O
disequilibrium NN O
focused VBD O
within IN O
the DT O
i82 JJ O
- : O
to TO O
- : O
6 CD O
. . O

7 CD O
interval NN O
( ( O
approximately RB O
250 CD O
kb NN O
) ) O
. . O

The DT O
zone NN O
of IN O
linkage NN O
disequilibrium NN O
is VBZ O
flanked VBN O
by IN O
the DT O
i97 NN O
locus NN O
, , O
positioned VBD O
30 CD O
kb NNS O
proximal JJ O
to TO O
i82 VB O
, , O
and CC O
the DT O
HLA NNP O
- : O
F NNP O
gene NN O
, , O
found VBD O
250 CD O
kb NNS O
distal JJ O
to TO O
HLA NNP O
- : O
A NN O
, , O
markers NNS O
of IN O
which WDT O
display VBP O
no DT O
significant JJ O
association NN O
with IN O
HFE NNP O
. . O

These DT O
data NNS O
support NN O
the DT O
possibility NN O
that IN O
HFE NNP O
resides NNS O
within IN O
the DT O
400 CD O
- : O
kb NN O
expanse NN O
of IN O
DNA NNP O
between IN O
i97 NN O
and CC O
HLA NNP O
- : O
F NN O
. . O

Alternatively RB O
, , O
the DT O
very RB O
tight JJ O
association NN O
of IN O
HLA NNP O
- : O
A3 NNP O
and CC O
allele VBD O
1 CD O
of IN O
the DT O
6 CD O
. . O

7 CD O
locus NN O
, , O
both DT O
of IN O
which WDT O
are VBP O
comprised VBN O
by IN O
the DT O
major JJ O
ancestral JJ O
or CC O
founder NN O
HFE NNP O
haplotype NN O
in IN O
Brittany NNP O
, , O
supports VBZ O
the DT O
possibility NN O
that IN O
the DT O
disease NN O
gene NN O
may MD O
reside VB O
immediately RB O
telomeric JJ O
to TO O
the DT O
6 CD O
. . O

7 CD O
locus NN O
within IN O
the DT O
linkage NN O
- : O
disequilibrium NN O
zone NN O
. . O

Additionally RB O
, , O
hemochromatosis NN B-Disease
haplotypes NNS O
possessing VBG O
HLA NNP O
- : O
A11 NN O
and CC O
the DT O
low JJ O
- : O
frequency NN O
HLA NNP O
- : O
F NN O
polymorphism NN O
( ( O
allele JJ O
2 CD O
) ) O
are VBP O
supportive JJ O
of IN O
a DT O
separate JJ O
founder NN O
chromosome NN O
containing VBG O
a DT O
second JJ O
, , O
independently RB O
arising VBG O
mutant JJ O
allele NN O
. . O

Overall JJ O
, , O
the DT O
establishment NN O
of IN O
a DT O
likely JJ O
"""" JJ O
hemochromatosis NN B-Disease
critical JJ O
region NN O
"""" NNP O
centromeric NN O
boundary NN O
and CC O
the DT O
identification NN O
of IN O
a DT O
linkage NN O
- : O
disequilibrium NN O
zone NN O
both DT O
significantly RB O
contribute VBP O
to TO O
a DT O
reduction NN O
in IN O
the DT O
amount NN O
of IN O
DNA NN O
required VBN O
to TO O
be VB O
searched VBN O
for IN O
novel JJ O
coding NN O
sequences NNS O
constituting VBG O
the DT O
HFE NNP B-Disease
defect NN I-Disease

Genomic NNP O
structure NN O
of IN O
the DT O
EWS NNP O
gene NN O
and CC O
its PRP$ O
relationship NN O
to TO O
EWSR1 NNP O
, , O
a DT O
site NN O
of IN O
tumor NN B-Disease
- : O
associated VBN O
chromosome NN O
translocation NN O
. . O

The DT O
EWS NNP O
gene NN O
has VBZ O
been VBN O
identified VBN O
based VBN O
on IN O
its PRP$ O
location NN O
at IN O
the DT O
chromosome NN O
22 CD O
breakpoint NN O
of IN O
the DT O
t NN O
( ( O
11 CD O
; : O
22 CD O
) ) O
( ( O
q24 NN O
; : O
q12 CC O
) ) O
translocation NN O
that IN O
characterizes VBZ O
Ewing NNP B-Disease
sarcoma NN I-Disease
and CC O
related VBN O
neuroectodermal JJ B-Disease
tumors NNS I-Disease
. . O

The DT O
EWS NNP O
gene NN O
spans NNS O
about IN O
40 CD O
kb NN O
of IN O
DNA NNP O
and CC O
is VBZ O
encoded VBN O
by IN O
17 CD O
exons NNS O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
exons NNS O
is VBZ O
identical JJ O
to TO O
that DT O
of IN O
the DT O
previously RB O
described VBN O
cDNA NN O
. . O

The DT O
first JJ O
7 CD O
exons NNS O
encode VBP O
the DT O
N NNP O
- : O
terminal JJ O
domain NN O
of IN O
EWS NNP O
, , O
which WDT O
consists VBZ O
of IN O
a DT O
repeated VBN O
degenerated JJ O
polypeptide NN O
of IN O
7 CD O
to TO O
12 CD O
residues NNS O
rich JJ O
in IN O
tyrosine NN O
, , O
serine NN O
, , O
threonine NN O
, , O
glycine NN O
, , O
and CC O
glutamine NN O
. . O

Exons NNS O
11 CD O
, , O
12 CD O
, , O
and CC O
13 CD O
encode NN O
the DT O
putative JJ O
RNA NNP O
binding NN O
domain NN O
. . O

The DT O
three CD O
glycine NN O
- : O
and CC O
arginine VB O
- : O
rich JJ O
motifs NNS O
of IN O
the DT O
gene NN O
are VBP O
mainly RB O
encoded VBN O
by IN O
exons NNS O
8 CD O
- : O
9 CD O
, , O
14 CD O
, , O
and CC O
16 CD O
. . O

The DT O
DNA NN O
sequence NN O
in IN O
the DT O
5 CD O
region NN O
of IN O
the DT O
gene NN O
has VBZ O
features NNS O
of IN O
a DT O
CpG NNP O
- : O
rich JJ O
island NN O
and CC O
lacks VBZ O
canonical JJ O
promoter NN O
elements NNS O
, , O
such JJ O
as IN O
TATA NNP O
and CC O
CCAAT NNP O
consensus NN O
sequences NNS O
. . O

Positions NNS O
of IN O
the DT O
chromosome NN O
22 CD O
breakpoints NNS O
were VBD O
determined VBN O
for IN O
19 CD O
Ewing NNP B-Disease
tumors NNS I-Disease
. . O

They PRP O
were VBD O
localized VBN O
in IN O
introns NNS O
7 CD O
or CC O
8 CD O
in IN O
18 CD O
cases NNS O
and CC O
in IN O
intron NN O
10 CD O
in IN O
1 CD O
case NN O
. . O
. . O

Norrie NNP B-Disease
disease NN I-Disease
gene NN O
: : O
characterization NN O
of IN O
deletions NNS O
and CC O
possible JJ O
function NN O
. . O

Positional JJ O
cloning NN O
experiments NNS O
have VBP O
resulted VBN O
recently RB O
in IN O
the DT O
isolation NN O
of IN O
a DT O
candidate NN O
gene NN O
for IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
pseudoglioma NN B-Disease
; : O
NDP NNP B-Disease
) ) O
, , O
a DT O
severe JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
neurodevelopmental JJ I-Disease
disorder NN I-Disease
. . O

Here RB O
we PRP O
report VBP O
the DT O
isolation NN O
and CC O
analysis NN O
of IN O
human JJ O
genomic JJ O
DNA NNP O
clones NNS O
encompassing VBG O
the DT O
NDP NNP B-Disease
gene NN O
. . O

The DT O
gene NN O
spans VBZ O
28 CD O
kb NN O
and CC O
consists VBZ O
of IN O
3 CD O
exons NNS O
, , O
the DT O
first JJ O
of IN O
which WDT O
is VBZ O
entirely RB O
contained VBN O
within IN O
the DT O
5 CD O
untranslated JJ O
region NN O
. . O

Detailed JJ O
analysis NN O
of IN O
genomic JJ O
deletions NNS O
in IN O
Norrie NNP B-Disease
patients NNS O
shows VBZ O
that IN O
they PRP O
are VBP O
heterogeneous JJ O
, , O
both DT O
in IN O
size NN O
and CC O
in IN O
position NN O
. . O

By IN O
PCR NNP O
analysis NN O
, , O
we PRP O
found VBD O
that IN O
expression NN O
of IN O
the DT O
NDP NNP B-Disease
gene NN O
was VBD O
not RB O
confined VBN O
to TO O
the DT O
eye NN O
or CC O
to TO O
the DT O
brain NN O
. . O

An DT O
extensive JJ O
DNA NN O
and CC O
protein JJ O
sequence NN O
comparison NN O
between IN O
the DT O
human JJ O
NDP NNP B-Disease
gene NN O
and CC O
related VBN O
genes NNS O
from IN O
the DT O
database NN O
revealed VBD O
homology NN O
with IN O
cysteine JJ O
- : O
rich JJ O
protein NN O
- : O
binding NN O
domains NNS O
of IN O
immediate JJ O
- : O
- : O
early JJ O
genes NNS O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
proliferation NN O
. . O

We PRP O
propose VBP O
that IN O
NDP NNP O
is VBZ O
a DT O
molecule NN O
related VBN O
in IN O
function NN O
to TO O
these DT O
genes NNS O
and CC O
may MD O
be VB O
involved VBN O
in IN O
a DT O
pathway NN O
that WDT O
regulates VBZ O
neural JJ O
cell NN O
differentiation NN O
and CC O
proliferation NN O
. . O
. . O

The DT O
normal JJ O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
allele NN O
, , O
or CC O
a DT O
closely RB O
linked VBN O
gene NN O
, , O
influences NNS O
age NN O
at IN O
onset NN O
of IN O
HD NNP B-Disease
. . O

We PRP O
evaluated VBD O
the DT O
hypothesis NN O
that IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
is VBZ O
influenced VBN O
by IN O
the DT O
normal JJ O
HD NNP B-Disease
allele NN O
by IN O
comparing VBG O
transmission NN O
patterns NNS O
of IN O
genetically RB O
linked VBN O
markers NNS O
at IN O
the DT O
D4S10 NNP O
locus NN O
in IN O
the DT O
normal JJ O
parent NN O
against IN O
age NN O
at IN O
onset NN O
in IN O
the DT O
affected JJ O
offspring NN O
. . O

Analysis NN O
of IN O
information NN O
from IN O
21 CD O
sibships NNS O
in IN O
14 CD O
kindreds NNS O
showed VBD O
a DT O
significant JJ O
tendency NN O
for IN O
sibs NN O
who WP O
have VBP O
similar JJ O
onset VBN O
ages NNS O
to TO O
share NN O
the DT O
same JJ O
D4S10 NNP O
allele NN O
from IN O
the DT O
normal JJ O
parent NN O
. . O

Affected JJ O
sibs NN O
who WP O
inherited VBD O
different JJ O
D4S10 NNP O
alleles NNS O
from IN O
the DT O
normal JJ O
parent NN O
tended VBD O
to TO O
have VB O
more RBR O
variable JJ O
ages NNS O
at IN O
onset NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
expression NN O
of IN O
HD NNP B-Disease
is VBZ O
modulated VBN O
by IN O
the DT O
normal JJ O
HD NNP B-Disease
allele NN O
or CC O
by IN O
a DT O
closely RB O
linked VBN O
locus NN O
. . O
. . O

Further JJ O
investigation NN O
of IN O
the DT O
HEXA NNP O
gene NN O
intron NN O
9 CD O
donor NN O
splice NN O
site NN O
mutation NN O
frequently RB O
found VBN O
in IN O
non JJ O
- : O
Jewish JJ O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
patients NNS O
from IN O
the DT O
British JJ O
Isles NNP O
. . O

In IN O
a DT O
previous JJ O
study NN O
we PRP O
found VBD O
that IN O
a DT O
Tay NNP B-Disease
- : I-Disease
Sachs NNP I-Disease
disease NN I-Disease
( ( O
TSD NNP B-Disease
) ) O
causing VBG O
mutation NN O
in IN O
the DT O
intron NN O
9 CD O
donor NN O
splice NN O
site NN O
of IN O
the DT O
HEXA NNP O
gene NN O
occurs VBZ O
at IN O
high JJ O
frequency NN O
in IN O
non JJ O
- : O
Jewish JJ O
patients NNS O
and CC O
carriers NNS O
from IN O
the DT O
British JJ O
Isles NNP O
. . O

It PRP O
was VBD O
found VBN O
more RBR O
frequently RB O
in IN O
subjects NNS O
of IN O
Irish NNP O
, , O
Scottish NNP O
, , O
and CC O
Welsh NNP O
origin VBP O
compared VBN O
with IN O
English NNP O
origin NN O
( ( O
63 CD O
% NN O
and CC O
31 CD O
% NN O
respectively RB O
) ) O
. . O

We PRP O
have VBP O
now RB O
tested VBN O
, , O
in IN O
a DT O
blind NN O
study NN O
, , O
26 CD O
American JJ O
TSD NNP B-Disease
carriers NNS O
and CC O
28 CD O
non JJ O
- : O
carriers NNS O
who WP O
have VBP O
British JJ O
ancestry NN O
for IN O
the DT O
intron NN O
9 CD O
splice NN O
site NN O
mutation NN O
. . O

Six CD O
of IN O
the DT O
carriers NNS O
and CC O
none NN O
of IN O
the DT O
controls NNS O
were VBD O
positive JJ O
for IN O
the DT O
mutation NN O
. . O

All DT O
six CD O
had VBD O
Irish NNP O
ancestry NN O
, , O
compared VBN O
with IN O
nine CD O
of IN O
the DT O
20 CD O
other JJ O
( ( O
intron JJ O
9 CD O
mutation NN O
negative JJ O
) ) O
TSD FW B-Disease
carriers NNS O
( ( O
p VB O
< RB O
0 CD O
. . O
5 CD O
) ) O
. . O

These DT O
results NNS O
confirm VBP O
the DT O
previously RB O
found VBN O
high JJ O
frequency NN O
of IN O
the DT O
intron NN O
9 CD O
mutation NN O
in IN O
non JJ O
- : O
Jewish JJ O
TSD NNP B-Disease
families NNS O
of IN O
British JJ O
Isles NNP O
, , O
particularly RB O
Irish JJ O
, , O
origin NN O
, , O
and CC O
reinforce VB O
the DT O
need NN O
to TO O
screen VB O
such JJ O
families NNS O
for IN O
this DT O
mutation NN O
. . O

Molecular JJ O
mechanisms NNS O
of IN O
oncogenic JJ O
mutations NNS O
in IN O
tumors NNS B-Disease
from IN O
patients NNS O
with IN O
bilateral JJ B-Disease
and CC I-Disease
unilateral JJ I-Disease
retinoblastoma NN I-Disease
. . O

The DT O
RB1 NNP O
gene NN O
from IN O
12 CD O
human JJ O
retinoblastoma NN B-Disease
tumors NNS I-Disease
has VBZ O
been VBN O
analyzed VBN O
exon SYM O
- : O
by IN O
- : O
exon NN O
with IN O
the DT O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
technique NN O
. . O

Mutations NNS O
were VBD O
found VBN O
in IN O
all DT O
tumors NNS B-Disease
, , O
and CC O
one CD O
- : O
third NN O
of IN O
the DT O
tumors NNS B-Disease
had VBD O
independent JJ O
mutations NNS O
in IN O
both DT O
alleles NNS O
neither DT O
of IN O
which WDT O
were VBD O
found VBN O
in IN O
the DT O
germ JJ O
line NN O
, , O
confirming VBG O
their PRP$ O
true JJ O
sporadic JJ O
nature NN O
. . O

In IN O
the DT O
remaining VBG O
two CD O
- : O
thirds NNS O
of IN O
the DT O
tumors NNS B-Disease
only RB O
one CD O
mutation NN O
was VBD O
found VBN O
, , O
consistent JJ O
with IN O
the DT O
loss NN O
- : O
of IN O
- : O
heterozygosity NN O
theory NN O
of IN O
tumorigenesis NN O
. . O

Point NN O
mutations NNS O
, , O
the DT O
majority NN O
of IN O
which WDT O
were VBD O
C NNP O
- : O
- : O
> NN O
T NNP O
transitions NNS O
, , O
were VBD O
the DT O
most RBS O
common JJ O
abnormality NN O
and CC O
usually RB O
resulted VBN O
in IN O
the DT O
conversion NN O
of IN O
an DT O
arginine JJ O
codon NN O
to TO O
a DT O
stop JJ O
codon NN O
. . O

Small JJ O
deletions NNS O
were VBD O
the DT O
second JJ O
most RBS O
common JJ O
abnormality NN O
and CC O
most RBS O
often RB O
created VBD O
a DT O
downstream NN O
stop NN O
codon NN O
as IN O
the DT O
result NN O
of IN O
a DT O
reading NN O
frameshift NN O
. . O

Deletions NNS O
and CC O
point NN O
mutations NNS O
also RB O
affected VBD O
splice JJ O
junctions NNS O
. . O

Direct JJ O
repeats NNS O
were VBD O
present JJ O
at IN O
the DT O
breakpoint NN O
junctions NNS O
in IN O
the DT O
majority NN O
of IN O
deletions NNS O
, , O
supporting VBG O
a DT O
slipped JJ O
- : O
mispairing NN O
mechanism NN O
. . O

Point NN O
mutations NNS O
generally RB O
produced VBN O
DNA NNP O
sequences NNS O
which WDT O
resulted VBD O
in IN O
perfect JJ O
homology NN O
with IN O
endogenous JJ O
sequences NNS O
which WDT O
lay VBD O
within IN O
14 CD O
bp NN O
. . O
. . O

PAX6 NNP O
mutations NNS O
in IN O
aniridia NN B-Disease
. . O

Aniridia NNP B-Disease
is VBZ O
a DT O
congenital JJ B-Disease
malformation NN I-Disease
of IN I-Disease
the DT I-Disease
eye NN I-Disease
, , O
chiefly NN O
characterised VBN O
by IN O
iris JJ B-Disease
hypoplasia NN I-Disease
, , O
which WDT O
can MD O
cause VB O
blindness NN B-Disease
. . O

The DT O
PAX6 NNP O
gene NN O
was VBD O
isolated VBN O
as IN O
a DT O
candidate NN O
aniridia NN B-Disease
gene NN O
by IN O
positional JJ O
cloning NN O
from IN O
the DT O
smallest JJS O
region NN O
of IN O
overlap NN O
of IN O
aniridia JJ B-Disease
- : O
associated VBN O
deletions NNS O
. . O

Subsequently RB O
PAX6 NNP O
intragenic JJ O
mutations NNS O
were VBD O
demonstrated VBN O
in IN O
Smalleye NNP O
, , O
a DT O
mouse NN O
mutant NN O
which WDT O
is VBZ O
an DT O
animal JJ O
model NN O
for IN O
aniridia NN B-Disease
, , O
and CC O
six CD O
human JJ O
aniridia NN B-Disease
patients NNS O
. . O

In IN O
this DT O
paper NN O
we PRP O
describe VBP O
four CD O
additional JJ O
PAX6 NNP O
point NN O
mutations NNS O
in IN O
aniridia NN B-Disease
patients NNS O
, , O
both DT O
sporadic JJ O
and CC O
familial JJ O
. . O

These DT O
mutations NNS O
highlight VBD O
regions NNS O
of IN O
the DT O
gene NN O
which WDT O
are VBP O
essential JJ O
for IN O
normal JJ O
PAX6 NNP O
function NN O
. . O

In IN O
addition NN O
, , O
the DT O
frequency NN O
at IN O
which WDT O
we PRP O
have VBP O
found VBN O
PAX6 NNP O
mutations NNS O
suggests VBZ O
that IN O
lesions NNS O
in IN O
PAX6 NNP O
will MD O
account VB O
for IN O
most JJS O
cases NNS O
of IN O
aniridia NN B-Disease
. . O
. . O

Detection NN O
of IN O
a DT O
novel JJ O
arginine NN O
vasopressin NN O
defect NN O
by IN O
dideoxy JJ O
fingerprinting NN O
. . O

Autosomal NNP B-Disease
dominant JJ I-Disease
neurohypophyseal NN I-Disease
diabetes NNS I-Disease
insipidus VBP I-Disease
is VBZ O
a DT O
familial JJ O
form NN O
of IN O
diabetes NNS B-Disease
insipidus VBP I-Disease
. . O

This DT O
disorder NN O
is VBZ O
associated VBN O
with IN O
variable JJ O
levels NNS O
of IN O
arginine NN O
vasopressin NN O
( ( O
AVP NNP O
) ) O
and CC O
diabetes VBZ B-Disease
insipidus NN I-Disease
of IN O
varying VBG O
severity NN O
, , O
which WDT O
responds VBZ O
to TO O
exogenous JJ O
AVP NNP O
. . O

To TO O
determine VB O
the DT O
molecular JJ O
basis NN O
of IN O
autosomal JJ B-Disease
dominant JJ I-Disease
neurohypophyseal NN I-Disease
diabetes VBZ I-Disease
insipidus RB I-Disease
, , O
the DT O
AVP NNP O
genes NNS O
of IN O
members NNS O
of IN O
a DT O
large JJ O
kindred VBN O
were VBD O
analyzed VBN O
. . O

A DT O
new JJ O
method NN O
, , O
called VBN O
dideoxy NN O
fingerprinting NN O
, , O
was VBD O
used VBN O
to TO O
detect VB O
an DT O
AVP NNP O
mutation NN O
that WDT O
was VBD O
characterized VBN O
by IN O
DNA NNP O
sequencing NN O
. . O

The DT O
novel NN O
defect NN O
found VBD O
changes VBZ O
the DT O
last JJ O
codon NN O
of IN O
the DT O
AVP NNP O
signal JJ O
peptide NN O
from IN O
alanine NN O
to TO O
threonine VB O
, , O
which WDT O
should MD O
perturb VB O
cleavage NN O
of IN O
mature NN O
AVP NNP O
from IN O
its PRP$ O
precursor NN O
protein NN O
and CC O
inhibit VB O
its PRP$ O
secretion NN O
or CC O
action NN O
. . O
. . O

Germinal JJ O
mosaicism NN O
in IN O
a DT O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
family NN O
: : O
implications NNS O
for IN O
genetic JJ O
counselling NN O
. . O

In IN O
this DT O
study NN O
we PRP O
describe VBP O
a DT O
three CD O
- : O
generation NN O
family NN O
in IN O
which WDT O
two CD O
siblings NNS O
were VBD O
affected VBN O
by IN O
Duchenne NNP B-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
DMD NNP B-Disease
) ) O
. . O

Immunohistochemical JJ O
analysis NN O
of IN O
muscle NN O
dystrophin NN O
and CC O
haplotype JJ O
analysis NN O
of IN O
the DT O
DMD NNP B-Disease
locus NN O
revealed VBD O
that IN O
the DT O
X NNP O
chromosome NN O
carrying VBG O
the DT O
DMD NNP B-Disease
gene NN O
was VBD O
transmitted VBN O
from IN O
the DT O
healthy JJ O
maternal NN O
grandfather NN O
to TO O
his PRP$ O
three CD O
daughters NNS O
, , O
including VBG O
the DT O
probands NNS O
mother NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
the DT O
grandfather NN O
was VBD O
a DT O
germinal JJ O
mosaic NN O
for IN O
the DT O
DMD NNP B-Disease
gene NN O
. . O

The DT O
definition NN O
of IN O
the DT O
carrier NN O
status NN O
in IN O
two CD O
possible JJ O
carriers NNS O
led VBD O
us PRP O
to TO O
give VB O
accurate JJ O
genetic JJ O
counselling NN O
and CC O
to TO O
prevent VB O
the DT O
birth NN O
of IN O
an DT O
affected JJ O
boy NN O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
demonstrate VB O
the DT O
usefulness NN O
of IN O
haplotype NN O
analysis NN O
and CC O
immunohistochemical JJ O
muscle NN O
dystrophin NN O
studies NNS O
to TO O
detect VB O
hidden JJ O
germinal JJ O
mosaicism NN O
and CC O
to TO O
improve VB O
genetic JJ O
counselling NN O
. . O
. . O

Genetic JJ O
mapping NN O
of IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
syndrome NN I-Disease
to TO O
a DT O
small JJ O
interval NN O
on IN O
chromosome NN O
17q12 CD O
- : O
21 CD O
: : O
exclusion NN O
of IN O
candidate NN O
genes NNS O
EDH17B2 NNP O
and CC O
RARA NNP O
. . O

A DT O
susceptibility NN O
gene NN O
for IN O
hereditary JJ B-Disease
breast NN I-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
BRCA1 NNP O
, , O
has VBZ O
been VBN O
assigned VBN O
by IN O
linkage NN O
analysis NN O
to TO O
chromosome VB O
17q21 CD O
. . O

Candidate NNP O
genes NNS O
in IN O
this DT O
region NN O
include VBP O
EDH17B2 NNP O
, , O
which WDT O
encodes VBZ O
estradiol VBP O
17 CD O
beta SYM O
- : O
hydroxysteroid NN O
dehydrogenase NN O
II NNP O
( ( O
17 CD O
beta SYM O
- : O
HSD NNP O
II NNP O
) ) O
, , O
and CC O
RARA NNP O
, , O
the DT O
gene NN O
for IN O
retinoic JJ O
acid JJ O
receptor NN O
alpha NN O
. . O

We PRP O
have VBP O
typed VBN O
22 CD O
breast NN B-Disease
and CC I-Disease
breast NN I-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
with IN O
eight CD O
polymorphisms NNS O
from IN O
the DT O
chromosome NN O
17q12 CD O
- : O
21 CD O
region NN O
, , O
including VBG O
two CD O
in IN O
the DT O
EDH17B2 NNP O
gene NN O
. . O

Genetic JJ O
recombination NN O
with IN O
the DT O
breast NN B-Disease
cancer NN I-Disease
trait NN O
excludes VBZ O
RARA NNP O
from IN O
further JJ O
consideration NN O
as IN O
a DT O
candidate NN O
gene NN O
for IN O
BRCA1 NNP O
. . O

Both DT O
BRCA1 NNP O
and CC O
EDH17B2 NNP O
map VBP O
to TO O
a DT O
6 CD O
cM NN O
interval NN O
( ( O
between IN O
THRA1 NNP O
and CC O
D17S579 NNP O
) ) O
and CC O
no DT O
recombination NN O
was VBD O
observed VBN O
between IN O
the DT O
two CD O
genes NNS O
. . O

However RB O
, , O
direct JJ O
sequencing NN O
of IN O
overlapping VBG O
PCR NNP O
products NNS O
containing VBG O
the DT O
entire JJ O
EDH17B2 NNP O
gene NN O
in IN O
four CD O
unrelated JJ O
affected VBD O
women NNS O
did VBD O
not RB O
uncover VB O
any DT O
sequence NN O
variation NN O
, , O
other JJ O
than IN O
previously RB O
described VBN O
polymorphisms NNS O
. . O

Mutations NNS O
in IN O
the DT O
EDH17B2 NNP O
gene NN O
, , O
therefore RB O
do VBP O
not RB O
appear VB O
to TO O
be VB O
responsible JJ O
for IN O
the DT O
hereditary JJ B-Disease
breast NN I-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
syndrome NN I-Disease
. . O

Single NNP O
meiotic JJ O
crossovers NNS O
in IN O
affected JJ O
women NNS O
suggest VBP O
that IN O
BRCA1 NNP O
is VBZ O
flanked VBN O
by IN O
the DT O
loci NN O
RARA NNP O
and CC O
D17S78 NNP O
. . O
. . O

A DT O
missense JJ O
mutation NN O
in IN O
the DT O
cholesteryl NN O
ester NN O
transfer NN O
protein VBZ O
gene NN O
with IN O
possible JJ O
dominant JJ O
effects NNS O
on IN O
plasma NN O
high JJ O
density NN O
lipoproteins NNS O
. . O

Plasma NNP O
HDL NNP O
are VBP O
a DT O
negative JJ O
risk NN O
factor NN O
for IN O
atherosclerosis NN B-Disease
. . O

Cholesteryl NNP O
ester NN O
transfer NN O
protein NN O
( ( O
CETP NNP O
; : O
476 CD O
amino NN O
acids NNS O
) ) O
transfers NNS O
cholesteryl VBP O
ester NN O
from IN O
HDL NNP O
to TO O
other JJ O
lipoproteins NNS O
. . O

Subjects NNS O
with IN O
homozygous JJ O
CETP NNP B-Disease
deficiency NN I-Disease
caused VBN O
by IN O
a DT O
gene NN O
splicing VBG O
defect NNS O
have VBP O
markedly RB O
elevated VBN O
HDL NNP O
; : O
however RB O
, , O
heterozygotes NNS O
have VBP O
only RB O
mild JJ O
increases NNS O
in IN O
HDL NNP O
. . O

We PRP O
describe VBP O
two CD O
probands NNS O
with IN O
a DT O
CETP NNP O
missense NN O
mutation NN O
( ( O
442 CD O
D NNP O
G NNP O
) ) O
. . O

Although IN O
heterozygous JJ O
, , O
they PRP O
have VBP O
threefold VBN O
increases NNS O
in IN O
HDL NNP O
concentration NN O
and CC O
markedly RB O
decreased VBD O
plasma JJ O
CETP NNP O
mass NN O
and CC O
activity NN O
, , O
suggesting VBG O
that IN O
the DT O
mutation NN O
has VBZ O
dominant JJ O
effects NNS O
on IN O
CETP NNP O
and CC O
HDL NNP O
in IN O
vivo NN O
. . O

Cellular JJ O
expression NN O
of IN O
mutant JJ O
cDNA NN O
results NNS O
in IN O
secretion NN O
of IN O
only RB O
30 CD O
% NN O
of IN O
wild JJ O
type JJ O
CETP NNP O
activity NN O
. . O

Moreover RB O
, , O
coexpression NN O
of IN O
wild JJ O
type NN O
and CC O
mutant JJ O
cDNAs NN O
leads VBZ O
to TO O
inhibition NN O
of IN O
wild JJ O
type JJ O
secretion NN O
and CC O
activity NN O
. . O

The DT O
dominant JJ O
effects NNS O
of IN O
the DT O
CETP NNP O
missense NN O
mutation NN O
during IN O
cellular JJ O
expression NN O
probably RB O
explains VBZ O
why WRB O
the DT O
probands NNS O
have VBP O
markedly RB O
increased VBN O
HDL NNP O
in IN O
the DT O
heterozygous JJ O
state NN O
, , O
and CC O
suggests VBZ O
that IN O
the DT O
active JJ O
molecular JJ O
species NNS O
of IN O
CETP NNP O
may MD O
be VB O
multimeric JJ O
. . O
. . O

Familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
in IN O
the DT O
colchicine NN O
era NN O
: : O
the DT O
fate NN O
of IN O
one CD O
family NN O
. . O

In IN O
order NN O
to TO O
demonstrate VB O
the DT O
effect NN O
of IN O
prophylactic JJ O
colchicine NN O
treatment NN O
on IN O
the DT O
natural JJ O
history NN O
of IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
, , O
a DT O
family NN O
is VBZ O
presented VBN O
with IN O
6 CD O
out IN O
of IN O
9 CD O
siblings NNS O
affected VBN O
by IN O
FMF NNP B-Disease
. . O

Each DT O
patient NN O
represents VBZ O
a DT O
different JJ O
stage NN O
of IN O
the DT O
amyloidotic JJ B-Disease
kidney NN I-Disease
disease NN I-Disease
of IN O
FMF NNP B-Disease
and CC O
the DT O
effect NN O
of IN O
continuous JJ O
colchicine NN O
treatment NN O
on IN O
its PRP$ O
course NN O
. . O

Considered VBN O
together RB O
, , O
the DT O
members NNS O
of IN O
this DT O
family NN O
present VBD O
an DT O
almost RB O
complete JJ O
clinical JJ O
, , O
genetic JJ O
, , O
and CC O
behavioral JJ O
picture NN O
of IN O
the DT O
disease NN O
. . O
. . O

Detection NN O
of IN O
a DT O
new JJ O
submicroscopic NN O
Norrie NNP B-Disease
disease NN I-Disease
deletion NN O
interval NN O
with IN O
a DT O
novel JJ O
DNA NNP O
probe NN O
isolated VBN O
by IN O
differential JJ O
Alu NNP O
PCR NNP O
fingerprint NN O
cloning NN O
. . O

Differential NNP O
Alu NNP O
PCR NNP O
fingerprint NN O
cloning NN O
was VBD O
used VBN O
to TO O
isolate VB O
a DT O
DNA NN O
probe NN O
from IN O
the DT O
Xp11 NNP O
. . O

4 CD O
- : O
- : O
> NN O
p11 NN O
. . O

21 CD O
region NN O
of IN O
the DT O
human JJ O
X NNP O
chromosome NN O
. . O

This DT O
novel JJ O
sequence NN O
, , O
cpXr318 NN O
( ( O
DXS742 NNP O
) ) O
, , O
detects VBZ O
a DT O
new JJ O
submicroscopic NN O
deletion NN O
interval NN O
at IN O
the DT O
Norrie NNP B-Disease
disease NN I-Disease
locus NN O
( ( O
NDP NNP O
) ) O
. . O

Combining VBG O
our PRP$ O
data NNS O
with IN O
the DT O
consensus NN O
genetic JJ O
map NN O
of IN O
the DT O
proximal JJ O
short JJ O
arm NN O
of IN O
the DT O
X NNP O
chromosome NN O
, , O
we PRP O
propose VBP O
the DT O
physical JJ O
order NN O
Xcen NNP O
- : O
DXS14 NNP O
- : O
DXS255 NNP O
- : O
( ( O
DXS426 NNP O
, , O
TIMP NNP O
) ) O
- : O
( ( O
DXS742 NNP O
- : O
( ( O
[ JJ O
MAOB NNP O
- : O
MAOA NNP O
- : O
DXS7 NNP O
] NNP O
, , O
NDP NNP O
) ) O
- : O
DXS77 NNP O
- : O
DXS228 NN O
) ) O
- : O
DXS209 NNP O
- : O
DXS148 NNP O
- : O
DXS196 NNP O
- : O
+ NN O
+ JJ O
+ NNP O
Xpter NNP O
. . O

The DT O
cpXr318 NN O
probe NN O
and CC O
a DT O
subclone NN O
from IN O
a DT O
cosmid NN O
corresponding VBG O
to TO O
the DT O
DXS7 NNP O
locus NN O
were VBD O
converted VBN O
into IN O
sequence NN O
- : O
tagged VBN O
sites NNS O
. . O

Finally RB O
, , O
DXS742 NNP O
, , O
DSX7 NNP O
, , O
DXS77 NNP O
, , O
and CC O
MAOA NNP O
were VBD O
integrated VBN O
into IN O
a DT O
physical JJ O
map NN O
spanning VBG O
the DT O
Norrie NNP B-Disease
disease NN I-Disease
locus NN O

Putative JJ O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy IN I-Disease
gene NN O
shares NNS O
unexpected VBD O
homology NN O
with IN O
ABC NNP O
transporters NNS O
. . O

Adrenoleukodystrophy NNP B-Disease
( ( O
ALD NNP B-Disease
) ) O
is VBZ O
an DT O
X JJ B-Disease
- : I-Disease
linked VBN I-Disease
disease NN I-Disease
affecting VBG O
1 CD O
/ JJ O
20 CD O
, , O
0 CD O
males NNS O
either CC O
as IN O
cerebral JJ B-Disease
ALD NNP I-Disease
in IN O
childhood NN O
or CC O
as IN O
adrenomyeloneuropathy JJ B-Disease
( ( O
AMN NNP B-Disease
) ) O
in IN O
adults NNS O
. . O

Childhood NNP O
ALD NNP B-Disease
is VBZ O
the DT O
more RBR O
severe JJ O
form NN O
, , O
with IN O
onset NN O
of IN O
neurological JJ O
symptoms NNS O
between IN O
5 CD O
- : O
12 CD O
years NNS O
of IN O
age NN O
. . O

Central NNP B-Disease
nervous JJ I-Disease
system NN I-Disease
demyelination NN I-Disease
progresses VBZ O
rapidly RB O
and CC O
death NN O
occurs NNS O
within IN O
a DT O
few JJ O
years NNS O
. . O

AMN NNP B-Disease
is VBZ O
a DT O
milder JJ O
form NN O
of IN O
the DT O
disease NN O
with IN O
onset NN O
at IN O
15 CD O
- : O
30 CD O
years NNS O
of IN O
age NN O
and CC O
a DT O
more RBR O
progressive JJ O
course NN O
. . O

Adrenal JJ B-Disease
insufficiency NN I-Disease
( ( O
Addisons NNP B-Disease
disease NN I-Disease
) ) O
may MD O
remain VB O
the DT O
only JJ O
clinical JJ O
manifestation NN O
of IN O
ALD NNP B-Disease
. . O

The DT O
principal JJ O
biochemical JJ O
abnormality NN O
of IN O
ALD NNP B-Disease
is VBZ O
the DT O
accumulation NN O
of IN O
very RB O
- : O
long JJ O
- : O
chain NN O
fatty JJ O
acids NNS O
( ( O
VLCFA NNP O
) ) O
because IN O
of IN O
impaired JJ O
beta NN O
- : O
oxidation NN O
in IN O
peroxisomes NNS O
. . O

The DT O
normal JJ O
oxidation NN O
of IN O
VLCFA NNP O
- : O
CoA NN O
in IN O
patients NNS O
fibroblasts NNS O
suggested VBD O
that IN O
the DT O
gene NN O
coding VBG O
for IN O
the DT O
VLCFA NNP O
- : O
CoA NNP O
synthetase NN O
could MD O
be VB O
a DT O
candidate JJ O
gene NN O
for IN O
ALD NNP B-Disease
. . O

Here RB O
we PRP O
use VBP O
positional JJ O
cloning NN O
to TO O
identify VB O
a DT O
gene NN O
partially RB O
deleted VBN O
in IN O
6 CD O
of IN O
85 CD O
independent JJ O
patients NNS O
with IN O
ALD NNP B-Disease
. . O

In IN O
familial JJ O
cases NNS O
, , O
the DT O
deletions NNS O
segregated VBN O
with IN O
the DT O
disease NN O
. . O

An DT O
identical JJ O
deletion NN O
was VBD O
detected VBN O
in IN O
two CD O
brothers NNS O
presenting VBG O
with IN O
different JJ O
clinical JJ O
ALD NNP B-Disease
phenotypes NNS O
. . O

Candidate NNP O
exons NNS O
were VBD O
identified VBN O
by IN O
computer NN O
analysis NN O
of IN O
genomic JJ O
sequences NNS O
and CC O
used VBN O
to TO O
isolate VB O
complementary JJ O
DNAs NNP O
by IN O
exon JJ O
connection NN O
and CC O
screening NN O
of IN O
cDNA NN O
libraries NNS O
. . O

The DT O
deduced JJ O
protein NN O
sequence NN O
shows VBZ O
significant JJ O
sequence NN O
identity NN O
to TO O
a DT O
peroxisomal JJ O
membrane NN O
protein NN O
of IN O
M NNP O
( ( O
r NN O
) ) O
70K CD O
that WDT O
is VBZ O
involved VBN O
in IN O
peroxisome JJ O
biogenesis NN O
and CC O
belongs NNS O
to TO O
the DT O
ATP NNP O
- : O
binding NN O
cassette NN O
superfamily RB O
of IN O
transporters NNS O
. . O
. . O

Targeted VBN O
modification NN O
of IN O
the DT O
apolipoprotein NN O
B NNP O
gene NN O
results NNS O
in IN O
hypobetalipoproteinemia NN B-Disease
and CC O
developmental JJ B-Disease
abnormalities NNS I-Disease
in IN O
mice NN O
. . O

Familial JJ B-Disease
hypobetalipoproteinemia NN I-Disease
is VBZ O
an DT O
autosomal JJ B-Disease
codominant NN I-Disease
disorder NN I-Disease
resulting VBG O
in IN O
a DT O
dramatic JJ O
reduction NN O
in IN O
plasma JJ O
concentrations NNS O
of IN O
apolipoprotein NN O
( ( O
apo NN O
) ) O
B NNP O
, , O
cholesterol NN O
, , O
and CC O
beta SYM O
- : O
migrating NN O
lipoproteins NNS O
. . O

A DT O
benefit NN O
of IN O
hypobetalipoproteinemia NN B-Disease
is VBZ O
that IN O
mildly RB O
affected JJ O
individuals NNS O
may MD O
be VB O
protected VBN O
from IN O
coronary JJ B-Disease
vascular JJ I-Disease
disease NN I-Disease
. . O

We PRP O
have VBP O
used VBN O
gene NN O
targeting VBG O
to TO O
generate VB O
mice NN O
with IN O
a DT O
modified JJ O
Apob NNP O
allele NN O
. . O

Mice NNP O
containing VBG O
this DT O
allele JJ O
display NN O
all DT O
of IN O
the DT O
hallmarks NNS O
of IN O
human JJ O
hypobetalipoproteinemia NN B-Disease
they PRP O
produce VBP O
a DT O
truncated JJ O
apoB NN O
protein NN O
, , O
apoB70 NN O
, , O
and CC O
have VBP O
markedly RB O
decreased VBN O
plasma JJ O
concentrations NNS O
of IN O
apoB NN O
, , O
beta SYM O
- : O
lipoproteins NNS O
, , O
and CC O
total JJ O
cholesterol NN O
. . O

In IN O
addition NN O
, , O
the DT O
mice NN O
manifest JJS O
several JJ O
characteristics NNS O
that WDT O
are VBP O
occasionally RB O
observed VBN O
in IN O
human JJ O
hypobetalipoproteinemia NN B-Disease
, , O
including VBG O
reduced VBN O
plasma JJ O
triglyceride NN O
concentrations NNS O
, , O
fasting VBG O
chylomicronemia NN B-Disease
, , O
and CC O
reduced JJ O
high JJ O
density NN O
lipoprotein VBP O
cholesterol NN O
. . O

An DT O
unexpected JJ O
finding NN O
is VBZ O
that IN O
the DT O
modified JJ O
Apob NNP O
allele NN O
is VBZ O
strongly RB O
associated VBN O
with IN O
exencephalus NN B-Disease
and CC O
hydrocephalus NN B-Disease
. . O

These DT O
mice NN O
should MD O
help VB O
increase VB O
our PRP$ O
understanding NN O
of IN O
hypobetalipoproteinemia NN B-Disease
, , O
atherogenesis NN B-Disease
, , O
and CC O
the DT O
etiology NN O
of IN O
exencephalus NN B-Disease
and CC O
hydrocephalus NN B-Disease
. . O
. . O

A DT O
novel JJ O
disease NN O
with IN O
deficiency NN B-Disease
of IN I-Disease
mitochondrial JJ I-Disease
very RB I-Disease
- : I-Disease
long JJ I-Disease
- : I-Disease
chain NN I-Disease
acyl IN I-Disease
- : I-Disease
CoA NNP I-Disease
dehydrogenase NN I-Disease
. . O

Palmitoyl NNP O
- : O
CoA NNP O
dehydrogenase NN O
activity NN O
in IN O
skin JJ O
fibroblasts NNS O
from IN O
seven CD O
patients NNS O
with IN O
unidentified JJ O
defects NNS O
of IN O
fatty JJ O
acid JJ O
oxidation NN O
was VBD O
measured VBN O
in IN O
the DT O
presence NN O
and CC O
absence NN O
of IN O
antibodies NNS O
against IN O
medium NN O
- : O
chain NN O
, , O
long JJ O
- : O
chain NN O
, , O
and CC O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NN O
dehydrogenases NNS O
( ( O
VLCAD NNP O
) ) O
. . O

Two CD O
of IN O
the DT O
patients NNS O
, , O
4 CD O
- : O
5 CD O
month NN O
old JJ O
boys NNS O
, , O
were VBD O
found VBN O
to TO O
have VB O
a DT O
novel JJ O
disease NN O
, , O
VLCAD NNP B-Disease
deficiency NN I-Disease
, , O
as IN O
judged VBN O
from IN O
the DT O
results NNS O
of IN O
very RB O
low JJ O
palmitoyl NN O
- : O
CoA NNP O
dehydrogenase NN O
activity NN O
and CC O
the DT O
lack NN O
of IN O
immunoreactivity NN O
toward IN O
antibody NN O
raised VBN O
to TO O
purified VB O
VLCAD NNP O
. . O
. . O

Molecular JJ O
characterization NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
patients NNS O
of IN O
Chinese JJ O
descent NN O
and CC O
identification NN O
of IN O
new JJ O
base NN O
substitutions NNS O
in IN O
the DT O
human JJ O
G6PD NNP O
gene NN O
. . O

The DT O
underlying VBG O
DNA NNP O
changes NNS O
associated VBN O
with IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
- : I-Disease
deficient NN I-Disease
Asians NNPS O
have VBP O
not RB O
been VBN O
extensively RB O
investigated VBN O
. . O

To TO O
fill VB O
this DT O
gap NN O
, , O
we PRP O
sequenced VBD O
the DT O
G6PD NNP O
gene NN O
of IN O
43 CD O
G6PD NNP B-Disease
- : I-Disease
deficient NN I-Disease
Chinese NNPS O
whose WP$ O
G6PD NNP O
was VBD O
well RB O
characterized VBN O
biochemically RB O
. . O

DNA NN O
samples NNS O
were VBD O
obtained VBN O
from IN O
peripheral JJ O
blood NN O
of IN O
these DT O
individuals NNS O
for IN O
sequencing VBG O
using VBG O
a DT O
direct JJ O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
sequencing VBG O
procedure NN O
. . O

From IN O
these DT O
43 CD O
samples NNS O
, , O
we PRP O
have VBP O
identified VBN O
five CD O
different JJ O
types NNS O
of IN O
nucleotide JJ O
substitutions NNS O
in IN O
the DT O
G6PD NNP O
gene NN O
at IN O
cDNA NN O
1388 CD O
from IN O
G NNP O
to TO O
A NNP O
( ( O
Arg NNP O
to TO O
His PRP$ O
) ) O
; : O
at IN O
cDNA NN O
1376 CD O
from IN O
G NNP O
to TO O
T NNP O
( ( O
Arg NNP O
to TO O
Leu NNP O
) ) O
; : O
at IN O
cDNA NN O
1024 CD O
from IN O
C NNP O
to TO O
T NNP O
( ( O
Leu NNP O
to TO O
Phe NNP O
) ) O
; : O
at IN O
cDNA NN O
392 CD O
from IN O
G NNP O
to TO O
T NNP O
( ( O
Gly NNP O
to TO O
Val NNP O
) ) O
; : O
at IN O
cDNA NN O
95 CD O
from IN O
A NN O
to TO O
G NNP O
( ( O
His PRP$ O
to TO O
Arg NNP O
) ) O
. . O

These DT O
five CD O
nucleotide JJ O
substitutions NNS O
account VBP O
for IN O
over IN O
83 CD O
% NN O
of IN O
our PRP$ O
43 CD O
G6PD NNP B-Disease
- : I-Disease
deficient NN I-Disease
samples NNS O
and CC O
these DT O
substitutions NNS O
have VBP O
not RB O
been VBN O
reported VBN O
in IN O
non JJ O
- : O
Asians NNPS O
. . O

The DT O
substitutions NNS O
found VBD O
at IN O
cDNA NN O
392 CD O
and CC O
cDNA NN O
1024 CD O
are VBP O
new JJ O
findings NNS O
. . O

The DT O
substitutions NNS O
at IN O
cDNA NN O
1376 CD O
and CC O
1388 CD O
account NN O
for IN O
over IN O
50 CD O
% NN O
of IN O
the DT O
43 CD O
samples NNS O
examined VBD O
indicating VBG O
a DT O
high JJ O
prevalence NN O
of IN O
these DT O
two CD O
alleles NNS O
among IN O
G6PD NNP B-Disease
- : I-Disease
deficient NN I-Disease
Chinese NNPS O
. . O

Our PRP$ O
findings NNS O
add VBP O
support NN O
to TO O
the DT O
notion NN O
that WDT O
diverse VBZ O
point NN O
mutations NNS O
may MD O
account VB O
largely RB O
for IN O
much JJ O
of IN O
the DT O
phenotypic NN O
heterogeneity NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
. . O
. . O

Identification NN O
of IN O
mutations NNS O
in IN O
Danish NNP O
choroideremia NN B-Disease
families NNS O
. . O

We PRP O
have VBP O
searched VBN O
for IN O
mutations NNS O
in IN O
the DT O
choroideremia NN B-Disease
gene NN O
( ( O
CHM NNP B-Disease
) ) O
in IN O
patients NNS O
from IN O
12 CD O
Danish JJ O
families NNS O
in IN O
which WDT O
CHM NNP B-Disease
is VBZ O
segregating VBG O
. . O

Employing VBG O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
, , O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
analysis NN O
, , O
and CC O
direct JJ O
DNA NNP O
sequencing NN O
, , O
different JJ O
mutations NNS O
have VBP O
been VBN O
identified VBN O
in IN O
6 CD O
patients NNS O
. . O

All PDT O
the DT O
mutations NNS O
will MD O
interfere VB O
with IN O
the DT O
correct JJ O
translation NN O
of IN O
the DT O
mRNA NN O
predicting VBG O
a DT O
truncated JJ O
protein NN O
or CC O
no DT O
gene NN O
product NN O
at IN O
all DT O
. . O
. . O

Structure NN O
and CC O
genomic JJ O
sequence NN O
of IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
kinase NN O
) ) O
gene NN O
. . O

The DT O
mutation NN O
causing VBG O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
has VBZ O
recently RB O
been VBN O
identified VBN O
as IN O
an DT O
unstable JJ O
CTG NNP O
trinucleotide NN O
repeat NN O
located VBN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
a DT O
gene NN O
encoding VBG O
for IN O
a DT O
protein NN O
with IN O
putative JJ O
serine NN O
- : O
threonine NN O
protein JJ O
kinase NN O
activity NN O
. . O

In IN O
this DT O
report NN O
we PRP O
present VBP O
the DT O
genomic JJ O
sequences NNS O
of IN O
the DT O
human JJ O
and CC O
murine JJ O
DM NNP B-Disease
kinase NN O
gene NN O
. . O

A DT O
comparison NN O
of IN O
these DT O
sequences NNS O
with IN O
each DT O
other JJ O
and CC O
with IN O
known VBN O
cDNA NN O
sequences NNS O
from IN O
both DT O
species NNS O
, , O
led VBD O
us PRP O
to TO O
predict VB O
a DT O
translation NN O
initiation NN O
codon NN O
, , O
as RB O
well RB O
as IN O
determine VB O
the DT O
organization NN O
of IN O
the DT O
DM NNP B-Disease
kinase NN O
gene NN O
. . O

Several JJ O
polymorphisms NNS O
within IN O
the DT O
human JJ O
DM NNP B-Disease
kinase NN O
gene NN O
have VBP O
been VBN O
identified VBN O
, , O
and CC O
PCR NNP O
assays NNS O
to TO O
detect VB O
two CD O
of IN O
these DT O
are VBP O
described VBN O
. . O

The DT O
complete JJ O
sequence NN O
and CC O
characterization NN O
of IN O
the DT O
structure NN O
of IN O
the DT O
DM NNP B-Disease
kinase NNP O
gene NN O
, , O
as RB O
well RB O
as IN O
the DT O
identification NN O
of IN O
novel JJ O
polymorphisms NNS O
within IN O
the DT O
gene NN O
, , O
represent VBP O
an DT O
important JJ O
step NN O
in IN O
a DT O
further JJ O
understanding NN O
of IN O
the DT O
genetics NNS O
of IN O
myotonic JJ B-Disease
dystrophy NN I-Disease
and CC O
the DT O
molecular JJ O
biology NN O
of IN O
the DT O
gene NN O
. . O
. . O

Autosomal NNP O
recessive JJ O
transmission NN O
of IN O
hemophilia NN B-Disease
A NNP I-Disease
due JJ O
to TO O
a DT O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
mutation NN O
. . O

The DT O
differential JJ O
diagnosis NN O
of IN O
the DT O
genetic JJ B-Disease
bleeding NN I-Disease
disorders NNS I-Disease
, , O
hemophilia VB B-Disease
A NNP I-Disease
and CC O
von NNP B-Disease
Willebrand NNP I-Disease
disease NN I-Disease
, , O
is VBZ O
occasionally RB O
confounded VBN O
by IN O
the DT O
close JJ O
molecular JJ O
relationship NN O
of IN O
coagulation NN O
factor NN O
VIII NNP O
and CC O
von NNP B-Disease
Willebrand NNP I-Disease
factor NN O
( ( O
vWF NN O
) ) O
. . O

This DT O
report NN O
describes VBZ O
the DT O
autosomal JJ O
inheritance NN O
of IN O
a DT O
hemophilia NN B-Disease
A NNP I-Disease
phenotype NN O
due JJ O
to TO O
a DT O
mutation NN O
of IN O
vWF NN O
that WDT O
results NNS O
in IN O
defective JJ O
factor NN O
VIII NNP O
binding NN O
. . O

The DT O
proband NN O
was VBD O
a DT O
female JJ O
patient NN O
with IN O
low JJ O
levels NNS O
of IN O
factor NN O
VIII NNP O
activity NN O
. . O

Polymerase NNP O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
amplification NN O
and CC O
DNA NNP O
sequencing VBG O
were VBD O
employed VBN O
to TO O
examine VB O
exons NNS O
encoding VBG O
the DT O
putative JJ O
factor NN O
VIII NNP O
binding VBG O
domain NN O
of IN O
vWF NN O
. . O

The DT O
patient NN O
was VBD O
found VBN O
to TO O
be VB O
homozygous JJ O
for IN O
a DT O
single JJ O
point NN O
mutation NN O
causing VBG O
a DT O
Thr NNP O
- : O
- : O
> NN O
Met NNP O
substitution NN O
at IN O
amino NN O
acid JJ O
position NN O
28 CD O
in IN O
the DT O
mature NN O
vWF NN O
subunit NN O
. . O

The DT O
phenotypic JJ O
expression NN O
of IN O
the DT O
mutation NN O
was VBD O
determined VBN O
to TO O
be VB O
recessive JJ O
because IN O
heterozygous JJ O
family NN O
members NNS O
were VBD O
clinically RB O
unaffected JJ O
. . O

Recombinant JJ O
vWF NN O
containing VBG O
the DT O
observed JJ O
amino NN O
acid JJ O
substitution NN O
was VBD O
expressed VBN O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
. . O

The DT O
mutant JJ O
vWF NN O
was VBD O
processed VBN O
and CC O
secreted VBN O
normally RB O
, , O
and CC O
was VBD O
functionally RB O
equivalent JJ O
to TO O
wild VB O
- : O
type NN O
vWF NN O
in IN O
its PRP$ O
ability NN O
to TO O
bind VB O
to TO O
platelets NNS O
. . O

However RB O
, , O
the DT O
mutant NN O
failed VBD O
to TO O
bind VB O
factor NN O
VIII NNP O
, , O
demonstrating VBG O
that IN O
the DT O
mutation NN O
was VBD O
functionally RB O
related VBN O
to TO O
the DT O
observed VBN O
hemophilia NN B-Disease
phenotype NN O
. . O

The DT O
family NN O
we PRP O
describe VBP O
demonstrates VBZ O
the DT O
recessive JJ O
inheritance NN O
of IN O
a DT O
recently RB O
recognized VBN O
class NN O
of IN O
genetic JJ O
bleeding NN O
disorders NNS O
, , O
we PRP O
call VBP O
"""" JJ O
autosomal JJ O
hemophilia NN B-Disease
. . O

"""" NN O
We PRP O
conclude VBP O
that IN O
vWF JJ O
mutation NN O
may MD O
be VB O
an DT O
under IN O
recognized VBN O
cause NN O
of IN O
hemophilia NN B-Disease
, , O
especially RB O
in IN O
cases NNS O
where WRB O
the DT O
inheritance NN O
pattern NN O
is VBZ O
not RB O
consistent JJ O
with IN O
X NNP O
- : O
linked VBN O
transmission NN O
. . O

Somatic JJ O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
mutation NN O
in IN O
clear JJ O
cell NN O
papillary JJ B-Disease
cystadenoma NN I-Disease
of IN I-Disease
the DT I-Disease
epididymis NN I-Disease
. . O

Papillary JJ B-Disease
cystadenoma NN I-Disease
of IN I-Disease
the DT I-Disease
epididymis NN I-Disease
is VBZ O
an DT O
uncommon JJ O
benign NN O
lesion NN O
that WDT O
may MD O
occur VB O
sporadically RB O
or CC O
as IN O
a DT O
manifestation NN O
of IN O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
disease NN I-Disease
. . O

Neither DT O
immunohistochemical JJ O
studies NNS O
nor CC O
molecular JJ O
genetic JJ O
analyses NNS O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
have VBP O
been VBN O
reported VBN O
previously RB O
for IN O
this DT O
lesion NN O
. . O

The DT O
authors NNS O
describe VBP O
two CD O
cases NNS O
of IN O
clear JJ O
cell NN O
papillary JJ B-Disease
cystadenoma NN I-Disease
of IN I-Disease
the DT I-Disease
epididymis NN I-Disease
, , O
both DT O
of IN O
which WDT O
were VBD O
initially RB O
confused VBN O
with IN O
metastatic JJ B-Disease
renal NN I-Disease
cell NN I-Disease
carcinoma NN I-Disease
. . O

Both DT O
lesions NNS O
showed VBD O
positive JJ O
immunohistochemical JJ O
staining VBG O
for IN O
low JJ O
and CC O
intermediate JJ O
molecular JJ O
weight NN O
keratins NNS O
( ( O
Cam NNP O
5 CD O
. . O
2 CD O
and CC O
AE1 NNP O
/ NNP O
AE3 NNP O
) ) O
, , O
EMA NNP O
, , O
vimentin NN O
, , O
alpha RB O
1 CD O
- : O
antitrypsin NN O
, , O
and CC O
alpha RB O
1 CD O
- : O
antichymotrypsin NN O
. . O

Each DT O
was VBD O
negative JJ O
for IN O
CEA NNP O
. . O

Because IN O
clear JJ O
cell NN O
papillary JJ B-Disease
cystadenoma NN I-Disease
is VBZ O
similar JJ O
to TO O
renal VB B-Disease
cell NN I-Disease
carcinoma NN I-Disease
histologically RB O
, , O
and CC O
because IN O
both DT O
occur VBP O
as IN O
components NNS O
of IN O
the DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau JJ I-Disease
disease NN I-Disease
complex NN O
, , O
the DT O
authors NNS O
analyzed VBD O
both DT O
cases NNS O
for IN O
the DT O
presence NN O
of IN O
mutations NNS O
in IN O
the DT O
VHL NNP B-Disease
gene NN O
. . O

A DT O
somatic JJ O
VHL NNP B-Disease
gene NN O
mutation NN O
was VBD O
detected VBN O
in IN O
one CD O
of IN O
the DT O
two CD O
tumors NNS B-Disease
by IN O
polymerase NN O
chain NN O
reaction NN O
followed VBN O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
. . O

Direct JJ O
sequencing NN O
revealed VBD O
a DT O
cytosine NN O
to TO O
thymine VB O
transition NN O
at IN O
nucleotide JJ O
694 CD O
, , O
resulting VBG O
in IN O
the DT O
replacement NN O
of IN O
an DT O
arginine NN O
with IN O
a DT O
stop NN O
codon NN O
after IN O
the DT O
sixth JJ O
amino NN O
acid NN O
of IN O
exon $ O
3 CD O
. . O

As IN O
the DT O
VHL NNP B-Disease
gene NN O
is VBZ O
believed VBN O
to TO O
function VB O
as IN O
a DT O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
VHL NNP B-Disease
gene NN O
mutations NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
initiation NN O
of IN O
tumorigenesis NN O
in IN O
sporadic JJ O
cystadenomas NN B-Disease
of IN I-Disease
the DT I-Disease
epididymis NN I-Disease
. . O

Identification NN O
of IN O
WASP NNP O
mutations NNS O
in IN O
patients NNS O
with IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
and CC O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
reveals NNS O
allelic JJ O
heterogeneity NN O
at IN O
the DT O
WAS NNP B-Disease
locus NN O
. . O

Mutation NN O
in IN O
the DT O
gene NN O
encoding VBG O
the DT O
recently RB O
isolated VBN O
WASP NNP O
protein NN O
has VBZ O
now RB O
been VBN O
identified VBN O
as IN O
the DT O
genetic JJ B-Disease
defect NN I-Disease
responsible JJ O
for IN O
the DT O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
Wiskott NNP I-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
, , O
a DT O
primary JJ O
immunodeficiency NN B-Disease
disease NN I-Disease
associated VBN O
with IN O
extensive JJ O
phenotypic NN O
variability NN O
. . O

To TO O
elucidate VB O
the DT O
range NN O
of IN O
WASP NNP O
mutations NNS O
responsible JJ O
for IN O
WAS NNP B-Disease
, , O
we PRP O
used VBD O
PCR NNP O
- : O
SSCP NN O
analysis NN O
to TO O
screen VB O
for IN O
WASP NNP O
gene NN O
mutation NN O
in IN O
19 CD O
unrelated JJ O
boys NNS O
with IN O
the DT O
diagnosis NN O
of IN O
classical JJ O
or CC O
attenuated VBN O
WAS NNP B-Disease
or CC O
isolated VBN B-Disease
thrombocytopenia NN I-Disease
. . O

All DT O
19 CD O
patients NNS O
had VBD O
WASP NNP O
mutations NNS O
, , O
each DT O
of IN O
which WDT O
localized VBD O
to TO O
the DT O
initial JJ O
three CD O
or CC O
terminal JJ O
three CD O
exons NNS O
of IN O
the DT O
gene NN O
, , O
and CC O
the DT O
majority NN O
of IN O
which WDT O
were VBD O
unique JJ O
in IN O
each DT O
case NN O
. . O

However RB O
, , O
a DT O
missense NN O
mutation NN O
which WDT O
results NNS O
in IN O
substitution NN O
of IN O
the DT O
arginine NN O
at IN O
WAS NNP B-Disease
codon VBG O
86 CD O
was VBD O
identified VBN O
in IN O
three CD O
boys NNS O
with IN O
severe JJ O
WAS NNP B-Disease
as RB O
well RB O
as IN O
in IN O
one CD O
boy NN O
presenting VBG O
with IN O
thrombocytopenia NN B-Disease
alone RB O
. . O

While IN O
the DT O
three CD O
mutations NNS O
found VBN O
in IN O
the DT O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
patients NNS O
leave VBP O
the DT O
reading NN O
frame NN O
intact JJ O
, , O
about IN O
one CD O
- : O
half NN O
of IN O
the DT O
gene NN O
alterations NNS O
detected VBN O
in IN O
both DT O
severe JJ O
and CC O
attenuated VBN O
WAS NNP B-Disease
patients NNS O
result VBP O
in IN O
frameshifted JJ O
transcript NN O
and CC O
premature NN O
translation NN O
termination NN O
. . O

These DT O
findings NNS O
therefore RB O
confirm VBP O
the DT O
association NN O
of IN O
WAS NNP B-Disease
with IN O
WASP NNP O
mutation NN O
and CC O
identify VB O
WASP NNP O
mutation NN O
as IN O
a DT O
cause NN O
for IN O
isolated JJ O
congenital JJ B-Disease
thrombocytopenia NN I-Disease
in IN O
males NNS O
. . O

While IN O
the DT O
WASP NNP O
gene NN O
defects NNS O
responsible JJ O
for IN O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
and CC O
other JJ O
mild JJ O
presentations NNS O
of IN O
WAS NNP B-Disease
do VBP O
not RB O
appear VB O
distinct JJ O
from IN O
those DT O
resulting VBG O
in IN O
severe NN O
WAS NNP B-Disease
, , O
these DT O
data NNS O
indicate VBP O
that IN O
analysis NN O
of IN O
WASP NNP O
gene NN O
mutation NN O
provides VBZ O
a DT O
valuable JJ O
tool NN O
for IN O
distinguishing VBG O
the DT O
spectrum NN O
of IN O
WAS NNP B-Disease
patients NNS O
and CC O
the DT O
subset NN O
of IN O
males NNS O
with IN O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
who WP O
represent VBP O
mild JJ O
cases NNS O
of IN O
WAS NNP B-Disease
. . O
. . O

WASP NNP O
gene NN O
mutations NNS O
in IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
and CC O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
thrombocytopenia NN I-Disease
. . O

The DT O
WASP NNP O
gene NN O
has VBZ O
been VBN O
recently RB O
cloned VBN O
from IN O
Xp11 NNP O
. . O

23 CD O
and CC O
shown VBN O
to TO O
be VB O
mutated VBN O
in IN O
three CD O
patients NNS O
with IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
screening NN O
protocol NN O
for IN O
identifying VBG O
WASP NNP O
gene NN O
alterations NNS O
in IN O
genomic JJ O
DNA NN O
and CC O
have VBP O
identified VBN O
a DT O
spectrum NN O
of IN O
novel JJ O
mutations NNS O
in IN O
12 CD O
additional JJ O
unrelated JJ O
families NNS O
. . O

These DT O
missense NN O
, , O
nonsense NN O
and CC O
frameshift NN O
mutations NNS O
involve VBP O
eight CD O
of IN O
the DT O
12 CD O
exons NNS O
of IN O
the DT O
gene NN O
. . O

Two CD O
mutations NNS O
creating VBG O
premature JJ O
termination NN O
codons NNS O
were VBD O
associated VBN O
with IN O
lack NN O
of IN O
detectable JJ O
mRNA NN O
on IN O
Northern NNP O
blots NNS O
. . O

Four CD O
amino NN O
acid NN O
substitutions NNS O
, , O
Leu27Phe NNP O
, , O
Thr48Ile NNP O
, , O
Val75Met NNP O
and CC O
Arg477Lys NNP O
, , O
were VBD O
found VBN O
in IN O
patients NNS O
with IN O
congenital JJ B-Disease
thrombocytopenia NN I-Disease
and CC O
no DT O
clinically RB O
evident JJ O
immune NN O
defect NN O
indicating VBG O
that IN O
the DT O
WASP NNP O
gene NN O
is VBZ O
the DT O
site NN O
for IN O
mutations NNS O
in IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
thrombocytopenia NN I-Disease
as RB O
well RB O
as IN O
in IN O
WAS NNP B-Disease
. . O

A DT O
T NNP O
- : O
cell NN O
line NN O
from IN O
a DT O
WAS NNP B-Disease
patient NN O
contained VBD O
two CD O
independent JJ O
DNA NNP O
alterations NNS O
, , O
a DT O
constitutional JJ O
frameshift NN O
mutation NN O
, , O
also RB O
present JJ O
in IN O
peripheral JJ O
blood NN O
leukocytes NNS O
from IN O
the DT O
patient NN O
, , O
and CC O
compensatory JJ O
splice NN O
site NN O
mutation NN O
unique NN O
to TO O
the DT O
cell NN O
line NN O
. . O

The DT O
distribution NN O
of IN O
eight CD O
missense JJ O
mutations NNS O
provides VBZ O
valuable JJ O
information NN O
on IN O
amino NN O
acids NNS O
which WDT O
are VBP O
essential JJ O
for IN O
normal JJ O
protein NN O
function NN O
, , O
and CC O
suggests VBZ O
that DT O
sites VBZ O
in IN O
the DT O
first JJ O
two CD O
exons NNS O
are VBP O
hot JJ O
- : O
spots NNS O
for IN O
mutation NN O
. . O

Evidence NN O
for IN O
inter NN O
- : O
generational JJ O
instability NN O
in IN O
the DT O
CAG NNP O
repeat NN O
in IN O
the DT O
MJD1 NNP O
gene NN O
and CC O
for IN O
conserved JJ O
haplotypes NNS O
at IN O
flanking VBG O
markers NNS O
amongst VBP O
Japanese JJ O
and CC O
Caucasian JJ O
subjects NNS O
with IN O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
. . O

The DT O
size NN O
of IN O
the DT O
( ( O
CAG NNP O
) ) O
n RB O
repeat JJ O
array NN O
in IN O
the DT O
3 CD O
' POS O
end NN O
of IN O
the DT O
MJD1 NNP O
gene NN O
and CC O
the DT O
haplotype NN O
at IN O
a DT O
series NN O
of IN O
microsatellite JJ O
markers NNS O
surrounding VBG O
the DT O
MJD1 NNP O
gene NN O
were VBD O
examined VBN O
in IN O
a DT O
large JJ O
cohort NN O
of IN O
Japanese JJ O
and CC O
Caucasian JJ O
subjects NNS O
affected VBN O
with IN O
Machado NNP B-Disease
- : I-Disease
Joseph NNP I-Disease
disease NN I-Disease
( ( O
MJD NNP B-Disease
) ) O
. . O

Our PRP$ O
data NNS O
provide VBP O
five CD O
novel JJ O
observations NNS O
. . O

First RB O
, , O
MJD NNP B-Disease
is VBZ O
associated VBN O
with IN O
expansion NN O
fo VBP O
the DT O
array NN O
from IN O
the DT O
normal JJ O
range NN O
of IN O
14 CD O
- : O
37 CD O
repeats NNS O
to TO O
68 CD O
- : O
84 CD O
repeats NNS O
in IN O
most JJS O
Japanese JJ O
and CC O
Caucasian JJ O
subjects NNS O
, , O
but CC O
no DT O
subjects NNS O
were VBD O
observed VBN O
with IN O
expansions NNS O
intermediate VBP O
in IN O
size NN O
between IN O
those DT O
of IN O
the DT O
normal JJ O
and CC O
MJD NNP B-Disease
affected VBD O
groups NNS O
. . O

Second JJ O
, , O
the DT O
expanded VBN O
allele NN O
associated VBN O
with IN O
MJD NNP B-Disease
displays NNS O
inter VBP O
- : O
generational JJ O
instability NN O
, , O
particularly RB O
in IN O
male NN O
meioses NNS O
, , O
and CC O
this DT O
instability NN O
was VBD O
associated VBN O
with IN O
the DT O
clinical JJ O
phenomenon NN O
of IN O
anticipation NN O
. . O

Third NNP O
, , O
the DT O
size NN O
of IN O
the DT O
expanded VBN O
allele NN O
is VBZ O
not RB O
only RB O
inversely RB O
correlated VBN O
with IN O
the DT O
age NN O
- : O
of IN O
- : O
onset NN O
of IN O
MJD NNP B-Disease
( ( O
r NN O
= NNP O
- : O
0 CD O
. . O
738 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
, , O
but CC O
is VBZ O
also RB O
correlated VBN O
with IN O
the DT O
frequency NN O
of IN O
other JJ O
clinical JJ O
features NNS O
[ VBP O
e NN O
. . O
g NN O
. . O
pseudoexophthalmos NN O
and CC O
pyramidal JJ O
signs NNS O
were VBD O
more RBR O
frequent JJ O
in IN O
subjects NNS O
with IN O
large JJ O
repeats NNS O
( ( O
p JJ O
< NN O
0 CD O
. . O
1 CD O
and CC O
p VB O
< JJ O
0 CD O
. . O
5 CD O
respectively RB O
) ) O
] NN O
. . O

Fourth NN O
, , O
the DT O
disease NN O
phenotype NN O
is VBZ O
significantly RB O
more RBR O
severe JJ O
and CC O
had VBD O
an DT O
early JJ O
age NN O
of IN O
onset NN O
( ( O
16 CD O
years NNS O
) ) O
in IN O
a DT O
subject NN O
homozygous JJ O
for IN O
the DT O
expanded VBN O
allele NN O
, , O
which WDT O
contrasts VBZ O
with IN O
Huntington NNP B-Disease
disease NN I-Disease
and CC O
suggests VBZ O
that IN O
the DT O
expanded VBN O
allele NN O
in IN O
the DT O
MJD1 NNP O
gene NN O
could MD O
exert VB O
its PRP$ O
effect NN O
either DT O
by IN O
a DT O
dominant JJ O
negative JJ O
effect NN O
( ( O
putatively RB O
excluded VBN O
in IN O
HD NNP B-Disease
) ) O
or CC O
by IN O
a DT O
gain NN O
of IN O
function NN O
effect NN O
as IN O
proposed VBN O
for IN O
HD NNP B-Disease
. . O

Finally RB O
, , O
Japanese JJ O
and CC O
Caucasian JJ O
subjects NNS O
affected VBN O
with IN O
MJD NNP B-Disease
share NN O
haplotypes VBZ O
at IN O
several JJ O
markers NNS O
surrounding VBG O
the DT O
MJD1 NNP O
gene NN O
, , O
which WDT O
are VBP O
uncommon JJ O
in IN O
the DT O
normal JJ O
Japanese JJ O
and CC O
Caucasian JJ O
population NN O
, , O
and CC O
which WDT O
suggests VBZ O
the DT O
existence NN O
either NN O
of IN O
common JJ O
founders NNS O
in IN O
these DT O
populations NNS O
or CC O
of IN O
chromosomes NNS O
susceptible JJ O
to TO O
pathologic JJ O
expansion NN O
of IN O
the DT O
CAG NNP O
repeat NN O
in IN O
the DT O
MJD1 NNP O
gene NN O
. . O

A DT O
4 CD O
- : O
megabase NN O
YAC NNP O
contig NN O
that WDT O
spans VBZ O
the DT O
Langer NNP B-Disease
- : I-Disease
Giedion NNP I-Disease
syndrome JJ I-Disease
region NN O
on IN O
human JJ O
chromosome NN O
8q24 CD O
. . O
1 CD O
: : O
use NN O
in IN O
refining VBG O
the DT O
location NN O
of IN O
the DT O
trichorhinophalangeal JJ B-Disease
syndrome NN I-Disease
and CC O
multiple JJ O
exostoses NNS O
genes NNS O
( ( O
TRPS1 NNP O
and CC O
EXT1 NNP O
) ) O
. . O

We PRP O
have VBP O
constructed VBN O
a DT O
physical JJ O
map NN O
covering VBG O
over IN O
4 CD O
Mb NNP O
of IN O
human JJ O
chromosome NN O
8q24 CD O
. . O

1 CD O
and CC O
used VBD O
this DT O
map NN O
to TO O
refine VB O
the DT O
locations NNS O
of IN O
the DT O
genes NNS O
responsible JJ O
for IN O
Langer NNP B-Disease
- : I-Disease
Giedion NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
map NN O
is VBZ O
composed VBN O
of IN O
overlapping VBG O
YAC NNP O
clones NNS O
that WDT O
were VBD O
identified VBN O
and CC O
ordered VBN O
in IN O
relation NN O
to TO O
sequence VB O
tagged VBN O
sites NNS O
mapped VBD O
to TO O
the DT O
Langer NNP O
- : O
Giedion NNP O
chromosomal JJ O
region NN O
on IN O
somatic JJ O
cell NN O
hybrids NNS O
. . O

The DT O
minimal JJ O
region NN O
of IN O
overlap NN O
of IN O
Langer NNP B-Disease
- : I-Disease
Giedion NNP I-Disease
syndrome JJ I-Disease
deletions NNS O
, , O
previously RB O
identified VBN O
by IN O
analysis NN O
of IN O
15 CD O
patients NNS O
, , O
was VBD O
placed VBN O
on IN O
the DT O
map NN O
by IN O
analysis NN O
of IN O
2 CD O
patients NNS O
whose WP$ O
deletions NNS O
define VBP O
the DT O
endpoints NNS O
. . O

The DT O
chromosome NN O
8 CD O
breakpoint NN O
of IN O
a DT O
balanced JJ O
t NN O
( ( O
8 CD O
; : O
9 CD O
) ) O
( ( O
q24 UH O
. . O
11 CD O
; : O
q33 NN O
. . O
3 CD O
) ) O
translocation NN O
from IN O
a DT O
patient NN O
with IN O
trichorhinophalangeal JJ B-Disease
syndrome NN I-Disease
( ( O
TRPS NNP B-Disease
I PRP O
) ) O
was VBD O
found VBN O
to TO O
be VB O
located VBN O
just RB O
within IN O
the DT O
proximal JJ O
end NN O
of IN O
the DT O
minimal JJ O
deletion NN O
region NN O
. . O

A DT O
deletion NN O
of IN O
8q24 CD O
. . O

11 CD O
- : O
q24 NN O
. . O

3 CD O
in IN O
a DT O
patient NN O
with IN O
multiple JJ O
exostoses NNS O
was VBD O
found VBN O
to TO O
overlap VB O
the DT O
distal JJ O
end NN O
of IN O
the DT O
LGS NNP B-Disease
deletion NN O
region NN O
, , O
indicating VBG O
that IN O
the DT O
EXT1 NNP O
gene NN O
is VBZ O
distal JJ O
to TO O
the DT O
TRPS1 NNP O
gene NN O
and CC O
supporting VBG O
the DT O
hypothesis NN O
that WDT O
Langer NNP B-Disease
- : I-Disease
Giedion NNP I-Disease
syndrome NN I-Disease
is VBZ O
due JJ O
to TO O
loss NN O
of IN O
functional JJ O
copies NNS O
of IN O
both DT O
the DT O
TRPS1 NNP O
and CC O
the DT O
EXT1 NNP O
genes NNS O

BRCA1 NNP O
mutations NNS O
in IN O
a DT O
population NN O
- : O
based VBN O
sample NN O
of IN O
young JJ O
women NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
. . O

BACKGROUND NNP O
. . O

Inherited VBN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
are VBP O
associated VBN O
with IN O
a DT O
high JJ O
risk NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
some DT O
families NNS O
. . O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
contribution NN O
of IN O
BRCA1 NNP O
mutations NNS O
to TO O
breast VB B-Disease
cancer NN I-Disease
in IN O
the DT O
general JJ O
population NN O
. . O

We PRP O
analyzed VBD O
DNA NNP O
samples NNS O
from IN O
women NNS O
enrolled VBN O
in IN O
a DT O
population NN O
- : O
based VBN O
study NN O
of IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
to TO O
assess VB O
the DT O
spectrum NN O
and CC O
frequency NN O
of IN O
germ JJ O
- : O
line NN O
BRCA1 NNP O
mutations NNS O
in IN O
young JJ O
women NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
. . O

METHODS NNP O
. . O

We PRP O
studied VBD O
80 CD O
women NNS O
in IN O
whom WP O
breast NN B-Disease
cancer NN I-Disease
was VBD O
diagnosed VBN O
before IN O
the DT O
age NN O
of IN O
35 CD O
, , O
and CC O
who WP O
were VBD O
not RB O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
family NN O
history NN O
. . O

Genomic NNP O
DNA NNP O
was VBD O
studied VBN O
for IN O
BRCA1 NNP O
mutations NNS O
by IN O
analysis NN O
involving VBG O
single JJ O
- : O
strand NN O
conformation NN O
polymorphisms NNS O
and CC O
with IN O
allele JJ O
- : O
specific JJ O
assays NNS O
. . O

Alterations NNS O
were VBD O
defined VBN O
by IN O
DNA NNP O
sequencing NN O
. . O

RESULTS NNP O
. . O

Germ NNP O
- : O
line NN O
BRCA1 NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
6 CD O
of IN O
the DT O
80 CD O
women NNS O
. . O

Four CD O
additional JJ O
rare NN O
sequence NN O
variants NNS O
of IN O
unknown JJ O
functional JJ O
importance NN O
were VBD O
also RB O
identified VBN O
. . O

Two CD O
of IN O
the DT O
mutations NNS O
and CC O
three CD O
of IN O
the DT O
rare JJ O
sequence NN O
variants NNS O
were VBD O
found VBN O
among IN O
the DT O
39 CD O
women NNS O
who WP O
reported VBD O
no DT O
family NN O
history NN O
of IN O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

None NN O
of IN O
the DT O
mutations NNS O
and CC O
only RB O
one CD O
of IN O
the DT O
rare JJ O
variants NNS O
was VBD O
identified VBN O
in IN O
a DT O
reference NN O
population NN O
of IN O
73 CD O
unrelated JJ O
subjects NNS O
. . O

CONCLUSIONS NNP O
. . O

Alterations NNS O
in IN O
BRCA1 NNP O
were VBD O
identified VBN O
in IN O
approximately RB O
10 CD O
percent NN O
of IN O
this DT O
cohort NN O
of IN O
young JJ O
women NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
. . O

The DT O
risk NN O
of IN O
harboring VBG O
a DT O
mutation NN O
was VBD O
not RB O
limited VBN O
to TO O
women NNS O
with IN O
family NN O
histories NNS O
of IN O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

These DT O
results NNS O
represent VBP O
a DT O
minimal JJ O
estimate NN O
of IN O
the DT O
frequency NN O
of IN O
BRCA1 NNP O
mutations NNS O
in IN O
this DT O
population NN O
. . O

Comprehensive NNP O
methods NNS O
of IN O
identifying VBG O
BRCA1 NNP O
mutations NNS O
and CC O
understanding VBG O
their PRP$ O
importance NN O
will MD O
be VB O
needed VBN O
before IN O
testing VBG O
of IN O
women NNS O
in IN O
the DT O
general JJ O
population NN O
can MD O
be VB O
undertaken VBN O
. . O
. . O

Novel NNP O
inherited VBD O
mutations NNS O
and CC O
variable JJ O
expressivity NN O
of IN O
BRCA1 NNP O
alleles NNS O
, , O
including VBG O
the DT O
founder NN O
mutation NN O
185delAG CD O
in IN O
Ashkenazi NNP O
Jewish NNP O
families NNS O
. . O

Thirty NNP O
- : O
seven CD O
families NNS O
with IN O
four CD O
or CC O
more JJR O
cases NNS O
of IN O
breast NN B-Disease
cancer NN I-Disease
or CC O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
were VBD O
analyzed VBN O
for IN O
mutations NNS O
in IN O
BRCA1 NNP O
. . O

Twelve NNP O
different JJ O
germ SYM O
- : O
line NN O
mutations NNS O
, , O
four CD O
novel NN O
and CC O
eight CD O
previously RB O
observed VBN O
, , O
were VBD O
detected VBN O
in IN O
16 CD O
families NNS O
. . O

Five CD O
families NNS O
of IN O
Ashkenazi NNP O
Jewish NNP O
descent NN O
carried VBD O
the DT O
185delAG CD O
mutation NN O
and CC O
shared VBD O
the DT O
same JJ O
haplotype NN O
at IN O
eight CD O
polymorphic JJ O
markers NNS O
spanning VBG O
approximately RB O
850 CD O
kb NNS O
at IN O
BRCA1 NNP O
. . O

Expressivity NN O
of IN O
185delAG CD O
in IN O
these DT O
families NNS O
varied VBD O
, , O
from IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
without IN O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

Mutation NN O
4184delTCAA CD O
occurred VBD O
independently RB O
in IN O
two CD O
families NNS O
. . O

In IN O
one CD O
family NN O
, , O
penetrance NN O
was VBD O
complete JJ O
, , O
with IN O
females NNS O
developing VBG O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
or CC O
ovarian JJ B-Disease
cancer NN I-Disease
and CC O
the DT O
male NN O
carrier NN O
developing VBG O
prostatic JJ B-Disease
cancer NN I-Disease
, , O
whereas NNS O
, , O
in IN O
the DT O
other JJ O
family NN O
, , O
penetrance NN O
was VBD O
incomplete JJ O
and CC O
only JJ O
breast NN B-Disease
cancer NN I-Disease
occurred VBD O
, , O
diagnosed VBN O
at IN O
ages NNS O
38 CD O
- : O
81 CD O
years NNS O
. . O

Two CD O
novel JJ O
nonsense JJ O
mutations NNS O
led VBD O
to TO O
the DT O
loss NN O
of IN O
mutant JJ O
BRCA1 NNP O
transcript NN O
in IN O
families NNS O
with IN O
10 CD O
and CC O
6 CD O
cases NNS O
of IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
cancer NN I-Disease
and CC O
ovarian JJ B-Disease
cancer NN I-Disease
. . O

A DT O
665 CD O
- : O
nt NN O
segment NN O
of IN O
the DT O
BRCA1 NNP O
3 CD O
- : O
UTR NN O
and CC O
1 CD O
. . O

3 CD O
kb NN O
of IN O
genomic JJ O
sequence NN O
including VBG O
the DT O
putative JJ O
promoter NN O
region NN O
were VBD O
invariant JJ O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
analysis NN O
in IN O
13 CD O
families NNS O
without IN O
coding VBG O
- : O
sequence NN O
mutations NNS O
. . O

Overall JJ O
in IN O
our PRP$ O
series NN O
, , O
BRCA1 NNP O
mutations NNS O
have VBP O
been VBN O
detected VBN O
in IN O
26 CD O
families NNS O
16 CD O
with IN O
positive JJ O
BRCA1 NNP O
lod NN O
scores NNS O
, , O
7 CD O
with IN O
negative JJ O
lod NN O
scores NNS O
( ( O
reflecting VBG O
multiple NN O
sporadic JJ O
breast NN B-Disease
cancers NNS I-Disease
) ) O
, , O
and CC O
3 CD O
not RB O
tested VBN O
for IN O
linkage NN O
. . O

Three CD O
other JJ O
families NNS O
have VBP O
positive JJ O
lod NN O
scores NNS O
for IN O
linkage NN O
to TO O
BRCA2 NNP O
, , O
but CC O
13 CD O
families NNS O
without IN O
detected VBN O
BRCA1 NNP O
mutations NNS O
have VBP O
negative JJ O
lod NN O
scores NNS O
for IN O
both DT O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

A DT O
new JJ O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
variant NN O
, , O
G6PD NNP O
Orissa NNP O
( ( O
44 CD O
Ala NNP O
- : O
- : O
> NN O
Gly NNP O
) ) O
, , O
is VBZ O
the DT O
major JJ O
polymorphic JJ O
variant NN O
in IN O
tribal JJ O
populations NNS O
in IN O
India NNP O
. . O

Deficiency NN B-Disease
of IN I-Disease
glucose JJ I-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( O
G6PD NNP O
) ) O
is VBZ O
usually RB O
found VBN O
at IN O
high JJ O
frequencies NNS O
in IN O
areas NNS O
of IN O
the DT O
world NN O
where WRB O
malaria NN B-Disease
has VBZ O
been VBN O
endemic JJ O
. . O

The DT O
frequency NN O
and CC O
genetic JJ O
basis NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
have VBP O
been VBN O
studied VBN O
in IN O
Africa NNP O
, , O
around IN O
the DT O
Mediterranean NNP O
, , O
and CC O
in IN O
the DT O
Far NNP O
East NNP O
, , O
but CC O
little JJ O
such JJ O
information NN O
is VBZ O
available JJ O
about IN O
the DT O
situation NN O
in IN O
India NNP O
. . O

To TO O
determine VB O
the DT O
extent NN O
of IN O
heterogeneity NN O
of IN O
G6PD NNP O
, , O
we PRP O
have VBP O
studied VBN O
several JJ O
different JJ O
Indian JJ O
populations NNS O
by IN O
screening VBG O
for IN O
G6PD NNP B-Disease
deficiency NN I-Disease
, , O
followed VBN O
by IN O
molecular JJ O
analysis NN O
of IN O
deficient NN O
alleles NNS O
. . O

The DT O
frequency NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
varies NNS O
between IN O
3 CD O
% NN O
and CC O
15 CD O
% NN O
in IN O
different JJ O
tribal NNS O
and CC O
urban JJ O
groups NNS O
. . O

Remarkably RB O
, , O
a DT O
previously RB O
unreported JJ O
deficient NN O
variant NN O
, , O
G6PD NNP O
Orissa NNP O
( ( O
44 CD O
Ala NNP O
- : O
- : O
> NN O
Gly NNP O
) ) O
, , O
is VBZ O
responsible JJ O
for IN O
most JJS O
of IN O
the DT O
G6PD NNP B-Disease
deficiency NN I-Disease
in IN O
tribal JJ O
Indian JJ O
populations NNS O
but CC O
is VBZ O
not RB O
found VBN O
in IN O
urban JJ O
populations NNS O
, , O
where WRB O
most JJS O
of IN O
the DT O
G6PD NNP B-Disease
deficiency NN I-Disease
is VBZ O
due JJ O
to TO O
the DT O
G6PD NNP O
Mediterranean NNP O
( ( O
188 CD O
Ser NNP O
- : O
- : O
> NN O
Phe NNP O
) ) O
variant NN O
. . O

The DT O
KmNADP NNP O
of IN O
G6PD NNP O
Orissa NNP O
is VBZ O
fivefold RB O
higher JJR O
than IN O
that DT O
of IN O
the DT O
normal JJ O
enzyme NN O
. . O

This DT O
may MD O
be VB O
due JJ O
to TO O
the DT O
fact NN O
that IN O
the DT O
alanine NN O
residue NN O
that WDT O
is VBZ O
replaced VBN O
by IN O
glycine NN O
is VBZ O
part NN O
of IN O
a DT O
putative JJ O
coenzyme NN O
- : O
binding NN O
site NN O
. . O
. . O

Evidence NN O
for IN O
linkage NN O
of IN O
bipolar JJ B-Disease
disorder NN I-Disease
to TO O
chromosome VB O
18 CD O
with IN O
a DT O
parent NN O
- : O
of IN O
- : O
origin NN O
effect NN O
. . O

A DT O
susceptibility NN O
gene NN O
on IN O
chromosome NN O
18 CD O
and CC O
a DT O
parent NN O
- : O
of IN O
- : O
origin NN O
effect NN O
have VBP O
been VBN O
suggested VBN O
for IN O
bipolar JJ B-Disease
affective JJ I-Disease
disorder NN I-Disease
( ( O
BPAD NNP B-Disease
) ) O
. . O

We PRP O
have VBP O
studied VBN O
28 CD O
nuclear JJ O
families NNS O
selected VBN O
for IN O
apparent JJ O
unilineal JJ O
transmission NN O
of IN O
the DT O
BPAD NNP B-Disease
phenotype NN O
, , O
by IN O
using VBG O
31 CD O
polymorphic JJ O
markers NNS O
spanning VBG O
chromosome NN O
18 CD O
. . O

Evidence NN O
for IN O
linkage NN O
was VBD O
tested VBN O
with IN O
affected JJ O
- : O
sib NN O
- : O
pair NN O
and CC O
LOD NNP O
score VBP O
methods NNS O
under IN O
two CD O
definitions NNS O
of IN O
the DT O
affected JJ O
phenotype NN O
. . O

The DT O
affected JJ O
- : O
sibpair NN O
analyses NNS O
indicated VBD O
excess JJ O
allele JJ O
sharing VBG O
for IN O
markers NNS O
on IN O
18p CD O
within IN O
the DT O
region NN O
reported VBD O
previously RB O
. . O

The DT O
greatest JJS O
sharing NN O
was VBD O
at IN O
D18S37 NNP O
64 CD O
% NN O
in IN O
bipolar JJ O
and CC O
recurrent JJ O
unipolar JJ O
( ( O
RUP NNP O
) ) O
sib NN O
pairs NNS O
( ( O
P NNP O
= NNP O
. . O
6 CD O
) ) O
. . O

In IN O
addition NN O
, , O
excess JJ O
sharing NN O
of IN O
the DT O
paternally NN O
, , O
but CC O
not RB O
maternally RB O
, , O
transmitted VBD O
alleles NNS O
was VBD O
observed VBN O
at IN O
three CD O
markers NNS O
on IN O
18q CD O
at IN O
D18S41 NNP O
, , O
51 CD O
bipolar NN O
and CC O
RUP NNP O
sib VBP O
pairs NNS O
were VBD O
concordant JJ O
for IN O
paternally RB O
transmitted VBN O
alleles NNS O
, , O
and CC O
21 CD O
pairs NNS O
were VBD O
discordant JJ O
( ( O
P NNP O
= NNP O
4 CD O
) ) O
. . O

The DT O
evidence NN O
for IN O
linkage NN O
to TO O
loci VB O
on IN O
both DT O
18p CD O
and CC O
18q CD O
was VBD O
strongest VBN O
in IN O
the DT O
11 CD O
paternal JJ O
pedigrees NNS O
, , O
i NN O
. . O

e NN O
e NN O
. . O
, , O
those DT O
in IN O
which WDT O
the DT O
father NN O
or CC O
one CD O
of IN O
the DT O
fathers NNS O
sibs VBP O
is VBZ O
affected VBN O
. . O

In IN O
these DT O
pedigrees NNS O
, , O
the DT O
greatest JJS O
allele NN O
sharing NN O
( ( O
81 CD O
% NN O
; : O
P NNP O
= NNP O
. . O
2 CD O
) ) O
and CC O
the DT O
highest JJS O
LOD JJ O
score NN O
( ( O
3 CD O
. . O
51 CD O
; : O
phi NN O
= VBZ O
0 CD O
. . O
0 CD O
) ) O
were VBD O
observed VBN O
at IN O
D18S41 NNP O
. . O

Our PRP$ O
results NNS O
provide VB O
further JJ O
support NN O
for IN O
linkage NN O
of IN O
BPAD NNP B-Disease
to TO O
chromosome VB O
18 CD O
and CC O
the DT O
first JJ O
molecular JJ O
evidence NN O
for IN O
a DT O
parent NN O
- : O
of IN O
- : O
origin NN O
effect NN O
operating VBG O
in IN O
this DT O
disorder NN O
. . O

The DT O
number NN O
of IN O
loci NN O
involved VBN O
, , O
and CC O
their PRP$ O
precise NN O
location NN O
, , O
require VB O
further JJR O
study NN O

A DT O
prevalent JJ O
mutation NN O
for IN O
galactosemia NN B-Disease
among IN O
black JJ O
Americans NNPS O
. . O

OBJECTIVE NN O
To TO O
define VB O
the DT O
mutation NN O
causing VBG O
galactosemia NN B-Disease
in IN O
patients NNS O
of IN O
black JJ O
American JJ O
origin NN O
who WP O
have VBP O
no DT O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
( ( O
GALT NNP O
) ) O
activity NN O
in IN O
erythrocytes NNS O
but CC O
good JJ O
clinical JJ O
outcome NN O
. . O

METHODS NNP O
We PRP O
discovered VBD O
a DT O
mutation NN O
caused VBN O
by IN O
a DT O
C NNP O
- : O
- : O
> NN O
T NNP O
transition NN O
at IN O
base NN O
- : O
pair NN O
1158 CD O
of IN O
the DT O
GALT NNP O
gene NN O
that WDT O
results NNS O
in IN O
a DT O
serine JJ O
- : O
to TO O
- : O
leucine NN O
substitution NN O
at IN O
codon NN O
135 CD O
( ( O
S135L NNP O
) ) O
. . O

We PRP O
developed VBD O
a DT O
method NN O
with IN O
which WDT O
to TO O
screen VB O
populations NNS O
for IN O
its PRP$ O
prevalence NN O
. . O

We PRP O
compared VBN O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
among IN O
erythrocytes NNS O
, , O
leukocytes NNS O
, , O
and CC O
transformed VBD O
lymphoblasts NNS O
, , O
as RB O
well RB O
as IN O
total JJ O
body NN O
oxidation NN O
of IN O
D NNP O
- : O
( ( O
13C CD O
) ) O
- : O
galactose NN O
to TO O
13CO2 CD O
among IN O
three CD O
genotypes NNS O
for IN O
GALT NNP O
( ( O
S135L NNP O
/ NNP O
S135L NNP O
, , O
Q188R NNP O
/ NNP O
Q188R NNP O
, , O
and CC O
Normal NNP O
/ NNP O
Normal NNP O
) ) O
. . O

RESULTS NN O
We PRP O
found VBD O
a DT O
48 CD O
% NN O
prevalence NN O
of IN O
the DT O
S135L NNP O
mutation NN O
among IN O
17 CD O
black JJ O
American JJ O
patients NNS O
with IN O
classic JJ B-Disease
galactosemia NN I-Disease
and CC O
a DT O
1 CD O
% NN O
prevalence NN O
in IN O
a DT O
population NN O
of IN O
50 CD O
black JJ O
Americans NNPS O
without IN O
galactosemia NN B-Disease
. . O

The DT O
S135L NNP O
mutation NN O
was VBD O
not RB O
found VBN O
in IN O
84 CD O
white JJ O
patients NNS O
with IN O
G NNP O
/ NNP O
G NNP O
galactosemia NN B-Disease
nor CC O
in IN O
87 CD O
white JJ O
control NN O
subjects NNS O
without IN O
galactosemia NN B-Disease
. . O

We PRP O
found VBD O
normal JJ O
whole JJ O
body NN O
oxidation NN O
of IN O
D NNP O
- : O
( ( O
13C CD O
) ) O
- : O
galactose NN O
by IN O
the DT O
patient NN O
homozygous JJ O
for IN O
S135L NNP O
and CC O
various JJ O
degrees NNS O
of IN O
enzyme JJ O
impairment NN O
among IN O
different JJ O
tissues NNS O
. . O

CONCLUSIONS NNP O
The DT O
S135L NNP O
mutation NN O
in IN O
the DT O
GALT NNP O
gene NN O
is VBZ O
a DT O
prevalent JJ O
cause NN O
of IN O
galactosemia NN B-Disease
among IN O
black JJ O
patients NNS O
. . O

Because IN O
GALT NNP O
activity NN O
varies NNS O
in IN O
different JJ O
tissues NNS O
of IN O
patients NNS O
homozygous JJ O
for IN O
S135L NNP O
, , O
they PRP O
may MD O
have VB O
a DT O
better JJR O
clinical JJ O
outcome NN O
than IN O
patients NNS O
who WP O
are VBP O
homozygous JJ O
for IN O
Q188R NN O
when WRB O
both DT O
are VBP O
treated VBN O
from IN O
infancy NN O
. . O
. . O

A DT O
high JJ O
incidence NN O
of IN O
BRCA1 NNP O
mutations NNS O
in IN O
20 CD O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

We PRP O
have VBP O
analyzed VBN O
20 CD O
breast SYM B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
, , O
the DT O
majority NN O
of IN O
which WDT O
show VBP O
positive JJ O
evidence NN O
of IN O
linkage NN O
to TO O
chromosome VB O
17q12 CD O
for IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
. . O

BRCA1 NNP O
mutations NNS O
cosegregating VBG O
with IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
were VBD O
identified VBN O
in IN O
16 CD O
families NNS O
, , O
including VBG O
1 CD O
family NN O
with IN O
a DT O
case NN O
of IN O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O

Nine CD O
of IN O
these DT O
mutations NNS O
have VBP O
not RB O
been VBN O
reported VBN O
previously RB O
. . O

The DT O
majority NN O
of IN O
mutations NNS O
were VBD O
found VBN O
to TO O
generate VB O
a DT O
premature NN O
stop NN O
codon NN O
leading VBG O
to TO O
the DT O
formation NN O
of IN O
a DT O
truncated JJ O
BRCA1 NNP O
protein NN O
of IN O
2 CD O
% NN O
- : O
88 CD O
% NN O
of IN O
the DT O
expected VBN O
normal JJ O
length NN O
. . O

Two CD O
mutations NNS O
altered VBD O
the DT O
RING NNP O
finger NN O
domain NN O
. . O

Sequencing VBG O
of IN O
genomic JJ O
DNA NNP O
led VBD O
to TO O
the DT O
identification NN O
of IN O
a DT O
mutation NN O
in IN O
the DT O
coding JJ O
region NN O
of IN O
BRCA1 NNP O
in IN O
12 CD O
families NNS O
, , O
and CC O
cDNA NN O
analysis NN O
revealed VBD O
an DT O
abnormal JJ O
or CC O
missing VBG O
BRCA1 NNP O
transcript NN O
in IN O
4 CD O
of IN O
the DT O
8 CD O
remaining VBG O
families NNS O
. . O

A DT O
total NN O
of IN O
eight CD O
mutations NNS O
were VBD O
associated VBN O
with IN O
a DT O
reduced JJ O
quantity NN O
of IN O
BRCA1 NNP O
transcript NN O
. . O

We PRP O
were VBD O
unable JJ O
to TO O
detect VB O
BRCA1 NNP O
mutations NNS O
in IN O
4 CD O
of IN O
the DT O
20 CD O
families NNS O
, , O
but CC O
only RB O
1 CD O
of IN O
these DT O
was VBD O
clearly RB O
linked VBN O
to TO O
BRCA1 NNP O
. . O

It PRP O
is VBZ O
expected VBN O
that IN O
the DT O
majority NN O
of IN O
clear JJ O
examples NNS O
of IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
syndrome NN I-Disease
will MD O
be VB O
associated VBN O
with IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
coding JJ O
region NN O
of IN O
BRCA1 NNP O
. . O
. . O

Brca1 NNP B-Disease
deficiency NN I-Disease
results NNS O
in IN O
early JJ O
embryonic JJ B-Disease
lethality NN I-Disease
characterized VBN O
by IN O
neuroepithelial JJ B-Disease
abnormalities NNS I-Disease
. . O

The DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
, , O
BRCA1 NNP O
, , O
has VBZ O
been VBN O
cloned VBN O
and CC O
shown VBN O
to TO O
encode VB O
a DT O
zinc NN O
- : O
finger NN O
protein NN O
of IN O
unknown JJ O
function NN O
. . O

Mutations NNS O
in IN O
BRCA1 NNP O
account NN O
for IN O
at IN O
least JJS O
80 CD O
% NN O
of IN O
families NNS O
with IN O
both DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
as RB O
well RB O
as IN O
some DT O
non JJ O
- : O
familial JJ O
sporadic JJ O
ovarian JJ B-Disease
cancers NNS I-Disease
. . O

The DT O
loss NN O
of IN O
wild JJ O
- : O
type NN O
BRCA1 NNP O
in IN O
tumours NN B-Disease
of IN O
individuals NNS O
carrying VBG O
one CD O
nonfunctional JJ O
BRCA1 NNP O
allele NN O
suggests VBZ O
that IN O
BRCA1 NNP O
encodes VBZ O
a DT O
tumour NN B-Disease
suppressor NN O
that WDT O
may MD O
inhibit VB O
the DT O
proliferation NN O
of IN O
mammary JJ O
epithelial JJ O
cells NNS O
. . O

To TO O
examine VB O
the DT O
role NN O
of IN O
BRCA1 NNP O
in IN O
normal JJ O
tissue NN O
growth NN O
and CC O
differentiation NN O
, , O
and CC O
to TO O
generate VB O
a DT O
potential JJ O
model NN O
for IN O
the DT O
cancer NN B-Disease
susceptibility NN O
associated VBN O
with IN O
loss NN O
of IN O
BRCA1 NNP O
function NN O
, , O
we PRP O
have VBP O
created VBN O
a DT O
mouse NN O
line NN O
carrying VBG O
a DT O
mutation NN O
in IN O
one CD O
Brca1 NNP O
allele NN O
. . O

Analysis NN O
of IN O
mice NNS O
homozygous JJ O
for IN O
the DT O
mutant JJ O
allele NN O
indicate VBP O
that IN O
Brca1 NNP O
is VBZ O
critical JJ O
for IN O
normal JJ O
development NN O
, , O
as IN O
these DT O
mice NNS O
died VBD O
in IN O
utero NN O
between IN O
10 CD O
and CC O
13 CD O
days NNS O
of IN O
gestation NN O
( ( O
E10 NNP O
- : O
E13 NN O
) ) O
. . O

Abnormalities NNS O
in IN O
Brca1 NNP B-Disease
- : I-Disease
deficient NN I-Disease
embryos NN O
were VBD O
most RBS O
evident JJ O
in IN O
the DT O
neural JJ O
tube NN O
, , O
with IN O
40 CD O
% NN O
of IN O
the DT O
embryos NN O
presenting VBG O
with IN O
varying VBG O
degrees NNS O
of IN O
spina NN B-Disease
bifida NN I-Disease
and CC O
anencephaly NN B-Disease
. . O

In IN O
addition NN O
, , O
the DT O
neuroepithelium NN O
in IN O
Brca1 NNP B-Disease
- : I-Disease
deficient NN I-Disease
embryos NN O
appeared VBD O
disorganized VBN O
, , O
with IN O
signs NNS O
of IN O
both DT O
rapid JJ O
proliferation NN O
and CC O
excessive JJ O
cell NN O
death NN O
. . O
. . O

Identification NN O
of IN O
mutations NNS O
in IN O
the DT O
ALD NNP O
- : O
gene NN O
of IN O
20 CD O
families NNS O
with IN O
adrenoleukodystrophy NN B-Disease
/ NNP O
adrenomyeloneuropathy NN B-Disease
. . O

Adrenoleukodystrophy NNP B-Disease
( ( O
ALD NNP B-Disease
) ) O
, , O
an DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
inherited JJ I-Disease
metabolic JJ I-Disease
disorder NN I-Disease
, , O
is VBZ O
the DT O
most RBS O
frequent JJ O
inborn JJ B-Disease
peroxisomal JJ I-Disease
disease NN I-Disease
. . O

It PRP O
leads VBZ O
to TO O
demyelination NN B-Disease
in IN I-Disease
the DT I-Disease
central JJ I-Disease
and CC I-Disease
peripheral JJ I-Disease
nervous JJ I-Disease
system NN I-Disease
. . O

Defective JJ O
beta NN O
- : O
oxidation NN O
of IN O
saturated JJ O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
( ( O
VLCFAs NNP O
; : O
C22 NNP O
0 CD O
- : O
C26 NNP O
0 CD O
) ) O
in IN O
peroxisomes NN O
has VBZ O
been VBN O
shown VBN O
to TO O
lead VB O
to TO O
an DT O
accumulation NN O
of IN O
VLCFAs NNP O
in IN O
leukoid JJ O
areas NNS O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
peripheral JJ O
nerves NNS O
, , O
adrenal JJ O
gland NN O
, , O
and CC O
blood NN O
. . O

The DT O
ALD NNP B-Disease
gene NN O
has VBZ O
been VBN O
recently RB O
identified VBN O
and CC O
encodes VBZ O
a DT O
745 CD O
- : O
amino NN O
- : O
acid NN O
protein NN O
. . O

We PRP O
screened VBD O
patients NNS O
with IN O
adrenoleukodystrophy NN B-Disease
/ NN O
adrenomyeloneuropathy NN B-Disease
( ( O
ALD NNP B-Disease
/ NNP O
AMN NNP B-Disease
) ) O
from IN O
20 CD O
kindreds NNS O
for IN O
mutations NNS O
in IN O
the DT O
ALD NNP B-Disease
gene NN O
. . O

Eleven NNP O
missense NN O
and CC O
two CD O
nonsense JJ O
mutations NNS O
, , O
five CD O
deletions NNS O
, , O
and CC O
one CD O
insertion NN O
were VBD O
detected VBN O
by IN O
direct JJ O
sequencing NN O
of IN O
eight CD O
reverse NNS O
transcribed VBD O
fragments NNS O
of IN O
the DT O
ALD NNP B-Disease
- : O
gene NN O
mRNA NN O
. . O

Four CD O
mutations NNS O
could MD O
be VB O
shown VBN O
to TO O
be VB O
de FW O
novo FW O
. . O

All DT O
mutations NNS O
could MD O
be VB O
confirmed VBN O
in IN O
carriers NNS O
by IN O
sequencing VBG O
genomic JJ O
DNA NN O
. . O

No DT O
correlation NN O
between IN O
the DT O
type NN O
of IN O
mutation NN O
and CC O
the DT O
severity NN O
of IN O
the DT O
phenotype NN O
could MD O
be VB O
observed VBN O
. . O

The DT O
mutations NNS O
were VBD O
not RB O
detected VBN O
in IN O
the DT O
ALD NNP B-Disease
gene NN O
of IN O
30 CD O
healthy JJ O
persons NNS O
. . O
. . O

The DT O
murine NN O
homolog NN O
of IN O
the DT O
human JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
Brca1 NNP O
maps NNS O
to TO O
mouse VB O
chromosome NN O
11D CD O
. . O

The DT O
recently RB O
cloned VBN O
human JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
, , O
BRCA1 NNP O
, , O
is VBZ O
located VBN O
on IN O
human JJ O
chromosome NN O
17q21 CD O
. . O

We PRP O
have VBP O
isolated VBN O
murine JJ O
genomic JJ O
clones NNS O
containing VBG O
Brca1 NNP O
as IN O
a DT O
first JJ O
step NN O
in IN O
generating VBG O
a DT O
mouse NN O
model NN O
for IN O
the DT O
loss NN O
of IN O
BRCA1 NNP O
function NN O
. . O

A DT O
mouse NN O
genomic JJ O
library NN O
was VBD O
screened VBN O
using VBG O
probes NNS O
corresponding VBG O
to TO O
exon VB O
11 CD O
of IN O
the DT O
human JJ O
BRCA1 NNP O
gene NN O
. . O

Two CD O
overlapping VBG O
mouse NN O
clones NNS O
were VBD O
identified VBN O
that IN O
hybridized VBD O
to TO O
human JJ O
BRCA1 NNP O
exons NNS O
9 CD O
- : O
12 CD O
. . O

Sequence NNP O
analysis NN O
of IN O
1 CD O
. . O

4 CD O
kb NN O
of IN O
the DT O
region NN O
of IN O
these DT O
clones NNS O
corresponding VBG O
to TO O
part NN O
of IN O
human JJ O
exon FW O
11 CD O
revealed VBD O
72 CD O
% NN O
nucleic JJ O
acid JJ O
identity NN O
but CC O
only RB O
50 CD O
% NN O
amino NN O
acid NN O
identity NN O
with IN O
the DT O
human JJ O
gene NN O
. . O

The DT O
longest JJS O
of IN O
the DT O
mouse NN O
Brca1 NNP O
genomic JJ O
clones NNS O
maps NNS O
to TO O
chromosome VB O
11D CD O
, , O
as IN O
determined VBN O
by IN O
two CD O
- : O
color NN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
. . O

The DT O
synteny NN O
to TO O
human JJ O
chromosome NN O
17 CD O
was VBD O
confirmed VBN O
by IN O
cohybridization NN O
with IN O
the DT O
mouse NN O
probe NN O
for IN O
the DT O
NF1 NNP O
- : O
gene NN O
. . O

This DT O
comparative JJ O
study NN O
confirms VBZ O
that IN O
the DT O
relative JJ O
location NN O
of IN O
the DT O
BRCA1 NNP O
gene NN O
has VBZ O
been VBN O
conserved VBN O
between IN O
mice NNS O
and CC O
humans NNS O
. . O

Atelosteogenesis NNP B-Disease
type NN I-Disease
II NNP I-Disease
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulfate NN O
- : O
transporter NN O
gene NN O
( ( O
DTDST NNP O
) ) O
: : O
evidence NN O
for IN O
a DT O
phenotypic NN O
series NN O
involving VBG O
three CD O
chondrodysplasias NNS B-Disease
. . O

Atelosteogenesis NNP B-Disease
type NN I-Disease
II NNP I-Disease
( ( O
AO NNP B-Disease
II NNP I-Disease
) ) O
is VBZ O
a DT O
neonatally RB O
lethal JJ O
chondrodysplasia NN B-Disease
whose WP$ O
clinical JJ O
and CC O
histological JJ O
characteristics NNS O
resemble VBP O
those DT O
of IN O
another DT O
chondrodysplasia NN B-Disease
, , O
the DT O
much RB O
less RBR O
severe JJ O
diastrophic JJ B-Disease
dysplasia NN I-Disease
( ( O
DTD NNP B-Disease
) ) O
. . O

The DT O
similarity NN O
suggests VBZ O
a DT O
shared VBN O
pathogenesis NN O
involving VBG O
lesions NNS O
in IN O
the DT O
same JJ O
biochemical JJ O
pathway NN O
and CC O
perhaps RB O
the DT O
same JJ O
gene NN O
. . O

DTD NNP B-Disease
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
recently RB O
identified VBN O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulfate NN O
- : O
transporter NN O
gene NN O
( ( O
DTDST NNP O
) ) O
. . O

Here RB O
, , O
we PRP O
report VBP O
that DT O
AOII NNP B-Disease
patients NNS O
also RB O
have VBP O
DTDST NNP O
mutations NNS O
, , O
which WDT O
lead VBP O
to TO O
defective JJ O
uptake NN O
of IN O
inorganic JJ O
sulfate NN O
and CC O
insufficient JJ O
sulfation NN O
of IN O
macromolecules NNS O
by IN O
patient JJ O
mesenchymal JJ O
cells NNS O
in IN O
vitro NN O
. . O

Together RB O
with IN O
our PRP$ O
recent JJ O
observation NN O
that IN O
a DT O
third JJ O
even RB O
more RBR O
severe JJ O
chondrodysplasia NN B-Disease
, , O
achondrogenesis NN O
type NN O
IB NNP O
, , O
is VBZ O
also RB O
caused VBN O
by IN O
mutations NNS O
in IN O
DTDST NNP O
, , O
these DT O
results NNS O
demonstrate VBP O
a DT O
phenotypic NN O
series NN O
of IN O
three CD O
chondrodysplasias NNS B-Disease
of IN O
increasing VBG O
severity NN O
caused VBN O
by IN O
lesions NNS O
in IN O
a DT O
single JJ O
sulfate NN O
- : O
transporter NN O
gene NN O
. . O

The DT O
severity NN O
of IN O
the DT O
phenotype NN O
appears VBZ O
to TO O
be VB O
correlated VBN O
with IN O
the DT O
predicted JJ O
effect NN O
of IN O
the DT O
mutations NNS O
on IN O
the DT O
residual JJ O
activity NN O
of IN O
the DT O
DTDST NNP O
protein NN O
. . O
. . O

Haplotype NNP O
and CC O
phenotype JJ O
analysis NN O
of IN O
six CD O
recurrent JJ O
BRCA1 NNP O
mutations NNS O
in IN O
61 CD O
families NNS O
: : O
results NNS O
of IN O
an DT O
international JJ O
study NN O
. . O

Several JJ O
BRCA1 NNP O
mutations NNS O
have VBP O
now RB O
been VBN O
found VBN O
to TO O
occur VB O
in IN O
geographically RB O
diverse JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

To TO O
investigate VB O
mutation NN O
origin NN O
and CC O
mutation NN O
- : O
specific JJ O
phenotypes NNS O
due JJ O
to TO O
BRCA1 NNP O
, , O
we PRP O
constructed VBD O
a DT O
haplotype NN O
of IN O
nine CD O
polymorphic JJ O
markers NNS O
within IN O
or CC O
immediately RB O
flanking VBG O
the DT O
BRCA1 NNP O
locus NN O
in IN O
a DT O
set NN O
of IN O
61 CD O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
selected VBN O
for IN O
having VBG O
one CD O
of IN O
six CD O
recurrent JJ O
BRCA1 NNP O
mutations NNS O
. . O

Tests NNS O
of IN O
both DT O
mutations NNS O
and CC O
family NN O
- : O
specific JJ O
differences NNS O
in IN O
age NN O
at IN O
diagnosis NN O
were VBD O
not RB O
significant JJ O
. . O

A DT O
comparison NN O
of IN O
the DT O
six CD O
mutations NNS O
in IN O
the DT O
relative JJ O
proportions NNS O
of IN O
cases NNS O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
was VBD O
suggestive JJ O
of IN O
an DT O
effect NN O
( ( O
P NNP O
= NNP O
. . O
69 CD O
) ) O
, , O
with IN O
57 CD O
% NN O
of IN O
women NNS O
presumed VBN O
affected JJ O
because IN O
of IN O
the DT O
1294 CD O
del NN O
40 CD O
BRCA1 NNP O
mutation NN O
having VBG O
ovarian JJ B-Disease
cancer NN I-Disease
, , O
compared VBN O
with IN O
14 CD O
% NN O
of IN O
affected JJ O
women NNS O
with IN O
the DT O
splice NN O
- : O
site NN O
mutation NN O
in IN O
intron NN O
5 CD O
of IN O
BRCA1 NNP O
. . O

For IN O
the DT O
BRCA1 NNP O
mutations NNS O
studied VBD O
here RB O
, , O
the DT O
individual JJ O
mutations NNS O
are VBP O
estimated VBN O
to TO O
have VB O
arisen VBN O
9 CD O
- : O
170 CD O
generations NNS O
ago RB O
. . O

In IN O
general JJ O
, , O
a DT O
high JJ O
degree NN O
of IN O
haplotype NN O
conservation NN O
across IN O
the DT O
region NN O
was VBD O
observed VBN O
, , O
with IN O
haplotype JJ O
differences NNS O
most RBS O
often RB O
due JJ O
to TO O
mutations NNS O
in IN O
the DT O
short JJ O
- : O
tandem NN O
- : O
repeat NN O
markers NNS O
, , O
although IN O
some DT O
likely JJ O
instances NNS O
of IN O
recombination NN O
also RB O
were VBD O
observed VBN O
. . O

For IN O
several JJ O
of IN O
the DT O
instances NNS O
, , O
there EX O
was VBD O
evidence NN O
for IN O
multiple JJ O
, , O
independent JJ O
, , O
BRCA1 NNP O
mutational JJ O
events NNS O
. . O

Isolation NN O
of IN O
the DT O
mouse NN O
homologue NN O
of IN O
BRCA1 NNP O
and CC O
genetic JJ O
mapping NN O
to TO O
mouse VB O
chromosome NN O
11 CD O
. . O

The DT O
BRCA1 NNP O
gene NN O
is VBZ O
in IN O
large JJ O
part NN O
responsible JJ O
for IN O
hereditary JJ B-Disease
human JJ I-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Here RB O
we PRP O
report VBP O
the DT O
isolation NN O
of IN O
the DT O
murine NN O
Brca1 NNP O
homologue NN O
cDNA NN O
clones NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
identified VBD O
genomic JJ O
P1 NNP O
clones NNS O
that WDT O
contain VBP O
most RBS O
, , O
if IN O
not RB O
all DT O
, , O
of IN O
the DT O
mouse NN O
Brca1 NNP O
locus NN O
. . O

DNA NN O
sequence NN O
analysis NN O
revealed VBD O
that IN O
the DT O
mouse NN O
and CC O
human JJ O
coding NN O
regions NNS O
are VBP O
75 CD O
% NN O
identical JJ O
at IN O
the DT O
nucleotide JJ O
level NN O
while IN O
the DT O
predicted JJ O
amino NN O
acid NN O
identity NN O
is VBZ O
only RB O
58 CD O
% NN O
. . O

A DT O
DNA NN O
sequence NN O
variant NN O
in IN O
the DT O
Brca1 NNP O
locus NN O
was VBD O
identified VBN O
and CC O
used VBN O
to TO O
map VB O
this DT O
gene NN O
on IN O
a DT O
( ( O
Mus NNP O
m NN O
. . O
musculus CC O
Czech NNP O
II NNP O
x NNP O
C57BL NNP O
/ NNP O
KsJ NNP O
) ) O
F1 NNP O
x NNP O
C57BL NNP O
/ NNP O
KsJ NNP O
intersubspecific JJ O
backcross NN O
to TO O
distal VB O
mouse NN O
chromosome NN O
11 CD O
. . O

The DT O
mapping NN O
of IN O
this DT O
gene NN O
to TO O
a DT O
region NN O
highly RB O
syntenic JJ O
with IN O
human JJ O
chromosome NN O
17 CD O
, , O
coupled VBN O
with IN O
Southern NNP O
and CC O
Northern NNP O
analyses NNS O
, , O
confirms NNS O
that IN O
we PRP O
isolated VBD O
the DT O
murine NN O
Brca1 NNP O
homologue NN O
rather RB O
than IN O
a DT O
related JJ O
RING NN O
finger NN O
gene NN O
. . O

The DT O
isolation NN O
of IN O
the DT O
mouse NN O
Brca1 NNP O
homologue NN O
will MD O
facilitate VB O
the DT O
creation NN O
of IN O
mouse NN O
models NNS O
for IN O
germline JJ O
BRCA1 NNP B-Disease
defects NNS I-Disease
. . O
. . O

Emerin NNP B-Disease
deficiency NN I-Disease
at IN O
the DT O
nuclear JJ O
membrane NN O
in IN O
patients NNS O
with IN O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
. . O

Mutations NNS O
in IN O
the DT O
STA NNP O
gene NN O
at IN O
the DT O
Xq28 NNP O
locus NN O
have VBP O
been VBN O
found VBN O
in IN O
patients NNS O
with IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
Emery NNP I-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EDMD NNP B-Disease
) ) O
. . O

This DT O
gene NN O
encodes VBZ O
a DT O
hitherto JJ O
unknown JJ O
protein NN O
named VBN O
emerin NN O
. . O

To TO O
elucidate VB O
the DT O
subcellular JJ O
localization NN O
of IN O
emerin NN O
, , O
we PRP O
raised VBD O
two CD O
antisera NN O
against IN O
synthetic JJ O
peptide NN O
fragments NNS O
predicted VBD O
from IN O
emerin JJ O
cDNA NN O
. . O

Using VBG O
both DT O
antisera NN O
, , O
we PRP O
found VBD O
positive JJ O
nuclear JJ O
membrane NN O
staining VBG O
in IN O
skeletal JJ O
, , O
cardiac JJ O
and CC O
smooth JJ O
muscles NNS O
in IN O
the DT O
normal JJ O
controls NNS O
and CC O
in IN O
patients NNS O
with IN O
neuromuscular JJ B-Disease
diseases NNS I-Disease
other JJ O
than IN O
EDMD NNP B-Disease
. . O

In IN O
contrast NN O
, , O
a DT O
deficiency NN O
in IN O
immunofluorescent JJ O
staining NN O
of IN O
skeletal JJ O
and CC O
cardiac JJ O
muscle NN O
from IN O
EDMD NNP B-Disease
patients NNS O
was VBD O
observed VBN O
. . O

A DT O
34 CD O
kD NN O
protein NN O
is VBZ O
immunoreactive JJ O
with IN O
the DT O
antisera NN O
- : O
- : O
the DT O
protein NN O
is VBZ O
equivalent JJ O
to TO O
that DT O
predicted VBN O
for IN O
emerin NN O
. . O

Together RB O
, , O
our PRP$ O
findings NNS O
suggest VBP O
the DT O
specific JJ O
deficiency NN B-Disease
of IN I-Disease
emerin NN I-Disease
in IN O
the DT O
nuclear JJ O
membrane NN O
of IN O
muscle NN O
cells NNS O
in IN O
patients NNS O
with IN O
EDMD NNP B-Disease
. . O
. . O

Growth NNP B-Disease
retardation NN I-Disease
and CC O
tumour JJ B-Disease
inhibition NN O
by IN O
BRCA1 NNP O
. . O

Inherited VBN O
mutations NNS O
in IN O
BRCA1 NNP O
predispose NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
but CC O
the DT O
role NN O
of IN O
BRCA1 NNP O
in IN O
sporadic JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
has VBZ O
previously RB O
been VBN O
elusive JJ O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
retroviral JJ O
transfer NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
BRCA1 NNP O
gene NN O
inhibits NNS O
growth NN O
in IN O
vitro NN O
of IN O
all DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cell NN O
lines NNS O
tested VBN O
, , O
but CC O
not RB O
colon NN B-Disease
or CC I-Disease
lung NN I-Disease
cancer NN I-Disease
cells NNS O
or CC O
fibroblasts NNS O
. . O

Mutant NNP O
BRCA1 NNP O
has VBZ O
no DT O
effect NN O
on IN O
growth NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
cells NNS O
; : O
ovarian JJ B-Disease
cancer NN I-Disease
cell NN O
growth NN O
is VBZ O
not RB O
affected VBN O
by IN O
BRCA1 NNP O
mutations NNS O
in IN O
the DT O
5 CD O
portion NN O
of IN O
the DT O
gene NN O
, , O
but CC O
is VBZ O
inhibited VBN O
by IN O
3 CD O
BRCA1 NNP O
mutations NNS O
. . O

Development NNP O
of IN O
MCF NNP B-Disease
- : I-Disease
7 CD I-Disease
tumours NNS I-Disease
in IN O
nude JJ O
mice NN O
is VBZ O
inhibited VBN O
when WRB O
MCF NNP O
- : O
7 CD O
cells NNS O
are VBP O
transfected VBN O
with IN O
wild JJ O
- : O
type NN O
, , O
but CC O
not RB O
mutant JJ O
, , O
BRCA1 NNP O
. . O

Most JJS O
importantly RB O
, , O
among IN O
mice NN O
with IN O
established VBN O
MCF NNP B-Disease
- : I-Disease
7 CD I-Disease
tumours NNS I-Disease
, , O
peritoneal JJ O
treatment NN O
with IN O
a DT O
retroviral JJ O
vector NN O
expressing VBG O
wild JJ O
- : O
type NN O
BRCA1 NNP O
significantly RB O
inhibits VBZ O
tumour JJ B-Disease
growth NN O
and CC O
increased VBD O
survival NN O
. . O
. . O

BRCA1 NNP O
is VBZ O
secreted VBN O
and CC O
exhibits JJ O
properties NNS O
of IN O
a DT O
granin NN O
. . O

Germline NNP O
mutations NNS O
in IN O
BRCA1 NNP O
are VBP O
responsible JJ O
for IN O
most JJS O
cases NNS O
of IN O
inherited JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

However RB O
, , O
the DT O
function NN O
of IN O
the DT O
BRCA1 NNP O
protein NN O
has VBZ O
remained VBN O
elusive JJ O
. . O

We PRP O
now RB O
show VBP O
that IN O
BRCA1 NNP O
encodes VBZ O
a DT O
190 CD O
- : O
kD NN O
protein NN O
with IN O
sequence NN O
homology NN O
and CC O
biochemical JJ O
analogy NN O
to TO O
the DT O
granin NN O
protein NN O
family NN O
. . O

Interestingly RB O
, , O
BRCA2 NNP O
also RB O
includes VBZ O
a DT O
motif NN O
similar JJ O
to TO O
the DT O
granin NN O
consensus NN O
at IN O
the DT O
C NNP O
terminus NN O
of IN O
the DT O
protein NN O
. . O

Both DT O
BRCA1 NNP O
and CC O
the DT O
granins NNS O
localize VBP O
to TO O
secretory JJ O
vesicles NNS O
, , O
are VBP O
secreted VBN O
by IN O
a DT O
regulated JJ O
pathway NN O
, , O
are VBP O
post VBN O
- : O
translationally RB O
glycosylated VBN O
and CC O
are VBP O
responsive JJ O
to TO O
hormones NNS O
. . O

As IN O
a DT O
regulated JJ O
secretory NN O
protein NN O
, , O
BRCA1 NNP O
appears VBZ O
to TO O
function VB O
by IN O
a DT O
mechanism NN O
not RB O
previously RB O
described VBN O
for IN O
tumour NN B-Disease
suppressor NN O
gene NN O
products NNS O
. . O
. . O

Ovarian JJ B-Disease
cancer NN I-Disease
risk NN O
in IN O
BRCA1 NNP O
carriers NNS O
is VBZ O
modified VBN O
by IN O
the DT O
HRAS1 NNP O
variable JJ O
number NN O
of IN O
tandem JJ O
repeat NN O
( ( O
VNTR NNP O
) ) O
locus NN O
. . O

Women NNS O
who WP O
carry VBP O
a DT O
mutation NN O
in IN O
the DT O
BRCA1 NNP O
gene NN O
( ( O
on IN O
chromosome NN O
17q21 CD O
) ) O
, , O
have VBP O
an DT O
80 CD O
% NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
and CC O
a DT O
40 CD O
% NN O
risk NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
by IN O
the DT O
age NN O
of IN O
70 CD O
( ( O
ref NN O
. . O
1 CD O
) ) O
. . O

The DT O
variable JJ O
penetrance NN O
of IN O
BRCA1 NNP O
suggests VBZ O
that IN O
other JJ O
genetic JJ O
and CC O
non JJ O
- : O
genetic JJ O
factors NNS O
play VBP O
a DT O
role NN O
in IN O
tumourigenesis NN O
in IN O
these DT O
individuals NNS O
. . O

The DT O
HRAS1 NNP O
variable JJ O
number NN O
of IN O
tandem JJ O
repeats NNS O
( ( O
VNTR NNP O
) ) O
polymorphism NN O
, , O
located VBN O
1 CD O
kilobase NN O
( ( O
kb NN O
) ) O
downstream NN O
of IN O
the DT O
HRAS1 NNP O
proto NN O
- : O
oncogene NN O
( ( O
chromosome JJ O
11p15 CD O
. . O
5 CD O
) ) O
is VBZ O
one CD O
possible JJ O
genetic JJ O
modifier NN O
of IN O
cancer NN B-Disease
penetrance NN O
. . O

Individuals NNS O
who WP O
have VBP O
rare JJ O
alleles NNS O
of IN O
the DT O
VNTR NNP O
have VBP O
an DT O
increased VBN O
risk NN O
of IN O
certain JJ O
types NNS O
of IN O
cancers NNS B-Disease
, , O
including VBG O
breast NN B-Disease
cancer NN I-Disease
( ( O
2 CD O
- : O
4 CD O
) ) O
. . O

To TO O
investigate VB O
whether IN O
the DT O
presence NN O
of IN O
rare JJ O
HRAS1 NNP O
alleles VBZ O
increases NNS O
susceptibility NN O
to TO O
hereditary VB B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
we PRP O
have VBP O
typed VBN O
a DT O
panel NN O
of IN O
307 CD O
female JJ O
BRCA1 NNP O
carriers NNS O
at IN O
this DT O
locus NN O
using VBG O
a DT O
PCR NNP O
- : O
based VBN O
technique NN O
. . O

The DT O
risk NN O
for IN O
ovarian JJ B-Disease
cancer NN I-Disease
was VBD O
2 CD O
. . O

11 CD O
times NNS O
greater JJR O
for IN O
BRCA1 NNP O
carriers NNS O
harbouring VBG O
one CD O
or CC O
two CD O
rare JJ O
HRAS1 NNP O
alleles NNS O
, , O
compared VBN O
to TO O
carriers NNS O
with IN O
only JJ O
common JJ O
alleles NNS O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
15 CD O
) ) O
. . O

The DT O
magnitude NN O
of IN O
the DT O
relative JJ O
risk NN O
associated VBN O
with IN O
a DT O
rare JJ O
HRAS1 NNP O
allele NN O
was VBD O
not RB O
altered VBN O
by IN O
adjusting VBG O
for IN O
the DT O
other JJ O
known VBN O
risk NN O
factors NNS O
for IN O
hereditary JJ B-Disease
ovarian JJ I-Disease
cancer NN I-Disease
( ( O
5 CD O
) ) O
. . O

Susceptibility NN O
to TO O
breast VB B-Disease
cancer NN I-Disease
did VBD O
not RB O
appear VB O
to TO O
be VB O
affected VBN O
by IN O
the DT O
presence NN O
of IN O
rare JJ O
HRAS1 NNP O
alleles NNS O
. . O

This DT O
study NN O
is VBZ O
the DT O
first JJ O
to TO O
show VB O
the DT O
effect NN O
of IN O
a DT O
modifying VBG O
gene NN O
on IN O
the DT O
penetrance NN O
of IN O
an DT O
inherited JJ B-Disease
cancer NN I-Disease
syndrome NN I-Disease

A DT O
novel NN O
homeodomain NN O
- : O
encoding VBG O
gene NN O
is VBZ O
associated VBN O
with IN O
a DT O
large JJ O
CpG NNP O
island NN O
interrupted VBN O
by IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
unstable JJ O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
associated VBN O
with IN O
a DT O
( ( O
CTG NNP O
) ) O
n FW O
trinucleotide JJ O
repeat NN O
expansion NN O
in IN O
the DT O
3 CD O
- : O
untranslated JJ O
region NN O
of IN O
a DT O
protein NN O
kinase SYM O
- : O
encoding VBG O
gene NN O
, , O
DMPK NNP O
, , O
which WDT O
maps VBZ O
to TO O
chromosome VB O
19q13 CD O
. . O

3 CD O
. . O

Characterisation NN O
of IN O
the DT O
expression NN O
of IN O
this DT O
gene NN O
in IN O
patient JJ O
tissues NNS O
has VBZ O
thus RB O
far RB O
generated JJ O
conflicting VBG O
data NNS O
on IN O
alterations NNS O
in IN O
the DT O
steady JJ O
state NN O
levels NNS O
of IN O
DMPK NNP O
mRNA NN O
, , O
and CC O
on IN O
the DT O
final JJ O
DMPK NNP O
protein NN O
levels NNS O
in IN O
the DT O
presence NN O
of IN O
the DT O
expansion NN O
. . O

The DT O
DM NNP B-Disease
region NN O
of IN O
chromosome NN O
19 CD O
is VBZ O
gene NN O
rich JJ O
, , O
and CC O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
repeat NN O
expansion NN O
may MD O
lead VB O
to TO O
dysfunction NN O
of IN O
a DT O
number NN O
of IN O
transcription NN O
units NNS O
in IN O
the DT O
vicinity NN O
, , O
perhaps RB O
as IN O
a DT O
consequence NN O
of IN O
chromatin JJ O
disruption NN O
. . O

We PRP O
have VBP O
searched VBN O
for IN O
genes NNS O
associated VBN O
with IN O
a DT O
CpG NNP O
island NN O
at IN O
the DT O
3 CD O
end NN O
of IN O
DMPK NNP O
. . O

Sequencing VBG O
of IN O
this DT O
region NN O
shows VBZ O
that IN O
the DT O
island NN O
extends VBZ O
over IN O
3 CD O
. . O

5 CD O
kb NN O
and CC O
is VBZ O
interrupted VBN O
by IN O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
. . O

Comparison NNP O
of IN O
genomic JJ O
sequences NNS O
downstream NN O
( ( O
centromeric JJ O
) ) O
of IN O
the DT O
repeat NN O
in IN O
human JJ O
and CC O
mouse NN O
identified JJ O
regions NNS O
of IN O
significant JJ O
homology NN O
. . O

These DT O
correspond NN O
to TO O
exons NNS O
of IN O
a DT O
gene NN O
predicted VBN O
to TO O
encode VB O
a DT O
homeodomain NN O
protein NN O
. . O

RT NNP O
- : O
PCR NN O
analysis NN O
shows VBZ O
that IN O
this DT O
gene NN O
, , O
which WDT O
we PRP O
have VBP O
called VBN O
DM NNP B-Disease
locus SYM O
- : O
associated VBN O
homeodomain NN O
protein NN O
( ( O
DMAHP NNP O
) ) O
, , O
is VBZ O
expressed VBN O
in IN O
a DT O
number NN O
of IN O
human JJ O
tissues NNS O
, , O
including VBG O
skeletal JJ O
muscle NN O
, , O
heart NN O
and CC O
brain NN O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
RB1 NNP O
gene NN O
in IN O
patients NNS O
with IN O
hereditary JJ B-Disease
retinoblastoma NN I-Disease
. . O

We PRP O
have VBP O
analyzed VBN O
the DT O
27 CD O
exons NNS O
and CC O
the DT O
promoter NN O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
in IN O
familial JJ B-Disease
or CC I-Disease
sporadic JJ I-Disease
bilateral JJ I-Disease
retinoblastoma NN I-Disease
by IN O
using VBG O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
. . O

For IN O
improvement NN O
over IN O
previous JJ O
studies NNS O
, , O
a DT O
new JJ O
set NN O
of IN O
primers NNS O
has VBZ O
been VBN O
designed VBN O
, , O
which WDT O
allow VBP O
for IN O
amplification NN O
of IN O
the DT O
coding NN O
and CC O
splicing NN O
sequences NNS O
only RB O
. . O

The DT O
positioning NN O
of IN O
the DT O
polymerase NN O
chain NN O
reaction NN O
( ( O
PCR NNP O
) ) O
primers NNS O
was VBD O
such JJ O
that IN O
the DT O
resulting VBG O
PCR NNP O
products NNS O
were VBD O
of IN O
different JJ O
sizes NNS O
, , O
which WDT O
enabled VBD O
us PRP O
to TO O
analyze VB O
two CD O
different JJ O
exons NNS O
simultaneously RB O
and CC O
still RB O
distinguish VB O
between IN O
the DT O
banding NN O
profiles NNS O
for IN O
both DT O
( ( O
biplex JJ O
analysis NN O
) ) O
. . O

By IN O
using VBG O
this DT O
approach NN O
, , O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
mutation NN O
in IN O
22 CD O
new JJ O
patients NNS O
, , O
but CC O
the DT O
overall JJ O
efficiency NN O
of IN O
the DT O
procedure NN O
when WRB O
we PRP O
used VBD O
a DT O
single JJ O
- : O
pass NN O
regimen NN O
was VBD O
only RB O
48 CD O
% NN O
. . O

The DT O
mutations NNS O
were VBD O
small JJ O
insertions NNS O
and CC O
deletions NNS O
and CC O
point NN O
mutations NNS O
in IN O
roughly RB O
equal JJ O
proportions NNS O
. . O
. . O

Type NNP B-Disease
II NNP I-Disease
human JJ I-Disease
complement NN I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
. . O

Allele NNP O
- : O
specific JJ O
amino NN O
acid JJ O
substitutions NNS O
( ( O
Ser189 NNP O
- : O
- : O
> NN O
Phe NNP O
; : O
Gly444 NNP O
- : O
- : O
> NN O
Arg NNP O
) ) O
cause NN O
impaired JJ O
C2 NNP O
secretion NN O
. . O

Type NNP B-Disease
II NNP I-Disease
complement NN I-Disease
protein NN I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
is VBZ O
characterized VBN O
by IN O
a DT O
selective JJ O
block NN O
in IN O
C2 NNP O
secretion NN O
. . O

The DT O
Type NNP O
II NNP O
C2 NNP O
null JJ O
allele NN O
( ( O
C2Q0 NNP O
) ) O
is VBZ O
linked VBN O
to TO O
two CD O
major JJ O
histocompatibility NN O
haplotypes NNS O
( ( O
MHC NNP O
) ) O
that WDT O
differ VBP O
from IN O
the DT O
MHC NNP O
of IN O
the DT O
more RBR O
common JJ O
Type NNP B-Disease
I PRP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
. . O

To TO O
determine VB O
the DT O
molecular JJ O
basis NN O
of IN O
Type NNP B-Disease
II NNP I-Disease
deficiency VBZ I-Disease
the DT O
two CD O
Type NNP O
II NNP O
C2Q0 NNP O
genes NNS O
were VBD O
isolated VBN O
and CC O
transfected VBN O
separately RB O
into IN O
L NNP O
- : O
cells NNS O
. . O

Subsequent JJ O
molecular JJ O
biology NN O
, , O
biosynthetic JJ O
, , O
and CC O
immunofluorescence NN O
studies NNS O
demonstrated VBD O
that IN O
C2 NNP O
secretion NN O
is VBZ O
impaired VBN O
in IN O
Type NNP B-Disease
II NNP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
because IN O
of IN O
different JJ O
missense NN O
mutations NNS O
at IN O
highly RB O
conserved VBN O
residues NNS O
in IN O
each DT O
of IN O
the DT O
C2Q0 NNP O
alleles NNS O
. . O

One CD O
is VBZ O
in IN O
exon JJ O
5 CD O
( ( O
nucleotide JJ O
C566 NNP O
- : O
- : O
> NN O
T NNP O
; : O
Ser189 NNP O
- : O
- : O
> NN O
Phe NNP O
) ) O
of IN O
the DT O
C2Q0 NNP O
gene NN O
linked VBD O
to TO O
the DT O
MHC NNP O
haplotype NN O
A11 NNP O
, , O
B35 NNP O
, , O
DRw1 NNP O
, , O
BFS NNP O
, , O
C4A0B1 NNP O
. . O

The DT O
other JJ O
is VBZ O
in IN O
exon JJ O
11 CD O
( ( O
G1930 NNP O
- : O
- : O
> VB O
A DT O
; : O
Gly444 NNP O
- : O
- : O
> NN O
Arg NNP O
) ) O
of IN O
the DT O
C2Q0 NNP O
gene NN O
linked VBD O
to TO O
the DT O
MHC NNP O
haplotype NN O
A2 NNP O
, , O
B5 NNP O
, , O
DRw4 NNP O
, , O
BFS NNP O
, , O
C4A3B1 NNP O
. . O

Each DT O
mutant JJ O
C2 NNP O
gene NN O
product NN O
is VBZ O
retained VBN O
early RB O
in IN O
the DT O
secretory JJ O
pathway NN O
. . O

These DT O
mutants NNS O
provide VBP O
models NNS O
for IN O
elucidating VBG O
the DT O
C2 NNP O
secretory NN O
pathway NN O
. . O
. . O

Defective JJ O
dimerization NN O
of IN O
von JJ B-Disease
Willebrand NNP I-Disease
factor NN O
subunits NNS O
due JJ O
to TO O
a DT O
Cys NNP O
- : O
> NN O
Arg NNP O
mutation NN O
in IN O
type NN B-Disease
IID NNP I-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
. . O

The DT O
same JJ O
heterozygous JJ O
T NNP O
- : O
> NN O
C NNP O
transition NN O
at IN O
nt JJ O
8567 CD O
of IN O
the DT O
von NN B-Disease
Willebrand NNP I-Disease
factor NN O
( ( O
vWF NN O
) ) O
transcript NN O
was VBD O
found VBN O
in IN O
two CD O
unrelated JJ O
patients NNS O
with IN O
type JJ B-Disease
IID NNP I-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
, , O
with IN O
no DT O
other JJ O
apparent JJ O
abnormality NN O
. . O

In IN O
one CD O
family NN O
, , O
both DT O
alleles NNS O
were VBD O
normal JJ O
in IN O
the DT O
parents NNS O
and CC O
one CD O
sister NN O
; : O
thus RB O
, , O
the DT O
mutation NN O
originated VBD O
de FW O
novo FW O
in IN O
the DT O
proposita NN O
. . O

The DT O
second JJ O
patient NN O
also RB O
had VBD O
asymptomatic JJ O
parents NNS O
who WP O
, , O
however RB O
, , O
were VBD O
not RB O
available JJ O
for IN O
study NN O
. . O

The DT O
structural JJ O
consequences NNS O
of IN O
the DT O
identified JJ O
mutation NN O
, , O
resulting VBG O
in IN O
the DT O
CyS2010 NNP O
- : O
> NN O
Arg NNP O
substitution NN O
, , O
were VBD O
evaluated VBN O
by IN O
expression NN O
of IN O
the DT O
vWF NN O
carboxyl SYM O
- : O
terminal JJ O
domain NN O
containing VBG O
residues NNS O
1366 CD O
- : O
2050 CD O
. . O

Insect NNP O
cells NNS O
infected VBN O
with IN O
recombinant JJ O
baculovirus NN O
expressing VBG O
normal JJ O
vWF JJ O
sequence NN O
secreted VBD O
a DT O
disulfide NN O
linked VBN O
dimeric JJ O
molecule NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
150 CD O
kDa NNS O
before IN O
reduction NN O
, , O
yielding VBG O
a DT O
single JJ O
band NN O
of IN O
80 CD O
kDa NNS O
after IN O
disulfide JJ O
bond NN O
reduction NN O
. . O

In IN O
contrast NN O
, , O
cells NNS O
expressing VBG O
the DT O
mutant JJ O
fragment NN O
secreted VBD O
a DT O
monomeric JJ O
molecule NN O
of IN O
apparent JJ O
molecular JJ O
mass NN O
of IN O
80 CD O
kDa NNS O
, , O
which WDT O
remained VBD O
unchanged JJ O
after IN O
reduction NN O
. . O

We PRP O
conclude VBP O
that DT O
CyS2010 NNP O
is VBZ O
essential JJ O
for IN O
normal JJ O
dimerization NN O
of IN O
vWF NN O
subunits NNS O
through IN O
disulfide JJ O
bonding NN O
of IN O
carboxyl NN O
- : O
terminal NN O
domains NNS O
and CC O
that IN O
a DT O
heterozygous JJ O
mutation NN O
in IN O
the DT O
corresponding JJ O
codon NN O
is VBZ O
responsible JJ O
for IN O
defective JJ O
multimer NN O
formation NN O
in IN O
type NN B-Disease
IID NNP I-Disease
von NNP I-Disease
Willebrand NNP I-Disease
disease NN I-Disease
. . O
. . O

Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBD I-Disease
protein NN O
, , O
a DT O
novel JJ O
effector NN O
for IN O
the DT O
GTPase NNP O
CDC42Hs NNP O
, , O
is VBZ O
implicated VBN O
in IN O
actin JJ O
polymerization NN O
. . O

The DT O
Rho NNP O
family NN O
of IN O
GTPases NNP O
control NN O
diverse JJ O
biological JJ O
processes NNS O
, , O
including VBG O
cell NN O
morphology NN O
and CC O
mitogenesis NN O
. . O

We PRP O
have VBP O
identified VBN O
WASP NNP O
, , O
the DT O
protein NN O
that WDT O
is VBZ O
defective JJ O
in IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
, , O
as IN O
a DT O
novel JJ O
effector NN O
for IN O
CDC42Hs NNP O
, , O
but CC O
not RB O
for IN O
the DT O
other JJ O
Rho NNP O
family NN O
members NNS O
, , O
Rac NNP O
and CC O
Rho NNP O
. . O

This DT O
interaction NN O
is VBZ O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
the DT O
G NNP O
protein SYM O
- : O
binding NN O
domain NN O
. . O

Cellular JJ O
expression NN O
of IN O
epitope NN O
- : O
tagged VBN O
WASP NNP O
produces VBZ O
clusters NNS O
of IN O
WASP NNP O
that WDT O
are VBP O
highly RB O
enriched VBN O
in IN O
polymerized JJ O
actin NN O
. . O

This DT O
clustering NN O
is VBZ O
not RB O
observed VBN O
with IN O
a DT O
C NNP O
- : O
terminally RB O
deleted VBN O
WASP NNP O
and CC O
is VBZ O
inhibited VBN O
by IN O
coexpression NN O
with IN O
dominant JJ O
negative JJ O
CDC42Hs NNP O
- : O
N17 NN O
, , O
but CC O
not RB O
with IN O
dominant JJ O
negative JJ O
forms NNS O
of IN O
Rac NNP O
or CC O
Rho NNP O
. . O

Thus RB O
, , O
WASP NNP O
provides VBZ O
a DT O
novel JJ O
link NN O
between IN O
CDC42Hs NNP O
and CC O
the DT O
actin JJ O
cytoskeleton NN O
, , O
which WDT O
suggests VBZ O
a DT O
molecular JJ O
mechanism NN O
for IN O
many JJ O
of IN O
the DT O
cellular JJ O
abnormalities NNS O
in IN O
WAS NNP B-Disease
. . O

The DT O
WASP NNP O
sequence NN O
contains VBZ O
two CD O
novel NN O
domains NNS O
that WDT O
are VBP O
homologous JJ O
to TO O
other JJ O
proteins NNS O
involved VBN O
in IN O
action NN O
organization NN O
. . O
. . O

X LS B-Disease
- : I-Disease
linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
is VBZ O
a DT O
frequent JJ O
cause NN O
of IN O
idiopathic JJ O
Addison NNP B-Disease
' POS I-Disease
s JJ I-Disease
disease NN I-Disease
in IN O
young JJ O
adult NN O
male JJ O
patients NNS O
. . O

X LS B-Disease
- : I-Disease
Linked VBN I-Disease
adrenoleukodystrophy NN I-Disease
( ( O
ALD NNP B-Disease
) ) O
is VBZ O
a DT O
genetic JJ B-Disease
disease NN I-Disease
associated VBN O
with IN O
demyelination NN B-Disease
of IN I-Disease
the DT I-Disease
central JJ I-Disease
nervous JJ I-Disease
system NN I-Disease
, , O
adrenal JJ B-Disease
insufficiency NN I-Disease
, , O
and CC O
accumulation NN O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
in IN O
tissue NN O
and CC O
body NN O
fluids NNS O
. . O

ALD NNP B-Disease
is VBZ O
due JJ O
to TO O
mutation NN O
of IN O
a DT O
gene NN O
located VBN O
in IN O
Xq28 NNP O
that WDT O
encodes VBZ O
a DT O
peroxisomal JJ O
transporter NN O
protein NN O
of IN O
unknown JJ O
function NN O
. . O

The DT O
most RBS O
common JJ O
phenotype NN O
of IN O
ALD NNP B-Disease
is VBZ O
the DT O
cerebral JJ O
form NN O
( ( O
45 CD O
% NN O
) ) O
that WDT O
develops VBZ O
in IN O
boys NNS O
between IN O
5 CD O
- : O
12 CD O
yr NN O
. . O

Adrenomyeloneuropathy NNP B-Disease
( ( O
AMN NNP B-Disease
) ) O
involves VBZ O
the DT O
spinal JJ O
cord NN O
and CC O
peripheral JJ O
nerves NNS O
in IN O
young JJ O
adults NNS O
( ( O
35 CD O
% NN O
) ) O
. . O

Adrenal JJ B-Disease
insufficiency NN I-Disease
( ( O
Addisons NNP B-Disease
disease NN I-Disease
) ) O
is VBZ O
frequently RB O
associated VBN O
with IN O
AMN NNP B-Disease
or CC O
cerebral JJ B-Disease
ALD NNP I-Disease
and CC O
may MD O
remain VB O
the DT O
only JJ O
clinical JJ O
expression NN O
of IN O
ALD NNP B-Disease
( ( O
8 CD O
% NN O
of IN O
cases NNS O
) ) O
. . O

The DT O
prevalence NN O
of IN O
ALD NNP B-Disease
among IN O
adults NNS O
with IN O
Addisons NNP B-Disease
disease NN I-Disease
remains VBZ O
unknown JJ O
. . O

To TO O
evaluate VB O
this DT O
prevalence NN O
, , O
we PRP O
performed VBD O
biochemical JJ O
analysis NN O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
in IN O
14 CD O
male NN O
patients NNS O
( ( O
age NN O
ranging VBG O
from IN O
12 CD O
- : O
45 CD O
yr NN O
at IN O
diagnosis NN O
) ) O
previously RB O
diagnosed VBN O
as IN O
having VBG O
primary JJ O
idiopathic JJ O
adrenocortical JJ B-Disease
insufficiency NN I-Disease
. . O

In IN O
5 CD O
of IN O
14 CD O
patients NNS O
( ( O
35 CD O
% NN O
) ) O
, , O
elevated VBD O
plasma JJ O
concentrations NNS O
of IN O
very RB O
long RB O
chain NN O
fatty JJ O
acids NNS O
were VBD O
detected VBN O
. . O

None NN O
of IN O
these DT O
patients NNS O
had VBD O
adrenocortical JJ O
antibodies NNS O
. . O

By IN O
electrophysiological JJ O
tests NNS O
and CC O
magnetic JJ O
resonance NN O
imaging VBG O
it PRP O
was VBD O
determined VBN O
that IN O
two CD O
patients NNS O
had VBD O
cerebral JJ B-Disease
ALD NNP I-Disease
, , O
one CD O
had VBD O
adrenomyeloneuropathy VBN B-Disease
with IN O
cerebral JJ O
involvement NN O
, , O
and CC O
two CD O
had VBD O
preclinical JJ O
AMN NNP B-Disease
. . O

Our PRP$ O
data NNS O
support NN O
the DT O
hypothesis NN O
that IN O
ALD NNP B-Disease
is VBZ O
a DT O
frequent JJ O
cause NN O
of IN O
idiopathic JJ O
Addisons NNP B-Disease
disease NN I-Disease
in IN O
children NNS O
and CC O
adults NNS O
. . O
. . O

Tumor NNP B-Disease
suppression NN O
and CC O
apoptosis NN O
of IN O
human JJ O
prostate NN B-Disease
carcinoma NN I-Disease
mediated VBN O
by IN O
a DT O
genetic JJ O
locus NN O
within IN O
human JJ O
chromosome NN O
10pter CD O
- : O
q11 NN O
. . O

Prostate NNP B-Disease
cancer NN I-Disease
is VBZ O
the DT O
second JJ O
leading JJ O
cause NN O
of IN O
male JJ O
cancer NN B-Disease
deaths NNS O
in IN O
the DT O
United NNP O
States NNPS O
. . O

Yet RB O
, , O
despite IN O
a DT O
large JJ O
international JJ O
effort NN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
molecular JJ O
mechanisms NNS O
that WDT O
underlie VBP O
this DT O
devastating JJ O
disease NN O
. . O

Prostate NNP O
secretory NN O
epithelial JJ O
cells NNS O
and CC O
androgen NN O
- : O
dependent JJ O
prostate NN B-Disease
carcinomas NN I-Disease
undergo JJ O
apoptosis NN O
in IN O
response NN O
to TO O
androgen VB O
deprivation NN O
and CC O
, , O
furthermore RB O
, , O
most JJS O
prostate JJ B-Disease
carcinomas NN I-Disease
become VBN O
androgen JJ O
independent JJ O
and CC O
refractory NN O
to TO O
further RBR O
therapeutic JJ O
manipulations NNS O
during IN O
disease NN O
progression NN O
. . O

Definition NN O
of IN O
the DT O
genetic JJ O
events NNS O
that WDT O
trigger VBP O
apoptosis NN O
in IN O
the DT O
prostate NN O
could MD O
provide VB O
important JJ O
insights NNS O
into IN O
critical JJ O
pathways NNS O
in IN O
normal JJ O
development NN O
as RB O
well RB O
as IN O
elucidate NN O
the DT O
perturbations NNS O
of IN O
those DT O
key JJ O
pathways NNS O
in IN O
neoplastic JJ O
transformation NN O
. . O

We PRP O
report VBP O
the DT O
functional JJ O
definition NN O
of IN O
a DT O
novel JJ O
genetic JJ O
locus NN O
within IN O
human JJ O
chromosome NN O
10pter CD O
- : O
q11 NN O
that WDT O
mediates VBZ O
both DT O
in IN O
vivo NN O
tumor NN O
suppression NN O
and CC O
in IN O
vitro JJ O
apoptosis NN O
of IN O
prostatic JJ B-Disease
adenocarcinoma NN I-Disease
cells NNS O
. . O

A DT O
defined JJ O
fragment NN O
of IN O
human JJ O
chromosome NN O
10 CD O
was VBD O
transferred VBN O
via IN O
microcell NN O
fusion NN O
into IN O
a DT O
prostate JJ B-Disease
adenocarcinoma NN I-Disease
cell NN O
line NN O
. . O

Microcell NNP O
hybrids NNS O
containing VBG O
only RB O
the DT O
region NN O
10pter CD O
- : O
q11 NN O
were VBD O
suppressed VBN O
for IN O
tumorigenicity NN O
following VBG O
injection NN O
of IN O
microcell NN O
hybrids NNS O
into IN O
nude JJ O
mice NN O
. . O

Furthermore RB O
, , O
the DT O
complemented JJ O
hybrids NNS O
undergo NN O
programmed VBD O
cell NN O
death NN O
in IN O
vitro NN O
via IN O
a DT O
mechanism NN O
that WDT O
does VBZ O
not RB O
require VB O
nuclear JJ O
localization NN O
of IN O
p53 NN O
. . O

These DT O
data NNS O
functionally RB O
define VBP O
a DT O
novel JJ O
genetic JJ O
locus NN O
, , O
designated VBN O
PAC1 NNP O
, , O
for IN O
prostate NN O
adenocarcinoma NN O
1 CD O
, , O
involved VBN O
in IN O
tumor NN O
suppression NN O
of IN O
human JJ O
prostate NN B-Disease
carcinoma NN I-Disease
and CC O
furthermore RB O
strongly RB O
suggest VBP O
that IN O
the DT O
cell NN O
death NN O
pathway NN O
can MD O
be VB O
functionally RB O
restored VBN O
in IN O
prostatic JJ B-Disease
adenocarcinoma NN I-Disease
. . O
. . O

Low JJ O
incidence NN O
of IN O
BRCA2 NNP O
mutations NNS O
in IN O
breast NN B-Disease
carcinoma NN I-Disease
and CC O
other JJ O
cancers NNS B-Disease
. . O

Inherited VBN O
mutant JJ O
alleles NNS O
of IN O
familial JJ O
tumour NN B-Disease
suppressor NN O
genes NNS O
predispose VBP O
individuals NNS O
to TO O
particular JJ O
types NNS O
of IN O
cancer NN B-Disease
. . O

In IN O
addition NN O
to TO O
an DT O
involvement NN O
in IN O
inherited JJ O
susceptibility NN O
to TO O
cancer NN B-Disease
, , O
these DT O
tumour NNS B-Disease
suppressor NN O
genes NNS O
are VBP O
targets NNS O
for IN O
somatic JJ O
mutations NNS O
in IN O
sporadic JJ B-Disease
cancers NNS I-Disease
of IN O
the DT O
same JJ O
type NN O
found VBD O
in IN O
the DT O
familial JJ O
forms NNS O
. . O

An DT O
exception NN O
is VBZ O
BRCA1 NNP O
, , O
which WDT O
contributes VBZ O
to TO O
a DT O
significant JJ O
fraction NN O
of IN O
familial JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
but CC O
undergoes JJ O
mutation NN O
at IN O
very RB O
low JJ O
rates NNS O
in IN O
sporadic JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

This DT O
finding NN O
suggests VBZ O
that IN O
other JJ O
genes NNS O
may MD O
be VB O
the DT O
principal JJ O
targets NNS O
for IN O
somatic JJ O
mutation NN O
in IN O
breast NN B-Disease
carcinoma NN I-Disease
. . O

A DT O
second JJ O
, , O
recently RB O
identified VBN O
familial JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
gene NN O
, , O
BRCA2 NNP O
( ( O
refs VB O
5 CD O
- : O
8 CD O
) ) O
, , O
accounts NNS O
for IN O
a DT O
proportion NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
roughly RB O
equal JJ O
to TO O
BRCA1 NNP O
. . O

Like IN O
BRCA1 NNP O
, , O
BRCA2 NNP O
behaves VBZ O
as IN O
a DT O
dominantly RB O
inherited VBN O
tumour NN B-Disease
suppressor NN O
gene NN O
. . O

Individuals NNS O
who WP O
inherit VBP O
one CD O
mutant NN O
allele NN O
are VBP O
at IN O
increased VBN O
risk NN O
for IN O
breast NN B-Disease
cancer NN I-Disease
, , O
and CC O
the DT O
tumours NN B-Disease
they PRP O
develop VBP O
lose VB O
the DT O
wild JJ O
- : O
type NN O
allele NN O
by IN O
heterozygous JJ O
deletion NN O
. . O

The DT O
BRCA2 NNP O
coding NN O
sequence NN O
is VBZ O
huge JJ O
, , O
composed VBN O
of IN O
26 CD O
exons NNS O
that IN O
span VBP O
10 CD O
, , O
443 CD O
bp NN O
. . O

Here RB O
we PRP O
investigate VBP O
the DT O
rate NN O
of IN O
BRCA2 NNP O
mutation NN O
in IN O
sporadic JJ B-Disease
breast NN I-Disease
cancers NNS I-Disease
and CC O
in IN O
a DT O
set NN O
of IN O
cell NN O
lines NNS O
that WDT O
represent VBP O
twelve VB O
other JJ O
tumour JJ B-Disease
types NNS O
. . O

Surprisingly RB O
, , O
mutations NNS O
in IN O
BRCA2 NNP O
are VBP O
infrequent JJ O
in IN O
cancers NNS B-Disease
including VBG O
breast NN B-Disease
carcinoma NN I-Disease
. . O

However RB O
, , O
a DT O
probable JJ O
germline NN O
mutation NN O
in IN O
a DT O
pancreatic JJ B-Disease
tumour NN I-Disease
cell NN O
line NN O
suggests VBZ O
a DT O
role NN O
for IN O
BRCA2 NNP O
in IN O
susceptibility NN O
to TO O
pancreatic JJ B-Disease
cancer NN I-Disease
. . O
. . O

Founding VBG O
BRCA1 NNP O
mutations NNS O
in IN O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
southern JJ O
Sweden NNP O
. . O

Nine NNP O
different JJ O
germ NNS O
- : O
line NN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
were VBD O
identified VBN O
in IN O
15 CD O
of IN O
47 CD O
kindreds NNS O
from IN O
southern JJ O
Sweden NNP O
, , O
by IN O
use NN O
of IN O
SSCP NNP O
and CC O
heteroduplex JJ O
analysis NN O
of IN O
all DT O
exons NNS O
and CC O
flanking VBG O
intron JJ O
region NN O
and CC O
by IN O
a DT O
protein NN O
- : O
truncation NN O
test NN O
for IN O
exon NN O
11 CD O
, , O
followed VBN O
by IN O
direct JJ O
sequencing NN O
. . O

All DT O
but CC O
one CD O
of IN O
the DT O
mutations NNS O
are VBP O
predicted VBN O
to TO O
give VB O
rise NN O
to TO O
premature VB O
translation NN O
termination NN O
and CC O
include VBP O
seven CD O
frameshift JJ O
insertions NNS O
or CC O
deletions NNS O
, , O
a DT O
nonsense JJ O
mutation NN O
, , O
and CC O
a DT O
splice NN O
acceptor NN O
site NN O
mutation NN O
. . O

The DT O
remaining VBG O
mutation NN O
is VBZ O
a DT O
missense JJ O
mutation NN O
( ( O
Cys61Gly NNP O
) ) O
in IN O
the DT O
zinc NN O
- : O
binding NN O
motif NN O
. . O

Four CD O
novel JJ O
Swedish NNP O
founding NN O
mutations NNS O
were VBD O
identified VBN O
the DT O
nucleotide JJ O
2595 CD O
deletion NN O
A DT O
was VBD O
found VBN O
in IN O
five CD O
families NNS O
, , O
the DT O
C NNP O
1806 CD O
T NNP O
nonsense JJ O
mutation NN O
in IN O
three CD O
families NNS O
, , O
the DT O
3166 CD O
insertion NN O
TGAGA NNP O
in IN O
three CD O
families NNS O
, , O
and CC O
the DT O
nucleotide JJ O
1201 CD O
deletion NN O
11 CD O
in IN O
two CD O
families NNS O
. . O

Analysis NN O
of IN O
the DT O
intragenic JJ O
polymorphism NN O
D17S855 NNP O
supports VBZ O
common JJ O
origins NNS O
of IN O
the DT O
mutations NNS O
. . O

Eleven NNP O
of IN O
the DT O
15 CD O
kindreds NNS O
manifesting VBG O
BRCA1 NNP O
mutations NNS O
were VBD O
breast SYM B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
, , O
several JJ O
of IN O
them PRP O
with IN O
a DT O
predominant JJ O
ovarian JJ B-Disease
cancer NN I-Disease
phenotype NN O
. . O

The DT O
set NN O
of IN O
32 CD O
families NNS O
in IN O
which WDT O
no DT O
BRCA1 NNP O
alterations NNS O
were VBD O
detected VBN O
included JJ O
1 CD O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
kindred VBD O
manifesting VBG O
clear JJ O
linkage NN O
to TO O
the DT O
BRCA1 NNP O
region NN O
and CC O
loss NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
chromosome NN O
in IN O
associated JJ O
tumors NNS B-Disease
. . O

Other JJ O
tumor NN B-Disease
types NNS O
found VBN O
in IN O
BRCA1 NNP O
mutation NN O
/ NNP O
haplotype NN O
carriers NNS O
included VBD O
prostatic JJ B-Disease
, , I-Disease
pancreas NNS I-Disease
, , I-Disease
skin NN I-Disease
, , I-Disease
and CC I-Disease
lung NN I-Disease
cancer NN I-Disease
, , O
a DT O
malignant JJ B-Disease
melanoma NN I-Disease
, , O
an DT O
oligodendroglioma NN B-Disease
, , O
and CC O
a DT O
carcinosarcoma NN B-Disease
. . O

In IN O
all DT O
, , O
12 CD O
of IN O
16 CD O
kindreds NNS O
manifesting VBG O
BRCA1 NNP O
mutation NN O
or CC O
linkage NN O
contained VBN O
ovarian JJ B-Disease
cancer NN I-Disease
, , O
as IN O
compared VBN O
with IN O
only RB O
6 CD O
of IN O
the DT O
remaining VBG O
31 CD O
families NNS O
( ( O
P NNP O
< NNP O
. . O
1 CD O
) ) O
. . O

The DT O
present JJ O
study NN O
confirms VBZ O
the DT O
involvement NN O
of IN O
BRCA1 NNP O
in IN O
disease NN O
predisposition NN O
for IN O
a DT O
subset NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
families NNS O
often RB O
characterized VBN O
by IN O
ovarian JJ B-Disease
cancers NNS I-Disease
. . O

Rapid JJ O
detection NN O
of IN O
regionally RB O
clustered VBN O
germ JJ O
- : O
line NN O
BRCA1 NNP O
mutations NNS O
by IN O
multiplex JJ O
heteroduplex JJ O
analysis NN O
. . O

UKCCCR NNP O
Familial NNP O
Ovarian NNP B-Disease
Cancer NNP I-Disease
Study NNP O
Group NNP O
. . O

Germ NNP O
- : O
line NN O
mutations NNS O
of IN O
the DT O
BRCA1 NNP O
gene NN O
are VBP O
responsible JJ O
for IN O
a DT O
substantial JJ O
proportion NN O
of IN O
families NNS O
with IN O
multiple JJ O
cases NNS O
of IN O
early JJ O
- : O
onset NN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Since IN O
the DT O
isolation NN O
of IN O
BRCA1 NNP O
last JJ O
year NN O
, , O
> VBP O
65 CD O
distinct JJ O
mutations NNS O
scattered VBD O
throughout IN O
the DT O
coding VBG O
region NN O
have VBP O
been VBN O
detected VBN O
, , O
making VBG O
analysis NN O
of IN O
the DT O
gene NN O
time NN O
consuming VBG O
and CC O
technically RB O
challenging JJ O
. . O

We PRP O
have VBP O
developed VBN O
a DT O
multiplex JJ O
heteroduplex NN O
analysis NN O
that WDT O
is VBZ O
designed VBN O
to TO O
analyze VB O
one CD O
- : O
quarter NN O
of IN O
the DT O
coding VBG O
sequence NN O
in IN O
a DT O
single JJ O
- : O
step NN O
screening JJ O
procedure NN O
and CC O
that DT O
will MD O
detect VB O
approximately RB O
50 CD O
% NN O
of IN O
all DT O
BRCA1 NNP O
mutations NNS O
so RB O
far RB O
reported VBN O
in IN O
breast NN B-Disease
/ NN I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
families NNS O
. . O

We PRP O
have VBP O
used VBN O
this DT O
technique NN O
to TO O
analyze VB O
BRCA1 NNP O
in IN O
162 CD O
families NNS O
with IN O
a DT O
history NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
identified VBD O
12 CD O
distinct JJ O
mutations NNS O
in IN O
35 CD O
families NNS O
. . O
. . O

A DT O
previously RB O
undescribed JJ O
mutation NN O
within IN O
the DT O
tetramerisation NN O
domain NN O
of IN O
TP53 NNP O
in IN O
a DT O
family NN O
with IN O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
. . O

We PRP O
report VBP O
details NNS O
of IN O
a DT O
family NN O
with IN O
classic JJ O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
in IN O
which WDT O
there EX O
is VBZ O
a DT O
mutation NN O
in IN O
codon JJ O
344 CD O
of IN O
the DT O
tumour NN B-Disease
suppressor NN O
gene NN O
TP53 NNP O
. . O

Codon NNP O
344 CD O
is VBZ O
a DT O
key JJ O
residue NN O
within IN O
the DT O
tetramerisation NN O
domain NN O
, , O
and CC O
the DT O
amino NN O
acid JJ O
substitution NN O
of IN O
a DT O
proline NN O
for IN O
a DT O
leucine NN O
is VBZ O
predicted VBN O
to TO O
have VB O
profound JJ O
implications NNS O
for IN O
tetramerisation NN O
and CC O
potentially RB O
DNA NNP O
binding NN O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
a DT O
mutation NN O
at IN O
this DT O
residue NN O
in IN O
either DT O
sporadic JJ B-Disease
tumours NN I-Disease
or CC O
in IN O
the DT O
germline NN O
and CC O
the DT O
first JJ O
report NN O
of IN O
a DT O
germline JJ O
mutation NN O
within IN O
the DT O
tetramerisation NN O
domain NN O
. . O

The DT O
family NN O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
remarkable JJ O
in IN O
the DT O
spectrum NN O
of IN O
tumours NNS B-Disease
, , O
and CC O
there EX O
is VBZ O
loss NN O
of IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
in IN O
a DT O
leiomyosarcoma NN B-Disease
from IN O
the DT O
proband NN O
. . O

A DT O
cell NN O
line NN O
has VBZ O
been VBN O
established VBN O
from IN O
the DT O
tumour NN B-Disease
of IN O
the DT O
proband NN O
and CC O
cytogenetic JJ O
and CC O
molecular JJ O
studies NNS O
carried VBD O
out RP O
, , O
providing VBG O
an DT O
extensive JJ O
analysis NN O
in IN O
this DT O
family NN O
. . O
. . O

The DT O
spectrum NN O
of IN O
RB1 NNP O
germ FW O
- : O
line NN O
mutations NNS O
in IN O
hereditary JJ B-Disease
retinoblastoma NN I-Disease
. . O

We PRP O
have VBP O
searched VBN O
for IN O
germ JJ O
- : O
line NN O
RB1 NNP O
mutations NNS O
in IN O
119 CD O
patients NNS O
with IN O
hereditary JJ B-Disease
retinoblastoma NN I-Disease
. . O

Previous JJ O
investigations NNS O
by IN O
Southern NNP O
blot NN O
hybridization NN O
and CC O
PCR NNP O
fragment VBD O
- : O
length NN O
analysis NN O
had VBD O
revealed VBN O
mutations NNS O
in IN O
48 CD O
patients NNS O
. . O

Here RB O
we PRP O
report VBP O
on IN O
the DT O
analysis NN O
of IN O
the DT O
remaining VBG O
71 CD O
patients NNS O
. . O

By IN O
applying VBG O
heteroduplex JJ O
analysis NN O
, , O
nonisotopic JJ O
SSCP NNP O
, , O
and CC O
direct JJ O
sequencing NN O
, , O
we PRP O
detected VBD O
germ JJ O
- : O
line NN O
mutations NNS O
resulting VBG O
in IN O
premature NN O
termination NN O
codons NNS O
or CC O
disruption NN O
of IN O
splice NN O
signals NNS O
in IN O
51 CD O
( ( O
72 CD O
% NN O
) ) O
of IN O
the DT O
71 CD O
patients NNS O
. . O

Four CD O
patients NNS O
also RB O
showed VBD O
rare JJ O
sequence NN O
variants NNS O
. . O

No DT O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
was VBD O
preferentially RB O
involved VBN O
in IN O
single JJ O
base NN O
substitutions NNS O
. . O

Recurrent JJ O
transitions NNS O
were VBD O
observed VBN O
at IN O
most JJS O
of IN O
the DT O
14 CD O
codons NNS O
within IN O
the DT O
RB1 NNP O
. . O

No DT O
mutation NN O
was VBD O
observed VBN O
in IN O
exons NNS O
25 CD O
- : O
27 CD O
, , O
although IN O
this DT O
region NN O
contains VBZ O
two CD O
CGA NNP O
codons NNS O
. . O

This DT O
suggests VBZ O
that IN O
mutations NNS O
within IN O
the DT O
3 CD O
- : O
terminal JJ O
region NN O
of IN O
the DT O
RB1 NNP O
gene NN O
may MD O
not RB O
be VB O
oncogenic JJ O
. . O

When WRB O
these DT O
data NNS O
were VBD O
combined VBN O
with IN O
the DT O
results NNS O
of IN O
our PRP$ O
previous JJ O
investigations NNS O
, , O
mutations NNS O
were VBD O
identified VBN O
in IN O
a DT O
total NN O
of IN O
99 CD O
( ( O
83 CD O
% NN O
) ) O
of IN O
119 CD O
patients NNS O
. . O

The DT O
spectrum NN O
comprises VBZ O
15 CD O
% NN O
large JJ O
deletions NNS O
, , O
26 CD O
% NN O
small JJ O
length NN O
alterations NNS O
, , O
and CC O
42 CD O
% NN O
base NN O
substitutions NNS O
. . O

No DT O
correlation NN O
between IN O
the DT O
location NN O
of IN O
frameshift NN O
or CC O
nonsense JJ O
mutations NNS O
and CC O
phenotypic NN O
features NNS O
, , O
including VBG O
age NN O
at IN O
diagnosis NN O
, , O
the DT O
number NN O
of IN O
tumor NN B-Disease
foci NN O
, , O
and CC O
manifestation NN O
of IN O
nonocular JJ B-Disease
tumors NNS I-Disease
was VBD O
observed VBN O
. . O
. . O

Phenotypic NNP O
characterization NN O
of IN O
individuals NNS O
with IN O
30 CD O
- : O
40 CD O
CAG NNP O
repeats NNS O
in IN O
the DT O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
gene NN O
reveals NNS O
HD NNP B-Disease
cases NNS O
with IN O
36 CD O
repeats NNS O
and CC O
apparently RB O
normal JJ O
elderly JJ O
individuals NNS O
with IN O
36 CD O
- : O
39 CD O
repeats NNS O
. . O

Abnormal NNP O
CAG NNP O
expansions NNS O
in IN O
the DT O
IT NNP O
- : O
15 CD O
gene NN O
are VBP O
associated VBN O
with IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

In IN O
the DT O
diagnostic JJ O
setting NN O
it PRP O
is VBZ O
necessary JJ O
to TO O
define VB O
the DT O
limits NNS O
of IN O
the DT O
CAG NNP O
size NN O
ranges VBZ O
on IN O
normal JJ O
and CC O
HD NNP B-Disease
- : O
associated VBN O
chromosomes NNS O
. . O

Most JJS O
large JJ O
analyses NNS O
that WDT O
defined VBD O
the DT O
limits NNS O
of IN O
the DT O
normal JJ O
and CC O
pathological JJ O
size NN O
ranges VBZ O
employed VBN O
PCR NNP O
assays NNS O
, , O
which WDT O
included VBD O
the DT O
CAG NNP O
repeats NNS O
and CC O
a DT O
CCG NNP O
repeat NN O
tract NN O
that WDT O
was VBD O
thought VBN O
to TO O
be VB O
invariant JJ O
. . O

Many JJ O
of IN O
these DT O
experiments NNS O
found VBD O
an DT O
overlap NN O
between IN O
the DT O
normal JJ O
and CC O
disease JJ O
size NN O
ranges NNS O
. . O

Subsequent JJ O
findings NNS O
that IN O
the DT O
CCG NNP O
repeats NNS O
vary VBP O
by IN O
8 CD O
trinucleotide JJ O
lengths NNS O
suggested VBD O
that IN O
the DT O
limits NNS O
of IN O
the DT O
normal JJ O
and CC O
disease JJ O
size NN O
ranges NNS O
should MD O
be VB O
reevaluated VBN O
with IN O
assays NNS O
that WDT O
exclude VBP O
the DT O
CCG NNP O
polymorphism NN O
. . O

Since IN O
patients NNS O
with IN O
between IN O
30 CD O
and CC O
40 CD O
repeats NNS O
are VBP O
rare JJ O
, , O
a DT O
consortium NN O
was VBD O
assembled VBN O
to TO O
collect VB O
such JJ O
individuals NNS O
. . O

All DT O
178 CD O
samples NNS O
were VBD O
reanalyzed VBN O
in IN O
Cambridge NNP O
by IN O
using VBG O
assays NNS O
specific NN O
for IN O
the DT O
CAG NNP O
repeats NNS O
. . O

We PRP O
have VBP O
optimized VBN O
methods NNS O
for IN O
reliable JJ O
sizing NN O
of IN O
CAG NNP O
repeats NNS O
and CC O
show VBP O
cases NNS O
that WDT O
demonstrate VBP O
the DT O
dangers NNS O
of IN O
using VBG O
PCR NNP O
assays VBZ O
that IN O
include VBP O
both DT O
the DT O
CAG NNP O
and CC O
CCG NNP O
polymorphisms NNS O
. . O

Seven NNP O
HD NNP B-Disease
patients NNS O
had VBD O
36 CD O
repeats NNS O
, , O
which WDT O
confirms VBZ O
that IN O
this DT O
allele NN O
is VBZ O
associated VBN O
with IN O
disease NN O
. . O

Individuals NNS O
without IN O
apparent NN O
symptoms NNS O
or CC O
signs NNS O
of IN O
HD NNP B-Disease
were VBD O
found VBN O
at IN O
36 CD O
repeats NNS O
( ( O
aged VBN O
74 CD O
, , O
78 CD O
, , O
79 CD O
, , O
and CC O
87 CD O
years NNS O
) ) O
, , O
37 CD O
repeats NNS O
( ( O
aged VBN O
69 CD O
years NNS O
) ) O
, , O
38 CD O
repeats NNS O
( ( O
aged VBN O
69 CD O
and CC O
90 CD O
years NNS O
) ) O
, , O
and CC O
39 CD O
repeats NNS O
( ( O
aged VBN O
67 CD O
, , O
90 CD O
, , O
and CC O
95 CD O
years NNS O
) ) O
. . O

The DT O
detailed JJ O
case NN O
histories NNS O
of IN O
an DT O
exceptional JJ O
case NN O
from IN O
this DT O
series NN O
will MD O
be VB O
presented VBN O
a DT O
95 CD O
- : O
year NN O
- : O
old JJ O
man NN O
with IN O
39 CD O
repeats NNS O
who WP O
did VBD O
not RB O
have VB O
classical JJ O
features NNS O
of IN O
HD NNP B-Disease
. . O

The DT O
apparently RB O
healthy JJ O
survival NN O
into IN O
old JJ O
age NN O
of IN O
some DT O
individuals NNS O
with IN O
36 CD O
- : O
39 CD O
repeats NNS O
suggests VBZ O
that IN O
the DT O
HD NNP B-Disease
mutation NN O
may MD O
not RB O
always RB O
be VB O
fully RB O
penetrant JJ O
. . O
. . O

Identification NN O
and CC O
expression NN O
of IN O
eight CD O
novel JJ O
mutations NNS O
among IN O
non JJ O
- : O
Jewish JJ O
patients NNS O
with IN O
Canavan NNP B-Disease
disease NN I-Disease
. . O

Canavan NNP B-Disease
disease NN I-Disease
is VBZ O
inherited VBN O
as IN O
an DT O
autosomal JJ O
recessive JJ O
trait NN O
that WDT O
is VBZ O
caused VBN O
by IN O
the DT O
deficiency NN B-Disease
of IN I-Disease
aspartoacylase NN I-Disease
( ( O
ASPA NNP O
) ) O
. . O

The DT O
majority NN O
of IN O
patients NNS O
with IN O
Canavan NNP B-Disease
disease NN I-Disease
are VBP O
from IN O
an DT O
Ashkenazi NNP O
Jewish NNP O
background NN O
. . O

Mutations NNS O
in IN O
ASPA NNP O
that WDT O
lead VBP O
to TO O
loss NN O
of IN O
enzymatic JJ O
activity NN O
have VBP O
been VBN O
identified VBN O
, , O
and CC O
E285A NNP O
and CC O
Y231X NNP O
are VBP O
the DT O
two CD O
predominant JJ O
mutations NNS O
that WDT O
account VBP O
for IN O
97 CD O
% NN O
of IN O
the DT O
mutant JJ O
chromosomes NNS O
in IN O
Ashkenazi NNP O
Jewish JJ O
patients NNS O
. . O

The DT O
current JJ O
study NN O
was VBD O
aimed VBN O
at IN O
finding VBG O
the DT O
molecular JJ O
basis NN O
of IN O
Canavan NNP B-Disease
disease NN I-Disease
in IN O
25 CD O
independent JJ O
patients NNS O
of IN O
non JJ O
- : O
Jewish JJ O
background NN O
. . O

Eight NNP O
novel NN O
and CC O
three CD O
previously RB O
characterized VBN O
mutations NNS O
accounted VBD O
for IN O
80 CD O
% NN O
( ( O
40 CD O
/ RB O
50 CD O
) ) O
of IN O
mutant JJ O
chromosomes NNS O
. . O

The DT O
A305E NNP O
missense NN O
mutation NN O
accounted VBD O
for IN O
48 CD O
% NN O
( ( O
24 CD O
/ RB O
50 CD O
) ) O
of IN O
mutant JJ O
chromosomes NNS O
in IN O
patients NNS O
of IN O
western JJ O
European JJ O
descent NN O
, , O
while IN O
the DT O
two CD O
predominant JJ O
Jewish JJ O
mutations NNS O
each DT O
accounted VBD O
for IN O
a DT O
single JJ O
mutant JJ O
chromosome NN O
. . O

The DT O
eight CD O
novel NN O
mutations NNS O
identified VBD O
included VBD O
1 CD O
- : O
and CC O
4 CD O
- : O
bp NN O
deletions NNS O
( ( O
32 CD O
deltaT NN O
and CC O
876 CD O
deltaAGAA NN O
, , O
respectively RB O
) ) O
and CC O
I16T NNP O
, , O
G27R NNP O
, , O
D114E NNP O
, , O
G123E NNP O
, , O
C152Y NNP O
, , O
and CC O
R168C NNP O
missense NN O
mutations NNS O
. . O

The DT O
homozygous JJ O
32 CD O
deltaT JJ O
deletion NN O
was VBD O
identified VBN O
in IN O
the DT O
only JJ O
known JJ O
patient NN O
of IN O
African NNP O
- : O
American JJ O
origin NN O
with IN O
Canavan NNP B-Disease
disease NN I-Disease
. . O

The DT O
heterozygosity NN O
for IN O
876 CD O
deltaAGAA JJ O
mutation NN O
was VBD O
identified VBN O
in IN O
three CD O
independent JJ O
patients NNS O
from IN O
England NNP O
. . O

Six CD O
single JJ O
- : O
base NN O
changes NNS O
leading VBG O
to TO O
missense VB O
mutations NNS O
were VBD O
identified VBN O
in IN O
patients NNS O
from IN O
Turkey NNP O
( ( O
D114E NNP O
, , O
R168C NNP O
) ) O
, , O
The DT O
Netherlands NNP O
( ( O
I16T NNP O
) ) O
, , O
Germany NNP O
( ( O
G27R NNP O
) ) O
, , O
Ireland NNP O
( ( O
C152Y NNP O
) ) O
, , O
and CC O
Canada NNP O
( ( O
G123E NNP O
) ) O
. . O

A DT O
PCR NNP O
- : O
based VBN O
protocol NN O
is VBZ O
described VBN O
that IN O
was VBD O
used VBN O
to TO O
introduce VB O
mutations NNS O
in IN O
wild JJ O
- : O
type NN O
cDNA NN O
. . O

In IN O
vitro JJ O
expression NN O
of IN O
mutant JJ O
cDNA NN O
clones NNS O
demonstrated VBD O
that IN O
all DT O
of IN O
these DT O
mutations NNS O
led VBD O
to TO O
a DT O
deficiency NN B-Disease
of IN I-Disease
ASPA NNP I-Disease
and CC O
should MD O
therefore VB O
result NN O
in IN O
Canavan NNP B-Disease
disease NN I-Disease
. . O
. . O

Identification NN O
and CC O
chromosomal JJ O
localization NN O
of IN O
Atm NNP O
, , O
the DT O
mouse NN O
homolog NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
. . O

Atm NNP O
, , O
the DT O
mouse NN O
homolog NN O
of IN O
the DT O
human JJ O
ATM NNP O
gene NN O
defective NN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
, , O
has VBZ O
been VBN O
identified VBN O
. . O

The DT O
entire JJ O
coding NN O
sequence NN O
of IN O
the DT O
Atm NNP O
transcript NN O
was VBD O
cloned VBN O
and CC O
found VBN O
to TO O
contain VB O
an DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
protein NN O
of IN O
3066 CD O
amino NN O
acids NNS O
with IN O
84 CD O
% NN O
overall JJ O
identity NN O
and CC O
91 CD O
% NN O
similarity NN O
to TO O
the DT O
human JJ O
ATM NNP O
protein NN O
. . O

Variable JJ O
levels NNS O
of IN O
expression NN O
of IN O
Atm NNP O
were VBD O
observed VBN O
in IN O
different JJ O
tissues NNS O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridization NN O
and CC O
linkage NN O
analysis NN O
located VBD O
the DT O
Atm NNP O
gene NN O
on IN O
mouse NN O
chromosome NN O
9 CD O
, , O
band NN O
9C CD O
, , O
in IN O
a DT O
region NN O
homologous JJ O
to TO O
the DT O
ATM NNP O
region NN O
on IN O
human JJ O
chromosome NN O
11q22 CD O
- : O
q23 NN O
. . O
. . O

The DT O
mouse NN O
homolog NN O
of IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBP I-Disease
protein NN O
( ( O
WASP NNP O
) ) O
gene NN O
is VBZ O
highly RB O
conserved VBN O
and CC O
maps NNS O
near IN O
the DT O
scurfy NN O
( ( O
sf NN O
) ) O
mutation NN O
on IN O
the DT O
X NNP O
chromosome NN O
. . O

The DT O
mouse NN O
WASP NNP O
gene NN O
, , O
the DT O
homolog NN O
of IN O
the DT O
gene NN O
mutated VBN O
in IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
, , O
has VBZ O
been VBN O
isolated VBN O
and CC O
sequenced VBN O
. . O
the DT O
predicted JJ O
amino NN O
acid JJ O
sequence NN O
is VBZ O
86 CD O
% NN O
identical JJ O
to TO O
the DT O
human JJ O
WASP NNP O
sequence NN O
. . O

A DT O
distinct JJ O
feature NN O
of IN O
the DT O
mouse NN O
gene NN O
is VBZ O
an DT O
expanded JJ O
polymorphic JJ O
GGA NNP O
trinucleotide NN O
repeat NN O
that WDT O
codes VBZ O
for IN O
polyglycine NN O
and CC O
varies NNS O
from IN O
15 CD O
to TO O
17 CD O
triplets NNS O
in IN O
different JJ O
Mus NNP O
musculus NN O
strains NNS O
. . O

The DT O
genomic JJ O
structure NN O
of IN O
the DT O
mouse NN O
WASP NNP O
gene NN O
is VBZ O
expressed VBN O
as IN O
an DT O
approximately RB O
2 CD O
. . O

4 CD O
- : O
kb NN O
mRNA NN O
in IN O
thymus NN O
and CC O
spleen NN O
. . O

Chromosomal JJ O
mapping NN O
in IN O
an DT O
interspecific JJ O
M NNP O
. . O

Musculus NNP O
/ NNP O
M NNP O
. . O
spretus NN O
backcross NN O
placed VBD O
the DT O
Wasp NNP O
locus NN O
near IN O
the DT O
centromere NN O
of IN O
the DT O
mouse NN O
X NNP O
chromosome NN O
, , O
inseparable JJ O
from IN O
Gata1 NNP O
, , O
Tcfe3 NNP O
, , O
and CC O
scurfy NN O
( ( O
sf NN O
) ) O
. . O

This DT O
localization NN O
makes VBZ O
Wasp NNP O
a DT O
candidate NN O
for IN O
involvement NN O
in IN O
scurfy NN O
, , O
a DT O
T NNP O
cell NN O
- : O
mediated VBN O
fatal JJ B-Disease
lymphoreticular JJ I-Disease
disease NN I-Disease
of IN O
mice NN O
that WDT O
has VBZ O
previously RB O
been VBN O
proposed VBN O
as IN O
a DT O
mouse NN O
homolog NN O
of IN O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
. . O

Northern NNP O
analysis NN O
of IN O
sf JJ O
tissue NN O
samples NNS O
indicated VBD O
the DT O
presence NN O
of IN O
WASP NNP O
mRNA NN O
in IN O
liver NN O
and CC O
skin NN O
, , O
presumably RB O
as IN O
a DT O
consequence NN O
of IN O
lymphocytic JJ O
infiltration NN O
, , O
but CC O
non JJ O
abnormalities NNS O
in IN O
the DT O
amount NN O
or CC O
size NN O
of IN O
mRNA JJ O
present NN O
. . O

Colchicine NN O
in IN O
breast NN O
milk NN O
of IN O
patients NNS O
with IN O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
. . O

OBJECTIVE NNP O
. . O

To TO O
clarify VB O
whether IN O
colchicine NN O
is VBZ O
excreted VBN O
in IN O
breast NN O
milk NN O
, , O
and CC O
to TO O
compare VB O
its PRP$ O
concentrations NNS O
in IN O
the DT O
serum NN O
and CC O
breast NN O
milk NN O
of IN O
lactating VBG O
women NNS O
who WP O
have VBP O
familial JJ B-Disease
Mediterranean NNP I-Disease
fever NN I-Disease
( ( O
FMF NNP B-Disease
) ) O
. . O

METHODS NNP O
. . O

Using VBG O
a DT O
specific JJ O
radioimmunoassay NN O
, , O
we PRP O
determined VBD O
colchicine JJ O
concentrations NNS O
in IN O
the DT O
serum NN O
and CC O
breast NN O
milk NN O
of IN O
4 CD O
patients NNS O
at IN O
various JJ O
time NN O
points NNS O
, , O
following VBG O
oral JJ O
administration NN O
of IN O
the DT O
drug NN O
. . O

The DT O
study NN O
evaluated VBD O
4 CD O
patients NNS O
with IN O
FMF NNP B-Disease
who WP O
had VBD O
been VBN O
taking VBG O
colchicine NN O
on IN O
a DT O
long JJ O
- : O
term NN O
basis NN O
. . O

RESULTS NNP O
. . O

Colchicine NN O
was VBD O
found VBN O
to TO O
be VB O
excreted VBN O
in IN O
breast NN O
milk NN O
. . O

Its PRP$ O
levels NNS O
ranged VBN O
between IN O
1 CD O
. . O

9 CD O
and CC O
8 CD O
. . O

6 CD O
ng JJ O
/ NNP O
ml NN O
, , O
which WDT O
were VBD O
similar JJ O
to TO O
those DT O
found VBN O
in IN O
the DT O
serum NN O
( ( O
parallel JJ O
concentration NN O
time NN O
curves NNS O
) ) O
. . O

However RB O
, , O
there EX O
appeared VBD O
to TO O
be VB O
a DT O
considerable JJ O
variation NN O
in IN O
colchicine NN O
milk NN O
concentration NN O
among IN O
the DT O
different JJ O
patients NNS O
, , O
which WDT O
might MD O
be VB O
related VBN O
to TO O
individual JJ O
breast NN O
milk NN O
composition NN O
and CC O
, , O
possibly RB O
, , O
to TO O
other JJ O
nutritional JJ O
or CC O
metabolic JJ O
factors NNS O
. . O

CONCLUSION NNP O
. . O

The DT O
extensive JJ O
peripheral JJ O
tissue NN O
binding NN O
and CC O
relatively RB O
low JJ O
concentration NN O
of IN O
colchicine NN O
in IN O
breast NN O
milk NN O
suggests VBZ O
that IN O
the DT O
amount NN O
ingested VBN O
by IN O
the DT O
infant NN O
is VBZ O
small JJ O
. . O

Furthermore RB O
, , O
based VBN O
on IN O
our PRP$ O
clinical JJ O
experience NN O
, , O
nursing NN O
appears VBZ O
to TO O
be VB O
safe JJ O
for IN O
lactating VBG O
women NNS O
with IN O
FMF NNP B-Disease
who WP O
continue VBP O
to TO O
take VB O
colchicine NN O
. . O

Abnormal NNP O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
levels NNS O
produce VBP O
only RB O
mild JJ O
myopathy NNS B-Disease
in IN O
mice NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
commonly RB O
associated VBN O
with IN O
CTG NNP O
repeat NN O
expansions NNS O
within IN O
the DT O
gene NN O
for IN O
DM NNP O
- : O
protein NN O
kinase NN O
( ( O
DMPK NNP O
) ) O
. . O

The DT O
effect NN O
of IN O
altered JJ O
expression NN O
levels NNS O
of IN O
DMPK NNP O
, , O
which WDT O
is VBZ O
ubiquitously RB O
expressed VBN O
in IN O
all DT O
muscle NN O
cell NN O
lineages VBZ O
during IN O
development NN O
, , O
was VBD O
examined VBN O
by IN O
disrupting VBG O
the DT O
endogenous JJ O
Dmpk NNP O
gene NN O
and CC O
overexpressing VBG O
a DT O
normal JJ O
human JJ O
DMPK NNP O
transgene NN O
in IN O
mice NN O
. . O

Nullizygous NNP O
( ( O
- : O
/ SYM O
- : O
) ) O
mice NN O
showed VBD O
only RB O
inconsistent JJ O
and CC O
minor JJ O
size NN O
changes NNS O
in IN O
head NN O
and CC O
neck NN O
muscle NN O
fibres NNS O
at IN O
older JJR O
age NN O
, , O
animals NNS O
with IN O
the DT O
highest JJS O
DMPK NNP O
transgene NN O
expression NN O
showed VBD O
hypertrophic JJ B-Disease
cardiomyopathy NN I-Disease
and CC O
enhanced VBD O
neonatal JJ O
mortality NN O
. . O

However RB O
, , O
both DT O
models NNS O
lack VBP O
other JJ O
frequent JJ O
DM NNP B-Disease
symptoms NNS O
including VBG O
the DT O
fibre NN O
- : O
type NN O
dependent JJ O
atrophy NN B-Disease
, , O
myotonia NN B-Disease
, , O
cataract NN B-Disease
and CC O
male JJ B-Disease
- : I-Disease
infertility NN I-Disease
. . O

These DT O
results NNS O
strengthen VBP O
the DT O
contention NN O
that WDT O
simple JJ O
loss NN O
- : O
or CC O
gain VB O
- : O
of IN O
- : O
expression NN O
of IN O
DMPK NNP O
is VBZ O
not RB O
the DT O
only JJ O
crucial JJ O
requirement NN O
for IN O
development NN O
of IN O
the DT O
disease NN O
. . O
. . O

Mice NNP O
lacking VBG O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase VBD O
develop VB O
a DT O
late JJ O
onset NN O
progressive JJ O
myopathy NN B-Disease
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disorder NN I-Disease
resulting VBG O
from IN O
the DT O
expansion NN O
of IN O
a DT O
CTG NNP O
repeat NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
a DT O
putative JJ O
protein NN O
kinase NN O
( ( O
DMPK NNP O
) ) O
. . O

To TO O
elucidate VB O
the DT O
role NN O
of IN O
DMPK NNP O
in IN O
DM NNP B-Disease
pathogenesis NN O
we PRP O
have VBP O
developed VBN O
Dmpk NNP B-Disease
deficient NN I-Disease
( ( O
Dmpk NNP O
- : O
/ SYM O
- : O
) ) O
mice NN O
. . O

Dmpk NNP O
- : O
/ SYM O
- : O
mice NN O
develop VB O
a DT O
late JJ O
- : O
onset NN O
, , O
progressive JJ B-Disease
skeletal NN I-Disease
myopathy NN I-Disease
that WDT O
shares NNS O
some DT O
pathological JJ O
features NNS O
with IN O
DM NNP B-Disease
. . O

Muscles NNS O
from IN O
mature NN O
mice NN O
show NN O
variation NN O
in IN O
fibre JJ O
size NN O
, , O
increased VBD O
fibre JJ B-Disease
degeneration NN I-Disease
and CC O
fibrosis NN B-Disease
. . O

Adult NNP O
Dmpk NNP O
- : O
/ SYM O
- : O
mice NN O
show NN O
ultrastructural JJ O
changes NNS O
in IN O
muscle NN O
and CC O
a DT O
50 CD O
% NN O
decrease NN O
in IN O
force NN O
generation NN O
compared VBN O
to TO O
young JJ O
mice NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
DMPK NNP O
may MD O
be VB O
necessary JJ O
for IN O
the DT O
maintenance NN O
of IN O
skeletal JJ O
muscle NN O
structure NN O
and CC O
function NN O
and CC O
suggest VBP O
that IN O
a DT O
decrease NN O
in IN O
DMPK NNP O
levels NNS O
may MD O
contribute VB O
to TO O
DM NNP B-Disease
pathology NN O
. . O
. . O

The DT O
tumor NN B-Disease
suppressor NN O
gene NN O
Brca1 NNP O
is VBZ O
required VBN O
for IN O
embryonic JJ O
cellular JJ O
proliferation NN O
in IN O
the DT O
mouse NN O
. . O

Mutations NNS O
of IN O
the DT O
BRCA1 NNP O
gone VBN O
in IN O
humans NNS O
are VBP O
associated VBN O
with IN O
predisposition NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
. . O

We PRP O
show VBP O
here RB O
that IN O
Brca1 NNP O
+ NNP O
/ NNP O
- : O
mice NN O
are VBP O
normal JJ O
and CC O
fertile JJ O
and CC O
lack JJ O
tumors NNS B-Disease
by IN O
age NN O
eleven JJ O
months NNS O
. . O

Homozygous JJ O
Brca1 NNP O
( ( O
5 CD O
- : O
6 CD O
) ) O
mutant NN O
mice NN O
die NN O
before IN O
day NN O
7 CD O
. . O

5 CD O
of IN O
embryogenesis NN O
. . O

Mutant JJ O
embryos NN O
are VBP O
poorly RB O
developed VBN O
, , O
with IN O
no DT O
evidence NN O
of IN O
mesoderm JJ O
formation NN O
. . O

The DT O
extraembryonic JJ O
region NN O
is VBZ O
abnormal JJ O
, , O
but CC O
aggregation NN O
with IN O
wild JJ O
- : O
type NN O
tetraploid JJ O
embryos NN O
does VBZ O
not RB O
rescue VB O
the DT O
lethality NN O
. . O

In IN O
vivo NN O
, , O
mutant JJ O
embryos NN O
do VBP O
not RB O
exhibit VB O
increased JJ O
apoptosis NN O
but CC O
show NN O
reduced VBD O
cell NN O
proliferation NN O
accompanied VBN O
by IN O
decreased JJ O
expression NN O
of IN O
cyclin NN O
E NNP O
and CC O
mdm SYM O
- : O
2 CD O
, , O
a DT O
regulator NN O
of IN O
p53 NN O
activity NN O
. . O

The DT O
expression NN O
of IN O
cyclin NN O
- : O
dependent JJ O
kinase NN O
inhibitor NN O
p21 NN O
is VBZ O
dramatically RB O
increased VBN O
in IN O
the DT O
mutant JJ O
embryos NN O
. . O

Buttressing VBG O
these DT O
in IN O
vivo NN O
observations NNS O
is VBZ O
the DT O
fact NN O
that IN O
mutant JJ O
blastocyst NN O
growth NN O
is VBZ O
grossly RB O
impaired VBN O
in IN O
vitro NN O
. . O

Thus RB O
, , O
the DT O
death NN O
of IN O
Brca1 NNP O
( ( O
5 CD O
- : O
6 CD O
) ) O
mutant NN O
embryos NN O
prior RB O
to TO O
gastrulation NN O
may MD O
be VB O
due JJ O
to TO O
a DT O
failure NN O
of IN O
the DT O
proliferative JJ O
burst NN O
required VBN O
for IN O
the DT O
development NN O
of IN O
the DT O
different JJ O
germ NN O
layers NNS O
. . O

Increased VBN O
coronary JJ B-Disease
heart NN I-Disease
disease NN I-Disease
in IN O
Japanese JJ O
- : O
American JJ O
men NNS O
with IN O
mutation NN O
in IN O
the DT O
cholesteryl NN O
ester NN O
transfer NN O
protein NN O
gene NN O
despite IN O
increased VBN O
HDL NNP O
levels NNS O
. . O

Plasma NNP O
high JJ O
density NN O
lipoprotein NN O
( ( O
HDL NNP O
) ) O
levels NNS O
are VBP O
strongly RB O
genetically RB O
determined VBN O
and CC O
show VB O
a DT O
general JJ O
inverse NN O
relationship NN O
with IN O
coronary JJ B-Disease
heart NN I-Disease
disease NN I-Disease
( ( O
CHD NNP B-Disease
) ) O
. . O

The DT O
cholesteryl NN O
ester NN O
transfer NN O
protein NN O
( ( O
CETP NNP O
) ) O
mediates VBZ O
the DT O
transfer NN O
of IN O
cholesteryl NN O
esters NNS O
from IN O
HDL NNP O
to TO O
other JJ O
lipoproteins NNS O
and CC O
is VBZ O
a DT O
key JJ O
participant NN O
in IN O
the DT O
reverse NN O
transport NN O
of IN O
cholesterol NN O
from IN O
the DT O
periphery NN O
to TO O
the DT O
liver NN O
. . O

A DT O
high JJ O
prevalence NN O
of IN O
two CD O
different JJ O
CETP NNP O
gene NN O
mutations NNS O
( ( O
D442G NNP O
, , O
5 CD O
. . O
1 CD O
% NN O
; : O
intron CC O
14G CD O
A NNP O
, , O
0 CD O
. . O
5 CD O
% NN O
) ) O
, , O
was VBD O
found VBN O
in IN O
3 CD O
, , O
469 CD O
men NNS O
of IN O
Japanese JJ O
ancestry NN O
in IN O
the DT O
Honolulu NNP O
Heart NNP O
Program NNP O
and CC O
mutations NNS O
were VBD O
associated VBN O
with IN O
decreased JJ O
CETP NNP O
( ( O
- : O
35 CD O
% NN O
) ) O
and CC O
increased VBD O
HDL NNP O
chol NN O
levels NNS O
( ( O
+ VB O
10 CD O
% NN O
for IN O
D442G NNP O
) ) O
. . O

However RB O
, , O
the DT O
overall JJ O
prevalence NN O
of IN O
definite JJ O
CHD NNP B-Disease
was VBD O
21 CD O
% NN O
in IN O
men NNS O
with IN O
mutations NNS O
and CC O
16 CD O
% NN O
in IN O
men NNS O
without IN O
mutations NNS O
. . O

The DT O
relative JJ O
risk NN O
( ( O
RR NNP O
) ) O
of IN O
CHD NNP B-Disease
was VBD O
1 CD O
. . O

43 CD O
in IN O
men NNS O
with IN O
mutations NNS O
( ( O
P NNP O
< NNP O
. . O
5 CD O
) ) O
; : O
after IN O
adjustment NN O
for IN O
CHD NNP B-Disease
risk NN O
factors NNS O
, , O
the DT O
RR NNP O
was VBD O
1 CD O
. . O

55 CD O
( ( O
P NNP O
= NNP O
. . O
2 CD O
) ) O
; : O
after IN O
additional JJ O
adjustment NN O
for IN O
HDL NNP O
levels NNS O
, , O
the DT O
RR NNP O
was VBD O
1 CD O
. . O

68 CD O
( ( O
P NNP O
= NNP O
. . O
8 CD O
) ) O
. . O

Similar JJ O
RR NNP O
values NNS O
were VBD O
obtained VBN O
for IN O
the DT O
D442G NNP O
mutation NN O
alone RB O
. . O

Increased VBN O
CHD NNP B-Disease
in IN O
men NNS O
with IN O
mutations NNS O
was VBD O
primarily RB O
observed VBN O
for IN O
HDL NNP O
chol NN O
41 CD O
- : O
60 CD O
mg NN O
/ NNP O
dl NN O
; : O
for IN O
HDL NNP O
chol NN O
> VBD O
60 CD O
mg NN O
/ NNP O
dl VBZ O
men NNS O
with IN O
and CC O
without IN O
mutations NNS O
had VBD O
low JJ O
CHD NNP B-Disease
prevalence NN O
. . O

Thus RB O
, , O
genetic JJ O
CETP NNP B-Disease
deficiency NN I-Disease
appears VBZ O
to TO O
be VB O
an DT O
independent JJ O
risk NN O
factor NN O
for IN O
CHD NNP B-Disease
, , O
primarily RB O
due JJ O
to TO O
increased VBN O
CHD NNP B-Disease
prevalence NN O
in IN O
men NNS O
with IN O
the DT O
D442G NNP O
mutation NN O
and CC O
HDL NNP O
cholesterol NN O
between IN O
41 CD O
and CC O
60 CD O
mg NN O
/ NNP O
dl NN O
. . O

The DT O
findings NNS O
suggest VBP O
that IN O
both DT O
HDL NNP O
concentration NN O
and CC O
the DT O
dynamics NNS O
of IN O
cholesterol NN O
transport NN O
through IN O
HDL NNP O
( ( O
i NN O
. . O
e NN O
. . O
, , O
reverse VB O
cholesterol NN O
transport NN O
) ) O
determine VBZ O
the DT O
anti JJ O
- : O
atherogenicity NN O
of IN O
the DT O
HDL NNP O
fraction NN O
. . O

Mapping VBG O
the DT O
homolog NN O
of IN O
the DT O
human JJ O
Rb1 NNP O
gene NN O
to TO O
chromosome VB O
14 CD O
of IN O
higher JJR O
primates NNS O
. . O

The DT O
Rb1 NNP O
gene NN O
has VBZ O
been VBN O
implicated VBN O
with IN O
retinoblastoma NN B-Disease
and CC O
is VBZ O
located VBN O
on IN O
human JJ O
Chromosome NNP O
( ( O
Chr NNP O
) ) O
13q14 CD O
. . O

2 CD O
2 CD O
. . O

A DT O
unique JJ O
sequence NN O
human JJ O
Rb1 NNP O
cosmid NN O
DNA NNP O
probe NN O
has VBZ O
been VBN O
used VBN O
to TO O
localize VB O
this DT O
region NN O
on IN O
apes NNS O
Chr NNP O
14 CD O
by IN O
the DT O
FISH NNP O
technique NN O
. . O

The DT O
conservation NN O
of IN O
the DT O
Rb1 NNP O
gene NN O
in IN O
higher JJR O
primates NNS O
at IN O
the DT O
corresponding JJ O
equivalent JJ O
chromosome NN O
locus NN O
( ( O
14q14 CD O
) ) O
of IN O
the DT O
human NN O
may MD O
serve VB O
as IN O
a DT O
phylogenetic JJ O
marker NN O
to TO O
further JJ O
trace NN O
the DT O
evolutionary JJ O
pathway NN O
of IN O
human JJ O
descent NN O
. . O

Wiskott NNP B-Disease
- : I-Disease
Aldrich JJ I-Disease
syndrome NN I-Disease
: : O
no DT O
strict JJ O
genotype NN O
- : O
phenotype NN O
correlations NNS O
but CC O
clustering VBG O
of IN O
missense JJ O
mutations NNS O
in IN O
the DT O
amino NN O
- : O
terminal JJ O
part NN O
of IN O
the DT O
WASP NNP O
gene NN O
product NN O
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome VBP I-Disease
protein NN O
( ( O
WASP NNP O
) ) O
gene NN O
was VBD O
found VBN O
to TO O
be VB O
mutated VBN O
in IN O
patients NNS O
presenting VBG O
with IN O
WAS NNP B-Disease
and CC O
in IN O
patients NNS O
showing VBG O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
thrombocytopenia NN I-Disease
. . O

Mutation NN O
analysis NN O
in IN O
19 CD O
families NNS O
of IN O
German JJ O
, , O
Swiss JJ O
and CC O
Turkish JJ O
descent NN O
by IN O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
and CC O
sequencing NN O
resulted VBD O
in IN O
the DT O
detection NN O
of IN O
seven CD O
novel NNS O
and CC O
10 CD O
known VBN O
mutations NNS O
. . O

A DT O
striking JJ O
clustering NN O
of IN O
missense JJ O
mutations NNS O
in IN O
the DT O
first JJ O
four CD O
exons NNS O
contrasted VBN O
with IN O
a DT O
random JJ O
distribution NN O
of IN O
nonsense JJ O
mutations NNS O
. . O

More JJR O
than IN O
85 CD O
% NN O
of IN O
all DT O
known VBN O
missense NN O
mutations NNS O
were VBD O
localized VBN O
in IN O
the DT O
amino NN O
- : O
terminal JJ O
stretch NN O
of IN O
the DT O
WASP NNP O
gene NN O
product NN O
; : O
this DT O
region NN O
contained VBD O
a DT O
mutational JJ O
hot JJ O
spot NN O
at IN O
codon NN O
86 CD O
. . O

No DT O
genotype NN O
- : O
phenotype NN O
correlation NN O
emerged VBD O
after IN O
a DT O
comparison NN O
of IN O
the DT O
identified JJ O
mutations NNS O
with IN O
the DT O
resulting VBG O
clinical JJ O
picture NN O
for IN O
a DT O
classical JJ O
WAS NNP B-Disease
phenotype NN O
. . O

A DT O
substitution NN O
at IN O
codon $ O
86 CD O
resulted VBN O
in IN O
an DT O
extremely RB O
variable JJ O
expression NN O
of IN O
the DT O
disease NN O
in IN O
a DT O
large JJ O
Swiss JJ O
family NN O
. . O

An DT O
extended JJ O
homology NN O
search NN O
revealed VBD O
a DT O
distant JJ O
relationship NN O
of IN O
this DT O
stretch NN O
to TO O
the DT O
vasodilator NN O
- : O
stimulated VBN O
phosphoprotein NN O
( ( O
VASP NNP O
) ) O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
maintenance NN O
of IN O
cyto NN O
- : O
architecture NN O
by IN O
interacting VBG O
with IN O
actin JJ O
- : O
like IN O
filaments NNS O
. . O
. . O

Influence NN O
of IN O
PAX6 NNP O
gene NN O
dosage NN O
on IN O
development NN O
: : O
overexpression NN O
causes VBZ O
severe JJ O
eye NN B-Disease
abnormalities NNS I-Disease
. . O

Aniridia NNP B-Disease
in IN O
man NN O
and CC O
Small NNP O
eye NN O
in IN O
mice NNS O
are VBP O
semidominant JJ B-Disease
developmental JJ I-Disease
disorders NNS I-Disease
caused VBN O
by IN O
mutations NNS O
within IN O
the DT O
paired JJ O
box NN O
gene NN O
PAX6 NNP O
. . O

Whereas NNP O
heterozygotes VBZ O
suffer VBP O
from IN O
iris JJ B-Disease
hypoplasia NN I-Disease
, , O
homozygous JJ O
mice NN O
lack NN O
eyes NNS O
and CC O
nasal JJ O
cavities NNS O
and CC O
exhibit NN O
brain NN B-Disease
abnormalities NNS I-Disease
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
gene NN O
dosage NN O
in IN O
more JJR O
detail NN O
, , O
we PRP O
have VBP O
generated VBN O
yeast JJ O
artificial JJ O
chromosome NN O
transgenic JJ O
mice NN O
carrying VBG O
the DT O
human JJ O
PAX6 NNP O
locus NN O
. . O

When WRB O
crossed VBN O
onto IN O
the DT O
Small NNP O
eye NN O
background NN O
, , O
the DT O
transgene NN O
rescues VBZ O
the DT O
mutant JJ O
phenotype NN O
. . O

Strikingly RB O
, , O
mice NNS O
carrying VBG O
multiple JJ O
copies NNS O
on IN O
a DT O
wild JJ O
- : O
type NN O
background NN O
show NN O
specific JJ O
developmental JJ B-Disease
abnormalities NNS I-Disease
of IN I-Disease
the DT I-Disease
eye NN I-Disease
, , O
but CC O
not RB O
of IN O
other JJ O
tissues NNS O
expressing VBG O
the DT O
gene NN O
. . O

Thus RB O
, , O
at IN O
least JJS O
five CD O
different JJ O
eye NN O
phenotypes NNS O
are VBP O
associated VBN O
with IN O
changes NNS O
in IN O
PAX6 NNP O
expression NN O
. . O

We PRP O
provide VBP O
evidence NN O
that IN O
not RB O
only RB O
reduced VBN O
, , O
but CC O
also RB O
increased VBD O
levels NNS O
of IN O
transcriptional JJ O
regulators NNS O
can MD O
cause VB O
developmental JJ B-Disease
defects NNS I-Disease
. . O
. . O

Heterodimer NNP O
formation NN O
and CC O
activity NN O
in IN O
the DT O
human JJ O
enzyme NN O
galactose VBD O
- : O
1 CD O
- : O
phosphate NN O
uridylyltransferase NN O
. . O

One CD O
of IN O
the DT O
fundamental JJ O
questions NNS O
concerning VBG O
expression NN O
and CC O
function NN O
of IN O
dimeric JJ O
enzymes NNS O
involves VBZ O
the DT O
impact NN O
of IN O
naturally RB O
occurring VBG O
mutations NNS O
on IN O
subunit NN O
assembly NN O
and CC O
heterodimer NN O
activity NN O
. . O

This DT O
question NN O
is VBZ O
of IN O
particular JJ O
interest NN O
for IN O
the DT O
human JJ O
enzyme NN O
galactose SYM O
- : O
l NN O
- : O
phosphate NN O
uridylyl JJ O
- : O
transferase NN O
( ( O
GALT NNP O
) ) O
, , O
impairment NN O
of IN O
which WDT O
results NNS O
in IN O
the DT O
inherited JJ B-Disease
metabolic JJ I-Disease
disorder NN I-Disease
galactosemia NN B-Disease
, , O
because IN O
many JJ O
if IN O
not RB O
most JJS O
patients NNS O
studied VBN O
to TO O
date NN O
are VBP O
compound VBN O
heterozygotes NNS O
rather RB O
than IN O
true JJ O
molecular JJ O
homozygotes NNS O
. . O

Furthermore RB O
, , O
the DT O
broad JJ O
range NN O
of IN O
phenotypic NN O
severity NN O
observed VBN O
in IN O
these DT O
patients NNS O
raises VBZ O
the DT O
possibility NN O
that IN O
allelic JJ O
combination NN O
, , O
not RB O
just RB O
allelic JJ O
constitution NN O
, , O
may MD O
play VB O
some DT O
role NN O
in IN O
determining VBG O
outcome NN O
. . O

In IN O
the DT O
work NN O
described VBD O
herein RB O
, , O
we PRP O
have VBP O
selected VBN O
two CD O
distinct JJ O
naturally RB O
occurring VBG O
null JJ O
mutations NNS O
of IN O
GALT NNP O
, , O
Q188R NNP O
and CC O
R333W NNP O
, , O
and CC O
asked VBD O
the DT O
questions NNS O
( ( O
i NN O
) ) O
what WDT O
are VBP O
the DT O
impacts NNS O
of IN O
these DT O
mutations NNS O
on IN O
subunit NN O
assembly NN O
, , O
and CC O
( ( O
ii NN O
) ) O
if IN O
heterodimers NNS O
do VBP O
form VB O
, , O
are VBP O
they PRP O
active JJ O
? . O

To TO O
answer VB O
these DT O
questions NNS O
, , O
we PRP O
have VBP O
established VBN O
a DT O
yeast NN O
system NN O
for IN O
the DT O
coexpression NN O
of IN O
epitope NN O
- : O
tagged JJ O
alleles NNS O
of IN O
human JJ O
GALT NNP O
and CC O
investigated VBN O
both PDT O
the DT O
extent NN O
of IN O
specific JJ O
GALT NNP O
subunit NN O
interactions NNS O
and CC O
the DT O
activity NN O
of IN O
defined JJ O
heterodimer NN O
pools NNS O
. . O

We PRP O
have VBP O
found VBN O
that IN O
both DT O
homodimers NNS O
and CC O
heterodimers NNS O
do VBP O
form VB O
involving VBG O
each DT O
of IN O
the DT O
mutant JJ O
subunits NNS O
tested VBN O
and CC O
that IN O
both DT O
heterodimer NN O
pools NNS O
retain VBP O
substantial JJ O
enzymatic JJ O
activity NN O
. . O

These DT O
results NNS O
are VBP O
significant JJ O
not RB O
only RB O
in IN O
terms NNS O
of IN O
their PRP$ O
implications NNS O
for IN O
furthering VBG O
our PRP$ O
understanding NN O
of IN O
galactosemia NN B-Disease
and CC O
GALT NNP O
holoenzyme NN O
structure NN O
- : O
function NN O
relationships NNS O
but CC O
also RB O
because IN O
the DT O
system NN O
described VBD O
may MD O
serve VB O
as IN O
a DT O
model NN O
for IN O
similar JJ O
studies NNS O
of IN O
other JJ O
complexes NNS O
composed VBN O
of IN O
multiple JJ O
subunits NNS O
. . O
. . O

Cleavage NN O
of IN O
huntingtin NN O
by IN O
apopain NN O
, , O
a DT O
proapoptotic JJ O
cysteine NN O
protease NN O
, , O
is VBZ O
modulated VBN O
by IN O
the DT O
polyglutamine NN O
tract NN O
. . O

Apoptosis NN O
has VBZ O
recently RB O
been VBN O
recognized VBN O
as IN O
a DT O
mode NN O
of IN O
cell NN O
death NN O
in IN O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
. . O

Apopain NNP O
, , O
a DT O
human JJ O
counterpart NN O
of IN O
the DT O
nematode JJ O
cysteine NN O
protease NN O
death NN O
- : O
gene NN O
product NN O
, , O
CED NNP O
- : O
3 CD O
, , O
has VBZ O
a DT O
key JJ O
role NN O
in IN O
proteolytic JJ O
events NNS O
leading VBG O
to TO O
apoptosis NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
apoptotic JJ O
extracts NNS O
and CC O
apopain VB O
itself PRP O
specifically RB O
cleave VBP O
the DT O
HD NNP B-Disease
gene NN O
product NN O
, , O
huntingtin NN O
. . O

The DT O
rate NN O
of IN O
cleavage NN O
increases NNS O
with IN O
the DT O
length NN O
of IN O
the DT O
huntingtin NN O
polyglutamine NN O
tract NN O
, , O
providing VBG O
an DT O
explanation NN O
for IN O
the DT O
gain NN O
- : O
of IN O
- : O
function NN O
associated VBN O
with IN O
CAG NNP O
expansion NN O
. . O

Our PRP$ O
results NNS O
show VBP O
that IN O
huntingtin NN O
is VBZ O
cleaved VBN O
by IN O
cysteine NN O
proteases NNS O
and CC O
suggest VBP O
that IN O
HD NNP B-Disease
might MD O
be VB O
a DT O
disorder NN B-Disease
of IN I-Disease
inappropriate JJ I-Disease
apoptosis NN I-Disease
. . O
. . O

The DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
BRCA1 NNP O
gene NN O
lies VBZ O
within IN O
a DT O
duplicated JJ O
region NN O
of IN O
human JJ O
chromosome NN O
17q21 CD O
. . O

To TO O
begin VB O
to TO O
address VB O
the DT O
hypothesis NN O
that WDT O
abnormal JJ O
regulation NN O
of IN O
the DT O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
BRCA1 NNP O
is VBZ O
a DT O
critical JJ O
step NN O
in IN O
sporadic JJ O
breast NN O
/ NNP O
ovarian JJ O
tumorigenesis NN O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
detailed JJ O
structure NN O
of IN O
the DT O
BRCA1 NNP O
genomic JJ O
region NN O
. . O

We PRP O
show VBP O
that IN O
this DT O
region NN O
of IN O
the DT O
genome NN O
contains VBZ O
a DT O
tandem JJ O
duplication NN O
of IN O
approximately RB O
30 CD O
kilobases NNS O
, , O
which WDT O
results NNS O
in IN O
two CD O
copies NNS O
of IN O
BRCA1 NNP O
exons NNS O
1 CD O
and CC O
2 CD O
, , O
of IN O
exons NNS O
1 CD O
and CC O
3 CD O
of IN O
the DT O
adjacent JJ O
1A1 CD O
- : O
3B CD O
gene NN O
and CC O
of IN O
the DT O
previously RB O
reported VBN O
295 CD O
base NN O
pair NN O
intergenic JJ O
region NN O
. . O

Sequence NNP O
analysis NN O
of IN O
the DT O
duplicated JJ O
exons NNS O
of IN O
BRCA1 NNP O
and CC O
1A1 CD O
- : O
3B CD O
and CC O
flanking VBG O
genomic JJ O
DNA NN O
reveals NNS O
maintenance NN O
of IN O
the DT O
intron NN O
- : O
exon NN O
structure NN O
and CC O
a DT O
high JJ O
degree NN O
of IN O
nucleotide JJ O
sequence NN O
identity NN O
, , O
suggesting VBG O
that IN O
these DT O
are VBP O
non JJ O
- : O
processed VBN O
pseudogenes NNS O
and CC O
that IN O
the DT O
duplication NN O
is VBZ O
a DT O
recent JJ O
event NN O
in IN O
evolutionary JJ O
terms NNS O
. . O

We PRP O
also RB O
show VBP O
that IN O
a DT O
processed JJ O
pseudogene NN O
of IN O
the DT O
acidic JJ O
ribosomal JJ O
phosphoprotein NN O
P1 NNP O
( ( O
ARPP1 NNP O
) ) O
is VBZ O
inserted VBN O
directly RB O
upstream JJ O
of IN O
pseudo JJ O
- : O
BRCA1 NNP O
exon VBZ O
1A CD O
. . O

We PRP O
believe VBP O
that IN O
these DT O
findings NNS O
could MD O
not RB O
only RB O
confound VB O
BRCA1 NNP O
mutation NN O
analysis NN O
, , O
but CC O
could MD O
have VB O
implications NNS O
for IN O
the DT O
normal JJ O
and CC O
abnormal JJ O
regulation NN O
of IN O
BRCA1 NNP O
transcription NN O
, , O
translation NN O
and CC O
function NN O
. . O
. . O

Deletion NN O
of IN O
small JJ O
nuclear JJ O
ribonucleoprotein NN O
polypeptide IN O
N NNP O
( ( O
SNRPN NNP O
) ) O
in IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
detected VBN O
by IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
: : O
two CD O
sibs NN O
with IN O
the DT O
typical JJ O
phenotype NN O
without IN O
a DT O
cytogenetic JJ O
deletion NN O
in IN O
chromosome NN O
15q CD O
. . O

The DT O
small JJ O
nuclear JJ O
ribonucleoprotein NN O
polypeptide IN O
N NNP O
( ( O
SNRPN NNP O
) ) O
gene NN O
is VBZ O
regarded VBN O
as IN O
one CD O
of IN O
the DT O
candidates NNS O
for IN O
Prader NNP B-Disease
- : I-Disease
Willi NNP I-Disease
syndrome NN I-Disease
( ( O
PWS NNP B-Disease
) ) O
. . O

We PRP O
describe VBP O
two CD O
sibs NN O
with IN O
typical JJ O
PWS NNP B-Disease
presenting VBG O
deletion NN O
of IN O
SNRPN NNP O
detected VBN O
by IN O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
( ( O
FISH NNP O
) ) O
. . O

Neither CC O
a DT O
cytogenetically RB O
detectable JJ O
15q12 CD O
deletion NN O
nor CC O
a DT O
deletion NN O
for IN O
the DT O
D15S11 NNP O
, , O
D15S10 NNP O
, , O
and CC O
GABRB3 NNP O
cosmid VBP O
probes NNS O
were VBD O
found VBN O
in IN O
either DT O
patient NN O
. . O

This DT O
implies VBZ O
a DT O
smaller JJR O
deletion NN O
limited VBD O
to TO O
the DT O
PWS NNP B-Disease
critical JJ O
region NN O
. . O

FISH NN O
with IN O
a DT O
SNRPN NNP O
probe NN O
will MD O
permit VB O
analysis NN O
of IN O
PWS NNP B-Disease
patients NNS O
with IN O
limited JJ O
deletions NNS O
not RB O
detectable JJ O
with IN O
other JJ O
probes NNS O
. . O
. . O

Expression NN O
of IN O
the DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease VB I-Disease
tumour NN I-Disease
suppressor NN O
gene NN O
during IN O
human JJ O
embryogenesis NN O
. . O

The DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
( ( I-Disease
VHL NNP I-Disease
) ) I-Disease
disease NN I-Disease
product NN O
is VBZ O
thought VBN O
to TO O
down VB O
- : O
regulate NN O
transcription NN O
by IN O
antagonizing VBG O
elongin SYM O
- : O
enhanced JJ O
transcriptional JJ O
elongation NN O
. . O

Germline NNP O
VHL NNP B-Disease
gene NN O
mutations NNS O
predispose VBP O
to TO O
the DT O
development NN O
of IN O
retinal JJ B-Disease
, , I-Disease
cerebellar JJ I-Disease
and CC I-Disease
spinal JJ I-Disease
haemangioblastomas NN I-Disease
, , O
renal JJ B-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
phaeochromocytoma NN B-Disease
. . O

In IN O
addition NN O
, , O
somatic JJ O
Inactivation NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
is VBZ O
frequent JJ O
in IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
and CC O
haemangioblastoma NN B-Disease
. . O

Regulation NN O
of IN O
transcript JJ O
elongation NN O
is VBZ O
an DT O
important JJ O
control NN O
mechanism NN O
for IN O
gene NN O
expression NN O
and CC O
the DT O
VHL NNP B-Disease
gene NN O
might MD O
modify VB O
the DT O
expression NN O
of IN O
proto NN O
- : O
oncogenes NNS O
and CC O
growth NN O
suppressor NN O
genes NNS O
during IN O
embryogenesis NN O
. . O

We PRP O
therefore RB O
investigated VBD O
the DT O
expression NN O
of IN O
VHL NNP B-Disease
mRNA NN O
during IN O
human JJ O
embryogenesis NN O
by IN O
in IN O
situ JJ O
hybridization NN O
studies NNS O
at IN O
4 CD O
, , O
6 CD O
and CC O
10 CD O
weeks NNS O
post NN O
conception NN O
. . O

Although IN O
VHL NNP B-Disease
mRNA NN O
was VBD O
expressed VBN O
in IN O
all DT O
three CD O
germ NN O
layers NNS O
, , O
strong JJ O
expression NN O
was VBD O
noted VBN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
, , O
kidneys NNS O
, , O
testis NN O
and CC O
lung NN O
. . O

Within IN O
the DT O
kidney NN O
, , O
VHL NNP B-Disease
mRNA NN O
was VBD O
differentially RB O
expressed VBN O
within IN O
renal JJ O
tubules NNS O
suggesting VBG O
that IN O
the DT O
VHL NNP B-Disease
gene NN O
product NN O
may MD O
have VB O
a DT O
specific JJ O
role NN O
in IN O
kidney NN O
development NN O
. . O

Two CD O
alternatively RB O
spliced VBD O
VHL NNP B-Disease
mRNAs NNS O
characterized VBN O
by IN O
inclusion NN O
( ( O
isoform VB O
I PRP O
) ) O
or CC O
exclusion NN O
( ( O
isoform VB O
II NNP O
) ) O
of IN O
exon $ O
2 CD O
are VBP O
transcribed VBN O
in IN O
adult NN O
tissues NNS O
. . O

To TO O
investigate VB O
if IN O
the DT O
two CD O
isoforms NNS O
are VBP O
differentially RB O
expressed VBN O
during IN O
embryogenesis NN O
, , O
VHL NNP B-Disease
mRNA NN O
was VBD O
reverse JJ O
transcribed NN O
from IN O
13 CD O
fetal JJ O
tissues NNS O
( ( O
8 CD O
- : O
10 CD O
weeks NNS O
gestation NN O
) ) O
. . O

The DT O
quantitative JJ O
distribution NN O
of IN O
VHL NNP B-Disease
mRNA NN O
within IN O
fetal JJ O
tissues NNS O
reflected VBD O
that IN O
seen VBN O
by IN O
in IN O
situ JJ O
hybridization NN O
and CC O
the DT O
ratio NN O
of IN O
the DT O
two CD O
VHL NNP B-Disease
isoforms NNS O
was VBD O
similar JJ O
between IN O
tissues NNS O
. . O

Although IN O
the DT O
genes NNS O
regulated VBN O
by IN O
the DT O
VHL NNP B-Disease
gene NN O
product NN O
have VBP O
not RB O
yet RB O
been VBN O
identified VBN O
, , O
our PRP$ O
findings NNS O
are VBP O
compatible JJ O
with IN O
the DT O
hypothesis NN O
that WDT O
VHL NNP B-Disease
- : O
mediated VBD O
control NN O
of IN O
transcriptional JJ O
elongation NN O
may MD O
have VB O
a DT O
role NN O
in IN O
normal JJ O
human JJ O
development NN O
. . O
. . O

Genetic JJ O
heterogeneity NN O
in IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
: : O
role NN O
of IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

The DT O
common JJ O
hereditary JJ O
forms NNS O
of IN O
breast NN B-Disease
cancer NN I-Disease
have VBP O
been VBN O
largely RB O
attributed VBN O
to TO O
the DT O
inheritance NN O
of IN O
mutations NNS O
in IN O
the DT O
BRCA1 NNP O
or CC O
BRCA2 NNP O
genes NNS O
. . O

However RB O
, , O
it PRP O
is VBZ O
not RB O
yet RB O
clear JJ O
what WP O
proportion NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
is VBZ O
explained VBN O
by IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
or CC O
by IN O
some DT O
other JJ O
unidentified JJ O
susceptibility NN O
gene NN O
( ( O
s JJ O
) ) O
. . O

We PRP O
describe VBP O
the DT O
proportion NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
explained VBN O
by IN O
BRCA1 NNP O
or CC O
BRCA2 NNP O
in IN O
a DT O
sample NN O
of IN O
North JJ O
American JJ O
hereditary NN B-Disease
breast NN I-Disease
cancers NNS I-Disease
and CC O
assess VB O
the DT O
evidence NN O
for IN O
additional JJ O
susceptibility NN O
genes NNS O
that WDT O
may MD O
confer VB O
hereditary JJ B-Disease
breast NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
risk NN O
. . O

Twenty NNP O
- : O
three CD O
families NNS O
were VBD O
identified VBN O
through IN O
two CD O
high JJ O
- : O
risk NN O
breast NN B-Disease
cancer NN I-Disease
research NN O
programs NNS O
. . O

Genetic JJ O
analysis NN O
was VBD O
undertaken VBN O
to TO O
establish VB O
linkage NN O
between IN O
the DT O
breast NN B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
and CC O
markers NNS O
on IN O
chromosomes NNS O
17q CD O
( ( O
BRCA1 NNP O
) ) O
and CC O
13q CD O
( ( O
BRCA2 NNP O
) ) O
. . O

Mutation NN O
analysis NN O
in IN O
the DT O
BRCA1 NNP O
and CC O
BRCA2 NNP O
genes NNS O
was VBD O
also RB O
undertaken VBN O
in IN O
all DT O
families NNS O
. . O

The DT O
pattern NN O
of IN O
hereditary JJ B-Disease
cancer NN I-Disease
in IN O
14 CD O
( ( O
61 CD O
% NN O
) ) O
of IN O
the DT O
23 CD O
families NNS O
studied VBN O
was VBD O
attributed VBN O
to TO O
BRCA1 NNP O
by IN O
a DT O
combination NN O
of IN O
linkage NN O
and CC O
mutation NN O
analyses NNS O
. . O

No DT O
families NNS O
were VBD O
attributed VBN O
to TO O
BRCA2 NNP O
. . O

Five CD O
families NNS O
( ( O
22 CD O
% NN O
) ) O
provided VBD O
evidence NN O
against IN O
linkage NN O
to TO O
both DT O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

No DT O
BRCA1 NNP O
or CC O
BRCA2 NNP O
mutations NNS O
were VBD O
detected VBN O
in IN O
these DT O
five CD O
families NNS O
. . O

The DT O
BRCA1 NNP O
or CC O
BRCA2 NNP O
status NN O
of IN O
four CD O
families NNS O
( ( O
17 CD O
% NN O
) ) O
could MD O
not RB O
be VB O
determined VBN O
. . O

BRCA1 NNP O
and CC O
BRCA2 NNP O
probably RB O
explain VBP O
the DT O
majority NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
that WDT O
exists VBZ O
in IN O
the DT O
North JJ O
American JJ O
population NN O
. . O

However RB O
, , O
one CD O
or CC O
more JJR O
additional JJ O
genes NNS O
may MD O
yet RB O
be VB O
found VBN O
that IN O
explain VBP O
some DT O
proportion NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O
. . O

An DT O
intronic JJ O
mutation NN O
in IN O
a DT O
lariat JJ O
branchpoint NN O
sequence NN O
is VBZ O
a DT O
direct JJ O
cause NN O
of IN O
an DT O
inherited JJ B-Disease
human JJ I-Disease
disorder NN I-Disease
( ( O
fish JJ B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
) ) O
. . O

The DT O
first JJ O
step NN O
in IN O
the DT O
splicing NN O
of IN O
an DT O
intron NN O
from IN O
nuclear JJ O
precursors NNS O
of IN O
mRNA NN O
results NNS O
in IN O
the DT O
formation NN O
of IN O
a DT O
lariat JJ O
structure NN O
. . O

A DT O
distinct JJ O
intronic JJ O
nucleotide NN O
sequence NN O
, , O
known VBN O
as IN O
the DT O
branchpoint NN O
region NN O
, , O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
this DT O
process NN O
. . O

We PRP O
here RB O
describe VBZ O
a DT O
point NN O
mutation NN O
in IN O
such JJ O
a DT O
sequence NN O
. . O

Three CD O
sisters NNS O
were VBD O
shown VBN O
to TO O
suffer VB O
from IN O
fish JJ B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
( ( O
FED NNP B-Disease
) ) O
, , O
a DT O
disorder NN O
which WDT O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
gene NN O
coding VBG O
for IN O
lecithin JJ O
cholesterol NN O
acyltransferase NN O
( ( O
LCAT NNP O
) ) O
. . O

Sequencing VBG O
of IN O
the DT O
LCAT NNP O
gene NN O
of IN O
all DT O
three CD O
probands NNS O
revealed VBD O
compound NN O
heterozygosity NN O
for IN O
a DT O
missense JJ O
mutation NN O
in IN O
exon NN O
4 CD O
which WDT O
is VBZ O
reported VBN O
to TO O
underlie VB O
the DT O
FED NNP B-Disease
phenotype NN O
, , O
and CC O
a DT O
point NN O
mutation NN O
located VBN O
in IN O
intron NN O
4 CD O
( ( O
IVS4 NNP O
T NNP O
- : O
22C CD O
) ) O
. . O

By IN O
performing VBG O
in IN O
vitro JJ O
expression NN O
of IN O
LCAT NNP O
minigenes NNS O
and CC O
reverse VB O
transcriptase NN O
PCR NNP O
on IN O
mRNA NN O
isolated VBN O
from IN O
leukocytes NNS O
of IN O
the DT O
patient NN O
, , O
this DT O
gene NN O
defect NN O
was VBD O
shown VBN O
to TO O
cause VB O
a DT O
null JJ O
allele NN O
as IN O
the DT O
result NN O
of IN O
complete JJ O
intron NN O
retention NN O
. . O

In IN O
conclusion NN O
, , O
we PRP O
demonstrated VBD O
that IN O
a DT O
point NN O
mutation NN O
in IN O
a DT O
lariat JJ O
branchpoint NN O
consensus NN O
sequence NN O
causes VBZ O
a DT O
null JJ O
allele NN O
in IN O
a DT O
patient NN O
with IN O
FED NNP B-Disease
. . O

In IN O
addition NN O
, , O
our PRP$ O
finding VBG O
illustrates VBZ O
the DT O
importance NN O
of IN O
this DT O
sequence NN O
for IN O
normal JJ O
human JJ O
mRNA NN O
processing NN O
. . O

Finally RB O
, , O
this DT O
report NN O
provides VBZ O
a DT O
widely RB O
applicable JJ O
strategy NN O
which WDT O
ensures VBZ O
fast RB O
and CC O
effective JJ O
screening NN O
for IN O
intronic JJ O
defects NNS O
that WDT O
underlie VBP O
differential JJ O
gene NN O
expression NN O
. . O
. . O

Mutations NNS O
associated VBN O
with IN O
variant JJ O
phenotypes NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

We PRP O
have VBP O
identified VBN O
14 CD O
families NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
in IN O
which WDT O
mutation NN O
of IN O
the DT O
ATM NNP O
gene NN O
is VBZ O
associated VBN O
with IN O
a DT O
less RBR O
severe JJ O
clinical JJ O
and CC O
cellular JJ O
phenotype NN O
( ( O
approximately RB O
10 CD O
% NN O
- : O
15 CD O
% NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
families NNS O
identified VBN O
in IN O
the DT O
United NNP O
Kingdom NNP O
) ) O
. . O

In IN O
10 CD O
of IN O
these DT O
families NNS O
, , O
all PDT O
the DT O
homozygotes NNS O
have VBP O
a DT O
137 CD O
- : O
bp NN O
insertion NN O
in IN O
their PRP$ O
cDNA NN O
caused VBN O
by IN O
a DT O
point NN O
mutation NN O
in IN O
a DT O
sequence NN O
resembling VBG O
a DT O
splice NN O
- : O
donor NN O
site NN O
. . O

The DT O
second JJ O
A NNP B-Disease
- : I-Disease
T NN I-Disease
allele NN O
has VBZ O
a DT O
different JJ O
mutation NN O
in IN O
each DT O
patient NN O
. . O

We PRP O
show VBP O
that IN O
the DT O
less JJR O
severe JJ O
phenotype NN O
in IN O
these DT O
patients NNS O
is VBZ O
caused VBN O
by IN O
some DT O
degree NN O
of IN O
normal JJ O
splicing NN O
, , O
which WDT O
occurs VBZ O
as IN O
an DT O
alternative JJ O
product NN O
from IN O
the DT O
insertion NN O
- : O
containing VBG O
allele NN O
. . O

The DT O
level NN O
of IN O
the DT O
137 CD O
- : O
bp NN O
PCR NNP O
product NN O
containing VBG O
the DT O
insertion NN O
was VBD O
lowest JJS O
in IN O
two CD O
patients NNS O
who WP O
showed VBD O
a DT O
later JJ O
onset NN O
of IN O
cerebellar JJ B-Disease
ataxia NN I-Disease
. . O

A DT O
further JJ O
four CD O
families NNS O
who WP O
do VBP O
not RB O
have VB O
this DT O
insertion NN O
have VBP O
been VBN O
identified VBN O
. . O

Mutations NNS O
detected VBN O
in IN O
two CD O
of IN O
four CD O
of IN O
these DT O
are VBP O
missense JJ O
mutations NNS O
, , O
normally RB O
rare JJ O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
patients NNS O
. . O

The DT O
demonstration NN O
of IN O
mutations NNS O
giving VBG O
rise NN O
to TO O
a DT O
slightly RB O
milder JJR O
phenotype NN O
in IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
raises VBZ O
the DT O
interesting JJ O
question NN O
of IN O
what WP O
range NN O
of IN O
phenotypes NNS O
might MD O
occur VB O
in IN O
individuals NNS O
in IN O
whom WP O
both DT O
mutations NNS O
are VBP O
milder NN O
. . O

One CD O
possibility NN O
might MD O
be VB O
that IN O
individuals NNS O
who WP O
are VBP O
compound VBN O
heterozygotes NNS O
for IN O
ATM NNP O
mutations NNS O
are VBP O
more RBR O
common JJ O
than IN O
we PRP O
realize VBP O
. . O
. . O

Mutation NN O
of IN O
the DT O
VHL NNP O
gene NN O
is VBZ O
associated VBN O
exclusively RB O
with IN O
the DT O
development NN O
of IN O
non JJ B-Disease
- : I-Disease
papillary JJ I-Disease
renal NN I-Disease
cell NN I-Disease
carcinomas NN I-Disease
. . O

To TO O
define VB O
the DT O
possible JJ O
role NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
in IN O
the DT O
development NN O
of IN O
sporadic JJ B-Disease
renal JJ I-Disease
cell NN I-Disease
carcinomas NN I-Disease
, , O
91 CD O
different JJ O
parenchymal JJ B-Disease
tumours NN I-Disease
of IN I-Disease
the DT I-Disease
kidney NN I-Disease
have VBP O
been VBN O
investigated VBN O
for IN O
mutation NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
by IN O
single JJ O
strand NN O
conformation NN O
polymorphism NN O
( ( O
SSCP NNP O
) ) O
and CC O
/ $ O
or CC O
heteroduplex NN O
( ( O
HD NNP O
) ) O
techniques NNS O
. . O

Chromosome NNP O
3p CD O
deletion NN O
was VBD O
detected VBN O
in IN O
98 CD O
per IN O
cent NN O
of IN O
non JJ B-Disease
- : I-Disease
papillary JJ I-Disease
renal NN I-Disease
cell NN I-Disease
carcinomas NN I-Disease
and CC O
in IN O
25 CD O
per IN O
cent NN O
of IN O
chromophobe NN O
renal JJ B-Disease
cell NN I-Disease
carcinomas NN I-Disease
. . O

In IN O
22 CD O
of IN O
the DT O
43 CD O
non SYM B-Disease
- : I-Disease
papillary JJ I-Disease
renal NN I-Disease
cell NN I-Disease
carcinomas NN I-Disease
, , O
abnormally RB O
migrating VBG O
DNA NNP O
bands NNS O
were VBD O
detected VBN O
by IN O
SSCP NNP O
and CC O
/ NNP O
or CC O
HD NNP O
analysis NN O
. . O

No DT O
mobility NN O
shift NN O
was VBD O
seen VBN O
in IN O
any DT O
of IN O
the DT O
23 CD O
chromophobe NN O
renal NN B-Disease
cell NN I-Disease
carcinomas NN I-Disease
. . O

In IN O
addition NN O
, , O
15 CD O
papillary JJ B-Disease
renal NN I-Disease
cell NN I-Disease
tumours NNS I-Disease
and CC O
ten JJ O
renal JJ B-Disease
oncocytomas NN I-Disease
, , O
which WDT O
are VBP O
characterized VBN O
by IN O
genetic JJ O
changes NNS O
other JJ O
than IN O
loss NN O
of IN O
chromosome NN O
3p CD O
sequences NNS O
, , O
were VBD O
analysed VBN O
for IN O
mutation NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
. . O

None NN O
of IN O
these DT O
tumours NNS B-Disease
showed VBD O
abnormal JJ O
migration NN O
patterns NNS O
. . O

The DT O
results NNS O
indicate VBP O
that DT O
mutation NN O
of IN O
the DT O
VHL NNP B-Disease
gene NN O
is VBZ O
associated VBN O
exclusively RB O
with IN O
the DT O
development NN O
of IN O
non JJ B-Disease
- : I-Disease
papillary JJ I-Disease
renal NN I-Disease
cell NN I-Disease
carcinoma NN I-Disease
. . O
. . O

The DT O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
protein NN O
, , O
emerin NN O
, , O
is VBZ O
a DT O
nuclear JJ O
membrane NN O
protein NN O
. . O

A DT O
large JJ O
fragment NN O
of IN O
emerin JJ O
cDNA NN O
was VBD O
prepared VBN O
by IN O
PCR NNP O
and CC O
expressed VBD O
as IN O
a DT O
recombinant JJ O
protein NN O
in IN O
Escherichia NNP O
coli NN O
. . O

Using VBG O
this DT O
as IN O
immunogen NN O
, , O
we PRP O
prepared VBD O
a DT O
panel NN O
of IN O
12 CD O
monoclonal JJ O
antibodies NNS O
which WDT O
recognise VBP O
at IN O
least JJS O
four CD O
different JJ O
epitopes NNS O
on IN O
emerin NN O
in IN O
order NN O
to TO O
ensure VB O
that IN O
emerin NN O
can MD O
be VB O
distinguished VBN O
from IN O
non JJ O
- : O
specific JJ O
cross NN O
- : O
reacting NN O
proteins NNS O
. . O

All PDT O
the DT O
mAbs NN O
recognised VBD O
a DT O
34 CD O
kDa NN O
protein NN O
in IN O
all DT O
tissues NNS O
tested VBN O
, , O
though IN O
minor JJ O
emerin SYM O
- : O
related JJ O
bands NNS O
were VBD O
also RB O
detected VBN O
in IN O
some DT O
tissues NNS O
. . O

Immunofluorescence NN O
microscopy NN O
showed VBD O
that IN O
emerin NN O
is VBZ O
located VBN O
at IN O
the DT O
nuclear JJ O
rim NN O
in IN O
all DT O
tissues NNS O
examined VBN O
. . O

A DT O
muscle NN O
biopsy NN O
from IN O
an DT O
Emery NNP B-Disease
- : I-Disease
Dreifuss NNP I-Disease
muscular JJ I-Disease
dystrophy NN I-Disease
( ( O
EMDM NNP B-Disease
) ) O
patient NN O
showed VBD O
complete JJ O
absence NN O
of IN O
emerin NN O
by IN O
both DT O
Western NNP O
blotting NN O
and CC O
immunohistochemistry NN O
, , O
suggesting VBG O
a DT O
simple JJ O
diagnostic JJ O
antibody NN O
test NN O
for IN O
EDMD NNP B-Disease
families NNS O
. . O

Biochemical JJ O
fractionation NN O
of IN O
brain NN O
and CC O
liver NN O
tissues NNS O
showed VBD O
that IN O
emerin NN O
was VBD O
present JJ O
in IN O
nuclei JJ O
purified VBN O
by IN O
centrifugation NN O
through IN O
65 CD O
% NN O
sucrose NN O
and CC O
was VBD O
absent NN O
from IN O
soluble JJ O
fractions NNS O
( ( O
post NN O
- : O
100 CD O
, , O
0 CD O
g NN O
) ) O
. . O

From IN O
these DT O
results NNS O
, , O
together RB O
with IN O
sequence NN O
and CC O
structural JJ O
homologies NNS O
between IN O
emerin NN O
, , O
thymopoietins NNS O
and CC O
the DT O
nuclear JJ O
lamina SYM O
- : O
associated VBN O
protein NN O
, , O
LAP2 NNP O
, , O
we PRP O
suggest VBP O
that IN O
emerin NN O
will MD O
prove VB O
to TO O
be VB O
one CD O
member NN O
of IN O
a DT O
family NN O
of IN O
inner JJ O
nuclear JJ O
membrane NN O
proteins NNS O
. . O
. . O

Mutation NN O
of IN O
MSH3 NNP O
in IN O
endometrial JJ B-Disease
cancer NN I-Disease
and CC O
evidence NN O
for IN O
its PRP$ O
functional JJ O
role NN O
in IN O
heteroduplex JJ O
repair NN O
. . O

Many JJ O
human JJ O
tumours NNS B-Disease
have VBP O
length VBN O
alterations NNS O
in IN O
repetitive JJ O
sequence NN O
elements NNS O
. . O

Although IN O
this DT O
microsatellite JJ B-Disease
instability NN I-Disease
has VBZ O
been VBN O
attributed VBN O
to TO O
mutations NNS O
in IN O
four CD O
DNA NNP O
mismatch NN O
repair NN O
genes NNS O
in IN O
hereditary JJ B-Disease
nonpolyposis NN I-Disease
colorectal NN I-Disease
cancer NN I-Disease
( ( O
HNPCC NNP B-Disease
) ) O
kindreds NNS O
, , O
many JJ O
sporadic JJ B-Disease
tumours NNS I-Disease
exhibit VBP O
instability NN O
but CC O
no DT O
detectable JJ O
mutations NNS O
in IN O
these DT O
genes NNS O
. . O

It PRP O
is VBZ O
therefore RB O
of IN O
interest NN O
to TO O
identify VB O
other JJ O
genes NNS O
that WDT O
contribute VBP O
to TO O
this DT O
instability NN O
. . O

In IN O
yeast NN O
, , O
mutations NNS O
in IN O
several JJ O
genes NNS O
, , O
including VBG O
RTH NNP O
and CC O
MSH3 NNP O
, , O
cause NN O
microsatellite JJ O
instability NN O
. . O

Thus RB O
, , O
we PRP O
screened VBD O
16 CD O
endometrial JJ B-Disease
carcinomas NN I-Disease
with IN O
microsatellite JJ O
instability NN O
for IN O
alterations NNS O
in IN O
FEN1 NNP O
( ( O
the DT O
human JJ O
homolog NN O
of IN O
RTH NNP O
) ) O
and CC O
in IN O
MSH3 NNP O
( ( O
refs VB O
12 CD O
- : O
14 CD O
) ) O
. . O

Although IN O
we PRP O
found VBD O
no DT O
FEN1 NNP O
mutations NNS O
, , O
a DT O
frameshift NN O
mutation NN O
in IN O
MSH3 NNP O
was VBD O
observed VBN O
in IN O
an DT O
endometrial JJ B-Disease
carcinoma NN I-Disease
and CC O
in IN O
an DT O
endometrial JJ B-Disease
carcinoma NN I-Disease
cell NN O
line NN O
. . O

Extracts NNS O
of IN O
the DT O
cell NN O
line NN O
were VBD O
deficient JJ O
in IN O
repair NN O
of IN O
DNA NNP O
substrates VBZ O
containing VBG O
mismatches NNS O
or CC O
extra JJ O
nucleotides NNS O
. . O

Introducing VBG O
chromosome NN O
5 CD O
, , O
encoding VBG O
the DT O
MSH3 NNP O
gene NN O
, , O
into IN O
the DT O
mutant JJ O
cell NN O
line NN O
increased VBD O
the DT O
stability NN O
of IN O
some DT O
but CC O
not RB O
all DT O
microsatellites NNS O
. . O

Extracts NNS O
of IN O
these DT O
cells NNS O
repaired VBD O
certain JJ O
substrates NNS O
containing VBG O
extra JJ O
nucleotides NNS O
, , O
but CC O
were VBD O
deficient JJ O
in IN O
repair NN O
of IN O
those DT O
containing VBG O
mismatches NNS O
or CC O
other JJ O
extra JJ O
nucleotides NNS O
. . O

A DT O
subsequent JJ O
search NN O
revealed VBD O
a DT O
second JJ O
gene NN O
mutation NN O
in IN O
HHUA NNP O
cells NNS O
, , O
a DT O
missense JJ O
mutation NN O
in IN O
the DT O
MSH6 NNP O
gene NN O
. . O

Together RB O
the DT O
data NN O
suggest NN O
that IN O
the DT O
MSH3 NNP O
gene NN O
encodes VBZ O
a DT O
product NN O
that WDT O
functions NNS O
in IN O
repair NN O
of IN O
some DT O
but CC O
not RB O
all DT O
pre SYM O
- : O
mutational JJ O
intermediates NNS O
, , O
its PRP$ O
mutation NN O
in IN O
tumours NNS B-Disease
can MD O
result VB O
in IN O
genomic JJ O
instability NN O
and CC O
, , O
as IN O
in IN O
yeast NN O
, , O
MSH3 NNP O
and CC O
MSH6 NNP O
are VBP O
partially RB O
redundant JJ O
for IN O
mismatch NN O
repair NN O
. . O
. . O

Comparative JJ O
genome NN O
mapping NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
region NN O
in IN O
mouse NN O
, , O
rat NN O
, , O
and CC O
Syrian JJ O
hamster NN O
. . O

Chromosomal JJ O
locations NNS O
of IN O
the DT O
Atm NNP O
( ( O
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
AT NNP B-Disease
) ) O
- : O
mutated VBN O
) ) O
and CC O
Acat1 NNP O
( ( O
mitochondrial JJ O
acetoacetyl NN O
- : O
CoA NNP O
thiolase NN O
) ) O
genes NNS O
in IN O
mouse NN O
, , O
rat NN O
, , O
and CC O
Syrian JJ O
hamster NN O
were VBD O
determined VBN O
by IN O
direct JJ O
R NNP O
- : O
banding VBG O
FISH NNP O
. . O

Both DT O
genes NNS O
were VBD O
colocalized VBN O
to TO O
the DT O
C NNP O
- : O
D NNP O
band NN O
of IN O
mouse NN O
chromosome NN O
9 CD O
, , O
the DT O
proximal JJ O
end NN O
of IN O
q24 NN O
. . O

1 CD O
of IN O
rat NN O
chromosome NN O
8 CD O
, , O
and CC O
qa4 SYM O
- : O
qa5 NN O
of IN O
Syrian JJ O
hamster NN O
chromosome NN O
12 CD O
. . O

The DT O
regions NNS O
in IN O
the DT O
mouse NN O
and CC O
rat NN O
were VBD O
homologous JJ O
to TO O
human JJ O
chromosome NN O
11q CD O
. . O

Fine NNP O
genetic JJ O
linkage NN O
mapping NN O
of IN O
the DT O
mouse NN O
AT NNP B-Disease
region NN O
was VBD O
performed VBN O
using VBG O
the DT O
interspecific JJ O
backcross NN O
mice NN O
. . O

Atm NNP O
, , O
Acat1 NNP O
, , O
and CC O
Npat NNP O
, , O
which WDT O
is VBZ O
a DT O
new JJ O
gene NN O
isolated VBN O
from IN O
the DT O
AT NNP O
region NN O
, , O
and CC O
12 CD O
flanking VBG O
microsatellite JJ O
DNA NN O
markers NNS O
were VBD O
examined VBN O
. . O

No DT O
recombinations NNS O
were VBD O
found VBN O
among IN O
the DT O
Atm NNP O
, , O
Npat NNP O
, , O
Acat1 NNP O
, , O
and CC O
D9Mit6 NNP O
loci NN O
, , O
and CC O
these DT O
loci NNS O
were VBD O
mapped VBN O
2 CD O
. . O

0 CD O
cM JJ O
distal NN O
to TO O
D9Mit99 NNP O
and CC O
1 CD O
. . O

3 CD O
cM NN O
proximal NN O
to TO O
D9Mit102 NNP O
. . O

Comparison NNP O
of IN O
the DT O
linkage NN O
map NN O
of IN O
mouse NN O
chromosome NN O
9 CD O
( ( O
MMU9 NNP O
) ) O
and CC O
that IN O
of IN O
human JJ O
chromosome NN O
11 CD O
( ( O
HSA11 NNP O
) ) O
indicates VBZ O
that IN O
there EX O
is VBZ O
a DT O
chromosomal JJ O
rearrangement NN O
due JJ O
to TO O
an DT O
inversion NN O
between IN O
Ets1 NNP O
and CC O
Atm NNP O
- : O
Npat NNP O
- : O
Acat1 NN O
and CC O
that IN O
the DT O
inversion NN O
of IN O
MMU9 NNP O
originated VBD O
from IN O
the DT O
chromosomal JJ O
breakage NN O
at IN O
the DT O
boundary NN O
between IN O
Gria4 NNP O
and CC O
Atm NNP O
- : O
Npat NNP O
- : O
Acat1 NN O
on IN O
HSA11 NNP O
. . O

This DT O
type NN O
of IN O
inversion NN O
appeared VBD O
to TO O
be VB O
conserved VBN O
in IN O
the DT O
three CD O
rodent NN O
species NNS O
, , O
mouse NN O
, , O
rat NN O
, , O
and CC O
Syrian JJ O
hamster NN O
, , O
using VBG O
additional JJ O
comparative JJ O
mapping NN O
data NNS O
with IN O
the DT O
Rck NNP O
gene NN O

An DT O
animal JJ O
model NN O
for IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
ND NNP B-Disease
) ) O
: : O
gene NN O
targeting NN O
of IN O
the DT O
mouse NN O
ND NNP B-Disease
gene NN O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
cellular JJ O
and CC O
molecular JJ O
processes NNS O
which WDT O
are VBP O
involved VBN O
in IN O
Norrie NNP B-Disease
disease NN I-Disease
( ( O
ND NNP B-Disease
) ) O
, , O
we PRP O
have VBP O
used VBN O
gene NN O
targeting VBG O
technology NN O
to TO O
generate VB O
ND NNP B-Disease
mutant JJ O
mice NN O
. . O

The DT O
murine NN O
homologue NN O
of IN O
the DT O
ND NNP B-Disease
gene NN O
was VBD O
cloned VBN O
and CC O
shown VBN O
to TO O
encode VB O
a DT O
polypeptide NN O
that WDT O
shares NNS O
94 CD O
% NN O
of IN O
the DT O
amino NN O
acid JJ O
sequence NN O
with IN O
its PRP$ O
human JJ O
counterpart NN O
. . O

RNA NNP O
in IN O
situ JJ O
hybridization NN O
revealed VBD O
expression NN O
in IN O
retina NN O
, , O
brain NN O
and CC O
the DT O
olfactory NN O
bulb NN O
and CC O
epithelium NN O
of IN O
2 CD O
week NN O
old JJ O
mice NN O
. . O

Hemizygous JJ O
mice NN O
carrying VBG O
a DT O
replacement NN O
mutation NN O
in IN O
exon JJ O
2 CD O
of IN O
the DT O
ND NNP B-Disease
gene NN O
developed VBD O
retrolental JJ O
structures NNS O
in IN O
the DT O
vitreous JJ O
body NN O
and CC O
showed VBD O
an DT O
overall JJ O
disorganization NN O
of IN O
the DT O
retinal JJ O
ganglion NN O
cell NN O
layer NN O
. . O

The DT O
outer NN O
plexiform NN O
layer NN O
disappears VBZ O
occasionally RB O
, , O
resulting VBG O
in IN O
a DT O
juxtaposed JJ O
inner NN O
and CC O
outer NN O
nuclear JJ O
layer NN O
. . O

At IN O
the DT O
same JJ O
regions NNS O
, , O
the DT O
outer NN O
segments NNS O
of IN O
the DT O
photoreceptor NN O
cell NN O
layer NN O
are VBP O
no RB O
longer RBR O
present JJ O
. . O

These DT O
ocular JJ O
findings NNS O
are VBP O
consistent JJ O
with IN O
observations NNS O
in IN O
ND NNP B-Disease
patients NNS O
and CC O
the DT O
generated VBN O
mouse NN O
line NN O
provides VBZ O
a DT O
faithful JJ O
model NN O
for IN O
study NN O
of IN O
early JJ O
pathogenic JJ O
events NNS O
in IN O
this DT O
severe JJ O
X NNP B-Disease
- : I-Disease
linked VBD I-Disease
recessive JJ I-Disease
neurological JJ I-Disease
disorder NN I-Disease
. . O
. . O

The DT O
hybrid JJ O
PAX3 NNP O
- : O
FKHR NNP O
fusion NN O
protein NN O
of IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
transforms NNS O
fibroblasts NNS O
in IN O
culture NN O
. . O

Pediatric NNP B-Disease
alveolar JJ I-Disease
rhabdomyosarcoma NN I-Disease
is VBZ O
characterized VBN O
by IN O
a DT O
chromosomal JJ O
translocation NN O
that WDT O
fuses VBZ O
parts NNS O
of IN O
the DT O
PAX3 NNP O
and CC O
FKHR NNP O
genes NNS O
. . O

PAX3 NNP O
codes NNS O
for IN O
a DT O
transcriptional JJ O
regulator NN O
that WDT O
controls VBZ O
developmental JJ O
programs NNS O
, , O
and CC O
FKHR NNP O
codes NNS O
for IN O
a DT O
forkhead JJ O
- : O
winged VBD O
helix NN O
protein NN O
, , O
also RB O
a DT O
likely JJ O
transcription NN O
factor NN O
. . O

The DT O
PAX3 NNP O
- : O
FKHR NNP O
fusion NN O
product NN O
retains VBZ O
the DT O
DNA NN O
binding VBG O
domains NNS O
of IN O
the DT O
PAX3 NNP O
protein NN O
and CC O
the DT O
putative JJ O
activator NN O
domain NN O
of IN O
the DT O
FKHR NNP O
protein NN O
. . O

The DT O
PAX3 NNP O
- : O
FKHR NNP O
protein NN O
has VBZ O
been VBN O
shown VBN O
to TO O
function VB O
as IN O
a DT O
transcriptional JJ O
activator NN O
. . O

Using VBG O
the DT O
RCAS NNP O
retroviral JJ O
vector NN O
, , O
we PRP O
have VBP O
introduced VBN O
the DT O
PAX3 NNP O
- : O
FKHR NNP O
gene NN O
into IN O
chicken JJ O
embryo NN O
fibroblasts NNS O
. . O

Expression NN O
of IN O
the DT O
PAX3 NNP O
- : O
FKHR NNP O
protein NN O
in IN O
these DT O
cells NNS O
leads VBZ O
to TO O
transformation VB O
the DT O
cells NNS O
become VBP O
enlarged JJ O
, , O
grow VB O
tightly RB O
packed VBN O
and CC O
in IN O
multiple JJ O
layers NNS O
, , O
and CC O
acquire VB O
the DT O
ability NN O
for IN O
anchorage NN O
- : O
independent JJ O
growth NN O
. . O

This DT O
cellular JJ O
transformation NN O
in IN O
vitro NN O
will MD O
facilitate VB O
studies NNS O
on IN O
the DT O
mechanism NN O
of IN O
PAX3 NNP O
- : O
FKHR NNP O
- : O
induced JJ O
oncogenesis NN O
. . O
. . O

Somatic JJ O
- : O
cell NN O
selection NN O
is VBZ O
a DT O
major JJ O
determinant NN O
of IN O
the DT O
blood NN O
- : O
cell NN O
phenotype NN O
in IN O
heterozygotes NNS O
for IN O
glucose JJ O
- : O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
mutations NNS O
causing VBG O
severe JJ O
enzyme JJ B-Disease
deficiency NN I-Disease
. . O

X LS O
- : O
chromosome NN O
inactivation NN O
in IN O
mammals NNS O
is VBZ O
regarded VBN O
as IN O
an DT O
essentially RB O
random JJ O
process NN O
, , O
but CC O
the DT O
resulting JJ O
somatic JJ O
- : O
cell NN O
mosaicism NN O
creates VBZ O
the DT O
opportunity NN O
for IN O
cell NN O
selection NN O
. . O

In IN O
most JJS O
people NNS O
with IN O
red JJ O
- : O
blood NN O
- : O
cell NN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
( ( I-Disease
G6PD NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
, , O
the DT O
enzyme NN O
- : O
deficient NN O
phenotype NN O
is VBZ O
only RB O
moderately RB O
expressed VBN O
in IN O
nucleated JJ O
cells NNS O
. . O

However RB O
, , O
in IN O
a DT O
small JJ O
subset NN O
of IN O
hemizygous JJ O
males NNS O
who WP O
suffer VBP O
from IN O
chronic JJ B-Disease
nonspherocytic JJ I-Disease
hemolytic JJ I-Disease
anemia NN I-Disease
, , O
the DT O
underlying JJ O
mutations NNS O
( ( O
designated JJ O
class NN O
I PRP O
) ) O
cause NN O
more RBR O
- : O
severe JJ O
G6PD NNP B-Disease
deficiency NN I-Disease
, , O
and CC O
this DT O
might MD O
provide VB O
an DT O
opportunity NN O
for IN O
selection NN O
in IN O
heterozygous JJ O
females NNS O
during IN O
development NN O
. . O

In IN O
order NN O
to TO O
test VB O
this DT O
possibility NN O
we PRP O
have VBP O
analyzed VBN O
four CD O
heterozygotes NNS O
for IN O
class NN O
I PRP O
G6PD VBP O
mutations NNS O
two CD O
with IN O
G6PD NNP O
Portici NNP O
( ( O
1178G CD O
- : O
- : O
> VB O
A DT O
) ) O
and CC O
two CD O
with IN O
G6PD NNP O
Bari NNP O
( ( O
1187C CD O
- : O
- : O
> NN O
T NNP O
) ) O
. . O

We PRP O
found VBD O
that IN O
in IN O
fractionated JJ O
blood NN O
cell NN O
types NNS O
( ( O
including VBG O
erythroid NN O
, , O
myeloid NN O
, , O
and CC O
lymphoid NN O
cell NN O
lineages NNS O
) ) O
there EX O
was VBD O
a DT O
significant JJ O
excess NN O
of IN O
G6PD NNP O
- : O
normal JJ O
cells NNS O
. . O

The DT O
significant JJ O
concordance NN O
that IN O
we PRP O
have VBP O
observed VBN O
in IN O
the DT O
degree NN O
of IN O
imbalance NN O
in IN O
the DT O
different JJ O
blood NN O
- : O
cell NN O
lineages VBZ O
indicates VBZ O
that IN O
a DT O
selective JJ O
mechanism NN O
is VBZ O
likely JJ O
to TO O
operate VB O
at IN O
the DT O
level NN O
of IN O
pluripotent JJ O
blood NN O
stem NN O
cells NNS O
. . O

Thus RB O
, , O
it PRP O
appears VBZ O
that IN O
severe JJ O
G6PD NNP B-Disease
deficiency NN I-Disease
affects VBZ O
adversely RB O
the DT O
proliferation NN O
or CC O
the DT O
survival NN O
of IN O
nucleated JJ O
blood NN O
cells NNS O
and CC O
that IN O
this DT O
phenotypic NN O
characteristic NN O
is VBZ O
critical JJ O
during IN O
hematopoiesis NN O
. . O
. . O

Analysis NN O
of IN O
meiotic JJ O
segregation NN O
, , O
using VBG O
single JJ O
- : O
sperm JJ O
typing NN O
: : O
meiotic JJ O
drive NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
. . O

Meiotic JJ O
drive NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
locus NN O
has VBZ O
recently RB O
been VBN O
suggested VBN O
as IN O
being VBG O
responsible JJ O
for IN O
maintaining VBG O
the DT O
frequency NN O
, , O
in IN O
the DT O
human JJ O
population NN O
, , O
of IN O
DM NNP B-Disease
chromosomes NNS O
capable JJ O
of IN O
expansion NN O
to TO O
the DT O
disease NN O
state NN O
. . O

In IN O
order NN O
to TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
have VBP O
studied VBN O
samples NNS O
of IN O
single JJ O
sperm NN O
from IN O
three CD O
individuals NNS O
heterozygous JJ O
at IN O
the DT O
DM NNP B-Disease
locus NN O
, , O
each DT O
with IN O
one CD O
allele NN O
larger JJR O
and CC O
one CD O
allele NN O
smaller JJR O
than IN O
19 CD O
CTG NNP O
repeats NNS O
. . O

To TO O
guard VB O
against IN O
the DT O
possible JJ O
problem NN O
of IN O
differential JJ O
PCR NNP O
amplification NN O
rates NNS O
based VBN O
on IN O
the DT O
lengths NNS O
of IN O
the DT O
alleles NNS O
, , O
the DT O
sperm NN O
were VBD O
also RB O
typed VBN O
at IN O
another DT O
closely RB O
linked VBN O
marker NN O
whose WP$ O
allele JJ O
size NN O
was VBD O
unrelated JJ O
to TO O
the DT O
allele JJ O
size NN O
at IN O
the DT O
DM NNP B-Disease
locus NN O
. . O

Using VBG O
statistical JJ O
models NNS O
specifically RB O
designed VBN O
to TO O
study VB O
single JJ O
- : O
sperm JJ O
segregation NN O
data NNS O
, , O
we PRP O
find VBP O
no DT O
evidence NN O
of IN O
meiotic JJ O
segregation NN O
distortion NN O
. . O

The DT O
upper JJ O
limit NN O
of IN O
the DT O
two CD O
- : O
sided VBD O
95 CD O
% NN O
confidence NN O
interval NN O
for IN O
the DT O
estimate NN O
of IN O
the DT O
common JJ O
segregation NN O
probability NN O
for IN O
the DT O
three CD O
donors NNS O
is VBZ O
at IN O
or CC O
below IN O
. . O

515 CD O
for IN O
all DT O
models NNS O
considered VBN O
, , O
and CC O
no DT O
statistically RB O
significant JJ O
difference NN O
from IN O
. . O

5 CD O
is VBZ O
detected VBN O
in IN O
any DT O
of IN O
the DT O
models NNS O
. . O

This DT O
suggests VBZ O
that IN O
any DT O
greater JJR O
amount NN O
of IN O
segregation NN O
distortion NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
must MD O
result VB O
from IN O
events NNS O
following VBG O
sperm JJ O
ejaculation NN O
. . O

LPP NNP O
, , O
the DT O
preferred JJ O
fusion NN O
partner NN O
gene NN O
of IN O
HMGIC NNP O
in IN O
lipomas NN B-Disease
, , O
is VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
LIM NNP O
protein NN O
gene NN O
family NN O
. . O

A DT O
major JJ O
cytogenetic JJ O
subgroup NN O
of IN O
lipomas NN B-Disease
is VBZ O
characterized VBN O
by IN O
recurrent JJ O
chromosome NN O
aberrations NNS O
, , O
mainly RB O
translocations NNS O
, , O
that IN O
involve VBP O
chromosome NN O
segment NN O
12q13 CD O
- : O
q15 NN O
. . O

Multiple JJ O
chromosomes NNS O
have VBP O
been VBN O
found VBN O
as IN O
the DT O
translocation NN O
partners NNS O
of IN O
chromosome NN O
12 CD O
but CC O
3q27 CD O
- : O
q28 NN O
is VBZ O
preferentially RB O
involved VBN O
. . O

In IN O
previous JJ O
studies NNS O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
the DT O
high JJ O
mobility NN O
group NN O
( ( O
HMG NNP O
) ) O
protein VBP O
gene NN O
HMGIC NNP O
at IN O
12q15 CD O
is VBZ O
consistently RB O
rearranged VBN O
as IN O
a DT O
consequence NN O
of IN O
these DT O
translocations NNS O
. . O

Here RB O
, , O
we PRP O
report VBP O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
the DT O
chromosome NN O
3 CD O
- : O
derived VBN O
translocation NN O
partner NN O
gene NN O
, , O
which WDT O
we PRP O
have VBP O
designated VBN O
LPP NNP O
( ( O
lipoma JJ B-Disease
preferred VBN O
partner NN O
gene NN O
) ) O
. . O

Using VBG O
3 CD O
- : O
RACE JJ O
analysis NN O
of IN O
HMGIC NNP O
fusion NN O
transcripts NNS O
in IN O
lipoma NN B-Disease
cell NN O
line NN O
Li NNP O
- : O
501 CD O
/ NN O
SV40 NNP O
, , O
ectopic VBZ O
genetic JJ O
sequences NNS O
were VBD O
obtained VBN O
, , O
which WDT O
by IN O
CASH NNP O
( ( O
chromosome JJ O
assignment NN O
using VBG O
somatic JJ O
cell NN O
hybrids NNS O
) ) O
and CC O
FISH NNP O
( ( O
fluorescence NN O
in IN O
situ JJ O
hybridization NN O
) ) O
analysis NN O
were VBD O
found VBN O
to TO O
originate VB O
from IN O
chromosome NN O
segment NN O
3q27 CD O
- : O
q28 NN O
. . O

In IN O
Northern NNP O
blot NN O
analysis NN O
, , O
an DT O
mRNA NN O
of IN O
over IN O
10 CD O
kb NN O
was VBD O
detected VBN O
by IN O
these DT O
ectopic NNS O
sequences NNS O
in IN O
a DT O
variety NN O
of IN O
human JJ O
tissues NNS O
but CC O
not RB O
in IN O
brain NN O
and CC O
peripheral JJ O
blood NN O
leukocytes NNS O
. . O

Upon IN O
partial JJ O
cDNA NN O
cloning NN O
, , O
features NNS O
of IN O
the DT O
genetic JJ O
organization NN O
of IN O
LPP NNP O
were VBD O
established VBN O
. . O

The DT O
gene NN O
was VBD O
found VBN O
to TO O
span VB O
a DT O
genomic JJ O
region NN O
of IN O
over IN O
400 CD O
kb NNS O
. . O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
a DT O
composite JJ O
cDNA NN O
of IN O
LPP NNP O
revealed VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
1836 CD O
nucleotides NNS O
encoding VBG O
a DT O
proline NN O
- : O
rich JJ O
protein NN O
containing VBG O
a DT O
leucine JJ O
- : O
zipper NN O
motif NN O
in IN O
its PRP$ O
amino NN O
- : O
terminal JJ O
region NN O
and CC O
three CD O
LIM NNP O
domains VBZ O
in IN O
its PRP$ O
carboxy JJ O
- : O
terminal JJ O
region NN O
. . O

The DT O
LPP NNP O
- : O
encoded VBD O
protein NN O
should MD O
be VB O
classified VBN O
as IN O
a DT O
novel JJ O
member NN O
of IN O
the DT O
group NN O
3 CD O
proteins NNS O
of IN O
the DT O
LIM NNP O
protein NN O
gene NN O
family NN O
. . O

Using VBG O
reverse JJ O
transcriptase NN O
combined VBN O
with IN O
polymerase NN O
chain NN O
reactions NNS O
in IN O
the DT O
analysis NN O
of IN O
a DT O
number NN O
of IN O
lipoma NN B-Disease
cell NN O
lines NNS O
and CC O
primary JJ B-Disease
lipomas NN I-Disease
, , O
it PRP O
appeared VBD O
that IN O
LPP NNP O
is VBZ O
frequently RB O
rearranged VBN O
also RB O
in IN O
cases NNS O
without IN O
a DT O
cytogenetically RB O
detectable JJ O
involvement NN O
of IN O
3q27 CD O
- : O
q28 NN O
. . O

Two CD O
alternative JJ O
HMGIC NNP O
/ NNP O
LPP NNP O
hybrid JJ O
transcripts NNS O
have VBP O
been VBN O
detected VBN O
; : O
the DT O
difference NN O
between IN O
them PRP O
is VBZ O
mainly RB O
the DT O
presence NN O
of IN O
either CC O
two CD O
or CC O
three CD O
LIM NNP O
domains NNS O
in IN O
the DT O
predicted JJ O
HMGI NNP O
- : O
C NNP O
/ NNP O
LPP NNP O
fusion NN O
proteins NNS O
. . O
. . O

Absence NN O
of IN O
disease NN O
phenotype NN O
and CC O
intergenerational JJ O
stability NN O
of IN O
the DT O
CAG NNP O
repeat NN O
in IN O
transgenic JJ O
mice NN O
expressing VBG O
the DT O
human JJ O
Huntington NNP B-Disease
disease NN I-Disease
transcript NN O
. . O

The DT O
mutation NN O
underlying VBG O
Huntington NNP B-Disease
disease NN I-Disease
( ( O
HD NNP B-Disease
) ) O
is VBZ O
CAG JJ O
expansion NN O
in IN O
the DT O
first JJ O
exon NN O
of IN O
the DT O
HD NNP B-Disease
gene NN O
. . O

In IN O
order NN O
to TO O
investigate VB O
the DT O
role NN O
of IN O
CAG NNP O
expansion NN O
in IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
, , O
we PRP O
have VBP O
produced VBN O
transgenic JJ O
mice NN O
containing VBG O
the DT O
full JJ O
length NN O
human JJ O
HD NNP B-Disease
cDNA NN O
with IN O
44 CD O
CAG NNP O
repeats NNS O
. . O

By IN O
1 CD O
year NN O
, , O
these DT O
mice NNS O
have VBP O
no DT O
behavioral JJ B-Disease
abnormalities NNS I-Disease
and CC O
morphometric JJ O
analysis NN O
at IN O
6 CD O
( ( O
one CD O
animal NN O
) ) O
and CC O
9 CD O
( ( O
two CD O
animals NNS O
) ) O
months NNS O
age NN O
revealed VBD O
no DT O
changes NNS O
. . O

Despite IN O
high JJ O
levels NNS O
of IN O
mRNA NN O
expression NN O
, , O
there EX O
was VBD O
no DT O
evidence NN O
of IN O
the DT O
HD NNP B-Disease
gene NN O
product NN O
in IN O
any DT O
of IN O
these DT O
transgenic JJ O
mice NN O
. . O

In IN O
vitro JJ O
transfection NN O
studies NNS O
indicated VBD O
that IN O
the DT O
inclusion NN O
of IN O
120 CD O
bp NN O
of IN O
the DT O
5 CD O
UTR NNP O
in IN O
the DT O
cDNA NN O
construct NN O
and CC O
the DT O
presence NN O
of IN O
a DT O
frameshift JJ O
mutation NN O
at IN O
nucleotide JJ O
2349 CD O
prevented JJ O
expression NN O
of IN O
the DT O
HD NNP B-Disease
cDNA NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
is VBZ O
not RB O
mediated VBN O
through IN O
DNA NNP O
- : O
protein NN O
interaction NN O
and CC O
that DT O
presence NN O
of IN O
the DT O
RNA NNP O
transcript NN O
with IN O
an DT O
expanded VBN O
CAG NNP O
repeat NN O
is VBZ O
insufficient JJ O
to TO O
cause VB O
the DT O
disease NN O
. . O

Rather RB O
, , O
translation NN O
of IN O
the DT O
CAG NNP O
is VBZ O
crucial JJ O
for IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
. . O

In IN O
contrast NN O
to TO O
that DT O
seen VBN O
in IN O
humans NNS O
, , O
the DT O
CAG NNP O
repeat NN O
in IN O
these DT O
mice NN O
was VBD O
remarkably RB O
stable JJ O
in IN O
97 CD O
meioses NNS O
. . O

This DT O
suggests VBZ O
that IN O
genomic JJ O
sequences NNS O
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
influencing VBG O
repeat NN O
instability NN O
. . O
. . O

FISH NNP O
studies NNS O
in IN O
a DT O
patient NN O
with IN O
sporadic JJ B-Disease
aniridia NN I-Disease
and CC O
t NN O
( ( O
7 CD O
; : O
11 CD O
) ) O
( ( O
q31 UH O
. . O
2 CD O
; : O
p13 NN O
) ) O
. . O

A DT O
2 CD O
year NN O
old JJ O
female NN O
presenting VBG O
with IN O
bilateral JJ B-Disease
sporadic JJ I-Disease
aniridia NN I-Disease
was VBD O
found VBN O
to TO O
have VB O
an DT O
apparently RB O
balanced JJ O
reciprocal JJ O
translocation NN O
with IN O
a DT O
chromosome NN O
11 CD O
breakpoint NN O
within IN O
band NN O
p13 NN O
. . O

Fluorescence NN O
in IN O
situ JJ O
hybridisation NN O
( ( O
FISH NNP O
) ) O
studies NNS O
with IN O
distal JJ O
11p13 CD O
specific JJ O
cosmids NNS O
showed VBD O
that IN O
the DT O
chromosome NN O
11 CD O
breakpoint NN O
lay NN O
between IN O
the DT O
aniridia NN B-Disease
( ( O
PAX6 NNP O
) ) O
locus NN O
and CC O
a DT O
region NN O
approximately RB O
100 CD O
kb NNS O
distal JJ O
to TO O
PAX6 NNP O
defined VBN O
by IN O
the DT O
cosmid NN O
FO2121 NNP O
. . O

Although IN O
this DT O
patient NN O
did VBD O
not RB O
have VB O
a DT O
detectable JJ O
deletion NN O
within IN O
PAX6 NNP O
, , O
her PRP$ O
aniridia NN B-Disease
may MD O
have VB O
resulted VBN O
from IN O
a DT O
disruption NN O
of IN O
the DT O
distal JJ O
chromatin NN O
domain NN O
containing VBG O
either CC O
enhancers NNS O
or CC O
regulators NNS O
for IN O
PAX6 NNP O
. . O

This DT O
case NN O
may MD O
therefore RB O
be VB O
another DT O
example NN O
of IN O
aniridia NN B-Disease
caused VBN O
by IN O
a DT O
position NN O
effect NN O
as IN O
recently RB O
described VBN O
in IN O
two CD O
familial JJ B-Disease
aniridia NN I-Disease
patients NNS O
in IN O
which WDT O
the DT O
phenotype NN O
cosegregated VBD O
with IN O
chromosome NN B-Disease
abnormalities NNS I-Disease
with IN O
11p13 CD O
breakpoints NNS O
. . O
. . O

Muscle NNP O
expression NN O
of IN O
glucose JJ B-Disease
- : I-Disease
6 CD I-Disease
- : I-Disease
phosphate NN I-Disease
dehydrogenase NN I-Disease
deficiency NN I-Disease
in IN O
different JJ O
variants NNS O
. . O

Muscle NNP O
expression NN O
of IN O
G6PD NNP B-Disease
deficiency NN I-Disease
has VBZ O
been VBN O
investigated VBN O
in IN O
Mediterranean NNP O
, , O
Seattle NNP O
- : O
like NN O
and CC O
A NNP O
- : O
variants NNS O
. . O

G6PD NNP O
activity NN O
was VBD O
detected VBN O
in IN O
samples NNS O
obtained VBN O
from IN O
biopsies NNS O
on IN O
the DT O
quadriceps JJ O
muscle NN O
of IN O
seven CD O
males NNS O
and CC O
one CD O
female NN O
. . O

The DT O
type NN O
of IN O
genetic JJ O
variant NN O
was VBD O
determined VBN O
by IN O
molecular JJ O
analysis NN O
of IN O
DNA NNP O
, , O
extracted VBD O
from IN O
blood NN O
samples NNS O
. . O

All DT O
variants NNS O
showed VBD O
the DT O
enzyme NN O
defect NN O
in IN O
muscle NN O
. . O

A DT O
statistically RB O
significant JJ O
relationship NN O
was VBD O
found VBN O
in IN O
the DT O
activity NN O
of IN O
G6PD NNP O
between IN O
erythrocytes NNS O
and CC O
muscle NN O
of IN O
the DT O
male JJ O
subjects NNS O
( ( O
r VB O
= RB O
0 CD O
. . O
968 CD O
; : O
p NN O
= VBZ O
0 CD O
. . O
8 CD O
) ) O
. . O

The DT O
equation NN O
for IN O
the DT O
best JJS O
fit JJ O
line NN O
was VBD O
Y NNP O
= NNP O
0 CD O
. . O

390X CD O
+ JJ O
0 CD O
. . O

198 CD O
198 CD O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
, , O
for IN O
a DT O
given VBN O
variant NN O
, , O
the DT O
extent NN O
of IN O
the DT O
enzyme NN O
defect NN O
in IN O
muscle NN O
may MD O
be VB O
determined VBN O
, , O
using VBG O
this DT O
equation NN O
, , O
from IN O
the DT O
G6PD NNP O
activity NN O
of IN O
erythrocytes NNS O

Gene NNP O
therapy NN O
for IN O
phenylketonuria NN B-Disease
. . O

Classical JJ O
phenylketonuria NN B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

Limitations NNS O
of IN O
the DT O
current JJ O
dietary JJ O
treatment NN O
for IN O
PKU NNP B-Disease
have VBP O
led VBN O
to TO O
the DT O
development NN O
of IN O
potential JJ O
treatments NNS O
based VBN O
on IN O
somatic JJ O
gene NN O
transfer NN O
. . O

Three CD O
different JJ O
vector NN O
systems NNS O
have VBP O
been VBN O
examined VBN O
. . O

Vectors NNS O
derived VBD O
from IN O
a DT O
recombinant JJ O
retrovirus NN O
or CC O
a DT O
DNA NN O
/ JJ O
protein NN O
complex NN O
can MD O
efficiently RB O
transduce VB O
the DT O
PAH NNP O
cDNA NN O
into IN O
PAH NNP B-Disease
- : I-Disease
deficient NN I-Disease
hepatocytes NNS O
in IN O
vitro NN O
, , O
but CC O
the DT O
application NN O
of IN O
these DT O
vector NN O
systems NNS O
is VBZ O
presently RB O
limited VBN O
by IN O
their PRP$ O
low JJ O
transduction NN O
efficiency NN O
in IN O
vivo NN O
. . O

In IN O
contrast NN O
, , O
a DT O
vector NN O
derived VBN O
from IN O
a DT O
recombinant JJ O
adenovirus NN O
can MD O
restore VB O
10 CD O
% NN O
- : O
80 CD O
% NN O
of IN O
normal JJ O
hepatic JJ O
PAH NNP O
activity NN O
into IN O
PAH NNP B-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
, , O
which WDT O
completely RB O
normalizes VBZ O
serum JJ O
phenylalanine NN O
levels NNS O
. . O

This DT O
treatment NN O
is VBZ O
transient JJ O
and CC O
cannot JJ O
be VB O
effectively RB O
re JJ O
- : O
administered VBN O
due JJ O
to TO O
the DT O
presence NN O
of IN O
neutralizing VBG O
antibodies NNS O
directed VBN O
against IN O
the DT O
recombinant JJ O
adenoviral JJ O
vector NN O
. . O

However RB O
, , O
these DT O
findings NNS O
suggest VBP O
that IN O
PKU NNP B-Disease
can MD O
be VB O
completely RB O
corrected VBN O
by IN O
somatic JJ O
gene NN O
therapy NN O
, , O
and CC O
provide VB O
some DT O
direction NN O
for IN O
the DT O
future NN O
development NN O
of IN O
adenoviral JJ O
vectors NNS O
. . O
. . O

Exon NNP O
- : O
intron NN O
structure NN O
of IN O
the DT O
human JJ O
neuronal JJ O
nicotinic JJ O
acetylcholine NN O
receptor NN O
alpha VBD O
4 CD O
subunit NN O
( ( O
CHRNA4 NNP O
) ) O
. . O

The DT O
human JJ O
neuronal JJ O
nicotinic JJ O
acetylcholine NN O
receptor NN O
alpha VBD O
4 CD O
subunit NN O
gene NN O
( ( O
CHRNA4 NNP O
) ) O
is VBZ O
located VBN O
in IN O
the DT O
candidate NN O
region NN O
for IN O
three CD O
different JJ O
phenotypes NNS O
benign JJ B-Disease
familial JJ I-Disease
neonatal JJ I-Disease
convulsions NNS I-Disease
, , O
autosomal JJ B-Disease
dominant JJ I-Disease
nocturnal JJ I-Disease
frontal NN I-Disease
lobe NN I-Disease
epilepsy NN I-Disease
, , O
and CC O
low JJ O
- : O
voltage NN O
EEG NNP O
. . O

Recently RB O
, , O
a DT O
missense JJ O
mutation NN O
in IN O
transmembrane NN O
domain VBP O
2 CD O
of IN O
CHRNA4 NNP O
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
with IN O
autosomal JJ B-Disease
dominant JJ I-Disease
nocturnal JJ I-Disease
frontal NN I-Disease
lobe NN I-Disease
epilepsy NN I-Disease
in IN O
one CD O
extended VBD O
pedigree NN O
. . O

We PRP O
have VBP O
determined VBN O
the DT O
genomic JJ O
organization NN O
of IN O
CHRNA4 NNP O
, , O
which WDT O
consists VBZ O
of IN O
six CD O
exons NNS O
distributed VBN O
over IN O
approximately RB O
17 CD O
kb NNS O
of IN O
genomic JJ O
DNA NNP O
. . O

The DT O
nucleotide JJ O
sequence NN O
obtained VBN O
from IN O
the DT O
genomic JJ O
regions NNS O
adjacent VBP O
to TO O
the DT O
exon NN O
boundaries NNS O
enabled VBD O
us PRP O
to TO O
develop VB O
a DT O
set NN O
of IN O
primer NN O
pairs NNS O
for IN O
PCR NNP O
amplification NN O
of IN O
the DT O
complete JJ O
coding NN O
region NN O
. . O

The DT O
sequence NN O
analysis NN O
provides VBZ O
the DT O
basis NN O
for IN O
a DT O
comprehensive JJ O
mutation NN O
screening NN O
of IN O
CHRNA4 NNP O
in IN O
the DT O
above JJ O
- : O
mentioned VBN O
phenotypes NNS O
and CC O
possibly RB O
in IN O
other JJ O
types NNS O
of IN O
idiopathic JJ B-Disease
epilepsies NNS I-Disease
. . O
. . O

Ashkenazi NNP O
Jewish NNP O
population NN O
frequencies NNS O
for IN O
common JJ O
mutations NNS O
in IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

BRCA1 NNP O
and CC O
BRCA2 NNP O
are VBP O
the DT O
two CD O
major JJ O
identified VBN O
causes NNS O
of IN O
inherited JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
, , O
with IN O
mutations NNS O
in IN O
either DT O
gene NN O
conferring VBG O
up RP O
to TO O
80 CD O
- : O
90 CD O
% NN O
lifetime NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
in IN O
carrier NN O
females NNS O
. . O

Mutations NNS O
in IN O
BRCA1 NNP O
account NN O
for IN O
approximately RB O
45 CD O
% NN O
of IN O
familial JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
and CC O
90 CD O
% NN O
of IN O
inherited JJ B-Disease
breast NN I-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
whereas JJ O
mutations NNS O
in IN O
BRCA2 NNP O
account NN O
for IN O
a DT O
comparable JJ O
percentage NN O
of IN O
inherited JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
cases NNS O
. . O

Over IN O
85 CD O
distinct JJ O
BRCA1 NNP O
mutations NNS O
and CC O
a DT O
growing VBG O
list NN O
of IN O
BRCA2 NNP O
mutations NNS O
have VBP O
been VBN O
identified VBN O
, , O
with IN O
the DT O
majority NN O
resulting VBG O
in IN O
protein NN O
truncation NN O
. . O

A DT O
specific JJ O
BRCA1 NNP O
mutation NN O
, , O
185delAG CD O
, , O
has VBZ O
a DT O
reported VBN O
increased VBN O
carrier NN O
frequency NN O
of IN O
approximately RB O
0 CD O
. . O

9 CD O
% NN O
in IN O
the DT O
Ashkenazi NNP O
Jewish NNP O
population NN O
, , O
but CC O
is VBZ O
also RB O
found VBN O
in IN O
rare JJ O
non NN O
- : O
Jewish JJ O
patients NNS O
with IN O
a DT O
different JJ O
haplotype NN O
. . O

The DT O
6174delT CD O
mutation NN O
in IN O
BRCA2 NNP O
was VBD O
recently RB O
identified VBN O
as IN O
a DT O
frequent JJ O
mutation NN O
in IN O
8 CD O
out IN O
of IN O
107 CD O
Ashkenazi NNP O
Jewish JJ O
women NNS O
diagnosed VBN O
with IN O
breast NN B-Disease
cancer NN I-Disease
by IN O
age NN O
50 CD O
( ( O
ref NN O
. . O
8 CD O
) ) O
, , O
as RB O
well RB O
as IN O
in IN O
three CD O
Ashkenazi NNP O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
patients NNS O
. . O

We PRP O
have VBP O
conducted VBN O
a DT O
large JJ O
- : O
scale NN O
population NN O
study NN O
to TO O
investigate VB O
the DT O
prevalence NN O
of IN O
specific JJ O
BRCA1 NNP O
and CC O
BRCA2 NNP O
mutations NNS O
in IN O
Ashkenazi NNP O
Jewish JJ O
individuals NNS O
who WP O
were VBD O
unselected VBN O
for IN O
breast NN B-Disease
cancer NN I-Disease
. . O

BRCA1 NNP O
mutation NN O
screening VBG O
on IN O
approximately RB O
3 CD O
, , O
0 CD O
Ashkenazi NNP O
Jewish NNP O
samples NNS O
determined VBD O
a DT O
carrier NN O
frequency NN O
of IN O
1 CD O
. . O

9 CD O
% NN O
for IN O
the DT O
185delAG CD O
mutation NN O
and CC O
0 CD O
. . O

13 CD O
% NN O
for IN O
the DT O
5382insC CD O
mutation NN O
. . O

BRCA2 NNP O
analysis NN O
on IN O
3 CD O
, , O
85 CD O
individuals NNS O
from IN O
the DT O
same JJ O
population NN O
showed VBD O
a DT O
carrier NN O
frequency NN O
of IN O
1 CD O
. . O

52 CD O
% NN O
for IN O
the DT O
6174delT CD O
mutation NN O
. . O

This DT O
expanded VBN O
population NN O
- : O
based VBN O
study NN O
confirms VBZ O
that IN O
the DT O
BRCA1 NNP O
185delAG CD O
mutation NN O
and CC O
the DT O
BRCA2 NNP O
6174delT CD O
mutation NN O
constitute VB O
the DT O
two CD O
most JJS O
frequent JJ O
mutation NN O
alleles NNS O
predisposing VBG O
to TO O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
among IN O
the DT O
Ashkenazim NNP O
, , O
and CC O
suggests VBZ O
a DT O
relatively RB O
lower JJR O
penetrance NN O
for IN O
the DT O
6174delT CD O
mutation NN O
in IN O
BRCA2 NNP O

Dual JJ O
roles NNS O
of IN O
ATM NNP O
in IN O
the DT O
cellular JJ O
response NN O
to TO O
radiation NN O
and CC O
in IN O
cell NN O
growth NN O
control NN O
. . O

The DT O
gene NN O
mutated VBN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
AT NNP B-Disease
) ) O
patients NNS O
, , O
denoted VBN O
ATM NNP O
, , O
encodes VBZ O
a DT O
putative JJ O
protein NN O
or CC O
lipid JJ O
kinase NN O
. . O

To TO O
elucidate VB O
the DT O
functions NNS O
of IN O
ATM NNP O
, , O
we PRP O
disrupted VBD O
the DT O
mouse NN O
ATM NNP O
gene NN O
through IN O
homologous JJ O
recombination NN O
in IN O
mice NN O
. . O

Consistent JJ O
with IN O
cellular JJ O
defects NNS O
of IN O
AT NNP B-Disease
patients NNS O
, , O
the DT O
ATM NNP O
- : O
/ SYM O
- : O
cells NNS O
are VBP O
hypersensitive JJ O
to TO O
gamma VB O
- : O
irradiation NN O
and CC O
defective JJ O
in IN O
cell NN O
- : O
cycle NN O
arrest NN O
following VBG O
radiation NN O
, , O
correlating VBG O
with IN O
a DT O
defective JJ O
up RP O
- : O
regulation NN O
of IN O
p53 NN O
. . O

In IN O
addition NN O
, , O
ATM NNP O
- : O
/ SYM O
- : O
mouse NN O
thymocytes NNS O
are VBP O
more RBR O
resistant JJ O
to TO O
apoptosis VB O
induced VBN O
by IN O
gamma JJ O
- : O
irradiation NN O
than IN O
normal JJ O
thymocytes NNS O
. . O

ATM NNP O
- : O
/ SYM O
- : O
fibroblasts NNS O
are VBP O
inefficient JJ O
in IN O
G1 NNP O
to TO O
S NNP O
- : O
phase NN O
progression NN O
following VBG O
serum JJ O
stimulation NN O
and CC O
senesce NN O
after IN O
only RB O
a DT O
few JJ O
passages NNS O
in IN O
culture NN O
. . O

They PRP O
have VBP O
an DT O
increased VBN O
constitutive JJ O
level NN O
of IN O
p21CP1 JJ O
/ NNP O
WAF1 NNP O
. . O

The DT O
ATM NNP O
protein NN O
is VBZ O
therefore RB O
critical JJ O
both DT O
for IN O
cellular JJ O
responses NNS O
to TO O
ionizing VBG O
radiation NN O
and CC O
for IN O
normal JJ O
cell NN O
- : O
cycle NN O
progression NN O
. . O

ATM NNP O
+ NNP O
/ NNP O
- : O
fibroblasts NNS O
and CC O
thymocytes NNS O
showed VBD O
intermediately RB O
defective JJ O
responses NNS O
to TO O
irradiation VB O
but CC O
no DT O
growth NN O
defect NN O
, , O
suggesting VBG O
that IN O
the DT O
increased JJ O
cancer NN B-Disease
risk NN O
of IN O
AT NNP B-Disease
heterozygotes NNS O
could MD O
be VB O
attributable JJ O
to TO O
poor JJ O
checkpoint NN O
function NN O
. . O
. . O

Targeted VBN O
disruption NN O
of IN O
ATM NNP O
leads VBZ O
to TO O
growth NN B-Disease
retardation NN I-Disease
, , O
chromosomal JJ B-Disease
fragmentation NN I-Disease
during IN I-Disease
meiosis NN I-Disease
, , O
immune JJ B-Disease
defects NNS I-Disease
, , O
and CC O
thymic JJ B-Disease
lymphoma NN I-Disease
. . O

ATM NNP O
, , O
the DT O
gene NN O
mutated VBN O
in IN O
the DT O
inherited JJ B-Disease
human JJ I-Disease
disease NN I-Disease
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
, , O
is VBZ O
a DT O
member NN O
of IN O
a DT O
family NN O
of IN O
kinases NNS O
involved VBN O
in IN O
DNA NNP O
metabolism NN O
and CC O
cell NN O
- : O
cycle NN O
checkpoint NN O
control NN O
. . O

To TO O
help VB O
clarify VB O
the DT O
physiological JJ O
roles NNS O
of IN O
the DT O
ATM NNP O
protein NN O
, , O
we PRP O
disrupted VBD O
the DT O
ATM NNP O
gene NN O
in IN O
mice NNS O
through IN O
homologous JJ O
recombination NN O
. . O

Initial JJ O
evaluation NN O
of IN O
the DT O
ATM NNP O
knockout NN O
animals NNS O
indicates VBZ O
that IN O
inactivation NN O
of IN O
the DT O
mouse NN O
ATM NNP O
gene NN O
recreates VBZ O
much RB O
of IN O
the DT O
phenotype NN O
of IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
. . O

The DT O
homozygous JJ O
mutant NN O
( ( O
ATM NNP O
- : O
/ SYM O
- : O
) ) O
mice NN O
are VBP O
viable JJ O
, , O
growth NN O
- : O
retarded VBN O
, , O
and CC O
infertile NN O
. . O

The DT O
infertility NN B-Disease
of IN O
ATM NNP O
- : O
/ SYM O
- : O
mice NN O
results NNS O
from IN O
meiotic JJ O
failure NN O
. . O

Meiosis NN O
is VBZ O
arrested VBN O
at IN O
the DT O
zygotene NN O
/ NNP O
pachytene NN O
stage NN O
of IN O
prophase NN O
I PRP O
as IN O
a DT O
result NN O
of IN O
abnormal JJ O
chromosomal JJ O
synapsis NN O
and CC O
subsequent JJ O
chromosome NN O
fragmentation NN O
. . O

Immune NNP B-Disease
defects NNS I-Disease
also RB O
are VBP O
evident JJ O
in IN O
ATM NNP O
- : O
/ SYM O
- : O
mice NN O
, , O
including VBG O
reduced JJ O
numbers NNS O
of IN O
B220 NNP O
+ NNP O
CD43 NNP O
- : O
pre NN O
- : O
B NNP O
cells NNS O
, , O
thymocytes NNS O
, , O
and CC O
peripheral JJ O
T NNP O
cells NNS O
, , O
as RB O
well RB O
as IN O
functional JJ O
impairment NN O
of IN O
T NNP O
- : O
cell NN O
- : O
dependent NN O
immune JJ O
responses NNS O
. . O

The DT O
cerebella NN O
of IN O
ATM NNP O
- : O
/ SYM O
- : O
mice NN O
appear IN O
normal JJ O
by IN O
histologic JJ O
examination NN O
at IN O
3 CD O
to TO O
4 CD O
months NNS O
and CC O
the DT O
mice NNS O
have VBP O
no DT O
gross JJ O
behavioral JJ B-Disease
abnormalities NNS I-Disease
. . O

The DT O
majority NN O
of IN O
mutant JJ O
mice NNS O
rapidly RB O
develop VBP O
thymic JJ B-Disease
lymphomas NN I-Disease
and CC O
die NN O
before IN O
4 CD O
months NNS O
of IN O
age NN O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
the DT O
ATM NNP O
gene NN O
product NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
a DT O
diverse JJ O
group NN O
of IN O
cellular JJ O
processes NNS O
, , O
including VBG O
meiosis NN O
, , O
the DT O
normal JJ O
growth NN O
of IN O
somatic JJ O
tissues NNS O
, , O
immune NN O
development NN O
, , O
and CC O
tumor NN B-Disease
suppression NN O
. . O
. . O

Cloning VBG O
and CC O
characterization NN O
of IN O
human JJ O
very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
cDNA NN O
, , O
chromosomal JJ O
assignment NN O
of IN O
the DT O
gene NN O
and CC O
identification NN O
in IN O
four CD O
patients NNS O
of IN O
nine CD O
different JJ O
mutations NNS O
within IN O
the DT O
VLCAD NNP O
gene NN O
. . O

Very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
( ( O
VLCAD NNP O
) ) O
is VBZ O
one CD O
of IN O
four CD O
straight JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
( ( O
ACD NNP O
) ) O
enzymes NNS O
, , O
which WDT O
are VBP O
all DT O
nuclear JJ O
encoded VBN O
mitochondrial JJ O
flavoproteins NNS O
catalyzing VBG O
the DT O
initial JJ O
step NN O
in IN O
fatty JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
. . O

We PRP O
have VBP O
used VBN O
the DT O
very RB O
fast RB O
, , O
Rapid NNP O
Amplification NNP O
of IN O
cDNA NN O
Ends NNP O
( ( O
RACE NNP O
) ) O
based VBN O
strategy NN O
to TO O
obtain VB O
the DT O
sequence NN O
of IN O
cDNAs NN O
encoding VBG O
human JJ O
VLCAD NNP O
from IN O
placenta NN O
and CC O
fibroblasts NNS O
. . O

Alignment NN O
of IN O
the DT O
predicted VBN O
amino NN O
acid JJ O
sequence NN O
of IN O
human JJ O
VLCAD NNP O
with IN O
those DT O
of IN O
the DT O
other JJ O
human JJ O
ACD NNP O
enzymes NNS O
revealed VBD O
extensive JJ O
sequence NN O
homology NN O
. . O

Moreover RB O
, , O
human JJ O
VLCAD NNP O
and CC O
human JJ O
acyl NN O
- : O
CoA NNP O
oxidase NN O
showed VBD O
extensive JJ O
sequence NN O
homology NN O
corroborating VBG O
the DT O
notion NN O
that IN O
these DT O
genes NNS O
are VBP O
evolutionarily RB O
related VBN O
. . O

Southern NNP O
blot NN O
analysis NN O
of IN O
genomic JJ O
DNA NN O
from IN O
hybrid JJ O
cell NN O
lines NNS O
was VBD O
used VBN O
to TO O
localize VB O
the DT O
VLCAD NNP O
gene NN O
to TO O
human JJ O
chromosome NN O
17p11 CD O
. . O

2 CD O
- : O
p11 NN O
. . O

13105 CD O
. . O

Using VBG O
Northern NNP O
and CC O
Western NNP O
blot NN O
analysis NN O
to TO O
investigate VB O
the DT O
tissue NN O
specific JJ O
distribution NN O
of IN O
VLCAD NNP O
mRNA NN O
and CC O
protein NN O
in IN O
several JJ O
human JJ O
tissues NNS O
we PRP O
showed VBD O
that IN O
VLCAD NNP O
is VBZ O
most RBS O
abundant JJ O
in IN O
heart NN O
and CC O
skeletal JJ O
muscle NN O
. . O

This DT O
agrees VBZ O
well RB O
with IN O
the DT O
fact NN O
that IN O
cardiac NN O
and CC O
muscle NN O
symptoms NNS O
are VBP O
characteristic JJ O
for IN O
patients NNS O
with IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
. . O

Northern NNP O
blot NN O
analysis NN O
and CC O
sequencing NN O
of IN O
cloned JJ O
PCR NNP O
amplified VBD O
VLCAD NNP O
cDNA NN O
from IN O
four CD O
unrelated JJ O
patients NNS O
with IN O
VLCAD NNP B-Disease
deficiency NN I-Disease
showed VBD O
that IN O
VLCAD NNP O
mRNA NN O
was VBD O
undetectable JJ O
in IN O
one CD O
patient NN O
and CC O
that IN O
the DT O
other JJ O
three CD O
have VBP O
mutations NNS O
in IN O
both DT O
VLCAD NNP O
alleles NNS O
. . O

Western JJ O
blot NN O
analysis NN O
of IN O
patient NN O
fibroblasts NNS O
showed VBD O
that IN O
the DT O
identified JJ O
mutations NNS O
result VBP O
in IN O
severely RB O
reduced JJ O
amounts NNS O
of IN O
VLCAD NNP O
protein NN O
. . O

Molecular JJ O
bases NNS O
of IN O
combined JJ B-Disease
subtotal JJ I-Disease
deficiencies NNS I-Disease
of IN I-Disease
C6 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
: : O
their PRP$ O
effects NNS O
in IN O
combination NN O
with IN O
other JJ O
C6 NNP B-Disease
and CC I-Disease
C7 NNP I-Disease
deficiencies NNS I-Disease
. . O

Combined VBN B-Disease
subtotal JJ I-Disease
deficiency NN I-Disease
of IN I-Disease
C6 NNP I-Disease
and CC I-Disease
C7 NNP I-Disease
, , O
in IN O
which WDT O
both DT O
proteins NNS O
are VBP O
expressed VBN O
at IN O
very RB O
low JJ O
levels NNS O
, , O
has VBZ O
been VBN O
observed VBN O
in IN O
homozygous JJ O
form NN O
in IN O
two CD O
families NNS O
. . O

A DT O
defect NN O
at IN O
the DT O
5 CD O
splice NN O
donor NN O
site NN O
of IN O
intron JJ O
15 CD O
of IN O
the DT O
C6 NNP O
gene NN O
explains VBZ O
the DT O
low JJ O
molecular JJ O
weight NN O
of IN O
the DT O
C6 NNP O
protein NN O
and CC O
is VBZ O
probably RB O
responsible JJ O
for IN O
its PRP$ O
low JJ O
expressed VBN O
concentration NN O
. . O

The DT O
C7 NNP O
defect NN O
is VBZ O
more RBR O
enigmatic JJ O
the DT O
protein NN O
is VBZ O
of IN O
normal JJ O
molecular JJ O
weight NN O
, , O
low JJ O
circulating VBG O
concentration NN O
, , O
and CC O
altered VBD O
isoelectric JJ O
point NN O
. . O

An DT O
Arg NNP O
> NNP O
Ser NNP O
codon NN O
substitution NN O
in IN O
exon JJ O
11 CD O
is VBZ O
the DT O
only JJ O
molecular JJ O
alteration NN O
within IN O
the DT O
mature NN O
C7 NNP O
protein NN O
. . O

These DT O
defects NNS O
are VBP O
associated VBN O
with IN O
a DT O
characteristic JJ O
set NN O
of IN O
polymorphic JJ O
DNA NNP O
markers NNS O
in IN O
the DT O
C6 NNP O
/ NNP O
C7 NNP O
region NN O
, , O
forming VBG O
a DT O
distinct JJ O
haplotype NN O
. . O

The DT O
haplotype NN O
has VBZ O
been VBN O
found VBN O
in IN O
combination NN O
with IN O
a DT O
number NN O
of IN O
other JJ O
haplotypes NNS O
containing VBG O
defective JJ O
genes NNS O
that WDT O
lead VBP O
either DT O
to TO O
C6 NNP B-Disease
or CC I-Disease
C7 NNP I-Disease
deficiency NN I-Disease
, , O
but CC O
with IN O
different JJ O
consequences NNS O
. . O

Where WRB O
it PRP O
is VBZ O
combined VBN O
with IN O
a DT O
C6 NNP B-Disease
- : I-Disease
deficient NN I-Disease
gene NN O
, , O
the DT O
serum NN O
C7 NNP O
levels NNS O
can MD O
be VB O
surprisingly RB O
high JJ O
, , O
possibly RB O
because IN O
there EX O
is VBZ O
no DT O
C6 NNP O
generating VBG O
C56 NNP O
to TO O
consume VB O
the DT O
C7 NNP O
. . O

In IN O
contrast NN O
, , O
where WRB O
the DT O
C7 NNP O
genes NNS O
are VBP O
both DT O
defective JJ O
( ( O
but CC O
still RB O
partially RB O
functional JJ O
) ) O
, , O
there EX O
may MD O
be VB O
a DT O
profound JJ O
deficit NN O
of IN O
circulating VBG O
C7 NNP O
because IN O
there EX O
is VBZ O
ample JJ O
C6 NNP O
to TO O
produce VB O
C56 NNP O
and CC O
consume VB O
the DT O
already RB O
small JJ O
amount NN O
of IN O
C7 NNP O
. . O

Each DT O
molecular JJ O
defect NN O
has VBZ O
also RB O
been VBN O
found VBN O
in IN O
isolation NN O
and CC O
has VBZ O
the DT O
expected VBN O
effect NN O
. . O
. . O

Genetic JJ O
bases NNS O
of IN O
human JJ O
complement NN B-Disease
C7 NNP I-Disease
deficiency NN I-Disease
. . O

Complement NNP B-Disease
C7 NNP I-Disease
deficiency NN I-Disease
( ( O
C7D NNP B-Disease
) ) O
is VBZ O
associated VBN O
frequently RB O
with IN O
recurrent JJ O
bacterial JJ B-Disease
infections NNS I-Disease
, , O
especially RB O
meningitis NNS B-Disease
caused VBN O
by IN O
Neisseria NNP B-Disease
meningitidis NN I-Disease
. . O

We PRP O
report VBP O
in IN O
this DT O
work NN O
the DT O
molecular JJ O
bases NNS O
of IN O
C7D NNP B-Disease
in IN O
two CD O
unrelated JJ O
Japanese JJ O
males NNS O
. . O

We PRP O
used VBD O
exon SYM O
- : O
specific JJ O
PCR NNP O
/ NNP O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
as IN O
a DT O
screening JJ O
step NN O
for IN O
mutations NNS O
. . O

Subsequent JJ O
direct JJ O
sequencing NN O
of IN O
the DT O
target NN O
exons NNS O
identified VBN O
homozygous JJ O
mutations NNS O
in IN O
exon JJ O
16 CD O
of IN O
case NN O
1 CD O
and CC O
in IN O
exon JJ O
15 CD O
of IN O
case NN O
2 CD O
. . O

The DT O
mutation NN O
of IN O
case NN O
1 CD O
was VBD O
a DT O
homozygous JJ O
T NNP O
to TO O
A DT O
transversion NN O
at IN O
nucleotide JJ O
2250 CD O
, , O
the DT O
third JJ O
nucleotide NN O
of IN O
the DT O
codon NN O
TGT NNP O
for IN O
Cys728 NNP O
, , O
leading VBG O
to TO O
a DT O
stop JJ O
codon NN O
TGA NNP O
( ( O
C728X NNP O
) ) O
. . O

In IN O
case NN O
2 CD O
, , O
a DT O
homozygous JJ O
2 CD O
- : O
bp NN O
deletion NN O
( ( O
2137delTG CD O
/ RB O
2138delGT CD O
/ JJ O
2139delTG CD O
) ) O
caused VBD O
a DT O
frameshift NN O
, , O
generating VBG O
a DT O
premature NN O
termination NN O
codon VBZ O
4 CD O
to TO O
6 CD O
nucleotides NNS O
downstream NN O
. . O

Family RB O
study NN O
in IN O
case NN O
1 CD O
confirmed VBD O
the DT O
genetic JJ O
nature NN O
of IN O
the DT O
defect NN O
. . O

Moreover RB O
, , O
we PRP O
detected VBD O
a DT O
novel JJ O
polymorphism NN O
in IN O
intron NN O
11 CD O
that IN O
presumably NN O
is VBZ O
linked VBN O
to TO O
the DT O
mutation NN O
responsible JJ O
for IN O
C7D NNP B-Disease
in IN O
case NN O
1 CD O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
pathogenesis NN O
of IN O
C7D NNP B-Disease
is VBZ O
heterogeneous JJ O
like IN O
most JJS O
of IN O
the DT O
other JJ O
deficiencies NNS B-Disease
of IN I-Disease
complement JJ I-Disease
components NNS I-Disease
. . O
. . O

HPRT NNP B-Disease
- : I-Disease
APRT NNP I-Disease
- : I-Disease
deficient NN I-Disease
mice NNS O
are VBP O
not RB O
a DT O
model NN O
for IN O
lesch JJ B-Disease
- : I-Disease
nyhan JJ I-Disease
syndrome NN I-Disease
. . O

Complete JJ B-Disease
hypoxanthine NN I-Disease
- : I-Disease
guanine NN I-Disease
phosphoribosyl NN I-Disease
- : I-Disease
transferase NN I-Disease
( ( I-Disease
HPRT NNP I-Disease
) ) I-Disease
deficiency NN I-Disease
in IN O
humans NNS O
results NNS O
in IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
which WDT O
is VBZ O
characterized VBN O
, , O
among IN O
other JJ O
features NNS O
, , O
by IN O
compulsive JJ O
self NN O
- : O
injurious JJ O
behavior NN O
. . O

HPRT NNP B-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
generated VBD O
using VBG O
mouse NN O
embryonic JJ O
stem NN O
cells NNS O
exhibit VBP O
none NN O
of IN O
the DT O
behavioral JJ O
symptoms NNS O
associated VBN O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
. . O

Administration NN O
of IN O
drugs NNS O
that WDT O
inhibit VBP O
adenine JJ O
phosphoribosyltransferase NN O
( ( O
APRT NNP O
) ) O
in IN O
HPRT NNP B-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
has VBZ O
produced VBN O
the DT O
suggestion NN O
that IN O
deficiency NN B-Disease
of IN I-Disease
APRT NNP I-Disease
in IN O
combination NN O
with IN O
HPRT NNP B-Disease
- : I-Disease
deficiency NN I-Disease
in IN O
mice NN O
may MD O
lead VB O
to TO O
self VB O
- : O
mutilation NN O
behavior NN O
[ NNP O
C NNP O
. . O
L NNP O
. . O
Wu NNP O
and CC O
D NNP O
. . O
W NNP O
. . O
Melton NNP O
( ( O
1993 CD O
) ) O
Nature NN O
Genet NNP O
. . O
3 CD O
, , O
235 CD O
- : O
240 CD O
] NN O
. . O

To TO O
test VB O
this DT O
proposition NN O
, , O
we PRP O
bred VBD O
HPRT NNP B-Disease
- : I-Disease
APRT NNP I-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
. . O

Although IN O
the DT O
doubly RB O
- : O
deficient NN O
mice NN O
excrete JJ O
adenine NN O
and CC O
its PRP$ O
highly RB O
insoluble JJ O
derivative NN O
, , O
2 CD O
, , O
8 CD O
- : O
dihydroxyadenine NN O
, , O
which WDT O
are VBP O
also RB O
associated VBN O
with IN O
human JJ O
APRT NNP B-Disease
deficiency NN I-Disease
, , O
additional JJ O
abnormalities NNS O
or CC O
any DT O
self JJ O
- : O
injurious JJ O
behavior NN O
were VBD O
not RB O
detected VBN O
. . O

Thus RB O
, , O
APRT NNP B-Disease
- : I-Disease
HPRT NNP I-Disease
- : I-Disease
deficient NN I-Disease
mice NN O
, , O
which WDT O
are VBP O
devoid NNS O
of IN O
any DT O
purine JJ O
salvage NN O
pathways NNS O
, , O
show VBP O
no DT O
novel JJ O
phenotype NN O
and CC O
are VBP O
not RB O
a DT O
model NN O
for IN O
the DT O
behavioral JJ B-Disease
abnormalities NNS I-Disease
associated VBN O
with IN O
the DT O
Lesch NNP B-Disease
- : I-Disease
Nyhan NNP I-Disease
syndrome NN I-Disease
as IN O
previously RB O
suggested VBN O

Somatic JJ O
alterations NNS O
of IN O
the DT O
DPC4 NNP O
gene NN O
in IN O
human JJ O
colorectal NN B-Disease
cancers NNS I-Disease
in IN O
vivo NN O
. . O

BACKGROUND NNP O
& CC O
AIMS NNP O
The DT O
chromosome NN O
region NN O
18q21 CD O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
frequently RB O
deleted VBN O
in IN O
colorectal JJ B-Disease
cancers NNS I-Disease
, , O
and CC O
such JJ O
frequent JJ O
allelic JJ O
loss NN O
is VBZ O
a DT O
hallmark NN O
of IN O
the DT O
presence NN O
of IN O
a DT O
tumor NN O
- : O
suppressor NN O
gene NN O
. . O

The DT O
DPC4 NNP O
gene NN O
, , O
which WDT O
is VBZ O
located VBN O
at IN O
18q21 CD O
, , O
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
tumor NN O
- : O
suppressor NN O
gene NN O
from IN O
examination NN O
of IN O
pancreatic JJ B-Disease
cancers NNS I-Disease
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
determine VB O
if IN O
it PRP O
might MD O
also RB O
be VB O
altered VBN O
in IN O
colorectal JJ B-Disease
cancers NNS I-Disease
. . O

METHODS NNP O
Mutation NNP O
analyses NNS O
of IN O
the DT O
DPC4 NNP O
gene NN O
were VBD O
performed VBN O
on IN O
complementary JJ O
DNA NN O
samples NNS O
from IN O
31 CD O
primary JJ O
colorectal JJ B-Disease
cancer NN I-Disease
specimens VBZ O
using VBG O
a DT O
combination NN O
of IN O
polymerase NN O
chain NN O
reaction NN O
, , O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
, , O
and CC O
DNA NNP O
sequencing NN O
. . O

RESULTS NNP O
Four NNP O
missense NN O
mutations NNS O
producing VBG O
amino NN O
acid JJ O
substitutions NNS O
and CC O
a DT O
somatic JJ O
12 CD O
- : O
base NN O
pair NN O
deletion NN O
in IN O
the DT O
coding JJ O
region NN O
of IN O
the DT O
DPC4 NNP O
gene NN O
were VBD O
detected VBN O
in IN O
the DT O
31 CD O
cancers NNS B-Disease
( ( O
16 CD O
% NN O
; : O
5 CD O
of IN O
31 CD O
) ) O
. . O

CONCLUSIONS NNP O
The DT O
DPC4 NNP O
gene NN O
may MD O
play VB O
a DT O
role NN O
as IN O
a DT O
tumor NN O
- : O
suppressor NN O
gene NN O
in IN O
a DT O
fraction NN O
of IN O
colorectal JJ B-Disease
cancers NNS I-Disease
; : O
however RB O
, , O
while IN O
allelic JJ O
loss NN O
at IN O
18q21 CD O
is VBZ O
very RB O
often RB O
seen VBN O
in IN O
colorectal JJ B-Disease
cancers NNS I-Disease
, , O
only RB O
a DT O
minority NN O
show NN O
DPC4 NNP O
mutations NNS O
, , O
suggesting VBG O
that IN O
there EX O
might MD O
be VB O
another DT O
tumor NN O
- : O
suppressor NN O
gene NN O
in IN O
this DT O
chromosome NN O
region NN O
. . O
. . O

Pleiotropic NNP O
defects NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
protein SYM O
- : O
deficient NN O
mice NN O
. . O

We PRP O
have VBP O
generated VBN O
a DT O
mouse NN O
model NN O
for IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
by IN O
using VBG O
gene NN O
targeting VBG O
to TO O
generate VB O
mice NN O
that WDT O
do VBP O
not RB O
express VB O
the DT O
Atm NNP O
protein NN O
. . O

Atm NNP O
- : O
deficient NN O
mice NN O
are VBP O
retarded VBN O
in IN O
growth NN O
, , O
do VBP O
not RB O
produce VB O
mature JJ O
sperm NN O
, , O
and CC O
exhibit NN O
severe JJ O
defects NNS O
in IN O
T NNP O
cell NN O
maturation NN O
while IN O
going VBG O
on IN O
to TO O
develop VB O
thymomas NN B-Disease
. . O

Atm NNP O
- : O
deficient NN O
fibroblasts NNS O
grow VBP O
poorly RB O
in IN O
culture NN O
and CC O
display VB O
a DT O
high JJ O
level NN O
of IN O
double JJ O
- : O
stranded VBD O
chromosome NN O
breaks NNS O
. . O

Atm NNP O
- : O
deficient NN O
thymocytes VBZ O
undergo RB O
spontaneous JJ O
apoptosis NN O
in IN O
vitro NN O
significantly RB O
more RBR O
than IN O
controls NNS O
. . O

Atm NNP O
- : O
deficient NN O
mice NN O
then RB O
exhibit VBD O
many JJ O
of IN O
the DT O
same JJ O
symptoms NNS O
found VBN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
patients NNS O
and CC O
in IN O
cells NNS O
derived VBN O
from IN O
them PRP O
. . O

Furthermore RB O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
Atm NNP O
protein NN O
exists VBZ O
as IN O
two CD O
discrete JJ O
molecular JJ O
species NNS O
, , O
and CC O
that IN O
loss NN O
of IN O
one CD O
or CC O
of IN O
both DT O
of IN O
these DT O
can MD O
lead VB O
to TO O
the DT O
development NN O
of IN O
the DT O
disease NN O
. . O
. . O

The DT O
DCC NNP O
protein NN O
and CC O
prognosis NN O
in IN O
colorectal JJ B-Disease
cancer NN I-Disease
. . O

BACKGROUND NNP O
Allelic NNP O
loss NN O
of IN O
chromosome NN O
18q CD O
predicts VBZ O
a DT O
poor JJ O
outcome NN O
in IN O
patients NNS O
with IN O
stage NN B-Disease
II NNP I-Disease
colorectal NN I-Disease
cancer NN I-Disease
. . O

Although IN O
the DT O
specific JJ O
gene NN O
inactivated VBN O
by IN O
this DT O
allelic JJ O
loss NN O
has VBZ O
not RB O
been VBN O
elucidated VBN O
, , O
the DT O
DCC NNP O
( ( O
deleted VBN O
in IN O
colorectal JJ B-Disease
cancer NN I-Disease
) ) O
gene NN O
is VBZ O
a DT O
candidate NN O
. . O

We PRP O
investigated VBD O
whether IN O
the DT O
expression NN O
of IN O
the DT O
DCC NNP O
protein NN O
in IN O
tumor NN B-Disease
cells NNS O
is VBZ O
a DT O
prognostic JJ O
marker NN O
in IN O
colorectal JJ B-Disease
carcinoma NN I-Disease
. . O

METHODS NNP O
The DT O
expression NN O
of IN O
DCC NNP O
was VBD O
evaluated VBN O
immunohistochemically RB O
in IN O
132 CD O
paraffin NN O
- : O
embedded VBD O
samples NNS O
from IN O
patients NNS O
with IN O
curatively RB O
resected VBN O
stage NN B-Disease
II NNP I-Disease
and CC I-Disease
III NNP I-Disease
colorectal JJ I-Disease
carcinomas NN I-Disease
. . O

The DT O
Cox NNP O
proportional JJ O
- : O
hazards NNS O
model NN O
was VBD O
used VBN O
to TO O
adjust VB O
for IN O
covariates NNS O
including VBG O
age NN O
, , O
sex NN O
, , O
tumor NN B-Disease
site NN O
, , O
degree NN O
of IN O
tumor NN B-Disease
differentiation NN O
, , O
and CC O
use NN O
of IN O
adjuvant JJ O
therapy NN O
. . O

RESULTS VB O
The DT O
expression NN O
of IN O
DCC NNP O
was VBD O
a DT O
strong JJ O
positive JJ O
predictive JJ O
factor NN O
for IN O
survival NN O
in IN O
both DT O
stage NN B-Disease
II NNP I-Disease
and CC I-Disease
stage NN I-Disease
III NNP I-Disease
colorectal JJ I-Disease
carcinomas NN I-Disease
. . O

In IN O
patients NNS O
with IN O
stage NN O
II NNP O
disease NN O
whose WP$ O
tumors NNS B-Disease
expressed VBD O
DCC NNP O
, , O
the DT O
five CD O
- : O
year NN O
survival NN O
rate NN O
was VBD O
94 CD O
. . O

3 CD O
percent NN O
, , O
whereas NNS O
in IN O
patients NNS O
with IN O
DCC NNP B-Disease
- : I-Disease
negative JJ I-Disease
tumors NNS I-Disease
, , O
the DT O
survival NN O
rate NN O
was VBD O
61 CD O
. . O

6 CD O
percent NN O
( ( O
P NNP O
< VBZ O
0 CD O
. . O
1 CD O
) ) O
. . O

In IN O
patients NNS O
with IN O
stage NN B-Disease
III NNP I-Disease
disease NN I-Disease
, , O
the DT O
respective JJ O
survival NN O
rates NNS O
were VBD O
59 CD O
. . O

3 CD O
percent NN O
and CC O
33 CD O
. . O

2 CD O
percent NN O
( ( O
P NNP O
= VBZ O
0 CD O
. . O
3 CD O
) ) O
. . O

CONCLUSIONS NNP O
DCC NNP O
is VBZ O
a DT O
prognostic JJ O
marker NN O
in IN O
patients NNS O
with IN O
stage NN B-Disease
II NNP I-Disease
or CC I-Disease
stage NN I-Disease
III NNP I-Disease
colorectal JJ I-Disease
cancer NN I-Disease
. . O

In IN O
stage NN B-Disease
II NNP I-Disease
colorectal NN I-Disease
carcinomas NN I-Disease
, , O
the DT O
absence NN O
of IN O
DCC NNP O
identifies VBZ O
a DT O
subgroup NN O
of IN O
patients NNS O
with IN O
lesions NNS O
that WDT O
behave VBP O
like IN O
stage NN B-Disease
III NNP I-Disease
cancers NNS I-Disease
. . O

These DT O
findings NNS O
may MD O
thus RB O
have VB O
therapeutic JJ O
implications NNS O
in IN O
this DT O
group NN O
of IN O
patients NNS O

Association NNP O
of IN O
anxiety NN B-Disease
- : I-Disease
related JJ I-Disease
traits NNS I-Disease
with IN O
a DT O
polymorphism NN O
in IN O
the DT O
serotonin NN O
transporter NN O
gene NN O
regulatory JJ O
region NN O
. . O

Transporter NNP O
- : O
facilitated VBD O
uptake NN O
of IN O
serotonin NN O
( ( O
5 CD O
- : O
hydroxytryptamine NN O
or CC O
5 CD O
- : O
HT NN O
) ) O
has VBZ O
been VBN O
implicated VBN O
in IN O
anxiety NN B-Disease
in IN O
humans NNS O
and CC O
animal JJ O
models NNS O
and CC O
is VBZ O
the DT O
site NN O
of IN O
action NN O
of IN O
widely RB O
used VBN O
uptake JJ O
- : O
inhibiting NN O
antidepressant NN O
and CC O
antianxiety NN O
drugs NNS O
. . O

Human NNP O
5 CD O
- : O
HT NN O
transporter NN O
( ( O
5 CD O
- : O
HTT NN O
) ) O
gene NN O
transcription NN O
is VBZ O
modulated VBN O
by IN O
a DT O
common JJ O
polymorphism NN O
in IN O
its PRP$ O
upstream JJ O
regulatory JJ O
region NN O
. . O

The DT O
short JJ O
variant NN O
of IN O
the DT O
polymorphism NN O
reduces VBZ O
the DT O
transcriptional JJ O
efficiency NN O
of IN O
the DT O
5 CD O
- : O
HTT NNP O
gene NN O
promoter NN O
, , O
resulting VBG O
in IN O
decreased JJ O
5 CD O
- : O
HTT NNP O
expression NN O
and CC O
5 CD O
- : O
HT NNP O
uptake VBP O
in IN O
lymphoblasts NNS O
. . O

Association NNP O
studies NNS O
in IN O
two CD O
independent JJ O
samples NNS O
totaling VBG O
505 CD O
individuals NNS O
revealed VBD O
that IN O
the DT O
5 CD O
- : O
HTT NNP O
polymorphism NN O
accounts NNS O
for IN O
3 CD O
to TO O
4 CD O
percent NN O
of IN O
total JJ O
variation NN O
and CC O
7 CD O
to TO O
9 CD O
percent NN O
of IN O
inherited JJ O
variance NN O
in IN O
anxiety NN B-Disease
- : I-Disease
related JJ I-Disease
personality NN I-Disease
traits NNS I-Disease
in IN O
individuals NNS O
as RB O
well RB O
as IN O
sibships NNS O
. . O
. . O

Phenotypic NNP O
and CC O
genotypic VB O
overlap NN O
between IN O
atelosteogenesis NN B-Disease
type NN I-Disease
2 CD I-Disease
and CC O
diastrophic JJ B-Disease
dysplasia NN I-Disease
. . O

Mutations NNS O
in IN O
the DT O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulfate NN O
transporter NN O
gene NN O
DTDST NNP O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
family NN O
of IN O
chondrodysplasias NN B-Disease
that WDT O
comprises VBZ O
, , O
in IN O
order NN O
of IN O
increasing VBG O
severity NN O
, , O
diastrophic JJ B-Disease
dysplasia NN I-Disease
( ( O
DTD NNP B-Disease
) ) O
, , O
atelosteogenesis NN B-Disease
type NN I-Disease
2 CD I-Disease
( ( O
AO2 NNP B-Disease
) ) O
, , O
and CC O
achondrogenesis NN B-Disease
type NN I-Disease
1B CD I-Disease
( ( O
ACG1B NNP B-Disease
) ) O
. . O

To TO O
learn VB O
more JJR O
about IN O
the DT O
molecular JJ O
basis NN O
of IN O
DTDST NNP B-Disease
chondrodysplasias NN I-Disease
and CC O
about IN O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
, , O
we PRP O
studied VBD O
fibroblast JJ O
cultures NNS O
of IN O
three CD O
new JJ O
patients NNS O
one CD O
with IN O
AO NNP B-Disease
- : I-Disease
2 CD I-Disease
, , O
one CD O
with IN O
DTD NNP B-Disease
, , O
and CC O
one CD O
with IN O
an DT O
intermediate JJ O
phenotype NN O
( ( O
AO2 NNP B-Disease
/ NNP O
DTD NNP B-Disease
) ) O
. . O

Reduced VBN O
incorporation NN O
of IN O
inorganic JJ O
sulfate NN O
into IN O
macromolecules NNS O
was VBD O
found VBN O
in IN O
all DT O
three CD O
. . O

Each DT O
of IN O
the DT O
three CD O
patients NNS O
was VBD O
found VBN O
to TO O
be VB O
heterozygous JJ O
for IN O
a DT O
c862t JJ O
transition NN O
predicting VBG O
a DT O
R279W NNP O
substitution NN O
in IN O
the DT O
third JJ O
extracellular JJ O
loop NN O
of IN O
DTDST NNP O
. . O

In IN O
two CD O
patients NNS O
( ( O
DTD NNP B-Disease
and CC O
AO2 NNP B-Disease
/ NNP O
DTD NNP B-Disease
) ) O
, , O
no DT O
other JJ O
structural JJ O
mutation NN O
was VBD O
found VBN O
, , O
but CC O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
and CC O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
analysis NN O
of IN O
fibroblast NN O
cDNA NN O
showed VBD O
reduced VBN O
mRNA NN O
levels NNS O
of IN O
the DT O
wild JJ O
- : O
type NN O
DTDST NNP O
allele IN O
these DT O
two CD O
patients NNS O
may MD O
be VB O
compound VBN O
heterozygotes NNS O
for IN O
the DT O
"""" NNP O
Finnish NNP O
"""" NNP O
mutation NN O
( ( O
as IN O
yet RB O
uncharacterized VBN O
at IN O
the DT O
DNA NNP O
level NN O
) ) O
, , O
which WDT O
causes VBZ O
reduced JJ O
expression NN O
of IN O
DTDST NNP O
. . O

The DT O
third JJ O
patient NN O
( ( O
with IN O
AO2 NNP B-Disease
) ) O
had VBD O
the DT O
R279W NNP O
mutation NN O
compounded VBD O
with IN O
a DT O
novel JJ O
mutation NN O
, , O
the DT O
deletion NN O
of IN O
cytosine NN O
418 CD O
( ( O
delta JJ O
c418 NN O
) ) O
, , O
predicting VBG O
a DT O
frameshift NN O
with IN O
premature JJ O
termination NN O
. . O

Also RB O
the DT O
delta NN O
c418 NN O
allele NN O
was VBD O
underrepresented VBN O
in IN O
the DT O
cDNA NN O
, , O
in IN O
accordance NN O
with IN O
previous JJ O
observations NNS O
that IN O
premature NN O
stop VB O
codons NNS O
reduce VB O
mRNA NN O
levels NNS O
. . O

The DT O
presence NN O
of IN O
the DT O
DTDST NNP O
R279W NNP O
mutation NN O
in IN O
a DT O
total NN O
of IN O
11 CD O
patients NNS O
with IN O
AO2 NNP B-Disease
or CC O
DTD NNP B-Disease
emphasizes VBZ O
the DT O
overlap NN O
between IN O
these DT O
conditions NNS O
. . O

This DT O
mutation NN O
has VBZ O
not RB O
been VBN O
found VBN O
so RB O
far RB O
in IN O
8 CD O
analyzed JJ O
ACG1B NNP B-Disease
patients NNS O
, , O
suggesting VBG O
that IN O
it PRP O
allows VBZ O
some DT O
residual JJ O
activity NN O
of IN O
the DT O
sulfate NN O
transporter NN O
. . O
. . O

Identification NN O
of IN O
WASP NNP O
mutations NNS O
, , O
mutation NN O
hotspots NNS O
and CC O
genotype JJ O
- : O
phenotype NN O
disparities NNS O
in IN O
24 CD O
patients NNS O
with IN O
the DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
. . O

The DT O
Wiskott NNP B-Disease
- : I-Disease
Aldrich NNP I-Disease
syndrome NN I-Disease
( ( O
WAS NNP B-Disease
) ) O
, , O
an DT O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
immunodeficiency NN I-Disease
disease NN I-Disease
caused VBN O
by IN O
mutation NN O
in IN O
the DT O
recently RB O
isolated VBN O
gene NN O
encoding VBG O
WAS NNP B-Disease
protein NN O
( ( O
WASP NNP O
) ) O
, , O
is VBZ O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
extensive JJ O
clinical JJ O
heterogeneity NN O
. . O

Cumulative JJ O
mutation NN O
data NNS O
have VBP O
revealed VBN O
that IN O
WASP NNP O
genotypes NNS O
are VBP O
also RB O
highly RB O
variable JJ O
among IN O
WAS JJ B-Disease
patients NNS O
, , O
but CC O
the DT O
relationship NN O
of IN O
phenotype NN O
with IN O
genotype NN O
in IN O
this DT O
disease NN O
remains VBZ O
unclear JJ O
. . O

To TO O
address VB O
this DT O
issue NN O
we PRP O
characterized VBD O
WASP NNP O
mutations NNS O
in IN O
24 CD O
unrelated JJ O
WAS NNP B-Disease
patients NNS O
, , O
including VBG O
18 CD O
boys NNS O
with IN O
severe JJ O
classical NN O
WAS NNP B-Disease
and CC O
6 CD O
boys NNS O
expressing VBG O
mild JJ O
forms NNS O
of IN O
the DT O
disease NN O
, , O
and CC O
then RB O
examined VBD O
the DT O
degree NN O
of IN O
correlation NN O
of IN O
these DT O
as RB O
well RB O
as IN O
all DT O
previously RB O
published VBN O
WASP NNP O
mutations NNS O
with IN O
disease NN O
severity NN O
. . O

By IN O
analysis NN O
of IN O
these DT O
compiled VBN O
mutation NN O
data NNS O
, , O
we PRP O
demonstrated VBD O
clustering VBG O
of IN O
WASP NNP O
mutations NNS O
within IN O
the DT O
four CD O
most JJS O
N NNP O
- : O
terminal JJ O
exons NNS O
of IN O
the DT O
gene NN O
and CC O
also RB O
identified VBD O
several JJ O
sites NNS O
within IN O
this DT O
region NN O
as IN O
hotspots NNS O
for IN O
WASP NNP O
mutation NN O
. . O

These DT O
characteristics NNS O
were VBD O
observed VBN O
, , O
however RB O
, , O
in IN O
both DT O
severe JJ O
and CC O
mild JJ O
cases NNS O
of IN O
the DT O
disease NN O
. . O

Similarly RB O
, , O
while IN O
the DT O
cumulative JJ O
data NNS O
revealed VBD O
a DT O
predominance NN O
of IN O
missense JJ O
mutations NNS O
among IN O
the DT O
WASP NNP O
gene NN O
lesions NNS O
observed VBN O
in IN O
boys NNS O
with IN O
isolated JJ B-Disease
thrombocytopenia NN I-Disease
, , O
missense JJ O
mutations NNS O
were VBD O
not RB O
exclusively RB O
associated VBN O
with IN O
milder NN O
WAS NNP B-Disease
phenotypes NNS O
, , O
but CC O
also RB O
comprised VBD O
a DT O
substantial JJ O
portion NN O
( ( O
38 CD O
% NN O
) ) O
of IN O
the DT O
WASP NNP O
gene NN O
defects NNS O
found VBN O
in IN O
patients NNS O
with IN O
severe JJ O
disease NN O
. . O

These DT O
findings NNS O
, , O
as RB O
well RB O
as IN O
the DT O
detection NN O
of IN O
identical JJ O
WASP NNP O
mutations NNS O
in IN O
patients NNS O
with IN O
disparate JJ O
phenotypes NNS O
, , O
reveal VB O
a DT O
lack NN O
of IN O
phenotype JJ O
concordance NN O
with IN O
genotype NN O
in IN O
WAS NNP B-Disease
and CC O
thus RB O
imply VB O
that DT O
phenotypic NN O
outcome NN O
in IN O
this DT O
disease NN O
cannot NN O
be VB O
reliably RB O
predicted VBN O
solely RB O
on IN O
the DT O
basis NN O
of IN O
WASP NNP O
genotypes NNS O
. . O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
3 CD O
' POS O
part NN O
of IN O
APC NNP B-Disease
exon FW O
15 CD O
do VBP O
not RB O
result VB O
in IN O
truncated JJ O
proteins NNS O
and CC O
are VBP O
associated VBN O
with IN O
attenuated JJ O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
. . O

Familial NNP B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
( ( O
FAP NNP B-Disease
) ) O
is VBZ O
an DT O
inherited JJ O
predisposition NN O
to TO O
colorectal JJ B-Disease
cancer NN I-Disease
characterized VBN O
by IN O
the DT O
development NN O
of IN O
numerous JJ O
adenomatous JJ B-Disease
polyps NNS I-Disease
predominantly RB O
in IN O
the DT O
colorectal JJ O
region NN O
. . O

Germline NNP O
mutations NNS O
in IN O
the DT O
adenomatous JJ B-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
APC NNP B-Disease
) ) O
gene NN O
are VBP O
responsible JJ O
for IN O
most JJS O
cases NNS O
of IN O
FAP NNP B-Disease
. . O

Mutations NNS O
at IN O
the DT O
5 CD O
end NN O
of IN O
APC NNP B-Disease
are VBP O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
relatively RB O
mild JJ O
form NN O
of IN O
the DT O
disease NN O
, , O
called VBN O
attenuated VBD B-Disease
adenomatous JJ I-Disease
polyposis NN I-Disease
coli NN I-Disease
( ( O
AAPC NNP B-Disease
) ) O
. . O

We PRP O
identified VBD O
a DT O
frameshift JJ O
mutation NN O
in IN O
the DT O
3 CD O
part NN O
of IN O
exon NN O
15 CD O
, , O
resulting VBG O
in IN O
a DT O
stop JJ O
codon NN O
at IN O
1862 CD O
, , O
in IN O
a DT O
large JJ O
Dutch NN O
kindred VBD O
with IN O
AAPC NNP B-Disease
. . O

Western JJ O
blot NN O
analysis NN O
of IN O
lymphoblastoid NN O
cell NN O
lines NNS O
derived VBN O
from IN O
affected JJ O
family NN O
members NNS O
from IN O
this DT O
kindred VBN O
, , O
as RB O
well RB O
as IN O
from IN O
a DT O
previously RB O
reported VBN O
Swiss JJ O
family NN O
carrying VBG O
a DT O
frameshift NN O
mutation NN O
at IN O
codon NN O
1987 CD O
and CC O
displaying VBG O
a DT O
similar JJ O
attenuated JJ O
phenotype NN O
, , O
showed VBD O
only RB O
the DT O
wild JJ O
- : O
type NN O
APC NNP B-Disease
protein NN O
. . O

Our PRP$ O
study NN O
indicates VBZ O
that IN O
chain NN O
- : O
terminating NN O
mutations NNS O
located VBN O
in IN O
the DT O
3 CD O
part NN O
of IN O
APC NNP B-Disease
do VBP O
not RB O
result VB O
in IN O
detectable JJ O
truncated JJ O
polypeptides NNS O
and CC O
we PRP O
hypothesize VBP O
that IN O
this DT O
is VBZ O
likely JJ O
to TO O
be VB O
the DT O
basis NN O
for IN O
the DT O
observed JJ O
AAPC NNP B-Disease
phenotype NN O
. . O
. . O

Complete JJ O
genomic JJ O
sequence NN O
and CC O
analysis NN O
of IN O
117 CD O
kb NN O
of IN O
human JJ O
DNA NNP O
containing VBG O
the DT O
gene NN O
BRCA1 NNP O
. . O

Over IN O
100 CD O
distinct JJ O
disease NN O
- : O
associated VBN O
mutations NNS O
have VBP O
been VBN O
identified VBN O
in IN O
the DT O
breast NN B-Disease
- : I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
susceptibility NN O
gene NN O
BRCA1 NNP O
. . O

Loss NNP O
of IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
in IN O
> JJ O
90 CD O
% NN O
of IN O
tumors NNS B-Disease
from IN O
patients NNS O
with IN O
inherited JJ O
BRCA1 NNP O
mutations NNS O
indicates VBZ O
tumor JJ B-Disease
suppressive JJ O
function NN O
. . O

The DT O
low JJ O
incidence NN O
of IN O
somatic JJ O
mutations NNS O
suggests VBZ O
that IN O
BRCA1 NNP O
inactivation NN O
in IN O
sporadic JJ O
tumors NNS B-Disease
occurs VBN O
by IN O
alternative JJ O
mechanisms NNS O
, , O
such JJ O
as IN O
interstitial JJ O
chromosomal JJ O
deletion NN O
or CC O
reduced JJ O
transcription NN O
. . O

To TO O
identify VB O
possible JJ O
features NNS O
of IN O
the DT O
BRCA1 NNP O
genomic JJ O
region NN O
that WDT O
may MD O
contribute VB O
to TO O
chromosomal JJ O
instability NN O
as RB O
well RB O
as IN O
potential JJ O
transcriptional JJ O
regulatory JJ O
elements NNS O
, , O
a DT O
117 CD O
, , O
143 CD O
- : O
bp NN O
DNA NNP O
sequence NN O
encompassing VBG O
BRCA1 NNP O
was VBD O
obtained VBN O
by IN O
random JJ O
sequencing NN O
of IN O
four CD O
cosmids NNS O
identified VBN O
from IN O
a DT O
human JJ O
chromosome NN O
17 CD O
specific JJ O
library NN O
. . O

The DT O
24 CD O
exons NNS O
of IN O
BRCA1 NNP O
span VBP O
an DT O
81 CD O
- : O
kb NN O
region NN O
that WDT O
has VBZ O
an DT O
unusually RB O
high JJ O
density NN O
of IN O
Alu NNP O
repetitive JJ O
DNA NNP O
( ( O
41 CD O
. . O
5 CD O
% NN O
) ) O
, , O
but CC O
relatively RB O
low JJ O
density NN O
( ( O
4 CD O
. . O
8 CD O
% NN O
) ) O
of IN O
other JJ O
repetitive JJ O
sequences NNS O
. . O

BRCA1 NNP O
intron NN O
lengths NNS O
range VBP O
in IN O
size NN O
from IN O
403 CD O
bp NN O
to TO O
9 CD O
. . O

2 CD O
kb NN O
and CC O
contain VB O
the DT O
intragenic JJ O
microsatellite NN O
markers NNS O
D17S1323 NNP O
, , O
D17S1322 NNP O
, , O
and CC O
D17S855 NNP O
, , O
which WDT O
localize VBP O
to TO O
introns NNS O
12 CD O
, , O
19 CD O
, , O
and CC O
20 CD O
, , O
respectively RB O
. . O

In IN O
addition NN O
to TO O
BRCA1 NNP O
, , O
the DT O
contig NN O
contains VBZ O
two CD O
complete JJ O
genes NNS O
Rho7 NNP O
, , O
a DT O
member NN O
of IN O
the DT O
rho JJ O
family NN O
of IN O
GTP NNP O
binding VBG O
proteins NNS O
, , O
and CC O
VAT1 NNP O
, , O
an DT O
abundant JJ O
membrane NN O
protein NN O
of IN O
cholinergic JJ O
synaptic JJ O
vesicles NNS O
. . O

Partial JJ O
sequences NNS O
of IN O
the DT O
1A1 CD O
- : O
3B CD O
B NNP O
- : O
box NN O
protein NN O
pseudogene NN O
and CC O
IFP NNP O
35 CD O
, , O
an DT O
interferon NN O
induced VBD O
leucine JJ O
zipper NN O
protein NN O
, , O
reside VB O
within IN O
the DT O
contig NN O
. . O

An DT O
L21 NNP O
ribosomal NN O
protein NN O
pseudogene NN O
is VBZ O
embedded VBN O
in IN O
BRCA1 NNP O
intron NN O
13 CD O
. . O

The DT O
order NN O
of IN O
genes NNS O
on IN O
the DT O
chromosome NN O
is VBZ O
centromere JJ O
- : O
1FP CD O
35 CD O
- : O
VAT1 NNP O
- : O
Rho7 NNP O
- : O
BRCA1 NNP O
- : O
1A1 CD O
- : O
3B CD O
- : O
telomere NN O

Identification NN O
of IN O
a DT O
RING NNP O
protein NN O
that WDT O
can MD O
interact VB O
in IN O
vivo NN O
with IN O
the DT O
BRCA1 NNP O
gene NN O
product NN O
. . O

The DT O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
gene NN O
, , O
BRCA1 NNP O
, , O
encodes VBZ O
a DT O
large JJ O
polypeptide NN O
that WDT O
contains VBZ O
the DT O
cysteine NN O
- : O
rich JJ O
RING NNP O
motif NN O
, , O
a DT O
zinc NN O
- : O
binding NN O
domain NN O
found VBD O
in IN O
a DT O
variety NN O
of IN O
regulatory JJ O
proteins NNS O
. . O

Here RB O
we PRP O
describe VBP O
a DT O
novel JJ O
protein NN O
that WDT O
interacts VBZ O
in IN O
vivo NN O
with IN O
the DT O
N NNP O
- : O
terminal JJ O
region NN O
of IN O
BRCA1 NNP O
. . O

This DT O
BRCA1 NNP O
- : O
associated VBD O
RING NNP O
domain NN O
( ( O
BARD1 NNP O
) ) O
protein NN O
contains VBZ O
an DT O
N NNP O
- : O
terminal JJ O
RING NN O
motif NN O
, , O
three CD O
tandem NN O
ankyrin NN O
repeats NNS O
, , O
and CC O
a DT O
C NNP O
- : O
terminal JJ O
sequence NN O
with IN O
significant JJ O
homology NN O
to TO O
the DT O
phylogenetically RB O
conserved VBN O
BRCT NNP O
domains VBZ O
that IN O
lie NN O
near IN O
the DT O
C NNP O
terminus NN O
of IN O
BRCA1 NNP O
. . O

The DT O
BARD1 NNP O
/ NNP O
BRCA1 NNP O
interaction NN O
is VBZ O
disrupted VBN O
by IN O
BRCA1 NNP O
missense NN O
mutations NNS O
that WDT O
segregate VBP O
with IN O
breast NN B-Disease
cancer NN I-Disease
susceptibility NN O
, , O
indicating VBG O
that IN O
BARD1 NNP O
may MD O
be VB O
involved VBN O
in IN O
mediating VBG O
tumour JJ B-Disease
suppression NN O
by IN O
BRCA1 NNP O
. . O
. . O

Detection NN O
of IN O
heterozygous JJ O
mutations NNS O
in IN O
BRCA1 NNP O
using VBG O
high JJ O
density NN O
oligonucleotide VBP O
arrays NNS O
and CC O
two CD O
- : O
colour NN O
fluorescence NN O
analysis NN O
. . O

The DT O
ability NN O
to TO O
scan VB O
a DT O
large JJ O
gene NN O
rapidly RB O
and CC O
accurately RB O
for IN O
all DT O
possible JJ O
heterozygous JJ O
mutations NNS O
in IN O
large JJ O
numbers NNS O
of IN O
patient NN O
samples NNS O
will MD O
be VB O
critical JJ O
for IN O
the DT O
future NN O
of IN O
medicine NN O
. . O

We PRP O
have VBP O
designed VBN O
high JJ O
- : O
density NN O
arrays VBZ O
consisting VBG O
of IN O
over IN O
96 CD O
, , O
600 CD O
oligonucleotides NNS O
20 CD O
- : O
nucleotides NNS O
( ( O
nt NN O
) ) O
in IN O
length NN O
to TO O
screen VB O
for IN O
a DT O
wide JJ O
range NN O
of IN O
heterozygous JJ O
mutations NNS O
in IN O
the DT O
3 CD O
. . O

45 CD O
- : O
kilobases NNS O
( ( O
kb NN O
) ) O
exon VBZ O
11 CD O
of IN O
the DT O
hereditary JJ B-Disease
breast NN I-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
gene NN O
BRCA1 NNP O
. . O

Reference NN O
and CC O
test NN O
samples NNS O
were VBD O
co JJ O
- : O
hybridized VBN O
to TO O
these DT O
arrays NNS O
and CC O
differences NNS O
in IN O
hybridization NN O
patterns NNS O
quantitated VBN O
by IN O
two CD O
- : O
colour NN O
analysis NN O
. . O

Fourteen NNP O
of IN O
fifteen JJ O
patient NN O
samples NNS O
with IN O
known JJ O
mutations NNS O
were VBD O
accurately RB O
diagnosed VBN O
, , O
and CC O
no DT O
false JJ O
positive JJ O
mutations NNS O
were VBD O
identified VBN O
in IN O
20 CD O
control NN O
samples NNS O
. . O

Eight CD O
single JJ O
nucleotide RB O
polymorphisms NNS O
were VBD O
also RB O
readily RB O
detected VBN O
. . O

DNA NN O
chip NN O
- : O
based VBN O
assays NNS O
may MD O
provide VB O
a DT O
valuable JJ O
new JJ O
technology NN O
for IN O
high JJ O
- : O
throughput NN O
cost NN O
- : O
efficient JJ O
detection NN O
of IN O
genetic JJ O
alterations NNS O
. . O

Autosomal NNP O
dominant JJ O
primary JJ O
hyperparathyroidism NN B-Disease
and CC I-Disease
jaw JJ I-Disease
tumor NN I-Disease
syndrome NN I-Disease
associated VBN O
with IN O
renal JJ B-Disease
hamartomas NN I-Disease
and CC O
cystic JJ B-Disease
kidney NN I-Disease
disease NN I-Disease
: : O
linkage NN O
to TO O
1q21 CD O
- : O
q32 NN O
and CC O
loss NN O
of IN O
the DT O
wild JJ O
type NN O
allele NN O
in IN O
renal JJ B-Disease
hamartomas NN I-Disease
. . O

Hereditary JJ B-Disease
hyperparathyroidism NN I-Disease
- : I-Disease
jaw NN I-Disease
tumor NN I-Disease
syndrome NN I-Disease
( ( O
HPT NNP B-Disease
- : I-Disease
JT NN I-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
disease NN I-Disease
( ( O
OMIM NNP O
145001 CD O
) ) O
that WDT O
has VBZ O
recently RB O
been VBN O
mapped VBN O
to TO O
chromosomal VB O
region NN O
1q21 CD O
- : O
q32 NN O
( ( O
HRPT2 NNP O
) ) O
. . O

Here RB O
we PRP O
report VBP O
two CD O
families NNS O
with IN O
HPT NNP B-Disease
- : I-Disease
JT NNP I-Disease
syndrome NN I-Disease
in IN O
which WDT O
adult VBP B-Disease
renal JJ I-Disease
hamartomas NN I-Disease
or CC O
cystic JJ B-Disease
kidney NN I-Disease
disease NN I-Disease
were VBD O
prominent JJ O
associated VBN O
features NNS O
, , O
possibly RB O
representing VBG O
a DT O
new JJ O
phenotypic NN O
variant NN O
of IN O
the DT O
HPT NNP B-Disease
- : I-Disease
JT NNP I-Disease
syndrome NN I-Disease
. . O

In IN O
the DT O
first JJ O
family NN O
, , O
renal JJ B-Disease
lesions NNS I-Disease
were VBD O
present JJ O
in IN O
five CD O
out IN O
of IN O
six CD O
affected JJ O
individuals NNS O
, , O
whereas NNS O
HPT NNP B-Disease
and CC O
JT NNP B-Disease
were VBD O
seen VBN O
in IN O
four CD O
and CC O
two CD O
cases NNS O
, , O
respectively RB O
. . O

In IN O
the DT O
second JJ O
family NN O
, , O
JT NNP B-Disease
was VBD O
found VBN O
in IN O
three CD O
of IN O
the DT O
five CD O
affected JJ O
individuals NNS O
and CC O
two CD O
affected VBD O
members NNS O
also RB O
exhibited VBD O
polycystic JJ B-Disease
kidney NN I-Disease
disease NN I-Disease
. . O

The DT O
possibility NN O
of IN O
the DT O
latter JJ O
cosegregating NN O
as IN O
a DT O
separate JJ O
autosomal JJ O
dominant JJ O
gene NN O
can MD O
not RB O
be VB O
ruled VBN O
out RP O
. . O

A DT O
sex NN O
- : O
dependent JJ O
penetrance NN O
of IN O
primary JJ B-Disease
HPT NNP I-Disease
, , O
resulting VBG O
in IN O
predominantly RB O
male JJ O
- : O
affected JJ O
cases NNS O
was VBD O
evident JJ O
in IN O
the DT O
two CD O
families NNS O
. . O

Twenty NNP O
microsatellite NN O
markers NNS O
in IN O
the DT O
HRPT2 NNP O
region NN O
were VBD O
typed VBN O
, , O
in IN O
addition NN O
to TO O
markers NNS O
in IN O
the DT O
multiple JJ B-Disease
endocrine NN I-Disease
neoplasia NN I-Disease
( ( I-Disease
MEN NNP I-Disease
) ) I-Disease
types VBZ I-Disease
1 CD I-Disease
and CC I-Disease
2 CD I-Disease
regions NNS O
at IN O
11q13 CD O
and CC O
10q11 CD O
. . O

The DT O
disease NN O
in IN O
these DT O
two CD O
kindreds NNS O
was VBD O
linked VBN O
to TO O
five CD O
markers NNS O
in IN O
the DT O
1q21 CD O
- : O
q32 NN O
region NN O
( ( O
logarithm JJ O
- : O
of IN O
- : O
odds NNS O
scores VBZ O
3 CD O
. . O
2 CD O
- : O
4 CD O
2 CD O
- : O
4 CD O
. . O
2 CD O
) ) O
, , O
whereas JJ O
linkage NN O
to TO O
the DT O
MEN1 NNP B-Disease
and CC O
MEN2 NNP B-Disease
regions NNS O
was VBD O
excluded VBN O
. . O

Meiotic JJ O
recombinations NNS O
detected VBN O
in IN O
affected JJ O
individuals NNS O
placed VBD O
the DT O
locus NN O
telomeric NN O
of IN O
D1S215 NNP O
, , O
thus RB O
narrowing VBG O
the DT O
HRPT2 NNP O
region NN O
from IN O
> $ O
60 CD O
to TO O
approximately RB O
34 CD O
centimorgans NNS O
. . O

Loss NNP O
of IN O
heterozygosity NN O
was VBD O
studied VBN O
in IN O
seven CD O
renal JJ B-Disease
hamartomas NNS I-Disease
from IN O
two CD O
affected JJ O
individuals NNS O
in IN O
the DT O
first JJ O
family NN O
, , O
as RB O
well RB O
as IN O
in IN O
a DT O
jaw NN B-Disease
tumor NN I-Disease
and CC O
a DT O
parathyroid JJ B-Disease
tumor NN I-Disease
from IN O
the DT O
second JJ O
family NN O
. . O

All DT O
renal JJ B-Disease
hamartomas NN I-Disease
showed VBD O
loss NN O
of IN O
heterozygosity NN O
at IN O
the DT O
1q21 CD O
- : O
q32 JJ O
region NN O
. . O

The DT O
losses NNS O
invariably RB O
involved VBD O
the DT O
wild JJ O
type NN O
allele NN O
derived VBN O
from IN O
the DT O
unaffected JJ O
parent NN O
, , O
suggesting VBG O
the DT O
inactivation NN O
of IN O
a DT O
tumor NN B-Disease
suppressor NN O
gene NN O
in IN O
this DT O
region NN O

Independent NNP O
origin NN O
of IN O
single JJ O
and CC O
double JJ O
mutations NNS O
in IN O
the DT O
human JJ O
glucose NN O
6 CD O
- : O
phosphate NN O
dehydrogenase NN O
gene NN O
. . O

The DT O
vast JJ O
majority NN O
of IN O
both DT O
polymorphic JJ O
and CC O
sporadic JJ O
G6PD NNP O
variants NNS O
are VBP O
due JJ O
to TO O
single JJ O
missense NN O
mutations NNS O
. . O

In IN O
the DT O
four CD O
polymorphic JJ O
variants NNS O
that WDT O
have VBP O
two CD O
point NN O
mutations NNS O
, , O
one CD O
of IN O
the DT O
mutations NNS O
is VBZ O
always RB O
376 CD O
A NNP O
- : O
- : O
> NN O
G NNP O
( ( O
126 CD O
Asn NNP O
- : O
- : O
> JJ O
Asp NNP O
) ) O
, , O
which WDT O
on IN O
its PRP$ O
own JJ O
gives VBZ O
rise NN O
to TO O
the DT O
nondeficient JJ O
polymorphic JJ O
variant NN O
, , O
G6PD NNP O
A NNP O
. . O

In IN O
a DT O
study NN O
of IN O
G6PD NNP B-Disease
deficient NN I-Disease
patients NNS O
who WP O
presented VBD O
with IN O
clinical JJ O
favism NN B-Disease
in IN O
Spain NNP O
, , O
we PRP O
have VBP O
found VBN O
a DT O
new JJ O
polymorphic JJ O
variant NN O
that IN O
we PRP O
have VBP O
called VBN O
G6PD NNP O
Malaga NNP O
, , O
whose WP$ O
only JJ O
abnormality NN O
is VBZ O
a DT O
542 CD O
A NNP O
- : O
- : O
> NN O
T NNP O
( ( O
181 CD O
Asp NNP O
- : O
- : O
> NN O
Val NNP O
) ) O
mutation NN O
. . O

This DT O
is VBZ O
the DT O
same JJ O
mutation NN O
as IN O
previously RB O
found VBN O
in IN O
association NN O
with IN O
the DT O
mutation NN O
of IN O
G6PD NNP O
A NNP O
in IN O
the DT O
double JJ O
mutant NN O
, , O
G6PD NNP O
Santamaria NNP O
. . O

G6PD NNP O
Malaga NNP O
is VBZ O
associated VBN O
with IN O
enzyme JJ B-Disease
deficiency NN I-Disease
( ( O
class NN O
III NNP O
) ) O
, , O
and CC O
the DT O
enzymic JJ O
properties NNS O
of IN O
G6PD NNP O
Malaga NNP O
and CC O
G6PD NNP O
Santamaria NNP O
are VBP O
quite RB O
similar JJ O
, , O
indicating VBG O
that IN O
in IN O
this DT O
case NN O
the DT O
effects NNS O
of IN O
the DT O
two CD O
mutations NNS O
are VBP O
additive JJ O
rather RB O
than IN O
synergistic JJ O
. . O

G6PD NNP O
Santamaria NNP O
might MD O
have VB O
been VBN O
produced VBN O
by IN O
recombination NN O
between IN O
G6PD NNP O
A NNP O
and CC O
G6PD NNP O
Malaga NNP O
; : O
however RB O
haplotype NN O
analysis NN O
, , O
including VBG O
the DT O
use NN O
of IN O
a DT O
new JJ O
silent JJ O
polymorphism NN O
, , O
suggests VBZ O
that IN O
the DT O
same JJ O
542 CD O
A NNP O
- : O
- : O
> NN O
T NNP O
mutation NN O
has VBZ O
taken VBN O
place NN O
independently RB O
in IN O
a DT O
G6PD NNP O
B NNP O
gene NN O
to TO O
give VB O
G6PD NNP O
Malaga NNP O
and CC O
in IN O
a DT O
G6PD NNP O
A NNP O
gene NN O
to TO O
give VB O
G6PD NNP O
Santamaria NNP O
. . O

These DT O
findings NNS O
help VBP O
to TO O
outline VB O
the DT O
relationship NN O
and CC O
evolution NN O
of IN O
mutations NNS O
in IN O
the DT O
human JJ O
G6PD NNP O
locus NN O
. . O
. . O

BRCA1 NNP O
R841W NNP O
: : O
a DT O
strong JJ O
candidate NN O
for IN O
a DT O
common JJ O
mutation NN O
with IN O
moderate JJ O
phenotype NN O
. . O

BRCA1 NNP O
mutations NNS O
cause VBP O
increased VBN O
risk NN O
for IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
frequently RB O
of IN O
early JJ O
onset NN O
. . O

Many JJ O
different JJ O
mutations NNS O
occur VBP O
in IN O
BRCA1 NNP O
, , O
including VBG O
several JJ O
examples NNS O
of IN O
recurrent NN O
mutations NNS O
, , O
each DT O
of IN O
which WDT O
accounts NNS O
for IN O
a DT O
significant JJ O
number NN O
of IN O
families NNS O
with IN O
heritable JJ O
cancer NN B-Disease
predisposition NN O
. . O

These DT O
common JJ O
mutations NNS O
have VBP O
an DT O
etiological JJ O
role NN O
in IN O
many JJ O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
and CC O
provide VB O
the DT O
opportunity NN O
to TO O
examine VB O
genotype JJ O
- : O
phenotype NN O
correlations NNS O
and CC O
genotype JJ O
- : O
environment NN O
interactions NNS O
in IN O
individuals NNS O
with IN O
the DT O
identical JJ O
BRCA1 NNP O
lesion NN O
. . O

We PRP O
report VBP O
a DT O
novel JJ O
missense NN O
change NN O
in IN O
BRCA1 NNP O
, , O
2640 CD O
C NNP O
- : O
- : O
> NN O
T NNP O
( ( O
R841W NNP O
) ) O
, , O
found VBN O
in IN O
3 CD O
cases NNS O
from IN O
a DT O
subject JJ O
group NN O
of IN O
305 CD O
breast NN B-Disease
and CC I-Disease
79 CD I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
from IN O
Orange NNP O
County NNP O
, , O
CA NNP O
. . O

These DT O
are VBP O
consecutive JJ O
, , O
population NN O
- : O
based VBN O
cases NNS O
not RB O
selected VBN O
for IN O
age NN O
or CC O
family NN O
history NN O
. . O

In IN O
all DT O
three CD O
cases NNS O
, , O
there EX O
is VBZ O
a DT O
strong JJ O
family NN O
history NN O
of IN O
breast NN B-Disease
, , I-Disease
ovarian JJ I-Disease
, , I-Disease
or CC I-Disease
other JJ I-Disease
cancers NNS I-Disease
possibly RB O
related VBN O
to TO O
a DT O
BRCA1 NNP O
defect NN O
and CC O
family NN O
members NNS O
showed VBD O
a DT O
high JJ O
concordance NN O
of IN O
cancer NN B-Disease
incidence NN O
with IN O
the DT O
presence NN O
of IN O
R841W NNP O
. . O

The DT O
age NN O
of IN O
cancer NN B-Disease
onset NN O
was VBD O
not RB O
always RB O
distinct VBP O
from IN O
typical JJ O
sporadic JJ O
cases NNS O
. . O

Testing VBG O
of IN O
a DT O
sample NN O
of IN O
413 CD O
unrelated JJ O
individuals NNS O
to TO O
examine VB O
the DT O
hypothesis NN O
that WDT O
R841W NNP O
might MD O
be VB O
a DT O
rare JJ O
polymorphism NN O
detected VBD O
one CD O
additional JJ O
instance NN O
in IN O
a DT O
woman NN O
with IN O
breast NN B-Disease
cancer NN I-Disease
diagnosed VBN O
at IN O
age NN O
77 CD O
years NNS O
, , O
and CC O
cancer NN B-Disease
in IN O
one CD O
parent NN O
. . O

R841W NN O
is VBZ O
likely JJ O
to TO O
be VB O
an DT O
etiologically RB O
significant JJ O
lesion NN O
with IN O
involvement NN O
in IN O
close JJ O
to TO O
1 CD O
% NN O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
of IN O
0 CD O
- : O
1 CD O
. . O
7 CD O
% NN O
) ) O
of IN O
all DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
in IN O
this DT O
population NN O
. . O

Ataxia NNP B-Disease
- : I-Disease
telangiectasia NN I-Disease
: : O
founder NN O
effect NN O
among IN O
north JJ O
African JJ O
Jews NNP O
. . O

The DT O
ATM NNP O
gene NN O
is VBZ O
responsible JJ O
for IN O
the DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
ataxia SYM B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
, , O
characterized VBN O
by IN O
cerebellar JJ B-Disease
degeneration NN I-Disease
, , O
immunodeficiency NN B-Disease
and CC O
cancer NN B-Disease
predisposition NN I-Disease
. . O

A DT B-Disease
- : I-Disease
T NN I-Disease
carriers NNS O
were VBD O
reported VBN O
to TO O
be VB O
moderately RB O
cancer NN B-Disease
- : I-Disease
prone NN I-Disease
. . O

A DT O
wide JJ O
variety NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
mutations NNS O
, , O
most JJS O
of IN O
which WDT O
are VBP O
unique JJ O
to TO O
single JJ O
families NNS O
, , O
were VBD O
identified VBN O
in IN O
various JJ O
ethnic JJ O
groups NNS O
, , O
precluding VBG O
carrier NN O
screening VBG O
with IN O
mutation NN O
- : O
specific JJ O
assays NNS O
. . O

However RB O
, , O
a DT O
single JJ O
mutation NN O
was VBD O
observed VBN O
in IN O
32 CD O
/ JJ O
33 CD O
defective JJ O
ATM NNP O
alleles NNS O
in IN O
Jewish NNP O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
families NNS O
of IN O
North JJ O
African JJ O
origin NN O
, , O
coming VBG O
from IN O
various JJ O
regions NNS O
of IN O
Morocco NNP O
and CC O
Tunisia NNP O
. . O

This DT O
mutation NN O
, , O
103C CD O
- : O
- : O
> NN O
T NNP O
, , O
results NNS O
in IN O
a DT O
stop JJ O
codon NN O
at IN O
position NN O
35 CD O
of IN O
the DT O
ATM NNP O
protein NN O
. . O

In IN O
keeping VBG O
with IN O
the DT O
nature NN O
of IN O
this DT O
mutation NN O
, , O
various JJ O
antibodies NNS O
directed VBN O
against IN O
the DT O
ATM NNP O
protein NN O
failed VBD O
to TO O
defect VB O
this DT O
protein NN O
in IN O
patient JJ O
cells NNS O
. . O

A DT O
rapid JJ O
carrier NN O
detection NN O
assay RB O
detected VBD O
this DT O
mutation NN O
in IN O
three CD O
out IN O
of IN O
488 CD O
ATM NNP O
alleles NNS O
of IN O
Jewish JJ O
Moroccan NNP O
or CC O
Tunisian JJ O
origin NN O
. . O

This DT O
founder NN O
effect NN O
provides VBZ O
a DT O
unique JJ O
opportunity NN O
for IN O
population NN O
- : O
based VBN O
screening NN O
for IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
carriers NNS O
in IN O
a DT O
large JJ O
Jewish NNP O
community NN O
. . O
. . O

Mutation NNP O
analysis NN O
of IN O
BRCA1 NNP O
and CC O
BRCA2 NNP O
in IN O
a DT O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
population NN O
. . O

A DT O
population NN O
- : O
based VBN O
series NN O
of IN O
54 CD O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
cases NNS O
from IN O
Southern NNP O
California NNP O
were VBD O
analyzed VBN O
for IN O
germ JJ O
- : O
line NN O
mutations NNS O
in IN O
the DT O
inherited JJ B-Disease
breast NN I-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
genes NNS O
, , O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

Nine NNP O
( ( O
17 CD O
% NN O
) ) O
of IN O
the DT O
patients NNS O
had VBD O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
at IN O
least JJS O
one CD O
first JJ O
- : O
degree NN O
relative NN O
. . O

A DT O
further JJ O
seven CD O
( ( O
13 CD O
% NN O
) ) O
of IN O
the DT O
patients NNS O
reported VBD O
breast JJ B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
at IN O
least JJS O
one CD O
second JJ O
- : O
degree NN O
relative NN O
and CC O
in IN O
no DT O
first JJ O
- : O
degree NN O
relatives NNS O
. . O

No DT O
germ JJ O
- : O
line NN O
BRCA1 NNP O
mutations NNS O
were VBD O
found VBN O
. . O

Two CD O
male JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
patients NNS O
( ( O
4 CD O
% NN O
of IN O
the DT O
total NN O
) ) O
were VBD O
found VBN O
to TO O
carry VB O
novel JJ O
truncating VBG O
mutations NNS O
in IN O
the DT O
BRCA2 NNP O
gene NN O
. . O

Only RB O
one CD O
of IN O
the DT O
two CD O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
patients NNS O
carrying VBG O
a DT O
BRCA2 NNP O
mutation NN O
had VBD O
a DT O
family NN O
history NN O
of IN O
cancer NN B-Disease
, , O
with IN O
one CD O
case NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
in IN O
a DT O
first JJ O
- : O
degree NN O
relative NN O
. . O

The DT O
remaining VBG O
eight CD O
cases NNS O
( ( O
89 CD O
% NN O
) ) O
of IN O
male NN B-Disease
breast NN I-Disease
cancer NN I-Disease
with IN O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
first JJ O
- : O
degree NN O
relatives NNS O
remain VBP O
unaccounted JJ O
for IN O
by IN O
mutations NNS O
in IN O
either CC O
the DT O
BRCA1 NNP O
gene NN O
or CC O
the DT O
BRCA2 NNP O
gene NN O
. . O
. . O

Molecular JJ O
basis NN O
for IN O
Duarte NNP B-Disease
and CC I-Disease
Los NNP I-Disease
Angeles NNP I-Disease
variant NN I-Disease
galactosemia NN I-Disease
. . O

Human NNP O
orythrocytes VBZ O
that WDT O
are VBP O
homozygous JJ O
for IN O
the DT O
Duarte NNP B-Disease
enzyme NN I-Disease
variant NN I-Disease
of IN I-Disease
galactosemia NN I-Disease
( ( O
D NNP O
/ NNP O
D NNP O
) ) O
have VBP O
a DT O
characteristic JJ O
isoform NN O
on IN O
isoelectric JJ O
focusing NN O
and CC O
50 CD O
% NN O
reduction NN O
in IN O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
( ( O
GALT NNP O
) ) O
enzyme NN O
activity NN O
. . O

The DT O
Duarte NNP O
biochemical JJ O
phenotype NN O
has VBZ O
a DT O
molecular JJ O
genotype NN O
of IN O
N314D NNP O
/ NNP O
N314D NNP O
. . O

The DT O
characteristic JJ O
Duarte NNP O
isoform NN O
is VBZ O
also RB O
associated VBN O
with IN O
a DT O
variant NN O
called VBN O
the DT O
"""" NNP O
Los NNP O
Angeles NNP O
( ( O
LA NNP O
) ) O
phenotype NN O
, , O
"""" NNP O
which WDT O
has VBZ O
increased VBN O
GALT NNP O
enzyme JJ O
activity NN O
. . O

We PRP O
evaluated VBD O
GALT NNP O
enzyme JJ O
activity NN O
and CC O
screened VBD O
the DT O
GALT NNP O
genes NNS O
of IN O
145 CD O
patients NNS O
with IN O
one CD O
or CC O
more JJR O
N314D NNP O
- : O
containing NN O
alleles NNS O
. . O

We PRP O
found VBD O
seven CD O
with IN O
the DT O
LA NNP O
biochemical JJ O
phenotype NN O
, , O
and CC O
all DT O
had VBD O
a DT O
1721C CD O
- : O
- : O
> NN O
T NNP O
transition NN O
in IN O
exon JJ O
7 CD O
in IN O
cis NN O
with IN O
the DT O
N314D NNP O
missense NN O
mutation NN O
. . O

The DT O
1721C CD O
- : O
- : O
> NN O
T NNP O
transition NN O
is VBZ O
a DT O
neutral JJ O
polymorphism NN O
for IN O
leucine NN O
at IN O
amino NN O
acid NN O
218 CD O
( ( O
L218L NNP O
) ) O
. . O

In IN O
pedigree JJ O
analyses NNS O
, , O
this DT O
1721C CD O
- : O
- : O
> NN O
T NNP O
transition NN O
segregated VBD O
with IN O
the DT O
LA NNP O
phenotype NN O
of IN O
increased JJ O
GALT NNP O
activity NN O
in IN O
three CD O
different JJ O
biochemical JJ O
phenotypes NNS O
( ( O
LA NNP O
/ NNP O
N NNP O
, , O
LA NNP O
/ NNP O
G NNP O
, , O
and CC O
LA NNP O
/ NNP O
D NNP O
) ) O
. . O

To TO O
determine VB O
the DT O
mechanism NN O
for IN O
increased JJ O
activity NN O
of IN O
the DT O
LA NNP O
variant NN O
, , O
we PRP O
compared VBN O
GALT NNP O
mRNA NN O
, , O
protein NN O
abundance NN O
, , O
and CC O
enzyme VB O
thermal JJ O
stability NN O
in IN O
lymphoblast NN O
cell NN O
lines NNS O
of IN O
D NNP O
and CC O
LA NNP O
phenotypes NNS O
with IN O
comparable JJ O
genotypes NNS O
. . O

GALT NNP O
protein VBD O
abundance NN O
was VBD O
increased VBN O
in IN O
LA NNP O
compared VBN O
to TO O
D NNP O
alleles NNS O
, , O
but CC O
mRNA NN O
was VBD O
similar JJ O
among IN O
all DT O
genotypes NNS O
. . O

When WRB O
LA NNP O
/ NNP O
D NNP O
and CC O
D NNP O
/ NNP O
D NNP O
GALT NNP O
biochemical JJ O
phenotypes NNS O
were VBD O
compared VBN O
to TO O
N NNP O
/ NNP O
N NNP O
GALT NNP O
phenotypes NNS O
, , O
both DT O
had VBD O
50 CD O
% NN O
, , O
as IN O
compared VBN O
to TO O
21 CD O
% NN O
, , O
reduction NN O
in IN O
GALT NNP O
activity NN O
in IN O
the DT O
wild JJ O
type NN O
( ( O
N NNP O
/ NNP O
N NNP O
) ) O
after IN O
exposure NN O
at IN O
identical JJ O
initial JJ O
enzyme NN O
activity NN O
to TO O
50 CD O
degrees NNS O
C NNP O
for IN O
15 CD O
min NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
codon NN O
change NN O
N314D NNP O
in IN O
cis NN O
with IN O
the DT O
base NN O
- : O
pair NN O
transition NN O
1721C CD O
- : O
- : O
> NN O
T NNP O
produces VBZ O
the DT O
LA NNP B-Disease
variant NN I-Disease
of IN I-Disease
galactosemia NN I-Disease
and CC O
that IN O
this DT O
nucleotide JJ O
change NN O
increases NNS O
GALT NNP O
activity NN O
by IN O
increasing VBG O
GALT NNP O
protein NN O
abundance NN O
without IN O
increasing VBG O
transcription NN O
or CC O
decreasing VBG O
thermal JJ O
lability NN O
. . O

A DT O
favorable JJ O
codon NN O
bias NN O
for IN O
the DT O
mutated JJ O
codon NN O
with IN O
consequently RB O
increased VBN O
translation NN O
rates NNS O
is VBZ O
postulated VBN O
as IN O
the DT O
mechanism NN O
. . O
. . O

The DT O
TSG101 NNP O
tumor NN B-Disease
susceptibility NN O
gene NN O
is VBZ O
located VBN O
in IN O
chromosome NN O
11 CD O
band NN O
p15 NN O
and CC O
is VBZ O
mutated VBN O
in IN O
human JJ O
breast NN B-Disease
cancer NN I-Disease
. . O

Recent JJ O
work NN O
has VBZ O
identified VBN O
a DT O
mouse NN O
gene NN O
( ( O
tsg101 JJ O
) ) O
whose WP$ O
inactivation NN O
in IN O
fibroblasts NNS O
results NNS O
in IN O
cellular JJ O
transformation NN O
and CC O
the DT O
ability NN O
to TO O
produce VB O
metastatic JJ B-Disease
tumors NNS I-Disease
in IN O
nude JJ O
mice NN O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
the DT O
human JJ O
homolog NN O
, , O
TSG101 NNP O
, , O
which WDT O
we PRP O
isolated VBD O
and CC O
mapped VBD O
to TO O
chromosome VB O
11 CD O
, , O
bands VBZ O
15 CD O
. . O

1 CD O
- : O
15 CD O
1 CD O
- : O
15 CD O
. . O

2 CD O
, , O
a DT O
region NN O
proposed VBN O
to TO O
contain VB O
tumor NN B-Disease
suppressor NN O
gene NN O
( ( O
s PRP O
) ) O
, , O
is VBZ O
mutated VBN O
at IN O
high JJ O
frequency NN O
in IN O
human JJ O
breast NN B-Disease
cancer NN I-Disease
. . O

In IN O
7 CD O
of IN O
15 CD O
uncultured JJ O
primary JJ O
human JJ O
breast NN B-Disease
carcinomas NN I-Disease
, , O
intragenic JJ O
deletions NNS O
were VBD O
shown VBN O
in IN O
TSG101 NNP O
genomic JJ O
DNA NNP O
and CC O
transcripts NNS O
by IN O
gel NN O
and CC O
sequence NN O
analysis NN O
, , O
and CC O
mutations NNS O
affecting VBG O
two CD O
TSG101 NNP O
alleles NNS O
were VBD O
identified VBN O
in IN O
four CD O
of IN O
these DT O
cancers NNS B-Disease
. . O

No DT O
TSG101 NNP O
defects NNS O
were VBD O
found VBN O
in IN O
matched JJ O
normal JJ O
breast NN O
tissue NN O
from IN O
the DT O
breast NN B-Disease
cancer NN I-Disease
patients NNS O
. . O

These DT O
findings NNS O
strongly RB O
implicate VBP O
TSG101 NNP O
mutations NNS O
in IN O
human JJ O
breast NN B-Disease
cancer NN I-Disease

Moderate NNP O
intergenerational JJ O
and CC O
somatic JJ O
instability NN O
of IN O
a DT O
55 CD O
- : O
CTG NN O
repeat NN O
in IN O
transgenic JJ O
mice NN O
. . O

Myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
is VBZ O
associated VBN O
with IN O
the DT O
expansion NN O
of IN O
a DT O
( ( O
CTG NNP O
) ) O
n FW O
trinucleotide JJ O
repeat NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
( ( O
UTR NNP O
) ) O
of IN O
the DT O
DM NNP B-Disease
protein NN O
kinase NN O
gene NN O
( ( O
DMPK NNP O
) ) O
. . O

The DT O
( ( O
CTG NNP O
) ) O
n FW O
repeat NN O
is VBZ O
polymorphic JJ O
and CC O
varies NNS O
in IN O
size NN O
between IN O
5 CD O
and CC O
37 CD O
repeats NNS O
in IN O
unaffected JJ O
individuals NNS O
whereas VBP O
in IN O
affected JJ O
patients NNS O
there EX O
are VBP O
between IN O
50 CD O
and CC O
4 CD O
, , O
0 CD O
CTGs NNP O
. . O

The DT O
size NN O
of IN O
the DT O
( ( O
CTG NNP O
) ) O
n RB O
repeat NN O
, , O
which WDT O
increases VBZ O
through IN O
generations NNS O
, , O
generally RB O
correlates VBZ O
with IN O
clinical JJ O
severity NN O
and CC O
age NN O
of IN O
onset NN O
. . O

The DT O
instability NN O
of IN O
the DT O
CTG NNP O
repeat NN O
appears VBZ O
to TO O
depend VB O
on IN O
its PRP$ O
size NN O
as RB O
well RB O
as IN O
on IN O
the DT O
sex NN O
of IN O
the DT O
transmitting JJ O
parent NN O
. . O

Moreover RB O
, , O
mitotic JJ O
instability NN O
analysis NN O
of IN O
different JJ O
human JJ O
DM NNP B-Disease
tissues NN O
shows NNS O
length VBP O
mosaicism NN O
between IN O
different JJ O
cell NN O
lineages NNS O
. . O

The DT O
molecular JJ O
mechanisms NN O
of IN O
triplet NN O
instability NN O
remain VBP O
elusive JJ O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
genomic JJ O
sequences NNS O
in IN O
instability NN O
, , O
we PRP O
produced VBD O
transgenic JJ O
mice NN O
containing VBG O
a DT O
45 CD O
- : O
kb NN O
genomic JJ O
segment NN O
with IN O
a DT O
55 CD O
- : O
CTG NNP O
repeat NN O
cloned VBD O
from IN O
a DT O
mildly RB O
affected JJ O
patient NN O
. . O

In IN O
contrast NN O
to TO O
other JJ O
mouse NN O
models NNS O
containing VBG O
CAG NNP O
repeats NNS O
within IN O
cDNAs NN O
, , O
these DT O
mice NN O
showed VBD O
both DT O
intergenerational JJ O
and CC O
somatic JJ O
repeat NN O
instability NN O
. . O
. . O

Missense JJ O
mutations NNS O
in IN O
the DT O
Fas NNP O
gene NN O
resulting VBG O
in IN O
autoimmune JJ B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
: : O
a DT O
molecular JJ O
and CC O
immunological JJ O
analysis NN O
. . O

Programmed NNP O
cell NN O
death NN O
( ( O
or CC O
apoptosis NN O
) ) O
is VBZ O
a DT O
physiological JJ O
process NN O
essential JJ O
to TO O
the DT O
normal JJ O
development NN O
and CC O
homeostatic JJ O
maintenance NN O
of IN O
the DT O
immune NN O
system NN O
. . O

The DT O
Fas NNP O
/ NNP O
Apo NNP O
- : O
1 CD O
receptor NN O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
apoptosis NN O
, , O
as IN O
demonstrated VBN O
by IN O
lymphoproliferation NN O
in IN O
MRL NNP O
- : O
lpr NN O
/ JJ O
lpr JJ O
mice NN O
and CC O
by IN O
the DT O
recently RB O
described VBN O
autoimmune JJ B-Disease
lymphoproliferative JJ I-Disease
syndrome NN I-Disease
( ( O
ALPS NNP B-Disease
) ) O
in IN O
humans NNS O
, , O
both DT O
of IN O
which WDT O
are VBP O
due JJ O
to TO O
mutations NNS O
in IN O
the DT O
Fas NNP O
gene NN O
. . O

We PRP O
describe VBP O
a DT O
novel JJ O
family NN O
with IN O
ALPS NNP B-Disease
in IN O
which WDT O
three CD O
affected VBD O
siblings NNS O
carry VBP O
two CD O
distinct JJ O
missense NN O
mutations NNS O
on IN O
both DT O
the DT O
Fas NNP O
gene NN O
alleles NNS O
and CC O
show VBP O
lack NN O
of IN O
Fas NNP O
- : O
induced JJ O
apoptosis NN O
. . O

The DT O
children NNS O
share NN O
common JJ O
clinical JJ O
features NNS O
including VBG O
splenomegaly NN B-Disease
and CC O
lymphadenopathy JJ B-Disease
, , O
but CC O
only RB O
one CD O
developed VBD O
severe JJ O
autoimmune JJ B-Disease
manifestations NNS I-Disease
. . O

In IN O
all DT O
three CD O
siblings NNS O
, , O
we PRP O
demonstrated VBD O
the DT O
presence NN O
of IN O
anergic JJ O
CD3 NNP O
+ NNP O
CD4 NNP O
- : O
CD8 NNP O
- : O
( ( O
double JJ O
negative JJ O
, , O
[ JJ O
DN NNP O
] NNP O
) ) O
T NNP O
cells NNS O
; : O
moreover RB O
, , O
a DT O
chronic JJ O
lymphocyte NN O
activation NN O
was VBD O
found VBN O
, , O
as IN O
demonstrated VBN O
by IN O
the DT O
presence NN O
of IN O
high JJ O
levels NNS O
of IN O
HLA NNP O
- : O
DR NNP O
expression NN O
on IN O
peripheral JJ O
CD3 NNP O
+ NNP O
cells NNS O
and CC O
by IN O
the DT O
presence NN O
of IN O
high JJ O
levels NNS O
of IN O
serum NN O
activation NN O
markers NNS O
such JJ O
as IN O
soluble JJ O
interleukin JJ O
- : O
2 CD O
receptor NN O
( ( O
slL JJ O
- : O
2R CD O
) ) O
and CC O
soluble JJ O
CD30 NNP O
( ( O
sCD30 NN O
) ) O
. . O
. . O

The DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
product NN O
, , O
a DT O
constitutively RB O
expressed VBN O
nuclear JJ O
protein NN O
that WDT O
is VBZ O
not RB O
up RP O
- : O
regulated VBN O
following VBG O
genome JJ O
damage NN O
. . O

The DT O
product NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
( ( O
ATM NNP O
) ) O
was VBD O
identified VBN O
by IN O
using VBG O
an DT O
antiserum NN O
developed VBD O
to TO O
a DT O
peptide NN O
corresponding VBG O
to TO O
the DT O
deduced VBN O
amino NN O
acid NN O
sequence NN O
. . O

The DT O
ATM NNP O
protein NN O
is VBZ O
a DT O
single JJ O
, , O
high JJ O
- : O
molecular JJ O
weight NN O
protein NN O
predominantly RB O
confined VBN O
to TO O
the DT O
nucleus NN O
of IN O
human JJ O
fibroblasts NNS O
, , O
but CC O
is VBZ O
present JJ O
in IN O
both DT O
nuclear JJ O
and CC O
microsomal JJ O
fractions NNS O
from IN O
human JJ O
lymphoblast NN O
cells NNS O
and CC O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

ATM NNP O
protein NN O
levels NNS O
and CC O
localization NN O
remain VBP O
constant JJ O
throughout IN O
all DT O
stages NNS O
of IN O
the DT O
cell NN O
cycle NN O
. . O

Truncated VBN O
ATM NNP O
protein NN O
was VBD O
not RB O
detected VBN O
in IN O
lymphoblasts NNS O
from IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
patients NNS O
homozygous JJ O
for IN O
mutations NNS O
leading VBG O
to TO O
premature VB O
protein JJ O
termination NN O
. . O

Exposure NN O
of IN O
normal JJ O
human JJ O
cells NNS O
to TO O
gamma VB O
- : O
irradiation NN O
and CC O
the DT O
radiomimetic JJ O
drug NN O
neocarzinostatin NN O
had VBD O
no DT O
effect NN O
on IN O
ATM NNP O
protein NN O
levels NNS O
, , O
in IN O
contrast NN O
to TO O
a DT O
noted JJ O
rise NN O
in IN O
p53 NN O
levels NNS O
over IN O
the DT O
same JJ O
time NN O
interval NN O
. . O

These DT O
findings NNS O
are VBP O
consistent JJ O
with IN O
a DT O
role NN O
for IN O
the DT O
ATM NNP O
protein NN O
in IN O
ensuring VBG O
the DT O
fidelity NN O
of IN O
DNA NNP O
repair NN O
and CC O
cell NN O
cycle NN O
regulation NN O
following VBG O
genome JJ O
damage NN O
. . O
. . O

Type NNP O
III NNP O
collagen NN O
is VBZ O
crucial JJ O
for IN O
collagen NN O
I PRP O
fibrillogenesis VBP O
and CC O
for IN O
normal JJ O
cardiovascular JJ O
development NN O
. . O

Type NNP O
III NNP O
collagen NN O
is VBZ O
a DT O
fibrillar JJ O
forming NN O
collagen NN O
comprising VBG O
three CD O
alpha1 NN O
( ( O
III NNP O
) ) O
chains NNS O
and CC O
is VBZ O
expressed VBN O
in IN O
early JJ O
embryos NN O
and CC O
throughout IN O
embryogenesis NN O
. . O

In IN O
the DT O
adult NN O
, , O
type NN O
III NNP O
collagen NN O
is VBZ O
a DT O
major JJ O
component NN O
of IN O
the DT O
extracellular JJ O
matrix NN O
in IN O
a DT O
variety NN O
of IN O
internal JJ O
organs NNS O
and CC O
skin NN O
. . O

Mutations NNS O
in IN O
the DT O
COL3A1 NNP O
gene NN O
have VBP O
been VBN O
implicated VBN O
as IN O
a DT O
cause NN O
of IN O
type NN B-Disease
IV NNP I-Disease
Ehlers NNP I-Disease
- : I-Disease
Danlos NNP I-Disease
syndrome NN I-Disease
, , O
a DT O
disease NN O
leading VBG O
to TO O
aortic JJ B-Disease
rupture NN I-Disease
in IN O
early JJ O
adult NN O
life NN O
. . O

To TO O
directly RB O
study VB O
the DT O
role NN O
of IN O
Col3a1 NNP O
in IN O
development NN O
and CC O
disease NN O
, , O
we PRP O
have VBP O
inactivated VBN O
the DT O
Col3a1 NNP O
gene NN O
in IN O
embryonic JJ O
stem NN O
cells NNS O
by IN O
homologous JJ O
recombination NN O
. . O

The DT O
mutated JJ O
allele NN O
was VBD O
transmitted VBN O
through IN O
the DT O
mouse NN O
germ JJ O
line NN O
and CC O
homozygous JJ O
mutant NN O
animals NNS O
were VBD O
derived VBN O
from IN O
heterozygous JJ O
intercrosses NNS O
. . O

About RB O
10 CD O
% NN O
of IN O
the DT O
homozygous JJ O
mutant NN O
animals NNS O
survived VBD O
to TO O
adulthood VB O
but CC O
have VB O
a DT O
much JJ O
shorter JJR O
life NN O
span NNS O
compared VBN O
with IN O
wild JJ O
- : O
type NN O
mice NN O
. . O

The DT O
major JJ O
cause NN O
of IN O
death NN O
of IN O
mutant JJ O
mice NN O
was VBD O
rupture NN O
of IN O
the DT O
major JJ O
blood NN O
vessels NNS O
, , O
similar JJ O
to TO O
patients NNS O
with IN O
type JJ B-Disease
IV NNP I-Disease
Ehlers NNP I-Disease
- : I-Disease
Danlos NNP I-Disease
syndrome NN I-Disease
. . O

Ultrastructural JJ O
analysis NN O
of IN O
tissues NNS O
from IN O
mutant JJ O
mice NN O
revealed VBD O
that IN O
type NN O
III NNP O
collagen NN O
is VBZ O
essential JJ O
for IN O
normal JJ O
collagen NN O
I PRP O
fibrillogenesis VBP O
in IN O
the DT O
cardiovascular JJ O
system NN O
and CC O
other JJ O
organs NNS O
. . O
. . O

Nonsense NNP O
mutation NN O
in IN O
exon JJ O
3 CD O
of IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
( ( O
PLP NNP O
) ) O
in IN O
a DT O
family NN O
with IN O
an DT O
unusual JJ O
form NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
. . O

We PRP O
report VBP O
a DT O
G NNP O
- : O
- : O
> VB O
A DT O
transition NN O
at IN O
nucleotide JJ O
431 CD O
of IN O
the DT O
proteolipid JJ O
protein NN O
gene NN O
( ( O
PLP NNP O
) ) O
results NNS O
in IN O
a DT O
nonsense JJ O
codon NN O
in IN O
a DT O
family NN O
with IN O
an DT O
unusual JJ O
form NN O
of IN O
Pelizaeus NNP B-Disease
- : I-Disease
Merzbacher PRP$ I-Disease
disease NN I-Disease
( ( O
PMD NNP B-Disease
) ) O
. . O

The DT O
mutation NN O
, , O
which WDT O
creates VBZ O
a DT O
second JJ O
AluI NNP O
restriction NN O
site NN O
, , O
results NNS O
in IN O
a DT O
nonsense JJ O
mutation NN O
in IN O
PLP NNP O
. . O

The DT O
clinical JJ O
picture NN O
resembles VBZ O
somewhat RB O
that IN O
of IN O
X NNP B-Disease
- : I-Disease
linked VBN I-Disease
spastic JJ I-Disease
paraplegia NN I-Disease
( ( O
SPG NNP B-Disease
) ) O
. . O

It PRP O
differs VBZ O
from IN O
this DT O
and CC O
both DT O
the DT O
classical JJ O
and CC O
connatal JJ O
forms NNS O
of IN O
PMD NNP B-Disease
in IN O
that DT O
it PRP O
is VBZ O
relatively RB O
mild JJ O
in IN O
form NN O
, , O
onset NN O
is VBZ O
delayed VBN O
beyond IN O
age NN O
2 CD O
years NNS O
, , O
nystagmus NN B-Disease
is VBZ O
absent JJ O
, , O
tremors NNS B-Disease
are VBP O
prominent JJ O
, , O
mental JJ B-Disease
retardation NN I-Disease
is VBZ O
not RB O
severe JJ O
, , O
some DT O
patients NNS O
show VBP O
dementia JJ B-Disease
or CC O
personality NN B-Disease
disorders NNS I-Disease
, , O
the DT O
disease NN O
is VBZ O
progressive JJ O
rather RB O
than IN O
static JJ O
in IN O
some DT O
, , O
and CC O
several JJ O
females NNS O
show VBP O
signs NNS O
of IN O
disease NN O
. . O

The DT O
nonsense JJ O
mutation NN O
, , O
which WDT O
is VBZ O
in IN O
exon JJ O
3B CD O
, , O
should MD O
block VB O
the DT O
synthesis NN O
of IN O
normal JJ O
PLP NNP O
but CC O
spare JJ O
DM20 NNP O
, , O
the DT O
isoform NN O
whose WP$ O
persistence NN O
has VBZ O
been VBN O
associated VBN O
with IN O
mild JJ O
forms NNS O
of IN O
PLP NNP B-Disease
- : I-Disease
associated JJ I-Disease
disease NN I-Disease
in IN O
both DT O
humans NNS O
and CC O
mice NN O
. . O
. . O

Common JJ O
BRCA1 NNP O
variants NNS O
and CC O
susceptibility NN O
to TO O
breast VB B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
the DT O
general JJ O
population NN O
. . O

Most JJS O
multiple JJ O
case NN O
families NNS O
of IN O
young JJ O
onset VBN O
breast NN B-Disease
cancer NN I-Disease
and CC O
ovarian JJ B-Disease
cancer NN I-Disease
are VBP O
thought VBN O
to TO O
be VB O
due JJ O
to TO O
highly RB O
penetrant JJ O
mutations NNS O
in IN O
the DT O
predisposing NN O
genes NNS O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

However RB O
, , O
these DT O
mutations NNS O
are VBP O
uncommon JJ O
in IN O
the DT O
population NN O
and CC O
they PRP O
probably RB O
account VBP O
for IN O
only RB O
a DT O
few JJ O
percent NN O
of IN O
all DT O
breast NN B-Disease
cancer NN I-Disease
incidence NN O
. . O

A DT O
much RB O
larger JJR O
fraction NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
might MD O
, , O
in IN O
principle NN O
, , O
be VB O
due JJ O
to TO O
common JJ O
variants NNS O
which WDT O
confer VBP O
more JJR O
modest JJ O
individual JJ O
risks NNS O
. . O

There EX O
are VBP O
several JJ O
common JJ O
polymorphisms NNS O
in IN O
the DT O
BRCA1 NNP O
gene NN O
which WDT O
generate VBP O
amino NN O
acid JJ O
substitutions NNS O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
frequency NN O
of IN O
four CD O
of IN O
these DT O
polymorphisms NNS O
Gln356Arg NNP O
, , O
Pro871Leu NNP O
, , O
Glu1038Gly NNP O
and CC O
Ser1613Gly NNP O
in IN O
large JJ O
series NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
cases NNS O
and CC O
matched JJ O
controls NNS O
. . O

Due JJ O
to TO O
strong JJ O
linkage NN O
disequilibrium NN O
, , O
these DT O
four CD O
sites NNS O
generate VBP O
only RB O
three CD O
haplotypes NNS O
with IN O
a DT O
frequency NN O
> $ O
1 CD O
. . O

3 CD O
% NN O
. . O

The DT O
most RBS O
common JJ O
haplotypes NNS O
, , O
defined VBN O
by IN O
the DT O
alleles NNS O
Gln356Pro871Glu1038Ser1613 NNP O
and CC O
Gln356Leu871Gly1038Gly1613 NNP O
, , O
have VBP O
frequencies NNS O
of IN O
0 CD O
. . O

57 CD O
and CC O
0 CD O
. . O

32 CD O
respectively RB O
, , O
and CC O
these DT O
frequencies NNS O
do VBP O
not RB O
differ VB O
significantly RB O
between IN O
patient JJ O
and CC O
control NN O
groups NNS O
. . O

Thus RB O
the DT O
most RBS O
common JJ O
polymorphisms NN O
of IN O
the DT O
BRCA1 NNP O
gene NN O
do VBP O
not RB O
make VB O
a DT O
significant JJ O
contribution NN O
to TO O
breast VB B-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
risk NN O
. . O

However RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
Arg356 NNP O
allele NN O
may MD O
have VB O
a DT O
different JJ O
genotype NN O
distribution NN O
in IN O
breast NN B-Disease
cancer NN I-Disease
patients NNS O
from IN O
that DT O
in IN O
controls NNS O
( ( O
Arg356 NNP O
homozygotes NNS O
are VBP O
more RBR O
frequent JJ O
in IN O
the DT O
control NN O
groups NNS O
, , O
P NNP O
= VBZ O
0 CD O
. . O
1 CD O
) ) O
, , O
indicating VBG O
that IN O
it PRP O
may MD O
be VB O
protective JJ O
against IN O
breast NN B-Disease
cancer NN I-Disease
. . O

If IN O
this DT O
finding NN O
can MD O
be VB O
confirmed VBN O
, , O
it PRP O
may MD O
provide VB O
an DT O
insight NN O
into IN O
the DT O
structural JJ O
features NNS O
of IN O
the DT O
BRCA1 NNP O
protein NN O
that WDT O
are VBP O
important JJ O
for IN O
its PRP$ O
function NN O
. . O

Kniest NNP B-Disease
dysplasia NN I-Disease
: : O
Dr NNP O
. . O
W NNP O
. . O

Kniest NNP O
, , O
his PRP$ O
patient NN O
, , O
the DT O
molecular JJ O
defect NN O
. . O

Kniest NNP B-Disease
dysplasia NN I-Disease
is VBZ O
a DT O
severe JJ O
chondrodysplasia NN B-Disease
caused VBN O
by IN O
the DT O
defective JJ B-Disease
formation NN I-Disease
of IN I-Disease
type NN I-Disease
II NNP I-Disease
collagen NN I-Disease
. . O

We PRP O
report VBP O
about IN O
Dr NNP O
. . O
Kniest NNP O
, , O
who WP O
first RB O
described VBD O
the DT O
condition NN O
in IN O
1952 CD O
, , O
and CC O
his PRP$ O
patient NN O
, , O
who WP O
, , O
at IN O
the DT O
age NN O
of IN O
50 CD O
years NNS O
is VBZ O
severely RB B-Disease
handicapped VBN I-Disease
with IN O
short JJ B-Disease
stature NN I-Disease
, , O
restricted VBD B-Disease
joint JJ I-Disease
mobility NN I-Disease
, , O
and CC O
blindness NN B-Disease
but CC O
is VBZ O
mentally RB O
alert JJ O
and CC O
leads VBZ O
an DT O
active JJ O
life NN O
. . O

Molecular JJ O
analysis NN O
of IN O
the DT O
patients NNS O
DNA NNP O
showed VBD O
a DT O
single JJ O
base NN O
( ( O
G NNP O
) ) O
deletion NN O
involving VBG O
the DT O
GT NNP O
dinucleotide NN O
at IN O
the DT O
start NN O
of IN O
intron NN O
18 CD O
destroying VBG O
a DT O
splice JJ O
site NN O
of IN O
the DT O
COL2A1 NNP O
gene NN O
. . O

This DT O
is VBZ O
in IN O
accordance NN O
with IN O
molecular JJ O
findings NNS O
in IN O
other JJ O
patients NNS O
with IN O
Kniest NNP B-Disease
dysplasia NN I-Disease
and CC O
confirms NNS O
, , O
in IN O
the DT O
original JJ O
patient NN O
, , O
that IN O
the DT O
disorder NN O
is VBZ O
caused VBN O
by IN O
small JJ O
inframe NN O
deletions NNS O
often RB O
due JJ O
to TO O
exon VB O
skipping VBG O
as IN O
a DT O
result NN O
of IN O
COL2A1 NNP O
splice NN O
site NN O
mutations NNS O
. . O
. . O

Cloning NN O
of IN O
the DT O
homogentisate NN O
1 CD O
, , O
2 CD O
- : O
dioxygenase NN O
gene NN O
, , O
the DT O
key JJ O
enzyme NN O
of IN O
alkaptonuria NN B-Disease
in IN O
mouse NN O
. . O

We PRP O
determined VBD O
48 CD O
amino NN O
acid NN O
residues NNS O
from IN O
five CD O
peptides NNS O
from IN O
the DT O
homogeneous JJ O
monomer NN O
of IN O
homogentisate NN O
1 CD O
, , O
2 CD O
- : O
dioxygenase NN O
( ( O
HGO NNP O
; : O
E NNP O
. . O
C NNP O
. . O
1 CD O
. . O
13 CD O
. . O
11 CD O
. . O
15 CD O
) ) O
of IN O
mouse NN O
liver NN O
. . O

After IN O
digestion NN O
with IN O
trypsin NN O
, , O
peptides NNS O
were VBD O
separated VBN O
by IN O
reversed JJ O
phase NN O
chromatography NN O
and CC O
amino NN O
acid NN O
sequenced VBD O
. . O

The DT O
deduced JJ O
codon NN O
sequence NN O
of IN O
three CD O
peptides NNS O
was VBD O
used VBN O
to TO O
derive VB O
degenerated JJ O
oligomeres NNS O
. . O

By IN O
combining VBG O
these DT O
oligos NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
amplify VB O
fragments NNS O
from IN O
100 CD O
to TO O
300 CD O
bases NNS O
( ( O
b NN O
) ) O
from IN O
mouse NN O
liver NN O
cDNA NN O
by IN O
polymerase NN O
chain NN O
reaction NN O
after IN O
reverse JJ O
transcription NN O
( ( O
RT NNP O
- : O
PCR NN O
) ) O
. . O

A DT O
fragment NN O
of IN O
200 CD O
b NN O
was VBD O
cloned VBN O
and CC O
used VBN O
as IN O
a DT O
probe NN O
to TO O
screen VB O
a DT O
mouse NN O
liver NN O
cDNA NN O
library NN O
. . O

One CD O
clone NN O
from IN O
this DT O
library NN O
contained VBD O
the DT O
complete JJ O
cDNA NN O
- : O
insert NN O
for IN O
HGO NNP O
as IN O
determined VBN O
by IN O
sequencing VBG O
. . O

The DT O
cDNA NN O
encodes VBZ O
for IN O
a DT O
protein NN O
of IN O
50 CD O
kDa NNS O
, , O
as IN O
predicted VBN O
. . O

The DT O
cDNA NN O
of IN O
mouse NN O
HGO NNP O
has VBZ O
an DT O
overall JJ O
identity NN O
of IN O
41 CD O
% NN O
to TO O
the DT O
corresponding JJ O
gene NN O
hmgA NN O
from IN O
Aspergillus NNP O
. . O

Sequence NN O
similarities NNS O
to TO O
human NNS O
expressed VBN O
sequence NN O
tags NN O
( ( O
EST NNP O
) ) O
clones NNS O
ranged VBD O
from IN O
70 CD O
% NN O
to TO O
20 CD O
% NN O
. . O

The DT O
positions NNS O
of IN O
122 CD O
conserved VBD O
amino NN O
acids NNS O
could MD O
be VB O
determined VBN O
by IN O
multiple JJ O
sequence NN O
alignment NN O
. . O

We PRP O
identified VBD O
one CD O
first JJ O
intron NN O
of IN O
928 CD O
b NN O
in IN O
the DT O
mouse NN O
gene NN O
. . O

The DT O
gene NN O
for IN O
HGO NNP O
seems VBZ O
to TO O
be VB O
expressed VBN O
in IN O
various JJ O
tissues NNS O
, , O
as IN O
shown VBN O
by IN O
RT NNP O
- : O
PCR NN O
on IN O
different JJ O
cDNAs NN O
. . O

FISH NN O
experiments NNS O
with IN O
the DT O
whole JJ O
murine NN O
cDNA NN O
as IN O
probe NN O
clearly RB O
revealed VBD O
signals NNS O
at IN O
the DT O
human JJ O
chromosomal JJ O
band NN O
3q13 CD O
. . O

3 LS O
- : O
q21 NN O
. . O

This DT O
corresponds VBZ O
well RB O
to TO O
the DT O
previous JJ O
assignment NN O
of IN O
the DT O
locus NN O
for IN O
the DT O
human JJ O
alkaptonuria NN B-Disease
gene NN O
( ( O
AKU NNP O
) ) O
to TO O
the DT O
same JJ O
chromosomal JJ O
region NN O
by IN O
multipoint NN O
linkage NN O
analysis NN O
. . O

We PRP O
therefore VBP O
conclude VBP O
that IN O
the DT O
HGO NNP O
cDNA NN O
encodes VBZ O
the DT O
gene NN O
responsible JJ O
for IN O
alkaptonuria NN B-Disease
. . O

PTEN NNP O
, , O
a DT O
putative JJ O
protein NN O
tyrosine NN O
phosphatase NN O
gene NN O
mutated VBN O
in IN O
human JJ O
brain NN B-Disease
, , I-Disease
breast NN I-Disease
, , I-Disease
and CC I-Disease
prostate NN I-Disease
cancer NN I-Disease
. . O

Mapping NN O
of IN O
homozygous JJ O
deletions NNS O
on IN O
human JJ O
chromosome NN O
10q23 CD O
has VBZ O
led VBN O
to TO O
the DT O
isolation NN O
of IN O
a DT O
candidate NN O
tumor NN B-Disease
suppressor NN O
gene NN O
, , O
PTEN NNP O
, , O
that WDT O
appears VBZ O
to TO O
be VB O
mutated VBN O
at IN O
considerable JJ O
frequency NN O
in IN O
human JJ O
cancers NNS B-Disease
. . O

In IN O
preliminary JJ O
screens NNS O
, , O
mutations NNS O
of IN O
PTEN NNP O
were VBD O
detected VBN O
in IN O
31 CD O
% NN O
( ( O
13 CD O
/ RB O
42 CD O
) ) O
of IN O
glioblastoma NN B-Disease
cell NN O
lines NNS O
and CC O
xenografts NNS O
, , O
100 CD O
% NN O
( ( O
4 CD O
/ RB O
4 CD O
) ) O
of IN O
prostate NN B-Disease
cancer NN I-Disease
cell NN O
lines NNS O
, , O
6 CD O
% NN O
( ( O
4 CD O
/ RB O
65 CD O
) ) O
of IN O
breast NN B-Disease
cancer NN I-Disease
cell NN O
lines NNS O
and CC O
xenografts NNS O
, , O
and CC O
17 CD O
% NN O
( ( O
3 CD O
/ RB O
18 CD O
) ) O
of IN O
primary JJ B-Disease
glioblastomas NN I-Disease
. . O

The DT O
predicted JJ O
PTEN NNP O
product NN O
has VBZ O
a DT O
protein NN O
tyrosine NN O
phosphatase NN O
domain NN O
and CC O
extensive JJ O
homology NN O
to TO O
tensin VB O
, , O
a DT O
protein NN O
that WDT O
interacts VBZ O
with IN O
actin JJ O
filaments NNS O
at IN O
focal JJ O
adhesions NNS O
. . O

These DT O
homologies NNS O
suggest VBP O
that IN O
PTEN NNP O
may MD O
suppress VB O
tumor NN B-Disease
cell NN O
growth NN O
by IN O
antagonizing VBG O
protein JJ O
tyrosine NN O
kinases NNS O
and CC O
may MD O
regulate VB O
tumor NN B-Disease
cell NN O
invasion NN O
and CC O
metastasis NN B-Disease
through IN O
interactions NNS O
at IN O
focal JJ O
adhesions NNS O
. . O
. . O

Heterogeneity NN O
in IN O
Schwartz NNP B-Disease
- : I-Disease
Jampel NNP I-Disease
chondrodystrophic JJ I-Disease
myotonia NN I-Disease
. . O

The DT O
Schwartz NNP B-Disease
- : I-Disease
Jampel NNP I-Disease
syndrome NN I-Disease
( ( O
SJS NNP B-Disease
; : O
chondrodystrophic JJ B-Disease
myotonia NN I-Disease
; : O
McK NNP O
255 CD O
, , O
800 CD O
) ) O
is VBZ O
a DT O
recessively RB B-Disease
inherited JJ I-Disease
condition NN I-Disease
defined VBN O
by IN O
myotonia NN B-Disease
, , O
short JJ B-Disease
stature NN I-Disease
, , O
and CC O
bone NN B-Disease
dysplasia NN I-Disease
. . O

Genetic JJ O
linkage NN O
between IN O
SJS NNP B-Disease
and CC O
chromosomal JJ O
region NN O
1q36 CD O
- : O
34 CD O
has VBZ O
been VBN O
observed VBN O
in IN O
several JJ O
families NNS O
, , O
but CC O
the DT O
gene NN O
has VBZ O
not RB O
yet RB O
been VBN O
identified VBN O
. . O

We PRP O
studied VBD O
the DT O
clinical JJ O
and CC O
radiological JJ O
features NNS O
in IN O
81 CD O
patients NNS O
from IN O
the DT O
literature NN O
and CC O
5 CD O
own JJ O
patients NNS O
trying VBG O
to TO O
identify VB O
distinct JJ O
subgroups NNS O
. . O

In IN O
addition NN O
, , O
we PRP O
tested VBD O
genetic JJ O
linkage NN O
to TO O
the DT O
SJS NNP B-Disease
locus NN O
on IN O
chromosome NN O
1 CD O
in IN O
one CD O
family NN O
with IN O
two CD O
affected JJ O
sibs NN O
. . O

We PRP O
found VBD O
that IN O
a DT O
group NN O
of IN O
patients NNS O
have VBP O
mild VBN O
skeletal JJ O
changes NNS O
which WDT O
may MD O
be VB O
secondary JJ O
consequences NNS O
of IN O
myotonia NN B-Disease
, , O
while IN O
another DT O
group NN O
of IN O
patients NNS O
appear VBP O
to TO O
have VB O
primary JJ O
bone NN B-Disease
dysplasia NN I-Disease
with IN O
myotonia NN B-Disease
. . O

Within IN O
this DT O
latter JJ O
group NN O
, , O
there EX O
are VBP O
differences NNS O
in IN O
age NN O
of IN O
manifestation NN O
, , O
clinical JJ O
course NN O
and CC O
pattern NN O
of IN O
bone NN O
changes NNS O
. . O

We PRP O
tentatively RB O
isolate VBP O
three CD O
different JJ O
types NNS O
of IN O
SJS NNP B-Disease
type NN I-Disease
1A CD I-Disease
, , O
usually RB O
recognized VBN O
in IN O
childhood NN O
, , O
with IN O
moderate JJ O
bone NN B-Disease
dysplasia NN I-Disease
, , O
corresponding VBG O
to TO O
the DT O
original JJ O
descriptions NNS O
of IN O
Schwartz NNP O
, , O
Jampel NNP O
and CC O
Aberfeld NNP O
; : O
type NN O
1B CD O
, , O
similar JJ O
to TO O
type VB O
1A CD O
but CC O
recognizable JJ O
at IN O
birth NN O
, , O
with IN O
more RBR O
pronounced JJ O
bone NN B-Disease
dysplasia NN I-Disease
resembling VBG O
Kniest NNP B-Disease
dysplasia NN I-Disease
; : O
and CC O
type VB O
2 CD O
, , O
manifest NN O
at IN O
birth NN O
, , O
with IN O
increased VBN O
mortality NN O
and CC O
bone NN B-Disease
dysplasia NN I-Disease
resembling VBG O
Pyle NNP B-Disease
disease NN I-Disease
. . O

Genetic JJ O
analysis NN O
of IN O
the DT O
family NN O
with IN O
two CD O
sibs NNS O
affected VBN O
by IN O
SJS NNP B-Disease
type NN I-Disease
2 CD I-Disease
showed VBD O
evidence NN O
against IN O
linkage NN O
to TO O
chromosome VB O
1p36 CD O
- : O
34 CD O
. . O

CONCLUSIONS NNP O
SJS NNP B-Disease
is VBZ O
clinically RB O
and CC O
radiologically RB O
heterogeneous JJ O
. . O

The DT O
causes NNS O
of IN O
heterogeneity NN O
are VBP O
not RB O
known VBN O
yet RB O
but CC O
are VBP O
likely JJ O
to TO O
include VB O
both DT O
different JJ O
mutations NNS O
at IN O
the DT O
SJS NNP B-Disease
locus NN O
on IN O
chromosome NN O
1 CD O
and CC O
the DT O
presence NN O
of IN O
a DT O
second JJ O
SJS NNP B-Disease
locus NN O
. . O

A DT O
tentative JJ O
clinico NN O
- : O
radiological JJ O
classification NN O
can MD O
be VB O
useful JJ O
for IN O
the DT O
characterization NN O
of IN O
patients NNS O
and CC O
the DT O
development NN O
of IN O
genotype NN O
- : O
phenotype NN O
correlations NNS O
. . O
. . O

A DT O
clinical JJ O
overview NN O
of IN O
WT1 NNP O
gene NN O
mutations NNS O
. . O

Mutations NNS O
in IN O
the DT O
WT1 NNP O
gene NN O
were VBD O
anticipated VBN O
to TO O
explain VB O
the DT O
genetic JJ O
basis NN O
of IN O
the DT O
childhood NN O
kidney NN B-Disease
cancer NN I-Disease
, , O
Wilms NNP B-Disease
tumour NN I-Disease
( ( O
WT NNP B-Disease
) ) O
. . O

Six CD O
years NNS O
on IN O
, , O
we PRP O
review VBP O
100 CD O
reports NNS O
of IN O
intragenic JJ O
WT1 NNP O
mutations NNS O
and CC O
examine VB O
the DT O
accompanying VBG O
clinical JJ O
phenotypes NNS O
. . O

While IN O
only RB O
5 CD O
% NN O
of IN O
sporadic JJ B-Disease
Wilms NNP I-Disease
tumours NNS I-Disease
have VBP O
intragenic JJ O
WT1 NNP O
mutations NNS O
, , O
> VBP O
90 CD O
% NN O
of IN O
patients NNS O
with IN O
the DT O
Denys NNP B-Disease
- : I-Disease
Drash NNP I-Disease
syndrome NN I-Disease
( ( O
renal JJ B-Disease
nephropathy NN I-Disease
, , O
gonadal JJ B-Disease
anomaly NN I-Disease
, , O
predisposition NN B-Disease
to TO I-Disease
WT NNP I-Disease
) ) O
carry VBP O
constitutional JJ O
intragenic JJ O
WT1 NNP O
mutations NNS O
. . O

WT1 NNP O
mutations NNS O
have VBP O
also RB O
been VBN O
reported VBN O
in IN O
juvenile NN B-Disease
granulosa NN I-Disease
cell NN I-Disease
tumour NN I-Disease
, , O
non SYM B-Disease
- : I-Disease
asbestos NN I-Disease
related JJ I-Disease
mesothelioma NN I-Disease
, , O
desmoplastic JJ B-Disease
small JJ I-Disease
round NN I-Disease
cell NN I-Disease
tumour NN I-Disease
and CC O
, , O
most RBS O
recently RB O
, , O
acute JJ B-Disease
myeloid NN I-Disease
leukemia NN I-Disease
. . O
. . O

A DT O
mutation NN O
in IN O
autosomal JJ B-Disease
dominant JJ I-Disease
myotonia NN I-Disease
congenita NN I-Disease
affects VBZ O
pore IN O
properties NNS O
of IN O
the DT O
muscle NN O
chloride NN O
channel NN O
. . O

Autosomal NNP B-Disease
dominant JJ I-Disease
myotonia NN I-Disease
congenita NN I-Disease
is VBZ O
an DT O
inherited JJ B-Disease
disorder NN I-Disease
of IN I-Disease
skeletal JJ I-Disease
muscle NN I-Disease
caused VBN O
by IN O
mutations NNS O
in IN O
a DT O
voltage NN O
- : O
gated VBN O
Cl NNP O
- : O
channel NN O
gene NN O
( ( O
CLCN1 NNP O
, , O
7q35 CD O
) ) O
. . O

Here RB O
, , O
we PRP O
report VBP O
that IN O
a DT O
mutation NN O
predicting VBG O
the DT O
substitution NN O
of IN O
Gly NNP O
230 CD O
by IN O
glutamic JJ O
acid NN O
( ( O
G230E NNP O
) ) O
between IN O
segments NNS O
D3 NNP O
and CC O
D4 NNP O
dramatically RB O
alters VBZ O
the DT O
pore NN O
properties NNS O
of IN O
a DT O
recombinant JJ O
human JJ O
muscle NN O
Cl NNP O
- : O
channel NN O
( ( O
hCIC JJ O
- : O
1 CD O
) ) O
expressed VBN O
in IN O
a DT O
mammalian JJ O
cell NN O
line NN O
( ( O
tsA201 NN O
) ) O
. . O

The DT O
G230E NNP O
mutation NN O
causes VBZ O
substantial JJ O
changes NNS O
in IN O
anion NN O
and CC O
cation NN O
selectivity NN O
as RB O
well RB O
as IN O
a DT O
fundamental JJ O
change NN O
in IN O
rectification NN O
of IN O
the DT O
current JJ O
- : O
voltage NN O
relationship NN O
. . O

Whereas NNP O
wild SYM O
- : O
type NN O
channels NNS O
are VBP O
characterized VBN O
by IN O
pronounced JJ O
inward JJ O
rectification NN O
and CC O
a DT O
Cl NNP O
> NNP O
thiocyanate NN O
> NNP O
Br NNP O
> NNP O
NO NNP O
( ( O
3 CD O
) ) O
> NN O
I PRP O
> VBP O
CH NNP O
( ( O
3 CD O
) ) O
SO NNP O
( ( O
3 CD O
) ) O
selectivity NN O
, , O
G230E NNP O
exhibits VBZ O
outward JJ O
rectification NN O
at IN O
positive JJ O
potentials NNS O
and CC O
a DT O
thiocyanate NN O
> NN O
NO NNP O
( ( O
3 CD O
) ) O
> NN O
I PRP O
> VBP O
Br NNP O
> NNP O
Cl NNP O
> NNP O
CH NNP O
( ( O
3 CD O
) ) O
SO NNP O
( ( O
3 CD O
) ) O
selectivity NN O
. . O

Furthermore RB O
, , O
the DT O
cation NN O
- : O
to TO O
- : O
anion NN O
permeability NN O
ratio NN O
of IN O
the DT O
mutant NN O
is VBZ O
much RB O
greater JJR O
than IN O
that DT O
of IN O
the DT O
wild JJ O
- : O
type NN O
channel NN O
. . O

Voltage NNP O
- : O
dependent NN O
blocks NNS O
by IN O
intracellular JJ O
and CC O
extracellular JJ O
iodide NN O
help NN O
to TO O
distinguish VB O
two CD O
distinct JJ O
ion NN O
binding VBG O
sites NNS O
within IN O
the DT O
hClC NN O
- : O
1 CD O
conduction NN O
pathway NN O
. . O

Both DT O
binding VBG O
sites NNS O
are VBP O
preserved VBN O
in IN O
the DT O
mutant NN O
but CC O
have VBP O
decreased VBN O
affinities NNS O
for IN O
iodide NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
Gly NNP O
230 CD O
is VBZ O
critical JJ O
for IN O
normal JJ O
ion NN O
conductance NN O
in IN O
hClC JJ O
- : O
1 CD O
and CC O
that IN O
this DT O
residue JJ O
resides NNS O
within IN O
the DT O
channel NN O
pore NN O
. . O
. . O

The DT O
incidence NN O
of IN O
PAX6 NNP O
mutation NN O
in IN O
patients NNS O
with IN O
simple JJ O
aniridia NN B-Disease
: : O
an DT O
evaluation NN O
of IN O
mutation NN O
detection NN O
in IN O
12 CD O
cases NNS O
. . O

Twelve NNP O
aniridia NN B-Disease
patients NNS O
, , O
five CD O
with IN O
a DT O
family NN O
history NN O
and CC O
seven CD O
presumed VBD O
to TO O
be VB O
sporadic JJ O
, , O
were VBD O
exhaustively RB O
screened VBN O
in IN O
order NN O
to TO O
test VB O
what WP O
proportion NN O
of IN O
people NNS O
with IN O
aniridia NN B-Disease
, , O
uncomplicated VBN O
by IN O
associated JJ O
anomalies NNS O
, , O
carry VBP O
mutations NNS O
in IN O
the DT O
human JJ O
PAX6 NNP O
gene NN O
. . O

Mutations NNS O
were VBD O
detected VBN O
in IN O
90 CD O
% NN O
of IN O
the DT O
cases NNS O
. . O

Three CD O
mutation NN O
detection NN O
techniques NNS O
were VBD O
used VBN O
to TO O
determine VB O
if IN O
one CD O
method NN O
was VBD O
superior JJ O
for IN O
this DT O
gene NN O
. . O

The DT O
protein NN O
truncation NN O
test NN O
( ( O
PTT NNP O
) ) O
was VBD O
used VBN O
on IN O
RT NNP O
- : O
PCR NN O
products NNS O
, , O
SSCP NNP O
on IN O
genomic JJ O
PCR NNP O
amplifications NNS O
, , O
and CC O
chemical JJ O
cleavage NN O
of IN O
mismatch NN O
on IN O
both DT O
RT NNP O
- : O
PCR NN O
and CC O
genomic JJ O
amplifications NNS O
. . O

For IN O
RT NNP O
- : O
PCR NN O
products NNS O
, , O
only RB O
the DT O
translated JJ O
portion NN O
of IN O
the DT O
gene NN O
was VBD O
screened VBN O
. . O

On IN O
genomic JJ O
products NNS O
exons NNS O
1 CD O
to TO O
13 CD O
( ( O
including VBG O
740 CD O
bp NN O
of IN O
the DT O
3 CD O
untranslated JJ O
sequence NN O
and CC O
all DT O
intron NN O
/ NNP O
exon NNP O
boundaries NNS O
) ) O
were VBD O
screened VBN O
, , O
as IN O
was VBD O
a DT O
neuroretina JJ O
specific JJ O
enhancer NN O
in IN O
intron NN O
4 CD O
. . O

Ten CD O
of IN O
the DT O
possible JJ O
12 CD O
mutations NNS O
in IN O
the DT O
five CD O
familial JJ O
cases NNS O
and CC O
five CD O
of IN O
the DT O
sporadic JJ O
patients NNS O
were VBD O
found VBN O
, , O
all DT O
of IN O
which WDT O
conformed VBD O
to TO O
a DT O
functional JJ O
outcome NN O
of IN O
haploinsufficiency NN O
. . O

Five CD O
were VBD O
splice NN O
site NN O
mutations NNS O
( ( O
one CD O
in IN O
the DT O
donor JJ O
site NN O
of IN O
intron NN O
4 CD O
, , O
two CD O
in IN O
the DT O
donor JJ O
site NN O
of IN O
intron NN O
6 CD O
, , O
one CD O
in IN O
each DT O
of IN O
the DT O
acceptor NN O
sites NNS O
of IN O
introns NNS O
8 CD O
and CC O
9 CD O
) ) O
and CC O
five CD O
were VBD O
nonsense JJ O
mutations NNS O
in IN O
exons NNS O
8 CD O
, , O
9 CD O
, , O
10 CD O
, , O
11 CD O
, , O
and CC O
12 CD O
. . O

SSCP NNP O
analysis NN O
of IN O
individually RB O
amplified JJ O
exons NNS O
, , O
with IN O
which WDT O
nine CD O
of IN O
the DT O
10 CD O
mutations NNS O
were VBD O
seen VBN O
, , O
was VBD O
the DT O
most RBS O
useful JJ O
detection NN O
method NN O
for IN O
PAX6 NNP O
. . O
. . O

Insulin NNP O
gene NN O
region NN O
contributes NNS O
to TO O
genetic JJ O
susceptibility NN O
to TO O
, , O
but CC O
may MD O
not RB O
to TO O
low JJ O
incidence NN O
of IN O
, , O
insulin FW B-Disease
- : I-Disease
dependent NN I-Disease
diabetes VBZ I-Disease
mellitus NNS I-Disease
in IN O
Japanese JJ O
. . O

In IN O
the DT O
Caucasian JJ O
population NN O
, , O
it PRP O
has VBZ O
been VBN O
demonstrated VBN O
that IN O
the DT O
insulin NN O
gene NN O
( ( O
INS NNP O
) ) O
region NN O
contains VBZ O
the DT O
insulin NN B-Disease
- : I-Disease
dependent NN I-Disease
diabetes VBZ I-Disease
mellitus JJ I-Disease
locus NN O
( ( O
IDDM2 NNP O
) ) O
. . O

In IN O
the DT O
Japanese JJ O
population NN O
, , O
however RB O
, , O
there EX O
has VBZ O
been VBN O
no DT O
report NN O
demonstrating VBG O
the DT O
contribution NN O
of IN O
IDDM2 NNP O
to TO O
the DT O
pathogenesis NN O
of IN O
IDDM NNP B-Disease
. . O

We PRP O
conducted VBD O
an DT O
association NN O
study NN O
of IN O
IDDM NNP B-Disease
in IN O
a DT O
large JJ O
number NN O
of IN O
Japanese JJ O
subjects NNS O
with IN O
multiple JJ O
polymorphisms NNS O
in IN O
INS NNP O
region NN O
. . O

We PRP O
found VBD O
a DT O
significant JJ O
association NN O
of IN O
the DT O
INS NNP O
region NN O
with IN O
IDDM NNP B-Disease
. . O

Alleles NNS O
positively RB O
associated VBN O
with IN O
IDDM NNP B-Disease
in IN O
INS NNP O
region NN O
were VBD O
the DT O
same JJ O
as IN O
those DT O
positively JJ O
- : O
associated VBN O
with IN O
IDDM NNP B-Disease
in IN O
Caucasian NNP O
population NN O
, , O
although IN O
positively RB O
- : O
associated VBN O
alleles NNS O
are VBP O
very RB O
common JJ O
( ( O
allele JJ O
frequencies NNS O
> VBP O
0 CD O
. . O
9 CD O
) ) O
in IN O
the DT O
Japanese JJ O
general JJ O
population NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
IDDM2 NNP O
is VBZ O
involved VBN O
in IN O
the DT O
genetic JJ O
susceptibility NN O
to TO O
IDDM NNP B-Disease
in IN O
Japanese NNP O
. . O

The DT O
high JJ O
frequencies NNS O
of IN O
disease NN O
- : O
associated VBN O
alleles NNS O
in IN O
the DT O
general JJ O
population NN O
suggest VBP O
that IN O
IDDM2 NNP O
locus NN O
is VBZ O
not RB O
responsible JJ O
for IN O
the DT O
low JJ O
incidence NN O
of IN O
IDDM NNP B-Disease
in IN O
Japanese NNP O
. . O

The DT O
human JJ O
complement NN O
C9 NNP O
gene NN O
: : O
identification NN O
of IN O
two CD O
mutations NNS O
causing VBG O
deficiency NN O
and CC O
revision NN O
of IN O
the DT O
gene NN O
structure NN O
. . O

The DT O
ninth JJ O
component NN O
of IN O
human JJ O
complement NN O
( ( O
C9 NNP O
) ) O
is VBZ O
the DT O
last JJ O
of IN O
the DT O
terminal JJ O
complement NN O
components NNS O
creating VBG O
the DT O
membrane NN O
attack NN O
complex NN O
. . O

C9 NNP O
is VBZ O
a DT O
single JJ O
- : O
chain NN O
serum NN O
protein NN O
that WDT O
is VBZ O
encoded VBN O
by IN O
a DT O
gene NN O
located VBN O
on IN O
chromosome NN O
5p CD O
. . O

Deficiency NN B-Disease
of IN I-Disease
terminal JJ I-Disease
complement NN I-Disease
components NNS I-Disease
is VBZ O
generally RB O
associated VBN O
with IN O
recurrent NN O
neisseria NNS B-Disease
infections NNS I-Disease
. . O

We PRP O
studied VBD O
a DT O
previously RB O
described VBN O
Swiss JJ O
family NN O
with IN O
inherited JJ B-Disease
C9 NNP I-Disease
deficiency NN I-Disease
. . O

To TO O
identify VB O
the DT O
genetic JJ O
basis NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
, , O
we PRP O
developed VBD O
an DT O
approach NN O
using VBG O
exon JJ O
- : O
specific JJ O
PCR NNP O
and CC O
direct JJ O
DNA NNP O
sequencing NN O
. . O

As IN O
a DT O
cause NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
, , O
we PRP O
found VBD O
two CD O
different JJ O
point NN O
mutations NNS O
, , O
both DT O
generating VBG O
TGA NNP O
stop JJ O
codons NNS O
in IN O
the DT O
coding NN O
sequence NN O
. . O

One CD O
mutation NN O
, , O
a DT O
C NNP O
to TO O
A NNP O
exchange NN O
, , O
was VBD O
detected VBN O
in IN O
exon JJ O
2 CD O
at IN O
cDNA NN O
position NN O
166 CD O
, , O
the DT O
other JJ O
, , O
a DT O
C NNP O
to TO O
T NNP O
exchange NN O
, , O
was VBD O
located VBN O
in IN O
exon JJ O
4 CD O
( ( O
cDNA JJ O
position NN O
464 CD O
) ) O
. . O

In IN O
family NN O
studies NNS O
of IN O
three CD O
first JJ O
- : O
degree NN O
relatives NNS O
with IN O
heterozygous JJ O
C9 NNP B-Disease
deficiency NN I-Disease
, , O
we PRP O
demonstrated VBD O
that IN O
the DT O
two CD O
mutations NNS O
are VBP O
segregating VBG O
independently RB O
. . O

Therefore RB O
, , O
these DT O
mutations NNS O
are VBP O
sufficient JJ O
to TO O
explain VB O
the DT O
complete JJ O
deficiency NN O
of IN O
both CC O
the DT O
probands NNS O
studied VBN O
. . O

DNA NN O
sequencing NN O
of IN O
the DT O
exon JJ O
- : O
intron NN O
junctions NNS O
revealed VBD O
a DT O
number NN O
of IN O
revisions NNS O
regarding VBG O
the DT O
boundaries NNS O
between IN O
exons NNS O
4 CD O
, , O
5 CD O
, , O
and CC O
6 CD O
as RB O
well RB O
as IN O
between IN O
exons NNS O
10 CD O
and CC O
11 CD O
. . O

No DT O
additional JJ O
introns NNS O
were VBD O
detected VBN O
in IN O
exons NNS O
6 CD O
and CC O
10 CD O
. . O

Furthermore RB O
, , O
DNA NNP O
marker NN O
studies NNS O
were VBD O
conducted VBN O
using VBG O
known VBN O
polymorphisms NNS O
of IN O
the DT O
C6 NNP O
, , O
C7 NNP O
, , O
and CC O
C9 NNP O
genes NNS O
, , O
confirming VBG O
the DT O
linkage NN O
of IN O
the DT O
observed JJ O
C9 NNP O
mutations NNS O
with IN O
defined JJ O
haplotypes NNS O
. . O
. . O

BRCA1 NNP O
mutations NNS O
in IN O
women NNS O
attending VBG O
clinics NNS O
that WDT O
evaluate VBP O
the DT O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
. . O

BACKGROUND NNP O
To TO O
define VB O
the DT O
incidence NN O
of IN O
BRCA1 NNP O
mutations NNS O
among IN O
patients NNS O
seen VBN O
in IN O
clinics NNS O
that WDT O
evaluate VBP O
the DT O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
, , O
we PRP O
analyzed VBD O
DNA NNP O
samples NNS O
from IN O
women NNS O
seen VBN O
in IN O
this DT O
setting NN O
and CC O
constructed VBN O
probability NN O
tables NNS O
to TO O
provide VB O
estimates NNS O
of IN O
the DT O
likelihood NN O
of IN O
finding VBG O
a DT O
BRCA1 NNP O
mutation NN O
in IN O
individual JJ O
families NNS O
. . O

METHODS NNP O
Clinical NNP O
information NN O
, , O
family NN O
histories NNS O
, , O
and CC O
blood NN O
for IN O
DNA NN O
analysis NN O
were VBD O
obtained VBN O
from IN O
263 CD O
women NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
. . O

Conformation NNP O
- : O
sensitive JJ O
gel NN O
electrophoresis NN O
and CC O
DNA NNP O
sequencing NN O
were VBD O
used VBN O
to TO O
identify VB O
BRCA1 NNP O
mutations NNS O
. . O

RESULTS NNP O
BRCA1 NNP O
mutations NNS O
were VBD O
identified VBN O
in IN O
16 CD O
percent NN O
of IN O
women NNS O
with IN O
a DT O
family NN O
history NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
. . O

Only RB O
7 CD O
percent NN O
of IN O
women NNS O
from IN O
families NNS O
with IN O
a DT O
history NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
but CC O
not RB O
ovarian JJ B-Disease
cancer NN I-Disease
had VBD O
BRCA1 NNP O
mutations NNS O
. . O

The DT O
rates NNS O
were VBD O
higher JJR O
among IN O
women NNS O
from IN O
families NNS O
with IN O
a DT O
history NN O
of IN O
both DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
. . O

Among IN O
family NN O
members NNS O
, , O
an DT O
average JJ O
age NN O
of IN O
less JJR O
than IN O
55 CD O
years NNS O
at IN O
the DT O
diagnosis NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
, , O
the DT O
presence NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
, , O
the DT O
presence NN O
of IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
in IN O
the DT O
same JJ O
woman NN O
, , O
and CC O
Ashkenazi NNP O
Jewish NNP O
ancestry NN O
were VBD O
all DT O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
detecting VBG O
a DT O
BRCA1 NNP O
mutation NN O
. . O

No DT O
association NN O
was VBD O
found VBN O
between IN O
the DT O
presence NN O
of IN O
bilateral JJ O
breast NN B-Disease
cancer NN I-Disease
or CC O
the DT O
number NN O
of IN O
breast NN B-Disease
cancers NNS I-Disease
in IN O
a DT O
family NN O
and CC O
the DT O
detection NN O
of IN O
a DT O
BRCA1 NNP O
mutation NN O
, , O
or CC O
between IN O
the DT O
position NN O
of IN O
the DT O
mutation NN O
in IN O
the DT O
BRCA1 NNP O
gene NN O
and CC O
the DT O
presence NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
in IN O
a DT O
family NN O
. . O

CONCLUSIONS NNP O
Among IN O
women NNS O
with IN O
breast NN B-Disease
cancer NN I-Disease
and CC O
a DT O
family NN O
history NN O
of IN O
the DT O
disease NN O
, , O
the DT O
percentage NN O
with IN O
BRCA1 NNP O
coding VBG O
- : O
region NN O
mutations NNS O
is VBZ O
less JJR O
than IN O
the DT O
45 CD O
percent NN O
predicted VBN O
by IN O
genetic JJ O
- : O
linkage NN O
analysis NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
even RB O
in IN O
a DT O
referral JJ O
clinic NN O
specializing VBG O
in IN O
screening VBG O
women NNS O
from IN O
high JJ O
- : O
risk NN O
families NNS O
, , O
the DT O
majority NN O
of IN O
tests NNS O
for IN O
BRCA1 NNP O
mutations NNS O
will MD O
be VB O
negative JJ O
and CC O
therefore RB O
uninformative JJ O
. . O
. . O

Mutations NNS O
in IN O
the DT O
arginine NN O
- : O
rich JJ O
protein NN O
gene NN O
( ( O
ARP NNP O
) ) O
in IN O
pancreatic JJ B-Disease
cancer NN I-Disease
. . O

The DT O
ARP NNP O
gene NN O
encodes VBZ O
a DT O
highly RB O
conserved VBN O
arginine NN O
- : O
rich JJ O
protein NN O
from IN O
chromosomal JJ O
band NN O
3p21 CD O
. . O

1 CD O
1 CD O
. . O

At IN O
the DT O
cytogenetic JJ O
level NN O
this DT O
region NN O
is VBZ O
frequently RB O
deleted VBN O
in IN O
a DT O
variety NN O
of IN O
different JJ O
solid JJ B-Disease
tumors NNS I-Disease
, , O
although IN O
not RB O
in IN O
pancreatic JJ B-Disease
cancer NN I-Disease
. . O

We PRP O
have VBP O
reported VBN O
the DT O
presence NN O
of IN O
a DT O
specific JJ O
mutation NN O
( ( O
ATG50 NNP O
- : O
- : O
> NN O
AGG NNP O
) ) O
or CC O
deletion NN O
of IN O
codon JJ O
50 CD O
of IN O
the DT O
ARP NNP O
gene NN O
in IN O
different JJ O
tumor NN B-Disease
types NNS I-Disease
( ( O
Shridhar NNP O
et RB O
al RB O
. . O
, , O
1996 CD O
, , O
1996a CD O
) ) O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
observed VBN O
mutations NNS O
involving VBG O
codon NN O
50 CD O
in IN O
11 CD O
of IN O
37 CD O
pancreatic JJ B-Disease
tumors NNS I-Disease
. . O

The DT O
frequency NN O
of IN O
codon NN O
50 CD O
mutation NN O
is VBZ O
roughly RB O
the DT O
same JJ O
in IN O
pancreatic JJ B-Disease
tumors NNS I-Disease
as IN O
in IN O
the DT O
other JJ O
types NNS O
of IN O
tumors NNS B-Disease
previously RB O
examined VBN O
. . O

In IN O
addition NN O
, , O
we PRP O
have VBP O
detected VBN O
mutations NNS O
at IN O
codon NN O
51 CD O
in IN O
multiple JJ O
PCR NNP O
subclones NNS O
in IN O
two CD O
other JJ O
pancreatic JJ B-Disease
tumors NNS I-Disease
. . O

Mutations NNS O
in IN O
the DT O
ARP NNP O
gene NN O
are VBP O
thus RB O
commonly RB O
observed VBN O
in IN O
pancreatic JJ B-Disease
cancer NN I-Disease
, , O
as RB O
well RB O
as IN O
many JJ O
other JJ O
cancers NNS B-Disease
. . O

Difficulties NNS O
in IN O
the DT O
ascertainment NN O
of IN O
C9 NNP B-Disease
deficiency NN I-Disease
: : O
lessons NNS O
to TO O
be VB O
drawn VBN O
from IN O
a DT O
compound NN O
heterozygote NN O
C9 NNP B-Disease
- : I-Disease
deficient NN I-Disease
subject NN O
. . O

A DT O
group NN O
of IN O
patients NNS O
with IN O
long JJ O
- : O
surviving VBG O
mismatched VBN O
kidney NN O
allografts NNS O
were VBD O
investigated VBN O
for IN O
complement NN O
function NN O
using VBG O
haemolytic JJ O
assays NNS O
in IN O
agarose JJ O
gels NNS O
. . O

One CD O
patient NN O
was VBD O
found VBN O
to TO O
have VB O
no DT O
alternative JJ O
pathway NN O
activity NN O
but CC O
a DT O
low JJ O
normal JJ O
classical JJ O
pathway NN O
. . O

Surprisingly RB O
, , O
investigation NN O
revealed VBD O
that IN O
the DT O
patients NNS O
complement NN O
was VBD O
normal JJ O
for IN O
all DT O
components NNS O
except IN O
C9 NNP O
, , O
which WDT O
was VBD O
functionally RB O
absent JJ O
. . O

The DT O
patient NN O
was VBD O
shown VBN O
to TO O
be VB O
heterozygous JJ O
for IN O
DNA NN O
markers NNS O
in IN O
the DT O
C6 NNP O
, , O
C7 NNP O
and CC O
C9 NNP O
region NN O
of IN O
chromosome NN O
5 CD O
and CC O
therefore RB O
appears VBZ O
to TO O
be VB O
a DT O
compound NN O
heterozygote NN O
for IN O
two CD O
uncharacterized JJ O
C9 NNP B-Disease
deficiency NN I-Disease
genes NNS O
. . O

Serological JJ O
analysis NN O
by IN O
ELISA NNP O
revealed VBD O
that IN O
he PRP O
has VBZ O
trace NN O
concentrations NNS O
of IN O
a DT O
non JJ O
- : O
functional JJ O
C9 NNP O
molecule NN O
. . O

Western JJ O
blot NN O
analysis NN O
was VBD O
not RB O
sufficiently RB O
sensitive JJ O
to TO O
permit VB O
detection NN O
of IN O
this DT O
molecule NN O
. . O

We PRP O
hypothesize VBP O
that IN O
the DT O
patient NN O
is VBZ O
heterozygous JJ O
for IN O
a DT O
complete JJ B-Disease
deficiency NN I-Disease
of IN I-Disease
C9 NNP I-Disease
and CC O
for IN O
a DT O
gene NN O
directing VBG O
hyposynthesis NN O
of IN O
a DT O
defective JJ O
C9 NNP O
. . O

We PRP O
also RB O
suggest VBP O
that IN O
C9 NNP B-Disease
deficiency NN I-Disease
may MD O
be VB O
more JJR O
common JJ O
among IN O
Caucasians NNPS O
than IN O
has VBZ O
been VBN O
reported VBN O
. . O
. . O

Screening VBG O
for IN O
ESR NNP O
mutations NNS O
in IN O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
patients NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
leukocyte JJ O
DNA NN O
from IN O
143 CD O
patients NNS O
with IN O
familial JJ O
clustering NN O
of IN O
breast NN B-Disease
and CC I-Disease
/ NN I-Disease
or CC I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
and CC O
tumour VB B-Disease
DNA NN O
from IN O
96 CD O
breast NN B-Disease
carcinomas NN I-Disease
were VBD O
screened VBN O
for IN O
base NN O
mutations NNS O
in IN O
the DT O
estrogen NN O
receptor NN O
gene NN O
( ( O
ESR NNP O
) ) O
. . O

Three CD O
patients NNS O
with IN O
a DT O
family NN O
history NN O
of IN O
cancer NN B-Disease
were VBD O
carrying VBG O
a DT O
Gly160Cys NNP O
germline NN O
substitution NN O
. . O

This DT O
alteration NN O
was VBD O
also RB O
detected VBN O
in IN O
eight CD O
( ( O
four CD O
females NNS O
and CC O
four CD O
males NNS O
) ) O
of IN O
729 CD O
controls NNS O
( ( O
366 CD O
female NN O
, , O
363 CD O
males NNS O
) ) O
, , O
indicating VBG O
that IN O
the DT O
substitution NN O
probably RB O
represents VBZ O
a DT O
polymorphism NN O
. . O

However RB O
, , O
in IN O
the DT O
229 CD O
female NN O
controls NNS O
in IN O
whom WP O
family NN O
history NN O
of IN O
cancer NN B-Disease
was VBD O
known VBN O
, , O
one CD O
of IN O
two CD O
who WP O
had VBD O
a DT O
sister NN O
with IN O
breast NN B-Disease
cancer NN I-Disease
was VBD O
carrying VBG O
the DT O
variant JJ O
allele NN O
. . O

Hence NNP O
, , O
a DT O
possible JJ O
clinical JJ O
significance NN O
of IN O
the DT O
glycine NN O
into IN O
cysteine NN O
cannot NN O
be VB O
completely RB O
ruled VBN O
out RP O
and CC O
should MD O
be VB O
further RB O
investigated VBN O
. . O

Somatic JJ O
mutations NNS O
were VBD O
not RB O
detected VBN O
in IN O
any DT O
of IN O
the DT O
tumours NNS B-Disease
studied VBN O
, , O
and CC O
the DT O
present JJ O
data NNS O
do VBP O
not RB O
provide VB O
support NN O
for IN O
somatic JJ O
ESR NNP O
base NN O
mutations NNS O
as IN O
an DT O
important JJ O
mechanism NN O
for IN O
hormonal JJ O
therapy NN O
resistance NN O
in IN O
estrogen NN B-Disease
receptor NN I-Disease
- : I-Disease
positive JJ I-Disease
breast NN I-Disease
carcinomas NN I-Disease
. . O
. . O

Molecular JJ O
bases NNS O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
: : O
three CD O
different JJ O
defects NNS O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
C7 NNP B-Disease
deficiency NN I-Disease
has VBZ O
been VBN O
investigated VBN O
in IN O
two CD O
Irish JJ O
families NNS O
and CC O
a DT O
number NN O
of IN O
Israeli NNP O
families NNS O
of IN O
Moroccan NNP O
Sephardic NNP O
Jewish NNP O
origin NN O
. . O

Exon NNP O
PCR NNP O
and CC O
sequencing VBG O
revealed VBD O
a DT O
heterozygous JJ O
point NN O
mutation NN O
at IN O
the DT O
3 CD O
splice NN O
acceptor NN O
site NN O
of IN O
intron NN O
1 CD O
in IN O
one CD O
Irish JJ O
family NN O
. . O

In IN O
the DT O
other JJ O
Irish JJ O
family NN O
, , O
exons NNS O
7 CD O
and CC O
8 CD O
failed VBD O
to TO O
amplify VB O
and CC O
they PRP O
were VBD O
shown VBN O
to TO O
be VB O
deleted VBN O
. . O

Marker NNP O
haplotype NN O
studies NNS O
of IN O
the DT O
C6 NNP O
and CC O
C7 NNP O
gene NN O
region NN O
and CC O
Southern NNP O
blots NNS O
show VBP O
that IN O
the DT O
Irish NNP O
family NN O
with IN O
the DT O
splice NN O
defect NN O
also RB O
segregate NN O
for IN O
the DT O
deletion NN O
, , O
which WDT O
is VBZ O
not RB O
easily RB O
detected VBN O
in IN O
heterozygotes NNS O
. . O

The DT O
Israeli NNP O
C7 NNP B-Disease
- : I-Disease
deficient NN I-Disease
cases NNS O
all DT O
share NN O
a DT O
C7 NNP O
haplotype NN O
and CC O
are VBP O
homozygous JJ O
for IN O
a DT O
mis JJ O
- : O
sense NN O
mutation NN O
in IN O
exon JJ O
9 CD O
. . O

However RB O
, , O
one CD O
individual NN O
is VBZ O
heterozygous JJ O
for IN O
markers NNS O
at IN O
adjacent JJ O
C6 NNP O
loci NN O
, , O
showing VBG O
that IN O
there EX O
has VBZ O
been VBN O
an DT O
intergenic JJ O
recombination NN O
and CC O
suggesting VBG O
that IN O
the DT O
deficiency NN O
mutation NN O
is VBZ O
of IN O
appreciable JJ O
antiquity NN O
. . O
. . O

Molecular JJ O
heterogeneity NN O
of IN O
classical JJ B-Disease
and CC I-Disease
Duarte NNP I-Disease
galactosemia NN I-Disease
: : O
mutation NN O
analysis NN O
by IN O
denaturing VBG O
gradient JJ O
gel JJ O
electrophoresis NN O
. . O

Classical JJ B-Disease
galactosemia NN I-Disease
is VBZ O
caused VBN O
by IN O
one CD O
common JJ O
missense NN O
mutation NN O
( ( O
Q188R NNP O
) ) O
and CC O
by IN O
several JJ O
rare JJ O
mutations NNS O
in IN O
the DT O
galactose JJ O
- : O
1 CD O
- : O
phosphate NN O
uridyltransferase NN O
( ( O
GALT NNP O
) ) O
gene NN O
. . O

The DT O
most RBS O
common JJ O
variant NN O
of IN O
GALT NNP O
, , O
the DT O
Duarte NNP O
variant NN O
, , O
occurs VBZ O
as IN O
two CD O
types NNS O
, , O
Duarte NNP O
- : O
1 CD O
( ( O
D NNP O
- : O
1 CD O
) ) O
and CC O
Duarte NNP O
- : O
2 CD O
( ( O
D NNP O
- : O
2 CD O
) ) O
, , O
both DT O
of IN O
which WDT O
carry VBP O
the DT O
sequence NN O
change NN O
N314D NNP O
. . O

D NNP O
- : O
1 CD O
increases NNS O
, , O
whereas NNS O
D NNP O
- : O
2 CD O
decreases NNS O
GALT NNP O
activity NN O
. . O

To TO O
study VB O
the DT O
molecular JJ O
genetics NNS O
of IN O
classical JJ B-Disease
and CC I-Disease
Duarte NNP I-Disease
galactosemia NN I-Disease
, , O
we PRP O
analyzed VBD O
the DT O
GALT NNP O
mutations NNS O
in IN O
30 CD O
families NNS O
with IN O
classical JJ B-Disease
galactosemia NN I-Disease
, , O
in IN O
10 CD O
families NNS O
with IN O
the DT O
D NNP O
- : O
2 CD O
variant NN O
and CC O
in IN O
3 CD O
individuals NNS O
carrying VBG O
the DT O
D NNP O
- : O
1 CD O
allele NN O
by IN O
denaturing VBG O
gradient JJ O
gel NN O
electrophoresis NN O
( ( O
DGGE NNP O
) ) O
. . O

DGGE NNP O
detected VBD O
59 CD O
of IN O
the DT O
60 CD O
classical JJ O
galactosemia NN B-Disease
alleles NNS O
. . O

Q188R NNP O
accounted VBD O
for IN O
60 CD O
% NN O
, , O
K285N NNP O
accounted VBD O
for IN O
28 CD O
% NN O
of IN O
these DT O
alleles NNS O
. . O

Eight CD O
novel JJ O
candidate NN O
galactosemia NN B-Disease
mutations NNS O
were VBD O
found VBN O
. . O

On IN O
all DT O
D NNP O
- : O
2 CD O
alleles NNS O
N314D NNP O
occurred VBD O
in IN O
cis NN O
with IN O
two CD O
intronic JJ O
sequence NN O
changes NNS O
, , O
on IN O
the DT O
D NNP O
- : O
1 CD O
alleles NNS O
in IN O
cis NN O
with IN O
a DT O
neutral JJ O
mutation NN O
in IN O
exon JJ O
7 CD O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
mutations NNS O
causing VBG O
galactosemia NN B-Disease
are VBP O
highly RB O
heterogeneous JJ O
and CC O
that DT O
K285N NNP O
is VBZ O
a DT O
second JJ O
common JJ O
galactosemia NN B-Disease
mutation NN O
in IN O
our PRP$ O
population NN O
. . O
. . O

Isolation NN O
of IN O
full JJ O
- : O
length NN O
ATM NNP O
cDNA NN O
and CC O
correction NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
cellular JJ O
phenotype NN O
. . O

A DT O
gene NN O
mutated VBN O
in IN O
the DT O
human JJ O
genetic JJ B-Disease
disorder NN I-Disease
ataxia NN B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
, , O
ATM NNP O
, , O
was VBD O
recently RB O
identified VBN O
by IN O
positional JJ O
cloning NN O
. . O

ATM NNP O
is VBZ O
a DT O
member NN O
of IN O
the DT O
phosphatidylinositol NN O
- : O
3 CD O
- : O
kinase NN O
superfamily RB O
, , O
some DT O
of IN O
which WDT O
are VBP O
protein JJ O
kinases NNS O
and CC O
appear VBP O
to TO O
have VB O
important JJ O
roles NNS O
in IN O
cell NN O
cycle NN O
control NN O
and CC O
radiation NN O
signal JJ O
transduction NN O
. . O

We PRP O
describe VBP O
herein RB O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
the DT O
cloning NN O
of IN O
a DT O
full JJ O
- : O
length NN O
cDNA NN O
for IN O
ATM NNP O
and CC O
correction NN O
of IN O
multiple JJ O
aspects NNS O
of IN O
the DT O
radio NN O
- : O
sensitive JJ O
phenotype NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
cells NNS O
by IN O
transfection NN O
with IN O
this DT O
cDNA NN O
. . O

Overexpression NN O
of IN O
ATM NNP O
cDNA NN O
in IN O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
cells NNS O
enhanced VBD O
the DT O
survival NN O
of IN O
these DT O
cells NNS O
in IN O
response NN O
to TO O
radiation NN O
exposure NN O
, , O
decreased VBN O
radiation NN O
- : O
induced JJ O
chromosome NN O
aberrations NNS O
, , O
reduced VBD O
radio NN O
- : O
resistant JJ O
DNA NNP O
synthesis NN O
, , O
and CC O
partially RB O
corrected VBN O
defective JJ O
cell NN O
cycle NN O
checkpoints NNS O
and CC O
induction NN O
of IN O
stress NN O
- : O
activated VBN O
protein JJ O
kinase NN O
. . O

This DT O
correction NN O
of IN O
the DT O
defects NNS O
in IN O
A NNP B-Disease
- : I-Disease
T NNP I-Disease
cells NNS O
provides VBZ O
further JJ O
evidence NN O
of IN O
the DT O
multiplicity NN O
of IN O
effector NN O
functions NNS O
of IN O
the DT O
ATM NNP O
protein NN O
and CC O
suggests VBZ O
possible JJ O
approaches NNS O
to TO O
gene NN O
therapy NN O
. . O
. . O

Fusion NNP O
genes NNS O
resulting VBG O
from IN O
alternative JJ O
chromosomal JJ O
translocations NNS O
are VBP O
overexpressed VBN O
by IN O
gene NN O
- : O
specific JJ O
mechanisms NNS O
in IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
. . O

Chromosomal JJ O
translocations NNS O
identified VBN O
in IN O
hematopoietic JJ B-Disease
and CC I-Disease
solid JJ I-Disease
tumors NNS I-Disease
result VBP O
in IN O
deregulated JJ O
expression NN O
of IN O
protooncogenes NNS O
or CC O
creation NN O
of IN O
chimeric JJ O
proteins NNS O
with IN O
tumorigenic JJ O
potential NN O
. . O

In IN O
the DT O
pediatric JJ O
solid JJ B-Disease
tumor NN I-Disease
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
, , O
a DT O
consistent JJ O
t NN O
( ( O
2 CD O
; : O
13 CD O
) ) O
( ( O
q35 NN O
; : O
q14 CC O
) ) O
or CC O
variant JJ O
t NN O
( ( O
1 CD O
; : O
13 CD O
) ) O
( ( O
p36 NN O
; : O
q14 CC O
) ) O
translocation NN O
generates VBZ O
PAX3 NNP O
- : O
FKHR NN O
or CC O
PAX7 NNP O
- : O
FKHR NNP O
fusion NN O
proteins NNS O
, , O
respectively RB O
. . O

In IN O
this DT O
report NN O
, , O
we PRP O
demonstrate VBP O
that IN O
in IN O
addition NN O
to TO O
functional JJ O
alterations NNS O
these DT O
translocations NNS O
are VBP O
associated VBN O
with IN O
fusion NN O
product NN O
overexpression NN O
. . O

Furthermore RB O
, , O
PAX3 NNP O
- : O
FKHR NN O
and CC O
PAX7 NNP O
- : O
FKHR NNP O
overexpression NN O
occurs NNS O
by IN O
distinct JJ O
mechanisms NNS O
. . O

Transcription NN O
of IN O
PAX3 NNP O
- : O
FKHR NNP O
is VBZ O
increased VBN O
relative JJ O
to TO O
wild VB O
- : O
type NN O
PAX3 NNP O
by IN O
a DT O
copy NN O
number NN O
- : O
independent JJ O
process NN O
. . O

In IN O
contrast NN O
, , O
PAX7 NNP O
- : O
FKHR NNP O
overexpression NN O
results NNS O
from IN O
fusion JJ O
gene NN O
amplification NN O
. . O

Thus RB O
, , O
gene NN O
- : O
specific JJ O
mechanisms NNS O
were VBD O
selected VBN O
to TO O
overexpress VB O
PAX3 NNP O
- : O
FKHR NN O
and CC O
PAX7 NNP O
- : O
FKHR NN O
in IN O
alveolar JJ B-Disease
rhabdomyosarcoma NN I-Disease
, , O
presumably RB O
due JJ O
to TO O
differences NNS O
in IN O
regulation NN O
between IN O
the DT O
wild JJ O
- : O
type NN O
loci NN O
. . O

We PRP O
postulate VBP O
that IN O
these DT O
overexpression NN O
mechanisms NNS O
ensure VB O
a DT O
critical JJ O
level NN O
of IN O
gene NN O
product NN O
for IN O
the DT O
oncogenic JJ O
effects NNS O
of IN O
these DT O
fusions NNS O
. . O
. . O

atm NN O
and CC O
p53 NN O
cooperate NN O
in IN O
apoptosis NN O
and CC O
suppression NN O
of IN O
tumorigenesis NN O
, , O
but CC O
not RB O
in IN O
resistance NN O
to TO O
acute VB B-Disease
radiation NN I-Disease
toxicity NN I-Disease
. . O

Mutations NNS O
in IN O
atm NN O
and CC O
p53 NN O
cause VBP O
the DT O
human JJ O
cancer NN B-Disease
- : I-Disease
associated VBN I-Disease
diseases NNS I-Disease
ataxia VBP B-Disease
- : I-Disease
telangiectasia NN I-Disease
and CC O
Li NNP B-Disease
- : I-Disease
Fraumeni NNP I-Disease
syndrome NN I-Disease
, , O
respectively RB O
. . O

The DT O
two CD O
genes NNS O
are VBP O
believed VBN O
to TO O
interact VB O
in IN O
a DT O
number NN O
of IN O
pathways NNS O
, , O
including VBG O
regulation NN O
of IN O
DNA NNP O
damage NN O
- : O
induced VBN O
cell NN O
- : O
cycle NN O
checkpoints NNS O
, , O
apoptosis NN O
and CC O
radiation NN O
sensitivity NN O
, , O
and CC O
cellular JJ O
proliferation NN O
. . O

Atm NNP O
- : O
null JJ O
mice NN O
, , O
as RB O
well RB O
as IN O
those DT O
null JJ O
for IN O
p53 NN O
, , O
develop VB O
mainly RB O
T NNP B-Disease
- : I-Disease
cell NN I-Disease
lymphomas NN I-Disease
, , O
supporting VBG O
the DT O
view NN O
that IN O
these DT O
genes NNS O
have VBP O
similar JJ O
roles NNS O
in IN O
thymocyte NN O
development NN O
. . O

To TO O
study VB O
the DT O
interactions NNS O
of IN O
these DT O
two CD O
genes NNS O
on IN O
an DT O
organismal JJ O
level NN O
, , O
we PRP O
bred VBD O
mice RB O
heterozygous JJ O
for IN O
null JJ O
alleles NNS O
of IN O
both DT O
atm NNS O
and CC O
p53 NN O
to TO O
produce VB O
all DT O
genotypic NN O
combinations NNS O
. . O

Mice NNP O
doubly RB O
null RB O
for IN O
atm NN O
and CC O
p53 NN O
exhibited VBD O
a DT O
dramatic JJ O
acceleration NN O
of IN O
tumour JJ B-Disease
formation NN O
relative NN O
to TO O
singly RB O
null JJ O
mice NN O
, , O
indicating VBG O
that IN O
both DT O
genes NNS O
collaborate VBP O
in IN O
a DT O
significant JJ O
manner NN O
to TO O
prevent VB O
tumorigenesis NN O
. . O

With IN O
respect NN O
to TO O
their PRP$ O
roles NNS O
in IN O
apoptosis NN O
, , O
loss NN O
of IN O
atm NN O
rendered VBN O
thymocytes VBZ O
only RB O
partly RB O
resistant JJ O
to TO O
irradiation VB O
- : O
induced JJ O
apoptosis NN O
, , O
whereas JJ O
additional JJ O
loss NN O
of IN O
p53 NN O
engendered VBD O
complete JJ O
resistance NN O
. . O

This DT O
implies VBZ O
that IN O
the DT O
irradiation NN O
- : O
induced JJ O
atm NN O
and CC O
p53 NN O
apoptotic JJ O
pathways NNS O
are VBP O
not RB O
completely RB O
congruent JJ O
. . O

Finally RB O
- : O
and CC O
in IN O
contrast NN O
to TO O
prior VB O
predictions NNS O
- : O
atm NN O
and CC O
p53 NN O
do VBP O
not RB O
appear VB O
to TO O
interact VB O
in IN O
acute JJ B-Disease
radiation NN I-Disease
toxicity NN I-Disease
, , O
suggesting VBG O
a DT O
separate JJ O
atm NN O
effector NN O
pathway NN O
for IN O
this DT O
DNA NNP O
damage NN O
response NN O
and CC O
having VBG O
implications NNS O
for IN O
the DT O
prognosis NN O
and CC O
treatment NN O
of IN O
human JJ O
tumours NNS B-Disease
. . O
. . O

Trinucleotide NNP O
repeat NN O
expansion NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
locus NN O
reduces VBZ O
expression NN O
of IN O
DMAHP NNP O
. . O

Myotonic NNP B-Disease
dystrophy NN I-Disease
, , O
or CC O
dystrophia NN B-Disease
myotonica NN I-Disease
( ( O
DM NNP B-Disease
) ) O
, , O
is VBZ O
an DT O
autosomal JJ B-Disease
dominant JJ I-Disease
multisystem NN I-Disease
disorder NN I-Disease
caused VBN O
by IN O
the DT O
expansion NN O
of IN O
a DT O
CTG NNP O
trinucleotide NN O
repeat NN O
in IN O
the DT O
3 CD O
untranslated JJ O
region NN O
of IN O
the DT O
DMPK NNP O
protein NN O
kinase VBD O
gene NN O
on IN O
chromosome NN O
19q13 CD O
. . O

3 CD O
( ( O
refs VB O
1 CD O
- : O
3 CD O
) ) O
. . O

Although IN O
the DT O
DM NNP B-Disease
mutation NN O
was VBD O
identified VBN O
more JJR O
than IN O
five CD O
years NNS O
ago RB O
, , O
the DT O
pathogenic JJ O
mechanisms NN O
underlying VBG O
this DT O
most RBS O
prevalent JJ O
form NN O
of IN O
hereditary JJ O
adult NN O
neuromuscular JJ B-Disease
disease NN I-Disease
remain VBP O
elusive JJ O
. . O

Previous JJ O
work NN O
from IN O
our PRP$ O
laboratory NN O
demonstrated VBD O
that IN O
a DT O
DNase NNP O
l NN O
- : O
hypersensitive JJ O
site NN O
located VBN O
adjacent JJ O
to TO O
the DT O
repeats NNS O
on IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
is VBZ O
eliminated VBN O
by IN O
repeat NN O
expansion NN O
, , O
indicating VBG O
that IN O
large JJ O
CTG NNP O
- : O
repeat NN O
arrays NNS O
may MD O
be VB O
associated VBN O
with IN O
a DT O
local JJ O
chromatin NN O
environment NN O
that WDT O
represses VBZ O
gene NN O
expression NN O
. . O

Here RB O
we PRP O
report VBP O
that IN O
the DT O
hypersensitive JJ O
site NN O
contains VBZ O
an DT O
enhancer NN O
element NN O
that WDT O
regulates VBZ O
transcription NN O
of IN O
the DT O
adjacent JJ O
DMAHP NNP O
homeobox NN O
gene NN O
. . O

Analysis NN O
of IN O
DMAHP NNP O
expression NN O
in IN O
the DT O
cells NNS O
of IN O
DM NNP B-Disease
patients NNS O
with IN O
loss NN O
of IN O
the DT O
hypersensitive JJ O
site NN O
revealed VBD O
a DT O
two CD O
- : O
to TO O
fourfold VB O
reduction NN O
in IN O
steady JJ O
- : O
state NN O
DMAHP NNP O
transcript NN O
levels NNS O
relative VBP O
to TO O
wild VB O
- : O
type NN O
controls NNS O
. . O

Allele NNP O
- : O
specific JJ O
analysis NN O
of IN O
DMAHP NNP O
expression NN O
showed VBD O
that IN O
steady JJ O
- : O
state NN O
transcript NN O
levels NNS O
from IN O
the DT O
expanded VBN O
allele NN O
were VBD O
greatly RB O
reduced VBN O
in IN O
comparison NN O
to TO O
those DT O
from IN O
the DT O
wild JJ O
- : O
type NN O
allele NN O
. . O

Together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
CTG NNP O
- : O
repeat NN O
expansions NNS O
can MD O
suppress VB O
local JJ O
gene NN O
expression NN O
and CC O
implicate NN O
DMAHP NNP O
in IN O
DM NNP B-Disease
pathogenesis NN O
. . O

Constitutively RB O
methylated VBN O
CpG NNP O
dinucleotides NNS O
as IN O
mutation NN O
hot JJ O
spots NNS O
in IN O
the DT O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
. . O

A DT O
wide JJ O
spectrum NN O
of IN O
mutations NNS O
, , O
ranging VBG O
from IN O
point NN O
mutations NNS O
to TO O
large JJ O
deletions NNS O
, , O
have VBP O
been VBN O
described VBN O
in IN O
the DT O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
. . O

Mutations NNS O
have VBP O
been VBN O
found VBN O
throughout IN O
the DT O
gene NN O
; : O
however RB O
, , O
these DT O
genetic JJ O
alterations NNS O
do VBP O
not RB O
appear VB O
to TO O
be VB O
homogeneously RB O
distributed VBN O
. . O

In IN O
particular JJ O
, , O
a DT O
significant JJ O
proportion NN O
of IN O
disease NN O
- : O
causing NN O
mutations NNS O
results NNS O
in IN O
the DT O
premature JJ O
termination NN O
of IN O
protein JJ O
synthesis NN O
, , O
and CC O
the DT O
majority NN O
of IN O
these DT O
mutations NNS O
occur VBP O
as IN O
C NNP O
- : O
- : O
> NN O
T NNP O
transitions NNS O
at IN O
CpG NNP O
dinucleotides NNS O
( ( O
CpGs NNP O
) ) O
. . O

Such JJ O
recurrent NN O
CpG NNP O
mutations NNS O
, , O
including VBG O
those DT O
found VBN O
in IN O
RB1 NNP O
, , O
are VBP O
likely JJ O
the DT O
result NN O
of IN O
the DT O
deamination NN O
of IN O
5 CD O
- : O
methylcytosine NN O
within IN O
these DT O
CpGs NNP O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
used VBD O
the DT O
sodiumbisulfite JJ O
conversion NN O
method NN O
to TO O
detect VB O
cytosine JJ O
methylation NN O
in IN O
representative JJ O
exons NNS O
of IN O
RB1 NNP O
. . O

We PRP O
analyzed VBD O
DNA NN O
from IN O
a DT O
variety NN O
of IN O
tissues NNS O
and CC O
specifically RB O
targeted VBD O
CGA NNP O
codons NNS O
in IN O
RB1 NNP O
, , O
where WRB O
recurrent JJ O
premature NN O
termination NN O
mutations NNS O
have VBP O
been VBN O
reported VBN O
. . O

We PRP O
found VBD O
that IN O
DNA NNP O
methylation NN O
within IN O
RB1 NNP O
exons NNS O
8 CD O
, , O
14 CD O
, , O
25 CD O
, , O
and CC O
27 CD O
appeared VBD O
to TO O
be VB O
restricted VBN O
to TO O
CpGs NNP O
, , O
including VBG O
six CD O
CGA NNP O
codons NNS O
. . O

Other JJ O
codons NNS O
containing VBG O
methylated VBN O
cytosines NNS O
have VBP O
not RB O
been VBN O
reported VBN O
to TO O
be VB O
mutated VBN O
. . O

Therefore RB O
, , O
disease VB O
- : O
causing NN O
mutations NNS O
at IN O
CpGs NNP O
in IN O
RB1 NNP O
appear VBP O
to TO O
be VB O
determined VBN O
by IN O
several JJ O
factors NNS O
, , O
including VBG O
the DT O
constitutive JJ O
presence NN O
of IN O
DNA NNP O
methylation NN O
at IN O
cytosines NNS O
within IN O
CpGs NNP O
, , O
the DT O
specific JJ O
codon NN O
within IN O
which WDT O
the DT O
methylated JJ O
cytosine NN O
is VBZ O
located VBN O
, , O
and CC O
the DT O
particular JJ O
region NN O
of IN O
the DT O
gene NN O
within IN O
which WDT O
that IN O
codon NN O
resides NNS O
. . O
. . O

The DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
product NN O
interacts NNS O
with IN O
Sp1 NNP O
to TO O
repress VB O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
promoter NN O
activity NN O
. . O

The DT O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
tumor NN I-Disease
suppressor NN O
gene NN O
( ( O
VHL NNP O
) ) O
has VBZ O
a DT O
critical JJ O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
clear JJ B-Disease
- : I-Disease
cell NN I-Disease
renal JJ I-Disease
cell NN I-Disease
carcinoma NN I-Disease
( ( O
RCC NNP B-Disease
) ) O
, , O
as IN O
VHL NNP O
mutations NNS O
have VBP O
been VBN O
found VBN O
in IN O
both DT O
von NNP B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
- : I-Disease
associated VBN I-Disease
and CC I-Disease
sporadic JJ I-Disease
RCCs NNP I-Disease
. . O

Recent JJ O
studies NNS O
suggest VBP O
that IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( ( O
VEGF NNP O
) ) O
mRNA NN O
is VBZ O
upregulated VBN O
in IN O
RCC NNP B-Disease
- : I-Disease
and CC I-Disease
von VB I-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
- : I-Disease
associated VBN I-Disease
tumors NNS I-Disease
. . O

We PRP O
have VBP O
therefore RB O
assessed VBN O
the DT O
effect NN O
of IN O
the DT O
VHL NNP O
gene NN O
product NN O
on IN O
VEGF NNP O
expression NN O
. . O

VEGF NNP O
promoter NN O
- : O
luciferase NN O
constructs NNS O
were VBD O
transiently RB O
cotransfected VBN O
with IN O
a DT O
wild JJ O
- : O
type NN O
VHL NNP O
( ( O
wt SYM O
- : O
VHL NN O
) ) O
vector NN O
in IN O
several JJ O
cell NN O
lines NNS O
, , O
including VBG O
293 CD O
embryonic JJ O
kidney NN O
and CC O
RCC NNP B-Disease
cell NN O
lines NNS O
. . O

wt SYM O
- : O
VHL NNP O
protein NN O
inhibited VBD O
VEGF NNP O
promoter NN O
activity NN O
in IN O
a DT O
dose JJ O
- : O
dependent NN O
manner NN O
up IN O
to TO O
5 CD O
- : O
to TO O
10 CD O
- : O
fold NN O
. . O

Deletion NN O
analysis NN O
defined VBD O
a DT O
144 CD O
- : O
bp JJ O
region NN O
of IN O
the DT O
VEGF NNP O
promoter NN O
necessary JJ O
for IN O
VHL NNP O
repression NN O
. . O

This DT O
VHL NNP O
- : O
responsive JJ O
element NN O
is VBZ O
GC NNP O
rich JJ O
and CC O
specifically RB O
binds VBZ O
the DT O
transcription NN O
factor NN O
Sp1 NNP O
in IN O
crude JJ O
nuclear JJ O
extracts NNS O
. . O

In IN O
Drosophila NNP O
cells NNS O
, , O
cotransfected VBD O
VHL NNP O
represses NNS O
Sp1 NNP O
- : O
mediated VBN O
activation NN O
but CC O
not RB O
basal JJ O
activity NN O
of IN O
the DT O
VEGF NNP O
promoter NN O
. . O

We PRP O
next RB O
demonstrated VBD O
in IN O
coimmunoprecipitates NNS O
that IN O
VHL NNP O
and CC O
Sp1 NNP O
were VBD O
part NN O
of IN O
the DT O
same JJ O
complex NN O
and CC O
, , O
by IN O
using VBG O
a DT O
glutathione NN O
- : O
S NNP O
- : O
transferase NN O
- : O
VHL NNP O
fusion NN O
protein NN O
and CC O
purified JJ O
Sp1 NNP O
, , O
that IN O
VHL NNP O
and CC O
Sp1 NNP O
directly RB O
interact VBP O
. . O

Furthermore RB O
, , O
endogenous JJ O
VEGF NNP O
mRNA NN O
levels NNS O
were VBD O
suppressed VBN O
in IN O
permanent JJ O
RCC NNP B-Disease
cell NN O
lines NNS O
expressing VBG O
wt SYM O
- : O
VHL NN O
, , O
and CC O
nuclear JJ O
run NN O
- : O
on IN O
studies NNS O
indicated VBD O
that IN O
VHL NNP O
regulation NN O
of IN O
VEGF NNP O
occurs VBZ O
at IN O
least JJS O
partly RB O
at IN O
the DT O
transcriptional JJ O
level NN O
. . O

These DT O
observations NNS O
support VBP O
a DT O
new JJ O
mechanism NN O
for IN O
VHL NNP O
- : O
mediated VBD O
transcriptional JJ O
repression NN O
via IN O
a DT O
direct JJ O
inhibitory NN O
action NN O
on IN O
Sp1 NNP O
and CC O
suggest VBP O
that IN O
loss NN O
of IN O
Sp1 NNP O
inhibition NN O
may MD O
be VB O
important JJ O
in IN O
the DT O
pathogenesis NN O
of IN O
von NN B-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
and CC O
RCC NNP B-Disease
. . O
. . O

Adult NNP B-Disease
onset MD I-Disease
globoid VB I-Disease
cell NN I-Disease
leukodystrophy NN I-Disease
( ( O
Krabbe NNP B-Disease
disease NN I-Disease
) ) O
: : O
analysis NN O
of IN O
galactosylceramidase NN O
cDNA NN O
from IN O
four CD O
Japanese JJ O
patients NNS O
. . O

We PRP O
examined VBD O
galactosylceramidase NN O
( ( O
GALC NNP O
) ) O
cDNA NN O
in IN O
four CD O
Japanese JJ O
patients NNS O
with IN O
adult JJ B-Disease
onset VBN I-Disease
globoid NN I-Disease
cell NN I-Disease
leukodystrophy NN I-Disease
( ( O
Krabbe NNP B-Disease
disease NN I-Disease
; : O
AO NNP B-Disease
- : I-Disease
GLD NN I-Disease
) ) O
by IN O
polymerase NN O
chain NN O
reaction NN O
/ NNP O
single JJ O
- : O
strand NN O
conformation NN O
polymorphism NN O
( ( O
PCR NNP O
- : O
SSCP NN O
) ) O
analysis NN O
, , O
subsequent JJ O
sequence NN O
determination NN O
, , O
and CC O
restriction NN O
enzyme FW O
digestion NN O
of IN O
PCR NNP O
products NNS O
, , O
initial JJ O
symptoms NNS O
were VBD O
the DT O
onset NN O
of IN O
slowly RB O
progressive JJ O
spastic JJ B-Disease
paraplegia NN I-Disease
from IN O
the DT O
middle NN O
of IN O
the DT O
second JJ O
decade NN O
, , O
and CC O
all DT O
patients NNS O
had VBD O
diminished VBN B-Disease
GALC NNP I-Disease
activity NN I-Disease
in IN O
their PRP$ O
leukocytes NNS O
. . O

We PRP O
identified VBD O
three CD O
missense NN O
mutations NNS O
( ( O
I66M NNP O
, , O
G270D NNP O
, , O
L618S NNP O
) ) O
and CC O
one CD O
exon NN O
- : O
6 CD O
skipping NN O
( ( O
535 CD O
- : O
573del CD O
) ) O
. . O

Two CD O
of IN O
the DT O
patients NNS O
had VBD O
only RB O
the DT O
I66M NNP O
mutant NN O
mRNA NN O
, , O
and CC O
one CD O
only RB O
the DT O
G27OD NNP O
mutant NN O
mRNA NN O
. . O

The DT O
fourth JJ O
patient NN O
carried VBD O
a DT O
compound NN O
heterozygous JJ O
mutation NN O
of IN O
535 CD O
- : O
573del CD O
and CC O
L618S NNP O
. . O

To TO O
determine VB O
the DT O
enzymatic JJ O
activities NNS O
produced VBN O
by IN O
these DT O
mutations NNS O
, , O
we PRP O
constructed VBD O
mutated VBN O
GALC NNP O
cDNAs NN O
and CC O
expressed VBD O
them PRP O
in IN O
COS NNP O
- : O
1 CD O
cells NNS O
. . O

Three CD O
mutations NNS O
, , O
viz NN O
. . O
, , O
G270D NNP O
, , O
L618S NNP O
, , O
and CC O
exon SYM O
- : O
6 CD O
skipping NN O
( ( O
535 CD O
- : O
573del CD O
) ) O
, , O
produced VBD O
diminished JJ B-Disease
GALC NNP I-Disease
activity NN I-Disease
as IN O
expected VBN O
. . O

The DT O
I66M NNP O
mutation NN O
in IN O
the DT O
wild JJ O
- : O
type NN O
GALC NNP O
cDNA NN O
( ( O
I289 NNP O
) ) O
had VBD O
normal JJ O
activity NN O
, , O
but CC O
when WRB O
this DT O
mutation NN O
and CC O
the DT O
V289 NNP O
polymorphism NN O
were VBD O
introduced VBN O
into IN O
the DT O
same JJ O
allele NN O
, , O
it PRP O
had VBD O
decreased VBN O
activity NN O
. . O

Thus RB O
, , O
the DT O
combination NN O
of IN O
a DT O
unique JJ O
mutation NN O
and CC O
polymorphism NN O
causes NNS O
conformational JJ O
change NN O
in IN O
the DT O
GALC NNP O
enzyme NN O
, , O
resulting VBG O
in IN O
low JJ O
enzymatic JJ O
activity NN O
. . O

AO NNP B-Disease
- : I-Disease
GLD NNP I-Disease
mutations NNS O
, , O
including VBG O
those DT O
found VBN O
here RB O
, , O
are VBP O
located VBN O
in IN O
the DT O
N NNP O
- : O
terminus NN O
( ( O
I66M NNP O
, , O
G270D NNP O
, , O
535 CD O
- : O
573del CD O
) ) O
or CC O
C NNP O
- : O
terminus NN O
( ( O
L618S NNP O
) ) O
of IN O
the DT O
GALC NNP O
enzyme NN O
, , O
whereas IN O
the DT O
reported JJ O
mutations NNS O
in IN O
the DT O
infantile JJ O
form NN O
( ( O
IF NNP B-Disease
- : I-Disease
GLD NN I-Disease
) ) O
are VBP O
in IN O
the DT O
central JJ O
domain NN O
. . O

This DT O
difference NN O
in IN O
mutation NN O
sites NNS O
may MD O
affect VB O
the DT O
clinical JJ O
features NNS O
of IN O
GLD NNP B-Disease
. . O
